<SEC-DOCUMENT>0000950170-23-017180.txt : 20230503
<SEC-HEADER>0000950170-23-017180.hdr.sgml : 20230503
<ACCEPTANCE-DATETIME>20230503161125
ACCESSION NUMBER:		0000950170-23-017180
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230503
DATE AS OF CHANGE:		20230503

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cerevel Therapeutics Holdings, Inc.
		CENTRAL INDEX KEY:			0001805387
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39311
		FILM NUMBER:		23883833

	BUSINESS ADDRESS:	
		STREET 1:		222 JACOBS STREET
		STREET 2:		SUITE 200
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		844-304-2048

	MAIL ADDRESS:	
		STREET 1:		222 JACOBS STREET
		STREET 2:		SUITE 200
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARYA Sciences Acquisition Corp II
		DATE OF NAME CHANGE:	20200303
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cere-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-05-03T16:04:21.7601+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cere="http://www.cerevel.com/20230331" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:srt="http://fasb.org/srt/2022" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-Q</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_90652cbd-aba8-4da1-8f12-b942c9f78721" name="dei:AmendmentFlag" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc">false</ix:nonNumeric><ix:nonNumeric id="F_8b2f3ca7-5df0-4c8a-96a7-fab3196d2c54" name="dei:DocumentFiscalPeriodFocus" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc">Q1</ix:nonNumeric><ix:nonNumeric id="F_5336dde7-7794-4979-8692-87d01f808589" name="dei:CurrentFiscalYearEndDate" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc">--12-31</ix:nonNumeric><ix:nonNumeric id="F_1f0cf8c7-35f8-4a8d-a01c-7fb92edd3948" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" contextRef="C_7913329b-0f1d-4200-bcd9-ef012e06c589">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</ix:nonNumeric><ix:nonNumeric id="F_02e0c39f-59cf-48e1-9099-37cdf410d6fd" name="dei:EntityCentralIndexKey" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc">0001805387</ix:nonNumeric><ix:nonFraction id="F_9feb81ed-2327-49d3-b434-e491e2b47f86" name="us-gaap:CommitmentsAndContingencies" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_cb1cf151-7d70-41f6-97dd-2800ab13dd5b" name="us-gaap:PreferredStockValue" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_6b4c346b-dbd4-43a8-9bdb-1f8c976acb19" name="us-gaap:CommitmentsAndContingencies" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_293c1bd4-3ed9-476f-92d6-7047da56d7a9" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList" contextRef="C_7913329b-0f1d-4200-bcd9-ef012e06c589">http://fasb.org/us-gaap/2022#OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax</ix:nonNumeric><ix:nonFraction id="F_8d1f5bfe-2f8b-4ace-a39c-60af1cf31d5c" name="us-gaap:PreferredStockValue" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" unitRef="U_USD" xsi:nil="true"></ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="cere-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_9eb38bce-595b-4efe-9ff4-a8a9196c17ff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5b04eb63-d32d-4cf7-8974-ef0d2c24455d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c8cfcc32-37ee-4a6c-b545-88aa98593ba7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1dcf3112-c3d6-445f-a9b1-a8a6aff84cd0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d2d20274-f65b-4fa5-8e5b-96f09f3d8fb8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e73b579d-5fcf-44e9-b4bd-a01478ea5126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4196d9fb-4e85-48d1-88b7-aefa2a19ebc8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e18c341f-7f07-4b88-b7c8-d5a4564e49f7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3cc8784c-e0c6-4b6a-85e8-a6747b0ab075"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8a957d0a-6024-4753-9804-3a0360e90e6b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_623d5c61-4653-419b-bf3c-247bbbbcf873"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ba176f35-ab1c-4a1b-9969-20f064b37357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_284250e0-ecad-485e-b02c-3498eba26ca3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cere:CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_55492269-e353-457a-9ac6-63c9a890f5a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e2cf588c-4935-44e7-a87b-fcb9e12be2cd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b7ca6fdd-c4aa-4736-9d2f-d4a2eadbaeb1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ab2f0a63-9c4c-4701-a647-f506a160b8d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestFundingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0729e16b-d27b-4daf-a728-90d90397b869"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:FirstAnniversariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1cc94817-d461-46f2-8d51-8d0b51788032"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4555fd95-af90-4446-9ef6-c7bf5c673ad1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d181ad3b-847c-47c7-bf08-243985685e37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dffe9ddc-8c99-41f9-a548-0172f9e0b2c2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestFundingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4872d125-2e56-4840-bde3-171e61b545d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2ff3f43c-87c0-4d83-99a4-d515d051d791"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d24b1d9c-01d0-4045-a903-8d6fc008d906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d05795e8-7fcc-4338-a3c6-f89d386c6435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestAndBainFundingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_db439bc0-f8f4-4c4e-9791-8b83a63b6885"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d68c6b2b-198c-4278-b56f-a68363510239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_40a019d3-e92f-4c7b-9557-6132ab2cd1c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca7f0c1c-48d7-455e-8ddc-e9b062b461a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_135ea648-306c-40d9-860b-a47360a9895c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1972858f-eae0-4299-8170-ba14d09bef4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">cere:RestrictedCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_effc1829-ed70-4ee5-8e04-afb0f9066e16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5b90efb7-656c-4625-b566-b99e3e6f4649"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c79a6dff-9b2a-4bbe-893e-f8d5995f53c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_75cbd078-eab8-4a1a-b86f-1ede351b764b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_99242e6a-e59a-4179-94bd-0b1937c5d461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestAndBainFundingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dd4efdc2-f871-4164-b259-04d75db7dd0a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9e127b71-4539-48d9-9d6b-1b9b6c4de7ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NASDAQIndexFutureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2029d649-08bb-4a87-a177-143045bff540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:FirstAnniversariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ecd82ae5-371b-498f-b1a6-1a95342b510d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bc22ae5e-bffd-445a-9a22-d08330898d6b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_60585c7b-083d-43f2-85ea-156ce6ac7bb8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_70d32b8b-7e10-4e7b-864c-8890ec4855c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2d54aabe-0480-4ce2-84e7-c3be541b8858"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">cere:PurchaserDiscountsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2713ad4a-1c03-4894-a1bc-032d17c08682"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_549c1b5b-f5c0-43b3-aeb2-af8128f7fddd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">cere:RestrictedCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f130d7e4-71de-45ed-8562-45858d825a2a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:SecondAnniversariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_529612ad-d864-4e48-8033-b7bbacbe0414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_834332ad-3dba-4592-8eb7-930c35444385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_54aef7f2-adfa-458b-a966-d50f782d3ddd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_abd57310-685b-4fc9-a762-295bbda69277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d374cc27-3d6a-4e93-87c5-2393b48f37f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:LongTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d366786f-fe3c-4859-907c-c7fecd5cc013"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bbe2ff29-60a6-4d1c-adfd-2653531ce2b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5bf423a6-8367-4279-bf95-e9c42308340c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_47e15855-977e-48e9-91e6-f3cd78249b53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4d6806dd-95ea-4244-b45f-b725e95152fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_75c3c100-0b73-4ef8-af8d-e6ea2c2b07ee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6d74330b-6d7c-493a-b8a3-9eb0e26049d9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputInceptionDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1c59bb28-7d9d-41f1-a3e6-9fdb1e61a326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3632aac0-7ea4-476f-ae3c-22fcfd7d2a0b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d4d1c9e3-62ea-42c4-ba8d-fcc51bb68150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestAndBainFundingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_12bb81cc-4118-4eec-9061-466a6e2d707f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cee0bc25-bebb-4a35-9362-2d58a9e6a342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:LongTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_15c8f494-814b-44c7-b085-58997b57d0ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5b514de5-a814-4d92-a947-476c997998cd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_62dad9f2-d603-4b31-9fef-bda26f8a826b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a2a1794f-7768-4f98-8c78-709345fc1417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_77182ead-68f3-4560-a065-2b0a465b0858"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7d230bc1-cefa-46e4-a861-24a211270b6e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">cere:MeasurementPeriodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7c3a2ba3-5a06-4c1a-8098-9614f0f55d00"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cere:ESPPSharesIssuableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d7e7b52c-2a39-4e61-89ff-8d10c8cb2f4b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_46d1eb9f-1608-412b-a122-ad9ff076c478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_33aaf712-2416-4ca9-a789-bdc80db6c833"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cere:AtmProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-10</xbrli:startDate><xbrli:endDate>2021-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_45210d29-9cd0-45f9-a714-edc3c13d8747"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestAndBainFundingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_21573dc6-6769-41aa-991d-b0f72b895688"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fec256c3-1d62-4da5-88de-9f274918ad60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_35f07075-ec20-4015-be83-0dc61fc1e438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5d000a15-9017-476b-9666-76dc3f8dd464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a4c793ea-57ae-4e0f-8312-eeac8baf5953"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2e9e51f7-25c0-4608-9ac4-8d13311a476a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cere:BainInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4bf2f962-7b29-42b6-974d-afe70add4992"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cad0267b-ea1e-4815-90e2-2028b29f8fc4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d0b1fde3-c686-4afd-a78c-adda507ab1d7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f1ad0af9-f8fb-47b4-9d88-2f035f335eb7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2ea39b76-7e86-4e9f-a3aa-1c43d8682c03"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cere:FinancingLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bdc36db1-2f84-4df3-9e62-252cc883a96c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c19150ee-ddf1-4d6e-b02f-c9d1f4985998"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">cere:OtherOfferingExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0a7718ed-8940-4540-a71e-a8480e029877"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_03207e80-ade5-41d3-ab71-391279e55fcc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">cere:RestrictedCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_533da935-ec87-4ed2-a0b1-6924af3f7975"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6ce49664-9b3e-4193-9202-c337a0a78589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_84a4ec65-be81-43b0-a2a8-aeab6b151380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cere:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5f8f5a42-ba06-4506-a0cc-bf786204f23c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4b64ecbc-3995-4a70-91be-00b3cba9da84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputInceptionDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8e7da2d2-92f1-43a3-bb9a-1d0277243751"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_23d05b6e-4f80-4669-8884-9503ff410b15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3479d27f-e186-4ab3-8410-a1a5d7ecfb11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_616d2b60-239d-4254-9414-de1400659e3e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestAndBainFundingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_174d7111-d0da-45ff-818a-2c32e6395735"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_67e3ff37-67dc-425c-9e5c-f367e23d4a36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7e166e56-61db-491e-be50-d60c4a5deb31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">cere:MeasurementPeriodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ff391d2b-6167-4ca8-b599-0176b18ff847"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_27a1eff3-cd98-489c-bf8d-10b9567d6a6f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9d7b2424-bafc-4343-b726-7e736ab93480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:ManagementAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7913329b-0f1d-4200-bcd9-ef012e06c589"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cere:FinancingLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b465d2c0-b208-43d9-8601-c79cda11d054"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_286de79d-0111-4ffc-942c-17519af10505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cere:AtmProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e5a1da7f-71cc-44ee-bf79-5b4c0a66ac10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cere:PfizerLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_89bb3f05-5b57-4cd0-a75d-a5ee2689d120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f46ced43-7a95-48b1-a3d2-c0ef57876a31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">cere:RestrictedCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4651d696-b2be-4638-8c92-24388e05ccf4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a5c731ba-b89c-4f18-9704-24f50e1a5925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5bed7e0c-dacd-4d4c-b250-020234b8f6be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a1b4107b-3ed7-40e8-9ad5-1379b770ce94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0cfe1f22-841b-4d40-be3c-5ab39c7eeed7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7926166c-1158-47a0-bad4-4df4c981c1ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cere:PfizerIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e9e3b32d-3528-4ff7-ad8b-b7449522bd16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_14d54740-4fd0-463e-8f77-ee503f66ded0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ddc57f0c-b90e-42fa-a10e-071a42e87507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cere:PfizerIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca5c0abd-f008-4c84-a189-a21791b234a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8ac1ae72-06b1-4095-a857-71c8c60c5b47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:ThirdAnniversariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ccf68073-2afb-4b1e-ab7c-853f69243b41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5a48c315-c949-4b47-9d4e-d9576b76a0dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a4ba2f01-2e93-4b42-9142-63c99321d789"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:SecondAnniversariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ee2b045d-5198-451f-83dc-eabf28665da6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c290d454-3c40-474b-a8cb-1192e1d1df68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3b482e46-cc89-4ce5-85f5-a366efdf2856"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_47e87e92-f44a-4427-9ca3-b597abbae8dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cere:BainInvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_be2d5f10-585c-4657-aa28-2c74500e83d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestFundingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_59a5c3ef-611c-4d06-809f-b96bb1ad592d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0b7810a3-d9b7-44b1-85d6-d1e3794eb8db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_57afd6d7-6dec-4c48-81b7-57d06bc6ff76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:ResearchCollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7297b579-f439-4a6b-92e5-a571272517af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cere:FinancingLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_92b2e51b-74ba-476d-a0bb-1a6c588851a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_516c25bf-7ea1-4aa4-a5d3-a5bed62d8860"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4cf7a89b-841c-4850-9973-eddacfecc0f0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cere:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fcc62a3a-53fa-4dc4-ae07-5eb1877c37d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_377cdbcd-01a6-4d76-a487-4dc2f01fee00"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_899c628a-be1d-4d05-b35c-2e06c2ed5337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8bc95105-86e8-4b58-bd13-577576fe83fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cere:ESPPSharesIssuableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8c284975-2e05-4ee0-a774-8114aaf9d295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2e7c8a68-2e85-4e0d-844b-1b1c499fef1f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_68912430-91ed-4690-8c20-dc2d611fbea4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bfd4f2a5-80b4-4cd6-9aa0-3d4d61332a45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0cd9a4b8-d9bd-4d67-875a-67846552b346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cere:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4929b4e3-f0dd-4495-b868-bcea2881f576"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e16b464e-4443-4323-83d1-f03a4129c2e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f76fd2db-e57c-466d-8c84-9a10342d867c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a7ea4b46-178f-4956-8746-80498e54c789"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cere:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4a52621-de21-4dff-a35d-fe8c89899498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_47e0732b-5a0a-4840-a434-85dd5768ae62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8de10066-7b96-4965-9078-908525b6b838"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3e5cfe38-545f-4b20-972d-38ee76239160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c61bf99f-af2e-40be-861d-98e1836d9630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_911f321f-1399-42d6-924b-a7af11513555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f1a2b453-d388-477c-8259-cf29dcec39b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e39da301-bc58-44e7-8b68-aa3c32c22b3d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a7fd9625-1e0b-4179-bd94-31438f3f9f0b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_03e49eb8-2103-485e-b8d0-fe702ee84736"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d67b9c2b-3a7f-4577-b857-ad3a7dad44da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:ThirdAnniversariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_efca2e92-f443-4333-9998-77bef5b93ff9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_77c90c0f-d4ef-4cc7-bf3d-e8aba928ea56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_72953f01-6eb8-48e3-9861-55ca4de20b51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a2e21f3d-b1a6-4ed0-b2c3-cd5451e8a75c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001805387</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_USDollarShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_Director"><xbrli:measure>cere:Director</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Instrument"><xbrli:measure>cere:Instrument</xbrli:measure></xbrli:unit><xbrli:unit id="U_Days"><xbrli:measure>cere:Days</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <p style="border-top:2.25pt double;padding-top:1.0pt;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Washington, D.C. 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;border-bottom:0.5pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:16.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_75103e70-76a9-4576-8efc-1701f3c6a07a" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;border-bottom:0.5pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Mark One)</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:4.0%;"></td>
    <td style="width:96.0%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_75e94afe-87ac-4604-a944-756025ff41c2" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the quarterly period ended </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_068733f9-afe1-4425-90ef-983bd4e168c7" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_abed7561-cf6f-4166-b930-2deb2d31eb0f" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:DocumentFiscalYearFocus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OR</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:4.0%;"></td>
    <td style="width:96.0%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ac2375b2-66b6-4491-8f39-d62d696530e4" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the transition period from _________________ to  _________________</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commission File Number: </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4f715c8f-e906-4114-8007-34521c405442" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">001-39311</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;border-bottom:0.5pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:14.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_530c99dc-49bf-49b5-bdff-022bdf79555d" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CEREVEL THERAPEUTICS HOLDINGS, INC.</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of Registrant as specified in its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;border-bottom:0.5pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:50.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ac2f062c-e28e-48aa-86c6-9653e917e9db" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0d1c50b4-bd1f-404d-8bf5-9f7308d125f6" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85-3911080</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">incorporation or organization)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(I.R.S. Employer</span></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1ee7fd72-9828-4f4d-9755-f51637b437d5" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">222 Jacobs Street</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b6c74ff6-1e58-4745-87f9-978352323fdd" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Suite 200</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9bba832f-6732-41ea-9f33-267db529f89b" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cambridge</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_eea85f43-a2fc-42fa-b717-be4295e2f0de" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityAddressStateOrProvince"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MA</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8ef9b18a-9b24-4a10-b4a5-8b71a2b5db7d" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">02141</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s telephone number, including area code: (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2219b12c-f8c5-4274-9b91-bbd0d1827727" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">844</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9bfc661f-ee34-4872-bb77-729e90567a84" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">304-2048</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:3.0pt;border-bottom:0.5pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:5.333%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:39.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:20.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:39.0%;"></td>
   </tr>
   <tr style="height:26.65pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_25a9cf9b-606d-4eb9-9434-cd990bf04756" contextRef="C_ccf68073-2afb-4b1e-ab7c-853f69243b41" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fa098cce-4251-4313-aa1f-1c10f192ec5f" contextRef="C_ccf68073-2afb-4b1e-ab7c-853f69243b41" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERE</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_28a75c17-c977-404e-a05c-3730150f28e8" contextRef="C_ccf68073-2afb-4b1e-ab7c-853f69243b41" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The NASDAQ Stock Market LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:5.333%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_19eae25a-c9b2-403f-89ec-7dc62afce01e" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityCurrentReportingStatus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">    No  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:5.333%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_60583fd2-8d63-4843-8d80-3cf72edeb6a1" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityInteractiveDataCurrent"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">    No  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:5.333%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:21.04%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:52.72%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:21.06%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:2.18%;"></td>
   </tr>
   <tr style="height:10.8pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6781c756-bcaf-4473-9b24-df8b91e03f17" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Large accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f76de658-f1d3-433c-ab78-5369c1c1471b" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Wingdings&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_81226095-60fa-4880-bc27-4cb0f5e1eb55" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:5.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:5.333%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">    No  </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_56fea903-43e5-4933-a59c-9af7854ffece" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="dei:EntityShellCompany" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="text-indent:5.333%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of April 28, 2023, the registrant had</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c9d6d9c3-8888-4b70-927e-cda75442daaf" contextRef="C_03e49eb8-2103-485e-b8d0-fe702ee84736" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">156,832,992</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shar</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">es of common stock, par value $0.0001 per share, outstanding.</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Table of Contents</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:10.1%;"></td>
    <td style="width:82.82%;"></td>
    <td style="width:7.08%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART I.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_ifinancial_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FINANCIAL INFORMATION</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1_financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statements (Unaudited)</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#condensed_consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Condensed Consolidated Balance Sheets</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#condensed_consolidated_statements_operat"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Condensed Consolidated Statements of Operations and Comprehensive Loss</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#stockholders_equity"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Condensed Consolidated Statements of Stockholders' Equity</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#condensed_consolidated_statements_cash_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Condensed Consolidated Statements of Cash Flows</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#notes_to_condensed_consolidated_financia"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notes to Condensed Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_2_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_3_quantitative_qualitative_disclosu"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_4_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART II.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_ii_other_info"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OTHER INFORMATION</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_2_unregistered_sales_equity_securit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_3_defaults_upon_senior_securities"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Defaults Upon Senior Securities</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_5_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 6.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_6_exhibits"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Signatures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">i</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;" id="special_note_regarding_forwardlooking_st"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CAUTIONARY</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain statements in this Quarterly Report on Form 10-Q, or this Quarterly Report, may constitute &#x201c;forward-looking statements&#x201d; for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team&#x2019;s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words &#x201c;anticipate,&#x201d; &#x201c;believe,&#x201d; &#x201c;contemplate,&#x201d; &#x201c;continue,&#x201d; &#x201c;could,&#x201d; &#x201c;estimate,&#x201d; &#x201c;expect,&#x201d; &#x201c;intends,&#x201d; &#x201c;may,&#x201d; &#x201c;might,&#x201d; &#x201c;plan,&#x201d; &#x201c;possible,&#x201d; &#x201c;potential,&#x201d; &#x201c;predict,&#x201d; &#x201c;project,&#x201d; &#x201c;should,&#x201d; &#x201c;will,&#x201d; &#x201c;would,&#x201d; &#x201c;can,&#x201d; &#x201c;target,&#x201d; &#x201c;future&#x201d; or the negative of these terms or similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Quarterly Report may include, for example, statements about:</span></p>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the format, objectives, likelihood of success, cost and timing of our clinical trials and other product development activities, including the design of clinical trials and preclinical studies, the timing of initiation and completion of clinical trials and related preparatory work, our ability to collect and interpret clinical trial data and the timing and outcome of regulatory interactions, including whether trials meet the criteria to serve as registrational;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to recruit and enroll suitable patients in our clinical trials;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential attributes and benefits of our product candidates;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain and maintain regulatory approval for our product candidates, and any related restrictions, limitations or warnings on the label of an approved product candidate;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain funding for our operations, including funding necessary to complete further development, approval and, if approved, commercialization of our product candidates;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the period over which we anticipate our available financial resources will enable us to fund our operating expense and capital expenditure requirements;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential for our business development efforts to maximize the potential value of our portfolio;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to identify, in-license or acquire additional product candidates;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to maintain our license agreement with Pfizer;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to compete with other companies currently marketing or engaged in the development of treatments for the indications that we are pursuing for our product candidates;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain and maintain intellectual property protection for our product candidates and the duration of such protection;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to contract with and rely on third parties to assist in conducting our clinical trials and manufacturing our product candidates;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size and growth potential of the markets for our product candidates, and our ability to serve those markets, either alone or in partnership with others;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the rate and degree of market acceptance of our product candidates, if approved;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the pricing and reimbursement of our product candidates, if approved;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory developments in the United States and foreign countries;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the impact of laws, regulations, accounting standards, regulatory requirements, judicial decisions and guidance issued by authoritative bodies;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to attract and retain key scientific, medical, commercial or management personnel;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our future financial performance;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to recognize the anticipated benefits of the tavapadon financing transaction (including our ability to receive future payments thereunder) and other financing and business development transactions; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to satisfy our payment obligations, remain in compliance with covenants under the 2027 Notes (as defined below), to service the interest on or to refinance the 2027 Notes or to make cash payments in connection with any conversion of the 2027 Notes, to the extent required; and</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effect of adverse market or macroeconomic conditions, market volatility resulting from global economic developments and the residual post-COVID environmental and other factors on any of the foregoing or other aspects of our business operations, including but not limited to our clinical trials and other product development activities, healthcare systems and the global economy as a whole.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ii</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The forward-looking statements contained in this Quarterly Report are based on current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the section titled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risk Factors</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; of this Quarterly Report. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. There may be additional risks that we consider immaterial, or which are unknown. It is not possible to predict or identify all such risks. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You should read this Quarterly Report completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Quarterly Report contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed as exhibits to this Quarterly Report. Unless the context otherwise requires, reference in this Quarterly Report to the terms &#x201c;Cerevel,&#x201d; &#x201c;the Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; and similar designations refer to Cerevel Therapeutics Holdings, Inc. and, where appropriate, our consolidated subsidiaries.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may from time to time provide estimates, projections and other information concerning our industry, the general business environment, and the markets for certain diseases, including estimates regarding the potential size of those markets and the estimated incidence and prevalence of certain medical conditions. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties, and actual events, circumstances or numbers, including actual disease prevalence rates and market size, may differ materially from the information reflected in this Quarterly Report. Unless otherwise expressly stated, we obtained the industry, market and competitive position data from our internal estimates and research, as well as from independent market research, industry and general publications and surveys, governmental agencies and publicly available information in addition to research, surveys and studies conducted by third parties that have not been independently verified which may, in the future, prove not to have been accurate.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SUMMARY OF MATERIAL RISKS ASSOCIATED WITH OUR BUSINESS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business is subject to numerous risks and uncertainties that you should be aware of before making an investment decision, including those highlighted in the section entitled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risk Factors</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.&#x201d; These risks include, but are not limited to, the following:</span></p>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The successful development of pharmaceutical products is highly uncertain.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biopharmaceutical company with a limited operating history. We have incurred significant financial losses since our inception and anticipate that we will continue to incur significant financial losses for the foreseeable future.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will need substantial additional funding, and if we are unable to raise capital when needed, we could be forced to delay, reduce or terminate our product discovery and development programs or commercialization efforts.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due to the significant resources required for the development of our pipeline, and depending on our ability to access capital, we must prioritize the development of certain product candidates over others. Moreover, we may fail to expend our limited resources on product candidates or indications that may have been more profitable or for which there is a greater likelihood of success.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business is highly dependent on the success of our product candidates. If we are unable to successfully complete clinical development, obtain regulatory approval for or commercialize one or more of our product candidates, or if we experience delays in doing so, our business will be materially harmed.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The regulatory approval processes of the U.S. Food and Drug Administration, or the FDA, and comparable foreign authorities are lengthy, time-consuming and inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for our product candidates, our business will be substantially harmed.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If our clinical trials fail to replicate positive results from earlier preclinical studies or clinical trials conducted by us or third parties, we may be unable to successfully develop, obtain regulatory approval for or commercialize our product candidates.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may incur unexpected costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of our product candidates.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">iii</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if any of our product candidates receives regulatory approval, it may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success, in which case we may not generate significant revenues or become profitable.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competitive products may reduce or eliminate the commercial opportunity for our product candidates, if approved. If our competitors develop technologies or product candidates more rapidly than we do, or their technologies or product candidates are more effective or safer than ours, our ability to develop and successfully commercialize our product candidates may be adversely affected.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We depend heavily on our executive officers, third-party consultants and others and our ability to compete in the biotechnology and pharmaceutical industries depends upon our ability to attract and retain highly qualified managerial, scientific and medical personnel. The loss of their services or our inability to hire and retain such personnel would materially harm our business.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">BC Perception Holdings, LP, or Bain Investor, and Pfizer Inc., or Pfizer, have significant influence over us, and may have interests different from yours.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on third parties to assist in conducting our clinical trials. If they do not perform satisfactorily, we may not be able to obtain regulatory approval or commercialize our product candidates, or such approval or commercialization may be delayed, and our business could be substantially harmed.</span></div></div>
  <div style="margin-left:6.667%;text-indent:0.0%;display:flex;margin-top:3.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We depend and expect in the future to continue to depend on in-licensed intellectual property. Such licenses impose obligations on our business, and if we fail to comply with those obligations, we could lose license rights, which would substantially harm our business.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The risks described above should be read together with the text of the full risk factors discussed in the section entitled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risk Factors</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; and the other information set forth in this Quarterly Report, including our condensed consolidated financial statements and the related notes, as well as in other documents that we file with the Securities and Exchange Commission, or the SEC. The risks summarized above or described in full elsewhere in this Quarterly Report are not the only risks that we face. Additional risks and uncertainties not presently known to us, or that we currently deem to be immaterial may also materially adversely affect our business, financial condition, results of operations and future growth prospects.</span></p>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">iv</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_ifinancial_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART I&#x2014;FINANCI</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AL INFORMATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1_financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1. Financi</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">al Statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CEREVEL THERAPEUTICS HOLDINGS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="condensed_consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONDENSED CONSOLIDA</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TED BALANCE SHEETS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands, except share amounts and per share data)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Unaudited)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:64.718%;"></td>
    <td style="width:1.742%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.899000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.742%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.899000000000001%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br />2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br />2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="8" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASSETS</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current assets:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cfbca051-bb0d-42d1-b430-38ee27267083" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">153,816</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b4b363ab-9bf0-4b82-ba49-faeee02ec7b2" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">136,521</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_71f0dae9-3610-4f86-a16a-02762621695e" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">673,171</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_37255516-423f-48cd-991d-5cfb433b6163" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">755,509</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1bbfc296-4d42-404d-84d0-e8b478f96967" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,795</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1ba2c285-529e-4e86-a6a9-c25c905955d4" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,621</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_df75cff0-92d0-4ae1-8880-beea39a04721" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">840,782</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a0288849-d172-4e55-bc8c-0e84f3edd0c0" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">905,651</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b7f3abfa-807c-42bb-82de-4af107230275" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,048</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c6895d91-03e5-4868-a540-3ecab21f2196" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,126</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_23e9a090-d40f-49ef-9b30-9d83f57770dd" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,006</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7fb3187c-6d18-4fe8-931f-af4a8c6c4d3d" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,467</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2df0191-abcc-4c9d-8363-f5707f072526" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,434</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5827fd02-1a65-43e7-8924-64556effd591" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,820</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c38cc3d5-9301-4c76-9259-589b76254c7f" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,867</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b0927f6b-8f0a-400c-975e-e4f287d2ca38" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,867</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other long-term assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1c71a8a5-8dec-4468-a3f2-9a36a2ed5550" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,208</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6be01824-6f50-48d8-bf3d-a15b8e5b8a17" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,891</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4f7b79a2-3216-4473-a00b-b153c9972250" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">930,345</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0ad325df-d2b3-49e9-b73d-e2659212f2f8" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,017,822</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="8" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_26802546-d14b-4901-9658-128374b6ad2c" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,315</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9afbd405-404a-480b-8ef9-d5e22593c331" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,061</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8671cfbc-4e6b-47fa-b978-701b479936df" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52,614</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6567461d-fce8-40c9-9530-dd0dccef0dd6" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,604</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities, current portion</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_19a1efa0-0dee-4979-8050-9e6b8bda602c" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,028</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_96a3d632-d0ef-41fe-a68d-bfd91c4bd283" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,899</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f56bfeb8-bdc9-4772-b29b-0c486167c4f7" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62,957</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73553e36-0182-443b-b549-b79fa9727754" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">72,564</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93d9b518-bf29-417b-81b1-f5de532759af" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,381</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ae2d2cc-06bc-455a-9630-c109e31c1c2b" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,190</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability, related party (Notes 5 and 7)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_832d5ba0-eb11-4167-a1ed-bf3d7d5f6d2c" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="cere:NoncurrentFinancingLiabilityRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">34,668</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_684599c6-b7a2-44cf-ad9a-6caf0d9a774e" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="cere:NoncurrentFinancingLiabilityRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,674</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability (Notes 5 and 7)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6d716446-a3ea-4f2c-9720-278fac3bd6cd" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="cere:NoncurrentFinancingLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">34,668</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7dea0715-1449-43d0-ad7f-6c5acbdc4879" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="cere:NoncurrentFinancingLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,674</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027 convertible senior notes, net (Note 6)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ea6818f-c02b-4c72-9ee3-dd00421bc5ae" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:ConvertibleDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">335,962</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6276d808-3c32-4743-83a2-c635b131c150" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:ConvertibleDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">335,482</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_623beedc-b673-4e44-8238-7c70f0c5c4c5" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">498,636</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f5cb2647-2de4-4a6b-8c5d-436f1f6bbffa" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">496,584</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_6b4c346b-dbd4-43a8-9bdb-1f8c976acb19;"><span style="-sec-ix-hidden:F_9feb81ed-2327-49d3-b434-e491e2b47f86;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commitments and contingencies (Notes 13 and 14)</span></span></span></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stockholders&#x2019; equity:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred stock, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad02f887-8569-4803-8fa1-215145cf0deb" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_e601acf8-8cb6-4cca-8e45-e76692c76712" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value: </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3281a38c-f5eb-4a6d-b115-675fea11b893" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_33e34c55-556b-427f-990c-7e4f614ca8e7" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares authorized; <br />&#160;&#160;&#160;&#160;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ee0576ee-4c80-4baf-9791-51938f73dd7b" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_2e550b59-90c1-480c-9233-cd6232b0e330" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_84775c1b-4376-459b-bcfa-362711261f60" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_6b202d58-975b-41a2-968d-c9b7ce7e070a" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares issued and outstanding as of March 31, 2023 and <br />&#160;&#160;&#160;&#160;December 31, 2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_cb1cf151-7d70-41f6-97dd-2800ab13dd5b;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_8d1f5bfe-2f8b-4ace-a39c-60af1cf31d5c;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aec28300-8f6b-44c9-aa0a-806b2cfa9574" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_0e582e10-5497-48cb-8884-bf27a7e5fb96" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value: </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d1103d1-f1e0-454f-9c08-975ee953700a" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_18b71a3e-9a27-49ba-a60e-246089016ac9" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">500,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares authorized; <br />&#160;&#160;&#160;&#160;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73d342e3-91d7-4e77-9d9e-9f9ee5b4a887" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_fbc700ae-f0c3-453b-a8c6-9f5660e23fd9" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">156,760,109</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a95f4944-33e1-4763-915e-37f483aa621d" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_cb3bf84f-791c-4ef5-8211-0edcf464edc3" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">156,502,285</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares issued and outstanding <br />&#160;&#160;&#160;&#160;as of March 31, 2023 and December 31, 2022, respectively</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f37d2159-0cc2-4a27-964b-fefa105efddd" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_82e58756-259d-4dcd-8ccd-cf80dc70d18f" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ead3025b-1f8a-4b7d-b302-6fb06b4ed818" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,500,046</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_58695340-5705-4d2c-ac6a-5239ee6d6a1e" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,485,880</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated other comprehensive income (loss)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc9e5b43-123b-425c-987f-d800d055264d" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,688</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_56ada548-aac1-4853-92fd-28f6cfaa82f9" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,097</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c035bfa1-cdf6-4459-80cc-da3b844b0ddc" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,072,041</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b0f4fe91-00f5-4349-9e62-ca5702cdf4cd" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">967,755</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stockholders&#x2019; equity</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0804a877-b0cb-4407-aff6-573d46e0851a" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">431,709</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f4e94a6c-39d7-4e0a-bcf9-fd4e87a09569" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">521,238</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities and stockholders&#x2019; equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4c7543e9-2643-4080-ada2-1cb1492378d7" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">930,345</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8d55e0a5-f927-4d89-82ed-161dc474a606" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,017,822</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CEREVEL THERAPEUTICS HOLDINGS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="condensed_consolidated_statements_operat"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONDENSED CONSOLIDATED STATEMENTS OF</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> OPERATIONS AND COMPREHENSIVE LOSS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands, except share amounts and per share data)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Unaudited)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:64.718%;"></td>
    <td style="width:1.742%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.899000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.742%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.899000000000001%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cdb66670-ce73-4215-a838-e169bdb14f29" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">78,181</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_63195a2a-83f9-4d5a-bcdd-2336c47a1412" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">55,023</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2faa554-64e0-46cc-a274-b98abfa11756" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,370</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3e10127-2795-463c-883c-3a54790b5f7b" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,507</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_48f2efb3-f7a3-4d1c-bede-dbc6f27a9968" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">99,551</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77b51da4-085e-416c-8537-61e01ba1740f" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">72,530</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_54a01dd8-5e04-41e6-a642-a436f2c87c97" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">99,551</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c24d952e-c52c-4e21-b4c1-0ea706da0635" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">72,530</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income (expense), net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_de8cb691-f0e1-40aa-86f6-894df1611d44" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:InterestIncomeExpenseNonoperatingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,440</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_acd75dae-f7f0-435d-a00a-604e4a1f5b85" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:InterestIncomeExpenseNonoperatingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">295</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3f34e9fa-2050-456a-8e5a-555fe2952ad9" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">11,090</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b88e1435-0670-4bac-811f-1d337fc805fd" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,941</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss before income taxes</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dfe149b2-a97d-440a-a2b4-6a1af6e84057" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">104,201</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2261be07-35b4-4e4e-869e-1d4c3550fbdb" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,294</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax benefit (provision), net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9e3097a7-e153-49a4-b55c-6dbfb03abf0c" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">85</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_32f3a1a3-d6dd-4104-9260-c6099fad0a50" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">104,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_46e60938-ecf0-45cc-b0df-273b70b93999" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,294</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_31573b50-bca5-4408-8009-acd7056d7fb4" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:EarningsPerShareBasic" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_a2654d77-6eba-4b67-bee8-9485636e9cb3" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:EarningsPerShareDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">0.67</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fd4f78ac-e889-4954-8d13-e2d9f294dcb3" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:EarningsPerShareBasic" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_b9c04907-8244-4548-a95a-932095b589f3" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:EarningsPerShareDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">0.46</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-average shares used in calculating net loss per share, basic and diluted</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f522bc3a-5f11-40d5-9020-6e35bfe1c4f6" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_1ea41f45-dcf9-466a-b366-9ee856350c71" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">156,648,365</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bce14634-9cd3-4639-8d68-17eee2bc0a81" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_7d46053c-76b1-42ec-bf52-b43ea7ad317e" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">147,984,926</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_38af907c-6782-453b-a16b-314e4c48a303" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">104,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b1dc4b61-4e35-4327-bc25-462d23fc8a3c" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,294</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive income (loss):</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in fair value attributable to instrument-specific credit risk</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_37c69656-0861-4d9a-99a2-635bbfffab02" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">906</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_23e4d695-2798-4711-b065-7743e1efa7f4" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,276</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized gains (losses) on securities available-for-sale</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bcbef964-e4ae-4418-afc1-3de952194070" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,497</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_17dfb59c-a325-4952-b2a7-d66ee5e162d7" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,624</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total other comprehensive income (loss)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1baecce5-4411-4216-9d16-88c7dccd1167" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">591</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e9a690e-bc6d-4c5e-aec0-4f9464ba3f75" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">348</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_55c8e0e7-fb95-45ee-b133-5a98b7b68127" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">103,695</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c0f47288-5280-4184-8103-bbe2012bbbe1" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,642</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CEREVEL THERAPEUTICS HOLDINGS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="stockholders_equity"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONDENSED</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#x2019; EQUITY</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands, except share amounts)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Unaudited)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:36.522%;"></td>
    <td style="width:1.003%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.927999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.103%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.407%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.103%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.407%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.103%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.407%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.103%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.407%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.103%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.407%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional<br />paid-in</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated other<br />comprehensive</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total<br />stockholders&#x2019;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">income (loss)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">deficit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73571c5e-30fd-4fd3-b831-121db6f409a6" contextRef="C_62dad9f2-d603-4b31-9fef-bda26f8a826b" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">156,502,285</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5b73b79b-793a-4104-ada1-af32e3b3475e" contextRef="C_62dad9f2-d603-4b31-9fef-bda26f8a826b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b7a15b3e-1e5a-4e8c-9e8f-2afea543132f" contextRef="C_cad0267b-ea1e-4815-90e2-2028b29f8fc4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,485,880</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_217cdc74-f31d-4af5-b7f7-d98219256d97" contextRef="C_3632aac0-7ea4-476f-ae3c-22fcfd7d2a0b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,097</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_46652bd5-78e9-41f9-aa80-1c5d69a6f642" contextRef="C_bbe2ff29-60a6-4d1c-adfd-2653531ce2b5" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">967,755</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ff555382-bef5-4a3c-bae9-269fb0e8d515" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">521,238</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock under equity incentive plans related to exercise of options</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7ed34278-bd6d-4c4d-acab-d928fe9c7760" contextRef="C_ccf68073-2afb-4b1e-ab7c-853f69243b41" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">257,824</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_59f4ef4e-0b2e-4c9d-97ba-0a4b5d1da8ec" contextRef="C_47e15855-977e-48e9-91e6-f3cd78249b53" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,574</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d69c4310-282d-4a60-b448-abf82d0dca5d" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,574</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity-based compensation expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_91e3bbae-00d6-4f22-ad89-b2954f1ddc7c" contextRef="C_47e15855-977e-48e9-91e6-f3cd78249b53" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,592</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dae2af9e-7bfe-4325-84c4-9d8b9d382224" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,592</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive income</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a4418cb-b862-46b8-8a75-bbcf96ac0140" contextRef="C_75c3c100-0b73-4ef8-af8d-e6ea2c2b07ee" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">591</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_39e9ff96-41a7-4d74-a697-bcb5df3382ae" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">591</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ffde6315-dc76-4729-ba97-99d4cfdb5152" contextRef="C_5a48c315-c949-4b47-9d4e-d9576b76a0dc" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">104,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d292d3a9-a14d-4834-b14d-790c08f7f37d" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">104,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at March 31, 2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ebc8f0c3-3502-40e6-b5b6-3df7aa693110" contextRef="C_135ea648-306c-40d9-860b-a47360a9895c" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">156,760,109</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cc4ccac5-07ef-4068-9c81-d982c3a14158" contextRef="C_135ea648-306c-40d9-860b-a47360a9895c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_97042799-5ec5-4aa9-a66b-462abe1fca19" contextRef="C_2e7c8a68-2e85-4e0d-844b-1b1c499fef1f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,500,046</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c77c6c65-3163-49b9-8f1f-868534ae5b09" contextRef="C_70d32b8b-7e10-4e7b-864c-8890ec4855c4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,688</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2280f85f-6edb-4408-986c-e5480b91c1ac" contextRef="C_3cc8784c-e0c6-4b6a-85e8-a6747b0ab075" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,072,041</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ac9def5-f321-4dce-9db7-3695de28bd9e" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">431,709</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CEREVEL THERAPEUTICS HOLDINGS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#x2019; EQUITY</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands, except share amounts)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Unaudited)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:36.891%;"></td>
    <td style="width:1.003%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.949999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.023%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.4079999999999995%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.023%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.4079999999999995%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.023%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.4079999999999995%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.023%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.4079999999999995%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.023%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.4079999999999995%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional<br />paid-in</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated other<br />comprehensive</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total<br />stockholders&#x2019;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">deficit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b498f660-1dc4-4ad4-83a7-eb815e7d65ea" contextRef="C_516c25bf-7ea1-4aa4-a5d3-a5bed62d8860" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">147,719,523</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a1909352-9bc8-4c08-859b-484dcfec0f42" contextRef="C_516c25bf-7ea1-4aa4-a5d3-a5bed62d8860" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_37b9e594-5f18-48fd-bf7d-33b3b42f94f9" contextRef="C_bdc36db1-2f84-4df3-9e62-252cc883a96c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,195,944</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_45d17ed5-15c5-4503-9a48-7d0da4477330" contextRef="C_ff391d2b-6167-4ca8-b599-0176b18ff847" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">986</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_61a68d85-41e6-45e3-9b68-ffbefe5977e0" contextRef="C_0b7810a3-d9b7-44b1-85d6-d1e3794eb8db" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">616,244</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9fdb32a-a8cb-49c2-8e4f-5c2aa6673413" contextRef="C_f1a2b453-d388-477c-8259-cf29dcec39b2" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">578,729</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock under equity incentive plans related to vesting of RSUs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8eca41a4-3bf9-4afc-bf0b-13f8c39eff64" contextRef="C_d24b1d9c-01d0-4045-a903-8d6fc008d906" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">14,270</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock under equity incentive plans related to exercise of options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d7538594-68fd-47fd-b36b-066289330c0b" contextRef="C_d24b1d9c-01d0-4045-a903-8d6fc008d906" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">449,005</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6904727e-64c8-49af-b7d0-2e19f3c96dd6" contextRef="C_35f07075-ec20-4015-be83-0dc61fc1e438" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,854</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2e901979-5dce-4f68-8c01-6bd2b73d1116" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,854</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity-based compensation expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_91f1889e-d09e-4f4e-be04-9d2870c27693" contextRef="C_35f07075-ec20-4015-be83-0dc61fc1e438" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,558</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_982f7cbe-f71f-4b5c-8e1e-c617a6e28459" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,558</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8d0189b2-d1a2-4274-a4cb-7ee777205ed5" contextRef="C_d366786f-fe3c-4859-907c-c7fecd5cc013" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">348</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d1f01081-b651-4875-b052-26bdf90dd7d6" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">348</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ebd73770-45e9-41c9-8010-c4bef2f58370" contextRef="C_77182ead-68f3-4560-a065-2b0a465b0858" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,294</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bf28d674-d162-49fe-819c-7226a9e79b0d" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,294</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at March 31, 2022</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ffd3349e-ae2b-44dc-a7d8-fd08bd8ecb68" contextRef="C_9eb38bce-595b-4efe-9ff4-a8a9196c17ff" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">148,182,798</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e802b9b7-8f6a-4530-bab2-5b8dba63f5bc" contextRef="C_9eb38bce-595b-4efe-9ff4-a8a9196c17ff" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a6d828f-6b0e-4f02-bb42-b83721a4231f" contextRef="C_3479d27f-e186-4ab3-8410-a1a5d7ecfb11" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,207,356</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8009b62-cc43-4aaf-96fd-fa92f03c5fcc" contextRef="C_5d000a15-9017-476b-9666-76dc3f8dd464" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,334</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0151f93a-5d29-43a4-91e3-0216ff491f7d" contextRef="C_1dcf3112-c3d6-445f-a9b1-a8a6aff84cd0" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">684,538</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a068ac64-88a4-4828-ac7b-a9c048aae697" contextRef="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">521,499</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CEREVEL THERAPEUTICS HOLDINGS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="condensed_consolidated_statements_cash_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONDENSED CONSOLIDATED S</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TATEMENTS OF CASH FLOWS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Unaudited)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:67.08%;"></td>
    <td style="width:1.622%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.837%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.622%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.837%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended <br />March 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows from operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a25a1e5a-1002-4df4-80ef-029f9fc63750" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">104,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3f253b70-df7f-4bfb-b010-364f09c6b4bd" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,294</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adjustments to reconcile net loss to net cash flows used in operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation and amortization</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_95c8728c-9762-4b12-a2d3-a27025033394" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,321</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_00cc287d-742d-403e-babb-acd37a1d490b" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,118</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adjustments to operating lease expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7b402b05-eb37-44ca-b63d-9d4b2c1e70d5" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:AdjustmentsToOperatingLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">280</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24b3de8c-0da9-4681-84df-e0bd570678eb" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="cere:AdjustmentsToOperatingLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">236</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity-based compensation</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba2af994-1372-45a8-b4d3-a9ae153d4bbb" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,592</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a093754c-6e68-452b-89cc-bbb40e00b58b" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,558</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value of financing liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ca66c1f3-f2e1-4d3c-9410-5ba0a0d9d281" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:ChangeInFairValueOfFinancingLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,082</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8d1adbed-f4c1-4b2a-afee-65b6e513889f" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="cere:ChangeInFairValueOfFinancingLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">3,940</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-cash interest expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2bdf05d7-61b3-44a6-a0d9-406afed977cf" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">480</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of premiums and accretion of discounts on marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5f90bce1-724c-4a85-8564-5013d6205354" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,206</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b24e40be-d060-4ed5-94a9-d5797f4a3158" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">553</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other non-cash items</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_65462eff-0535-48a6-b353-b34b2ec92819" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:OtherNoncashIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in operating assets and liabilities, net:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9774ce2e-1191-44bb-baa0-7c5cce5981c7" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">147</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bdb3d168-d06e-4137-868e-972f1d22f0d7" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,811</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b595a4a2-efd5-44e9-aa2d-204cbcedf9e5" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">440</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_853eb2db-d891-4d26-b26e-2eb9ba054842" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">106</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_803ce0ca-60a9-4eeb-a5bd-497d4e9ea79d" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,768</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8d8047e0-4f89-41b5-bcff-279eb000cd39" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,499</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses and other liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb939449-553f-4987-9e61-808c6c3ad94a" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">7,263</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b57ec675-6c33-4b3d-abfd-3539f7c65e56" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">4,613</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:40.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:40.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash flows used in operating activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e52546c5-64ac-4222-b4e2-d536a87f5bca" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">94,923</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6ace786d-ff35-46ec-a30a-a057b4fb3e2d" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">67,648</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows from investing activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of marketable securities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3f938335-22e4-44d6-9164-e61bea65fae7" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">187,631</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_68d81b09-1c6f-459d-8e35-55c6c9945bfe" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60,242</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maturities and redemptions of marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c369883f-8a0d-4fd8-b39a-5ed435fba68f" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">298,750</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b20533fd-db4e-4329-9b96-afcef6003e07" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,897</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of property and equipment</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_afc77d06-0f65-410f-bcff-56b368e3f8c4" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">336</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d2e1deec-0007-46e1-ac0d-ea6d808629a2" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,197</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:40.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:40.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash flows provided by (used in) investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7ed8d02d-5869-48ed-9f7b-86d8e62d29a7" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">110,783</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_af6dcbbc-ab10-4855-844a-91b161d1c46f" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">38,542</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows from financing activities:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from the exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a0f2f1d-59fd-491f-b6b6-0fd5196b59bd" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,574</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_749ab798-ba34-4c53-b711-21b78423f62d" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,854</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred costs related to financing activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_75b8cb32-387c-476c-b0e8-47c1ea44ed26" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:PaymentsOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">139</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e501587f-8416-45bc-80d3-3c0a074d330e" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:PaymentsOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">251</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:40.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:40.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash flows provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_99869ea2-4f26-4f03-b7fb-d4b7c798e0ea" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,435</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3d463699-42c2-4978-a165-07930aa80936" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,603</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net increase (decrease) in cash, cash equivalents and restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_75c1e45b-399a-4106-8739-960a01e35b56" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,295</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fdabbd89-ccc9-40eb-b18e-36f5e832326e" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">103,587</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash, cash equivalents and restricted cash, beginning of the period</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_17291517-6e93-4818-bcca-b9cb2a111bdc" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">138,388</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4b3c1f81-f42a-4ac0-bd6e-ddc428bef886" contextRef="C_f1a2b453-d388-477c-8259-cf29dcec39b2" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">197,218</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash, cash equivalents and restricted cash, end of the period</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8a0c8036-788c-42ea-8f47-21ae6a33a724" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">155,683</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f31044be-aed5-4d7c-aa92-29f1e4fbb32f" contextRef="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">93,631</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reconciliation of cash, cash equivalents and restricted cash:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21c6824b-2bb7-4891-9eb9-8338e210c10f" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">153,816</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ac7687a6-7fc9-4774-b0e2-a0e04812f5db" contextRef="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">91,764</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4355bc90-1f66-47fa-a490-925d54b9c2ec" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,867</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d0910b8e-c44e-454e-8400-109801e2ead1" contextRef="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,867</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash, cash equivalents and restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bdec2803-b9f0-41bf-b9b1-f2a4e7e7ba5c" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">155,683</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fa8c2a3c-56b8-4851-a891-70a953711d9a" contextRef="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">93,631</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental disclosure of cash flow information:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash paid for interest</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_adc921a0-cbc2-4e82-b32b-50f49843287c" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,289</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental cash flow disclosures from non-cash investing and financing activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fixed asset additions included in accounts payable and other current liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fc4daf4e-bff0-4f34-b3a6-7dd0dc6993ab" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">779</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4076a59f-6895-4838-a4e6-06af2cdda739" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">731</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CEREVEL THERAPEUTICS HOLDINGS, INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="notes_to_condensed_consolidated_financia"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONDENSED CONSOLID</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ATED FINANCIAL STATEMENTS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Unaudited)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3e7f970b-316c-4fe2-8d91-0aac798a7047" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:NatureOfOperations" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. Nature of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless the context otherwise requires, references in these notes to &#x201c;Cerevel,&#x201d; &#x201c;the company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d; and any related terms are intended to mean Cerevel Therapeutics Holdings, Inc. and its consolidated subsidiaries.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biopharmaceutical company pursuing a targeted approach to neuroscience that combines a deep understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. We seek to transform the lives of patients through the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer's disease psychosis, epilepsy, panic disorder and Parkinson&#x2019;s disease. We are advancing our extensive and diverse pipeline with numerous clinical trials underway or planned, including three ongoing Phase 3 trials and an open-label extension trial for tavapadon in Parkinson's, two ongoing Phase 2 trials and an open-label extension trial for emraclidine in schizophrenia, an ongoing Phase 2 proof-of-concept trial and an open-label extension trial for darigabat in focal epilepsy and a planned Phase 2 proof-of-concept trial for darigabat in panic disorder.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information on our formation, please read Note 1, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Nature of Operations</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 (our Annual Report).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0e90a12a-0a8f-4724-aa97-2df5e2e8b891" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:RisksAndLiquidityTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2. Risks and Liquidity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to risks and uncertainties common to clinical-stage companies in the biopharmaceutical industry. These risks include, but are not limited to, the introduction of new products, therapies, standards of care or new technological innovations, our ability to obtain and maintain adequate protection for our in-licensed technology, data or other intellectual property and proprietary rights and compliance with extensive government regulation and oversight. In addition, we are dependent upon the services of our employees, including key personnel, consultants, third-party contract research organizations (CROs), third-party contract manufacturing organizations (CMOs) and other third-party organizations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our product candidates, currently under development or that we may develop, will require significant additional research and development efforts, including extensive clinical testing and regulatory approval prior to commercialization. These efforts require significant amounts of additional capital, adequate personnel infrastructure and extensive compliance and reporting capabilities. There can be no assurance that our research and development activities will be successfully completed, that adequate protection for our licensed or developed technology will be obtained and maintained, that products developed will obtain necessary government regulatory approval or that any approved products will be commercially viable.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our unaudited condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets and the satisfaction of liabilities in the ordinary course of business. We have incurred significant operating losses since our inception and, as of March 31, 2023, had not yet generated revenues. In addition, we anticipate that our expenses will increase significantly in connection with our ongoing activities to support our research, discovery and clinical development efforts and we expect to continue to incur significant expenses and operating losses for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have funded our operations primarily with the net proceeds received from the issuance of preferred stock, common stock and convertible senior notes, net proceeds from the consummation of our Business Combination (as defined in Note 15, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Related Parties</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements), and our Funding Agreements (as defined in Note 5, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements). We believe that our available cash, cash equivalent and marketable securities as of March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, will enable us to fund our operating expense and capital expenditure requirements through at least 12 months from the issuance date of these financial statements.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b61e36fa-214e-4c6b-8950-2afcccf6b97e" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3. Summary of Significant Accounting Policies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d416ff58-b6d1-4734-b3e2-07b7c039c226" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying unaudited condensed consolidated financial statements include those of the company and its subsidiaries, Cerevel Therapeutics, Inc., Cerevel Therapeutics, LLC and Cerevel MA Securities Corp., after elimination of all intercompany accounts and transactions. The accompanying unaudited condensed consolidated financial statements and notes hereto have been prepared in conformity with the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting and, therefore, omit or condense certain footnotes and other information normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) as set forth in the Financial Accounting Standards Board&#x2019;s (FASB) accounting standards codification. Any reference in these notes to applicable guidance is</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Update (ASU) of the FASB.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the opinion of management, all adjustments necessary for a fair statement of the financial information, which are of a normal and recurring nature, have been made for the interim periods reported. Results of operations for the three months ended March 31, 2023 and 2022, are not necessarily indicative of the results for the entire fiscal year or any other period. Our unaudited condensed consolidated financial statements for the three months ended March 31, 2023 and 2022, have been prepared on the same basis as and should be read in conjunction with our audited consolidated financial statements and notes included in our Annual Report.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5d455974-387b-4030-a004-4f02adb493f6" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:UseOfEstimates" escape="true"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, the fair value of our financing liabilities, the fair value of stock options, the accrual for research and development expense and the recoverability of our net deferred tax assets and the related valuation allowance. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors and adjust those estimates and assumptions when facts and circumstances change. Actual results could differ materially from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_615c9ecc-f922-4fbb-863e-8a02f970dbf4" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with our entering into the lease agreement for our headquarters in Cambridge, MA, in July 2019, we were required to provide a security deposit in the form of a letter of credit. We have classified this amount as restricted cash in our condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to our other significant accounting policies, please read Note 4, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Summary of Significant Accounting Policies</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our audited consolidated financial statements included in our Annual Report.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2299a034-b28d-4f5e-bc13-e04e80b59387" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Guidance</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the company as of the specified effective date. Unless otherwise discussed, the company believes that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a7f87ee9-a447-4205-a2ca-43640f69027f" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:LicenseAgreementTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4. Pfizer License Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2018, we entered into a license agreement with Pfizer (the Pfizer License Agreement) pursuant to which we were granted an exclusive, sublicensable, worldwide license under certain Pfizer patent rights, and a non-exclusive, sublicensable, worldwide license under certain Pfizer know-how to develop, manufacture and commercialize certain compounds and products, which currently constitute substantially all of our asset portfolio, in the field of treatment, prevention, diagnosis, control and maintenance of all diseases and disorders in humans, subject to the terms and conditions of the Pfizer License Agreement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the Pfizer License Agreement, we are solely responsible for the development, manufacture, regulatory approval and commercialization of compounds and products in the field and we will pay Pfizer tiered royalties on the aggregate net sales during each calendar year, determined on a product-by-product basis, with respect to products under the Pfizer License Agreement, and we may pay potential milestone payments to Pfizer, based on the successful achievement of certain regulatory and commercial milestones. To date, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73b2284c-e17f-49cf-bf42-ceeb461340d7" contextRef="C_e5a1da7f-71cc-44ee-bf79-5b4c0a66ac10" name="us-gaap:RoyaltyExpense" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_546edad6-c042-4623-ad9e-940698449865" contextRef="C_e5a1da7f-71cc-44ee-bf79-5b4c0a66ac10" name="cere:RegulatoryApprovalMilestonePayments" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_d544fc76-d8e3-4a61-a6af-64d4941d82c2" contextRef="C_e5a1da7f-71cc-44ee-bf79-5b4c0a66ac10" name="cere:CommercialApprovalMilestonePayments" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> regulatory or commercial approval milestone payments or royalty payments have been made or become due under this agreement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to our Pfizer License Agreement, please read Note 6, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pfizer License Agreement, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to our audited consolidated financial statements included in our Annual Report.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6dbe210c-11f7-4d7c-b826-4d8ec3690cc9" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:FairValueOptionTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5. Financing Liabilities</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Funding Agreements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2021, we entered into a funding agreement with NovaQuest Co-Investment Fund XVI, L.P. (NovaQuest and the NovaQuest Funding Agreement) and a funding agreement with BC Pinnacle Holdings, LP (Bain, the Bain Funding Agreement and, together with the NovaQuest Funding Agreement, the Funding Agreements), pursuant to which NovaQuest and Bain will provide funding to support our development of tavapadon for the treatment of Parkinson&#x2019;s disease.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the Funding Agreements, we will receive up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2310b23a-7900-4a95-a67d-9d4dfeb73a35" contextRef="C_dffe9ddc-8c99-41f9-a548-0172f9e0b2c2" name="cere:ExpectedFundingReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal"><ix:nonFraction id="F_c7368b03-61c7-441c-8596-62f46ebd11d3" contextRef="C_529612ad-d864-4e48-8033-b7bbacbe0414" name="cere:ExpectedFundingReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">62.5</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in funding from each of NovaQuest and Bain, for a combined total of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a4d85026-927c-4e28-989e-8bf621ff6869" contextRef="C_72953f01-6eb8-48e3-9861-55ca4de20b51" name="cere:ExpectedFundingReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">125.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in funding (the Total Funding Commitment), of which approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_75f103c1-9e75-4d41-bd3a-57680bd48f10" contextRef="C_72953f01-6eb8-48e3-9861-55ca4de20b51" name="cere:ReceivedFunding" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">31.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_89e1ef91-29a5-4a69-993d-adf164d0a68c" contextRef="C_a2e21f3d-b1a6-4ed0-b2c3-cd5451e8a75c" name="cere:PercentageOfFundingReceived" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Total Funding Commitment, net of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5cb4d65-e7ac-4043-b3fb-0e2082cbd4ff" contextRef="C_45210d29-9cd0-45f9-a714-edc3c13d8747" name="cere:FundingCommitmentFeesIncurred" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of fees incurred by Bain and NovaQuest) was received in April 2021, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_53889d56-85e2-4a4b-8cb2-9fa688274169" contextRef="C_2029d649-08bb-4a87-a177-143045bff540" name="cere:ExpectedFundingReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">37.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a098cdbc-732e-4357-806c-c2fd3d4ed954" contextRef="C_0729e16b-d27b-4daf-a728-90d90397b869" name="cere:PercentageOfFundingReceived" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">30</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Total Funding Commitment) was received in April 2022, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cbc8eefe-eac2-4226-9a6a-cbd325487ffc" contextRef="C_f130d7e4-71de-45ed-8562-45858d825a2a" name="cere:ExpectedFundingReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">31.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_060c8778-62af-493d-bce1-df5f8e0f2907" contextRef="C_a4ba2f01-2e93-4b42-9142-63c99321d789" name="cere:PercentageOfFundingReceived" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Total Funding Commitment) was received in April 2023 and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_29798776-b442-4b86-98f3-b456d2c03793" contextRef="C_d67b9c2b-3a7f-4577-b857-ad3a7dad44da" name="cere:ExpectedFundingReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">25.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_26859e16-c3fc-4720-8f68-201bf36343b1" contextRef="C_8ac1ae72-06b1-4095-a857-71c8c60c5b47" name="cere:PercentageOfExpectedFundingReceived" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">20</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Total Funding Commitment) is expected to be received in April 2024, subject to certain customary funding conditions.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In return</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we agreed to pay NovaQuest and Bain significant regulatory milestone, sales milestone and royalty payments upon approval of tavapadon by the FDA that collectively will not exceed $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a08d195c-ad34-42dc-8e3f-f01206f25a79" contextRef="C_616d2b60-239d-4254-9414-de1400659e3e" name="cere:PayableOnFundingAgreement" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal">531.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. In addition, we have the option to satisfy our payment obligations to NovaQuest and Bain upon the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0e48a67e-0973-4b5f-86c6-ce0d10e0c630" contextRef="C_d05795e8-7fcc-4338-a3c6-f89d386c6435" name="cere:ContractualObligationDescriptionRepaymentTiming"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">earlier of FDA approval or May 1, 2025</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, by paying an amount equal to the Total Funding Commitment multiplied by an initial factor of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f812ce2d-1810-451c-8a58-f5da777874fc" contextRef="C_99242e6a-e59a-4179-94bd-0b1937c5d461" name="cere:PercentageOfFundingCommitment" unitRef="U_pure" decimals="INF" format="ixt:numdotdecimal">3.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">x. This factor will increase ratably over time up to a maximum of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6547ebb2-cc31-497d-9304-38e21e533770" contextRef="C_d4d1c9e3-62ea-42c4-ba8d-fcc51bb68150" name="cere:PercentageOfFundingCommitment" unitRef="U_pure" decimals="INF" format="ixt:numdotdecimal">4.25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">x, less amounts previously paid to NovaQuest and Bain.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We determined that each funding agreement represents a financial instrument that is considered to be a debt host containing embedded redemption features due to certain contingencies related to repayment. We elected to account for the Funding Agreements in accordance with the fair value option as permitted under ASC 825, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 and December 31, 2022, the estimated fair value of the financing liability related to potential amounts payable to Bain under the Bain Funding Agreement, which is reflected in our condensed consolidated balance sheets as financing liability, related party, totaled approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_52d0346a-ec67-403c-b377-532574e25c72" contextRef="C_12bb81cc-4118-4eec-9061-466a6e2d707f" name="cere:NoncurrentFinancingLiabilityRelatedParty" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">34.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cfe3d67a-4304-458f-830a-aaa64c73ea71" contextRef="C_effc1829-ed70-4ee5-8e04-afb0f9066e16" name="cere:NoncurrentFinancingLiabilityRelatedParty" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">28.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022, the estimated fair value of the financing liability related to potential amounts payable to NovaQuest under the NovaQuest Funding Agreement, which is reflected in our condensed consolidated balance sheets as financing liability, totaled approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3148368a-65e1-4d3d-9747-e3e39be610ad" contextRef="C_be2d5f10-585c-4657-aa28-2c74500e83d3" name="cere:NoncurrentFinancingLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">34.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2cb4e268-dbab-4135-b268-fb61ffc15152" contextRef="C_ab2f0a63-9c4c-4701-a647-f506a160b8d3" name="cere:NoncurrentFinancingLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">28.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c6f08398-2f5c-4e31-b22f-ddc4627b195a" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in estimated fair value of the financing liabilities in our unaudited condensed consolidated statements of operations and comprehensive loss are summarized as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.716%;"></td>
        <td style="width:1.422%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.719999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.422%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.719999999999999%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability, related party</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value recognized in other (income) expense, net</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0288eece-e888-465c-83ff-8bef77ca6475" contextRef="C_0a7718ed-8940-4540-a71e-a8480e029877" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,541</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fc4f13ec-6428-45a1-ae36-d054bf10b5ff" contextRef="C_5b514de5-a814-4d92-a947-476c997998cd" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,970</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e8e3ff6c-1bb2-4b8a-a7dd-aeabf3c216a4" contextRef="C_0a7718ed-8940-4540-a71e-a8480e029877" name="us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">453</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bf27e90f-c843-410b-9343-86a4a0f110ab" contextRef="C_5b514de5-a814-4d92-a947-476c997998cd" name="us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">638</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value recognized in other (income) expense, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5f9fbbc9-ef0f-470f-a191-93c7731d79c6" contextRef="C_2713ad4a-1c03-4894-a1bc-032d17c08682" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,541</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f62cd4bf-d54c-4945-9cab-a8ced3065dad" contextRef="C_d0b1fde3-c686-4afd-a78c-adda507ab1d7" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,970</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f38dcfb4-8cd5-4607-811c-95ceaecc4dcd" contextRef="C_2713ad4a-1c03-4894-a1bc-032d17c08682" name="us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">453</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b5e49e2-2bab-4cb2-ac5f-2e75470b16e7" contextRef="C_d0b1fde3-c686-4afd-a78c-adda507ab1d7" name="us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">638</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in fair value attributable to instrument-specific credit risk were derived by benchmarking against the prior period credit spread to isolate the impact directly associated with the change in the credit spread utilized between periods.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to our Funding Agreements, please read Note 8, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our audited consolidated financial statements included in our Annual Report.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_bf27d0d3-f8b9-4173-9d0f-e1e973d501ca" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:LongTermDebtTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6. 2027 Convertible Senior Notes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2022, we completed the offering of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e77cf387-bffe-40f6-9e84-d67c7dc41825" contextRef="C_c79a6dff-9b2a-4bbe-893e-f8d5995f53c4" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal">345.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million aggregate principal amount of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ca7f715d-4787-477c-b4e4-688dc2857476" contextRef="C_c79a6dff-9b2a-4bbe-893e-f8d5995f53c4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">2.50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% Convertible Senior Notes due 2027 (the 2027 Notes). The aggregate net proceeds from the 2027 Notes offering totaled approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_12ad9853-3cfb-4afd-911a-593d33c4f98a" contextRef="C_c8cfcc32-37ee-4a6c-b545-88aa98593ba7" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">334.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, after deducting the initial purchasers' discounts of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aa70b1f9-93d1-42bd-ac0b-13e336a18ff5" contextRef="C_2d54aabe-0480-4ce2-84e7-c3be541b8858" name="us-gaap:DeferredFinanceCostsGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">9.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and other offering expenses of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5adf6ced-709e-4920-a52a-2c2485ee0a89" contextRef="C_c19150ee-ddf1-4d6e-b02f-c9d1f4985998" name="us-gaap:DeferredFinanceCostsGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. We accounted for the debt issuance costs as a debt discount for accounting purposes, which was recorded as a reduction in the carrying value of the debt in our unaudited condensed consolidated balance sheet and is being amortized to interest expense using the effective interest method over the expected life of the 2027 Notes, or approximately their five-year term.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_10ac3d8b-9814-46bb-abdb-c43632358ac7" contextRef="C_77c90c0f-d4ef-4cc7-bf3d-e8aba928ea56" name="us-gaap:DebtInstrumentPaymentTerms"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2027 Notes accrue interest at a rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_46be4dcc-359e-48e0-9a30-a7e34dd42e57" contextRef="C_c79a6dff-9b2a-4bbe-893e-f8d5995f53c4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">2.50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% per annum, payable </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5ca72953-0502-42e5-96f1-490e5b24ce5e" contextRef="C_77c90c0f-d4ef-4cc7-bf3d-e8aba928ea56" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">semi-annually</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in arrears on February 15 and August 15 of each year, beginning on February 15, 2023.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> As of March 31, 2023 and December 31, 2022, accrued interest on the 2027 Notes of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_00c0821e-1985-4ccd-b98e-1639d6bf0482" contextRef="C_d2d20274-f65b-4fa5-8e5b-96f09f3d8fb8" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_85f2e6a6-1bc0-4fe5-9f9d-2668105aea8e" contextRef="C_c4a52621-de21-4dff-a35d-fe8c89899498" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">3.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was included in accrued expenses and other current liabilities in our condensed consolidated balance sheets.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2027 Notes mature on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1146a6c0-d90f-4926-9993-2c27d3321610" contextRef="C_c8cfcc32-37ee-4a6c-b545-88aa98593ba7" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">August 15, 2027</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unless earlier converted, redeemed or repurchased. We will settle conversions by paying or delivering, as applicable, cash, shares of our common stock or a combination of cash and shares of our common stock, at</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">election, subject to terms and conditions provided in the indenture between us and U.S. Bank Trust Company, National Association, as trustee (the Indenture).</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holders of 2027 Notes may convert all or any portion of their Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2027, only in the following circumstances: (i) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on December 31, 2022, if the last reported sale price per share of our common stock exceeds </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9dd9e85b-a8dd-4663-9c84-949d5c4dadcf" contextRef="C_60585c7b-083d-43f2-85ea-156ce6ac7bb8" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">130</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the conversion price for each of at least </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_04bb8521-73de-4e28-bbfe-74b6f4a9732a" contextRef="C_60585c7b-083d-43f2-85ea-156ce6ac7bb8" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" unitRef="U_Days" decimals="INF" format="ixt:numdotdecimal">20</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> trading days, whether or not consecutive, during the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a9f736b-afb0-4b10-96d3-0d9983f31fe7" contextRef="C_c8cfcc32-37ee-4a6c-b545-88aa98593ba7" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" unitRef="U_Days" decimals="INF" format="ixt:numdotdecimal">30</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (ii) during the five consecutive business days immediately after any 10 consecutive trading day period (the Measurement Period) in which the trading price per $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d43f8e34-6405-4e2e-9b36-4aacd3e02d35" contextRef="C_7e166e56-61db-491e-be50-d60c4a5deb31" name="cere:PerPrincipalAmountForTradingPrice" unitRef="U_USDollarShare" decimals="0" format="ixt:numdotdecimal">1,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> principal amount of notes for each trading day of the Measurement Period was less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_940d3bd9-0000-4ece-99e2-e8465e1c231b" contextRef="C_7d230bc1-cefa-46e4-a861-24a211270b6e" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">98</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (iii) upon the occurrence of certain corporate events or distributions on our common stock, as defined in the Indenture; and (iv) if we call the 2027 Notes for redemption.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From and after May 15, 2027, noteholders may convert their notes at any time at their election until the close of business on the second scheduled trading day immediately before the maturity date. The initial conversion rate is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d353a879-531c-4dc5-8d5a-f46bb3a0f899" contextRef="C_533da935-ec87-4ed2-a0b1-6924af3f7975" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" unitRef="U_pure" scale="0" decimals="4" format="ixt:numdotdecimal">21.5633</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock per $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73f597cd-7230-43aa-ae9f-123bd9846c2a" contextRef="C_a5c731ba-b89c-4f18-9704-24f50e1a5925" name="cere:PerPrincipalAmountForConversion" unitRef="U_USDollarShare" decimals="0" format="ixt:numdotdecimal">1,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> principal amount of the 2027 Notes, which represents an initial conversion price of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f8f38e21-aea1-4463-97ee-5814491fde3e" contextRef="C_a5c731ba-b89c-4f18-9704-24f50e1a5925" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" unitRef="U_USDollarShare" scale="0" decimals="2" format="ixt:numdotdecimal">46.38</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share of common stock, or a total of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_575b3890-df88-41e7-8fcc-e7abb6fc27c7" contextRef="C_533da935-ec87-4ed2-a0b1-6924af3f7975" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" unitRef="U_Instrument" decimals="INF" format="ixt:numdotdecimal">7,439,338</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events outlined within the Indenture. In addition, if certain corporate events that constitute a &#x201c;Make-Whole Fundamental Change&#x201d; (as defined in the Indenture) occur, then the conversion rate will, in certain circumstances, be increased for a specified period of time.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may not redeem the 2027 Notes at any time before August 20, 2025, and no sinking fund is required to be provided for the 2027 Notes. The 2027 Notes will be redeemable, in whole or in part (subject to certain limitations), at our option at any time, on or after August 20, 2025, and on or before the 50th scheduled trading day immediately before the maturity date, under certain circumstances defined within the Indenture.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_cefae69a-d73b-4d39-b00f-0004671e20f9" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfDebtTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The net carrying amount of the 2027 Notes included in our condensed consolidated balance sheets consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.156%;"></td>
        <td style="width:1.662%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.759999999999998%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.662%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.759999999999998%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, <br />2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br />2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal amount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad9c640a-bb1f-42d8-90b5-a293d39b67d7" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">345,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dfa01a11-d955-43c4-9054-8b5c1f94ae98" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">345,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unamortized debt discount</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c7ff9891-092d-4aac-bdc7-5002e96bb2b2" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,038</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba393147-5f75-48da-b74f-e14861125365" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,518</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net carrying amount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6653c2c7-bda4-4c33-8c63-c88bdbdd00e3" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">335,962</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8129843b-3668-40db-983c-c32ea7ba50f7" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">335,482</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ff0a5ba2-c35d-4233-85af-a7ec1a6f1c5b" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:ScheduleOfInterestExpenseTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table sets forth the total interest expense related to the 2027 Notes recognized in interest income (expense), net in our </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unaudited condensed consolidated statements of operations and comprehensive loss for the periods presented:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.225%;"></td>
        <td style="width:1.433%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.062000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.433%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.849%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_de1e5426-a913-400e-9d70-581fbfdf7e29" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:InterestExpenseDebtExcludingAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,156</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of debt issuance costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_120986e7-57b7-4401-b029-1c1abecea4d0" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">480</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total interest expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_489eb575-4734-4074-b1f2-8c8d39cdc1c6" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,636</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective interest rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_838582c3-2d63-4ced-9dfa-71408b956acb" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">3.1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7e9dc5bb-2dfb-4150-ae60-580d31a8472f" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future minimum payments under the 2027 Notes as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023, are as follows (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.128%;"></td>
        <td style="width:1.937%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:15.934999999999999%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f5ff925c-2549-4d6e-998d-f4a677aceaed" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,312</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6398a423-dfd7-4dcd-9499-6ce8466cc309" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,625</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2387220a-ea61-4b2d-a1a2-a5d42c84f0b0" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,625</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c144b06a-68b6-4629-bc8d-eaf3f6b0be61" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,625</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fba98e6a-cb02-4dd0-bb58-938378023143" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">353,625</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total future payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4301c71a-0a5f-4569-9237-91cfd88fa4e3" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:LongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">383,812</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: amounts representing interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_140aadf0-7cd4-4761-9a4d-22cdec99a249" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="cere:DebtInstrumentInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">38,812</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total principal amount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_59e513a8-7927-47f6-a013-9cc799f9c595" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">345,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1) For the nine months ended December 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to our 2027 Convertible Senior Notes, please read Note 9, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2027 Convertible Senior Notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our audited consolidated financial statements included in our Annual Report.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c94df195-1b4c-4c89-88c0-33273cd3025b" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7. Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_32a8ce07-5bff-477d-9c17-6f1f99e87a6a" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The tables below present information about our assets and liabilities that are measured and carried at fair value on a recurring basis and indicate the level within the fair value hierarchy we utilized to determine such fair values:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.511%;"></td>
        <td style="width:1.223%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.15%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.223%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.15%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.223%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.15%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.223%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.15%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted<br />Prices in<br />Active<br />Markets<br />(Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br />Other<br />Observable<br />Inputs<br />(Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br />Unobservable<br />Inputs<br />(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6e639460-72eb-49fd-8bd1-a594e1b3986b" contextRef="C_5bed7e0c-dacd-4d4c-b250-020234b8f6be" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">133,866</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dfd6d625-8c19-419c-8ea8-18d8bc93e517" contextRef="C_ca5c0abd-f008-4c84-a189-a21791b234a2" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">133,866</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ca5c725-2c51-45a3-8932-cb34abc62d72" contextRef="C_bc22ae5e-bffd-445a-9a22-d08330898d6b" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,950</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_337f365c-4269-4966-bd22-5f0aa0c85ce1" contextRef="C_54aef7f2-adfa-458b-a966-d50f782d3ddd" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,950</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (current)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ed68ce9-d17b-4002-beaa-1ac28058bf8c" contextRef="C_fcc62a3a-53fa-4dc4-ae07-5eb1877c37d1" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,909</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f134315f-2a0b-42b7-9356-4d8fbee0cddb" contextRef="C_68912430-91ed-4690-8c20-dc2d611fbea4" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,909</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83efe4aa-19c1-405e-84e6-ed92b7e532bc" contextRef="C_5b90efb7-656c-4625-b566-b99e3e6f4649" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">230,658</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_538e2038-9baa-4b85-96cd-115004a67084" contextRef="C_89bb3f05-5b57-4cd0-a75d-a5ee2689d120" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">230,658</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_272cb3af-23ed-4ca6-826a-5aadd5cab94e" contextRef="C_5f8f5a42-ba06-4506-a0cc-bf786204f23c" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,477</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d3e460f4-b863-4e2c-9089-711669dfd70a" contextRef="C_4196d9fb-4e85-48d1-88b7-aefa2a19ebc8" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,477</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a4674b12-80ac-4a0c-92fe-19c70a798148" contextRef="C_bc22ae5e-bffd-445a-9a22-d08330898d6b" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">415,127</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e357d63c-e88d-41e5-9d32-3422cf5867c5" contextRef="C_54aef7f2-adfa-458b-a966-d50f782d3ddd" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">415,127</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (non-current)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7454896a-4ed4-4d6c-a25b-5f0ca0fba1a6" contextRef="C_5b90efb7-656c-4625-b566-b99e3e6f4649" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,048</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b82b409f-3cf3-4099-a3ad-836de3f0c20f" contextRef="C_89bb3f05-5b57-4cd0-a75d-a5ee2689d120" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,048</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_412728df-aba9-47fc-b4f6-ffea6f794606" contextRef="C_f46ced43-7a95-48b1-a3d2-c0ef57876a31" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,867</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0204a520-d3d6-42a9-955b-c2ca138231b8" contextRef="C_549c1b5b-f5c0-43b3-aeb2-af8128f7fddd" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,867</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_29f54d65-a954-4e51-ae39-c3ea0a6f4f83" contextRef="C_55492269-e353-457a-9ac6-63c9a890f5a7" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">153,642</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a201edb9-1426-40d0-bb95-9152235fd153" contextRef="C_d68c6b2b-198c-4278-b56f-a68363510239" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">711,260</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b982e72f-f4ca-492c-97ed-09d9eac520f7" contextRef="C_174d7111-d0da-45ff-818a-2c32e6395735" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">864,902</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability, related party</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_261b18dd-476e-4d3c-a800-490eea3ba936" contextRef="C_bfd4f2a5-80b4-4cd6-9aa0-3d4d61332a45" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">34,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_570fed6b-0553-419f-bce6-95dbf6f9aef7" contextRef="C_5b04eb63-d32d-4cf7-8974-ef0d2c24455d" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">34,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83541a1f-8185-4736-bd5e-e2fdebac067d" contextRef="C_a4c793ea-57ae-4e0f-8312-eeac8baf5953" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">34,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fdf5944a-a303-484b-9d2a-4c617878b03e" contextRef="C_27a1eff3-cd98-489c-bf8d-10b9567d6a6f" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">34,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fa5cfc0e-b45f-4d61-a5a9-8ebdc2c9532c" contextRef="C_a2a1794f-7768-4f98-8c78-709345fc1417" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">69,336</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9e549a11-d085-4dbd-a6fb-26daf3a4b69c" contextRef="C_174d7111-d0da-45ff-818a-2c32e6395735" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">69,336</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.903%;"></td>
        <td style="width:1.123%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.152000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.123%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.152000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.123%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.152000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.123%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.152000000000001%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted<br />Prices in<br />Active<br />Markets<br />(Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br />Other<br />Observable<br />Inputs<br />(Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br />Unobservable<br />Inputs<br />(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f62a994b-24da-438e-b5fd-9a9bbbb74e08" contextRef="C_ca7f0c1c-48d7-455e-8ddc-e9b062b461a2" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">136,521</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bbff286a-b170-49e1-b2d0-6e0d2a9ecd61" contextRef="C_e16b464e-4443-4323-83d1-f03a4129c2e8" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">136,521</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (current)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6e61c66a-325d-4533-841a-e592c75b60b1" contextRef="C_75cbd078-eab8-4a1a-b86f-1ede351b764b" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">103,238</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_14dcfb3e-433b-4393-ae55-a9d387ffbaad" contextRef="C_4872d125-2e56-4840-bde3-171e61b545d5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">103,238</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_34503bea-c758-4390-9b82-6bfdb2a374ce" contextRef="C_4555fd95-af90-4446-9ef6-c7bf5c673ad1" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">165,555</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2caca35c-1504-4bf2-94fa-90411de90c9d" contextRef="C_e2cf588c-4935-44e7-a87b-fcb9e12be2cd" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">165,555</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_734b4186-8a1a-4e15-a3c5-ef2075d47e41" contextRef="C_3e5cfe38-545f-4b20-972d-38ee76239160" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,416</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11e15c3a-14c3-49a6-841e-42260bde7e75" contextRef="C_a7fd9625-1e0b-4179-bd94-31438f3f9f0b" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,416</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_747b8491-5845-451a-8e77-50e35a2e8554" contextRef="C_6ce49664-9b3e-4193-9202-c337a0a78589" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">477,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9007773e-043c-4a37-a8fe-466be7408539" contextRef="C_db439bc0-f8f4-4c4e-9791-8b83a63b6885" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">477,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (non-current)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_70a6ab2e-ebc7-4c97-9862-7f8700bbd85a" contextRef="C_4555fd95-af90-4446-9ef6-c7bf5c673ad1" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,126</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cd5701b7-7c40-4a77-953e-b0cedee410b1" contextRef="C_e2cf588c-4935-44e7-a87b-fcb9e12be2cd" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,126</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ecfd4dbd-3ef7-429d-a75c-46de4e6f4102" contextRef="C_03207e80-ade5-41d3-ab71-391279e55fcc" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,867</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5501e78f-4eda-4ee5-ae7f-a84f3459b641" contextRef="C_1972858f-eae0-4299-8170-ba14d09bef4d" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,867</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7bb78a1b-6ad0-4ca3-85b5-19faf102ea58" contextRef="C_67e3ff37-67dc-425c-9e5c-f367e23d4a36" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">241,626</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba477823-c7d1-4d0c-84db-3c02706a5c90" contextRef="C_4929b4e3-f0dd-4495-b868-bcea2881f576" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">710,397</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1e89a9fb-f166-49cf-ad63-1ddedd497da5" contextRef="C_4d6806dd-95ea-4244-b45f-b725e95152fe" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">952,023</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability, related party</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f0daeb44-2a28-4040-b760-ba88d67c0669" contextRef="C_e39da301-bc58-44e7-8b68-aa3c32c22b3d" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,674</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4cf9e1ba-2de9-4190-bb84-830c1675a155" contextRef="C_c61bf99f-af2e-40be-861d-98e1836d9630" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,674</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad526da9-5446-4aae-b824-422e9025f301" contextRef="C_dd4efdc2-f871-4164-b259-04d75db7dd0a" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,674</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_45a730e1-2906-46bc-ada9-1e9c423f18b3" contextRef="C_ecd82ae5-371b-498f-b1a6-1a95342b510d" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,674</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ceca2348-18a1-4a89-a486-6e3311f4974b" contextRef="C_5bf423a6-8367-4279-bf95-e9c42308340c" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">57,348</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6ea75d48-a828-4613-909e-5df47077ac65" contextRef="C_4d6806dd-95ea-4244-b45f-b725e95152fe" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">57,348</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There have been </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_525c9399-70d3-4d43-b45c-9141e500bb62" contextRef="C_174d7111-d0da-45ff-818a-2c32e6395735" name="cere:FairValueLiabilitiesBetweenLevelTransferAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_ea6fe403-611c-49e9-86bd-a7f43642fa20" contextRef="C_4d6806dd-95ea-4244-b45f-b725e95152fe" name="cere:FairValueLiabilitiesBetweenLevelTransferAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_8e3ff23d-7e0e-4bce-8c3f-94e508918587" contextRef="C_174d7111-d0da-45ff-818a-2c32e6395735" name="cere:FairValueAssetBetweenLevelTransferAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_a2f9b2f8-11c7-468d-928f-0d905ecf968d" contextRef="C_4d6806dd-95ea-4244-b45f-b725e95152fe" name="cere:FairValueAssetBetweenLevelTransferAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> changes in valuation techniques, inputs utilized or transfers between fair measurement levels in the periods presented. The fair value of our Level 2 instruments were determined using third-party pricing sources. The pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly. We validate the prices provided by our third-party pricing services by understanding the models used, obtaining market values from other pricing sources and analyzing pricing data in certain instances. After completing our validation procedures, we did not adjust or override any fair value measurements provided by our pricing services as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The carrying amounts reflected in our condensed consolidated balance sheets for our cash and cash equivalents, prepaid expenses and other current assets, accounts payable, accrued expenses and other current liabilities approximate fair value due to the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">short-term nature of these assets and liabilities. As of March 31, 2023, our financing liabilities represented our only Level 3 assets or liabilities carried at fair market value. Changes in the fair value remeasurement of our financing liabilities can result from changes in one or multiple inputs, including adjustments to discount rates, changes in the expected achievement or timing of any sales-based, development or regulatory milestones, changes in the amount or timing of expected net cash flows, changes in the probability or timing of certain clinical events and changes in the assumed probability or timing associated with regulatory approval. These fair value measurements represent Level 3 measurements as they are based on significant inputs not observable in the market.</span></p><p style="text-indent:2.267%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Marketable Securities</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_02a9cd65-cf7b-4fdc-9666-4203e522af70" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The estimated fair value and amortized cost of our available-for-sale marketable debt securities, by contractual maturity and security type, are summarized as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.512%;"></td>
        <td style="width:1.123%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.248999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.123%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.248999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.123%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.248999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.123%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.248999999999999%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due in one year or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_caed5def-e2e1-4e2b-8520-607c71f4f1fa" contextRef="C_8a957d0a-6024-4753-9804-3a0360e90e6b" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,970</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9768dd00-15cc-45fe-87d4-0016755e270d" contextRef="C_8a957d0a-6024-4753-9804-3a0360e90e6b" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">61</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c9fcd0a8-8267-4614-a740-11d2af1d6965" contextRef="C_8a957d0a-6024-4753-9804-3a0360e90e6b" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,909</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bdd52223-7979-4684-b2dd-76780b56f7eb" contextRef="C_8e7da2d2-92f1-43a3-bb9a-1d0277243751" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">231,391</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f3d3a3e-6eb1-43e8-a9d0-8fa58a03d388" contextRef="C_8e7da2d2-92f1-43a3-bb9a-1d0277243751" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">37</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_47d1d58a-b414-46ff-a6d1-b3b0d430ed62" contextRef="C_8e7da2d2-92f1-43a3-bb9a-1d0277243751" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">770</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2fe06802-bf49-4621-a2c6-3a1b56dc15b7" contextRef="C_8e7da2d2-92f1-43a3-bb9a-1d0277243751" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">230,658</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ce686df1-0395-4d79-8533-e89339a34c67" contextRef="C_e73b579d-5fcf-44e9-b4bd-a01478ea5126" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,485</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_39027448-1967-48f8-a09d-eed158032050" contextRef="C_e73b579d-5fcf-44e9-b4bd-a01478ea5126" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1b31d23a-712c-488c-9cf3-93f687758075" contextRef="C_e73b579d-5fcf-44e9-b4bd-a01478ea5126" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,477</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f5a562e4-117d-41cc-94aa-e88d10b3dfcb" contextRef="C_0cfe1f22-841b-4d40-be3c-5ab39c7eeed7" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">415,820</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_61671e0b-f061-47f5-879c-505cad09e486" contextRef="C_0cfe1f22-841b-4d40-be3c-5ab39c7eeed7" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d2eb614a-a55e-4344-8190-b37d9b7b2f1d" contextRef="C_0cfe1f22-841b-4d40-be3c-5ab39c7eeed7" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">719</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_487bd321-4f6d-4cdb-b630-47b4ee0f39cd" contextRef="C_0cfe1f22-841b-4d40-be3c-5ab39c7eeed7" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">415,127</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due after one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4294f88b-8f43-4819-a1ab-63d8d04159d3" contextRef="C_d374cc27-3d6a-4e93-87c5-2393b48f37f2" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35,986</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7c7e93cc-f4a1-4142-8bfa-4440dd8d4f31" contextRef="C_d374cc27-3d6a-4e93-87c5-2393b48f37f2" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a63e090a-7091-430b-9bff-ec5335b86ee8" contextRef="C_d374cc27-3d6a-4e93-87c5-2393b48f37f2" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,048</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total marketable securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6fef9623-24d1-4260-aa1b-96080319f244" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">710,652</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_352d8cbf-35c3-4fdf-be2d-e5bef9188d56" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">125</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_31e0b511-64a3-420d-acb3-be713bdff749" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,558</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_503f2a7f-123d-4379-9f95-cee84e213f29" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">709,219</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.822%;"></td>
        <td style="width:1.043%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.253%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.043%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.253%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.043%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.253%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.043%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.253%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due in one year or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_26f227f6-8d6c-403c-894c-1c97746b7695" contextRef="C_abd57310-685b-4fc9-a762-295bbda69277" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">103,800</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f913c86e-1bcf-4fd6-a739-99825bdefebb" contextRef="C_abd57310-685b-4fc9-a762-295bbda69277" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">562</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2351433f-1e06-4e54-8231-5c4718b2a95d" contextRef="C_abd57310-685b-4fc9-a762-295bbda69277" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">103,238</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8266632c-ed67-4a94-b7dd-c0e3420b0511" contextRef="C_b7ca6fdd-c4aa-4736-9d2f-d4a2eadbaeb1" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">166,327</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_78ffb01d-ddc4-48be-89ba-038a3b1f727f" contextRef="C_b7ca6fdd-c4aa-4736-9d2f-d4a2eadbaeb1" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ec4731f1-34a4-48e5-9b66-c8cc0b6dc2b7" contextRef="C_b7ca6fdd-c4aa-4736-9d2f-d4a2eadbaeb1" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">787</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_049dc627-4950-4375-a19c-d6f1540b5d44" contextRef="C_b7ca6fdd-c4aa-4736-9d2f-d4a2eadbaeb1" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">165,555</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b22868a1-ea68-466c-b04d-2dadaa777c5f" contextRef="C_4651d696-b2be-4638-8c92-24388e05ccf4" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,454</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83dc8e73-f475-4f73-a563-345e625fcd47" contextRef="C_4651d696-b2be-4638-8c92-24388e05ccf4" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">38</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eb531197-ae3a-4473-875f-870e831e3d73" contextRef="C_4651d696-b2be-4638-8c92-24388e05ccf4" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,416</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9fd54315-d6e4-44ac-9595-5726eb99e466" contextRef="C_ba176f35-ab1c-4a1b-9969-20f064b37357" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">478,657</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_95638f69-a9ca-4f08-a991-2b2f38a56d26" contextRef="C_ba176f35-ab1c-4a1b-9969-20f064b37357" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">71</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c2e3862f-74a2-433f-86b4-5211a6f21990" contextRef="C_ba176f35-ab1c-4a1b-9969-20f064b37357" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,428</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_15b2ebe7-2e04-4c34-99f0-d2142cc289ce" contextRef="C_ba176f35-ab1c-4a1b-9969-20f064b37357" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">477,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due after one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0d3ef5d9-c45f-42dd-8559-1194a4133b78" contextRef="C_cee0bc25-bebb-4a35-9362-2d58a9e6a342" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,327</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3afebdf9-bea3-4edf-aa69-0cc3e4c41144" contextRef="C_cee0bc25-bebb-4a35-9362-2d58a9e6a342" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2e44a38e-fe0d-42d2-9e1c-547e6967dbdb" contextRef="C_cee0bc25-bebb-4a35-9362-2d58a9e6a342" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">208</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ae86c6f-de5b-4149-9041-ce3f84bc75e4" contextRef="C_cee0bc25-bebb-4a35-9362-2d58a9e6a342" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">58,126</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total marketable securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6e384935-d42c-4031-95f9-afd4a2ae0ad6" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">816,565</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a13f919-40d7-40d5-bf7b-7194a326d8a8" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">93</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_30764b5b-9eec-4480-ae53-8aa56589d320" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,023</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b3a5cd8-f923-4a5f-a4a2-73e92fd51a10" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">813,635</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad7c7237-b76a-4c02-abec-c0d374296f1a" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:MarketableSecuritiesRealizedGainLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_8e05aefc-8f7a-47b3-9a2d-3326dee52b76" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:MarketableSecuritiesRealizedGainLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> realized gains or losses recognized on the sale or maturity of marketable securities during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three months ended March 31, 2023 and 2022. To date, we have not recognized any allowances for credit losses or impairments in relation to our available-for-sale marketable securities as these marketable securities are comprised of high credit quality, investment grade securities that we do not intend or expect to be required to sell prior to their anticipated recovery, and the decline in fair value of these securities is attributable to factors other than credit losses. All marketable securities with unrealized losses presented in the previous tables have been in a continuous unrealized loss position for less than 12 months or the loss is not material. Based on our evaluation, we determined credit losses related to marketable securities were immaterial for the three months ended March 31, 2023.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted average maturity of our marketable securities as of both March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_758e49c7-c864-45c2-b6e5-e976ec488e00" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:MarketableSecuritiesWeightedAverageMaturityTerm" format="ixt-sec:durwordsen"><ix:nonNumeric id="F_def91091-ec7c-470b-a221-956881fc6481" contextRef="C_59a5c3ef-611c-4d06-809f-b96bb1ad592d" name="cere:MarketableSecuritiesWeightedAverageMaturityTerm" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five months</span></ix:nonNumeric></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:2.267%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon execution of the Funding Agreements, we determined that the agreements qualified for election under the fair value option and initially measured the financial instruments at their issue-date estimated fair value. We revalue the related financial liabilities on a recurring basis at each reporting period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023, the financing liability, related party and financing liability each totaled approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6bfeb25-5d72-433c-8bc2-ef899ce8acfb" contextRef="C_23d05b6e-4f80-4669-8884-9503ff410b15" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">34.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. We determined their respective estimated fair values using a Monte Carlo simulation model under the income approach determined by using probability assessments of the expected future cash receipts and expected future cash payments and a discount rate of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a0b394cf-765d-4b0a-8af6-7057bb8506af" contextRef="C_4b64ecbc-3995-4a70-91be-00b3cba9da84" name="cere:FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal"><ix:nonFraction id="F_5e32fd6c-63b9-4a6a-a88b-0cf9fa83f85f" contextRef="C_6d74330b-6d7c-493a-b8a3-9eb0e26049d9" name="cere:FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">10.0</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022. The probability assessments of the expected future cash receipts and expected future payments and the timing of expected future repayments are based on significant inputs that are not observable in the market and are subject to remeasurement at each reporting date.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5171b7f4-c3cb-420f-af32-f6966ce24dfb" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table provides a rollforward of the estimated fair value associated with our combined total financing liabilities:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.288%;"></td>
        <td style="width:1.941%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:15.771%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended <br />March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beginning balance, total financing liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_378803a3-c177-4463-88bf-5b152ef5cc51" contextRef="C_2ea39b76-7e86-4e9f-a3aa-1c43d8682c03" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">57,348</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Funding commitment received</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value recognized in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_1f0cf8c7-35f8-4a8d-a01c-7fb92edd3948;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other (income) expense, net</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_acf10696-68a2-4225-acbd-98f98914403a" contextRef="C_7913329b-0f1d-4200-bcd9-ef012e06c589" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,082</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value attributable to instrument-specific credit risk recognized in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_293c1bd4-3ed9-476f-92d6-7047da56d7a9;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other comprehensive (income) loss</span></span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_880b4ee8-8636-4af8-bdf2-3ebc5ba94709" contextRef="C_7913329b-0f1d-4200-bcd9-ef012e06c589" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">906</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ending balance, total financing liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6ea5df3b-27de-4bba-8cd2-db6ea0d63215" contextRef="C_7297b579-f439-4a6b-92e5-a571272517af" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">69,336</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to the fair value of our financing liability and financing liability, related party, please read Note 5, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</span></p><p style="text-indent:2.267%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2027 Convertible Senior Notes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of the 2027 Notes, which were issued in August 2022, may differ from the carrying value. The fair value is determined utilizing prices for the 2027 Notes observed in market trading. As the market for the trading of the 2027 Notes is not considered to be an active market, the estimate of fair value is considered a Level 2 measurement. As of March 31, 2023, the estimated fair value of the 2027 Notes, which have an aggregate carrying value of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f7ee7dc-d0a3-43a9-86f8-2ab5a6c29a93" contextRef="C_d2d20274-f65b-4fa5-8e5b-96f09f3d8fb8" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">336.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7b501f50-4a83-4a86-a6e3-fcf8fbc27b8e" contextRef="C_d2d20274-f65b-4fa5-8e5b-96f09f3d8fb8" name="us-gaap:DebtInstrumentFairValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">289.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to the 2027 Notes, please read Note 6, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2027 Convertible Senior Notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span><span><ix:nonNumeric id="F_c07c8962-c25a-492f-acc6-221c3fff1c12" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" escape="true" continuedAt="F_c07c8962-c25a-492f-acc6-221c3fff1c12_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Financial Statement Components</span></ix:nonNumeric></span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_c07c8962-c25a-492f-acc6-221c3fff1c12_1"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Prepaid Expenses and Other Current Assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5b605563-1656-49eb-b88e-03c5893b29fd" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.156%;"></td>
        <td style="width:1.662%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.759999999999998%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.662%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.759999999999998%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br />2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br />2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid clinical trial services</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_82e7c9bc-006f-486c-927a-8a57c2ac4c40" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="cere:PrepaidClinicalTrialServicesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,551</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f239e8d9-5669-4123-b5e3-11dbd09570f2" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="cere:PrepaidClinicalTrialServicesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,872</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid research and development expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f8f0366e-d019-42e6-b934-bb5f30abe2c7" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="cere:PrepaidResearchAndDevelopmentExpensesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,592</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a50408e4-1d1f-4abe-865e-1282bd5b6451" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="cere:PrepaidResearchAndDevelopmentExpensesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,228</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid insurance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba31aea9-3024-4773-af5c-5eaf108f1197" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,171</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9bb4cee-c0c4-45a6-ba13-dabff6a6b512" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,460</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other prepaid expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3d0add28-deb5-4050-af22-98b882d9ef46" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:OtherPrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,912</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_96631a5f-8fbb-463d-9b50-8291ed5534b8" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:OtherPrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,556</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest receivable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c7afd3be-80b0-4475-8c39-c331a3922ebb" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:InterestReceivableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,202</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f5d09915-ab58-4174-9bcb-1c5a7ecb2bd8" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:InterestReceivableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,046</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3c68d4ea-d664-4fde-a269-414a806ad9a7" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,367</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d9b9456b-1633-4924-bf59-3067467740ef" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,459</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_01213566-e2f4-45be-b4f6-e7d5a0cf06f8" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,795</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e853a563-fe7f-45f7-88a1-40873ca957f4" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,621</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment, Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b4f38f28-984f-4319-8706-b238470f2200" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.411%;"></td>
        <td style="width:1.541%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.754000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.541%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.754000000000001%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br />2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br />2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment and software</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7e27eca4-50b7-4a52-943c-581783cb0287" contextRef="C_3b482e46-cc89-4ce5-85f5-a366efdf2856" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,009</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a19fe518-324d-4130-acd8-d96609a7cc14" contextRef="C_14d54740-4fd0-463e-8f77-ee503f66ded0" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3">996</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_17479ad1-31d8-423c-9916-cbfa422647f2" contextRef="C_efca2e92-f443-4333-9998-77bef5b93ff9" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">459</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8e7f0840-04ca-4814-ba22-9e6cbc493099" contextRef="C_47e0732b-5a0a-4840-a434-85dd5768ae62" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3">459</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b7a5668-312e-48a7-834b-0e9ee7078ba1" contextRef="C_84a4ec65-be81-43b0-a2a8-aeab6b151380" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,886</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d2f8daa-11cb-4ef3-b938-bbbed21b570c" contextRef="C_4cf7a89b-841c-4850-9973-eddacfecc0f0" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,489</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3cba9482-6e02-4915-859f-e33b10ac9fc5" contextRef="C_f1ad0af9-f8fb-47b4-9d88-2f035f335eb7" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,461</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e3bb5f1a-14ef-44c5-a9d5-c2608f3ac6ce" contextRef="C_2ff3f43c-87c0-4d83-99a4-d515d051d791" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,461</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction in progress</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cca0c703-f3c2-404c-bc0a-f8ec67ddd3b1" contextRef="C_e9e3b32d-3528-4ff7-ad8b-b7449522bd16" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">705</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_39dc652e-226b-49b6-b395-1f815c8815ff" contextRef="C_8c284975-2e05-4ee0-a774-8114aaf9d295" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">321</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: Accumulated depreciation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2d8040ce-d58a-423e-9838-9ff1a3b31273" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,514</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3adbaa26-4938-4091-8c41-5e2ad68562be" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,259</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_656b786b-439b-4419-a5f0-b536ffe6652d" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,006</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_df1fff2c-2f7f-4cfa-bff7-efddf0ae20b0" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,467</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude></ix:nonNumeric></div><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Long-Term Assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b64ab8e7-d978-4f7c-8fa9-d0274299ac16" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other long-term assets consisted of the following:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.156%;"></td>
        <td style="width:1.662%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.759999999999998%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.662%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.759999999999998%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br />2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br />2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other prepaid expenses, net of current portion</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_10853d43-f507-412d-a6e9-ab6cb78a29bf" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PrepaidExpenseOtherNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,932</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08758faa-a0be-4512-8b8f-63682d6f5c45" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PrepaidExpenseOtherNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,792</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred expenses associated with financing activities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8d2bb594-c556-4f63-b66a-20e37bdbe5ea" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:DeferredFinanceCostsNoncurrentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">287</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fa5ce578-47bb-4b57-9a90-63121c0fadca" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:DeferredFinanceCostsNoncurrentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">286</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6656cd2a-da25-4e71-b87e-0466e28643c4" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">989</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_80897923-a11f-4d22-9b65-a36a8a7c24a3" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">813</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other long-term assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6226f4a7-de2b-4b65-a558-2f0801b15835" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,208</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0c848573-8476-4dfd-b222-7e09b8edb673" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,891</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 and December 31, 2022, other prepaid expenses, net of current portion, primarily consisted of deposits paid under certain contract research organization agreements that will be held until the completion of the related clinical trials that are anticipated to end more than 12 months from the balance sheet date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accrued Expenses and Other Current Liabilities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5ed1c743-e8f6-4c90-ac1f-d8a4441884d3" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.436%;"></td>
        <td style="width:1.542%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.739999999999998%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.542%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.739999999999998%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br />2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br />2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued external research and development services</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b0562290-ca96-4beb-a214-9e3863e6c792" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="cere:AccruedExternalResearchAndDevelopmentServicesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">41,397</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6de4174c-7757-4256-9b86-d2021df450e3" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="cere:AccruedExternalResearchAndDevelopmentServicesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,967</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued compensation and personnel costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_62476063-447d-4607-a411-39f814f5e4d3" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,377</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_391b1c20-42f9-4bb3-834f-35b52f2093af" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,057</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued property and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1cfb9261-09cd-48e6-a12b-8164e93850bc" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="cere:AccruedPropertyAndEquipmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">439</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2f1a5087-a18b-4051-a9c6-cdd21837f6c9" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="cere:AccruedPropertyAndEquipmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued professional fees and consulting services</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9e8ffb5-589b-4204-b72c-295ef4d4d66a" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,365</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_20f469e8-5858-4283-a9e5-f5ded1970d6a" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,187</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1601c998-1a03-4deb-8799-4a258b2a6ca0" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,078</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bbe714b9-cd6b-4925-a18f-d5895830360e" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,210</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_23d05d38-7772-4719-98e0-5a73c1e4c4e8" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">958</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0c7a304d-8aa8-4c4c-9ba6-286a20d142ea" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,143</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c0b5ccfb-34ee-4b17-9095-f7475a62939e" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52,614</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5eebf274-b3ae-4220-9706-288ce2f85edb" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,604</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Income (Expense), net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4f1f28bf-7fbb-4502-9c63-d09c77e18d17" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income (expense), net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.716%;"></td>
        <td style="width:1.422%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.719999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.422%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.719999999999999%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_38ce7081-00f7-448f-a489-80fe3b35a7e7" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:InterestIncomeNonoperatingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,076</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_42bf976f-763d-4834-bf34-ee6edba064f7" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="cere:InterestIncomeNonoperatingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">295</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_57e83b9a-8a98-448f-89f9-7eb94bb7121a" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,636</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income (expense), net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_03426aa1-e1b6-4da2-a48e-bcf98d1f1a6c" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:InterestIncomeExpenseNonoperatingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,440</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a8ce7797-6b7d-4b54-bcc9-7726cbf0f6b9" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:InterestIncomeExpenseNonoperatingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">295</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income (Expense), net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2d6e4eea-0afd-488b-a6dc-ff25640abcac" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.436%;"></td>
        <td style="width:1.542%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.739999999999998%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.542%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.739999999999998%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain (loss) on fair value remeasurement of financing liability, related party</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c262a97e-8d9e-4ea0-b3e6-ea5588ca8895" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5,541</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4554611f-43ce-4b23-ad9a-3682c1a09297" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="cere:GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,970</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain (loss) on fair value remeasurement of financing liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ea02561c-6cd1-47d9-a311-b7b256df2293" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:GainLossOnFairValueRemeasurementOfFinancingLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5,541</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_43aa388f-089a-43ab-85ed-7971c11167f1" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="cere:GainLossOnFairValueRemeasurementOfFinancingLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,970</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ab6b4f06-c96f-4d0d-a563-b6f9063b0bfe" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:OtherNonoperatingIncomeExpenseOther" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">8</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_904f7739-b5ed-4421-91fa-36154046839b" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="cere:OtherNonoperatingIncomeExpenseOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_07345cc2-7278-466c-b228-77ced576cf53" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">11,090</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a91f2985-5252-4c56-b84d-75a5f79a837b" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,941</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span><span><ix:nonNumeric id="F_8b456a4d-2e11-4536-a772-70292f425d5c" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true" continuedAt="F_8b456a4d-2e11-4536-a772-70292f425d5c_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Stockholders&#x2019; Equity</span></ix:nonNumeric></span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_8b456a4d-2e11-4536-a772-70292f425d5c_1"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the terms of our certificate of incorporation, we have </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21dd3293-bb3a-4087-8162-d25ffcd4d57e" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_ede175d2-3b78-4f35-aca6-9fa4d3a82b0b" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> authorized shares of preferred stock, par value $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7e78614b-a571-4972-98e2-d6db3f16fcc9" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_9f73a934-51b4-4308-9651-c59d2f580f6e" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, all of which shares of preferred stock are undesignated. Our board of directors or any authorized committee thereof is expressly authorized, without further action by our stockholders, to issue such shares of preferred stock from time to time on terms it may determine, to divide shares of preferred stock into one or more series and to fix the designations, preferences, privileges and restrictions of preferred stock. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_78a5ce2b-e3a5-4721-a940-3d8a110ed332" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_181602f6-36ab-4e9b-901a-0575714c0759" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_6fb368e5-aeb6-463d-84c1-6c18f93a0e85" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_252c0733-a120-4ce8-bac7-44598577ae14" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> issued and outstanding shares of preferred stock as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022.</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Common Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the terms of our certificate of incorporation, we have </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e479185-c6ca-4bf3-87f8-19cc2c2ddf09" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_6a14ca00-d95a-4d55-ac6e-81c84d1f5b98" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">500,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> authorized shares of common stock, par value $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83441a03-5c5d-4f16-bb93-d1980007bfd4" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_f74ce50b-f173-40d2-af8c-a7daf2d4faa4" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_USDollarShare" decimals="INF" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1eb38ba3-bdf4-43dc-a2a5-2538a6e7030b" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">156,760,109</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a17c6135-492a-4ff7-bf96-745bcd328da1" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">156,502,285</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock issued and outstanding as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022, respectively.</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Voting</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The holders of our common stock are entitled to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_06034287-e34c-4760-9880-70935dcd49df" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:CommonStockVotingRights"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one vote</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for each share of common stock held of record by such holder on all matters voted upon by our stockholders, provided, however, that, except as otherwise required in our certificate of incorporation or by applicable law, the holders of our common stock are not entitled to vote on any amendment to our certificate of incorporation (or on any amendment to a certificate of designations of any series of preferred stock) that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon, and there is no cumulative voting.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Dividends</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to any other provisions of our certificate of incorporation, holders of our common stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are entitled to receive ratably, in proportion to the number of shares of common stock held by them, such dividends and other distributions in cash, stock or property when, as and if declared thereon by our board of directors from time to time out of our assets or funds legally available therefor. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7aded220-e0ab-48f1-bb18-b1d27d48ba0d" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:DividendsPayableCurrentAndNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> dividends have been declared to date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">ATM Program</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In November 2021, we entered into an open market sales agreement with Jefferies LLC, as sales agent, to provide for the issuance and sale of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a3050a0-5cd9-44df-9b1e-7f5e57617a58" contextRef="C_33aaf712-2416-4ca9-a789-bdc80db6c833" name="cere:SaleAndIssuanceOfStockNotYetIssued" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal">250.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of our common stock from time-to-time in &#x201c;at-the-market&#x201d; offerings (the ATM Program). As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_76b284fd-1bc1-499f-a545-93d6ab50c1be" contextRef="C_286de79d-0111-4ffc-942c-17519af10505" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_dbcb2ae9-2569-4764-9e23-73f23e0e4cbc" contextRef="C_59a5c3ef-611c-4d06-809f-b96bb1ad592d" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> sales had been made pursuant to the ATM Program.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_5403db72-eaaa-4289-b121-2b519f0d0c23" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10. Equity-Based Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.253%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equity-based Compensation Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e39c512b-c734-45a6-bc53-6911f114a373" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true" continuedAt="F_e39c512b-c734-45a6-bc53-6911f114a373_1"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes equity-based compensation expense included in our unaudited condensed consolidated statements of operations and comprehensive loss:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.401%;"></td>
        <td style="width:1.502%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.797%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.502%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.797%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83d53336-3914-4325-a647-f90fed347b54" contextRef="C_1c59bb28-7d9d-41f1-a3e6-9fdb1e61a326" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,339</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9bd43404-03d9-46e0-8c65-a94bf383f7b4" contextRef="C_40a019d3-e92f-4c7b-9557-6132ab2cd1c4" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,006</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3dd61df6-506c-4f87-b4de-2f7b661ec5fa" contextRef="C_a1b4107b-3ed7-40e8-9ad5-1379b770ce94" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,253</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_34b8a3fe-6faa-4aec-ae04-84f819a0b89b" contextRef="C_c290d454-3c40-474b-a8cb-1192e1d1df68" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,552</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation expense included in total operating expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_88f1db47-1162-4a31-89e4-e90005553ba8" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,592</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5bca1ef3-c17c-4f5d-af8b-167c7c8dc463" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,558</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes equity-based compensation expense by award type included in our unaudited condensed consolidated statements of operations and comprehensive loss:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_e39c512b-c734-45a6-bc53-6911f114a373_1">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.401%;"></td>
        <td style="width:1.502%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.797%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.502%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.797%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c72ea9ea-659c-41c4-be7a-1413ef433138" contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,663</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4050a7ea-78fb-4571-9fc6-3b3493af107a" contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,359</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_91696951-7a3e-4c8a-a706-97a742d863a2" contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">703</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb2ca80d-2dd3-44f2-bece-d30b5823fb62" contextRef="C_d7e7b52c-2a39-4e61-89ff-8d10c8cb2f4b" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fc8474f4-81ee-4fba-95e3-bc68765310df" contextRef="C_0cd9a4b8-d9bd-4d67-875a-67846552b346" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">226</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a2d55fbf-1bf7-479f-8e1a-f298c9b5c920" contextRef="C_a7ea4b46-178f-4956-8746-80498e54c789" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">190</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation expense included in total operating expense</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a7cedc5a-a54e-4c55-b21b-9f258669a8aa" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,592</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7f949623-a153-402d-89ed-585208010759" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,558</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude></ix:continuation></div><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock Options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options granted during the three months ended March 31, 2023 and 2022 had a weighted average grant-date fair value of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2da3c822-30ca-4c2c-a241-16b24d8038af" contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2" format="ixt:numdotdecimal">26.21</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f1843f31-08c2-4376-b318-4b67625f628b" contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2" format="ixt:numdotdecimal">23.62</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_01f0eb4d-628d-4caa-bcf7-e68006d2ae66" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true" continuedAt="F_01f0eb4d-628d-4caa-bcf7-e68006d2ae66_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average assumptions that we used to determine the fair value of stock options granted to employees are summarized as follows: </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_01f0eb4d-628d-4caa-bcf7-e68006d2ae66_1">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.35%;"></td>
        <td style="width:1.166%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.656%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.166%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.661000000000001%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c59afe00-1ac3-499d-8088-2c9740cd4ebb" contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">3.76</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0ca7e27c-c323-4910-ad5e-1e1dba77fb75" contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.85</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_442f2f91-3176-430f-931c-ebd91985df17" contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.08</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4ad236f1-74a7-49e1-ae74-e28503bc52b1" contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.08</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3bbf4346-05ed-45c6-8557-24d1004072ed" contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">90.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1501a98a-eb8a-42ef-b7f6-a04169e895e2" contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">96.2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_696e930b-13e7-42f9-888e-b0edf18cacfc" contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fb87335a-c223-4cc0-9d13-a40573af33ec" contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, total unrecognized equity-based compensation expense relating to stock options was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_02dafbd7-312b-4344-bb3a-0bea1c7630cf" contextRef="C_46d1eb9f-1608-412b-a122-ad9ff076c478" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">132.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. This amount is expected to be recognized over a weighted average period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0412a789-3145-432d-8448-322ba44f805e" contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.0</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_30317269-dd0a-4bca-95ad-18fda709dae8" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our stock option activity for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three months ended March 31, 2023:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.65%;"></td>
        <td style="width:1.001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.614999999999998%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.302%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.914000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.116%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.302%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.094999999999999%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br />Shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br />Average<br />Exercise<br />Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br />Average<br />Remaining<br />Contractual<br />Life<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br />Intrinsic<br />Value<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(in millions)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_95f414e3-cc6b-4f45-8c1d-9cfcc6fd18e1" contextRef="C_21573dc6-6769-41aa-991d-b0f72b895688" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">17,178,861</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_faa11440-9773-4411-9fb2-f6455969198c" contextRef="C_21573dc6-6769-41aa-991d-b0f72b895688" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">13.59</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a1edc90e-9016-4be4-a5bd-3b6c723315f8" contextRef="C_92b2e51b-74ba-476d-a0bb-1a6c588851a7" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.55</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8eba0f61-e222-419f-b6dc-725fb932e0fc" contextRef="C_21573dc6-6769-41aa-991d-b0f72b895688" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">309.9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_785ba6e0-05cb-47f0-af1b-ef67ea573db0" contextRef="C_8de10066-7b96-4965-9078-908525b6b838" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,015,264</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_39dff4ef-33fe-4f88-9edf-8793427f5883" contextRef="C_8de10066-7b96-4965-9078-908525b6b838" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">34.29</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c89e9c08-1eed-4936-aa11-fc18553f21bc" contextRef="C_8de10066-7b96-4965-9078-908525b6b838" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">257,824</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2788bd52-5d51-4a7d-a8d6-ac269091ffb2" contextRef="C_8de10066-7b96-4965-9078-908525b6b838" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">6.10</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited, canceled or expired</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_50270fbb-ddbb-4d20-a2bf-c8649094faf1" contextRef="C_8de10066-7b96-4965-9078-908525b6b838" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">517,077</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e363d076-8c0e-49ad-b618-b836e3077324" contextRef="C_8de10066-7b96-4965-9078-908525b6b838" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">21.38</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at March 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d09e24c9-3159-4bdc-9529-d1c29afd54fa" contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,419,224</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93066ced-c7f2-4ca9-b31e-1954166acfdc" contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">15.74</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e34769aa-ad55-4f0a-9b33-af0d6a128464" contextRef="C_8de10066-7b96-4965-9078-908525b6b838" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.49</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_456e588d-60e4-4d61-966e-7fe7c4360230" contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">199.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options vested and expected to vest as of March 31, 2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a9d7cb26-a03e-4306-86de-754b1f8a6b29" contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,419,224</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_54962822-1ab1-4fa5-b6b8-b9e119f399c4" contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2">15.74</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_71bd3312-f488-4176-8958-2fae7798fd9b" contextRef="C_8de10066-7b96-4965-9078-908525b6b838" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.49</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8051b344-a40d-463d-b3f3-dd941d488b1a" contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">199.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options exercisable as of March 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_362ebfa8-343e-495e-862a-c3565dd95453" contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,619,438</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5c6a2ae3-dfa7-4fd5-a72b-97857f5ad4ce" contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_USDollarShare" scale="0" decimals="2" format="ixt:numdotdecimal">9.70</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_babf07c3-f244-45c9-b92d-edbc210decf8" contextRef="C_8de10066-7b96-4965-9078-908525b6b838" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.62</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ea2cec11-fcc3-49ec-81e7-057a987231de" contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">161.3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate intrinsic value represents the difference between the closing stock price of our common stock and the exercise price of in-the-money options. Our closing stock price as reported on the Nasdaq Stock Market on March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5964bc6-bca1-4116-a8e5-5dad2f5c99fa" contextRef="C_9e127b71-4539-48d9-9d6b-1b9b6c4de7ad" name="cere:ClosingPriceOfCommonStock" unitRef="U_USDollarShare" scale="0" decimals="2" format="ixt:numdotdecimal">24.39</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options granted during the three months ended March 31, 2023 include our annual long-term incentive awards, which were granted in February 2023.</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Stock Units</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9d3ba08d-012e-44fb-af57-239e282acca6" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our restricted stock activity as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.636%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.831999999999997%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.861%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.291999999999998%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted Stock Units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number<br />of Units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br />Average<br />Grant Date<br />Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-vested at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b98a734-01cf-4b10-ad85-f3d4a15b6f57" contextRef="C_899c628a-be1d-4d05-b35c-2e06c2ed5337" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,932</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c9902dbf-07cb-4fdf-9b0b-6b35b9243856" contextRef="C_899c628a-be1d-4d05-b35c-2e06c2ed5337" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2" format="ixt:numdotdecimal">26.41</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f6e27b47-4586-4446-b1f5-979b233a697b" contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">570,922</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d13962a5-9a0c-43fe-8965-a5ae6a4a857e" contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2" format="ixt:numdotdecimal">34.38</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_88695575-5d3e-4bf6-8435-21cf0c284338" contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">30,737</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c00f496-2784-48b2-93b5-684a36e2b4fe" contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2" format="ixt:numdotdecimal">34.41</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-vested at March 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_305484e9-8015-4f13-8056-1403706ab928" contextRef="C_1cc94817-d461-46f2-8d51-8d0b51788032" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">559,117</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_23c2f2b8-5746-447e-8b44-a3a2f89dac77" contextRef="C_1cc94817-d461-46f2-8d51-8d0b51788032" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_USDollarShare" scale="0" decimals="2" format="ixt:numdotdecimal">34.11</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, total unrecognized equity-based compensation expense relating to restricted stock unit awards was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_06507c8b-58d0-4de1-9eca-e51f47d0db0a" contextRef="C_1cc94817-d461-46f2-8d51-8d0b51788032" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">18.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which is expected to be recognized over a weighted average period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7052be1d-697a-4f93-b986-daf69b5f8d65" contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.8</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_711117f6-dfd7-46c4-b40c-1c5b9a9a14b5" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11. Net Loss Per Share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4f9dd041-4d16-434f-8f10-f3108fe94a57" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table sets forth the computation of the basic and diluted net loss per share:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands, except share amounts and per share data)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_953a2fd7-7741-460c-ad4d-c0031ff28ccf" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">104,286</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_14b8027c-6688-4b74-8816-14c99bf25181" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,294</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Denominator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-average shares used in calculating net loss per share, basic and diluted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ae2a75b0-51d4-4f81-aefa-22e07e00e0fc" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_c1ef667b-8c0d-4268-8c82-2697ceff5214" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">156,648,365</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b459541a-edc9-4434-b9d6-4afa9fff8fe8" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_d02e88e3-196c-48ec-8dbf-0ecabe4799a4" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">147,984,926</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d4db4fc7-0341-4259-be91-b70d1871e651" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:EarningsPerShareBasic" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_64cbc886-1899-404a-af14-87fe8cc5ad66" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:EarningsPerShareDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">0.67</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1d5b20fe-d849-4811-8b2a-da41874ff262" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:EarningsPerShareBasic" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_1e0be976-c661-4909-9e34-e25b8023447f" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:EarningsPerShareDiluted" unitRef="U_USDollarShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">0.46</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since we were in a loss position for all periods presented, diluted net loss per share is the same as basic net loss per share as the inclusion of all potential dilutive securities would have been anti-dilutive. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9c7fd929-1d59-4064-8ee6-b2c337535496" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true" continuedAt="F_9c7fd929-1d59-4064-8ee6-b2c337535496_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The shares in the table below were excluded from the calculation of diluted net loss per share due to their anti-dilutive effect: </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_9c7fd929-1d59-4064-8ee6-b2c337535496_1">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.96%;"></td>
        <td style="width:1.16%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.36%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.16%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.36%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br />2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br />2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c885868f-d249-49b7-b2a4-7cba7bd9d98c" contextRef="C_623d5c61-4653-419b-bf3c-247bbbbcf873" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,419,224</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c4464aa9-f15a-455f-97f5-80b0c875a7e3" contextRef="C_911f321f-1399-42d6-924b-a7af11513555" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">17,901,741</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c5ffe7f5-8db5-498c-93bc-b541f62166d0" contextRef="C_fec256c3-1d62-4da5-88de-9f274918ad60" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">559,117</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad73d19c-eafc-4eb8-8eeb-48c3f6354567" contextRef="C_b465d2c0-b208-43d9-8601-c79cda11d054" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">14,270</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ESPP shares issuable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2b16451d-b81c-452c-879f-29b1f71000cc" contextRef="C_8bc95105-86e8-4b58-bd13-577576fe83fb" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">32,410</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_06b38142-7d8a-41f1-8f3b-9b820b0cdee0" contextRef="C_7c3a2ba3-5a06-4c1a-8098-9614f0f55d00" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">14,889</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock issuable upon conversion of the 2027 Notes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0707758b-cbee-4b5b-a329-424242f7b798" contextRef="C_284250e0-ecad-485e-b02c-3498eba26ca3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,439,338</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5bd0dc13-73d3-4df0-8071-9821b8acac5d" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">26,450,089</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c9f302db-99cf-4724-ab70-7a94ebfee9ea" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">17,930,900</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_42ffd9b8-dcad-4ac4-bcfd-e50c5b6b92ac" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12. Income Taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2023 and 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_02e92101-d3a5-4dfc-9c34-7d9745ea23d5" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="cere:IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_0e15b131-d331-4263-bd00-387514799197" contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6" name="cere:IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t record income tax benefits for net operating losses incurred or for the research and development tax credits generated in each period due to the uncertainty of realizing a benefit from those items. Our tax provision and the resulting effective tax rate for interim periods is determined based upon our estimated annual effective tax rate, adjusted for the effect of discrete items arising during the interim quarterly period. The impact of such inclusions could result in a higher or lower effective tax rate during a particular quarterly period, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarterly period, we update our estimate of the annual effective tax rate, and if the estimated annual tax rate changes, a cumulative adjustment is made in that quarter.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have evaluated the positive and negative evidence bearing upon our ability to realize our deferred tax assets, which primarily consist of net operating loss carryforwards and research and development tax credits. We have considered our history of cumulative net losses, estimated future taxable income and prudent and feasible tax planning strategies, and have concluded that it is more likely than not that we will not realize the benefits of our deferred tax assets. As a result, as of March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we have recorded a full valuation allowance against our net deferred tax assets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c96930bd-135a-437d-86fc-29e0e80181b3" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:LegalMattersAndContingenciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13. Legal Proceedings</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We, from time to time, may be subject to various legal proceedings and claims that may arise in the ordinary course of business. We were not subject to any material legal proceedings as of March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and, to the best of our knowledge, no material legal proceedings are currently pending or threatened.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_378cc67b-3316-432e-a6d4-b7c236fcae5e" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14. Commitments and Contingencies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023, we have several ongoing clinical studies in various clinical trial stages. Our most significant contracts relate to agreements with CROs for clinical trials and preclinical studies and CMOs for the manufacturing of drug substance, which we enter into in the normal course of business. The contracts with CROs and CMOs are generally cancellable, with notice, at our option.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Guarantees and Indemnification Obligations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">enter into standard indemnification obligations in the ordinary course of business. Pursuant to these obligations, we indemnify and agree to reimburse the indemnified party for certain losses and costs incurred by the indemnified party. The term of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">these </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">indemnification obligations is generally perpetual after execution of the agreement. In addition, we have entered into indemnification obligations with members of our board of directors and our executive officers that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or executive officers. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited. To date, we have </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ef4303bc-539f-4b1e-b62c-97450b9edfd0" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="cere:LossOrMaterialCostsRelatedToIndemnificationObligation" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t incurred any losses or any material costs related to these indemnification obligations and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_60259fd0-09fc-41bb-aa68-6e8329b0935b" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="cere:ClaimsOutstanding" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> claims with respect thereto were outstanding. We do not believe that the outcome of any claims under indemnification arrangements will have a material effect on our financial position, results of operations and cash flows, and we have </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4dc2a493-f619-4a50-85e4-5eda46a0c136" contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d" name="us-gaap:ContractualObligation" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_0072bbf2-f25b-410b-8ba4-9615857a7e1d" contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e" name="us-gaap:ContractualObligation" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t accrued any liabilities related to such obligations in our condensed consolidated financial statements as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c4bad249-5a5a-4c8a-a729-b8a7e90cadb6" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15. Related Parties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Pfizer held </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c5481185-fe08-4b11-a0c3-71c4e5ef518e" contextRef="C_ddc57f0c-b90e-42fa-a10e-071a42e87507" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_1e0c798b-3685-46c0-9210-7e59a0820383" contextRef="C_7926166c-1158-47a0-bad4-4df4c981c1ea" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">27,349,211</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock and had nominated </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b30d029-cc66-4747-aa51-6f2a2ace7977" contextRef="C_ddc57f0c-b90e-42fa-a10e-071a42e87507" name="cere:NumberOfMembersNominatedToBoardOfDirectors" unitRef="U_Director" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_0be43598-2ddb-4be8-94bc-2cdc3e20f3cc" contextRef="C_7926166c-1158-47a0-bad4-4df4c981c1ea" name="cere:NumberOfMembersNominatedToBoardOfDirectors" unitRef="U_Director" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> members to our board of directors. For information related to our license agreement with Pfizer, please read Note 4, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pfizer License Agreement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Bain Investor held </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_49d2fd82-b859-4ea5-8e22-e2fefafc14d4" contextRef="C_47e87e92-f44a-4427-9ca3-b597abbae8dd" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_049bf8b8-2d50-4f01-8c89-972b21deb881" contextRef="C_2e9e51f7-25c0-4608-9ac4-8d13311a476a" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">60,632,356</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock and had nominated </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a629b3f9-c30d-43b0-9d09-578fef662a2a" contextRef="C_47e87e92-f44a-4427-9ca3-b597abbae8dd" name="cere:NumberOfMembersNominatedToBoardOfDirectors" unitRef="U_Director" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f76f04d2-573e-4d30-b1cc-0f111c843aec" contextRef="C_2e9e51f7-25c0-4608-9ac4-8d13311a476a" name="cere:NumberOfMembersNominatedToBoardOfDirectors" unitRef="U_Director" decimals="INF" format="ixt-sec:numwordsen">four</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> members to our board of directors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research Collaboration and License Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2022, we entered into a research collaboration and license agreement with Pfizer, pursuant to which we will collaborate to identify, screen and evaluate compounds directed at certain targets for neuroscience diseases using Pfizer&#x2019;s chemical library. Under the terms of the agreement, we will be required to reimburse Pfizer for certain research services and make a contingent development milestone payment and single-digit royalty payments on net sales of products containing one or more compounds derived from the collaboration. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2c6587a2-01ef-4576-a866-692d9669502e" contextRef="C_57afd6d7-6dec-4c48-81b7-57d06bc6ff76" name="cere:ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> amounts have been incurred under the agreement to date.</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Funding Agreement</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2021, we entered into a funding agreement with Bain, pursuant to which Bain will provide up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_17747c5d-6d39-40a2-b07c-109166cf4e6f" contextRef="C_529612ad-d864-4e48-8033-b7bbacbe0414" name="cere:ExpectedFundingReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">62.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in funding (the Bain Funding Commitment) to support our development of tavapadon for the treatment of Parkinson&#x2019;s disease over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_afaeb87c-3ba8-436f-b031-4016ece533d0" contextRef="C_d181ad3b-847c-47c7-bf08-243985685e37" name="cere:PeriodOverWhichFundingSupportReceived" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, of which approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_14fe3c92-6adf-4a5d-a5de-b00019275d06" contextRef="C_529612ad-d864-4e48-8033-b7bbacbe0414" name="cere:ReceivedFunding" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">15.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6e1da8a6-274f-4f0a-a6a4-d140c845924b" contextRef="C_d181ad3b-847c-47c7-bf08-243985685e37" name="cere:PercentageOfFundingReceived" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Bain Funding Commitment, net of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8c14d192-3a30-46f3-879a-f6522f660664" contextRef="C_d181ad3b-847c-47c7-bf08-243985685e37" name="cere:FundingCommitmentFeesIncurred" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of fees incurred by Bain) was received in April 2021, approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_622cdb3a-8db8-419d-ad86-353e94c153fe" contextRef="C_e18c341f-7f07-4b88-b7c8-d5a4564e49f7" name="cere:ReceivedFunding" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">18.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9246a32f-4d6e-4097-abd5-24aa33761918" contextRef="C_834332ad-3dba-4592-8eb7-930c35444385" name="cere:PercentageOfFundingReceived" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">30</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Bain Funding Commitment) was received in April 2022 and approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ce594d2e-af3c-4ecc-b430-34a397c7b901" contextRef="C_377cdbcd-01a6-4d76-a487-4dc2f01fee00" name="cere:ReceivedFunding" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">15.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d358cd26-8c17-4f69-b52e-24e2fe507029" contextRef="C_4bf2f962-7b29-42b6-974d-afe70add4992" name="cere:PercentageOfFundingReceived" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Bain Funding Commitment) was received in April 2023. For additional information related to our funding agreement with Bain, please read Note 5, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Management Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following the closing of the business combination in October 2020 pursuant to which ARYA Sciences Acquisition Corp II (ARYA) acquired Cerevel Therapeutics, Inc., with Cerevel Therapeutics, Inc. becoming a wholly-owned subsidiary of ARYA and ARYA being renamed Cerevel Therapeutics Holdings, Inc. (the Business Combination), we entered into a management agreement with Bain Capital Private Equity, LP and Bain Capital Life Sciences, LP, providing for the expense reimbursement and indemnification of such entities. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5baefca9-9509-44b8-a750-551f6df878ab" contextRef="C_9d7b2424-bafc-4343-b726-7e736ab93480" name="us-gaap:ManagementFeeExpense" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> amounts have been incurred under the management agreement to date.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to the Business Combination, please read Note 3, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business Combination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our audited consolidated financial statements included in our Annual Report.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b8013df0-14c9-49c3-86fe-ca4981db9446" contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16. Subsequent Events</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have completed an evaluation of all subsequent events after the unaudited balance sheet date of March 31, 2023, through May 3, 2023, the issuance date of these financial statements, to ensure that these unaudited condensed consolidated financial statements include appropriate disclosure of material events both recognized in these unaudited condensed consolidated financial statements as of March 31, 2023, and material events which occurred subsequently but were not recognized in these unaudited condensed consolidated financial statements. We have concluded that no such subsequent events other than the following have occurred that require disclosure:</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Funding Agreement Receipts</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the Funding Agreements, we received </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cd518aa2-a4a6-43a3-be10-b557c3a08506" contextRef="C_f130d7e4-71de-45ed-8562-45858d825a2a" name="cere:ReceivedFunding" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">31.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a368a650-f6d0-43b4-b234-345690c8a186" contextRef="C_a4ba2f01-2e93-4b42-9142-63c99321d789" name="cere:PercentageOfFundingReceived" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Total Funding Commitment) in April 2023. For additional information related to our Funding Agreements, please read Note 5, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_2_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2. Management&#x2019;s Discussion and Analysis of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Financial Condition and Results of Operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited condensed consolidated financial statements and notes thereto included elsewhere in this Quarterly Report, and the audited consolidated financial statements and accompanying notes, as well as Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations, contained in our Annual Report on Form 10-K for the year ended December 31, 2022, or our Annual Report. Certain of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report, including information with respect to plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the section entitled &#x201c;Risk Factors,&#x201d; our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. You should carefully read the section entitled &#x201c;Risk Factors&#x201d; to gain an understanding of the material and other risks that could cause actual results to differ materially from our forward-looking statements. Please also see the section entitled &#x201c;Cautionary Note Regarding Forward-Looking Statements.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overview</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Introduction</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biopharmaceutical company pursuing a targeted approach to neuroscience that combines a deep understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system, or CNS, target receptor selective pharmacology to discover and design new therapies. We seek to transform the lives of patients through the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer's disease psychosis, epilepsy, panic disorder and Parkinson&#x2019;s disease. We are advancing our extensive and diverse pipeline with numerous clinical trials underway or planned, including three ongoing Phase 3 trials and an open-label extension trial for tavapadon in Parkinson's, two ongoing Phase 2 trials and an open-label extension trial for emraclidine in schizophrenia, an ongoing Phase 2 proof-of-concept trial and an open-label extension trial for darigabat in focal epilepsy and a planned Phase 2 proof-of-concept trial for darigabat in panic disorder. See &#x201c;&#x2014;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our Pipeline</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; below. We have built a highly experienced team of senior leaders and neuroscience drug developers who combine a nimble, results-driven biotech mindset with the proven expertise of large pharmaceutical company experience and capabilities in drug discovery and development.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our portfolio of product candidates is based on a differentiated approach to addressing neuroscience diseases, which incorporates three key pillars: (1) targeted neurocircuitry, where we seek to unlock new treatment opportunities by precisely identifying and targeting the neurocircuit that underlies a given neuroscience disease, (2) targeted receptor subtype selectivity, where we selectively target the receptor subtype(s) related to the disease physiology to minimize undesirable off-target effects while maximizing activity and (3) differentiated pharmacology, where we design full and partial agonists, antagonists and allosteric modulators to precisely fine-tune the receptor pharmacology and neurocircuit activity to avoid over-activation or over-suppression of the endogenous physiologic range. In addition, our portfolio is supported by robust data packages and rigorous clinical trial execution designed to elucidate the key points of differentiation for our compounds. We believe that this science-driven approach is critical to achieving optimal therapeutic activity while minimizing unintended side effects of currently available therapies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Behind our portfolio stands a team with a multi-decade track record of drug approvals and commercial success. This track record has been driven by their extensive experience with empirically-driven clinical trial design and implementation, a history of successful interactions with regulatory agencies and relationships with global key opinion leaders. We believe that the distinctive combination of our management team and our existing pipeline has the potential to bring to patients the next generation of transformative neuroscience therapies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our Pipeline</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our current portfolio of programs. This table does not include multiple additional preclinical programs that have not yet been disclosed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><img src="img33027544_0.jpg" alt="img33027544_0.jpg" style="width:692px;height:538px;" />&#160;</p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our Lead Programs</span></p>
  <div style="margin-left:5.861%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.819469082951805%;">1.</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emraclidine is a positive allosteric modulator, or PAM, that selectively targets the muscarinic acetylcholine 4 receptor subtype, or M4. In June 2021, we announced positive topline results for a Phase 1b trial of emraclidine in schizophrenia, consisting of Part A, a multiple ascending dose, or MAD, assessment and Part B, a pharmacodynamic, or PD, assessment. Emraclidine demonstrated a clinically meaningful and statistically significant improvement in the Positive and Negative Syndrome Scale, or PANSS, total score at six weeks and was generally well tolerated compared with placebo at the two dose levels evaluated in Part B. We initiated two Phase 2 clinical trials in schizophrenia in June 2022 and a 52-week open-label extension trial to begin development of the required safety database in September 2022. Data are expected from the Phase 2 trials in the first half of 2024. In parallel, we will be prioritizing nonclinical and clinical safety pharmacology studies, including hepatic and renal insufficiency studies, along with other registration-enabling activities. In December 2022, we announced data from an eight-week ambulatory blood pressure monitoring trial providing clear evidence that emraclidine does not induce an increase in blood pressure with chronic dosing in people living with schizophrenia. </span></div></div>
  <p style="margin-left:10.4%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we plan to evaluate the potential of this mechanism in other populations, including Alzheimer&#x2019;s disease psychosis. We initiated a Phase 1 trial evaluating the safety, tolerability and pharmacokinetics, or PK, in elderly healthy volunteers in December 2022 to support the future development of emraclidine in Alzheimer's disease psychosis. In the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:10.4%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fourth quarter of 2022, the FDA granted Fast Track Designation for emraclidine for the treatment of hallucinations and delusions associated with Alzheimer's disease psychosis.</span></p>
  <div style="margin-left:5.861%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.819469082951805%;">2.</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Darigabat is a PAM that selectively targets the alpha-2/3/5 subunits of the GABA</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:sub;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> receptor. In the second half of 2020, we initiated a Phase 2 proof-of-concept trial, known as REALIZE, in patients with drug-resistant focal onset seizures, or focal epilepsy. Data from the REALIZE trial are expected mid-year 2024. </span></div></div>
  <p style="margin-left:10.4%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2022, we announced positive topline results for a Phase 1 trial of darigabat in a panic symptoms model in healthy volunteers. Both doses of darigabat demonstrated clinically meaningful and statistically significant anxiolytic activity compared with placebo in this proof-of-principle trial. Darigabat was generally well tolerated, with no serious adverse events and no discontinuations in the darigabat cohorts. We intend to initiate a Phase 2 proof-of-concept trial of darigabat in panic disorder in the second quarter of 2023.</span></p>
  <div style="margin-left:5.861%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.819469082951805%;">3.</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tavapadon is a selective dopamine D1/D5 receptor partial agonist that we are developing for the treatment of Parkinson&#x2019;s disease. We initiated a registration-directed Phase 3 program for tavapadon beginning in January 2020, which includes two trials as monotherapy in early-stage Parkinson&#x2019;s, known as TEMPO-1 and TEMPO-2, one trial as adjunctive therapy in late-stage Parkinson&#x2019;s, known as TEMPO-3, and an open-label extension trial, known as TEMPO-4. Data are expected from the TEMPO-3 trial in the first half of 2024 and the TEMPO-1 and TEMPO-2 trials in the second half of 2024.</span></div></div>
  <div style="margin-left:5.861%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.819469082951805%;">4.</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CVL-871 is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a modest level of partial agonism, which we believe may be useful in modulating the complex neural networks that govern cognition, motivation and apathy behaviors in neurodegenerative diseases. In the second quarter of 2021, the FDA granted Fast Track Designation for CVL-871 for the treatment of dementia-related apathy. We are conducting a Phase 2a exploratory trial in dementia-related apathy. Data are expected from this Phase 2a exploratory trial in the second half of 2024.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that our lead programs have target product profiles that may enable them to become backbone therapies in their respective lead indications, either replacing standards of care as monotherapies or enhancing treatment regimens as adjunct to existing therapies. Results from the clinical trials mentioned above will guide the potential development of our product candidates in additional indications with similar neurocircuitry deficits.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our Other Programs</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to the lead programs described above, we plan to further characterize and appropriately advance our early clinical and preclinical pipeline across multiple potential neuroscience indications. Our other programs include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CVL-354, our selective kappa opioid receptor antagonist, or KORA, for the treatment of major depressive disorder, or MDD, and substance use disorder, for which we initiated a Phase 1 PET receptor occupancy trial in healthy volunteers in March 2023; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our selective PDE4 inhibitor (PDE4D-sparing) program for the treatment of psychiatric, neuroinflammatory and other disorders; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our selective M4 agonist program for the treatment of psychiatric and neurological indications; </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also pursuing other undisclosed targets, including those with disease-modifying potential for leading neuroscience diseases. These programs include those initiated by Pfizer as well as others developed internally through the application of human genetic analyses and new technology platforms, such as artificial intelligence and DNA-encoded chemical libraries, to establish novel chemical lead series that are designed to enable better understanding of therapeutic potential.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business Environment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The biopharmaceutical industry is extremely competitive. We are subject to risks and uncertainties common to clinical-stage companies in the biopharmaceutical industry. These risks include, but are not limited to, the introduction of new products, therapies, standards of care or technological innovations, our ability to obtain and maintain adequate protection for our in-licensed technology, data or other intellectual property and proprietary rights and compliance with extensive government regulation and oversight. We are also dependent upon the services of key personnel, including our Chief Executive Officer, executive team and other highly skilled employees. Demand for experienced personnel in the pharmaceutical and biotechnology industries is high and competition for talent is intense. Please read the section entitled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risk Factors</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; for additional information.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We face potential competition from many different sources, including pharmaceutical and biotechnology companies, academic institutions and governmental agencies, as well as public and private research institutions. Many of our competitors are working to develop or have commercialized products similar to those we are developing and have considerable experience in undertaking clinical trials and in obtaining regulatory approval to market pharmaceutical products. Our competitors may also have significantly greater financial resources, established presence in the market, expertise in research and development, manufacturing, preclinical and clinical</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">testing, obtaining regulatory approvals and reimbursement and marketing approved products. Other smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties also compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our financial condition and results of operations may also be impacted by other factors we may not be able to control, such as global supply chain disruptions, global trade disputes and/or political instability. Increases in interest rates, especially if coupled with reduced government spending and volatility in financial markets, may have the effect of further increasing economic uncertainty and heightening these risks. Additionally, rising inflation rates may affect us by increasing operating expenses, such as employee-related costs and clinical trial expenses, and as a result negatively impacting our results of operations.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risks and Liquidity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Product development is very expensive and involves a high degree of risk. Only a small number of research and development programs result in the commercialization of a product. We will not generate revenue from product sales unless and until we successfully complete clinical development, are able to obtain regulatory approval for and successfully commercialize the product candidates we are developing or may develop. We currently do not have any product candidates approved for commercial sale. In addition, we operate in an environment of rapid change in technology. We are also dependent upon the services of our employees, consultants, third-party contract research organizations, or CROs, third-party contract manufacturing organizations, or CMOs, and other third-party organizations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our product candidates, currently under development or that we may develop, will require significant additional research and development efforts, including extensive clinical testing and regulatory approval prior to commercialization. These efforts require significant amounts of additional capital, adequate personnel infrastructure and extensive compliance and reporting capabilities. There can be no assurance that our research and development activities will be successfully completed, that adequate protection for our licensed or developed technology will be obtained and maintained, that products developed will obtain necessary regulatory approval or that any approved products will be commercially viable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that our available financial resources will enable us to fund our operating expense and capital expenditure requirements through at least 12 months from the issuance date of our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report. Our estimate may prove to be wrong, and we could use our available capital resources sooner than we currently expect. Further, changing circumstances, some of which may be beyond our control, could cause us to consume capital significantly faster than we currently anticipate, and we may need to seek additional funds sooner than planned.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the future, we will require additional capital to meet operational needs and capital requirements. We are eligible to receive up to $125.0 million pursuant to the Funding Agreements (as defined herein), of which approximately $31.1 million (net of $0.2 million of fees), $37.5 million and $31.3 million was received in April 2021, April 2022 and April 2023, respectively, and $25.0 million is expected to be received in April 2024, subject to certain customary funding conditions. Except for this source of funding, we do not have any committed external source of liquidity. Until such time, if ever, as we can generate substantial product revenue, we will need substantial additional funding to support our continuing operations and pursue our growth strategy, and we may finance our operations through a combination of additional private or public equity offerings, debt financings, collaborations, strategic alliances, marketing, distribution or licensing arrangements with third parties or through other sources of financing. We intend to consider opportunities to raise additional funds through the sale of equity or debt securities when market conditions are favorable for us to do so. In addition, we may seek additional capital due to favorable market conditions or strategic considerations, even if we believe that we have sufficient funds for our current or future operating plans. However, the trading prices for our common stock and for other biopharmaceutical companies have been highly volatile. As a result, we may face difficulties raising capital through sales of our common stock or such sales may be on unfavorable terms. Similarly, adverse market or macroeconomic conditions or market volatility resulting from global economic developments, political unrest, high inflation, the post-COVID environment or other factors, could materially and adversely affect our ability to consummate an equity or debt financing on favorable terms, or at all. To the extent that we raise additional capital through the sale of private or public equity or convertible debt securities, the ownership interest of our stockholders will be diluted, and the terms of these securities may include liquidation or other preferences and anti-dilution protections that could adversely affect the rights of our common stockholders. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends, that could adversely impact our ability to conduct our business. If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or drug candidates, or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, limit, reduce or terminate our research, product development or future commercialization efforts, grant rights to develop and market product candidates that we would otherwise prefer to develop and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">market ourselves, obtain funds through arrangement with collaborators on terms unfavorable to us or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of our stockholders.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred significant operating losses since our inception and, as of March 31, 2023, we had not yet generated revenues. We have funded our operations primarily with the net proceeds received from the issuance of preferred stock, common stock and convertible senior notes, net proceeds from the consummation of our Business Combination (as defined herein) and our Funding Agreements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we anticipate that our expenses will increase substantially if, and as, we:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">advance our clinical-stage product candidates through clinical development, including as we advance these candidates into later-stage clinical trials;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seek regulatory approvals for any product candidates that successfully complete clinical trials;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hire additional clinical, quality control, medical, scientific and other technical personnel to support our clinical operations;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">experience an increase in headcount as we expand our research and development organization and market development and pre-commercial planning activities; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">undertake any pre-commercial or commercial activities to establish sales, marketing and distribution capabilities;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">advance our preclinical-stage product candidates into clinical development; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seek to identify, acquire and develop additional product candidates, including through business development efforts to invest in or in-license other technologies or product candidates;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maintain, expand and protect our intellectual property portfolio; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">make milestone, royalty or other payments due under the Pfizer License Agreement and any future in-license or collaboration agreements; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">make milestone, royalty, interest or other payments due under the Funding Agreements, our 2027 Notes and any future financing or other arrangements with third parties. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Components of Operating Results</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenues</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have not generated any revenues since our inception and do not expect to generate any revenues from the sale of products in the near future, if at all. If our development efforts for our current product candidates or additional product candidates that we may develop in the future are successful and can be commercialized, we may generate revenue in the future from product sales. Additionally, we may enter into collaboration and license agreements from time to time that provide for certain payments due to us. Accordingly, we may generate revenue from payments from such collaboration or license agreements in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We support our drug discovery and development efforts through the commitment of significant resources to our preclinical and clinical development activities. Our research and development expense includes:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">employee-related expenses, consisting of salaries, benefits and equity-based compensation for personnel engaged in our research and development activities; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expenses incurred in connection with the preclinical and clinical development of our product candidates, including costs incurred under agreements with CROs and investigative clinical trial sites;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expenses incurred with consultants and other third parties who supplement our internal capabilities and conduct research and development activities on our behalf; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">costs associated with research materials and supplies and services associated with our laboratory; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">materials and supply costs associated with the manufacture of drug substance and drug product for preclinical testing and clinical trials; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">certain indirect costs incurred in support of overall research and development activities, including facilities, depreciation and technology expenses. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expense research and development expenses as incurred. Payments we make for research and development services prior to the services being rendered are recorded as prepaid assets in our consolidated balance sheets and are expensed as the services are provided. We estimate and accrue the value of goods and services received from CROs, CMOs and other third parties each reporting period based on estimates of the level of services performed and progress in the period when we have not received an invoice from such organizations. When evaluating the adequacy of accrued liabilities, we analyze progress of the studies or clinical trials, including the phase of completion of events, invoices received and contracted costs. We reassess and adjust our accruals as actual costs become known or as additional information becomes available. Our historical accrued estimates have not been materially different from actual costs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our external research and development expenses for our clinical stage product candidates are tracked on a program-by-program basis and consist primarily of fees, reimbursed materials and other costs paid to consultants, contractors, CROs and CMOs. External research and developments costs that directly support our discovery activities and preclinical programs are classified within other research and development programs. Program costs for the periods presented do not reflect an allocation of expenses associated with personnel costs, equity-based compensation expense, activities that benefit multiple programs or indirect costs incurred in support of overall research and development, such as technology and facilities-related costs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect that our annual research and development expenses will increase substantially in connection with our planned preclinical and clinical development activities both in the near-term and beyond as we continue to invest in activities to develop our product candidates and preclinical programs and as certain product candidates advance into later stages of development. Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size, scope and duration of later-stage clinical trials. Furthermore, the process of conducting the necessary clinical trials to obtain regulatory approval is costly and time-consuming, and the successful development of our product candidates is highly uncertain. As a result, we cannot accurately estimate or know the nature, timing and costs that will be necessary to complete the preclinical and clinical development for any of our product candidates or when and to what extent we may generate revenue from the commercialization and sale of any of our product candidates or achieve profitability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The duration, costs and timing of clinical trials and development of our product candidates will depend on a variety of factors that include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">per patient trial costs; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of patients that participate in the trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of sites included in the trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the countries in which the trials are conducted; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the length of time required to enroll eligible patients; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of doses that patients receive; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the drop-out or discontinuation rates of patients; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential additional safety monitoring or other studies requested by regulatory agencies; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the duration of patient follow-up; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the efficacy and safety profile of our product candidates; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the impact of adverse macroeconomic, labor and other market conditions on our supply chain and clinical trial operations and timelines.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in any of these assumptions could significantly impact the cost and timing associated with the development of our product candidates. Additionally, future competition and commercial and regulatory factors beyond our control may also impact our clinical development programs and plans.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General and Administrative</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expense general and administrative costs as incurred. General and administrative expenses consist primarily of salaries, benefits and equity-based compensation for personnel in executive, finance, human resources, market research and development, legal and other corporate functions. General and administrative expenses also include legal fees incurred relating to corporate and patent matters, professional fees incurred for auditing, consulting services, market development and pre-commercial planning activities, and insurance costs, facilities-related costs and depreciation expenses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We estimate and accrue for services provided by third parties related to the above expenses by monitoring the status of services provided and receiving estimates from our service providers. We reassess and adjust our accruals as actual costs become known or as additional information becomes available.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect that our annual general and administrative expenses will increase both in the near-term and beyond as we continue to build general corporate infrastructure to support the growth of our organization as we expand our research and development organization and market development and pre-commercial planning activities.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Income (Expense), Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income consists of interest earned on our cash, cash equivalents, marketable securities and restricted cash. Interest expense consists of interest charged on the outstanding principal balance of the 2027 Notes and amortization of debt issuance costs utilizing the effective interest method over the expected term of the 2027 Notes.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income (Expense), Net</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net primarily consists of gains (losses) on the fair value remeasurement of our financing liabilities. Other income (expense), net also reflects amounts for other miscellaneous income and expense unrelated to our core operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As permitted under ASC 825, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we elected the Fair Value Option for our financing liabilities, wherein the financial instruments were initially measured at their issue-date estimated fair value and are subsequently remeasured at estimated fair value on a recurring basis at each reporting period date. Changes in the fair value of our financing liabilities, excluding the impact of the change in fair value attributable to instrument-specific credit risk, are separately presented as a component of other income (expense), net in our consolidated statements of operations and comprehensive loss. The portion of the fair value adjustment attributed to a change in the instrument-specific credit risk is recognized and separately presented as a component of other comprehensive income (loss). Changes in the fair value of our financing liabilities can result from changes to one or multiple inputs, including changes to discount rates, changes in the expected achievement or timing of any sales-based, development and regulatory milestones, changes in the amount or timing of expected net cash flows, changes in the probability or timing of certain clinical events and changes in the assumed probability or timing associated with regulatory approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant judgment is employed in determining the appropriateness of the assumptions underlying the initial fair value determination for each of these instruments and for each subsequent period through their settlement or termination.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Tax Benefit (Provision), Net</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To date, we have not recorded any significant amounts related to income tax expense, we have not recognized any reserves related to uncertain tax positions, nor have we recorded any income tax benefits for net operating losses incurred to date or for our research and development tax credits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We account for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in our consolidated financial statements or our tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax bases of existing assets and liabilities and for loss and credit carryforwards, which are measured using the enacted tax rates and laws in effect in the years in which the differences are expected to reverse. The realization of our deferred tax assets is dependent upon the generation of future taxable income, the amount and timing of which are uncertain. Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of March 31, 2023, we continue to maintain a full valuation allowance against all of our deferred tax assets based on our evaluation of all available evidence.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We file income tax returns in the U.S. federal tax jurisdiction and state jurisdictions and may become subject to income tax audits and adjustments by related tax authorities. Our initial tax return period for U.S. federal income taxes was the 2018 period. We currently remain open to examination under the statute of limitations by the Internal Revenue Service and state jurisdictions for the 2021, 2020 and 2019 tax years. To the extent we have loss and credit carryforwards, the tax years in which the carryforward was generated may still be adjusted upon examination by the Internal Revenue Service or state tax authorities to the extent utilized in a future period. We record reserves for potential tax payments to various tax authorities related to uncertain tax positions. The nature of uncertain tax positions is subject to significant judgment by management and subject to change, which may be substantial. These reserves are based on a determination of whether and how much a tax benefit taken by us in our tax filings or positions is more likely than not to be realized following the resolution of any potential contingencies related to the tax benefit. We develop our assessment of uncertain tax positions, and the associated cumulative probabilities, using internal expertise and assistance from third-party experts. As additional information becomes available, estimates are revised and refined. Differences between estimates and final settlement may occur resulting in additional tax expense. Potential interest and penalties associated with such uncertain tax positions is recorded as a component of our income tax benefit (provision), net. To date, no amounts are being presented as an uncertain tax position.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Results of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our results of operations:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.365%;"></td>
    <td style="width:1.397%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.695%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.397%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.615%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.998%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.533%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78,181</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55,023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,370</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,507</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99,551</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72,530</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(99,551</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(72,530</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income (expense), net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,440</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">295</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2083</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(11,090</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,941</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(381</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss before income taxes</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(104,201</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(68,294</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax benefit (provision), net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(85</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">**</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(104,286</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(68,294</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">** &#x2013; Not meaningful</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the components of research and development expense:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.745%;"></td>
    <td style="width:1.277%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.675%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.277%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.495000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.998%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.533%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tavapadon</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,479</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,449</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emraclidine</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,971</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,673</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">127</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Darigabat</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,547</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,411</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CVL-871</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">944</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">880</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other research and development programs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,093</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,966</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(15</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unallocated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,678</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,427</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Personnel costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,130</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,211</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity-based compensation</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,339</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,006</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78,181</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55,023</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2023, compared to the same period in 2022, the increase in research and development expense primarily reflects increased spending associated with our emraclidine program as well as an increase in personnel costs and equity-based compensation. The increase in costs associated with our emraclidine program was due to the advancement of our two ongoing Phase 2 trials and an open-label extension trial for emraclidine in schizophrenia as well as our Phase 1 trial of emraclidine to support future development in Alzheimer's disease psychosis, partially offset by a reduction in costs associated with our emraclidine ambulatory blood monitoring trial that was completed in December 2022. The increase in personnel costs and equity-based compensation reflects the continued growth of our workforce as we expand capabilities to advance our pipeline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2023 and 2022, expense associated with other research and development programs was reduced by $0.1 million and $0.9 million, respectively, related to the reimbursement of certain research and development costs received from the National Institute of Drug Abuse, or NIDA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General and Administrative</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.93%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.715%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.535%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.256%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,370</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,507</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2023, compared to the same period in 2022, the increase in general and administrative expense was primarily due to higher personnel costs, including equity-based compensation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Income (Expense), Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.411%;"></td>
    <td style="width:1.398%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.705%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.398%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.625%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.464%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,076</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">295</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2977</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2,636</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">**</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total interest income (expense), net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,440</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">295</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2083</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income, net primarily consists of interest earned on our cash, cash equivalents, marketable securities and restricted cash. For the three months ended March 31, 2023, compared to the same period in 2022, the increase in interest income, net, reflects a higher average comparable cash, cash equivalent and marketable security balance and higher returns earned on our marketable securities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense consists of interest accrued on the principal balance of the 2027 Notes issued in August 2022 and the amortization of debt issuance costs. For additional information related to the 2027 Notes, please read Note 6, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2027 Convertible Senior Notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income (Expense), Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the components of other income (expense), net:</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:56.418%;"></td>
    <td style="width:1.358%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.477%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.358%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.718%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.998%;"></td>
    <td style="width:0.998%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.315999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.358%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br />March 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain (loss) on fair value remeasurement of financing liability, related party</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(5,541</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,970</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(381</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain (loss) on fair value remeasurement of financing liability</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(5,541</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,970</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(381</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(8</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(900</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(11,090</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,941</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(381</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2023, other income (expense), net primarily reflects net losses recognized on the fair value remeasurement of our financing liabilities associated with the Funding Agreements that were entered into in April 2021. The changes in the fair value remeasurement of our financing liabilities associated with the Funding Agreements were due to the impact of changes in market inputs, such as risk-free rates, and the passage of time.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2022, other income (expense), net primarily reflects net gains recognized on the fair value remeasurement of our financing liabilities associated with the Funding Agreements that were entered into in April 2021. The changes in the fair value remeasurement of our financing liabilities associated with the Funding Agreements were primarily due to the impact of adjustments to our discount rates and credit spread, resulting from increases in the risk-free rates, partially offset by the passage of time.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to the fair value of our financing liabilities associated with the Funding Agreements, please read Note 5, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and Note 7, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fair Value Measurements,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liquidity and Capital Resources</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sources of Liquidity and Capital</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred significant operating losses since our inception, and we expect to continue to incur significant and increasing expenses and operating losses for the foreseeable future. Our net losses totaled $104.3 million and $68.3 million for the three months ended March 31, 2023 and 2022, respectively. We have not yet generated revenues.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our cash, cash equivalents and marketable securities totaled $863.0 million as of March 31, 2023. Until required for use in our business, we typically invest our cash in money market funds and investment grade short to intermediate-term fixed income securities. We attempt to minimize credit risk related to our cash, cash equivalents and marketable securities by maintaining balances primarily in custodial accounts only with accredited financial institutions and maintaining a well-diversified portfolio that limits the amount of exposure as to institution, maturity, and investment type.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2020, ARYA Sciences Acquisition Corp II, or ARYA, completed the acquisition of Cerevel Therapeutics, Inc., a private company, pursuant to the Business Combination Agreement dated July 29, 2020, as amended on October 2, 2020. We refer to this transaction as the Business Combination. Net proceeds from the Business Combination totaled approximately $439.5 million. Upon closing of the Business Combination, Cerevel Therapeutics, Inc. became a wholly owned subsidiary of ARYA and ARYA was</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">renamed Cerevel Therapeutics Holdings, Inc., and the then existing stockholders of Cerevel Therapeutics, Inc. exchanged their equity interests of Cerevel Therapeutics, Inc. for shares of common stock of Cerevel Therapeutics Holdings, Inc. Prior to the Business Combination, our operations were funded primarily from the issuance of convertible preferred stock, convertible common stock and common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the consummation of the Business Combination, there were 4,983,314 public warrants and 166,333 private placement warrants, or collectively, the warrants, outstanding. Each outstanding warrant of ARYA became one warrant to purchase one share of our common stock. Each whole warrant entitled the holder to purchase one share of our common stock at an exercise price of $11.50 per share. The warrants became exercisable beginning on June 9, 2021. In July 2021, we announced the redemption of all of the outstanding public warrants with a redemption date of August 30, 2021, or the Redemption Date. An aggregate of 4,822,947 public warrants were exercised prior to the Redemption Date for an equal number of shares of our common stock resulting in gross proceeds of approximately $55.5 million. The 160,367 public warrants that remained unexercised following the Redemption Date were redeemed for the redemption price of $0.01 per public warrant. In September 2021, the 166,333 private placement warrants were cashless exercised and settled in exchange for the issuance of 111,426 shares of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2021, we entered into a funding agreement, or the NovaQuest Funding Agreement, with NovaQuest Co-Investment Fund XVI, L.P., or NovaQuest, and a funding agreement, or the Bain Funding Agreement, with BC Pinnacle Holdings, LP, or Bain, pursuant to which NovaQuest and Bain will provide up to $125.0 million in funding, or the Total Funding Commitment, to support our development of tavapadon for the treatment of Parkinson&#x2019;s disease over four years, of which approximately $31.1 million (25% of the Total Funding Commitment, net of $0.2 million of fees incurred by Bain and NovaQuest) was received in April 2021, $37.5 million (30% of the Total Funding Commitment) was received in April 2022, $31.3 million (25% of the Total Funding Commitment) was received in April 2023 and $25.0 million (20% of the Total Funding Commitment) is expected to be received in April 2024, subject to certain customary funding conditions. We refer to the NovaQuest Funding Agreement and the Bain Funding Agreement, collectively, as the Funding Agreements and NovaQuest and Bain, collectively, as the Funding Investors.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In July 2021, we completed a follow-on public offering of our common stock pursuant to which we issued and sold 14,000,000 shares of our common stock at a price to the public of $25.00 per share. The aggregate net proceeds from this offering totaled approximately $328.3 million, after deducting underwriting discounts and commissions of $21.0 million and offering expenses of approximately $0.7 million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In November 2021, we entered into an open market sales agreement with Jefferies LLC, as sales agent, to provide for the issuance and sale of up to $250.0 million of our common stock from time-to-time in &#x201c;at-the-market&#x201d; offerings, or the ATM Program. As of March 31, 2023, no sales had been made pursuant to the ATM Program.</span></p>
  <p style="text-indent:4.267%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2022, we completed a follow-on public offering of our common stock pursuant to which we issued and sold 7,250,000 shares of our common stock at a price to the public of $35.00 per share. The aggregate net proceeds from this offering totaled approximately $238.3 million, after deducting underwriting discounts and commissions of $14.6 million and offering expenses of approximately $0.9 million.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2022, we completed the offering of $345.0 million aggregate principal amount of the 2027 Notes pursuant to, and which are governed by, an indenture, or the Indenture, between us and U.S. Bank Trust Company, National Association, as trustee, or the Trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, or the Securities Act. The aggregate net proceeds from the 2027 Notes offering totaled approximately $334.8 million, after deducting the initial purchasers' discounts of $9.5 million and other offering expenses of approximately $0.7 million.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Future Funding Requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our primary use of cash is to fund operating expenses, primarily related to our research and development activities. Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our outstanding accounts payable, accrued expenses and prepaid expenses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred significant operating expenses since our inception, and we expect to continue to incur significant and increasing expenses and operating losses for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our future funding requirements will depend on many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, progress, results and costs of researching and developing our current product candidates, as well as other additional product candidates we may develop and pursue in the future; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing of, and the costs involved in, obtaining marketing approvals for our product candidates and any other additional product candidates we may develop and pursue in the future; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of future product candidates that we may pursue and their development requirements; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to receipt of regulatory approval, the costs of commercialization activities for our product candidates, to the extent such costs are not the responsibility of any future collaborators, including the costs and timing of establishing product sales, marketing, distribution and manufacturing capabilities; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to receipt of regulatory approval, revenue, if any, received from commercial sales of our product candidates or any other additional product candidates we may develop and pursue in the future; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the achievement of milestones that trigger payments under the Pfizer License Agreement and the Funding Agreements; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the royalty payments due under the Pfizer License Agreement and the Funding Agreements; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we in-license or acquire rights to other products, product candidates or technologies; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish collaboration arrangements for the development of our product candidates on favorable terms, if at all; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our receipt of additional funding under the Funding Agreements;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the settlement method used for the outstanding 2027 Notes;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our headcount growth and associated costs as we expand our research and development and market development and pre-commercial planning activities; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and protecting our intellectual property rights, including enforcing and defending intellectual property related claims; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of operating as a public company. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because of the numerous risks and uncertainties associated with the development and commercialization of our product candidates, we are unable to estimate the total amounts of increased capital outlays and operating expenditures associated with our current and anticipated clinical trials and preclinical studies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our expectations with respect to our ability to fund current planned operations is based on estimates that are subject to risks and uncertainties. Our operating plan may change as a result of many factors currently unknown to us and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by us, and we may need to seek additional funds sooner than planned.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information on risks associated with our substantial capital requirements, please read the sections entitled </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#x201c;&#x2014;Risks and Liquidit</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">y</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#x201d;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risk Factors</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; included elsewhere in this Quarterly Report.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Working Capital</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our total working capital, defined as current assets less current liabilities:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.526%;"></td>
    <td style="width:1.401%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.751000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.401%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.751000000000001%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.401%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.77%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br />2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br />2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">840,782</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">905,651</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(7</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(62,957</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(72,564</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(13</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total working capital</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">777,825</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">833,087</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(7</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The decrease in working capital at March 31, 2023 from December 31, 2022, reflects a net decrease in total current assets of $64.9 million, partially offset by a net decrease in total current liabilities of $9.6 million.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The net decrease in total current assets was primarily driven by cash used in operations as discussed in further detail below.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The net decrease in current liabilities was primarily due to decreases in accrued expenses and other current liabilities, primarily related to the timing of payments associated with accrued employee compensation and other personnel costs and accrued interest on the 2027 Notes, partially offset by increases in accrued external research and development services.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flows</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our sources and uses of cash:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.046%;"></td>
    <td style="width:1.497%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.695%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.497%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.695%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.018%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.552%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended <br />March 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash flows used in operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(94,923</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(67,648</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash flows provided by (used in) investing activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110,783</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(38,542</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(387</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash flows provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,435</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,603</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(45</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net increase (decrease) in cash, cash equivalents and restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,295</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(103,587</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(117</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)%</span></p></td>
   </tr>
  </table>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flows Used in Operating Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash flows used in operating activities represent the cash receipts and disbursements related to all of our activities other than investing and financing activities. We expect cash provided by financing activities will continue to be our primary source of funds to finance operating needs and capital expenditures for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash flows used in operating activities is derived by adjusting our net loss for:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">non-cash operating items such as depreciation and amortization, adjustments to operating lease expense, equity-based compensation, amortization of debt issuance costs and amortization of premiums and accretion of discounts on marketable securities; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in operating assets and liabilities reflecting timing differences between the receipt and payment of cash associated with transactions and when they are recognized in results of operations; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in the fair value remeasurement of our financing liabilities. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2023, cash used in operating activities primarily reflects our net loss for the period of $104.3 million, adjusted for net non-cash adjustments totaling $20.0 million and a net change of $10.6 million in our net operating assets and liabilities. Our non-cash adjustments primarily consisted of $12.6 million of equity-based compensation expense and $11.1 million associated with the change in fair value of financing liabilities associated with the Funding Agreements. The net changes in our operating assets and liabilities primarily reflects decreases in accrued expenses and other liabilities and accounts payable. The net decrease in accrued expenses and other liabilities was primarily related to the timing of payments associated with accrued employee compensation and other personnel costs as well as accrued interest on the 2027 Notes, offset by increases in accruals related to external research and development services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2022, cash used in operating activities primarily reflects our net loss for the period of $68.3 million, adjusted for net non-cash adjustments totaling $6.1 million and a net change of $5.4 million in our net operating assets and liabilities. Our non-cash adjustments primarily consisted of $8.6 million of equity-based compensation expense, partially offset by the fair value remeasurement of our financing liabilities associated with the Funding Agreements totaling $3.9 million. The net changes in our operating assets and liabilities reflects a decrease in accrued expenses and other liabilities, a decrease in accounts payable and a decrease in prepaid expenses and other current assets. The net decrease in accrued expenses and other liabilities was primarily driven by a decrease in accrued compensation and other personnel costs, partially offset by increases in accruals related to purchases of property and equipment and professional fees and consulting services. The decrease in prepaid expenses and other current assets was primarily due to the recognition of expenses for prepaid insurance premiums, software licenses and advances related to clinical trial services.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flows Provided by (Used in) Investing Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2023, net cash provided by investing activities reflected $298.8 million of maturities and redemptions of marketable securities, partially offset by $187.6 million used for purchases of marketable securities and $0.3 million used for purchases of property and equipment.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2022, net cash used in investing activities reflected $60.2 million used for purchases of marketable securities and $2.2 million used for purchases of property and equipment, partially offset by $23.9 million in maturities and redemptions of marketable securities.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flows Provided by Financing Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2023, net cash provided by financing activities primarily reflected $1.6 million of proceeds received from the exercise of stock options.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2022, net cash provided by financing activities primarily reflected $2.9 million of proceeds received from the exercise of stock options.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contractual Obligations and Other Commitments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our contractual obligations primarily consist of our obligations under non-cancellable operating leases, convertible debt obligations, contracts and other purchase obligations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our most significant contracts relate to agreements with CROs for clinical trials and preclinical studies, CMOs and other service providers for operating purposes, which we enter into in the normal course of business. These contracts are generally cancelable at any time by us following a certain period after notice and therefore, we believe that our non-cancelable obligations under these agreements are not material. In addition, we have obligations with respect to potential future royalties payable, contingent development, regulatory and commercial milestone payments and potential amounts related to uncertain tax positions. The timing and amount of such obligations are unknown or uncertain as of March 31, 2023.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pfizer License Agreement</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2018, we entered into a license agreement with Pfizer, or the Pfizer License Agreement, pursuant to which we were granted an exclusive, sublicensable, worldwide license under certain Pfizer patent rights, and a non-exclusive, sublicensable, worldwide license under certain Pfizer know-how to develop, manufacture and commercialize certain compounds and products, which currently constitute substantially all of our asset portfolio, in the field of treatment, prevention, diagnosis, control and maintenance of all diseases and disorders in humans, subject to the terms and conditions of the Pfizer License Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the Pfizer License Agreement, we are solely responsible for the development, manufacture, regulatory approval and commercialization of compounds and products in the field and we will pay Pfizer tiered royalties on the aggregate net sales during each calendar year, determined on a product-by-product basis, with respect to products under the Pfizer License Agreement, and we may pay potential milestone payments to Pfizer, based on the successful achievement of certain regulatory and commercial milestones. To date, no regulatory or commercial approval milestone payments or royalty payments have been made or become due under this agreement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information on our Pfizer License Agreement, please read Note 4, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pfizer License Agreement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Funding Agreements</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2021, we entered into the Funding Agreements, pursuant to which we will receive a combined total of up to $125.0 million to support our development of tavapadon for the treatment of Parkinson&#x2019;s disease, of which approximately $31.1 million (25% of the Total Funding Commitment, net of $0.2 million of fees incurred by Bain and NovaQuest) was received in April 2021, $37.5 million (30% of the Total Funding Commitment) was received in April 2022, $31.3 million (25% of the Total Funding Commitment) was received in April 2023 and $25.0 million (20% of the Total Funding Commitment) is expected to be received in April 2024, subject to certain customary funding conditions. In return, we agreed to pay NovaQuest and Bain significant regulatory milestone, sales milestone and royalty payments upon approval of tavapadon by the FDA that collectively will not exceed $531.3 million. In addition, we have the option to satisfy our payment obligations to NovaQuest and Bain upon the earlier of FDA approval or May 1, 2025, by paying an amount equal to the Total Funding Commitment multiplied by an initial factor of 3.00x. This factor will increase ratably over time up to a maximum of 4.25x, less amounts previously paid to NovaQuest and Bain.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to our Funding Agreements, please read Note 5, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2027 Convertible Senior Notes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2022, we completed the offering of $345.0 million aggregate principal amount of the 2027 Notes pursuant to, and which are governed by the Indenture between us and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2027 Notes accrue interest at a rate of 2.50% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2023. The 2027 Notes mature on August 15, 2027, unless earlier converted, redeemed or repurchased. We will settle conversions by paying or delivering, as applicable, cash, shares of our common stock or a combination of cash and shares of our common stock, at our election.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2027 Notes are our senior, unsecured obligations and are (i) equal in right of payment with our existing and future senior, unsecured indebtedness; (ii) senior in right of payment to our existing and future indebtedness that is expressly subordinated to the 2027 Notes in right of payment; (iii) effectively subordinated to our future secured indebtedness, to the extent of the value of the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collateral securing that indebtedness; and (iv) structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent we are not a holder thereof) preferred equity, if any, of our subsidiaries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to the 2027 Notes, please read Note 6, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2027 Convertible Senior Notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Management Agreement</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Business Combination, we entered into a management agreement with Bain Capital Private Equity, LP and Bain Capital Life Sciences, LP, providing for the expense reimbursement and indemnification of such entities. To date, no amounts have been incurred under the management agreement.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contract Research and Manufacturing Organizations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 and December 31, 2022, we recorded accrued expenses of approximately $36.8 million and $30.8 million, respectively, in our condensed consolidated balance sheets for expenditures incurred by CROs and CMOs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Tax Related Obligations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To date, we have not recognized any reserves related to uncertain tax positions. As of March 31, 2023 and December 31, 2022, we had no accrued interest or penalties related to uncertain tax positions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Off-balance sheet arrangements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have not entered into any off-balance sheet arrangements and do not have holdings in any variable interest entities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Critical Accounting Policies and Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This management&#x2019;s discussion and analysis of our financial condition and results of operations is based on our unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Our most critical accounting policies and estimates are described under the heading &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x2014;Critical Accounting Policies and Estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; in our Annual Report, and a discussion of some of the significant estimates and assumptions made in our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report is set forth in Note 3, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Summary of Significant Accounting Policies</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report. There have been no material changes to our critical accounting policies and estimates described in our Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For a discussion of new accounting standards and their expected impact on our consolidated financial statements or disclosures, please read Note 3, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Guidance</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_3_quantitative_qualitative_disclosu"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3. Quantitative and Qualitati</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ve Disclosures About Market Risk.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The primary objectives of our investment activities are to ensure liquidity and to preserve capital. We are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate sensitivities, which are affected by changes in the general level of U.S. interest rates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We had cash, cash equivalents and marketable securities of $863.0 million and $950.2 million as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 and December 31, 2022, these balances consisted of bank deposits, highly liquid money market funds and investment grade short to intermediate-term fixed income securities.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Rate Sensitivity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of our marketable securities is subject to change as a result of potential changes in market interest rates. The potential change in fair value for interest rate sensitive instruments has been assessed on a hypothetical 100 basis point adverse movement across all maturities. As of March 31, 2023, we estimate that such hypothetical 100 basis point adverse movement would result in a hypothetical loss in fair value of approximately $3.1 million to our interest rate sensitive instruments. As of December 31, 2022, we estimate that such hypothetical 100 basis point adverse movement would result in a hypothetical loss in fair value of approximately $3.6 million to our interest rate sensitive instruments. Fluctuations in interest rates have not been significant for us in any periods presented.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2027 Notes bear interest at a fixed rate and therefore have minimal exposure to changes in interest rates. However, because these interest rates are fixed, we may be paying a higher interest rate, relative to market, in the future if our credit rating improves or other circumstances change. Our cash flows on this debt obligation are not subject to variability as a result of changes in interest rates.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equity Price Risk</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2027 Notes include conversion and settlement provisions that are based on the price of our common stock at conversion or maturity of the 2027 Notes. The number of shares of common stock and/or amount of cash we may be required to pay upon conversion or maturity of the 2027 Notes is determined by the price of our common stock. The fair value of the 2027 Notes is dependent on the price and volatility of our common stock and will generally increase or decrease as the market price of our common stock changes.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to the 2027 Notes, please read Note 6, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2027 Convertible Senior Notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Foreign Currency Exchange Risk</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently do not have significant exposure to foreign currencies as we hold no foreign exchange contracts, option contracts, or other foreign hedging arrangements. Further, our operating activities are predominately denominated in U.S. dollars. Fluctuations in exchange rates have not been significant for us in any periods presented.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_4_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4. Controls</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and Procedures.</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain &#x201c;disclosure controls and procedures&#x201d; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#x2019;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the benefits of possible controls and procedures relative to their costs.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our management, with the participation of our Chief Executive Officer and Interim Chief Financial Officer, who serve as our principal executive officer and principal financial officer, respectively, has evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2023. Based on such evaluation, our Chief Executive Officer and Interim Chief Financial Officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of March 31, 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) under the Exchange Act that occurred during the quarter ended March 31, 2023, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_ii_other_info"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART II&#x2014;OTHER </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">INFORMATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1. Legal </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceedings.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required with respect to this item can be found in Note 13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Legal Proceedings</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report and is incorporated by reference into this Item 1.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the future, we may become party to legal matters and claims arising in the ordinary course of business, the resolution of which we do not anticipate would have a material adverse impact on our financial position, results of operations or cash flows.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1A. Risk</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Factors.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Investing in our securities involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with the other information in this Quarterly Report, including our condensed consolidated financial statements and the related notes included in this Quarterly Report and in the section titled &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations,&#x201d; before deciding whether to invest in our securities. The occurrence of one or more of the events or circumstances described in these risk factors, alone or in combination with other events or circumstances, may have a material adverse effect on our business, reputation, revenue, financial condition, results of operations and future prospects, in which event the market price of our common stock could decline, and you could lose part or all of your investment. Unless otherwise indicated, reference in this section and elsewhere in this Quarterly Report to our business being adversely affected, negatively impacted or harmed will include an adverse effect on, or a negative impact or harm to, the business, reputation, financial condition, results of operations, revenue and our future prospects. The material and other risks and uncertainties summarized elsewhere in this Quarterly Report and described below are not intended to be exhaustive and are not the only ones we face. Additional risks and uncertainties not presently known to us, or that we currently deem immaterial, may also impair our business operations. This Quarterly Report also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of a number of factors, including the risks described below. See the section titled &#x201c;Cautionary Note Regarding Forward-Looking Statements.&#x201d;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Business</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The successful development of pharmaceutical products is highly uncertain.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successful development of pharmaceutical products is highly uncertain and is dependent on numerous factors, many of which are beyond our control. Product candidates that appear promising in the early phases of development may fail to reach the market for several reasons, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">clinical trial results may show the product candidates to be less effective than expected (for example, a clinical trial could fail to meet its primary or key secondary endpoint(s)) or have an unacceptable safety or tolerability profile; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to receive the necessary regulatory approvals or a delay in receiving such approvals, which, among other things, may be caused by patients who fail the trial screening process, slow enrollment in clinical trials, patients dropping out of trials, patients lost to follow-up, length of time to achieve trial endpoints, additional time requirements for data analysis or New Drug Application, or NDA, preparation, discussions with the FDA, an FDA request for additional preclinical or clinical data (such as long-term toxicology studies) or unexpected safety or manufacturing issues;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">preclinical study results may show the product candidate to be less effective than desired or to have harmful side effects;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">post-marketing approval requirements; or</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the proprietary rights of others and their competing products and technologies that may prevent our product candidates from being commercialized.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The length of time necessary to complete clinical trials and submit an application for marketing approval for a final decision by a regulatory authority varies significantly from one product candidate to the next and from one country or jurisdiction to the next and may be difficult to predict.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we are successful in obtaining marketing approval, commercial success of any approved products will also depend in large part on the availability of coverage and adequate reimbursement from third-party payors, including government payors such as the Medicare and Medicaid programs and managed care organizations in the United States or country-specific governmental organizations in foreign countries, which may be affected by existing and future healthcare reform measures designed to reduce the cost of healthcare. Third-party payors could require us to conduct additional studies, including post-marketing studies related to the cost effectiveness of a product, to qualify for reimbursement, which could be costly and divert our resources. If government and other</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">healthcare payors were not to provide coverage and adequate reimbursement for our products once approved, market acceptance and commercial success would be reduced.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, if any of our product candidates receive marketing approval, we will be subject to significant regulatory obligations regarding the submission of safety and other post-marketing information and reports and registration, and will need to continue to comply (or ensure that our third-party providers comply) with current Good Manufacturing Practices, or cGMPs, and Good Clinical Practices, or GCPs, for any clinical trials that we conduct post-approval. In addition, there is always the risk that we, a regulatory authority or a third party might identify previously unknown problems with a product post-approval, such as adverse events of unanticipated severity or frequency. Compliance with these requirements is costly, and any failure to comply or other issues with our product candidates post-approval could adversely affect our business, financial condition and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are a clinical-stage biopharmaceutical company with a limited operating history. We have incurred significant financial losses since our inception and anticipate that we will continue to incur significant financial losses for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biopharmaceutical company with a limited operating history. We were formed in July 2018 and our operations to date have been limited to pre-commercial activities. Substantially all of our product candidates were initially developed by Pfizer, which we in-licensed pursuant to the Pfizer License Agreement, entered into shortly after our formation. We have not yet demonstrated an ability to generate revenues, obtain regulatory approvals, manufacture any product on a commercial scale or arrange for a third party to do so on our behalf or conduct sales and marketing activities necessary for successful product commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have no products approved for commercial sale and have not generated any revenue from product sales to date. We will continue to incur significant research and development and other expenses related to our preclinical and clinical development and ongoing operations. As a result, we are not profitable and have incurred losses in each period since our inception. Net losses and negative cash flows have had, and will continue to have, an adverse effect on our stockholders&#x2019; equity and working capital. Our net losses totaled $104.3 million and $68.3 million for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023, we had not yet generated revenues. We expect to continue to incur significant losses for the foreseeable future, and we expect these losses to increase as we continue our research and development of, and seek regulatory approvals for, our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We anticipate that our expenses will increase substantially if, and as, we:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">advance our clinical-stage product candidates through clinical development, including as we advance these candidates into later-stage clinical trials;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seek regulatory approvals for any product candidates that successfully complete clinical trials;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hire additional clinical, quality control, medical, scientific and other technical personnel to support our clinical operations;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">experience an increase in headcount as we expand our research and development organization and market development and pre-commercial planning activities; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">undertake any pre-commercial or commercial activities to establish sales, marketing and distribution capabilities;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">advance our preclinical-stage product candidates into clinical development; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seek to identify, acquire and develop additional product candidates, including through business development efforts to invest in or in-license other technologies or product candidates;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maintain, expand and protect our intellectual property portfolio; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">make milestone, royalty or other payments due under the Pfizer License Agreement and any future in-license or collaboration agreements; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">make milestone, royalty, interest or other payments due under the Funding Agreements, our 2027 Notes and any future financing or other arrangements with third parties. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biopharmaceutical product development entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate efficacy or an acceptable safety profile, gain regulatory approval, secure market access and reimbursement and become commercially viable, and therefore any investment in us is highly speculative. Accordingly, before making an investment in us, you should consider our prospects, factoring in the costs, uncertainties, delays and difficulties frequently encountered by companies in clinical development, especially clinical-stage biopharmaceutical companies such as ours. Any predictions you make about our future success or viability may not be as accurate as they would otherwise be if we had a longer operating history or a history of successfully developing and commercializing pharmaceutical products. We may encounter unforeseen expenses, difficulties, complications, delays and other known or unknown factors in achieving our business objectives.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, our expenses could increase beyond our expectations if we are required by the FDA or other regulatory authorities to perform clinical trials in addition to those that we currently expect, or if there are any delays in establishing appropriate manufacturing arrangements for or in completing our clinical trials or the development of any of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have never generated revenue from product sales and may never be profitable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to become and remain profitable depends on our ability to generate revenue or execute other business development arrangements. We do not expect to generate significant revenue, if any, unless and until we are able to obtain regulatory approval for, and successfully commercialize, one or more product candidates we are developing or may develop. Successful commercialization will require achievement of many key milestones, including demonstrating safety and efficacy in clinical trials, obtaining regulatory approval for these product candidates, manufacturing, marketing and selling those products for which we may obtain regulatory approval, satisfying any post-marketing requirements and obtaining reimbursement for our products from private insurance or government payors. Because of the uncertainties and risks associated with these activities, we are unable to accurately and precisely predict the timing and amount of revenues, the extent of any further losses or if or when we might achieve profitability. We may never succeed in these activities and, even if we do, we may never generate revenues that are significant enough for us to achieve profitability. Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our failure to become and remain profitable may depress the market price of our common stock and could impair our ability to raise capital, expand our business, diversify our product offerings or continue our operations. If we continue to incur losses as we have since our inception, investors may not receive any return on their investment and may lose their entire investment.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We will need substantial additional funding, and if we are unable to raise capital when needed, we could be forced to delay, reduce or terminate our product discovery and development programs or commercialization efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our operations have consumed substantial amounts of cash since inception. We expect to continue to spend substantial amounts to continue the clinical and preclinical development of our product candidates. We will need to raise additional capital to complete our currently planned clinical trials and any future clinical trials. Other unanticipated costs may arise in the course of our development efforts. If we are able to gain marketing approval for product candidates that we develop, we will require significant additional amounts of funding in order to launch and commercialize such product candidates and will also be required to make certain milestone and royalty payments under the Pfizer License Agreement and the Funding Agreements. We cannot reasonably estimate the actual amounts necessary to successfully complete the development and commercialization of any product candidate we develop, and we may need substantial additional funding to complete the development and commercialization of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our future need for additional funding depends on many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, progress, results and costs of researching and developing our current product candidates, as well as other additional product candidates we may develop and pursue in the future; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing of, and the costs involved in, obtaining marketing approvals for our product candidates and any other additional product candidates we may develop and pursue in the future; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of future product candidates that we may pursue and their development requirements; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to receipt of regulatory approval, the costs of commercialization activities for our product candidates, to the extent such costs are not the responsibility of any future collaborators, including the costs and timing of establishing product sales, marketing, distribution and manufacturing capabilities; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subject to receipt of regulatory approval, revenue, if any, received from commercial sales of our product candidates or any other additional product candidates we may develop and pursue in the future; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the achievement of milestones that trigger payments under the Pfizer License Agreement and the Funding Agreements; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the royalty payments due under the Pfizer License Agreement and the Funding Agreements; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we in-license or acquire rights to other products, product candidates or technologies; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish collaboration arrangements for the development of our product candidates on favorable terms, if at all; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our receipt of additional funding from the Funding Investors under the Funding Agreements;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the settlement method used for the outstanding 2027 convertible senior notes, or the 2027 Notes;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our headcount growth and associated costs as we expand our research and development and market development and pre-commercial planning activities; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and protecting our intellectual property rights, including enforcing and defending intellectual property related claims; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of operating as a public company. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot be certain that additional funding will be available on acceptable terms, or at all. For instance, the trading prices for our common stock and for other biopharmaceutical companies have been highly volatile. As a result, we may face difficulties raising capital through sales of our common stock or such sales may be on unfavorable terms. Similarly, adverse market or macroeconomic conditions or market volatility resulting from global economic developments, political unrest, high inflation, the post-COVID environment or other factors, could materially and adversely affect our ability to consummate an equity or debt financing on favorable terms, or at all. To the extent that we raise additional capital through the sale of private or public equity or convertible debt securities, the ownership interest of our stockholders will be diluted, and the terms of these securities may include liquidation or other preferences and anti-dilution protections that could adversely affect the rights of our common stockholders. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends, that could adversely impact our ability to conduct our business. If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or drug candidates, or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or other arrangements when needed, we may be required to delay, limit, reduce or terminate our research, product development or future commercialization efforts, grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves, obtain funds through arrangement with collaborators on terms unfavorable to us or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of our stockholders.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that our available financial resources will enable us to fund our operating expense and capital expenditure requirements through at least 12 months from the issuance date of our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report. Our estimate may prove to be wrong, and we could use our available capital resources sooner than we currently expect. Further, changing circumstances, some of which may be beyond our control, could cause us to consume capital significantly faster than we currently anticipate, and we may need to seek additional funds sooner than planned.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Due to the significant resources required for the development of our pipeline, and depending on our ability to access capital, we must prioritize the development of certain product candidates over others. Moreover, we may fail to expend our limited resources on product candidates or indications that may have been more profitable or for which there is a greater likelihood of success.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently have five clinical-stage product candidates as well as several other product candidates that are at various stages of preclinical development. We seek to maintain a process of prioritization and resource allocation to maintain an optimal balance between aggressively pursuing our most advanced product candidates and indications and ensuring the development of additional potential product candidates and indications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due to the significant resources required for the development of our product candidates, we must decide which product candidates and indications to pursue and advance and the amount of resources to allocate to each. Our decisions concerning the allocation of research, development, collaboration, management and financial resources toward particular product candidates, therapeutic areas or indications may not lead to the development of viable commercial products and may divert resources away from better opportunities. If we make incorrect determinations regarding the viability or market potential of any of our product candidates or misread trends in the pharmaceutical industry, in particular for disorders of the brain and nervous system, our business, financial condition and results of operations could be materially and adversely affected. As a result, we may fail to capitalize on viable commercial products or profitable market opportunities, be required to forego or delay pursuit of opportunities with other product candidates or other diseases and disease pathways that may later prove to have greater commercial potential than those we choose to pursue, or relinquish valuable rights to such product candidates through collaboration, licensing or royalty arrangements in cases in which it would have been advantageous for us to invest additional resources to retain sole development and commercialization rights.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect our expenses to increase in connection with our planned operations. Unless and until we can generate a substantial amount of revenue from our product candidates, we expect to finance our future cash needs through public or private equity offerings, debt financings, royalty-based financing, collaborations, licensing arrangements or other sources, or any combination of the foregoing. In addition, we may seek additional capital due to favorable market conditions or strategic considerations, even if we believe that we have sufficient funds for our current or future operating plans.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that we raise additional capital through the sale of common stock, convertible securities or other equity securities, the ownership interest of our stockholders may be diluted, and the terms of these securities could include liquidation or other preferences and anti-dilution protections that could adversely affect the rights of our common stockholders. In addition, royalty-based financing or debt financing, if available, may result in our relinquishing rights to valuable future revenue streams or fixed payment obligations and may involve agreements that include restrictive covenants that limit our ability to take specific actions, such as incurring additional debt, making capital expenditures, creating liens, redeeming stock or declaring dividends, that could adversely impact our ability to conduct our business. In addition, securing financing could require a substantial amount of time and attention from our management team and may divert a disproportionate amount of our attention away from day-to-day activities, which may adversely affect our management team&#x2019;s ability to oversee the development of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we raise additional capital through collaborations, strategic alliances or marketing, distribution or licensing arrangements, or royalty-based financings with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates, or grant licenses on terms that may not be favorable to us. If we are unable to raise additional capital when needed, we may be required to delay, limit, reduce or terminate our research, product development or future commercialization efforts, grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves, obtain capital through arrangement with collaborators on terms unfavorable to us or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of our stockholders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Covenants in our Funding Agreements place restrictions on our operating and financial flexibility and if we do not effectively manage our covenants, our financial condition and results of operations could be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2021, we entered into the Funding Agreements pursuant to which the Funding Investors committed to provide funding to support our development of tavapadon for the treatment of Parkinson&#x2019;s disease. The Funding Agreements impose various diligence, milestone payment, royalty payment and other obligations on us. Pursuant to the Funding Agreements, we are required to comply with various covenants relating to the conduct of our business and the development and commercialization of tavapadon, including obligations to use commercially reasonable efforts to develop and commercialize tavapadon in the United States and certain limits on our ability to incur indebtedness, create or incur liens or dispose of assets. Compliance with these covenants may limit our flexibility in operating our business and our ability to take actions that might otherwise be advantageous to us and our stockholders.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are required to make payments to the Funding Investors upon the achievement of certain regulatory and sales milestones. In addition, if we suspend or terminate the development of tavapadon or fail to perform certain diligence obligations, under certain circumstances, we will pay the Funding Investors a combined amount equal to the total amount funded by the Funding Investors up to the date of termination, plus 12% interest compounded annually. We may not have sufficient capital to make the required payments to the Funding Investors on a timely basis or at all. In conjunction with the Funding Agreements, we also entered into security agreements with the Funding Investors pursuant to which we granted the Funding Investors a security interest in the assets material to the development and commercialization of tavapadon in the United States to secure our obligations under the Funding Agreements. If we are unable to comply with such obligations, then the Funding Investors may be able to foreclose on the collateral that was pledged to the Funding Investors. Any of the foregoing events could significantly and adversely affect our financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our business is highly dependent on the success of our product candidates. If we are unable to successfully complete clinical development, obtain regulatory approval for or commercialize one or more of our product candidates, or if we experience delays in doing so, our business will be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To date, as an organization, we have not completed the development of any of our product candidates. Our future success and ability to generate revenue from our product candidates, which is dependent on our ability to successfully develop, obtain regulatory approval for and commercialize one or more of our product candidates. All of our product candidates will require substantial additional investment for clinical development, regulatory review and approval in one or more jurisdictions. If any of our product candidates encounters safety or efficacy problems, development delays or regulatory issues or other problems, our development plans and business would be materially harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may not have the financial resources to continue development of our product candidates if we experience any issues that delay or prevent regulatory approval of, or our ability to commercialize, our product candidates, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that our product candidates are safe and effective; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">insufficiency of our financial and other resources to complete the necessary clinical trials and preclinical studies; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">negative or inconclusive results from our clinical trials, preclinical studies or the clinical trials of others for product candidates similar to ours, leading to a decision or requirement to conduct additional clinical trials or preclinical studies or abandon a program; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product-related adverse events experienced by subjects in our clinical trials, including unexpected toxicity results, or by individuals using drugs or therapeutic biologics similar to our product candidates; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delays in submitting an Investigational New Drug, or IND, application or comparable foreign applications or delays or failure in obtaining the necessary approvals from regulators to commence a clinical trial or a suspension or termination, or hold, of a clinical trial once commenced; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">conditions imposed by the FDA, the European Medicines Agency, or EMA, or comparable foreign regulatory authorities regarding the scope or design of our clinical trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">poor effectiveness of our product candidates during clinical trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">better than expected performance of control arms, such as placebo groups, which could lead to negative or inconclusive results from our clinical trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delays in enrolling subjects in our clinical trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">high drop-out rates of subjects from our clinical trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">inadequate supply or quality of product candidates or other materials necessary for the conduct of our clinical trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">higher than anticipated clinical trial or manufacturing costs; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unfavorable FDA, EMA or comparable regulatory authority inspection and review of our clinical trial sites; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure of our third-party contractors or investigators to comply with regulatory requirements or the clinical trial protocol or otherwise meet their contractual obligations in a timely manner, or at all; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delays and changes in regulatory requirements, policies and guidelines, including the imposition of additional regulatory oversight around clinical testing generally or with respect to our therapies in particular; or </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">varying interpretations of data by the FDA, EMA and comparable foreign regulatory authorities. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The regulatory approval processes of the FDA and comparable foreign authorities are lengthy, time-consuming and inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for our product candidates, our business will be substantially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are not permitted to commercialize, market, promote or sell any product candidate in the United States without obtaining regulatory approval from the FDA. Foreign regulatory authorities, such as the EMA, impose similar requirements. The time required to obtain approval by the FDA and comparable foreign authorities is inherently unpredictable, but typically takes many years following the commencement of clinical trials and depends upon numerous factors, including substantial discretion of the regulatory authorities. In addition, approval policies, regulations, or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#x2019;s clinical development and may vary among jurisdictions. For instance, jurisdictions outside of the United States, such as the European Union or Japan, may have different requirements for regulatory approval, which may require us to conduct additional clinical, nonclinical or chemistry, manufacturing and control studies. To date, we have not submitted an NDA to the FDA or similar drug approval submissions to comparable foreign regulatory authorities for any product candidate. We must complete additional preclinical studies and clinical trials to demonstrate the safety and efficacy of our product candidates in humans before we will be able to obtain these approvals.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical testing is expensive, difficult to design and implement, can take many years to complete and is inherently uncertain as to outcome. We cannot guarantee that any clinical trials will be conducted as planned or completed on schedule, if at all. The clinical development of our initial and potential additional product candidates is susceptible to the risk of failure inherent at any stage of development, including failure to demonstrate efficacy in a clinical trial or across a broad population of patients, the occurrence of adverse events that are severe or medically or commercially unacceptable, failure to comply with protocols or applicable regulatory requirements and determination by the FDA or any comparable foreign regulatory authority that a product candidate may not continue development or is not approvable. It is possible that even if any of our product candidates have a beneficial effect, that effect will not be detected during clinical evaluation as a result of one or more of a variety of factors, including the size, duration, design, measurements, conduct or analysis of our clinical trials. Conversely, as a result of the same factors, our clinical trials may indicate an apparent positive effect of such product candidate that is greater than the actual positive effect, if any. Similarly, in our clinical trials we may fail to detect toxicity of, or intolerability caused by, such product candidate, or mistakenly believe that our product candidates are toxic or not well tolerated when that is not in fact the case. Serious adverse events or other adverse events, as well as tolerability issues, could hinder or prevent market acceptance of the product candidate at issue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current and future product candidates could fail to receive regulatory approval for many reasons, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or comparable foreign regulatory authorities may disagree as to the design or implementation of our clinical trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that a product candidate is safe and effective for its proposed indication; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the results of clinical trials may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for approval; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be unable to demonstrate that a product candidate&#x2019;s clinical and other benefits outweigh its safety risks; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from clinical trials or preclinical studies; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the data collected from clinical trials of our product candidates may not be sufficient to support the submission of an NDA to the FDA or other submission or to obtain regulatory approval in the United States, the European Union or elsewhere; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or comparable foreign regulatory authorities may find deficiencies with or fail to approve the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This lengthy approval process as well as the unpredictability of clinical trial results may result in our failing to obtain regulatory approval to market any product candidate we develop, which would substantially harm our business, results of operations and prospects. The FDA and other comparable foreign authorities have substantial discretion in the approval process and determining when or whether regulatory approval will be granted for any product candidate that we develop. Even if we believe the data collected from future clinical trials of our product candidates are promising, such data may not be sufficient to support approval by the FDA or any other regulatory authority.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, even if we were to obtain approval, regulatory authorities may approve any of our product candidates for fewer or more limited indications than we request, may not approve the price we intend to charge for our products, may grant approval contingent on the performance of costly post-marketing clinical trials or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. Any of the foregoing scenarios could materially harm the commercial prospects for our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The FDA, EMA or comparable foreign regulatory authorities may disagree with our regulatory plan for our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The general approach for FDA approval of a new drug is dispositive data from two or more adequate and well-controlled clinical trials of the product candidate in the relevant patient population. Adequate and well-controlled clinical trials typically involve a large number of patients, have significant costs and take years to complete. The FDA or other regulatory authorities may disagree with us about whether a clinical trial is adequate and well-controlled or may request that we conduct additional clinical trials prior to regulatory approval. In addition, there is no assurance that the doses, endpoints and trial designs that we intend to use for our planned clinical trials, including those that we have developed based on feedback from regulatory agencies or those that have been used for the approval of similar drugs, will be acceptable for future approvals. For example, while we have designed our registration-directed Phase 3 program for tavapadon after receiving input and feedback from the FDA, there can be no assurance that the design of our planned clinical trials will be satisfactory to the FDA or that the FDA will not require us to modify our trials or conduct additional testing, or that completing these trials will result in regulatory approval. See the section entitled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business&#x2014;Our Lead Programs&#x2014;Tavapadon&#x2014;Our Solution&#x2013;Tavapadon&#x2014;Ongoing Clinical Trials&#x2014;TEMPO-1: Phase 3 Fixed-Dose Monotherapy (Early-Stage) Parkinson&#x2019;s Trial</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; in our Annual Report for a description of our discussions with the FDA regarding the proposed primary endpoint of our Phase 3 trials of tavapadon as monotherapy in early-stage Parkinson&#x2019;s. Even if our Phase 3 clinical trials as monotherapy in early-stage Parkinson&#x2019;s achieve their primary endpoint, there can be no assurance that the FDA will find them sufficient to support approval if, for example, the FDA determines the contribution of the MDS-UPDRS Part II score to the primary endpoint results to be inadequate. Our Phase 2 early-stage Parkinson&#x2019;s trial of tavapadon did not use the MDS-UPDRS Part II score as a primary endpoint and was therefore not powered to show a statistically significant difference from placebo for this measure. In addition, based on our end-of-Phase 2 meeting with the FDA where we presented single-dose electrocardiogram, or ECG, multiple-dose ECG and a model-based analysis of Phase 1 data, we plan to collect time-matched pharmacokinetic and ECG measures in a subset of patients as a sub-study in our ongoing Phase 3 fixed-dose monotherapy early-stage Parkinson&#x2019;s trial. However, there can be no assurance that we will not be required to conduct additional testing on the safety and tolerability of tavapadon, including with respect to arrhythmia. Additionally, we are developing CVL-871 for the treatment of dementia-related apathy. There are no currently approved therapies for dementia-related apathy, and we may experience challenges in defining this indication. There are limited precedents for trial design,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">trial endpoints and regulatory pathway for this indication, which may make clinical development and regulatory approval of CVL-871 more challenging.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our clinical trial results may not support approval of our product candidates. In addition, our product candidates could fail to receive regulatory approval, or regulatory approval could be delayed, for many reasons, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA, EMA or comparable foreign regulatory authorities may not file or accept our NDA or marketing application for substantive review; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA, EMA or comparable foreign regulatory authorities may disagree with the dosing regimen, design or implementation of our clinical trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be unable to demonstrate to the satisfaction of the FDA, EMA or comparable foreign regulatory authorities that our product candidates are safe and effective for any of their proposed indications; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the results of our clinical trials may not meet the level of statistical significance required by the FDA, EMA or comparable foreign regulatory authorities for approval; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be unable to demonstrate that our product candidates&#x2019; clinical and other benefits outweigh their safety risks; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA, EMA or comparable foreign regulatory authorities may disagree with our interpretation of data from our preclinical studies or clinical trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the data collected from clinical trials of our product candidates may not be sufficient to the satisfaction of the FDA, EMA or comparable foreign regulatory authorities to support the submission of an NDA or other comparable submission in foreign jurisdictions or to obtain regulatory approval in the United States or elsewhere; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA, EMA or comparable foreign regulatory authorities may find deficiencies with or fail to approve the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the approval policies or regulations of the FDA, EMA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business interruptions resulting from the COVID-19 pandemic and the post-COVID environment could cause a disruption of the development of our product candidates and adversely impact our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public health crises such as pandemics or similar outbreaks could adversely impact our business. For instance, the COVID-19 pandemic and the post-COVID environment, including supply chain, labor market and other disruptions, as well as volatility in the global financial markets, in each case, driven by the pandemic, have impacted and may further impact our clinical trials or preclinical studies. For instance, certain of our clinical trials, including our Phase 3 trials of tavapadon for the treatment of Parkinson&#x2019;s, our Phase 2a trial of CVL-871 for the treatment of dementia-related apathy and our Phase 1 trial of emraclidine in elderly healthy volunteers to support development in Alzheimer's disease psychosis, predominantly enroll elderly subjects, and we remain particularly vigilant about patient safety given the elderly nature of these populations. While we have taken measures to revise clinical trial protocols to allow for remote visits, including home delivery of study medication, home health care visits to collect safety data and telemedicine visits to collect clinician-based trial assessments, such measures may not be sufficient to prevent missing data from impacting trial outcomes or delays in enrollment and trial completion caused by COVID-19. The primary endpoint in our monotherapy early-stage Parkinson&#x2019;s trials is based, in part, on a physical assessment of motor symptoms performed by a clinician, which cannot be completed remotely, and, if a substantial number of subjects are unable to complete in-person assessments, the completeness and interpretability of the data that we are able to collect from these trials or our other clinical trials would be impacted, which may create data integrity challenges, require changes to the statistical analysis plan, require the enrollment of additional subjects or otherwise negatively affect our ability to use such data to obtain regulatory approval. Similarly, if patients are reluctant to participate in our trials due to fears of COVID-19 infection resulting from regular visits to a healthcare facility or unable to comply with clinical trial protocols due to quarantines or travel restrictions that impede patient movement or interrupt healthcare services, we may not be able to meet our current trial completion timelines. In addition, Paxlovid, a treatment for COVID-19 granted emergency use authorization in the U.S. and marketing authorization by health authorities in Europe, is contraindicated for concurrent use with some of our product candidates. As such, increased use of Paxlovid in the general population may cause delays in enrollment or increase the early termination rate in our clinical trials, which may impact our expected clinical trial timelines.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, COVID-19 and the post-COVID environment may impact our ability to retain principal investigators and site staff for our clinical trials as healthcare providers may have heightened exposure to COVID-19 or may be impacted due to prioritization of hospital resources toward the pandemic and restrictions on travel. Our clinical trial sites may be located in geographies that are disproportionately affected by the COVID-19 pandemic or actions taken by governmental and health authorities to address the pandemic. Furthermore, as a result of supply chain, labor market and other disruptions driven by the pandemic and the post-COVID</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">environment, COVID-19 has impacted and may further negatively affect our operations or the operations of our vendors, suppliers and business partners, including the third-party contract research organizations, or CROs, clinical sites and other vendors that we rely upon to carry out our clinical trials or the operations of our third-party manufacturers and other suppliers, which could result in delays or disruptions in the supply of our product candidates. The negative impact COVID-19 or the post-COVID environment has on patient enrollment, site staffing or treatment or the timing and execution of our clinical trials has caused and could cause further delays to our clinical trial activities, which could adversely affect our ability to obtain regulatory approval for and to commercialize our product candidates, increase our operating expenses and have a material adverse effect on our business and financial results. COVID-19 and the post-COVID environment have also caused volatility in the global financial markets, including inflationary headwinds, which may negatively affect our ability to raise additional capital on attractive terms or at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The extent to which COVID-19 and the post-COVID environment impact our business, results of operations and financial condition will depend on future developments, which, despite progress in vaccination efforts, are highly uncertain and cannot be predicted with confidence, including the duration of the pandemic, new information that may emerge concerning the severity of COVID-19, such as new variants or subvariants, which may impact rates of infection and vaccination efforts and the extent and effectiveness of actions to contain COVID-19 or treat its impact, including vaccination campaigns, COVID-19 treatments and lockdown measures, among others. In addition, recurrences or additional waves of COVID-19 cases could cause other widespread or more severe impacts depending on where infection rates are highest. We cannot presently predict the scope and severity of any potential business shutdowns or disruptions, but if we or any of the third parties with whom we engage were to experience prolonged business shutdowns or other disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively affected, which could have a material adverse impact on our business, results of operations and financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are dependent on third parties having accurately generated, collected, interpreted and reported data from certain preclinical studies and clinical trials that were previously conducted for our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have in-licensed the rights to substantially all of our current product candidates from Pfizer, for which they undertook prior research and development. We had no involvement with or control over the preclinical and clinical development of any of our product candidates prior to obtaining our in-license. In addition, we had no involvement in the development of third-party agents designed to be used in combination with our product candidates, such as L-dopa, which we intend to study in combination with tavapadon in our Phase 3 adjunctive late-stage Parkinson&#x2019;s trial. Therefore, we are dependent on these third parties having conducted their research and development in accordance with the applicable protocols, legal and regulatory requirements, and scientific standards; having accurately reported the results of all preclinical studies and clinical trials conducted with respect to such product candidates and having correctly collected and interpreted the data from these studies and trials. These risks also apply to any additional product candidates that we may acquire or in-license in the future. If these activities were not compliant, accurate or correct, the clinical development, regulatory approval or commercialization of our product candidates will be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If our clinical trials fail to replicate positive results from earlier preclinical studies or clinical trials conducted by us or third parties, we may be unable to successfully develop, obtain regulatory approval for or commercialize our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The results observed from preclinical studies or early-stage clinical trials of our product candidates may not necessarily be predictive of the results of later-stage clinical trials that we conduct. Similarly, positive results from such preclinical studies or early-stage clinical trials may not be replicated in our subsequent preclinical studies or clinical trials. For instance, while darigabat demonstrated anti-epileptic activity similar to lorazepam, a commonly prescribed benzodiazepine, or BZD, in a Phase 2 photoepilepsy trial, only seven patients were treated with darigabat in that trial and we may not be able to replicate the observed results from that trial in our ongoing Phase 2 proof-of-concept trial in focal epilepsy. Similarly, while darigabat demonstrated anxiolytic effects in a model of carbon dioxide inhalation that is associated with symptoms of anxiety/panic in healthy participants, we may not be able to replicate these results in patients with panic disorder. Furthermore, our product candidates may not be able to demonstrate similar activity or adverse event profiles as other product candidates that we believe may have similar profiles. For instance, although they both activate muscarinic receptors, in later-stage trials, emraclidine may not be able to replicate the anti-psychotic benefit observed in prior clinical trials of xanomeline.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, in our planned future clinical trials, we may utilize clinical trial designs or dosing regimens that have not been tested in prior clinical trials. For instance, in our Phase 3 clinical trials for tavapadon in Parkinson&#x2019;s, we are using a slower titration method than was used in prior clinical trials. While we believe that the slower titration method may mitigate certain gastrointestinal and other adverse events, we cannot provide any assurances that it will provide the desired effects and it may result in unanticipated issues.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There can be no assurance that any of our clinical trials will ultimately be successful or support further clinical development of any of our product candidates. There is a high failure rate for drugs proceeding through clinical trials. Many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical trials after achieving positive results in early-stage development, and we cannot be certain that we will not face similar setbacks. These setbacks have been caused</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">by, among other things, preclinical findings made while clinical trials were underway or safety or efficacy observations made in preclinical studies and clinical trials, including previously unreported adverse events.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses and many companies that believed their product candidates performed satisfactorily in preclinical studies and clinical trials nonetheless failed to obtain FDA, EMA or comparable foreign regulatory authority approval. For instance, prior clinical trials conducted by Pfizer with certain of our product candidates before we in-licensed them were terminated before conclusion of the trials. These trials included a Phase 2 trial of tavapadon in late-stage Parkinson&#x2019;s, a concurrent Phase 2 clinical trial of tavapadon in early-stage Parkinson&#x2019;s and two Phase 2 trials of darigabat. These clinical trials did not meet their primary endpoints and, even though we believe the data generated from these trials support our rationale for further clinical development of these product candidates, our belief is partially based on post-hoc analyses of such data.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may incur unexpected costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To obtain the requisite regulatory approvals to commercialize any of our product candidates, we must demonstrate through extensive preclinical studies and clinical trials that our product candidates are safe and effective in humans. We may experience delays in completing our clinical trials or preclinical studies and initiating or completing additional clinical trials or preclinical studies, including as a result of regulators not allowing or delay in allowing clinical trials to proceed under an IND, or not approving or delaying approval for any clinical trial grant or similar approval we need to initiate a clinical trial. We may also experience numerous unforeseen events during our clinical trials that could delay or prevent our ability to receive marketing approval or commercialize the product candidates we develop, including:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulators, institutional review boards, or IRBs, or other reviewing bodies may not authorize us or our investigators to commence a clinical trial, or to conduct or continue a clinical trial at a prospective or specific trial site; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not reach agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may experience challenges or delays in recruiting principal investigators or study sites to lead our clinical trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the number of subjects or patients required for clinical trials of our product candidates may be larger than we anticipate, enrollment in these clinical trials may be insufficient or slower than we anticipate, and the number of clinical trials being conducted at any given time may be high and result in fewer available patients for any given clinical trial, or patients may drop out of these clinical trials at a higher rate than we anticipate; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our third-party contractors, including those manufacturing our product candidates or conducting clinical trials on our behalf, may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may have to amend clinical trial protocols submitted to regulatory authorities or conduct additional studies to reflect changes in regulatory requirements or guidance, which may be required to resubmit to an IRB and regulatory authorities for re-examination; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulators or other reviewing bodies may find deficiencies with, fail to approve or subsequently find fault with the manufacturing processes or facilities of third-party manufacturers with which we enter into agreements for clinical and commercial supplies, or the supply or quality of any product candidate or other materials necessary to conduct clinical trials of our product candidates may be insufficient, inadequate or not available at an acceptable cost, or we may experience interruptions in supply; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential for approval policies or regulations of the FDA or the applicable foreign regulatory agencies to significantly change in a manner rendering our clinical data insufficient for approval. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulators or IRBs of the institutions in which clinical trials are being conducted may suspend, limit or terminate a clinical trial, or data monitoring committees may recommend that we suspend or terminate a clinical trial, due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, safety issues or adverse side effects, failure to demonstrate a benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. Negative or inconclusive results from our clinical trials or preclinical studies could mandate repeated or additional clinical trials and, to the extent we choose to conduct clinical trials in other indications, could result in changes to or delays in clinical trials of our product candidates in such other indications. We do not know whether any clinical trials that we conduct will demonstrate adequate efficacy and safety to result in regulatory approval to market our product candidates for the indications that we are pursuing. If later-stage clinical trials do not produce favorable results, our ability to obtain regulatory approval for our product candidates will be adversely impacted.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our failure to successfully initiate and complete clinical trials and to demonstrate the efficacy and safety necessary to obtain regulatory approval to market our product candidates would significantly harm our business. Our product candidate development costs will also increase if we experience delays in testing or regulatory approvals and we may be required to obtain additional funds to complete clinical trials. Delays in our development of tavapadon in the United States could also prevent us from, or delay us in, receiving additional payments under the Funding Agreements, as well as put us in potential breach of our development and commercialization obligations under the Funding Agreements. We cannot assure you that our clinical trials will begin as planned or be completed on schedule, if at all, or that we will not need to restructure or otherwise modify our trials after they have begun. Significant clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize our product candidates or allow our competitors to bring products to market before we do and impair our ability to successfully commercialize our product candidates, which may harm our business and results of operations. In addition, many of the factors that cause, or lead to, delays of clinical trials may ultimately lead to the denial of regulatory approval of our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if we complete the necessary preclinical studies and clinical trials, the marketing approval process is expensive, time-consuming and uncertain and may prevent us from obtaining approvals for the commercialization of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any product candidate we develop and the activities associated with its development and commercialization, including its design, testing, manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale, and distribution, are subject to comprehensive regulation by the FDA and other regulatory authorities in the United States and by comparable authorities in other countries. Failure to obtain marketing approval for a product candidate will prevent us from commercializing the product candidate in a given jurisdiction. We have not received approval to market any product candidates from regulatory authorities in any jurisdiction and it is possible that none of the product candidates we are developing or may seek to develop in the future will ever obtain regulatory approval.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have no experience in submitting and supporting the applications necessary to gain marketing approvals and expect to rely on third-party CROs or regulatory consultants to assist us in this process. Securing regulatory approval requires the submission of extensive preclinical and clinical data and supporting information to the various regulatory authorities for each therapeutic indication to establish the product candidate&#x2019;s safety and efficacy. Securing regulatory approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the relevant regulatory authority. Any product candidates we develop may not be effective, may be only moderately effective, or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude its obtaining marketing approval or prevent or limit commercial use.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The process of obtaining marketing approvals, both in the United States and abroad, is expensive, may take many years if additional clinical trials are required, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity, and novelty of the product candidates involved. Changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may cause delays in the approval or rejection of an application. The FDA and comparable authorities in other countries have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional preclinical, clinical or other studies. In addition, varying interpretations of the data obtained from preclinical and clinical testing could delay, limit, or prevent marketing approval of a product candidate. Any marketing approval that we may ultimately obtain could be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we experience delays in obtaining approval or if we fail to obtain approval of any product candidates we may develop, the commercial prospects for those product candidates may be harmed, and our ability to generate revenues will be materially impaired.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interim, topline and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data becomes available and are subject to audit and verification procedures that could result in material changes in the final data.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, we may publish interim, topline or preliminary data from our clinical trials. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Preliminary or topline data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, interim and preliminary data should be viewed with caution until the final data are available. Adverse differences between preliminary or interim data and final data could significantly harm our reputation and business prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we do not achieve our projected development and commercialization goals in the timeframes we announce and expect, the development and commercialization of our product candidates may be delayed, and our business and results of operations may be harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For planning purposes, we sometimes estimate the timing of the accomplishment of various scientific, clinical, regulatory and other product development objectives. These milestones may include our expectations regarding the commencement or completion of scientific studies and clinical trials, the submission of regulatory filings or commercialization objectives. From time to time, we may publicly announce the expected timing of some of these milestones, such as the completion of an ongoing clinical trial, the initiation of other clinical programs, receipt of marketing approval or a commercial launch of a product. The achievement of many of these milestones may be outside of our control. All of these milestones are based on a variety of assumptions which, if not realized as expected, may cause the timing of achievement of the milestones to vary considerably from our estimates, including:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our available capital resources or capital constraints we experience; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the rate of progress, costs and results of our clinical trials and research and development activities, including the extent of scheduling conflicts with participating clinicians and collaborators; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to identify and enroll patients who meet clinical trial eligibility criteria; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our receipt of approvals by the FDA and other regulatory authorities and the timing thereof; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other actions, decisions or rules issued by regulators; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to access sufficient, reliable and affordable supplies of materials used to manufacture our product candidates; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the efforts of our collaborators with respect to the commercialization of our product candidates; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the securing of, costs related to, and timing issues associated with, product manufacturing as well as sales and marketing activities. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we fail to achieve announced milestones in the timeframes we expect, the development and commercialization of our product candidates may be delayed, and our business and results of operations may be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be subject to additional risks because we intend to evaluate our product candidates in combination with other compounds.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We intend to evaluate our product candidates in combination with other compounds. The use of our product candidates in combination with other compounds may subject us to risks that we would not face if our product candidates were being administered as a monotherapy. For instance, in our Phase 3 adjunctive late-stage Parkinson&#x2019;s trial, we are evaluating tavapadon in combination with L-dopa for the treatment of late-stage Parkinson&#x2019;s, and L-dopa&#x2019;s safety issues may be improperly attributed to tavapadon or the administration of tavapadon with L-dopa may result in safety issues that such other therapies or tavapadon would not have when used alone. The outcome and cost of developing a product candidate to be used with other compounds is difficult to predict and dependent on a number of factors that are outside our control. If we experience efficacy or safety issues in our clinical trials in which our product candidates are being administered with other compounds, we may not receive regulatory approval for our product candidates, which could prevent us from ever generating revenue or achieving profitability.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may experience difficulties in patient enrollment in our clinical trials for a variety of reasons. The timely completion of clinical trials in accordance with our protocols depends, among other things, on our ability to enroll a sufficient number of patients who remain in the study until its conclusion.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patient enrollment is affected by many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effects of the COVID-19 pandemic and the post-COVID environment on our ability to recruit and retain patients; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the patient eligibility criteria defined in the protocol; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size of the patient population required for analysis of the trial&#x2019;s primary endpoints; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the proximity of patients to study sites; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the design of the trial; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to recruit clinical trial investigators with the appropriate competencies and experience; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">competing clinical trials and clinicians&#x2019; and patients&#x2019; perceptions as to the potential advantages and risks of the product candidate being studied in relation to other available therapies, including any new drugs that may be approved for the indications that we are investigating; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain and maintain patient consents; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the risk that patients enrolled in our clinical trials will drop out of the trials before completion. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For instance, enrollment in our Phase 3 TEMPO program of tavapadon in Parkinson&#x2019;s has been impacted due to residual post-COVID landscape challenges and other factors. Following a detailed review of all environmental factors, data are expected from TEMPO-3 in the first half of 2024 and TEMPO-1 and TEMPO-2 in the second half of 2024. Furthermore, we are currently evaluating darigabat in a Phase 2 proof-of-concept trial in focal epilepsy, known as REALIZE. The recent approval and increased uptake of certain partial-onset seizure treatments, which are contraindicated in the REALIZE trial, as well as patients not meeting the necessary seizure frequency requirements and post-COVID landscape challenges at the clinical trial sites, have impacted our expected timeline for this trial. As a result, data from the REALIZE trial are expected mid-year 2024. Because certain of the prior clinical trials of our product candidates were terminated prior to the conclusion of the trial, we may experience challenges in recruiting principal investigators and patients to participate in ongoing and future clinical trials for such product candidates if we are unable to sufficiently demonstrate the potential of such product candidates to them. In addition, our clinical trials may compete with other clinical trials for product candidates that are in the same therapeutic areas as our product candidates, and this competition will reduce the number and types of patients available to us, because some patients who might have opted to enroll in our trials may instead opt to enroll in a trial being conducted by one of our competitors. Since the number of qualified clinical investigators is limited, we may conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of patients who are available for our clinical trials in such clinical trial site. Furthermore, if significant adverse events or other side effects are observed in any of our clinical trials, we may have difficulty recruiting patients to our trials and patients may drop out of our trials. Finally, business disruptions, including those relating to natural disasters, geopolitical incidents or macroeconomic conditions, may disrupt our clinical trials. For instance, our Phase 3 TEMPO program of tavapadon in Parkinson&#x2019;s included less than 10% of our clinical sites located in Ukraine, and, as a result of the war in Ukraine, we are not enrolling any new patients at those clinical sites at this time. The ongoing conflict has impacted and may further impact our ability to collect and interpret data from patients who were enrolled at those clinical sites. We will continue to closely monitor the rapidly evolving geopolitical situation in Ukraine and its impact on our clinical trial operations and timelines.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our inability to enroll a sufficient number of patients for our clinical trials would result in significant delays or might require us to abandon one or more clinical trials or our development efforts altogether. Delays in patient enrollment may result in increased costs, affect the timing or outcome of the planned clinical trials, product candidate development and approval process and jeopardize our ability to seek and obtain the regulatory approval required to commence product sales and generate revenue, which could prevent completion of these trials, adversely affect our ability to advance the development of our product candidates, cause the value of the company to decline and limit our ability to obtain additional financing if needed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in methods of product candidate manufacturing or formulation may result in additional costs or delay.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As product candidates proceed through preclinical studies to late-stage clinical trials towards potential approval and commercialization, it is common that various aspects of the development program, such as the vendors used to manufacture drug product or manufacturing methods and formulation, are altered along the way in an effort to optimize processes and results. Such changes carry the risk that they will not achieve these intended objectives. Any of these changes could cause our product candidates to perform differently and affect the results of planned clinical trials or other future clinical trials conducted with the materials manufactured using altered processes. Such changes may also require additional testing, FDA notification or FDA approval. This could delay or prevent completion of clinical trials, require conducting bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay or prevent approval of our product candidates and jeopardize our ability to commence sales and generate revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our product candidates may cause undesirable side effects or have other properties that could delay or prevent their regulatory approval, limit the commercial profile of an approved label, or result in significant negative consequences following regulatory approval, if obtained.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Undesirable side effects caused by any of our product candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or comparable foreign regulatory authorities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Undesirable side effects have been observed in our product candidates to date. For example, in clinical trials of tavapadon, a dose-dependent increase in the frequency of nausea and headache was observed, with nausea, vomiting, dyskinesia, fall, fatigue, sleep disorder and tremors being the most common adverse events leading to discontinuation of tavapadon. In clinical trials of emraclidine,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">some moderate treatment-emergent increases in heart rate and blood pressure were observed following single doses of emraclidine (&gt;10 mg), which may be due to emraclidine&#x2019;s activity on the M4 receptor subtype and its subsequent reduction of striatal dopamine levels. These observed cardiovascular changes were asymptomatic and transient in nature, generally peaking within one to four hours following an oral dose before being generally resolved within 24 hours without intervention. In our Phase 1b trial of emraclidine, modest asymptomatic elevations in blood pressure and heart rate were observed with emraclidine compared to placebo, which decreased over time. Placebo-adjusted heart rate changes two hours post-dose at week six were 4.4 and 5.3 beats per minute for the emraclidine 30 mg once-daily and 20 mg twice-daily groups, respectively. The average blood pressure changes at week six for both emraclidine cohorts showed no clinically meaningful differences versus placebo.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may also observe additional safety or tolerability issues with our product candidates in ongoing or future clinical trials. Many compounds that initially showed promise in clinical or earlier-stage testing are later found to cause undesirable or unexpected side effects that prevented further development of the compound. Results of future clinical trials of our product candidates could reveal a high and unacceptable severity and prevalence of side effects or unexpected characteristics, despite a favorable tolerability profile observed in earlier-stage testing.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If unacceptable side effects arise in the development of our product candidates, we, the FDA or comparable foreign regulatory authorities, the IRBs, or independent ethics committees at the institutions in which our trials are conducted, could suspend, limit or terminate our clinical trials, or the independent safety monitoring committee could recommend that we suspend, limit or terminate our trials, or the FDA or comparable foreign regulatory authorities could order us to cease clinical trials or deny approval of our product candidates for any or all targeted indications. Treatment-emergent side effects that are deemed to be drug-related could delay recruitment of clinical trial subjects or may cause subjects that enroll in our clinical trials to discontinue participation in our clinical trials. In addition, these side effects may not be appropriately recognized or managed by the treating medical staff. We may need to train medical personnel using our product candidates to understand the side effect profiles for our clinical trials and upon any commercialization of any of our product candidates. Inadequate training in recognizing or managing the potential side effects of our product candidates could result in harm to patients that are administered our product candidates. Any of these occurrences may adversely affect our business, financial condition and prospects significantly.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, clinical trials of our product candidates are conducted in carefully defined sets of patients who have agreed to enter into clinical trials. Consequently, it is possible that our clinical trials may indicate an apparent positive effect of a product candidate that is greater than the actual positive effect, if any, or alternatively fail to identify undesirable side effects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have concentrated our research and development efforts on the treatment of disorders of the brain and nervous system, a field that faces certain challenges in drug development.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have focused our research and development efforts on addressing disorders of the brain and nervous system. Efforts by pharmaceutical companies in this field have faced certain challenges in drug development. In particular, many neuroscience diseases such as panic disorder, schizophrenia or dementia-related apathy rely on subjective patient-reported outcomes as key endpoints. This makes them more difficult to evaluate than indications with more objective endpoints. Furthermore, these indications are often subject to a placebo effect, which may make it more challenging to isolate the beneficial effects of our product candidates. There can be no guarantee that we will successfully overcome these challenges with our product candidates or that we will not encounter other challenges in the development of our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if any of our product candidates receives regulatory approval, it may fail to achieve the degree of market acceptance by physicians, patients, third-party payors and others in the medical community necessary for commercial success, in which case we may not generate significant revenues or become profitable.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have never commercialized a product, and even if any of our product candidates is approved by the appropriate regulatory authorities for marketing and sale, it may nonetheless fail to achieve sufficient market acceptance by physicians, patients, third-party payors and others in the medical community. Many of the indications for our product candidates have well-established standards of care that physicians, patients and payors are familiar with and, in some cases, are available generically. Even if our product candidates are successful in registrational clinical trials, they may not be successful in displacing these current standards of care if we are unable to demonstrate superior efficacy, safety, ease of administration and/or cost-effectiveness. For example, physicians may be reluctant to take their patients off their current medications and switch their treatment regimen to our product candidates. Further, patients often acclimate to the treatment regimen that they are currently taking and do not want to switch unless their physicians recommend switching products or they are required to switch due to lack of coverage and adequate reimbursement. Even if we are able to demonstrate our product candidates&#x2019; safety and efficacy to the FDA and other regulators, safety or efficacy concerns in the medical community may hinder market acceptance.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Efforts to educate the medical community and third-party payors on the benefits of our product candidates may require significant resources, including management time and financial resources, and may not be successful. For example, even if tavapadon ultimately receives regulatory approval, we may have difficulty in convincing the medical community that tavapadon&#x2019;s selective</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">dopamine D1/D5 receptor partial agonism has the potential to deliver promising therapeutic benefits above and beyond nonselective dopamine agonists. If any product candidate is approved but does not achieve an adequate level of market acceptance, we may not generate significant revenues and we may not become profitable. The degree of market acceptance of our product candidates, if approved for commercial sale, will depend on a number of factors, including:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the efficacy and safety of the product; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the potential advantages of the product compared to competitive therapies; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the prevalence and severity of any side effects; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether the product is designated under physician treatment guidelines as a first-, second- or third-line therapy; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability, or the ability of any future collaborators, to offer the product for sale at competitive prices; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the product&#x2019;s convenience and ease of administration compared to alternative treatments; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the willingness of the target patient population to try, and of physicians to prescribe, the product; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limitations or warnings, including distribution or use restrictions contained in the product&#x2019;s approved labeling; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the strength of sales, marketing and distribution support; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in the standard of care for the targeted indications for the product; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">availability and adequacy of coverage and reimbursement from government payors, managed care plans and other third-party payors. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any failure by one or more of our product candidates that obtains regulatory approval to achieve market acceptance or commercial success would adversely affect our business prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to discover, develop and commercialize other product candidates, we may be unable to grow our business and our ability to achieve our strategic objectives would be impaired.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although the development and commercialization of our current product candidates are our initial focus, as part of our longer-term growth strategy, we plan to develop other product candidates. In addition to the product candidates in our clinical-stage pipeline, we have in-licensed additional assets that are in earlier stages of development. We intend to evaluate internal opportunities from our existing product candidates or other potential product candidates, and also may choose to in-license or acquire other product candidates to treat patients suffering from other disorders with significant unmet medical needs and limited treatment options. These other potential product candidates will require additional, time-consuming development efforts prior to commercial sale, including preclinical studies, clinical trials and approval by the FDA and applicable foreign regulatory authorities. All product candidates are prone to the risks of failure that are inherent in pharmaceutical product development, including the possibility that the product candidate will not be shown to be sufficiently safe and effective for approval by regulatory authorities. In addition, we cannot assure you that any such products that are approved will be manufactured or produced economically, successfully commercialized or widely accepted in the marketplace or be more effective than other commercially available alternatives.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we intend to devote substantial capital and resources for basic research to discover and identify additional product candidates. These research programs require substantial technical, financial and human resources, whether or not any product candidates are ultimately identified. Our research programs may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development for many reasons, including the following:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the research methodology used may not be successful in identifying potential product candidates; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">competitors may develop alternatives that render our product candidates obsolete; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product candidates that we develop may nevertheless be covered by third parties&#x2019; patents or other exclusive rights; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a product candidate may, on further study, be shown to have harmful side effects or other characteristics that indicate it is unlikely to be effective or otherwise does not meet applicable regulatory criteria; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a product candidate may not be capable of being produced in commercial quantities at an acceptable cost, or at all; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a product candidate may not be accepted as safe and effective by patients, the medical community or third-party payors. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the future, we may also seek to in-license or acquire product candidates or the underlying technology. The process of proposing, negotiating and implementing a license or acquisition is lengthy and complex. Other companies, including some with substantially greater financial, marketing and sales resources, may compete with us for the license or acquisition of product</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">candidates. We have limited resources to identify and execute the acquisition or in-licensing of third-party products, businesses and technologies and integrate them into our current infrastructure. Moreover, we may devote resources to potential acquisitions or in-licensing opportunities that are never completed, or we may fail to realize the anticipated benefits of such efforts. We may not be able to acquire the rights to additional product candidates on terms that we find acceptable, or at all.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, future acquisitions may entail numerous operational and financial risks, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exposure to unknown liabilities; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disruption of our business and diversion of management&#x2019;s time and attention to develop acquired products or technologies; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">incurrence of substantial debt, dilutive issuances of securities or depletion of cash to pay for acquisitions; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">higher than expected acquisition and integration costs; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">difficulty in combining the operations and personnel of any acquired businesses with our operations and personnel; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">increased amortization expenses; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">impairment of relationships with key suppliers or customers of any acquired businesses due to changes in management and ownership; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">inability to motivate key employees of any acquired businesses. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are unsuccessful in identifying and developing additional product candidates, either through internal development or licensing or acquisition from third parties, our potential for growth and achieving our strategic objectives may be impaired.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The number of patients with the diseases and disorders for which we are developing our product candidates has not been established with precision. If the actual number of patients with the diseases or disorders we elect to pursue with our product candidates is smaller than we anticipate, we may have difficulties in enrolling patients in our clinical trials, which may delay or prevent development of our product candidates. Even if such product candidates are successfully developed and approved, the markets for our products may be smaller than we expect and our revenue potential and ability to achieve profitability may be materially adversely affected.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our pipeline includes product candidates for a variety of neuroscience diseases. There is no precise method of establishing the actual number of patients with any of these disorders in any geography over any time period. With respect to many of the indications in which we have developed, are developing, or plan to develop our product candidates, we have estimates of the prevalence of the disease or disorder. Our estimates as to prevalence may not be accurate, and the actual prevalence or addressable patient population for some or all of those indications, or any other indication that we elect to pursue, may be significantly smaller than our estimates. In estimating the potential prevalence of indications we are pursuing, or may in the future pursue, including our estimates as to the prevalence of Parkinson&#x2019;s, epilepsy and schizophrenia, we apply assumptions to available information that may not prove to be accurate. In each case, there is a range of estimates in the published literature and in marketing studies, which include estimates within the range that are lower than our estimates. The actual number of patients with these disease indications may, however, be significantly lower than we believe. Even if our prevalence estimates are correct, our product candidates may be developed for only a subset of patients with the relevant disease or disorder or our products, if approved, may be indicated for or used by only a subset. Moreover, certain of our product candidates are being developed for indications that are novel, such as dementia-related apathy. In the event the number of patients with the diseases and disorders we are studying is significantly lower than we expect, we may have difficulties in enrolling patients in our clinical trials, which may delay or prevent development of our product candidates. For instance, due to slower-than-expected enrollment, we now expect data from our CVL-871 Phase 2a trial in dementia-related apathy in the second half of 2024. If any of our product candidates are approved and our prevalence estimates with respect to any indication or our other market assumptions are not accurate, the markets for our product candidates for these indications may be smaller than we anticipate, which could limit our revenues and our ability to achieve profitability or to meet our expectations with respect to revenues or profits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Competitive products may reduce or eliminate the commercial opportunity for our product candidates, if approved. If our competitors develop technologies or product candidates more rapidly than we do, or their technologies or product candidates are more effective or safer than ours, our ability to develop and successfully commercialize our product candidates may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The clinical and commercial landscapes for the treatment of neuroscience diseases are highly competitive and subject to rapid and significant technological change. We face competition with respect to our indications for our product candidates and will face competition with respect to any other drug candidates that we may seek to develop or commercialize in the future, from major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide. There are a number of large</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pharmaceutical and biotechnology companies that currently market and sell drugs or are pursuing the development of drug candidates for the treatment of the indications that we are pursuing. Potential competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that a significant number of product candidates are currently under development for the same indications we are currently pursuing, and some or all may become commercially available in the future for the treatment of conditions for which we are trying or may try to develop product candidates. Our potential competitors include large pharmaceutical and biotechnology companies, specialty pharmaceutical and generic drug companies, academic institutions, government agencies and research institutions. See the section entitled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business&#x2014;Competition</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; in our Annual Report for examples of the competition that our product candidates face.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In most cases, we do not currently plan to run head-to-head clinical trials evaluating our product candidates against the current standards of care, which may make it more challenging for our product candidates to compete against the current standards of care due to the lack of head-to-head clinical trial data.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our competitors may have significantly greater financial resources, established presence in the market, expertise in research and development, manufacturing, preclinical and clinical testing, obtaining regulatory approvals and reimbursement and marketing approved products than we do. Accordingly, our competitors may be more successful than we may be in obtaining regulatory approval for therapies and achieving widespread market acceptance. Our competitors&#x2019; products may be more effective, or more effectively marketed and sold, than any product candidate we may commercialize and may render our therapies obsolete or non-competitive before we can recover development and commercialization expenses. If any of our product candidates are approved, it could compete with a range of therapeutic treatments that are in development. In addition, our competitors may succeed in developing, acquiring or licensing technologies and drug products that are more effective or less costly than our product candidates, which could render our product candidates obsolete and noncompetitive.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we obtain approval for any of our product candidates, we may face competition based on many different factors, including the efficacy, safety and tolerability of our products, the ease with which our products can be administered, the timing and scope of regulatory approvals for these products, the availability and cost of manufacturing, marketing and sales capabilities, price, reimbursement coverage and patent position. Existing and future competing products could present superior treatment alternatives, including being more effective, safer, less expensive or marketed and sold more effectively than any products we may develop. Competitive products may make any products we develop obsolete or noncompetitive before we recover the expense of developing and commercializing our product candidates. Such competitors could also recruit our employees, which could negatively impact our level of expertise and our ability to execute our business plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, our competitors may obtain patent protection, regulatory exclusivities or FDA approval and commercialize products more rapidly than we do, which may impact future approvals or sales of any of our product candidates that receive regulatory approval. If the FDA approves the commercial sale of any product candidate, we will also be competing with respect to marketing capabilities and manufacturing efficiency. We expect competition among products will be based on product efficacy and safety, the timing and scope of regulatory approvals, availability of supply, marketing and sales capabilities, product price, reimbursement coverage by government and private third-party payors, regulatory exclusivities and patent position. Our profitability and financial position will suffer if our product candidates receive regulatory approval but cannot compete effectively in the marketplace.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller and other early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites, as well as in acquiring technologies complementary to, or necessary for, our programs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are unable to develop our sales, marketing and distribution capability on our own or through collaborations with marketing partners, we will not be successful in commercializing our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently have no marketing, sales or distribution capabilities. We intend to establish a sales and marketing organization, either on our own or in collaboration with third parties, with technical expertise and supporting distribution capabilities to commercialize one or more of our product candidates that may receive regulatory approval in key territories. These efforts will require substantial additional resources, some or all of which may be incurred in advance of any approval of the product candidate. Any failure or delay in the development of our or third parties&#x2019; internal sales, marketing and distribution capabilities would adversely impact the commercialization of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Factors that may inhibit our efforts to commercialize our product candidates on our own include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to recruit and retain adequate numbers of effective sales and marketing personnel; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability of sales personnel to obtain access to or persuade adequate numbers of physicians to prescribe any future products; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unforeseen costs and expenses associated with creating an independent sales and marketing organization. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">With respect to our existing and future product candidates, we may choose to collaborate with third parties that have direct sales forces and established distribution systems to serve as an alternative to our own sales force and distribution systems. Our future product revenue may be lower than if we directly marketed or sold our product candidates, if approved. In addition, any revenue we receive will depend in whole or in part upon the efforts of these third parties, which may not be successful and are generally not within our control. If we are not successful in commercializing any approved products, our future product revenue will suffer and we may incur significant additional losses.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we do not establish sales and marketing capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product liability lawsuits against us or any of our future collaborators could divert our resources and attention, cause us to incur substantial liabilities and limit commercialization of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are exposed to potential product liability and professional indemnity risks that are inherent in the research, development, manufacturing, marketing and use of pharmaceutical products. Currently, we have no products that have been approved for commercial sale; however, the use of our product candidates by us and any collaborators in clinical trials, and the sale of these product candidates, if approved, in the future, may expose us to liability claims. We face an inherent risk of product liability lawsuits related to the use of our product candidates in patients and will face an even greater risk if product candidates are approved by regulatory authorities and introduced commercially. Product liability claims may be brought against us by participants enrolled in our clinical trials, patients, health care providers, pharmaceutical companies, our collaborators or others using, administering or selling any of our future approved products. If we cannot successfully defend ourselves against any such claims, we may incur substantial liabilities or be required to limit commercialization of our product candidates. Regardless of the merits or eventual outcome, liability claims may result in:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">decreased demand for any of our future approved products; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injury to our reputation; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">withdrawal of clinical trial participants; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">termination of clinical trial sites or entire trial programs; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significant litigation costs; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">substantial monetary awards to, or costly settlements with, patients or other claimants; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product recalls or a change in the indications for which they may be used; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">loss of revenue; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">diversion of management and scientific resources from our business operations; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability to commercialize our product candidates. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although the clinical trial process is designed to identify and assess potential side effects, clinical development does not always fully characterize the safety and efficacy profile of a new medicine, and it is always possible that a drug, even after regulatory approval, may exhibit unforeseen side effects. If our product candidates were to cause adverse side effects during clinical trials or after approval, we may be exposed to substantial liabilities. Physicians and patients may not comply with any warnings that identify known potential adverse effects and patients who should not use our product candidates. If any of our product candidates are approved for commercial sale, we will be highly dependent upon consumer perceptions of us and the safety and quality of our products. We could be adversely affected if we are subject to negative publicity associated with illness or other adverse effects resulting from patients&#x2019; use or misuse of our products or any similar products distributed by other companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we maintain product liability insurance coverage consistent with industry norms, including clinical trial liability, this insurance may not fully cover potential liabilities that we may incur. The cost of any product liability litigation or other proceeding, even if resolved in our favor, could be substantial. We will need to increase our insurance coverage if we commercialize any product that receives regulatory approval. Insurance coverage is becoming increasingly expensive. If we are unable to maintain sufficient insurance coverage at an acceptable cost or to otherwise protect against potential product liability claims, it could prevent or inhibit</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the development and commercial production and sale of our product candidates, which could harm our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cyber-attacks or other failures in our telecommunications or information technology systems, or those of our collaborators, CROs, third-party logistics providers, distributors or other contractors or consultants, could result in information theft, data corruption and significant disruption of our business operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We, along with our collaborators, CROs, third-party logistics providers, distributors and other contractors and consultants, utilize information technology, or IT, systems and networks to process, transmit and store electronic information in connection with our business activities. As use of digital technologies has increased, cyber incidents, including third parties gaining access to employee accounts using stolen or inferred credentials, computer malware, viruses, spamming, phishing attacks or other means, and deliberate attacks and attempts to gain unauthorized access to computer systems and networks, have increased in frequency and sophistication. These threats pose a risk to the security of our, our collaborators&#x2019;, CROs&#x2019;, third-party logistics providers&#x2019;, distributors&#x2019; and other contractors&#x2019; and consultants&#x2019; systems and networks, and the confidentiality, availability and integrity of our data. We may not be successful in preventing cyber-attacks or successfully mitigating their effects. Like other companies, we have on occasion experienced, and will continue to experience, threats to our data and systems, including malicious codes and viruses, phishing, business email compromise attacks or other cyber-attacks. Similarly, our collaborators, CROs, third-party logistics providers, distributors and other contractors and consultants may not be successful in protecting our clinical and other data that is stored on their systems. Any cyber-attack, data breach or destruction or loss of data could result in a violation of applicable U.S. and international privacy, data protection and other laws and subject us to litigation and governmental investigations and proceedings by federal, state and local regulatory entities in the United States and by international regulatory entities, resulting in exposure to material civil and/or criminal liability. Further, our general liability insurance and corporate risk program may not cover all potential claims to which we are exposed and may not be adequate to indemnify us for all liability that may be imposed, which could have a material adverse effect on our business and prospects. For example, the loss of clinical trial data from completed or ongoing clinical trials for any of our product candidates could result in delays in our development and regulatory approval efforts and significantly increase our costs to recover or reproduce the data. In addition, we may suffer reputational harm or face litigation or adverse regulatory action as a result of cyber-attacks or other data security breaches and may incur significant additional expense to implement further data protection measures.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our ability to use our net operating losses and research and development tax credits to offset future taxable income may be subject to certain limitations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had U.S. federal net operating loss carryforwards totaling $448.7 million, all of which have an indefinite carryforward period. As of December 31, 2022, we had state net operating loss carryforwards totaling $438.3 million, with $433.4 million expiring at various dates between 2031 and 2042 and the remaining $4.9 million having an indefinite carryforward period. As of December 31, 2022, we also had U.S. federal and state research and development tax credit carryforwards of $21.3 million and $3.2 million, respectively, which begin to expire in 2039 for federal purposes and 2034 for state purposes. The net operating losses which are limited in life and tax credit carryforwards could expire unused and be unavailable to offset future income tax liabilities. In addition, in general, under Sections 382 and 383 of the U.S. Internal Revenue Code, as amended, or the Code, a corporation that undergoes an &#x201c;ownership change&#x201d; is subject to limitations on its ability to utilize its pre-change net operating losses or tax credits, or NOLs or credits, to offset future taxable income or taxes. For these purposes, an ownership change generally occurs where the aggregate stock ownership of one or more stockholders or groups of stockholders who own at least 5% of a corporation&#x2019;s stock increase their ownership by more than 50 percentage points over their lowest ownership percentage within a specified testing period. Our existing NOLs or credits may be subject to limitations arising from previous ownership changes, and if we undergo an ownership change in the future, our ability to utilize NOLs or credits could be further limited by Sections 382 and 383 of the Code. In addition, future changes in our stock ownership, many of which are outside of our control, could result in an ownership change under Sections 382 and 383 of the Code. Our NOLs or credits may also be impaired under state law. Accordingly, we may not be able to utilize a material portion of our NOLs or credits. If we determine that an ownership change has occurred and our ability to use our historical NOLs or credits is materially limited, it would harm our future operating results by effectively increasing our future tax obligations. Section 382 and 383 of the Code would apply to all net operating loss and tax credit carryforwards, whether the carryforward period is indefinite or not.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, our ability to utilize our historical NOLs or credits is conditioned upon us attaining profitability and generating U.S. federal and state taxable income. We are a clinical-stage biopharmaceutical company with a limited operating history. We have incurred significant net losses since our inception and anticipate that we will continue to incur significant losses for the foreseeable future; and therefore, we do not know whether or when we will generate the U.S. federal or state taxable income necessary to utilize our historical NOLs or credits that may be subject to limitation by Sections 382 and 383 of the Code.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, stockholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing we conduct in connection with Section 404 of the Sarbanes-Oxley Act, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our consolidated financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we identify any future material weaknesses, the accuracy and timing of our financial reporting may be adversely affected, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports or applicable stock exchange listing requirements, investors may lose confidence in our financial reporting and our stock price may decline as a result. We also could become subject to investigations by the Nasdaq Stock Market, or Nasdaq, the SEC or other regulatory authorities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, pursuant to Section 404 of the Sarbanes-Oxley Act, we are now required to furnish a report by our management on our internal control over financial reporting and an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. Our compliance with such requirement necessitates that we incur substantial accounting expense and expend significant management efforts. We will continue to dedicate significant internal and external resources to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will be able to conclude that our internal control over financial reporting is effective, or such conclusion may not be reached within the prescribed timeframe. The price of our common stock could decline substantially due to a loss of confidence in the reliability of our financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Managing our Business and Operations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We depend heavily on our executive officers, third-party consultants and others and our ability to compete in the biotechnology and pharmaceutical industries depends upon our ability to attract and retain highly qualified managerial, scientific and medical personnel. The loss of their services or our inability to hire and retain such personnel would materially harm our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our success depends, and will likely continue to depend, upon our ability to hire, and our ability to retain the services of our executive officers and other key employees within our organization. Our executive officers and other key employees may terminate their employment with us at any time. The loss of their services might impede the achievement of our operational and strategic objectives.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to compete in the biotechnology and pharmaceutical industries depends upon our ability to attract and retain highly qualified managerial, scientific and medical personnel. In particular, we will need to retain and, in some cases, hire, qualified personnel with expertise in clinical development and operations, preclinical research and development, manufacturing, quality management, medical and regulatory affairs, finance and accounting and other areas in connection with the continued development of our product candidates. We currently rely, and for the foreseeable future will continue to rely, on third-party consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development objectives and activities as well as the development of our commercialization strategies.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our industry has experienced a high rate of turnover of management personnel in recent years. Replacing executive officers or other key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to develop, gain regulatory approval of and commercialize products successfully and the culture fit to be a leader in our organization. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these additional key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There can be no assurance that the services of third-party consultants and advisors will continue to be available to us on a timely basis when needed, that we will be able to manage our existing consultants and advisors or that we can find qualified replacements on economically reasonable terms, or at all. Our consultants and advisors may be employed by other entities and may have commitments under consulting or advisory contracts with those entities that may limit their availability to us. If we are unable to continue to attract and retain highly qualified consultants and advisors, our ability to develop and commercialize our product candidates will be limited.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be able to hire and/or retain a sufficient number of employees or employees with the required expertise to develop our product candidates or operate our business successfully.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023, we had 319 full-time employees. Our focus on the development of multiple initial product candidates requires us to optimize cash utilization and to manage and operate our business in a highly efficient manner. We cannot assure you that we will be able to hire and/or retain adequate staffing levels to develop our product candidates or run our operations and/or to accomplish all of the objectives that we otherwise would seek to accomplish. If we are not able to effectively expand our organization by hiring new qualified employees, our clinical trials may be delayed or terminated, we may not be able to successfully execute the tasks necessary to further develop and commercialize our product candidates and, accordingly, may not achieve our development and commercialization goals.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our employees, independent contractors, consultants, collaborators and CROs may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements, which could cause significant liability for us and harm our reputation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are exposed to the risk that our employees, independent contractors, consultants, collaborators and CROs may engage in fraudulent conduct or other illegal activity. It is not always possible to identify and deter misconduct by employees and other third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. Misconduct by those parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities that violates:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">study and trial protocols or the FDA regulations or similar regulations of comparable non-U.S. regulatory authorities, including those laws requiring the reporting of true, complete and accurate information to such authorities;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing standards;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">federal and state healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable non-U.S. regulatory authorities; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">laws that require the reporting of financial information or data accurately.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Activities subject to these laws could also involve the improper use of information obtained in the course of clinical trials or creating fraudulent data in our preclinical studies or clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. Activities subject to these laws also involve the improper use or misrepresentation of information obtained in the course of clinical trials, creating fraudulent data in our preclinical studies or clinical trials or illegal misappropriation of product materials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws, standards or regulations. Additionally, we are subject to the risk that a person or government could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, disgorgement, integrity oversight and reporting obligations, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations, any of which could have a material adverse effect on our ability to operate our business and our results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We expect to expand our organization, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect to experience significant growth in the number of our employees and the scope of our operations. To manage these growth activities, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel. Our management may need to devote a significant amount of their attention to managing these growth activities. Due to our limited financial resources and the limited experience of our management team in managing a company with such anticipated growth, we may not be able to effectively manage the expansion or any necessary relocation of our operations, retain key employees, or identify, recruit and train additional qualified personnel. Our inability to manage the expansion or any necessary relocation of our operations effectively may result in weaknesses in our infrastructure, give rise to operational mistakes, loss of business opportunities, loss of employees and reduced productivity among remaining employees. Our expected growth could also require significant capital expenditures and may divert financial resources from other projects, such as the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">development of additional product candidates. If we are unable to effectively manage our expected growth, our expenses may increase more than expected, our ability to generate revenues could be reduced and we may not be able to implement our business strategy, including the successful commercialization of our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Organizational Structure</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Bain Investor and Pfizer have significant influence over us, and may have interests different from yours.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023, Bain Investor and Pfizer own, collectively, approximately 56.1% of the outstanding shares of our common stock. Furthermore, so long as they own certain specified amounts of our equity securities, Bain Investor and Pfizer have certain rights to nominate our directors. As long as such entities each own or control a significant percentage of outstanding voting power, they will have the ability to strongly influence all corporate actions requiring stockholder approval, including the election and removal of directors and the size of our board of directors, any amendment of our certificate of incorporation or bylaws, or the approval of any merger or other significant corporate transaction, including a sale of substantially all of our assets. Some or all of these entities may have interests different than yours. For example, because these entities acquired their shares at prices substantially below the price at which other stockholders may have purchased shares or have held their shares for a longer period, they may be more interested in selling our company to an acquirer than other investors or they may want us to pursue strategies that deviate from the interests of other stockholders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">As a &#x201c;controlled company&#x201d; within the meaning of Nasdaq listing standards, we qualify for exemptions from certain corporate governance requirements. We have the opportunity to elect any of the exemptions afforded a controlled company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because Bain Investor and Pfizer, together, control more than a majority of the total voting power of our common stock, we are a &#x201c;controlled company&#x201d; within the meaning of Nasdaq listing standards. Under Nasdaq rules, a company of which more than 50% of the voting power is held by another person or group of persons acting together is a &#x201c;controlled company&#x201d; and may elect not to comply with the following Nasdaq rules regarding corporate governance:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the requirement that a majority of our board of directors consist of independent directors; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the requirement to have a nominating/corporate governance committee composed entirely of independent directors and a written charter addressing the committee&#x2019;s purpose and responsibilities; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the requirement to have a compensation committee composed entirely of independent directors and a written charter addressing the committee&#x2019;s purpose and responsibilities; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the requirement of an annual performance evaluation of the nominating/corporate governance and compensation committees. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Currently, 10 of our 11 directors are independent directors, and we have an independent nominating and corporate governance committee and an independent compensation committee. However, for as long as the &#x201c;controlled company&#x201d; exemption is available, our board of directors in the future may not consist of a majority of independent directors and may not have an independent nominating and corporate governance committee or compensation committee. As a result, in the future, you may not have the same protections afforded to stockholders of companies that are subject to all of the Nasdaq rules regarding corporate governance.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our Amended and Restated Registration and Shareholder Rights Agreement provides that the doctrine of corporate opportunity does not apply with respect to certain of our stockholders, directors, non-voting observers or certain of their affiliates who are not our or our subsidiaries&#x2019; full-time employees.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The doctrine of corporate opportunity generally provides that a corporate fiduciary may not develop an opportunity using corporate resources or information obtained in their corporate capacity for their personal advantage, acquire an interest adverse to that of the corporation or acquire property that is reasonably incident to the present or prospective business of the corporation or in which the corporation has a present or expectancy interest, unless that opportunity is first presented to the corporation and the corporation chooses not to pursue that opportunity. The doctrine of corporate opportunity is intended to preclude officers, directors or other fiduciaries from personally benefiting from opportunities that belong to the corporation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the Amended and Restated Registration and Shareholder Rights Agreement, dated October 27, 2020 and as amended, by and between us and the other parties thereto, to the fullest extent permitted by law, the doctrine of corporate opportunity and any analogous doctrine does not apply to (1) Bain Investor, Pfizer, ARYA Sciences Holdings II and Perceptive Life Sciences Master Fund Ltd, (2) any member of our board of directors, non-voting observer or any officer who is not our or our subsidiaries&#x2019; full-time employee or (3) any affiliate, partner, advisory board member, director, officer, manager, member or shareholder of Bain Investor, Pfizer, ARYA Sciences Holdings II or Perceptive Life Sciences Master Fund Ltd who is not our or our subsidiaries&#x2019; full-time</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">employee (any such person listed in (1), (2) or (3) being referred to herein as an External Party). Therefore, we have renounced any interest or expectancy in, or being offered an opportunity to participate in, business opportunities that are from time to time presented to any External Party.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result, the External Parties are not prohibited from operating or investing in competing businesses. We therefore may find ourselves in competition with the External Parties, and we may not have knowledge of, or be able to pursue, transactions that could potentially be beneficial to us. Accordingly, we may lose a corporate opportunity or suffer competitive harm, which could negatively impact our business or prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our certificate of incorporation and amended and restated bylaws, and Delaware law, contain certain provisions, including anti-takeover provisions, that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our certificate of incorporation and amended and restated bylaws, or our bylaws, and the General Corporation Law of the state of Delaware, or the DGCL, contain provisions that could have the effect of rendering more difficult, delaying, or preventing an acquisition deemed undesirable by our board of directors or depress the trading price of shares of our common stock. These provisions could also make it difficult for stockholders to take certain actions, including electing directors who are not nominated by the current members of our board of directors or taking other corporate actions, including effecting changes in our management. Among other things, our certificate of incorporation and bylaws include provisions:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">permitting our board of directors to issue shares of preferred stock, including &#x201c;blank check&#x201d; preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that create a classified board of directors whose members serve staggered terms, with one class being elected each year by our stockholders;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regarding the limitation of the liability of, and the indemnification of, our directors and officers;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prohibiting stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of stockholders after such date and could delay the ability of stockholders to force consideration of a stockholder proposal or to take action, including the removal of directors;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requiring that a special meeting of stockholders may be called only by a majority of our board of directors, which could delay the ability of stockholders to force consideration of a proposal or to take action, including the removal of directors;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">controlling the procedures for the conduct and scheduling of our board of directors and stockholder meetings; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">permitting our board of directors to amend our bylaws, which may allow our board of directors to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the bylaws to facilitate an unsolicited takeover attempt; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regarding advance notice procedures with which stockholders must comply to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders&#x2019; meeting, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in our board of directors, and also may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#x2019;s own slate of directors or otherwise attempting to obtain control of our board of directors.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These provisions, alone or together, could delay or prevent hostile takeovers and changes in our control or changes in our board of directors or management.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, our certificate of incorporation includes a provision substantially similar to Section 203 of the DGCL, which may prohibit certain stockholders holding 15% or more of our outstanding capital stock from engaging in certain business combinations with us for a specified period of time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our bylaws designate specific courts as the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#x2019; ability to obtain a preferred judicial forum for disputes with us or our directors, officers, stockholders, employees or agents. If, however, our forum provisions are found to be unenforceable, we and our stockholders may incur additional costs associated with resolving such matters.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for state law claims for (1) any derivative action or proceeding brought on our behalf, (2) any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders, (3) any action asserting a claim arising pursuant to any provision of the DGCL or our certificate of incorporation or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">bylaws, (4) any action to interpret, apply, enforce or determine the validity of our certificate of incorporation or bylaws or (5) any action asserting a claim against us governed by the internal affairs doctrine; provided, however, that the foregoing provisions will not apply to any claims arising under the Exchange Act or the Securities Act. Our bylaws further provide that, unless we consent in writing to the selection of an alternative forum, the United States District Court for the District of Massachusetts will be the sole and exclusive forum for resolving any action asserting a claim arising under the Securities Act. In addition, our bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock is deemed to have notice of and consented to these forum provisions; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the U.S. federal securities laws and the rules and regulations thereunder.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These choice of forum provisions in our bylaws may impose additional litigation costs on stockholders in pursuing such claims and may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it believes to be favorable for disputes with us or any of our directors, officers, or other employees, which may discourage lawsuits with respect to such claims. In addition, while the Delaware Supreme Court ruled in March 2020 that federal forum selection provisions purporting to require claims under the Securities Act be brought in federal court are &#x201c;facially valid&#x201d; under Delaware law, there is uncertainty as to whether other courts will enforce our federal forum provision. If our forum provisions are found to be unenforceable, we and our stockholders may incur additional costs associated with resolving such matters. The Court of Chancery of the State of Delaware and the U.S. District Court for the District of Massachusetts may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Dependence on Third Parties</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We rely on third parties to assist in conducting our clinical trials. If they do not perform satisfactorily, we may not be able to obtain regulatory approval or commercialize our product candidates, or such approval or commercialization may be delayed, and our business could be substantially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have relied upon and plan to continue to rely on third parties, such as CROs, clinical data management organizations, medical institutions and clinical investigators, to conduct our clinical trials and expect to rely on these third parties to conduct clinical trials of any other product candidate that we develop. Our ability to complete clinical trials in a timely fashion depends on a number of key factors. These factors include protocol design, regulatory and IRB approval, patient enrollment rates and compliance with GCPs. We have opened clinical trial sites and are enrolling patients in a number of countries where our experience is limited. In most cases, we use the services of third parties, including CROs, to carry out our clinical trial-related activities and rely on such parties to accurately report their results. Our reliance on third parties for clinical development activities may impact or limit our control over the timing, conduct, expense and quality of our clinical trials. Moreover, the FDA requires us to comply with GCPs for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected. The FDA enforces these GCPs through periodic inspections of clinical trial sponsors, principal investigators, clinical trial sites and IRBs. For certain commercial prescription drug products, manufacturers and other parties involved in the supply chain must also meet chain of distribution requirements and build electronic, interoperable systems for product tracking and tracing and for notifying the FDA of counterfeit, diverted, stolen and intentionally adulterated products or other products that are otherwise unfit for distribution in the United States.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We remain responsible for ensuring that each of our trials is conducted in accordance with the applicable protocol, legal and regulatory requirements and scientific standards. Our failure or the failure of third parties to comply with the applicable protocol, legal and regulatory requirements and scientific standards can result in rejection of our clinical trial data or other sanctions. If we or our third-party clinical trial providers or third-party CROs do not successfully carry out these clinical activities, our clinical trials or the potential regulatory approval of a product candidate may be delayed or be unsuccessful. Additionally, if we or our third-party contractors fail to comply with applicable GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA may require us to perform additional clinical trials before approving our product candidates, which would delay the regulatory approval process. We cannot be certain that, upon inspection, the FDA will determine that any of our clinical trials comply with GCPs. We are also required to register certain clinical trials and post the results of completed clinical trials on a government-sponsored database, ClinicalTrials.gov, within certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, the third parties conducting clinical trials on our behalf are not our employees, and except for remedies available to us under our agreements with such contractors, we cannot control whether or not they devote sufficient time, skill and resources to our ongoing development programs. For instance, we have terminated the participation of one investigator involved with our clinical trials due to issues observed during a site monitoring visit, and we notified the FDA accordingly. Moreover, many CROs, including some of those that we have engaged to conduct our clinical trials, are experiencing enrollment challenges as a result of, among other things, high employee turnover driven by the post-COVID macroeconomic environment and the inexperience of new employees. Furthermore, at clinical trial sites, the availability of staff and trial participants has been limited due to a decrease in the number of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">clinical investigative sites across the globe. Accordingly, enrollment in some of our clinical trials has been slower than expected as a result of these changes in the post-COVID clinical trial landscape. These contractors may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials or other drug development activities, which could impede their ability to devote appropriate time to our clinical programs. If these third parties, including clinical investigators, do not successfully carry out their contractual duties, meet expected deadlines or conduct our clinical trials in accordance with regulatory requirements or our stated protocols, we may not be able to obtain, or may be delayed in obtaining, regulatory approvals for our product candidates. If that occurs, we will not be able to, or may be delayed in our efforts to, successfully commercialize our product candidates. In such an event, our financial results and the commercial prospects for any product candidates that we seek to develop could be harmed, our costs could increase and our ability to generate revenues could be delayed, impaired or foreclosed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also rely on other third parties to store and distribute drug supplies for our clinical trials. Any performance failure on the part of our distributors could delay clinical development or regulatory approval of our product candidates or commercialization of any resulting products, producing additional losses and depriving us of potential product revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any of the third-party organizations we utilize may terminate their engagements with us under certain circumstances. The replacement of an existing CRO or other third party may result in the delay of the affected trials or otherwise adversely affect our efforts to obtain regulatory approvals and commercialize our product candidates. Although we believe we have diversified our risk by engaging a number of CROs and other third-party organizations and there are a number of other CROs we could engage to continue these activities, we may not be able to enter into alternative arrangements or do so on commercially reasonable terms. In addition, while we believe there may be suitable replacements for one or more of these service providers, there is a natural transition period when a new service provider begins work. As a result, delays may occur, which could negatively impact our ability to meet our expected clinical development timelines and harm our business, financial condition and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In particular, we plan to rely on a hybrid functional service provider, or FSP, approach, where, rather than relying on a small number of third-party services providers for a full suite of services, we plan to use a wider number of third-party service providers on an &#xe0; la carte basis grouped by specific function. We may not be able to realize the cost savings typically associated with the hybrid FSP approach, or this approach may require us to incur increased startup or integration costs. Our hybrid FSP approach may also require us to manage and monitor an increased number of service providers and contractual relationships. Finally, this approach may require us to handle certain functions, such as collecting, transmitting and storing patient data in compliance with applicable data privacy laws, internally rather than outsourcing them to third parties. Handling these functions internally may require us to spend more time and capital hiring and training employees, and any failure to do so successfully may negatively impact our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Under the Funding Agreements, the Funding Investors have the right to suspend payments to us or take other actions that may be adverse to our interests in certain circumstances.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the Funding Agreements, while the Funding Investors agreed to provide up to an additional $25.0 million in April 2024, such payments are subject to certain customary funding conditions, and, if those funding conditions are not satisfied or waived, we will not receive such payments. The Funding Investors may also suspend their obligation to make payments to us following the occurrence of enumerated events such as an uncured material breach, a material adverse effect (which includes certain adverse developments related to the development and regulatory approval of tavapadon) or a bankruptcy event. The Funding Investors&#x2019; obligation to make development payments will resume upon their notice to us that the condition allowing them to suspend payments has been resolved or cured to their reasonable satisfaction. The Funding Investors may terminate their obligation to make any further development payments if such condition is not resolved or cured within 12 months. If the Funding Investors&#x2019; payment obligations terminate in these circumstances, we will remain obligated to make the milestone and royalty payments contemplated in the Funding Agreements to the Funding Investors in the event we nonetheless receive FDA approval for tavapadon and commercialize tavapadon in the United States. Our ability to receive payments under the Funding Agreements also depends on the ability of the Funding Investors to meet their funding commitments. If we do not receive additional payments under the Funding Agreements, our business, results of operations, cash flows and financial condition could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may seek to establish collaborations and, if we are not able to establish them on commercially reasonable terms, we may have to alter our development and commercialization plans.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The advancement of our product candidates and development programs and the potential commercialization of our current and future product candidates will require substantial additional cash to fund expenses. For some of our programs, we may decide to collaborate with other pharmaceutical and biotechnology companies with respect to development and potential commercialization. Likely collaborators may include large and mid-size pharmaceutical companies, regional and national pharmaceutical companies and biotechnology companies. In addition, if we are able to obtain regulatory approval for product candidates from foreign regulatory authorities, we may enter into collaborations with international biotechnology or pharmaceutical companies for the commercialization of such product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We face significant competition in seeking appropriate collaborators. Whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#x2019;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#x2019;s evaluation of a number of factors. Those factors may include the potential differentiation of our product candidate from competing product candidates, design or results of clinical trials, the likelihood of approval by the FDA or comparable foreign regulatory authorities and the regulatory pathway for any such approval, the potential market for the product candidate, the costs and complexities of manufacturing and delivering the product to patients and the potential of competing products. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available for collaboration and whether such a collaboration could be more attractive than the one with us for our product candidate. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our product candidates or bring them to market and generate product revenue.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaborations are complex and time-consuming to negotiate and document. Further, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators. Any collaboration agreements that we enter into in the future may contain restrictions on our ability to enter into potential collaborations or to otherwise develop specified product candidates. We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we enter into collaborations with third parties for the development and commercialization of our product candidates, our prospects with respect to those product candidates will depend in significant part on the success of those collaborations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may enter into collaborations for the development and commercialization of certain of our product candidates. If we enter into such collaborations, we will have limited control over the amount and timing of resources that our collaborators will dedicate to the development or commercialization of our product candidates. Our ability to generate revenues from these arrangements will depend on any future collaborators&#x2019; abilities to successfully perform the functions assigned to them in these arrangements. In addition, any future collaborators may have the right to abandon research or development projects and terminate applicable agreements, including funding obligations, prior to or upon the expiration of the agreed upon terms.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaborations involving our product candidates pose a number of risks, including the following:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators have significant discretion in determining the efforts and resources that they will apply to these collaborations;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may not perform their obligations as expected;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may not pursue development and commercialization of our product candidates or may elect not to continue or renew development or commercialization programs, based on clinical trial results, changes in the collaborators&#x2019; strategic focus or available funding or external factors, such as an acquisition, that divert resources or create competing priorities;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product candidates;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a collaborator with marketing and distribution rights to one or more products may not commit sufficient resources to the marketing and distribution of such product or products;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disagreements with collaborators, including disagreements over proprietary rights, including trade secrets and intellectual property rights, contract interpretation, or the preferred course of development might cause delays or termination of the research, development or commercialization of product candidates, might lead to additional responsibilities for us with respect to product candidates, or might result in litigation or arbitration, any of which would be time-consuming and expensive;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may not properly maintain or defend our intellectual property rights or may use our proprietary information in such a way as to invite litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential litigation;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability; and</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner or at all. If any future collaborator of ours is involved in a business combination, it could decide to delay, diminish or terminate the development or commercialization of any product candidate licensed to it by us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our use of third parties to manufacture our product candidates may increase the risk that we will not have sufficient quantities of our product candidates, raw materials, active pharmaceutical ingredients, or APIs, or drug products when needed or at an acceptable cost.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not own or operate manufacturing facilities for the production of clinical or commercial quantities of our product candidates, and we lack the resources and the capabilities to do so. Our current strategy is to outsource all manufacturing of our product candidates to third parties.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently rely on and engage third-party manufacturers to provide all of the API and the final drug product formulation of all of our product candidates that are being used in our clinical trials and preclinical studies. Although we believe that there are several potential alternative manufacturers who could manufacture our product candidates, we may incur added costs and delays in identifying and qualifying any such replacement. For instance, there are a limited number of suppliers who have spray-dried dispersion capabilities required to manufacture darigabat, and we can provide no assurance that we will be able to find an alternative manufacturer at an acceptable price. In addition, we typically order raw materials, API and drug product and services on a purchase order basis and do not enter into long-term dedicated capacity or minimum supply arrangements with any commercial manufacturer. We may not be able to timely secure needed supply arrangements on satisfactory terms, or at all. Our failure to secure these arrangements as needed could have a material adverse effect on our ability to complete the development of our product candidates or, to commercialize them, if approved. We may be unable to conclude agreements for commercial supply with third-party manufacturers or may be unable to do so on acceptable terms. There may be difficulties in scaling up to commercial quantities and formulation of our product candidates, and the costs of manufacturing could be prohibitive.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of the third-party manufacturers we rely on have only recently begun working with us and have limited or no experience manufacturing our API and final drug products. If our manufacturers have difficulty or suffer delays in successfully manufacturing material that meets our specifications, it may limit supply of our product candidates and could delay our clinical trials.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we are able to establish and maintain arrangements with third-party manufacturers, reliance on third-party manufacturers entails additional risks, including:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the failure of the third-party manufacturer to comply with applicable regulatory requirements and reliance on third parties for manufacturing process development, regulatory compliance and quality assurance;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing delays if our third-party manufacturers give greater priority to the supply of other products over our product candidates or otherwise do not satisfactorily perform according to the terms of the agreement between us;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limitations on supply availability resulting from capacity and scheduling constraints of third parties;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the possible breach of manufacturing agreements by third parties because of factors beyond our control;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the possible termination or non-renewal of the manufacturing agreements by the third party, at a time that is costly or inconvenient to us; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the possible misappropriation of our proprietary information, including our trade secrets and know-how.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we do not maintain our key manufacturing relationships, we may fail to find replacement manufacturers or develop our own manufacturing capabilities, which could delay or impair our ability to obtain regulatory approval for our product candidates. If we do find replacement manufacturers, we may not be able to enter into agreements with them on terms and conditions favorable to us and there could be a substantial delay before new facilities could be qualified and registered with the FDA and other foreign regulatory authorities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, if any third-party manufacturer with whom we contract fails to perform its obligations, we may be forced to manufacture the materials ourselves, for which we may not have the capabilities or resources, or enter into an agreement with a different manufacturer. In either scenario, our clinical trials supply could be delayed significantly as we establish alternative supply sources. In some cases, the technical skills required to manufacture our product candidates may be unique or proprietary to the original manufacturer and we may have difficulty, or there may be contractual restrictions prohibiting us from, transferring such skills to a back-up or alternate supplier, or we may be unable to transfer such skills at all. In addition, if we are required to change third-party manufacturers for any reason, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations. We will also need to verify, such as through a manufacturing comparability</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">study, that any new manufacturing process will produce our product candidate according to the specifications previously submitted to the FDA or another regulatory authority. We may be unsuccessful in demonstrating the comparability of clinical supplies, which could require the conduct of additional clinical trials. The delays associated with the verification of a new third-party manufacturer could negatively affect our ability to develop product candidates or commercialize our products in a timely manner or within budget. Furthermore, a third-party manufacturer may possess technology related to the manufacture of our product candidate that such third party owns independently. This would increase our reliance on such third-party manufacturer or require us to obtain a license from such third-party manufacturer in order to have another third party manufacture our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If any of our product candidates is approved by any regulatory agency, we intend to utilize arrangements with third-party contract manufacturers for the commercial production of those products. This process is difficult and time consuming and we may face competition for access to manufacturing facilities as there are a limited number of contract manufacturers operating under cGMPs that are capable of manufacturing our product candidates. Consequently, we may not be able to reach agreement with third-party manufacturers on satisfactory terms, which could delay our commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Some of our manufacturers are located outside of the United States. There is currently significant uncertainty about the future relationship between the United States and various other countries, including China, with respect to trade policies, treaties, government regulations and tariffs. Increased tariffs could potentially disrupt our existing supply chains and impose additional costs on our business. Additionally, it is possible further tariffs may be imposed that could affect imports of APIs used in our product candidates, or our business may be adversely impacted by retaliatory trade measures taken by China or other countries, including restricted access to such raw materials used in our product candidates. Given the unpredictable regulatory environment in China and the United States and uncertainty regarding how the U.S. or foreign governments will act with respect to tariffs, international trade agreements and policies, further governmental action related to tariffs, additional taxes, regulatory changes or other retaliatory trade measures in the future could occur with a corresponding detrimental impact on our business and financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, seizures or voluntary recalls of product candidates, operating restrictions and criminal prosecutions, any of which could significantly affect supplies of our product candidates. The facilities used by our contract manufacturers to manufacture our product candidates must be evaluated by the FDA. We do not control the manufacturing process of, and are completely dependent on, our contract manufacturing partners for compliance with cGMPs. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or others, we may not be able to secure and/or maintain regulatory approval for our product candidates manufactured at these facilities. In addition, we have no control over the ability of our contract manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the FDA finds deficiencies or a comparable foreign regulatory authority does not approve these facilities for the manufacture of our product candidates or if it withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for or market our product candidates, if approved. Contract manufacturers may face manufacturing or quality control problems causing drug substance production and shipment delays or a situation where the contractor may not be able to maintain compliance with the applicable cGMP requirements. Any failure to comply with cGMP requirements or other FDA, EMA and comparable foreign regulatory requirements could adversely affect our clinical research activities and our ability to develop our product candidates and market our products, if approved.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA and other foreign regulatory authorities require manufacturers to register manufacturing facilities. The FDA and corresponding foreign regulators also inspect these facilities to confirm compliance with cGMPs.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contract manufacturers may face manufacturing or quality control problems causing drug substance production and shipment delays or a situation where the contractor may not be able to maintain compliance with the applicable cGMP requirements. Any failure to comply with cGMP requirements or other FDA, EMA and comparable foreign regulatory requirements could adversely affect our clinical research activities and our ability to develop our product candidates and market our products following approval, if obtained.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If any third-party manufacturer of our product candidates is unable to increase the scale of its production of our product candidates or increase the product yield of its manufacturing, then our manufacturing costs may increase and commercialization may be delayed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In order to produce sufficient quantities to meet the demand for clinical trials and, if approved, subsequent commercialization of our product candidates, our third-party manufacturers will be required to increase their production and optimize their manufacturing processes while maintaining the quality of our product candidates. The transition to larger scale production could prove difficult. In addition, if our third-party manufacturers are not able to optimize their manufacturing processes to increase the product yield for our product candidates, or if they are unable to produce increased amounts of our product candidates while maintaining the same quality then we may not be able to meet the demands of clinical trials or market demands, which could decrease our ability to generate profits and have a material adverse impact on our business and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may need to maintain licenses for APIs from third parties to develop and commercialize some of our product candidates, which could increase our development costs and delay our ability to commercialize those product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Should we decide to use any APIs in any of our product candidates that are proprietary to one or more third parties, we would need to maintain licenses to those APIs from those third parties. If we are unable to gain or continue to access rights to these APIs prior to conducting preclinical toxicology studies intended to support clinical trials, we may need to develop alternate product candidates from these programs by either accessing or developing alternate APIs, resulting in increased development costs and delays in commercialization of these product candidates. If we are unable to gain or maintain continued access rights to the desired APIs on commercially reasonable terms or develop suitable alternate APIs, we may not be able to commercialize product candidates from these programs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Government Regulation</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our product candidates in other jurisdictions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Obtaining and maintaining regulatory approval of our product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction, while a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in others. For example, even if the FDA grants marketing approval of a product candidate, the EMA or comparable foreign regulatory authorities must also approve the manufacturing and marketing of the product candidate in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the United States, including additional preclinical studies or clinical trials, as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the United States, a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we intend to charge for our products is also subject to approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may also submit marketing applications in other countries. Regulatory authorities in jurisdictions outside of the United States have requirements for approval of product candidates with which we must comply prior to marketing in those jurisdictions. Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our products in certain countries. If we fail to comply with the regulatory requirements in international markets and/or receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of our product candidates will be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if we receive regulatory approval of any product candidates, we will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If any of our product candidates are approved, they will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record-keeping, conduct of post-marketing studies and submission of safety, efficacy and other post-market information, including both federal and state requirements in the United States and requirements of comparable foreign regulatory authorities. In addition, we will be subject to continued compliance with cGMP and GCP requirements for any clinical trials that we conduct post-approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturers and manufacturers&#x2019; facilities are required to comply with extensive FDA, EMA and comparable foreign regulatory authority requirements, including ensuring that quality control and manufacturing procedures conform to cGMP regulations and applicable product tracking and tracing requirements. As such, we and our contract manufacturers will be subject to continual review and inspections to assess compliance with cGMP and adherence to commitments made in any NDA, other marketing application and previous responses to inspection observations. Accordingly, we and others with whom we work must continue to expend time, money and effort in all areas of regulatory compliance, including manufacturing, production and quality control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any regulatory approvals that we receive for our product candidates may be subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase 4 clinical trials and surveillance to monitor the safety and efficacy of the product candidate. Certain endpoint data we hope to include in any approved product labeling also may not make it into such labeling, including exploratory or secondary endpoint data such as patient-reported outcome measures. The FDA may also require a risk evaluation and mitigation strategies, or REMS, program as a condition of approval of our product candidates, which could entail requirements for long-term patient follow-up, a medication guide, physician communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. In addition, if the FDA, EMA or a comparable foreign regulatory authority approves our product candidates, we will have to comply with requirements including submissions of safety and other post-marketing information and reports and registration.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA may impose consent decrees or withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with our product candidates, including adverse events of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, imposition of post-market studies or clinical trials to assess new safety risks or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on the marketing or manufacturing of our products, withdrawal of the product from the market or voluntary product recalls; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fines, warning letters or holds on clinical trials; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">refusal by the FDA to approve pending applications or supplements to approved applications filed by us or suspension or withdrawal of approvals; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product seizure or detention or refusal to permit the import or export of our product candidates; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, under FDORA, sponsors of approved drugs and biologics must provide 6 months&#x2019; notice to the FDA of any changes in marketing status, such as the withdrawal of a drug, and failure to do so could result in the FDA placing the product on a list of discontinued products, which would revoke the product&#x2019;s ability to be marketed. The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Products may be promoted only for the approved indications and in accordance with the provisions of the approved label. The policies of the FDA, EMA and comparable foreign regulatory authorities may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">While we may in the future seek designations for our product candidates with the FDA and comparable foreign regulatory authorities that are intended to confer benefits such as a faster development process, an accelerated regulatory pathway or regulatory exclusivity, there can be no assurance that we will successfully obtain such designations. In addition, even if one or more of our product candidates are granted such designations, we may not be able to realize the intended benefits of such designations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA and comparable foreign regulatory authorities offer certain designations for product candidates that are designed to encourage the research and development of product candidates that are intended to address conditions with significant unmet medical need. These designations may confer benefits such as additional interaction with regulatory authorities, a potentially accelerated regulatory pathway and priority review. However, there can be no assurance that we will successfully obtain such designations for our product candidates. In addition, while such designations could expedite the development or approval process, they generally do not change the standards for approval. Even if we obtain such designations for our product candidates, there can be no assurance that we will realize their intended benefits.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For example, we may seek a Breakthrough Therapy Designation for some of our product candidates. A breakthrough therapy is defined as a therapy that is intended, alone or in combination with one or more other therapies, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the therapy may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. As a condition of approval under the accelerated approval pathway, the FDA may require that a sponsor of a drug receiving accelerated approval perform adequate and well controlled post-marketing clinical trials. These confirmatory trials must be completed with due diligence, and the FDA is permitted to require, as appropriate, that such studies be underway prior to approval or within a specified period after the date of approval. Sponsors must also update FDA on the status of these studies, and under FDORA, the FDA has increased authority to withdraw approval of a drug granted accelerated approval on an expedited basis if the sponsor fails to conduct such studies in a timely manner, send the necessary updates to the FDA, or if such post-approval studies fail to verify the drug&#x2019;s predicted clinical benefit. In addition, the FDA currently requires, unless otherwise informed by the agency, pre-approval of promotional materials for products receiving accelerated approval, which could adversely impact the timing of the commercial launch of the product. For therapies that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Therapies designated as breakthrough therapies by the FDA are also eligible for accelerated approval. Designation as a breakthrough therapy is within the discretion of the FDA. Accordingly, even if we believe one of our product candidates meets the criteria for designation as a breakthrough therapy, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a Breakthrough Therapy Designation for a product candidate may not result</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in a faster development process, review or approval compared to therapies considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our product candidates qualify as breakthrough therapies, the FDA may later decide that such product candidates no longer meet the conditions for qualification.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA has granted Fast Track Designation for emraclidine for the treatment of hallucinations and delusions associated with Alzheimer's disease psychosis and CVL-871 for the treatment of dementia-related apathy, and we may seek Fast Track Designation for some of our other product candidates. If a therapy is intended for the treatment of a serious or life-threatening condition and the therapy demonstrates the potential to address unmet medical needs for this condition, the therapy sponsor may apply for Fast Track Designation. The FDA has broad discretion whether or not to grant this designation, so even if we believe a particular product candidate is eligible for this designation, there can be no assurance that the FDA would decide to grant it. The receipt of Fast Track Designation for emraclidine for the treatment of hallucinations and delusions associated with Alzheimer's disease psychosis and for CVL-871 for the treatment of dementia-related apathy, and any future receipt of Fast Track Designation for other product candidates, does not guarantee a faster development process, review or approval compared to conventional FDA procedures, and receiving a Fast Track Designation does not provide assurance of ultimate FDA approval. In addition, the FDA may withdraw Fast Track Designation if it believes that the designation is no longer supported by data from our clinical development program.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Some of our programs may be partially supported by government grant awards, which may not be available to us in the future or subject us to federal regulations such as &#34;march-in&#34; rights, certain reporting requirements and a preference for U.S. industry.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have received a notice of award for cooperative grant funding from the National Institute on Drug Abuse, or NIDA, to support the development of CVL-354 in opioid use disorder. To fund a portion of our future research and development programs, we may apply for additional grant funding from NIDA or other governmental agencies. However, funding by these governmental agencies may be significantly reduced or eliminated in the future for a number of reasons. For example, some programs are subject to a yearly appropriations process in Congress. In addition, we may not receive full funding under current or future grants because of budgeting constraints of the agency administering the program or unsatisfactory progress on the study being funded. Therefore, we cannot assure you that we will receive any future grant funding from any government agencies, or, that if received, we will receive the full amount of the particular grant award. Any such reductions could delay the development of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, any intellectual property rights generated through the use of U.S. government funding are subject to the Bayh-Dole Act of 1980, or Bayh-Dole Act. These U.S. government rights in certain inventions developed under a government-funded program include a non-exclusive, non-transferable, irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government has the right to require us to grant exclusive, partially exclusive, or non-exclusive licenses to any of these inventions to a third party if the government determines that: (1) adequate steps have not been taken to commercialize the invention; (2) government action is necessary to meet public health or safety needs; or (3) government action is necessary to meet requirements for public use under federal regulations, which we refer to as march-in rights. The U.S. government also has the right to take title to these inventions if we fail, or the applicable licensor fails, to disclose the invention to the government, elect title, and file an application to register the intellectual property within specified time limits. In addition, the U.S. government may acquire title to these inventions in any country in which a patent application is not filed within specified time limits. Intellectual property generated under a government funded program is also subject to certain reporting requirements, compliance with which may require us, or the applicable licensor, to expend substantial resources. In addition, the U.S. government requires that any products embodying the subject invention or produced through the use of the subject invention be manufactured substantially in the United States. The manufacturing preference requirement can be waived if the owner of the intellectual property can show that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the United States or that under the circumstances domestic manufacture is not commercially feasible.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of any funding from NIDA, or if we enter into future arrangements involving government funding, and we make inventions as a result of such funding, intellectual property rights to such discoveries may be subject to the applicable provisions of the Bayh-Dole Act. To the extent any of our current or future intellectual property is generated through the use of U.S. government funding, the provisions of the Bayh-Dole Act may similarly apply. Any exercise by the government of certain of its rights could harm our competitive position, business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our relationships with healthcare providers and physicians and third-party payors will be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">It is possible that governmental and enforcement authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws and regulations. Healthcare providers, physicians and third-party payors in the United States and elsewhere play a primary role in the recommendation and prescription of pharmaceutical products. Arrangements with third-party payors and customers can expose pharmaceutical manufacturers to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">financial arrangements and relationships through which we conduct research and would sell, market and distribute our products. As a pharmaceutical company, even though we do not and will not control referrals of healthcare services or bill directly to Medicare, Medicaid or other third-party payors, federal and state healthcare laws and regulations may affect our ability to operate. Such enumerated laws include, without limitation, the federal Anti-Kickback Statute, the federal civil and criminal False Claims Act and Physician Payments Sunshine Act and regulations. These laws will impact, among other things, our proposed sales, marketing and educational programs. In addition, we may be subject to patient privacy laws by both the federal government and the states in which we conduct our business. See the section entitled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business&#x2014;Government Regulation&#x2014;Healthcare and Privacy Laws and Regulation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; in our Annual Report.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, we are subject to state and foreign equivalents of each of the healthcare laws and regulations described above, among others, some of which may be broader in scope and may apply regardless of the payor. Many U.S. states have adopted laws similar to the federal Anti-Kickback Statute and False Claims Act, and may apply to our business practices, including, but not limited to, research, distribution, sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental payors, including private insurers. In addition, some states have passed laws that require pharmaceutical companies to comply with the April 2003 Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers and/or the Pharmaceutical Research and Manufacturers of America&#x2019;s Code on Interactions with Healthcare Professionals. Several states also impose other marketing restrictions or require pharmaceutical companies to make marketing or price disclosures to the state and require the registration of pharmaceutical sales representatives. Privacy and data protection laws from outside of the United States, including, for example, the European Union General Data Protection Regulation, the UK General Data Protection Regulation and the UK Data Protection Act 2018, or, collectively, the GDPR, also govern the privacy and security of personal information, including health information in some circumstances, and many of these laws differ from each other in significant ways, thus complicating compliance efforts. In addition, in the United States, there are a number of states that have enacted laws that govern the privacy and security of personal information, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. There are ambiguities as to what is required to comply with these state requirements and if we fail to comply with an applicable state law requirement we could be subject to penalties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Ensuring business arrangements comply with applicable healthcare and privacy laws, as well as responding to possible investigations by government authorities, can be time and resource-consuming and can divert a company&#x2019;s attention from the business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ensuring that our internal operations and future business arrangements with third parties comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices do not comply with current or future statutes, regulations, agency guidance or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of the laws described above or any other governmental laws and regulations that may apply to us, we may be subject to significant penalties, including administrative, civil and criminal penalties, damages, fines, disgorgement, the exclusion from participation in federal and state healthcare programs, individual imprisonment, reputational harm and the curtailment or restructuring of our operations, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws. Further, defending against any such actions can be costly and time consuming, and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired. If any of the physicians or other providers or entities with whom we expect to do business is found to not be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs and imprisonment. If any of the above occur, our ability to operate our business and our results of operations could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Coverage and reimbursement may be limited or unavailable in certain market segments for our product candidates, if approved, which could make it difficult for us to sell any product candidates profitably.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The success of our product candidates, if approved, depends on the availability of coverage and adequate reimbursement from third-party payors. We cannot be sure that coverage and reimbursement will be available for, or accurately estimate the potential revenue from, our product candidates or assure that coverage and reimbursement will be available for any product that we may develop.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patients who are provided medical treatment for their conditions generally rely on third-party payors to reimburse all or part of the costs associated with their treatment. Coverage and adequate reimbursement from governmental healthcare programs, such as Medicare and Medicaid, and commercial payors is critical to new product acceptance. See the section entitled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business&#x2014;Government Regulation&#x2014;Pharmaceutical Insurance Coverage and Healthcare Reform</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; in our Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the United States, no uniform policy of coverage and reimbursement for products exists among third-party payors. As a result, obtaining coverage and reimbursement approval of a product from a government or other third-party payor is a time-consuming and costly process that could require us to provide to each payor supporting scientific, clinical and cost-effectiveness data for the use of our products on a payor-by-payor basis, with no assurance that coverage and adequate reimbursement will be obtained. In the United States, the principal decisions about reimbursement for new medicines are typically made by CMS. CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare and private payors tend to follow CMS to a substantial degree. Even if we obtain coverage for a given product, the resulting reimbursement payment rates might not be adequate for us to achieve or sustain profitability or may require co-payments that patients find unacceptably high. Additionally, third-party payors may not cover, or provide adequate reimbursement for, long-term follow-up evaluations required following the use of product candidates, once approved. Patients are unlikely to use our product candidates, once approved, unless coverage is provided and reimbursement is adequate to cover a significant portion of their cost. There is significant uncertainty related to insurance coverage and reimbursement of newly approved products. It is difficult to predict at this time what third-party payors will decide with respect to the coverage and reimbursement for our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. We cannot be sure that reimbursement will be available for any product candidate that we commercialize and, if reimbursement is available, the level of reimbursement. In addition, many pharmaceutical manufacturers must calculate and report certain price reporting metrics to the government, such as average sales price and best price. Penalties may apply in some cases when such metrics are not submitted accurately and timely. Further, these prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs. Payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, increasing efforts by governmental and other third-party payors in the United States and abroad to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for newly approved products and, as a result, they may not cover or provide adequate payment for our product candidates. There has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs and reform government program reimbursement methodologies for drugs.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to marketing and reimbursement regulations in certain foreign countries, please read &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#x2014;EU drug marketing and reimbursement regulations may materially affect our ability to market and receive coverage for our products in the EU Member States.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Ongoing healthcare legislative and regulatory reform measures may have a material adverse effect on our business and results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in regulations, statutes or the interpretation of existing regulations could impact our business in the future by requiring, for example, (1) changes to our manufacturing arrangements, (2) additions or modifications to product labeling, (3) the recall or discontinuation of our products or (4) additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business. See &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business&#x2014;Government Regulation&#x2014;Pharmaceutical Insurance Coverage and Healthcare Reform</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; in our Annual Report.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The containment of healthcare costs has become a priority of federal, state and foreign governments, and the prices of products have been a focus in this effort. There have been a number of federal and state proposals during the last few years regarding the pricing of pharmaceutical products, limiting coverage and the amount of reimbursement for drugs and other medical products, government control and other changes to the healthcare system in the United States. Governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic products. For instance, in August 2022, the Inflation Reduction Act of 2022, or the IRA, was signed into law. The IRA includes several provisions that will impact our business to varying degrees, including provisions that allow the U.S. government to negotiate Medicare Part B and Part D pricing for certain high-cost drugs and biologics without generic or biosimilar competition, require companies to pay rebates to Medicare for drug prices that increase faster than inflation, create a $2,000 out-of-pocket cap for Medicare Part D beneficiaries, impose new manufacturer financial liability on all drugs in Medicare Part D and delay the rebate rule that would require pass through of pharmacy benefit manager rebates to beneficiaries. In particular, the IRA allows CMS to begin</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">negotiating prices for certain high-cost Medicare-covered small molecule drugs after they have spent seven years on the market. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. All of our disclosed product candidates are small molecule drugs and certain of them are being developed in indications that may rely heavily on Medicare reimbursement, such as Parkinson&#x2019;s disease and Alzheimer&#x2019;s disease psychosis. Accordingly, these new price-negotiation provisions may have a negative impact on our future revenue and profits. The effect of IRA on our business and the healthcare industry in general is not yet fully known. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit our revenue generated from the sale of any approved products. Even if we do receive a favorable coverage determination for our products by third-party payors, coverage policies and third-party payor reimbursement rates may change at any time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, CMS may develop new payment and delivery models, such as bundled payment models. In addition, recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their commercial products, which has resulted in several Congressional inquiries and proposed and enacted state and federal legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for pharmaceutical products. Congress has indicated that it will continue to seek new legislative measures to control drug costs. The continuing efforts of the government, insurance companies, managed care organizations and other payers of healthcare services to contain or reduce costs of healthcare may adversely affect:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the demand for any of our product candidates, if approved;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to set a price that we believe is fair for any of our product candidates, if approved;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to generate revenues and achieve or maintain profitability;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the level of taxes that we are required to pay; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of capital.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect that healthcare reform measures that may be adopted in the future may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved product. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products. Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical products. We cannot be sure whether additional legislative changes will be enacted, or whether the FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals or clearances of our product candidates, if any, may be.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Off-label use or misuse of our product candidates may harm our reputation in the marketplace or result in injuries that lead to costly product liability suits.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If our product candidates are approved by the FDA, we may only promote or market our product candidates in a manner consistent with their FDA-approved labeling. We will train our marketing and sales force against promoting our product candidates for uses outside of the approved indications for use, known as &#x201c;off-label uses.&#x201d; We cannot, however, prevent a physician from using our product candidates off-label, when in the physician&#x2019;s independent professional medical judgment he or she deems it appropriate. Furthermore, the use of our product candidates for indications other than those approved by the FDA may not effectively treat such conditions. Any such off-label use of our product candidates could harm our reputation in the marketplace among physicians and patients. There may also be increased risk of injury to patients if physicians attempt to use our product candidates for these uses for which they are not approved, which could lead to product liability suits that might require significant financial and management resources and that could harm our reputation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Inadequate funding for the FDA or other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disruptions at the FDA or other government agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical employees and stop critical activities. If a prolonged government shutdown occurs, including as a result of reaching the debt ceiling, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since March 2020, when foreign and domestic inspections were largely placed on hold, the FDA has been working to resume pre-pandemic levels of inspection activities, including for routine surveillance, bioresearch monitoring and pre-approval inspections. Should the FDA determine that an inspection is necessary for approval and an inspection cannot be completed during the review cycle due to restrictions on travel, and the FDA does not determine a remote interactive evaluation to be adequate, the FDA has stated that it generally intends to issue, depending on the circumstances a complete response letter or defer action on the application until an inspection can be completed. During the COVID-19 pandemic, a number of companies announced receipt of complete response letters due to the FDA&#x2019;s inability to complete required inspections for their applications. Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic and may experience delays in their regulatory activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">EU drug marketing and reimbursement regulations may materially affect our ability to market and receive coverage for our products in the EU Member States.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We intend to seek approval to market our product candidates in both the United States and in selected foreign jurisdictions. If we obtain approval in one or more foreign jurisdictions for our product candidates, we will be subject to rules and regulations in those jurisdictions. In some foreign countries, particularly those in the European Union, the pricing of drugs is subject to governmental control and other market regulations which could put pressure on the pricing and usage of our product candidates. In these countries, pricing negotiations with governmental authorities can take considerable time after obtaining marketing approval of a product candidate. In addition, market acceptance and sales of our product candidates will depend significantly on the availability of adequate coverage and reimbursement from third-party payors for our product candidates and may be affected by existing and future healthcare reform measures.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Much like the federal Anti-Kickback Statute prohibition in the United States, the provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is also prohibited in the European Union. The provision of benefits or advantages to reward improper performance generally is typically governed by the national anti-bribery laws of EU Member States and the Bribery Act 2010 in the United Kingdom. Infringement of these laws could result in substantial fines and imprisonment. EU Directive 2001/83/EC, which is the EU Directive governing medicinal products for human use, further provides that, where medicinal products are being promoted to persons qualified to prescribe or supply them, no gifts, pecuniary advantages or benefits in kind may be supplied, offered or promised to such persons unless they are inexpensive and relevant to the practice of medicine or pharmacy. This provision has been transposed into the Human Medicines Regulations 2012 and so remains applicable in the United Kingdom despite its departure from the European Union.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payments made to physicians in certain EU Member States must be publicly disclosed. Moreover, agreements with physicians often must be the subject of prior notification and approval by the physician&#x2019;s employer, his or her competent professional organization and/or the regulatory authorities of the individual EU Member States. These requirements are provided in the national laws, industry codes or professional codes of conduct, applicable in the EU Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, in some foreign countries, including some countries in the European Union, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing and reimbursement vary widely from country to country. For example, some EU Member States have the option to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. Reference pricing used by various EU Member States and parallel distribution, or arbitrage between low-priced and high-priced EU Member States, can further reduce prices. An EU Member State may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. In some countries, we may be required to conduct a clinical trial or other studies that compare the cost-effectiveness of any of our product candidates to other available therapies in order to obtain or maintain reimbursement or pricing approval. There can be no assurance that any country that has price controls or reimbursement limitations for biopharmaceutical products will allow favorable reimbursement and pricing arrangements for any of our products. Historically, products launched in the European Union do not follow price structures of the United States and generally prices tend to be significantly lower. Publication of discounts by third-party payors or authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and other countries. If pricing is set at unsatisfactory levels or if reimbursement of our products is unavailable or limited in scope or amount, our revenues from sales and the potential profitability of any of our product candidates in those countries would be negatively affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are subject to evolving global data protection laws and regulations, which may require us to incur substantial compliance costs, and any failure or perceived failure by us to comply with such laws and regulations may harm our business and operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The global data protection landscape is rapidly evolving, and we may be or become subject to or affected by numerous federal, state and foreign laws and regulations, as well as regulatory guidance, governing the collection, use, disclosure, transfer, security and processing of personal data, such as information that we collect about participants and healthcare providers in connection with clinical trials. Implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future, which may create uncertainty in our business, affect our or our service providers&#x2019; ability to operate in certain jurisdictions or to collect, store, transfer use and share personal data, result in liability or impose additional compliance or other costs on us. Any failure or perceived failure by us to comply with federal, state, or foreign laws or self-regulatory standards could result in negative publicity, diversion of management time and effort and proceedings against us by governmental entities or others. For example, states, such as California, Virginia, Colorado, Utah and Connecticut have recently enacted consumer privacy laws that grant rights to data subjects and places privacy and security obligations on entities handling personal data of consumers or households. While we are not currently subject to laws such as the CCPA, some observers note that the CCPA and similar legislation could mark the beginning of a trend toward more stringent privacy legislation in the United States, which could increase our potential liability and adversely affect our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to our operations in the United States, which may be subject to healthcare and other laws relating to the privacy and security of health information and other personal information, we may seek to conduct clinical trials in the United Kingdom or the European Economic Area, or the EEA, and may become subject to additional European data privacy laws, regulations and guidelines. We will be subject to the data protection laws of the European Union and United Kingdom in relation to personal data we collect from these territories. These laws impose additional obligations and risk upon our business, including substantial expenses and changes to business operations that are required to comply with these laws. The withdrawal of the United Kingdom from the European Union, or Brexit, and the subsequent separation of the data protection regimes of these territories mean we are required to comply with separate data protection laws in the European Union and United Kingdom, which may lead to additional compliance costs and could increase our overall risk.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The GDPR, which deals with the processing of personal data and on the free movement of such data, imposes a broad range of strict requirements, including requirements relating to having lawful bases for processing personal data and transferring such information outside the EEA/UK, including to the United States, providing details to those individuals regarding the processing of their personal data, keeping personal data secure, having data processing agreements with third parties who process personal data, responding to individuals&#x2019; requests to exercise their rights in respect of their personal data, reporting security breaches involving personal data to the competent national data protection authority and affected individuals, appointing data protection officers, conducting data protection impact assessments and record-keeping.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The GDPR imposes strict rules on the transfer of personal data out of the EEA/UK to countries not regarded by European Commission and the United Kingdom government as providing adequate protection, or the third countries, including the United States. These transfers are prohibited unless an appropriate safeguard specified by data protection laws is implemented, such as the Standard Contractual Clauses, or the SCCs, approved by the European Commission, or a derogation applies. The UK has published its own transfer mechanism, the International Data Transfer Agreement and International Data Transfer Addendum, or the IDTA, which enables transfers from the UK and has implemented a similar Transfer Equivalence Test. We will be required to carry out Equivalence Tests and transition to the new form of SCCs and IDTA in relation to our existing agreements with service providers outside the EEA/UK who we utilize for the processing of EEA/UK personal data and any other parties outside the EEA/UK who we transfer EEA/UK personal data to. The international transfer obligations under the EU and UK data protection regimes will require effort and cost and may result in us needing to make strategic considerations around where EEA/UK personal data is located and which service providers we can utilize for the processing of EEA/UK personal data, particularly as the enforcement around GDPR international transfer compliance obligations is currently unclear. The UK Government has also now introduced a Data Protection and Digital Information Bill, or the UK Bill, into the UK legislative process with the intention for this bill to reform the UK&#x2019;s data protection regime following Brexit. If passed, the final version of the UK Bill may have the effect of further altering the similarities between the UK and EU data protection regime. This may lead to additional compliance costs and could increase our overall risk.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot assure you that our efforts to comply with any obligations under European privacy laws will be sufficient. If we are investigated by a European data protection authority, we may face fines and other penalties. Any such investigation or charges by European data protection authorities could have a negative effect on our reputation and materially harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">As a result of our business combination with a special purpose acquisition company, regulatory obligations may impact us differently than other publicly traded companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On October 27, 2020, Cerevel Therapeutics, Inc. completed a business combination with ARYA, a special purpose acquisition company, or SPAC, pursuant to which we became a publicly traded company. As a result of this transaction, regulatory obligations have, and may continue, to impact us differently than other publicly traded companies. For instance, the SEC and other regulatory agencies may issue additional guidance or apply further regulatory scrutiny to companies like us that have completed a business</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">combination with a SPAC. Managing this regulatory environment, which has and may continue to evolve, could divert management&#x2019;s attention from the operation of our business, negatively impact our ability to raise additional capital when needed or have an adverse effect on the price of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Additional laws and regulations governing international operations could negatively impact or restrict our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we further expand our operations outside of the United States, we must dedicate additional resources to comply with numerous laws and regulations in each jurisdiction in which we plan to operate. The U.S. Foreign Corrupt Practices Act, or FCPA, prohibits any U.S. individual or business from paying, offering, authorizing payment or offering anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with certain accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Compliance with the FCPA is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered foreign officials. Certain payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Various laws, regulations and executive orders also restrict the use and dissemination outside of the United States, or the sharing with certain non-U.S. nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. If we expand our presence outside of the United States, it will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing or selling certain products and product candidates outside of the United States, which could limit our growth potential and increase our development costs.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The failure to comply with laws governing international business practices may result in substantial civil and criminal penalties and suspension or debarment from government contracting. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#x2019;s accounting provisions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are subject to certain U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions and other trade laws and regulations. We can face serious consequences for violations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Among other matters, U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions and other trade laws and regulations, which are collectively referred to as Trade Laws, prohibit companies and their employees, agents, CROs, legal counsel, accountants, consultants, contractors and other partners from authorizing, promising, offering, providing, soliciting or receiving, directly or indirectly, corrupt or improper payments or anything else of value to or from recipients in the public or private sector. Violations of Trade Laws can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm and other consequences. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities and other organizations. We also expect our non-U.S. activities to increase in time. We plan to engage third parties for clinical trials and/or to obtain necessary permits, licenses, patent registrations and other regulatory approvals and we can be held liable for the corrupt or other illegal activities of our personnel, agents or partners, even if we do not explicitly authorize or have prior knowledge of such activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Intellectual Property</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We depend and expect in the future to continue to depend on in-licensed intellectual property. Such licenses impose obligations on our business, and if we fail to comply with those obligations, we could lose license rights, which would substantially harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are dependent on patents, know-how and proprietary technology, both our own and licensed from others. We are and may in the future become a party to license agreements pursuant to which we in-license key intellectual property for our product candidates and their use. Soon after we began our operations in July 2018, we entered into the Pfizer License Agreement pursuant to which we in-licensed substantially all of our current product candidates and the patents and patent applications related to them. The Pfizer License Agreement excludes the field of treatment of prevention, diagnosis, control and maintenance of inflammatory bowel diseases and disorders in humans by compounds or products exerting a therapeutic effect on Leucine-Rich Repeat Kinase 2, or the LRRK2 field, which is retained by Pfizer. The Pfizer License Agreement imposes various diligence, milestone payments, royalty, insurance and other obligations on us. For example, under the terms of the Pfizer License Agreement, we are obligated to use commercially reasonably efforts to develop and seek regulatory approval for each of the product candidates licensed to us in certain designated</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">countries. If we fail to comply with any of these obligations, Pfizer may have the right to terminate the Pfizer License Agreement, in which event we would not be able to develop or market our product candidates covered by such licensed intellectual property. Upon Pfizer&#x2019;s termination of the Pfizer License Agreement for our material breach or either party&#x2019;s termination for bankruptcy, insolvency or other similar proceeding or force majeure, we would grant Pfizer an exclusive, sublicensable, royalty-free, worldwide, perpetual license under certain intellectual property we develop during the term of the Pfizer License Agreement. Any termination of our existing or future licenses could result in the loss of significant rights and would cause material adverse harm to our ability to commercialize our product candidates. See the section entitled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business&#x2014;Pfizer License Agreement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; in our Annual Report for additional information.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, Pfizer has an exclusive right of first negotiation in the event that we seek to enter into any significant transaction with a third party with respect to a product either globally or in certain designated countries. Significant transactions include exclusive licenses, assignments, sales, exclusive co-promotion arrangements, and other transfers of all commercial rights to a product globally or in the designated countries, as well as exclusive distribution agreements globally or in certain designated countries. This right of first negotiation may limit or delay our ability to enter into arrangements with other companies related to our product candidates and could discourage, delay or prevent a merger, acquisition or change of control of our company.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disputes may also arise between us and our licensors regarding intellectual property subject to a license agreement, including:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope of rights granted under the license agreement and other interpretation-related issues;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether and the extent to which our technology and processes infringe intellectual property of the licensor that is not subject to the licensing agreement;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our right to sublicense patent and other rights to third parties under collaborative development relationships;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our diligence obligations with respect to the use of in-licensed technology in relation to our development and commercialization of our product candidates and what activities satisfy those diligence obligations; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and us and our partners.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates. The Pfizer License Agreement imposes, and we expect that future license agreements will impose, various diligence, milestone payments, royalty, insurance and other obligations, and our failure to comply could give the applicable licensor a right to terminate the license, thereby impairing or preventing us from developing and marketing the product candidates covered by the applicable agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we have the right to control the maintenance, prosecution and enforcement of rights in-licensed under the Pfizer License Agreement, we are required to conduct our activities in compliance with the terms of the Pfizer License Agreement, which imposes on us certain obligations and grants Pfizer certain rights with respect to these activities. Additionally, we may have limited control over the maintenance, prosecution or enforcement of other rights that we in-license, and we may also have limited control over activities previously or separately conducted by our licensors. For example, we cannot be certain that activities conducted by Pfizer or any other present or future licensors have been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents and other intellectual property rights. We may also have limited control over other intellectual property that is not licensed to us but that may be related to our in-licensed intellectual property. We may have limited control over the manner in which our licensors initiate an infringement proceeding against a third-party infringer of the intellectual property or defend certain of the intellectual property that is licensed to us. It is possible that the licensors&#x2019; infringement proceedings or defense activities may be less vigorous than had we conducted them ourselves.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are generally also subject to all of the same risks with respect to protection of intellectual property that we own, as we are for intellectual property that we license, which are described below. If we or our licensors fail to adequately protect this intellectual property, our ability to commercialize products could materially suffer.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our success depends in part on our ability to protect our intellectual property, and patent terms may be inadequate to protect our competitive position. It is difficult and costly to protect our proprietary rights and technology, and we may not be able to ensure their protection.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial success will depend in large part on obtaining and maintaining patent, trademark and trade secret protection for our proprietary technologies and our product candidates, their respective components, formulations, combination therapies, methods used to manufacture them and methods of treatment, as well as successfully defending these patents against third-party challenges. Our ability to stop unauthorized third parties from making, using, selling, offering to sell or importing our product candidates is affected by the extent to which we have rights under valid and enforceable patents that cover these activities. If our patents expire, or we are unable to secure and maintain patent protection for any product or technology we develop, or if the scope of the patent</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">protection secured is not sufficiently broad, our competitors could develop and commercialize products and technology similar or identical to ours, and our ability to commercialize any product candidates we may develop may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the statutory expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date. While various extensions such as patent term adjustments and/or extensions, may be available, the life of a patent, and the protection it affords, is limited. Our current composition of matter patents, and patents that may issue from our pending patent applications, covering new chemical entities, pharmaceutical compositions comprising those entities, and their use in methods of treating various diseases and/or disorders, which we licensed from Pfizer, in connection with the formation of our company, are expected to expire between 2033 and 2039, not including any patent term extensions or adjustments. Our earliest patents may expire before, or soon after, our product candidates achieve marketing approval in the United States or foreign jurisdictions. Once the patents protecting any of our product candidates expire, we may be open to competition from competitive products, including generics. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. The expiration of the patents covering our lead product candidates, and our inability to secure additional patent protection, could also have a material adverse effect on our business, results of operations, financial condition and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The patenting process is expensive and time-consuming, and we may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. In addition, we may not pursue or obtain patent protection in all relevant markets. It is also possible that we will fail to identify patentable aspects of our research and development before it is too late to obtain patent protection. Moreover, in some circumstances, we may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents, covering technology that we license from or license to third parties and are reliant on our licensors or licensees.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The strength of patents in the biopharmaceutical field involves complex legal and scientific questions and can be uncertain. The patent applications that we own or in-license now or in the future may fail to result in issued patents with claims that cover our product candidates or uses thereof in the United States or in other countries. Even if the patents do successfully issue, third parties may challenge the validity, enforceability or scope thereof, which may result in such patents being narrowed, invalidated or held unenforceable. Furthermore, even if they are unchallenged, the patents covering our product candidates may not adequately protect our product candidates or prevent others from designing around our claims. If the breadth or strength of protection provided by the patents we hold with respect to our product candidates is threatened, it could dissuade companies from collaborating with us to develop, and threaten our ability to commercialize, our product candidates. Further, if we encounter delays in our clinical trials, the period of time during which we could market our product candidates under patent protection would be reduced.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, because some patent applications in the United States may be maintained in secrecy until the patents are issued, and most patent applications in the United States and many foreign jurisdictions are typically not published until 18 months after filing, and publications in the scientific literature often lag behind actual discoveries, we cannot be certain that others have not filed patent applications for technology covered by our issued patents or any pending applications, or that we or, if applicable, a licensor were the first to invent the technology or file patent applications directed to it. Our competitors also may have filed, and may in the future file, patent applications covering our products or technology similar to ours. Any such patent application may have priority over our patents or any patent applications, which could require us to obtain rights to issued patents covering such technologies. Furthermore, for U.S. applications in which at least one claim is entitled to a priority date before March 16, 2013, an interference proceeding can be provoked by a third party or instituted by the U.S. Patent and Trademark Office, or USPTO, to determine who was the first to invent any of the subject matter covered by the patent claims of the application. For U.S. applications in which all claims are entitled to a priority date after March 16, 2013, third parties can provoke derivations proceedings to determine if we or our licensor, as the case may be, derived the invention from them.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we or one of our licensors is a party to such proceedings involving a U.S. patent application on inventions owned by or in-licensed to us, we may incur substantial costs, divert management&#x2019;s time and expend other resources, even if we are successful. An unfavorable outcome could result in a loss of our current patent rights and could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms or at all.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may be required to disclaim part or all of the term of certain patents or certain patent applications. There may be prior art of which we are not aware that may affect the validity or enforceability of a patent claim. There also may be prior art of which we are aware, but which we do not believe affects the validity or enforceability of a claim, which may, nonetheless, ultimately be found to affect the validity or enforceability of a claim. No assurance can be given that if challenged, our patents would not be held by a court to be invalid or unenforceable or that even if our patents are valid and enforceable, a competitor&#x2019;s technology or product would be found by a court to infringe our patents. We may analyze patents or patent applications of our competitors that we believe are relevant to our activities, and consider that we are free to operate in relation to our product candidates, but our competitors may achieve issued claims, including in patents we consider to be unrelated, which block our efforts or may potentially result in our product candidates or our activities infringing such claims. The possibility exists that others will independently develop products which have the same effect</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">as our products and which do not infringe our patents or other intellectual property rights or will design around the claims of patents that cover our products.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The degree of future protection for our patent applications and patents is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage. For example:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">others may be able to make or use compounds that are similar to the compositions of our product candidates but that are not covered by the claims of our patents or to design around those claims;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the APIs in our current product candidates may eventually become commercially available in generic drug products, and no patent protection may be available with regard to their formulation or method of use;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we or our licensors, as the case may be, may fail to meet our obligations to the U.S. government in regard to any in-licensed patents and patent applications funded by U.S. government grants, leading to the loss of patent rights or their exclusivity;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we or our licensors, as the case may be, might not have been the first to file patent applications for these inventions;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">it is possible that our pending patent applications will not result in issued patents;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">it is possible that there are prior public disclosures that could invalidate our or our licensors&#x2019; patents, as the case may be, or parts of our or their patents;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">it is possible that there are unpublished applications or patent applications maintained in secrecy that may later issue with claims covering our products or technology similar to ours;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the laws of foreign countries may not protect our or our licensors&#x2019;, as the case may be, patent rights to the same extent as the laws of the United States;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the claims of our owned or in-licensed issued patents or patent applications, if and when issued, may not cover our product candidates;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our owned or in-licensed issued patents may not provide us with any competitive advantages, may be narrowed in scope, or be held invalid or unenforceable as a result of legal challenges by third parties;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inventors of owned or in-licensed patents or patent applications may become involved with competitors, develop products or processes which design around our patents, or become hostile to us or the patents or patent applications on which they are named as inventors;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">it is possible that our owned or in-licensed patents or patent applications omit individual(s) that should be listed as inventor(s) or include individual(s) that should not be listed as inventor(s), which may cause these patents or patents issuing from these patent applications to be held invalid or unenforceable because such omissions or inclusions are held to be done with deceptive intent;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may engage in scientific collaborations with one or more third parties, and such collaborators may develop adjacent or competing products to ours that are outside the scope of our patents; or</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may not develop additional proprietary technologies for which we can obtain patent protection.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to patent protection, we rely heavily upon know-how and trade secret protection, as well as non-disclosure agreements and invention assignment agreements with our employees, consultants and third parties, to protect our confidential and proprietary information, especially where we do not believe patent protection is appropriate or obtainable. It is our policy to require our employees, consultants, outside scientific collaborators, sponsored researchers and other advisors to execute confidentiality agreements upon the commencement of employment or consulting relationships with us. These agreements provide that all confidential information concerning our business or financial affairs developed or made known to the individual or entity during the course of the party&#x2019;s relationship with us is to be kept confidential and not disclosed to third parties except in specific circumstances. In the case of employees, the agreements provide that all inventions conceived or completed by the individual, and which are related to our current or planned business or research and development or made during normal working hours, on our premises or using our equipment or proprietary information, are our exclusive property. In addition to contractual measures, we try to protect the confidential nature of our proprietary information using physical and technological security measures. Such measures may not, for example, in the case of misappropriation of a trade secret by an employee or third party with authorized access, provide adequate protection for our proprietary information. Our security measures may, for example, not prevent an employee or consultant from misappropriating our trade secrets and providing them to a competitor, and recourse we take against such misconduct may not provide an adequate remedy to protect our interests fully.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Enforcing a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, the subject of our trade secrets may be independently developed by others in a manner that could prevent legal recourse by us. If any of our confidential or proprietary information, such as our trade secrets, were to be disclosed or misappropriated, or if any such information was independently developed by a competitor, our competitive position could be harmed. In addition, courts outside the United States are sometimes less willing to protect trade secrets than U.S. courts. Thus, we may not be able to meaningfully protect our trade secrets.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we choose to go to court to stop a third party from using any of our trade secrets, we may incur substantial costs. These lawsuits may consume our time and other resources even if we are successful.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Third-party claims of intellectual property infringement may prevent or delay our product discovery and development efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our commercial success depends in part on our ability to develop, manufacture, market and sell our product candidates and use our proprietary technologies without infringing the proprietary rights of third parties. There is a substantial amount of litigation involving patents and other intellectual property rights in the biotechnology and pharmaceutical industries. We may be exposed to, or threatened with, future litigation by third parties having patent or other intellectual property rights alleging that our product candidates and/or proprietary technologies infringe their intellectual property rights. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing our product candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our product candidates may give rise to claims of infringement of the patent rights of others. Moreover, it is not always clear to industry participants, including us, which patents cover various types of products or their methods of use or manufacture. There may also be third-party patents of which we are currently unaware with claims to materials, formulations, methods of manufacture or methods for treatment related to the use or manufacture of our product candidates. Because patent applications can take many years to issue, there may be currently pending patent applications which may later result in issued patents that our product candidates may infringe. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. If any third-party patents were held by a court or jury to cover the manufacturing process of our product candidates, constructs or molecules used in or formed during the manufacturing process, or any final product itself, or uses or formulations thereof, the holders of any such patents may be able to block our ability to commercialize the product candidate unless we obtained a license under the applicable patents, or until such patents expire or they are finally determined to be invalid or unenforceable. Such a license may not be available on commercially reasonable terms or at all. If we are unable to obtain a necessary license to a third-party patent on commercially reasonable terms, or at all, our ability to commercialize our product candidates may be impaired or delayed, which could in turn significantly harm our business. Even if we obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, if the breadth or strength of protection provided by our patents and any patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If a third party claims that we infringe its intellectual property rights, we may face a number of issues, including, but not limited to:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">infringement and other intellectual property claims, which, regardless of merit, may be expensive and time-consuming to litigate and may divert our technical and management personnel's attention from our core business;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">substantial damages for infringement, which we may have to pay if a court or jury decides that the product candidate or technology at issue infringes on or violates the third party&#x2019;s rights, and, if the court finds that the infringement was willful, we could be ordered to pay treble damages and the patent owner&#x2019;s attorneys&#x2019; fees;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a court prohibiting us from developing, manufacturing, marketing or selling our product candidates, or from using our proprietary technologies, unless the third party licenses its product rights to us, which it is not required to do;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">if a license is available from a third party, we may have to pay substantial royalties, upfront fees and other amounts, and/or grant cross-licenses to intellectual property rights for our products; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">redesigning our product candidates or processes so they do not infringe, which may not be possible or may require substantial monetary expenditures and time.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In any third-party litigation, there could also be public announcements of the results of hearings, motions or other interim proceedings or developments, and, if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. This type of litigation or proceeding could substantially increase our operating losses and reduce our resources available for development activities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Uncertainties resulting from the initiation and continuation of patent litigation or other intellectual property related proceedings could adversely affect our ability to compete in the marketplace.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">have a material adverse effect on our ability to raise the funds necessary to continue our operations or could otherwise have a material adverse effect on our business, results of operations, financial condition and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Generally, conducting clinical trials and other development activities in the United States is protected under the Safe Harbor exemption as set forth in 35 U.S.C. &#167;271. If and when any of our product candidates are approved by the FDA, third parties may then seek to enforce their U.S. patents by filing a patent infringement lawsuit against us. While we may believe that any claims of such patents that could otherwise materially adversely affect commercialization of our product candidates, if approved, and of which we are now aware, are not valid and enforceable, we may be incorrect in this belief, or we may not be able to prove it in a litigation. In this regard, patents issued in the United States by law enjoy a presumption of validity that can be rebutted only with evidence that is &#x201c;clear and convincing,&#x201d; a heightened standard of proof.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, even in the absence of litigation, we may need to obtain licenses from third parties to advance our research or allow commercialization of our product candidates. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all. In that event, we would be unable to further develop and commercialize our product candidates, which could harm our business significantly.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Third parties may assert that our employees, consultants, collaborators or partners have wrongfully used or disclosed confidential information or misappropriated trade secrets.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As is common in the biotechnology and pharmaceutical industries, we employ individuals who were previously employed at universities or other biopharmaceutical or pharmaceutical companies, including our competitors or potential competitors. Although no claims against us are currently pending, and although we try to ensure that our employees and consultants do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of a former employer or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. This risk is similarly applicable with respect to claims by third parties against any current or future licensors.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We or our licensors may be subject to claims challenging the inventorship or ownership of the patents and other intellectual property that we own or license now or in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We or our licensors may be subject to claims that former employees, collaborators or other third parties have an ownership interest in the patents and intellectual property that we in-license or that we may own or in-license in the future. While it is our policy to require our employees and contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own or such assignments may not be self-executing, for example, as part of employment or consulting agreements, or may be breached. Our licensors may face similar obstacles. We or our licensors could be subject to ownership disputes arising, for example, from conflicting obligations of employees, consultants or others who are involved in developing our product candidates. Litigation may be necessary to defend against any claims challenging inventorship or ownership, including in derivation proceedings in the USPTO. If we or our licensors fail in defending any such claims, we may have to pay monetary damages and may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property, which could adversely impact our business, results of operations and financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be successful in obtaining or maintaining necessary rights to develop any future product candidates on acceptable terms.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because our programs may involve additional product candidates that may require the use of proprietary rights held by third parties, the growth of our business may depend in part on our ability to acquire, in-license or use these proprietary rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For example, we may develop products containing our compounds and pre-existing pharmaceutical compounds. Our product candidates may also require specific formulations to work effectively and efficiently and rights to these formulations may be held by others. We may be unable to acquire or in-license any compositions, formulations, methods of use, processes or other third-party intellectual property rights from third parties that may be necessary or important to our business operations. We may also fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all, which would harm our business. We may need to cease use of the compositions or methods covered by such third-party intellectual property rights, and may need to seek to develop alternative approaches that do not infringe on such intellectual property rights which may entail additional costs and development delays, even if we were able to develop or in-license such alternatives or replacement technology, which may not be feasible. Even if we are able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, we may from time to time collaborate with academic institutions to accelerate our preclinical research or development under written agreements with these institutions. In certain cases, these institutions may provide us with an option to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">negotiate a license to any of the institution&#x2019;s rights in technology resulting from the collaboration. Regardless of such option, we may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property rights to others, potentially blocking our ability to pursue our program. In many cases, these institutions also have obligations to the U.S. government or other funding sources. These obligations may restrict the scope of any license that we may be able to negotiate. If we are unable to successfully obtain rights to required third-party intellectual property or to maintain the existing intellectual property rights we have, we may have to abandon development of such program and our business and financial condition could suffer.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The licensing and acquisition of third-party intellectual property rights is a competitive area, and companies, which may have a competitive advantage over us due to their size, cash resources and greater clinical development and commercialization capabilities, may also be pursuing strategies to license or acquire third-party intellectual property rights that we may consider necessary or attractive in order to commercialize our product candidates. There can be no assurance that we will be able to successfully complete such negotiations and ultimately acquire the rights to the intellectual property surrounding the additional product candidates that we may seek to acquire.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we do not obtain patent term extension and data exclusivity for any product candidates we may develop, our business may be materially harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depending upon the timing, duration and specifics of any FDA marketing approval of any product candidates we may develop, one or more of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Action of 1984, or Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent extension term of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent per eligible drug may be extended and only those claims covering the approved drug, an approved method for using it or a method for manufacturing it may be extended. Patent term extensions tied to marketing approval in foreign jurisdictions may also be available for our patents. However, we may not be granted an extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or the term of any such extension is less than we request, our competitors may obtain approval of competing products following our patent expiration, and our business, financial condition, results of operations and prospects could be materially harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be involved in lawsuits to protect or enforce our patents or the patents of our licensors, which could be expensive, time-consuming and unsuccessful.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competitors may infringe our patents or the patents of our licensors. To counter such infringement or unauthorized use, we may be required to file infringement claims in various jurisdictions, which can be expensive and time-consuming. If legal proceedings are initiated against a third party to enforce a patent covering one of our product candidates, the third-party defendant could counterclaim that the patent is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace, and there are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to validity, for example, we cannot be certain that there is no invalidating prior art, of which we, our patent counsel and the patent examiner were unaware, or not appreciative of its potential relevance, during prosecution. Such proceedings could result in revocation or amendment to our patents in such a way that they no longer cover our product candidates. In addition, a court may refuse to stop the other party from using the technology at issue on the grounds that the public interest favors the third party&#x2019;s continued use of our technology on a royalty basis. An adverse result in any litigation or defense proceedings could also put any related patent applications at risk of not issuing or being unable to be the basis of future litigation. Defense of these claims of invalidity, regardless of their merit, as well as assertion of our infringement claims, would involve substantial litigation expense and would be a substantial diversion of employee resources from our business. If we are otherwise unable to adequately protect our rights, we would lose at least part, and perhaps all, of the patent protection on our product candidates. Such a loss of patent protection could have a material adverse impact on our business and our ability to commercialize or license our technology and product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third parties may also choose to challenge the patentability of claims in our U.S. patents by requesting that the USPTO review the patent claims in an ex-parte re-examination, inter partes review or post-grant review proceedings. These proceedings are expensive and may consume our time or other resources. Third parties may also choose to challenge our patents in patent opposition proceedings in the European Patent Office, or EPO, or similar proceedings in other foreign patent offices. The costs of these opposition or nullity proceedings could be substantial and may consume our time or other resources. If we fail to obtain a favorable result at the USPTO, EPO or other patent offices, then our patents may be cancelled or narrowed in scope.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during such litigation. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Periodic maintenance fees on patents and patent applications are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of the patent applications and patents. The USPTO and various foreign governmental patent agencies also require compliance with a number of procedural, documentary, fee payment and other provisions during the patent application process and following the issuance of a patent. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result, if not cured, in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. In such an event, our competitors might be able to enter the market, which would have a material adverse effect on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in patent law in the United States and in ex-U.S. jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our products.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involve both technological and legal complexity, and is therefore costly, time-consuming and inherently uncertain. In addition, the United States has recently enacted and is currently implementing and proposing wide-ranging patent reform legislation. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents, particularly those directed to pharmaceutical and biopharmaceutical products and uses could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. We cannot predict how these decisions or any future decisions by the U.S. Congress, the federal courts or the USPTO may impact the value of our patents. Similarly, any adverse changes in the patent laws of other jurisdictions could have a material adverse effect on our business and financial condition.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recent or future patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our patents. Under the Leahy-Smith America Invents Act, or America Invents Act, enacted in 2013, the United States moved from a &#x201c;first-to-invent&#x201d; to a &#x201c;first-to-file&#x201d; system. Under a &#x201c;first-to-file&#x201d; system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be entitled to a patent on the invention regardless of whether another inventor had made the invention earlier. The America Invents Act includes a number of other significant changes to U.S. patent law, including provisions that affect the way patent applications are prosecuted, redefine prior art and establish a new post-grant review system. The effects of these changes are now being felt in the prosecution of pending patent applications and the enforcement of issued patents. The effect of these changes could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, now and in the future, all of which could have a material adverse effect on our business and financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be able to protect our intellectual property rights throughout the world.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Filing, prosecuting and defending patents on product candidates in all countries throughout the world is expensive. While many of our licensed patents, including the patents covering our lead product candidates, have been issued in major markets and other countries, our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States where we have issued patents, or from selling or importing products made using our inventions in other jurisdictions. Competitors may also use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we do not have patent protection or where we have patent protection but where enforcement is not as strong as that in the United States. These products may compete with our products in and our patents or other intellectual property rights may not be effective or sufficient to prevent such competition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to pharmaceutical and biopharmaceutical products, which could make it difficult for us or our licensors to stop the infringement of our owned or licensed patents or marketing of competing products by third parties in violation of our proprietary rights generally. The initiation of proceedings for infringement against third parties or by third parties to challenge the scope or validity of our patent rights in foreign jurisdictions could also result in substantial cost and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and any related patent applications at risk of not issuing and could provoke third parties to assert claims against us or our licensors. We may not prevail in any lawsuits that we initiate or are initiated against us and the damages or other remedies awarded in lawsuits that we initiate, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need for name recognition by potential partners or customers in our markets of interest. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Common Stock and Convertible Senior Notes</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The amount of our future losses is uncertain and our quarterly and annual operating results may fluctuate significantly or fall below the expectations of investors or securities analysts, each of which may cause our stock price to fluctuate or decline.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our quarterly and annual operating results may fluctuate significantly in the future due to a variety of factors, many of which are outside of our control and may be difficult to predict, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing and success or failure of clinical trials for our product candidates or competing product candidates, or any other change in the competitive landscape of our industry, </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to successfully recruit and retain subjects for clinical trials, and any delays caused by difficulties in such efforts, including as a result of COVID-19; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the risk/benefit profile, cost and reimbursement policies with respect to our product candidates, if approved, and existing and potential future therapeutics that compete with our product candidates; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain marketing approval for our product candidates and the timing and scope of any such approvals we may receive; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing and cost of, and level of investment in, research and development activities relating to our product candidates, which may change from time to time; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost of manufacturing our product candidates, which may vary depending on the quantity of production and the terms of our agreements with manufacturers; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to attract, hire and retain qualified personnel; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expenditures that we will or may incur to develop additional product candidates; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the level of demand for our product candidates should they receive approval, which may vary significantly; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the changing and volatile U.S. and global economic environments; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">future accounting pronouncements or changes in our accounting policies. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The cumulative effects of these factors could result in large fluctuations and unpredictability in our quarterly and annual operating results. As a result, comparing our operating results on a period-to-period basis may not be meaningful. This variability and unpredictability could also result in our failing to meet the expectations of industry or financial analysts or investors for any period. If our operating results or revenue fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if the forecasts we provide to the market are below the expectations of analysts or investors, the price of our common stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">could decline substantially. Such a stock price decline could occur even when we have met any previously publicly stated guidance we may provide.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Because of potential volatility in our trading price and trading volume, we may incur significant costs from class action securities litigation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The stock market in general, and Nasdaq and biotechnology and pharmaceutical companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Historically, securities class action litigation has often been brought against companies following periods of volatility in the market price of a company&#x2019;s securities. This type of litigation, if instituted, could result in substantial costs and a diversion of management&#x2019;s attention and resources, which could harm our business, operating results, or financial condition. Additionally, the dramatic increase in the cost of directors&#x2019; and officers&#x2019; liability insurance may cause us to opt for lower overall policy limits or to forgo insurance that we may otherwise rely on to cover significant defense costs, settlements, and damages awarded to plaintiffs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Conversion of the 2027 Notes will dilute the ownership interest of our existing stockholders or may otherwise depress the price of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The conversion of some or all of the 2027 Notes will dilute the ownership interests of existing stockholders. Any sales in the public market of our common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the 2027 Notes may encourage sales of our common stock by investors who view the 2027 Notes as a more attractive means of equity participation in us and/or short selling of our common stock pursuant to hedging or arbitrage activity that we expect many investors in the 2027 Notes to employ. In addition, anticipated conversion of the 2027 Notes into shares of our common stock could depress the price of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our issuance of additional capital stock in connection with financings, acquisitions, investments, our stock incentive plans or otherwise will dilute all other stockholders.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect to issue additional capital stock in the future that will result in dilution to all other stockholders. We expect to grant equity awards to employees and directors under our stock incentive plans. We may also raise capital through equity financings in the future. As part of our business strategy, we may acquire or make investments in complementary companies, products, or technologies and issue equity securities to pay for any such acquisition or investment. Any such issuances of additional capital stock may cause stockholders to experience significant dilution of their ownership interests and the per share value of our common stock to decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Because we have no current plans to pay cash dividends on our common stock, you may not receive any return on investment unless you sell your common stock for a price greater than that which you paid for it.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have never declared or paid any cash dividends on our capital stock and have no current plans to pay cash dividends on our common stock in the foreseeable future. Any future determination to declare dividends will be made at the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements, general business conditions, and other factors that our board of directors may deem relevant. As a result, capital appreciation, if any, of our common stock will be your sole source of gain for the foreseeable future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our indebtedness and liabilities could limit the cash flow available for our operations, expose us to risks that could adversely affect our business, financial condition and results of operations and impair our ability to satisfy our obligations under the 2027 Notes.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023, we had $498.6 million of liabilities, including $69.3 million of secured financing liabilities pursuant to the Funding Agreements and $336.0 million aggregate carrying value of indebtedness pursuant to the 2027 Notes. We may also incur additional indebtedness (including financial liabilities) to meet future financing needs. We are not restricted under the terms of the Indenture from incurring additional debt, securing then-existing or future debt, recapitalizing our debt or taking a number of other actions that are not limited by the terms of the Indenture that could have the effect of diminishing our ability to make payments on our indebtedness, including the 2027 Notes, when due.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our indebtedness could have significant negative consequences for our security holders and our business, results of operations and financial condition by, among other things:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">increasing our vulnerability to adverse economic and industry conditions;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limiting our ability to obtain additional financing on acceptable terms or at all;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requiring the dedication of a substantial portion of our cash flow from operations to service our indebtedness, which will reduce the amount of cash available for other purposes;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limiting our flexibility to plan for, or react to, changes in our business;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">diluting the interests of our existing stockholders as a result of issuing shares of our common stock upon conversion of the 2027 Notes; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">placing us at a possible competitive disadvantage with competitors that are less leveraged than us or have better access to capital.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business may not generate sufficient funds, and we may otherwise be unable to maintain sufficient cash reserves, to pay amounts due under our indebtedness, including the 2027 Notes, and our cash needs may increase in the future. In addition, any future indebtedness that we may incur may contain financial and other restrictive covenants that limit our ability to operate our business, raise capital or make payments under any then-existing indebtedness. If we fail to comply with these covenants or to make payments under any then-existing indebtedness when due, then we would be in default under that indebtedness, which could, in turn, result in that and any then-existing other indebtedness becoming immediately payable in full.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be unable to raise the funds necessary to repurchase the 2027 Notes for cash following a fundamental change, or to pay any cash amounts due upon conversion, and any other then-existing indebtedness may limit our ability to repurchase the 2027 Notes or pay cash upon their conversion.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Noteholders may, subject to a limited exception, require us to repurchase their 2027 Notes following a fundamental change at a cash repurchase price generally equal to the principal amount of the 2027 Notes to be repurchased, plus accrued and unpaid interest, if any to, but excluding, the fundamental change repurchase date. In addition, upon conversion, we will satisfy part or all of our conversion obligation in cash unless we elect to settle conversions solely in shares of our common stock. We may not have enough available cash or be able to obtain financing at the time we are required to repurchase the 2027 Notes or pay any cash amounts due upon conversion. In addition, applicable law, regulatory authorities and the agreements governing any other indebtedness may restrict our ability to repurchase the 2027 Notes or pay any cash amounts due upon conversion. Our failure to repurchase the 2027 Notes or pay any cash amounts due upon conversion when required will constitute a default under the Indenture. A default under the Indenture or the fundamental change itself could also lead to a default under agreements governing any other indebtedness, which may result in that other indebtedness becoming immediately payable in full. We may not have sufficient funds to satisfy all amounts due under any other indebtedness and the 2027 Notes. For additional information on the 2027 Notes, please read Note 6, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2027 Convertible Senior Notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Provisions in the Indenture could delay or prevent an otherwise beneficial takeover of us.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain provisions in the 2027 Notes and the Indenture could make a third-party attempt to acquire us more difficult or expensive. For example, if a takeover constitutes a fundamental change, then noteholders will have the right to require us to repurchase their notes for cash. In addition, if a takeover constitutes a make-whole fundamental change, then we may be required to temporarily increase the conversion rate. In either case, and in other cases, our obligations under the 2027 Notes and the Indenture could increase the cost of acquiring us or otherwise discourage a third party from acquiring us or removing incumbent management, including in a transaction that holders of our common stock may view as favorable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The accounting method for convertible debt securities that may be settled in cash, such as the 2027 Notes, could have a material effect on our reported financial results.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accounting method for reflecting the 2027 Notes on our consolidated balance sheets, accruing interest expense for the 2027 Notes and reflecting the underlying shares of our common stock in our reported diluted earnings per share may adversely affect our reported earnings and financial condition.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the Financial Accounting Standards Board published an Accounting Standards Update, which we refer to as ASU 2020-06, which simplified certain of the accounting standards that apply to convertible notes. ASU 2020-06 eliminated the cash conversion and beneficial conversion feature models that require separate accounting for embedded conversion features as a component of equity. Instead, the entity would account for the convertible debt or convertible preferred stock securities as a single unit of account, unless the conversion features require bifurcation and recognition as derivatives. Additionally, the guidance requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and to include the effect of potential share settlement for instruments that may be settled in cash or shares. ASU 2020-06 became effective for us beginning on January 1, 2022.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In accordance with ASU 2020-06, the 2027 Notes are reflected as a liability on our consolidated balance sheets, with the initial carrying amount equal to the principal amount of the 2027 Notes, net of issuance costs. The issuance costs are treated as a debt discount for accounting purposes, which will be amortized into interest expense over the term of the 2027 Notes. As a result of this amortization, the interest expense that we expect to recognize for the 2027 Notes for accounting purposes will be greater than the cash interest payments we will pay on the 2027 Notes, which will result in lower reported net income or higher reported net loss, as the case may be.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the shares of common stock underlying the 2027 Notes are reflected in our diluted earnings per share using the &#x201c;if converted&#x201d; method, in accordance with ASU 2020-06. Under that method, diluted earnings per share would generally be calculated assuming that all the 2027 Notes were converted solely into shares of common stock at the beginning of the reporting period, unless the result would be anti-dilutive. The application of the if-converted method may reduce our reported diluted earnings per share to the extent we are profitable in the future, and accounting standards may change in the future in a manner that may adversely affect our diluted earnings per share.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, in certain circumstances, including if any of the conditions to the convertibility of the 2027 Notes is satisfied, then we may be required under applicable accounting standards to reclassify the liability carrying value of the 2027 Notes as a current, rather than a long-term, liability. This reclassification could be required even if no noteholders convert their 2027 Notes and could materially reduce our reported working capital.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Future offerings of debt or equity securities by us may adversely affect the market price of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the future, we may attempt to obtain financing or to further increase our capital resources by issuing additional shares of our common stock or offering debt or other equity securities, including commercial paper, medium-term notes, senior or subordinated notes, debt securities convertible into equity or shares of preferred stock. Future acquisitions could require substantial additional capital in excess of cash from operations. We would expect to obtain the capital required for acquisitions through a combination of additional issuances of equity, corporate indebtedness and/or cash from operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuing additional shares of our common stock or other equity securities or securities convertible into equity may dilute the economic and voting rights of our existing stockholders or reduce the market price of our common stock or both. Upon liquidation, holders of such debt securities and preferred shares, if issued, and lenders with respect to other borrowings would receive a distribution of our available assets prior to the holders of our common stock. Debt securities convertible into equity could be subject to adjustments in the conversion ratio pursuant to which certain events may increase the number of equity securities issuable upon conversion. Preferred shares, if issued, could have a preference with respect to liquidating distributions or a preference with respect to dividend payments that could limit our ability to pay dividends to the holders of our common stock. Our decision to issue securities in any future offering will depend on market conditions and other factors beyond our control, which may adversely affect the amount, timing and nature of our future offerings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General Risk Factors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Adverse market or macroeconomic conditions or market volatility resulting from global economic developments, including those affecting the financial services industry, could adversely affect our business operations and our financial condition and results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adverse market or macroeconomic conditions or market volatility resulting from global economic developments, political unrest, high inflation, the post-COVID environment or other factors, could materially and adversely affect our business operations. For instance, actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation, or the FDIC, as receiver. Similarly, on March 12, 2023, Signature Bank Corp. and Silvergate Capital Corp. were each swept into receivership, and uncertainty remains over liquidity concerns in the broader financial services industry. We may maintain cash balances at third-party financial institutions in excess of the FDIC standard insurance limit. Although the U.S. Department of Treasury, FDIC and Federal Reserve Board have announced a program to provide up to $25.0 billion of loans to financial institutions secured by certain of such government securities held by financial institutions, widespread demands for customer withdrawals or other liquidity needs of financial institutions may exceed the capacity of such program, and there is no guarantee that the U.S. Department of Treasury, FDIC and Federal Reserve Board will provide access to uninsured funds in the future in the event of the closure of such banks or financial institutions, or that they would do so in a timely fashion. These events could result in a variety of material and adverse impacts on our current and projected business operations and our financial condition and results of operations, including, but not limited to, the following:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delayed access to deposits or other financial assets or the uninsured loss of deposits or other financial assets; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential or actual breach of contractual obligations that require us to maintain letters of credit or other credit support arrangements; or </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">termination of cash management arrangements and/or delays in accessing or actual loss of funds subject to cash management arrangements. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, any further deterioration in the macroeconomic economy or financial services industry could lead to losses or defaults by our partners, vendors or suppliers, which in turn, could have a material adverse effect on our current and/or projected business operations and results of operations and financial condition. For example, a partner may fail to make payments when due, default under their agreements with us, become insolvent or declare bankruptcy, or a supplier may determine that it will no longer deal with us as a customer. In addition, a vendor or supplier could be adversely affected by any of the liquidity or other risks that are described above as factors that could result in material adverse impacts on us, including but not limited to delayed access or loss of access to uninsured deposits or loss of the ability to draw on existing credit facilities involving a troubled or failed financial institution. The bankruptcy or insolvency of any partner, vendor or supplier, or the failure of any partner to make payments when due, or any breach or default by a partner, vendor or supplier, or the loss of any significant supplier relationships, could cause us to suffer material losses and may have a material adverse impact on our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in tax law could adversely affect our business and financial condition.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The rules dealing with U.S. federal, state, and local income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application), including with respect to net operating losses and research and development tax credits, could adversely affect us or holders of our common stock. In recent years, many such changes have been made and changes are likely to continue to occur in the future. Future changes in tax laws could have a material adverse effect on our business, cash flow, financial condition or results of operations. We urge investors to consult with their legal and tax advisers regarding the implications of potential changes in tax laws on an investment in our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our disclosure controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to management, recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements or insufficient disclosures due to error or fraud may occur and not be detected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities research analysts may establish and publish their own periodic projections for us. These projections may vary widely and may not accurately predict the results we actually achieve. Our share price may decline if our actual results do not match the projections of these securities research analysts. Similarly, if one or more of the analysts who write reports on us downgrades our stock or publishes inaccurate or unfavorable research about our business, our share price could decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, our share price or trading volume could decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If Nasdaq delists our shares of common stock from trading on its exchange for failure to meet Nasdaq&#x2019;s listing standards, we and our stockholders could face significant material adverse consequences including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a limited availability of market quotations for our securities; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reduced liquidity for our securities; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a determination that our common stock is a &#x201c;penny stock&#x201d; which will require brokers trading in our common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a limited amount of news and analyst coverage; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a decreased ability to issue additional securities or obtain additional financing in the future. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The price of our common stock may be volatile.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The price of our common stock may fluctuate due to a variety of factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in the industries in which we and our customers operate; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">variations in our operating performance and the performance of our competitors in general; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">material and adverse impact of the COVID-19 pandemic and post-COVID environment on the markets and the broader global economy; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">actual or anticipated fluctuations in our quarterly or annual operating results; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">publication of research reports by securities analysts about us, our competitors or our industry; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the public&#x2019;s reaction to our press releases, other public announcements and filings with the SEC; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our failure or the failure of our competitors to meet analysts&#x2019; projections or guidance that we or our competitors may give to the market; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additions and departures of key personnel; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in laws and regulations affecting our business; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">commencement of, or involvement in, litigation involving us; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in our capital structure, such as future issuances of securities or the incurrence of additional debt; </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the volume of shares of our common stock available for public sale; and </span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.398%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.559494254318427%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">general economic and political conditions such as recessions, interest rates, fuel prices, foreign currency fluctuations, international tariffs, social, political and economic risks and acts of war or terrorism. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These market and industry factors may materially reduce the market price of shares of our common stock regardless of our operating performance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_2_unregistered_sales_equity_securit"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2. Unregistered Sales of Equi</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ty Securities and Use of Proceeds.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_3_defaults_upon_senior_securities"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3. Defaults Upon</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Senior Securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4. Mine Saf</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ety Disclosures.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_5_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5. Other</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Information.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_6_exhibits"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 6. E</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">xhibits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:90.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:5.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:5.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:5.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:5.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1805387/000156459021015106/cere-ex31_371.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of Incorporation of Cerevel Therapeutics Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Annual Report on Form 10-K filed by the registrant on March 24, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.2</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1805387/000119312522174248/d291012dex31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated By-laws of Cerevel Therapeutics Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by the registrant on June 15, 2022).</span></a></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:90.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1805387/000119312522222349/d392963dex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indenture, dated as of August 16, 2022, between Cerevel Therapeutics Holdings, Inc. and U.S. Bank Trust Company, National Association, as trustee (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by the registrant on August 16, 2022).</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.2</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1805387/000119312522222349/d392963dex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of certificate representing the 2.50% Convertible Senior Notes due 2027 (incorporated by reference to Exhibit A to Exhibit 4.1 to the Current Report on Form 8-K filed by the registrant on August 16, 2022).</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="cere-ex10_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Separation Agreement, by and between Abraham Ceesay and Cerevel Therapeutics, LLC, dated as of February 21, 2023.</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.1*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="cere-ex31_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.2*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="cere-ex31_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.1*+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="cere-ex32_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.2*+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="cere-ex32_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.INS</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Instance Document &#x2013; the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.SCH*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.CAL*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.DEF*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.LAB*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.PRE*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibit 101.*)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:86.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">* Filed or furnished herewith.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">+ This certification will not be deemed &#x201c;filed&#x201d; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, except to the extent specifically incorporated by reference into such filing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.46%;"></td>
    <td style="width:5.04%;"></td>
    <td style="width:3.04%;"></td>
    <td style="width:46.46%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CEREVEL THERAPEUTICS HOLDINGS, INC.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: May 3, 2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ N. Anthony Coles</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">N. Anthony Coles</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Principal Executive Officer)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: May 3, 2023</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Mark Bodenrader</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Bodenrader</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interim Chief Financial Officer</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(Principal Financial Officer)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>2
<FILENAME>cere-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html>
 <head>
  <title>EX-10</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img188018671_0.jpg" alt="img188018671_0.jpg" style="width:207px;height:82px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 10.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 21, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PERSONAL AND CONFIDENTIAL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Abraham Ceesay</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Re:	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Separation Agreement</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dear Abe:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This letter confirms your separation from employment with Cerevel Therapeutics, LLC (together with parent and subsidiary entities, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  This letter also proposes an agreement between you and the Company (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) under which you would receive severance benefits from the Company.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regardless of whether you sign the Agreement below, the following bulleted terms and conditions apply in connection with the ending of your employment:</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company shall pay you, at the applicable time, your &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Final Compensation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; (as such term is defined in the Employment Agreement, by and between you and the Company, dated April 13, 2021 (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employment Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;)) and as applicable here, i.e. (i) your Base Salary ($532,118) for the final payroll period of your employment, through the Separation Date (as defined below); and (ii) reimbursement, in accordance with Section 2(f) of the Employment Agreement, for business expenses incurred by you but not yet paid to you as of the Separation Date, provided that you submit all expenses and supporting documentation required within thirty (30) days of the Separation Date, and provided further that such expenses are reimbursable under Company policies then in effect. </font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company shall provide you with the opportunity to continue group health coverage under the law known as &#x201c;COBRA&#x201d;, subject to your COBRA eligibility as applicable.  You will be notified by separate cover of your rights under COBRA.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Except as expressly provided in this Agreement and under COBRA, your employee benefits shall terminate (if they have not earlier terminated) as of the Separation Date, as provided in the Employment Agreement and/or the applicable employee benefit plans.</font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You are subject to continuing obligations under Section 3 and 5(e) of the Employment Agreement and the Restrictive Covenant Agreement (as such term is defined in the Employment Agreement), including, without limitation, your obligation to refrain from soliciting Company employees and customers for 24 months following the Separation Date and disclosing or using Confidential Information (as defined in the Restrictive Covenant Agreement) at any time (along with any other confidentiality, restrictive covenant and other ongoing obligations you have to any of the Releasees (as defined below), and except as waived herein, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ongoing Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). </font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company granted you options to purchase an aggregate of 695,820 shares of the Company&#x2019;s common stock and an aggregate of 29,083 restricted stock units pursuant to the Company&#x2019;s 2020 Equity Incentive Plan and applicable award agreements (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity Documents</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), of which 599,764 remain unexercised as of the date hereof.  As of the expected Separation Date of March 9, 2023, of these unexercised options, options to purchase an aggregate of 138,242 shares have vested and are exercisable under the Equity Documents (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested Options</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), and options to purchase an aggregate of 461,522 shares and 29,083 restricted stock units are unvested.  The exercise of any Vested Options shall be subject to the terms of the </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(76,78,86,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Cerevel Therapeutics, LLC &#149; 222 Jacobs Street, Suite 200 &#149; Cambridge, MA 02141 &#149; cerevel.com</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;"></font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity Documents, including, without limitation, the time limits on exercise (as amended hereby). Any awards that remain unvested shall become null and void as of the Separation Date.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The remainder of this letter proposes an agreement (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) between you and the Company.  With those understandings, you and the Company agree as follows:</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Separation Date</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provided you enter into and comply with this Agreement, the Company will continue to employ you until March 9, 2023, unless, prior to that date, (i) you resign from your employment for any reason; or (ii) the Company terminates your employment due to  your material breach of this Agreement or any Ongoing Obligation; or (iii) your employment is terminated for &#x201c;Cause&#x201d; as defined in in your Employment Agreement ((i), (ii) or (iii), a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specified Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  Subject to the foregoing sentence, the actual last date of your employment with the Company, whether it is March 9, 2023 or an earlier date, is the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Separation Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.&#x201d;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You acknowledge and agree that you have received adequate notice of your termination under the Employment Agreement and that the Company has no further notice obligations under the Employment Agreement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severance Benefits</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provided you (i) enter into and comply with this Agreement and (ii) do not experience a Specified Termination prior to March 9, 2023 (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severance Conditions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), you will be eligible for the following &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severance Benefits</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;:</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Waiver of Signing Bonus Repayment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  The Company shall waive any right to recovery of fifty percent (50%) of the Signing Bonus (as such term is defined in the Employment Agreement). </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0.0pt;justify-content:flex-start;margin-bottom:12.0pt;min-width:6.667%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Extension of Option Exercise Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  Notwithstanding anything to the contrary in the Equity Documents (which provide that any vested stock options may be exercised for a period of three months from the date of termination), you shall have a period of six months from the Separation Date to exercise any Vested Options, and this agreement shall be deemed to amend the Equity Documents accordingly. </font></div></div>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Release of Claims</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In consideration for, among other terms, the Severance Benefits, to which you acknowledge you would otherwise not be entitled, you voluntarily release and forever discharge the Company, its affiliated and related entities, its and their respective predecessors, successors and assigns, its and their respective employee benefit plans and fiduciaries of such plans, and the current and former officers, directors, shareholders, managers, members, partners, employees, attorneys, accountants and agents of each of the foregoing in their official and personal capacities (collectively referred to as the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Releasees</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) generally from all claims, demands, debts, damages and liabilities of every name and nature, known or unknown (&#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Claims</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) that, as of the date when you sign this Agreement, you have, ever had, now claim to have or ever claimed to have had against any or all of the Releasees.  This release includes, without limitation, all Claims:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">relating to your employment by and termination of employment with the Company; </font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of wrongful discharge or violation of public policy; </font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of breach of contract; </font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of defamation or other torts; </font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">under the Employment Agreement;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of retaliation or discrimination under federal, state or local law (including, without limitation, Claims of discrimination or retaliation under the Age Discrimination in Employment Act, the Americans with Disabilities Act, Title VII of the Civil Rights Act of 1964, and M.G.L. c. 151B);</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">under any other federal or state statute;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for wages, bonuses, incentive compensation, commissions, stock, stock options, vacation pay or any other compensation or benefits, either under the Massachusetts Wage Act, M.G.L. c. 149, &#167;&#167;148-150C, or otherwise; and</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for damages or other remedies of any sort, including, without limitation, compensatory damages, punitive damages, injunctive relief and attorney&#x2019;s fees; </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, however, that this release shall not affect your rights under this Agreement and the vested equity rights under the Equity Documents, any claim or right you may have under COBRA, any claim or right you may have for unemployment insurance or workers&#x2019; compensation benefits, any claims to enforce this Agreement, any claims that cannot be waived as a matter of law, and/or any claim or right that may arise after the execution of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You acknowledge and represent that, except as expressly provided in this Agreement, the Company has paid or provided, and/or you are not otherwise owed, any and all salary, wages, bonuses, accrued vacation/paid time off, premiums, leaves, any notice of termination under the Employment Agreement, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions, stock, stock options, vesting, and any and all other benefits and compensation due to you.  You specifically represent that you are not due to receive any commissions or other incentive compensation from the Company.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You agree not to accept damages of any nature, other equitable or legal remedies for your own benefit or attorney&#x2019;s fees or costs from any of the Releasees with respect to any Claim released by this Agreement.  As a material inducement to the Company to enter into this Agreement, you represent that you have not assigned any Claim to any third party.</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Resignation from Other Positions</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You agree that, effective as of the Separation Date, you have resigned from any other position you occupy at the Company or any Company affiliate, including, without limitation, as an officer of the Company and any Company affiliate, and will execute such documents and take such actions as the Company reasonably requires in good faith to effectuate such resignations.</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nondisparagement  </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You agree not to make any disparaging statements concerning the Company or any of its affiliates or current or former officers, directors, shareholders, employees or agents.  These nondisparagement obligations shall not in any way affect your obligation to testify truthfully in any legal proceeding.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">6.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unemployment Insurance</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If you apply to the Massachusetts Department of Unemployment Assistance for unemployment compensation benefits under state law, the Company shall not dispute your eligibility for such benefits.  This shall not affect the Company&#x2019;s obligation to respond truthfully to governmental agency requests for information related to unemployment compensation eligibility.</font></p>
  <div style="margin-left:0.13%;text-indent:0.0%;display:flex;margin-top:2.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:4.935%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.941423851006308%;">7.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ongoing Obligations</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;" id="you_agree_not_to_make_any_disparaging_st"><font id="x__ongoing_obligations_"></font><font id="x__return_of_property"></font><font id="x0__confidentiality_of_agreement_related"></font><font id="x__nondisparagement"></font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You hereby acknowledge and agree that the Ongoing Obligations remain in full effect and are incorporated by reference herein, provided that the Company hereby waives the 12-month post-employment noncompetition provision under Section 3.2 of the Restrictive Covenant Agreement and shall not be obligated to make any Garden Leave Pay (as defined therein).</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">8.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Return of Property</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You confirm that, to the best of your knowledge, you have returned or will return to the Company all Company property, including, without limitation, passwords, account access, computer equipment, software, keys and access</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cards, credit cards, files and any documents (including computerized data and any copies made of any computerized data or software) containing information concerning the Company, its business or its business relationships.  You also commit to deleting and finally purging any duplicates of files or documents that may contain Company information from any computer or other device that remains your property after the Separation Date.  In the event that you discover that you continue to retain any such property, you shall return it to the Company immediately.</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">9.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Confidentiality of Agreement-Related Information</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You agree, to the fullest extent permitted by law, to keep all Agreement-Related Information completely confidential.  &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement-Related Information</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d; means the negotiations leading to this Agreement.  Notwithstanding the foregoing, you may disclose Agreement-Related Information to your spouse, your attorney and your financial advisors, and to them only provided that they first agree for the benefit of the Company to keep Agreement-Related Information confidential.  Nothing in this section shall be construed to prevent you from disclosing Agreement-Related Information to the extent required by a lawfully issued subpoena or duly issued court order; provided that you provide the Company with advance written notice and a reasonable opportunity to contest such subpoena or court order.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">10.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Communications Concerning Your Separation</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Your separation from the Company will be announced by the Company on or around February 22, 2023. You will be provided the opportunity to review and provide reasonable comments on the relevant portion of the Company&#x2019;s draft Form 8-K and on any applicable press release the Company decides to issue (collectively, the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Communications</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;), </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that such comments do not unreasonably delay finalizing the Communications and are otherwise reasonably acceptable to the Company.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that a potential employer requests a reference concerning you from the Company&#x2019;s Chief Executive Officer or Chief Human Resources Officer, the Company will only confirm your dates of employment and last job title.  If asked about the circumstances of your separation from employment with the Company, you shall state that you resigned and shall not make any further comment about your employment separation.</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">11.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Protected Disclosures and Other Protected Actions</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nothing contained in this Agreement limits your ability to file a charge or complaint with any federal, state or local governmental agency or commission (a &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government Agency</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  In addition, nothing contained in this Agreement limits your ability to communicate with any Government Agency or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including your ability to provide documents or other information, without notice to the Company, nor does anything contained in this Agreement apply to truthful testimony in litigation.  If you file any charge or complaint with any Government Agency and if the Government Agency pursues any claim on your behalf, or if any other third party pursues any claim on your behalf, you waive any right to monetary or other individualized relief (either individually, or as part of any collective or class action); provided  that nothing in this Agreement limits any right you may have to receive a whistleblower award or bounty for information provided to the Securities and Exchange Commission.</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">12.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Defend Trade Secrets Act Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">You understand that pursuant to the Defend Trade Secrets Act of 2016, you shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">13.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Provisions</font></div></div>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Termination and Return of Payments; Certain Remedies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If you breach any of your obligations under this Agreement, in addition to any other legal or equitable remedies it may have for such breach, the Company shall have the right to terminate and/or enforce the return of its non-wage payments to you or for your benefit under this Agreement.  The termination and/or return of such payments in the event of your breach will not affect your continuing obligations under this Agreement.   Without limiting the Company&#x2019;s remedies hereunder, if the Company prevails in any action to enforce this Agreement, then you shall be liable to the Company for reasonable attorneys&#x2019; fees and costs incurred by the Company in connection with such action.</font></div></div>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Enforceability; Taxes</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.  All compensation and benefits provided or referred to hereunder shall be subject to taxes as required by applicable law.  </font></div></div>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Waiver; Absence of Reliance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  No waiver of any provision of this Agreement shall be effective unless made in writing and signed by the waiving party.  The failure of a party to require the performance of any term or obligation of this Agreement, or the waiver by a party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.  In signing this Agreement, you are not relying upon any promises or representations made by anyone at or on behalf of the Company.  </font></div></div>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jurisdiction; Governing Law; Interpretation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  You and the Company hereby agree that the state and federal courts of Massachusetts located in Boston shall have the exclusive jurisdiction to consider any matters related to this Agreement, including, without limitation, any claim of a violation of this Agreement.  With respect to any such court action, you submit to the jurisdiction of such courts, you acknowledge that venue in such courts is proper and you and the Company waive any right to a jury with respect to such court action.  This Agreement shall be interpreted and enforced under the laws of Massachusetts, without regard to conflict of law principles.  </font></div></div>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">(e)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Entire Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement, the Ongoing Obligations (which are incorporated herein by reference) and the Equity Documents constitute the entire agreement between you and the Company and supersede any previous agreements or understandings between you and the Company.  </font></div></div>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">(f)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Time for Consideration; Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  You acknowledge that you have been given the opportunity to consider this Agreement for twenty-one (21) days before signing it (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consideration Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and that you have knowingly and voluntarily entered into this Agreement.  You acknowledge that the above release of claims expressly includes without limitation claims under the Age Discrimination in Employment Act.  You are advised to consult with an attorney before signing this Agreement, and you acknowledge that you have in fact done so.  To accept this Agreement, you must return a signed original or a signed PDF copy of this Agreement so that it is received by the undersigned at or before the expiration of the Consideration Period.  If you sign this Agreement before the end of the Consideration Period, you acknowledge by signing this Agreement that such decision was entirely voluntary and that you had the opportunity to consider this Agreement for the entire Consideration Period.  For the period of seven (7) business days from the date when you sign this Agreement, you have the right to revoke this Agreement by written notice to the undersigned.  For such a revocation to be effective, it must be delivered so that it is received by the undersigned at or before the expiration of the seven (7) business day revocation period (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revocation Period</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;).  This Agreement shall not become effective or enforceable during the Revocation Period.  It will become effective on the day after the Revocation Period ends (the &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;). </font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0.0%;font-size:0;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-family:Times New Roman;justify-content:flex-start;min-width:4.533%;">(g)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Counterparts</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.  This Agreement may be executed in separate counterparts.  When all counterparts are signed, they shall be treated together as one and the same document.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Please indicate your agreement to the terms of this Agreement by signing and returning to the undersigned the original or a PDF copy of this letter within the time period set forth above.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Very truly yours,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cerevel Therapeutics, LLC</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:46.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By: 	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ N. Anthony Coles       ___________</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">____		</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2/21/2013</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_____________________</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">        N. Anthony Coles, MD				                  Date</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	Chief Executive Officer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:53.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This is a legal document.  Your signature will commit you to its terms.  By signing below, you acknowledge that you have carefully read and fully understand all of the provisions of this Agreement and that you are knowingly and voluntarily entering into this Agreement.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Abraham Ceesay</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">________________________	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2/21/2023</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_____________________</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Abraham Ceesay	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">					                </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">	</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>3
<FILENAME>cere-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 31.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, N. Anthony Coles, certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this Quarterly Report on Form 10-Q of Cerevel Therapeutics Holdings, Inc.;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#x2013;15(f) and 15d&#x2013;15(f)) for the registrant and have:</font></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:48.78%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.0%;"></td>
    <td style="width:46.22%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: May 3, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ N. Anthony Coles</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">N. Anthony Coles</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>4
<FILENAME>cere-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 31.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, Mark Bodenrader, certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this Quarterly Report on Form 10-Q of Cerevel Therapeutics Holdings, Inc.;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#x2013;15(f) and 15d&#x2013;15(f)) for the registrant and have:</font></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:9.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:48.88%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.0%;"></td>
    <td style="width:46.12%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: May 3, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Mark Bodenrader</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Bodenrader</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interim Chief Financial Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Financial Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>cere-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 32.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Quarterly Report on Form 10-Q of Cerevel Therapeutics Holdings, Inc. (the &#x201c;Company&#x201d;) for the quarter ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: May 3, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ N. Anthony Coles</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">N. Anthony Coles</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>6
<FILENAME>cere-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 32.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Quarterly Report on Form 10-Q of Cerevel Therapeutics Holdings, Inc. (the &#x201c;Company&#x201d;) for the quarter ended March 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:4.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: May 3, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Mark Bodenrader</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mark Bodenrader</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interim Chief Financial Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Principal Financial Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img33027544_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img33027544_0.jpg
M_]C_X  02D9)1@ ! @$"6 )8  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M)0 !  (" @,! 0            D*!P@&"P,$!0(! 0$  00# 0
M    !@,$!0<! @@)$   !@$" 0,," T."0<$!AL  0(#! 4&!P@1$A,)(=,4
M5)34%546%U<9D2+2E9;6& HQDI/5=K9WEZ?G.%AH03(C4Z2TM58WM]=X.1I1
M<[,D-'4VIJAA0C-T-8BX)>9GAW&Q4F)#AL>8R-A)66DZ@7*R)L9'2'DJ8T0G
MZ((HH61%*1$  @$" @0'"@8-"04& P$1  $"$0,$!2$Q$@9!49'1$Q0'87&!
MH5*2TE,5%K$B,I-4%\'A0G*BLC-STS0U50CP8H(CH[-D=#;"XY0W&.)C@R2T
M=?%#PT2DU(0E)E9V.,2U149EE>2%Q?_:  P# 0 "$0,1 #\ O\
M
M
M
M
M
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M!DN6Q2P6&LP:X=E.7AG*LGX60?%9KF6-=<3>N23X*TCYJI%<AJT,N8\
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M+*,KRZ*C@</9M4X8Q2?AE2K?=;;(=B<PQV,;>)O7)UX')T\"U+P(P*,B68
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M^6E1QKJ4XZ:<6TJQ?<;H;%R7>7"9M2S/^JQGDMZ)?>OA[ST]]*I+N(620
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M9M6HKR(QC\"1$[^+Q6)>UB;D[C_G2;^%F+1=EN
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M7Q7W)+7&7<>O3LN5&;(RC/<%G$/ZE[.(2^-!ZUW5Y2[JU:*I51(<(R9H
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M5%<B2(S=OW[\MN_.<Y<<FV_&<)%<I
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MD_B7(_(EX>"7'%Z>*JTFR,JSG!9O:V\,Z74OC0?RH\ZXFM'>>@W@& ,L
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M[<NRV[LI2GQMMOE9QT5#H
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M;%S6GKC)<<7PKQK4TGH-D8#,<)F=A8C"2VH<*X8OBDN!^)\#:-CABR^
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M=TGSAV.
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MXB#TI_"GJ:? U5-:4S8V&Q6'QEF.(PTU.S+4U_*J:X4]*X3)HM"N
M
M
M
M
M
M
M
M                  !35Z<#I.KW5+.\GV<Z'Y&] TBP6P72ZP9!3R>;7J9G
M%9((['$TS&%FXYA.&3V>QWVB-"+"U9=4M+C$>,M>\=P=T[>$P\,\S"-<;<5;
M47]Q!ZI4\N2TKBBUJ;9K'>O/IXB]++,)*F&@Z3:^ZDM:^]CJ[K[B17$&SR$
M
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M6U@+;^*O*?E/_9XEW6R'\34C0
M                            >[66=E2V5?<4]A-J;>IFQ+.JM:R6_ LJ
MRR@/MRH-A7SHKC4F'-AR6DN-.MJ2XVXDE),C(C'$X1N1<)I2A)4:>E-/6FN%
M,YC*4)*46U).J:UI\:+WG0Y=(^O>MI),TZU0GL'N,T=JZ]O*I/!#)ZCX89LU
MM5J0PP1DE-N4PTQ+UMI/,MSG&9"";1-;CL^>=]]UUD.-6*PB_P#Q9?;V?YDM
M;AWJ:8<-*K3LMO;F[.>>U<,[&(?_ )VTE7^='4I=_@EW:/AHIG!!B4   !PK
M4?4/#])<!S#4W4"ZC8[A6!X[:Y3DUS+,^:@U%/$<F2W$-I(W94IQ#7(88;)3
MTAY26VTJ6M*3KX7#7\;B883#1<K]R2C%<;;I_P#%ZDM+*5^]:PUF5^\]FU"+
M;?<1UX?2#;\]2=^6M5CG.1R;*ETTQ^3/KM(M-')2%5^&8RZZA/94QF,?8DS+
M\@1';?M)I\XM;A)8;7V,PPA'IC=K=W"[NX!8>TE+%22=R?#*7<X5%:HKPZVS
M2V<YQ?S?%.[.JL1T0CP17I/A?@U)&A8D)B
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MEP17 DN!+QZWI;-=!DRR
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MMX>VJ1BM27V6];;TMZ7I-,8C$7L5>EB,1)RO2=6W_+D6I+0C@8N"B
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MVSY8['4
M            DKZ-'I$\^V%ZPPI;DRSOM!<UM8$;5_3QM9R&W8*C1#\M\6BO
M.(9B9MCD8R<;Y*FT64=KL1]22-EZ/%MZMV<-O%@7%)1S&VGT<^[KV)<<9?@O
MXRX4\[D6=WLGQ*=6\'-_'C_M+^<O&M#X&NP<Q;*,>S?&<>S+$K>%D&+9925>
M28W>UKQ2*ZYHKN"Q95-I!?+@3L2?!DMNMJZG%*B'FR]9NX>[*Q>BXWH2<9)Z
MTTZ-/O,W+;N0NVXW;;3MR2::U-/2F?>%,[@
M
M
M
M
M
M
M                                                         !I!
MTC>Y&3M1V9ZW:Q4TQN'F,#&T8QI\XHTFZC.\UFQ\7QV?&961HDN8_(LU6BVS
MZBF8*^/4XC/[KY6LXSS#X&:K8<MJ?WD5M27AIL]]F)SO'/+LKNXF#I=4:1^^
MEH3\%:^ ZWY]]^4^]*E/.R9,EUQ^1(?<6\^^^\LW'7GG7#4XZZZXHU*4HS-1
MGQ/JCU"DDJ+0D:0;;=7K/$
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M=5;&&CTCXG)-*"\$GM+[TB^]N/>#REV[;I=O/8_HTK+Q+9_I%#,>AS40
M
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M@]-U[4OO8ZEWG+3_ $2GB-V&M
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MM2^^EJKWHZ5]\RM:-I$&
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MQ%W_ +M]^NCO11#2)P1@
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MQT+EU]]LTF&>,4
M                      %USYO+N:L=5=L.::"9-8+G7NW7)H+>-N2'25(/
M3/4%-I:4->7.*5(E> ,FJ+=GE\>0Q#>B,$24H3QT1VEY5'!YM;S&TJ6\5![7
MYR%$WX8N/?:DS:>Y>/EB,!+!W'6=B6C[V56N1J7@HBP2-;$R
M
M
M
M
M
M
M
M           "NI\Y)RN17[4M$L.9<<;;R?7MBYEDA)DE^/BF!9>PEAYPG"+F
M^RLE:<)!H42EMI5Q2:."MF]EUE2SC$7W]QAJ>=./HD*WXN..76K2^ZO5Y(RY
MRF*-YFKP
M                 "^'T!F72,EZ.G"JA]_GDX%J3JCB,9/(=2<:/*R'RW)A
M2W5*2[^S9DM9*1P025DGARDJ,_//:-95K>>Y-?\ S+5N7X.Q_LFW=S[KN9)&
M+^XN3CX]K_:)HA!24%1SYS%E$Z1J!M0PLS6FLJ,.U0RA!$[[1^=D5UB-2Z;C
M)-IXKBQ\71R%*6K@3RB22>*C7N?LJLQ6&QE_[N4[<?!%2?\ M>(UQOW<;O8>
MU]RHS?*XK[!5]&V2 @
M                         !V;VT3*)^;[3]L&:6AK.SR_;QHKE%B;CO/N
M'/O]-L:MI9K>YMKGEG(EJXJY">4?5X%] >4LZLQP^<XNQ#Y$,3=BN\IR2^ W
MQEMQW<NP]V7RI68-^&*9L.,87H %&3YPG?S[?I 2K9:^5%Q71'3BDJT$:C)N
M'*FY3DKW%)F:26JQR!\SX$7$N'ZH] ]FMN,-V]N.N>(FWWZ1C\$4:FWSG*6<
M[+U1M12\;^%D&HGY$P
M                        .9:=97(P/4'!<XB..,RL,S+&,KC/,I-;K4C'
M;N#;LN-)2XRI3B'(9&DB6@S,OHE]$4,596(PUS#R^3<A*/G)K[)4LW'9O0NK
M7&2?(ZG:9CR,>@0   ZY[I5LJE9CTB.[.WF./NO0]59V*H5(/E.%%P6JJL(@
MMI/G'/V!J%CS:&BX]1M*2X)_6EZ<W/LQL;LX.$=3LJ7AFW-^.1I/>&X[N=8F
M3UJXUYJ4?L$?8DAA@
M                         V7V89-(PS=]M;RF-*9AKI-PFCLYU^0\3$4H
M:-0,?3/;F/&MLFX,B"MQM\^4G@TI75+Z(Q6>VE?R3%V6J[6&NKNUV'2G=KJ[
MI?97<=K,L/<6BEZ'XRJ=F</*AO< #JZ-;,GL<VUFU<S.X<6[;9=J=GN3VCKB
MR<<<L;[*K6UFN+<2VTE:UR9:C,R2DC,^/ OH#UM@+4;&!LV(?(A:A%=Y121H
M'%7)7<5<NR^5*Y)OOMMF,1=%
M                                 )4NA2R>?C/25[<NPUN''R!_4;&+
M6,AU+29<"VTJS;FT/*-IXS;AVC$:622))K7'2GE)(S,1#?RU&[NKBMK7'8DN
MXU<A\*JO"2#=:X[>>V*:GM)^&$OLT?@.P3'FXW*8,W/Y8_@6VG</G4624*5A
M>AFK661IBD/NIB/XY@.07#,E3<4RDN$PY#)9I;_9#X<$]7@,AE-E8C-<-AVJ
MJYB+<:<>U-+[):9A<=G 7[RT.%F;Y(MG6&CU@:%
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MXYI<M_<RLOE4HT\39=:&B#:8
M
M
M
M
M
M
M                                               5H_G+7\A^V?[J
MV7?:@T-J=E?Z_B_S,?QB"[]?JEC\X_Q2GL-V&M
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M57\N U7B+%W"WYX>^MF["337=7V.)\*TG$16*(
M                =EQL0_(=V:?U4MN_\T6'CROO#^W\=_G+W]Y(WIE'[)PO
M^7M_B1-K1AS(@ 42>G^_M$,D^Y3I?_!<T>A.SC_3,/SUSX4:DWQ_;4OS</@9
M"@)X14
M              .UE'C\]"@  !UN/21?E\[O_P"L%J9]LTX>HMU_].8+_+6_
MQ4:.SS]L8G\]/X6:4#/&+
M                             #*VA'\N&C7W5M._MOIQ:9A^H7_S,_Q6
M7&#_ %NU^<C^,CM#QY*-^@ =6+G?^W&9?97D7\+S!ZZP_P"KV_O(_ CS[=_*
MR^^?PG%!6.@
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MS_3D?\S#\69+=ROVP_S,OAB7BAH$VP
M
M
M
M
M
M
M                                                     %:/YRU_
M(?MG^ZMEWVH-#:G97^OXO\S'\8@N_7ZI8_./\4I[#=AK0
M                                                       O%?-W
MOR!KG^L%J)]K.GPT#VF?ZCC_ ):'XTS:^Y7['?YZ7P1)VQKTEQ3V^<M?RX[9
M_N49;]M[0W9V5_L_%_GH_BFM-^OUNQ^;E\)6C&U""@
M %D;YM7^4=N&^XE6?;W2C5O:G^S<+^??XC)[N)^7Q/WD/AD<O^<P_P J.U3[
M =2OMBQ@4NRK]3QGYV'XLCMOY^4PW>N?# K%#:Y #L$>A3S6ZS;HVMO4B]3.
M7+QMK/<*BSIO+-%A2XMJ+E590*@J7U50:NE;8KD\#-*5PE)+APY)>;M_,/;P
M^].)5NFS/8FUQ.4(MU[K=9>$W/NQ>G?R.Q*>M1<?!&3BO$DBKATX]!7(Z3'5
MZ%C$$W[2_IM))-A75D7G)$K);'3K%XJ&F(D1DG'Y]E&;BN&1$MQYYTSXFI7
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M]<^%&I-\?VU+\W#X&0H">$5
M                               #M91X_/0H   =;CTD7Y?.[_\ K!:F
M?;-.'J+=?_3F"_RUO\5&CL\_;&)_/3^%FE SQBP
M                                               RMH1_+AHU]U;3
MO[;Z<6F8?J%_\S/\5EQ@_P!;M?G(_C([0\>2C?H '5BYW_MQF7V5Y%_"\P>N
ML/\ J]O[R/P(\^W?RLOOG\)Q05CH
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M/].1_P S#\69+=ROVP_S,OAB7BAH$VP
M
M
M
M
M
M
M                                                      %:/YRU
M_(?MG^ZMEWVH-#:G97^OXO\ ,Q_&(+OU^J6/SC_%*>PW8:T
M                                                         +Q7
MS=[\@:Y_K!:B?:SI\- ]IG^HX_Y:'XTS:^Y7['?YZ7P1)VQKTEQ3V^<M?RX[
M9_N49;]M[0W9V5_L_%_GH_BFM-^OUNQ^;E\)6C&U""@
M  %D;YM7^4=N&^XE6?;W2C5O:G^S<+^??XC)[N)^7Q/WD/AD<O\ G,/\J.U3
M[ =2OMBQ@4NRK]3QGYV'XLCMOY^4PW>N?# @$V];9-<-TV>UFG6B&G]YFEY/
MEQF)LZ)#D(QS&8C[S3+MSEF0J:.LQZFAD\2W7I"T\2X)0E;BDH5L;,\VR_*,
M.\3C[D;<$M"K\:7<C'6V^YX2'8#+<;F5U6L)!RTZ7]S'NMZE3EXDR_1B<G0W
MHI]BF"X_J5FT2!AVB^%G7/SEK91;ZA:AW$BSRF_K<+I7#8DV-QF&8VD]^%"3
MRE1X[AKD.)98?D)\Z7EF&]^\%RYA;;=^_<K3@A!4BG)\"C%)-\+U*K2-Q6^J
M9%E<879*-BS"E>-ZW1<+DZNG&RAEK+NDU*U;W495NV38NXQJ5;:H0=3L8F0'
M.S%X988U8P).!1*QRQ1)3(;PR#2P(\8WD+2I$1'*3P]J/0^!RC"X+)X9,UMX
M6-EVY)_=*2>W6GE-MOOFH,9F5[%9G+,X_%O.XI1_F[--G774DNXRVST'/2%:
MY;Q*76;3G<'=Q<SR[2IG#+W&\Z:HZ>CL[?'<D5>5DZIR)B@BU=1(ETTRDCKC
MR41$OR4RW>?6M3:5*TUO_NUE^27+&*RV+A8O;2E"K:4HT:<:U=&FZJM%14UF
MQ]U,ZQ6:VKMK&-2O6MGXU$JJ5=:5%54UI*M>YIUFZ5#=EI#LAW>9CJ+I1@=!
MJ;O<SW"\(0WG&HE45KANV["J_'DTU6G#J,GFDW6I&8)8<FNRW5(;@PSCM\'&
MW7V7LINADV-S_)H8;&7)6L@MW)_%@Z2OS;J]I\$(ZJ<+KW&K7>'-<-E&-Z:Q
M;C<S:=M*LEHA!5I3C<G74UHUZ*)RF;'M^>DFK^R+"]7M=-?]-;++JO#KI_7A
M_(I>'8I*I+:#-M/"\"VPJN*&W'@IKC;;AI:A_P#E*,;2TI6XZ:3B.?[O8S Y
M]<P67X:ZK+N+HJ*4JITHU)UTUUZ=#KJH9_*\TL8O+(8R]=AM;%;CJDHM?*37
M!3X-)3!V?[3Y^^G=]7:,X J1C>$7F19'E>29#'KS46#Z3U5DY+FV*8:4/1V)
MZH<F-75[3O!A5E+CMN*2A2E%O3.LY6[V2/'8FD\3&$8Q5?EW&M5>*M9/AV4^
M$U;EV6QSG-Y8>Q\7"N<I-I4V;=>!<#TI+B;U41._TI6[*MZ-33_3G8)L1CP]
M(+*5B$?+=2,ZQU$=6;5U39O/U=4CRB)!R_.%F"ZI^996KI>$(\3L7L53*74&
MWKW=')I;U8F[O'O"W?@I[,(2^2VM+T>1&J48K0W6M:,E^\.:+(;%O*<I2M3<
M:MI:8QK3AURDTZR=7PZVFH*MO?21;PMO6JM-J=4:Y:F9JVQ;L3<LPO4/.\LS
M#$,]KS<?\(5V2U-W;S&GWY4>:^3,U'(FPWG3>8=0YU1L',]U\DS/!RPD\/:M
MO9I&4(1C*#X'%I+B55J:T-$/P.?YG@L2K[O7+D*_&C.3DI+AUMT?$UI3Y"T#
MTM^SG2S>?LT/>?I?CL2NU9Q#2VCUNJ,CAU\6+;Y_I&]C$+)+G&LL=8>;38R*
M7#'CL:YY?9,AAZ!V(QP;DKX:EW,SS&9%GGL/%R;P4[SM.+>B%S:<5*/%66B6
MI-.KTHV#O)E=C-,M>.LK_P S;AMQ:6F4:5<7QZ-*X4]6MUI(C?9J0
M                   #LN-B'Y#NS3^JEMW_ )HL/'E?>']OX[_.7O[R1O3*
M/V3A?\O;_$B;6C#F1  HD]/]_:(9)]RG2_\ @N:/0G9Q_IF'YZY\*-2;X_MJ
M7YN'P,A0$\(J
M                    ':RCQ^>A0   ZW'I(OR^=W_]8+4S[9IP]1;K_P"G
M,%_EK?XJ-'9Y^V,3^>G\+-*!GC%@
M                                   !E;0C^7#1K[JVG?VWTXM,P_4+
M_P"9G^*RXP?ZW:_.1_&1VAX\E&_0 .K%SO\ VXS+[*\B_A>8/76'_5[?WD?@
M1Y]N_E9??/X3B@K'0
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MXLR6[E?MA_F9?#$O%#0)M@
M
M
M
M
M
M
M                                             *T?SEK^0_;/]U;+
MOM0:&U.RO]?Q?YF/XQ!=^OU2Q^<?XI3V&[#6@
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M:DY13T<IK?&68X?%W</"KA"Y**KKI&32KW=!CX7!;@
M '9<;$/R'=FG]5+;O_-%AX\K[P_M_'?YR]_>2-Z91^R<+_E[?XD3:T8<R( %
M$GI_O[1#)/N4Z7_P7-'H3LX_TS#\]<^%&I-\?VU+\W#X&0H">$5
M                                                           #
MM91X_/0H   =;CTD7Y?.[_\ K!:F?;-.'J+=?_3F"_RUO\5&CL\_;&)_/3^%
MFE SQBP
M               RMH1_+AHU]U;3O[;Z<6F8?J%_\S/\5EQ@_P!;M?G(_C([
M0\>2C?H '5BYW_MQF7V5Y%_"\P>NL/\ J]O[R/P(\^W?RLOOG\)Q05CH
M
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MS,OAB7BAH$VP
M
M
M
M
M
M
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MG^Y1EOVWM#=G97^S\7^>C^*:TWZ_6['YN7PE:,;4(*
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M[8A:C;M[2:DY-_&2HZI<9;;P[N8;)\)#$6;DYSE<V76E/DMUT+N$)HGI$0
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M6K<HR=5)R?Q57B2TEUG.ZN%RO+9XRW=N2N1<=#I33)+@5>'C*^0V20<
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MYN/ZONHGVRZ?C7O:9_IR/^9A^+,ENY7[8?YF7PQ+Q0T";8
M
M
M
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M)UJ;A#"&2
M                                         ^/>Y%C^+UZ[?)KVGQVJ
M;<:9<L[VSA5%>V\^KD,M+FV#\>,EQY?42DU<5'U"'>W:N7I;%J,I3XDFWR(Z
MSG"W':N-1CQMT1]1EYF0RU(CNMOL/MH>8?96EUEYEU)+;=:<0:D.-N(41I41
MF1D?$AU::='K.R::JM1Y!P
M
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M%33*]X-Z<'C,!+!X#:E*Y3:;5$DG5K3K;I3BI734K)C:YK\
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MK<>DB_+YW?\ ]8+4S[9IP]1;K_Z<P7^6M_BHT=GG[8Q/YZ?PLTH&>,6
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MWMV;:I;ACY12XDIM)<ANO,I.>07IR^4\*V_# Z_0>D#2@
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MX T#V=?ZHM?FKGXK-K;V_L*]WX?CQ*&(]#FG@
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MT6M):->ENNC579V[64XC*,'.UB7%W9W-JBTI*B2TZ*O00[=,AT6FX4M:]?\
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M:.FE/3%Z&VFF]?[P9!/)KD9VY.>#FZ)O6GY,J:.ZFM>G1H(MQ+B.$[?S=_\
M+YN/ZONHGVRZ?C7O:9_IR/\ F8?BS);N5^V'^9E\,2\4- FV
M                                      #4O(=^VR'%7I,:]W=;;HDV
M%8/54ZM:UHT^L+6!81E/MR8L^JK;^78PG(KL=;;O.M()MPN0HR49$>9M[NY_
M>2=O!8IQ:JGT4TFNXVDF8Z><95;=)XFPFG2FW&M>\G4Y'HSO VQ;B,DN\1T/
MULP34_(\<K'+FZJ\2M#LGH-2W/CUBK);J&4QW81SY;39.-K6E1N),C,C(Q2Q
MV29MEEJ-_,,/<LVI.B<E2KI6G?HCOA<RP&-F[>$NPN3BJM)UT:JFR(Q9?
M                 'PI^48S5VU70V>145=>W?.>!:6?;U\2VM^:_P"E\%UT
MB0W,G\WP]MS2%\/U14C9NS@[D(R=N.MI-I=]ZD='<A&2A*24WJ5=+[R/NBF=
MP
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M%1M;XW\9C<-A\/;C"%RY&-ROQOE22^*]%-'"UK>K1IM0C4)L$
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MCS,;J
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MVWT=?(HM7<VMJG-0FP$#)4
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M:DZ)53TQ=$DEHT:/)9+0(:2,
M                           *T?SEK^0_;/\ =6R[[4&AM3LK_7\7^9C^
M,07?K]4L?G'^*4]ANPUH     ;V=&+_:";1ONVXA^^EB.[V_Z:QOYB1G-VOV
MYA_OW^*RW%T]?]G%J+]GVE'VYP!IKLZ_U1:_-7/Q6;%WM_85[OP_'B4,1Z'-
M/  7AN@6WFW.XC;?=Z)Z@6[EKJ)MO>I*2NM+":<BTR'2R_:G>1KTA4E]<J;*
MQ.152JEUQ".;:A-UY+4;KIFK0/:)D5O+,TCC\-'9PN*JVDM$;BIM=[:JI=_:
MIH1MO=+-)YA@'8ONN(L-*O"XOY+?=T->!-Z60K=/1LQI]NVY&GUKT_IV:C3G
M<@W=WT^NA(2B!2:KT\B*[G+49DG7%1(F3M6T6V;29(;.7(F)923;1(1.^SO/
M9YGE<L!B9;6*PM$F];MOY/FT<>\HUUD6WQRN.$Q<<=95+-ZNU34IK2W_ $EI
M[Z;X3072/HV-\FNV(XWGNE6W;,,IPO+S1Y-Y/X0Q6DI;5IR047LQB=D>05#*
M*YN3RD.2G#1';4VLEK3S:^3),9O3N_E]Z>'Q>*A"_#Y4:2;7<I&+T]S68;#[
MO9QBK4;]BPY6II-/:BJI\.F2/>W!]&?O1VKZ9+U=UZTDBX%A*,CK,6[-/4/3
M/*)BK6X9DO5R2K\+S#(Y7,2"ANIY9D7(4CVQ$1I,^F6[UY%F^+ZEEUYW+^RY
M?(G%46O3*,3G%[OYK@,*\7B[:A:4DG\:+>G4_BMZ*Z-=>Y0T.$B,*;@;7MAF
MZO>*]/7H+I1;9/0U+SD:XS2SF5N+X16S&FVG5U[F49#+KJR;;)1(;4<*(J1,
M2AQ+AM$WQ66$S?>+)\C2]HWE&X]44G*;[NRJM+NNB[IE<NR3,<T^-A;?]4GI
MDW2/*]?@3IPFYUGT%6_5N#:R<3J]&]2IU*XXQ9T6"ZQ8O*N(4EOG"*)*1D)X
MY C2W%LN)2V[(0HU(41D7 8./:#N[M15YW[49:G.U)+OZ*NG>1EI[FYQ&+E!
MV9R7 IZ>]I27*T:A:_; MS.U_2' ]9=<\-CX#2ZAY9<X;38O;SS1G4*UI?"R
MGGKO'TQC;KJ^:Q3./17>R%]D1W&G4ER'$J&:RW>/*LWQMS Y?-W)VH*3DE\1
MITU/A:K1Z-#37 8O'9'C\NPD,7C%&,9SV=FM9)Z==%2E%70WK1I<,Z8@VMVT
M;(=T>[RQD0] ](\AS*N@/&Q;98^<+'<&IWB0;JHUAF612:S'D6!-%RDQ$/N3
M'$_K&E##YKG^49+':S&]&$GJCIE-]Z*JZ=VE.Z9/+\FS',W_ .4MMV^&3T17
MA>OO*K-YW.@GWV.IGQJ1&AN4Y)5LJ=L<+H-9<=>RB"MLR;?C3(U@S75L1Z/)
M43*S=E(;)U1%RC+JB/\ UA;O*DKG6(6I:I.T]E]ZE6^/0C,O<S-Z.DK#DN!2
M=?Q:>,B]UBT2U9V^YS9::ZT8#D6G6;U26W9-%D4/L=UZ(\I:8]E63&5OUMU4
M2U-*YF9#>?BO<D^0XK@8EN!Q^#S+#K%8&Y&[AWPQ?#Q-:T^--)]PCF+P>*P-
MYV,7"4+JX'Q<::T-=U-HQ:+LMC>;;3T;F\S=I5EDFC6C%U888KGN:SO*)M7A
M.'351U(;=13W.43*QO(7$.N$A15R99H42N7R>2HRC^:[TY'DT^BQU^*O^1%.
M4EWU&NS_ $J&:P&[^:YC'I+%NEEZI2^*GWJZ7WTFNZ;9R^@@WXJ8N2QEC1#.
M[:@D=B6V.8EK%0/7<"5QEME&FHNX]'7U\@WX3C9(DR&5<XA1</:K-.'7:'N\
MG'I>L6X2U2E:=&N-4JWKX$S)/<S-TGLRL2:X%-U\<4N5D7>L6ANKVWW,I>G^
MM6G>4Z;9?#23JJ?)ZQV$J7%4?)185,TN<KKNK=41DB7#>?C.&1DE9\#$LP.8
M8+,K"Q. NPNV7PQ=:=QK6GW&DR.XO XO 7>AQEN5NYW=3[S6A^!LY9H%M6W!
M;H[#(ZK0'3&\U,L,1AU]ADD6DDT\=RJA6C\F-7R'_"]E7)6B2_$<27(-9D:>
MKPZG&CF.;Y;E$8SS&[&U&;:BW72UKU)\94P.68[,G)8*V[CA2NE*E:TUM<3-
MFO5&]([^:GGWOEAGQG&*]\]U_IEKDEZ)D/=C/?H[\Z'I&KNO>V'7G:_=T6-Z
M]Z;W.FMYDM4]=T=;=2J>1(L*EB6N [.:*HLK%"&4S&U-ERS29J2? CX&,MEV
M;9=FT)7,NNQNVX.C:KH>NFE(Q^.RW'9<XQQMMP<TZ:4ZTUZF^,Y9H+LHW3;G
MZ&[R?031O(]2J''+=%#=V5)+H8[-=;N0F+!$%Y%M;USQN*A24.$:4J3P5]'C
MQ(4LQS[*,IN1LYC?C:N2C5)UTJM*Z$^$J8+)\RS&V[N#M.=M2HW6*TT3II:X
M&C-5CT3O2(U-?.M;':UG<2OK(<JPGRG;+#N;C0H3"Y,J0YR<F4KD,L-J4? C
M/@0L([X[LSDH1Q=MR;HE26M_T2\>[&>I5>'=/OH>D1X"2F!)+M">B-WS:^X@
MUJ'3:61=/=/I$4I\/,=8\AKM.*Z=7*A]G-VL.LMU*R=^DD1U-J:GE [">)PC
M;=4DEFB*YAOIN_EU_JL[SNXFM'&U%S:?$VOBU[E:KA1(<'NOF^,M]*H*W;IH
M=Q[-?!1RY4NX<ZSWH3-_N&XF[FV/Z?8CK#CS,=4IQ_1K/Z#,Y[C;4J1#D(K:
M1QRJNL@D19+')<9K8\QTC5U$GR'.1;X??W=R]>ZO=N3L7/\ O8.*X]+TI?TF
MEXBM?W1SFU;Z2$;=U<4)5?C4:^"K(H9T&=5S9=;9PY5=8P)#T.= G1WHDV%+
MCN*:D19<60AM^/(8=2:5H6DE)41D9$8F,91G%3@TX-536E-=QD9E"4).$TU-
M.C3T-/NHW'T7Z.[>IN&PRCU$T<V^YEFF"Y+(F1:'+&)..T]%:.U]Q.Q^P5$L
M,BNZAA<>ONJR1&?>XDRRXRLEJ3R3&#QV\V0Y;?EA<=B86\1!*L?C-JJ4EH2>
MM--+NF5PN19MC;,<1A;+E9E6CK%5HVGKDN%-'W]PG1G[T=JVF9ZN:]:1QL$P
MDLDK<5.=YP],<HE^%;AB4_7?^3\-S'(I78TCL)U'+Y/M%)]L24F2CI9;O7D6
M;XOJ677G<Q&RY4V+D51:],HQ.^,W?S7 85XO%VU"TI)/XT6].IZ&]%=''W*:
M3F^W7HD]]6YO$XV?8)I$>/X19,ID4F3:DW=?@D7(8[C+CS,R@K;=99!:5DA*
M$DU-;AG"=-Q)H>41*--#,]\]W\IO/#XB]M7UKC!.>SW&UH3[E:]PKX'=C-\=
M;Z6$%;MO4YO9KWE1OPM)/@J?)D]$_P!(*UEV883#VV99<7.#3H,&]<J+7%)5
M6?A2$FQJYM7:+OV8=O6V$-7*;?CJ<;):5M+-+S;C:.\=\=VW9A?EBH1A<3:J
MI)Z'1IJFAI\#[^IHXENQG:N2MQL.6RZ54HT?=56JK^6L]KU1O2._FIY][Y89
M\9QQ[Y[K_3+7)+T3CW8SWZ._.AZ1IEK#HSJ?H#GMMI?K#B%C@F?4;%9*ML9M
M7H#\Z"Q<UT:WK''7*V7.B&4RMF-/))+AF25EQX'U!G,%CL)F6'6+P,U<P\FT
MI*M'1T>M+4S%8O!XG 7NKXN.Q>HG2J>AZM3:,Y:*;!=X&XS"4:CZ)Z&91J%A
M+EK84B<@IIV-M1/"U7S/9\%35E>09:'HQ2&S/E-D1DLC(S(Q88_>/),LQ'5<
M?B(6L11/9:E6CU/0F7F$R/-<=96(PMESLMNCK%:G1ZY)G(]2NC7WR:/X-DFI
M>I>W;,,1P7$(!6>29)96&**@U4%4AB(F0^F)D,F2LER9+:"2AM:C4LB(A2PN
M].[^-Q$,+A<5">(FZ1BE*K?(5+^[V<X>S*_>L.-J";;VH:$N]*IHX,^88 "\
M5\W>_(&N?ZP6HGVLZ?#0/:9_J./^6A^-,VON5^QW^>E\$2=L:])<4]OG+7\N
M.V?[E&6_;>T-V=E?[/Q?YZ/XIK3?K];L?FY?"5HQM0@H
M                  ![];:6=--9LJ>QGU-C&,U1Y];+D09L=2DFDU,RHKC3
M[1FDS(S2HNH8ZSA"Y%PN)2@^!JJY&=[=RY:EMVI.,UPIM/E1D^VW!Z]WU=+I
M[S6_5ZYJ9[7,3JNVU*S.QKIK/*2OF9<*9=/1I+7*21\E:5%Q(A:0RW+K<E.&
M'L1FM34(IKPT+F699C);,K]YQ? YRYS$(O2S
M    #LN-B'Y#NS3^JEMW_FBP\>5]X?V_CO\ .7O[R1O3*/V3A?\ +V_Q(FUH
MPYD0 *)/3_?VB&2?<ITO_@N:/0G9Q_IF'YZY\*-2;X_MJ7YN'P,A0$\(J
M        !V76GWY$&$?U5,:_FCA#RM?_ &]/_./^\-^P_55^;7P'6BCU2:")
M3^A5N+^HZ2W;:B@97*<MY>H]/;0R=)EN102=)LZ?MWGC-2"<14QHO9Z4<?;.
MQ$EP/Z!Q'?NW:GNKBG=T;*@T_P"=TD*<M:>$D6ZDYPSVRH:I*:?=6Q)_"D_
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M$S3"0QV"FIX>:T/X4UP-/0T0+&X+$9?B987%1V;L>1K@:?"G]IT=48E%X6H
M        !E;0C^7#1K[JVG?VWTXM,P_4+_YF?XK+C!_K=K\Y'\9':'CR4;]
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M@K/6OUGHX[?WU%6O=KK[IFH6!=
M                                                        %<?I
M]=_-WHS@M)M'TINW*K.=8,>D7FJMS!/DSJ/2>8_-IXF-PY2%$J'89]80I2)*
MDF3K59$<09<F:A9;/[.=W+>.Q$LZQD=K#V)4MIZG<5'M/C4$U3^<UY)"-\,X
MEA;*RW#NEZ[&LWQ0U4[\G6O<7=,2?-Y=DF/HQ3(M[6H%%#L\@M+>TP;0P[%A
M,A-!4TREP,YS>N;>;<9;M+>V-=-%DH-,B*S!G-D?(E'QO>TO/[O31R'#2:M*
M*G=IPMZ80?<2^,UJ;<>(M]R\JAT<LUO).;;C;KP):)27=;^*GK5'QEI,:C)^
M>"5%C3HTB%-CL3(<QAZ++B2F6Y$:5&D-J:?CR&'4K:?8?:6:5H41I4DS(R,C
M'*;BU*+:DGH9PTFJ/2F4@-?=HE?LXZ:?;5BF+5[=7I7J%N@VY:KZ81F&5,5]
M+C>2ZUT#-GBD<SY3+3&(9+738<=KEJ<16IBK<X&X-^Y;G4L\W$Q5Z\ZXRUA+
M]NYQN4;3I+^E%IO^=7B-4XS+8Y9O38MVU3#SQ%J<.))S55_1::7<H7AAH$VN
M                                                        !UZ/
M1Q_VI^@?W?KS_P"YR4>E=Z/](8G_ "R_V33&1_Z@L_GG]D["X>:C<X
M
M               %/SYRW_+3MC^Y=FGVV0ANOLK_ %'%_GH_BLUKOU^M8?\
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M;;9;0TTA#332$MMMMI2AMMM"22A"$)(DH0A)$1$1<"(4VVW5ZSL?L
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MOK9_I+3'QUBOOB]B//9ML
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MEQ3V^<M?RX[9_N49;]M[0W9V5_L_%_GH_BFM-^OUNQ^;E\)6C&U""@
M
M !V7&Q#\AW9I_52V[_S18>/*^\/[?QW^<O?WDC>F4?LG"_Y>W^)$VM&',B !
M1)Z?[^T0R3[E.E_\%S1Z$[./],P_/7/A1J3?']M2_-P^!D* GA%0
M   .S TVCOR]D^ Q8K#TF5)VM8M'C1H[:WGY#[VDT%MEAAEM*G'7G7%$E*4D
M:E*,B(N(\JXAJ.>S;T)8N7]XS?MO3A4EKZ-? =>!3[3-T^0V42FH]MFO=M:S
MEJ;B5\#2#4"3*?4VVMYTT--8^I7(98;4XXH^"6VTJ4HR21F7IFYG.46H.Y<Q
M6'C!:V[D.<TC'*LSG)1CA[]7_,ES%I'H9.BUSC:U>76[G=1!KL'S&+B5K6Z>
MX3:V4,I> T=K"2YE.=YK.8EG6TUJ]0I=A-0W'5'"AORERB;=-M+.HM^=[L/F
M]N.390W<L;:<YI/X[7R815*M5TUX6E31KV%NON_>RV4L=CJ+$.-(QK793TMM
MZJO51:E73IT:/=.)TFV$;CGJ?:UM]R*/E.EN&9$G(]2-0*M3;U%G.9U;<F'3
MT>*3B3QM,5Q?LI]UV>VHXME.6VJ/RV(S4B1(-P-U,1EBEF^91<,7..S"#UPB
M];DN"4M"2UQ6O2VEB-[,^LXJ*RW!24K2=9R6IM:HI\*3TMK16E.$B=Z.?\O3
M9[_6+TG^W&J$QWH_TYC?\M<_%9'MWOVUAOSGV&7"^F:U;T7T&T2TIU?U)TYB
M:M:A85JLB;H#@F1)D.Z>O:EO8[:H\J-1(;!-G:X_AM,EZ<Q"YU!R[),9LRYL
MW'F=)[C8+'YCC[V"PMUV<-<LTO3C\O8VE\6#X')T3?!&O>>S-X\7A<#A(8O$
M6U<NPN)VXO5MT=&_O55KNI4TT:J79ETK/2%9KEC^83=T^J%),=E%)9I\-MF\
M/Q.&ELTFS%8Q3'F(%$[%:2@DF3[#RG2XFZIQ2E*5N2QN=NU8LJQ'"6I*FN2V
MI/N[3JZ]ZG<H:XN[SYW<N=)T[CIU1227<I33X:]TN1=&#NJL.D V5LY9J]44
MUQE42WRW135Z.FNBLT&8S8--4RI<YZD::;@Q6,GP_+8:IL5M"8Q2'7B:0ADT
M-HT?O9D\=V\]Z'!2DK+C&[;TZ8IMT5=;V91='KI2NG2;,R+,7F^61OWDNEJX
M32U57<[J:=.Z42-S^EL+1#<?KSH[62%RZG3'5_43!J:6[RN>E4N-97:U5-)?
M2IZ0I$B161FEN)-QPTK49&I1EQ/T+E&,EF&5X?'3T3NV(3??E%-^.IJ/,\,L
M'F%["Q^1"Y)+O5T>*A,+\WETATDU(W99YE&H,.IOLOTITW:RO2_'+EAF7':N
M)N0PJ:VS:-#?)3+]EB462RS&4I*^QWK-,A!)>::<1">TO&XW"Y/;LX9RC8O7
M=FY)<23:C7BEI;X]FFIM$GW)P^'NXZ[>NT=ZW!."?=;3DEQK0J\&T<G^<?V\
M:1NTTFJ(.8RK(H&A=2NZPE%[(G5N,7#F:9H]&METAR78E+;Y%32F"<X(;=?C
M1F7%$:5)4JCV7P:R>].5M*N(=)THY+9C55UM1:\#;*F_,O\ SEF*FW_5Z85T
M*C=)4X&ZM5X4CX/S?'<IJ)AF[/Y.*;FPL=+-8\5RVP?Q>5*6]5X_F>&44S*H
M&64\=U2DUTR;554N!,2QR$S$/LJ>):HK!MU.TK*\-?R;VILI8NQ.*VN%QD]E
MQ?'1M-5U4=-;.FY6.OPQTL VWAYP;2XI+35<54W6FO1Q'//G'^A6+8+KUH?K
MAC\"OJ[/7'#LOI,P:@MFR[;Y%I1+Q5IK)K%!-);<GSL>SJ#!-PEFI;=:CE)2
M:>4Y;]E^87L1EV(P%UMPP\XN->"-Q2^*NXG!NG\[D[[\X6U;Q5C%025R[&2E
MW=C9HWW:2I7B2XC0'H>=N^%[E-]NF&(ZBUC%[A.'U^0ZH7N.S&H[]?D*L+B-
M/T=1:Q92'H\ZFD9/,@JFQEMK1+B(<967(<4HI'OOF>(RO=Z[>PKV;\W&VI<,
M=K6UQ/93H^!T? 8G=7!6<;F\8WU6W;BYTX&TTE7N5:?=I34;C?.&=2]9I.[>
MFTFOK6]K-%\?TSQ"_P!.L587*@8K<2+55@C(<I=AMO=A7%PS>0GJ\GEIXQF(
M2&T)1Q6MW"=FF%P*R:6,MQB\?*[)3EKDDJ;,>-*CK3AK7O93?;$8OKT,,Y26
M$Z--+5%NKJWQM46O5P4KIB^V7;VM:-D^K./Z@:;9+;*Q<K:"K/\ 3=VQD>26
M?XX3I-V=9:5*W%046AP5N=@SR;[(@R#2XA1IY2%RW/<@P.?8.6&Q4(]-LO8G
M3XT)<#3UTKK6IHCV49QBLIQ$;EJ3>'K\:'!)<.C@EQ/CUZ*HD/Z?K.L0U6W/
MZ!:I8%<5MWB>;;0].;6MEPI4-^2@IV?ZJ7S+%LQ$>D=@V3=3?1.6TXKG$<>2
M?4(A&>SC#WL'E.)P>(BXWK>-FG5/R+:T5UJL69O?1QN8^SB(-.W/#JG@E)_!
M)' NA?V!4.\_7NZRK52J<M-"]$(M7=Y74*,VXF;Y?</R"Q#")CB'F9'@=Y%=
M*GV/-<OEQX:8R^04M*TW&_6\=S(LNC9P<J9AB&U%\,(KY4EW=*4>ZZ_<E'=7
M)K>98J6(Q*KA+--#U2D]2?&EK:[R>ALS#TX^^3-<[UZR#:#IO>3,1T#T+9J,
M3N<5QI2J.HS+-(M7#E6A6\."B(4J@PXY#=5 KUI.&R]"=D(0?+:4FR[/]W\/
MA\NCG>*BIYCB*R4I:7&-72E=4I?*;UT:7&7>]V<7YXMY78DX8:VDI):-IM5H
MZ:XI.E-5:U3HB,?8WNTU!V<;A\!U5P[(;*NH$7]/6:F8ZQ*-%3FFGDNSB%DU
M#;PW4/0WU*KB6[$?6VIR%,;:?:-*T$8E>\&38;/,LN82_%.[LMVY<,9I?%:>
MO7H:X55,P&2YG>RS'PNPDU8<DIK@<6]->ZEI3X.]4M-]/]LZQ/4S;6]NHH*:
M+#U5T*E4C.06T-EIJ7E>EV0W4*@G55KS48WK*1BEU;1;"$XZZE,.'V>DB4;Q
M$G479QGE["9JLHN2;P>(3HGJC<2;37%M).+XWL\1L#>_++>*R]XZ$?\ S-G3
M5:W"OQD^-+Y2XJ.FME*0;X-4  9%TOU=U1T3R?RTTAU RW37+O!TNH\I,*O;
M#'KKP7/4PN; *QK7X\DHDI<9LW$<KDJY!<?H"VQ>"PF/L]7QMN%VS5/9DDU5
M:G1EQA<9B<%<Z;"3<+M*57$^#Q(G-Z'#>7NQU?W_ .DF!:I[C-9-0L*MJ+5!
M^SQ7+]0,COJ&>]6::Y395SLJLL9[\5YR%816WFC4DS0X@E%U2&O=^,BR; [N
M7L3@\+8M7U*W248)-5G%/2EPK03/=?-\RQF:JSBKTYVMB3H]54C</YS1_LEL
M^^R+6O\ @W3(87LI_+XW[RU\,S(;]?JEC\X_Q2I4-RFM            .UE'
MC\]"@  !UN/21?E\[O\ ^L%J9]LTX>HMU_\ 3F"_RUO\5&CL\_;&)_/3^%FE
M SQBP         #L3.B0_LX]J7W/Y_VXY,/,N^7^I\9^=_V4;OR+]C8;\S'X
M"DAN#VS;D+_<AK>=%M]UNNBNM;M2CISJ=*,\L2MBL<\NO!_@SL.A>[/[/YY'
M,\UR^=Y9<GCQ(;\RW-<KMY7A^DQ.'CLX>%:W(*E(*M:O13A-59CEN8SS&_*%
MB\XN].C4).M9.E-&FI-9T/'1":R8YK/B6Z;=)ADW3FATW?._TSTUR9!Q,SR#
M-FT/L4^29%2)=3.Q:IQ*0?9L=B83,R3/;84;)1TJYV!;[;ZX&[@9Y1E$U=N7
M=$YQ^2H\,8O5)RU-K0E7375*=V=VL3A\3',,PCL;"^)#AJ]%7Q46I:ZZ=%-.
M2NG"Z473JSTYO-FFWK+JS-;O*Y46-K?FV-2XUGC6/X_6RV;#S>U%W&-Z):Y%
M;V45D[5R*XIF!%:7#6M;[S[<:UW W2Q4<5'/,R@[=N"K:C+1*4FJ;;6M12^3
M76].I)NXWKS^S##RRS"24K\]$VM*C'AC7RGJ:X%6NDJ6#<IK0[$&:>E">B>Q
MMW71.0.Z01]DNG4K4*-BBS;R6?C<327'),VLHG22HFK2TYHH[*U&VA"W2-;C
M22-Q/F>'7/?"2R_9ZZ\?/8VODJ3N2HWW%K?P/4;QN=763MXNO5>K_'I6NSL:
M:4TZBGIJOTLF[C+3J\7T<S:5M<T6PZ(U2Z<:/Z$/GAU3B>.Q$H:A0YN25S4;
M*,FL%MM$N3(E2>;>D+<<0RUSBDGNW![FY+9K=QUM8O'3=9W+OQG*3UM1?Q8K
MB26KA=#66*WHS*[)0P<EA\+%4C""6A+5II7DHNX3V=!'TBFM&Y2UU)VXZ^Y3
M.U%R7",/3J5@N>72FW<I?QB/D%7CN34&2V*&FW;XX%KDU<]"ER#7+2AYYIQQ
MQM+"6M==H6[&!RJ%K-,N@K5JY/8G!?)VJ.47%<%5&54M&A-4TUENZ>>8G,>D
MPF-EM7H1VHRX7&M'6G$VM/=TD2W3\:)8WI+OM>R?%HL>#$URTUQW52\A16$Q
MF&<R<NLEP[(Y"&DNN)6Y='BC%C(=)+?/3)KRC2:N4M<S[.<?=QN[W0WFW+#W
M7;3_ )M(RCR;32[B1'-\\)##YHK\$DKUM-_?)M/Q4\-2/?8IISIUJYO$VY::
MZM2&6=/,RU5QBFR6/(>7&8N8[TOG(6,/2&G&7H[.6VC3%8I;:T.(*69I4E1$
M927>'%8K!9)BL5@_UF%F3CPTXY?T567@,+DEBQB<UL6,33H93TI\.AM+^DTE
MW:T+6_S@WP!B&PO \5QV]8P)#>M&%U5!@^-V!8Y7Y'B];A^9Q)^--XQ5N184
M_&Z-#\.4;7,''B.QX_#D&I"5Z=[-NDO;Q7+MR/2?U$G*<EM.,G*+4MIZ5)Z5
M6M75FQ=\&H9-2,W!])%))TVE1IQIPJFFG<*H&R[<IJ)M4W&Z9:KZ>7-A!<@9
M525^5T4>4MJLS7#+&QCQ,CQ.\B&KL6;#LZQYPFE.I4J)*)J2R:'V6W$[BS[*
M\-F^5WL)B8IU@W%\,9)5C)/@H]?&JIZ&:[R7'7\!F-JY9;47.*DN"46Z--<.
MAZ.)Z2W=\X"T*Q;4+8S:ZQ2H%>WF6@.8X9=TUZILTVBL=SO*Z33K(,99?2TX
M:X%C89-7SG&UFA/.5J%$HC(T+TOV;YA>PV\$<"F^@Q,))K@VH1<U+OI1:K_.
MY-C;X86U>R>6(DETMF46GP_&DHM=YUU=Q<129T\Q%_/\_P &P2,^463FV8XS
MB,>2:4J*._DEU"IFGS2M2$*)ER:2N!J(CX=4R&^<5>6&PUS$-55N$I4^]3?V
M#5>%LK$8JWAVZ*=R,:\6TTOLEN7INX&5[1=ANWW0C;4U;Z=:&^5:=/LYE8MS
ME=,G5U9C3]A04V2W=7V$MY6<VC4^QMG%H)=M.C&MY9\IQ#NF-P96<ZWBQ.89
MKLW<?L;<-K31N5&XIU^2J*/DIZ."FR]ZG=R[)K=C+]JWAU-1>SHI&CHF]:JT
MJOA>AO2ZU)--]3]0]'LOJ,^TMS3(\"S.BD(DU>18O:2JJRC+0HC4VIV,X@I,
M1\BY+S#I+8>;,T.(4DS(]S8K"8;'6)8;%VXW+$EIC)57_P >ZM*X#6F&Q6(P
M=U7L+.4+JX4_AX&NXZHL1](=O%B;XNA[V_:G6\FABZLX[N=QC']5:&(]"B2$
MY#CNF>K%38W]14)?7+9I,C1=UL\D)234=<LV"-7,D9ZSW9R26[^^V)PD%)X.
M6$D[;TO1*=MI-ZJQI)=VE>$G.>8_VONQ9Q>A75>CMKNJ,XNBTZ&VFNXR*OHQ
M]EKF^3=-C&F%P<^)IEC4*1GNKEI7+)B6SA5)(BL>!H,DW&CCV6674V+6MN-F
MIV,W)<E)0LHZDB7[V9[[OY1/%VZ/%S>Q;3\I\+7%%)R[M$N$CF[V4K-LP5JY
M7JT%M3[W!&O\YZ..E6M1+UTY>[FST,\WW1Z;:7CTETQQ33NFM-1J[!>=Q],N
MNMU26L6TX;DQ.8F-T4>GB>$;)*'%)M'+%I,A2S;>2J%=G^2PS#I=Y<U_KL7.
MZU!S^-I7RIT>BM72/DT=*:"3[VYI<P2MY1@7T5O83ELZ/BZ5&"IJ6BKIK5%6
ME45U-#]<-3MNFIV*ZNZ1958XCFV(V+4ZOL(+IDQ,8(^3-I[B$KE1;>BMXJEQ
MY<20AQB0PXI*DF1C9V89?A,TPD\%C8*=B:HT^#B:? UK36E,@V"QN(R_$1Q.
M&DXW(OP-<*:X4_Y:2[3TDNW[!ND#Z.6#KW5X[&AZDXWHE3;E-)[=LFG+>+53
ML*@Y[D>!O3T0U2[*KR3%G7F6XQ&TVNU:AOF9$T9*T+NMF6(W;WG>7SD^JRON
MQ<7!52<%.G XRHZ^3M+A-L9W@;.<Y/TT%6ZK?26VM?R=JE>*2T4U5H^!%#T>
MAC3@ &4]#:["KC6S1ZHU)FMUNG5KJGI]79]8NDE34#"IV6U$;*IKJ5NL)4W%
MHG7W%$:T$9)_7%]$6F82OPP%^>%5<2K,W!<<E%[*Y:%W@(VIXZS&_3H7=@I5
MU;.TJU[E"^OTO51@S_1J;CZJ]ETE%2Q,.Q=_%26F/&B%?T&8XO;8=3T;+'-I
M0_86%8S$8;8+@33AD9<T2B'G;<N>(6]6%G;4I7'<EM<+HXR4F^\FVZ_";@WA
MA:EDF(C=HH*W5=]4<?&E0Z]4>E#2A92^;593DD?7_<3A+$R7Y(V^CU1E-G (
MUJ@'DF.9I4U-%,47 VVI::S*;%">!DI:#/CQ)!<G5G:G9M/+L+?:73*\XI\.
MRXMM=ZL43[<2Y/IL1:J^CV8NG!6K7C7+3N'/_G,>"XS!RK:9J5%988R_)J'5
MG"KEXB(I%GC^&3L#NL>3[5!<44T_.+$E&I1F?9J2(B(CXV_95B+LK6,PKJ[$
M96Y+N.2FGRJ*Y"IOW:M_^6OZ%=>W'NM+9:\$6WYQ5N&VS7H         !E;0
MC^7#1K[JVG?VWTXM,P_4+_YF?XK+C!_K=K\Y'\9':'CR4;]  ZL7._\ ;C,O
MLKR+^%Y@]=8?]7M_>1^!'GV[^5E]\_A.*"L=          #LP--H[\O9/@,6
M*P])E2=K6+1XT:.VMY^0^]I-!;9889;2IQUYUQ1)2E)&I2C(B+B/*N(:CGLV
M]"6+E_>,W[;TX5):^C7P'7@4^TS=/D-E$IJ/;9KW;6LY:FXE? T@U DRGU-M
MK>=-#36/J5R&6&U..*/@EMM*E*,DD9EZ9N9SE%J#N7,5AXP6MNY#G-(QRK,Y
MR48X>_5_S)<Q:1Z&3HM<XVM7EUNYW40:[!\QBXE:UNGN$VME#*7@-':PDN93
MG>:SF)9UM-:O4*7834-QU1PH;\I<HFW3;2SJ+?G>[#YO;CDV4-W+&VG.:3^.
MU\F$52K5=->%I4T:]A;K[OWLME+'8ZBQ#C2,:UV4]+;>JKU46I5TZ=&CW3B=
M)MA&XYZGVM;?<BCY3I;AF1)R/4C4"K4V]19SF=6W)AT]'BDXD\;3%<7[*?==
MGMJ.+93EMJC\MB,U(D2#<#=3$98I9OF47#%SCLP@]<(O6Y+@E+0DM<5KTMI8
MC>S/K.*BLMP4E*TG6<EJ;6J*?"D]+:T5I3A*^&(?[6XO]D5)_"48;)Q'Y"?W
MC^!D-P?ZW:_.1_&1V%W2HY'H9ANS+/LRW!XA8:B8/B5]A.0U>G<&6_ BY[GE
M=DL%W!L5R*<PRXN)A]ED)L^%UD:5>#D/$CG'#0RYYKW0M9A?SRW8RV:M8B<9
M1<WI<(.+VY17E)?)_G4[ZW/GES"6<MN7L;#I+$=E[/E24ELI]QRI6NBFNJT%
M,_5+I9]^>I>0^%8&O65:3X_"2W#QK3_1>1YM<*Q6DB\45M'6UV.=BRIT*MC<
MEEM<]^6]S:$I-?)2DBWCA-S-W<+:V)8>%ZZ],IW?CRD^%MO0F^XD:QQ.]&<W
M[CG"[T5O@C!))+BU5?A9:3Z$;?AJ3O+T0U QC6>Q3DFJ&A%UB]3/S3L>-$FY
M;B.90;EW%)UZQ#8CQ7<BAR<5L8TB2A".RVFF7'"-\WG'-1[^[O87(\PMW<"M
MG"8B,FHZU&46MI*NFGQHM+@TI:*)3[=?.+V:X.2Q+3Q-J23?&FM#:U)Z&M'%
M4JL=*QHEC>W[?UN'T]PV+'@8D[DE1F]!6PV$Q8E3%U(Q:CSR730HB77D18%+
M;9!)B1D),DE'90:4H29(3M_<_'W<RW<PV)OMN\HN$F^'8DX)]]I)ONLU[O+A
M(8/.;UNVDK<FII??*K_"KX#(70S:2:3:S;_-*<6U@BU=Q0U=9EN8T&)W;+4F
MIS',L3I7K:AIK"&]Q9GQH)-/6JHSA*9D^#N:=0MI:T*M=^<9C,#NY>NX)N-R
M3C%R6N,9.C:?!71&O!M:-)7W4P^'Q.<0CB*-1BY13U.2I31PT59> E]^<NVD
M./CNU"AA9?(AS5V&J<FST_B7C[<*QJ"8P5%-DMGC+4CL0_!$Z')C0I;C*3XR
M'VT*5R%$B%=E<9.[C+DH)QI;I-K2G\>L5+7I33:[B)+OU*F'L)3:;E*L:Z)*
MB=6N'9:5'P5(BNAQW*:B:#[XM&L8QJYL%8/K=F--I5J#AYREG27<3+9":FDN
MGH*U*CM7.*WDB/,CRT)3)2RAZ.2^9D/(7--^,KPV8;OW[UV*ZQAX.Y"7"MG2
MU7BDJIK56CUI$;W4QU_#9M;L0;Z"ZW&4>#5H=.--+3Q51,K\Y-T*Q9S3/0?<
MI#@5\+,:[4!W1:^L&6S;LL@H<EQG)<UQQF<M+1HDQ\7F878\P:EI6WX461$M
M)_L<'[+<PO+%XC*I-NP[72I<"<91C*GWRDJ_>\LEWYPMIX6SC:+IE<V*\:<9
M2T]YQT<57QE;S9!HG2;C-V^@&BN3JDIQ?/=1Z2NRE,)\HLR1B\$W;K(X<.4?
M'L65.I*Q]EMTB4IM:R425&1)/:.?X^YEF2XG'V:=-;M-QKJVGH3\#:="$9+A
M+>.S2SA;OY*4]/=23DUX:4)]OG%68:F:<P]LVAF"]FX'MMF85?K1C.(QUX_B
M5SD6,3:VHAXS/CU:F($BLP[&G8:X-<;:&&.S5.<E9D@VM<=F5C"8J6+S#$4N
M9HIQ^-+3)1E5N2KIK*5:RUNE._,]]KV)L6K&'L-PP<E*JCH3:HE%TX$FZ1U=
MQT5*Z.W[<=K+M>U$I]3]$\XN,-R6IEQGWVH<I\Z3(H3#Z'G:+*Z0G40<AH9Q
M(Y#T:0E23(^4DT+)*T[/S+*\#F^&EA,?;C.U)>&+XXO6FN!H@V!S'%Y;>5_"
M3<9)Z5]S+N27"O'Q-/23<=-WN%Q+=EMZZ.'7S$W:R,K+<9UOEY/CC%A$E6N*
M9%.1H[&LJ*:RTZN646OOL>LF8[KJ4<^VT3A)+EF10'<'+;V39GFF6WJO8G:V
M94=)1724:[ZE%OB);O=B(8_ X+'6J;$E/172G)0=/!LM$</1C[+7-\FZ;&-,
M+@Y\33+&H4C/=7+2N63$MG"J21%8\#09)N-''LLLNIL6M;<;-3L9N2Y*2A91
MU)$HWLSWW?RB>+MT>+F]BVGY3X6N**3EW:)<)@MWLI6;9@K5RO5H+:GWN"-?
MYST<=*M:B7KIR]W-GH9YONCTVTO'I+ICBFG=-::C5V"\[CZ9==;JDM8MIPW)
MB<Q,;HH]/$\(V24.*3:.6+29"EFV\E4*[/\ )89ATN\N:_UV+G=:@Y_&TKY4
MZ/16KI'R:.E-!)][<TN8)6\HP+Z*WL)RV='Q=*C!4U+15TUJBK2J*ZFA^N&I
MVW34[%=7=(LJL<1S;$;%J=7V$%TR8F,$?)FT]Q"5RHMO16\52X\N)(0XQ(8<
M4E23(QL[,,OPF:82>"QL%.Q-4:?!Q-/@:UIK2F0;!8W$9?B(XG#2<;D7X&N%
M-<*?\M)=IZ27;]@W2!]'+!U[J\=C0]2<;T2IMRFD]NV33EO%JIV%0<]R/ WI
MZ(:I=E5Y)BSKS+<8C:;7:M0WS,B:,E:%W6S+$;M[SO+YR?597W8N+@JI."G3
M@<94=?)VEPFV,[P-G.<GZ:"K=5OI+;6OY.U2O%):*:JT? BAZ/0QIP "1;HE
ML?TZR?I$]KM1JCV"O&%9O93X<>R2RJ!-S:FQ#([C3>#()\S;4J7J# K$,MFA
MSGY!MM&DB<-28QOG<Q5K=G%SPE>EZ-)TUJ+E%3?F.5>)59G=V869YY8C>IL[
M3:KJVE%N/C2:UZ:=\LA?..:[$)6S;3*?:SZZ)F-7KY0KQ&,[)0BULZ^7AF:1
M<IB08GMW9$%E"H4B2X24I:6RP1K(W$H<U?V83OQSR[&";L2P[VN)-2BXMOCU
MI=]Z.*<[ZQMRRA.;I.-Z+CW71IKD;?@*4XWN:I+T'S?')[S(.C\;K;>?(FP\
M,UKU'QC'&7W774UE&]!Q7+%P(Y.+634?P[E$Y\D()*24^H^'$S,_/O:3:MV]
MY'*"2E.Q"4NZ_C1KR12\!M[="<IY)!2==F<DN]6OV2M%TS>$XU@?22;DJS%V
MV8T.YML-S:RA,F@^Q<ESO3S$\NR=QWDJ-1/6U]<2)ZB423_SOZ!EP4>U=Q<1
M=Q&ZV%E>^5%2@GQQA.48\B27@('O7:MVL\N]&U\91DUQ-Q5>7Y7A(O!+2.@
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MCL#>PDXQ3K-UC)\471/1W4C6F:99@\#!7,+B[6(3E2D:52HW5TD^\:0C/F%
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M?'Z)BI&]=C!VHRDK<M:3='WUJ9T=N$I*;BG-:G32N\S[HIG<
M
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ML7&/R59HN]5$)W?;EGN'E+6[GV&=B</,QNH
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MC7I+BGM\Y:_EQVS_ '*,M^V]H;L[*_V?B_ST?Q36F_7ZW8_-R^$K1C:A!0
M
M      [+C8A^0[LT_JI;=_YHL/'E?>']OX[_ #E[^\D;TRC]DX7_ "]O\2)M
M:,.9$ "B3T_W]HADGW*=+_X+FCT)V<?Z9A^>N?"C4F^/[:E^;A\#(4!/"*@
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M9':'CR4;]  ZL7._]N,R^RO(OX7F#UUA_P!7M_>1^!'GV[^5E]\_A.*"L=
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M(F.S?]DXK_+W/Q)'6CCU0:+
M                                 )V_F[_Y?-Q_5]U$^V73\:][3/\
M3D?\S#\69+=ROVP_S,OAB7BAH$VP                         5U\;_\
MKC/4#^KK"_FKPD;-N_\ +&U_FG_>3(5;_P!;3_,?[$2&?IW=MIZ&[X+[/:B
M43#=Q=.QJA6K90E$5O,&U(IM181&2$&N;(OHZ+=\SY75N$]7]0ISV>YI[0R"
M.&FZW\++HW][K@^]3XJ^](OO=@>J9L[T52U?6VOOM4O'\9_?%JCHI-RQ[I-C
MNCN;64\I^:8=6*TEU$<,D\^>7:?1X=:F?,Y'['V;D>,/5ML[R22@E6!D24D1
M$6H-\,J]D9_?L15+$WTD/O9U=%W(RVH_T386[N.]H93:NR=;L5L2[\='C5'X
M3;/</K1CNW;0W577#*BYRETQPB]RMV&2C0Y;3:^&OP-0QUDE1(F9!<KCP65*
MX(2[(2:C)/$RPV68&[F>86<OL_+NW%&O$F]+[T55OO&1QN*A@L)<Q=SY-N#?
M?IJ7A>CPD070[:)Y!CVS76W=+J0MR=JWO*ML_P!4L@M93:43'L6AIR:/CG/$
M:5.$=S=V-Q<),E\A<6R8+DI-!F<UWWQ]N[GF'RC"Z,%@8PMI<&T]G:Y$HQ[\
M61O=G"SAEEW,+^G$XIRFWW--.5N4N\T55^C:_+ZV@_=_TW^V&(-O[T_Z<QO^
M6G^*S7N1_MC#?GH_"=D4/+IO U=WB;M-,]EFAF2ZX:GN/R8-8Y'I\8Q>N>8:
MN\XS*S;?52XK2G(/FT/RDQG7Y#QDM,2#'?D&E9-&A67R3)L7GN80R_"44GIE
M)ZH16N3\22X6TN$Q^9YC8RO"2Q=_2EH26N4GJ2^SQ)-E?K:UI]O/Z9Z=E.MV
MXO<#J%H;M,K<BL\>Q/2O1*R<Q%O*YK"$IL*NL4XU(AV-701I?,R;R[9N9#TI
M;T:.TV@GN8V1F^)R+<6,,!EF&M8C.7%2E<NK:V5P-\*;I50@XI*C;>BL-R^S
MFF]#EB\;>G9RY2:4+;V:\:7&EPREM::I<-,H;O>B,RG;3I'E&X#8CN4W+8IJ
M)I542\UOL3O-4;&:WEN,XQ#L+*Y*AFXY6T,]O(X=8IY;<244V'8-(5&YMM3Q
MJ79Y+OI9S7&PRW>'"X6>%O24%)6TMF4FDJJ3:V6Z:51QUU="XS+=NY@,-+&9
M1?OQO6UM-.;TI5;I1+33@=4]7"98Z&CI5\HW=JM]O&X.57R-<<3QXLAQ'-8<
M1FL3JABE8<>'>(N8$5IFLBYK0./LON*BI:;L8CSCB6&E1'ENV>_.Y]K)=G,\
MM367SELRBW7HY/2J/6XO2M/R6J5>TJ7.[&\-S,JX+&M=;C&L9:MM+75:MI=S
M6N#0ZS;:PZMX'H/IAF^L.IUVWCV":?4,O(<CM%H4\XB+&Y#;$.#%0?.S[:UF
MO-18<9OBY)EO-M((UK(A L#@L1F.+MX+"1VL1=DHQ7V7Q)+2WP)-DJQ.)LX/
M#SQ.(>S9@JM_RX7J2X7H*L6$;G=\W32[C,DTLT?U&R+:QM2PSF[C-)>$2GZ_
M)H&'2IS\.DCY/DE/)A6V2YUF9174L53<V-2M(9?<4AY,92WMO8C*=W]Q,KAC
M,;:CC,XN:([>F+E2KV8NJC"/#*CEI2JJZ-?VL?FV]..EA\+.6'RZ&F6SH>SP
M5:TN4N*JCKUTT[:[HNB#T+V\;<-7M=\%W/;M<,U&TDTZR?4"OS2PU6CV)7>0
M8[4R+6-7V<*KH<;G<]E%NPW';5#G1'&I3[:^4LDFVO"Y3OKF&9YI8R[$83!7
M,+>NQ@XJW2BDZ53;DOBK3I3T)]\R.8;M83!8&[C+.(Q,+]N#DI.=:M*M'1+6
M]&AK28WZ$3I2]7=;\^<VD[C,AEZ@WK^-7&0Z5:FW+I/Y=+5C3#<ZZPS+9W))
M[)5G2I?GQ+*0:IR.Q7FGW'R<9-FZW^W1P67X;VSE<5;MJ:C<MKY*VM"E%?<Z
M:)Q6C2FDJ.M#=3>#$XN][-QTG.>RW"3^5HUQ?'HTIO3H=:Z*3/=)+^0+N^^X
M!J1]KTL07=;_ %'@O\S#\9$HSS]CXG\S+X"GKT-^Y&^V[:U:LEIWIG?:R:VZ
MJZ2.Z>:)::TC*DQLASEW*J&_5+RBV-UAFBQ#'**FEV-E)6XWR8L52>6T1F\W
MNW?C*[>9X"SUF[&Q@+-[;NS?W,-EQ^*N&4FU&*XWPZGK/=G'3P6*N=!;=W%W
M+>S;BN&54]+X(I)MOB7!K)C-5.BKZ3O=I'DYIN+WWT6,Y)8LORH&C^$M9J>E
MV+%(6<B/1L1Z&QQBG87$)+3+TLJ^SE.<TDW)4LT)<5",'O?NGDS5C+,NE.TM
M=R>STDN[I4GITM+:BN)1U$GQ&[V?9BNEQN,4;CU0CM;"[FAI>&C?=9"/@NY?
M?)T4FZ6ST]RS,,HE+P#((4+4'2:\RFXR3334#%9O-VC<^E8LG51HR+VGL>RZ
MNWC,QYL9;W[(DN,B,J>XC*MW]\,H6)LP@NDBW"XHJ,X26BCIQ-4E%MITT<#(
MI9Q^;;NY@[-R4GL/XT&VXR6O17C3JI*C7*B_)@.;4&I6"X5J-BDDYN+9_B6.
M9MC4Q1-DJ70953P[VFDJ)EU]HC?KI[:SY*UIZO449=4>=,38N87$7,+>5+UN
M<HR7$XMI^-&X;-V%^S"_;TVYQ4EWFJKQ$?W2C;_F=@.@]=F%#15V5:K:AWKV
M)Z98_<JDIHFI<2'X0O<IR%$1Z+,E4N.0UM)5'8=:>DRY<=OEMMJ<=;DFZ.[C
MWCS%V+DG#!VH[5QK7I=%%5T)R==+5$DWKHGAL_SE9-@U=@E+$3=(IZN-M]Q<
M7"VB'SH\M#LHZ77!=3M<=X&[;<=>SL9U)F83"TAT\RR'IY@E%&308[DE=D3-
M1 K9]!S<]RY?C,LQ8$)YM5>:WG7^4CA-MY<PL[EXBUE^28+"QC.TINY.+G-Z
M91<:MIZ*)NK:TZ$B,Y+A+F\EFYB\SQ-]N-S9V(O9BM"=:4:X::$M6ELQ)TE.
MQS6+HRJC#=RFT'<ON!@Z=/97%QO*ZBXU"LW+[#\CL8SDBCLES*1NGI\FP[("
MK78<J//@F;#Q,-.*EMRC2Q>[K;P8'>N=S*L[PN&>*V'*+4%245K5'5QE&J::
M>E5:V6M-OGF4XK(8QQV67[RL;5&G)UBWJ>BB<72C37$M-=$VG1%[\[_?7MTL
MKG49JO:UDTJR%G#=0Y-7$:KX&3,S:]-EC.;1ZR,VB%4N7T5$AB3&9X,IFP'W
M&D,L.M-(@6^F[MO=[,U#"UZC>CM0KI<:.DH5UNFAIO31I.K39*MV\XGF^"<K
M].M6Y;,J:*Z*J5."NFJXT]2HC.6]_;3N&W&8YBD;;WNYS3:Q>XFSE3\Y.+5+
M\VNU!FVQ8\NABY':5U[275)#H5T\E"'8Q2>I9.*4RYS:4+Q^09KEF5W9O,L%
M;QEN>S3:='!+:KLIIIMU6NGR5I5:EWFV!QN.A%8+$RP\XUU+1*M*5:::I1ZJ
MZ]127NMV>][23<JSA6O>Z;<@_(T?USA5^HE*]K5J9;4K$K!\S3#R1RLJ2OVX
M$R"Y&AR.QC9CI;D1G"Y">0YP/?,,FR#&Y5T^78/"I7\.W!]%;3^/&L:NE4]*
MK5Z'WC5<LQS7#8[HL9B+];5[XRVY-?%EIHJTXZ<:+(.?:=])GTGT)66X[J0_
ML$VGWL+G].\/=DW"];M2:"4TTN!EFH,3$I=1-K*G(F#4XW6/6\-IF.M!'$FI
M-,U[5^&Q6ZFZ<NANVEF6<Q?QY:.B@^&,')--Q\K9;;X8_)4WO6<^S]=+"YU/
M+FOBQT]))<#E2E$^+:6C@>MP9[U-H.^'HM\NPK4:+K_E]UB^4W#D;%=8-/,M
MS.A=:RF"T[8KQO,*F78.+KK:?!;?D,L+?GP["(A\N<6;<AI&P,ASO(-[K%S"
MO#0C>A'XUN<8OXKT;46EI2=$W1.+IQID3S3+<VW?NQOJ])VY/1.+DM.NDE70
M^'A35>ZBTCT2&^"\WP[76\GU 7&7K!IID;^G^I4J)%CP(V12FX,2VQ_-(U?"
M88@UR,@J)I-OLM$EM-A#DJ;;;94T@M2;YY!;R#-NBPU>I78[<*Z=G31QJ]+H
MUH?$U5MU)_NYFT\VR_I+WZS;ELR[O"I4X*KQI\%#8;>3M[UMW$8-28YH=NGS
M+:OD-19RK&;DN'42[M[)HZV6$QJ6R5&R7%["OA-/LFOG8\@W.*^JE:.6VYC,
MCS+ 99B)7<PP<,9:DJ*,G39[J^+)-]QKG5[F>"Q6-LJWA,1+#S3K6*K7N/2F
MO RD3O!U>Z1;;AKMJ3M_UDW>;AK6_P 1L*QF8[3ZXZH-XAD=1.K*R]QJ_J*U
M-[ A%"LZF5&D<@XZ'&9/+0Z1/MN#?F28+=C-,OM9E@<%AE;FG2MJWM1:;4DW
M1NJ::UZ5JT,U5F6)SO XNY@\5B;[G%K5<G1JB::5>%4>K7W2_AHW,EV.D.E5
MA82I,Z?.TWP>9-FS'W9,N9+DXQ5O294J2\I;TB3(>6I:UK4:EJ,S,S,QYRQT
M8QQMZ,4E%79I):DMIFX<,W+#6V]+<(_ B$?IBNDIU.T!RG =H>UR=&JM=]4H
MU/,R+.%I@NRL'ILIMU4&*4>/^$VGJJ+E&4S6GG'IDDO_ "7!2VXVGG)3;\:>
M[D;K83,;-S.LW3>766]F&GX[BJR<J:=F*I1+Y3JGH33BN\V>XC!W(9;E[IC+
ME*RT?%3=$E715\;U+OU7(L2Z#'![['(]SN,W9;L-3];;2&U)R/.Z/50ZRM@7
M;A+E2/)MC)J'*;N3&B64AQ2'["4ZJ09$YS+!J4V*=[M!Q%NZ[>5X/!V< G\6
M#MU;6KXVRXK2N!+1JJ]9WM[I6IPVL=B<1<Q;6F2G15[E4WKXWIXD0N])SH9O
M;V%)T\Q"YW-:L:X;5KK.(N4Z:SLJRB]D.4>:8LQ,=:PW*&'[.;)JY3518ONQ
MT1)+5;9M&\^AAM]AQ#,ZW3S#(-XNEOPPEG#YQ&VXS48K3&5/C1T*NE).JVHZ
M%5IJL6S["9KE&Q:G?N7<O<ZQ;;T27W+TZ-#>IT>ETJM%QK<)IOF^KNCV9Z=:
M<:O9#H/FF2L5#-+JQBE8S;W^)' R"IMIZZ^O?L*E+RKBK@/U[AE)9<;9EK6A
M1+2D:0RW%8?!8VWBL58CB+$*UMR=%*L6E5T>IM2U/4;-QMB[B<-*Q8NRLW94
MI-*K6E/0JK6M&OA*1O2&Y#TDNRW6]_1G4[>UN!S*KN,4C9)A^68UJ[J7C-'F
M6%VTVUJC=L<>AY*AB!;L6%9*C3H3KDLV^2DR==8<:6O?>[5K=;/<OZ]A,!AH
M3C/9E&5NW)QDDGHDXZ51IIZ.\FF:JSJ>>97B^JW\7>E%QK%J<DI1=5I5=#JF
MFM/?I0F)T%UNWY;Y-K>A6C.S7)YNF&,X3I;A>*;A]YVJDBZ5D%WJ)$H8)9!@
MVDRY\6SR:^MJ(^*+.[;0DU2E$VU,B(2V_,A&8X#=W=_-\1CL\@KUVY>E*SA;
M=**#;V9W*4BD_N8<6N,M*C)L'B\WS; 6<+E<G;MPMQ5R_.M7*FF,-;;7#+CX
M5K<>6^?HJ-[VU+3^WW,P]T.4:]5^+/-V.H-Y77VH%#J-C$6=+.,K*B38Y)?R
M+NEBR)9=GR&IR)45+QO*95'1(?:DV[^^&09QB8Y5+"0PTIZ()J#A*B^3HBJ-
MTT*E'2E:T3PN;;O9MEUEX]8B5Y1TR:<E)=W2W5<;K5:Z4JS-G1M=-[J?08C?
MZ'[@J/43<CJ6J+6PMM[]$UX7U&U%S*UM8]/#TRS&^EN+>EE(DV3<MF]EI?DQ
MX<:6ETY3W8C*K#>G<'"7+T<PRV5K"X6K=^NB$(I5=R*6K51P5$VXTV5M,NLC
MWKQ$+4L)C5._?HNBIIE*3=-F3\-=IZ:)UJZ(VLU0Z-_I2M[,:7G6XS>/CVAS
MMT3LVCV\::JS&PP+#(,R*CF:&Z5C]_15DVVBF7,OR7'<A<,E+4F8XE7(&'PF
M]&Z.0M8?*\#+$*.AWI[*G)KA54VEPI?$^]1D<1D>\&:IW<=BHVJZK<=IQCW'
M1I5[OQN^09NZN[\^B.W23L L]1[Y=EBDVHM+G#Y>2W63Z1ZK8;8J*7'FL5=V
MDF7*^\AD\PW/:C1;2O?)U*%LOMK(; 6"W=WTRA8F-J.S--*6RHW+<EHI5<*=
M'2KC)4UID2ZSF^[>8.S*;VHM-QJW"<7W'P/CHFNXR]_HEJOC^NNC^F.LN*I6
MUC^J&"XSG%9%==2](KV<CJ8MDNJF.(0VE4ZI>D*C/\$IX/-*+@7#@//./P=S
M+\;=P-[\I9N2@^[LNE5W'K7<-NX7$0Q>&MXJW\BY!27<JJT\&HRB+0N
M
M       .L1W35LVGW.;C*BR<E.V-5KOJ]6SW9S3K$UV;!U!R&+*<F,R%N/LR
MEOM*-Q*U*6E9F1F9\1ZPRB49Y3A9QILO#VVJ:J.$=1H7,(N./OQE\I7IK\)G
M9!;:;Z'E.W+0#)ZXR57Y'HGI5?05)<0\E4.WP6AL(QI=;_8W2-B0G@I/45]$
MNH/+V:VY6<TQ-F7RHW[B??4VC>&!FKF!LW(ZI6H/EBF9L%@70   00_.$=;;
MO339/4:>8],DP96NNIU+B%^]'4XRMS"<=KK',;N&F2UP6WX0NJFK8=;Y1%(A
MN/MJY2%+2>PNS7 6\5GTL3=2:P]IR7W\FHI^!.3[CHR([YXJ=C*E9@Z.]<47
M]ZDY/E:7@J:G?-H],:IG$-SNLK\5+MY89)A.F-9-<2GE0*JGK)^57L6*LC)9
M)MY=[7+D$HC+_,6>3P]MQS/:IBYN_A,"G_5J$KC7&VU%<B4J=]F.W%P\5:Q&
M*?RW*,%W$E5\M5R(M'C4A/RO=\XWTP@Y-M"TSU/1%0N\TNUHKJ]$TV6UN1L7
MU!QVY@7D9+QIYUE$N_HJ52B)1(4;)<HC,DFG979ABY6LZNX2O]7>L-T_G0DF
MN1.7*0S??#JYEMO$4^/;NI>"2=?&HF&OFUNLUU=Z=;C-![6;)DU.!9'ANH>(
M,/NJ>;@LYW&OJC*H40E\3BPT3\3A22:2?(-^6\O@2E+-5]VIX&W;Q6%S&"2G
M<C*$N[L4<6^-TDUWDD6NXV*E.Q?P<G\6$HRC_2JGXTGX62E],)_9L[J/L1Q?
M^<C"Q$=R?]4X/[^7XDB0;S?L/$?>K\:) [\VG@PG===REB[#BN6$/2?%8L2<
MN.TN9%C3\N6Y.CQI*D&^PQ,<@L*=0E1)<-E!J(S0GAL/M4E)9?A8IO9=Z55P
M:(Z.2KY2([BI/%WY46TK:\;+AHTD;+*#/3KPXL7I*=9G(T=EA<[&M))DQ;3:
M4*DRO-?BT7LAXTD7./''BMHY1]7DH(OU!Z+[/9-[JV$WJG<2^<D:>WM26>W:
M<,8?B(O%: 5\"IT(T5K*N##K:VOTFTZAP*^OC,PX,*)'Q"G:CQ8D2.AN/&C,
M-))*$(2E*4D1$1$- YE*4\POSFVYN]-MO2V]IZ6S;&#C&.$M1BDHJW'0N\C4
MWI8JFONNCIW80[*.B5'9TT\+-MK_ %J;"AR*BO:F07_OXEI7,NI_]\@AF=SI
MRM[SX.4'1]+3P.+3Y4V8[>*,9Y)B5+5T=?"FFO&BO'\VNE2$;G-?H27G$Q)&
M@[,I^.2S)EV1$U!Q9J*\M'ZU3D=N:\E!GU4DXKA]$QLOM32]DX:7W2Q'PPES
M(A>XS?7[RX.A_P!I%RH:.-G'7Y]*+_:Q:Y?=<TS^U#3X>D-T?]'8?\S<_&F:
M;W@_U%>_.1_%B=@8/-YN0QSJ_I?C&MFEFH6D>:1&YN+:CX??8==-.-$Z;<2]
MKGX)S&$\MM2)M>XZF1'<2I"VGVD+2I*DDHKK!8N[@,9:QMATO6IJ2[Z=:=YZ
MGW"AB</;Q6'GAKNFW.+B_"OL'7F;$=2LIVK[^=#KM4AZ%,QG6JMTUSN-#=D&
MU+QS([\]/LY@J92EM4Y#=;92'6&W$<.R66E\DEI2:?2N\.%LYONYB+=*QG8<
MX5\J*VX/N:4J]QLTOE%^YE^<69ZG&ZHR[S>S+Q-^$M-_.$=;;O339/4:>8],
MDP96NNIU+B%^]'4XRMS"<=KK',;N&F2UP6WX0NJFK8=;Y1%(AN/MJY2%+2>H
MNS7 6\5GTL3=2:P]IR7W\FHI^!.3[CHS8.^>*G8RI68.CO7%%_>I.3Y6EX*F
MIWS:/3&J9Q#<[K*_%2[>6&283IC637$IY4"JIZR?E5[%BK(R62;>7>URY!*(
MR_S%GD\/;<<SVJ8N;OX3 I_U:A*XUQMM17(E*G?9CMQ</%6L1BG\MRC!=Q)5
M?+5<B+1XU(3\KW?.-],(.3;0M,]3T14+O-+M:*ZO1--EM;D;%]0<=N8%Y&2\
M:>=91+OZ*E4HB42%&R7*(S))IV5V88N5K.KN$K_5WK#=/YT))KD3ERD,WWPZ
MN9;;Q%/CV[J7@DG7QJ)AKYM;K-=7>G6XS0>UFR9-3@61X;J'B##[JGFX+.=Q
MKZHRJ%$)?$XL-$_$X4DFDGR#?EO+X$I2S5?=J>!MV\5A<Q@DIW(RA+N[%'%O
MC=)-=Y)%KN-BI3L7\')_%A*,H_TJI^-)^%FSWSA[\@6K^[_IU]KV>C$]F?\
MJ.7^6G^- O\ ?3]CK\]'X)&J7S9K_8/=Q]EVD7\#9Z,QVJ_K&"^\N?# Q^XG
MY'$_?0^"1:%&I2?'7H[IO[7/5+^NW_\ )3@CTKE'^B[/^0_^FS3&/_U)<_S?
M^V=A</-1N<@G^</?D"U?W?\ 3K[7L]&PNS/_ %'+_+3_ !H$1WT_8Z_/1^"1
MKS\VEBQD:(;F9J(["9DC57$(K\M++:9+\:'B+[L2.\^22=<8BNSGU-H49I0I
MY9I(C6KCDNU1OVAA(U>RK,M'?EI^!<A9[BI=4OOAZ1?BEEX:K)T==-THJ_ /
M2.[J)E,AFMD0M8I5O&7%89:2W9N0ZFT=G<T3?-+DOV3BGW%*29N.K4I7$U&9
M^F]T?ZS=?!QGI3L4\%6J<F@TIO!\3/,0XZ&KM?#1/X3L61YD-UG72=(#JID>
M[GI"M8K%F4X^FXU@/1W3V/)=),>#C.*WJ-/,30RTZMIF"W9=A>$)".4E)2IC
MRU*,U*4?IO=O!VLEW:L1:^38Z6?=E);<N_2M%W$C2><XBYF6=76N&[L1[R>R
MN]76^ZV=A5IY@N/:7X#A6FV)0T5^+8#BF/X;CL)"&FRC4N-546GK6C0PVTT2
MTQ(:.4:4I(U<3X=4>:\3B+N+Q-S%7G6]<FY2?=DZOX3<]FS##V86+:I;A%17
M>2HCF(H%4Z]'HX_[4_0/[OUY_P#<Y*/2N]'^D,3_ )9?[)IC(_\ 4%G\\_LG
M87#S4;G
M                             I^?.6_Y:=L?W+LT^VR$-U]E?ZCB_P ]
M'\5FM=^OUK#_ )N7PHDK^;P_D"VGW?\ 47[7L"$6[3/]1Q_RT/QIF<W+_8[_
M #TO@B3L#7I+@ *%?3SS8DKI(=3F(T9AAZMP?2>%/=9=YQR9+<P2IL4292.!
M<P^F#/99)/ZK32%?\X>B>SN+6Z]IMMIW+C7<^.U\*;\)J#>]IYY<2UJ$*^:G
M]DL:= ;"E1>CFP5^0R;;5EJ-JI-@K,T&4B*WE#M<MY))49I),V \WP5P/B@S
MX<#(SUAVBR3WGN):U:MI^;7X&B;[GIK)(-\,Y_#0T:^<R_[![1_LNU=_@; A
M(.RK]8QOWEOX9F)W[_(X;[Z?P1-V^@%_L[,3^ZCJE_#; P':-_J:?YFW\!E=
MSOV)'\Y/X3"?SBS1'--0MK^F.JN*5]A<5>B6H-E*SB% Y3O@S%LWJ8]665S(
MJ6S4["IKRIAQ7'$JXL)L36I)M$XXU?\ 9EC[&&S:[@[S49XBTMAOAE!UV4^-
MIM]W9XZ)VF^V$NWL!;Q%M-QM3>UW%)4KX&DO"1Y=&5TXF/;:=*,0VX;DL'R.
M[P7">RZW"=3<&*)8WU)039TRQ8I,HQ6PDUZ;:#3RIJT,3(<HI#<,D-=BO*;)
M:Y-O7N!<S7&3S3*[D8XBY1SMST)M)*L9*M&Z:4U2NFJJ87(=[(8'#QP..A)V
M8:(RCI:6NC3I6G&GJT499<T>W>[.M[>*WN):5:PX1J-&RG'+6ER+ GY+]#FC
ME%<U<N%<1IV#9/&J<G*(J X\AQXHBX_ E&2U)ZIZKQN2YWD%Z-[&6+EIPDG&
M>N-4TU2<:QK6FBM2=X7,LLS6V[>'NPFI1:<=4J-:?BNC\5#(FU[;3IYM&T9Q
MS0K2N3D\K",6FY!.J59=;1[JY0[DMY/R&R;<FQ:ZJCJ8\)63JFTI83R25U>)
M\3.US?-<3G6.EF&,4%B)I)[*HOBI16AM\"XRME^!LY;A8X3#[3M1;I5U>EMO
M@7"RE/TZ&N5OJYO_ -0\5<E2U8MH=48WICB\!YQ:([4E%-"R7+K!$/@33,F;
ME-[)8-TN4M^-#CF:N2E"$;W[/LOA@MV[5Y)=-B)2N2?A<8JO<BDZ<#;-6[VX
MN6)SF=O3T=E**Y*M\KY$BQ!IOTU?1D:;Z=X%IW4:L90U4X%A>+875M1](-1F
M8[5=BU'!HX3;#2,::0TRB-!224DE))21$1%] :TQ6XF]>*Q-S$SLPV[ER4G_
M %D-<FV_NNZ32QO3D-BS"Q&Y+9A%17Q):DJ<1CK=+TR/1RZT;:=?])*S5'*)
MMQJ1HUJ3AE#'?TIU CMJR+(,0MZ['G.R)= U$CKCW;[#B7'5);;4@E*,B(Q<
MY1N/O/@,UPV-G9@H6K\)/^LA\E23EJEQ5*.8;SY)BL!>PT;DG*=J45\26MQ:
M7!QD)'0!Y7:8]TB&,4T!YQN'G>ENI^,7;:'"0A^O@T\?-6$NH-M?.DBWQ&,H
MB(T&1EQX\"-*I]VCV87=V9SE\JW>MR7?;V/@DR*;G7)0SJ,5JG;FGWJ;7PQ1
M:]Z07H_-..D%TTQ?!\UR>]P2^P7(Y&28;FN/PH-I)KG;"O56W%58U-@IEFRI
M;9E+#CK;;\5\GXC"DO$E*T.:=W;WDQ6[>+GB+$(W+=R.S*+;5:.J::U-:>!J
MC>CBV)G.36,YL1M79.$X2K&2TTKH::>M/P:4M)[>R+91H[T=&B=_A6,Y;.M(
M]K>RLVU"U'SF764_9\U$2/715N-H6S4X_14]9%0VTV;B^"U..+=4ISJ=<_S[
M';SX^-^[!)J.Q"$*NBK7OMMOX%30<Y5E6&R3"2M6Y-IO:E*5%W.\DE_\2(_I
ML.D/VC:D;5\YVU:6ZM5&JFI^09+@\U:-/&W<FQ&CA8QEM1>3I-OG40BQ1[GF
M82V6VH$J<^4@TI=;;2?+$SW#W9SK"YO;S7%V96<)&$U\?XLFY1:5(/XW#72D
MJ:FR-[U9UEM_+YX'#W%<Q$I1^3IBJ-/3+5R-Z3%?S8W_ /+<_P"[9_\ )]%Y
MVK__ &#_ ,?_ .B6^X?_ -K_ /"_^H2E=-GHCFFN&P'4:!@5?875_IWD.*ZK
M.4%7RESKFAQ1^9&R9MF*EM:IQU&/7$FSYA)I<<[!X-\MSD-+B.X6/L9?O':E
MB6HV[L96ZO4G*FSWJR2C7NZ=&E2#>K"7<7DTU93<X24Z+A2U\B;?@*Y_17],
M(>QK%;#1#5G!+?/-%;/*)64U-MB4F$WFV!V-PW"8O&H=7:O0ZG):*<<),A,9
M4N \Q)4ZM+KA.\VC9V]^Y/O!>6/P=R-O'J&RU*NQ-*M*M5<6JTK1IJFA4J0G
M=_>;V3;>$Q,'/"N54U\J+>O0]#7#2JTUTEK?;ATC^S'=4]!J](]<,8DY=/)M
M+6G^5G)PC.UR7%(;.%!Q[*&:U^_?;<<2E2JM4YGBHN"S&G\TW7SW)TYXW#S5
MA?=Q^/#ON4:T_I49L/ YYE>8M1PUV/2O[E_%ER.E?!4R)MBVCZ2;1JS4RET?
M1D<2FU3U.O=5[RJN[2-80*G(L@CPHDN%C4>+6UR:RBCQ:]EMEA?/.(0VDC<5
MP(6N;9UC<ZG:N8W9<[-I6TTJ-Q5766EU>EU>CO%? 9;ALMC<AAMI1N7'-IO0
MF^+0J+05;_G'>N5ODNX[2C0*+*EMXKI?INSFMA"-Q;429FVH-G8LN2%QTD3<
MOP7BU!!3'>4:C;5,DH22>*S<VWV7Y?"UE=[,6ETUZ[L)\*A!+DK)NJ[B\$ W
MWQ<IXZW@U7H[<-I_?2;^!)4[[-]]BW2W]';MOV@[?-%;_4S(JK)\'TWIH^85
MT#2O/9<2'FMR;^1YI':FP,>5"G\WE5Q,)4AI2T/JXN$M9*Y1QW>#<S>;-,ZQ
M./MVHRM7+KV6[D%6*^+'0Y57Q4M'!J,OE.\>28'+;.%G<DKD+:VEL2^4],N#
MC;-IIW3H]&=90IE=/U4RJ7!L(LB%-BO:1:D*9DQ)32V),=U/D[[9MYEQ25%^
MJ1C$1[/MZX24HV8*2=5_60U^<9![VY#).+N2:?\ ,ES%3GHOLG>P?I']KEAB
MLZ2[&DZRQ<0CS#_S1Z;CN:L6F$SER&E-+Y'9E%>N&MLTD?MC3Q2?!1;CWMLK
M$;KXN-Y*JL.5.*4*37(T:[R"X[.>8>5MZ.EV?!*L?@9V*X\R&ZP   K_ /3_
M &X,L8T)TQVIT615>/Y+N:SRJ9R2TM[-%544>FN(7%3)F3<@L5HY%343LPFU
M:G9#BTH.'!F$9*02^&Q^SC+>ES"[G%R+E:PEM[*2JW.2=%%<+45+1QN)#M\<
M;T>$MY?"2C._-5;=$HQ:UO@6U33Q)F[&BV]#HW]"](]-M',.W<Z -XSIGA>/
M894*5J+CK;TJ/0UL>"NQEEV>Z:IUH^TN3(4:E*6^ZM1F9F9C X_(MZ,PQMW'
M7\%B>ENW)2?Q)<+K35J6I=PRN%S3(\)AK>%M8FST=N"BOC+@5*Z^'60#]/CF
M&T_7_P RVO>@NO.DVHVH-#V=I7G>.8;E])=WLS$9'A#*,1O^PH3QR>P<<M_"
M<:2X?.<56L<B))(49[&[.K.<9;T^79CA[UK#2I<A*46DI:(R57PR6RU]ZR';
MX7<NQG18S!WK<[R^))1DF]G2XOO)U3[Z-I_FW^Y95Y@>L.U*_L.7.P>Q:U:T
M]CO.-FX>+Y(]'ILWK8K?M5HATN3(@R_^?RG;ETS,B(B/$=J&5='B+&<6U\6X
MNCG]]'3!]]QJN]%&0W'Q^W9NY=-Z8/;CWGHDO Z/^D6>1J<GI&ITPG]FSNH^
MQ'%_YR,+$JW)_P!4X/[^7XDC!;S?L/$?>K\:)!#\VECQU:X[F)2F&52F=*<2
MCLR5-(.0U'DY>ZY)8:>-/.-LR'(C2EI(R2M32#,C-)<-A=JC?L_"1KHZ:7XO
MVV1'<5+K=]\/1Q^$M&:^;6MO>Z*FJ*'7[2C%=3:_'Y4B;0G>QY+5C22)C;34
MTZBZJY5?=5S<Y##9/MLR$-O\T@UI4:$<-29=F^991<E<RV].U*2HZ:G355.J
M=."JT:2?XS+\%F$5#&6XW(QU5UKO-4:Y32?I.<VI-F71H:L5.C%)"T_AM8K1
MZ,Z=5&)144\'&H^>W$3&[21 7$1RX$J'C,ZREHDEQ?<GDE:G"=<-TL]NGA[F
M>;U69XZ3N2VW=FY:7+83DJUUUDHJFJG!308K/KL,KR*Y'"I06RH12T4VG1T\
M#;KQE:KH3=W>UO9IJ)KKJ)N*RJQQ>VR/"\3PO W:S#<BRJ1+KI5Y8WF9MK=Q
M^KL%UK+4FBIC-+JFR?49&DE<T9HVIO[DN;YYAL/ALL@IPC<E*=91C1T2C\IJ
MNN7>\)!MU<RR_*[UZ_C9.,I148TBWHJW+4G35$L1^O?Z-GTN9=]Z34CXNC67
MU>;T^HA\Y#TB:>]V1^MEYDN8K+],UNBV\;O=RV#ZM[>,CL<CIV-&J/#,LD6.
M+WF+.%D5'E^:6+#G8]]!@RY:W*2^C-FXA)MDEE*2/B2AM;<;*<SR7*KF"S.*
MC/IW*-)*7Q7&*X&^%/E()O1F&"S+'PQ."DY1Z)1=4UI4I/A[C1;KZ*G*[3,^
MCOVG7-P\X_,C:6Q,80XZX3JSK\'N+?"J=)KYMOJ-U&/L)(C(S21$1FHRY1Z7
MWPLPL;S8R$/DN]M>&:4WXY,V1N]<E=R7#2EKZ.G@BW%>)&E5!T!^VJCW2M[A
M?.%G<S$H6HYZGU6C"H%/'I85XB[=R2'2.Y0P964K$*ZX-KFHG8[<E41DF79+
MAJ4X>>N=HN:W,H]F=%;5YVNC=VKJU39;V=6TUK=:5=4EJ,5#<_ PS#KNW/HU
M/;4**E:UI77LI\%*TT5)4-==VVVG;-7.66NVM6 Z<FA@I+--<734G+;!@RX\
MY3X34IL<PO"X=4^PX+YD0B&7Y-FN:RV,OL7+NG6E\5=^;I%>%HD.+S+ 8".U
MB[L(=QO2^]%5D_ CK[^D*UOP?<?O+UWULTV5;N8-GF2U4W&W[VM.HLY4"LQ/
M'Z$YKU:MY]V(S-D52WF$N&3IL+0:T(6:D)]([M9?B,KR/#X#%;/6+<&I4=55
MRDZ5[E=/=--9UB[6.S2]BK%>AG)4JJ/0DM7@.R9'ELWD
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M3I5TNSBM5-227@-?;R6+.%SJ]8P\5"S'8HEH2K"+?C;9':),80
M #LN-B'Y#NS3^JEMW_FBP\>5]X?V_CO\Y>_O)&],H_9.%_R]O\2)M:,.9$ "
MB3T_W]HADGW*=+_X+FCT)V<?Z9A^>N?"C4F^/[:E^;A\#(4!/"*@
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M 'D3KN=^VH_FY_ 2;_.<O_R(_P#O)_\ R A%.RC_ .W_ /@?_6,SOY_]D_\
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M)86VYJU':E2FA?9?<57HU&(A>EH   $O?05?VENB?V.ZO?S3Y@(5VA?Z6O\
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M68P<:6PXQ+C+Y#J#2:D\%%U#&6LW</C\+&]#9N86[!25:-.,E556E&.NPQ&
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M%ZX26N+Y4T^%-/1J-?9OE=_*,6\->TQI6,N"4>/N/@:X'W*,U0&8,8
M    27=#O_:4;6/LKRS^;/-A%=]_]+8S[R/]Y SN[/[=P_WS_%D=AN/-)N@U
M2WW_ )#N\O\ JI;B/YHLP&8W>_;^!_SEG^\B8[-_V3BO\O<_$D=:./5!HL
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M&=WCRC+,+DMZ]A[%N%V.Q1I:56Y%/3WFT4SQO(U:
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MBYLN!%Q/C(^U>*VL!+[IJ\N3HJ?"S#[AMTQ4>#^K_P#J<Q:H&H#810AZ=_\
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MT$H01%U"&NM]4H[TXQ+0ND7CA%OQDPW:;>1X=OR'^-(DD$6,X
M
M!0-Z;;;S9Z%;]=3+Y,)YO$-=NQ]8\4GFR91Y,S(4E'SJ$<A*$L+G0LXB3GEM
MD9N(C2XZU_\ 2$:O1NX69PS#=VU;K_7X?^JDNXOD/O.#2[Z?$:>WJP4L)G%R
M=/ZJ]\=>'Y7AVJ^!HLR]!ON2J===C&$X2[/9=SG;R\YI5E->;W*E(HF'I5AI
MU;%&-"5LUTS%'$0&E<5I<DU4G@9<DTIU3V@97/+]X+E]+_R^)_K(ONZIKOJ6
MGO21.]T\='%Y3"TW_76?B-=S[E]ZFCOIDQHA!)@ -==TVZ/2C9[I#9ZUZR3K
M2+B%;=8[CZ(M#"8L\@M;7)+1BNBQ*>LD3:Y$]Z'&4_.D()TEH@PWW$)6I!(5
MD\HRC&9WC5@,"D[SC)Z71)15:MT=*Z$NZTBRS#,,/EF&>*Q3?1II:-+;;IH6
MCOON)D#WSC&O+.ML&U/6*B;M%XPC4*=':5,@3:MYJ/J7@+>14:[:IL8L:RK)
MQQ<1<2;4A#+K"U+;<02SX%L/LQEU?-L9@;FSTO1+4T_R<]ET:T-?&UK7K1$-
M]H]-@,/BH5Z/;XJ?*C553TKY/"?<^;4WT&1M]W'8NVLCLJ?6.AOI;?*/E)@Y
M)A,*OKUFGD$1$M_%9)$?*,SY)]0N'5I]J=N2S+"WG\F5AKPQFV_QD=]Q9IX*
M_;^Z5U/EC1? RR>-6DY(./G"&0UU-T?CM9,<Y,K+=:M-Z*I02D$;DV)'R7)W
MN*5*)1H16XZ^9\DCX'P_4$_[-K4KF\FW'5"Q-OO?%C\,D1/?.<89-LO7*[%+
MQOX$1^?-G<&LEWVZ[4IUEYJGC5&F&#09"C(H\ZRFS,MO[5EHN0I2GJJ+7PE+
MXJ224S$=17$S1).U7$0Z/!X5?+<KDWW$E%+EJ^0PVXEJ6WB+_P!S2$?#\9OD
MT<I,_P!,)_9L[J/L1Q?^<C"Q!MR?]4X/[^7XDB4;S?L/$?>K\:)!/\VD_EIW
M.?<NPO[;)HV#VJ?J.$_/2_%1$MQ?UK$?FX_"RX&-*&RBA#T[_P#:3:N?8CI)
M_-OCH]%=GG^EK'W]S\>1I_>[]N7?O8?BHO&Z'_R+:0?<NP#[4ZD: Q_Z]>_/
M3_&9MG"_JMO\W'X$:I]*=_9Y;M?N1W'[\KQF-T?]2X+\^OLF.W@_8N)_-,KE
M_-L/RIM>/N *_G%PP;/[4OV1A_\ ,_[$B$;C?M"]^9_VHES$:--GG7Y]*+_:
MQ:Y?=<TS^U#3X>D-T?\ 1V'_ #-S\:9IO>#_ %%>_.1_%B=@8/-YN0 #K9=+
MZM_5[I <(@842K7R^W;T\BA?C))]MVNN=6V9[5FHVUFWV%'K73DNN<OFT,H4
MLU$DC,>I,7-8+=NY+$:.CP3KWU;I3OUT=\T;AXO$YS!6M.WB53O.=:\FDLD_
M.5<1GS] =N6=,MR5UV,:N9%C,Y3?5C-2,SP]RR@+DI)!F2S+"7DMJY1)+E*(
M^)J+AJ[LLOQCF.*P[IM3LQDOZ,J/\=$YWZM-X.Q>7R8W&O.C7_9/U\VIOH,C
M;[N.Q=M9'94^L=#?2V^4?*3!R3"85?7K-/((B);^*R2(^49GR3ZA<.KQVIVY
M+,L+>?R96&O#&;;_ !D-Q9IX*_;^Z5U/EC1? RR>-6DY(./G"&0UU-T?CM9,
M<Y,K+=:M-Z*I02D$;DV)'R7)WN*5*)1H16XZ^9\DCX'P_4$_[-K4KF\FW'5"
MQ-OO?%C\,D1/?.<89-LO7*[%+QOX$1^?-G<&LEWVZ[4IUEYJGC5&F&#09"C(
MH\ZRFS,MO[5EHN0I2GJJ+7PE+XJ224S$=17$S1).U7$0Z/!X5?+<KDWW$E%+
MEJ^0PVXEJ6WB+_W-(1\/QF^31RF^7SA[\@6K^[_IU]KV>B/=F?\ J.7^6G^-
M R^^G['7YZ/P2-4OFS7^P>[C[+M(OX&ST9CM5_6,%]Y<^&!C]Q/R.)^^A\$B
MT*-2D^.O1W3?VN>J7]=O_P"2G!'I7*/]%V?\A_\ 39IC'_ZDN?YO_;.PN'FH
MW.03_.'OR!:O[O\ IU]KV>C879G_ *CE_EI_C0(COI^QU^>C\$C /S:?^0?<
MG]US&/M-0,CVJ?M'"_F)?C%IN+^IW_SJ_%+*PU83DZZ/I7/[1/=E]U&1_ E,
M/3>YW^F<'^9^RS2F\7[;Q/YS[".Q<'F0W6=:_G*'=)]_V5GF;3$!6GF[VWDY
M(B:GE0F6,:UC?E6+KW/&PEZO5'B*62C-*7&3)7$B/B/4N'IC-VX=!IZ7!+9I
MK^-:T>'3RFC;W_E\YETNC8Q+KX)Z3LGTJ2M*5H42DJ(E)4DR4E25%Q)23+B1
MD9'U#'EHWD?T =>CT<?]J?H']WZ\_P#N<E'I7>C_ $AB?\LO]DTQD?\ J"S^
M>?V3L+AYJ-S@
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M7\HM8J[9K?E9VF]N:TTK6BE3Q4*C W2:P
MG;^;O_E\W']7W43[9=/QKWM,_P!.1_S,/Q9DMW*_;#_,R^&)>*&@3;
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M\/\ >O\ &D25B*F=
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MM%S@H[;:4..NCE* ?31:C8+JATANLV1Z=Y529ICL2LT\QQ5_CEA&MJ5^XQ_
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M
M                  ^)?Y-C>)P"M,IR"DQJL-]N*5C?VL"F@')>2M34<IEC
M(C1S?=2THTHY7*423X%U#%2W:NWI;%F,ISIJ2;?(CI.Y"VMJY)1CQMT^$I<_
M.$=>M(-9-P>C-)I3J!C&HCFG>FUQ!RVSPZX@9%0UEK?Y%V;#IO#E5(E5LFVC
MPX7.266G%G')UM*S)9J0G>G9KEV-P.6W[F,MSM*[=3BI)Q;48T;H]-*O0^&C
M-7[YXS#8K&6H8><9[$'5Q::3;U56BNC3Q&X'0*[\=M6E>@V6[<=8M2\7TES6
M/JC>9QC=EG]Q"QG$\IHLFH\:@''AY1;.Q:2#>U=G1.H<B2GV5OM/LJCF\?/)
M:PO:+N]FN,S&&:8&U.]8Z%0DH)RE%Q<GIBM+33UI.E'6FBN2W0S? X?!RP.*
MN1MW>D<DY.B::2UO15-:GW*5TTG]RO?!LVPFI?N\FW4;?JZ PA:^"-6\&L)T
MDT<#6U75-9=S+:UDD2N/-1F'7>'5Y/ C&N+.09Y?FK=K!XER?_=S2\+:27?;
M1,;F;97:CMW,192^_B^1)U?@("-]O2K9SO4BVFSCHTL&U(U&=SQ$S&M1=3ZC
M%;&%(M\6L4N0IM+B$:8EF7C.+W<-3J+2]NT59-0B=;2AMM2I*=C;O;GX?(FL
M\WJN6K2MTE"VY)TDM*<J?*DG\F$-JKH].HA^;[PW<T3RS(H3FYZ)32>E/@7$
MGPRE31RFW'12=#O6[/I437C7]RBR[<6]#=;Q>IJGCLL8T>@V4)<6P17SEMM-
M7F=3HDIR-+L&TG%B,J6Q#4XE;DE["[X;[RSM/+LMVH997XS>B5QIZ*K@@GI2
MUMZ94U+([N[LQRQ]<QE)8ZFA+2H5UTXY<#>I:EQN>!QQMEM;KJT---(4XXXX
MI*&VVT)-2UK6HR2A"$D9F9GP(AKQ)MT6LEY4Z^<BZM:99;"VP8%BF=XKD^7X
MY;:H7^1T6/7=?=3L?J[.'AE?5R+MNND22JSM)<"0F.AXT+>['=-)&2#,;C[+
ML'B[,L7B+UN<+$E;47)-*33DW2NNB:K355&NM^,38N+#V;<XRNQ<VTFG1/9I
M6FJNFG>-O/F_NX#1I[9]&T2>U%Q2LU7QG4O-YDS KB[KJK)I]9D,B%9U5Q0U
M4Z2S+O:MY#JF5NQ4N$S(:4APDF:#7A>TC+<<L[>/5J;P<[4*32;BG&J:;6A/
MATZUJ,GN=C<*\L6$<XK$QN2^*VDVGI32X5WN$UFZ?'5+.-ON[;8MKU@,MB)D
M^ 4F6WE I_EN1Y4S'\LH9-A5VC#:FEO4US76O8DE"5I-V.^ZCBGCQ&5[.L)A
M\RR;,,NQ*K:N2BGWI1=&NZFJKB:18;X8B[@LQPF,LZ+D%)KP-53[C3H^X3J;
M+]]N@V]W3>IS'3#**R+EZ*^,><Z56=E$;SG!;KF4'.B3JI:FI=E2=D<KL.UC
MMJAS&BZBD.I>9:U]GN[V8Y!BI6,7!NQ7XEQ)[$UP-/4GQQ>E=ZC<MRO-\'FM
MA7</)=)3XT&_C1?>X5Q/4^_5+!'3!:XZ0Z5[%]>,4U#R6BC91JI@=GA6GF&R
M),=_(LER6W6VS73JNF(W)BX..R6^SI$PT)CQBC%Q<)U325Y'<G+\;C-X,/>P
MT).U9N*4Y?<QBM:;U5EJ2UNNJE2SWEQ>&P^4WK=^2Z2Y!QC'A;>JB[FMO@IQ
MT-1?F]VUW,M%=MVH>LN=5$J@LMQN0XM8XQ53D+9FO:=8'7W3.,W\F,X2'8A7
M]MEMHY'0I)&Y"0P^1FAY S7:5F]C'YI:P.'DI1PL9*36K;FUM+NT48U[M5P&
M-W,R^[A<#/%7DXROR32_FQ3H_"VZ=RCX3!GS@'8+E.HL6@WF:34$V_M<+QMC
M#M9\=I*UZ;:.XC629T^AU#;CPTK?EMXV4YZ':KY"UM5_8SQFEB*\I.0[.-X[
M.&<LBQDE&%R6U:DW1;3HG#3Y5$X]VJUM%IOED]R^EFF&BY2A'9FDM-%JEX-3
M[E'J3,?]#MTP&E&GND^.[5-U.3HP5."]D5^E&JELF0[C$K%7G95@QAV836&G
MEX_+QUUQ3-=-=+L)Z"IJ.XIA<="I-QOON3C,3C)9QE$.DZ33<MKY2EH6U%?=
M*6N2UIU>E/11W9WEP]G#QR[,);&QHA-ZJ>3+BIP/531HIIG[R[?WLCP?&'<P
MR#=AM_\  +<5Z8R[1ZIXAEEC9L,$DW2H:#$[6[O\B?22B_8H$62Z?$N"3&N;
M.[F?XB[T%O!XGI*TTVY12[[DDH^%HF-S.,JM6^EGB;.Q3@G%M]Y)MOP)D=6U
M+<5N6Z0S>BC<#IG;9YH[T?VAU1DN(4%=/B]@M[E\IM3>A2)UA4V,636R&:Z=
M%;D*?03LFBC16XK+C$RQF*:D^<99E6[61>S<7&W?WDQ$HR;6GH(K31-.NE:*
M:IMMM.,8UPN78W'9UFG7+#G:R:TG%)__ #6^&CT:.6*5%1R=(??G&^GV75&[
MS374J=!DKPK,]$J3'<>N"2\N&5WAV498]D%$;BD\TS,B1\BARS0D^"FYA*+J
M\OA->S#$V9Y+=PL6NGMXARDN&DHQV7WGLM> C.^]FY',K=]K^JE:23[L6ZKQ
MI^$F#Z)'I"-J-MLRT>TKR_6?3G2S4O1_%589E&)ZCY;C^#/2V*698KK\AQZ7
MD,BEK\BK+*D2W)?5%4Z[#>-Q$CJI)UV$[Y[M9Q#/+^,L6+M["WY[490BYTJE
M524:N+3T*M$]%.)2;=S.LNEE=K#W;L+=^U'9:E)1U5HU6E4UIT:N$UNZ8+>]
MI[N:VRZN:![4JZ=N%K\*\CM0->]7L#44W2W23%*+,*IVI;+*>05;F=[D%TAE
M*&JIR2PS7MRI)NJ**^364W)R#$Y5FMG,LX:PTKFU"S;GHN7).+K\77%)5TRH
MZT5-*K8[RYK9Q^ NX/+D[T8;,KDX_(@E)4TZI-OBKHJZZ'33[YNWN.T1T7S'
M<[@^K6I.*:<7&IU7I%:X5*S6ZKL9HKA.G[NJ#>1U[=_<R8=4S;M-YI#=8BK=
M2[):2\ILE<TH9OM,RO'XZQA,1@K4[L+3N*6RG)K;Z/9=%5T^*ZO@T5UF,W*Q
MV$PMW$6L3<C"5Q0<=II)[.W55>BOQEHX=/$;H_.&<O;E[>=INK&FN65EA"K-
M=9-OBN98I<0[2*=FUBMA94UQ16U:[*@RBAS*):TNMN*2EU!?1ZO#!=FEAQS/
M&8/%0:D\/249)K1M)--/3I3U&4WTNUP6&Q%B2:5ZJDG731M--=XD0Z.+I,M(
M=\.F6/0[#),?Q/<52U<2%J)I=.FQZR?8VL9I+,K*\#ARWDN7^*7#B.?Y$8WG
MZM;G8\DB_877XSO1NIC<@Q<I1C*>62;<+B54EY,VM4EJTT4M:X4LUD>?8;-K
M$4Y*.-2^-#55\<>-/N:M3X&]I-X&N.D.@6WO5',]9LEHJ/&G<(RFJC5=M)C]
MFYC965++@Q,3H*EPUR;VTN7Y2&"89;<)*'#<=Y#*5K3B<DR_&YCF5FQ@82E=
MZ2+JM44FGM-\"6NK[RTF0S/%X;!X*Y=Q4DK>PU1_=-K4EPM__'05[/FX>UW,
MJ:PU>W:Y+42JC&,CQ)&D&FTF6A;*LHCOY'5Y+G5M#9<)*EU-988K5Q6I!<IM
M^0<AM)\6%C97:AF]BY&SDUJ2E=C/I)T^Y^*XP3[K4I-K@5'PD,W(R^[&5W,;
MB:MRCL1[NE.3[R:2KQUXC>+IR-A>2;K=#\=U;THII-[K!H&B[EMXS50')EUG
MFGMUV$_D-%5L1B.587M!*KF["OC)2XMY)RV64*>D((X_V?[Q6LGS"6"QDE'!
M8FBVFZ*$U79;XDZ[,GP?%;T)F6WLR>YF.$CB<,JXFS70M<HO6EQM4JEWTM+(
MBNAEZ53#MIT"XVP[E)5A1:4VV3R;S!L[.%-FHTWR:V=CQ<@Q_)ZR,P]8,8E;
M2F2EE(9;4JNG&^IYM34A3L::;\[H7\YE'-LJ2EC(PI.%4MN*U2B]6TM5'\I4
MHZJCC6Z^\-K+D\!CJK#N58R\EO6FM='KKP.M=>BTF[ONV4LXP68N;M-N?DZ;
M'/IG(UCP%QQ:N8.3V&BO;OEV;EL3:3(X1,G+)9&CF^61I&HUN]GSN] L%BNE
MKJZ*?+6E*=VM.Z; ]KY5T?2]9L;'W\?@K6O<UD6M1N^UOZ2/>7IGBFRC*LZT
MVV>;<\N9S#6S7V'63::+K!91F6TITZKZS(*SL:?5VD"6IB-6V4<UF4ERUDQ?
M\R@I7+IY+@-U\CNWL^A;NYWBH;-JRVF[:\MM/0TU5RB^!03^-(P$<RQ>>9I;
MMY5*<,LL2VKERE-M^2DUJ:U)\>TUH1/P-<DP/PXXVRVMUU:&FFD*<<<<4E#;
M;:$FI:UK49)0A"2,S,SX$0)-NBU@AGZ3/I6="=N&A^>X=I)JKBF>[C<QQ^RQ
M?"Z/ ;Z%DRL#EW+#E;,S;*[>BDRZ[&Y.+Q'URH,.0Z4V9.*.26#C&\^U.=U-
MS\PS3'V[^-LSMY7"2E)S3CMI:5&*='+:>AM:$JZ:T3B^?;PX3 X2=K#7(SQT
MDU%1:>S71M-K0J:TGI;IHI5K2?YOQN%VJZ;;=,UTSRG5_ \%UNRC6*YR*SQS
M/+ZKP^PO:56-XM48JWBLV\EPX&31FB@2U=C1G5S6)"Y!N,I:-IQS/=I&69QB
MLSMXNS8N7,!"PHJ4$Y)/:DY;257'6M+T-4TUJC%;FXW+[&"GA[EV$,7*ZVU)
MJ+:HDJ5U\.A:=>@LRUEI674"):TUC!MJN>RF1!LJR7'GP)L=?'DOQ)D5QV/(
M95PZBD*-)_X1JJ<)VY.$TXS6M-4:\!/(RC);46G%\*/C97FV&8)7>%\XR[&,
M-J3-U)6F5W]5CU=RF6')3R>S;>7#C<6HS*W%%RO:MH-1]0C,=[.'OXB6QAX3
MG/BBG)\BJ=+EVU9CM791C'C;27C.OKZ7%G1!_?EK/DV@.?8EJ%A>>RJK.;>R
MPFRC7F/UN?7\%"\[K8]] <?J[I^9D3#UF\]%==9;<L39-7.-+(O26Y;S!;NV
M+696YVK]M."4U1N"?Q'1Z52-(I/3\6NIFFMY%A'F]VY@YQG:G23<75*3^4JZ
MGITZ..G 6=NB<Z4'0[6K;MIUI-JUJAC&!:]:68W48':UNH625>/+U"J\>BM5
M6.Y7B]M<R(,7(K"PIXS)6$5"U6#4UIYQ;:F5MO.:GWQW2S# 9G=QF"LSN9=>
MDYIPBY;#EIE&25=E)_)>IJBK6J4]W=S_  F*P4,-B;D88RW%1:DTMI+0FF];
M:UK76O!I,F=-%K/I5C71]Z^8=;9_BC&7YU78CCF)8JW>5LC(KZU=SK&+5;,"
MF9DKGNLQ*BMD2GG>03;3#*E&KCR2.UW%P.,N[R8:_"W/H;;E*4J/92V)+2]6
MMI+NLN-Z<5A[>37K4IQZ6:BDJJK>TGH7>52!_P";T:Y:1Z1;@M9Z/5'4'%]/
MY>HNG5#6X;)R^WAX_4W=O39(<J53,7-F[&JVK=Z--2N/'<=0[*Y*R:):D\D;
M"[2\OQN-RVQ<PEJ=R-JZW+93;2<=#HM--&E\'"1#<O%X;#8R[#$3C!S@E':=
M$VGJJ]%=.A<)=%I[RER&"W9X_<5=Y6O<.9L*>PB6<%WE-H=+FY<)Y^.OBTZE
M1<%'[51'] R&BYV[EJ6Q<BXRXFJ/QFT8SC-;4&G'C6DX)K7I-B^N^D>I&C6:
MLF[B^IF&W^&VZFT-KDPV+RO?AMVD'G"-#=G427$2HJ_HMR&4++@9$+C 8R]E
MV-M8ZQ^6M34EW:.M'W'J?<91Q6&MXS#3PMW\G<BXOPK7WUK7=*$.*2]?^ARW
MY5UIE&-2IMC@%M9UTR,ZU+J,;UHTCO3<KYD[';-YF0TNOO*XDR(KR>R/!MM&
M0E]"G8SK(]%7HY;OONZX69I1NQ36IRM7%I2DN-/0UHVHO1H:9J"V\9NSFZE<
MC64&UQ*<'HT/B:TK71K3I5"YOH5TG&QS<!BM=DF+[B--L4GS(J'YN$ZGY;C^
MG6<4S_[*F1#F4.46<!<XXBV5$N1 7,AFDTJ2\I*T&>C,PW3W@RV\[5[#79Q3
MT2MQ<X/NIQ3I7B='W#9^$S[*<9;4[=^W&3^YFU&2\#?C55W35'>MTM>E^)8^
MO1793D=7N:W8ZG<O$].:;2)QO/\ '\4LK:,\T65V-_2)L,;N)U(V2WV*V-(D
MK)]HES4L14N+/,Y#N9B[UWK^?1>$R:U\:;N?$<DON4G223U.32T?)JZ&/S7>
M/#VX=5RJ2OYC<T14/C)-\+:JG3B5>[1&9;/;UN/A]%5J3H'J=J->ZV;C[K;?
MJ54VU]:S_"EA:97?8]=3(>#PKU,=%IDB*]$ANG:L)[C\JQ<2;SJTMN)::L(9
MGE<M[[68X2U'#Y7'%0:25$HJ23FUJC7Y3BJ*.I:JNYE@L<MWKF#Q$W=QSL23
M;TU;3^+76Z?)J]+ULJ(]$EN4T\VD;W<,U UDDOX]@UC0Y?IYDE^Y!?E*P][(
MH;:(-Q80&8<JQ["BW5<S'EFRE+T=AYQP^4EM;:]T[YY5B<YR">&P*4L0I1G%
M5^5LO2DZTK1MJNAM4X:FM]W,=8RW-8WL5\6RXRBWY->%K7K5&72]3.DGV+:5
MX0[GEYN?T?OZY4)R754NGN<8]J)EV1+(EH9AT.*X?86]Q+?D2D<QSBVFHS#I
M_L[K*24I.BL)NMO#C,1U:WA+\95HW.$H1CW7*22[O&UJ3-HW\]RC#VNFGB+4
ME30HR4I/O*+;^QQM%&+I(LDU"SS>/JYJ=J3I1DNBMOJF]C&?4F Y>IE60U^%
M7.)4C&&S;;F/V)BTLZ""R],C?KX$U3T5PB=86DO0&ZUK#8?([.$PMZ%^%G:@
MYQ^2YJ3VDNXFVD^%4:T,U-GD[U[,[E^_;E:E<I)1EKV6ELU[K6M<#JM:+_.B
MF[#;CN'J,9M-(-9=.\RDY72(OZ[&*[+:%>;1HA,)?FL6^&E8'D=385/*-$QA
M^.A<9Q)DOAPXCSEC\FS3+)SAC;%V"A*CDXO8KP4E39:? T])N+"YC@<;&,L-
M=A)R54DUM>&-:JG#HT&PPQA>@
M    %:/YRU_(?MG^ZMEWVH-#:G97^OXO\S'\8@N_7ZI8_./\4I[#=AK0
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M,>&P\L1E]R4]A-N,DJM+3\5I*K[E-/ ^ KE#9Y!"?3:YT(F);I<<H;_#-_\
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M^%&I-\?VU+\W#X&0H">$5
M                             #M91X_/0H   =;CTD7Y?.[_ /K!:F?;
M-.'J+=?_ $Y@O\M;_%1H[//VQB?ST_A9I0,\8L
M                                              ,K:$?RX:-?=6T[
M^V^G%IF'ZA?_ #,_Q67&#_6[7YR/XR.T/'DHWZ !U8N=_P"W&9?97D7\+S!Z
MZP_ZO;^\C\"//MW\K+[Y_"<4%8Z
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M>FNC1WC4O$/]K<7^R*D_A*,,SB/R$_O'\#,=@_UNU^<C^,B_5TW7]F!N;_\
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M0@DP
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MMI2I1-ZZ42H7^$RW 8!N6#M1MR:HZ<*7&;)C%E\
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M2CK.,9Q<):8M4?>9%UZD7HP/S9/PT;A/Z6!+??[>SZ7_ &5G]&8#W4R#Z/\
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M0_;/]U;+OM0:&U.RO]?Q?YF/XQ!=^OU2Q^<?XI3V&[#6@
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M^;+_ .R6\'[(M%/X-U-&FNU;\O@OO+OPP-E[B_JE_P#.+\4B#Z;K^T_W-_\
MJ7_\/>DXFNX/^D\)_P"+_?7"*[U_M_$?T/[N!%,)@1X           #LN-B'
MY#NS3^JEMW_FBP\>5]X?V_CO\Y>_O)&],H_9.%_R]O\ $B;6C#F1  HD]/\
M?VB&2?<ITO\ X+FCT)V<?Z9A^>N?"C4F^/[:E^;A\#(4!/"*@
M                                                        !VLH
M\?GH4   .MQZ2+\OG=__ %@M3/MFG#U%NO\ Z<P7^6M_BHT=GG[8Q/YZ?PLT
MH&>,6
M             &5M"/Y<-&ONK:=_;?3BTS#]0O\ YF?XK+C!_K=K\Y'\9':'
MCR4;]  ZL7._]N,R^RO(OX7F#UUA_P!7M_>1^!'GV[^5E]\_A.*"L=
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M "=OYN_^7S<?U?=1/MET_&O>TS_3D?\ ,P_%F2W<K]L/\S+X8EXH:!-L
M                   !HGN!Z-'9+NEU#?U6UWT5\NL^DU%70O7WG'U:QCEU
M5,AUNMB^"\.SS'J5/8R'E%RRC$XOC[92N!"0Y;O5GV48;J>77^CPRDW38MRT
MO7IE"3\9B,9D659A>ZQC+6W>HE7:FM"U:(R2\1A+U(O1@?FR?AHW"?TL"_\
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MBXZ>]HX*&4Q&78/%818&_#:PL4DHUDODZM*:>CO]\TP]2+T8'YLGX:-PG]+
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M)-/;N.C6K0Y-<J)(Q%C.
M
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MX&22B+&<
M
M
M
M      "M'\Y:_D/VS_=6R[[4&AM3LK_7\7^9C^,07?K]4L?G'^*4]ANPUH
M
M        7BOF[WY US_6"U$^UG3X:![3/]1Q_P M#\:9M?<K]CO\]+X(D[8U
MZ2XI[?.6OY<=L_W*,M^V]H;L[*_V?B_ST?Q36F_7ZW8_-R^$K1C:A!0
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M_N@9E]L=D-^X']2L_FH?BHU3F'Z_?_/3_&9NWT1O]H[M3^SZR^TS)Q@M\_\
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MM_'?YR]_>2-Z91^R<+_E[?XD3:T8<R( %$GI_O[1#)/N4Z7_ ,%S1Z$[./\
M3,/SUSX4:DWQ_;4OS</@9"@)X14
M                                   .UE'C\]"@  !UN/21?E\[O_ZP
M6IGVS3AZBW7_ -.8+_+6_P 5&CL\_;&)_/3^%FE SQBP
M                                                    RMH1_+AH
MU]U;3O[;Z<6F8?J%_P#,S_%9<8/];M?G(_C([0\>2C?H '5BYW_MQF7V5Y%_
M"\P>NL/^KV_O(_ CS[=_*R^^?PG%!6.@
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M3;
M
M
M                     < SG2?2S5#P7YR]-< U#\!]F^!?+G#<=RWP/X3[
M$\)>"_#]=8>#_"'@]CG^:Y'.\PWRN/(3PN</C,9A*]4NW+6U2NQ*4:TK2M&J
MTJZ5XV4;V&P^(IT]N$Z:MJ*=*ZZ53I6AC_Y)^UG\VK0#[S>G7Q<%S[9S?Z7B
M?G9^D4?9V7^HL^9'F/KT.V_;QBMS79%B^@NB^-Y!424S*F]H=+L'I[FKEH(R
M1*KK.OHH\V%)02CX+:6E1<?HCI<S3,[T':O8F_.U)4:=R;37=3=&=H8'!6Y*
M=NS:C-:FH137>:1F@6!=
M
M
M
M                  !6C^<M?R'[9_NK9=]J#0VIV5_K^+_,Q_&(+OU^J6/S
MC_%*>PW8:T
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MU8P=V]>DHVHVY-MNB2H];(3@+<[N.LPMIRF[D="TO6B^=TW7]F!N;_\ 4O\
M^(32<>>-P?\ 5F$_\7^YN&V=Z_V!B/Z']Y Z_,>D#39;5^;+_P"R6\'[(M%/
MX-U-&FNU;\O@OO+OPP-E[B_JE_\ .+\4B#Z;K^T_W-_^I?\ \/>DXFNX/^D\
M)_XO]]<(KO7^W\1_0_NX$4PF!'@           .RXV(?D.[-/ZJ6W?\ FBP\
M>5]X?V_CO\Y>_O)&],H_9.%_R]O\2)M:,.9$ "B3T_W]HADGW*=+_P""YH]"
M=G'^F8?GKGPHU)OC^VI?FX? R% 3PBH
M                                       =K*/'YZ%   #K<>DB_+YW
M?_U@M3/MFG#U%NO_ *<P7^6M_BHT=GG[8Q/YZ?PLTH&>,6
M                                                      &5M"/Y
M<-&ONK:=_;?3BTS#]0O_ )F?XK+C!_K=K\Y'\9':'CR4;]  ZL7._P#;C,OL
MKR+^%Y@]=8?]7M_>1^!'GV[^5E]\_A.*"L=
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M/].1_P S#\69+=ROVP_S,OAB7BAH$VP
M
M
M
M
M
M
M                                                      %:/YRU
M_(?MG^ZMEWVH-#:G97^OXO\ ,Q_&(+OU^J6/SC_%*>PW8:T
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M)=]0DWWZ-]TM+V(W'4GB(VW*>O9BKB3?>;C'P:%W",_>MTC&6[H\>QO1;3?
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M?VU+\W#X&0H">$5
M                       #M91X_/0H   =;CTD7Y?.[_\ K!:F?;-.'J+=
M?_3F"_RUO\5&CL\_;&)_/3^%FE SQBP
M                                       RMH1_+AHU]U;3O[;Z<6F8
M?J%_\S/\5EQ@_P!;M?G(_C([0\>2C?H '5BYW_MQF7V5Y%_"\P>NL/\ J]O[
MR/P(\^W?RLOOG\)Q05CH
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M<'B,)#$VW6,E*YHX.&S1IIM-/0TZ,EE_?'),39EA[]G$2LS5&G&&E?.>/6N
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M\ "=OYN_^7S<?U?=1/MET_&O>TS_ $Y'_,P_%F2W<K]L/\S+X8EXH:!-L
M
M
M
M
M
M
M
M                    !6C^<M?R'[9_NK9=]J#0VIV5_K^+_,Q_&(+OU^J6
M/SC_ !2GL-V&M
M                       "\5\W>_(&N?ZP6HGVLZ?#0/:9_J./^6A^-,VO
MN5^QW^>E\$2=L:])<4]OG+7\N.V?[E&6_;>T-V=E?[/Q?YZ/XIK3?K];L?FY
M?"5HQM0@H
M                 =EQL0_(=V:?U4MN_P#-%AX\K[P_M_'?YR]_>2-Z91^R
M<+_E[?XD3:T8<R( %$GI_O[1#)/N4Z7_ ,%S1Z$[./\ 3,/SUSX4:DWQ_;4O
MS</@9"@)X14
M                   .UE'C\]"@  !UN/21?E\[O_ZP6IGVS3AZBW7_ -.8
M+_+6_P 5&CL\_;&)_/3^%FE SQBP
M                                    RMH1_+AHU]U;3O[;Z<6F8?J%
M_P#,S_%9<8/];M?G(_C([0\>2C?H '5BYW_MQF7V5Y%_"\P>NL/^KV_O(_ C
MS[=_*R^^?PG%!6.@
M                        27=#O_:4;6/LKRS^;/-A%=]_]+8S[R/]Y SN
M[/[=P_WS_%D=AN/-)N@U2WW_ )#N\O\ JI;B/YHLP&8W>_;^!_SEG^\B8[-_
MV3BO\O<_$D=:./5!HL
M                            G;^;O_E\W']7W43[9=/QKWM,_P!.1_S,
M/Q9DMW*_;#_,R^&)>*&@3;
M
M
M
M
M
M
M                                              5H_G+7\A^V?[JV
M7?:@T-J=E?Z_B_S,?QB"[]?JEC\X_P 4I[#=AK0
M                                                 O%?-WOR!KG^
ML%J)]K.GPT#VF?ZCC_EH?C3-K[E?L=_GI?!$G;&O27%/;YRU_+CMG^Y1EOVW
MM#=G97^S\7^>C^*:TWZ_6['YN7PE:,;4(*
M                                          '9<;$/R'=FG]5+;O\
MS18>/*^\/[?QW^<O?WDC>F4?LG"_Y>W^)$VM&',B !1)Z?[^T0R3[E.E_P#!
M<T>A.SC_ $S#\]<^%&I-\?VU+\W#X&0H">$5
M                                            #M91X_/0H   =;CT
MD7Y?.[_^L%J9]LTX>HMU_P#3F"_RUO\ %1H[//VQB?ST_A9I0,\8L
M
M ,K:$?RX:-?=6T[^V^G%IF'ZA?\ S,_Q67&#_6[7YR/XR.T/'DHWZ !U8N=_
M[<9E]E>1?PO,'KK#_J]O[R/P(\^W?RLOOG\)Q05CH
M                                                 $EW0[_VE&UC
M[*\L_FSS817??_2V,^\C_>0,[NS^W</]\_Q9'8;CS2;H-4M]_P"0[O+_ *J6
MXC^:+,!F-WOV_@?\Y9_O(F.S?]DXK_+W/Q)'6CCU0:+
M                                                     )V_F[_Y
M?-Q_5]U$^V73\:][3/\ 3D?\S#\69+=ROVP_S,OAB7BAH$VP
M
M
M
M
M
M
M
M           %:/YRU_(?MG^ZMEWVH-#:G97^OXO\S'\8@N_7ZI8_./\ %*>P
MW8:T
M              +Q7S=[\@:Y_K!:B?:SI\- ]IG^HX_Y:'XTS:^Y7['?YZ7P
M1)VQKTEQ3V^<M?RX[9_N49;]M[0W9V5_L_%_GH_BFM-^OUNQ^;E\)6C&U""@
M
M       !V7&Q#\AW9I_52V[_ ,T6'CROO#^W\=_G+W]Y(WIE'[)PO^7M_B1-
MK1AS(@ 42>G^_M$,D^Y3I?\ P7-'H3LX_P!,P_/7/A1J3?']M2_-P^!D* GA
M%0
M          [64>/ST*   '6X])%^7SN__K!:F?;-.'J+=?\ TY@O\M;_ !4:
M.SS]L8G\]/X6:4#/&+
M                          #*VA'\N&C7W5M._MOIQ:9A^H7_ ,S/\5EQ
M@_UNU^<C^,CM#QY*-^@ =6+G?^W&9?97D7\+S!ZZP_ZO;^\C\"//MW\K+[Y_
M"<4%8Z
M              !)=T._]I1M8^RO+/YL\V$5WW_TMC/O(_WD#.[L_MW#_?/\
M61V&X\TFZ#5+??\ D.[R_P"JEN(_FBS 9C=[]OX'_.6?[R)CLW_9.*_R]S\2
M1UHX]4&BP
M                  "=OYN_^7S<?U?=1/MET_&O>TS_ $Y'_,P_%F2W<K]L
M/\S+X8EXH:!-L
M
M
M
M
M
M
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MO_N1[A_XO^R_W@_NQOZ;G_#9^/T/K7_P']O_ +D>X?\ B_[+_>#^[&_IN?\
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MO_N1[A_XO^R_W@_NQOZ;G_#9^/T/K7_P']O_ +D>X?\ B_[+_>#^[&_IN?\
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M_<CW#_Q?]E_O!_=C?TW/^&S\?H?6O_@/[?\ W(]P_P#%_P!E_O!_=C?TW/\
MAL_'Z'UK_P" _M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_^ _M_P#<CW#_ ,7_
M &7^\']V-_3<_P"&S\?H?6O_ (#^W_W(]P_\7_9?[P?W8W]-S_AL_'Z'UK_X
M#^W_ -R/</\ Q?\ 9?[P?W8W]-S_ (;/Q^A]:_\ @/[?_<CW#_Q?]E_O!_=C
M?TW/^&S\?H?6O_@/[?\ W(]P_P#%_P!E_O!_=C?TW/\ AL_'Z'UK_P" _M_]
MR/</_%_V7^\']V-_3<_X;/Q^A]:_^ _M_P#<CW#_ ,7_ &7^\']V-_3<_P"&
MS\?H?6O_ (#^W_W(]P_\7_9?[P?W8W]-S_AL_'Z'UK_X#^W_ -R/</\ Q?\
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MCY7!3HY:N^1'.=UO:V->,Z?HZQ2IL;6KN[:^ TG_ +L;^FY_PV?C]&>^M?\
MP']O_N3%>X?^+_LO]X/[L;^FY_PV?C]#ZU_\!_;_ .Y'N'_B_P"R_P!X/[L;
M^FY_PV?C]#ZU_P# ?V_^Y'N'_B_[+_>#^[&_IN?\-GX_0^M?_ ?V_P#N1[A_
MXO\ LO\ >#^[&_IN?\-GX_0^M?\ P']O_N1[A_XO^R_W@_NQOZ;G_#9^/T/K
M7_P']O\ [D>X?^+_ ++_ '@_NQOZ;G_#9^/T/K7_ ,!_;_[D>X?^+_LO]X/[
ML;^FY_PV?C]#ZU_\!_;_ .Y'N'_B_P"R_P!X/[L;^FY_PV?C]#ZU_P# ?V_^
MY'N'_B_[+_>#^[&_IN?\-GX_0^M?_ ?V_P#N1[A_XO\ LO\ >#^[&_IN?\-G
MX_0^M?\ P']O_N1[A_XO^R_W@_NQOZ;G_#9^/T/K7_P']O\ [D>X?^+_ ++_
M '@_NQOZ;G_#9^/T/K7_ ,!_;_[D>X?^+_LO]X/[L;^FY_PV?C]#ZU_\!_;_
M .Y'N'_B_P"R_P!X/[L;^FY_PV?C]#ZU_P# ?V_^Y'N'_B_[+_>#^[&_IN?\
M-GX_0^M?_ ?V_P#N1[A_XO\ LO\ >#^[&_IN?\-GX_0^M?\ P']O_N1[A_XO
M^R_W@_NQOZ;G_#9^/T/K7_P']O\ [D>X?^+_ ++_ '@_NQOZ;G_#9^/T/K7_
M ,!_;_[D>X?^+_LO]X/[L;^FY_PV?C]#ZU_\!_;_ .Y'N'_B_P"R_P!X/[L;
M^FY_PV?C]#ZU_P# ?V_^Y'N'_B_[+_>#^[&_IN?\-GX_0^M?_ ?V_P#N1[A_
MXO\ LO\ >#^[&_IN?\-GX_0^M?\ P']O_N1[A_XO^R_W@_NQOZ;G_#9^/T/K
M7_P']O\ [D>X?^+_ ++_ '@_NQOZ;G_#9^/T/K7_ ,!_;_[D>X?^+_LO]X/[
ML;^FY_PV?C]#ZU_\!_;_ .Y'N'_B_P"R_P!X/[L;^FY_PV?C]#ZU_P# ?V_^
MY'N'_B_[+_>#^[&_IN?\-GX_0^M?_ ?V_P#N1[A_XO\ LO\ >#^[&_IN?\-G
MX_0^M?\ P']O_N1[A_XO^R_W@_NQOZ;G_#9^/T/K7_P']O\ [D>X?^+_ ++_
M '@_NQOZ;G_#9^/T/K7_ ,!_;_[D>X?^+_LO]X/[L;^FY_PV?C]#ZU_\!_;_
M .Y'N'_B_P"R_P!X/[L;^FY_PV?C]#ZU_P# ?V_^Y'N'_B_[+_>#^[&_IN?\
M-GX_0^M?_ ?V_P#N1[A_XO\ LO\ >#^[&_IN?\-GX_0^M?\ P']O_N1[A_XO
M^R_W@_NQOZ;G_#9^/T/K7_P']O\ [D>X?^+_ ++_ '@_NQOZ;G_#9^/T/K7_
M ,!_;_[D>X?^+_LO]X/[L;^FY_PV?C]#ZU_\!_;_ .Y'N'_B_P"R_P!X/[L;
M^FY_PV?C]#ZU_P# ?V_^Y'N'_B_[+_>#^[&_IN?\-GX_0^M?_ ?V_P#N1[A_
MXO\ LO\ >#^[&_IN?\-GX_0^M?\ P']O_N1[A_XO^R_W@_NQOZ;G_#9^/T/K
M7_P']O\ [D>X?^+_ ++_ 'A:S&GS88   5N-R/S>_P"4'KYK!KC\KGR1\Z^H
M.39WY+^8/P_X!\H[-^Q\%>&O/32^%.P^>Y'/]B1N<X<>;3] ;1ROM*]FY=8R
M_J6WT-J,-KIJ5V52M.B=*\57WR#X[<SKN,NXOK.STDW*G1UI5UI7;5>1&$_[
ML;^FY_PV?C]%_P#6O_@/[?\ W):>X?\ B_[+_>#^[&_IN?\ #9^/T/K7_P !
M_;_[D>X?^+_LO]X/[L;^FY_PV?C]#ZU_\!_;_P"Y'N'_ (O^R_W@_NQOZ;G_
M  V?C]#ZU_\  ?V_^Y'N'_B_[+_>#^[&_IN?\-GX_0^M?_ ?V_\ N1[A_P"+
M_LO]X/[L;^FY_P -GX_0^M?_  ']O_N1[A_XO^R_W@_NQOZ;G_#9^/T/K7_P
M']O_ +D>X?\ B_[+_>#^[&_IN?\ #9^/T/K7_P !_;_[D>X?^+_LO]X/[L;^
MFY_PV?C]#ZU_\!_;_P"Y'N'_ (O^R_W@_NQOZ;G_  V?C]#ZU_\  ?V_^Y'N
M'_B_[+_>#^[&_IN?\-GX_0^M?_ ?V_\ N1[A_P"+_LO]X/[L;^FY_P -GX_0
M^M?_  ']O_N1[A_XO^R_W@_NQOZ;G_#9^/T/K7_P']O_ +D>X?\ B_[+_>#^
M[&_IN?\ #9^/T/K7_P !_;_[D>X?^+_LO]X/[L;^FY_PV?C]#ZU_\!_;_P"Y
M'N'_ (O^R_W@_NQOZ;G_  V?C]#ZU_\  ?V_^Y'N'_B_[+_>#^[&_IN?\-GX
M_0^M?_ ?V_\ N1[A_P"+_LO]X/[L;^FY_P -GX_0^M?_  ']O_N1[A_XO^R_
MW@_NQOZ;G_#9^/T/K7_P']O_ +D>X?\ B_[+_>#^[&_IN?\ #9^/T/K7_P !
M_;_[D>X?^+_LO]X/[L;^FY_PV?C]#ZU_\!_;_P"Y'N'_ (O^R_W@_NQOZ;G_
M  V?C]#ZU_\  ?V_^Y'N'_B_[+_>#^[&_IN?\-GX_0^M?_ ?V_\ N1[A_P"+
M_LO]X/[L;^FY_P -GX_0^M?_  ']O_N1[A_XO^R_W@_NQOZ;G_#9^/T/K7_P
M']O_ +D>X?\ B_[+_>#^[&_IN?\ #9^/T/K7_P !_;_[D>X?^+_LO]X/[L;^
MFY_PV?C]#ZU_\!_;_P"Y'N'_ (O^R_W@_NQOZ;G_  V?C]#ZU_\  ?V_^Y'N
M'_B_[+_>#^[&_IN?\-GX_0^M?_ ?V_\ N1[A_P"+_LO]X/[L;^FY_P -GX_0
M^M?_  ']O_N1[A_XO^R_W@_NQOZ;G_#9^/T/K7_P']O_ +D>X?\ B_[+_>#^
M[&_IN?\ #9^/T/K7_P !_;_[D>X?^+_LO]X/[L;^FY_PV?C]#ZU_\!_;_P"Y
M'N'_ (O^R_W@_NQOZ;G_  V?C]#ZU_\  ?V_^Y'N'_B_[+_>#^[&_IN?\-GX
M_0^M?_ ?V_\ N1[A_P"+_LO]X/[L;^FY_P -GX_0^M?_  ']O_N1[A_XO^R_
MW@_NQOZ;G_#9^/T/K7_P']O_ +D>X?\ B_[+_>#^[&_IN?\ #9^/T/K7_P !
M_;_[D>X?^+_LO]X/[L;^FY_PV?C]#ZU_\!_;_P"Y'N'_ (O^R_W@_NQOZ;G_
M  V?C]#ZU_\  ?V_^Y'N'_B_[+_>#^[&_IN?\-GX_0^M?_ ?V_\ N1[A_P"+
M_LO]X/[L;^FY_P -GX_0^M?_  ']O_N1[A_XO^R_WARO _FVGD3G&&9G\L[P
MGY(Y7CN3^#?DZ]A>$/ %O#M>P>S//K+[$[+[$YOG>:=YOE<KD*X<#HXCM2Z?
M#SL=1IMPE&O35I5-5IT15L[C=%>A=ZU79DG3H]='7UA:(&I2?  58K[YM#X;
MO+FY^6KV-X7M;&S[&^3CSW8_9\QZ5S'/>?EKG>:YWD\KD)Y7#CP+Z V[;[5.
MCMQM]0KLQ2_+\2_,FOI[B;4G+K6MU_)?[P^3_=C?TW/^&S\?H[_6O_@/[?\
MW)U]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q
M^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\
M']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_
M]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;
M/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7
M^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_
M '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q
M^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\
M']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_
M]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;
M/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7
M^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_
M '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q
M^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\
M']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_
M]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;
M/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7
M^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_
M '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q
M^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\
M']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_
M]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7^\']V-_3<_X;
M/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_ '(]P_\ %_V7
M^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_P#@/[?_
M '(]P_\ %_V7^\']V-_3<_X;/Q^A]:_^ _M_]R/</_%_V7^\-F-G?0+?)-W*
M:5[AOE6>7WFSMK:T\D/,9Y*^&_"F,W>.\QX?\\.1^#>8\,\]RNPI'*YOD<"Y
M7*3BL[[1/;.57LLZGT?2I+:Z7:I22EJZ*-=5-:+_ "S=#V=CK>-ZQM]&V]GH
MZ5JFM>VZ:^(L-C6A-#%.O&F/GLT.UET9\-^3/G<TIU$TQ\I/!OAGR?\ +W$+
MC%?#?@?PA4^%O!/A;G^QNRHW/\WR.=;Y7+*\R[%]0S"QCMG;Z&]"YLUI78DI
M4K1TK2E:.G$RWQF'ZUA+N%KL]);E"M*TVHM5I55I755=\K1?W8W]-S_AL_'Z
M-J?6O_@/[?\ W)!/</\ Q?\ 9?[P?W8W]-S_ (;/Q^A]:_\ @/[?_<CW#_Q?
M]E_O!_=C?TW/^&S\?H?6O_@/[?\ W(]P_P#%_P!E_O!_=C?TW/\ AL_'Z'UK
M_P" _M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_^ _M_P#<CW#_ ,7_ &7^\']V
M-_3<_P"&S\?H?6O_ (#^W_W(]P_\7_9?[P?W8W]-S_AL_'Z'UK_X#^W_ -R/
M</\ Q?\ 9?[P?W8W]-S_ (;/Q^A]:_\ @/[?_<CW#_Q?]E_O!_=C?TW/^&S\
M?H?6O_@/[?\ W(]P_P#%_P!E_O!_=C?TW/\ AL_'Z'UK_P" _M_]R/</_%_V
M7^\']V-_3<_X;/Q^A]:_^ _M_P#<CW#_ ,7_ &7^\']V-_3<_P"&S\?H?6O_
M (#^W_W(]P_\7_9?[P?W8W]-S_AL_'Z'UK_X#^W_ -R/</\ Q?\ 9?[P?W8W
M]-S_ (;/Q^A]:_\ @/[?_<CW#_Q?]E_O!_=C?TW/^&S\?H?6O_@/[?\ W(]P
M_P#%_P!E_O!_=C?TW/\ AL_'Z'UK_P" _M_]R/</_%_V7^\']V-_3<_X;/Q^
MA]:_^ _M_P#<CW#_ ,7_ &7^\']V-_3<_P"&S\?H?6O_ (#^W_W(]P_\7_9?
M[P?W8W]-S_AL_'Z'UK_X#^W_ -R/</\ Q?\ 9?[P?W8W]-S_ (;/Q^A]:_\
M@/[?_<CW#_Q?]E_O!_=C?TW/^&S\?H?6O_@/[?\ W(]P_P#%_P!E_O!_=C?T
MW/\ AL_'Z'UK_P" _M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_^ _M_P#<CW#_
M ,7_ &7^\']V-_3<_P"&S\?H?6O_ (#^W_W(]P_\7_9?[P?W8W]-S_AL_'Z'
MUK_X#^W_ -R/</\ Q?\ 9?[P?W8W]-S_ (;/Q^A]:_\ @/[?_<CW#_Q?]E_O
M!_=C?TW/^&S\?H?6O_@/[?\ W(]P_P#%_P!E_O!_=C?TW/\ AL_'Z'UK_P"
M_M_]R/</_%_V7^\']V-_3<_X;/Q^A]:_^ _M_P#<CW#_ ,7_ &7^\']V-_3<
M_P"&S\?H?6O_ (#^W_W(]P_\7_9?[P?W8W]-S_AL_'Z'UK_X#^W_ -R/</\
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M 2P
M                                                   ()?7@XO\
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M?$\*#:'KP<7_ #=[_P"^/7?$\*#:'KP<7_-WO_OCUWQ/"@VAZ\'%_P W>_\
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MO_OCUWQ/"@VAZ\'%_P W>_\ OCUWQ/"@VAZ\'%_S=[_[X]=\3PH-H>O!Q?\
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M?$\*#:'KP<7_ #=[_P"^/7?$\*#:'KP<7_-WO_OCUWQ/"@VAZ\'%_P W>_\
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MO_OCUWQ/"@VAZ\'%_P W>_\ OCUWQ/"@VAZ\'%_S=[_[X]=\3PH-H>O!Q?\
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M?$\*#:'KP<7_ #=[_P"^/7?$\*#:'KP<7_-WO_OCUWQ/"@VAZ\'%_P W>_\
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MO_OCUWQ/"@VAZ\'%_P W>_\ OCUWQ/"@VAZ\'%_S=[_[X]=\3PH-H>O!Q?\
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M?$\*#:'KP<7_ #=[_P"^/7?$\*#:'KP<7_-WO_OCUWQ/"@VAZ\'%_P W>_\
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MO_OCUWQ/"@VAZ\'%_P W>_\ OCUWQ/"@VAZ\'%_S=[_[X]=\3PH-H>O!Q?\
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M?$\*#:'KP<7_ #=[_P"^/7?$\*#:'KP<7_-WO_OCUWQ/"@VAZ\'%_P W>_\
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MO_OCUWQ/"@VAZ\'%_P W>_\ OCUWQ/"@VAZ\'%_S=[_[X]=\3PH-H>O!Q?\
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M?$\*#:'KP<7_ #=[_P"^/7?$\*#:'KP<7_-WO_OCUWQ/"@VAZ\'%_P W>_\
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MO_OCUWQ/"@VAZ\'%_P W>_\ OCUWQ/"@VAZ\'%_S=[_[X]=\3PH-H>O!Q?\
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MI@
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                          2-
M]%'^6SIQ_J#4/[1[P#E:RVN.#N4#1R4P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                            )&^BC_+9TX_U!J']H]X!RM9;7'!W*!HY
M*8
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                          $C
M?11_ELZ<?Z@U#^T>\ Y6LMKC@[E T<E,
M
M
M
M
M
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M$^EB!DU,_/I'Y1L'RS8Y\I""(R6A)I41*G#BUIX# @'
M
M
M
M
M
M
M
M                           2-]%'^6SIQ_J#4/[1[P#E:RVN.#N4#1R4
MP
M
M
M
M
M
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MJJFR";2EM$J56\TXZE)$2'%&DOH#DZ25&8I X
M
M
M
M
M
M
M
M                   D;Z*/\MG3C_4&H?VCW@'*UEM<<'<H&CDI@
M
M
M
M
M
M
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M<KU@K:*[@Q;:I+&\SQ>94RJVR9;FP)4.1D&"WT]V,]$>0IM2GU&I!D9F9]4
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M+;C1TD:U&:E&7$^J.5J.DE232U5." <
M
M
M
M
M
M
M           $C?11_ELZ<?Z@U#^T>\ Y6LMKC@[E T<E,
M
M
M
M
M
M
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M,5 <
M
M
M
M
M
M                                            $C?11_ELZ<?Z@U#^
MT>\ Y6LMKC@[E T<E,
M
M
M
M
M
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M[4A+;ESB]S&;L:2;(:024LSVXSW8\M*2)"9;#I(Y3?)4?)T:IWC7@#@
M
M
M
M
M
M
M                                   D;Z*/\MG3C_4&H?VCW@'*UEM<
M<'<H&CDI@
M
M
M
M
M
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ML^UVTBPK/)O@_#LIU"Q6BR*04CL,U5EC;Q8S\0IO%/8/A#EE'Y_B7,\[R_\
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M7<(XQR=
M
M
M
M
M
M                                               "1OHH_P MG3C_
M %!J']H]X!RM9;7'!W*!HY*8
M
M
M
M
M
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ME&9J,^)]4<G37I>L\0
M
M
M
M
M
M                                                           D
M;Z*/\MG3C_4&H?VCW@'*UEM<<'<H&CDI@
M
M
M
M
M
M
M
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M;^YR:\E\%%V5;WUC)M;*3P4I:BY^;+6KJF9]7Z)CDZ-U=3X '
M
M
M
M
M
M
M
M      $C?11_ELZ<?Z@U#^T>\ Y6LMKC@[E T<E,
M
M
M
M
M
M
M
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MQ<-V?>9%:SKJWFNF9J-R78V3\F9(7Q4?56L_H@=6V]9\(
M
M
M
M
M
M
M
M    $C?11_ELZ<?Z@U#^T>\ Y6LMKC@[E T<E,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                  "1OHH_RV=./]0:A_:/> <K66UQ
MP=R@:.2F
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M.H=5SJI*7"3S32G.'()E!GRN3P^B*-_ NQ;=QRK3N?;*EK$J[/82H<[%@70
M&K<[_3IG_6I'^66)5#Y"[R,'/Y3[YZH['4
M
M
M
M
M
M
M
M
M
M
M
M
M                                       \:_US/^,/_).CE \@X
M
M                                          !S' _]I8?^*F?O5T6>
M/_5I=]?"7.%_++O,SZ(^94 #5N=_ITS_ *U(_P LL2J'R%WD8.?RGWSU1V.H
M
M
M
M
M
M
M
M
M
M
M
M
M
M    !XU_KF?\8?\ DG1R@>0<
M
M          YC@?\ M+#_ ,5,_>KHL\?^K2[Z^$N<+^67>9GT1\RH &K<[_3I
MG_6I'^66)5#Y"[R,'/Y3[YZH['4
M
M
M
M
M
M
M
M
M
M
M
M
M                                \:_US/\ C#_R3HY0/(.
M
M                                     <QP/_:6'_BIG[U=%GC_ -6E
MWU\)<X7\LN\S/HCYE0 -6YW^G3/^M2/\LL2J'R%WD8.?RGWSU1V.H
M
M
M
M
M
M
M
M
M
M
M
M
M                                                         !XU
M_KF?\8?^2='*!Y!P
M
M #F.!_[2P_\ %3/WJZ+/'_JTN^OA+G"_EEWF9]$?,J !JW._TZ9_UJ1_EEB5
M0^0N\C!S^4^^>J.QU
M
M
M
M
M
M
M
M
M
M
M
M
M                      /&O]<S_C#_ ,DZ.4#R#@
M
M                           ',<#_ -I8?^*F?O5T6>/_ %:7?7PESA?R
MR[S,^B/F5  U;G?Z=,_ZU(_RRQ*H?(7>1@Y_*??/5'8Z@
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 'C7^N9_QA_Y
M)T<H'D'
M                                                     .8X'_M+
M#_Q4S]ZNBSQ_ZM+OKX2YPOY9=YF?1'S*@ :MSO\ 3IG_ %J1_EEB50^0N\C!
MS^4^^>J.QU
M
M
M
M
M
M
M
M
M
M
M
M
M               /&O\ 7,_XP_\ ).CE \@X
M
M                     !S' _\ :6'_ (J9^]719X_]6EWU\)<X7\LN\S/H
MCYE0 -6YW^G3/^M2/\LL2J'R%WD8.?RGWSU1V.H
M
M
M
M
M
M
M
M
M
M
M
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MKH)UA7E#DE;H)LN<Y?M#XD74%WA[ZQ$'-*E'3X.<H7K3LRV6ZZ*D@(KE(
M                                                  /&O]<S_C#_
M ,DZ.4#R#@
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MHWCL9A)8>^E;Q;U+[F7>? ^X_ V;OB%$D
M
M
M
M
M
M
M
M
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MR@9_K)ZR?O'"15RW\@_OW\"*>,_*K[W[++,PR!:
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M?1%:W<5V"N1K1E*<'"3@]:,[#N=0        \:_US/\ C#_R3HY0/(.
M
M                                         <QP/_:6'_BIG[U=%GC_
M -6EWU\)<X7\LN\S/HCYE0 -6YW^G3/^M2/\LL2J'R%WD8.?RGWSU1V.H
M !@S<7K%&T/TLO,S-++]TXIJDQ6"_P!5N;DEDA[L(G4\4FY&@,,.RWDD:36S
M'4DC)1D,WN]E$L[S2&"TJS\J;7!!:_"VU%=UIF,S?,(Y;@98C0[FJ*XY/5R:
M6^XBN?>7EODMQ9Y!?6$FUNKF;(L;.QEKYR1,F2G%.O/.JX$DC4M742DB2DN!
M)(B(B'H>Q8LX:S'#V(J%F$4HI:DD:CNW;EZY*[=;E<DZMOA;/E"J=
M
M
M                                   /(R\['=:?8=<8?8<0\R\RM3;K
M+K:B6VZTX@TK;<;6DC2HC(R,N)#AI23C))Q:THY3:=5H:)^]G&O$C6S313.0
M22?SG"78M-DKQ\DG;6,^RXNER%:$^U2Y9LQG6WN'#E28SJB)*5)(:%WPR*.2
MYE7#JF!OIRA_-:^5#^BVFOYK2UIFT]WLT>98.EUUQ-NBEW5P2\.FO=3-N1$S
M/
M
M
M
M
M
M
M
M
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MF%NXU&XMF3X>#[1Q<PDHK:@ZKQ_;+.XR!9@    '32:N_P!IQJ?_ %[\U_\
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MJ)"E&D^%:W>M7?R<DRG.W.'RTT;+BH=  /&O]<S_ (P_\DZ.4#R#@
M
M                                      ',<#_VEA_XJ9^]719X_P#5
MI=]?"7.%_++O,SZ(^94 #5N=_ITS_K4C_++$JA\A=Y&#G\I]\]4=CJ     1
M#])?E,AW)=,\)0XI,6!1VV4R&4K+D/R+>>53#<=;)1F:HK=(^3:C21<'ED1G
MU>&VNS;"Q6&Q.-?RI3C!=Q16T^7:5>\B [Y7V[UG#?<J+ERNBY-E\I%^-FD+
M
M
M                                             -Z.CVRF12Z]IH4N
MK*)F6*WM8]'Y:2:7*JFD9#%D&A2B-;K#-6^A/)XJ)+JOU#,R@_:!A8WLBZ>G
MQ[-V,J]R7Q&O"Y+D1)MU+[MYIT7W-R$EX5\9? ^4G0&D#9@
M
M
M
M
M
M
M
M
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M*!Y!P
M                                                  #F.!_[2P_\
M5,_>KHL\?^K2[Z^$N<+^67>9GT1\RH &K<[_ $Z9_P!:D?Y98E4/D+O(P<_E
M/OGJCL=0    "$SI(_Y<L5^Y11_;?G0W1V<_L2[_ )J7]W:-<;X?M.'YB/X\
MR/H3\B@
M
M                                                   !M=L@_*AT
MQ_\ CI_-YE@BN^W^F,3_ .'_ 'MLSN[7[:L_T_[N18*&@C:H
M
M
M
M
M
M
M
M
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M/QF79V3K1+;+L.HJX[TN0M2T(;896M2DI29E&[2<KD8K6Y+X3,3=(-O51G=
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M#_D(?>+X$8N[^5E]\_A-Z15*9XU_KF?\8?\ DG1R@>0<
M
M                              YC@?\ M+#_ ,5,_>KHL\?^K2[Z^$N<
M+^67>9GT1\RH &K<[_3IG_6I'^66)5#Y"[R,'/Y3[YZH['4     A,Z2/^7+
M%?N44?VWYT-T=G/[$N_YJ7]W:-<;X?M.'YB/X\R/H3\B@
M
M
M                             !M=L@_*ATQ_^.G\WF6"*[[?Z8Q/_A_W
MMLSN[7[:L_T_[N18*&@C:H
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MKDJ4JZ+NZ6=;.9Y?B+JL6+L)W7P)UU:3*XQ1?
M  '@E2HT*.[+FR6(D5A!N/R93S<>.RV7T5NO.J0VV@O\)F1#M&,IR4()N3U)
M:6SB4HQ6U)I17"Q%E1IL=J7"DL2XKZ"<8DQ7FY$=YL_H+:>:4MMQ!_X2,R"4
M90DX334EK3T-",HR6U%IQ?"CSCJ<@
M
M
M
M
M
M
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M:$20PYUX_P \E_+ VE?U;+G^=#)!A,R_+K[Q?"S)X/\ )/[[["+7?0'?V/\
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ME \@X
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MB/.97'5(6?$WFUDAM9)490;>'?[*-WL:LONQNWL2DG-0V?B)Z4FY-?&:TT7
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M-J+3::3:3U--KC3+_.]W<9DBA<O2C.Q-T4HUT2UT:>JJJUKK1FH8EI'P
M                                                      VNV0?E
M0Z8__'3^;S+!%=]O],8G_P /^]MF=W:_;5G^G_=R+!0T$;5
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M=-/8XMG:>S3N4U=PVI@^F6$M+$_K'1QVOOJ*OAKK.;"R+D
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ME=<9;K8KHG'XT'X=:?<DDWP$HR_-\#F2IAY_UO#%Z)+P</?3:,[C!F3
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MAD(6TTZ/6237I6H_0X
M
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M$MK^&DG*XFMG7W2UN,D61XU_KF?\8?\ DG1R@>0<
M
M                          YC@?\ M+#_ ,5,_>KHL\?^K2[Z^$N<+^67
M>9GT1\RH &K<[_3IG_6I'^66)5#Y"[R,'/Y3[YZH['4     A,Z2/^7+%?N4
M4?VWYT-T=G/[$N_YJ7]W:-<;X?M.'YB/X\R/H3\B@
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M8/!*70J>U*4E2K2:22XM+JW330B\&SB$@
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M"42CXDE1<>)CO&[<C!VXRDK<M:3='WUJ9U<(.2FTG-:G32N\SWQT.P
M               'R,@_[!N_]467[S>%6Q^7A]^OA.EW\E+[U_ 01[#ORE,0
M_P!49=]K5D-Y[]?Z;O??V_QT:PW7_;%O[V?XK)\QH<VD
M         >O*B19T=V).C1YD1]/(?BRF6Y$=Y'$CY#K+R5MN)XD1\#(RZ@[1
MG*$E.#:FM36AKPG$HQDMF23B^!G]C1H\-AF+$CLQ8L=M+3$:,TVPPPT@N"&V
M66DI;;;274(DD1$$I2G)RFVY/6WI;"2BMF*2BCSCJ<@
M                      'Y6M#:%..*2AM"5+6M:B2A"$D:E*4I1D24I(N)
MF?4(ARDVZ+6-6EZB#/=WNOM=5[RRP/![)Z%I?4REQ'7H;JFG,YEQ7")=E.6V
MHC70MR&^,*/QY+B22^Z7+-"&-W;I;JVLJL1Q^.BI9G-5H_\ Y2? OY]/E/@^
M2M%7+6>?Y[/'77A<,Z8*+IH^[:X7_-XEX7IHEHJ)P1D
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M4N%O5X2<PH
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M;XN**T+OU;U-F.98G,[[O7W\5?)CP17<[O&];Y$8<&8,>
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M"2T)O[A\&GR>/BUKA)M!I<V.
M
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M14\)' BY$2LJX\6%'3P(NHA!%U!V48Q5(I)'5MR=9.K/CYSIKISJ?5HI-2L
MPG4.E;7SK=1G.*T66U:'.=8>YQ$"_@6$1*^>BM+XDCCRFTG]%)<.)0A-4FDU
MW54YC*4?DMKO'(:6BI,;KV:C':>JH:J,:SCUE+7Q*NO8-Q9N.&S"@LL1FC<6
MHS5R4EQ,^)CE1452*21PVWI>EGT76FGVG&'VVWF'FUM/,NH2XTZTXDT.-N-K
M(T.-N(,R4DR,C(^!CG7H>HX,/TFW7;[C5^]E>.:%:-X_E$EXI$C)*33'":J_
MD2"?1))]ZX@4C%BZ\4EM+G*4X:N6DE<>)<135FTG51C7O([])<:HY.G?9F05
M#H<.SC3O3_4VE/'-2<%P[4+'CD,RSH<XQBDRRE.5'42V))U=]!GP3D,+(C0O
MF^4D^J1D.LH0FJ32:[JJ=E*4=,6TSYN!:1Z4:5,2XNE^F.GFF\:>HESH^!87
MC>'L3%D9&2Y;./5M<W(41D7561F.(VX0^1%+O*@E.4OE-OOG,K:HJ;ZNE5%[
M5UUU4SD):FU=M"C6-=,;2M#J6Y4*8T]&D(2XVE1$M)D2DD?T2'9I-4>E'";3
MJM9Q;!M+]--,("JO373O!=/*Q9&2Z[!L2H,2@+)3[TDR5$H*^OCJ(Y,AQP^*
M?U[BE?149GQ&$(?(27>5#ERE+Y3;.=#L=3QK_7,_XP_\DZ.4#R#@
M
M                                     ',<#_VEA_XJ9^]719X_]6EW
MU\)<X7\LN\S/HCYE0 -6YW^G3/\ K4C_ "RQ*H?(7>1@Y_*??/5'8Z@    $
M)G21_P N6*_<HH_MOSH;H[.?V)=_S4O[NT:XWP_:</S$?QYD?0GY%
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M_CI_-YE@BN^W^F,3_P"'_>VS.[M?MJS_ $_[N18*&@C:H
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MAO@U:
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MQOXZ[F5Q55B*C'[Z=:M=Z*:_I$0WOQCM86&#@]-UUE][&E%X6T_ 0U#<)KP
M
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M5^W@8OXD8[4N^]"Y$OPB,@;+(8
M                                  &S6T/4N3IIKKALKGU-TV53F<+R
M!DU\AEV!D,AF)$D/&?%*4UEP<:2:N''D-*3Q(E&(UO;EL<RR.]&G]=:B[D._
M!-M?THUCX5Q&9R#&2P>9VY5_JYO8EWI:%R.C\!8>'GTVR !!!OSU,DYOK=.Q
MAF0:Z'3>,WC\%E*CYE5Q*:CSLCF<D_H2#EJ;B+_4Y,)/#]7CO/<7+8X+)8XJ
M2_K\2]MO^:JJ"[U*R_I,UCO1C'B<R=E/^JLK97?>F3Y='@-)A-"-@
M                        6$=FNI,G4O0;&)EE)7+N\5=E85<2'%&MU]ZC
M1'76/NK4I3CC[U!,AJ=6H^4X]RU?JC0&^&71RW/;L+:I9NI7(KBVJU7>VU*B
MX%0VON]C'C,KA*;K<A6#_HZOP6J]TVG$7,V
M
M
M                                           'C7^N9_QA_P"2='*!
MY!P
M                                                #F.!_P"TL/\
MQ4S]ZNBSQ_ZM+OKX2YPOY9=YF?1'S*@ :MSO].F?]:D?Y98E4/D+O(P<_E/O
MGJCL=0    "$SI(_Y<L5^Y11_;?G0W1V<_L2[_FI?W=HUQOA^TX?F(_CS(^A
M/R*                                             $N?1#?RJ:L?<
M_KOMCBC4O:W^RL)_F'^(R?[@?KF(_-+\8VIZ0_;%G^X"_P!,+##+G!*MG&J?
M)8<].89.G'WGG;&;4O,*@H5#E=DMH1&42SXER3,O\(B_9[O-@,@P^*MXR%^4
MKDX-='#;U*2==*IKT&<WLR3%YM<L2PTK45",D]N6SK<=6A\1K!HAT5F9SLFH
M,@U7S; G<%B3FYMC383:V.0VMVB#)7SE.].>IZVGKXLU3*4NO-/RG$M+4DD(
M<ZJ9-G?:E@[>&N8?*K%]8YQHI7(J$8U7RJ;3DVN!-15>%HPN6[CXAWX7L?<M
M/#)U<8-R<J<#;223X:5T<3./=+@A#>MFFC;:$MMMZ41D-MH224(0G+<F2E"$
MI(DI2E)<"(NH1"X[)FWDN);U];?]W H[^Z,PL):NA_VF11C:A!"27H\]PVK%
M-KWIYI?)S*_O=/<J3.QM_%+NVF6574LPL?L)51)QYF<N4FC772*]I/(C$TV[
M'(VE%^M4C7':#N]E5[(<1F<;-N&86J35R,4I2K-*2FU3:JF],JM/3QUF6Z6;
M8^WFEK RN2GA+E8[,FVE2+:V:UV:46A:&M'%22SI"\^P?2?'=,=2[G%(^9ZB
M8[>W\72>HNR6]B%9?64*L?L,OR* VVA=J[C3-8RJ#'Y]M)R7R69&:"<:UOV?
M8#&YKB,3EMFZ[.77(0=^4?RCBG)*W!_<[>T]IT>A4X:.9;UXO#8"Q9QERVKF
M+A-]$G\E2:59R7#LTT*NM^%0L2][NZN9DA90O6O,&)R9:9:($1^)%QM"D*-2
M&#Q9B(C'G8A$? VW(RTK+]=RCZHW-#<K=:&&ZJL%9<*4JTW/O[;>W7NI]XUS
M+>;/97NFZS-2K6BIL^;39IWT6(MO^H53NIVVX[DF9T5=+9SBAM\;SK'E-N'5
MR9\"7-QZ];:;49.,PK-44Y+"4N*7';?0DG#6CE#SWG^7W=UMX[F&P<Y*5BY&
M=J?W232G'PQKLO1IH]%'0VSE6+MYWD\+^(BFKL'&<>!M-QEX'2JXD]=2"W5'
M=9::7/76B.U1<C2C2S%[B=72,AKT%YP]0[F"XB%8Y3D62S&56<(Y<J(HXS44
MHBFXW)0I*$<EAK>.6;JVLTC#.MZ:8K-+L$U!_DK47I4(07Q71/2Y;57ITOXS
MUGCL]G@92RS(OZC!6Y-.2^7<DM#E*3TJK6BE'3B6A9[V![S]6[/6FBTJU1S2
MWS?&<]\(P*V9DLDK&UHLC8KY-C7.Q[9]*K%Z'9+@G$..MQ;:7'T+02>"N5@=
M_=S<IMY+<S7++,+&)L4;4%2,H52=8K155VJI5HFF93=7>/'W<QC@<=<E=LW:
MI.6EQDDVM.NCI2G&T<\Z7?3RI83I/JE"A-1[B;)NL*OIK3;2%6,=B-'M\>*4
MM/)<<>@DB<E"CY7[&X2>)$E)'8=DF87I=;RN<F[,5&Y%<3;<9T[C^+X>^76_
MV$MJ-C'15+C;@WQJE8U[WQN4APQC+\LPFS*[PW)\@Q*X)KF"M<:N;&CL>8-]
MB2;!S:R3%DFP<B,VX:#5R36VD^'%)<-PXG"87&VNAQEJW=LUKLSBI*M&JTDF
MJT;7A9KRQB,1AI])AISMW*4K%N+IKUJG$BTCL@U2RG6#;9@689K,79Y02KVB
MM;=PFTO6ZJ"\GUL.PDI:;;3V8]7,LD^KJFZ\E3A]5? O,&^^5X7*-Y+^$P2V
M<-\648\$=J*;2[E:TXE1<!NW=O&W\PR>UB<2ZW_C)OCV9-)]^B5>[I(8M2=Y
M=SB>=MZ=:)IL]+=$\-SV0[<1\7>;KLZU%D1[\W,GR+)<F0VF>4V]YMXF6&UM
MM,LJ;;<)9-H2WN3+MSK.*P/M'.MG%9U>L+9<U6U:3C\2$(:J1T5;JVZM4JZZ
M]QN\=RQC.J9=6QEMN[\91T3N?&^-*4M=9::)4T:^"F_V\;>/MXS/;!FE!AN>
MUF6Y#J!6UE338]7M22M83KEE76,B9>0Y4=IRF:K(T5:CYXDJ6^24(XF?*3 M
MS]S]X<%O/9Q&,L2M8?#RE*4W39?Q6DHM/XVTWP<%6R4[P;PY3?R6[;P]V-R[
M=BE&*UJK3JUP47'PZ##71&X)@L]&J.H,QB#8Z@45A34%84EMMZ3CF/V4*3*=
ML:]*^/8[U_+8<86\1<X3<,T)427'"7F.UK'8ZV\+E\'*. N1E.5-4YQ:5'QJ
M*:=-595UI4QVX6&PTHW\6Z/%QDHKCC%JM5]\ZJO\WOFGO213VIF[//FHN0/W
M<2)!Q1DH:[)VPB8[-3B]0W94T)"W76H!%+:-]YAO@2'WUD9$KB12_LYMN&ZF
M'<K:A-RFZ[-'-;<J2?'HT)O6DB/[XR4L]N)3<HJ,=%:J+V55+BXVN-FX_1+:
MNY793=0-&;>PEV>-4]%'S3&&ICRGRQYU-G%J+BN@*<-3C5?9JL8[Q,),F6GF
M7%I22GG#5#^UC*,);MX?.;45'$SN.W.FC;^*Y1;[L:-5UM-)Z$J2'</'W[CN
MY?<;E9C%3C7[G31I=QZ'34G7C9J5TEFF]+IWN=M'Z&+&@PM0<5I=0GX$-'-,
M1K2RGW5%<.$T2$)0[9V>..S7.!J(W9*CXEQY)2OLVS*]F.[,8WVY3P]V5JKU
MN*491Y(S45W$8#?+!VL)G3=I)1NVU<:7&W*+Y7&K[K-5]#]);W7'5/#],<?,
MV962V:6IM@;2G6J:EBMKF7=R^DN!*175C#KB4FI/.N$ELC)2R$ISO-K&297>
MS/$:86HZ%Y4GHC%=^32[BJ^ P>68"[F>.MX*UH<WI?%%:6_ N5T7"3E[NL]H
M]C6W#%=+M"H:,4O\UDSJ.DMVB9<MXT&MBQ7LPS"5/427IV4R5V$5E$@T?L"I
M7+;YHF64%I#=+ 7]^-X[N:9Z^EP]E*4HZ=EMM]';2X(*DG2NG9HZ[4F;-S_%
MV]V<GA@\L2A=N-QB^%)+X\^[+2E7@;KP)$!.-':Y#G&/I7=6#%S=Y14,JR!4
M]Q-HQ.L+2.SX4\)/R&W4S&77><YY;J3)1<HU%]$;ZQ/18?!7*0B[,+4OB4^*
MTHOXM$M7!2AJRQTE[%PK*2NSN+XU=-6UIKQ\-:EG[>]IWC&;;7-46+]J(M_#
M,1L,QQRVLE<[-KKS%HBK"*J+.=);Y3;EJ,J"L^/%\I1I5^NXCS)N3F.)P6]&
M%E8;V;UY6YQCJ<9NCJM5(UVNYLU-T[R82SB<DOJZE6W;<XMZU**JJ/C=*=VM
M"K;CW_;]'_KBL_?K ]/XC\A/[Q_ S2>'_+P^_7PHLZ=(O^1MK%_ZOOYT\''F
M?L[_ -8X/_Q?[BX;FWN_T]B/_#_O8%8['LFR3$;1B\Q/(+S&+J+Q*-<8];3Z
M6TCD9I4?,6%;(C2VN*D$?M5EU2+_  #TQB,-AL7:=C%VX7;+UQG%2B^^FFC3
M%F_>P\^EP\Y0N+ABW%\JHRQ[T;6M>>ZR:*WQZB7,K);K#,R?Q^'D5B[SUK85
M#]/5V<5JU?-!.39L*1*>3V2XI3KK1H)?%2#4OSIVCY+@,GSJW[/@K5F]94W!
M:(J2E*+V5P)I+0M"=::Z+;^Y^98K,<MD\7)SNV[CBI/6U1-5XVJO3PJE>,A
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M!Y8JSH)6-9'=SKB#6(9I+.QKYE"5DY,53.PY\-"E(C\VV\TI:%%Q42DP#?\
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M_P =/YO,L$5WV_TQB?\ P_[VV9W=K]M6?Z?]W(L%#01M4
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M ,=/YO,L&W-]O],8G_P_[VV0'=K]M6?Z?]W(L%#01M4
M                (KNDXE2$0=&823/L21+SV4^7MN3V1$9P]J*9F1\CB3<U
M[AQ+C]'A^KQVCV:1BYXR;^6E:2[SZ2OP(A&^;>SAX_<MS\6Q3X61,#:Q!
M
M       "P=LE=<>VP:8+=6:U$WE[1*5]$FV,]REAE'_L-LMI27_(0T#OHE'>
M;%):OZOQVH,VMNVV\EL5_G_CR-JA%C.$*/22ONJUKQ",I9FPSI;4OMM]3DH=
MD99F3;RRZG'BXB*V1_\ VI#<_9S%>Q;TONGBI+DMVZ?"S7.^#?M*VN#H%^-/
MF(]1L B8
M                 !9HT1DO3=%](9DE9N2)>E^ 27W#ZAN//XI4NNK,BZG%
M2UF8\UYU&,,YQ<(Z(K%74N\IR-RY;)RR[#REK=B#_!1E 8PO2OCO9DR9.YO4
MSLE"VS8<Q:,PTI1J)$9K"\<YE:./#DHDI5SW#]0W#&_MRXQCNUAMG37;;[_2
M3^#5X#5.\CD\YO;7!L\FQ'_XFJHE)@P
M                                       ]ZKDRH5E73(*5JFQ)T23#
M2USG.*E,2&W8Z6^9,G>6;J"X<DR5Q^AU1TNQC.U*$_D.+3[S6D[0E*,U*/RD
MTUWRU4/+9O  "LCK-)?F:P:JRI)FJ1(U'S=UXS(RX+7DUF:DDD_UJ4F? B_4
M(N ]*Y-&,,HPL8_)6&M_B1-,YC)RS"_*6MWI_C,QJ,D68
M                $P?1GR9*L,U0AK0LH;&3T<EAPU&;:I,JJD-2T)1PX)6A
MJ&R:C_5)1?X!J+M)C%8S"S7RW:DGWE)4^%FP-S7+J]^/W*G'E:T_ B34:U)D
M
M
M
M        'C7^N9_QA_Y)T<H'D'
M
M            .8X'_M+#_P 5,_>KHL\?^K2[Z^$N<+^67>9GT1\RH &K<[_3
MIG_6I'^66)5#Y"[R,'/Y3[YZH['4     A,Z2/\ ERQ7[E%']M^=#='9S^Q+
MO^:E_=VC7&^'[3A^8C^/,CZ$_(H
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ME52-73CDEM/PMF#,>_[?H_\ 7%9^_6!G,1^0G]X_@9C</^7A]^OA19TZ1?\
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M7IR6R]I4=*:='#701C>?,L+FF9+%8.KM='%:51U3?V&C3P2\CH
M                               &UVR#\J'3'_XZ?S>98(KOM_IC$_\
MA_WMLSN[7[:L_P!/^[D6"AH(VJ                            &A6BFO
MF26VZ/6K2#,+]V?6(M[OS?1)$>"TBM/&K&6<VHBNQH[$E]4JH?-[]F-W@B"H
MR4DS/E3O.LAPUK=C!9OA+:C<V(]*TWIVTJ2=6TJ25-%-,N2+Y;FEZYG>)R_$
M3K#:?1K1HV6ZI4XUITU^2;ZB"$H/$\RS(9=CR&FWV'VULOL/(2ZR\RZDT.M.
MM+)2'&W$*,E),C(R/@8Y3<6I1;4D]#.&DU1Z4ROGO%TGIM(=:[.FQN,W QS(
MJBOR^EK&3,VJN/9R)\"9!9)2UFB,U;U,DV4=0FV5(01<$D9[^W0S6]F^2QO8
MEN6(MS=N4O*:2:??V9*O&ZLU3O!@;> S*5NRJ69Q4TN*M4URIT[A)*Q%L;CH
M^^803C\I&B3KR4K)9K.%415RB2@B2:E$W6PN#9<.J1%^IU1KF4[=G?[:U0Z[
M3PR=/QGI)@HSN;J4URZMXEI^!&A.P&XC5>XJJB2%I0O(,7R>GB\KJ<J2B(U=
MD@CY1$2E,TR^'T>/T.'$Q.]_;,KN[TIQU6[L)/O5V?\ :(ONK<4,WC%_=PDE
MR5^P3Q#19L\   *^NZ3\K+.OLNQG^!\>&_=U_P#2EC\U/\:9JK._V[=_.1^"
M)8*&@C:IJCO?_)>U._\ B7_.'B8E6Y/^I\-_XG]U<,'O+^Q;W]#^\B:==&5_
MV]J[_JC$/WY?B7]I7Y#"??W/@@1[<S\KB/O8?#(ES&IB>D!F_'\I3+_]48C]
MK5:-\;B_Z;L_?W/QV:MWH_;%S[V'XJ)RL'_V*P_[%\?_ ()B#2.._7;WYV?X
MS-EX;]6M_>1^!'OY'D-/B5#;Y-D$YFNI:*OE6=G-?426V(D1I3KBBXF1K<42
M>2A!<5.+,DI(U&1"GA\/>Q=^&&P\7*].2BDN%O\ EIXEI.]Z[;L6I7KKI;BF
MV^XB O(K?.=YNX)EBO0]';NIG@ZBB23YR)AV$5SCCRY$PVC-'&+&6Y)DFD_V
M>8Z:$?KVTEOC#VL#N=D#E<HW!5DUKN7'HHN^Z)<455ZFS5MZYB=XLU2AH4G2
M*X(07'\+XV]' 3O8#@V/Z;8?081B\7L6EQ^ W"C)49*?D.<5.RY\MPB23LVP
MEN+>>5P(E.+/@1%P(M&8_'8C,<9<QN)=;UR57Q+B2[B5$NXC9V%PUK!X>.&L
M*EN"HOLM]UO2SX5O>8[J/B^IV*8M=1;:TKJ[),-NX\!PS?J+V55SH)U\A2VR
M0W,:=4?4]L1&0N+-C$9=BL-BL5!PM2E"Y%O5**DG5=PIW+MG&6;UBQ)2FE*#
MIP2::IWR![:;-:JMQ^E#TOBV2LF57<%\4&F3:5MA51T&7),R4<J8DN!E]'J=
M3Z(WGO7!W=W<5&/JZ^",E)^)&L,BDH9O8<O+IRIKX66+AYY-MG\,R(C,S(B(
MC,S,^!$1=4S,SZA$1 "MI@L)6=[A\9CU27'&LDU;@2F5)X<MNNE94B<_*49$
MLB3%K^6ZHR)7!*#ZA_0'HW'3ZCN_=E=HG;PC7A4*)>%Z#3^&CUK-H*&J=]<C
ME6O@6DLF#SD;@*^N"?EI57]8"=]NDP;]QO\ HR7_ +>O[M&JL-_J./\ FW^.
MRP4-!&U3AFHTV/6Z>YY8S'"9B0,,RB;*=49$EJ/%I)S[[BC49$1(:09GQ,BZ
M@O,NA*YF%BW#3.5Z"7?<DD6^,DH82[.7R5;DWX(L@3V=U$RXW(:8M0VU+[!M
M9]O*623-#$.KI;*6^XZKB1(2KFR;29_16M)%Q,R(][;WWH6=W<2YOY4%%=UR
MDDN?O(U=N_;E<SBRH\$FWWDFRP1D'_8-W_JBR_>;PT%8_+P^_7PFUKOY*7WK
M^ @CV'?E*8A_JC+OM:LAO/?K_3=[[^W^.C6&Z_[8M_>S_%9/F-#FTB*/I.__
M ,2'_K*__  ;4[,__MO_ (/_ -4@V^G_ -F_\3_8-E]AWY->(?ZWR[[9;(1K
M?G_4E[[RW^)$S.['['M_?3_&9N*(@2 KQ[;_ ,JG /L_G?\ M68]!;Q?Z7Q'
M^77V#4V4?MRU^=?V2PX//IMD^%E$&19XSD5;$22I5A16\&,E1\E*I$NOD,,I
M4K@?)(W'"XG^H*^%G&UB;=V?R8SBWWDTRE?BYV9PC\IQ:7A17NVHR:ZNW%Z8
M(O8<21#E7TRA?A6D5N3'7*OJ:TH(C+T61P0;R;"P;Y!*(^2Z23X&9<#W_O5&
MY<W>Q+L-J:MJ2<71TC*,G1KN)^ U3D;A#-[/2I.+FXT:X9)Q6COOE+ OD/A7
M\3\7^#]3WH-!]>QOKKOGRYS:G5L-ZN'FKF'D/A7\3\7^#]3WH'7L;ZZ[Y\N<
M=6PWJX>:N8^K6TE+3$\5/45=44@VSD%6P(D$GS:Y9-&\45IKG3;YQ7)Y7'AR
MCX?1%*Y?O7J=-.4Z:JMNG*5(6K=O\G&,:\22^ TEZ1'^0&)]T#'/X.OQ-.SW
M]O/_ "\_AB1O>W]E+\['X)&/^C0_V"U*^R^L_@9(R':3^O8;\S+\8M=S?U6]
M^<7P$EPUL3$KF;K_ ,HO5G[*'/WC"'H?=7_3V$_-?99J//?VO?\ O_L(L9CS
MP;<-$>D1_D!B?= QS^#K\3GL]_;S_P O/X8D8WM_92_.Q^"1C_HT/]@M2OLO
MK/X&2,AVD_KV&_,R_&+7<W]5O?G%\!NAKEJ]3:(:=6V=V\=4]R.XQ74M2VZE
MARXO9Q.=@P"?4E9,M<EEQYY?)4I$=I:DI4HB2<-R3*+V=YA# V7LIU<I:]F*
MUNG(DN%M:M9(LSQ]O+<)+%7%5K0EQR>I?9?<3(Q]+Y.NF]_,+MG+<_M\2TPH
M41W,AK<24Y4UBDSU/%!H*Z$EQ2+.?)1'=6J18*F%&;2:C)7*;;5LK,XY'N3A
M(/"8>%W,[E=AW/C2T4K-O[E*JT0V:OO-J&8*69[RXB2OW96\%'Y2CH6G5%+A
M>O3*M.1$D.*:#Z3:28_8.8-A=15VD2IG+;R-]GPCDQO(ANGSY7\[G[)A2EER
MN0RXVTE7ZU*>H0UUB\]S7-K\5CKTY6G-?$3I#7JV51/PIOC9+[&5X# 6F\-;
MC&:B_C:Y:O*>GDT$-6R#\J'3'_XZ?S>98-P[[?Z8Q/\ X?\ >VS7N[7[:L_T
M_P"[D6"AH(VJ                                 $?W2*81*R'1ZFRV
M$RIYW!,G9D6')ZO,T>0,^"I3_ N*E&BV* 1\.H2%*4?4(3WL]QL</F\\)-T5
M^TTOOH?&2\W:(KO;AG=R^-^*TVIZ?O9:'X]DA(&ZC6X
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M%,-ID&
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MMPSM9BL13XEV"T]V.A^+9Y3083PBP
M                                     9@T!PB1J)K)IWBC+"GV)N3U
MLNU(D\HFZ.H>*VNW5GP-*235PG23RNH:S(OU1B,^QL<OR?$8J3I)6FH_?26S
M'\)HR&589XO,;-A*J<TW]ZM,O$F66!YO-Q  5XMX>$R,(W"Z@L.-*1$R:S\M
MJQXRX)E1\HY5A-=;^A[5F[5+8/\ ]\R8]!;H8V.-W?P\D_CVH]'+N.&A?@[+
M\)J?>##/#9M=3^3-[:[NUI?X55X#6024PH
M     $Z?1^81)Q;0OP[.8-F5GF26.01N6DDNG31&8U)6\LN'+Y#KU=(?;X]0
MVWR4745Q/1^_V-CBL\Z"#K&Q;4']\ZR?PI/NHV;NKAG8RSI9*DKLW+P*B7P-
M^$WE$()*
M
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M#_R3HY0/(.
M                                                        <QP/
M_:6'_BIG[U=%GC_U:7?7PESA?RR[S,^B/F5  U;G?Z=,_P"M2/\ ++$JA\A=
MY&#G\I]\]4=CJ     0F=)'_ "Y8K]RBC^V_.ANCLY_8EW_-2_N[1KC?#]IP
M_,1_'F1]"?D4                                             )<^
MB&_E4U8^Y_7?;'%&I>UO]E83_,/\1D_W _7,1^:7XQ][I@?]K=$/L=S3^$Z
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M_2>-_-K\>)EMUOV_AOOG^)(DIZ7[_871C[+<H_@>N&M^R+]>QOYJ'XS)EO\
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MW'"6SP2CH:?V'J:TIM:2[Q>!Q>!E&.+MRMRG%25>%/\ EI6M/0TF<"%^6@
M                                       &UVR#\J'3'_XZ?S>98(KO
MM_IC$_\ A_WMLSN[7[:L_P!/^[D6"AH(VJ
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M!'N5:^49'=RQ@<OPO3WKMI8NZM/QX_%CP1UZ^%]VBX#:[-MP>D6%8M=9+(U
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M<59HKJT3CPQEQ=YZXOA7=32U%FF6WLLQ3L7*NV],9>4N=<*X'W*&%1FC'
M
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MO"GPQDN"2X5X5549J'%X2_@<1+#8A4N1?@:X&N-/@YSA O2V
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M:N6+DK-Z+C=BZ-/@/CBL4P
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MNMJ-#C3K:R2MMQM:3)23(C(RX&-Z)J24HM.+6AFL&FG1Z&CQCDX
M                   #/^W707(=><YB4D)F3$Q6M>CR\RR-+?\ F]35\I2^
MQ675ES;EQ:$TIJ*T7*5RC-Q2>:;<46 WAS[#Y%@7>FT\5)-6X<,I<;_FQUR?
M@UM&5RC*[N:8I6HU5A.LY<2XN^]27AU)EBBHJ:ZAJ:RCJ(K4&JIJ^'5UL)@N
M2S$@0([<6)&:+JF2&6&DI+]7@0\]W;MR_=E?O-RNSDY2;X6W5OPLVU;MPM6X
MVK:I;BDDN)+0CZ(IG<
M
M                             #^&1*(TJ(E)41DI)D1D9&7 R,CZAD9
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M' 6;?5U-I.3K\-"TQ5R?2N*;450LG"_+0
M                /&O]<S_C#_R3HY0/(.
M
M                    <QP/_:6'_BIG[U=%GC_U:7?7PESA?RR[S,^B/F5
M U;G?Z=,_P"M2/\ ++$JA\A=Y&#G\I]\]4=CJ     0F=)'_ "Y8K]RBC^V_
M.ANCLY_8EW_-2_N[1KC?#]IP_,1_'F1]"?D4
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M_P#'3^;S+!%=]O\ 3&)_\/\ O;9G=VOVU9_I_P!W(L%#01M4
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MZA.L.-N$1F1*X&8N\'CL9E]Y8C!7)6[RX4_$UJ:[C310Q&%P^+M]#B81G;?
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M?G%Y7\?/;G%46A)):Z))+QU?=,A@LOPF7VW:PD=F+=7I;;?=J9-&-+P
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MI^/-<3:U)\,8]YR:T$PRK=K#8&2OXEJ[B5I6CXL7W%PONOOI)F]0@Y)@
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M;>MONLYJ+(N0
M
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M4        /&O]<S_ (P_\DZ.4#R#@
M
M              ',<#_VEA_XJ9^]719X_P#5I=]?"7.%_++O,SZ(^94 #5N=
M_ITS_K4C_++$JA\A=Y&#G\I]\]4=CJ     0F=)'_+EBOW**/[;\Z&Z.SG]B
M7?\ -2_N[1KC?#]IP_,1_'F1]"?D4
M
M
M              -KMD'Y4.F/_P =/YO,L$5WV_TQB?\ P_[VV9W=K]M6?Z?]
MW(L%#01M4
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M>ONT9M#!YOE^/DH8:XG=I79::?C7P&<!A#)
M
M
M
M
M
M
M
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M0L;B2Q4DM72/X2YCIL)O7L?8.VJ$D,,        'C7^N9_QA_P"2='*!Y!P
M
M                                            #F.!_P"TL/\ Q4S]
MZNBSQ_ZM+OKX2YPOY9=YF?1'S*@ :MSO].F?]:D?Y98E4/D+O(P<_E/OGJCL
M=0    "$SI(_Y<L5^Y11_;?G0W1V<_L2[_FI?W=HUQOA^TX?F(_CS(^A/R*
M
M
M                                            &UVR#\J'3'_XZ?S>
M98(KOM_IC$_^'_>VS.[M?MJS_3_NY%@H:"-J@
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M:MVXSXU%)\J1RT6A7
M
M
M
M
M
M
M
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M?\8?^2='*!Y!P
M                                                          #F
M.!_[2P_\5,_>KHL\?^K2[Z^$N<+^67>9GT1\RH &K<[_ $Z9_P!:D?Y98E4/
MD+O(P<_E/OGJCL=0    "$SI(_Y<L5^Y11_;?G0W1V<_L2[_ )J7]W:-<;X?
MM.'YB/X\R/H3\B@
M
M                                                           !
MM=L@_*ATQ_\ CI_-YE@BN^W^F,3_ .'_ 'MLSN[7[:L_T_[N18*&@C:H
M
M
M
M
M
M
M
M
M
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M#R#@
M                                                 ',<#_VEA_XJ
M9^]719X_]6EWU\)<X7\LN\S/HCYE0 -6YW^G3/\ K4C_ "RQ*H?(7>1@Y_*?
M?/5'8Z@    $,/24U3[.JV"7:DK*-8:>MU32S+]C4_3Y)>RY"4*^B:T-WK1J
M+]0E)_PC<?9Q=B\JOV/NHXC:\$H12_%9KO?&#6.M7.!VJ<DI/_:1'*-B$1
M
M
M                                           -P]B%4_8;E<.EM)6I
MNBJLOM9)H+BE##V,6E(E3I_\U!R;AM/'_P!T9%^J(AOU=C;W;O0>NY.W%=_;
MC+X(LD&[$'/.;<EJC&;?FM?9)]1H<VD
M
M
M
M
M
M
M
M
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M2T"Y*(      'C7^N9_QA_Y)T<H'D'
M
M                .8X'_M+#_P 5,_>KHL\?^K2[Z^$N<+^67>9GT1\RH &K
M<[_3IG_6I'^66)5#Y"[R,'/Y3[YZH['4     T>WY:1S-1M)&LFI8JY=_II+
MEWR&&D<M^1C4R.VUD[+">!*-R.W$C3#X'U6X:TD2E&GA-MQ<VAEV;/#7G3#X
ME*->!33^(WWZN/?DN"I&MZ,!+%X#IK:K=LMR_HOY7P)^ @H&\360
M
M
M                                    !,!T<VD<REHLEU?N(JX[N5-%
MC6*<ZCD..4,*8F3=V">)&I46QMXC#3?ZWJP5GP-*D&-1]H>;0O7[>46756GM
MS^^:I%=]1;;^^7=)_NC@)6[4\PN*CG\6/WJ>E]YM)?T23@:T)F
M
M
M
M
M
M
M
M
M
M                                              !U+V=?_7%>8_\
MYZG(?_'-+$;N?K4OSC^$S$/R"^\^P=M")(8<        /&O]<S_C#_R3HY0/
M(.
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M!IQ:JFM*:[A#6G%N,DU)'A')P
M
M
M    B,S(B(S,SX$1=4S,_H$1?JF8 WTVV[)LOU)GP,IU*@V&'Z?L.LRDP)K+
ML+(\L0E27$Q84-XFY%74OH_Z28ZE*EH411TKY1NM03>/?3"9="6%RV4;V/::
MJG6%ONMZI27!%:G\IJE'*,GW;Q&,FK^,3MX1::/1*7<2UI=U^#C4V];6P*>O
M@U-5#C5U960XU?70(;*(\2%!ALHCQ8D9ALDMLL1V&TH0E)$24D1$-+7+ER]<
ME=NMRNR;;;TMMZ6V^%MFR(0A;@K=M)0BJ)+4DM21[HZ'8
M
M
M
M
M
M
M
M
M
M                                         #2J3T;^P*9JD_K?*V:;
M:Y&L,K/G=59.ISVCV$.9R_J4_D2LN>SQW)E4YVR\L=RA1V"IQN]D',/G>5R^
MJ*#PUARVW%;5:^$JJ]=2V5)TH;JBN4@        \:_US/^,/_).CE \@X
M
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MR["-2P]F$9KAI5\KJ_&9B&(,@
M
M
M
M
M
M
M
M
M
M                                    !XU_KF?\8?\ DG1R@>0<
M
M                                          YC@?\ M+#_ ,5,_>KH
ML\?^K2[Z^$N<+^67>9GT1\RH &K<[_3IG_6I'^66)5#Y"[R,'/Y3[YZH['4
M
M
M
M
M
M
M
M
M
M
M
M
M
M    \:_US/\ C#_R3HY0/(.
M
M         <QP/_:6'_BIG[U=%GC_ -6EWU\)<X7\LN\S/HCYE0 -6YW^G3/^
MM2/\LL2J'R%WD8.?RGWSU1V.H
M
M
M
M
M
M
M
M
M
M
M
M
M                             !XU_KF?\8?^2='*!Y!P
M
M                                 #F.!_[2P_\ %3/WJZ+/'_JTN^OA
M+G"_EEWF9]$?,J !JW._TZ9_UJ1_EEB50^0N\C!S^4^^>J.QU
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      /&O]<S
M_C#_ ,DZ.4#R#@
M                                                           '
M,<#_ -I8?^*F?O5T6>/_ %:7?7PESA?RR[S,^B/F5  U;G?Z=,_ZU(_RRQ*H
M?(7>1@Y_*??/5'8Z@
M
M
M
M
M
M
M
M
M
M
M
M
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MI">21-G^J*^'QEO$3<(IITKI[Z*5W#RM14FTU4XJ+LMP
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M!3VL2XK5&/V45I!9%P=WUHA_(MI!]R_ /M3J1*;?Y./WJ^ PD_EOOLR@.YT
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M+F83#?AXXAWBX9Q:9DN<<))+/'8FUT5BTN%[3?AV2\LSV[LWP*BY*D(&RO\
M+(VE_P!9G0?^=/%1:0^6N^BO+Y+[QW6(E1@@                       Y
MC@?^TL/_ !4S]ZNBSQ_ZM+OKX2YPOY9=YF?1'S*@
M
M
M
M
M
M
M
M
M
M
M
M
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MGLK_ "R-I?\ 69T'_G3Q48N'RUWT7TODOO'=8B5&"
M    #F.!_P"TL/\ Q4S]ZNBSQ_ZM+OKX2YPOY9=YF?1'S*@
M
M
M
M
M
M
M
M
M
M
M
M
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MI]AM'4-9=3CQZHO<#AK]FZY7(TCLTUKC7$RVQ-ZW<MJ,'5U[O$S%XRA8@
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MN!^Z\'V2GGLK_+(VE_UF=!_YT\5&+A\M=]%]+Y+[QW6(E1@@
M           YC@?^TL/_ !4S]ZNBSQ_ZM+OKX2YPOY9=YF?1'S*@ :MSO].F
M?]:D?Y98E4/D+O(P<_E/OGJCL=0
M
M
M
M
M
M
M
M
M
M
M
M
M                               #QK_7,_XP_P#).CE \@X
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MK'=W6XBXW;;H-?-S-[01,4LM<M5<RU(7BL&<JTBXQ%R:YE3ZW'&K94*M7;^
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M9<TE1\I2N3G;./A=DK;BU-\AC+N%E!.2:<5RED47Y:
M    <QP/_:6'_BIG[U=%GC_U:7?7PESA?RR[S,^B/F5  U;G?Z=,_P"M2/\
M++$JA\A=Y&#G\I]\]4=CJ
M
M
M
M
M
M
M
M
M
M
M
M
M                          >-?ZYG_&'_ ))T<H'D'
M                        #J7OG$O]LQO=^RK2W^8/2D1O%_K,_OC,6/R,
M>\2T_,VORP-VO]6RF_G0QL7.6_EW]X_A12QGY)???89V' S9C
M                                                   .8X'_ +2P
M_P#%3/WJZ+/'_JTN^OA+G"_EEWF9]$?,J !JW._TZ9_UJ1_EEB50^0N\C!S^
M4^^>J.QU
M
M
M
M
M
M
M
M
M
M
M
M
M             /&O]<S_ (P_\DZ.4#R#@
M           !4.Z1[YKWE6_7>KKINWK]YF/Z8P]8[;%+-C!9FAEEEDF@+&M/
ML2PA3+N0L:JX\U9',7C!R244-CD$\2."N3RU8N]E\[MV5Q2239?6\7&$%!IZ
M$;>="WT#F0=$OK+J]JM;[F*;7)C5'3*%IZU25NE,W3YVE=B9569)X4<GRL_S
M!$]MQ%>;/,DTR9&HE<L^' 5,)@Y8>XYR::<:>-<QTOXB-V"BDUIJ6-1D"T
M
MYC@?^TL/_%3/WJZ+/'_JTN^OA+G"_EEWF9]$?,J !JW._P!.F?\ 6I'^66)5
M#Y"[R,'/Y3[YZH['4
M
M
M
M
M
M
M
M
M
M
M
M
M                      \:_P!<S_C#_P DZ.4#R#@
M
M                            ',<#_P!I8?\ BIG[U=%GC_U:7?7PESA?
MRR[S,^B/F5  U;G?Z=,_ZU(_RRQ*H?(7>1@Y_*??/5'8Z@
M
M
M
M
M
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M[;4+M&XT=4Z:UW'P]W3JX=[1!B3@
M
M
M
M
M                                       >-?ZYG_&'_DG1R@>0<
M
M                                           YC@?^TL/_ !4S]ZNB
MSQ_ZM+OKX2YPOY9=YF?1'S*@ :MSO].F?]:D?Y98E4/D+O(P<_E/OGJCL=0
M
M
M
M
M
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M/%]=SS%8A.L7=<5WH?$7BBB;9/8ZMEEBUP]&F^_+XS\;,W#"F2
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MHU&BHE76^Z^#N=W@WJ$'),
M
M
M
M
M                                 !XU_KF?\8?^2='*!Y!P
M
M                                     #F.!_[2P_\ %3/WJZ+/'_JT
MN^OA+G"_EEWF9]$?,J !JW._TZ9_UJ1_EEB50^0N\C!S^4^^>J.QU
M
M
M
M
M
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M-/AIJ? W1TR^5YQA<U@W9K&['7%Z^^J:&OY-+0;!C &5
M
M
M
M
M                                         \:_US/^,/\ R3HY0/(.
M
M                                              <QP/\ VEA_XJ9^
M]719X_\ 5I=]?"7.%_++O,SZ(^94 #5N=_ITS_K4C_++$JA\A=Y&#G\I]\]4
M=CJ
M
M
M
M
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M\)JCT:V(E.SO4'-GF24WCF-0*&*XM)\$S,FL%2G%L&9<#=:AX\M"C(^*4/\
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MP:1-E@
M
M
M
M
M  >-?ZYG_&'_ ))T<H'D'
M
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M;C7Y,EIC+[V7#W5H:X4B98',<)F-KI,+*M-:>B2[Z^SJ? S*@Q9?
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M>2PMQEYM7ZBDJ,C%&<)VYNW<3C-.C35&N^F5(RC.*E!IQ>IK2CVAU.0
M             _*UH;0MQQ:6VVTJ6M:U$E"$)(U*6M2C)*4I27$S/J$0Y2;=
M%K&K2]1ZL"QK[2.F763H=C$4I2$RH$IB9'4M!\%H2]'6XV:D'U#+CQ(QVN6[
MEJ6Q=BXSXFFGR,ZQG":VH-./&G4]P=#L
M                                :9;\\O\ )C;S>U[3Q-2\SNJ+%H_
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M(NJKZ._L>UD6Z<[:HIVL*H+[^24*^<ZFJ,(GFF?1F],;E]R_HIN5/-5"PB-
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M^"7*8O<[#TMWL6^%J"\&E_"N0E)&L";
M
M
M
M
M                            >-?ZYG_&'_DG1R@>0<
M
M                                YC@?^TL/_%3/WJZ+/'_JTN^OA+G"
M_EEWF9]$?,J !JW._P!.F?\ 6I'^66)5#Y"[R,'/Y3[YZH['4     X)J9J%
M0Z5X/D.>9(X::N@@JD&PVI)2+"8ZM,>OJX9+]J<NQFNMLHX^U2:^4K@DC,K[
M+<OOYICK>!PR_K;DJ5X$M;D^XE5OG+;&8NU@<-/%7OD07*^!+NMZ"N9JOJME
MVL>8V.99?.7(E2EK:KJ]"U>#J*K2XI46HJV#X)9BQDJZI\.6\X:G'#4XI2C]
M#Y5E6$R?!QP>$C2*UOAE+AE)\;Y$M"T(U%CL=?S#$/$8AUD]2X(K@2[B\>MZ
M3&HR19@
M
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M'<J:NR7K3S:UT&UTO2+:^]K\?:[E*UK\)8N'GDVV
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MK"EL^T.D^+Y6Q1[5?YNUL^'5PF%W.6(ZS=<:]4V-/%M55/#2O@\!,0-0FP
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M@P\2AMKXH4YY23&(-DTKAQ-*D4:I:^'ZIHX'U#XC);GX/K>\6'B],+<G<?\
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M8NIG=UKEN>4QC&FW"4E+CUN2KX)&ZPAA(S$,K6W"6-6JG1B*Y8V^8V%7/MK
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M=.^U1>-HB%Z/7&47>OOAAUM*D8?AU_=,K4GB29DY<'&VDI/@?)<5%O'U$?\
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M;W8MXO>'$RK\6$^C7<V%LO\ "3??9)MW["P^4V5PRCM/^DZKQ4-F!&S,@
M
M
M
M
M                                                     >-?ZYG_
M !A_Y)T<H'D'
M                                                          .8
MX'_M+#_Q4S]ZNBSQ_P"K2[Z^$N<+^67>9GT1\RH &K<[_3IG_6I'^66)5#Y"
M[R,'/Y3[YZH['4     BLZ2S.)+473C3B*^:(TQRSS&Y9(R+G51.33T)JX>V
M-M*GYYFD_:FHDG]%)<-H]F^!BYXC,9+XR4;<7W_C2^"/C(1OCB6HV<'%Z'6;
M\&B/^T1-#:Q!
M
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M'?E*8A_JC+OM:LAO/?K_ $W>^_M_CHUANO\ MBW][/\ %9/F-#FT@
M    /0CU=9#E2YL2N@Q9L\TJG2X\2.Q*FJ29FE4N0TVEV0:34? UF?#B.\KM
MR<5"<I.$=2;;2[RX#JH0C)RBDI/6Z:7WSWQT.P
M  !K!KAN#1A4[S8Z<U4[.-;KZ(ENBQBLB*?CT79K7&/?Y)+=24.+ B-*Y_FS
M4?*2DC=-IE1NE)LDW?>-M^T\QG&QDMM_&G)T<J:X06MMZJ\E7H,+F6:]6EU+
M!Q=W,IKXL4ODU^ZD]22U_#1:3[FVW1/S(:?^![*:W;YCD5B_DF:W39K6W,NY
MB4I[&C.O$3[D*N923:5*))NNFX]R4&Z:"H;QYU[;Q_36X[&#MQ4+<>**X7P5
M;T]Q46FE2KD^6^S<+T<WM8B;VIOCD^!=Q>-U>BM#8,8 RH        :4;_\
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M/$E0]P=#L
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M)2C(N!J42$I3Q5]$^!$7_(-;$Q/T
M
M
M
M
M                        /&O]<S_C#_R3HY0/(.
M
M                            <QP/_:6'_BIG[U=%GC_U:7?7PESA?RR[
MS,^B/F5  U;G?Z=,_P"M2/\ ++$JA\A=Y&#G\I]\]4=CJ     0G])(XX>MV
M)M&M9M(TKIG$-FHS;2XYEV;)<6E''DI6XEI)*,NJ9)+C] ANCLY2]BW7P]:E
M_=VS7&^#?M*VN#H%^/,CW$_(H
M
M
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MXNW+FQFF$PM["/7%0HTNYM.2?>:T\:UF2N;LVX0VL%B+]O$+4W*J\-$GX4_
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M6JCJJ).MKN_G]^]?67X]UN.JC)ZZK[F7V'KKH=:DHHUB34
M
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M)(B.[&6W,3BGFN)3<(MN+?W4WKEWEI_I=XF'&H38
M
M
M
M
M
M                    !XU_KF?\8?\ DG1R@>0<
M
M                          YC@?\ M+#_ ,5,_>KHL\?^K2[Z^$N<+^67
M>9GT1\RH &K<[_3IG_6I'^66)5#Y"[R,'/Y3[YZH['4     A,Z2/^7+%?N4
M4?VWYT-T=G/[$N_YJ7]W:-<;X?M.'YB/X\R/H3\B@
M
M
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MR+6AU5:.FG71Z5I9E[^&P6:*U>VMJ-N:E&46M:X*Z=&JJ,TC#&1   #2C?\
M_DZ6WV48M^_EB:;A?ZAA^:G\!'-ZOV1+[^/PFG71J_RJ9Y]S]7VQTHE_:/\
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MMWW?C@<:DKO5.CFJUTJWLO2M?@-?7;\/:SQ.&?\ 5]8VX\'W5463AYR-P@
M
M
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M];;)-"$+<%;MI1A%426A)+@1[XIG8
M
M
M
M
M
M         \:_US/^,/\ R3HY0/(.
M
M              <QP/\ VEA_XJ9^]719X_\ 5I=]?"7.%_++O,SZ(^94 #5N
M=_ITS_K4C_++$JA\A=Y&#G\I]\]4=CJ     0F=)'_+EBOW**/[;\Z&Z.SG]
MB7?\U+^[M&N-\/VG#\Q'\>9'T)^10
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MK6CO*W<C%3E&2@]3:='WGPGSQ4.@
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M2S]Y<_$D1_>?]CW/OH?C(UHZ,3_\=_\ ZM?_ ,/Q)>TS_P"Q?^-_](PVY?\
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M -J=F?\ ]M_\'_ZI!M]/_LW_ (G^P;+[#OR:\0_UOEWVRV0C6_/^I+WWEO\
M$B9G=C]CV_OI_C,CVZ0VNEP]?FY;[9ICVV#X[+A.%Q-+C3$BUKWBY7 DDXW)
MAKXIXF9)-)_JD-@=GUR$\AV(_*A?FGX5%_ R)[V0E'-=IZI6HM>-?8)-]ME1
MA64Z"Z37!XQC$QT\)IJN5)71UCKKTZ@C^ )ZWW7&'G'9)S:QSG%*5Q4YQ,R+
MCP+6F\=[&X7/<79Z6ZET\I);4M"D]I4TZJ25.X3/)[>&OY78N;$&^C2;V5KC
M\5^-&;O(?"OXGXO\'ZGO087KV-]==\^7.9+JV&]7#S5S'FCX?B41]F5%Q;'(
MTF.XAZ/(CTE8R^P\VHEMNLNMQ4N-.-J(C2I)D9&74'$L9BYQ<97;CBUI3E*C
M\9RL/AXO:C""DOYJYCD8MBL5X]M_Y5. ?9_._P#:LQZ"WB_TOB/\NOL&ILH_
M;EK\Z_LEAP>?3;)%UTFO_8.D7^M\O_>= -G=FOY?%_>6_AD0K?/\EA_OI_!$
MS=L _)TJ?LHRG]_(&%W]_P!0S_-0^ R6ZO[(C]_+X3=<0LD97CVW_E4X!]G\
M[_VK,>@MXO\ 2^(_RZ^P:FRC]N6OSK^R6'!Y]-LD:/27_P"P6FOV7V?\#*&R
M>S;]>Q/YF/XQ#M\OU6S^<?P&0.CN_D!E_= R/^#J 8_M"_;R_P O#X9%UNE^
MRG^=E\$3AO255TM[3+ ;1MLUPX&<.Q)3A<3-IVQHIZXIJ(B,B;7X/<(U&9$2
MN27T3%YV<7(1S._:?RY6*KP25?A1;[XPD\%:FODJ[1^&+I\!\3HY8V+W^G.?
M4UI245K94^;,VBG+"JA39;4&]HH$2*CGI+;RRC&_C[YH21)(E<L^)\>I7[1)
M8JQF-B]:G.%N=C9T2:58R;>A<-)KQ%+=&-B[A+MN<8RG&Y72DW244EK^]9(E
MY#X5_$_%_@_4]Z#7O7L;ZZ[Y\N<EO5L-ZN'FKF'D/A7\3\7^#]3WH'7L;ZZ[
MY\N<=6PWJX>:N8Y(RRS'9:CQVFV&&&T,L,,H2TRRRTDD----()*&VVT)(DI(
MB(B+@0MFW)N4FW)O2RLDDJ+0D0([\?RE,O\ ]48C]K5:-[[B_P"F[/W]S\=F
MKMZ/VQ<^]A^*B<K!_P#8K#_L7Q_^"8@TCCOUV]^=G^,S9>&_5K?WD?@1RD6I
M7   ##.48IH[N,QB=4VJ:+.:BIMIU4J?63$.3L=R"*VQV<Q#M(2RE5EFPAUH
MW6R41+2:2<2I)\!F,+BLXW=Q,;MKI+%Z<%*DEHG!UHW%Z)1>FCY&F8^_8R_-
M[+A/9NVXR:JGIC):Z-:4]5?&: :B]&O*:*3.TKSQ$E)$XXQC^:Q^8?,D\5DT
MWD=0RIAUU9>U03D!E''ARG"(S,I]EW:/%TAFEBG'.V]'F2T\DGW$17%[G259
M8&[7^;/TEZ*[YIQC.3ZR;1=4#8DQ9]#:PW8Z[W%YKZE4664W.N(2:S86]"GP
MY*$.%&FL\M3*^)H42B4D2_$X;)][<LVHN-RTT]F:7QK<O#I36C:B]:U\!'K-
M_,<AQM&G":^5%_)DO@:XFM7 6$\=O(63X_19)6J4JNR&FK+R I7#E*A6T)B?
M%4KAQ+E&Q(3Q&@,18GAL1/#7/REN<HOOQ;3\:-KV;L;UJ-Z'R)Q4EWFJH^R*
M)4  THW_ /Y.EM]E&+?OY8FFX7^H8?FI_ 1S>K]D2^_C\)IUT:O\JF>?<_5]
ML=*)?VC_ ++L?YC_ &)$?W._7KOYK_:1,X-.&PP (3^D6SZ+D>J^/X7!D=D,
MX!CZTV!)6E3;%]DKL>?,CI)"E$2T54. :S/@KE&:3+VO$]T=GF EA\JN8V:H
M\1<T=V,*I/SG(UQO=BHWL=##1=5:AI^^EI?B43<K8/I5-P#2)_*+F,J+<ZE3
MHUZAAPB2\UC4)AQC'">(N)DJ6F5(EHZO4:E(XD2N40AV_F:0Q^;K"V76SAHN
M-?Y[=9\E%'OQ9(=UL#+"X!W[BI<O/:_HKY/+5OO-&3]XGY->JO\ JBJ^V6D&
M,W0_U)A?OY?B2+W>#]CW_O5^,C1'HS_]M=3_ +%Z7^%GQ.>TG]2PWYV7XI&-
MS?UF]]XOA)9,FRS&<+JU7>67M7CM0F1'B*LK>8S!A)DRE\W'95(?4AM+CR^H
MDC/JF-58;"XG&7>APD)7+U&Z1571:W1<1.[U^SAX=)?E&%NM*MT6DUQUGV<Z
M1ZR395_)BS<1R^6:G).18R<=CPE(/_X>ZJI#+L&Q=,^JMU),27/^<Z9$1"19
M-O?FV3P6'BXW<(M4)U=%Q1DM*[VE+@1A\QW?P&82=UIV\0]<H\/?6I]_0^Z1
MOZL[!M6-/X,Z\Q:97ZCT4%MQ]Y%3'?KLF:CM&DUO*QYY<M$HDH5QY,65)=X)
M4?((BXGL7*M_,JQ\XV,4I8:_+1\9IPK]_HI_2BEW2(8_=;'82+NV&KUI<6B7
MFZ:^!M]PR[L$W!Y3)RAK1/*;)^YI9U7/EX9(GON2)]-,IXQS9%(P^Z:G'*A^
MJ8><;;4HRC+8)+9$E9D6)W\W?PL<*\ZPL5"]&:5Q)44E)T4FO*4FDWPUTZ47
M^ZV;7W?]FWVY6W%N%=::TT[U*]ZF@\729UTM&1Z4VQMGV#(I,EKFWBXF12X4
MZKDO-KZG)29LST&GJ\5<%?X#'/9K<@\/BK/W:G!^!J2^PQOE"2O6+GW+C)>%
M-/[)L=L7K\0R?;OCA2\>QVRL*&\RJDL),JFKY4LWUW4F]91)D/M/.NN(@WC/
M)X\.#?)(BX%Q..[\7,7AMX;FQ<N1MW(0DDI-*FRHZ$N[%^$R^[,,/>RF&U"#
MG"4DVTF]>UI\$D;@>0^%?Q/Q?X/U/>@B/7L;ZZ[Y\N<S_5L-ZN'FKF/Z6$86
M1D98ABY&1D9&5!4D9&75(R,HG4,@Z[C?77?/ESCJV&]7#S5S'"=<M7J;1#3J
MVSNWCJGN1W&*ZEJ6W4L.7%[.)SL& 3ZDK)EKDLN//+Y*E(CM+4E*E$23O<DR
MB]G>80P-E[*=7*6O9BM;IR)+A;6K66^9X^WEN$EBKBJUH2XY/4OLON)D8^E\
MG73>_F%VSEN?V^):84*([F0UN)*<J:Q29ZGB@T%="2XI%G/DHCNK5(L%3"C-
MI-1DKE-MJV5F<<CW)PD'A,/"[F=RNP[GQI:*5FW]RE5:(;-7WFU#,%+,]Y<1
M)7[LK>"C\I1T+3JBEPO7IE6G(B2'%-!])M),?L',&PNHJ[2)4SEMY&^SX1R8
MWD0W3Y\K^=S]DPI2RY7(9<;:2K]:E/4(:ZQ>>YKFU^*QUZ<K3FOB)TAKU;*H
MGX4WQLE]C*\!@+3>&MQC-1?QM<M7E/3R:"&K9!^5#IC_ /'3^;S+!N'?;_3&
M)_\ #_O;9KW=K]M6?Z?]W(GVN[NHQNJG7M_90ZBFK&%2K"SGOHC0X4=)D2GI
M#[ADAIM)J+B9GPZHT/9LWL1=C8L1<[TG112JV^)(VE<N6[-MW;K4;<55MZD:
M_P"J^W#1K<1 @9):1N19V%9#DU&=XG*CQ["=62(R'ZUUV0;$JONZ]<9Q"FC?
M:<431\&UH(QG\JWBSC=Z<L-:?]5&34K5Q-I23H]%4XNM:T:TZTS%8[*,NS:*
MO37QW%-3B]+5-'&I+BJM6ID=FIO1V:CXS'EVFGN05F?P(Z'7_!+["J#)C:0A
M;O-Q8[K\RJLG$)1R>I)8<<49<AKB? MA99VA9=B9*UF%N6'F]&TGM0\+HI+D
M:7"R)8W=+&64YX2<;L5P?)EX-:?*N\?&V8:[YIIQJA3:09')GNXCDUXO&'*&
MW4^F1B>4/O.Q8:ZUB07.UZW[CDQI<7VB%*=-9IYQ'5J[Y9%@LQRR>;X916+M
MPV]J-*7()5=6M=(Z8RUZ*:F4]W<TQ&#QL<!>;ZO.6SLO[F6I4XM.AKNUUF2>
MDSKI:,CTIMC;/L&129+7-O%Q,BEPIU7)>;7U.2DS9GH-/5XJX*_P&,=V:W(/
M#XJS]VIP?@:DOL,O-\H25ZQ<^Y<9+PII_9-CMB]?B&3[=\<*7CV.V5A0WF54
MEA)E4U?*EF^NZDWK*),A]IYUUQ$&\9Y/'AP;Y)$7 N)QW?BYB\-O#<V+ER-N
MY"$DE)I4V5'0EW8OPF7W9AA[V4PVH0<X2DFVDWKVM/@DC<#R'PK^)^+_  ?J
M>]!$>O8WUUWSY<YG^K8;U</-7,?TL(PLC(RQ#%R,C(R,J"I(R,NJ1D91.H9!
MUW&^NN^?+G'5L-ZN'FKF.4"U*X
M
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M2I*/AE&J7AH9C"9OEV.>SA[L7/R7\67@3HWX*F;!A3(@
M
M
M
M          :+Y5TGW1NX38651E._K9O3W5-;S*&YHG]RFC[M]375<_(BV-9;
MTD7+W[6KF5TN(XS(0^RV;#R>;7R5\$BC+$X>.N<>6I55FZ]47R'-]O\ OMV<
M;K,GR3#-MNY/2+6_*,0J_#F2T^FV85N42:BF.P:JDVLE5:X\QX/=L'T-(>2M
M3:U++DF9'Q'-N_9NO9MR3=#B5JY!5FJ(VQ%4I@
M                                  >-?ZYG_&'_ ))T<H'D'
M
M                                       .8X'_ +2P_P#%3/WJZ+/'
M_JTN^OA+G"_EEWF9]$?,J !JW._TZ9_UJ1_EEB50^0N\C!S^4^^>J.QU
M (3.DC_ERQ7[E%']M^=#='9S^Q+O^:E_=VC7&^'[3A^8C^/,CZ$_(H
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MN;>!X)9)?ZSL]#T3V=7RJ?$V>[6E*? 52QZG-%@
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M:7WM<:ZE*6I2E*-2E&:E*49FI2C/B:E&?5,S/Z)C8^K0M1#C^
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M>E<-5JEX&I2?
M
M
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M[BA-UBR&;YFU^6!NU_JV4W\Z&-BVRW\N_O'\**V,_)+[[[#.PX&;,8
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MF9$'8X             #QK_7,_XP_P#).CE \@X
M
M                        !S' _P#:6'_BIG[U=%GC_P!6EWU\)<X7\LN\
MS/HCYE0 -6YW^G3/^M2/\LL2J'R%WD8.?RGWSU1V.H    !"9TD?\N6*_<HH
M_MOSH;H[.?V)=_S4O[NT:XWP_:</S$?QYD?0GY%
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M*C7"B1[UYM@\VO6+V#E79M?&5&MEMUII2K3C541]B?D2
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MG".I-MI=Y<!\\5#H
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MA,5B-K#S5)+8MJJ[Z@FO RK8R'*L->C?L6MF[%U3VINC[SDT?:U$VV:*ZL9
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MY8?#-QP2T:-#GW7W.*/+IU:.B;$:
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MMZ,?+"8#H;;I=O-Q_HKY7PI>$@H&\360
M                                        9]VSZMRM&]7,9R54M3&/
MSY3-!E[1J/F'L;LY#+4R0ZCE))2ZEPD3&^J7MV"+CP4HCP.\N4QSC*;N&I7$
M16U;X]N*T+^E\E]QF5R;'RR_'PO5I:;V9_>O7R:_ 6.QYV-N@ 1?](UJY+JJ
MK&M'J:8MA61,>4^7$THTK>IXLQ4>AKG%)5[:/,M(;[[J#(CY41H_H&9'LWL[
MRF%V[<S>\JJV]BW]\U63[ZBTE]\R%[W8^5NW#+[;IMK:EWD_BKPM-OO(B'&V
MB @                               3Z;(]7)6J.C42%=25R<EP&6G%;
M.0\YSDB?7-QVY&/V;QF:EFMRO5V,M2C-;KT1:S_7#0^^N4QRO.'.RJ8:^MN*
MX$ZTG'ET]Q22X#:6[>/EC<N4;CK>M/9?=7W+Y-'=:;-Q!$"0
M
M
M
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MO)*N-C\A4R"QV7(AK)+3Z6WE<V+5XNSTJLQJY/BU%?J]SHW<>A+CUDI8NB@
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M9_(AWV7V"^5+O(WI^:U?V/FCOW4-=OYR;D5LN_5_Z3*>+_+>!%B,7Q:@
M        !XU_KF?\8?\ DG1R@>0<
M
M              YC@?\ M+#_ ,5,_>KHL\?^K2[Z^$N<+^67>9GT1\RH &K<
M[_3IG_6I'^66)5#Y"[R,'/Y3[YZH['4     A,Z2/^7+%?N44?VWYT-T=G/[
M$N_YJ7]W:-<;X?M.'YB/X\R/H3\B@
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M%ZXR6B47WGJ?"J/4S7>:9=>RK'3P5[2XO0_*B]*?A6M<#JN Q&,L8\
M                                   #=KH_ORB:W[$\H_>K A>_W^GI
M?G8?"R2;J_M9?FY$[PT8;.
M
M                                                       #1?I
M-1I6&Z+-XU6R51['42Y;H7S;5R'?)V$PNPO.0HCY7)D+3&BN%PX*9DK(SZO
MYQN%ET<9G/6;BK;P\-I??MTCR:9+NI$9WJQ;P^7=#!TG>EL_T5IE]A/N,@O&
M[S68
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MRK-?"Y23^!$=(V&1$
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M:Q5ZUP.VGR.G^TR8D:A-@
M
M
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M;LW%=MJXN%&-N0=N;@^ V)%0Z     'C7^N9_P 8?^2='*!Y!P
M
M                                   #F.!_[2P_\5,_>KHL\?\ JTN^
MOA+G"_EEWF9]$?,J !JW._TZ9_UJ1_EEB50^0N\C!S^4^^>J.QU     (3.D
MC_ERQ7[E%']M^=#='9S^Q+O^:E_=VC7&^'[3A^8C^/,CZ$_(H
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MRB:W[$\H_>K A>_W^GI?G8?"R2;J_M9?FY$[PT8;.
M                       \+\AB*TM^4^S&8;Y/+>?<0RTCE*)">6XXI*$\
MI:B(N)]4SX#F,92>S%-R[APVHJLG1'SO*"A\=U'OE#Z\*G07_(GR,Z]+:\J/
M*AY04/CNH]\H?7@Z"_Y$^1CI;7E1Y4>1FZIY#J&6+:L?></DMM,SXKCJU?\
MN4-H=4I1_P#(1#AV;L5649)=YA7+;=%)-]]'TQ3.X
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M:FJK[*[Z>A]TY8+4K@
M            $6'2<1I:J[1J6CE]@L3<[C2>!N<WV7*8Q)V%RR(N:-?,PY')
MXGRB+E<.IRAM#LTE!7,9!_+<;37>3N5^%$(WS4MC#R^Y3GRO9I\#(EAM<@@
M
M        !8/V2LNL;8=+T/-J;6IK+GB2HN!FU)SS*9##A?\ O76'4J+_  D9
M#0.^DE+>;%-:56VN2U!/QFUMVTUDMA/^=^/(VI$6,X0]])=B\AC-=-\T)LSB
MVN+V&+K=3RS)N1C]L]:MMN]4VVS>;R51M_04OD+^B2>IMWLWQ498/$X.OQH7
M5/P3CL_[&GOKC(!OC8:Q-G$_<R@X^:Z_[1&6-E$,
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M^/XC6&]-F5K-I7'\FY",EX%L_P"R:5"9D<
M      E/Z,[%WE6.J.:.LJ3'8A4.+PGS+VCSTI^7;6C*%?\ NHJ(<,U%_@>2
M-7]I.*BK>%P2?QFY3:XDDHQY:RY";[FV'MW\2]248KPU;Y*+E):1J@G8
M
M
M
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MMGNWYLE+4I:B;9TSQUII!&HS,D--()*2^@E)$1=0AE,)^K0[Q97_ ,M+ODB
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M^7EX/@1.F+LMP    #QK_7,_XP_\DZ.4#R#@
M
M                     ',<#_VEA_XJ9^]719X_]6EWU\)<X7\LN\S/HCYE
M0 -6YW^G3/\ K4C_ "RQ*H?(7>1@Y_*??/5'8Z@    $)G21_P N6*_<HH_M
MOSH;H[.?V)=_S4O[NT:XWP_:</S$?QYD?0GY%
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M#"$*Z]E)5[]"E<O7KM.EG*5-56W3E/E"J4P
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M6Y-/B[C7<:HUW&;/PN)MXO#PQ-G\G.-5S/NIZ'W3EHM"N
M !^5)2M*D+22DJ(TJ2HB4E25%P-*B/B1D9'U2#5I6L%>G3&NB4^\#&JFO:2Q
M J]<UUT)A"4H0S$A9;(C1FD)0E"$I;9:21$1$1$74(AZ S*Y.]NC<O7'6Y/
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M@EE^"MX1/:<4ZOC;;;\%7H[AE<8HO@
M                        #5;>-I+,U;T5N(-+%7,R?%);&78_%92:GYSU
M:S(8LJUDD^W==FT\M_FFB(^=DH:3PX\#*4;H9M#*<YA<O/9PUU.W-\"3HT_!
M)*KX%4PF\& EC\NE&VJWH/;BN.FM>%-T7'0KX&1D9D9&1D? R/J&1E]$C+]0
MR&_S5
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MIGI#N=0
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MP0CJ\+TR?=;-NY3@%EN!AAM=S7)\<GKY-2[B1FT84R0
M
M
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M;<E)RTNI8>^;4_V*&RW_ +QG_BRUW%_@?U6/A^%EKBOR\O!\")TQ=EN
M>-?ZYG_&'_DG1R@>0<
M
M    YC@?^TL/_%3/WJZ+/'_JTN^OA+G"_EEWF9]$?,J !JW._P!.F?\ 6I'^
M66)5#Y"[R,'/Y3[YZH['4     A,Z2/^7+%?N44?VWYT-T=G/[$N_P":E_=V
MC7&^'[3A^8C^/,CZ$_(H
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M_*)K?L3RC]ZL"%[_ '^GI?G8?"R2;J_M9?FY$[PT8;.
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MB+7[,\/?GA[E.DMS<7356+HZ>%&<M7(WK4;L/D2BFN\U5'UA2.X
M                                        !&)NBV,R,JM++4/1EJ&S
M=6+SDV_P5YV/7P[&6[[9^QQN6Z;,.%-E.\5O1GUMLN+4I:'$'P;7LO=C?>.%
MM1R_.6W9BJ1NJK:7 IK6TM2:JUH33UJ&9WNR[\WB\NITC=90U)OCB]2;X4]'
M#5:B*/)<2RC#+)RGRW'KG&[-I2TJA75=+KGU<VKD*6TB4TWS[)G]!Q'*0HC(
MR,R,C&U,-B\+C+:O82Y"Y:?#%IKQ:GW'I(->L7\//H[\)0GQ--?"<>%P40
M
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MKOQ='X:4XFS7V,RS'8&5,3;E&/'KB_Z2T?9XT8H&5+$
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M7P69Y?F,-O WK=U4U)Z5WX_*7>:3()B<%B\'+9Q-N<'W5H?>>I^!LX(+XM0
M                       #,6FF@6K6K4J.UA>&6LN \HB7D,YA=7C49OC[
M=UV[FI:A.FVGB9M,J=?41>T0H^H,/F6?93E,6\9>@KB^X3VIO^BM/A=%QLR&
M#RK'X^26'MR<']T]$>5Z/ JON$R>VG:)BNA3;>1W#\?*]27X[C+MYS*DUE$U
M(029$+&XSY$Z@UH,VW)CA)D/(,TDEE"UMGI[>3>W%9X^KVD[67)_)KIE34YM
M<JBM"?&TF;"R?(+&6+IKC4\8U\K@CW(\^M]Q:#<,1$D
M
M
M
M&"]8-S^W#;[375_KCKOI%I+58]&[+MW]0-0L6Q=Z*A43LYAE,&VM(T^5.FQC
M)4:,RTY(E&I*64+4I)'3G=M6_ER2\)WC;G+Y*;.G)U)U<Q*[WHY]KQ4>$Y^"
M6^Z#*=7*OD0DQ[F;B4_5>=F4+D5TU^*ABSDT[J>#+SK9)=/DJ4G@9E&).LFU
MPLS25%0[AS0W=_M:W+8SCN7:#;@M(M4Z;*HT9^G+$<\QVSME.RHO9?@NQQY$
M\L@I;^(T2BE5TV-'GQ'$+;>9;6A22DT+UJXDX23KW=/(8:5JY!_&3-CA5*8
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M+OG*C*7R4V=6]\Y:W&Z+;E^E!RW*="=0<<U0Q#"M)----++,\.LH=[B-AE=
M5];7<;'<BK7Y-7D$*K\H6HSLF*XXQV8T\TE2N;,SP&-G&YB&X.L:+29;#1E"
MTE+0RU9\WAZ5[9!/Z/707;%J/K[IAHEKKH7!R# [K"-7,UH-/BRR')S+)+_&
M<BP&XRR=4566Q[2BMFDR8D1U<Z%-9?0XR3',/OW^!Q-E65;FU&2KKT<-2UQ-
MFX[CG%-I\1-IJQTG_1TZ'T<B_P!3=[>V2ABL0WYZ*V%K#A64Y581(Y+-YRDP
MG$;:^S'(#2;9IY$&!(6IPR01&I22.[EB</%5<XT[CK\!;JS=;HHOX/A*C'2.
M])7NQZ>*V3L*Z)O0W5BZVT6-U":UMUEO\=5B-;GK]-9QK:NA93D]@^J@TLTC
MJ78L:TYFRE1\@OY)1V>PV>1V%-QM_$7,8^APZ>QP]WO\2+VU:AAUTEUK:_EX
MR?OH5>A)TOZ*O3Z?EN46%'JGN\U&IDU>I>K%?%E%0XOCSLF)8GI?I4W:1XME
M#P]J?!8>GSWV8\^^F1VWGVF&68D.+>X3"1PZVI:;K\7<1;7[[NNBT0)#>D4T
MPS76O8/O.TBTXA+M,^U)VP:X87AU0VZ;#EUD>0:=9#75-(V[^M0[=3'T14\K
M@CE/%RC)/$5L3%SL3C'70IV6HW8MZJG6?= #O*TEV"=)7A^HNXR8_A>G&3X3
MJ!HKE^6V$"6M.F]CE"JN957M_6LUDZU:KH^2XQ'KYZFT-.06)CDAU7-,.MKP
M6$NQLWU.?R=1D[\)7+3C'6=C7K%TO?1G:(:<+U0RK>OMXR"C>K7;&@IM,-4,
M2U8S?,B2\N&U%P[!].[7(\FOWWK%/8QK:C=C1WN/9#K*$K6G-RQ>'A':<T^]
MI?(8V-B])TV6N^=9+TTF6:NZG=(SKQK7K+H%G&VJZUR:T^U/Q'2S49R&YF,#
M3"RTZQ>BT\N<@37K=B5]_?8YCK4BTK24IVEM52JU\^R(CI# XARE><Y)Q;TT
M[YE+24;:BG6F@[5C;MO8VG[K\;Q')=OVX#2G4M.:XXUE%1CF/YQCDK.8U<<=
MI^<Q>X*FQ/*\?M:-;O,V$29$9D07TJ;>2A1&0D-N_:NTV))M\%=/(8F=JY"N
MTG1</!RE9SYXUII?9!L[VN:HUE9:SJ?3?<!<X_DDJ#$7)@4L747!9IUME=/-
M(6JOBO6N'-0VGG#0P<F4VT:N==92JPS.+<(2X$WXZ<Q=8)Z9+AHC5;YL)TN.
MSO;IM@SW:!NCU>Q'0?+*?5_(-2M.\ISUR308/F&)YK2XM!LJR3F4E4C'ZG*,
M;R.D?6XW.=KFY$";'..3ZH\Q:*> Q-JU!V[CIIK_ "Y#OBK,YR4X*NBA;UV_
M[]]F>ZS,\CT^VV[D=*];\NQ&B5DV256FV2,92FHH2M6*1-G+LJQ#U24=VSDM
MMM\E]2G242D$I'MADK=^S=ELVY)RI4LI6KD%M35$=6IOSK,ZV9],YKWEVJ&)
MS9%OIYOLO=P\6G><2R6:89:ZS+UGQ"PKY\^)+CN1<PQ6?&6AYQIY#:WE(<0:
MFUH$?N)V[[4M:E]DRT&IVTUJ:.S+TZZ73HS=3=)(&M5)O?VV4V&RJN!93XN<
M:N81@N98T]8L.O1Z/*\#RFZJ\NH,D6J,ZVB"_#2_(6V?,)=3R5'GHXK#RCM;
M:2[NOD,6[%Y2V=E_8Y2CQ\Y@W@IW]SML.O6B>DNH*=F&GUGK)I)I;NERBHEX
MWC&OVI%@[A-MG;>"8Q<QH.40\-Q=C&68T"UL(\9-S.:M&F&R.L?X8G&W5>DI
MP3Z-:$^,O\-;Z-.,FMO73B+%?S:3>QM/+HK]O.@-IN TIQ?6;2/(]7L7S/3?
M,LXQS$,N9L<]UZU)U"Q!^GI,BL:V?D55?8]FL(H\N"V_'7-)Z*2N?8<0F^P-
M^TK"A*24U76Z:VV6N)M7'=<DFXOB[Q9V&0+0     \:_US/^,/\ R3HY0/(.
M
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M&I8Y?G69Y7"5O 7>CA-U?Q82JUH^ZB_$9A]8OO)],7X/M+/B.,/]7>YWT/\
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MG\5-<#4:KC+3'[T9SF$':N7-BR]:@MFO?>F7?5:=PT^$O(\
M                              &[71_?E$UOV)Y1^]6!"]_O]/2_.P^%
MDDW5_:R_-R)WAHPV<
M$:/27_[!::_9?9_P,H;)[-OU[$_F8_C$.WR_5;/YQ_ <%Z.;+\2Q>DU4;R7*
M,=QUR9:XHN(B]NZRI7*0S$O$O*C)GR8YOI:-Q)*-/$DFHN/T2%[VAX3%XF_A
M7AK5RXE"==F+E33'71.A:[HXBQ9MWU>G"#<HTVFE71+C9NKJ=NQT2TTIIDYS
M-*/*[EMA9P,9Q*V@WEE-EFT:X\>2[7.RHM0RZ9D:GI*D$E!\I*5GR4JAF6;J
MYUF5Y05F=JRWIG<BXI+A:K1R?<7#Q:R1XW/<MP=MR=R-RY31&+4FWX*I=]^,
MAOQ/3_5+=OJS>7L2 X7E#?.6659,N.ZG'L6@ON(Y$8Y*N2EYR#7)0S#B)6J0
M\AM/'VI+<3N#%X_*]T\JA8E)?U=ND(5^/-KAIP5>F4M2KQT1KVQA,=GV/E=B
MOERK*7W,5Q>!:$M;Y63O0JNDT<TL.OHXJO >G>&S'8D=Q9F])8H:M^8ZY(=2
MDS5)G.,*<=61=5QPS(OU!HR=V_G&:=)??]?B+RJ^)RDEH[BK1=Q&SXPMY?@=
MBTOZJS;=/Z*KROA(J]D3E1J[K]G>;:G'#R;-#IGLDI6[@D26$3W[2-'FSH$&
M23K1*I(;C3$1!&:8C*_V-)<A"D;2WU5W*,AL8++*V\%MJ$MG0Z*+:3:\IU<O
M*:TZW6#[MNWC\UNXG&TGB=G:5>.JJTNXJ)<2U:M$O&48GC6:TTO'LLHZW(*6
M<VIN37VD5N4PKB1D3C?++EQY#?'BAULTN-JX&E1&1&-2X7%8G!7EB,).5N]'
M4XNC^VN-/0^$GUZQ9Q-MVK\5.V^!JO\ +OZR.7;GI$O0S>/J#B,=,][&9^F5
MK.Q.>\AUTG*NQR3$I\6)+E<A#2Y=<4&3&4OJ&XIGE\"Y? MA[Q9LL[W/P^+E
MLK$QQ,5-+RE"XFTN)U3[E:<!$<HP#RS>&[AU5V79;B^XY1:3?&J-> V/W-[<
M,/U;P/)IU=C-<QJ17UTRWQV\K(4>);V=I"9=DMT]C(CM)<LXUN9*9Y+W+YMQ
MPG$F2BXG'=VMXL7E..MPN79/+I249QDVXJ+T;23^2XZ]&M*C,OG.3X?'X6<H
M02QB3<9)4;:TT?&GJT]\BWV/V^'0M<ZRBS7':&ZCY57S*>ED7M5$LCILE:-$
MZLD0^S6GDQ'YR8KL0E)3RS<?07*(N/'9^^UK&3R.5_!7+D)6I*4E&36U#4TZ
M4JE52XJ)D)W:N8>.9QM8F$)*XFEM).DM:I756C7A)\DI2A*4(224I(DI2DB2
ME*4EP)*2+@1$1%U"&A]>EZS:1&5O4TPPW--0]%\!Q+':FLU-U"R*8NVO:R$S
M$?;Q2.VAN=8WK<9+)69L?LLAMQ9./);@O(29$HB/9>YF9XS!9?C,?B[DY99A
M[:V8MMK;>I1K\FNA-*BK),AF\>"P^(Q>&PMB$8XV[-UDE3XO"Y4U\+XZ19NS
M08CI?MXT]LGZ6H@8WC6+TDBSN[-#+"[>S:K(JWWYEI8*2W)MK23R#)!+5[9Q
M26VTI3R4%"K^+S/>#,(QO3E<Q-V:C%:=F.TZ)16J,5P]S2ZZ622U8P64X1NW
M%0LPC63X71:V^%__  1$-B$C)][NY&$UF<N6SB,)-A=/TD1]U$?'\(JI#1-U
M$$VB)+<RTERXT:1,]JXMQ\W"/VK;9;;Q<<-N5NXW@TGBY4BI-:9W)+Y3[D4F
MU'514X6R X=WMY,X2Q#?5U5T7W,%P+NMM)ONUXD3?T6/T>,4\+'\>J8%-25T
M=$6%5UT9J-#CL(2220AEM)),U$7%2CXJ69F:C,S,QI2_B+^)O2Q&(G*=Z3JY
M-U;9LFU:M6;:M68J-M*B25$5TI&H%QBFX:XS[$HZJ:=#U/N;"!44S!PFNPG<
MBDDYCZ(3:(Y'#F05G%<94A/+0LTJ(C,QZ%CE]G%;OPP&+>W!X:*<I.NG87QZ
MZ=*?QD^ U(\7<L9M+%8=;,E>;26C1M/XM-&AK10LBCSH;?*YK)94K=+-1@ZX
M+>8.:UW+6-O69)57L6[N836X4F:E9&E4:,ZHG%EP5Q2GAR5?K3]#/JJW7B\;
MM/"+!1V]G6X]&JI=UZN8U&NG]MM8:G6.LO9KJKMNE>X3&XAM#TAIT2;/-:=.
MJ>;6[RYV1YAG!N6DFULI!FN0\S6//.5L!CG%GS:4H4XE!$2G%<DC+4&+WMS:
M]2U@Y]5P4%2%NU\512U?&6EOCTT[B-@X?(,OMUGB(]/B9.LISTMOO:E\/=-"
M=]NW+#=,&,9U%T_JV\?I[VV7CE[11%.>#(]LJ#(L:R;6LN.+.&4R)7R4O-(X
M-$II*DI2:E\9WN-O%C,SE=R['S=R]"&W&3^4XU2DF^&C:HWITNO 1?>?*,/@
ME#%X6.Q;E+9E%:JTJFN*J3JM6@VWZ/W-K+*]"CJ+1]R0[@V3V.-5[KJC<7X$
M7"KKFO:-PTDHTQ';-YAM)FKD,M(21DDB244W^P5O"YYTMI)*_:4W]]5Q?+LI
MOC;9GMU<3._EG1S=7:FXKO437)5KO)&R>LVI]9H[IMD^?V;:9/@:&2:RO-9H
M.TNYKB(=17$I)*<2W(G/(YU:24;3!+<X<$&(WD^67<WS&U@+6C;>E^3%:9/P
M+5QNBX3,9CC89?@YXJ>G96A<<GH2Y=?$JLB.VT8-;;LM<<@SO5J9(R.GQIB-
M=7\=Y3A0YLR;)?;QK%V6DJ)$"A1V-(=YA!DDV8IM\/V12BVSO)CK6ZF26\#E
M*5N]<;C%\*22VY]V6E*KX95X$B!9-AIY[F4\5CVYVX*LN)M_)CW(Z]'$J<)-
MG%JJN#7-T\&M@0ZEF.J(U5Q8<>/7-15)4E49N"RVB,B.I*C(T$DDF1GU!I>5
MV[.X[TY2=UNNTVVZ\===>Z;(C;A&'1Q25NE*):*<5-1#=O8TA:T.S[$M7-+.
M7B$3(9TE2FZ%9UZ,?R^N)$KLFK0R:$0XEU">4HF&RYI*V'BY)(6E W!N7F[S
MO 7<IS3^NG;BOE:=NV]%)<;B^%Z=*X54U[O'@%EN*MX_ _U<9M_)T;,UIJN)
M-<&K0^!DBNU[6PM=-+*[))W8[64U,AR@RZ+&3S;16\1MIQ%@PSP+FHUO">;D
M)21<AMQ2VDF?-F8UYO-DOL/-)8:%7A9K:MM^2^!]V+JNZJ/A);DN9>T\"KTJ
M=/%[,UW5P]YJCY5P$>>_+4"5D6N&,:76]B_7X'BR<<DVS#+RV6W)N0K:DV=S
M(/DJ;<=@T<AMN.:D.<Q^RFG_ *59#8.XN7QP^27<SM14L==VU%]R&B,5WY)M
MZJZ.)$3WHQ<KV90P5QM86&RWWY:WX(Z%Q:>-DN^,8YC6+4-=0XG55E1CT.*T
MU7P:IEIJ$4?FDDAPC;XE)6^@B4MU9K6Z9\I2E&9F>I<3B,3BK\K^*G*>(D]+
MD]-?L4XM2U(GUFS9L6E:L1C&TEH2U?R[O"1E[\=M]% IHFL&G]$U5V#5I'K\
MRJJ6)S46>W8K-$#(&8,1HFV)[,_DLR%((N?)]"S+E(4I>RMQ=XK]R\\HQ]QR
MMN+=N4GI5-<*O6J:5Q4:U/1#-Z,GM1MK,,+'9GM4FDM#KJE1<-=#XZU)-K.F
MQW,:9$+(*.JR&EGM,RE5E_5P[.$ZEQKE-*?@6#,B.;B4.F7MDF9<3(:TM7L1
M@[VWAYSMWHNFU&3B_ TTR9SMV<1;V;L8SMO@DDUR,@YWT:58=I=JQ5-X15L4
M55E&*Q[V32PT&W7P;)-I9U\E5<URC3%B2FHC:^821(;<Y7)X)424[MW'S3&9
MGE4WC9.=VU=<5)ZVMF+5>-JKTZVJ5XWK7>; X?!8Z*PT5&$X;5%J3JUHXDZ:
MB63:O^3OI)]B$/\ RT@:JWI_U#B_SS^!$ZR/]DV/S:-*>DDU'NX?D1I=7RG8
ME-:P9&5Y VRMQL[53$U4"EAR#0:2<APWHS[RFE<I*WN:69$II!B9]G.76)]/
MFEQ)WH24(?S:JLFNZZI5X%5<+(YOAC+L>CP4'2W);4N[IHEWE1NG'1\!OKH-
MBV%8MI/@L?!(-='I[#%Z*S7.A(:-ZZES:V/(DVMC+0A#DV=)?=4I:E]5!GR$
MDA*20F"9[BL;BLUORQTI.]&[*-']RDVE%+@27/I>DE&5V,-8P%I85)6W"+JN
M%M:V^%O[1J]O<VXXYEV!7.I^+4<:!G>*-E:6CM7%2RO**-*THLV[%B,V12[*
MO85V0R^9&Z:&EMF:B4GD2?<K>+$83'PRS%3<L#=^+':?R)?<T;U)O0UJJT^.
MN%WDRBSB,++&V(I8J&ET7RH\->-K6GKT4-J-!'3=T/T?Y2'FW&M,L&BOH?;6
MV\B1"QJMB24N(<(ED:7V%%U>J?T1%\]5,[QE*4>)NM4XG-M>)F;RMURW#\?0
MP7)%(RT,27X
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MAIEM#33:20VTTA+;;:$EP2E"$D24I(OH$1<!;-MNKTLKI)*BU'D'
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M(A*2?_*1CAXW&25)7KK7WTN<Y6&PZ=5;A7[U<QR<6Q6
M
M
M
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MGQOG.W6K_E>)<QO5ZM391\BCU=?F6_\ Z./0]YQM6?2SY\OY0?+SSI?RI?\
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M<=Q^IB-$26XM935$:'70(S:2X)0TVA)%] A<QC&*I%)+N%%MR=9.K.1#DX
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MD'
M                                                .8X'_M+#_P 5
M,_>KHL\?^K2[Z^$N<+^67>9GT1\RH &K<[_3IG_6I'^66)5#Y"[R,'/Y3[YZ
MH['4     A,Z2/\ ERQ7[E%']M^=#='9S^Q+O^:E_=VC7&^'[3A^8C^/,CZ$
M_(H
M
M                                              &[71_?E$UOV)Y1
M^]6!"]_O]/2_.P^%DDW5_:R_-R)WAHPV<
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M-/,O-*)2%I,TJ29&1\!KF490DX334TZ-/0TUK37&3!-22E%IQ:T,\XZG(
M
M
M
M
M
M
M
M
M                     !XU_KF?\8?^2='*!Y!P
M
M                         #F.!_[2P_\ %3/WJZ+/'_JTN^OA+G"_EEWF
M9]$?,J !JW._TZ9_UJ1_EEB50^0N\C!S^4^^>J.QU     (3.DC_ )<L5^Y1
M1_;?G0W1V<_L2[_FI?W=HUQOA^TX?F(_CS(^A/R*
M
M
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M,_<K22=VS&<J>564>5J*;XZU,]NK>N7<JV9UI"Y**[U$_$VT;O"%$D
M
M
M
M
M
M
M
M
M                   /&O\ 7,_XP_\ ).CE \@X
M
M                         !S' _\ :6'_ (J9^]719X_]6EWU\)<X7\LN
M\S/HCYE0 -6YW^G3/^M2/\LL2J'R%WD8.?RGWSU1V.H    !"KTDT5Y&LV'3
ME$7,2-,:V*VKJ\3>AY5ESSY'U.3P)$YOZ!F?5ZO#J<=S=G$T\GO0^Z6);Y86
MZ? S7.^$7[1MRX'92Y)3YR/$;!(F
M
M
M           &\G1ZPW9.X-#S9>TKL)R68_U%'P:6Y5UY'Q21DG]GG(ZJN!?J
M?1,B.$=H$U'(-EZY7X)?A/X$R3;IQ;S6JX+4G\"^R3J#1YLP
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MZ7P16I<2H2O9AE^"4;,)3A:@DHQ59.G$N%LAXW0+UKW!9W79+!V\ZNX[4TE
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MR>,87H
M
M
M
M
M
M
M
M                              !XU_KF?\8?^2='*!Y!P
M
M                                  #F.!_[2P_\5,_>KHL\?^K2[Z^$
MN<+^67>9GT1\RH &K<[_ $Z9_P!:D?Y98E4/D+O(P<_E/OGJCL=0    "-[I
M'--I5]@>*:D5L9;SF#V4JLO>91RE(HLD.(AB<^KZ/,5]Q"::+A] YIF?4(S+
M8O9WF4;&.NY=<=%?BI1^^A6J7=<6W_1(AO=@Y7<+#&057:;4OO94T^!I+PD-
M W$:\
M
M                                                "6_HV]-),.MS
M75BPCJ:1<&UAV...-+0M^%!?;L<@E,K5P2]#>L$164J3Q+GHKJ3/BDR+4_:-
MF49W;.56W5P_K)]QM4@N^EM/O27&3S<_!N,+F.FOE?$CWEID^]6B[Z9*2-8$
MV                                                         PY
MG6X'1S33(X&)9QG=709!9,-26(#\:TDDQ'?6;;#]G,@0)<"F:>-)FE4QU@E)
M+E%[7JC,8'(,XS+#RQ>"L2N8>+HVG%5:UJ*;3E_13XC'XG-<OP=Y6,3=C"ZU
MJTOE:32\+1^-<-8J71[3*VSMUV-/ENQT0\0@(<YUO(,@LF5JIXK"F#4;L17
MWWEH/J1FUJ29GR2/G),GO9OF<,"DXQ3K<?D03^,]/#P+NM'&99A;R_!2Q3HY
M4I!>5)ZEWN%]PXKM=TNL=-M-D3,H2IS4+4"REYWGTM]*.RSO+U9RD5[YHXI2
MJLC.)0XA)FV4I3RD]18N=Y\SMYCF6QA?V?AXJU:2U;,=%5]\]7#L[*>HH9)@
MIX/![5_];NMSF^':EIIX%XZFR CIF
M
M
M
M
M
M
M
M
M                                    /&O]<S_C#_R3HY0/(.
M
M                                        <QP/_:6'_BIG[U=%GC_U
M:7?7PESA?RR[S,^B/F5  U;G?Z=,_P"M2/\ ++$JA\A=Y&#G\I]\]4=CJ
M  ?+NZ6JR.GLZ"\@Q[.FN8,JMM*^4DUQYD&8RMB3'=(C2KDN-+,N)&2B^B1D
M9$8JV;UW#WHW[$G&]"2<6M::TIG2Y;A>MRM74I6Y)II\*9 +N6VNY7H3?2["
M)&F76FMA,<.@R=MLWCKVWG"./2Y(IE!(@VC!+)M#JB0S-)/+:X*YQIK?.[>\
M^%SRPK<VH9E&/QH:J\<H<<7K:UQU/11O5F<9)?RRZYQ3E@V_BRXNY+B?=U/6
MN%+542DP8
M
M                                                !L=MYVVYGKUD
M+#<*/(J<(@2VBR7+GVC1%C,)6A4BOJ%.(4W8WKK)_L;224AHS);II3PY4=W@
MWCP>18=N;4\;)?$MK6WP.7%'C?#J569?*<GQ&:74HIQPR?QI\'>7'+N<'"6"
M<3Q:CPC&Z3$L:@MUM%C]?'K*V&WU>;CQT<.6ZL_;/RI#AJ<>=5Q6ZZM2U&:E
M&9Z"Q6*OXW$SQ>)DY7[DG)ONOX$M26I+0M!M:Q8M8:S&Q95+4%1+^7#QOA9R
M$6Y5
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M-$D2&#7Y+
M
M
M
M
M
M
M
M
M                  \:_P!<S_C#_P DZ.4#R#@
M
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MZU^!T/XPA]95_P"B0^<?H#W,M_2)>8O2'JRJ/TO6OP.A_&$/K*O_ $2'SC]
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M#U95'Z7K7X'0_C"'UE7_ *)#YQ^@/<RW](EYB](>K*H_2]:_ Z'\80^LJ_\
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M*-M:DE1+O)'T!3.X
M
M
M
M
M
M
M
M
M
M                           'C7^N9_QA_P"2='*!Y!P
M
M                                #F.!_P"TL/\ Q4S]ZNBSQ_ZM+OKX
M2YPOY9=YF?1'S*@ :MSO].F?]:D?Y98E4/D+O(P<_E/OGJCL=0
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      #QK_7,
M_P",/_).CE \@X
M                                                           !
MS' _]I8?^*F?O5T6>/\ U:7?7PESA?RR[S,^B/F5  U;G?Z=,_ZU(_RRQ*H?
M(7>1@Y_*??/5'8Z@
M
M
M
M
M
M
M
M
M
M
M
M
M                    'C7^N9_QA_Y)T<H'D'
M
M                        .8X'_M+#_P 5,_>KHL\?^K2[Z^$N<+^67>9G
MT1\RH &K<[_3IG_6I'^66)5#Y"[R,'/Y3[YZH['4
M
M
M
M
M
M
M
M
M
M
M
M
M                                             \:_US/^,/\ R3HY
M0/(.
M                                                  <QP/\ VEA_
MXJ9^]719X_\ 5I=]?"7.%_++O,SZ(^94 #5N=_ITS_K4C_++$JA\A=Y&#G\I
M]\]4=CJ
M
M
M
M
M
M
M
M
M
M
M
M
M            >-?ZYG_&'_DG1R@>0<
M
M                YC@?^TL/_%3/WJZ+/'_JTN^OA+G"_EEWF9]$?,J !JW.
M_P!.F?\ 6I'^66)5#Y"[R,'/Y3[YZH['4
M
M
M
M
M
M
M
M
M
M
M
M
M                                      \:_P!<S_C#_P DZ.4#R#@
M
M                                            ',<#_P!I8?\ BIG[
MU=%GC_U:7?7PESA?RR[S,^B/F5  U;G?Z=,_ZU(_RRQ*H?(7>1@Y_*??/5'8
MZ@
M
M
M
M
M
M
M
M
M
M
M
M
M      'C7^N9_P 8?^2='*!Y!P
M
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MB7$QV#.[3E=SO>X#;AQKE&Q+B8[!G=IRNYWO<!MPXURC8EQ,=@SNTY7<[WN
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MQ+B8[!G=IRNYWO<!MPXURC8EQ,=@SNTY7<[WN VX<:Y1L2XF.P9W:<KN=[W
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MB7$QV#.[3E=SO>X#;AQKE&Q+B8[!G=IRNYWO<!MPXURC8EQ,=@SNTY7<[WN
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M,9PBXJ4DB+B8L\=.+PS2:K5?"7&%C)7DVG2C,[# F4
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                               -#+:VM4VMFE-G
M8)2FPFI2E,V21)(I+A$1$3G B(A(H0AL+0M2X#$2E+:>EZSYWABV\:6/=LGK
MH[;$.)<AQM2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/
M#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(
M<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXT
ML>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M
M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/
M70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#
M%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<
M2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL
M>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2
MXV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/7
M0V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%
MMXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2
MY!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>
M[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2X
MV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70
MV(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%M
MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y
M!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[
M9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV
M/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V
M(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MX
MTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!
MM2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9
M/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/
M#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(
M<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXT
ML>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M
M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/
M70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#
M%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<
M2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL
M>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2
MXV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/7
M0V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%
MMXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2
MY!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>
M[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2X
MV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70
MV(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%M
MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y
M!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[
M9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV
M/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V
M(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MX
MTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!
MM2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9
M/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/
M#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(
M<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXT
ML>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M
M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/
M70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#
M%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<
M2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL
M>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2
MXV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/7
M0V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%
MMXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2
MY!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>
M[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2X
MV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70
MV(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%M
MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y
M!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[
M9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV
M/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V
M(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MX
MTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!
MM2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9
M/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/
M#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(
M<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXT
ML>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M
M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/
M70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#
M%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<
M2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL
M>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2
MXV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/7
M0V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%
MMXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2
MY!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>
M[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2X
MV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70
MV(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%M
MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y
M!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[
M9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV
M/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V
M(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MX
MTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!
MM2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9
M/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/
M#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(
M<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXT
ML>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M
M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/
M70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#
M%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<
M2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL
M>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2
MXV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/7
M0V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%
MMXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2
MY!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>
M[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2X
MV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70
MV(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%M
MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y
M!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[
M9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV
M/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V
M(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MX
MTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!
MM2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9
M/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/
M#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(
M<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXT
ML>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M
M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/
M70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#
M%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<
M2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL
M>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2
MXV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/7
M0V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%
MMXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2
MY!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>
M[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2X
MV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70
MV(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%M
MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y
M!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[
M9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV
M/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V
M(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MX
MTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!
MM2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9
M/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/
M#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(
M<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXT
ML>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M
M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/
M70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#
M%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<
M2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL
M>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2
MXV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/7
M0V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%
MMXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2
MY!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>
M[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2X
MV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70
MV(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%M
MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y
M!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[
M9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV
M/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V
M(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MX
MTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!
MM2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9
M/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/
M#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(
M<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXT
ML>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M
M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/
M70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#
M%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<
M2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL
M>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2
MXV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/7
M0V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%
MMXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2
MY!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>
M[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2X
MV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70
MV(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%M
MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y
M!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[
M9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV
M/#%MXTL>[9/70V(<2Y!M2XV/#%MXTL>[9/70V(<2Y!M2XV>%VXM^7&_\JV/5
M>5Q_SZ3U?\W?/]M_PD.5"&G0N0X<I56EGF\,6WC2Q[MD]='&Q#B7(<[4N-CP
MQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'
M$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+
M'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4
MN-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3U
MT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ
M;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$
MN0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'
MNV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N
M-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT
M-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;
M>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N
M0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'N
MV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-
MCPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-
MB'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>
M-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0
M;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV
M3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-C
MPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B
M'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-
M+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;
M4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3
MUT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CP
MQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'
M$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-CPQ;>-+'NV3UT-B'$N0;4N-D@@C9F"
M/NX_[6M/]8S?WRZ))#Y"[R,/+Y3[Y\X=S@
M
M
M
M
M
M
M
M
M
M
M
M
M                                       \+O\ TD;_ !ROWO('*X3A
MZUWSS#@Y
M                                                        "141
M@S)'W<?]K6G^L9O[Y=$DA\A=Y&'E\I]\^<.YP
M
M
M
M
M
M
M
M
M
M
M
M
M                                          >%W_I(W^.5^]Y Y7"<
M/6N^>8<'(
M                                                         2*B
M,&9(^[C_ +6M/]8S?WRZ))#Y"[R,/+Y3[Y\X=S@
M
M
M
M
M
M
M
M
M
M
M
M
M                                            \+O_ $D;_'*_>\@<
MKA.'K7?/,.#D
M
M)%1&#,D?=Q_VM:?ZQF_OET22'R%WD8>7RGWSYP[G
M
M
M
M
M
M
M
M
M
M
M
M
M                                             !X7?^DC?XY7[WD#
ME<)P]:[YYAP<@
M
M!(J(P9DC[N/^UK3_ %C-_?+HDD/D+O(P\OE/OGSAW.
M
M
M
M
M
M
M
M
M
M
M
M
M                                               #PN_])&_QROWO
M('*X3AZUWSS#@Y
M
M  "141@S)'W<?]K6G^L9O[Y=$DA\A=Y&'E\I]\^<.YP
M
M
M
M
M
M
M
M
M
M
M
M
M                                                >%W_ *2-_CE?
MO>0.5PG#UKOGF'!R
M
M    $BHC!F2/NX_[6M/]8S?WRZ))#Y"[R,/+Y3[Y\X=S@
M
M
M
M
M
M
M
M
M
M
M
M
M                                                  \+O_21O\<K
M][R!RN$X>M=\\PX.0
M
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M!_C8'U>YGZ^Q^'Z(][L#ZJ[^#Z0]>QMX]$.L_P!3P?XV!]7N9^OL?A^B/>[
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M[ ^JN_@^D/7L;>/1#K/]3P?XV!]7N9^OL?A^B/>[ ^JN_@^D/7L;>/1#K/\
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M BTHRC)QDFI)T:>M&=34DI1:<6>R.#D
M
M
M
M
M
M
M
M
M                                       /4GSX-5!FVEI-B5M96Q),
M^QL9\EF'!@08;*Y$N;-ER%MQXL2+';4MQQ:DH0A)J49$1F.-6EZAKT+6:-V/
M2D=&K5\SV3O^V:N\_P YR/!VY/2"WY/-<CE<]X)RZ;V/QYPN3SG)Y?5Y/'DG
MPI/$6%KG'EK\!45FZ]469IV^[LMM6ZVNR2WVWZV:>ZTU>'S:^MRB?I_D$6_C
M44^U8D2JZ)9.Q3-,=^9'B.+;2?54E!F.T+MN[7HW6AQ.W.'RU2IL,*AT
M                                                     \+O_21O
M\<K][R!RN$X>M=\\PX.0
M
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M61:B6D?
M
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M(4BH
M
M
M
M
M
M
M
M
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M<'(
M                                                   2*B,&9(^[
MC_M:T_UC-_?+HDD/D+O(P\OE/OGSAW.     "%/ILM?K'3W0[#M%\>FO0K/6
MNYL7LC>C.DESR%PLJV385CO)X/,HOKZV@EQ(R)UB+(:/E)4HA.]P\NCB<PGC
MKJK"Q%;/W\JT?@2?A:9%=Z\9*SA(X6#I*ZW7[V--'A;7(RJV-O&O0
M
M
M                                    LS]!QK]/R/ ]1]N]]-5(5IW)
MC9Q@B'36MQG&<GFR&,HJVC_Z-J%59,;,I!'[93MN[U>"2(M5;_Y;&UB+69VU
M3I5L3^^BOBOON-5_11/-TL8YV;F"F_D?&CWGK7@='X63TC79,
M
M
M
M
M
M
M
M
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M_P!7\**6%_*^ B^^9[_R*;V/NI:2?:GEHHY=JGX/LE3%_<^'[!<?&3+,
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M9TQ7Y1=[G+ 0O2V            \+O\ TD;_ !ROWO('*X3AZUWSS#@Y
M
M                                            "141@S)'W<?]K6G^
ML9O[Y=$DA\A=Y&'E\I]\^<.YP     57^G3M93VYW2ZD6HSA5^@]/:QT<MPT
MIE7&H.H<28HFS6;2#6U1L$:DI)2N21*,R2GAMWL^@EE-ZY]T\0UR0@U\+->[
MW2;Q]N/ K*?+*7,0GB>$5
M
M
M    "6_H5K>16[SE0V>5S=_I)G51+Y+AH+L=F;C=ZGEI(C)Y/95(W[4^!$?!
M7T4D1PS?N"ED6T]<;T'XI+[)(]UI..:47W5N2^!_8+<(TR;)
M
M
M
M
M
M
M
M
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M(
M                                                 2*B,&9(^[C_
M +6M/]8S?WRZ))#Y"[R,/+Y3[Y\X=S@     JF].=^5IIY_5UQ+^<O5P;@[/
M_P!C7?\ -2_$MFN][?VE#\POQID,(G)%P
M
M
M                E9Z&?\MJC^YUJ!^\(@A^_/[!E^=A\+)#NO\ M:/WDO@+
M>XTL;+
M
M
M
M
M
M
M
M
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MM=\\PX.0
M                                                        D5$8
M,R1]W'_:UI_K&;^^71)(?(7>1AY?*??/G#N<     %4WISORM-//ZNN)?SEZ
MN#<'9_\ L:[_ )J7XELUWO;^TH?F%^-,AA$Y(N
M
M           'T(%3:VINIJZRPLE,DE3R8$*3,-HEFHD&Z4=MPVR6:3X<>''@
M8ZSN0M_+DE7C="I;LW;M>BC*5-=$W\!]"]Q/*L7[%\IL9R#'>SN?["\.TUC4
M=F=C<SV3V+X0C1^R.Q^R&^7R./(Y:>/#E%QZ6K]B]7H9PG37LM.G?H<W</B+
M%.GA.%=6U%JM-=*HX^*I2
M                          )6>AG_ "VJ/[G6H'[PB"'[\_L&7YV'PLD.
MZ_[6C]Y+X"WN-+&RP
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M&BQ<-9$W
M
M
M
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M$E)F9F.L\+BK<=J=NY&*X7%I? <QQ%B;V83@Y<2:?V3FPH%8
M
M                                                   (V>F)_LM]
M]_\ 5MU'_@A8M\5^KR[Q6P_Y9?RX"B;\V*_M:]*_N6ZW?:%8#%8+]9CX?@9>
MXC\B_!\*.S8&=,8   $$/SE+^Q\W)_9+H+_/QIT++'_J_A1<87\KX"+[YGO_
M "*;V/NI:2?:GEHHY=JGX/LE3%_<^'[!<?&3+,ZM7YQK_;+[QO\ N]?^%;0X
M8+&?K,O!\",GA_R*\/PL[07"_P#8[$_L:HOX+BC-6_D1[R,=/Y;[[.2CN=0
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M<@
M                                                 !(J(P9DC[N/
M^UK3_6,W]\NB20^0N\C#R^4^^?.'<X     *IO3G?E::>?U=<2_G+U<&X.S_
M /8UW_-2_$MFN][?VE#\POQID,(G)%P
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M_P#IE4T;@->@
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MS9_I_B2+G@T8;1
M
M
M
M            "$G?MTM-3HC<W.CVWB/3YCJ;5./5^69S8DBQP[![!)+:?IZN
M(P\E.3977N\>R>6HH$!Y)-.%)=)]AB>[N[FSQ\(X[,]J&$>F,%HE-<;\F+X.
M%K2J*C<4SC>..$F\+@J2OK0Y/3&+XEQM</ M6EU2KAZKZ^ZTZY6SUSJWJ;F.
M=RW75/-L7ES)<IX)J<6[S51C["F*&DBI<<4I+,.,PR@U'R4EQ&T,'EV R^'1
MX*U"W'N+2^^];[[;9!\1C,5BY;6)N2F^Z]"[RU+P(Q"+PM@
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M#%Y'?4;OQ\-+Y$TM#[CXI=SPIO338>5YMA\TM;5OXMZ/RHO6NZN-=WEH;K#
MF5
M
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M*G#5%C>MS4Y.CI6I+J+HH@  !X7?^DC?XY7[WD#E<)P]:[YYAP<@
M
M                                       !(J(P9DC[N/\ M:T_UC-_
M?+HDD/D+O(P\OE/OGSAW.     "J;TYWY6FGG]77$OYR]7!N#L__ &-=_P U
M+\2V:[WM_:4/S"_&F0PB<D7
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MVIO?^P[GW\/QD48!Z"-0
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MD5I;5%WJU>DW$&$,F
M             !$5T@72A8[MAE2]*-)(E/G.MIQ__++\YU4G%=-4R&TKC^'&
MH;S3MOD[S2R<:K4NM)80:79*R(T,/33=O=*[FR6,QKE;P%=%/E3[U=4?YW#J
M7&HUG.\$,O?5\,E/%\/%'O\ &^YX7Q.M#J[NEW#:[SI4W575W-LK9E*?4=(]
M<R*[%8R9!KYUN!B50<#&H#:T+Y"B9BHY2")*N)$0VI@LHRS+HJ.#LVX-<-*R
M\,G63\+()B<PQN,=<1=G*O!6BY%1+D,!#(EF
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M<=C"6K=N/\V*7P+20^]B<1B9;5^<YONMOX3'(N2B
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MS/B9F9]4S,QNHUJ?P
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M+@
M
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M_P!W*Z&C\SG_ (A=U/\ 3B*?4\-Y/C?.=NL7N/Q+F']W*Z&C\SG_ (A=U/\
M3B'4\-Y/C?..L7N/Q+F-@]*>AFZ+71AV%(PC9!H9(EUIQUP9NH&/S-8)\5^(
MYST:6U/U<LLXF%.8>X*3(Y?/$I*3Y7%*>':.%P\=45X=/PG#OW6J;1)7 KX%
M5"BUM7"B5M=!8;BPJ^!&9APH<9E)(9CQ8L=#;$=AI!$24(224D7 B%=))46H
MI-MNKUGMCD'X=:;?;<9>;0\R\A;3K3J$N-NMN)-"VW$+(TK0M)F1D9&1D8#4
M02ZZ_-P.BOUTSVVU$=TCR_2BXR"9+LKVIT8SR?AN'V%E,6AQV9%PZ;$OL>QI
M)&@^$:GCUT(C6I1LFH^4+.6!L2==*[Q<+$W4J:&;:[+^B,V"[![ES,-O&AL"
MNU)>@N5KNJF:W5WG^H#4-]E<>8Q37&3S9T7$6[%AQ3<I-+&K42VSY+Q+21$5
M2UAK-IUBOC<;.D[URYH;T=PX9O9Z%CH_-_.=.ZK:Y:4VD#5F7 KZRUU,TVRN
MTP?*,@A5+,*'6)R9J&<K'<EF5]7 ;@L2YT"1,:@I2PATFVF2;XNX6S=EM234
MNX<POW+:V51KNF9MDW1F;,^CT8R_Y+&E3^$6VH#-9&S7)+?,<SS._P BB4KT
MM^HAR)>5WMK'@0J]R<ZI#,)F*VI2S4LE+,U#M:P]JS5P6EG6Y>G<T2U&U6L.
MC>ENX'3;*M']:<%QW4K3/-H**[*,-RF"BPI[6.Q*8GQ%K;,T/1IM=8Q&9,22
MPMJ3$E,MO,N(=0A959PC<CLS58G2,I0>U%T9!F]\V Z)MW)7;U&GFKT>K<6M
M2,+9UJRU6-,)6@TI;:E2%/YB:&C/E)Y=LM7$NJ9EQ(6G4+%:_&Y2XZU<XE_+
MPDLFU;8IM%V2T$S'MKF@N!Z2-6L2'!OKVF@2++-\HB5ZW78,?+-0<BE7&<91
M'A/R''&&Y]A(;86ZLVTI-:N-Q;LV[2_JU3X2C.Y.Y\IZ#6/>UT,G1_;^\J3J
M+KGI#)@:JG&B0IFJ6F>16. YE=089,MQX^3JK>>Q[+768L=$=J5:5\R;&BH2
MRP\VV1)*G=PMFZ]J2I+C1WA?N05%I7=,+;=?F\O19[<<RJ=0:C0VTU2RW'Y[
M=GC\[6W,KC4"HJ)K)I7'D)PM1U>!VKL5U).,KL*N8METB<;-*TI476&"L0=:
M-ONG,L3=DJ:%WC>W>;T?^T[?[A%#@FZ32FOS^OQ*=*LL,NXME;XQF&&R[ H2
M+4\:RO')M;<U\*Y:K8Z)L/G5PIA1V3>:6IEE2*MVQ;O*DUJU'2%V=MUB:B;1
M^@DZ.#9?J9BVM&D^E.4V^KF$/39.)9]J#J3E^2V%#+L&)T*3,@T4:PJ,,[-\
M&SUQD/.5BW&VOUIDM2UKIV\'9MR4E5R7&SO/$7)K9T)$PPNB@   'A=_Z2-_
MCE?O>0.5PG#UKOGF'!R
M
M       $BHC!F2/NX_[6M/\ 6,W]\NB20^0N\C#R^4^^?.'<X     *IO3G?
ME::>?U=<2_G+U<&X.S_]C7?\U+\2V:[WM_:4/S"_&F0PB<D7
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M6Q^4^51[.MTUTUZ"#@; (8
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M)'*!2*@
M !JAO;W"?)BVU:C:JPS85D\2!'Q_!XSZ.<;D9GDDA%73.K:-)MO,5'/.6#S:
MC23C$-:2/E&1'F,ARWVMFMK!R_)-UG]['2^7Y*[K,;FV-ZA@)XA?E*4C]\]"
MY-?@*-UM;6E_:V=[=V$RVNKJPFVUO:V,AV786=I8R7)D^PG2WU+>E3)LMY;C
MKBS-2UJ,S,S,;_A"%N"MVTHVXI)):$DM"2[B-32E*<G.;;DW5MZVWPGSQV.
M
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M%P:P]ITNWFUWHKY7+5+O5*EHW(:Y
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M">&ZMQ\-&SD,+J^5>N3D_ ]A?B^,UIO/>=S-96WJMQC%>%;7^T16B7D>
M
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MME5[\6U7DV5X#86Z=YSP$[+^XN:.\TG\->4FD$%)4
M
M
M                                                 'A=_P"DC?XY
M7[WD#E<)P]:[YYAP<@
M
M     !(J(P9DC[N/^UK3_6,W]\NB20^0N\C#R^4^^?.'<X     *IO3G?E::
M>?U=<2_G+U<&X.S_ /8UW_-2_$MFN][?VE#\POQID,(G)%P
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MSK4#]X1!#]^?V#+\[#X62'=?]K1^\E\!;W&EC98
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MRK<.DN]VY+4GWJOP./$8O)D\;B[^;S^3.6Q;^\CP^'1X:DM AI(P
M                                                (..G8MI\?0+1
MVD9)XJVSU==L)SB%+)CLJHPZ^8@,O$2>0M3B+=]:"4HO^C,R(^'%,_[/81>9
M7[C^4K%%X9*OP(B6]TFL':@ODNY7DBZ?"RKL-M$
M                                                "Z1T5<^99;!M
M )$Z0N2^W#U#@(<<X<I,.JU:SVKKHY<DB+D1*^&TTG]7DH+CQ/JC1>]\8PWC
MQ*BJ*L'X7;@WRMFTMWFY9/9;UTEXIR2)"!&C-%5SITK.8[NATPIUO*57P-!*
M2SBQS4KD-3+;4/4>+/>2DU<@E/L4L9)F1$9DV7$SX%PV]V?0BLIO3^Z>):\"
MA"GPLU[O=)^T+<?N593Y92YD0I"=D5
M                                        +Z^U>UF7NV';C=V+G/6%
MQH-I!:SWO;?LLRPT^QZ7*<]NI:O;OO*/JF9]7Z)CSOF\(V\VQ5N/R8XBXEWE
M.2-P9=)SR^Q*6MV8/\%&>1CB\*9W2S8Q(QS?=K$^XRIJ'D\3 <GK%+-:C?CR
M]/\ &JZ<\1K0@N3X=JYB"))J21((N/$C(MY;FW5=W>L)?*@YQ?@G)KQ-&K]X
M[;AF]U\$E%KS4OA3(X!)S!@
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MEYTJ?[)/=T+;6%O7>"5Q+D5?]HG8&O27@
M
M
M                                        !X7?^DC?XY7[WD#E<)P]
M:[YYAP<@
M                                                       !(J(P
M9DC[N/\ M:T_UC-_?+HDD/D+O(P\OE/OGSAW.     "J;TYWY6FGG]77$OYR
M]7!N#L__ &-=_P U+\2V:[WM_:4/S"_&F0PB<D7
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M]GVE'VYP!H?LZ_U1:_-7/Q6;4WM_85[OP_'B4,1Z'-/
M                                 $K/0S_EM4?W.M0/WA$$/WY_8,OS
ML/A9(=U_VM'[R7P%O<:6-E@
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MO8IG,GCRCD:%:R(AWR&T*1(M\2B6:H-E,@$2$FI&287-6_%5R>"VY*%<G@?
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M.NXVY\JY-OO+@7@5%X#9.#PT,'A;>&A\F$4N^^%^%U9EL69<@
M                                             1@=+MHU8ZM;.\CM
M*2*J7<Z19'4ZIHCLMJ7)?I*F':4F4I;-"5&3$"@OW[!TCX$:(/'Z)$)9N7CH
MX+.XPN.D+\7;\+:<>5I17?(_O+A98G+)2AIE:DI^!53Y$Z^ IW#=IK,
M
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MPK?18R*T*L'\,?\ :\17-&SB$@
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M/MJNQ\67>;^*_ VT^^BM2-ID%
M                                 "6#HA=MEGK%N8J=4+2L=5I]H4MK
M+9U@ZA:(DW.E(=1@])&>+@;DZ%8<;99)XI;;KR2YR>>;)<.WUS6&!RJ6$@__
M #.(^*EPJ'W;[S7Q?#HU,D6[6!EBL>L1)?U-GXU?YWW*Y=/@[I;P&ES90 %6
M_IK]MMCAVL-)N/HX+CF):KPH&/Y9(99_8:C4'&:QJ!".4M!);:;R;%8#*HY<
M#4M^NE*4?MDD>V]P\TC?P,LKN/\ KK+;CW82=7YLFZ]R2-?;U8&5K%+'07]7
M<5'W))4\:7B9!^)\10                              ]VMK;"XL8%14
MP9=G:VLV+6UE; CNRYUA83GVXL*#"BL)6_)ERY+J6VVT)-:UJ(B(S,<3G&$7
M.;2@E5MZ$DM;?<1S&,I248IN3=$N-EY;9+M]/;)MITVTJFHC^4\*M=OLZD1W
M$O-R,UR1]=M>M(D)2VF5'J''T5\=TDIYR-#;,RXF9GY_S[,O:V:W<9&O1-TA
M]['0N]7Y3[K9MK*<%U# 6\._RB59??/2^35WD;6C#F1
M
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M*D+2A)K6I++#[CBB0DC,S(NH1#E3BW1--AQDE5IT/M#L=0
M                             \+O_21O\<K][R!RN$X>M=\\PX.0
M
M                                            D5$8,R1]W'_:UI_K
M&;^^71)(?(7>1AY?*??/G#N<     %4WISORM-//ZNN)?SEZN#<'9_\ L:[_
M )J7XELUWO;^TH?F%^-,AA$Y(N
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M[LY)/BK%I]YD,WNLW;>>7;DXM6YJ#B^!I0C%T[S31Y.@J_M+=$_L=U>_FGS
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M(TEU5<L)E2WIGJ"Y:URS;L*Q&&9&JP@N$AQTT3(::TY,59-M*5P6E)\E)G]
MC'HWKV"45-WK6P]3VXT?>=33ZR_'MN*L7MI?S)<QCX7):
M                                 !*ST,_Y;5']SK4#]X1!#]^?V#+\
M[#X62'=?]K1^\E\!;W&EC98
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M)?"^-MLD. P%C+L.L/86C6V];?&_Y:$1?].Q^3WH_P#=E3]I&4B6=GO[3O\
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MWY3J#2IMZOF6\&7X+*O860;4K+34[KT.5?E432=9:FZ)):$N%4L'E.+Q./\
M:F;;*N)IQ@M-*:J\&C@56V]+[LT@@I*3U+"!"M8$ZKLHK$ZNLH<F!80I3:7H
MTR%,97'E19#2R-#K$AAQ2%I/J*29D8YC*4)*<'22=4^)HXE%23C)5BU1E:SH
MY-FM97[^=;;E$N%DFG>U/+\II,:MD<)L6TR^RGV])B<9U2W#;5:8U2,RY$OD
MF\<2SCLD1F9H<&T]Y\\G+=S#PHX8K&0BY+52*2<O!)T2XXM]X@F1Y7&.<795
M4K&'DTGQR=4O"E5OB:19>&JR>
M                       !X)46+/BR8,Z-'F0ID=Z+,ARF6Y$65%D-J9D1
MI,=Y*VGX[[2S2M"B-*DF9&1D8Y3<6I1;4D]#.&DU1Z4RHQTB/1O9EMORK(-3
MM+**PR/;Y<3'K-MRN:>L)^EKDM;CS]%D;+9.24XS$=XI@V:R-I+)H8DK)\DK
M?W/NSO18S2S'"8R2CF4533H5SNQ_G/ACQZ5HU:VSO([N!N/$8=.6";KHTN'<
M?<XGX'IUQ.B8D=
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MG9:CB4OCVV_C1?&N./%)>&CT&K<SRK$Y9=V;B;LM_%GP/F?&N2JTFG(S9C
M
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M@OX"3O8=.>#UUUN/<EW/YVKCH12B8$>
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MI&LLTR;%9;-N2<L-71-:N]+B?B? S0T2$Q
M 'UJ&@O<IN*['<9IK3(;^XE-PJJDI($JTMK*8[QYN+ KX+3\N7(7PZB&T*4?
M#Z Z7+ENS!W;LE&W%5;;HDNZWJ.T(3N24+:<IO4DJM^ LV=&ET8$[1JUJ=P.
MX:!$7J0Q&*3@&G2S9F,Z?OR"(RR7(I#+KL67F11S-$6,@ULUA+4XM2Y?-]AZ
MIWJWLCCH2RW+&^JU^//5M_S8\.SQO7+5\FNU/,BR!X62QN-7]?\ <Q\GNO\
MG<2X._JG.&OR7
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ME?O>0.5PG#UKOGF'!R
M
M      $BHC!F2/NX_P"UK3_6,W]\NB20^0N\C#R^4^^?.'<X     *IO3G?E
M::>?U=<2_G+U<&X.S_\ 8UW_ #4OQ+9KO>W]I0_,+\:9#")R1<
M                                         "7W;QTSFO>V/ <,P/33
M0#9^A>%XS Q5G.;72K,TZAY#!KVE-(EY5DU!JE0';6,A*SYUPF6D+,_UA"%9
MGN+EN:XFYB<5B<;_ %DW+85R.PF_)B[;HO"R483>S'X*Q##V;6'V8144W&56
MDJ:6IK3QZ#8G^\A;XO17M2^ ^KO].8QGU79!Z[&>?;_1%U[\9MZO#^;/](<8
MR'YP=NVRKDKR#0?9G<2FH[L:).M=*M1;>7 0[Q/C$7;:R3FV^0X?+))I4V:B
M]LDRXD*UKLVR:SHM8C'1C72E<@D^_2TCK+?7-):[6&;^]GZ9KKJGTTW2'ZH5
M+N/MZUM:94+K33'@[2'%<?P27':8;YII$#*(<.3FM8A".H28UFTGZ'4X$7#)
M83<3=G"3Z5V'=N<=R3FO#&JB_#%EIB-[<ZOQV8SC;C_,BEXW5KP-$7UW>7>3
M6TZ^R.XM<@O+1]4JSNKNPEVMM8R5$252)UC/>?F2WU)21&MQ:E&1?1$NMV[=
MJ"MVHJ-M:DDDEWDM"([<N7+LW<NRE*X];;;;[[>D^6.QT,Y[=-Q^KVU35.DU
MAT4RAS%\RI4O15J7':GU-Y32U-G98]D-3((XUK2626DDZTKDK0I*76EMO-MN
M(Q^9Y7@LXPDL%CX;=B7@:?!*+X&OM.JT%[@,PQ66XA8G"2I<U/A37$UQ>/B9
M._\ WDS66?C*ZC(MKFCUU:RJ]V)9R/*7*FL9G/.DI*C7B\YBVD>#UI,B5'<L
M7347']DZO4U[]5N!C=V[6+OQBG5?%CM+^DJ:>[1=XF"W[N[-)8:+E33\=TY-
ME_"1/[O.D@W1;SKJBDZE9;%QG$,1GQ+3"],--V)V+8#C-I7DI-?=1ZY5C86-
MI?P6U&EB;/E2GXJ5K1&-AM:D',,EW7RC([<EA8.=^::E<G24Y)ZU6B23X4DD
M^&I'<RW@S',YQ=R6Q:@ZQC"J2:=4WIJVN!O5P)$E>$_.--SM-I^UBF?:-:/Z
MFY*S6,U;N96)W]"W>-ERV9LK*,7JY*ZFPE6,-1(=3#571N7RE$UR5<V46Q'9
MAE4\2[V&OW[5JM=E4=/O9/2J/56K[IGK._.+C:4+]B$[M/E)N*??5'XGS$:U
MET@>H%WNPD[M\BT9VW93D[M*O'X^EV3:93+316'7HJCJ(+C6&%D\:<Y95C?!
M]F2Y8*<*67.JXGU!*([M8:&3K)K=_%0M;6UTD;B5UNM7\;9I1ZJ4U:#"2WAQ
M4LR]I.U8=S8V5%Q;BE6NK:K7NU\!(/ ^<9[TZJ#"JZO1[:16UM;$CP*ZN@:?
M:L0X,"##91'B0H42/K@W'BQ(L=M*&VT)2A"$DE)$1$0CDNS#(9R<YW\:Y-U;
M<[;;;X7_ %1DUOOFJ5%;PU/O9_I#7C<9TQ^M^Z/!<OPG5';KLVD2<OQR3C)Y
M]7Z1Y<]J1C460TZTW.Q+*LBU/R!RFM(*7U]CN\TZEHUJX)/B8R66;CY?E.(A
MB,)B<=2$MK8=R.Q+N2C&VJI\.DM<9O7CL;8G8OVL-LSBU51EM*JI5-S=&N B
M+$T(P2U[8.F)UTVCZ>8WI_I/H'M%0]C]*Y0R=0+C2S,$ZEY9!<L7+,SS+*\:
MU.QM5\ZA]2$IY3*$$VPT7)XH(Q#,VW(R[.<3/$XS$XWXTMK85R.Q%TI\6,K<
MJ<O"R3X+>O'8"Q'#V+6'V8Q2JXRVG3C:FJOP&Q5M\XKWF7U;-IKW1C:%=4]E
M'<B6-5;:=:JV-;81'2Y+L:;!F:W/194=Q/44AQ"DF7T2&-AV99';DIV[^-C-
M:FIVTUWFK1=/??-6J.UAFOO9_I#2G:-M8SCI1-X&4U%1#PK2*AO)U]JOJ?(P
M>@*IPO3?$9=Y&;DU.G^(2+)]9<Y96[$"IKCE.$RA7..+-EAU19W.LWP^Z.20
ME-W+UR*5NWMNLIRIKG*G$FY.FG4M+1C\MR^]O'FDY/9M6V]J>RJ)+BBFWI?!
M5Z-+TTHY:MSNL>WGH2\NKM$MEV"9/F6XBVQ:+D6H>HFJ^JFH]EAE/6WL.17T
ML*[TKQ/(L0T_S'*I41I=@RIZNCL5:%QG".2M:4189E.!S/?VR\?GMR$,LC/9
MA"W;@I-IU=+DE*<8K5K;EIU:W)<?C,#NFUA,LMREBYQVFY3FXK@3<4U%MT>I
M*G(C19GI\ND9:DM/KSG3B2TV^V\N$]I7C"8S[:'"6J*ZN.TQ,)AU)<A1H>0[
MR3]JLE<%"0OLYW8:IL7:_G&8;WTSCBL^:_2)!]@W3T:\:J[BM+M#]QF$Z;VN
M-:N9I38!49?@=/<8SDV.Y1ETQFEQ=4V%,R*VH[JCDY!)C1WD(9B26&Y"WR=>
MYM,=4;WC[.\NP>67LPRRY=5VS;<W&;4HRC'3*CV4T]FKUM.E*+69C)M[\3B\
M;#"8Z%O8N245*-4TWJJFW6KHN"G=/B?.4-$\,I<GV[Z^TT"+79GG,;,=/<V>
MCM1V%9%#Q!B@M,1M):&([;DNTJXUS-ANR7G''%Q"ALEP;CH(=^RW'WYVL3EL
MVW8M[,X_S7*JDN\Z)T7#M/A.N_.$MJ-G&QHKK;@^ZJ57)IY2,#8ITMVY/8O1
M/:?XY%QK4_2%^>]9,Z>9R5BV6.SICW/V4K#,AJI+$^A7:.^V>8>;G03<4IU,
M=+RUN*EN\.YF5[P7.LW7*SC4J;<*?&2U*47H=.!JCX*TT$?RC>;&Y3;Z"BNX
M7@B]#7>:U5XFGW*&[.I?SC+<+D]=QT]T"T8T^RU$*; @9Q<.76H%W0LSTH2^
M]C[,Q-! BR#YM)FF2W,C.*27.,K(N P.%[,<MM2_\SB;]RQ5-P5()TXZ5?)1
M\3,M?WYQ4X4L6+<+G&Y.5/!2/PD96W_I(-TVW_<AD6Z"!G#FHFHF=PW*C4E.
MI9RL@K,\H')<"6BGLD,2H$NJ9JUU<<JU5>[%\&M-)88),8UL+E69;KY1F65Q
MRF5OHL-;=8;%$X.C55KK6KVJUVM;TZ3 X+>#,<'CI8YRZ2Y-4FI:I*M::*4I
M]S30N*F@D U\Z?S7/6W3ZWP-G;WH/CRK[&K+'9V1W$3(<WMJH[V ]77=GB*+
M"?60Z"9(CN)YA3J)JHZD$HU.*))HCF7=G&7X#$K$/$XB2C)/95()T=4I43JN
M/54S>)WVQ-ZT[=NQ;C)JE6W+OT5(_"1T]'INJQO9?NCPW<#E&&6V>5N*TV7U
MB:&DM(U18F_E..S\=[-9DS&GHB^Q(]BXHVW$\%\>!&D^"BDV\V3W<]RB>6V;
MD;<YRBZM57Q76FC3P&"R',K.58_K=^,I0V&J1I6KIITM(VPPOIR=\V):EZ@Y
ME9Y)C&HV#ZB9%=7%AHMJ53.9)@%%56Y2H[.+XH\Q+J\FH:2JK7TL-1VIW8KY
MM$Y)9?6MTW,/?[/]W[V%M6(1G:Q%J*2NP>S-M4^-+7%MO36E56B:T&2M;X9K
M;Q$[LMB=B<J[$EHBN*+5'JT::\=-9RNDZ4K:)0VQY]"Z)3;:SJVE3DN-D;.8
MN%I_"MEN(6BR@Z2R]-IM' <CFCE-''E-/,O<'&W4*+JT;FZ&=7(=6EG.*ZEJ
MV=GX[7$[G2)OPK2M#*L=YLMA<Z:.6V%?K6JDM?'3H]9JAO4Z33='OG=:J=4L
MDK\=TTK[)%K3:2X)$?IL+B3V6B9CV-L<B5.NLIM6$<HVWK&5(1&6XX<9N.EQ
M23S&0[J91N^MO"1<\6U1W)Z94XEJ45]ZE7A;,7FV\./S;^KNM0PU:[$=7<J]
M<GW]'"DB/@24P9*;L4Z6[<GL7HGM/\<BXUJ?I"_/>LF=/,Y*Q;+'9TQ[G[*5
MAF0U4EB?0KM'?;/,/-SH)N*4ZF.EY:W%1'>'<S*]X+G6;KE9QJ5-N%/C):E*
M+T.G U1\%::"1Y1O-C<IM]!17<+P1>AKO-:J\33[E#=G4OYQEN%R>NXZ>Z!:
M,:?9:B%-@0,XN'+K4"[H69Z4)?>Q]F8F@@19!\VDS3);F1G%)+G&5D7 8'"]
MF.6VI?\ F<3?N6*IN"I!.G'2KY*/B9EK^_.*G"EBQ;A<XW)RIX*1^$C*V_\
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MX*Z/P607C8)#@
M E9Z&?\ +:H_N=:@?O"((?OS^P9?G8?"R0[K_M:/WDO@+>XTL;+
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MU+3>?QIOCD]??IJ\!MJ,,9(
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M2_2'N*^%NFG]$8?6!G/JL+YL_P!(/=++?+O\L?0'J,=I?I#W%?"W33^B,/K
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M2_2'N*^%NFG]$8?6!G/JL+YL_P!(/=++?+O\L?0'J,=I?I#W%?"W33^B,/K
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MY]5A?-G^D'NEEOEW^6/H#U&.TOTA[BOA;II_1&'U@9SZK"^;/](/=++?+O\
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MIW%Q:HKO15(KD,QA<OP6"5,+;C!\>M\KJ_&9]&.+T
M
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M0V32=9'YE"N5(2ZXO$2QMV5WXCI;KQ(OXX:VH?&594[I>U&8,>
M
M                               !(J(P9DC[N/\ M:T_UC-_?+HDD/D+
MO(P\OE/OGSAW.     "J;TYWY6FGG]77$OYR]7!N#L__ &-=_P U+\2V:[WM
M_:4/S"_&F0PB<D7
M                                 ":[H*MU.EVVC=G?5VKMW Q'&-9\
M"5I_79I;RDPJ+'LK:R&HNJ)&0S72*-64USV(]%5,>6AB+(6RIY2&3<=;@?:%
MD^+S7)XSP47.[8N;;BE5N-&G1<+6AT6EJM--$2[<_,;&"Q\[.(:C&]%)2>I2
M3T)]^KT\=%PDA?34]%QK_K5K5(W:[<<<?U:J\MQ/&(&?8502HC^855GC-=$Q
MZKOL9J7'F5Y316] Q#)3$#GYK#[+KIMK9<Y34:W$WMRW+\#[&S270SA.3A)U
MV6I.K4G]RTZZ7H::5:Z\UO3N_C,=B5F&!2N?$2E&M'HU-5='5/5K5.&NBN7(
MVC[K8ESY.RMLFX-B_.6Q *D=T9U&1;*FRE-IBQ$5ZL;*6N3*4\CFT$@U.<M/
M)(^)#9ZSG)Y6^E6+PSM4K7I84IQUVJ$&>59HI;+PU_:_-SYB8WHS^BXU>P36
M'!MW.\:MB[9]"]!L@K=1VW=7K&KPR]OLLQJ7'GXDU*J[^5%DXE2UN1%&EORK
M-N.M\V"CQVUK=-UB#[U[W8+$X&YDN2-XK,,1%P_JTY)1EHEI7RFU5)1KKJWH
MHY5D&[F*L8J.99FE9P]E[24FJMK4WP12>FKTU6KA-?.F7Z0/&-[VN.,T.E$B
M9+T2T1AW]+B5W*8=@GF^2Y!+@'E69QH+Z6I4:DELT<*-6HDH3(['CJ?4AI4E
M3*,EN-NW>R#+YW<8DL?B&G):]B*KLQKQZ6Y4T5=--*EAO5G-K-,3&SA6WA;-
M=/!*3I5KN*E$^_P,AP$X(J
M                                     2L]#/\ EM4?W.M0/WA$$/WY
M_8,OSL/A9(=U_P!K1^\E\!;W&EC98
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MQX_1. XN6&EB)RP<91PK?Q5+3)+NOC)985Y68K$.+OTTM:J]PYR+<K
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MY7AJWIT4KJKI)7Q#B1@
M
M
M
M
M
M
M                              5<L,_^NL]6?ZC5;]K&F8QR_:+[WV$7
MG_V3^7&1H?.XMHGDYJ=M^WMXW6FW5ZD5$C0?5"6T;+<=&:8C'G9/IO/D(Y)/
MR++(\/<MXBG.4I*(^.LI,DF9&JCF%NDU<6IZ/"COA9U@X<7V26WYKUO /<%T
M?KFA>1VJ)N?[1LM=P#F7IC4BRD:4Y><W*=,+.2SRDOQXL%[PQ0Q4FCFRBT39
M$M2N4E%S@+FU:V'KB_$REBH4GM\#^$D5Z8K>&K8_T>>X/6:HM_ ^HEGC9Z7:
M/OM+BE8IU0U*)W',?M*IF8\RS*FX;"?EY IO]D_S:H=5S;A)-"JV*N=%9;X7
MH7A*=B&W<7$M)Q/HH]FWR&NC#TNT<MZ=%/J1=Z>7VJ^LK:FHZ+ ]4M2:=5[=
MUEN[%0EF58854G QPG2-9*CTS1$M9$2CZ6;?186CUN+;\*.UR>W?7$FEXSKL
M>AM_M3-B7]8K!/WXX,18_+P^^7PE]<_)R^]?P';:"1&)(B>E6Z-[9]NAVL;G
M,RSC0S3*!K14:-:AYMB^N]'@]%5ZK4V781B=UD^-39^95#%5DF2TK5M"(I=9
M-FKB2X[KJ#)"EDXFUQ-BU.W*32VTFZ\)7LW9QFHU^*W2A3=^:K_VI#O]6W5S
M^%\#&.P/ZPN\R[Q'Y%^#X3LE'GF8S+LB0ZU'CQVG'GWWG$-,LLM(-;KKKJS2
MAMIM"3-2C,B(BXF,UJTO48W7H1UJ/2#;U]<.G3Z1O3G:CHIE5M4;;Y^L%?IE
MH1B:5/M8[(B-S'X&4;C<YI$RX!W]OY/,V%NPV\HGJN@:[#C(1)=F.2\'>NSQ
M5Y1C\FM$OLF3MPC9MU>NFDO_ .S+9/M\V':*8UH?M\PBMQNDJ(40\DR=R%!/
M-=2<G1#C1;/-]0+^/&CR+[)+A<9*EJ5R8\5I*(T5IB*RRRWF+5F%F.S%:>/C
M,?<N2N.KU<1";\Y*Z.K;_K!LJU6WA5V'8_ANXO0&-096G4*AK(=59ZB8E*R2
MEQJ_PS4*1"AF[DS#%;<G,JI$@E2X,V(VTV^W%?E-NVN-L0=MW4J37C*^&N2V
M^C>F+\1%3\SU_EAWO?<UT;^VC.10R[\I+O?9*N+_ ":[_P!AE[L98L     #
M1;I)-D^)]('L[U>VU9$W5QKW)*95[I;D]HPIU&#ZMXXT_-P3*4/,MN38D5NR
M4<*Q./P>?IYLR.7%+RB.CB+2O6G#AX.^5+4^CFI<'"=9YT=N[K4[HH^D Q[4
M'**>\ITZ>YGD.BVYK35!17+6?A*;_P G=3<5=82^<21D6(7-0FQ@)3(;:5;U
M+"5.\PISE8.U<E8NJ7$]/V3)3@KD''C+6^[/4F!T\'23:0;"M$LF1EW1];5E
MT^OFZ;4W#ISLC&-2\E*(3==BM5DU<:XBS.+=%CE<E+S$M,J=?3$MO)JVU)OK
MDNMWU:A^1CI?\O$BVA'J]ISE^4?\OMLMTU]? J8$&JJX46NK*R'&KZZO@L-1
M84"!"91&APH<9E*&8\6+';2AMM!$E"$D1$1$,FDDJ+463;;J]9Y)DR)7Q)4^
M?)8AP8,9^9,ER74,1HL2,TIZ1)D/.&EMEAAE!J6I1D24D9GU ;257J"571:S
MKTLJULSKYQ5TPN!: V.3W-7L9TVR[,+_ !G#JB;*JHRM%].67%WVH%@PHJV>
MK4'6IV-%@-25M+E8_'NF6&R-N*^Z]AG*6,Q"BW_5U\7.S(J*P]IM?*^R7\]+
M=)M,]$<!QS2S2+!,7TYT[Q*N:JL>P[$:>'3459#:023)N'$;;0])DJXN2'W>
M6_)>4IQU:W%*4>8C",([,4E$Q\I2D]J3JR@7\Y9VJX_L3WN[?]VNU[G-%+?7
MV)E>=N>;UR1C;E!KKI)D6-R\DU QQ5?(:8HI>20L\IY$AF(TRTNQ9DR5DMR6
MZ9X?&VE:NJ4-">GPF0P\W.%):6BYUT7F\)_?AL3V^[F+9B'"S+,\6E4^I,"O
MCIA08NI>#7-EA6<O5U>F5.574]S?T+UC7L+><<:KIC!+4:N(R>'N]+:4W\KA
M[Y97H='<<5JX#K^OG!&M6XO6OI6=9M,<\1DTNOT@RO&M-]!-*6X[]Q5PL:LZ
M3'+2ALL>Q9$>1&N+K5:7;-6KZS8?E33F,Q%&MF-'9;Q&*E.=^2EP.B_EW3(6
M8QC:5.%'9F8)45\+3[$Z5O#Z;#:]&)T\5S!:JJ@UE%CC;U6P4K&H=-#;37Q*
M^N4XN.3"$\VE*>3PX#-P2V$J)*FK[1C9/X[=:Z=9UHG3P:!X]T>'2N2\BVM2
M%Z3-Y%2:=;H\ @88GP0QI9G%KD%_%L6L2:;XQZRM3FV$2;:)#:0F%!:G%$8:
M1&9;:3A,5!6K[4-"T-=PR5F3G:3EK.Q_VQ:N*W ;;-O6O*Z\ZE6MNAVDVKBJ
MM24H56JU)P*@S(Z]2$/RD).&=SS9D3KA%R>HI7T3S=N3G;C)ZVD_$8V:49N*
MU)L@S^<-]'[M8SOH^MQNX^!HQIMAVX+2HJ'4VIU=Q3#J7',SOY<O4"DAY?5Y
MK=4,6LL,T@Y)49'8JY-FY*2Q9/(F)+G4*Y=IC+-OH7<22FN'PE?#W)[:@W6+
M*P'S>G:CJ=O3U)W*Z"1-7;W2/;-D&$Z>6FZSR"E'4ZFZHXC4Y%>^26C>-Y*@
MU.XOC&;6DJ6YD<IMM;C]9!.%PY$M9'886T[LW"M(4T]WN%U>FK<=JE771WR3
MWIX>@SR]F+MIM>C/V>8P[IK@V)Y5B.HV,:/TU>>I\B_?GT\F@R?-+&WM5YEJ
M;&DU<5<=J4\[83(3[;RGE\)9&5?%85IKH8_%IP:RG8OJ2?2/XU>\6%>@^VJZ
MP[->C>T/T4UYK&<>U/CS<^S.^Q)J>Q9N8<SG>;7>356-SYD-Z1 7<0ZN>RY.
M;86IIB8ZZT2G#;-Q=[A+<K5E1G\JM2VQ$XSN5CJ2H2U"Y*( '4FX'F>XRRZ7
MO#,]RO',FL=SJ-_V.Y+DF&L.RYMZ6I-9KM#GW&(LN2&DK.# G1'("26VB,U!
M;X*0EA)I*.)SZ7:?R]KQU,NU'9I]S3Q';9"1F(*]GSGK"<1R?HG-2\BR&!!D
MWNG&J.C&4X',D\A,NMR*USNMP6R<KUFI*U.R<.R^S:<;+E$II1J-/M"4FQQZ
M3L5>M-%SA6^D:X*%?/YHMJ7F%3O<W#:10I4A>!YSMCGY]D=6@^+"<HTVU.T\
MH\2NW>4X1)*'6ZFV\0R2DU*5.1Q,B28M,ODU><>!Q*^*2=NO"F7;]]6YVJV9
M;0-PNYVU:KI:M(=-;O(,?J[:9V!77^<S"9H=.\8ES")2X[64YY;UM=RD)6YQ
ME>T0M?)2>4O7.BM2GPI%E;CMS4>!G7/="AHK9](UTNV#95N&GNZGE67F<[K-
M:)>2\A]W.+K%9;5M5>%(L=IFOD5UEJI?TQS(!M(@NUW.QN:YE1-##8:'38A;
M>G35]TR-V71VFX\6@[1$9XQ9AC<5H1@.Y[0O5;;[JA6MVF":N83>85D#"FD.
M/1&K:(I$*ZKC7P['NL=LTL3X#Z32N/-C-.H,E((RZ7(*Y!PEJ:.T).$E):T=
M8AT4>Z'4KHR.D^PNHR*T76XXO5^3MDW*8U'N.9QNQQV=F+F!7MK,<D-HC2CT
MXR=*+V"\I+*U*KS9YQIJ0]QP5BX[-Y/@K1]XR=R"N0<>'@.U6$@,4=2;@>9[
MC++I>\,SW*\<R:QW.HW_ &.Y+DF&L.RYMZ6I-9KM#GW&(LN2&DK.# G1'("2
M6VB,U!;X*0EA)I*.)SZ7:?R]KQU,NU'9I]S3Q';9"1F(*]GSGK"<1R?HG-2\
MBR&!!DWNG&J.C&4X',D\A,NMR*USNMP6R<KUFI*U.R<.R^S:<;+E$II1J-/M
M"4FQQZ3L5>M-%SA6^D:X*%>WYHWJ5F%3O@U^TCA2I"\$SG;38Y]D=6@^+"<H
MTVU&P.BQ*[=Y3A$DH=9J;;Q3)*34I4U'$R)(M<O;5UK@<?LHK8M)VT^%/[#.
MPE&8+  "H?OCUQU-Z<[=_(Z+C9WDLRAV8:)Y%59#O;W)T7/2J?)Y5!=.):P[
M');25U-Q50+JJ=:HF'5+9R"_AKGI2=94E*>Q=V<L7=Z"U^33TO\ EXB]MQ5B
M'23^6_Y4YRK#CFF6(:*]-[0Z-Z?09%7@6DO2JU>F6$5DN=+M)5=B&![N&,6Q
MJ#)LY[K\ZQD1*:J9;6^^M;SRDFM:C49F+&45"^XK4IT\9<Q;E;4GK:^P=L<)
M$8D
M                                            "141@S)'W<?]K6G^
ML9O[Y=$DA\A=Y&'E\I]\^<.YP     53>G._*TT\_JZXE_.7JX-P=G_[&N_Y
MJ7XELUWO;^TH?F%^-,AA$Y(N
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M;BLQQV.?_F[L[BXFW3P+4O C#0OBS
M                                              E9Z&?\MJC^YUJ!
M^\(@A^_/[!E^=A\+)#NO^UH_>2^ M[C2QLL
M
M
M
M
M
M
M
M
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MJO5P'7-9I_\ 7!^6?_GE+W_QM2AA;GZS+\X_A,C#\DOO5\!VIXD!B@
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M>]O[1A^87XTR%\3DBX
M
M
M 2O=#&R\[O7J5MM..(CZ;9^](6A"EI895%KXZ77E)(R:;-]]""4K@7+6DOHF
M1"'[\M+(95X;L/LDAW73>:JGD2+>0TL;+
M
M
M
M
M
M
M
M
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MV69"W'#2A)F? CX$1F,\IP;HFJ]\QCA):6G0^Z.QU
M *<'S@?IX<PT/R?)MBNRG+58]J37PE5FX'76A>,KO3Z58LL/>;32^V9>X56<
M-5SI^&KEM*I%,;Z8T)QFR;>=A8S%XMINU:\+^PB]L6%3I)^!%5KHS-BN?=*!
MO1Q?1 \BNX=1;.7.INN^ISSWA>]Q_3ZKGQ7\NR14JU5*7999DMU;QJV"[(3(
M)5K9M/2$J90^HK"S:=ZXH+AU]XN;DU;@Y,[3/:_M#VX;---ZO2K;;I/BFF.*
M5T=EJ6Y35[:\CR:8TVVVY=9IE<HG\BR^^E$TGG)=A)?=Y*4H2:6T(0G/6[5N
MTMF"H8R=R<W63/K[B-KVWS=EI]9Z7;B]),*U:PNS8?;*NRNG8ES:B0_'>C%;
MXO?-$S?8ED$9J0OF+&LDQ)K!J,VW4F9A<M6[JI-)G$)R@ZQ9UAW3,=%]?]&%
MN?+"ZJ599%H#JO$M<QT"S*T<;?M)%%72XL?(L'R5]J/$8>R[ )EE%:DNM-DU
M*@S84K@VN0MAG!XBP[%S9UQ>HR=JXKD=I:^$[ 7H*_[)39%]RVS^WW,!E\'^
MK1\/PLL,1^6?@^!$LPN2B !#YTZ>]+Y$G1SZSYA0VYU>J>K,1.@^D!QY9P[)
MC+=1H4^'<9%7/H8E.1Y>$X)%MKAASD<@YD)ADUMJ>2LK7&7>CLNGRI:$5\/#
M;N:=2TG5/C!&2.S/^;4;RV]S_1U8QI??VK4O4K:-9L:)7L1QV(5@[ITB(JST
M:NSA1WW'6*E.)I=H(SKB&C?>QN0?!1I-:LU@;FW9V'KC\' 8_%0V9[7 RPH+
MTM@ (C>E$Z-[9GN0VJ;E<GS;0#2V#JK0:*:E9?B6LF.X10T&IN/97A^(6N2X
MW8JRZCBU=]<UL6WJF3D5TN2Y$F1S<96GDN&8M<18M2M2ELI22;JBO:NW%-*K
M:;6LZHX8(R1?U^:K:":%ZG]'SK+DFI>BVDVH>11MY.?TD>^SG3G#\MNH]+#T
M2V]SXE0S:7]-83FJN+.M93S<=+A-(=DNK2DE.+,\K@;=N5EN44WM<*7$BQQ,
MYQN)1;2IQ]\SWTUO0;[2=4]INL.O.VW13"="MP6B&&9-JM 3H]C-5A>,ZF46
M(UKV09CB&3X/CT2#CTZVLZ"!*>K9T6,Q8^%4-)6ZZRZ\TOMBL+;=MSMJDEIT
M'%B_/:4)NJ9URC#[\5]F3&>=CR8[K;\>0PXME]A]E9.-/,NMFEQIUIQ)*2I)
MD:3+B75&(+\[';YLSTCFK&]#;GJEHGKWD=MG>IVUJ?@T*JU&OGES<@S'3#/8
M>1,XI&RBV=6Y*O\ *<3L<+G19%C(/LF9#>AJ?6_)3(?<S&!O2N1<)NKCJ[Q8
M8FVHM3CPZRS0+\M0 (?.G3WI?(DZ.?6?,*&W.KU3U9B)T'T@./+.'9,9;J-"
MGP[C(JY]#$IR/+PG!(MM<,.<CD',A,,FMM3R5E:XR[T=ET^5+0BOAX;=S3J6
MDZI\8(R1V9_S:C>6WN?Z.K&-+[^U:EZE;1K-C1*]B..Q"L'=.D1%6>C5V<*.
M^XZQ4IQ-+M!&=<0T;[V-R#X*-)K5FL#<V[.P]<?@X#'XJ&S/:X&6%!>EL
M                                   $BHC!F2/NX_[6M/\ 6,W]\NB2
M0^0N\C#R^4^^?.'<X     *Z?3P:6SS?T*UJB1G'*Q#&0:87\HB6;428IPLJ
MQ-D^"#02I[/AD^JHC_S<N!'U>&S>SS%QIB,!)_'^+<7=7R9<GQ>4A&]^'=;.
M*7R=,'\*Y?C<A7;&S"%
M
M
M  !/#T%&ETZRU8UAUC?CN)I\3P6'I_!?<;,F)%YF5W O))Q733P<D5=7B/)=
M22O:(GHY1>W28UYVA8N,<'8P*?QYW'-]Z*:\;EH[Q+]T</*6)NXI_)C#9\,F
MGXE'QEF\:I)Z
M
M
M
M
M
M
M
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M:TG9OC.F,                                      "141@S)'W<?\
M:UI_K&;^^71)(?(7>1AY?*??/G#N<     &"MRN@F*[F-%LVT<RU1Q8>45Z3
MJKEIE+TK',DKG4SL?R"(A1H-:ZVS90IULEH[(C&XPI1)=4,AE68WLJQ]O'6=
M,H/2O*B]$D^^N1T? 6>/P=O'X6>%N:I+0^)K4_ ^5:"CWK;HKJ%M\U)R+2S4
MVD=I<GQV4I'*X.+K;JL<<<*NR&@FK;:3945NRWSD=Y)$?T4.)0ZAQM&_<!C\
M-F6%CC,)+:M27A3X8M<#7"OL49J?%X6]@K\L/B%2Y'D:X&N-/@YS% O"W
M
M
M                                     .>Z8:8YOK)G>-Z;:<T,S),O
MRJP;KJJLAH,^JKBN1-FO\#:@5=;&2M^5)=-+,>.VMQ:B2DS%OB\7A\#AYXK%
M24+$%5M_ N-O4EK;T%;#X>[BKT;%B+E=DZ)?RX%PO@+NVT#;/CNT[0O%M):5
MYBRM8_/7F;Y&RTIGRHS:U0QX9MDMKX+;A,HCLPX2%$2T08K*5\IPEJ5H3.\U
MNYSF$\;<T0>B$?)@M2[^MONM\!M;+,!#+L)'#0TRUR?')ZW]A=Q(V=&),@
M
M
M
M
M
M
M
M
M
M
M        >%W_ *2-_CE?O>0.5PG#UKOGF'!R   '589I_P#7!^6?_GE+W_QM
M2A'[GZS+\X_A,K#\DOO5\!VIXD!B@                   "OM\YTN9M7T2
M>J\&+'GO,9'JCHC36+D-M"X\2$QG];D*)%JI2B4U 584+#25)XF<IUE/#@9F
M5ECW_4>%%SA?RG@YCK)1A3('9-_-66&&>BU-QIEIIR5N/U=?DK;;0A<A]-9@
M\9+SZDD2GG4QH[;9*5Q,D-I3]!)$69R_\@_OG\",?BORB^]^RRR0+XMC"&1[
MFMMN'7EEC&7;@]$,5R2FD=B6^/9'JQ@='>54KD(<[&LJFSOXL^#(YMQ*N0ZV
ME7)41\.!D*;NVDZ.44^^CLK<VJJ+IWCXGRP-I7YT>W7[]NFGQF''36?+CRHY
MZ.YY,N1CY8&TK\Z/;K]^W33XS!TUGRX\J'1W/)ER,S1B>88EGN/U^68+E..9
MIBMMV5X+R;$[NLR/'[+L&;)K9W@^YIY4RNF=AV,-Z.[S;BN;?:6A7!25$512
M4E6+31U::='H9AG=MN+Q3:1MGUOW*9J2':#1O3K(LT77*DL1'+^W@Q%-8SBD
M-^2ZPPFSR[)I$.KB$I:25)EMIX]4=+MQ6K;F^!':W';FH\97/^:\;>\LO=.M
MS724:RJ5>:L[QM4LEK:/)YS<54R;B>.Y5;7&HN007&6B=AQ\XU>GRH\N.:S1
MRL8CFA"$D1KLL!!TE>EK;IS^,N,5+5;6I:3'OSM+9MY<Z"Z-[V\5IT.W^AE\
MG2C5.?&:CHDNZ6ZC62%X99VDA:"?=K\1U,64&,TA?%+^6.*Y!ERE(XS"W6*N
MK@T/[!SA)Z7#PE"FDNK?&[FHR+'[.=2WU!9P+JDN:R2]"LJFWJI34ZMLZZ9'
M6V_$G0)K"'674*);;B"41D9$,47IW '1X[L*?>]LOV^[F*Q^(JRU%P&M5G,&
M&7(:H]3L>4[C.I=$EDVH[C4>MS>HG(C&IMLGH?,O(3S;B#.0V+G2VE/AII[Y
MBKL-BXX\!N@*Q3-==X'Y)6Z/^KKK;_-IDPI7OR,_O7\!WM_E(_?+X3IIA'3+
M%L'H*4]-5/V>ZJ5/1PN;9:314]PV3RLAR?64HKN9(U9+3O2 [^MH8\E%O%.H
M/#(]'R52J\V><??Y#O.%^QWV&ZUT;5BFQ7N:]!;W>@VOZWY5.[]@T@Z6';UT
MW#4VJUBZ3JEU9U+TXQ.37P8F:XS>X!;Z.XPQ9R6(SKD.IT=BOX%I79WTE],$
MY]A15[TR3S#:NR")A"J5^.)KM7Z_8\6@[VI6J4MT-Q^BQWY] )MTR?$;?5#9
MAK#I[JO6FP]'UVUHNZ_=M28Q9P'%RHMVU"Q_'L&:H;EE\DG&GT&G2)K3A),E
M-D7+%2Q=PL'6<'7C>GQ:/@.MR%Z2I&2^#QZ2_?I#K+I1K]@%%JIHIJ'B6J.G
M63,N/4F885=PKZDG&RLV94;LN$ZX4:P@2$FU)C.DW(C/)4VZA"TFDLQ"<;D=
MJ#K$QTHR@Z25&9+'8X-=]VVXO%-I&V?6_<IFI(=H-&].LBS1=<J2Q$<O[>#$
M4UC.*0WY+K#";/+LFD0ZN(2EI)4F6VGCU13NW%:MN;X$=[<=N:CQE<_YKQM[
MRR]TZW-=)1K*I5YJSO&U2R6MH\GG-Q53)N)X[E5M<:BY!!<9:)V''SC5Z?*C
MRXYK-'*QB.:$(21&NRP$'25Z6MNG/XRXQ4M5M:EI,>_.TMFWESH+HWO;Q6G0
M[?Z&7R=*-4Y\9J.B2[I;J-9(7AEG:2%H)]VOQ'4Q908S2%\4OY8XKD&7*4CC
M,+=8JZN#0_L'.$GI</"4*:2ZM\;N:C(L?LYU+?4%G NJ2YK)+T*RJ;>JE-3J
MVSKID=;;\2= FL(=9=0HEMN()1&1D0Q1>G< ='CNPI][VR_;[N8K'XBK+47
M:U6<P89<AJCU.QY3N,ZET263:CN-1ZW-ZB<B,:FVR>A\R\A/-N(,Y#8N=+:4
M^&FGOF*NPV+CCP&Z K%,XAGVH6 Z58A=Z@ZH9QB&F^!8U'9EY'F^?9+2X?B&
M/Q9$N/ CR;O)<AFUU-51WYTMIE"WWFTJ==0@C-2B(^)2C%;4FDNZ<I-NBTL^
M'I3K1H[KQBZ\XT.U8TTUEPINTETB\OTISO%M1,71=0&HS\^H7D&(6MQ4IM(3
M,UE;T<WN=;2Z@U)(E)X\1G&:K!IKN:0XRBZ233,ECL<
M               2*B,&9(^[C_M:T_UC-_?+HDD/D+O(P\OE/OGSAW.
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MT![N9SZG\.'I#U3N_P#] ?X4]%?Z1@]\=W/I/]G=] >[F<^I_#AZ0]4[O_\
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M'NYG/J?PX>D/5.[_ /T!_A3T5_I&#WQW<^D_V=WT![N9SZG\.'I#U3N__P!
M?X4]%?Z1@]\=W/I/]G=] >[F<^I_#AZ0]4[O_P#0'^%/17^D8/?'=SZ3_9W?
M0'NYG/J?PX>D/5.[_P#T!_A3T5_I&#WQW<^D_P!G=] >[F<^I_#AZ0]4[O\
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MA3T5_I&#WQW<^D_V=WT![N9SZG\.'I#U3N__ - ?X4]%?Z1@]\=W/I/]G=]
M>[F<^I_#AZ0]4[O_ /0'^%/17^D8/?'=SZ3_ &=WT![N9SZG\.'I#U3N_P#]
M ?X4]%?Z1@]\=W/I/]G=] >[F<^I_#AZ0]4[O_\ 0'^%/17^D8/?'=SZ3_9W
M?0'NYG/J?PX>D/5.[_\ T!_A3T5_I&#WQW<^D_V=WT![N9SZG\.'I#U3N_\
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M=7=O%2I:B_BPCHC'P<+[KJ^\M!,LNRK"9;#9L*MQZY/Y3YEW%H\)MH,,9(
M
M
M
M
M
M
M
M
M
M
M         #PN_P#21O\ '*_>\@<KA.'K7?/,.#D   *\MK\V^VCVV]&RWP/Z
MT[C6]2+/=!,W5O8LU:Z9EA#>;S-5G-77*!N,O395]Y*IOG#CD@YQR^Q.H;_.
M?L@L98&,KCN;3JY5\=2Z6):@HTU*A8:%\6H                   !#7\X
MT<M]:>B7W:5&/L=D76"XWB^L;"%*=2A-1I+F^.9QFCZR:(S7V-@-1:N))1&C
MG$I,^'#E)M<9%RP[IP:2OAI;-U=W0=5@,$9(["7YHQJ5&O=CVX/2MVS7+M].
MMS4S*$U[KYN*JL8U(TUP:/3ML-&H^QX<S(,$N74D1$2GE.JZIF8RV72K;E'B
M=>7_ .!8XM?&4N-?!_\ $M?#(EH0F;V^@$Z/?>]EFI6K.68EG6G&ONIK[5I>
M:QX#J%E;TY^_A54"HKI\O!<LM<BT[7#1"JX[4B/$K("GVTJ-+K3ZS?*TNX.U
M=;EI4WPE>&(G!):'%'6%ZIX!8Z4:G:CZ6W$V%96^FN>9?@%I8UO/^#I]CAV0
MV..SIM?V4TQ)["E2:Y3C7.(0YS:BY22/B0PC5'0R182^;G]%KMEZ1S.=S.0[
MH(64Y/B.W^MT>:IL H,FL\0K<GM=5)>I3CTW(KO'G8.3IATT/3533;$*9#4X
MJ<:U.?L:2.[P>'A?<G.M%3Q__ M[]UVDMG6SL,=OVW[1_:QH_A>@>@>%Q=/-
M)-/(MG#Q#$(=G>W3-2S=7MIDUNM=ODUI=Y!9RK/(+N7+??ERWWW7WUJ4L^(S
M$(1MQ4(*D48^4G-[4M95W^= ;@LMU*D[3>BQT145MJGN5U)Q+-,NIHLLT..5
M;V1N8-H]C-LVW&E&BJRG/YDRS><XH7%/'&7#)3;AC'X^;DXV(ZVZ\Q=X6*2=
MQZOY5."Z1='1\YQT&TRPG1S2+>]M>P?333J@AXQAF*5CV-2(=+2P$J)B*B59
M;3YUE->4M:G'9$E]Z3(>6IQUQ;BE*/I&QCHK9BZ17=.[NX:3J]+[Q^-8NCC^
M<VZ_Z89KHSK%O<VNYUIEJ)2/X[F6)V;V-QX=U4R%M/*85+K-J$"SA/-2&&W6
M9$9]F0P\VEQI:%I2HDK&.FMF3K%]T*[AHNJT/O%(75C3#,=%-4-1-'M0JTZ?
M.]+<VR?3_,*SBM2(61XC<S**X99=<;94_&*=!6;3O)(G6S2LNHHACVG%N+UH
MN4TU5:BY/\T<WD.-R]P.Q+*K,C8D-)W$Z0L277S4W(9.FPW5FBC./K6P3;S*
MJ"QBQ&2;-*F[&0:5\IQ2,CE]RC=I\.E?9+7%0JE-<!=\&5+$UUW@?DE;H_ZN
MNMO\VF3"E>_(S^]?P'>W^4C]\OA.FF$=,L=B=\T=_LW]:_Z[FI'\Q&VP9C+_
M ,B_OG\",?B_RB^]^RRS[D./466T%WBN45%=D&-9+4V-#D%#<0V+"INJ6WB/
M0+2JLX$E#D:; L(4A;3S3B5(<;6:3(R,7S2DMF6E,MTVG5:SJ&.DMVVTFT3?
MINFV[XMRD8?IUJQ=M81&<[--ZNP/)V8F9X-3R'[!;DR=)IL2R.'$=DK4?93C
M)O)/DK(1V[#H[LH+4F9:$MJ"EQHDZ^;<;Y-2=MN_O3S;^B]M)NAVZNX<P#,,
M(=DNNT]?G[]3*<P#4&I@FR^43((UM!9JY3K1LID5DU?/FLXT8VJ^#NRMWE'[
MF3HRG?@IVV^%:3LQ1G#&%1/YT!N"RW4J3M-Z+'1%16VJ>Y74G$LTRZFBRS0X
MY5O9&Y@VCV,VS;<:4:*K*<_F3+-YSBA<4\<9<,E-N&,9CYN3C8CK;KS%YA8I
M)W'J_E4X+I%T='SG'0;3+"='-(M[VU[!]--.J"'C&&8I6/8U(ATM+ 2HF(J)
M5EM/G64UY2UJ<=D27WI,AY:G'7%N*4H^D;&.BMF+I%=T[N[AI.KTOO'XUBZ.
M/YS;K_IAFNC.L6]S:[G6F6HE(_CN98G9O8W'AW53(6T\IA4NLVH0+.$\U(8;
M=9D1GV9##S:7&EH6E*B2L8Z:V9.L7W0KN&BZK0^\4A=6-,,QT4U0U$T>U"K3
MI\[TMS;)]/\ ,*SBM2(61XC<S**X99=<;94_&*=!6;3O)(G6S2LNHHACVG%N
M+UHN4TU5:BY/\T<WD.-R]P.Q+*K,C8D-)W$Z0L277S4W(9.FPW5FBC./K6P3
M;S*J"QBQ&2;-*F[&0:5\IQ2,CE]RC=I\.E?9+7%0JE-<!=\&5+$J(_.L]SV7
M)T5P79-I5%M;F;D58C<UN130-HG.8OH7@V84^$X"YE41MJ1(A8ODVL5_'D=E
M\&2:F4#"36;;CA#&9A<T*TN^_L%YA8:YOO(T ^:7[RU8)K[K%LERJX99QO73
M'UZK:6PYDJ*PEO573NO)K+ZBH84AN5.L,QTT2<Y\N6X33&)I-"$DIU1TL!<V
M;CMO5+X45,5"L-I:T7[1F#'@                               2*B,&
M9(^[C_M:T_UC-_?+HDD/D+O(P\OE/OGSAW.
M
M
M
M
M
M
M
M
M
M
M
M
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MWRZ))#Y"[R,/+Y3[Y\X=S@
M
M
M
M
M
M
M
M
M
M
M
M
M                           \+O\ TD;_ !ROWO('*X3AZUWSS#@Y
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M/NX_[6M/]8S?WRZ))#Y"[R,/+Y3[Y\X=S@
M
M
M
M
M
M
M
M
M
M
M
M
M                                       \+O\ TD;_ !ROWO('*X3A
MZUWSS#@Y
M                #A6I"]16\ S-S2&-A4S5)&-7"M/8FI$Z]K, DY@F"\=
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MHC!F2/NX_P"UK3_6,W]\NB20^0N\C#R^4^^?.'<X
M
M
M
M
M
M
M
M
M
M
M
M
M                                             /"[_P!)&_QROWO(
M'*X3AZUWSS#@Y
M
M "141@S)'W<?]K6G^L9O[Y=$DA\A=Y&'E\I]\^<.YP
M
M
M
M
M
M
M
M
M
M
M
M
M                                               >%W_I(W^.5^]Y
M Y7"</6N^>8<'(
M   !'SAW2K]'OJ%K9"VY8-N@P;+-;+',[/3Z!I]0UV86-M+RZFE38=M5,28^
M-+JG$5SM;(4])*1V(VRRMTW>:2:Q06)L2EL*7QJTU/F*KL74MIK1X"085RD
M          !IYN>Z0#9OLQM<3HMS^ON&:/W&<U]G;8I69&W>2IEQ64\F+#L9
MS+%%46RV(K$J8ALEO$V3B^42.5R%\FE<OVK3I<=&^^5(6KDU6*JC8#2?5?3_
M %RTXQ#5S2K(V,OTYSVH:O\ #\HBPK.OB7U*^ZZU&M(4:Y@UUAV#,YDUL.+9
M2EYHTN(-3:TJ/O"49Q4HZ8LZ2BXO9EK,ACL<
M              !(J(P9DC[N/^UK3_6,W]\NB20^0N\C#R^4^^?.'<X
M
M
M
M
M
M
M
M
M
M
M
M
M
M/"[_ -)&_P <K][R!RN$X>M=\\PX.0
M                  T.Z3G=8SLJV(;E-Q34MF)DF':>3JO3WGBD+)_4[-I$
M;"=.D$S$X2WF8^7Y!$D2";-)HBLNN*6VA"G$T,1<Z*S*2UTT=]E2S#;N)<!3
M3^:>;3%ZH;N=5]W645CLO']N.#NXSA=C,BO*;<U;U>9G5+]C!L7'B:D2Z'3>
M'=,2V>0XM/AV.XI39\CG,;@+>U=VWJBO&R\Q4]FWL\+.P=&9,>
M !UE72ZY_E72C=-I9Z':82E6,*KU,PO9;IC+B1)MBQ7QL1R>73YYDS\9;T9$
MJHK-0[O([-R0TIF,JK92[SAH(WU8+$2=_$M1XZ(R=J*MVE7BJSLF]+].,3T>
MTUT^TEP.M13X1IAA.+:?8?4MGRDUN,8=1P<>HH1+/JK.-65[2#4?549<3ZIC
M-PBH14%J2H8V4G*3D];9SH=C@
M   )%1&#,D?=Q_VM:?ZQF_OET22'R%WD8>7RGWSYP[G
M
M
M
M
M
M
M
M
M
M
M
M
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M+*E9M(TSRKYU;F&CF8-8KN7Z*W7#05R5$<F08>5:J6E9F$MEN;'CF^UB&?Z
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M4MMAZ2PW);8DI)Q*''$$LC(E*+JG?)[24EJ:+=K9;B]:9]L<G
M                   !(J(P9DC[N/\ M:T_UC-_?+HDD/D+O(P\OE/OGSAW
M.
M
M
M
M
M
M
M
M
M
M
M
M
M      #PN_\ 21O\<K][R!RN$X>M=\\PX.0
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MH,^$Z]%EQW"ZJ5MK4D_U#%=--56E%)IIT>L^B.0
M          !(J(P9D
M
M
M
M
M
M
M
M
M
M
M
M
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MY54Q+RCL6?U4IEUTUM?)/VR3/@? R,9Z,E.*E'4T8N47&3B]:.:CL<
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M2HC/.X/]6C7N_"S&8C\L_!\")CQ=%$
MD5$8,R1]W'_:UI_K&;^^71)(?(7>1AY?*??/G#N<
M
M
M
M
M
M
M
M
M
M
M
M
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M#1%T1JIIET%O1*Z2353\5V0Z5VKZG3>-O4VPSK6N$2S.,?!-;K+EV>UR&O\
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MML>%;^:R[-E&VE+9R)"S2E*>!%(;<%;@H+4D8F<MN;D^%F;1W.H
M                    !(J(P9DC[N/^UK3_ %C-_?+HDD/D+O(P\OE/OGSA
MW.
M
M
M
M
M
M
M
M
M
M
M
M
M       #PN_])&_QROWO('*X3AZUWSS#@Y
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MHS0J<]'NT(</G#2^1<A5..7W).MR27C9W>*@ODILM=;#.C2VE=''@DO#]MV
MJ@7M_%KF<]U4RR6C(M4M1'ZUI"&'<FR54:(Q%KTO$IYNJJXU=31WW''68C;C
MCBE7]FQ;L*D-?"RTN79W'\;5Q&_ KE,
M  "141@S)'W<?]K6G^L9O[Y=$DA\A=Y&'E\I]\^<.YP
M
M
M
M
M
M
M
M
M
M
M
M
M                                                >%W_ *2-_CE?
MO>0.5PG#UKOGF'!R
M
M    $BHC!F2/NX_[6M/]8S?WRZ))#Y"[R,/+Y3[Y\X=S@
M
M
M
M
M
M
M
M
M
M
M
M
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M0Y?3O-K4XA#C5GCT^QA.(6MI1$9+,C-)E^H8JQG"?R6GWF4W&4?E)HYP.QP
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MVM:?ZQF_OET22'R%WD8>7RGWSYP[G
M
M
M
M
M
M
M
M
M
M
M
M
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M_P"UK3_6,W]\NB20^0N\C#R^4^^?.'<X
M
M
M
M
M
M
M
M
M
M
M
M
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MYQ+36J^E\>XS'!)3CQN<PRS,QE_(ZXD&CEOS)T5)++D\E=? W-B]LO5+1X>
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M
M
M
M
M
M
M
M
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MUIJRI;&':P''&5FV\VW,@O/QUK:67)41*,TGU#'"::JG5'+3BZ-49]8<G
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MVP/ZPN\SC$?D7X/A.R8&;,:
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M28B<ISXVV_\ X' Q<%(
M
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MJBXUPD_PUP3(
M
M
M
M
M
M
M
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MG6SJX>\7F(V>B>UX.^=E0,X8T     \+O_21O\<K][R!RN$X>M=\\PX.0
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M-2EK4HS4I2E'Q,SZIF-Y:M"-7GY
M
M
M          6^>B2W3V6X/;[(PK,K)^SU%T0DU>+VEC,><D3KW#K*-)7A-W/D
MO+4[*L4-5DNOD+5REN=@(><4IQ]1C2V^>40RW,E?L*F%Q"<DEJ4E\I+N:4UW
MZ+0C96[>82QN"Z*ZZW[5$WQQ?R7W]#7@KPDJXAY(@
M
M
M
M
M
M
M
M
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M:,1);,G'B9UDG3+_ -O=KA]W?;=_-GHJ,%B?UB7WQE+7Y*/>.S]&?,4
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M35P4WCD C0HH+EL3!3UPR4VD^:-SD<4EU.H0Z[,:[5%M'.U*FS5[)]D=C@
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M%J)3SR8L5UTTIXJ)MM2N'!)F7; _K"[S.,1^1?@^$[)X9LQH
M                          2*B,&9(^[C_M:T_P!8S?WRZ))#Y"[R,/+Y
M3[Y\X=S@     K ].YETV9KCHK@:Y#BJ_'=*)N71XI\HFFYN9Y?;TTR0D^/(
M4X^Q@;"3ZG$B;+_"-L]GMF,<OOXBGQI7E'P1BFOQV0#>^XWB[5G[F-NOG2:_
MV406C8!$@
M
M                                                    F2Z$++)5
M-NORG&>R317YCH_D;+L,U.$V_9T5_C%M7R"0@C0J1%@HFI2:^!$AY? ^)D1P
M??ZRIY/"[3XT+\=/<:DGXZ<A)]T[CCF,K=?BRM/E33YRU\-/&Q0
M
M
M
M
M
M
M
M
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MTJV6P3I\[RR+,8>[TUI3X>'OF/NPZ.;CP<!O>*Q3
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MXI*G\N%EI=5E*MIMO^7<)31<E$
M  "141@S)'W<?]K6G^L9O[Y=$DA\A=Y&'E\I]\^<.YP     53>G._*TT\_J
MZXE_.7JX-P=G_P"QKO\ FI?B6S7>]O[2A^87XTR&$3DBX
M
M
M                            2L]#/^6U1_<ZU _>$00_?G]@R_.P^%DA
MW7_:T?O)? 6]QI8V6
M
M
M
M
M
M
M
M
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M=_[#+W8RQ8'5.])!_;<;C/Z[C7V\4HCU_P#+R^^?PF6M_DX_>KX#M8A(3$@
M=6[O'_\ K@S4#_\ ..X/_.WB8C]W]9E]^_A,K;_)1^]7P':1"0&*(%NDJZ +
M;CTDNX&AW&99JOJ;I'F;>*4>%YM$P:!BMG69I48T[9JIK/A>USLFFRIB)8HA
MN2S7+C.0H<=!14K0IU=G?P<;T]NK3+BWB';CLTJB53'V=M^PW;II_@MKG6%:
M*:%:*X1CN X[>ZI9U38Y60:/&:V-5UY6N493/KHTZWF(9);SBE\Y(D.&9)XJ
M(A771V(*+:4$N%E)[=V3:56RA+\Y=Z0O:OOIU1VU4VUS/9>I]9H74:P5.9YK
M#QRZI\,FW&9V6GBX=;BEI?Q*R9DIUS>)O*DRF(W@]2'V%1Y$A*U&C$XV]"[-
M=&ZI(O\ #VY6X-2UMEK;YN5_8T;.?^\+_P"*G7$9'!_JT?#\++/$?EGX/@1)
M?O _)*W1_P!776W^;3)A5O?D9_>OX#I;_*1^^7PG78_-BO[6O2O[ENMWVA6
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M))(N^7_D7]\_@1TQ?Y1?>_99:#%^6P
M
M         !(J(P9DC[N/^UK3_6,W]\NB20^0N\C#R^4^^?.'<X     *IO3G
M?E::>?U=<2_G+U<&X.S_ /8UW_-2_$MFN][?VE#\POQID,(G)%P
M
M
M                                  E9Z&?\MJC^YUJ!^\(@A^_/[!E^
M=A\+)#NO^UH_>2^ M[C2QLL
M
M    #BUCG.$TYNE;9CBU6;#ZHKY6.0U,(V9*%*0N.Z4F6T;;Z%H,C0?!1&1E
MPZ@JQP^(G\B$W7BBW]@IRO6H_*E%=]H^] L(%K#CV-7.AV5?,:)Z)/@269D.
M4RKCR78\J.MQA]I7#J*2HR,4Y1E"3C--26M/0SO&49+:BTXOB/;'!R
M
M
M
M
M
M
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M*^:._P!F_K7_ %W-2/YB-M@[Y?\ D7]\_@1TQ?Y1?>_99:5%^6P
M
M                              !(J(P9DC[N/^UK3_6,W]\NB20^0N\C
M#R^4^^?.'<X     *IO3G?E::>?U=<2_G+U<&X.S_P#8UW_-2_$MFN][?VE#
M\POQID,(G)%P
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M8G/,AGDG1;=Q7.EVM2I39V>Z]>UXB-P2DP(
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MM+3P5IPF(W5Q>+N8BY8N2E/#[%=+;HZI*C?'IT<-*\!9%&KB<@
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MK\Z_@1L+)?V58_-HW*&#,H
M
M
M
M
M
M
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M<E)*JH6\!DBS
M                                                    )%1&#,D?
M=Q_VM:?ZQF_OET22'R%WD8>7RGWSYP[G     !5-Z<[\K33S^KKB7\Y>K@W!
MV?\ [&N_YJ7XELUWO;^TH?F%^-,AA$Y(N
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M"/&8B=EVHM*D7)O2Z<,$O&11B8$<
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MQF/N*[C;L[DTJ+:=:+N<"\!3P^%PV$@X8:$81;JZ*E>_QF3A:%P
M              %7+IV/RA-'_N-)^W?*1MOL]_9E_P#/_P"Q$U_O=^NVOS7^
MTR</H]/R*-MWW-:S]\S! -Y?V]BOSK^!$LR7]E6/S:-RA@S*
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MS8\P];YOM])V._>UP'ZP![E;O>JEY\^<>\N;^LCYL>8>M\WV^D['?O:X#]8
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M^;'F'K?-]OI.QW[VN _6 /<K=[U4O/GSCWES?UD?-CS#UOF^WTG8[][7 ?K
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M5:]*U'[ Y
M
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MA;:N'!23(S(.IX;R?&^<=8O<?B7,32"Z*(
M
M             !(J(P9DC[N/^UK3_6,W]\NB20^0N\C#R^4^^?.'<X     *
MIO3G?E::>?U=<2_G+U<&X.S_ /8UW_-2_$MFN][?VE#\POQID,(G)%P
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M;A))):VW30D8>%Z68
M     2L]#/\ EM4?W.M0/WA$$/WY_8,OSL/A9(=U_P!K1^\E\!;W&EC98
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M+4
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MJ
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MP
M       +)'0S[T+G)RE;3]2;AZRETE*_=:-VUB^X_-72U*>7>X"Y)>=6Z^U3
M03*;5HY)\S"9E-<I+3,=LM7;\Y%"U3.<+&D92I=2U5>J?A>B7&VGK;9.=U\T
ME<KEU]U:58-\2UQ\&M=RJX$6"!K<F8
M
M
M
M                   !X7?^DC?XY7[WD#E<)P]:[YYAP<@
M
M                                  !(J(P9DC[N/^UK3_6,W]\NB20^
M0N\C#R^4^^?.'<X     *IO3G?E::>?U=<2_G+U<&X.S_P#8UW_-2_$MFN][
M?VE#\POQID,(G)%P
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M(F1&                                                 E9Z&?\
M+:H_N=:@?O"((?OS^P9?G8?"R0[K_M:/WDO@+>XTL;+
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M7BKJ]4:QQF(ZUC+N*IL])<E.G%M2;IX*DXPUKH,/;L5KL0C&O'1)5.?BV*P
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MHJB5=;IITNBX>#06V7Y7A,MC*.&3K)Z6W5NFI=Y&TPQ!D0
M                    "&#IPLZFX_M?PK"X,A;!:@:KU3=NA"W23-HL7H[N
MZ<ANI2WS2T%?G6O^W61DI@N"5=52)UN!AXW,VN7Y+\G9=.XY-*O)M+PD6WLO
M.&7PM+[NXJ]Y)OX:%4X;?->
M                               !=LZ-7,[7/=C>WF^NG%/3HN*6V))<
M6HUK57Z?YADF!4YK4?54HJC&F",SZIG]$:&WIL0P^\&)MV_DN:EX9QC-^.3-
MJY%=E>RFQ.>M1:\$9.*\2-Y!'S+E8'IV\TL9NN.B^GBW'/!.-Z4R\TC-<>#1
MV.;9?=4<US@2_;.%&P".7527 CZAGQ/AMGL]L1CE]_$_=SO*/@C%-?CL@&]]
MV3Q=JS]S&WM>&4FO]E$%HV 1(
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MUCO+==S-IQ?R81C%<BD_&V1D"5F!
M                                   V,VA9O,TZW2;?LPA2E0_!>K>#
ML3W4.*9-=%<7T.DR.*IQ/$T-SL?LI+"SX&7)</B1EQ(\9G6'CBLHQ-B2K6S.
MG?2;CR-)E[EMUV,PLW4Z4N1KWFZ/Q-E\0>>3;X
M
M
M
M                           !X7?^DC?XY7[WD#E<)P]:[YYAP<@
M
M                                          !(J(P9DC[N/^UK3_6,
MW]\NB20^0N\C#R^4^^?.'<X     *IO3G?E::>?U=<2_G+U<&X.S_P#8UW_-
M2_$MFN][?VE#\POQID,(G)%P
M               ,@:3_ ,J>FGW0,-^V.M%KCOU*]^:G^*R[R_\ 7['YZ'XR
M.PZZ3C^S\W=?<0S+]Y$/-6Z?^I,%_F(FYL[_ &1B?S$_Q6=<*/3YHX "2CH@
M,5D9?TD&UNO8A%-36YC>Y5()2G&VHT?#\&RG)U3774<.0<9RJ2ILE&27'N0W
MU>61'%M]KT;.Z^+E)TK!1\,IQC3Q\FDD&ZT)3SVQ152<F^XE"6GEIX2X!TRN
M45>*]&WN7=LY#+2[RCQ'%ZMAQWFG)UI?ZA8G"9CQ4\A:GGF8ZG9"D$7_ $3"
MU&:4D:BTGN/9G>WHPB@ODRE)]Q1A)_:\)LO>*[&SDN(E/4[>SX9-17C90-TZ
MU(SW2+-*+473#+K_  3.<9D.RJ'*<9L9%5<UCLB*_ E%'EQEH7S,V!*=COM*
MY3;[#JVW$J0M23]'8K"X;&V)87%PC<P\UIC)53X?$]*XGI1IK#XF_A+T<1AI
M.%Z.IKD-W*[3'I(>DXRBJRQ>.ZS;A9%>T[05><9&E-5I]CT=4E<J96P\JNU4
M&GU'Q?4;CS#+S;KAD7%"C))# 2Q>ZVZ=J5E2L89/2X1TSEHUN*K-]RJH9GJ^
M?[PSC=G&Y=BE12=(P2;TT>B/?I5Z.XB179IT>>CVV+=;M\N-TF\W2*KUPJM7
M\!/!=M^B:K+5G,I>H*LEKF<;H-1;^EKY$+ 8R+M;29IO0UQNQ^6OLYA*#<*,
M9[O+C<VR?$V\IP-YY>[,]N_=I;BH;+VG!-UFZ:J.M=&RS/95D6&RS,+-S'XJ
MWUU36S:A\9U>A5>M+C^*DM;DDF2<?.0OR'=*_P"M;@_\T6N8BG9=^W[W^3G_
M 'EHRV_'[)M_YB/XEPI0#?!JPOG= I_9Q:=?9]JO]N<\>>.T7_5%W\U;_%1N
M'=+]A6>_/\>11QU8_E3U+^Z!F7VQV0W[@?U*S^:A^*C5.8?K]_\ /3_&9C\7
M1:$C?1&_VCNU/[/K+[3,G$8WS_TOC/S2_&B9[=C]NX?OR_$D3K_.8/Y+-JOW
M0-2/M<QL:\[*_P!=Q?YJ'XS)AOS^H6?SW^RRM-LRULKMN6ZK036VZ;EN8_IY
MJ5CMSDZ(#9/SSQ1V5X-RHX,=25%)F(QZ=)-IKVIN.$224GCRBVKGN GFF3XG
M 6Z=+=M24:ZMK7&O<JD0+*,9# 9G9Q=S\G">GO/0WX$VZ<.HMO=.IIV6Y;H^
ML2UHT>DM9]0Z;YOB^KR;?&'T6L&STMO\<O,>MKZ B,OERXL"1?5TUYU"5JBP
MF)#CB4MH=6WIGL^Q7LK>2> QJZ.Y=MRMTEH:N*2:3[]))<;:IP5V3O9AGC\F
M5_#/:5N2N:--8T:;7>4MJO$F4ML P3*M4,WQ+3G!J>5?YAG&0U.+XU30FUNR
M+"YNIK,"#'22$J-"#?>(UK,N2V@C4HR21F-ZXG$6<)AYXK$24;%N+E)O@256
M:KP^'NXJ_##V56[.22\/V%K?$M)>RZ4+53#=I/1BY-I7D.0UTS+LRT@IMN6!
MUCL>'(GY992,:K<4R*WA5<PG%,PJ3&429[TODEV$[S!(6F2[')7GO=+!W\YW
MKAB[46K-N\[TWII%*3DDVN%RHDN'3P)FX-X,3:P.2787'\:=MVXKA;DMGQ*K
M?<10?'HHTR;/Z$;NMU^@=1;8%M^UGU)P*GS.S1(FXMAUD^;%E?2FHD I];6\
MQ+5#R"8Q#CL')A):EO-M-MFM24)(L3F.2Y-F,UB<RL6KD[:^5):DM-&]&A:7
M1Z%I,G@<US3!QZO@+DXQF_DI)U;T:$T]+[AM!IGT3V^#5Z#/U*U$Q2NT#P*0
M^Y;Y-JYNFRQG2^MCG8.G+E7-S$R+LG.GSFN/FX<IRN-IYQ?MG>*C,8G%[XY!
M@I+"X:;Q&(6B-O#QZ1Z-25/B=RE='$9'#[LYQC*XC$)6K;TN=UT>G2VUIE7A
M>TEWRRQT)FBFVW0K'-P>(:(;G:[<YFBK;365J]>XGB5O0Z<XO,3$SAG%Z?#;
MV>U)@YB3Y(LE29L2?(0I#;"E,Q><2ES5>_F/S3,+N&OYAA'A+&S-6U*2<Y*L
M=IR2TQX*)I<.ET)UNSA,#@K-VQ@[ZQ$]I.<DJ13:=$GI3T+323>INE45P>FZ
M_M/]S?\ ZE__  ]Z3C:&X/\ I/"?^+_?7"!;U_M_$?T/[N!R+H*O[2W1/['=
M7OYI\P%+M"_TM?\ O[?]Y$N-SOVU'\W/X"3?YSE_^1'_ -Y/_P"0$(IV4?\
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MF[8P=]8B>TG.25(IM.B3TIZ%II)O4W2J*X/3=?VG^YO_ -2__A[TG&T-P?\
M2>$_\7^^N$"WK_;^(_H?W<#17;+^4CM]^[?I1]OE )#FO[+Q/^7N?B,Q>6?M
M+#_G[?XR+K_3U_V<6HOV?:4?;G &A^SK_5%K\U<_%9M3>W]A7N_#\>)0Q'H<
MT\                                                  2L]#/^6U
M1_<ZU _>$00_?G]@R_.P^%DAW7_:T?O)? 6]QI8V6
M      15],I^1'D?W0-/OX6=$OW'_;\?S4_@(]O1^R9??Q^$C&Z"?\H36#[C
M2OMWQ82SM"_9EC\__L2,!NC^NW?S7^TBT:-2&P    A7Z0+I62VZY;:Z)Z(4
M5/E&IM1':1EN69#S\G&<*GS8[4EBHA541V,YD&0L0WTNO&M]N)#<4A"TR%\\
MTU.]V]S_ &G96/S"4H823^+%?*DEPM\$:ZM%7KT:&XKG.\74KKPF$2E?6MO5
M'N4X7XEW3^:.;%=>]SN/5&H_2!ZYZF9##R.-"NZ[;YC=RK#<:JX<HBE1T9O
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M>U29\>IP/9N_5N4\A<EJA=@WWM,?A:(1NM-1S5)ZY6Y)>)_ BW<-+FR@
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M6RTN[*+4OQ5(B^]=EW,NC=7_ ,NXJ]YIKX:%4$;A-=@
M                                                  !=XZ.7!+/3
MC9+MZQFW:>CSWL.EY:['D$27X[6H62WNH$1AYOD-J9<9B9.VDVU$2VS+DJ]L
M1C0F\^(ABL^Q-V&F.VH^9%0?CB;7R.S*QE5BW+7LU\YN7V3=@8$RI6.Z=W K
M&'K!HGJAS+RZC(M-;# B?2A2H[%CAF46F0FRZX2>0R]+C9YRFTJ,C<2RLTD?
M(5PVOV>XF,L%B,)]W&ZI^"45'Q;'C(#O?9DL5:Q'W,K>SX8MO_:((!L(B(
M
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M^.)%L):1\
M               #9S9=@$S4[=?M]P^'&.4F7JGB5K9M$RF018_B]HSE&2.K
M:6AQI2&:"FDJ/EI-'4]L7#B,5GN)CA,GQ-^3I2S)+[Z2V8^-HO\ *[+Q&8V;
M2TUN)OO)U?B3+V@\]FW0
M
M
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MW_I(W^.5^]Y Y7"</6N^>8<'(
M
M             2*B,&9(^[C_ +6M/]8S?WRZ))#Y"[R,/+Y3[Y\X=S@
MJF].=^5IIY_5UQ+^<O5P;@[/_P!C7?\ -2_$MFN][?VE#\POQID,(G)%P
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MW-_^I?\ \/>DXFNX/^D\)_XO]]<(KO7^W\1_0_NX'(N@J_M+=$_L=U>_FGS
M4NT+_2U_[^W_ 'D2XW._;4?S<_@)-_G.7_Y$?_>3_P#D!"*=E'_V_P#\#_ZQ
MF=_/_LG_ (O_ -,JFC<!KTLP_-I\#N)FM6Y/4Y$998_CFEV,X'(F*6E#:[C-
M,L;R"'&9;4WRI2VH6!/J=4A?!@EMDLOV9LQJKM4Q$(X'"X6O]9*[*=.Y&-/A
MGX>#4R?[B6I=+B+U'L*,8UX*MM^*G@KW3%WSC+5>JR_=SISI?53"E.Z0:20D
MY&RE#)%6Y-G]M*R-4!:TIY]3JL48J))DHS02)*>21&:S.\[,<'.SDMW%S5%?
MO?%[L8+9KYVTO 6^_&(C<QUK#1^5;MMOOR>KDBGX43&]%5LJT2V;;/,;W59W
MBU;=ZP97I0[KEEN=3*^';7N&8/.Q9_+J[$\).9R$4)QL.=0<\V5M/39SKJ'G
ME,(80U!]\,^Q^>9W/*,/-QP,+W11@FTI34MERE37\;5K25**M:RG=[*L-E>7
M1Q,XKK4[>U*3UI-5V5Q)+736])4MWG[YM=M[NI-IF>J656B<3CVUC(P#2^'8
M2$83I]3R'$MQ8534H4W$DW"H++2)MFZV<R<XCBM9(2VVWN7(MW\NR#"JQA(+
MIME;=QKX\WPU>NE=4=2\9K;-LYQF;7W.])K#U^+#[F*X-'"^-OAK2BT%@KYL
MO_LEO!^R+13^#=31K;M6_+X+[R[\,":;B_JE_P#.+\4B#Z;K^T_W-_\ J7_\
M/>DXFNX/^D\)_P"+_?7"*[U_M_$?T/[N!HKME_*1V^_=OTH^WR@$AS7]EXG_
M "]S\1F+RS]I8?\ /V_QD77^GK_LXM1?L^TH^W. -#]G7^J+7YJY^*S:F]O[
M"O=^'X\2AB/0YIX
M     E9Z&?\ +:H_N=:@?O"((?OS^P9?G8?"R0[K_M:/WDO@+>XTL;+
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M:7HI7DH:JRJ<(YQ:G)I0Z77P::T+N(T(;6
M            #@NIVG.+:NZ>YEICFL+PABV<8_98Y<QTFE+Z8MBPII,N$ZI*
M^QK&O>-$B,\1&IF0TAQ/MDD+C"8J]@L3#%X=TO6Y*2\' ^X]37"M!1Q%BWB;
M$L/=5;<XM/P_96M=THY[H=L^H>U35>ZTQS^$XM##CLW%,H9C.LTV:8PX\M%?
M?U#BS6C]D07(E1^6M<.4E;*S,T\I6_LIS7#9Q@XXO#/7HE'AC+A3^P^%:34V
M88"_EV(>'O+O/@DN!K[*X'H-=1DRR
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MFJKUF[A[LK-Z+C=BZ-/^7(]3UHXB*Q3
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MGJ:9K)IQ;C)-23TH]0<G
M                         !9[Z'O9!;Z84\G<[JG3.UF89I2*JM,<>LHZ
MV;#'\,L5-/S\IG1I"$N0[3+$,MHAIY*7&JSE*,S3,-"-3[[9_#%S64X.5;%N
M5;C6J4EJBN-1X?YWWI/MV<IEAX]?Q"I=FJ03UJ+X>^^#N=\G5&OB7
M
M
M                                      &%]Q&X'2O:OHKJ)N!UKR1K
M%-,],<??R#)K932I,E;9.LPZZIJ8*#)VSO[^VE,0:^(CV\J9(;:3P-7$=+DX
MVX.<_DH[0A*<MF.LZ^[*MR&_+YRAO7K]MF%Y'9:+[78+TC+K#3VNGR7\$TPT
MKQVTK6I6I>J4:!(JUZKZC/3I,-BMCR%=CM6TQIF&4",J7,+#N=[&W=A:(\7
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ME*RUF[&]#;C_ / L+EMVY;+-P!5.@
M                      >%W_I(W^.5^]Y Y7"</6N^>8<'(
M
M                                     2*B,&9(^[C_ +6M/]8S?WRZ
M))#Y"[R,/+Y3[Y\X=S@     JF].=^5IIY_5UQ+^<O5P;@[/_P!C7?\ -2_$
MMFN][?VE#\POQID,(G)%P
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MG[:7YN?V"PUTCNC^W3I3\5NM#]$]>=,'MV^V3,LG9QW%K&^*#,7:N1(\?4/
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MJO6VJNBUMM*E"!WMS'AH2NXC%VH65PN-/ADEXR L;&(0
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MAY;-_#1U*=:I<2DM-.XTZ<%# 8_=W XZ;NQK:O/6XTH^ZUQ]ZE>$UST\Z$/
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M.&MR4MK:MP<9/0]#;E*JTU[YE<!E5K+I.5JY>FG&E)R32[R25'HY#<L8,R@
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M\44N)MHD.7;MX/!25Z\^EOK554BGQJ.G3WV^-),E@$.)&
M
M
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MW*XM4R:RVMI\2LQ^ERVXTYOG%1JW.M&M1,9H\,KLEK%NU\IUAC)*E<I^2R_
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M(E),E)41&1D9&1D9<2,C+J&1D,J6)K'O"W>Z([&= LSW&Z_Y"]1X)B#<>.Q
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M0OV.C^-'Y'P$Z@O"W          /"[_TD;_'*_>\@<KA.'K7?/,.#D
M
M                                          )%1&#,D?=Q_P!K6G^L
M9O[Y=$DA\A=Y&'E\I]\^<.YP     53>G._*TT\_JZXE_.7JX-P=G_[&N_YJ
M7XELUWO;^TH?F%^-,AA$Y(N
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MFS8CL681A#BBDER(ZW;]^^]J_.<Y+ADV_A/A"H4@
M                            E9Z&?\MJC^YUJ!^\(@A^_/[!E^=A\+)#
MNO\ M:/WDO@+>XTL;+
M
M
M
M
M
M
M
M
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M_21O\<K][R!RN$X>M=\\PX.0
M
M            D5$8,R1]W'_:UI_K&;^^71)(?(7>1AY?*??/G#N<     %4W
MISORM-//ZNN)?SEZN#<'9_\ L:[_ )J7XELUWO;^TH?F%^-,AA$Y(N
M
M            &ZFPG>MG&Q#7ZJUEQ.K9RBFF5<G$]0L'ES7:^-E^%V4N%,FP
M&)[;<CP7=09M<Q*@2S9>2S)9(G&W&5NM+P6\>0X?>'+7@;SV+B>U"=*[,E5)
MTX4TVFJJJX:T9E\ES:YD^,6(BMJU)4E&NM=SNK@KW5PD]NYW7'H<^E0J<<R_
M4+6S+=KVO5%31J"KR3)\/LH=DU4KFG,;H\O["@WV Y915TR;*5&4U<PID9;R
MU\ZADU-*UUE6 WWW0G*QAK$,7ETI5<8R35=58Z5.+:I7XK3IJKI)GC<3NQO#
M",[]WH<5&-$W\626NC;3C))]UTTT:KIC8L.C8V6Q+%];/2Y[;GL;8=2XY/\
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MWR)42T(B>9YGB<UQ3Q.(?<C%:HKB7V7PLUK&5,<
M                                                      2L]#/^
M6U1_<ZU _>$00_?G]@R_.P^%DAW7_:T?O)? 6]QI8V6
M
M
M
M
M
M
M
M
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MV89?8QTORNQ'+N_L'W&(I//(@PR9BH6IMA!C,6;2LVU!&/N3=R>TS;D53H
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M-_CE?O>0.5PG#UKOGF'!R
M
M         $BHC!F2/NX_[6M/]8S?WRZ))#Y"[R,/+Y3[Y\X=S@     JF].=
M^5IIY_5UQ+^<O5P;@[/_ -C7?\U+\2V:[WM_:4/S"_&F0PB<D7
M
M
M                                 "5GH9_RVJ/[G6H'[PB"'[\_L&7Y
MV'PLD.Z_[6C]Y+X"WN-+&RP
M
M
M
M
M
M
M
M
M                           "MW\Y/Z-[(]Z&U&CURT?QV7D>NNU)>09)
M&QNGBN2[S/=(;]F"YJ+C=5"9=:<L[_'5TT2\KV"2_(=:AS8D1IR3-0A5CCK+
MN0Z2/RH_ 76&N;,MAZG\)$)\T[WXXW@.:ZM["M1+V)3M:N7+.KNA+D]\HT:P
MU#K:)FDU'PY+\F;S3EOD>)T53.K6&F$&LJ>:2EK<<8;%M@+JC)VI:GJ[Y5Q5
MO:CMK6O@+WXRY8  4Z?G7N_;'<;T@P;H^\&O&)F=:D7F/ZJ:WQ(3D>06.Z<8
MM)<L<#QBX+VZHEIF.:,1KAIM)I?9B4;:UD34QHW,9F%Y45E:];^P7N%@]-Q]
MY'._FNG1G9#H+I?D^^[67'U4^?;@<5@8UH?2V4=YFVQ_1"1,C7UEE\MA]*.Q
MWM5K6!7OP2Y'+33US+Z'#;L5(3S@+-$[TM;U<YQBKE?ZM>$MJR9,>''?ERWV
M8L2*R[)DR9+J&(\:.PA3KS[[SJDMLLLMI-2E*,DI21F9\!D=6EZBSUZ$5X]=
M.ESUXW2:K9#M,Z%[2BFW!9[C[J:_5/>1FZEQMK&B2G)K$1Y5;<K:*OU"NF8Z
MWGF5M./-/$QRZZ!>H2^AFQGB9W)='A55\+X$74;$8+;ONBXC^:$?-]M,,ASQ
MG<3TF^M6>](=N1FKB2Y9Y[:V]1HKC*HTEZ=&H,?PB--:F7>.UDB0I#<*8['H
M'&O:IIHZ5*0?,,$F]N^W.?B.)8ETV;2V8E@#$<.Q'3_&J;#,#Q;',)P_'(#%
M7CV)XC1UF-XU0UD5!-QJZFHJ:+"JZN!'07);98:;;074(B%ZHJ*I%)(MVVW5
MNK.1CDX   #%NM.MNDVW733*-8M;\]QS3333#(/9^19;E$Y$&NAMJ6EF-%93
MP7*L;6QDK2Q$A1FWI<R0M#3+;CBTI/I.<;<=N;I%':,93>S'65V9V[;I.^F&
MF6^.='90R]BFQQR;84<[?%JY5S&-8-5H,=V(S(GZ%88RN-8U,)_EOI9E0W"5
MP:/EWE7.0Y 38NYB,3HL?%M<?\OL<I<[%JPJW/C3XOY?9-U=FG0/[$=IEU'U
M,R;$K+=-N'>GJO[K77<@^WG]U(RN1.*UE9'0XE9%)Q&@MDVI<_'L5QYMZPLN
M)V+BS4M5:U@[5O3+XT^-\Q3GB+D]"T+N<Y-$1$DB2DB2E)$1$1$1$1%P(B(N
MH1$0NR@?T =<K\ZCVG7FD>_BMW+U]-++3[=-@6-39-ZVRZ=8QJIIC25V Y+0
M*4EOL:))=PRGH+%)&HE2G)4A9$:FW5#"XZVXWMK[F2\?#_+NF1PTE*W3A1;C
MZ!;<50[C.BQVLSZR8AR[T>PN/MXS.L.8F;)I+O1MIC%::-+4E*#8.VP)FFM&
M6C+BU%L&D<5<GE'D,'-3L+C6C^7@+7$1V;KXGI)AQ=% I5_.^MQM$G%]I^TF
MNEQ9622<BR/<1E\)$AHYE)3UE79:<:>O/1BY3Q,Y++NLE)"E<A)'5GPY?$^1
MB\QFJQMK7KYB]PD71RX&;A_-3]H]YHGLIU$W'9A3N5%]NRSRNL,5;DHE-3).
MD.E,>XQ_$+63%ELL*A^&LOO\DD1S0E3<NM5#DI<6AY!(J9?;<;;N/[I^)'3%
M2K)07 6/]:=;=)MNNFF4:Q:WY[CFFFFF&0>S\BRW*)R(-=#;4M+,:*RG@N58
MVMC)6EB)"C-O2YDA:&F6W'%I2=[.<;<=N;I%%O&,IO9CK*[,[=MTG?3#3+?'
M.CLH9>Q38XY-L*.=OBU<JYC&L&JT&.[$9D3]"L,97&L:F$_RWTLRH;A*X-'R
M[RKG(<@)L7<Q&)T6/BVN/^7V.4N=BU85;GQI\7\OLFZNS3H']B.TRZCZF9-B
M5ENFW#O3U7]UKKN0?;S^ZD97(G%:RLCH<2LBDXC06R;4N?CV*X\V]867$[%Q
M9J6JM:P=JWIE\:?&^8ISQ%R>A:%W.<FB(B21)21)2DB(B(B(B(BX$1$74(B(
M790/Z   CJWG=%/L?Z0#,L1SW=/I7;9_D^"XR]B&,SJ_4?47"FX%#(M9-R]$
M7#PO)Z&',6NPF+7SKR''"(^22B27 6]W#6KTMJ=:I4*MN].VMF-*5(;MU_S9
M'0BEPG(M3.C@U&UHVS;C\3H+:?@]5#U3R&QP[,IT?GK)O%IN06$I.?XG/N5,
MMPHUBQ=+AQ3)#DB&^?*<*VNX"*CM66U-%>&*;=+B5"+[H4^G_P!QN%:^X#L]
MWWYM?ZI:<ZAY76Z88KJCJ*<R1JQI+J!9S(V.XY6YID<IA5SEV*V>0\B#8.W9
MNV59(D]E.S2C,.L'0PV+G&:A<=8/CUHJ7K$9+:@J2^$OSC,&/          /
M"[_TD;_'*_>\@<KA.'K7?/,.#D
M
M              )%1&#,D?=Q_P!K6G^L9O[Y=$DA\A=Y&'E\I]\^<.YP
M 5C.G>PN5#UBT/U%YA?861::6V%E*)+AM]E89E$V\4PI?.J:2OFL\)22Y"%*
M+C[99%P1M?L\OJ6!Q&%K\:-U2\Z*7^P0'>^TUBK5_@E;<?-=?]H@B&PB(@
M
M
M                                        !,]T'F&3+K='FV8\PDZO
M"=(KEIV2IKG.:N,GR''8%9';6:DE'<DUL.P7R^J9I94GAP49I@V_]^-O*+=C
M[NY>7)&,F_&URDHW3M.>83N_<PM/E;27BJ6LAI\V(
M
M
M
M
M
M
M
M
M                                               !5AZ3GYMMAVO^
MH$[=!L'S:KVR[BUY"QFUGA[TBUQW2S(LRA3$6K&8XC<8E#DY#I!G1VK*99R*
M^/*KWYJ4NI8A/*>E.8^_@MI[=G1+BX/!Q%W:Q-%LW-*XSCVG?2/]/#LNQ>%@
M>]#HM,XW@-XU(\"Q]:]O]UV;DEY10%(2>3Y3$TCQ?62BMY2X++CR7UUN+&Z@
MVTRT-2"><7UC?Q=I4NP<DN'[:J<RM6+FF$DF_P"6HT$UI^=B;A-9U0]*-H&V
M'!M$\SSN^K<-QO4O5;49K4B;72,EE-T]=9P\<5BV"X;C=K&L)K2TR+67=UC"
M4*4^PX@S)-*>87)+9MI1;X:UYCO'"P6F3J2 [#_FX#L76*?N]Z5#5"JW5Z\Y
M)?2\SL-,(SMCD.FIY7+F*D,W>HV37\2JFZE/QHZ6DHI6ZV!0PE-\Q_Y0BI:)
M-:U@GM=)B'67%SG2YB4ELVM7'S%K9IIMAMMEEM#++*$----(2VVTVVDD(;;0
M@B2A"$D1$1$1$1#(EGK(MNFBT)W'[F.CDU\T.VI4UOD>LFH2M/:>NQVES7'=
M/I-]BR-2,4FY]3RLERO),2Q]NHL<*BSFIL63.;;GQ%.1C0[SO-+ML5"Y<LN%
MOY396L2A"YM3U4*$/]W*Z9?\SG_B%VK?TXC%]3Q/D^-<Y>]8L\?B?,/[N5TR
M_P"9S_Q"[5OZ<0ZGB?)\:YQUBSQ^)\P_NY73+_F<_P#$+M6_IQ#J>)\GQKG'
M6+/'XGS$^'S=7HGM_P#L3WL:H:N;JM _-9IYD6UK-M.*;(/.GHMF_9F9V^K.
MB.35U-X)TXU&R^\C]D4>(6+_ &0[&1$1V/R%.I<<:0N[P>'O6KKE<5%LTUKC
M7$RAB+MN<$HNKKW>Z7.ADBS  JT?.3.C\WZ[]U[3J#:)II;ZJ83I\G5NXU)Q
M]K5?3/ *&#E-N>!0L'N)M)J3J!A<2^MVJEBZ8BRH[4IR$R_(;-;123)W'XVS
M>NRCT:K%+C7V2[P]RW;B]IT=2K9_=RNF7_,Y_P"(7:M_3B++J>)\GQKG+CK%
MGC\3YA_=RNF7_,Y_XA=JW].(=3Q/D^-<XZQ9X_$^8?W<KIE_S.?^(7:M_3B'
M4\3Y/C7..L6>/Q/F+G7S=797N9V)[)]4-(]U6FOFLU#R+=+FVH]-C_EE@&;]
MF89;Z3:(XS77/A;3C*LOHX_9%YB%BQV.[)1+1V/RU-);<:6O)8.U.U:<;BH]
MJOB7$6>(G&<TXNJISDF>^+9)H;T@.WW*=O&O-*_,QVZ4BUQK)JE;4;+-.\U@
M1Y+5%G.'V#K;S<6ZJ#E.)4VZAR+-BNNQ9+;L=YQM5:]:A>AL2_\ @4[=R5N6
MTBJOM8V1],=T%&N.:S-O^DM;T@&T'4=]A_-,-P#*H6,7<XZE?-4F4Q,-OI4C
M)L#U3BU[KC#SE7#R2HG0^#,IQQQJ&N)CH6\3A)UBMJ#XN'F9>2G9OQHW27=)
M7[_IJ-R]_1)I]%>A6Z36TU8M66XU'7:RZ)6ND.E<6T6T2Y#N0:E2HMRU7UD)
M*7%(4_$B%+4A#1N1U.DI%R\5=I\6U/:[J?,458MUTSC3P<Y$YH'T!6]?I!-T
MEQO8Z83*Z[!H>67L2_MM"\0N*RRSG(*FI;=@XWI\<W%[&VQ/2;3>HJXD)MIJ
M+86]X_")UJ1V)8.N3RMX82[>GTF(T)\OVBK*_;MQV+6E^(NF8OB^-X1C6/89
MAU#48MB.)4E5C6+XS05\6IHL>QZC@L5E-24U7";9AUU555T5MB.PTA+;32$I
M21$1$,HDHK9CH2+)MMU>LK"_.3.C\WZ[]U[3J#:)II;ZJ83I\G5NXU)Q]K5?
M3/ *&#E-N>!0L'N)M)J3J!A<2^MVJEBZ8BRH[4IR$R_(;-;123)VPQMF]=E'
MHU6*7&OLEUA[ENW%[3HZE6S^[E=,O^9S_P 0NU;^G$674\3Y/C7.7'6+/'XG
MS#^[E=,O^9S_ ,0NU;^G$.IXGR?&N<=8L\?B?,/[N5TR_P"9S_Q"[5OZ<0ZG
MB?)\:YQUBSQ^)\Q<Z^;J[*]S.Q/9/JAI'NJTU\UFH>1;I<VU'IL?\LL S?LS
M#+?2;1'&:ZY\+:<95E]''[(O,0L6.QW9*):.Q^6II+;C2UY+!VIVK3C<5'M5
M\2XBSQ$XSFG%U5.<X'2?.7-D5WO/1M%:PG6!NNFZNHT3J-<FZ['IV"668.7K
MN)QK J6%<O96WB%AE!-QHTY$9UU;+R9#D=IHE&718^V[FQ1[-:5.[PLMFM?C
M<18L%\6H '3M[R69=GOYW5L8$B7)GV&[_7)G"V\>*04]^7+UGRA&.(HRB\F4
M4MUYQDHW-\'.6:>3U> C4_EOOLS"U'<+UB9Z*VO3:+:=LTP8B;%Q@B)AR>3#
M92ULD2&R)I<@E&GVJ>I^H7T!)%6BKKH8ATJZ:CW1R<        !X7?\ I(W^
M.5^]Y Y7"</6N^>8<'(
M
M       2*B,&9(^[C_M:T_UC-_?+HDD/D+O(P\OE/OGSAW.     #0OI&MK4
MC=5MOOL9QR*E_4C"9:<[TX1RT-*L;RKBR6)^,J=<6TT2<GI9+\9KG%H91...
MZXHD-F)%NQFZR?-(W;K_ /*W%L3[B;T2_HNC?#2J6LP^>9>\QP+MV_R\'M1[
MK6M>%:._0I63(<NNERJ^PBR8,^#)?AS84QAV-+ARXSJF9,65&>2AZ/)CO(4A
M:%I)2%$9&1&0WM&4914HM.+54UJ:-5M.+H]#1ZPY
M
M
M                    !^D(6XM#;:%+<6I*$(0DU+6M1DE*$)21J4I2CX$1
M=4S#5I8+C_1:;4++;'M[*?F=<NMU0U>F0,QS"!):-J=05,>&MG#\2G(427&Y
ME/!F2)4EM:2<CS;!]E7'FR&D-[LYAFV9;-AUPEE.,7P-U^-)=QM)+C23X39V
M[V72P&"VKJIB+K4I=Q?<KP:6^)MHDO$5,\
M
M
M
M
M
M
M
M
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MWSS#@Y
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M!HORT
M
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M#@7==&IM1 B5@
M
M
M
M
M
M
M
M
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MLVY;44]I<;.D\1<FJ.B1*^+DH@
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M=_Z2-_CE?O>0.5PG#UKOGF'!R
M
M             $BHC!F2/NX_[6M/]8S?WRZ))#Y"[R,/+Y3[Y\X=S@
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M33:"2AMMM"2)*2(B(BX$+9MMU>LK))*BU'D Y
M
M
M
M
M
M
M
M
M
M                                                  #PN_\ 21O\
M<K][R!RN$X>M=\\PX.0
M
M       D5$8,R1]W'_:UI_K&;^^71)(?(7>1AY?*??/G#N<
M
M
M
M
M
M
M
M
M
M
M
M
M                                                    'A=_Z2-_
MCE?O>0.5PG#UKOGF'!R
M
M       $BHC!F2/NX_[6M/\ 6,W]\NB20^0N\C#R^4^^?.'<X
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      /"[_TD
M;_'*_>\@<KA.'K7?/,.#D
M
M         )%1&#,D?=Q_VM:?ZQF_OET22'R%WD8>7RGWSYP[G
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      !X7?\
MI(W^.5^]Y Y7"</6N^>8<'(
M
M           2*B,&9(^[C_M:T_UC-_?+HDD/D+O(P\OE/OGSAW.
M
M
M
M
M
M
M
M
M
M
M
M
M                                                        #PN_
M])&_QROWO('*X3AZUWSS#@Y
M
M           "141@S)'W<?\ :UI_K&;^^71)(?(7>1AY?*??/G#N<
M
M
M
M
M
M
M
M
M
M
M
M
M                                                          'A
M=_Z2-_CE?O>0.5PG#UKOGF'!R
M
M             $BHC!F2/NX_[6M/]8S?WRZ))#Y"[R,/+Y3[Y\X=S@
M
M
M
M
M
M
M
M
M
M
M
M
M                                                           \
M+O\ TD;_ !ROWO('*X3AZUWSS#@Y
M
M                "141@S)'W<?]K6G^L9O[Y=$DA\A=Y&'E\I]\^<.YP
M
M
M
M
M
M
M
M
M
M
M
M
M
M  >%W_I(W^.5^]Y Y7"</6N^>8<'(
M
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M._@]N83R;G)'TA[HYEY=CEEZ \X]'VK:_4(G?P>W,)Y-SDCZ0]T<R\NQRR]
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M=_![<PGDW.2/I#W1S+R['++T!YQZ/M6U^H1._@]N83R;G)'TA[HYEY=CEEZ
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M._@]N83R;G)'TA[HYEY=CEEZ \X]'VK:_4(G?P>W,)Y-SDCZ0]T<R\NQRR]
M><>C[5M?J$3OX/;F$\FYR1](>Z.9>78Y9>@/./1]JVOU")W\'MS">3<Y(^D/
M=',O+L<LO0'G'H^U;7ZA$[^#VYA/)N<D?2'NCF7EV.67H#SCT?:MK]0B=_![
M<PGDW.2/I#W1S+R['++T!YQZ/M6U^H1._@]N83R;G)'TA[HYEY=CEEZ \X]'
MVK:_4(G?P>W,)Y-SDCZ0]T<R\NQRR] ><>C[5M?J$3OX/;F$\FYR1](>Z.9>
M78Y9>@/./1]JVOU")W\'MS">3<Y(^D/=',O+L<LO0'G'H^U;7ZA$[^#VYA/)
MN<D?2'NCF7EV.67H#SCT?:MK]0B=_![<PGDW.2/I#W1S+R['++T!YQZ/M6U^
MH1._@]N83R;G)'TA[HYEY=CEEZ \X]'VK:_4(G?P>W,)Y-SDCZ0]T<R\NQRR
M] ><>C[5M?J$3OX/;F$\FYR1](>Z.9>78Y9>@/./1]JVOU")W\'MS">3<Y(^
MD/=',O+L<LO0'G'H^U;7ZA$[^#VYA/)N<D?2'NCF7EV.67H#SCT?:MK]0B=_
M![<PGDW.2/I#W1S+R['++T!YQZ/M6U^H1._@]N83R;G)'TA[HYEY=CEEZ \X
M]'VK:_4(G?P>W,)Y-SDCZ0]T<R\NQRR] ><>C[5M?J$3OX/;F$\FYR1](>Z.
M9>78Y9>@/./1]JVOU")W\'MS">3<Y(^D/=',O+L<LO0'G'H^U;7ZA$[^#VYA
M/)N<D?2'NCF7EV.67H#SCT?:MK]0B=_![<PGDW.2/I#W1S+R['++T!YQZ/M6
MU^H1._@]N83R;G)'TA[HYEY=CEEZ \X]'VK:_4(G?P>W,)Y-SDCZ0]T<R\NQ
MRR] ><>C[5M?J$3OX/;F$\FYR1](>Z.9>78Y9>@/./1]JVOU")W\'MS">3<Y
M(^D/=',O+L<LO0'G'H^U;7ZA$[^#VYA/)N<D?2'NCF7EV.67H#SCT?:MK]0B
M=_![<PGDW.2/I#W1S+R['++T!YQZ/M6U^H1._@]N83R;G)'TA[HYEY=CEEZ
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M._@]N83R;G)'TA[HYEY=CEEZ \X]'VK:_4(G?P>W,)Y-SDCZ0]T<R\NQRR]
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M=_![<PGDW.2/I#W1S+R['++T!YQZ/M6U^H1._@]N83R;G)'TA[HYEY=CEEZ
M\X]'VK:_4(G?P>W,)Y-SDCZ0]T<R\NQRR] ><>C[5M?J$3OX/;F$\FYR1](>
MZ.9>78Y9>@/./1]JVOU")W\'MS">3<Y(^D/=',O+L<LO0'G'H^U;7ZA$[^#V
MYA/)N<D?2'NCF7EV.67H#SCT?:MK]0B=_![<PGDW.2/I#W1S+R['++T!YQZ/
MM6U^H1._@]N83R;G)'TA[HYEY=CEEZ!S\9DBQK!/_P!.F?\ 6Y'^66(!>_*R
M^^?PFYL-^K6_O(_ CU13*X
M
M
M
M
M
M
M
M
M
M
M
M
M                          !XU_KF?\8?^2='5ZUW_L,[1U2[WV4>0=CJ
M
M                                                &U(V&:2-8)_^
MG3/^MR/\LL0"]^5E]\_A-S8;]6M_>1^!'JBF5P
M
M
M
M
M
M
M
M
M
M
M
M
M                                          #QK_7,_P",/_).CJ]:
M[_V&=HZI=[[*/(.QU
M
M     #:D;#-)&L$__3IG_6Y'^66(!>_*R^^?PFYL-^K6_O(_ CU13*X
M
M
M
M
M
M
M
M
M
M
M
M
M                                                           !
MXU_KF?\ &'_DG1U>M=_[#.T=4N]]E'D'8Z@
M
M                      !M2-AFDC6"?_ITS_K<C_++$ O?E9??/X3<V&_5
MK?WD?@1ZHIE<
M
M
M
M
M
M
M
M
M
M
M
M
M                 \:_US/^,/\ R3HZO6N_]AG:.J7>^RCR#L=0
M
M                                        VI&PS21K!/\ ].F?];D?
MY98@%[\K+[Y_";FPWZM;^\C\"/5%,K@
M
M
M
M
M
M
M
M
M
M
M
M
M                                   'C7^N9_QA_P"2='5ZUW_L,[1U
M2[WV4>0=CJ
M                                                          &U
M(V&:2-8)_P#ITS_K<C_++$ O?E9??/X3<V&_5K?WD?@1ZHIE<
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      \:_P!<
MS_C#_P DZ.KUKO\ V&=HZI=[[*/(.QU
M
M                   #:D;#-)&L$_\ TZ9_UN1_EEB 7ORLOOG\)N;#?JUO
M[R/P(]44RN
M
M
M
M
M
M
M
M
M
M
M
M
M               >-?ZYG_&'_DG1U>M=_P"PSM'5+O?91Y!V.H
M
M                                      ;4C89I(U@G_P"G3/\ K<C_
M "RQ +WY67WS^$W-AOU:W]Y'X$>J*97
M
M
M
M
M
M
M
M
M
M
M
M
M                                    /&O]<S_C#_R3HZO6N_\ 89VC
MJEWOLH\@['4
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M?G9\X^J;LS_<65_\/;YA\HW7GTNZ@?":SZ^'OSOC^\\;\[/G'U3=F?[BRO\
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M_P##V^8?*-UY]+NH'PFL^OA[\[X_O/&_.SYQ]4W9G^XLK_X>WS#Y1NO/I=U
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MV?./JF[,_P!Q97_P]OF'RC=>?2[J!\)K/KX>_.^/[SQOSL^<?5-V9_N+*_\
MA[?,/E&Z\^EW4#X36?7P]^=\?WGC?G9\X^J;LS_<65_\/;YA\HW7GTNZ@?":
MSZ^'OSOC^\\;\[/G'U3=F?[BRO\ X>WS#Y1NO/I=U ^$UGU\/?G?']YXWYV?
M./JF[,_W%E?_  ]OF'RC=>?2[J!\)K/KX>_.^/[SQOSL^<?5-V9_N+*_^'M\
MP^4;KSZ7=0/A-9]?#WYWQ_>>-^=GSCZINS/]Q97_ ,/;YA\HW7GTNZ@?":SZ
M^'OSOC^\\;\[/G'U3=F?[BRO_A[?,/E&Z\^EW4#X36?7P]^=\?WGC?G9\X^J
M;LS_ '%E?_#V^8?*-UY]+NH'PFL^OA[\[X_O/&_.SYQ]4W9G^XLK_P"'M\P^
M4;KSZ7=0/A-9]?#WYWQ_>>-^=GSCZINS/]Q97_P]OF'RC=>?2[J!\)K/KX>_
M.^/[SQOSL^<?5-V9_N+*_P#A[?,/E&Z\^EW4#X36?7P]^=\?WGC?G9\X^J;L
MS_<65_\ #V^8?*-UY]+NH'PFL^OA[\[X_O/&_.SYQ]4W9G^XLK_X>WS#Y1NO
M/I=U ^$UGU\/?G?']YXWYV?./JF[,_W%E?\ P]OF'RC=>?2[J!\)K/KX>_.^
M/[SQOSL^<?5-V9_N+*_^'M\P^4;KSZ7=0/A-9]?#WYWQ_>>-^=GSCZINS/\
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M>*MI[#?!&[%U=FXUI49-QEIV)SI*FQPG)J8
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M:3D638G/<TPV'MX'"6I7+G]?;E+8@JMI1<JZ-2K7N&U V(:6
M                                 ."9MJ=I[IO&;E9SF%%C*'D&Y'9L
MIS2)TM"342E0JULW+&:2309'S32^!EP&'S;>#)<BMJYF^*LX=-52E);3^]BJ
MREX$R2[N[G;T[VWG9W;P&)QDHNDG;@W"+_GW'2$-?W4D<AQS(:?+**IR;'YA
M6%'>P(]G53B8DQBEP9;9.QWRCS&8\IDG&U$?)<0A1?JD0O<#C<+F6#M8_!2V
M\)>@IPE1JL6JITDDU7NI,Q6;95C\CS*_D^:6^BS'#796[D*QELSBZ2CM0<HN
MCX8MKB9]H79CP                  ^;<W%;CU/:W]S*1!J*.MG7%K-<2XM
MN'6UD5V;.E+0RAQY:(\5A2S)"5*,BZA&?4%#%8JQ@L+<QF*DH8:S;E.<G7XL
M8IRD]%7H2;T)LO,OP&+S7'V,LR^#N8_$WH6K<$TG.Y<DH0BFVDG*32JVEITM
M(U>E;X-M4?F^:SR7.Y?*Y78N(9DCFN3R>'.=FT,/CR^4?#D\KZ!\>'4XZ^N=
MK6X<*;.,E.O%9OZ/.MQ\53<MG^'+M>NUV\LA;IY6*PKKWMB]+5W::]%=)DS2
M'7K3S6\L@/ IEG*\F#JBMBLJM^M-OPUX2[ -GGC,GB7X*>Y7 _:\DN/T2&>W
M9WQR3>WI_8TKDNK[&WM0<:;>ULTKK^1+O>$A^_?9EO5V<O"^\UNS#KG2=%T=
MR-RO1='MUIJITD*5UU=-1F<2HU\
M
M
M
M
M
M
M                           >G86$"H@3K6UG0ZRKK(<FPLK*PDLPH%?
MA,KDS)TZ9)6U'B0XD=I3CKKBDH;0DU*,B(S'*3DZ+2V<2E&$7*32BE5MZDN-
MFAEGTKO1A5/,=E=(;LJ=[(YSF_!FYO1RZY/-<WRN?\#9A/[&X\X7)YSD<O@?
M)X\E7"YC@<9+5:GX4U\-#'7,XRNU3:OVG7BDI?BUIX3-^W3=_M@W<UN3W.V7
M7/3K6^JPN=75F5S]/,@C7\6@L+:/)E5L.R=C>UCOS8T-U;:3ZJDH,QTOX:_A
MJ=/%QKJU<'>*V$S#!X[:ZI-3V:5T-4K6FM+B9L@*!>
M                                       >-?ZYG_&'_DG1U>M=_P"P
MSM'5+O?91Y!V.H
M
M  ;4C89I(U@G_P"G3/\ K<C_ "RQ +WY67WS^$W-AOU:W]Y'X$>J*97
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M5G&A8&7
M
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ML7S'-I1498K(97FEJ3N6%.BTO5M4UOOLL*CVN?+
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M/HS_ /\ '7_ZN/\ \/1ANP3_ /BW_P""_P#[02;^+_\ _EW_ /#_ /\ 8B5
M>B#Q8
M
M
M
M
M
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M+;MM7(+BT/DYFWW#(8'>?!8J2MWT[-QO15UB_P"E14\*2[I8G&))*
M & -9]V&UG;A-HJW</N5T T&L<IBS9V,U^L^LFG6ETW(H5:\Q'L9E%%SC(Z-
M^WBP'Y32'G(Z7$-+<22C(U$1U;=B_=5;4)27<3?P%O>Q>$P\E'$7;<)-5I*2
MBZ<>EHRQA>;X9J3B>/Y[IUEV,9]@V65D:ZQ;,\+OZK*<3R6FF(YR';8_D5'+
MG4]S62D=5M^,\XTLNJE1CI*$H2<9IJ2X'H95MW+=V"N6I1E;>IIII]YK0<G'
M4[@           >-?ZYG_&'_ ))T=7K7?^PSM'5+O?91Y!V.H
M
M                                     ;4C89I(U@G_ .G3/^MR/\LL
M0"]^5E]\_A-S8;]6M_>1^!'JBF5P    "*'I)<LE*LM-L%;<4B$S!M<LF-$:
MN1(E29!4]8XLOUAJAM199)X=7@^KC^IQ\Y=NV97'?P&41=+2A.])<;;V(O\
MHI3I]\SVY_"/D=E83-]Y)I/$2N6\-!\,8QCTMQ+A^,Y6J_>(B]'GT]E
M
M
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M(B(@E*,(N<VE%*K;T))<+.L(3N35NVG*Y)I))5;;T))+2VWJ1\RJR"AO>R/
MEW47/8B^:E>"K*'8=C.\5%S<CL1Y[F5\4F7!7 ^H8H8?&X/&;75+MJ[LNCV)
M1E1\3V6Z>$O<;E>9Y;L^T</?P^VJQZ2W.&TN..TE5=U&K&^G\G#+?];8G]L=
M<-=]KW^A<3^<L_WL3='\-O\ S:P/YC$_W%PUMZ,__P#'7_ZN/_P]$$[!/_XM
M_P#@O_[0;<_B_P#_ .7?_P /_P#V(E0'H@\6
M
M
M
M
M
M
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MCJ
M                                                  &U(V&:2-8)
M_P#ITS_K<C_++$ O?E9??/X3<V&_5K?WD?@1ZHIE<     A;Z1G^6[%ON5TG
MVVYP/*W;C_JS#_\ MUO^^Q!]"/X3O^76-_\ >KW_ *7!F@8TR>G@
M
M
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M)T:D
M
M
M
M
M
M                                                 (Q.FD_LH=_O
M]6;4?^"S%_EGZ];[[^!F'S_]CW_O5^,B@K\UD_M@M)/N4ZZ_S>60D>:_J%S^
MC^,B"[N?MFS_ $_Q)':2B&FTCKNOG>^\K -8-QVWW:9I[D+=]-VP46?Y'JZ_
M4SFI5) U#U87AK53AD[F)*T+RC"<8PDI,I)H+L4L@)@U\\F0TU*<EP\K5B5Z
M>CI&J=Y5H_#5^"C-=[U8VWB,9##6VFK*=7_.E2J\"2[SJGJ)<_FE6QK,]O\
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MO6N_]AG:.J7>^RCR#L=0
M
M        VI&PS21K!/\ ].F?];D?Y98@%[\K+[Y_";FPWZM;^\C\"/5%,K@
M   $+?2,_P MV+?<KI/MMS@>5NW'_5F'_P#;K?\ ?8@^A'\)W_+K&_\ O5[_
M -+@S0,:9/3P
M
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MNT[LDJ;5=6DWA&VSSB
M
M
M
M
M
M
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M_7,_XP_\DZ.KUKO_ &&=HZI=[[*/(.QU
M
M                    #:D;#-)&L$__ $Z9_P!;D?Y98@%[\K+[Y_";FPWZ
MM;^\C\"/5%,K@    $+?2,_RW8M]RND^VW.!Y6[<?]68?_VZW_?8@^A'\)W_
M "ZQO_O5[_TN#- QID]/
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M7#780<MERHY3C&FA/2T:;C69OT
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M'?C<BKT;O;^2@T%E&:SW8)^VX.UU/7U]:EXN)\GCX31+1U"_YG5,_H%FNQ'
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M5H3='KIHDE&]CR.   $#N^G\H_+?]4XG]KE</'O:]_KK$_F[/]U$^E_\-O\
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M=E/W*[O[;<'&B>P[_5F(_P#;KG]]ASUS_%C_ ,NL%_[U9_\ 2XPFD'JD^>Y
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M[][QY=/*<\S3%8K+;CBY6YR3BW&2E%ZN"231ED20@X
M
M
M
M
M
M
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M"9G+N*B345LJ-RHL^_1;71N&IQ,B.VM,5G&8G-K]Q[&'_J[/!37R\'@Y69_
M;MX2PE<QG]?B=;K793[WW7?EKXEJ*F7SMZ#!J.DTTSHZF'%JZ2CV9:2UM+3U
MT=F%5T]<WJ;K@^BOJZ^,AJ)7PD/R'%DTTA#9+6H^'%1\<SE#<L'M2TR<G5\+
M[Y%=Y8QAFCMP25N,(I):$E2M$M256WHX6V7W.B[_ +,WH[/ZBNT?^8#3\1C&
M?K=W\Y+\9FP<L_9N'_,6_P 5&]0MR]   #QK_7,_XP_\DZ.KUKO_ &&=HZI=
M[[*/(.QU
M                                                        #:D;
M#-)&L$__ $Z9_P!;D?Y98@%[\K+[Y_";FPWZM;^\C\"/5%,K@    $+?2,_R
MW8M]RND^VW.!Y6[<?]68?_VZW_?8@^A'\)W_ "ZQO_O5[_TN#- QID]/
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MVZ5T5I771'R7[!,-U+MYR/![6UT69SA6E*[,+L:TJZ5I6E73C*M0^?9]H
M
M W2V#_E"5WV*Y/\ O9D;5[&_]:P_R]WX$>>_XG/^5EW_ #N'_&9.</71\W0
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MQFJ/5M1E'[DWTTHWN:)3,!H6\TR)_$<FIZ6! N*R937U@W)E5\1B*]-JI55
MM&Y468XCEMMK64A!&9*2?)Y9[CW<[6=T[N368YK?>&Q]JU&,X2A<DFXI)R@X
M1FFI/2DWM+A6BK\R[[_PZ=HF'WGQ4MWL)''9/?Q$YVKD;MF#C&<G)0N1N3MN
M,H)TE)+HWK3T[*UPW:Y_EFN^FT?,\2PVQKM%\-R.&M&3W[#D&YRBTL6I52FV
MJ:SVZ6L5KGGBCJ?6KENR)*"X$I#J&X+VDYUF6^&11S7+<+.WNKA;\?ZVXG&=
MV<DX;<(<%F+>RY-U<IK4U)1VUV&[L9'V:;W2W?SS,+5WM"S#"33P]F2G:P]N
MVXW7:NW-%<3<2Z102I&W;DZM2A*7L[(-Q&ENF.#9/A.?7IXU-D9;)RBOGRH5
MA+KYT:?34=4Y$0Y71)BV)<1VEY9DZ24K0Z7),S2HBJ=DN^^[V091B,ISF]U>
MZ\2[L9.,G&2E"W!QK%2I*+A732J:IJ92_B,[*=\]\=Y,'O%NQANN8>.!CAYP
MC.$9PE"[>N*35R4$XR5VBV6VG%[22:)3K*9&L,6GSX;I/1)U!*F17B2M!.QI
M-<X\PZ2'$H<23C2R/@HB,N/5(C'H:_=MW\OG>M.MJ=ER3XTXU3TZ=1XMPEB[
MA<YM86^MF_;Q48R6ATE&XDU553HU30Z%=S0G4Q[2'5'&<]37KM(M0]*:MH+1
M%SSU-8PWZ^S5'4?M42H\62IUHU&2#<0DE&23,>(]T,_ENSO#A\Y4'<MVFU.*
MUN$HN,Z=U)U7!5)/14^J_:5N?#?O<S&;LNZK-^_&+M3>I7;<XSMJ7'&4HJ,J
M5>RVTJI$]6+ZZ:09?1MY#3:B8D=><=,F2FPO*ZJG5B322E(MJ^QD1IE:XUQX
M*)U"2_5(S+@9^Q<OWOW9S/"+&X7'8;H=FKVKD82A]_&34HM=U+D/F7G/9MOW
MD.9/*LPRK'=:V]F.Q9N7(7'QVIVXRC<3X-EONT=41R[MM<//W;4&B6BC$[,X
MK5J5E;3*6,X^S>V\9IQF'$K7.2DW:>I0^Z[(E*Y,9;AI62N0T3BM'=I.]OOC
MB;.Z>ZBGBK:N;4Y6TVKDTFHQCQPA5N4W2#='6D:OUCV&]G/U98'%=HO:'*WE
M]Z5CH[4+TE%V;4FG.5Q<%VZU&,+:K<2K%K:GLK=_:_H.SH1I_P""YRX\O,,B
M?9M<MGQE&XP4EMI3<&GB.FE!NP:=IQ9)49%RWG75EP2HDEMKL^W.CN?DO5[S
MC+-+[4[TEJJE2,(OAC!-T?#)R>II+SGVR]I=SM+WHZ[AE.&0X2+MX6$M$MEN
ML[LEII.ZTFU71",(ZXMO9,3LU&:=;X-,BS[1.RN8<<WKW3Q_RKA&VA2G5U+;
M?,9+&]KRN#!5:NRU=3CRH:2XD7$:O[6\@]L[J7,5:C7&8%]-&FO86BZN]L?'
M?=@NZ;\_ARWP>[':)9R_$3V<MS6/5IU>A76]K#R^^Z3^J7<NRUNAJST=FFKM
ME>9+JK:-NKA8W'7BN+<\E:F4VUJA,J^E15*]HV["K5--'R>/**<KCP,NKKSL
M0R&5_%W]XL0F[5B/0V:ZMN>FXUQ.,:+1ZQFZ/XK=[X83+<'N5@W%8C%R6)Q-
M*5Z*V]FS&7"U.YM25=3LQIK):QZ3/#8   ?&R.CA9/CU]C5BGE5^0TUI1ST\
M"5RH5M!?@2D\D^HKBQ(5U/U1:X["6LPP5[ 7_P A?M3MR^]G%Q?B9D,IS+$9
M/FN&S?".F*PN(MWH/^?:FIQ\<40A[4;&9I#NF@8KD1=AR)5CD.F=N1EP(K"0
M\IBO0WRE));<K(:V*E"B,^4A9&GCQ+CY,[.;]W=GM#AEV.^+.4[F%G]\W2-.
MX[D8)<:=54^BW;;A,/OWV+W<[RK^LM0M6,PM?>159M\3C8N7&UP-4=-).J/7
MI\V3YES<U>.U-C>W<Z/64]1#?L+*PE+Y$>'#C-J=?D/+X&9-MMI,SZAF+?%8
MK#X'#3QF+G&WAK47*4GJC%:6WWB\R_+\;FN.M9;EUN5['W[D86X1593G)TC%
M+C;(R]Y^Y+27.=,%8#A&2)RJ[GWU5.D.UL.<BMKH=6Z^\XZ]83(T:/)=D.DE
M#:&#</@9J4:2Y/*T'VI[][MYON_[&RF_UC%SO0DW&,MF,8-MMRDDFV]"4:\;
MHJ5]@_P^]D>_.[>^2WGWCPCP676L-<A%7)0=RY.XDDE",I2BHJKDYJ/!%)NN
MSJIL^UHQG174V?;9D<EC',AQN50S+")%>FNU<GL^OLH<UV+&)R4_$,X*VEI:
M0MPC=2HB,DF0UUV8[U8#=3/YXG--I8&_8=N4DG)P>U&49-+2U\5IT3>E.F@W
M9V\]GV<=H6Y]K Y!L2S;"XN-Z,)24%<CL3MR@I2I%2^.I)R:C\5INK1*ZWO
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M)Q^'A;P4ZK:;Q4*J<'ITPM;5W1K<$GQD_P"/9Q\O@
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ME7OM4>Y#Z]LI^@8CSX#_ *1]XOWO@OFKO./62X1Z-<J]]JCW(?7ME/T#$>?
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M[[5'N0^O;*?H&(\^ _Z1]XOWO@OFKO./62X1Z-<J]]JCW(?7ME/T#$>? ?\
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M)<(]&N5>^U1[D/KVRGZ!B//@/^D?>+][X+YJ[SCUDN$>C7*O?:H]R'U[93]
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M[[5'N0^O;*?H&(\^ _Z1]XOWO@OFKO./62X1Z-<J]]JCW(?7ME/T#$>? ?\
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M)<(]&N5>^U1[D/KVRGZ!B//@/^D?>+][X+YJ[SCUDN$>C7*O?:H]R'U[93]
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M[[5'N0^O;*?H&(\^ _Z1]XOWO@OFKO./62X1Z-<J]]JCW(?7ME/T#$>? ?\
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M:2WO[,=^-QJW-XL!=M8.J2O1I<L-O0ETMMRC%O@C-QD_),Q"4$!
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M/_).CJ]:[_V&=HZI=[[*/(.QU
M
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MN7 ^#@.&C'&?
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MT_W7EW_#6?0,U]9/:+^_\Z_X[%?I1YB]$?0YI7][W$OK0'NANG^Z\N_X:SZ
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MJW9MQLV8QA9A%1C&*244E1)):$DM"2T)'B'4[@
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MKLPQ&]DTIQMS2E;PG"E%:8ROTHY7&OZN7Q;6ISGH<-/'I<
M                                                   YA@V?9=IM
MD,/*,*O)M%<0U%P?BN?L,ICEI6N%8Q%DJ+8P'C07+9>0MM7 CX<2(RR>49SF
M>18V.895>G9Q4>%:FO)DM4HOAC)-,P.\F[&1;W95<R;>'#6\3@+BU26F+I13
MMR7QH35=$XM27'1M$[^VW<12:^8JY)YIFIS2B1'9RJ@0LS;0XZ2DLV]2;BE.
MNT\];:N22C-R.X1MK-7M''/8.XF^^$WRRYSHK6:V4E>M\&G5.%=+A+NZ8OXK
MKHE+YI=KG93F/9CG:L[4K^[V)<GAK[6EI:[5VBHKL$U6E(SC2<4OC0ALB)V:
MD  ^+D60TN)T5KDN16#%51TD%^QL["29DU&BQT&M:N2@E..NKZB6VT)4XZX9
M(0E2E$1VN.QN%RW!W,?CIJWA+,'*<GJ27C;X$E5MT23;2,AE659AGF96,HRJ
MU*_F.)N1MVX1URE)T6O0DM;DVHQ2<I-)-D$.XK=-F.N%K+K8;\S'=.8T@RJL
M88>-IRQ;:7^Q6.3+8<-$^>Z:26EGBJ/%ZB4$I9*><\?;\=H>:;VXB5BTY6,C
MC+XEI.CDEJE=H_C2>O9^3#4JM.3^EO91V+Y!V<X*&+Q$;>+WLG'^LQ#55;;6
MFWATU6$%J<Z*Y<TN6S%JW'5<:[-T@
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MU^3:B]E:')RG6;P<(B;'
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M7J/ISN)V>[M=GN4QRW(;*5YQ72WY).]?DONKD]=*U<8*D(5>S%5;>)1&R<
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MENK<NA<G24-/1-II]%HMR,C>)Y.
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M;_Q&[L_Z=QS[5Q_K/P8\QQ[N9-ZG\.?I&]6N?1I[)]R>V;1[9WK5HMY:;<M
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M_P#89VCJEWOLH\@['4
M
M      -J1L,TD:P3_P#3IG_6Y'^66(!>_*R^^?PFYL-^K6_O(_ CU13*X
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MHO9[.QO!<E?S[*L1U>Y=D]J=ZU**G9N7&]+N4V[<F],NC4VW*4C0D:?/38
M                                            &Z6P?\H2N^Q7)_WL
MR-J]C?\ K6'^7N_ CSW_ !.?\K+O^=P_XS)SAZZ/FZ
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M.?YEALXSK%9I@\-:P6%Q%^=R-BW3H[2DZJW!*,4HQU12C%):$CD@OS$
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MU.X
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MN.2LO3ZM1N7%PQG&VR$T>4#Z(
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MMRW+JN&;7R6XJ5^:KP[,K=N,EP.['A9%2/.I[7
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MD9S=*;4>C;KLIF@@TT>G0
M                             D=Z/+5.349I=:3SWUKJLMAR;VA:4HS*
M+D=-&YV>VR@S(DHLZ)EQ;I]4^5";(BZJC&\^Q+>*YALUN[MWFWAL3%W+:XKL
M%627W]M-O\W'C9Y-_BIW+LX[=[#[[X6*6.P-R-F\TOE6+LJ0;?';O-**XKTJ
MO0D3!CTX>"P   @KWPZJ2L]UDLL9C2UKQO3@W,;@QDK/F%WB>0K)IRFR4I)2
MO"">PS/]KAIZA&9CR%VM[Q7,YWHN8"W)O X&MJ*X.D_^;*G'M?$[T%W3Z3?P
MX[E6=V-P+.<7H)9MFU,1.5-*LZ>KP3\G8?2K^==EK5#3,:M/0
M                   ![<"?-JI\*SKI+T*PK9<:? F1UFW(B38;R)$62PXG
MVS;S#[:5I475)1$8J6;UW#WH8BQ)POPDI1DM#4HNJ:?&FJHH8K#8?&X:Y@\7
M"-S"WK<H3A)5C*$DXRBUPJ2;37"F60M$]1&]5]+,,SPDH;E7=2DK5ELN2VQ=
MUS[U7=M-(XFI#!6D)TVB/JFT:3_5'NG=//([Q[NX7.-"N7;?QTN"Y%N%Q+N;
M<73N4/DKVB;J2W)WTS#=EMNSAK_]6WK=FXE<LMOAET<X[5/NDUP&4Q(B%
M
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MC:B(CZ0M9+9EM3N2FUP:6O$OL]]%2YB=Z<7;V+5F-E/170I?A2JEIUJ->)G
M>CF^:^89I)JNG=)TCVJL#=[KM(R#RZ+ XYY!::5,ZA2[$KZRS'4#)LN[%RS6
MVZ<NU&\ENQA5M8ZLW%38L_G$DRQ><N4>BPB<8TI7A\"X._K[PRW=96[BQ&92
M5R=:["JU7CD]#?=5*<;:T%M5*221)21)2DB2E*2(B21%P(B(NH1$0P1,$DE1
M:C^@                                     /&O]<S_ (P_\DZ.KUKO
M_89VCJEWOLH\@['4
M       #'VJ^JVG>ANF^9ZO:MY;58)IKIY0S<GS/+[M;R*NAHZ]!+E3I78S,
MB2Z2>))0VTVXZZXI*$)4M1)/O:MSO35NVJS>I%'$8BSA;,K]^6S:CK>E]S@J
M]9K3M9Z1C93O9O\ *L7VK:^XQK1=X13P[[+8F+U.7,-4%58S3KZZ18S[O':J
MN:<GRT+2PSSIO.DTXI"#2TX::]_!8G#14[\=F+=-:>GP-EK@\UP&/N.UA+FW
M-*K^+):*TX4EPFZXM3(
M           ;4C89I(U@G_Z=,_ZW(_RRQ +WY67WS^$W-AOU:W]Y'X$>J*97
M     (6^D9_ENQ;[E=)]MN<#RMVX_P"K,/\ ^W6_[[$'T(_A._Y=8W_WJ]_Z
M7!F@8TR>G@                                                D
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M_P H2N^Q7)_WLR-J]C?^M8?Y>[\"//?\3G_*R[_G</\ C,G.'KH^;H
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MF6RMPO6)3:<^BN55)M))RA.,X526THJ5%6BSV)D:R
M         ".SI'[-YC3'!:A!J)FQSDYSQI5P)1U=%9M--K+AQ4DSM#5PX\.*
M2/@9D1EI#MTQ$X9!@\,OD3Q>T_Z%N:7X_B/5O\)>#MW-\<RQ\J=):RW87_B7
MK;;7S=..C[]8<AY?/?(
M                           6 MF<R1.VTZ8OR5FXXB+DL-*C_4CUV9Y'
M7Q$?J]1J+%0G_P"P/9_9;=G>W#R^=QUDHW8^"-^[%<B21\O?X@,/:PW:]G-N
MRJ0<\//^E<PEB<GX92;\)L\-@&FR&?I'9\AS5[#*Q2B.)#TWA3V$=7BF18Y/
MD\>4K]=R>"VJMDNH1'[7JF?4X>6NW.].6\V%P[_)QP,9+ORNW4_%")] /X3,
M-:AN)F&,2_K[F;3@W_-MX?#RCR.Y+E(]QI4]3
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MJ&JPUV;J
M                #ZE)9NTEU47,=2TOU-I LV5-F1+2[ EM2FU(,^H2R6T7
M#_E%QA,1+"8JUBH5V[=R,UWXM-? 6>8X.&8Y??R^[1V[]F=MUU4G%Q=>Y1EH
MP?0<^,H %:[6RQ?MM8M5+"29F[)U#S$R(U<KFVF\@GM1V"5P3RD1X[:4)/A]
M!)#PAO7?GB=Z,QOS^5+&W_ NDDDO J+P'UU[.\);P.X.286U\B&587PMV(.3
M[\I-M]UF,!'R8@
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M_%MX^Y%=[H[,OADSYX_Q68>U9[2</<MJD[V469R[LE?Q,*^;"*\!OD-Q'F<
M
M                                                 \:_US/^,/\
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M9OTTPEK\'!)=[3QI$H(LC+
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M\OC?Q\,:)=(;^6%J_P#_ ! _FOPD:C[;/^9V9_\ X/\ ^DL'I7^%7_D)D/\
M^&__ +QQ9I:-5GH0G>Z*C6+P[@^7:+6LKEV&$3#RG&&G#,UKQB^DFBWC,%RU
M?L-3D*R=7Q)/MK-)%QZO)]>_PZ;S]:RO%;J8B5;N%ETUE/U5QTN)=R%RDN_=
MX>#YI?QL[@^S=X\!VAX*%,+F-OJV(:U+$68UM2EW;MA.*UZ,.ZTX<8WNTZLH
M]_%O=WD1J'HS35<[<G;S)#+94\6KK9#LN?42/;]C<PSF["S7%,N)UA&9M\WU
M1',;V<X?!=L5V]C(J.ZMFW+-)MI;"M0;E*#6K95].+AKZ+32A,LM[<,9F7\,
M=C+\MN2N=H&(O0R"U&+?2RNW(J$+L?NMIX-JERM.L4^-M:",36_4^QUFU8SK
M4NRYQ"\IO9,J!&=5REU])&)$"@K#/E*(SKJ6*PR9EU%*09_JC0N]6?XC>C>+
M%Y]B:[>)O.23T[,%\6W#^A!1CX#V-V<[FX3L_P!R,MW0P=''!8:,9R6J=Z59
MW[G_ (EV4Y]Q-+@/[HAI5:ZVZJX9IA4/E#D93:''DV"FN>365,*-(L[JS-GE
M-D\J!4PGG4MFI/.+22.)<KB&ZN[V)WJWAPN081[-W$W*.5*[$$G*<Z:*[,(R
ME2JK2G".T;?7!=G>Y68;Y8^/26<%8VHPK3I+LY1MVK=:.FW=G"+='LIN5'0G
M0UDF:3]'CHE'FZ38-2N:@Y+);Q>@N;F.4^ZM+ H:Y-ED&2W');FR:^N99YSL
M)AQB.J2\VAMMMM2S3ZXWIGNWV);JPN;MX2T\^Q$NBMW+BVKDGLUG=N3T-QBD
MGT<7&&W**44MH^;6X%C?C^*OM%GA]^,RQ"W5P<'B+]JU+8LVX;>S;L8>UIA&
M=QO9Z6<9W%;A*4IRDHIP/ZDZN:DZO7;V0:CYC=Y58./.O,HL9:_!U=SRC4IB
MGJ&>:JZ>*7'J-1F6FR+]0>0<\WCSS>3%O'9YBKN)Q#;:VY?%C5UI""I"$>*,
M(J*X$?2_='<;='<3+HY7NE@,-@L*HI/HXKI+E%1.[==;EV7'*Y*4GQEDO)/R
M#[_^J/:_S-OCW7BO^35S_P#1B7_H6?(S*?\ ]9G#?_IW;_\ WJBK</GT?9XF
M_P"B)_V=UQ_UU@G[QR@>L/X:/U;./SF&^"^?.;^.S]J[M_Y?&_CX8CSWT?E8
MZS_9!6?:Q1#2G:U_S%S7_,+^[@>J?X;?^1^[W^5N?^HO&I@UT;P+*71K4TVJ
MVIXM*EH-M&09+F-S!)7 E*A%=/4Z5J3Q-22<D5#AIXD7*09&7$C(S]U]@N$O
M8;L[LW;JI&_B;UR/WJET?XUN7@TZJ,^1/\7N88?'=MF,L6'66%P>%M3^_P"B
M5VG@C=BG2M'5:TTH/]:S>UHW5Y_$PU*)K^>:OS\>QE7$T,SESL@*@J91J/E&
MW'F&E#IJ,O:H5Q,BX<"\E;T.6]':!C895_62QN9SA9_G;=W8@^XI:'W*GT<[
M/%#L^[%,KO[P-VK>69#;OXCA<%"QTUV/=E#3&BUM452:9_3/1/H^]"+;4F!B
ME?ENH-1 @P&\HN(Z'+S)<OMG$Q(L6#*<1(/&:+LEU3KC,3D&4-@^6IYXB4KU
M3<W?W3[%MS[F?6\/;Q6?6XQBKMQ5G<OST)0;KT5M.LFH4?1Q=7*=&_GI:WP[
M1?XI.TNQNCB<==P.ZM^[.;P]J35G#X6VMJ4IQ3CUB]LI1C*YM+I9K95NVVHP
M8:P;A-7-=;=^TU&S"RM(RW^>A8Y%><@8I4$DB2TW5X_'<* P;39$DWEI<DN\
M.4ZZM7%1^2-YM\]Y-[L4\5GN*N78UK&VGLVH=R%M?%CHX:.3URDW5GTCW"[+
M-Q>S7 1P6Z> LV;JC2=^24\3=XW<OR6W*KJ]E.-N.J$(QHBQ1L0_)+T9_P!2
MW?VW9"/;O8W_ ,M<K_-W?_473Y1_Q,?\\MX/\Q9_]+8*MP^?1]GBV-@3\75#
M:YC":)3;[>9:(PJJ*@W4\&YMCA::E^"\[RFDI=AV"EL.GQ225H5U2X<1]%\E
M<-X>S;#V\$U+K63JVM/W<L/T;BWHTQG6+U:4SX@;SV[VYG;3C)9FG&67[QSN
MR=-<(8OI8S2TU4X4G'0ZIK05/Y$=^(^_%E,N1Y,9YV/(8>0IMUE]E:FW676U
M$2D.-N),E$?5(R'SJE&4).$TU-.C3UIK6C[>6KMN_:C>LR4K4XJ46G5--533
MX4UI3/".IW+0NZO\BS4;[F-/_P#=TH]^=HW_ "DQG^0L_C6CXU=B7_ZP^4_^
M\7O@O%7H> S[*EL?'YI:L;6Z^33NE+=SS0[L6.;/)-1V5UA"H+T8TMH,DR(]
MB\MI:"3[5Q!IX=3@/HO@KOO)V:PEA7MW,7DSBJ>7/#N#CHX5.L6J:U0^(&:8
M?W'[:;MK'QZ.WEF\FU*OJ[6,4U*K>F,K:4DV],6G4J<F1I,TJ(R,C,C(RX&1
MEU#(R/JD9&/G0?;]--56H_@ M6;:FVM-=IFELW)%KBQ<>TGA99<*4@DN0X#]
M4]E4I*VU*21.Q(<HTJ)1E[9)\> ^AVX*CN]V9Y??Q[<;5C+NGGQJ$HROO1QJ
M,N5::'Q0[7Y3WP[<LZPV4)3OXK/)86UIT2G&XL-&CIJE.-4U70]%2K)<63US
M;6EO((DOVMC.LGTEPX)>G2793A%R4H3P);I_021?\A#Y[7[LL1?G?G\J<W)]
M]NI]I<#A(8# V<#:TV[-J%M=Z$5%<? N-EG31K\A?$OZO<C[4)@][[L_\FK/
M_LES^YF?'3?_ /\ UE,=_P#I5'_U4"KT/ 9]E20#HS?RJ:#[$<S_ (+&X^PC
M_F-AOS%_^ZD>7_XP/^2>+_SV$_O3:7I??_R>?_6S_P#(S&QOXF?_ ."?_AG_
M .RFEOX#O_YJ_P#]9_\ ] A:'E8^A(
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M4]DF(WGR_+>CSR&5VKT;O6,5*ER4;;E+8E?=MU<GH<-E5T(EV'I<\*
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M$MW(T<;G12G.<HM:''I;EQ1DFU**4DZ-&U0V*:4
M       #1OI L5D7VAC5U%0I:L-RVGN9?)+E&5;/9FX^^?)+J\$S;:,HS_42
MD^/4ZI:C[:,NGC-T5B[:J\+B83E][)2MO\*<7WD>C_X7<ZM99VD2RZ\Z+,,#
M=M1_.0<+Z_ M7$EPMKO$(8\F'T7
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ME)*]:Q-O$Q5=,HW8*U-I<479@I/^?'C(S!H,]@@
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MN TH&J#T.
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MZF8$$--F@
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MC;37<:9\UOXE<[M9QVHW[%F2E# 86SAJK5M)2O37?C.]*+XFFN W(&T300
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M4J)1$I)DI*B)25),C)1&7$C(RZAD9"F7*::JM1_0
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M9A__ &ZW_?8@^A'\)W_+K&_^]7O_ $N#- QID]/
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MK&4)I2C*+6AJ2::?"F>F*97
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MKYM'),!>IL6(P=S$RJJ[+6EQN;.GHX6[LHIUGL.+B?-R3<3N7TKC>'M5-O\
M4R<3:-/9UOA>2%(*M:4?)-Z8;4G(^QD-J,O;/H8969DDG",^(H8[???W=VWU
MS>+);<LM7RIV+M=E<<J.[2G')1B]6TB[RGLI[(-];WLS<K>B_#/'\BUB[&ST
MCXH5C8VF^*#G)4;V&C(VV+<;-W!2-277Z2#1P,4M:A%''85(<L7:>Z.[.&[<
MN./O153N14\%<P24$OE=0RY)C.;@;\W=]9X^4[4+-G#7(=&E5R<+G2;+FVVM
MKXFG9HJU[A$^V/LFP_9;:RB%O$7,3BL;8NN])[*MJ[9Z';5I)*6Q6[HVZNE.
M&J-KQL<TB:1ZF[UL8Q[)RT_TLQFPU:S9R8JL2S3/J:I$V7$DG$BRXL:?*NY#
M!DHW"CM$RGDF7/<25R=39_VK9?@LP]B[NX>>99LY;%(.EO:\E22D[C6FNRMG
M1\O73T7N?_#QG.:Y-[T;Z8RUD>[JM])6ZJWG;\J492A&S%Z-EW);;K^3TJOK
MRM5MZD"N.^D[>L1DUR"5)=IZ_)&Y>2-PS):FTE$BY%+>?E$DD\6V8[CQFKAS
M23Y1)Z7-X^U:S8ZY<R3#2L+2X1NIW5'@T*ZVWJT*+E_-6FE6SN3_  ]8K%>S
M+.]6/ABW2*NSP[C8<M%?C2L148ZZ2E<C#1\MJC?)M$-XN!:N6K>(W%?*T_SQ
MQUR.Q07,E$B#92FCY#D.KME,0379)<)1=BOL,/&9<&R<,CX7^Z7:?DV\N(66
M8J$L%G#=%;FZQDUKC"=(_&K]Q*,9<6UI,-VC=@>\VXN">>X"[#--VE%2=ZU%
MQG;B]*G<M;4Z6Z4_K(3G%:Y;*I7:?(+.12T-W<1*J;>2JFHLK.-25J278W$B
M!">E,U5>@R,E3;!QHF6B/Z+BR&Q,;B)X7!W<5;MSO7+=J4U;C\J;C%M0C_.D
MU1=UFE\KP=K,,SPV OWK>&LW[]NW*]<T6[49S47<F^"$$]J7\U,CORWI!['#
M[1REN= LDIK9CV[];D^3N8]/;869]COE%>Q"4ZMM\DF:5<.09%Q2I1=4:1S+
MMJOY9B'A,5DU^UB5KC=N]'*G Z.RW1\G$V>J\C_A:PF?8)9AE^\^$Q&!EH5S
M#X=7X.2^5':6*BDX\*UKA2,O8YO'PU6B\#5;.(":"QM;:XIZ?#:><5U<WDNL
M?YI/@UMYBN63)I6GGG722RR9D1KY2T(.38'M1RM[JPWCS>'0W[ER<(6(2Z2=
MQP=/BIJ.C55ND8\+JTB!YMV!9_'M!N[D[N77BL+8L6KMW%W8=#:LQN1K_6-.
MXJZ]F,:SFJTC2,I+77+=^6L5(ZFQ\QJ,9QQ]XD0GLMC93SLE"B);9)LNQZ2"
MIYULC424-K(B/J<HBXG!\R[8MZ,)+I_9"P^!D_BN\KM7Q?&I;C5K3H3\/#M?
M(OX9]P<Q@\)[R/&9M&-9K"RPU(O4_P"KVKTZ)Z*N2KW*T6S6V[=ECNO+TK'9
MM0>*9Q A+L%U1S4S:VW@LN-M/RJ:6MN-(4]'4ZE3L9QOEMH5RDK<22U)GVXO
M:1@=\92P-VUU;-H0VMC:VHSBG1N$M#JJJL6JI:4Y)-K3W:WV'YMV9VX9KA[Z
MQV[EVXH*YL.%RU-IM1NQ3E&DDFHW%*DFJ.,&XI[<C99HLU^3MYQNRU5FZKYK
M=W>=V4:8A_"*&_<;5CN!LI;C*-NJK6OV"3);G-+=:=6E)(XH,T+?1V0J%K<G
M W]XI[QYM>O8R_&5;%NXUT6'5%HA%:&U)-INE-#:<UMO:+[5,WP>Y5O<C=[#
MX;+,).VXXR]835_&.LM-VX],8N#4913;=))2C;ET2V!$T-7&JFMNZ>BTNR&%
MI[B^.V&H^J%H<=N-BE,Z;;<!Z>E"H#=I*9CS9!3)33A.MQ6F5N*9X*6II"T+
M5KK>SM#P>[V-ADF7V)X[>"Y1*S!T47+Y*FTI/::>TH*+;CI;BFF]V=G?8MF>
M^>57-ZLYQ=K*=S;.TY8FZJN:@VINW%RA'9BTXRN2FHJ55%3E&45P>7JSO.J(
M"K^QV[XK-JFT*DO5%/DS4G(V8O56E/8T6\L7Y$A+1$1H9BN.<H_^C+@:2Q%W
M>3M3PUGKE_),//#I5<(74[J7>5R3;IP1@W7[E:B1V-Q_X?L=B5EF$WKQMO&M
M[*NW<.XV'+4_C2LVU&-=3G<C&GW3T-_(TDWI3-6]9<5TYC80UBU;;5=VFW3;
M2Y$V[C9%35MQ:/0X+S*(4;L)$>O22C?C(=Y1.$9)X)XVV[7:K=WEWIP^1V\(
ML/8N6[FWMMRN*[",YN,6ME;-(KY44ZUT+07V_/\ #W8W&W QN]E[,98W%V+U
MGHNBC&%F5B[<M6U.:;G+;<IMK8N.--G2])OT-RGF(
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MBX1\F0
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M[L+^7XBVIVYQ=8RC)537#WTZ-.J:331\D6Q>@
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M.#L
M         !*YL"T&G5YR-;LI@G&.9"D5> Q931ID*B2RYNTR=*%$2F6I;!'$
MB*^BZRM]?#D*:6OT9V,[G7;+EO9F$-G:@X8=-::/1.[W$U\2#X8N;I1Q;\2_
MQ/\ :9AL4H]G62W-M6[D;F-E%_%VHZ;>'KPN+I=NK[F2MQKM1G&,H@]!GC,
M"//?CH+,S?'H>JN*PG)>18; 7"R*!&94[)L\32Z[*3,80V2EN2,>D/.NJ21<
M517G%&?[$E*M)]L.YUW-L%'>++H.6-PL-F[%*KG9JWM*FMVVVVN&$I.OQ4GZ
MH_AH[3</NYFMS<K.KBMY5F%Q3L3DZ1MXFBCL-O0HWXJ,4ZZ+D8*GQVU#6/+A
M[^
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MW\,':78P-R?9YG-Q0MW[CN8.4GHZ27Y3#Z="Z1KI+:T)SVXZ93BG$R/-Y[@
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M2<I2??DVSZ8N"S
M    .,YKA^.ZAX;EN 9? .UQ/.<9OL/R>K3+FP#LL=R:JETMU *=6R(EC".9
M6S76^=8=:>;Y7*0M*B(R[0G*W-7(:)1::[ZTE.[:A?M2LW--N<7%]YJC\10(
MZ?WYOOM8V.;996\C:1>YUAE1C><XCBN=Z-YGDCV;8TNHS.85'5W."Y!:QG,Q
MKK2NO'&>RXUG/LV94=]2VG(RH_-R9/EN97<5<=F\EM;-4UHU<:\/VB 9[D-C
M+K$<5AI2V')1<94>M-III+BU.O?(K?F_?1@Z/=)_NPS_  /7[(,MJ]*=(-*'
MM2;BBP:RCTF0YG<R<KQ[&J3'W;N56V7@G'B19R9$YV.E,U?,M-,K;YQ;S5WF
M.+G@\.KEM)S<DM.K4W]@QN1Y=:S/&.Q>E*-N,')TI5T:5*NM-==3U4X:KLL=
ME&Q/;+T>NDMMHGM4P6?@. 7^<6>I-]7V>8YAFTVVS>YH,9Q>QO7[/,KN\F15
M2*'#JV/V-%5'A([&Y:64N..K7$\3B;N*N=)>IM4IHT:/Y,V1@,!A\NLNQAJ[
M#DY.KJZM)? D<;WW=';M:Z1_3;'-+=TV(7V48[AV2/Y?B,G&LSR3#;?'LED4
MT^A7:QI-%/CQ+!95UBXDF9[$N-RN"N;,RZO;"XR]@Y.5JFG6FOY/QE/,<KPN
M9PC#$[7Q6VG%T:KKXUQ:UP=\ZP[IM^C5Q;HLMZ+6W[3_ #K)=0--\RTEQ#6;
M3^TS5-0O-*W'\CO\RPR71Y5-H*ZEI+6SA9/I_8K;DQH$%MR(\R1LI6E2E2W
M8KKF'Z5JDDZ/BJN+P-&M\WR[V9C'ATW*VXJ46]='5::<337=I4L2= [\WQV*
M[MMC.F6\C=;6Y_JQD>LUOJ+X%P"%GEY@6#8GC^GFIF9Z8MH,\%>H,OM+RYL<
M0D2Y#SMMV.EE;#;3#:D.N/8S,<TO8>^[%E);*56U5U:KHX-3,[DF[V&QN#6,
MQ3D]INB3HJ)TTZ*UJGPK07I(,*+608==":YB%7Q8\*(SRW'.9BQ&4,1VN<>6
MXZYS;39%RE*4H^'$S,Q')-R;D];9.H0C;@K<-$(I)=Y:$>V.#L
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M_;K?]]B#Z$?PG?\ +K&_^]7O_2X,T#&F3T\
M                     !]K'<DR+$+B'D6)W]UB^05_9'8%[CMK.I;B#V7%
M?@RNP[.M?C38W9,*2XRYR%IY;3BD'Q2HR.ZP./QV68J..RV]=P^-A79N6IRM
MSC5.+V9Q:DJQ;BZ/2FT]#,?FN493GV N95GF%P^-RN[L[=F_;A>M3V9*<=JW
M<C*$MF<8RC5.DHJ2TI,R?\I+<3Z?-:?OIYS]?1(/?O??]\YK_P 7B/TA#?JC
M[*/_ ,V-WO\ ^W8/]"/E);B?3YK3]]/.?KZ'OWOO^^<U_P"+Q'Z0?5'V4?\
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M$L0PN%A"UA;4(PA"$5&,(Q248QBDE&,4DHQ222225#UAT*H
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MDX46N+H?4+=?"0W][$,)@<\V;CQF3='*4J.DH0<(76Y:%.,H1N;3I2:VJE@
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MX.[;O67JE"2E'EBVCTA2+@
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MZG<
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ME)41\#2HCX&1D9=4A%VFG1ZR>IJ24HNJ9_ .0
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M'WIQK"7@DSV#D&_VY>]%J-[(<SP>(VON5<4;B^^M3V;L7W)03,;#!$N
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M]O)>T6-R[&-(QQMN.U.G!UBVM,Z<-VVG.6C:MRE6;C>RW2O4C WW8^88/D]
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M+<:NG\Z4FYSHMJ3HJ92$A(6
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M7XTRU[\VH_L3]EO_ 'C?_%GKN,-FOZ_<_H_BHE.[G[&L_P!/\>1.H,<9L
M(>NE?Z:#;/T4V(5<7/(\[5+<!G%#.N],] L5LHM=<VM<P[)@1<JSC('X\]C
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MU_KF?\8?^2='5ZUW_L,[1U2[WV4>0=CJ
M  1 ]/E_8^[ZON4U7\X>%C(Y5^OV_P"E^*S";Q_L:]_0_'B=1<)D:M.U[^;4
M?V)^RW_O&_\ BSUW$-S7]?N?T?Q4;2W<_8UG^G^/(G4&.,V0O_.&LGKL2Z&W
M>]96:9#C,_#-/L8CMQ$L+?78YCK5IKBE8KD2)$9*H\>=<-NR#2HW$1FW%(0M
M220K(Y2O_/V_Z7XK,'O(TLFO)ZWL?CQ.I0$R-7'8L_,XJ"RB[&-SF2OL\BJN
MMULBHKWC)9*?EX]I'IQ*LN22D$A33;>0QR)25'Q5RB,BX=6-9[)=+;CPJ+?*
M_M,GFY\)*Q?FU\5SBO"DZ_"N4M[# DQ.K:^=-_VP6K?W*="OYO*T3+*OU"W_
M $OQF:MWC_;-[^A^)$?-9/[8+23[E.NO\WED&:_J%S^C^,ANY^V;/]/\21VD
MHAIM( "ES\\1W='BNBNW#91CEES5KJSE=AKEJ5'BS4-R&\&T[0]CN"5-I!Y*
MG'ZG*\UNYLYI9FDDRL73PY75Y,@R*SIGB']ZOA?V"%;WXJBM8*/#\=^.,?\
M:\1)A\V2VC'MBZ+G37,[RJ57Y]NKO+3<-D*GU-NR"Q3(&8M'I-&:>;ZG@R9I
MQ20;EEHS-33UR_QX&9D5KG%_I<7T:^3!4\+TO["\!D=U\)U?+NGDOZR]*O\
M16B*^%^$L+#$DD  Z0;7?^7#67[JVHGVWW V&:2+J/S*_P#^B5?]SC_YJD1W
M/O\ Y7]+_9)ON=_]I_\ #_VR]0(\38_"UH:0MQQ:6VVTJ6XXM1(0A""-2EK4
MHR2E*4EQ,SZA$"5="UG#:2J]"1T=.I>20<RU&S_+ZQJ6Q6Y5FV59)7,3T,M3
MF8-Y>S[.(U-:CORH[<MN/*23B4.N()9&25*+@9[#-)EE#YH[065MTIV1V<)G
MEP\7VI:LV]N\9+)+$29F.EF/1^"DH4CG7+&[9(DJ-/%/*,C,RX'B\XDE@6GK
M<DERU^P2'=B$I9M!I:(PDWW%2GPM%U[IV]3(VDW1$[[LGE+6A%OHL_IFWS?'
MEJDZSY-CND$5' HLPS0J1G*>7[0BY'*,UM%Q=1'\KCM8^VGQM\B;)GO#/8R>
M\^%J*Y917P&I?029GH]LOZ#_ &E9ON-U3TVT0QS*(^J.>S\HU-S&AP:A?\NM
M9\]L\39C6.3R*=N;8V6)O5G-L-FZZ\XLDL\XDVS.XS*%[$YA*%J+DXJ*T*O
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M?;;G \K=N/\ JS#_ /MUO^^Q!]"/X3O^76-_]ZO?^EP9H&-,GIX
M
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MXJ2JN!T>E<!Z(IEP
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M91BH-5=S%8:*[E+JG7DA3PD[ ]?'S6   "(CI)O]L],_L8N?X59'FCMV_:N
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M[E:^&IN&-GFA2-?I)6FCPO3-Y24F^WE%RTVL_P!>EIVI:4\E/5_6J6RV9_\
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MMI5E<M3^5.$%\:<)UE&*E)3DELJ28;W/(P
M
M
M
M
M
M
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M-9?NK:B?;?<#89I(NH_,K_\ Z)5_W./_ )JD1W/O_E?TO]DF^YW_ -I_\/\
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M_P#[=;_OL0?0C^$[_EUC?_>KW_I<&:!C3)Z>
M
M
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M;<YZDWT<G&3I\;9J]+;)XA[#/F@
M
M
M
M
M
M
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MT<V_4+G]'\9%WNXW[9L_T_Q)':H"&FT0
M   -J1L,TD:P3_\ 3IG_ %N1_EEB 7ORLOOG\)N;#?JUO[R/P(]44RN
M0T]([ >;U;PNT41]CS-.8L!H^3P2;U;DV22'R)?'VQDBU;XEPZG4_P /4\M]
MN=F4=Y<+B'\B6!45WXW;K?XZ/?\ _"9BK<]QLPP2_*V\VE-]ZYA[$5H[]N7?
M\!'J-*'J<
M
M                                                    -Y.CZKG)
MFO3TM"5FW4X-D,UU22+D))Z73UB"<,S+@2ES^IPZIF7^#CPVYV+6)7=\7<5=
MFU@[DGX90A_M'G#^*3%PP_9G&Q)K:OYE8@N/1&[<=/!#O>&A-X/69\Z
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M3>%8C+<%BLMM9#=E11;NQNRAH>S.2M36M:=EJJT-T;1F.S3?'L4W+E@L]S3
M9YB-[L/&LI)6)8>-U[2V[47B+3=(O1TD726E)-)K6[3C9AN?THR9C+<'S[2R
MIN6H[L)U:K3)I<:;7R%M.2:^;$DX&XS(BOK80HRX$I*D)4DTK2E103(^ROM
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M.(MN]AYVE2LH26G5I36DN<'>CAL9:Q$J[-NY&3IKI&2>C5IT:-)%UBFQ35W
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M;I)QCM1EN@-J'GP
M
M
M
M
M
M
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M6BT4KK,GBW,@          >-?ZYG_&'_ ))T=7K7?^PSM'5+O?91Y!V.H
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M+N<2\.OP+C)=NIETW<>8W52VDU#NMZ&UW$JKBTOA1>+$<)T
M                  !M2-AFDC6"?_ITS_K<C_++$ O?E9??/X3<V&_5K?WD
M?@1ZHIE<     T/W]Z6R<TTN@9M5,*?M--I<J?,:;1RG'<8MD1F;IQ))2:U'
M6OQ(TE7$^2B.V\HQI[MEW>N9KN]#-L,JXC 2<I):W:G13?\ 1:C+B45)GI;^
M&+?2SN]OG=W=QLE'!9O;C"+;T+$6G)VEQ?UBE<MKA<Y6T0GCRB?1
M
M
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MK
M
M
M
M
M
M
M
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MX'HIHT)<%#A/_P"DQ_\ U=3_ (_1U_\ Q3_A_P  [_\ Y2?X[^U'_P"DQ_\
MU=3_ (_0_P#Q3_A_P!_^4G^._M1_^DQ__5U/^/T/_P 4_P"'_ '_ .4G^._M
M3M>Q#3:13AZ>CYNEF.Z?4;(-ZVP^+4^>[(R\)ZT:&S[6NQF+J9>08S+<?/\
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MO\3_ &?_ &RJ%TEFROU=^]C6G9WYRO._YH/-S_\ O%\C?-_Y0^<#2; ]4?\
M9'RJS;P3X)\MNP?^U)//]C<]^Q\YS3>:PF(ZUAXWZ;.U716NIM:Z+B(MF.#]
MGXV>$VMO8III2M8J6JKXZ:RX3M=^:,^:#6+;MN*]8)Y0^:_4O2/6KR.^2CX)
M\.>1.4X_G/DUY0?*4L_!GA/P9V+V9V#(YGE\YS#G#FSPU[._E6NBXU7:\'DD
MGPVZFU"WB.L:U&5-CO.E=O[!=<$=)P          >-?ZYG_&'_DG1U>M=_[#
M.T=4N]]E'D'8Z@
M !UG.I.T?=]TL73K/9MJOM@W&8;MZU6W.0*^5EFI.C.KF&835;7M'4)8BQ'L
M@R3%ZNKQV?E^DV J*.RIQA#U_:DDOV5_BJ9*Y:P.!I&47*$.-:9?;DS5DK6(
MS?-]J49J-V[PIZ(^+Y,5W-1V8+##$5AF-&9:C1HS3;$>.PVAEAAAE!-M,LM-
MDEMIIIM))2E)$22+@74$-;;=7K-I1BHI1BDHI427 >4#D             -'
M]^71X;7.D>TA7H_N:P8[R' <E3L(SO'WX]-J5IE>2VV6W[S \I<ASSK7Y28S
M12HDAB76ST-(3*C/I0@DW6%Q=["3V[3T/6GJ?\N,Q^899A<RM='B%\9?)DOE
M1[W<?"G5>&C*X&C_ $!72C]&1G.HV6]$_OUT-5CNJ+U&SF>);D=)JRLN;G'L
M31DLC%:>7D<;3[69J985$W))'%^L3BK4Y3A+?(DM-LEEIYG@<7%1QEN6A\#T
M=_0XOQ,C5O(,WRVY*YEEZVZJFE)2:UTHXRCK[J,#[KNA1^<0](M:4U+O&WM[
M8K+3FHLE6L/#:;-,VQW3ZG=4^TA$N)IMIUH!C=+E.0UD9:RA2[E;LMIOG$%-
M;YU?+JVLPRO"K^HA*KXEIY9/5X2VOY+O#F,__.SC1:MJ7Q>+1&":3[M.^S<K
M8?\ -,=I&WW)JK47=QJ+9[P,IIY;<^IT]7C7FZT/ARH[\*5#<R3&VKW(<EU$
M<AR(BN+,VQB4LMA];,NKD)X&=MB<[N33CAX["XWI?)J7C+_ [IV+4E<QT^D?
MDJJCX7K?B\);!KZ^!40(-5508=95UD.-7UM;7QF84"O@0F41H<&##C(:CQ(<
M2.TEMIIM*4-H224D1$1#"-N3J]+9+HQC"*C%)12HDM27$CW!P<@
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MRTV],G;CH.--GIP
M
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MHQBEJ22HDNXC1.,QF+S#%7,;C[MR]C+LG*=R<G.<Y/7*4I-N3?"VZGO"L6P
M
M
M
M
M
M
M
M
M
M          '5"?.5_P"VPWI?]W+_ ,)FA F65?J%O^E^,S5N\?[9O?T/Q(G:
MHX+_ +$8=]BN/?P1#$1O?EI_?/X39.#_ %2U^;C^*CE0IER          >-?
MZYG_ !A_Y)T=7K7?^PSM'5+O?91Y!V.H
M
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M*;G>7C?G(?HQ_P!4W:9ZO*_F+GZ<>KVT&[=U ^$-9\7P^I3<[R\;\Y#]&/\
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M6?T#@
M
M
M
M
M
M
M
M
M
M "NCON^;5[0]_P#NLU4W<:H:W;D,0SK5GR'\.8[@-IIC&Q.O\@].,0TSK/!+
M.0Z;7]PCLNGPR.^_STMWC)=<-')0:4)RV&S:YAK$;$81:C735\+;^R1K,-V[
M6/Q<\7*[*+G30DG2D5'C[A8=J*UJFJ:NH86XZQ55T*M9<>Y)NN-08S45M;O(
M2A'.+0T1JX$1<?H$,7*3G)R>MNI(;5M6K4;2TJ,4N14/HCJ5          #Q
MK_7,_P",/_).CJ]:[_V&=HZI=[[*/(.QU
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M;%Z+C*E=/$=\-B\/C+;NX::G;3I5<>ATT]]&6Q2+@
M                                                   VI&PS21K!
M/_TZ9_UN1_EEB 7ORLOOG\)N;#?JUO[R/P(]44RN
M
M
M
M
M
M
M
M
M
M
M
M
M                                             >-?ZYG_ !A_Y)T=
M7K7?^PSM'5+O?91Y!V.H                            =7YT_737:I;Z
MM=,^VW:-9A98ILRTCRZZQ"OJL8MWXK.O]]C5BNML=1LWE5TDF<@Q%^U@+<QN
MM6:HC4(FIKK9S'>#$QR[ 0PEM3DJXB2TOB[B^SQOP4U?G><7<RONW!TP<'\5
M<?\ .?&WP<2[M6Y5OFTG0F[6]<]ND;?GNTT_QW72?FF9Y;C^BVF&8(\-:;8[
MC>#6<O$;S*<PP]]*:G+\ENLJA6,=B%:-S:V'"B,R$M*DOI5'L\VS"]9N+#V'
MLNE6^'3P+B[^OO<.3W<R;#8NT\9BUMQVMF,>#1K;X]=$M6NM:JEKO5/HN.CE
MUGPP\!U V1;8[#'6ZN335G@/1W"<+OL<KY<9B(\UB&78548]E>'.=CQ&4I<J
MYL1Q',MFE1&VCAA88[&0EM*[-ONMM<CJB5W<GRN]#8E8M)?S8J+Y8T9UX/3B
M]#_GW1'ZCHS#0W-LYMMG.Y+PGAE)9.6\^+=XU9LN,9/.T,U4EU2H5?EE9(:J
M$6E)(D-I*S8KW>=8.17.2'I1E^.CC8?&25Z.M?97<^#X=?9SE$\JO+9;EA9U
MV7PZ-<9=U:-.IZUJ:5G+YGA_9FZY?UZM3/Y@-L8PN>?K<?S:_&D2K=']FS_/
MO\6!9AW 9]<:4Z#:VZHX]&K9F0:;:1ZDY]1P[IF5(IY=QAV&W.15D:VCP9E=
M-?K7YM<A+Z&9##JFC42'$*,E%B[%M7;\+4J[,II/PNA(<9>EA\)=OPHYPMRD
MJZJJ+:KJT:#KR_[X?TF7H-V*_>SU_P#_ )YP27V'A/*N<L?1('[W9EY%CDEZ
M9=MZ(C>)J9O[Z/';WNUUBH\%QO4?5CSL>45+II69!3X3"\A-<-2]-*CP+6Y3
MD^97L;LFBPV*[)Y^RD\N6XZI'-MJ0TB/XVQ##8J5FVVX1IKUZ4GW.,F>4XNY
MC\OMXN\HJY/:JE6FB36BK;U+C))!:F1
M                                    -J1L,TD:P3_].F?];D?Y98@%
M[\K+[Y_";FPWZM;^\C\"/5%,K@
M
M
M
M
M
M
M
M
M
M
M
M
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MJ1L,TD:P3_\ 3IG_ %N1_EEB 7ORLOOG\)N;#?JUO[R/P(]44RN
M
M
M
M
M
M
M
M
M
M
M
M
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M;<GPO2R>PMPM05NU%1MK4DJ)=Y(^L.#L
M&U(V&:2-8)_^G3/^MR/\LL0"]^5E]\_A-S8;]6M_>1^!'JBF5P
M
M
M
M
M
M
M
M
M
M
M
M
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MEEB 7ORLOOG\)N;#?JUO[R/P(]44RN
M
M
M
M
M
M
M
M
M
M
M
M
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MSH8V+?//U2/YQ?BR+[=']I3_ ##_ !H'8=B*FQ#IFNE$_M,ND3_KU;N/Y_\
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M_P#TZ9_UN1_EEB 7ORLOOG\)N;#?JUO[R/P(]44RN
M
M
M
M
M
M
M
M
M
M
M
M
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MSV;<9VTIU:23:TI-MJJ>K2]*T'51=(5LHVR:#ZSUN,[&-Z>G6][#]0<O;QW
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MR$'O6W9NRM2UQDUR&W,-?CBL/;Q$=$9P4J:Z55:>#4S*0IE<
M                -J1L,TD:P3_].F?];D?Y98@%[\K+[Y_";FPWZM;^\C\"
M/5%,K@
M
M
M
M
M
M
M
M
M
M
M
M
M          'C7^N9_P 8?^2='5ZUW_L,[1U2[WV4>0=CJ
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M(W!@</U3!V\-HK""3IJ;II>GC=69\%$N@
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M=3Q?JKGFRYA[3RWZ18^<CSCP%>>)K7WNE]9#J>+]5<\V7,/:>6_2+'SD><>
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M=3Q?JKGFRYA[3RWZ18^<CSCP%>>)K7WNE]9#J>+]5<\V7,/:>6_2+'SD><>
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M=3Q?JKGFRYA[3RWZ18^<CSCP%>>)K7WNE]9#J>+]5<\V7,/:>6_2+'SD><>
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M=3Q?JKGFRYA[3RWZ18^<CSCP%>>)K7WNE]9#J>+]5<\V7,/:>6_2+'SD><>
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MT5[&,PF(<H6+MN<]FM(RBW2JTT39ZHIE8
M                                         -1MYVQ?;#O_ -)'-%]T
MNFD#4'$F;!%WCTYN9.HLMPK(FFE,LY%AF64S\2ZH+,FE&V\EMTXTU@S8ELOQ
MU+:5<8;%7L+/;LNE=:X'W_Y5++'9?A<QM=%B8U2U-:&GW'\*TI\*T(J9:O\
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M._"S.Y?DN!RU[=E.5[RI:7X-27@5>-LDU%D98
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MY4.-&(!&2?
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M-V"VIQDH\;31UMXK#79;%JY"4^)23?(F<Q%,K@
M       &U(V&:2-8)_\ ITS_ *W(_P LL0"]^5E]\_A-S8;]6M_>1^!'JBF5
MP
M
M
M
M
M
M
M
M
M
M
M
M
M     #QK_7,_XP_\DZ.KUKO_ &&=HZI=[[*/(.QU
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M@%[\K+[Y_";FPWZM;^\C\"/5%,K@
M
M
M
M
M
M
M
M
M
M
M
M
M                                'C7^N9_QA_Y)T=7K7?\ L,[1U2[W
MV4>0=CJ                            %7KYV[C&/V_1;460653"EW>);
MG=+)6-VKK1=GT[MOCV?T]JF')2:74Q[&NDJ;>:,S:<-+:U)-;3:D9K(V^M27
M!T;^%<Y%=[HQ>7VY46TKR5>&CC*J\-%7O(ZS42DUX=S+T7?]F;T=G]17:/\
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M_H?B1,U?-$?[4C./ZG^K'\Y&BHIYS^I/[Y%7=C]KP^]E\!V78B)LT
M                       VI&PS21K!/_TZ9_UN1_EEB 7ORLOOG\)N;#?J
MUO[R/P(]44RN
M
M
M
M
M
M
M
M
M
M
M
M
M                 >-?ZYG_ !A_Y)T=7K7?^PSM'5+O?91Y!V.H
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MW(_RRQ +WY67WS^$W-AOU:W]Y'X$>J*97
M
M
M
M
M
M
M
M
M
M
M
M
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M[3;T)J4[;;24]I[*VE&PS2X
M
M
M
M
M
M
M
M
M
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M$?[4C./ZG^K'\Y&BHIYS^I/[Y%7=C]KP^]E\!V78B)LT
M              VI&PS21K!/_P!.F?\ 6Y'^66(!>_*R^^?PFYL-^K6_O(_
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M+UMNKDVY-MML^.+4OP
M
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M?+CMC[/'V<;XW,LPVT\DQ$>FPLGI?12;3MR>FLK4DX-MUE'8FZ;=#8H3@U0
M
M
M
M
M
M
M
M
M
M
M         >-?ZYG_ !A_Y)T=7K7?^PSM'5+O?91Y!V.H
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M+*9!+-A3JHCSQ-I?)I7(,^'*Y)\./ Q")0G#Y::[ZH;:MWK-ZO13C*FNC3^
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MYWH.2_FQKP$9HT(>P
M
M
M D,Z.;)Y%?JEE^*FM90,CPU5BILE$2566.VD,H:U(-22/DP;B67$B-1<?H<#
M,RW9V'9A.SO#B<NJ^AOX7:I_.M3CL_@SGW?&>5_XL,GM8K<O 9U1=9PF8='6
MG_R[]N>VJ_?VK7$O#1.90>HSP"
M
M
M
M
M
M
M
M
M
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MX=E7;:H\R*IV,^MM1H6DU(6I)]0S(/;F+\FWR2](>Z.6^7?Y8^@6IAAB4@
M!5?WW?-1]G&Z;43)=6M =4,IV?9AF5DNXR/&<>PNHU)T97;3+!Z=<VU%IT_?
M8)<8M*MSDK)46!?,U$8TH./!:(EI<S6'SN]:AL7H[;7#6C\.AU(IC-T\+?NN
MYAKCM)ZX[.TO!IC1=S3W# 6WOYG'M>PG(8USN1W6ZK:^U4&R9FLXG@.!TF@E
M):PV>84=1DLQ[+-7<EE0I2T.$\Y63ZB3S:R)MUI:><54N9[<<:6[:C+C;KXJ
M(HV=S[,9UOWY2AQ**B^5N7P$X>[7H8=AV[7:;@VS^VTJA:1Z>:/KF3=#+K1R
M/68SE.D-Q9<%7D_'IDZOMHENQF+R27D#%HU,*[?),J0HY[4>8S86,QQ-F^[[
M>TY?*3X:=[53@IJXC,8O(L!B<+'"QCT<85<7'6F]=:UVJT5:Z736BNY-^9=X
M0YE;DRNZ0C*HN#G*;6UCLW;543\K1")A"78[F9,:W5M0[*7))2TO%0H0E!D@
MVE&1K/)>WO\ NOPO^R8+W._Q/]G_ -LGDV+]!_M>V!;>MS^A&C6H^OZK+=Y@
M1X#JWK'+S6BK-3*F'&Q;/L6H+?2UZDQ.#CF!WF'M:EVLRKE*@3Y#<YQIR0Y)
M2RVVG'8G,;N)NPNN,5T;JEIXT]/'J[AF\!D>'P.&NX>,YR=Z.S)Z%P27Q51T
MT2>NNGD(]LE^:+]'EF=[991F&Y/I!LKR6X?*3;Y%DNL6B%[>VLE+3;*9%E;6
MFVN5/G/DRTE!+=<4KDI(N/ B%S[<Q?DV^1^D67NEESTNY?K]]'T#X?\ <\.C
M-].6^K[YF@'_ ,[&'MS%^3;Y)>D<>Z.6^7?Y8^@24='7T(^WCHS-1YNH.A>X
M+>/FD"9AE_AA:7:QZKX/D>D4)O(KJFO9>20,)P_2C F8V6QY=.:&)G/&2&ID
MDE(4;O*3;XG,[^+M]%<C!*O G7QME[@,@PF78A8BQ.ZY)-4DXTTZ-2BOA)EA
MCC.'B?88E,/1I++4F-):<8D1WVT/,/L/(-MUEYIPE-NM.MJ-*DJ(R41\#Z@)
MM.JUG$HJ2<9).+5&GPE4_=O\TFV-ZZYSD&H&@6IVHVT^7DLJ?93,%QZEI=1M
M):NTG',DN/XMB=S-QW(L;KE6,E*_!S%X=='81V/"8AM<@F\W9SR]".S>@IM<
M-:/PZ&O@(GBMTL-=N.>&N2M1? UM)=[3%I=]LPOH]\S<VJ8W854W7'=KKCJO
M'@NP)$^HP+$,,T=K;E<9YQV7#E.6<K5BWB55D@FVEHC2FI;;?.<W)2M:%M5)
MY]-K^KMI2[KKXDE\)2M[GVE*MZ_*4.)147RN4O@)K,]Z%O:/?;,\0V*:29/N
M&VIZ)8CJCYVUR]MVKTK'-0LMR63C&3XO=0,WS+4&EU*DY%C621\G.3-@K:0V
MJ5 A\T;3,<F56$<RQ*Q#Q,MF5S9V=*T)5KHHT9B>0X&6"6 ATD+*GMMQ>ERI
MLZ6TUI7 DM2(LO[GAT9OIRWU??,T _\ G8Q<^W,7Y-ODEZ18>Z.6^7?Y8^@/
M[GAT9OIRWU??,T _^=C#VYB_)M\DO2'NCEOEW^6/H%B_:/MHQW9YMXTZVX8E
MJ%JWJICFFK.2QZK.M<\L@YQJC<Q\DS'(<R4QDF3UE#C$&P9HWLB57UR6X+"8
MU7%C,<%&T:U8S$7Y8F\[TTE*5-6K0J=WB,_@L);P.&CA;3D[<*T<J-Z6WIHD
MN'1HU%>[?=\U'V<;IM1,EU:T!U0RG9]F&962[C(\9Q["ZC4G1E=M,L'IUS;4
M6G3]]@EQBTJW.2LE18%\S41C2@X\%HB6ES*8?.[UJ&Q>CMM<-:/PZ'4CV,W3
MPM^Z[F&N.TGKCL[2\&F-%W-/<,!;>_F<>U["<AC7.Y'=;JMK[50;)F:SB> X
M'2:"4EK#9YA1U&2S'LLU=R65"E+0X3SE9/J)/-K(FW6EIYQ52YGMQQI;MJ,N
M-NOBHBC9W/LQG6_?E*'$HJ+Y6Y? 3A[M>AAV';M=IN#;/[;2J%I'IYH^N9-T
M,NM'(]9C.4Z0W%EP5>3\>F3J^VB6[&8O))>0,6C4PKM\DRI"CGM1YC-A8S'$
MV;[OM[3E\I/AIWM5."FKB,QB\BP&)PL<+&/1QA5Q<=:;UUK7:K15KI=-:*[D
MWYEWA#F5N3*[I",JBX.<IM;6.S=M51/RM$(F$)=CN9DQK=6U#LI<DE+2\5"A
M"4&2#:49&L\E[>_[K\+_ +)@O<[_ !/]G_VR6S13YN!L^T'VS:J;<-/=>=XV
M(/:X9?IEF.J.L6!ZKXIA>IUTYI/!S^!BV*U#T+3J;B]'A"V=3;?LR)X.?ES>
M?0E^6XAIM*;2><7Y7E=48?%323J];3XUIT+B,C:W8P=O#2P\KEU[4HRDTTJ[
M*DDDJ/123JM.FFG@-57/F>G1HNK6Z[KKOL<<<6IQQQS4[0):W%K,U+6M:MLA
MJ4M2CXF9]4S'?VYB_)M\DO2*?NCEOEW^6/H'X_N>'1F^G+?5]\S0#_YV,/;F
M+\FWR2](>Z.6^7?Y8^@6'=FVU/$]E&WG!MMV#:A:O:H8KI^J]339AKGEE;FV
MHTJ)=WUC>MUEGD%1CN*5SU90)L.P:UEJ"RF+7QV62Y7(Y1XW$XB>*N]+<45)
MK@U?"S.8# VLNP_5K,IRA5OXS3>GO):/ ;0B@7H
M       ;4C89I(U@G_Z=,_ZW(_RRQ +WY67WS^$W-AOU:W]Y'X$>J*97
M (6^D9_ENQ;[E=)]MN<#RMVX_P"K,/\ ^W6_[[$'T(_A._Y=8W_WJ]_Z7!F@
M8TR>G@
M
M                                                 W2V#_E"5WV*
MY/\ O9D;5[&_]:P_R]WX$>>_XG/^5EW_ #N'_&9.</71\W0
M
M
M
M
M
M
M
M
M
M                                                        #QK_
M %S/^,/_ "3HZO6N_P#89VCJEWOLH\@['4
M
M                      -J1L,TD:P3_P#3IG_6Y'^66(!>_*R^^?PFYL-^
MK6_O(_ CU13*X    !"WTC/\MV+?<KI/MMS@>5NW'_5F'_\ ;K?]]B#Z$?PG
M?\NL;_[U>_\ 2X,T#&F3T\
M
M
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MX2G>DZ*,4Y2;XDE5M]X1I4:;':E0Y#$N*^@G&),9UM^.\V?T%M/-*6VX@_\
M"1F06[EN[!7+4E*VU5---/O-:&+UF]A[LK.(A*%Z+HXR3C)/B:=&GWSSCN4@
M                   #XC>38V[=*QMK(*1S(D1W9:J%NU@+NDQ6%-H>DJJT
MR#G)CLK=22EFWR4FHB,^J0M%C\#+%=0C>LO'*+?1[<=NBUO8KM4555THJF1E
MD^;0R]9O/"XE94Y**O.W-6MIU:CTFSL;32;2K5T=-1]L79C@
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MXR2:\*/;%4H
M
M
M
M
M
M
M                                                        'C7^
MN9_QA_Y)T=7K7?\ L,[1U2[WV4>0=CJ
M
M                   &U(V&:2-8)_\ ITS_ *W(_P LL0"]^5E]\_A-S8;]
M6M_>1^!'JBF5P    "%OI&?Y;L6^Y72?;;G \K=N/^K,/_[=;_OL0?0C^$[_
M )=8W_WJ]_Z7!F@8TR>G@
M                                                       #SQXT
MF8\B/$CORI#G*YMB.TX^\OD(4M?(::2I:N2A)F? NH1&8[1A*<MF";D^!:64
M[MVU8MN[?E&%I:W)I)5=%5O1KT=\^P[BF4L0G;-[&K]FM82:GK!VGL6X3*4J
M)"E.RUQB8;22SX&9J+J]05W@L9&V[TK5U65KELRHO#2A8PSK)KF(6$MXO#2Q
M<M4%=@YOAT14JO1Q(^ +8R0
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MV"97E^*P>Y^)S;&;PQI&U.L7AE)2CM;4IV[4I1V=I*4%)-T:;CI-PALXT,
M        <!FZK:75EPYCUCJ3@-??LRFX#M'-S''8EPU.=-"6H;E8_8MS42G5
M.))+9H):C47 NJ0PUW>/=ZQBG@K^/P4,:I*+MROVE-2>J+@Y;57545*DGP^Y
M.^>,P"S7"91FEW*Y0<U>AA;\K3@JUFKD;;@XJCK*M%1Z=!SX9DC
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MTYX:_2BN05-J,EI4;EMM*<:\,9+XLD9]$R-8@
M
M
M
M
M
M
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MBMA,PP>.VNJ34]FE=#5*UIK2XF;("@7@
M                            'C7^N9_QA_Y)T=7K7?\ L,[1U2[WV4>0
M=CJ
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M?;;G \K=N/\ JS#_ /MUO^^Q!]"/X3O^76-_]ZO?^EP9H&-,GIX
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M5.DHV[B:JJIT:UIM<15B'SW/M*
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MB(B+J$1$/!>,T;QW?\[+^]9]?<K;>Y&';U^RK?\ Z=%EX>]#Y!
M  0&ZU_E@Y%]U3'_ -]TP\;;U_\ ,Z__ .XV_A@?3GL\_P"0N%_]EO\ XMTG
MR'LD^8P           &@72'Y5:4VDF/X[7O+CQ<NRMF/<FA1D<FOIX;UDW!6
M1?19=LDQWC_Y6"+Z!F-,]MN8XC"[M6<#9;C;Q.)2GW8PBY*/><MF7]%'I_\
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MCBK,6KMN/<G*-VSQ?&3:K%4G2'KP^;0
M
M
M
M
M
M
M    5!-\F]WYS+L(TGO===3=&NCXU'TDQ)3"LUS31/'M4LM:PV#+F1*^)<W^
M/Y'J3AF7HHWILU"')D:NDL1"XKE*8;X+.0X?#Y/B9]';<ND? VU]HA&,QF]&
M!M._?V.A3HVE%I5U5X4GQTIP<)'KLC^<-]-AO_W X]MJT"P78F>I&2TF3Y!7
MGFN"ZF8YCZ*[$J>1=VRI5HSJW:.MNG$C&EI*6%FMPR(^!<5%<WLLRZQ;=V[M
M*"UZ7PNA8X7/<\QE^.&P\H.[*M%LQ6I-O2^XF2]ZCZI?.NL!Q6PR>IT"Z.+5
M*17))US%-.).6/95)CI/B^_7Q,UU>PFLGJCM<5\PU+5*=X<EEIUPTH.RC#(Y
M/9VI+O[2^P92Y<WNMQ<W&#2XE!ODK5^#21V[>/G=6JF ZE.:3=(]LYBX584=
M]*QK/<CT59RO#LNP"RBS51GVKW1#56TOK*9(KDF136TY%"D(-M:VH[AJ0P5>
M[D=J4=K#3:?!72GX5J[^DM,-O;B(3V,;:BXK0W&L9+C=&VF^Y\7P%RS2G5?0
MG>%H11:F:6Y-BVLV@^M.(SDU]K%:5.Q_*L9N&9=)?4=S4V<9B9#DM*[)KK6K
MGQV)D.2V]%E,MO-N-IP,X7L-=V9IQNQ=>9HF5J]ALPPNW;:GA[D6GWGH::UK
MB:*?7SDOH8ME6AFRB7O$VMZ/XYH#G.D^>8)4YS38&4^'AN>8-GEQ#P9F/)Q5
M^V.EH\@H<FM:Z4Q.KH[:WV%2FY3;YN,OQ<[E6/Q%^\[-][2<:K0M%.\OAXB'
M[Q9-@L'A8XK"1V&II-5;333TZ6Z-4X.,Y'\S'_D/WS?=6T=^U#,AUS[_ .5_
M2_V2IN=_]I_\/_;+J0CQ-@                     (LND?NNEUQM&&WG1C
MXIM/SRK@X]DS^I.'Z^OY-%SBWR"._ =Q>+IX_%R/#L.0Q,A=E-O^$[.,DG^;
M]LA'*4,A@EE[BUC')3KH:K2G@,)FKSN,XRRO8=K9TI[-:U_G=SB? ^X4Q=1_
MG5/3 Z0Y_F6EFINC^U7"M0M/<EN,0S3$[W1_4B+;8]DE!.>KK:JG,EK8M'/1
M)C"D\I"EMN%P4A2D&E1YV.48"45*.TXM53VB'SWDSFW)PG**G%T:<%5-:T]&
MM%@73G5GYT7JCI[@>IF-8-T6B,<U$PS%\ZH$6;FK,6R129=20;^J3816LUDM
M1IR8-@V3K:7'$H<XD2E$7$["=O);<W;DY[46T]>M:.(S-J]O7>M1O6U;=N<5
M)?(U-57#Q&$M9NDZ^<7;#V;7.]V/1R;=M<]#:(GY=WGFVV5FCI5T)MGEO6-G
M;46HFI]QA^-P$,*6[-NL/BL(4Y[:01<E)=K>"RG%/9L7)*?%7[$E5^!G2[FN
M\F7QVL78A*WK<J5HM6N$J+PJNGO&Y'1]_.7M@F]S(<<TPS=Z^VH:VY+(@55-
MB&KL^LF8#E&0V"H\>/0X;JY6IATLR?*GR"CQ6KJ%C\F<\:&X[+CJTMBUQ.3X
MBPMNVU<@N+0^3F;?<,A@=Y\%BI*W?3LW&]%76+_I45/"DNZ6)QB22@
M !@#6?=AM9VX3:*MW#[E= -!K'*8LV=C-?K/K)IUI=-R*%6O,1[&911<XR.C
M?MXL!^4TAYR.EQ#2W$DHR-1$=6W8OW56U"4EW$W\!;WL7A,/)1Q%VW"35:2D
MHNG'I:,L87F^&:DXGC^>Z=9=C&?8-EE9&NL6S/"[^JRG$\EIIB.<AVV/Y%1R
MYU/<UDI'5;?C/.-++JI48Z2A*$G&::DN!Z&5;=RW=@KEJ496WJ:::?>:T')Q
MU.X           'C7^N9_P 8?^2='5ZUW_L,[1U2[WV4>0=CJ
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M&;?+([W+KL+.,A<N.D$WI[Z:^R8K.\/=Q65W;-A;5UI-+CI)2=.[1.G&=/\
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M *LP_P#[=;_OL0?0C^$[_EUC?_>KW_I<&:!C3)Z>
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M?94
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M'OIFV46U2SA\QQ$(:E\2-V2AH6A5A1TX-1D09PB@
M
M
M
M
M
M
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MX_$83$85_P!=%I/4]:?A7_Q,S@LSP68+_P K-2DE5K5)>!\E55=TW(%L7X
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MFO\ :D6ONA;_ +*'8%_5FTX_@LAALS_7KG?7P(E.0?L>Q]Z_QF2=BP,P
M       !XU_KF?\ &'_DG1U>M=_[#.T=4N]]E'D'8Z@
M         5@OG3&[ZZTGV783LXTM<L+'6W?9GL#3NOQ_'UOJR&3IAC-I1SLO
MCPF8C#[SLC,\HLZ''6XJC9\(1+.:A"EDRZV>:R6QMWWB)?)@M'??,J\J(IO7
MC':PL<%;?Q[KT\>S'QZ94IQT:XSK_>D!V2:E='GNFS[:WJE*;N+["X>*V]=E
M4.M>K*;+\?R[&:O(JZ\HVW)<]#T)EV>] >4V^\EN="D-&HEMK2F26+UO$6E=
MMZ8/[&@@N+PM[!7Y8:^J78TKPZTFO$R8/YK;O7/;#TC5;HIDMRU6Z9;RZ%G2
M.S;EKBL0&=5Z1R=>Z*VCDAU3<DY\ZXDV.-0V6U*2](R9/*;4I*%MV.;8?IL(
MY+Y</C+O</BT^!&6W<QG5<RC!_D[OQ'WW\E^=1=YL[/P0\V>   $=.X'I<.C
M4VN7%SC>MN\[1#&,KQTG"R##*7)EZAYQ1O-P7;+L*WPK36'E^55UD[":);<5
MZ&B0[SK1(0I3S)+O+>7XVZMJ%N5.[1?#0Q=_.\JP\MB[>AM?S:RY=E.GA-?=
M/_G"/0X:F6_@/'-\>!ULWBV7/:@8-K)I-4?LB'W$_P#WP:J:;X;0<"3&5RO\
MY]JHTDK@:T$JH\JQZ5>C\<><HK>+)FZ*]^#-?[)M8CI1^C,<0AQ/2);&"2M*
M5I)>[301I9$HB41+;<S]#C:B(^JE1$HCZAEQ%!X/%K1T5SS7S%XLTRUJJQ%F
MC_GQYSF^G6_O8GJ_F='IQI+O4VE:HZAY,[*8QO ].MQVCN;9GD+\&OEVTYFC
MQ?&LRL[RV=AU<!^2ZF.PX;<=EQQ7!"%&766&Q,(N4[<U%<+BTO@.\,PP%R:M
MV[]F4VZ)*<6WWDF;:B@79J=N+WV[--H_,L[E=S6C&C5G+AR+"!C>:YW1U^8V
MD&*TAY^53X4W*?RVX8;0Z@N5%A.D:G$)+BI:"5<6<)B<1ILPDX\>I<KT%CBL
MSP&#>SB;L(SXM<N/Y*J_$1Y,?./NA:D72*%O>Q5)G+L#K"??T0W+Q:4I*7SC
MFXO)).C#6.HK^<3Q*6J440T>W)SD&2A<^RL?ZO\ "CSEE[QY-Z[\"?HDDVWG
M>;M.W9P9L_;5N*T?UL35I;7<0-/<[H+^]HT/<KF%WV-QIAY!1ID<@^;.7%9)
MPB,T\>!BUO87$8?\M"45Q\'*M!?X7,<#C/U:["4N*M'YKH_$;,"@7AC#4+6[
M1C21^LC:K:NZ8:92;MJ4_31]0L^Q3"W[=B$MEN:]6-9';5KD]J(Y(;2ZIHED
MV;B25P-1<:MNQ>NJMJ$I)<2;^ M[V+PN':CB+MN$FJI2DHUY6C5Z[Z4KHT,<
M7)9M^D&V5QI4.8Y7S(+6Y[1>=91)C*W&GX\JL@9G*L([D=UI2'"6VGFUER5<
M#Z@JQP6,DZ*U/PIKX2VN9OE=N.U+$6J=R2D^2-69IV_[M=LNZR+ED_;7KKIE
MKE7X+85M5EUEICE=7EU;0V-O&D3*R).L*A^3"2]-BQ7%H)*U<20K]4C'2]AK
M^'ITT7':U> K83'X/';759J>Q2M*Z*UIK2XF:][F.E@Z.79]<VF,;AMWFD6#
MYA1K)N[P2NM;#4#4.E=4AQ:6;?3[36LS#-*Q]:&S,D/P&UF1IX%[9/&I:P&,
MOQV[=MN/&Z*O>JU7P%OB<YRS"3Z._>BKBUI5DUW'LIT?<>D^?MDZ73HVMXF0
MU&';>=W>EF:9MD+LEC'\$N7,@TUSV_D1%O(?BTF#:I46%99;RB1'6ZEJ/#<<
M6PDWDD;7MQS=R_&68[=R#45PJCY:-T.,/G65XJXK5B]%W'J34HU[BVDJON(D
M;%F90PCGFYC;AI9<3L>U.W Z(Z<7]9#:L;*CSS5;!,0N*^O?C]F,3IU;D-]7
M38D-Z)^RH=<0E"F_;$?)ZHK0P^(N1V[=N<H\:BVO$BUNX[!69NW>O6H7%P2G
M%/D;J::9%TA'0ZEE%=GE]O'Z.VWS6*IQ-9F*-;MO.399 ,NP%+-F^K\AL[FN
M)1U\;@?.MDHX[?#B;:>3<PP^9./1QC=4.+2ER.B+"]C<AC<5ZY/#2NO[I;,G
MRI-KPFY>@NY30#=+B%IG^W+6'3W6S"*3*;+";;*]-LFK,KH8&6U$&JM+&@D6
M54_(C(LHU7>PI1HY7MHTMEU/%MQ"CM;UB[8EL7HN,FJ^ R&%Q>&QMMW<+-3M
MJ5&U76J.FFG&C-PI%R:<[C>D)V/[1IZ*;<CNFT5TCR1V(F>UA^3YO4^7+L!:
M5*;GM8+6O3\O<@O<DR0\F$;2U>U2HU=07-G!XK$*MJ#<>/4N5T1C\5FN7X.6
MSB+L8SXM+:[ZC5KPHTAQ#YP_T-.<71T%+O@P^%.(R(W\OTUUTT]I>J^B-U,D
MS[2W&L=47..$?4E=1OBO]8DU%7]E8_U?X4><M%O%DS=.F_ GZ)M=J%THG1]:
M98!IGJGD>[#26TT\U@U*H-(=/<NT[N)>KU-=ZAY-%LIE30RI&D\#-3QULV*B
M1V3-LRAU\%:"1)?96I"54X8#&3DX*W+:7'HY*TKX"XN9SE=J$;DK\-B3T4K+
MNZ5%-KPT-@=:MT6V;;9Y-?**W$Z%:!>6GAGR.\]6KF :6>5GD[X*\H/)KRYR
M"B\.^ O#L'LSL7G>Q>S&.<Y//-\JWMV;MVO11E*FNB;IR%Y>Q.&PU.L7(6]K
M5M24:TUTJU6E4=85\Y(U@TEUTZ5'5#4/1+5'3K6+ +#331F! SG2S-L:U"P^
M;.J\%KX=G"B9-B5G;TLF772T&T^VA]2V7"-*R)1<!,,LA.W@80N)QFJZ&J/Y
M3X#6.?W;=[-KMRS*,[;V:---/XD5H:T:]!L#\U2UZT,V[](7K)FNX#6?2?0S
M#;39EJ'BU9ENL6HN(:98S8Y--UOV[VT/'8-]FMQ254N]EU5)-DM1&W52'(\1
MYQ*#0TX::&<V[EW"QC:C*4ND6A)O@EQ%YNO?L8?,)SOSA"#LM5DTE7:AHJZ:
M=!V&FG6_O8GJ_F='IQI+O4VE:HZAY,[*8QO ].MQVCN;9GD+\&OEVTYFCQ?&
MLRL[RV=AU<!^2ZF.PX;<=EQQ7!"%&49EAL3"+E.W-17"XM+X"?0S# 7)JW;O
MV93;HDIQ;?>29MJ*!=@                          ;4C89I(U@G_ .G3
M/^MR/\LL0"]^5E]\_A-S8;]6M_>1^!'JBF5P    "%OI&?Y;L6^Y72?;;G \
MK=N/^K,/_P"W6_[[$'T(_A._Y=8W_P!ZO?\ I<&:!C3)Z>
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MM796,7:C79A?@HRK"K<NCN0E"<*MTK*#E)P;-9Q!#;X
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M !$?.C>+_4&._P Y>_O)&%-WOY.&J7^J:O[8Z813M,_T+F'YN'][ V)V$?\
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MLY?VIYWA["2MO&.YHT?&O1C=E^%-_:U&?Q,S5Y#ATCZ4EJE@RN27*/ $)-7
MN4:4Y%=FE)G]$R2:SX%^IQ,>7NW1+WAP;X>I?_5N'OO^$MOW+S)<'M1_W%GF
M)!MILI<O;KI6ZM*4FB@?BD2>/ T0K>RA-J/B9GREMQR,_P!3B9\!NKLWN.[N
M/ETGK5EKS9RBO@/+7;A9C8[5\ZA%MIXI2T\<[5N;Y'*B[AL2)N:I
M
M
M
M
M
M
M                        C$Z:3^RAW^_U9M1_X+,7^6?KUOOOX&8?/_V/
M?^]7XR*"OS63^V"TD^Y3KK_-Y9"1YK^H7/Z/XR(+NY^V;/\ 3_$D=I*(:;2.
MNZ^=[[RL U@W';?=IFGN0MWTW;!19_D>KK]3.:E4D#4/5A>&M5.&3N8DK0O*
M,)QC"2DRDF@NQ2R F#7SR9#34IR7#RM6)7IZ.D:IWE6C\-7X*,UWO5C;>(QD
M,-;::LIU?\Z5*KP)+O.J>HES^:5;&LSV_P"TS57=9J/3SJ&YW?7.&N:=5%DA
MZ/+\S.FK&2)QW+3A2(L=^(UGV0Y?8R(RE*<;EU4.#+9/FI"379YWB(SN1P\7
M\C2^^]2\"^$RNZ6"E;LW,;<5.DHH]Y:WWFZ>;R[J?.>/[&7<S]E6W[^?S3D6
M^3?KJ^]9=[U?LO\ \2/V2KO\W&WBZY:0:1[K-L>R[1KSW;VM>,XTZR#3>ORE
MJ56:+:4:>XU2W5'F>M^M.5(D041L2P^QR&#':K8SQ3[2?-889(S42%YK,K%F
MZ[=W$RV</#:KQMNE$N1UX?A46R+&XK#QO8? P<\9>V-GBBEM5D^]M*E=''JH
MY0]Q'S?+I@MSM%>ZFZU=+U(SO6V=5':1M*HT?4[%-$8N1QH)JBX]CD_&,BQ_
M'\0I#EJ4V4J#@T<N*U/KC&XXYQM+.:X&RU"U;E&WQT7*]-7RU,EB=W,XQ2=[
M$7X7+U-3<N_1:*+D2(-^C)Z6S?%T7&^6MVY[L-2=1KK1"OU6C:);C-(=9\OL
M<LBZ2]B7C6)6&>X'<9#:SV\2DX"I)35G7R4TUW4-*2M+A*AS(U_B\'8QMG;@
METCC6,EP\*J^%/[9A\LS3%95BE;N.70*5)P==&FCHN"2IW-5'H.T+$,-I@
M    0R=/%TAN6=&[L RO5K3!;$?6K4S,J+0[1RVE0XME%Q7+\NJ,CR"PS636
M369,.:K%<-Q"TDPT2&G8BK7L1$A#C2U-KR.686.*Q.S<_)Q57W>!+Q\B9@]X
M,PG@, Y672_.6RGPK6V_ E3N-IE;/YICI7M_W/:L;TM=-Q.!QM<-UFGU_I9E
MV-:H:OK5J#+@0]2W-17,DR6G9R,K%I&H+^1XLE<R\D\[8DS):;BNM)5,Y[+9
MS=O6;4(V6XVW5.FCBHN.FO5X2-;K8?"8K$798J*G?BDX[6E:6]IT>ANM->G3
MH+RNL&B.D&X' +K2S6[37"]4].\AAN0K;$<WQ^NOZ:0TX@T)=9CSF'3@SHW4
M4Q)CFU)C.)2XTM"TI44<M7KMF6W:DXR[GV>/PDYQ&$PV*M]%B(1G;XFM7>X5
MWU0ZF[<M#U+Z&'I;=8:K:_G%C0W>V;6E4_36?*?F26+33?)X%1G6-X'GC#%B
MVYE5)88)DL6IO&7'FRL4I=7P96I)-S:VX8S")W$G&<-*^'D>I^$U3>5S+,QE
M&Q)JY9N/9?>>BO?6M:GI6H[7S;EK30[D-ONA^X+%X[T+'M;])=/-6*>!)6E<
MJM@:@8G4Y2Q5S#09I*=6)M.QWR_YKK:B_4$*OVG9O2M/[F37)SFU<'B%B\+;
MQ*I\>"?>;6E>!Z#,XI%R   '49=/Q_;";Z?NHT?\VV$"<X']3M?>+X#4>;_M
M3$?G9?"=ISLR_(^VH_U:]"_YK\6$.QGZW=_.2_&9L_+/V;A_S%O\5&R@MR],
M-[B-&<:W%Z":SZ"9C%8EXQK+I?G.F=TT^IYM"(6:8W8T#DI#\4TRXLB$J<3S
M3S)I>9=;2XV9+2DRJV+KLWH75]S)/G7A1;8S#K%82YAG3X\&E7C:T/P.C.F,
MT(U7SC:AN3TKUDI$6-1GF@.KV+9F5>Q-76S?"V Y3%G6F.RY+/.DF-9E7O0)
MC:B<9=8><;<2MM2DJGDXQG!PE\EII]YFGK=R=JY&[!TG&2:?=3JCNI['/<3J
M,!G:GVES%@X-68?)SVQR!Y7&%#Q.%2KR&7<NK:YSC%CT[2GU&GE>T+J<1 NB
MF[O0I?UFUL^&M/A-R=8M+#=:;I9V-NO\VE?@*!V/=,-NAZ;OI+=*]EF+[@M5
M=A6S753*L\I*)O;])BT&MV24>'89EV<4+V<ZEM23N*W),\\E&X+D2N=51U_9
MQ,NQ+$FW)+TGZE8R_"RO*"N7XJM7]CB2U\?=-?O-,7G>/AA)796,).324>]H
M3I1R;T+2Z*M:$S^XKYM'IM-TNRJWVF[QM[6G&Y>KJ+6WP'+]0-Q5YD^+Y-EY
M07EM5V>G74E/?UL/)Y1J8D6=7(9>@JDJD'&F(1V(Y8VL[NN:C?A#HN&B=5W=
M+>KB,OB=T["M2G@[EWK*TK:<6GW-"C2O'71Q$0WS?3IJMW6-[Q<9Z.?>YGF9
M:JXOG^093IKAN1ZKV<K(=5-']8\<;MGHN)W.:6TB7DF2XQ?V5*_1]@V+TUZN
ML78?8KL>*B0TN[S/+[,[$L192C<BJNFIKA[E>&O#\&+R#.L5:Q<,%B92GAYO
M95=+C)Z%1O32M%2M%K7=N5[^M"-Q&X_;A?Z6[7-QUIM4U>LLBQ2SJ=9:=BUE
M3J6JIK9J;>U:(E1/K94E%_7H5%4DWDH23G+,C-)$>"P=ZQ8O;>(AMPHU2B>G
MCTDQS3#8O%X96L%<Z*]M)[56M&G16.GB.MVZ?W;)O/VK:WZ#X)O)WJ9#O3O;
MS2JYRW",GOHMY \BJF7ETNGMJ&)#NK6W,O"$RD:D..MK23G!*5)]H1G*L!>P
M]^TYX>"A#:I2B6FBTZ.^:ZSC"XS"8F-K&W7=N.":>U*5$VU3XVG6F3<]&AT9
M_2]Z][$=M6K6BO3%9UH/I1EV J=P+1^'3YE91, QRGO[K'X-#%F1,I@15QV4
MU)K0EME"&DN$@N))XG98O&8"SB)6[UE2N*E7LQ=:I/ATF6RW*\XQ6"A?PV*=
MNPZTCMS5*2:>A:-:;T%IOHV]M.ZS:QH;E6GV\#=M<[R]2[C5>\S*CU/O(%M7
MRZ'!K#$,%I*S FV;BTMI2H]7?X]9V!*2XELU6BB))&2C/!XV]8OW5/#PV(*-
M*42TU>G1X"793A<9@\/*UC;KNW7-M.LI45$J5EIUIOBTE6?I\_G#^ONCNXC/
M-C&R?(&]*(VETFLQW6K<#7U=9?Z@S<NEP8MC?8=IE'N#=I\;K<6B6"(DZP6V
MFUD6S3S45Z"U'*1+S.6Y9:=J.(Q"VI254GJ2X*KAKKTZ.Y4BV>Y_B>L3P6"D
MX6X.DI+Y3:UI/[E)Z-&ETUTT$K,3YN)MMU%P.%;ZE[Y>D8U@U.R/'HTN1KG<
M[E9IVME)L8Z9T2VK*&ZQZ_C1JCER#=9AS7I[R6W%)<D+6?.%:O.;]J;A&W;C
M!.E-.BG!5-+Q%_#=;!W[2NSOWIW91KM:*.NE.C3?#J<J]U%8B;OMZ2?YOSTC
MV5;=M5]P.I6Y_0;&LCQRUML,U*R?(<MQ_5;0O*>19U&9:>MYM:V\O2[4,Z20
MZT\=9+3#9R" [%E+L8;!*<RKL87,\,KNRHSDM#X4UH[E4GP/7KT$=CB\QR#'
MRP^VY0A+3%OXLDZ.J3K1M4TK2M3KI1V36)9319SBF,YMBT]NUQG,<>I<IQVT
M9)26;*BR&MC6U1/:2LDK)N97RVW$D9$?!75$1G"5N;MR^5%M/OHV7:NPO6HW
MK?R)Q4EWFJHY".I4   #QK_7,_XP_P#).CJ]:[_V&=HZI=[[*/(.QU
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M>N:=3=*IUW88JK*]38=]C_9%_B]YB%@5E4HQ2 N8V=/D,@D$3R.2[R5<3Y/
M\!>S?$W[4K,XP49*FA.OPLF.&W9P&%Q$,3;G><X2JJN-*]VD5\).X,62(
M                       #:D;#-)&L$_\ TZ9_UN1_EEB 7ORLOOG\)N;#
M?JUO[R/P(]44RN     0M](S_+=BWW*Z3[;<X'E;MQ_U9A__ &ZW_?8@^A'\
M)W_+K&_^]7O_ $N#- QID]/
M           !+3T27\INJ_V"5?VP,CT;_#=_J7,/\BO[V!X<_CF_T;DG_N=S
M^XD?<Z73_:K1+['\T_A''Q>?Q*_M7*O\O>_'@8W^!3]B;Q?YK"?W=XAZ'F8]
MZ@ 2>[2ND"IMOFE+NF>58'<9*FLM[6TQRQH[&OADIBW=;EOUMHU-;)37,SU/
M.)DMFZ:D.D@VBY'*5OOLW[9[&Y.[TLAQV"N8A0NSG:E"<8Z)T;A).+U2VFI*
MKTTV=%7XX[<OX7,?VI[[1WPR7,[&#=ZQ;MW[=ZW.>FTG&-RVX/36&Q%VY**3
MBY;;VJ+0'4[.[+5C4C,-0)\!B%99MD=A=KJZ\G'68B["2:F($=2D\[(-ALTM
M\LR)3JBY1D1GP&F\]S:_O!G>*SF_",+^+OSN.,:T3G)O97"Z5I76]9Z@W.W:
MPFY&Z6 W6PMV5S"9=A(65<G1.2MQHYRX(U=946B*T5HB;KHMM.-0L%PG4ZPS
M7$\@Q6ORFXQ:7C:,@@R*IZR9@PKEN?-BUTTFIJ(YE)8Y+RFD(?29&A2R2?#U
MA_#QD>=93EN8XC-,-?P^'Q,[#M=)%PVU%7=J48RHZ?&C\:E)<#=-'SI_C1WM
MW6WEWAR;"[O8["XW%8*QB8XCH)QN*VYSLN$)7(5@Y?%G6"DY0==I1;TQJ=(2
MRTSO U@0RTVTA3F"O&AI"6TF[(TTPQ]]TTH(B-QY]Q2UJ^BI:C,^)F8T5VU0
MA#M-S-022KAWH5-+PMAM]]MMM\+;9Z[_ (6+D[G8-D,KDG*5,8JMUT1S#%QB
MM/ DDDN!)):$?%V2ZRGHIN$PZ[FRBC8QD[WD/ERG%J0PW39"_':8L'E$2R2W
M2W+,68L^2HS:96DN'*XE9=E>]/NGOIA<;=ELY?>?07ZNBZ.ZTMIZ]%N:A<>C
M2HM<)D?XB>S_ .L3LLS#+L/#;SG!QZYA:*LG=L1DW!:M-VT[EI:4MJ<9.NS0
ME.Z4C1L\NTGI-6:J)SMSIC8]BW*FFS4\]A^2/QXC[BS0?+=34WA17$ER3)IJ
M0^OBE)*X^AOXA=U_:.[UG>;#1KB<!/9N46EV;K2J^/8N;-%30IS>A)GBS^"_
M?_V%OOB=QL;.F7YQ:VK2;T+%8>,I)*NA=+9Z1-U6U*%J-&VJ0 --./.-LLMK
M=>=6AIIII"G''7'%$E#;:$D:EK6HR(B(C,S,>-4G)J,563/J%.<+<'<N-1A%
M-MMT22UMO@2X620;NYK>B>A^ANTFL=:1<5U0QJ?JWV/R>4YEM]V4["JY+J4K
M4]V _+E\"-PN5'9B+-"2)'#=W:1<CNKNIE'9O8:6*MVUB\;2E>GNIN,)/3I@
MI26O3%6W141Y+["<//M$[1MY.W/&*3P%Z^\NRS:K186SLJ=R*T4Z11M_<Z)R
MOQ4G65=*M&-2YFCNJ>#ZFP8#=J]B%XQ9NUCKO8Z;&"IMV'904R>:?[%>EUTE
MUMMWFW.:6HE\E7)X'J[=C/;N[.\&$SZS!7)X6]&>PW3:CJE&M'3:BVE*CHW6
MCH>A>T'=##[_ &Y>9;GXFZ[-O'X:5M7$MKHYU4K<]FL=I1N1C)QVEM).-56I
MN[O"WZU.XS3VKTYQ/!K+&ZWPY!O[RSR";"E37'JV,^W$KZR/ Y;33'9$M:W'
MUKY:DMI22$DI0VMVF]L-G?K)K628#!SP^'5Z-V<KDE*3<8M*,5%42K)MR;JZ
M+0M)YT[!?X9<;V3;TWM[,[S*SB\9U:=BS;L0G&"5R47*=R4Z-RV8)1@E1-MN
M3HC2K1_37474;,Z*)I[B&1Y-,A755(DOTE?)>C526IC+Q2K*T2E$"H9;)'$G
M9#K2"/A[;B9#5.[N19WGF8V[&2X:_B+\;D6^CBVHZ5IE)?%@OYTFDN,]#[^;
MW[J;I9!B<1O5C\)@\/<P]R,5>G%2N-P:V;=O3.ZW7Y,(R?<H6'>D19:<V?ZL
MK<:;<7'<P%YA:T)4IEU6I>',&ZRI1&;;AL/+0:BX'R%J+Z!F/;O;="$NS+,G
M))N+P[55J?6K*JN)T;5>)M<)\J/X4[DX=O.1QA)J,EC5))TJO9^*E1\:JDZ/
MA2>M(K&#P(?8PL5=%LM:]LTM*UJ4EK4S*D-I4HU$V@ZS&W#0@C,R0DW'%*X%
MU.4HS^B9CVW_  \-O<.ZF]"S&[3YNRSY1?QHQC'M@MN*2;R;#-]U])B%5\>A
M)=Y)$$.M+CCNL>K#CJUN.+U*SI2UN*-:U'Y46G54I1FI1_\ LCQ_O,W+>3,)
M2;<GC;_][(^EW9[&,-P<CA!)1648.B6A?J]LX117EMC-U59%13I%9=4=A$M:
MJQB.&U)A3X+Z),62RM/ TK:>;(_\!_0/J#%X7%8C!8FWC,).5O%6IJ<)1='&
M475-/C35219EEV!S?+[^59E:A>R_$VI6[EN2K&<)IQE%KB:;1:P1%I-T>V>&
MU;LQNP=7M,:Z5);Y#O,U%Y:5,>:V\T@U*7SV-Y(A+C9\5ESL8CXJ+JG]$E;P
MO:)V?1CB5'8S/+XMZZ0NR@I57#_57E5:],.%:_B;*]F/8OVPW)X&4^LY#G-R
M,755NV;=V4&F]5,1AVXRT+XMQZ$]55VJL+;!\MK;5II#-YA^1P[!IB2CG&VK
M;'[-N2AJ0WQ+EH1,B$2T\2XD1D/GCA[U_+,?#$05,5A[RDD^"5N2:JN^M)]J
ML;A<%O'D=[!7&Y9=C\)*#<71NW?MN+<7P-QE5,D]W%]))4ZQZ,7FFF-:;V=!
M;9C$@P<AL;JUA3Z^LAM3&)TUJF3$9;?L'WUQ$-MNO(CDVE:E<@U$D;^WY[=+
M.]6ZUW(,%@)V+^)45=G.:E&*C)2:@DDY-N*2E+9HF_BUHSQOV3_PCX[<#M!P
MV]^;YO9Q6"P$YSL6[5J<)W).$H0=UR;4%%2<G&#GM-);239&/B.$9CGUNS0X
M1B]]EER^:>16X_53;64E"E$CGGFX;+IQXR#/BMUSDMH(C-2B(C,:%R[*\RS?
M$K!Y5A[V)Q4M4+<)3EWZ13HN-O0N%GL3/=XLAW8P,LSWBQN%P.7QUW+]R%J-
M>).;6U)\$563>A)LL\ZBTT^KV3YK1Y%$-NXI]K]_!MXDM3,MR-=5&E<I$E+C
MJ5OLNR8=E%,R<2I1<X@E)4?4,>_,XPE[#=DF)P6/A3%6MWIQG&5&U<MX-UKK
M3<9QUIO2JI\)\<-U,PPN-_B*R_,LIN5P&(WSLSM2C6*E:NYE%QHJ)J,[<J;+
M2^*Z-:T57A\]#[4%H;9KIM3:';8</D3&&(5A=XWYR\UL.0A#[DFZKRNDHF.*
M)'5HZ$V(G SY">8,R/VQJ/W_ -EF1X3=#L]PV(O*,;UZQUN_+A>W'I%5NGY.
MULQIJ33?"V?&C^(#>[,.TCMDQ]G#RE<PN&Q?L_"0TM*-J?0MQ6G\M?V[M:5>
MVEP)*M7J'FUOJ1G66Y[?.K>MLMO[.]F&M?+YE4^4X\U$:,DH2F/!84EEI*22
ME#;:4D1$1$/"6<9IBL[S7$9OC'M8K$WIW)=^3;HNXM22T))):#Z\[J[NX#=+
M=O [LY9%1P.!PMNS"FBNQ%)R>OXTW6<FVVY-MMMG#B,TF2DF9&1D9&1\#(RZ
MI&1EU2,C&-,\TFJ/46A]U[CCVS#4EUUQ;KKNFE2XZZXI2W''%NTREN.+49J6
MM:C,S,SXF8]^]I$I3[)L9.;;D\#9;;TMMRM:6?&CL/A"W_$)E%NVE&$<WNI)
M*B22O427 EP(K P8<FQFPZ^&TI^9/E1X<5E/ZYZ3*=0PPTG_ -\XZLB+_P!D
M>!;=N=VY&U;59R:27&VZ)'V1Q&(M87#W,5?>S8MPE.3XHQ3;?@2J6D,SAPMJ
M^S_(X&'DB*]IMI;,@5,U@S9-W+)L0X2<B=,S2I4F;E5F<YTBY)J6LTIY/$N'
MT$S:U:[.NRZ_8RWXMS Y>X1E%TK>FMGI=.FKO3Z1ZM+HJ:*?&+=[$8CMJ[>L
M)BL^K.WF^=1G=A+33#0EM] OYL,-;Z&+TT23==-:LZE*6I2UJ4M:U&I:U&:E
M*4H^*E*4?$U*49\3,_HCY\-MNKUGVB244HQ244M".48-EMI@69XKFU(\XQ:X
MID%3D$%QI?(4;]5-9F):49DI*F9!-&VXE1*0M"C2HC29D=_E68XC*,RP^:81
MN.)P]Z%R+_G0DI+P:*-/0UH>@PV\>1X+>;=_&[NYC%2P..PMVQ--5^+<@X-\
M::K5----)III,LR[R=/Z?67:[GBT,HE2*7%UZF8G*/J/,3\<K7KMM<?ARD\[
M94AR8AD?$C3)/JD?!1>].U+)\+O5V=XN[!*4[.'ZW9D]:=N#N:.[*UMPIJ^-
MWF?'SL WHQ_9_P!L^61E)PM8C&++\3'@E"_<5EJ7<MWNCNUUUMK@JG5P'S\/
MLZ6D="9\RJV3X):5SZXMA6Z#%/@RF^3SD:9#Q:3(C/M\HE)Y;+[:5%Q(RXD/
MH#NC?O87LAPV)P\G"_;R:4HR6M2C:DTUW4TF?&+M)PN'QW\1698+%Q4\+>WF
MV)Q>J4)XF,91=.!IM,J[2I4J=*DS9LE^9-F/O2I<N4\Y(E2I4AQ3TB3)D/*6
MZ^^^ZLU+6HS4I1F9F9F/ $YSNS=VZW*Y)MMMU;;TMMO2VWI;>L^S-FS9PUF&
M'P\(V\/;BHQC%*,8QBJ1C&*HE%))))42T(D&Z,2RG0MT,*)%DNLQK?!\MA63
M"#+FYD5AF'9LLO),CXDW/@,N$9<#)2/H\#,CW-V!XB]9[0[5JU)JW=PMZ,UY
M45';2?>E&+[Z/+7\8V$PV([&;M^_!2O8?,<+.VWKA)RE;;7?A.47P4?'0V)Z
M7FOC-V6@EJA/"9-@ZDU[Z_:\%1JQ_!I,1/$DDOVCML\?5,R]MU"+J\9U_$OA
M[<<3D^*7Y:<,3!]Z#L./=UW)</V:ZG_@1Q5Z>$WGP,G_ .7MW,!.*T_*N1QD
M9/BTJU#@KHTUT4AH'ET^@(
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M1QW:AGEZ,G)1S"Y;J^.TU::\#A1=Q&=1+S6P
M
M
M
M
M
M
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MW+T   /&O]<S_C#_ ,DZ.KUKO_89VCJEWOLH\@['4
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MJ9_/_MC%OGGZI'\XOQ9%]NC^TI_F'^- [)$14V(
M       &U(V&:2-8)_\ ITS_ *W(_P LL0"]^5E]\_A-S8;]6M_>1^!'JBF5
MP    "%OI&?Y;L6^Y72?;;G \K=N/^K,/_[=;_OL0?0C^$[_ )=8W_WJ]_Z7
M!F@8TR>G@                                                EIZ
M)+^4W5?[!*O[8&1Z-_AN_P!2YA_D5_>P/#G\<W^C<D_]SN?W$C[G2Z?[5:)?
M8_FG\(X^+S^)7]JY5_E[WX\#&_P*?L3>+_-83^[O$/0\S'O4 "4'9WT?*M:L
M=K]4=4[:RH,#L7W58[C]-S3-]E,6*\XP]8R+"0V^W34SDII3;?):<D24I6I)
MLHYMQS?O9AV+RWMP4-X,_NSL9+.3Z.$**Y>46TY;334(;2HOBRE*CILK9D_&
MO;Y_%*NSO-;NYFY=BSBMYK45T]^[5V<-*24E;C"+B[MU1:E*LHPMMQ3Z26W"
M/YU+W8:1:%7-CA6SK2?!J6322)-9,UDO:PLHOY\F.?,/.8K*NG9LY<%M]"^3
M)EOOL22/BB,E')6OIGO:)NSNEBIY9V89;A+4[4G%XZ[#IKLFM%;+N;34:I_&
MDY1G6JMQ5&^VZ'8COWVE9?:WA[?,\S+$6L1&-R.56;G5K$(R^,EB8V5"&VTU
M6W:A"=NE)7I2K&.X/1H:KZD:NQ];L@U*S2_S"S9M<'8AG;3W%P*QER+E+SS5
M/3,\S3TR)#AD;I16&>=Y".7RB0CD[0[ ]XL]WD]KXO/<7?Q5Y3PZCMR;C!-7
MVU"&B$$]%5",:T5=2IH7^,#<C='<6YNYE>Z.787 8.5G&.?102G<:EADG=NN
MMVZXKY/23ELUELTVI5C1Z0W\L+5__P"('\U^$C1/;9_S.S/_ /!__26#U]_"
MK_R$R'_\-_\ WCBS2T:K/0A9[VOYU4;IMJ4"!ERBM94S';72W41M:T+D/6,*
MN362)RU\5FW.M*:9&GDO@E2'G^*>')(Q[[[/<VPW:'V;QPN9_P!9<=B>#Q/&
MY1CL[5=/QI6Y0N5X)NJU'QO[9MV\?V+=MUW%9$NALPQ=O,L"TFHJ$[CN*"6B
ML+=V-RS32G"%'K:(@]L6WU5/NFRB#J5S47$]M$B_SG/9\AMLX+S&%ON/4"^#
MO.-N1+2:VS.)!I5ST)EPNH9D9>9-PMSNK]H%^SG](Y=D+NXC$MT<6L.ZPUU3
M4YJ,J?=6U(]X]L?:BL?V+X/$[H;4\\WPA8P>"A%O;4L6DKRT4:E;@YVJIK9O
M2@]*5'J9K)J7:ZPZH9OJ5<J=*5EE]+L&([J^6JNJD<F)1U*5<I1&U44T=B,C
MJG[5HNJ?T1KS>;/<3O-G^+SW%UZ;$WI2HW79CJA!=R$%&"[D4;PW W0P.X6Y
MN7;H9>H]!@<-&#DE3I+C^->NM<=V[*=Q]V3/SI%I3EFM>H&/Z<X7&:>NKZ0M
M/9$I:FJ^K@1FU2+&VLGD(<6U!KXJ%+7R4J6LR)"$J<4E)\;M[O9EO3G-C(\J
MBI8R_*B;T1C%*LIR>FD8Q3;HF]%$FVD^=^M]LC[/-UL5O;O#.4<NPL%\6*K.
MY.3V;=JVFTG.<FHJK26F4FHIM2V9IMUVE['L J\QU8HYVN6H-M(7$QRCN7R@
M5=W:Q6VWIQ0\>:6]50L?KVWFSE/V";-2#<024J6XAH_1^;;C]G/9+DUK,]Y;
M4\WSR[)JU;F]B$YQHY4MJL8VXIK;E<Z76J1K)1/#.[W:OVX_Q';T7\@W'Q-K
M=O=6Q!2OWK4=NY:MR;4-N^TKD[\VI='"P\.GLR<I*,)3-),BWP:Z9Q85.+X[
M;U^D.".6D*'&P[2: WAL6+"?EM,J:3=5W-Y"EQ;"N2LV9+#2CZJ6T]0BU+F'
M:OO?FDX8# W899E&VDK&"BL/%)M)K;A2YI6OXZ7$D>B\I_AR[-=W,-?SG-K%
MW/MY59G*6*S.;Q<I346T^BN5L43TK:MSDEH<Y$SG2&_D>ZO_ /Q _G0PD>K.
MVS_ECF?_ .#_ /J[!\^OX5?^?>0__AO_ .[L65B!X"/L<6*.BT_)HG_=/RG^
M",8'MK^'?_0EW_W*[_=V#Y1_QI?\W[7_ +-AO[W$D$&LW\L&JWW2<Z^VBT'C
M_>7_ %%C_P#.W_[V1]+NS_\ T'DG_M&#_P#3VS&PPI+BU3LO:<B[5]$TR$FR
M?D6Q(]OP+]@D39TIETSX\"0Y'=2LC_P&/H;V3QE:[.<J5S1_Y=O3Q.Y-I^%-
M,^*7\0MR%[MKWB=I[2]H..CCC"$6N^I)KOHK-N45KJ7JI,H,,AN7-MFF;V$3
M'HC)H2<UZXN9!PC-Q2B999-#Q+6XI1-MMD:E&22,QX)CA,3G>>/!99!W<3BL
M2XVXK[ISF]GN+7I;=$M+=#[!QS+ [H[EPS3>"XL/@<ORZ$K\G7XBM6EMZ-;=
M5112K)T256D2YHV7[;MIVES^K&Y*5.U.NX78<=G'X;\FOQZ7DDQM;D+'L?JX
M\B!,O)*ULNFI^>^F,J.TMU<=I*%#TK]5>X_9QN\]Y-_)3S#%QHE:@W"U*[)5
MC;MI.,KCT2;E.2CLIR=M4/"DOXA.UOMPWSCN/V10MY-EUS:D[\XQN7XV(.D[
M]^Y*,X68I.-(68.XKDHPC=FY(TISG?EJM81I.-:/5F,[?M/^<<3!QS36FK*R
MT[&ZJ65V&1M06)1V*6^'*>@MP.4?T4C5.;=KN\5Z$L#NS"QDN3-_%M82$83I
MP.=U14G.FN4.CKQ'H?=O^&?<G"WH9OO[>QF].]%%MW\PNW+EO:X5;P[FX]'7
M5"]*]3C)M<LD2IFQ;)9<Z7,L)LK:;<R)D^QF2;"PFRG]'I+LB7.GS77YDZ9)
M=4:W7G5K==6HU*4:C,QZRQURY>['KUZ]*4[TMVIN4I-RE)O!-N4I2;<I-Z6V
MVV]+=3YUY)9LX?\ B4PEC#6[=K#PWYM1C"W&,(0BLTBHQA""480BDE&,4HQ2
M222215H'SW/M$6S81G<[78BJATGSM= V#K'V4DX3QSM/$'"=:0ODDX3G.I-)
M'P(^/5'T8M5Q/9I%8=U=S(ELM<.UA?BTY4?#S$4R_MIGUY;*L;T2Z1/138Q[
MVTVM5*-.FHJ9#YSGW#  M"[J_P BS4;[F-/_ /=TH]^=HW_*3&?Y"S^-:/C5
MV)?_ *P^4_\ O%[X+Q6MTYG0ZO4+!+*Q0VY7UV98O.G-O&26G(<2[@R)2'5*
M2M)-J8;42C,C+A^H/"F47;5C-L+?OI.S#$6Y23U.*G%M/OH^NV]>&Q&,W6S+
M!X1N.*NY?B(0:UJ<K,XQ:U:4VJ%F??)$?F[4-:&8Z#<<1CD&6I)$HS)BOR*E
MGRE\$DH^#<:,M1_J$1=7@75'O?M@MSN]F^:1@JM6K;\$;UN3Y$FSX]?PW7[>
M'[;]WKEUTB\7./AGA[T(KPRDEX2K*/GN?:0 "V+EDEK$MJV0R+U#;":#0.Q3
M9,/J2E//0=/W6GH9F:5DIQY]'-)21*-:U$1$9F1']%LQDLN[,KSQ=(]#D<E)
M-\*PM-GOM_%2X6Z*I\0<CM3SSMMPMO+6Y/%;T0=MQ7!/')J?!1*+VFZJB3;:
M2J5.A\Z3[?%H71K\A?$OZO<C[4)@]^;L_P#)JS_[)<_N9GQJW_\ _P!93'?_
M *51_P#50*O0\!GV5) .C-_*IH/L1S/^"QN/L(_YC8;\Q?\ [J1Y?_C _P"2
M>+_SV$_O3:7I??\ \GG_ -;/_P C,;&_B9__ ()_^&?_ +*:6_@._P#YJ_\
M]9__ - A:'E8^A(
M &XNQ>QKZG7F)86L^%60(^*9,J1-L)3$*(PE4>.DE/29*VV6B-2B(C4HNJ8V
M?V0W[&&WQC>Q$X6[,<-=K*348K0M;=$C0?\ $EA,5CNS.YA<%:N7L3/'8?9A
M"+G)_&EJC%-OP(SOOAW+XKEM#'TET[NXU_$>LF+',[RK=[(J'$5CA/5E%!G-
MF<:U2J>293[K)K90IAE*5J4;B43#M;W]R[,L''=O)+L;UIW%*_<@ZP>RZPMQ
MEJG\:DY.-8IQBDV]I+6O\.79!G61YG+?C>O#3PM^-IPPEFXMFZG<5+EZ<'\:
MW\2MN$94DU.;E%)0<MU-O6I6D<_2W3_'\4S;&G'Z3$L>JY=-(M(4"]BV#%?%
MCS2G4\I]N:V^_9FYQ6E*F77#,VUK29&>UMR<^W:O;O8+!9=B[#G:PUN$H.<8
MW%)12EM0;4DW.NFCBW\EM'GKM3W0WZPV^F:9IG>78N-K$8Z_<C=C;G.S*$IR
ME#8NQBX-*W30VI1BEMQBZHV0$Z-2'!,ZR'3V#27--GV38S35-M4S:ZTC7MY6
MU?/UEG$DQ9+7)F265J*3&-Q*>!&:N!\./ 8?.,;DEG"7<+G.(P]K#7+<HS5R
MY&%83BTU\9K6J]\DN[65;U8G,</F&[&#QF(QUB_"Y;E9LW+FS<MRC*+^)%KX
MLMENNK14KIT&1/:;ZBUV2XO8)LSP[*T3Z>P;)V*S<1*JR,V7%(<1SK42XAM<
M%H4GCS;II47T2'A_!XZ619Y#'Y?/I.JXG:A)52FH2T/3I2G%:4UJ=&CZNYGE
M4-[=U+N49S:=E8_!.%V#I)VI7+>E53HY6INJ:?RHII\)8)TOURTUU:IZVRQ7
M)ZI=A.80N1C,N?#CY+62N;Y3\.94+>*69L+)1$ZVE;+I)-3:U)ZH]I;O[W9#
MO+A;=_+L1;Z>:TVI2BKL'PQE"M='&DXNE4VCY<;Y=F^]^XV/O83.\'?6%MR:
MCB(PE+#W(U^+*-U+9TJCV9-3C6DHIZ"(W=[HK>:/:IR<ZQ]B2SB.5W2\DHK6
M(TOFJ'(G)/A";3NND2FXSS,\E2(9'R4JCF24\3:7P\U=IFZF+W8WBEF^"4EE
MF)N]+;FEHMW6]J4&]2:E64...A5V6>Z>PCM"R[?W<N&[>:2A+/<#AUA[UN35
M;UA1V(74M<DX4A=UM33<J*<:R.:%[MM-=3L7KBR3)J+$,YB0FD9!3WLZ-219
M$QE)(?GT<JP>:B384M1&ZEI#BGV",TK3P22U;RW0[2LAS_+X=?Q%G#9O&"Z2
M%R2MIR6N5MR:4HO71-RCJ:T5?DSM([#-[]SLYN^R<'B<?NY.XW8NV82O2C!N
ML87HP3E"<?DN3BH3='%U>RO)KIN$TY@8=D6&XQ;Q=0\VR['+ZFI\8PB7&OI*
M"GT\UF19VLNO7*AU-=6QE*?=-U1.FTDU)0:24I/;>_?;([.5W\KR^[''9MB;
M%R$+5B2N/XT))RG*-8PC%?&=76BJDU5KKV;=EF]F)S_"9_G-B>5;NX#%V;MW
M$8R,K,7L78.-NW&:C*[<N22A%16SM.CDFTG%3M%U#QS3/6_'[[+)B*VBF0+B
MCF6CI*./6KLHAE$E2N0E2DQ3F,MMN+X<&TN&M7!*3,>=>S3.\#D&]MG&9E)6
M\'*$[<IO5':7Q6^YM))O@3J]"9[6[==U<VWP[.L5EF1VW>S*W=M7HVU3:N*W
M+XT8UI\;9<I16N3CLK2T3S8_EF+9;&<F8KDN/Y-#94A#LO'[FNNHS2W$FIM+
MC];)DM(4M)&9$9D9D0]B8+,LNS*V[N78BSB+2UNW.,TJ\;BVCYG9IDF=9'>6
M'SO!XK!WY)M1OVKEJ32T-I7(Q;IPZ".7I*O^PM)O];9;^\Z$:-[>/U/+?SE[
M\6V>LOX1/VEGGYC"_C7C/FQ;\G#$O];99]L=B)EV0_Z%PWYR]_>R-8?Q)?\
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M)Y2C6B/<J6PA*"XERN<EK^@7$^/_ "$/,W;K;7MG 3BOZR6&DN2>C\9GN_\
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M/^'N>B/E&Z#>EW /A+6]?#WYW._>>"^=CSCZI^TS]Q9I_P /<]$?*-T&]+N
M?"6MZ^'OSN=^\\%\['G'U3]IG[BS3_A[GHCY1N@WI=P#X2UO7P]^=SOWG@OG
M8\X^J?M,_<6:?\/<]$?*-T&]+N ?"6MZ^'OSN=^\\%\['G'U3]IG[BS3_A[G
MHCY1N@WI=P#X2UO7P]^=SOWG@OG8\X^J?M,_<6:?\/<]$?*-T&]+N ?"6MZ^
M'OSN=^\\%\['G'U3]IG[BS3_ (>YZ(^4;H-Z7< ^$M;U\/?G<[]YX+YV/./J
MG[3/W%FG_#W/1'RC=!O2[@'PEK>OA[\[G?O/!?.QYQ]4_:9^XLT_X>YZ(^4;
MH-Z7< ^$M;U\/?G<[]YX+YV/./JG[3/W%FG_  ]ST1\HW0;TNX!\):WKX>_.
MYW[SP7SL><?5/VF?N+-/^'N>B/E&Z#>EW /A+6]?#WYW._>>"^=CSCZI^TS]
MQ9I_P]ST1\HW0;TNX!\):WKX>_.YW[SP7SL><?5/VF?N+-/^'N>B/E&Z#>EW
M /A+6]?#WYW._>>"^=CSCZI^TS]Q9I_P]ST1\HW0;TNX!\):WKX>_.YW[SP7
MSL><?5/VF?N+-/\ A[GHCY1N@WI=P#X2UO7P]^=SOWG@OG8\X^J?M,_<6:?\
M/<]$?*-T&]+N ?"6MZ^'OSN=^\\%\['G'U3]IG[BS3_A[GHCY1N@WI=P#X2U
MO7P]^=SOWG@OG8\X^J?M,_<6:?\ #W/1'RC=!O2[@'PEK>OA[\[G?O/!?.QY
MQ]4_:9^XLT_X>YZ(^4;H-Z7< ^$M;U\/?G<[]YX+YV/./JG[3/W%FG_#W/1'
MRC=!O2[@'PEK>OA[\[G?O/!?.QYQ]4_:9^XLT_X>YZ(^4;H-Z7< ^$M;U\/?
MG<[]YX+YV/./JG[3/W%FG_#W/1'RC=!O2[@'PEK>OA[\[G?O/!?.QYQ]4_:9
M^XLT_P"'N>B/E&Z#>EW /A+6]?#WYW._>>"^=CSCZI^TS]Q9I_P]ST1\HW0;
MTNX!\):WKX>_.YW[SP7SL><?5/VF?N+-/^'N>B/E&Z#>EW /A+6]?#WYW._>
M>"^=CSCZI^TS]Q9I_P /<]$?*-T&]+N ?"6MZ^'OSN=^\\%\['G'U3]IG[BS
M3_A[GHCY1N@WI=P#X2UO7P]^=SOWG@OG8\X^J?M,_<6:?\/<]$\\?<+H3)<)
MIO5_3E*C(SXR,NI(C? OH\7I4QEHC_P%RN)_J#O#?;="Y+9CF>!KW;UM+E<D
MBG=[+.TJS#;GD.;-?S<+>D^2,&_$9.J+NER"&FPH;>KNX"S-*)U1/B64-:B(
MC-*9,-UYE1D1EU"5^J)!AL7A<;:Z?!W;=VR_NH24H\L6T0['9=F&5WWA<SL7
ML/BEKA=A*W)?T9I/Q'U!<%D      !PO(M2-/,1=./E6=X=C4@B(^QK[)J6I
MDGQ0;B23'GS6'EJ6A)FDB29J(NH,5C<]R3+);&8XS"V)\5R["#X]4I)DARK=
M+>K/8=+DF68_&6O*LX>[=CKI\J$))4>O3HX3A7RC=!O2[@'PEK>OC$^_.YW[
MSP7SL><D/U3]IG[BS3_A[GHCY1N@WI=P#X2UO7P]^=SOWG@OG8\X^J?M,_<6
M:?\ #W/1'RC=!O2[@'PEK>OA[\[G?O/!?.QYQ]4_:9^XLT_X>YZ(^4;H-Z7<
M ^$M;U\/?G<[]YX+YV/./JG[3/W%FG_#W/1'RC=!O2[@'PEK>OA[\[G?O/!?
M.QYQ]4_:9^XLT_X>YZ(^4;H-Z7< ^$M;U\/?G<[]YX+YV/./JG[3/W%FG_#W
M/1'RC=!O2[@'PEK>OA[\[G?O/!?.QYQ]4_:9^XLT_P"'N>B/E&Z#>EW /A+6
M]?#WYW._>>"^=CSCZI^TS]Q9I_P]ST1\HW0;TNX!\):WKX>_.YW[SP7SL><?
M5/VF?N+-/^'N>B/E&Z#>EW /A+6]?#WYW._>>"^=CSCZI^TS]Q9I_P /<]$?
M*-T&]+N ?"6MZ^'OSN=^\\%\['G'U3]IG[BS3_A[GHCY1N@WI=P#X2UO7P]^
M=SOWG@OG8\X^J?M,_<6:?\/<]$?*-T&]+N ?"6MZ^'OSN=^\\%\['G'U3]IG
M[BS3_A[GHCY1N@WI=P#X2UO7P]^=SOWG@OG8\X^J?M,_<6:?\/<]$?*-T&]+
MN ?"6MZ^'OSN=^\\%\['G'U3]IG[BS3_ (>YZ(^4;H-Z7< ^$M;U\/?G<[]Y
MX+YV/./JG[3/W%FG_#W/1'RC=!O2[@'PEK>OA[\[G?O/!?.QYQ]4_:9^XLT_
MX>YZ(^4;H-Z7< ^$M;U\/?G<[]YX+YV/./JG[3/W%FG_  ]ST1\HW0;TNX!\
M):WKX>_.YW[SP7SL><?5/VF?N+-/^'N>B/E&Z#>EW /A+6]?#WYW._>>"^=C
MSCZI^TS]Q9I_P]ST1\HW0;TNX!\):WKX>_.YW[SP7SL><?5/VF?N+-/^'N>B
M/E&Z#>EW /A+6]?#WYW._>>"^=CSCZI^TS]Q9I_P]ST1\HW0;TNX!\):WKX>
M_.YW[SP7SL><?5/VF?N+-/\ A[GHCY1N@WI=P#X2UO7P]^=SOWG@OG8\X^J?
MM,_<6:?\/<]$?*-T&]+N ?"6MZ^'OSN=^\\%\['G'U3]IG[BS3_A[GHCY1N@
MWI=P#X2UO7P]^=SOWG@OG8\X^J?M,_<6:?\ #W/1'RC=!O2[@'PEK>OA[\[G
M?O/!?.QYQ]4_:9^XLT_X>YZ(^4;H-Z7< ^$M;U\/?G<[]YX+YV/./JG[3/W%
MFG_#W/1'RC=!O2[@'PEK>OA[\[G?O/!?.QYQ]4_:9^XLT_X>YZ(^4;H-Z7<
M^$M;U\/?G<[]YX+YV/./JG[3/W%FG_#W/1'RC=!O2[@'PEK>OA[\[G?O/!?.
MQYQ]4_:9^XLT_P"'N>B/E&Z#>EW /A+6]?#WYW._>>"^=CSCZI^TS]Q9I_P]
MST1\HW0;TNX!\):WKX>_.YW[SP7SL><?5/VF?N+-/^'N>B/E&Z#>EW /A+6]
M?#WYW._>>"^=CSCZI^TS]Q9I_P /<]$?*-T&]+N ?"6MZ^'OSN=^\\%\['G'
MU3]IG[BS3_A[GHCY1N@WI=P#X2UO7P]^=SOWG@OG8\X^J?M,_<6:?\/<]$?*
M-T&]+N ?"6MZ^'OSN=^\\%\['G'U3]IG[BS3_A[GHCY1N@WI=P#X2UO7P]^=
MSOWG@OG8\X^J?M,_<6:?\/<]$]R%K]H?8.<S%U=TY4Z:D(2V]F-#%4XMQ7)0
MADI4YDWEJ5U.".4?$R_PD*UK?/=*]+9MYG@=KNW[:K7BK)5\!;XCLP[1L+#I
M+V19LH4;;6%O222UM[,'1=UT,IPIT*QC-3:^9%GPWT\MB7"D-2HSR/\ W33[
M"UM.)_Y2,R$AM7;5^VKMB49VGJ<6FGWFM#(7B,-B,)>EA\5;G:OQ='&<7&2?
M=32:\*/:%0H@      8]OM6M+,6D.Q,CU'P6CFL<KG8%IE='#L$F@R2M/8#\
MY$Q2TF?5(D&9#"8S>3=[+YNUCL=@[-U:XSO6XR\URVO$2G+-QM],ZM1OY3E.
M98G#RU3MX:].#KJ^.H.-.[6AQCY1N@WI=P#X2UO7QC_?G<[]YX+YV/.9GZI^
MTS]Q9I_P]ST1\HW0;TNX!\):WKX>_.YW[SP7SL><?5/VF?N+-/\ A[GHCY1N
M@WI=P#X2UO7P]^=SOWG@OG8\X^J?M,_<6:?\/<]$?*-T&]+N ?"6MZ^'OSN=
M^\\%\['G'U3]IG[BS3_A[GHCY1N@WI=P#X2UO7P]^=SOWG@OG8\X^J?M,_<6
M:?\ #W/1'RC=!O2[@'PEK>OA[\[G?O/!?.QYQ]4_:9^XLT_X>YZ(^4;H-Z7<
M ^$M;U\/?G<[]YX+YV/./JG[3/W%FG_#W/1'RC=!O2[@'PEK>OA[\[G?O/!?
M.QYQ]4_:9^XLT_X>YZ(^4;H-Z7< ^$M;U\/?G<[]YX+YV/./JG[3/W%FG_#W
M/1'RC=!O2[@'PEK>OA[\[G?O/!?.QYQ]4_:9^XLT_P"'N>B/E&Z#>EW /A+6
M]?#WYW._>>"^=CSCZI^TS]Q9I_P]ST1\HW0;TNX!\):WKX>_.YW[SP7SL><?
M5/VF?N+-/^'N>B/E&Z#>EW /A+6]?#WYW._>>"^=CSCZI^TS]Q9I_P /<]$?
M*-T&]+N ?"6MZ^'OSN=^\\%\['G'U3]IG[BS3_A[GHCY1N@WI=P#X2UO7P]^
M=SOWG@OG8\X^J?M,_<6:?\/<]$?*-T&]+N ?"6MZ^'OSN=^\\%\['G'U3]IG
M[BS3_A[GHCY1N@WI=P#X2UO7P]^=SOWG@OG8\X^J?M,_<6:?\/<]$?*-T&]+
MN ?"6MZ^'OSN=^\\%\['G'U3]IG[BS3_ (>YZ(^4;H-Z7< ^$M;U\/?G<[]Y
MX+YV/./JG[3/W%FG_#W/1'RC=!O2[@'PEK>OA[\[G?O/!?.QYQ]4_:9^XLT_
MX>YZ(^4;H-Z7< ^$M;U\/?G<[]YX+YV/./JG[3/W%FG_  ]ST1\HW0;TNX!\
M):WKX>_.YW[SP7SL><?5/VF?N+-/^'N>B/E&Z#>EW /A+6]?#WYW._>>"^=C
MSCZI^TS]Q9I_P]ST1\HW0;TNX!\):WKX>_.YW[SP7SL><?5/VF?N+-/^'N>B
M/E&Z#>EW /A+6]?#WYW._>>"^=CSCZI^TS]Q9I_P]ST1\HW0;TNX!\):WKX>
M_.YW[SP7SL><?5/VF?N+-/\ A[GHCY1N@WI=P#X2UO7P]^=SOWG@OG8\X^J?
MM,_<6:?\/<]$?*-T&]+N ?"6MZ^'OSN=^\\%\['G'U3]IG[BS3_A[GHCY1N@
MWI=P#X2UO7P]^=SOWG@OG8\X^J?M,_<6:?\ #W/1'RC=!O2[@'PEK>OA[\[G
M?O/!?.QYQ]4_:9^XLT_X>YZ(^4;H-Z7< ^$M;U\/?G<[]YX+YV/./JG[3/W%
MFG_#W/1'RC=!O2[@'PEK>OA[\[G?O/!?.QYQ]4_:9^XLT_X>YZ(^4;H-Z7<
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MR,C,C(Q(HRC.*E%IQ:JFM37&B%SA.W-V[B<9Q;335&FM#33U-<*/V.3J
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MW$6,1!:W;N0N)=]Q;(KFN09[D4U:SO!8O!W9:E?LW+3?>5R,6SD@OC$@
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M%Q?!(O=TI)9E--I-V9)=WXT'H\";\!V2XBIL4
M     -J1L,TD:P3_ /3IG_6Y'^66(!>_*R^^?PFYL-^K6_O(_ CU13*X
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MM1=R"DUJ<HUUHA0'E(^B
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M."RV'9?NW.*:4.M[#T6K=O9=K#*G"Z1G<5?BQC"+KMR2E6'HH\4
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M
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M9C3<I2E)RDVY-U;>MOC9Z<A"%N"MVTHPBDDDJ)):$DEJ2X$?@<'8
M                                                       ,BZ=Z
ML:@Z4VK=M@N3V5(LGD.RH#;RGJ>S)/)(VK2H>-<"<A:$$GBM!K2750I*B(RS
MF1[R9UNYB%B<HQ%RTZU<4ZPGW)P?Q9<6E57 T])%-Z]Q]UM]L$\#O)@[.(CL
MM1FU2[;[MNZJ3@TW6B=']TFJHF[VT;E:/7RA?8?98I,]HF&W,BQ]M:E1WXRE
MDRW>4BW5*=>JWW5)2XA1J<B/*)"S4E33COK+<+?S";Y8-PFE:SFRD[MM:FM2
MN6ZZ7!O0UK@VDZIQE+YT=K_9#F79CF<;EJ4L1NSB9-6+[2VE)*KLWDM"N)5<
M6J1NQ3E%)QG"&T V":;  XWE^6T&"8U<Y=E$]JMHJ*$Y-GRW#+B2$\$M,,-\
M24_+EOK2TRTGVSKJTH3Q,R%AF>98/)\!=S/,)JW@[,'*3?B2XY-T45K;:2TL
MR^0Y'F>\N<8?(LFM.]F6)N*$(KC>EMO[F,4G*<GHC%.3T(@^UWW@ZC:N3IE9
M13I^$8%RE-1J"KEJCV-FP1F7/Y%:130_+6^1\3BMK3$07 C2XI/.J\E;X=IV
M>;RWI8?"3GA,FU*W!TE-<=V:TRKY">PM"I)K:?T:[-.P7=/<7#6\9F5NUF.\
MU*RO7([5NV_)L6Y5C%1X+DD[KTNL$]A:B#6AO4
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M'$9VHK;Q=Z*E=E+AZ.M59A75&W1T2VY3DMIZ]"$FTP
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M%>WLW MRC8M1<[^#3<J16F5S#UK*D564[3;T5=NE%;<H@]!GC,
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M1NN8K.;,;6+VXJBG&OAJT_L/PDBW6Q4K^7.U-UE:GLK[UI->.J7<18B&))*
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M+R.,LG%7<&X6FFI6VD^.L:(UQ9N/"YE"[B(N+MWU*2X522;7?.V5TEW%[?\
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MW_?8@^A'\)W_ "ZQO_O5[_TN#- QID]/
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MR<\3=G*<Y/7*4FW*3[K;;9[0J%$
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M2C"*222HDEJ27 EP(\XW+ER]<E>O2E*[*3<I-MMMNK;;TMMZ6WI;/*.QT
M     #7+=9JA*TGT5R:^JY!Q<@MU1\5QR0D^2Y&M;M+R7)C"N/M9-=51Y,EH
M^!ESK*>)&7$0;M%W@N;N;J8C&8>6SC;M+-I\*G<K\9=V,%.2[L4;9[$]S;.^
M_:%@\LQL-O*[&UB;\>"5NS2D'_-N7)6[<OYLW1U*]JE*6I2E*-2E&:E*49FI
M2C/B:E&?$S,S/JF/%+;;J]9]3$E%*,51(_@'(
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MH
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M@_K+C4&]:Z)I44G6,T:$/8
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M^C_\-FYEC=S<&WGMV"]JYL^FE)K2K,6XV()^2XUN]UW>&B-*!JD]#@
M
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M)9IF-N.*O2X7TBVK,.-*W9<5LUT3<W1.31JP->&Z0
M              L#;1M496JNBF/V=K(5)R#&WGL/OY#BS6[+F4S,9<.<\I1F
MMQ^=32XSCRS_ %[ZG#'M'LTWAN;Q;J6<1B'M8VPW9N/A<H);,GQN4'!R?#*I
M\NNW3<RSN5VAXK!X**AE>+BL59BE11A=<E*"6I1A=C<C%<$%$V:$^-/
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M*J6Y;V6.V->_</8C1/5ZXK+AFF$JR6XDN4]Q*2Y';MNS.XTG<VJ>"B^S7O\
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M  !XU_KF?\8?^2='5ZUW_L,[1U2[WV4>0=CJ
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M[%ON5TGVVYP/*W;C_JS#_P#MUO\ OL0?0C^$[_EUC?\ WJ]_Z7!F@8TR>G@
M
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M?"8'-,#'-[.78:U=PT[UN%^W=MVH6YQZ.;C.24XO9G&+C)4:>DU+&O#>
M
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MFYTUN"C.U=IL]):FJQELU=&G6$E5I2C*C:HS+HDQ!
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MER4?O7>AM^-0X?M0\#S">]@
M                               G[V5K<7MFTS-U2UJ)&7((W%*4HFV\
M\RAME)&HS/D(:2E*2^@22(BZ@]F=E3D]P< Y5;I>Y%B+M/%J[A\P?XA8PCVP
M9PH))5PKT<;P6';??;JWW:FTHV&:7(8.D;-[SSXDE7.=CEIA5&T1\KFN>5E>
M8D_R#_6\X:$M\KAU>')X_J#RQVY.7O5ADZ['L^%.*O37Z^'57P'T%_A-5OZO
ML<U3I?;-RO'3JV%V:]RNU3P]TC^&ESU"
M                                          64M$U/JT:TD5*YPI2M
M,<"5)YU)H=Y\\5JC>YQ)D1I<YSCQ(R(R,>\-U'-[K9:[E>D]GX>M==>AA6O=
MJ?(KM#5I=H&>JQ3H5G&-V::5L]9N4H^*FHR<,^0X@"WH.2G-RVI92^!+;=Q=
MME"5&I"(I87CBHO)(UKY)N,*2M9%P+EJ5U"^@/&/:I*Y+?W']+K3M)=[H+5.
M5:7W6SZ@?P^0LQ[(<HZ#Y+CB&WPN76[^UP+4ZI=Q+2S5P:^-S
M                                                         ![M
M:N6W8P'('^G(FQ5P^J2?\[2^VJ/[92D)3^S$75,R(O\ "0JV'<C?A*S^64UL
M]^NCQEOBXV)82['$_JSMR4_O:/:X^"O 6DQ]"CXP@ 5I]9%R7-7M5%S>7V8K
M4?-SE<M)(64@\FL^>)2$DE*#)SB7)(B(OH$0\&[T.Y+>;,7=KTKQU^O?Z6=?
M&?7G<"-F.XF21P].@64X/9II6SU>W33PZ.'A,;C!$M
M                                                  #-NVU;R->]
M(S8-:5GG= A1M\>5S+DU")!'R>KR%,*42OU.29\>H)9N(Y+?++'"M>N6]7%M
M:?%6O<-=]KD82[,<]5RCC[-O/3QJ#<?#6E.[0L9CW&?)T   *O62K?<R._7*
MY9R5W=JN0;I&ESGU3GS=YQ)D1I7SAGQ+@7 Q\^\>YO'7G<KTCNSK777:=:^$
M^RN4*W'*<+&S3H5A[>S3538C2G<IJ/B"T,B
M        $O71M+DGA&I3:C_S1&55*V"YQP^$ERH6F4?-&DFD<6FF?;$9J5PX
M&1$E/'TQV$N?LG'Q?Y-8B%-/"X:=&K4HZ>'AU(\)?Q<1M+>/*)Q_+O!74]"^
M2KOQ=.MZ7/0U1<%:NDDPWN>1@
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M24I21$22(N!$1%U"(B&")@DDJ+4?T
M      !XU_KF?\8?^2='5ZUW_L,[1U2[WV4>0=CJ
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M
M   #:D;#-)&L$_\ TZ9_UN1_EEB 7ORLOOG\)N;#?JUO[R/P(]44RN     0
MM](S_+=BWW*Z3[;<X'E;MQ_U9A__ &ZW_?8@^A'\)W_+K&_^]7O_ $N#- QI
MD]/
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MX25S$5C.#4HR7]=K32:-6! #=
M                                               &Z6P?\H2N^Q7)
M_P![,C:O8W_K6'^7N_ CSW_$Y_RLN_YW#_C,G.'KH^;H
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MV\)*4=4KD)W+EQ5X7"5UVI:J.#7!5[C#:!H,
M                          U?WA:;S-2]#,D@5<=<NZQF1$S*HBMI-;DE
M^E1);L&&D)(UKD.T4Z6EI*2,UNFE/ZHU]VG9%=S[=&_9P\7+%X>2OP2UMVZJ
M27==N4Z+A=%PFY>P;>VQNAVD83$XV2AE^,C+"79/0HJ\XN$F]2BKT+3DWH4:
MO@*_X\8GU!
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M5V"XY3M-3^]LR[A$0/-![K
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M5R>C\K#ND<@T:>L@
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M&R^4T\RRK_RUV-=*@JNQ*FO9=JD$^&5N=-1J -9&^
M                                                  WAV%:;2LNU
MD;S&1%6JBT[@2;-V0M!G&<OK.._64L'E?MZ$//S$\/UIQ2X_1(CVWV.9%<S+
M>A9I.+ZG@8.;? [DTX6X]_3*:^\TZSSE_$UO=9R+<!Y!:FEF6:W8VU%/XRLV
MY*Y>GWFU"T^/I'34Z3?CUH?.8   *]^[#3:7IIK?F,-4<VJ?)K"3F..O)21,
M.UF02GY;T=GAU$E5V9OQ>2?MB2R2OH*(S\5=H^0W,AWMQ5IQIA<1-W[3X'"X
MVVE]Y/:A3^:GPH^IG8AO=8WO[.L!B%*N/P=J.%OKA5RQ&,5)_G+>Q<KJK)K6
MFEK>(*;:                                 ">_9=IM+TYT,I/"D=46
MZS.;)S6PCNHY+\9FU8B1J:,YRB)Q"O D".ZIM1$;3KRTF7'B9^R.RO(KF1[H
MVNL1V<5BIN_)/6E-)03X?R<8MK@<FM=3YD?Q![W6-[.TC$]2FIY?E]N.$MR3
MT2=N4I79+@?]=.<5)5VHQBZTI3;$;'-(
M
M                    !XU_KF?\8?\ DG1U>M=_[#.T=4N]]E'D'8Z@
M
M                                           !M2-AFDC6"?\ Z=,_
MZW(_RRQ +WY67WS^$W-AOU:W]Y'X$>J*97     (6^D9_ENQ;[E=)]MN<#RM
MVX_ZLP__ +=;_OL0?0C^$[_EUC?_ 'J]_P"EP9H&-,GIX
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M<ZS9=ZXK=F<[CG*%RDI+I4K4%1MP<=FDH8!Y;/H*
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MU;J[_;E;[V7>W3S3!8]1591M7(NY!/4YVG2Y#^G")C08,EP
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M@1Y[_B<_Y67?\[A_QF3G#UT?-T
M  "(CI)O]L],_L8N?X59'FCMV_:N _R\_P ='NS^$;_3^<?YRU_=LV1Z/?\
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M2[O";!L]@^0XW$>S,LWQR*_G3=%94E\:?#&,HW9.33T4C!RU_%5&CD>G.\G
M=5=3,9T\P^DNUHR"GL;!ZXN51ZQVLGUT.RL'J==6CLTIKW8D EFZS)-LB<ZG
M*Y"A?9'VHY-O%G^'R3++5YJ_:E)SG2#A*,92<-CXVT]F-:QE33PT9B=[.P'>
M?<G<_&;U9]B,,I87$6X*U:VKBN0N3MP5U7'L;"VITV96U+XNFFTC;\;--#@
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M]?PG"[!7+;4K<DFFG5-/2FFM#36E-:SQC@[
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M?W"VLMS:Y:P.]J24K4GLV[[2TSP\I.CKK=IOI(Z:;<8[9IZ-8F^0
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M@[L</GZA6[A)R2N1:7QG;;ITUOBE#2E3;C!NAKN(0;5
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MU%.Y8DU&_:?"IVZUHGH4X[5N7W,F8E$;)P
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M.Y\B7PB(B(B(B(B(B(BX$1%U"(B+Z!$/31X0;;=7K/Z!P
M                                 'C==:8:<??<;999;6Z\\ZM+;333
M:36XXXXLR0AM"",S,S(B(N)@DVZ+6<-J*<I.D4<9\NL(_CCBOPAJ._!4Z&]Y
M$N1EOUS">MM^='G'EUA'\<<5^$-1WX'0WO(ER,=<PGK;?G1YS[5=;5=PPN34
M65?:QFW5,+D5TR/.80^E"'%,K=C..MI=2VZE1I,^)$HC^@9#K*,H.DDT^Z5K
M=VW=6U:E&4:TJFG\!^;*YIZ9MMVXM:VJ:>6;;+EE.BP6W7$IY2D-KE.M)6LD
M]4R(S/@$83G\A-]Y5.+EZU:H[LHQ3XVE\)\?RZPC^..*_"&H[\';H;WD2Y&4
MNN83UMOSH\X\NL(_CCBOPAJ._ Z&]Y$N1CKF$];;\Z/.<I2HE$2DF2DJ(E)4
MDR,E$9<2,C+J&1D*9<IIJJU']
M           'C7^N9_QA_P"2='5ZUW_L,[1U2[WV4>0=CJ
M
M                                  &U(V&:2-8)_P#ITS_K<C_++$ O
M?E9??/X3<V&_5K?WD?@1ZHIE<     A;Z1G^6[%ON5TGVVYP/*W;C_JS#_\
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M"5WV*Y/^]F1M7L;_ -:P_P O=^!'GO\ B<_Y67?\[A_QF3G#UT?-T
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MDR,N)#Q3O3".Z^_N)GE2Z..&Q<;EM+0HUV;FRN**;V4M6SHI0^IO9_<N;_\
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M\!<N2MMO9Z2W.THW$JT4TI2BWPQ='J5->=CFBU'JG"R6USB3)N,/Q;((+T+
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M;;]X\++#QL=+/^MQ%F.(LW8I5TSG;5N<&]+V%!RJZMR!#=!Y=
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M6OWU?^;P_P"A'R0-M_HNJ_?;)OKV'U9;B_N^WY]W](/KX[6OWU?^;P_Z$?)
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MQVM?OJ_\WA_T(^2!MO\ 1=5^^V3?7L/JRW%_=]OS[OZ0?7QVM?OJ_P#-X?\
M0CY(&V_T75?OMDWU[#ZLMQ?W?;\^[^D'U\=K7[ZO_-X?]"/D@;;_ $75?OMD
MWU[#ZLMQ?W?;\^[^D'U\=K7[ZO\ S>'_ $(^2!MO]%U7[[9-]>P^K+<7]WV_
M/N_I!]?':U^^K_S>'_0CY(&V_P!%U7[[9-]>P^K+<7]WV_/N_I!]?':U^^K_
M ,WA_P!"/D@;;_1=5^^V3?7L/JRW%_=]OS[OZ0?7QVM?OJ_\WA_T(^2!MO\
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MQVM?OJ_\WA_T(^2!MO\ 1=5^^V3?7L/JRW%_=]OS[OZ0?7QVM?OJ_P#-X?\
M0CY(&V_T75?OMDWU[#ZLMQ?W?;\^[^D'U\=K7[ZO_-X?]"/D@;;_ $75?OMD
MWU[#ZLMQ?W?;\^[^D'U\=K7[ZO\ S>'_ $(^2!MO]%U7[[9-]>P^K+<7]WV_
M/N_I!]?':U^^K_S>'_0CY(&V_P!%U7[[9-]>P^K+<7]WV_/N_I!]?':U^^K_
M ,WA_P!"/D@;;_1=5^^V3?7L/JRW%_=]OS[OZ0?7QVM?OJ_\WA_T(^2!MO\
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M4I2E'PXF9F(Y)N3<GK;)U"$;<%;AHA%)+O+0CVQP=@
M                          #QK_7,_P",/_).CJ]:[_V&=HZI=[[*/(.Q
MU
M                                                 #:D;#-)&L$_
M_3IG_6Y'^66(!>_*R^^?PFYL-^K6_O(_ CU13*X    !"WTC/\MV+?<KI/MM
MS@>5NW'_ %9A_P#VZW_?8@^A'\)W_+K&_P#O5[_TN#- QID]/
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M_ CSW_$Y_P K+O\ G</^,R<X>NCYN@
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M?<'"3S_);TL?NW!KI&X[-ZPGH3N*/Q9VZT3N0V:-_&A%+:>[8VP>=0
M
M
M
M
M
M
M
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MF_G0QL9///U2/YQ?BR,#NC^TI_F'^- [#L14V( !UMWSP_\ M,M#?ZBNF?\
M/_N<$JR/]4E^<?XL37>]W[2A^87XTRU[\VH_L3]EO_>-_P#%GKN,-FOZ_<_H
M_BHE.[G[&L_T_P >1.H,<9L   (%^E/Z>#1?H^,ZI=L^E>GEWNLWLYA)Q2NH
M-!<)G/18F.V&<3*^-B,#.KVMJ\@M&<IRABR:?J,=KH$RVL$OQC<*''F1I3F4
MP663Q,>FNO8L<?"Z<7$NZR.YMO!;P%SJN'CTF+T:.!5U)TTM]Q<IK-CL'YUE
MKO30=0D93T<FT-FZ;.;%T?S"NRNYR>DA2CY<-FZ?JL'W Q&IS<9*5.-G=D\A
M;AI=9;61M-UY/)++V-F=QKA3?/%<BH6EN.]F)72[=JPGI46H\/\ 1FU3BDZ\
M>DC_ -=.F]Z;3HEM7,8P;I*MM&@NM.FV5H?7B^HNFB;'"8FH+%?(A+MW\(U)
MH'K/%XEE41I:FY%1<8E"M$FIA]3;<=:'9%U#+\MQMMSPLG%KNMT?=4M/C5>,
MQ]S.\]RN\K>8QC-/C255P[,H:*]].G"BU9L)W][=ND;T#I]P.W/(I5A1O2O
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MB4,'BL)=PESH[FK@? U_+6B79=F.'S*QTUAT:T2B]<7Q/N<3U/OU2W5%L7X
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MCJ]:[_V&=HZI=[[*/(.QU
M
M         #:D;#-)&L$__3IG_6Y'^66(!>_*R^^?PFYL-^K6_O(_ CU13*X
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M3^&9H\=9I^TL1^?N?CL^F.['^F\O_P C8_NH$J_1%_[5:V_8_A?\(Y /1?\
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M3O<O/);S[GY5O)-4GF&6X;$-:-#O687&M%4J.332U-4+ VX'^SDD_<6TF_\
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M%PEFXI6GC,TMN2I2<8X7&23X:)RA&6A\&MK76Z'AH^MP
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M\
M
M
M
M
M
M
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MO=EOD7^2/IC^],;/OS*.E _^5OTO_P#GA ]AXORK?++T1[W9;Y%_DCZ93O\
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MNX-7)?*E:J^^XU(S>M0L9E*Q"NQ"^XJNNBG1';T"#&WP           /&O\
M7,_XP_\ ).CJ]:[_ -AG:.J7>^RCR#L=0
M
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MTZTO&_\ &-D5_*^V.[FDX4P^98##7HRIHD[<.K25:NLH]#&JT-1<=%&FZ_\
MJCC=EAVI.>XK;LKCV5!E^154MMQ/),W(=K*:)U/ZBFGT)):%%Q)2%$9=0R'C
M#/,!?RO.<7EV*6SB+&(N0DN[&;7CI5<:/J)N;F^$S_=++,ZP$E+"8K 6+L6N
M*=N+IWT]#6M--/2CEVVW\HG0/[M.EGV\T0RVXG^M\F_]UPG_ *BV8'M<_P"5
M&\__ .CV8_\ H[Q+5TN'^P>COV79'_ T,>C?XE?V;E7Y^]^);/#G\"W^I,__
M ,CA_P"]F06#R0?24L.9!_9=Q_N$8S_E:H>T<=_^KS'_ -KL_P!Y ^5F5?\
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M+B(7&O*C&2<H_P!*-8OOD3W\W8M;Z;EYINK>:2Q^"NVHM_<SE%]'/^A<V9^
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MAU!L/Z@YFS'OLGEJ;:]JKGVCCOH-1FI)RG"(B(S-?GOM7G'*IY7N+8?]5D^
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M2N^Q7)_WLR-J]C?^M8?Y>[\"//?\3G_*R[_G</\ C,G.'KH^;H
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MQ7/RJA&48R<KRK&<W&$8V_B6XM-2C( -SGEX
M
M
M
M
M
M
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M\DZ.KUKO_89VCJEWOLH\@['4
M
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M\3G_ "LN_P"=P_XS)SAZZ/FZ
M
M
M
M
M
M
M
M
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M<S_C#_R3HZO6N_\ 89VCJEWOLH\@['4
M
M                   -J1L,TD:P3_\ 3IG_ %N1_EEB 7ORLOOG\)N;#?JU
MO[R/P(]44RN     0M](S_+=BWW*Z3[;<X'E;MQ_U9A__;K?]]B#Z$?PG?\
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ML%0\CGTG
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M,-F71/:LV4G\B4EI4(R^-*.BY=DHIQMQ2E'QQF^2=H7\5V\N$OXW!XO(.QW
MW-N#OK9OXG:6F["#6S.[./Q(32E8P\92I.[-RC<B)RG)[W-<DO,MR>Q?ML@R
M.SF6]O8R3(W94Z<\I]]SDI(D--DI7)0V@DMMH(D)(DD1%YMQ^.Q>:8V[F./F
M[F-OW)3G)ZY2DZM\NI+0EH6@]UY+DV6[O93ALCR>U&QE>$LQM6K<=480227&
MWHJY.KDZRDVVV? %H9,                    W2V#_ )0E=]BN3_O9D;5[
M&_\ 6L/\O=^!'GO^)S_E9=_SN'_&9.</71\W0
M
M
M
M
M
M
M
M
M                                         ",3I!.D*U/V36>"4^G'
M1^;PMZTK.J.[MCL-L^G.0YGCN'2J6QKH15&=6]%CN1N8_-MH\Y3\(NQW5/I8
M<]J1)Y0OL)A+.(BY7+T+='2CI7OZ6C$9CF6)P5Q6[&%NWTXUK&M$ZM4=(R[Y
M1?Z9#-.EDZ6_6#3;-K+HEM[.BNG^CN+7N,8#@D?;IN'SFU.1E%M%LLER6_R9
MS2+%XLBPN6ZBO:3'CU[+45N&E/+>49N'(<%U+!6G;C>MR;=6]J*^SJY2%9K[
M6S3$*]/"WH1C&B2A-Z*MZ732]/$N\;W=#SO\Z5SHU="X&U?5'H;=\^N.B]+E
M629%AE]C&WO7?",^P*-ELQ^^OJ9,"?HW=4>;U<G)Y#\MA#\BJDQESG^,EYI+
M+"+?'8? XR:NJ_;C<I37%I^-:?#X"]RG&9OE=IV'@[URRW5?$G%INE=.RZK1
MJIKX2YMH=N?R;67:+'W16>VC7W2+)Y.):FY.6V;53"[#&=?F)>GMYF%-78U*
MPN1%*P9O<_;Q9J92M<T:I42TB+2E1.%QP,[$(8GH%<BX52VN#333KX*Z=/ 3
M&SB[MS /&2LSC=V9/HW7:K&M%J3K*FC1PHI\]-#OTZ1+I)MMR=J>BO0T](=I
M=@5WF6+9AG6;:D;;=9;;*+=G$'G+.IQJCQK'=-'ZVD8/(.8DOSUV4EUUJ,3*
M6&R<6H9S 8?!X.X[LL1;E)JFM*GC=2(9QC,SS2PL/'!WX6U+:;V9-NB:2^2J
M:WQUT:N&*3HD'.EPZ*'<A<:W8KT56]#5K%<YP:7ISJ3IS;[8MP^+2+K'GKJH
MR&#8XYED72R[5CN2T]M2M\T\] L(KD9^0TN.:W&GF+O&/ XRST4KUM::I[4=
M#T]W3K,;ED<VRS%=9MX:])-;+3A/2FT]>SH=4M.GO,[$+8=NWS/>;HU<:I9Y
MM/W$[.,@I,\L,%>TMW+87:X1FEHFMQ7#\B<S+'H-S5TTVUP:;-REZNB3SC,\
M_+JY230A3:D)C&*L0P]Q0MW(W(M5JN^]&AO3H\9L'+\7>QMAW;UF=B:E39E6
MKT)UTJ.C335P'R]^6\K,MEV 8?FN%;/MSV\>QRW*9.,NX7M>T_M=0<EQ=#-+
M-MFLBRF'4P+%^JQQ]^(F)V2;:B*0ZA)$HSX#MA<-;Q#:N7(VTJ:Z:>]5HIYC
MCK^"C%V;%R^Y5KLUT4IKI%ZSKP.EOI.E4Z5'=J]N0M^BHWNZ54%#I[CFDNGF
M#L;9-PF3V%3A&,7.49(P]D.0JTNIX]K>VN1YG92W38AQF([3S<=).FR<AZ38
M.6"P=E68WK;TU;VHJKY2 YG#-LSQ3Q-S#7HJB26Q-T2X*T[K;T+2]1+OT/72
M*])GT=VVW$MH6M?0P;^=5=*]/K?-;' L[TZV[ZYT&<4%=FN47&=V>/7.*9'I
M=(HLJ0O,<DL'VIK=I4JC1WDM*8D*1SAV6-PV"Q=WIHW[<9M:=,6G3PK@[YE<
MIQ^;9;8ZK<P=ZY:3;7Q9IJNEKY+35=/!K9>FKY9SX$&<J+)A*F0XTM4*:V;,
MR(<AE#QQ9;)\3:DQS7R'$_\ -61D(Y);,FJUHR<VY.<(S::;2='K5>!]U'N#
M@['QLB?L(N/WLFI0X[:1J:S?K6VF#DNN6#,)]R&AN,25G(<7(2DB1R3Y9]3@
M?$=[:BYQ4ODU5>\4K[G&Q.5K\HH.G#IIHT<.DZCVUVZ].M;Z^9#NF=VX=*57
M;C<HM;.XN-:L:T&W1XCJ*N7;LJBS&:_)L5PZFL:2J*O,H;$&"N/!BP4(BL--
MQVT-)FG3X#H^BV[/1TI3:C2G>J:JZGG'3=8Z+$]/6NUL3K7CK2M3,'_Z3'_]
M74_X_12__%/^'_ +C_\ *3_'?VH__28__JZG_'Z'_P"*?\/^ /\ \I/\=_:F
MU^PS^\+_ "Y=F/GJ]<SYF_E7[=?.UYT?EO>;/S9^=_#_ "\\XOE9_P#>MY"^
M2W9?A?PG_P"3_!_.]D?L/+%'$^S.KW.CZ#I-B5*;%:T=*4X>(N\#[?Z[9Z;K
MG0]+#:VNDI3:5:UT4IKKHH=F8(F;'*)G2X?-V=Q>ENX]W?WT4<)^QFQL\@ZT
M6&A^.RZBMS[2S52GOVLK\L-%8MN4>FRC%G;R.F>C'C4J?!E$IF&S,BNM18DF
MP6:6KMOH,8TITI5ZI+N\3XZZ/@(!FV[V(PU[K661<K5:[*^5!UX%K:KJI5KP
M5).-N_SF3;WC>GV/XUTFFDNO6QW<A55;,'*Z;+M!]4WL(SBYK6XL:WO,!C0\
M?GYI3,/R'2?D5EI 1X,Y]#"9DS@3JK2]DUQSVL+*,K+U:=*^P^_XC)87>FQ&
MTH9A"<<2M#HM#[M*II\:I3B? M).DMZ7+<+TJVD]MLGZ';;!N1U7PK6YJSP_
M5S<O,TRO,,PRWP;F62O\&PS([YZLH<4I<D5SU5D%OE,JG04;G:]F.X<U,ENY
MPF7V\#+K.-G!26I5T+NZ=;XDN_KU6.9YU>S:WU'*[5QVY?*=-+7%HK1<;;TZ
MM"K60?H'>@=@=&7 M=?]?[7',[W@9WCC^-$6-/R['"]%,+L9;<NRQ?%[*6W"
M+(\KR,H40[>W.(TF.EI4" I454F3/L\RS)8I=#9JK*>E^5Q:.(RF0Y"\ ^M8
MJCQ35$EI44]>GAD]6C0E72ZEC;(G["+C][)J4..VD:FLWZUMI@Y+KE@S"?<A
MH;C$E9R'%R$I(D<D^6?4X'Q&*MJ+G%2^355[Q(K[G&Q.5K\HH.G#IIHT<.DZ
MCVUVZ].M;Z^9#NF=VX=*57;C<HM;.XN-:L:T&W1XCJ*N7;LJBS&:_)L5PZFL
M:2J*O,H;$&"N/!BP4(BL--QVT-)FG3X#H^BV[/1TI3:C2G>J:JZGG'3=8Z+$
M]/6NUL3K7CK2M3,'_P"DQ_\ U=3_ (_12_\ Q3_A_P  N/\ \I/\=_:C_P#2
M8_\ ZNI_Q^A_^*?\/^ /_P I/\=_:FU^PS^\+_+EV8^>KUS/F;^5?MU\[7G1
M^6]YL_-GYW\/\O/.+Y6?_>MY"^2W9?A?PG_Y/\'\[V1^P\L4<3[,ZO<Z/H.D
MV)4IL5K1TI3AXB[P/M_KMGINN=#TL-K:Z2E-I5K712FNNBA;CZ:+H1/6]W>W
MNY^4W\GKS#U6I=9V-YE_.SY5><27A$KG^>\[&FG@/P/Y&\GD\F9V1V3QXM<W
MP7AL!F/4H2AL;6TZZZ?89*,XR+VK>A=Z7H]F-*;.U737RD0@?W*__P"J5?\
M!Q__ !4B^]O?]U^%_P!DQ'N=_B?[/_MC^Y7_ /U2K_@X_P#XJ0]O?]U^%_V1
M[G?XG^S_ .V5+;W9]X%Z1:YV!^<3LGP3O5L-GWG9\DN9[([ US>T7\XGD)Y3
M.\USO->$O!'AE7)X]C]FG_TXSD+VWAU?IK@I4[ZK2I$;V'Z+&3PE:[-UPK37
M26S6E?#2OA+T_1V?-</D#;S=$-W7RYO.QYFK7*;/S??)E\A/*/REP'*\'YCR
ML^4%F7@?L+RG[*Y7@V5SG,<WP3R^<1'<1G/3V)6>CIM*E=JO^R3?![K=4Q5O
M$]/M;$DZ;%*T[NVZ<A;3&$):          >-?ZYG_&'_ ))T=7K7?^PSM'5+
MO?91Y!V.H
M                                                         ;4C
M89I(U@G_ .G3/^MR/\LL0"]^5E]\_A-S8;]6M_>1^!'JBF5P    "%OI&?Y;
ML6^Y72?;;G \K=N/^K,/_P"W6_[[$'T(_A._Y=8W_P!ZO?\ I<&:!C3)Z>
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M)\=$DN"C$DD
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M5<3IK6A:"C>PV'Q.SUBW"YL34H[45+9DDTI1JG223:36E)OC/4'0K
M                !NEL'_*$KOL5R?\ >S(VKV-_ZUA_E[OP(\]_Q.?\K+O^
M=P_XS)SAZZ/FZ
M
M
M
M
M
M
M
M
M
M        =2UG7_UQ;F/_ .>JR'_QSS!-[/[/A^97XIJ7&?MB[_F9?CL[:40@
MVT           !XU_KF?\8?^2='5ZUW_ +#.T=4N]]E'D'8Z@
M
M                                    !M2-AFDC6"?_ *=,_P"MR/\
M++$ O?E9??/X3<V&_5K?WD?@1ZHIE<     A;Z1G^6[%ON5TGVVYP/*W;C_J
MS#_^W6_[[$'T(_A._P"76-_]ZO?^EP9H&-,GIX
M
M
M                     -TM@_Y0E=]BN3_O9D;5[&_]:P_R]WX$>>_XG/\
ME9=_SN'_ !F3G#UT?-T
M
M
M
M
M
M
M
M
M
M              K@V_S9G9[<[W;3?8_KCN4:U+M=U,W=J]BC-KI>6#-YS.U<
M=UB<QYJ.O31=_P"2:+]TXR4'/.9V'U#D<Y^R#,1SBY"PK"A&BALUJ^*A%KNZ
M]F[BY8MWI)RN.=-E<,JTK4L?##DI            \:_US/\ C#_R3HZO6N_]
MAG:.J7>^RCR#L=0
M
M   VI&PS21K!/_TZ9_UN1_EEB 7ORLOOG\)N;#?JUO[R/P(]44RN     1"]
M)'CK[&;:=9;S*CC6F*S\=-\DJ-"7Z&V>LB9<5Q-"%*;R,S01\#41*X<>2?#S
M/VZX&<,VP.94_J[F'E:KW;<W*G)=T<>GBT>[?X2,VMW-W<VR/:736<;"_L\-
M+UI6ZKA>FQ1\55JKIC9&B#UR
M
M
M       $@'1UX](L-7\ER'FB5!QW");#CYMDOF[&[M*QF"TE1E^Q+>A0I9\H
MCXF2#+Z!GPW/V(8*=[>:_C:?U-C"23?%*Y.*BNY6,9\E.$\O?Q79K:PNX>#R
MK:IB<7F,9)5I6W9MW'-]U*<[6C55IZTB: >J#Y]
M
M
M
M
M
M
M
M
M
M                                                 'C7^N9_QA_Y
M)T=7K7?^PSM'5+O?91Y!V.H
M
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M/3%(K@
M
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MI9);/#T<+=4I51M(-A&F
M
M
M
M
M
M
M
M
M
M                              #QK_7,_P",/_).CJ]:[_V&=HZI=[[*
M/(.QU
M                                                     #:D;#-)
M&L$__3IG_6Y'^66(!>_*R^^?PFYL-^K6_O(_ CU13*X      &H6XC:)AVMQ
MO9'5/M8AJ"31$=XS%YZOOB9:2W'CY%";4VMU:$MI;1+:/GVD=127DI0@M9[[
M]FF5[V-X[#R6%SJGY1*L;E%1*[%4KJ24U\9+6I))+>_95VZY_P!G2CE.-C+'
M[K5_(N5)V:NLI6)NJ2;;D[4OB2>IVVY2<6&:[1=?\(DK:?T_M,EB$LTLV6%(
M7E,:21'PYQ$2M;7<QT&?[?%95_R#SQFW9IOGE-QQG@KE^W71*Q_6I]W9BMM?
MTH1/:6[O;KV7[QVE.UFEG!WZ:;>+:PTH]QRN-6I/[RY-=TQ6K2;51*C2K3/4
M!*DF:5)5AF1DI*B/@9&1UO$C(Q'7NWO$G1X#&U_,7?1)JM^=RI*JSC*VG_B[
M'Z0_GFGU2]&N?_ W(OK<./=S>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\T^J7HUS_
M .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;D7UN#W<WA^@8
MWYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F+OHCWXW+_?&5
M_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\T^J7
MHUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;D7UN#W<W
MA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F+OHCWXW+
M_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\
MT^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;D7UN
M#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F+OHC
MWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE?_%6
M/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;
MD7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F
M+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE
M?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7
M/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z
M!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_
M 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3Z
MI>C7/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=
MS>'Z!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCW
MXW+_ 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2
M#S3ZI>C7/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?
M6X/=S>'Z!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+
MOHCWXW+_ 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\
M58_2#S3ZI>C7/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^
M!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!
MC?F+OHCWXW+_ 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?
M&5_\58_2#S3ZI>C7/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ
M-<_^!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S
M>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWX
MW+_?&5_\58_2#S3ZI>C7/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-
M/JEZ-<_^!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6
MX/=S>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+O
MHCWXW+_?&5_\58_2#S3ZI>C7/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C
M](/-/JEZ-<_^!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!
MN1?6X/=S>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C
M?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_
M !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS
M_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>
M'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;D7UN#W<WA^@8WYB[Z(]^-R_W
MQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_P#%6/T@\T^J
M7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\T^J7HUS_ .!N1?6X
M/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;D7UN#W<WA^@8WYB[Z(]^
M-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_P#%6/T@
M\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\T^J7HUS_ .!N
M1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;D7UN#W<WA^@8WYB[
MZ(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_P#%
M6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\T^J7HUS_
M .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;D7UN#W<WA^@8
MWYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F+OHCWXW+_?&5
M_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\T^J7
MHUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;D7UN#W<W
MA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F+OHCWXW+
M_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE?_%6/T@\
MT^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;D7UN
M#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F+OHC
MWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE?_%6
M/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7/_@;
MD7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z!C?F
M+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_ 'QE
M?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3ZI>C7
M/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=S>'Z
M!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCWXW+_
M 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2#S3Z
MI>C7/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?6X/=
MS>'Z!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+OHCW
MXW+_ 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\58_2
M#S3ZI>C7/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^!N1?
M6X/=S>'Z!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!C?F+
MOHCWXW+_ 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_\
M58_2#S3ZI>C7/_@;D7UN#W<WA^@8WYB[Z(]^-R_WQE?_ !5C](/-/JEZ-<_^
M!N1?6X/=S>'Z!C?F+OHCWXW+_?&5_P#%6/T@\T^J7HUS_P"!N1?6X/=S>'Z!
MC?F+OHCWXW+_ 'QE?_%6/T@\T^J7HUS_ .!N1?6X/=S>'Z!C?F+OHCWXW+_?
M&5_\58_2&3,/VG:_YG+9CQ=.+VA86LB>L,PCKQ6)$;Y1H4\\U<)C6+R$F7ZU
MAAYPRZI),NJ,_EG9QOGFEQ0MX&]9@WIE>70I=UJ=)/O1C)\2(AGW;?V7[OV)
M7;V;8;$W4M$,+)8F4G2M$[6U;3[LYPC70VF2@;=]F>)Z/2(F695*C9GG[*$.
M191QC308W(X$I2Z*-)3S\J<A?43.?2APB(C;:9,U<KT#N1V6Y;NQ..99C*.*
MSE:G3^KM/_NT]+EQ7)4?DQBZU\;=JW\0&>;^VIY)DL)Y?NO)M2CM?U^(CQ7I
M1T1@UKLP;C6NW.XJ4W5&UCSR
M
M
M
M
M
M
M
M
M
M                                   !XU_KF?\ &'_DG1U>M=_[#.T=
M4N]]E'D'8Z@
M                                                          !M
M2-AFDC6"?_ITS_K<C_++$ O?E9??/X3<V&_5K?WD?@1ZHIE<
M
M
M
M
M
M
M
M
M
M
M
M
M                                                     \:_US/^
M,/\ R3HZO6N_]AG:.J7>^RCR#L=0
M
M                VI&PS21K!/\ ].F?];D?Y98@%[\K+[Y_";FPWZM;^\C\
M"/5%,K@
M
M
M
M
M
M
M
M
M
M
M
M
M           'C7^N9_QA_P"2='5ZUW_L,[1U2[WV4>0=CJ
M
M                                  &U(V&:2-8)_P#ITS_K<C_++$ O
M?E9??/X3<V&_5K?WD?@1ZHIE<
M
M
M
M
M
M
M
M
M
M
M
M
M                              \:_P!<S_C#_P DZ.KUKO\ V&=HZI=[
M[*/(.QU
M                                                       #:D;#
M-)&L$_\ TZ9_UN1_EEB 7ORLOOG\)N;#?JUO[R/P(]44RN
M
M
M
M
M
M
M
M
M
M
M
M
M                                                   >-?ZYG_&'
M_DG1U>M=_P"PSM'5+O?91Y!V.H
M
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M'ZJ'(A[7S3Z1=\YCR;H/%%?W,W[D.HX/U4.1#VOFGTB[YS/MBZ,<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M)SO),NP673Q&'@U=3C1[3>MI/0V98$C(.:K#7ANT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                    #E^"_P"TD/\ Q4O][.C)Y1^O
M1[S^!F WF_9%S[Z/XR,]"8&L358:\-V@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                            <OP7_:2'_BI?[V=&3RC]>CWG\#,!O-^R
M+GWT?QD9Z$P-8FJPUX;M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                      @WT&^<)='UN8W5XSL]T5>UIS;5;,<[R/!,<L*_
M3NO+!;5W$V+NPO,IBY,O+"-S#HM#CLNS*84<UN06N6EHU&2#REW*,39LN].4
M%&*JU5U[VJE?"1[#[RX#$XF.%M0O.<Y;*=(T[_RJTX=6K@)R!BR0@
M                                            <OP7_:2'_BI?[V=&
M3RC]>CWG\#,!O-^R+GWT?QD9Z$P-8FJPUX;M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MTK29&1F1C M-.CT-$RC*,HJ46G%JJ:U-'LC@Y
M                 .7X+_M)#_Q4O][.C)Y1^O1[S^!F WF_9%S[Z/XR,]"8
M&L358:\-V@
M
M
M
M
M
M
M
M
M
M
M
M
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M*;G&#>M4JE7BU>$BF$WHQ^(QEJQ*%E6YW8Q=%*J4I):]JE:/B\!>\$;)V
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MKBJ17,=YE@,9/"*SMJ%/C;=*U2>K9>JM-? :"?WU#_ZFK_QC_P#\*PN/8/\
MWOX/_:+/WQ_PW]I_V!_?4/\ ZFK_ ,8__P#"L'L'_O?P?^T/?'_#?VG_ &#<
M+8'\ZA^7)O"T+VG_ "$_-?YZLIG8UY??*>\MO)KL+&[S(>S?);Y/.)>&><\#
M<SS?A*)PYSE\H^3R54K^2]#9E=Z6NS%NFSQ?TBXPF]76L5;PW0;.W-1KMUI5
MZZ;"KREN88,EP                               '+\%_P!I(?\ BI?[
MV=&3RC]>CWG\#,!O-^R+GWT?QD9Z$P-8FJPUX;M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MI46GD.8?W1'I2/X\;/\ [[&I']"HI^V<%QRY"K[L9OY$?.0_NB/2D?QXV?\
MWV-2/Z%0]LX+CER#W8S?R(^<C?GHNOFUG2"[--_>VC<YJQEFV>PT[TBS6QR#
M*8>%ZC9Q;Y0_ F8CD="VFGK;32NA@2Y"9ENTI27);!$V2C(S,B2=#%9KA+N'
MG;@Y;4HM+07F7[O9GA\=:OW8Q5N%Q-_&6I,OA",&P0
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M?]/';#^Y_P#[KP7_ -\CY:^V3TF?[FZ@?%0/K7W ^G_V&)_0C_IX[8?W/_\
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M/BH'UK[@?3_[#$_H1_T\=L/[G_\ NO!?_?(^6OMD])G^YNH'Q4#ZU]P/I_\
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M-S-[-U9*.\678O!Q;HI7+<E"3XHW*.$G][)G/1F2,@
M
M
M
M
M
M
M
M
M
M
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M(TF9&,9*,H2<9IJ2X'H9((7(78*Y:DI6WJ:=4^\T?6'!V
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M))<"2H>H*96
M
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MSMISO8*-6G'7*>&6EJ4=;LZ4U^2HTK<I5!Z)/%0
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MP-C?'<C>7</,UE.\V'=C$RAMP:DIPN0K3:A.+:=&J-:)1?RDJHR.,Z1(
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MDK63-K.YMPT\.*2Y1$9_KCX<3UW<[=,@5>AP>,EIT5Z..CP3EI[FGOFZK/\
M"5OC*G6,SRR&C3L]/.CXE6W"J[NCO&\&G.:Q-1\&QG.8,*170\FJVK2/!EK:
M<DQFW5+233SC)FTI9&CZ*>H-M9'FUO/,HP^;V82A:Q%M3471M)\#IH/.6]F[
MU_=/>/&;MXFY"[?P=YVY3BFHR:II2>E+3PG-1EB/
M
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M9WGW9MG:R;.^CFKEOI+5VVV[=V%:554I*46J3C))IZ56+C*681)R!
M                     !\/)LCIL0Q^YRC(9B*^DH:Z5:6<Q:5K)F)$:4ZZ
M:&FR4Z\\HD\E#:"-;BS)*2-1D0M,?CL+EF"NYAC9*&$LP<YRXE%5>A:6^)+2
MWH6DR63Y3C\^S3#Y-E=MW<QQ5V-NW%4592=%5O0EPN3:44FVTDS5/27>QIGJ
MOF[.#1JG(<:L+1;S>.R[Q,!42W?92MPH3AP9<DZ^?(80:FD*Y;:U$:.<Y9H2
MO7.[?:OD&\>;+*(6K]B]<;5IW-FDVM.R]EO9DUI2=4]6U6B>[-^/X>-\-R-W
M);R7K^$QF%LI._&RY[5I.BVUMQCMPC)TDU2234MC9VG'<@;1- @
M
M
M
M
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MP/['$_"7V19K<R_%1MS;>$FTI+@5?NEW5P\:[M*=GF(<;0
M                  Y?@O\ M)#_ ,5+_>SHR>4?KT>\_@9@-YOV1<^^C^,C
M/0F!K$U6&O#=H      &D^^36*9IKI>SC-#+.)DNHSTRG;D-+4B5 QR*RVK(
M9D92>JV_(3*9B)4? R3)6M!DM!&6J.US>B[D.[ZP&#ELX_'.4$UKC:27227$
MW6,%W)-K2CT1_#AN#8WNWREG&9V]O*,IC&ZXM5C._)OH(23UQCLSNM:F[<8R
M3C)IP;CR.?1X
M
M                                                         G.V
M/ZQRM3=+5X[>RER\HTZ=ATDJ2\OER+"@DLN*QV?(6H^6Y(;:BO1%J/BI?8J5
MJ4:W#'KKLEWHN9_N\\#C).688%QMMO7*VT^BD^-I*4'Q[";;;9\W?XC=P;.Y
M^^BS7+8*&39M&5Z,4J1A?BUT\(K4HMRC=2U+I'%)1BC=(;5//8
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M>;LRP>&QN?7\!>M8J[*$%AYW9M.,5)[726+22H]%&W7@-C1.34X
M  $*?2%8S24>L-%9U,"/ DY+AL:QNBBM-,M3;*/;VL$K!U#:$\J8]$8;0XLS
M/EDTDSZO$S\I=M> PF$WGLW\-",)W\*I3HDE*2G..TZ?=-))OAHCZ&_PL9QF
M.9;A8G!XZ[*[9P>82MVMIMN%N5JU/83;^0I.3BN#:?!1*3':[^3YI/\ 8E#_
M ,M(&^^SW_166_Y:/PL\?]LW_-+//\]/X(F>Q,C60
M
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M#'VNCF[T(PC9MRITE:3EMS:K"*C\55<G+0E*5(>B3Q6
M
M
M
M
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M2Q<RF;:Q(V/H@2G76&XTU5LXR33BEH2A? S41%Q&<(F=Y0->&[0
M                      .7X+_M)#_Q4O\ >SHR>4?KT>\_@9@-YOV1<^^C
M^,C/0F!K$U6&O#=H      $*/2&WC]AK;4TYNK[$Q_!JEEM@^/-HEV5C;V$J
M0@C_ .>_'<CH49=0R:3_ (!Y1[;<7._O9;PU7T=G!P5.#:E*<F_"G%/O(^AW
M\*V6V\+V=W\?1=/BLRNMRX7&W;M0C%]Q24VOOF:&C3QZ8
M
M
M                              -]^CONW8&M%Y3<X11;[!;,E-&HR)<R
MLM*>9&<2DB,EK:C'((B/AP2LSX_J'N3L1Q<K.]5["U_J[V#GH_G0G"2?@6UR
ML\R?Q5Y=#$]GV&S"G]=A<RMZ>*%RW=C)=Q.6QX4O!-2/59\]
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M2E&2XU)-IKNIFLL9@L9EV*G@LPM7;&-MRI.W<C*$X/BE"24HON-)GOBL6P
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MF1K(
M                             @WW\Y9Y0Z]2:5IXG(V%8U247(0HU-)F
MS6W<BF+^B:3>Y-RTTOA] V22?528\C]LN9==WQEA8NL,)8MV^YM23NR\/QTG
MWJ:T?1[^&+(_9?9G#,)QI=S'&7KU7KV(-6(KO5M2DJ^55:&B3K:5B?DAM\TX
M@N-*;E6M0YE$LUI)+BUY/+D748UI+Z!MUTMALN/5Y*"X]7B-_P#9MEOLS<K
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M_?3L^5J[O+A.CP=Y[,+L)1N6G*E=ARBWLSHFU&:BY)-QJHMK- E1KX
M
M
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MCCQ,\KB,JP=K#W)Q3VXPDUI>M*I',%O#FE_&V;-R<>CG=A%K9CJ<DGP<1?\
MA%C8@                             !I)J3TE/1]:-YSD6F6K&]';/IQ
MJ)B$U%=E.$9IK'@^.91CT]V+'G-Q+BDM+F-/@2'(<MIU*7$)-3;B5%U#(Q=P
MP.+N14X6Y.+54S&7<YRRS<E:NWHJY%T:TZ&O <&];KT6_P#],'V?_?\ M-_C
M .WL[&^KD=/;N4>OCX^8>MUZ+?\ ^F#[/_O_ &F_Q@#V=C?5R'MW*/7Q\?,;
M,:-;J]L.XMEQ_0#<5H;K:AA*52D:4:K8+J _"-3'9'-6$7%KVTDU\A#/MEM/
MH;<;X'RDD9&*%S#XBTJW82BN-ITY=1>6<=@L2U&Q=MSDU6BDF^/56OB,^"B7
M0
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M-W\JN8[%1Q$X_P#E+<DVWJDUI45Q\&UP4UZU7LRQ$#9H
M               '+\%_VDA_XJ7^]G1D\H_7H]Y_ S ;S?LBY]]'\9&>A,#6
M)JL->&[0      (,=_'Y0EC]BN,?O9X>1>V3_6L_\O:^!GTB_AC_ .5EK_.X
MC\9&EHU4>A
M
M                                                       #=+8/
M^4)7?8KD_P"]F1M7L;_UK#_+W?@1Y[_B<_Y67?\ .X?\9DYP]='S=
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M ]/]GO\ HK+?\M'X6>!NV;_FEGG^>G\$3/8F1K(
M
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MTJK@;3T-E@P>TSY;
M
M
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MZ=Y792+B#I-6W<QF"6I>E\F>M^7B#F(O2.S;"KB*166\$I"'(Y3#BS(V5QV
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MK+<-BX=+8I&XU5-:GWTN/C6GOZC#8#/L?EEWJ^+VIV8NCC+Y4>#0WIT>2]'
MJ:SL.='=8=,MP&E^$:SZ-9I2:A:8:C447),-S''I/9-7<U4DUMFI'+2W(B38
M4IER-+B2$-2H4MEV.^VV\TXA,5NVYV;CM7%2:>E&Q,/B+6*LQQ%A[5J2JG_+
MA3T-<#,E#H5@      *7V[?YQ=O:T%Z6_(=A.'Z7;6;+1^IW):1Z.QLDR7"=
M6IFI*\9SY[ F[B<_<5>M]/BZKV,G*9'8SJ:=,=!H;Y;+G!7+D5C*,-=PT;TI
M3VG"NM4U?>D'Q>\N/P^/N86$++MQN.*JI5HG3RDJ^ N@B.DX
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M=!(:88:;:;21$E)$,/*<IR<YMN3X7K)1;M6[,%:M14;:U)*B1R,=3N
M                         !R_!?\ :2'_ (J7^]G1D\H_7H]Y_ S ;S?L
MBY]]'\9&>A,#6)JL->&[0      (,=_'Y0EC]BN,?O9X>1>V3_6L_P#+VO@9
M](OX8_\ E9:_SN(_&1I:-5'H0
M
M
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MP7[ 2^V&Y'E[MT_U#@_\G_\ 5F>^OX2_]&9E_P"Z?_0M$B>UW\GS2?[$H?\
MEI W?V>_Z*RW_+1^%GE+MF_YI9Y_GI_!$SV)D:R
M
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M)1\#QR-<,4D>4I2%*,D,X]!2XKDF? DGR>/4'BS,F][>T6Y;C\:UBLR5M/\
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M^1VW_6YCC(U5==JPNDEHX:7'9[GAH33CU6?/4
M
M
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ME@
M                                                   #E^"_[20_
M\5+_ 'LZ,GE'Z]'O/X&8#>;]D7/OH_C(ST)@:Q-5AKPW:      !!COX_*$L
M?L5QC][/#R+VR?ZUG_E[7P,^D7\,?_*RU_G<1^,C2T:J/0@
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MU]ZHPNVY2Y(R;./"U,H
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M6SU!_")^S<\_/X7\6\;?;*/R9-,__CE_.!E8V9V4?Z P'_C_ /J;QHC^(?\
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M_)\TG^Q*'_EI W?V>_Z*RW_+1^%GE+MF_P":6>?YZ?P1,]B9&L@
M
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MJ_P<%E^KQ%QV)9;'"[LW<Q?Y7%8EZ?YEM*,5X).YREG_ !59[/'[^8?)8O\
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MUIW'4VM$F[K7\KE*61I4Z>22W[2$X2>)\$%5/1TI/_G)21_JC;G9GERRW<G
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M<IYB
M
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M@."U20J^)%J&H3N=TZ78;=:PRW"1%<2XHE-D@D&2CXEU3$WPC<L+;;TMVX_
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M^%*J\9JG+)2L9O95MZ5?4? Y;+Y4V=L2(2;9
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MM7824>/6N55,CALWRW%RV+%Z+F]2=8M]Y22;\!O$+4R(
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M+<*[+X.X6-G-\S=Z%;]VFTONG37Q':3"%FUP
M     #E^"_[20_\ %2_WLZ,GE'Z]'O/X&8#>;]D7/OH_C(ST)@:Q-5AKPW:
M     !!COX_*$L?L5QC][/#R+VR?ZUG_ )>U\#/I%_#'_P K+7^=Q'XR-+1J
MH]"
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MXW ^KS)[N5RS7-,WN7K_ $LKN.O=-.+V(PV+;HG"W\7:V6Y?&;==)A01@V$
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M1W+TG<NX2ZY;%N<;TOC7,+)N-5-O8M25RVXJ+MS@B'D4^E@
M                                                       ;I;!_
MRA*[[%<G_>S(VKV-_P"M8?Y>[\"//?\ $Y_RLN_YW#_C,G.'KH^;H
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M,KZ2>(ABMJY)Q<8QZ-3BXJNF3<I:TJ43TZ4>B?X>>R'>G=3/9;XY^K-G!W<
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MFXM2ELI-49)J-^GCT
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ME<E:4FH2FHZ(SE&CE%52;:3=*GUA<EB
M
M
M                      !UCGSL_P#M7B_JS:.?PIG@F&4?J,>^_A9K#>7]
ML7/O8_BHM$]"KT:O1\ZQ=%MLXU,U7V7;9]1M0\OTVL[+*<VS31S!\CRC(;!&
M=9;#1,N+NTII,^?(1$BMM)4XM1I;;2DNH1$,3F.-Q5K&SMVYR4%31_13)'D>
M4Y=B<KM7[]J,KLMJK==-)R2X>)$Y^C6T#:?MU<4_H%MET!T5EN<.?L-+-(,
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M^'@7*^\1G$;T6.DZ#+[<[]YNBX$WW%1R?(N^:Q=(AI1TX&Y#8GNRU7W9Z]:
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MH]?R^]CO]<#;1_/1A0SU[\E+[U_ 0VQ^6A]\OA.Z/$ -T
M               '+\%_VDA_XJ7^]G1D\H_7H]Y_ S ;S?LBY]]'\9&>A,#6
M)JL->&[0      (,=_'Y0EC]BN,?O9X>1>V3_6L_\O:^!GTB_AC_ .5EK_.X
MC\9&EHU4>A
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M;5QZZS4$INOWU26OU1>5>FW'_@78_& >DO\ IJS7]ZX?YF?IGAG_ *Z\D_\
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MQA,-@XX7&JQ;C9<W5='&X]ISDVVMN*JE%/BXM,1K ] @
M                                      &Z6P?\H2N^Q7)_WLR-J]C?
M^M8?Y>[\"//?\3G_ "LN_P"=P_XS)SAZZ/FZ
M ?.LZBINXJH-S5UUO"7QY<.SA1I\5?%)H/E1Y33K2N*%&1\2^@? 4,1AL-B[
M?18JW"[:?W,XJ2Y&FB[P>.QV77EB<OO7;&(6J5N<H27#HE%IZ^Z?"J\ P.DF
M-V%+A.(U$]HC)J=5XW30)C9&9&9-R8D)IY!&9%]!7Z@L\/DN3X2ZKV%PF&M7
MEJE"U",EX5%,R6,WHWFS&P\+F&8XZ_A9:X7,1=G%]^,IM/D.7#)F"
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MY+1P<1RX9,P0
M
M
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MB(B(B(BX$1%U"(B+Z!$/7&K0M1\XFVW5ZS^@<
M
M
M
M            '6.?.S_[5XOZLVCG\*9X)AE'ZC'OOX6:PWE_;%S[V/XJ+LO0
M&_V/NQ7[E-K_ #AYH,!FOZ_<_H_BHFF[G[&L_P!/\>1+\,<9L   .JPVP?\
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MR0G&GF76S4AUIU"B4E23,E$?$A-[W[/G^9?XIJ3!_MBU_F8_CH[:H0@VV
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M!3"Z/7\OO8[_ %P-M'\]&%#/7OR4OO7\!#;'Y:'WR^$[H\0 W0
M                    <OP7_:2'_BI?[V=&3RC]>CWG\#,!O-^R+GWT?QD9
MZ$P-8FJPUX;M       @QW\?E"6/V*XQ^]GAY%[9/]:S_P O:^!GTB_AC_Y6
M6O\ .XC\9&EHU4>A
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M/]78+_VV/]]>-L?P.?\ +W-O_>7_ .FL$5(\\GM<
M                                   W2V#_ )0E=]BN3_O9D;5[&_\
M6L/\O=^!'GO^)S_E9=_SN'_&9.</71\W0
M
M
M
M
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M;R$,V18
M
M
M                                          CZZ0#6/I!-'\5P.7L
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M@+275)N4ZZ5K27?HOA9+\HQ.<8AOVC:C;M*.ATI)RT:TY/@T_)2KJ):QCC.
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MORC$YQB&_:-J-NTHZ'2DG+1K3D^#3\E*NHEK&.,X
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M+Y-?X5DV.YEB=M-H,IQ*]J,FQJ]K738L:6_H;"/:TUM ?(C-F;76,1MYI?\
MS5H(Q*]>AZC7:;3JM9W@6GF0R,NP#!LLEM(CR\GP_&<AE,-JY;;,BZI85D\T
MA7(;Y2&W))D1\E/$B^@7T! +T5"[*"U*37(S<N%N2NX:W=G\J5N+??:3*G7S
MQK3?")NQ;;?J])QRK<U'QG=G0:;TN7'$8*ZAX1G.CVLV3Y-CB9Y-]DG5V5]I
MY42E,FOFR=B$HBXF9C,9%<FK\[5?B.%:=U-+[)&-[[%MX2WB:?UJN;->XU)T
M?ACHXJOC.O5T\I)V39_@V.5EJ[16609AC-)77;'/$_33K6ZA0(EJSV.]&D<[
M7R'TO)Y#C:^*/:J2? RDY #L=.DBZ%72+0'H;-SVF&S30R1JYN5M:[37-=0M
M7KNI:SS<WK<[B.KN#Z@:F7;^5S(\[))4^P@4DVS\ TZV([ZFUMQXSLETR>C.
M$S&Y?QZ=^6S:=4EJ2XJ\;[KX7HH3S,\BLX3*)+"0V\0FG*359-+7371<-%P+
M35JIUTNENCFJ>MFIN+Z,Z3X%D^>ZIYG?,8SC>#8]5R)E_8W3SYL*BG$Y*.PF
MX:DJ7*?D&U'ALMK=?6VTVM:9)*481<I-**6ED%A"=R:MVTY3DZ)+2V^X=SWL
M_P!'KC;QM*VN: 9#8Q+B_P!#-NNB6CUY;P&U,P;2XTRTTQG"K.QA,K=?6U$G
M3:1;K:36LTH41&H_HB"8B<;F(G<C\F4Y-=YMLW%@K4[&#LV;GY2%J$7WU%)G
M2=">FFSLD?F>']F;KE_7JU,_F VQB*YY^MQ_-K\:1L3=']FS_/O\6!:^&&)2
M4)?GGNGN%4^=[ M3:O&::OSW.\>W)XIF.51*^+'NLDH-/)F@T["JVYL&FD2K
M&/C<C/K<XA.K63!3G"1P)1B29%<G*%RVW\2+37<K6OP$$WOLVX7K-^*I<FI)
MOCV=FGATM=ZA5TZ+O^TRZ.S^O5M'_G_T_&7QGZI=_-R_%9&\L_:6'_/V_P 9
M'<RB"&WSJT/G"NRG>5BW2=;E=6LLTFU6SK3?63+:W+]+-4Z##LCR?#K3#W,:
MI*RGQ%F^J(,^OK;G X]<50]7/K9E(1$;?)HX[[#KDTRV]:N82$;;6U&*37"G
MPZ.Z])JK/,-B+&979WD]F=QN+X&FZJC[BHNY0G$^:&;4MU.C4[=SK#JMICG>
ME&C6I^,:4XWA[>H.,7.)S-2,JQ:XS.P5?XU771P)TRAP^JNY$=V<J&J+(?MB
M;C/J7'EMIQV>7;,H0M)IWE*O>5.'BKHY#.;I8?$QO7,1)-89PI5Z$W713CHJ
M\IS/YY?AU#,VV[,=0'HB3R?'=<,^PZMG$W'Y;=#F6!L7=W$4Z;"I?)>L,$KU
MI2EU+?%!FI*CY!HZY"W6['@^+]DJ;XQCLX>?W59KP?%_EX64ONC<U(RC23I
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MC'[V>'D7MD_UK/\ R]KX&?2+^&/_ )66O\[B/QD:6C51Z$
M                                         -X>CINF*?=GIXW(>-AN
M[@YA2I4:6S0I^1B=O+BLN*6?*1S\J$A"31Q4;BDI_6F9C:_8EBH87M)P'2/9
MC<5Z'AE9N;*\,DDJ<+7!4\Y?Q7Y?=Q_8=FTK,=J>'N86[3379CB;49-4U[,9
MMNNC93>M(F"Z1K'GK[:AG<B.@W'<<M,2R'FTF9*-EC(Z^MEK(B(R44>':..J
M(S(B2@S^B1$?IOMTP,L9V<XJ['2\/>LW?!TBMOD5QOO)G@O^$S-;>6=M^6VK
MKI#&6,58KW78G<BNYM2M1BJ<+2U-M5G!X-/L"      !,1T3VK1PK[/]%;&3
MPC7<9O/,8:6XHD)M:U,>JR2,T@^*5OV%8J&\7#DF2(*S/C^IZ:_ARWEZ#'XS
M=6_+^KOQZ>TF]'20I&ZDN.<-F7!HM/7P>"/XW]QNLY7E?:'A(?UV&F\'B&EI
MZ*YM7,/)O@C"XKL>'XUZ.KA_?2PZ2G$N\ UJK8O!BWBN8'E+K;2B0FRKRD6N
M-2GUH0:%R)U>Y,8-2U$?(A-)+B7ZWM_$;NUT..P>]5B/]7>CU>ZTM&W"LK3;
MXY0<XZ>"VJ5X.O\ !!OSUC+<T[/,9/\ K</-8W#)O3T=S9MXB*3=5&%Q6IT2
M:VKTVZ<.,MHZ&] ]MNN^ZJ>A$?([2">EVE+CO-\\NTFNL)F3XJ%(4IUI-T]&
M<5P4D^;JI!&7#@8CG9Q3<_<;..T.[\7'7(=3P;X>DG3;E'1P2<):UHM7$3+M
MTE+M.[7-V>Q3#-RRFS<]HYDE6BMP3V(2==#=I7(JJ?QL3:?<(Q%K6ZM;CBU.
M..*4MQQ:C6M:UF:E+6I1FI2E*/B9GU3,:';;=7I;/8T8QA%0@DH)426A)+4D
MC\#@Y) .C-_*IH/L1S/^"QN/L(_YC8;\Q?\ [J1Y?_C _P"2>+_SV$_O3>[I
M:?Y'],_NDK^U>Z&X/XDO].Y=_G9?W4CS1_ W_KS./_:%_P"HM$"(\>'TW  V
M+VJZ-4FOFM6.Z99#:VM+5W-?D,MZPIBB'8-+IZ2;:,I:*<Q)C\EUV*25<4&?
M),^' Q->SW=?#;X[UX?=_&7+EFQ>C=;E"CDMBW*:IM)K2XT?<-4=M?:!F/9C
MV>8O?'*K%G$8W#W;$5"[M;#5V]"VZ[$HRT*3:H]>LEC]4MH_Z3-2?I,7^LH]
M'?\ 3;N[^\<;YMKT3P__ -<F_G[GRCEQ'Z4>J6T?])FI/TF+_64/^FW=W]XX
MWS;7HC_KDW\_<^4<N(_2D/6XC3.JT<UHSW3.DL+"UJ\3LHD&'86G8Q6$E$BH
MKK%:Y)1&6(_+2[,4DN2A)<DB_5ZH\R;Z9#8W8WHQF0X:<[EC#75%2E3::V8R
MJZ47#P'O7LIWPQN__9]EF^&8VK5C&XZS*<H6]K8BXW9PI':;E2D$]+>ELD3V
M0;%,7RS%(>N>NS#<O%YC#MIB.'/REQ*^550E.J<R;+'FG&G5USAQU*CQ.6AM
MQE/.O\MM9-GNSLF[(LOS3+8[W[X)/*VG.S9<MF,H1K6[>::>QH>S"JVDMJ58
MM)^4OXC?XE,YR/.[G9MV:2<,ZMR5O%8J,5*<;DTJ8?#)IKI%M)7+M'*,GL6]
MF<7):]ZP;\-4K//&TZ(W:M)]+\,GO1<$Q7$ZZMJJZ771EK9:L<AJT0S@6/A)
M!<X4%UI4.,E24I;-:5.KA6\O:[O#B,W7NI=>6;OX6;6'LV(QMP<4]$KL$MF;
MEKV))PC6B5:R>T]P_P"&C<O![LM]HV'6>;YYA:4L;B<3<N7;D;DDF[=BXY;=
MOHW\7IHR5VXTY.2BU".W6@G2H1YDF!CNX#'6*TG>1'\X.(QWU0VW#5R4O7^+
MFJ1)9:-'5<?@..^V_6Q229FG9FYO\0^W.&!WTL*,71=9LIT7=N6=.CA<K;[U
MOBT5VG?P5W+%J[FW9=BY76JRZCBI+::XK&)^+%NNB,+T8Z-=]M4>]NN&VW1C
M==A<:UDMU:K>QJ$3,,U1QM,5^Q99DQR=K7US(ZD(R&A5Q2HXKRS1R#5S2F7#
MY9;?WMW#W5[2,JCBWT?6[EK:L8NU1RHU\6K7Y6WJ^))Z%79<&ZGFGLX[7.T'
ML0WAG@K3O=0M7W#%Y=B')6VXRI<2C*KL7M:5R"K6FVKD5LNL?G^$7VFN:Y1@
M63LML7V)W4ZDLDL+-V,X_">4VF3$=4E"GH<QKDO,K-*36TM)\"X\!X&SC*L7
MD>:8C)\>E'&8:[*W.FE5BZ53X8O7%\*:9]BMV-X\LWNW>P6\^3R<LLQV'A>M
MU5))35=F2JZ3BZQFJNDDU5GIY7EV49U>S,HS*_M<GR*Q3&3.NKN:_86,I,**
MS!B)?E2%K=6F/#C-MH(S]JA!$*>89CC\VQ<L?F=Z[B,;.FU<N2<YRV4HJLFV
MW2*27$DD7&29%DV[66V\FW?PMC!Y5:<MBU9@H6X[<G.5(Q22VI2E)\;;9QP6
M1E25#H\--,?Q.MS_ '<ZEMMQ\/TOJK6%BJY"$*6_>(A)7=VD)EWD$[+AP9+<
M"%P,TO2YRTIX.-$9>@NQ7(\%EMG&]I>?)+*LMMSC:K3XUW9^/**>N48R5N'
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M/]78+_VV/]]>'\#G_+W-O_>7_P"FL$5(\\GM<
M                                W2V#_E"5WV*Y/^]F1M7L;_UK#_+W
M?@1Y[_B<_P"5EW_.X?\ &9.</71\W0
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M8P%FU8L>S;#V;<(PC5SO5=(I*KHM/<-UAM<\\
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M_P!+'9GZS-/G[?Z >L)UY[3P#X/67U_#ZZ]\?)P7S<OT@_Z6.S/UF:?/V_T
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MGGK?W^'??;<RS/,L#LYIDMM-RN6(M7816N5RPW*22UMVY75%*LG%&XPV@:"
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M?]+'9GZS-/G[?Z >L)UY[3P#X/67U_#ZZ]\?)P7S<OT@_P"ECLS]9FGS]O\
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MF:?/V_T ]83KSVG@'P>LOK^'UU[X^3@OFY?I!_TL=F?K,T^?M_H!ZPG7GM/
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MWQ\G!?-R_2#_ *6.S/UF:?/V_P! /6$Z\]IX!\'K+Z_A]=>^/DX+YN7Z0?\
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MTL=F?K,T^?M_H!ZPG7GM/ /@]9?7\/KKWQ\G!?-R_2#_ *6.S/UF:?/V_P!
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MXJ$[6)MR<90G%QE&2='&46DTT]#32:>L]D5"B
M
M
M
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MGAY%[9/]:S_R]KX&?2+^&/\ Y66O\[B/QD:6C51Z$
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M2//)[7
M -TM@_Y0E=]BN3_O9D;5[&_]:P_R]WX$>>_XG/\ E9=_SN'_ !F3G#UT?-T
M                                                 @)W>YW.U-UA
MRR]B(D2,1P^>QI[33DH<. 3]6F:]-2A_DI9<>L+5N:^@RZJHY(ZID23/QIVF
M9Q>S_>?$XRTI/+,+-8:$M.S6&TY:=3<I[<E_-IP)'T[["-VL-N?N%@<MON,<
M]Q]J6.NP;6W2YL*%8ZTH6W:@ZZ%/:U-M$B>PC4DLPT=5B,Q_G+?3BQ54FE2T
M*=706JY%A1/*(CY:4-+*3%01EP)$5/ S/CPW?V-Y[[3W8]F777$X&>QW>CG6
M5M^#XT%W((\I?Q-[HO(=_5GMB-,!FUKI="T*];4;=Y<56NCN/3KN/0M%=XQM
MP\X@                : ;_ /,LPPS#, E8?E>28I*F9/81YDG&[VTHGY;"
M*HW$,27JN5%<?90Y[8DJ,TDKJ\.(TQVSYIF>5Y5@KF68F_AKD\1)2=JY.VVM
MBM&X--JO SU!_"_N_D.\&\.:6<^P6$QMFW@X2C'$6;=Z,9.Y1N*N1DDVM%51
MTT&2ME&29%E>A59;Y1?7626SF19&PNTO[2=<6*V6)B$LLKFV+\B2IIE)\$I-
M7!)?0&>[*,=CLQW0MXG,+UV_B7?NK;N3E.5%+0MJ3;HN!5T$1_B'RC*LD[2K
MV R;"X?"8%82PU;LVX6K:;AI:A!1C5\+I5\)MJ-DFC2.WI'_ .2[!?L^+[7K
MD:0[=/\ 3V#_ ,Y_]*9ZL_A+_P!9YE_[7_\ 7M'+.CW_ )!97V?9#_!]",EV
M*_Z.E_G+GXMLPG\4W_,R'_M=C^\O&\PVZ>;@
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M-M.[-TEU>,E7H+3U*BT79I_'E5)N"BC4$:R-[@
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MS#).S7)(X+!QA=SJ[%=9Q-/CW9:]E5JXVHO1""HM&U*LVV\"B'&S
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MI/@^YBJ1@HQ22QP,&2P
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ME-255I3/F_*,HR<9)J2=&GK3/T.3@
M
M
M
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MI1DE*4IUGPHU*4H^!$DB+JF,]=_)2^]?P$-L?EH??+X3ND! #=
M                    !R_!?]I(?^*E_O9T9/*/UZ/>?P,P&\W[(N??1_&1
MGH3 UB:K#7ANT      "#'?Q^4)8_8KC'[V>'D7MD_UK/_+VO@9](OX8_P#E
M9:_SN(_&1I:-5'H0
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M_E"5WV*Y/^]F1M7L;_UK#_+W?@1Y[_B<_P"5EW_.X?\ &9.</71\W0
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MU'MBH4
M     TSWT:AR<'T0F55;(7'L\^M&,3)QI1)=;IW8\B??++B9&;4F#$[#<X$9
M\F7^I]$M6]KV=W,HW2EAK$G'$8VXK.C6H-.5SP.*V'W)GH#^&W=6SO'VC6\;
MBXJ6#RNS+$T>IW5*,+*[\9RZ6/=M> @K'D(^DP
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M8LUX+EY2=R:XI1MQV/O;K(AQYG/=@
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M"CNK;P>[F-WNO176\;?Z"VWK5FS1RH]:V[LFI+AZ*+(XQHT]9
M                                                        ;9[*
M]0W\$UWQF$M]2*C.C7AEHSRE<AQ^S-*J%TFR/D&^W?-1VR49<4M/.$7ZXQLC
MLJSN>3[X8>TW3#8S^HFN-S_)NG&KBBJ\"<N,T?\ Q"[JV]Y>S3&8B,4\?EM,
M7;?"HV_RRKKV79<Y-<,HP;U$]H]CGS)   "!_>]J')S;76\J4O+538"RQBE8
MP3BC:*6RA,N^E&U^L;DNVTA;"U%Q-;49OB?M2(O'O:UG=S-M[[V&3?5<$E9@
MJZ*KXUQTXW-N+XU"/$?2[^'/=6SN[V;8;'.*6/S23Q-QTT[+>S9C76XJU%32
MX)7)TUU>GXUD;X                                GMV5ZAR-0-"*!%
M@\;]KA<R5A,UY:E*<>8J68DFF<5R^*SY%%81FC5Q42UM*/CQXI+V/V4YW/.M
MS[*O.N(PDG8D^%J"3@_FY15>%I]Y?,G^(7=6UNOVEXIX6.S@LPMQQ<$M2=UR
MC=6C1IO0N2IHHI):J-[9C9!H\
M
M
M
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MO DW3P4)7E6'S?#MPS&["[:4?BTJY5KPMQ3>CC;9+&+ S(
M              <OP7_:2'_BI?[V=&3RC]>CWG\#,!O-^R+GWT?QD9Z$P-8F
MJPUX;M       @QW\?E"6/V*XQ^]GAY%[9/]:S_R]KX&?2+^&/\ Y66O\[B/
MQD:6C51Z$
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M[S;$W889NM(P<WUBY"K=(N:6'MK7"%F<5\61% /.Y[<
M                                              #=+8/^4)7?8KD_
M[V9&U>QO_6L/\O=^!'GO^)S_ )67?\[A_P 9DYP]='S=
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M@]=3;0;)-'
M          $7'27.22AZ-LI)?8BY.>N/F2#-!26FL/3%)3G#@E9M//<DN/MB
M(S_4ZGGOMZE/HLKBJ]$Y8AOOI6*:>\Y?R1[._A!A9=_/[DJ=.H8)+3IV6\5M
M:.*JA5\&CC(IAYT/;
M                           !/ULJ6M>V73-2U*69)S!!&I1J,D-Y]E+;
M:2,S,^2A"221?0(B(B'LSLI;>X. ;TO^N_\ 47CY@_Q#1C'MASA122KA7X7@
ML,WRO2^Z;3#89I<A?Z1I;AZTXFV:EFRC2^H6A!F?(2XYE>9I=4DOH$M:6D$K
M_D(AY7[<G+WJPT=.RLOARN]?K\"/H-_"=&"[/<=-)=(\YNIOAHL-A*>!5=.^
MR/\ &F#U
M                 %GW#W'WL2Q9V5RNRG<<I')/+03:^?7615/<ILDH)M7.
M&?%)$7 ^IP'T!RN4Y9;AY7/RCL6V^#3L*NCOGQOSZ%JWGF-A8IT,<7>4:.JV
M5<E33IKHX:Z3D8OC$@ 0 [T')+FY?4SLI!-K0]B[;:"7RTE&1A6-E%67!2R2
M;S')<474X*6?$B/B0\8]JDKDM_<?TBHT[27>Z"U3E5'WV?4#^'R%F'9!D_0N
ML7'$-NE/C/%W]I:EJ=8I\26EFKHU\;F
M                                      YUI>N2UJ7IV[#22YC>=8DN
M*E2C0E4E%_7J82I9*0:"-TBXGQ+A_A&7W?E<CGV!E:_*K&66N_TD:>,C>^<;
M,]S\VAB'2P\MQ2DZ5^*[$ZZ.'17069A[X/CZ   %:76%;[FK>J3DKE]DN:C9
MNN1SB>0OGUY-9J=Y:.">0OG#/B7 N!CP9O.YRWES"5RO2/'7Z]_I9U\9]>MP
MHVX;BY+"S3H5E.#4::518>W2CX50QR,&2P
M     "7/HV')1XCJ>TM)%"1D="Y'7RO;*E.UDQ,Q)IYP^!(9:8,CY)<>4?5/
MAP3Z6[")7/9F81?Y)7[;7?<);7B4>#EX/"W\7,;*SW)IQ?\ YAX2\I+^:KD=
MG@X6Y\+U:E73):-\GD(
M
M                           (\>D.W,;R=L."8=F&T'8[9;WILVPR%&HF
M-4FI]5I_=X32UE=#EU%I5U,FFR"\S>1=25R&"AUD-Z0VIDO:F:TD=[@[&&ON
M4<1<Z-JE.[KKI>C1H,3FN+S#"1A+ V>F3KM:VU2E-"TZ=/(57\O^>*:R:?9/
M>X1GO1FL81F>+6<JER;$<OUZRG&LGQVY@N&S-J;V@N=!H5K46<-U)I=8D--N
MMJ+@I)&,PLCL-55R33[Q%WO=C8MQE9MJ2^^YS=S:GT^W2>;W<<7F>V#H4KK4
MW"$V4BG;SKY3,/"\%EVD-PF9\"NS34+2W$\7M)5:Z9(E(C2W3BJ,B=Y!F*-[
M*\#8T7K^RZ5IHKR:RZPV\&<8M;6&PJG&M*I2I7BK6GC+:0P!-"N9TCW2_=(=
ML$SO5&='Z);*]7-L&#SS71;E<?UCD3,?M,78Q^)=6.69A083IKG<W3&FK)"I
M,=Z1=.18Z51R-3B3<0D9G"Y?@\3"-+W]:UICHK7A5'I9%,QSK-L#>FGAD\-&
M6B=)--<#;3HJ_:(:8GSSG4&?*C08/1VX[-G39#,2'#B;D+N3*ERI+B68\:-'
M9T.6\_(?>62$(01J4HR(B,S%[["L^LER(Q?O?B_56_PN<L>]'7OGZ1;=IFZ?
ME-=%[D6S'12;I]/RBFU.S#6:KN<DG924['D46'3-([G%,-U#I7+>ILIDI<F7
M":3$5!YIU*5N)(L9C,+@[$*VKNW=KJT/X#/Y7F.:XR\EB<-T>&<6]K2N]\K7
M7N=\F,&,)
M
M                                             <OP7_:2'_BI?[V=
M&3RC]>CWG\#,!O-^R+GWT?QD9Z$P-8FJPUX;M       @QW\?E"6/V*XQ^]G
MAY%[9/\ 6L_\O:^!GTB_AC_Y66O\[B/QD:6C51Z$
M
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MI+0M!N3(LDRW=O)<+D&46U:RS!V(6;45P0MQ457563I64M<I-R>ELXX+(RH
M
M  ;I;!_RA*[[%<G_ 'LR-J]C?^M8?Y>[\"//?\3G_*R[_G</^,R<X>NCYN@
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M!V.@
M   !HKT@.#/Y-HS$R>$V;DK LABV<DDHY:_ MN@Z>PY)%[8N;FOQ'5'U2)MM
M1F7 N):A[:,HGC]UHYA:5;F#OJ;_ #<_B2Y).#?<3/2?\+V\EO)^T">3XATL
MYGA96XZ:+IK3Z6'+!78I<,I)+B<)(\G'T3
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MW?S7=*_)*[<4,5:7'L_U=[ONCLM)::*3U)D4H\YGMD
M                                                #GFE^%2]1=0\
M.PB$VMQS([^OKWS;Y7&/7&\3UM-4:2-1-5]6T\^LRXF2&S,AF-W\JNYYG>%R
MFTFY7[T8NG!&M9R[T8*4GW$1K?+>&QNGNKF&\>(:4,)A9SC7[JY2EJ'?G<<(
M+NR19A;;0TA#32$-MMH2VVVVDD(;0@B2A"$)(DI0E)<"(NH1#WLDHI1BDHI:
M$?("4I3DYS;<VZMO2VWK;?&?L<G4 "%[I#,&D4FK%-F[3"_!F;X[&9=D\"Y)
MWN-\*Z6P9I+VO"G7 4GE'Q49JX=1(\K=MF43PF\EK-HI]7Q=A)O_ +RU\62\
MSHVN/3Q'T&_A6WDM9CN1B-W)R77,NQ<FH_\ <W_ZR,OG5>3IJ^+76: #3)Z@
M
M       V5VBX-(SO7W XZ6%NP,:L4YI;.D1&W&BXRM$^&IXC(R-N3=E$C\/U
M3>_P<1/.S3*)YQOE@X)-V</<Z>;XE:^-&O<=S8C_ $C4/;KO):W:[,<SNRDE
MB<9:ZI:7#*6(3A-+NQL]+/\ HE@L>TSY;@  ! #O'P:1A&O^:\I@VJ_+9+>:
MU3O)Y*9+=^2GK1PN!$GE-Y U,0?T3/D\3^B/&/:AE$\IWSQ=52SB9*_!\:N:
M9OYQ37@KPGU [ MY+6\?9?EU);6*P,'A+B\EV-%M>&P[37?IP&KHU\;F
M                            G0V(8-(Q#0J':SF%L3<ZO+#*DI=(DNIJ
ME,Q:FH+@1%^P2(U8<IOCQ,T2>/'@9$7KOL?RB>6;H1Q-Y4NXR]*]IU[%%"'@
M:AMKN3/FW_$MO):S[M*N8+#24L/EN&AAM&KI*RNW?#&5SHY=VW3@J]T!M0\^
M@
M
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MD"V,@
M
M     <OP7_:2'_BI?[V=&3RC]>CWG\#,!O-^R+GWT?QD9Z$P-8FJPUX;M
M    @QW\?E"6/V*XQ^]GAY%[9/\ 6L_\O:^!GTB_AC_Y66O\[B/QD:6C51Z$
M
M
M                                             -TM@_Y0E=]BN3_O
M9D;5[&_]:P_R]WX$>>_XG/\ E9=_SN'_ !F3G#UT?-T
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MCIE>7*>*OZ:N5^_*<K:GQRA;G)JM7L78).B-\QN(\S
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MA.E-N">EVKC3<):::82>U%FO@A1M(
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MH^J^Y&^F2[^[OV=X,DFG:FJ7+;:V[-Q);5JXEJE&NAZI1:G&L9)F-A@B6@
M
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M]3<BSW*=Y<ILYWDEZ&(RS$0VH3CXTUKC*+K&49)2C)--)HXV+$RP
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ME)U<I2;E*3?"VVVWQGMBH4
M
M                      #B^<9EC^G6%9?J#ELY-9BN"8OD&99-9++E(K\?
MQBIEW=S.67$N*8E;!<<,N)=1([0A*Y-6X_*DTEWWH*=Z[&Q9G?G\B$7)]Y*K
M.M'P?=WD7S@GIA]!]'-Y>:9_BFSK--1\\5IKM\PB_734.*4^*:=9WD>"4MA(
MC+6U)S?,7Z5B#?9(33MBYX0DL0%5\5<=,.7NRLNP4I8=)W8QJV^'C;[VEI5-
M91Q,\[S6$,;*4;$YT27W*X$N#2Z)RIW2^7BW1$=%MA^+0<.J>CXV@2ZFO@)K
M8\O*= ].<YRER.EA,8G)V<YK09!FUG/YM/$Y4FP=E&YQ6;G+,U",RQ^,E+;=
MV=>XZ+D5%XB?0R;*K=OHHV+>R^-5?G.LO&4D/G''12:==&7J3H3O!V1JR/1C
M -3LUMZ>;C>+Y9>PG]']:**.C+L<N],+T[%648_59/61["0S%9EFBEEU:BBJ
M:CO,1X\BRO&SQEN5N]1W(\/&GQKX? 0C>#*K>67X7<+56;E:*NF+5-3UTTJF
MEO7W"SE\W0Z4?.^DCVDY;4:YV<6\W&;:,CH<*U#R:.Q&AOY]A^65MA/TVU"M
MX$*/%@P,@N/)^WK9R6$$U(DTZI9$@Y)M-8?-L)##7E.UHMSKHXFM=.YI7_P)
M/NWF=W'X:5O$.MZTTMKC3K2O=T--\.AO34L)#%$C.L<^=G_VKQ?U9M'/X4SP
M3#*/U&/??PLUAO+^V+GWL?Q479>@-_L?=BOW*;7^</-!@,U_7[G]'\5$TW<_
M8UG^G^/(E^&.,V !TS71=_VF71V?UZMH_P#/_I^)WC/U2[^;E^*S4&6?M+#_
M )^W^,CN91!#;X   1L=+5OXC]&UL:U8W-1*:!DN=P/!.#:1XU;*<347.J6:
MR'*[&EW:&)$25*H<=9;DW%A&9>8?EP:UUAIUIQQ+J+S 87K>(5IZ()5?>7/H
M7C,5G.8/+<#*_!5NM[,>+:==+[R3?=I3NE.CH MO>E730[KMV.Y#I-<@S3=1
MJYI#7:2VN&8?GM[,9T^GUN9VVI+ED[845*_7LNXWAUC11&J[&XZ86.QTV+W.
M1)1.\EC/YE>N8&Q"&$2C!MJM-7>[^FK^R0[(<+8S;&7)YC*5RY&*=&W\:KHV
MWKT:*)4U\2H7'L[Z'OHL]1,,ML$O.C^VF5=/<5[E;)LL$T/P'3/,XS+D=<;G
MZG4'3NEQ?.J:P0A?*3)BV+,@G")?+Y1$8P$,?C(3VU<FWW75<CT$SNY+E=VU
MT3L6TN.*49><J-^%NO#4ZZK>I@&O?S?GI5,JJ-I>K.58W H8V-ZB:3W%C.;G
MMYUHWFS:Y2,$U8H6$Q*;,JFONZRPIYC,EA"9+E<W/83&?-A;,JL3MYA@U*[%
M-26E=U:-'%QKA1KK%VK^2YG*&'FU.VZQEQIJJKP/0Z-4H]/ =EYL,W8XYOFV
M>Z ;KL7@-4\+67 HE[:T+$E4YC&LRJ9T_%M0<58G.-LN3V,6SRALJY#ZD-J>
M3&)9I2:N241Q5CJV(E8K51>CO/2O$S9>78OK^"MXNE'-:5W4VG3N53IW#6+I
MB.DPQ?HN=GN1ZUKA5V2ZOYA//3K;_@MF4I==D6I=G73)K5MD3<!3<M.&8150
MWK2SX.QNRB8:@(D,2)S#A5LOP;QE_9>BU'3)]SB[[YV6F=9G'+,)MQTXB>B"
M[O"WW(^-T7#54\NA/V):C].;NIU7WW])'FV8ZXZ3Z0WE51/5F16APJO5/5"4
MP5_!TUB5])V!"Q/2K3NAEL6%A35+-9%=79P6&DFP[-0,]C\5'+K$;.&2C-ZN
MXN%]U]_6ZMU(?DV GG>,GB<=*4[4:.3;TR;U1KP*FNFI42I6JOF.[+]H#VG!
MZ/N;6=N_FJ.I71%ITC1G3MO#&ZA:EN*@,XZWCR*MECGG#<+D-I,G3YPC)?MA
M&^MXK:V^DGM??,G7LS+G;Z+H+6Q2GR5\-*U[M:UTZRA-TS6R+4SH'=W^D^^#
MHY<TR_1[2'6&UN:^NJ*JRD6%/ISJ!7&U=WFD-W$LG94?+]*LYI6^SZRLMDS4
MI[!F,KZD2*X<EP&)CF.'E:Q*3G'7W5P/N/O:GI5*D$SC 7,DQL,1@92A:G5Q
M==,6M<:\*TJE=:='6C;N7=$7TE.']*+M#QW7FKJXN)ZD8[:.Z>:Y8%%6ZJ'B
MNIM16UMA/>H52GY$R1AV3UMI'L:MQQ;BVV7U177%R(KYB/X_!O!W]A:;;TQ?
M<XGW5S/A)GDV9K,\)TDJ*_%TFN[P-=Q_#5<%3[?2U;^(_1M;&M6-S42F@9+G
M<#P3@VD>-6RG$U%SJEFLARNQI=VAB1$E2J''66Y-Q81F7F'Y<&M=8:=:<<2Z
MCC 87K>(5IZ()5?>7/H7C.<YS!Y;@97X*MUO9CQ;3KI?>2;[M*=TIT= %M[T
MJZ:'==NQW(=)KD&:;J-7-(:[26UPS#\]O9C.GT^MS.VU)<LG;"BI7Z]EW&\.
ML:*(U78W'3"QV.FQ>YR)*)WDL9_,KUS V(0PB48-M5IJ[W?TU?V2'9#A;&;8
MRY/,92N7(Q3HV_C5=&V]>C11*FOB5"X]G?0]]%GJ)AEM@EYT?VTRKI[BO<K9
M-E@FA^ Z9YG&9<CKC<_4Z@Z=TN+YU36"$+Y29,6Q9D$X1+Y?*(C& AC\9">V
MKDV^ZZKD>@F=W)<KNVNB=BVEQQ2C+SE1OPMUX:G75;U, U[^;\]*IE51M+U9
MRK&X%#&QO432>XL9S<]O.M&\V;7*1@FK%"PF)39E4U]W66%/,9DL(3)<KFY[
M"8SYL+9E5B=O,,&I78IJ2TKNK1HXN-<*-=8NU?R7,Y0P\VIVW6,N--55>!Z'
M1JE'IX#LO-AF[''-\VSW0#==B\!JGA:RX%$O;6A8DJG,8UF53.GXMJ#BK$YQ
MMER>QBV>4-E7(?4AM3R8Q+-*35R2B.*L=6Q$K%:J+T=YZ5XF;+R[%]?P5O%T
MHYK2NZFTZ=RJ=.X;<BW+T "A#\X[Z5O4W<ZQKMLGV6(M;O;5M@A8_?;[=;<2
MFM.45Y=6>H>+:=8SI@W=QY#<0\)HM2,GKX<]IEQ^7>7A*0AEN!3RWI4GRO Q
MPZ5^_HOS^2GK6AOE:KWEX37V\&;3QLIX/"5>$MZ9M:I.J6OR5)I+@;H^(]WY
MEW_MOTA/V*[:?X7UO'&>_D;?WS^ [;H?K=W\W_M(OHB,D_
M
M   U(W![]MEFU&^JL5W(;H=$M&<JO('A:KQ;.\_H:;)I50;BV6[<L>=EJN&J
ME]]I;;4IQE+#KC:TH6I2%$5S9P>)Q"VK,&X\>I<K+#%9G@,'/H\3=C&YQ:6_
M"E5KN5U\!G+2C5_2K7;!:74[174C!]6-.LB0^JDS?3O**;,,7LU17EQ9K$6Z
MHIDZ N77RVELR6>63T=]"FW$H6E22HW+5RU+8NQ<9\3+FQB+&)MJ[AYQG;?"
MG7P/B?&GI7"9%'0K                                      !R_!?]
MI(?^*E_O9T9/*/UZ/>?P,P&\W[(N??1_&1GH3 UB:K#7ANT      "#'?Q^4
M)8_8KC'[V>'D7MD_UK/_ "]KX&?2+^&/_E9:_P [B/QD:6C51Z$
M
M
M                                    -U-@J%JW!P%)2I1-XGDRW#2D
MS)"#8C-DI9D7!*36M*>)]3B9%^J-J]C2;WU@UJ6&N_ CSU_$[**[++J;2;QV
M'2[KK)Z/ F^\B<P>NCYO
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M+\KC7!%-_%@NY""C"/<BJG,!DS @
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M=6SSCN4@   QOJ?I-@NL&/+QO.:9NRBI-QROG-&4>WI93B"2<VHL$I4[$?\
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M.R3]]6?FL1^A'R0-R'HNM??;&OKT'U9;]?N^YY]K](/KX[)/WU9^:Q'Z$?)
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M]Z=^,//*,IA[+W?FFIPA-RO7HO7&Y=I&D'PV[<8IIN,Y7(FZ0VJ>>P
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M6VSQUG6>9OO'F5W.,\Q%S%9E>=97)NK?$DM"C%+1&$4HQ5%%)*AR(7QB@
M
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M54WI:6G0N#06*!B"2G5S_.GM8\2U8Z6;-*7$[*/:^9'1O2W1S)I40D+B-Y;
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M8;H?K=W\W_M(OHB,D_
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M4Y2MW%%+2]E\Q2CF.7SDH0OV7-NB2G%MMZDE72V;FB@7@
M           '+\%_VDA_XJ7^]G1D\H_7H]Y_ S ;S?LBY]]'\9&>A,#6)JL-
M>&[0      (<^D:Q.1 U(PS,D-**!D>)JIE.$GBGPICEE)>?)2RZB5+@74<D
MD?5/FU<./ ^'E_MRRV=G/<+FB7]3?PVQ7^?:DV_P;D:=YGOG^$W/+6)W2S#(
M)/\ \UA,=TJ7_=W[<4J+N3LSJ_YRKW8ZQI ]6@
M
M
M                      $C71Q8I(FZA9QF:VE]@T&*-4*'#Y24'99%:19;
M?(41DEU;,*A>)2?;$DG4F9$9I,;R[#,NG=SO%YJT^ALX96Z_SKLTUWZ1MRKQ
M57</)W\6>=VL/NKEN[\6NLXK'.\UP]'8MRBZ\2<[T:/179:6IDPP].G@H
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MHE.XC>,;</.(
M
M
M
M
M
M
M                                             >)]]B*P])DO-1HT
M9IQ^1(?<0RPPPR@W'7GG7#2VTTTVDU*4HR))%Q/J DVZ+6<2DHIRDTHI5;?
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M_8KMI_A?6\97/?R-O[Y_ 1O=#];N_F_]I%]$1DGX
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M88"Y"[@K]N,[<XNL90DJQDGQ-.I\\42Z
M
M
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MCM[K;MJX539!9,,OE(:HK/('Y%(2D+2MMMUIMEBPE,(4GJMO27$+(S)9*2?
M:WP_8_N58Q:Q3M7IP3JK<[C=ON522DUW')IZG5&\,9_$MVIXO+G@%B,+9N2C
MLN];L1C>HTTVFVX1;K\J-N+3HXM/2;@1(D6!%CPH,:/#AQ&6HT6)$9;CQ8T=
ME!-LL1V&4H:99:;224I21)21<"+@-G6[=NS;C:LQC"U%)**2226A)):$EP)&
MAK]^]B;T\1B9RN8B<G*4I-RE*3=7*4G5MMZ6VZMZSV!W*0
M
M
M
M
M
M
M
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MR<E)5TD^R/-;N:V[D[L8Q<)):*\*[I,*,>9P
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MC 3:E-N.B+;H3*S&<+,87'6:BDWQM+2]/&?4'4J
M  !R_!?]I(?^*E_O9T9/*/UZ/>?P,P&\W[(N??1_&1GH3 UB:K#7ANT
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MB'7+-VR]F]&4)<337PFS+&)PV*CMX:Y"Y#CC)26GNIL]44RL
M
M
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M1TE)*9M>-CFD0
M
M
M
M
M
M
M
M
M                PQN,T,Q+<YH)K'MVSVQR*HPG6[3?+]+\KM,0EUD#*:^@
MS6DF4-K,QZ;<U%_4Q+B/#FK5'<DP9;"'2(UM+3Q2=6S=E8NQO0HY1==.HM\7
MAK>,P\\-=;5N:HZ4KKKHJFO$5J/[GAT9OIRWU??,T _^=C&4]N8OR;?)+TB/
M>Z.6^7?Y8^@/[GAT9OIRWU??,T _^=C#VYB_)M\DO2'NCEOEW^6/H#^YX=&;
MZ<M]7WS- /\ YV,/;F+\FWR2](>Z.6^7?Y8^@;8;'OFVFQK8)NBTPW:Z.ZJ[
MK\DU'TG\M?)VEU+SG2"XPF;Y=Z>9;II;^&JW%M"L-O9/8U%F4IV-S%E&Y$MM
MI2^<;2MI='$9KB,39=FY&"A*FI.NAI\;XBZP6[N"P&)CB[,KKN0K1-QII36F
MD4]3XR0W?WT>&"=(1C. XKG6OFZ?0B%@%CDD]F7M>U3I],++*V<HKZ^NGU&:
MR+C"<T:O*5AJN2IB.3;))<6LU&LC(BH83&W,'M='&#VJ:TWJKJHUQEYF656,
MS4%?E<BH5ILM*NU2M:I\6CPD)#_S/?HU)3[TJ5KQOODR9+KC\B0_JAH&\^^^
M\LW'GGGG-LJG'777%&I2E&9J,^)]47OMS%^3;Y)>D8GW1RWR[_+'T#EV"_--
M]B.EUUY2:9[KND=T[R+L=V)X?P7771S$;KL20DT/Q?"E!MRKYW8[R#X+1SG)
M474,@>=XIZ'&W3O/TCE;I9<G57+Z?WT?0+10PQ*"!;>=\WPVR[Z]6=0]5=:=
MU6_V+%U&OX>1S-)<1URT_8T6QF?!K*VL9;P[ \KT6R]NFC<*Q#YDJ0^OLE:U
MDHN)$64LYMB+%M6X1MTBJ:G7PZ2/8G=K!8N_*_=N7MJ<FZ*4:)OBK%FE7]SP
MZ,WTY;ZOOF: ?_.QBK[<Q?DV^27I%O[HY;Y=_ECZ!)1T='0C[>>C)U%L<^T(
MW![R,QKK+#\@Q!S2O6#5?!\AT@CGD=OCUS-RB)@^':48"PSF#+^.-M,S3>5R
M67WTJ0HUDI-MBLRO8NWT=R,$JUJDZ^-LOL!D.$RZ^L18G><J-4;5-/&E%?"3
M+#'F;  CHZ2KHR-!NE-TAPC1;<%ENKN'XM@6I$75"GGZ.7V&X_?R;^)C&2XF
MW#LI6;8#J%7/4ZJ[*9"U-M167S?0V9.DDE(7=X3&7<')RM*+<E337[#1C<RR
MK#YI&$,1*:4&VMEI:^.J9"Q_<\.C-].6^K[YF@'_ ,[&+[VYB_)M\DO2,1[H
MY;Y=_ECZ _N>'1F^G+?5]\S0#_YV,/;F+\FWR2](>Z.6^7?Y8^@/[GAT9OIR
MWU??,T _^=C#VYB_)M\DO2'NCEOEW^6/H$K_ $8/0[[9NB<\^'R=<YUUS3S^
M^;3RQ\]638!D7@WS6>7_ )/^37D-ICISV'V9YQYW9G979G.<TQS?,\ESG;+%
MXZ[C=GI5%;-:4KPTXV^(RN691ALJV^KRG+I*5VFG\FM*4BN-DKXLS*$"6];Y
MNKL*W<:D>??#4ZA;1]P)WR<KDZG[;+F#BC5SE3<E4YG);G#YU?/HXN0MV:NR
MU6-)X%LI$LN=?DNKZHRN'S?$V8[%RER'=U\O.F1S&[LX'%3=VPW9NMU^+IC7
MCV>#P-+N'#'^B:Z5Z1CZL =^<":Z^;E;2Z94=&TK3YG54\4<=6TN)Y\6=7V\
M]\KO!BS;*^Y?912>#Y((R)LNWM#![6UU6%>_]C9H='D>9N.P\PN[/WK^'I*F
M1=COS>;83LSU&\^UY#SK=7N(+)9691-7MR=O79E*HLLEV+%PO)\=Q2)65V-M
MY4BZCE/;N[-JUO8\]QQYB:T:B2GIB<VQ-^/1PI"WW-?+S4*N!W;P.$FKUUN]
M>7E?)KQ[/'WV^,G;&+)"1T=)5T9&@W2FZ0X1HMN"RW5W#\6P+4B+JA3S]'+[
M#<?OY-_$QC)<3;AV4K-L!U"KGJ=5=E,A:FVHK+YOH;,G222D+N\)C+N#DY6E
M%N2IIK]AHQN995A\TC"&(E-*#;6RTM?'5,A8_N>'1F^G+?5]\S0#_P"=C%][
M<Q?DV^27I&(]T<M\N_RQ] ?W/#HS?3EOJ^^9H!_\[&'MS%^3;Y)>D/='+?+O
M\L?0']SPZ,WTY;ZOOF: ?_.QA[<Q?DV^27I#W1RWR[_+'T"5_HP>AWVS=$YY
M\/DZYSKKFGG]\VGECYZLFP#(O!OFL\O_ "?\FO(;3'3GL/LSSCSNS.RNS.<Y
MICF^9Y+G.V6+QUW&[/2J*V:TI7AIQM\1E<LRC#95M]7E.724KM-/Y-:4I%<;
M)7Q9F4  @K^<K_V)^]+_ +N7_BST(&1RK]?M_P!+\5F$WC_8U[^A^/$@"^9=
M_P"V_2$_8KMI_A?6\97/?R-O[Y_ 1O=#];N_F_\ :1?1$9)^
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MT>\_@9@-YOV1<^^C^,C/0F!K$U6&O#=H
M
M
M
M
M
M
M
M
M
M
M
M
M                       $+?SAK3S/]5>A[W>X#I?@^8:D9U?>8'P'A> X
MS=9AEESX+W0Z*7-GX)QS'H5C<6/@ZGKI$M_F65\S&8<=7P0A2BR&5M1Q]MR:
M2^-^*S"[PQE+)[T8IM_$U??Q(-OFB.W3<'H1F.^U_7#0G631IC)L9V\LXV]J
MMIAFVG;60.U-IK&NT:I',OHZ=%JY6HL(YR$L&X;)/MFOART\<GG<X2M046F]
MIZGW".[I6[D,7=<XR2Z-:TUPHNVB.$\
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M^P50NB[_ +3+H[/Z]6T?^?\ T_&:QGZI=_-R_%9%LL_:6'_/V_QD=S*((;?
M                          Y?@O\ M)#_ ,5+_>SHR>4?KT>\_@9@-YOV
M1<^^C^,C/0F!K$U6&O#=H
M
M
M
M
M
M
M
M
M
M
M
M
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MTSCR1H,<UQQ2-/8>O,!UBIZB'%S:CNZ_BB=#C3;9"YU6^\TT4^JE1Y*"Y+G
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M)B%%D5_N:R/3V]M*B)86> Y/H#N#LLEQF>_'2[(H;2QPC3#+<+F6$)XS:4[
MM9<-:BXH>4D^(B,\HQT9[,8J4>.JIXW7Q&RK>\V4SM*<YRA<IIBXR;KQ52:[
MVGD)U<&S+']1L*P_4+$I;EABN=XMC^98S/=BR8+LW'\HJ8EW32W(4UIB9#<D
MUTYM9M.H0ZV:N2I)*(R&.N0E;F[<OE1;3[ZT&<LW87[,+]OY$XJ2[S54<I'4
MJ                       !R_!?]I(?^*E_O9T9/*/UZ/>?P,P&\W[(N??
M1_&1GH3 UB:K#7ANT
M
M
M
M
M
M
M
M
M
M
M
M
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M,P&\W[(N??1_&1GH3 UB:K#7ANT
M
M
M
M
M
M
M
M
M
M
M
M
M
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M5%ZY-:JK@7&GI>JE'4OCB,D_
M                          Y?@O\ M)#_ ,5+_>SHR>4?KT>\_@9@-YOV
M1<^^C^,C/0F!K$U6&O#=H
M
M
M
M
M
M
M
M
M
M
M
M
M
M       '$,KT^P'/&.Q<XPC$,SB\R[&[&RO&J;(F.QWT.-O1^9MX4QOF7FWE
MI4CAR5)69&7 S%2%V[;_ "<I1[S:^ HW<-A[[K>MPFZ4^-%/1X48:^1EL^_-
M1VU_>+TO^*PJ=<Q?K;GG2YRA[,RWZ/8^;CS&<\<Q+%,/AG78EC./8M7J-*E0
M,<I:VDAFI/*Y*CBUD:*P9IY9\#Y/4XG_ (12G<N7'6Y)R?==2XM6+-E-681@
MGKV4E\!R$="J
M               '+\%_VDA_XJ7^]G1D\H_7H]Y_ S ;S?LBY]]'\9&>A,#6
M)JL->&[0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M    .7X+_M)#_P 5+_>SHR>4?KT>\_@9@-YOV1<^^C^,C/0F!K$U6&O#=H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MJ.%OJ\IN32>BE-:IQECF6\<\QPDL+*THJ33KM5U.NJB.<C+$:
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MH9H29=0E*(SZ@!.I)\.#L4#1R4P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                       )&^BC_+9TX_U!J']H]X!RM9;7'!W*!HY*8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                     $C?11_E
MLZ<?Z@U#^T>\ Y6LMKC@[E T<E,
M
M
M
M
M
M                                                          #-
MU9MEW(73*I-/M^UMM8R'CCKDUVE.=S8Z'TH;<4RM^/0N-(=2VZE1I,R,DJ(S
MZAD%3G9:T-'-8NR3=S,-9-;==64&@B-796'VD$C(S,BY"IK,=+A]3JDGB9?J
MA5'.PWQ<J-=<BQV\Q&^N<6R:JFT>18]9S::[I[%E4>=66E?(7%FPI3*_;-O1
MWVU),OH=3J<2 ZM4T'Q@
M
M
M
M
M
M
M
M                                       2-]%'^6SIQ_J#4/[1[P#E
M:RVN.#N4#1R4P
M
M
M
M
M
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M2FGG$./H7SJ&T*(^#NG71PEAD#DI3;SORL]QOW9,^^V*<.4=):S68#@
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MSC#39+-')PX\1%@!T
M
M
M
M
M
M
M
M  )&^BC_ "V=./\ 4&H?VCW@'*UEM<<'<H&CDI@
M
M
M
M
M
M                                                     %@#HCMG
M5/)JT[I]1:ANPF.3Y=?H]5V,<EQ:\JR0J+:Y_P P\V:'['PBTN'6+X\(QL/O
M$E3BH[C7#.\="KPLETW2:R-Z : :H:L%S2K'%\;>+'F7DH6U(RJYD1Z+%FGF
MEF7/1O#]G'4^DN)\PE9\.H!R4G[R[M\EN;;(L@LIEQ>WMC,M[BVL'UR9UE9V
M,AR7.G3)#AFMZ3*DNJ6M1GQ-1F.2FW72SY8 M%]$5N!MM5="[S3/*+%^SR'1
M6RK:NMF3'S>EOX)D+$Q[&8SCCO%Y[P)+JIL-!\3)J(W';ZA$7'@J)U5>$S_O
MRV@46ZK2B>FNKXK&KN&0)UEIO??L;#\F2A'9,C#K*2I3:%TV1*9)M)NGR8DH
MT/I,B)U+@:]#*?<F-(A29$.8P[%EQ'W8TJ-(;4T_'D,.*:?8>:625M.LNH-*
MDF1&DR,C')3>C0]99&Z$S^1+5_[J<7[4J<<<)47R/"_L&U/2B?D+:Y?^K/\
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MK)49KZ!U
M
M
M
M
M
M
M                                                   "1OHH_P M
MG3C_ %!J']H]X!RM9;7'!W*!HY*8
M
M
M
M
M
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MTEIDWW3$H'4
M
M
M
M
M
M                                                    "1OHH_RV
M=./]0:A_:/> <K66UQP=R@:.2F
M
M
M
M
M
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M:@9ME6;SZ^$IU<*!-RN]GWTJ%$6^I;ZHL5^>I#9K,UFA)<3,P.CUG"@
M
M
M
M
M
M
M                                     $C?11_ELZ<?Z@U#^T>\ Y6L
MMKC@[E T<E,
M
M
M
M
M
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MZ*'D;+BYE-',CXE @7,64F(DR)3<3FD&:C2:U<HZR5-/&:2 =0
M
M
M
M
M
M
M                               )&^BC_+9TX_U!J']H]X!RM9;7'!W*
M!HY*8
M
M
M
M
M
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M2B,BY1TD]-.(TR Z@
M
M
M
M
M
M                                                          2-
M]%'^6SIQ_J#4/[1[P#E:RVN.#N4#1R4P
M
M
M
M
M
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M.25(/AP,N!<%#AR;T+0C58#J
M
M
M
M
M
M
M       $C?11_ELZ<?Z@U#^T>\ Y6LMKC@[E T<E,
M
M
M
M
M
M
M
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MB?5')3UZ7K/$
M
M
M
M
M
M
M                               "1OHH_P MG3C_ %!J']H]X!RM9;7'
M!W*!HY*8
M
M
M
M
M
M
M                                    ?3J[JYI'E2*6VLZB0M/(6_5S
MY5>\M/5+DJ=B.M+4G@H^H9\.J!RFUJ9S].N6M:4DE.L&J24I(DI2G4#+"2E)
M%P(B(K?@1$041SMSXWRG"[S*LHR=WLC)<DOLA?YQ3O/7EQ86SO.K-1K<YR?(
MD+YQ9K/B?'B?$P.')O6V?! X
M
M
M
M
M
M
M                                              D;Z*/\MG3C_4&H
M?VCW@'*UEM<<'<H&CDI@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                2-]%'^6SIQ_J#4/[1[P#E:RVN.#N4#1R4P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                              )&^BC_ "V=./\
M4&H?VCW@'*UEM<<'<KS>H^RK\XC'_O<V/QO'-3KLCU'V5?G$8_\ >YL?C>%1
MLCU'V5?G$8_][FQ^-X5&R/4?95^<1C_WN;'XWA4;(]1]E7YQ&/\ WN;'XWA4
M;(]1]E7YQ&/_ 'N;'XWA4;(]1]E7YQ&/_>YL?C>%1LCU'V5?G$8_][FQ^-X5
M&R/4?95^<1C_ -[FQ^-X5&R/4?95^<1C_P![FQ^-X5&R/4?95^<1C_WN;'XW
MA4;(]1]E7YQ&/_>YL?C>%1LCU'V5?G$8_P#>YL?C>%1LCU'V5?G$8_\ >YL?
MC>%1LCU'V5?G$8_][FQ^-X5&R/4?95^<1C_WN;'XWA4;(]1]E7YQ&/\ WN;'
MXWA4;(]1]E7YQ&/_ 'N;'XWA4;(]1]E7YQ&/_>YL?C>%1LCU'V5?G$8_][FQ
M^-X5&R/4?95^<1C_ -[FQ^-X5&R/4?95^<1C_P![FQ^-X5&R/4?95^<1C_WN
M;'XWA4;(]1]E7YQ&/_>YL?C>%1LCU'V5?G$8_P#>YL?C>%1LCU'V5?G$8_\
M>YL?C>%1LCU'V5?G$8_][FQ^-X5&R/4?95^<1C_WN;'XWA4;(]1]E7YQ&/\
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M;'XWA4;(]1]E7YQ&/_>YL?C>%1LCU'V5?G$8_P#>YL?C>%1LCU'V5?G$8_\
M>YL?C>%1LCU'V5?G$8_][FQ^-X5&R/4?95^<1C_WN;'XWA4;(]1]E7YQ&/\
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M;'XWA4;(]1]E7YQ&/_>YL?C>%1LCU'V5?G$8_P#>YL?C>%1LCU'V5?G$8_\
M>YL?C>%1LCU'V5?G$8_][FQ^-X5&R/4?95^<1C_WN;'XWA4;(]1]E7YQ&/\
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MD;2N42>'4X\0"5"8(<'8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M5')P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M!M*,>9DUDG?Z;,_ZU(_RJQ?K4N\8>7RGWSU1R<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                   ;2C'F9-9)W^FS/^M2/\JL7ZU+
MO&'E\I]\]4<G
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M         &THQYF362=_ILS_ *U(_P JL7ZU+O&'E\I]\]4<G
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                              &THQYF362=_ILS
M_K4C_*K%^M2[QAY?*??/5')P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                    !M*,>9DUDG?Z;,_ZU(_RJQ?K4N\8>7RGWSU1R<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                       ;2C'F
M9-9)W^FS/^M2/\JL7ZU+O&'E\I]\]4<G
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M^K^+=6N+UKNKC7=Y:&?Q8F2
M                                             ]"9:U==Q\(64"!P
M;4\?9DR/%X,IY7*=/GW$<&T\D^*OH%P,=E&4ODILZRG"/RFEWV?VOM:RW95)
MJ;&!9QT.J87(KYD>:RAY*$.*94[&<=0EU*'4J-)GQ(E$?ZI!*,HNDDT^Z(SA
M-5@TUW'4]X=3L
M
M
M
M
M
M
M
M
M
M                                                 !M*,>9DUDG?
MZ;,_ZU(_RJQ?K4N\8>7RGWSU1R<     &.=6=2J723 ,ASN\_96*>+_F4%*R
M0]:VTE11ZNK85P4:53)BTI4LDJYIHEN&7)08KX;#SQ5^-F&MO7Q+A9:XW%6\
M%AI8BYJBM"XWP+POG*[.>9UDFI.5V^999/7875Q(-YY9\4L1F$^TBP(+/$TQ
MH$%@B;:;+]:E/5,S,S.=6;-O#VU:M*D%_*O?-8XG$7<5>E?O.MR3_DEW%P'$
M!5*
M
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M:1FMU_U"?YY_BP-^AA22
M
M
M
M
M
M
M
M
M
M                                                         ;2C
M'F9-9)W^FS/^M2/\JL7ZU+O&'E\I]\]4<G     !%GTD.9R$EISI]'=4B*Z5
MGE]HT2SY+SK9E3TBC07 N#!*G_1X\367#APZLCR&TOZR^]>B*^%_8(AO3??]
M5AEJTR?P+[)%@)&0\
M
M
M))^CBS*1%S#/<!=>4<*XQ^-E,1I:_P!C:GT<^/62N80:N!/38EV@U\"XJ3%3
M_P"Y& SZTG:A>6M2IX&J_8\9*MU[[5^YAG\F4=I=].GC3\1+H(P34
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M-^#Q%E4OI5=/NES_  ZN(Q.29Q/#7(X7$.N&DZ)O[A\']'C7!KXZS2")D\,
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M\!"S8P
M
M
M
M
M
M
M
M
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M2Q:>B3XCK\&<POE-.<M+K;5Q&2FJHL;EN5N5&;U#L=
M                     VE&/,R:R3O]-F?]:D?Y58OUJ7>,/+Y3[YZHY.
M   "&#I&%K/6K%4&I1H3I;3+2@U'R$K7EF:DM24\>!*63:2,_HF22_P"5Y%^
MJ2_./\6)!-Z/U^"X.A7XTC0,9LC8
M
M
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MN
M
M
M
M
M
M
M
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MUDNV"'F&5*+CS)9K@^JV&4N I<]N1<ZJBU"R4T>U/J$KJE^K6L?*:[A:XO\
M)I]W[#.Q(%T6                                       ;2C'F9-9)
MW^FS/^M2/\JL7ZU+O&'E\I]\]4<G     !"]TB_\MN+?<LI/MMS<2S(OU27Y
MQ_BQ()O1^OP_,K\:9H*,T1L
M
M
M      -T=A'Y0E=]BN3_ +V9&)SK]1?WR,]NY^TU]Y(G*$/-@@
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M1G:YW*3QFRW\515"]W;A&.7;:2VI3=7QTT(W<4E*TJ0M)*2HC2I*B)25)47
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MJ*?V/L&<W>NRN99%2^XE*/@U_9-Q!BC.
M
M
M
M
M
M
M
M
M          !K7O._(]W7_P!6O77^:_*1UG\A]YG>W^4C]\OA.E %B98["'YL
M!N3T5VC]#-NIU_W!9W4Z>:78!O7U/L;R^M'#4])?5H!MD174-#6LDN?D&47T
MPTQJ^NB-NRYLEQ+;2%*,7-IJ-MMZJECB(RG>48Z]G[+(3-R'2RX+TTW2+[>M
M.-YN:YAM?Z,>DU.;AU>G]#/1(E$IR)80Z7-M8;Z"MJ)$R+-K-R/63;5I$J'A
M%+/D%#-9E.LYE-SZ2:VM$"O&WT,'L*MP[+#3; L"TMT_PS3C2W&J'#M.,(QN
MHQK",7Q>*Q"QZBQBIA,Q*>NJ(\;]A3"8AMI)*B-1K_7*4I1F9W:22HM1CFVW
M66LYJ!P !TV72OZSWFX#I*=[^J-^ZEU^SW(:G8U4\DI"39P_3C(96FN!1'2D
MNO.G(@X1B->RZ?M$&XVHT(;1R6TV,W63?=,M;6S!+N&\'S:#!&\WZ93:O(D]
MBK@X-7:U9W+CR26:Y#E5HCJ!64_89$TZCLJ'D-U#DERS01-L+,E<LDD?:U^4
M1TONEJ7\N$[6T7AC  (,OG).$+SCH9]W[<9AE^QQ9C1W-X"GUM-)CHQG7?3.
M7=OH<<;69/)Q9<]+:4&E3BU$CCP49'3N_DV5\,Z75W:_ =3R+,R1V4?S0S6#
M(<ZZ.#4C3&]D*DPM#MRF84>'<242(&)YSBV(9^Y5IXJ42E(S6ZNI9J+DEPF$
M7#B1F=U8?Q:=TL,6DII\:+#F\[\CW=?_ %:]=?YK\I%2?R'WF4+?Y2/WR^$Z
M4 6)ECLE/F=W]F;KE_7JU,_F VQBZL?(\)C\7^47WOV620]-/TJ.B71V;4M4
M8DG.:";N=U(P7)</T*TGKYK%GECN59+2R:NOSO(J.%-8GTF!8<<XK&5-DKBM
MRC83$C.*E/M(/M<FHKNG6Q:E.:?W*.IZP#3W/=5\RH-.]+\*RO47/LKF^#<8
MPK!\?M<JRO()_,NR50Z;'Z2+.M;*0B,PXZI++2S2VVI9\$I,RL]>HR3:6EZC
ML\_FZG1&YGT:>WS.,_U\9A1-S>Y-W%[',L5@RV;&/I3@F+,63N(Z>2;*'*EU
MEEE:IU]-GW<B&LXI/.L1&U/%"[)?N[4'!5>MF.Q%U7'LQ^2BQ@*I;@
M                               !M*,>9DUDG?Z;,_ZU(_RJQ?K4N\8>
M7RGWSU1R<     $+W2+_ ,MN+?<LI/MMS<2S(OU27YQ_BQ()O1^OP_,K\:9H
M*,T1L
M
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M16
M
M
M
M
M
M
M
M                                        #6O>=^1[NO\ ZM>NO\U^
M4CK/Y#[S.]O\I'[Y?"=* +$RQ8RV!=#)J#TBO1&[@-P&B6J&I<[7#1?=#F=7
MA.VEV\A>9O4B+BVCVC^1W<NIHWV&'*G6V]KLW=AP;-<HXTIFNC0'6VR>[*9J
MQ@Y0;6NI1G>4+BA+4UK*[$^!.JITVLLX4NMLJV7(@6-=/CO0YT"=#>7'EPIL
M20AN1%EQ9#:D.-K2E:%I-*B(R,A2*Q?S^;$]-4O4JFQGHV-T>5)7GV*4YP-J
MNH5Y+/GLUQ*EB./JT5OK"6^I3V4XC5L*7CCA\"F4\=4$^2_#C%,N+5S[A^ L
ML39_^9'P\Y=5%P68 '2D[V:&1BN\W=QB\N-+ARL;W.Z]T,F'/E29TZ+(I]5<
MKKWHTV;,?E2YDMAR.:7'777''%D:E*4HS,["7RGWS,1U+O$O'S7.\JZGICM!
M8%A*['EY-I]KW1T;7,R'>S;2/I!EF2.Q>6RTXW&Y%+C\Q[EO&VV?,\@E&XM"
M5=[7Y1?RX"EB/R+\'PH[3X7AC  (9OG">05V-=#=OCL;13J(TG!,$Q]HV6C>
M6=CEFLVFV*TZ301D9-+MKE@G%?00V9J/J$*=W\F_Y<)6P_Y9>'X&=2*+,R9V
M,'S.+&[>#L5W,93*C*9I\AW5RJJI?62TJER<;TFTY>M'&DJ0E*XS1W[""<2:
MB-U+B>H:#%U8^2^^6.+^4EPT++^\[\CW=?\ U:]=?YK\I%2?R'WF6]O\I'[Y
M?"=* +$RQ8ZZ.'HQ=X>Z/HM-Q6[79INEUQPW4W1W<#F>-1]K>GF39?C%#JQ6
M8CI7I'F627%!-Q7*ZQQ>JMA59BAB#%77R#LBJ&(25DX^TIJK&$G!RB_ 49W8
MQN*$EK6LKJVT^UM+.?8WDVPL;F9+?D6DZVD29=G*G..*.2]/DS%N2GY:W>)K
M4XHUFKCQ/B*16+Z'S33?9M;L<:N]D]_I;I+I9NPAL6^0X;JI1X?CM!E^Y? J
M]<ZZGX_DF5QX+-QD&>Z8Q9#[K<-V0OLJA)<EEKE0[!U5Q9DOD\)9XJ$OEIO9
MX47<Q<%D                                        ;2C'F9-9)W^F
MS/\ K4C_ "JQ?K4N\8>7RGWSU1R<     $+W2+_RVXM]RRD^VW-Q+,B_5)?G
M'^+$@F]'Z_#\ROQIF@HS1&P
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M[/R:Z#PCDX
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MN#A;?#+B^&FHB-K!XW/<6\5=3AAV]? DON8UU]_56K?$3'X=B-!@>,TV(8O
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M;3]!2S(CZAF+' W%:QEN<M"VEX]'V3)9G:=_+[UN*K)P;7?6G[!$_L3U$QS
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M7^BPU7&*HW6M7PT^SP5U:"GE=S&7L-TV-HIS;<4E2D7JK]CAI2NDST+(R(
M                          :Y:H[J]%])Y$FLO,D5<9#$Y27\;Q9A-S:,
M.I(^,>:Z3T>JK9)&1<6I,EETB,CY/#JB_P /EN+Q*VH1I!\+T+G?@1B\7G&
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MA[O_ /??@_\ :'O7_A_P_P#L#UEW_H5_"/\ ^88>[_\ WWX/_:'O7_A_P_\
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M_P"P/67?^A7\(_\ YAA[O_\ ??@_]H>]?^'_  _^P/67?^A7\(__ )AA[O\
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MK_P_X?\ V!ZR[_T*_A'_ /,,/=__ +[\'_M#WK_P_P"'_P!@>LN_]"OX1_\
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MK_P_X?\ V!ZR[_T*_A'_ /,,/=__ +[\'_M#WK_P_P"'_P!@>LN_]"OX1_\
MS##W?_[[\'_M#WK_ ,/^'_V!ZR[_ -"OX1__ ###W?\ ^^_!_P"T/>O_  _X
M?_8'K+O_ $*_A'_\PP]W_P#OOP?^T/>O_#_A_P#8'K+O_0K^$?\ \PP]W_\
MOOP?^T/>O_#_ (?_ &!ZR[_T*_A'_P#,,/=__OOP?^T/>O\ P_X?_8'K+O\
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M+::='K,XFFJK2F>4<'(
M
M
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MQ&A6PN#,82Z1-J0E;A<I9*,SX]+<YN:3>@JW[=N-IN*2>CX3L#A<E@
M              :4[W>D*VJ='=A.':A[L,_L]/L3SW*7L,QBQK,)S/.')V1,
M5,N\<A.P<*H[Z=#05;!=<)UYM#1FGD\KE&1'UE)1TLJ6[<KE5'@(UO[SUT,O
MYS&5_P#ROVO?]'0Z=- J=5N]P?WGKH9?SF,K_P#E?M>_Z.@Z: ZK=[AS; OG
M(?0UZ@7L;'8>[Z)C-A->:8AR,]TEUMPNB=6[SG*5)RF\TZBXS3LL<@N6Y/F1
M6_;ER35[;ARKL'PG#PUU<%27G2/6_1K7[$HN>Z&ZKZ<ZPX3,/DQ\KTRS3'<X
MH%N\5I7'7:8W8V,-F6RMM2'&5K2ZVM"DK22DF1=TT]**,HRBZ231E <G
M
M !K7O._(]W7_ -6O77^:_*1UG\A]YG>W^4C]\OA.E %B98[)3YG=_9FZY?UZ
MM3/Y@-L8NK'R/"8_%_E%][]ED?OSH7H7T5+N0])EM=P]PX$Z6J7N^P#'(:31
M72Y2FFX^X*FJ(<8E%#FR5&UF)MF9MON,VRF^0NUE-]+MO[J/A*N'O5_JY:^
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M M;AQDOO7EN>VNZ8V]:Z.6CY+)C!4*(
M         ;2C'F9-9)W^FS/^M2/\JL7ZU+O&'E\I]\]4<G     !"]TB_P#+
M;BWW+*3[;<W$LR+]4E^<?XL2";T?K\/S*_&F:"C-$;
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MPPVAEEEE"6F666DDAMIIM!)0VVVA)$E)$1$1<"%@VVZO695))46H\@X.0
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M!]NQR"8A1DMQA,E+$=B#%=>+EK;8;;YQ7 W#6:4F5IBL=?Q=%<:4%JBM"+_
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M245KB<WQ-^/1PI"V^+73BKS4+[!Y!@\+-79UNW5PRU)\:7.V;BC%&<
M                      "*K>%NYLV+.TTFTKM50&8"G:_,\MKGC3.>G)-3
M4O':64WP5":A*(T2Y+:B=6Z1M(-"4+-V297ED7%8G$JK>F,7\+^PO#WH?G>=
M34W@L'*E-$I+77R4^"G"]=='?BZ,S,S,S,S,S,S,^)F9_1,S_5,Q(B('\
M
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MBKEU)XA_@]Q=WC?V#7^;YS<QTW9LMQPBY9=U]SB7A>G5IF,J8(
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MJI\:9[HZG8
M
M
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M?XYBN-,=A5T=#?+:AH<<X<IQ2U&:C[6Y.4*O6=;\(PN;,="H3.CN40
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M+$@F]'Z_#\ROQIF@HS1&P
M              G:Z)O"(T+3?4O4-QEDY^0YC$Q2.\IHCDMUN+U$6S<YEXR,
MT1IDW)C):4F7+7&(U$?)1PAV\MYO$6['!&%?"W3['C-B[F8=1P=W$M?&G<V?
M!%)_#)\AK-TK.2O6.N>&8R2W>PL:TXARR;7U&TV607UTY-<93RC(TN0:V&1J
MX$9J09?021GD-V[:C@YW.&5SQ)+G9BM\KKEC[=G[F%JOAE)U\21%\)"0\ #+
M.A^KU]H5J9CNIV.18MA8X_X2;.LGN/-P+*+:U4VJE1)IQU)=-KFIG.)X'Q2X
MA*BX&1&+;&86&,P\L//1&5-/%1U+[+L=<R[%QQ=I)RC70]3335'RG'-2<WF:
ME9_F.H%A"C5L[,LBM<CEP(:W7(D.1:RW);L>,M\U/*9:6X9)-1FKA]$=\/96
M'L0L1=5"*5>\4L7B'B\5<Q4DE*Y)RHN"IN/T<.K)Z=;AZW&YLCFJ'52 YALM
M"S5S*+TE]GXM*Y*7$$<E=DRJ$V9DLB3/7U.KRDXO/L-T^!=Q?+MO:\&I^+3X
M#.[JXWJN9JS)_P!7>6S_ $M<7\*\)(5THFDOE=HW3:F5T/G;C3"Z05BZTVDW
MEXCD[D>NG\LT(-YY,&[1!=21F:&6EOKZA&HQ@]WL3T6*>'D_B7%H^^6E<JKX
MB3;W8+I\ L5%?'LRT_>RT/D='W%4K\";&LR23H]\?J\/?U;W0Y8P1XYHGA5H
MW3&XYS1SLLNZ^0E<6$ODK)4KP.2H7)/AQ<M6N''J\,#G<Y75:RZU^4O35>\G
MSZ? 2S=BU"P[^;W_ ,E8MNG=DUIIW::/Z2(^<IR2VS+)L@RV^D*EW6375G?6
MLE7']FL+:8].EK(C,^2@WGSY)?02G@1=0AF[=N-JW&U#1"*27>1&+UZ>(O2O
MW'6Y.3;[[=3X([E(L9]&)^3!'^SW+O\ VJP03>#]HO[R)M+=/]CK\Y+X2'O?
M'^5=K/\ 9#7_ &MT@E.4?LVU]Z_A9"-XOVU?^^7XL35 9(P@      &W6R;0
M>KW :XUN,Y(E;N(8W43<RRJ(VXZPNTK:R77P(U,F2RMMQ@K*UM8Z'30I+G8Q
M.F@TJ(E)QF;8R6"P;N6_RLGLKN-UT^!)^$SF[^70S+,%:O?D(1<I+C2:27A;
M7@J2$=)]E&>:<8KI'A^ 7;V&:;7L3):JSH,5X42'G:!%"596R7*_L=TJ-,"P
M634-KDQS4VHW4JX-<G![O6[-^Y=NWUMXA--.6G76KT\/=)-O=>Q.$LV+.%D[
M>%EM)J.C5LT6C@HWH6CCX"&3$LURW [V)DV&9'<8S?074O1[2GG/PY1*2KEF
MAU32R3)8</J+:<);;B3,E),C,A*[MJU>@[=V*E!\#('8Q%_#7%>P\Y0N+A3_
M )5[ST%GW3Y['=V>V'%96HM-&G0=1L.0UD49M"&SCWT)R14V-M3+6RKP;+C7
M4!R3#6E)FP?)X&HBXJU[?5S+<PDK#:E;EH[VM)\>AT?&;=PSM9SE,)8F*<+M
MOXR[NIM<5&JKB*Q>H6'S-/<\S/!+!PGIN'93?8S)D)2:427*2SDUQRFDGU>9
ME%'YQ'^%*B&P;%U7[,+T=4XI\JJ:DQ5AX7$W,-+7;FX]^CI7PFP.QF@5D>ZW
M1N$1>UAW]A?N*,CY*$XSCMSD*#4KF7R3RW:U*$\2+BM1%RD&9**QSB>QEMU\
M:2Y6E]DR>[MOI<YL1X%)OS8M_8)1]5^DWHM+]2<UT[5I'97KF&9#88\[;LYE
M&@-3WJYXV'GD0W,;DKCESJ33R3<7P,OHF(]AMWYXC#PO]*H[<:TV>/PDOQN]
MEK!XNYA>AE)VY-5VDJT[E#'WK<Z'T&V_P]A?%05_=F?KEYOVRU]];7T>7GKT
M3&^L/2:TNJ6EV>:=,Z06E,[F6,V= W:NYG$G-P%V#"F4REQ$8W%5(2T9\323
MB#/_  BOA=WYX?$0ONZFH23ILZZ>$M<;O;:Q>$N896)1=R#C7:3I54KJ(D!)
MB$@ ;4;3]M%QN,STH4E4FGTYQCF;/4'*TFVPU7UB>6ZFJA2Y"3C(N;9#"TM&
MHEI8;2M]:5);Y*L;F680P-FJTWY:(KC?&^XO'J,SDN4SS7$TE6.%AIG+N<2[
MK\2TED?1>]TZR'33&YNDK,9C3J'X8QS%40F.8@K@8C?VN*.R()*<=<?@RIM*
MZZR^M1NR&EI=7[=:A \5"_#$26)KT[HWQ_&2>GNZ?!J-J8&YA;N%C+!TZJJQ
MC352+<='<JM#X5I*D^0?]O7?^M[+]^O#9</D+O(TM>_*R^^?PGR!W*8
M                                                ;H["/RA*[[%<
MG_>S(Q.=?J+^^1GMW/VFOO)$Y0AYL$
M                       (W>D.SQ]N@PC2:H4X[997:E?V<2.@EO/5]<X<
M&FAFGB:U%8W,A2T$DN)KAEU2^@K/Y'93G/$R^3%47?>OD7PD6WFQ#5JW@H?+
MG*K7<6A+POX#=O2# X^F6F>%X,PEM+E!1Q&+!;7)Y#]S()4Z\E)-)<#3+N)+
M[A?1ZBBZI_1&(Q5YXC$3O/[IZ.]P>(S^"PRPF$MX=?<QT]_6WX74R.+<N@
M
M                                  ,#[E]2W]*-&<ORFO>)B\=BM46.
MN$9$XU<W;I06);/$R(WJN.MV6DNJ1]C]4C+J"]R_#K$XN-N7R-;[RY]7A,=F
MN+>#P,[T=%RE(]]Z*^#7X"N^XXMU:W75K<<<6IQQQQ1K6XM9FI:UK49J4M2C
MXF9]4S$Y-9-MNKUGX X
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MBW9PL<-!TE=>G[U:^5M>"J(81*R"
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M?CJFJ/OKG7P$XW9Q;NX>6%F]-MU7WKX/ _A)$!@R3@
M
M
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MFXRKPIF6:4HT>IH[F#3+4''-6M-M/M5</EHGXEJ9@^)Z@XM.;<:>;FXYF=#
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M#K+S:E-N-K)23,C(Q7+-IIT>L^B
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MI+\X_P 6)!-Z/U^'YE?C3-!1FB-@
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MOUX3Z'R%WD:IO?E9??/X3Y [E,
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MTE2B)2DMJ=X$9]4R(1N<=B;CQ-HF%N6W;C/C2?*CZHZG<
M                                    ".SI'I[S6FF!UB25S$W.7)SI
MDHB3SE=0V3#*5)Y!FHS39K,O;$1</H'U#+.Y#%/$3EPJ'PM<Q&-Z9-82W#@=
MRO(GSD.XE)!P
M                    G\V92GYFVG3)V0X;CB(^3Q4J5]$F(.;9)"BM_P#L
M-1HZ$E_R$(5FJ2S"XEW/Q4;(R)N656F]=)>*<D;/C'&7(9^D:ER%ZPX? 4X9
MQ8VFM?+9:XGR42)N496S)<(N/)(W&Z]HCZG$^07_ ""5Y$EU64N'I'\"YR"[
MT2?7H1X%:3Y92YD1^#-D:
M                               +*>C<U^RT@TJL92B5)GZ;X--D*+E<
M%/RL8JWWE%RU+7P-QP_HF9_X3,0'%I1Q5R*U*Y+X6;5P,G/!69/6[4'^"C)
MMRZ("MZ4]^=N3U$)XG4(A'C,",TZ1$;;#&(T2S-'!*3-J0^ZMY)GQXDY]'AP
M$TRF*C@+=.&K_"9KC/I.6:W:\&ROP5_\35D9(PX
M            ;X='E-D1]<+B*VK]@GZ>W;<AL^)DKF+G')+2R(C(B<0MO@1G
MQX)4HOU1AL\2>#3X5-? R1;LR:S"26IVG\,2:L1(GH
M
M
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M*$<E":MK\FBVQ&B\_P"7 3.BH40
M
M                       -I1CS,FLD[_39G_6I'^56+]:EWC#R^4^^>J.3
M@     A>Z1?^6W%ON64GVVYN)9D7ZI+\X_Q8D$WH_7X?F5^-,T%&:(V
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M;V7[]>$^A\A=Y&J;WY67WS^$^0.Y3
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M,<TN;*I51?AV43A81_L9B/V,4'\%1!$+WY67WS^$V!A_R$/O%\!R<4RL
M                                               !I-OYQ&1D>A*[
M>(TIQW"LHI\@D\@SY7@V2W,H)?!LN)+2V]<,NJ/AQ0AHU<222N.7R6ZK>,V7
MJG%KPZ_L& WCLN[EVW'7;FI>#3'[)!Z)>:_
M                                           "QAMRQ!_!=#M-,:EH
M-J9&QIBQG,*+@N//R%^1D4Z*LN!?LD:7:K;5_P"^2?5/Z(@F/NJ]C+EQ:MJG
M)H^P;0RNP\/E]JU+Y2A5]^7QGXV9K%H7Y$]TD6(2&[K3G/6F37$EU=CB$Y]+
M1<F/(KY:[FK9=>X<3.8W9S#;3^IS"S_5,27(;JV+EEZTU+ET/X$0W>FPU<M8
ME?):<7X-*Y:OD(Q1(2)
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MW[F)?R8QV?"W7Q4\9+F(P34
M
M
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M4%0H@
M
M ;2C'F9-9)W^FS/^M2/\JL7ZU+O&'E\I]\]4<G     !"]TB_P#+;BWW+*3[
M;<W$LR+]4E^<?XL2";T?K\/S*_&F:"C-$;
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MJKKJU<)$<7E&[<;5VY#$1=]1DTNEA\JC:5->O@(9Q*B!@
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MKRI/^6E%[AL58QEI7L/+:MOQ/B:XSFXHEP
M            'RKVDK,EI;?'KJ*B;47M;.J+2&LU)3)@6,9R)+8-2#2M'.,.
MJ+E),E),^)&1CM"<K<U.#I*+JN^CI<MPNVY6KBK"2::[CT,KN:Y:-Y#HCG=C
MBEPT^_6+<=EXQ>*;-,>^HUN?YO*;6E*6RFQTJ)J4T75:?(^'%"D+5.<'BH8N
MRKL?E<*XG_+4:QS# W<OQ#LS^1KB^-<_&N!^ PX+LL0
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M6#6AFLKUFYA[LK-U4N1=&OY>)\*./BH4@
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MPM"_
M
M
M                   .F;U<_M.-3OZ]^:?^(&R%A+Y3[YF(_)7>.YD%^8<
M  .)YZI*,%S1:U)2A.)Y&I2E&24I2FGF&I2E'P(DD1=4QP]1VA\M=]'6 ?-9
M7&T=,)H^E:T(4[I9KLVTE2B2;CA:<6SIH;(S(UK)IM2N!<3Y*3/Z!&+2U^47
M\N R.(_(OP?"CM*Q>&,**WSU+_Z&K_WQ_P#YE86]_@\)>83[KP?9)JOFPO\
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MB7YM-_8G;+/^\;_XL]>!5M?DU_+A+;$?EGX/@1.H*A1
M      #7K='NLV_[+='+[7_<UJ)$TOTFQJPH*FVRB31Y3D[R;3)[>)1TE?7X
MUA-'DN674N983$\IN%!D*982Y(=)$=EUU'#DHJKU':,)3=(JK-7MG_2]]'5O
MVU)M](-J&XV'JEJ11XC/SNPQ9_33673Z66*U=I44UC:096J&G6%5ML<*POHB
M7(\1]^4E#O.&WS:%K3UC.,G1/2=I6KD%M26@DF'<I@
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MU8TUDR\DCZO!8NDZJJU%@TXMQ>M,YJ!P
M&THQYF362=_ILS_K4C_*K%^M2[QAY?*??/5')P     0O=(O_+;BWW+*3[;<
MW$LR+]4E^<?XL2";T?K\/S*_&F:"C-$;
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MWLOWZ\)]#Y"[R-4WORLOOG\)\@=RF
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M)GEN4X?+H[4?C7VM,G\"7 O&^%FR@QYE0
M
M
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MER5W0?3JFOKMNS3$-^=<ON3I+27''I+KRC4NK%75HDTT6\YX>2;C%J7\NZ6
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M)!-Z/U^'YE?C3-!1FB-@
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MB.CAJWQ4(N#,S,S,S,S,S,S/B9F?5,S,_HF8D1#C>W:OO@R;0&KD:?Y73+U
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M<;61*(E$2D*(^J1&)A!-12>NAKNZU*Y*2U.3^$^:.QT
M                                    #='81^4)7?8KD_[V9&)SK]1?
MWR,]NY^TU]Y(G*$/-@@                                !6WS;^6W+
MONIW_P!MLL3VS^J1_-K\4U9B?U^Y^>E^,RR0($;3   "-[HW?]A=2/LLK/X'
M(9[/ORUO[U_"1;=;]7N_?KX#??.<1K<^P[)L+MU.MUV3TL^GDO,<.?C%-86T
MW,C\KVAR(;QI=02N*36@N41EQ(8:S=E9NQNQ^5%IDCQ%F&)L3L3^3.+7+P^
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M?Y&,)5G7ZB_OD0?=S]I+[R1.0(>;!
M
M
M
M
M
M
M
M
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M7ND7_EMQ;[EE)]MN;B69%^J2_./\6)!-Z/U^'YE?C3-!1FB-@
M
M
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MQ4.TQILXU0<GBE3:9^-H6FJ5%,R,E=C(C.^VX\L^!$,AALWQ5AI7'MV^)Z_
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M\H*#]B>3?Y&,)5G7ZB_OD0?=S]I+[R1.0(>;!
M
M
M
M
M
M
M
M
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MR+]4E^<?XL2";T?K\/S*_&F:"C-$;
M
M
M            #='81^4)7?8KD_[V9&)SK]1?WR,]NY^TU]Y(G*$/-@@
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M>0IQ)?J\1%L3AXX=I1N0N)^2ZT[Y.,%BYXN,G.U=M.-/EJE:\7'W3+HM2]
M
M
M
M
M
M
M
M
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M>W0C(6S5[8^HHNH7T3E.0R3P\X<*G7E2YB#[TP:Q=NYP.W3D;?\ M$=8SI&
M
M
M                                           WMZ/6G=GZX6=F3?%B
MCP2ZD+=-2DDA^;8TU<PV1)(R6XZU(=,B5P+DH4?'B1$>&SR2C@U'A<U\#9(M
MV8.68.?!&V_&TN<FN$2)Z                                    !^$
M---FX;;;;9O.<ZZ:$)2;KO(0WSCAI(C6YR&TIXGQ/@DB_4"IQ1'[ Y
M
M
M
M
M
M
M
M
M
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M@JW;3VEW5]TN33X""P3$UZ
M
M
M     $U>PG223A&FT[.KJ(N-=:CNPY<%I]M2'H^*5R7BIW.2OJM^%GI3THN!
M$3D=3"CX]3A$LZQ*O8A68/XEOX7KY-7?J3W=S!/#X5XBXJ7+M&OO5JY:M]ZA
MO@,,2(
M
M
M
M
M
M
M
M
M
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M-7ZO<#M+KZQ[+=0\GM,NR-VN@%KX\4&"Y<7#QLL\M7--F2>)\.(MW;N-U:^
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MR.*I;               &THQYF362=_ILS_K4C_*K%^M2[QAY?*??/5')P
M   #(C(R,B,C(R,C+B1D?T2,OU2, 1)[J=E]I76%CJ)HY4.6--,6_/R'":Y'
M+GT\E:C=D3L;A(+ESJI]1FI4)HE/1EG^PH4R?)8DV6YM&458Q3I-:I/A[C[O
M=X>'3KA><9%.,GBL#&MMZ906M=V*X5W-:X-&J--QM;2UM.H6VXVM3;C;B30M
MM:#-*T+0HB4E:5%P,CZI&) 15IIT>L_ '
M
M
M          '](C,R(B,S,R(B(N)F9_0(B_5,P!(7M?V87>7V%=G.K53)I<+C
M+;FUN,3T.1;C*EI-#D=4Z(M*7ZW'E_17SG(?E)+@A)-K)T8/,<VA:B[.&:=W
MA:U+G?P>(DV4Y%<O26(QL7&PM*B]<N^N"/C?>TDQC33;+;;++:&F6D(::::0
MEMMIMM))0VVA)$E"$)(B(B(B(B$5;KI>LG"22HM1^P.0
M
M
M
M
M
M
M
M
M
M
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M%@U:I:%'$<F64J.DUR(;Z8_:Q%UVN Z8J:V5!:V7UA<EB
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M?A,AALJP&$>U9MQV^-Z7X&ZT\%#.(LS(
M
M
M
M
M
M
M
M
M
M
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M)K)._P!-F?\ 6I'^56+]:EWC#R^4^^>J.3@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                               #:48\S)K)._TV9_UJ1_E5B_6I=XP\
MOE/OGJCDX
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M      VE&/,R:R3O]-F?]:D?Y58OUJ7>,/+Y3[YZHY.
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                        -I1CS,FLD[_39G_6I'^5
M6+]:EWC#R^4^^>J.3@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M              #:48\S)K)._P!-F?\ 6I'^56+]:EWC#R^4^^>J.3@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                   #:48\S)K)
M._TV9_UJ1_E5B_6I=XP\OE/OGJCDX
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                          VE&/,R8!EXS?+ER5HJY2DKD/*2HDIX*2IQ
M1D9>V^@9&+Q7(4UF,E9N[3^*]9Z_DOD'BJ7](GW0YZ2'&CKT-WR6/)?(/%4O
MZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR
M6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@
MZ2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(
M/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&A
MT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ
M1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6
M/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z
M2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/
M%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT
M-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1
M/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/
M)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2
M'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%
M4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-
MWR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/
MN@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)
M?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'
M&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4
MOZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-W
MR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N
M@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?
M(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&
MAT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4O
MZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR
M6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@
MZ2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(
M/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&A
MT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ
M1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6
M/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z
M2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/
M%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT
M-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1
M/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/
M)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2
M'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%
M4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-
MWR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/
MN@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)
M?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'
M&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4
MOZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-W
MR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N
M@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?
M(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&
MAT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4O
MZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR
M6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@
MZ2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(
M/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&A
MT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ
M1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6
M/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z
M2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/
M%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT
M-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1
M/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/
M)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2
M'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%
M4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-
MWR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/
MN@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)
M?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'
M&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4
MOZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-W
MR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N
M@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?
M(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&
MAT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4O
MZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR
M6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@
MZ2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(
M/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&A
MT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ
M1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6
M/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z
M2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/
M%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT
M-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1
M/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/
M)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2
M'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%
M4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-
MWR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/
MN@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)
M?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'
M&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4
MOZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-W
MR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N
M@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?
M(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&
MAT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4O
MZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR
M6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@
MZ2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(
M/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&A
MT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ
M1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6
M/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z
M2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/
M%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT
M-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1
M/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/
M)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2
M'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%
M4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-
MWR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/
MN@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)
M?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'
M&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4
MOZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-W
MR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N
M@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?
M(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&
MAT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4O
MZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR
M6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@
MZ2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(
M/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&A
MT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ
M1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6
M/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z
M2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/
M%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT
M-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1
M/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/
M)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2
M'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%
M4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-
MWR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/
MN@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)
M?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'
M&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4
MOZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-W
MR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N
M@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?
M(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&
MAT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4O
MZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR
M6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@
MZ2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(
M/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&A
MT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ
M1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6
M/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z
M2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/
M%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT
M-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1
M/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/
M)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2
M'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%
M4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-
MWR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/
MN@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)
M?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'
M&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4
MOZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-W
MR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N
M@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?
M(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&
MAT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4O
MZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR
M6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@
MZ2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(
M/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&A
MT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ
M1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6
M/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z
M2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/
M%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT
M-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1
M/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/
M)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2
M'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%
M4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-
MWR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/
MN@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)
M?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'
M&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4
MOZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-W
MR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N
M@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?
M(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&
MAT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4O
MZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR
M6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@
MZ2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(
M/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&A
MT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ
M1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6
M/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z
M2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/
M%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT
M-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1
M/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/
M)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2
M'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%
M4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-
MWR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/
MN@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)
M?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'
M&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4
MOZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-W
MR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N
M@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?
M(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&AT-WR6/)?(/%4OZ1/N@Z2'&
MAT-WR6;#"R,J
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M               &D(X*@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                         !P#,=6-+-/)4.%J!J5@&#3;%A<JOB9CF6.X
MS*G16W.9<DPX]U8PG9+#;OM5+02DDKJ&?$<5.5%O4FS%:]XFUU+\6*C733J1
M(FO)8C-0K]B>IQY:VVT-GV$3Y-*<6X1)Y?)Y75X<>!\%4=NCGQ,V3')T
M /FRKJFA3H57,MJR)9V7*\'5TJ?%8G3^1^O["B.NHD2N1^KR$JX *'T@
M               ?/L[:JI8BI]S9U]3!0M#:YEG-C0(B7'#Y+:%2)3C3*5N*
MZB2,^)G] !K/>;<;=;0ZTM#K3J$N-N-J2MMQM:24A:%I,TK0M)D9&1\#( ?H
M
M
M
M
M
M
M
M
M
M
M
M
M
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M5S("GJB%P(C2:E(XM*;',=13O4V]!(N.Q2
M
M
M
M
M
M
M
M
M
M
M
M
M
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MVG6C<1Q/@?#B7'J -1[Z$);2E"$I0A"20A"")*4)21$E*4D1$E*2+@1%U"(
M?T
M
M
M
M
M
M
M
M
M
M
M
M
M
M $=?2D?DFWGV:85_"+HZRU%6S\LT"Z(#^6O4[[EI_;9CPZQUE6_\E=\L(BH6
MI5]Z2/6.@U>W(3BQ6<S:8_IYCE?@#%G#>)^NM+2OL;>WO9L%U"UM/,LV5RJ'
MSJ/:/%#):#4@TJ53DZLO+47&&G6R8_HY]$[C1C;K6^4\)VNRC4.YDY[9U\A*
MT2ZN#80:^!05LMI:4*CR$U-<B2XTHN6T[*6A7MD\"[15$6]V6U+1J1J5J=N
MU8W<[GWMKNB6?S-+M-:.9>5V69I1/.Q[Z_8QE"TY18M3(KT2P.M[,:5!@0XS
M[3<PED](<-ESDL\5JZ(J**A#;DJLSU/Z,O 6JM3V*ZVZ]T&<(;6\QF#V91YW
M.62^4XN3/KHE94R'6%R#Y9H9EQW>H7%TSXFKG9.G3/A2H:?:#%N#P3I%M-],
M]=LTOLTMJ?'\RHJJYM+>=8P[G$/(/-LAI+F _(6EV<F7+97RW)/.26WN<:<5
MRVN">%7:TE26R[3<=1N]O#T/W*W*,HU3T'U_SVBDUM0Q,5I' L9E9536*>O9
M1-5CD^'.;2S;RVX[C_,/,*3)?5R2<09EQY:>M%.W*'R9)=\B3VW:P;C-=]8L
M3TLM]UFJ&#,Y2Y/9C7:KBWN5+F0:^39-5C,0[:M:1)LT1%--...DA+II+DK,
MR0KJFVZ5*TXQC&NRF65L*Q^;BN)8[C=ED=ME\^DJ85;,RB^63MU?2(K*6G+2
MT<2:DKFRU)Y;AD? U&.Y:MU=2*O?_B&OVDE-D.O.GVYS4"IQ>5D-9%F:;+N9
M]:Q4+N7D0F$XG+A3>9D1FW_;JB.,-J;:)QPG5$GD#K*JTE:TXR^*TJF9]D^D
M&X^!6T&K>O.N6>9"YD6/G,J=*K2UG6-=6P;J,R_7V.2OS9*R5>)BK):8C;*>
MQ%*X..*<Y3;?*3ULZW)1^3%(PQO2W\Y5B^<'M]VX(1,U"5:1L;R'*VH4>T?@
M9'9/,0XF)8E"DI?A2KY$F2EJ2^\VXB.^?,H3SR5J;X;X$=K=M-;4]1S7".CD
M\IJ"+>[C=;-8\SU*M&BF6_@7.GF:6CDR2)QVMKW[2#;3+!48^2A3_*:87R")
MME"2+CSL\9P[M'2"5#0BZW#:C;&-S>5Z<8AJ9F&K6E&)VM3#M<6SRT59%)A6
M%166EG @27#<9I[^G=G+9*9#:BM.R&?V5A3?%L^M:/N%395R%6J2+$V/WE=D
M]#29+3O'(J<AJ*V\JWS3R#?KK:$S/A/&GB?)-R-(2KAQZG$5"U:HZ%6_>]*9
M@[VM5)LE1HCP\SQ25(625+-#,?',7>=42$D:E&E"#/@1&9BF]9>6_P FB5[)
MXF[O>:R]::=Y:>VS;Y8M<<5FRBL(VI6HM0^EM4?)9C%2XQ8U=';1U&N/&*;"
M0Y&<+EE)2HG"[:7WBBNCMZ],B-O<OMIW&[/Y-'J$SJQD&14=K9(@M9YC%YDM
M+:U>0&2Y[,*ZCKL7I,8YR8:G&'DR'FW5,J)?(42"7U::*L)PGHH2Y]'ON=O=
MQNE-M'S>0S,U#TYLH--D-BPTQ'.]JK2*\_CM_*C,&AJ/833@2V'R0VAI;D4W
M$$7+-".T75%&[!1EHU,SYN"TIU'U8QJNJ--M;,AT2M8$QZ7)N,?K%6+ERTIM
MHF:Z8;-Q2RHD9#C9JY;3IKXJZI*3RD+Y:J=(R47I52N%K[GN[32/4S+]+-0-
M>M5YUI0RH;<A<#4G-$4-O DPX=G3VD"&5G%CE'F07V7>2;25MO<I*RYQ*A3=
M5H+N*A)521:-T^D/R\"PB5*?>DR9.(8U(DR9#BWGY#[U-"<>??><4IQUYUQ1
MJ4I1FI2C,S/B*A9O6S1G?UO+M-LU)CV*8%$@2]2\VB3IT6?:,]E0,4H(J^P_
M#*H"C2W86<R>I2(;;G*CD<=U;R5$E+;G#="I;M[>EZC >V?;1"W=Z24VM>M^
MNNMV8Y'DMC?,N4E=EB**BQ5ZFO+&H[#A5_85C&)4J+&;DD<9,5A")'))DE$I
M1\)556=ISV);,4J&M&Z33G6?8-G6'Y9H[K)J&_I_E#DPJ=%U=O3^P+>J<:DS
ML<RFI-*<:R&!+8E(D1UNPT$[P=2;1+9)USAUCJ.\'&XJ22J3-;4==V]QFB6+
M:DNPX];>/*F4>65D0W#B0LFIG28G]A\ZI:TPK!E;4QA"EN*:9DI;4M2DJ,^Z
M=46\X[$J&GNY;;INKGS-8]2,;W2W&.Z>HJ<GR6)IXQ-R9+,:AKJ)^7*HFR9E
MI@H3,:BN)X$GFT\YPX<!PTRI"4-":TD-FT+#-1]0=<*+$=*]1)>EV76U3D78
M^70WI[+L:% J9%G.B*56NLRE-SFH?(,B5PX\#/Z Z+7H*\VE&K5434X#M/WE
M8YG6%9#E&\2ZR?&:'+<<N<BQIV9EBFLAHJNXASK>C<3)G+CJ;MJ]AR.9.$:#
M)SVQ&7$=Z/C*#G;:HHZ3-&ZG0[<#J2:LGT1W!Y-IK.I,73%B:>UR'H%-E%S#
ME6\Y4R3D4&SC2ZV=9,36(J37'D,([&09D7*4I)I\!UA**T252!S0W=7K#C>M
MFG^1ZA:GZSYM38_>R7)N)2LUS#()-RZ_"EQ48_&I9]I(8>D6U@IF.32F^1RS
M+E%P3U.B;J7$H1<6DD;D[RJK>'9:0/ZZ:P:A.Z;44N]J*W'M!,(D6J6Z2%>J
MDIC*S.YK)$",_;1XB%FXN3V;^R.$TGL<U\RCLZTJSI;V-K9BJ]T^WT:F=ZP:
ML8CKGH\]J7D]7$A8_066(9F^J3D-O@=K93YL60BH78RTMG&GL1>6F*MPFTK:
M6M!%RG>4C5Z#BZHQ:E0P?O&J]XNU^]Q:-=;HM5,OQ?*H]HO'<FI<PS#$W7)=
M6J"5I6W-1"OY*8LMEN:PXSQE24.-K4:%$I+J2X=4=K?1S6I5)1NC6R3(LKVN
MTMME%_=9):JR_,(ZK._M)UQ8*89L$$RPJ;8OR))LM$H^2GE<E/'J$.T=12NI
M*>@W+S_.\8TQPS),_P RL456,XK5OVMM-4DW%I89Y*&X\9E/MY,Z;)<0Q'93
M[=Y]Q"$\5*(<E-)MT6LA-QS6;<KTB.K5OA. Y;;:)Z'X]R;#(G\;?=B7$7'W
MY+L>N:N;>O>CSKC)<A)A9-P42&:Y"6W5&EPF5*<ZU<N\7#C"TJO3(SMK3L)T
MTTHTCSW4W&=9M=<>RW!,2N<IBY%+SAJ85C:5,%V:S$F1H5942><NI[:&D*8D
ML+0\ZE7%1$:5'%4.L;DG))I49Q#HX-ZV>:D90K0G5NUD959NT]A;81F5@X3M
M\^=.VF38X]>R>23EPHZXG9+$QTSDIYAQ#JW24V;:+X&+MM);429H=R@
M
M
M
M
M
M
M
M
M
M
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MZ!<8]<=DGH&H_A_/^*H;0Z!<8]<=DGH&H_A_/^*H;0Z!<8]<=DGH&H_A_/\
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ME<S)84?)=:6276ED:5I2HC(<E)IIT>LY,.3@
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M1D7TJ7)L;ROET*YUQX7HZ9B"RS26,@N::7*-3SI>W(D<5=5&CJ5KEU2C1$O
M[E
M
M
M
M
M
M
M
M
M
M                            X)J=J1BND>!Y+J+FL[P?CF+5SEA.<0DE
MR9*^4EF'70&5*04BRM)KK<>.WQ22WG$D9D7$RXU'*3DZ+652MRFYO4/<QFTG
M(\LG/1,<A2I*</PN,^YX%QBM69(;2VUQ)$RXDLMI.7,67./N<23R&DMM(IMU
M+R$%!46LUQ'!W
M
M                                                       V3VS[
MG]0]LN;Q<AQ6<_.QB=*BIS/")+YE3Y15H<03Z22M#R*V\88(^Q)[:.=87[51
M.,*=9<Y3H=)P4U1ZRUGIMJ)BVK&"XSJ)A<]-CC>55C5E7O\ M2>9-1J9EU\U
MI*EE'L:N:TY&DM<3-I]I:>/4%366;3BZ/6<X')P
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M4@
M
M
M
M
M
M
M
M
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M1'B4R:TD25&2D@FZEXT<'8
M             "#[I?-69C;VF6B-?)<9B/1)&I&3,H69%,Y4F;CV*,N<C@9M
M1G(=FXM"N4E2U-*X$;9&.DGP%Q8CKD0A#H7
M
M
M                    !.-T0>K4R0WJ9HC8RG7X\%B-J/BS"UFM,)ER3%H,
MM9;-:C4U&<E2JMU#:.""=<>7PY3AF?>+X"WOQU2)N!W+<
M                  /%(D,1&'Y4I]F-%C,N2),F0XAEB.PRA3CS[[SBDMM,
MM-I-2E*,DI21F9\ !%'TG^LVEEAM]<P&HSS%[W,+K,,<DQJ"@NZZZL8T*J<?
MG3)]FQ729"JR&ELDH0M_D<ZXLDH)7!1IZR>@K68O:K30:']%UJG@.F>N.5)S
M_)ZK$8N68#)I*:VOIC%;3.7#-_26**Z5:2G&HD!^7$C.FRIY2&W%M\V2N<4V
MA?6.LJWDW'1QECFFR+'\C87*QZ]I[Z,TI"')--9PK1AM3B"<0E;T%]]M"EMF
M2B(SXFD^/T!W+5IK6?8')P<3SZ,Y,P3-8C/)YZ5B61QFN6?)3SC]/,:1RE<#
MX)Y2BXG_ (!P<K6B"+HVMYF.:5(EZ'ZK6[%)AUS:N6V%97/7S=9CMU8<VBQI
M;J4H^;KZ2V=;2^U)5R68LHW3>43;QK:ZQ? 7%VVW\9:R?UFQKY,%%I'G0WZQ
MR/V8W8LRF'8*XA(-SLI$M"U1U1^;+E<LE<GD]7CP'<MBO=N.QJGWB;^:S$])
MW8V2T$.#B='G645!D]3,5^.RWW<NN2LFB['EL5U=*3"9=2HT2932&FEJ)2#.
MF],M!=1>Q:K+66'14+4^!EF,5&:XOD>'Y!'[+H\JH[7'KB,7()3U;<P7Z^:V
M@UH<0EPX\A7)4:3Y*N!\.H.#E.CJ5*JW1S42EW#V6W.HGR8&46V9R])[&9&-
MQB/.I)MJU'EV4E"%&XJBE5+*+!Q/$S5&+JD?T!3IIH7FTG#:X*5+:.'XK38+
MB>-X9CT9,.BQ6CJ\?J8R227-P*F&S"C<LTDDEO*;9)2U<.*UF:CZIF*A9MU=
M7K/K65="N*Z?4V<9N96VD*576$1WE<U*A36'(TN,YR32KFWV'5)/@9'P,<G&
MK252M;-)]1]DNX2#)JURVF\>R%C+M+LN=9=.OR"FB3BD0FY*VEMMO28[?^9V
ML3EI,^*B,N9>;6NDU1E[&2N1)]M"=]6@&L^*UEC,SK&=/LP5%:3?85FM]74$
MV!:-L\J:W3S+9^%$R*LY2%.,/QE*6;' WFV7"6VCNFF6TK<HO55'$]>]]>GV
M)P2PG0BTJ];=;\I=32X;C.#/IRFJAV<U"DMV=Q:U!R:MYJMZJU0VGU2'%IY+
MA,M<X\V;XM8C;;TRT1,\Z$UN<Z8:,8G!U_U'8R#.6X[TO(\@R"RJF8\"1.><
ME-4+=N;<)-FBF8632I+RWG'7$K-*S:YM*>5JTG65'+XJT%;#=MG..9/NXU/S
M?'+&/>XZ6<UCD2RK'FI42R:QZ!35LMZODH5V/*CO2:QSF74*-IQ/!25&DR,Z
M;UEW!-02X:%I7!-3-/\ 4VGA7N YACV5ULZ&U.:<IK2),?:8=)'M9L-MTYE?
M(96X2'67VVW6G.*%I2HC(5"S::UFE?24Y[A4+:EJ5B,G*J!&49%,PJ!38\5K
M"7<SY-9J'C-Q8I9K4/JF<B#7T\A;JS026^;X*,E&1'Q+45+2>VGP$?'1-:DX
M-A6H.J5#EV3T^-3LNQ[&U8ZJ\L(E7$LWZ*?;+GP(\R:\Q'78\S:(<;8)7..-
MH<4DCY!CK$J7DVDT6!9-K5PX164NR@1:Y3:'4V$F9'8A*:<1SC;A2G7$L&VX
MW[9)\K@9=4A4+8JU](?EV,YINNU"M\3NZW(:EB'BE2JTJ)3,ZN<L*K&*N)91
MX\V.IR/).%,0MEPT*4E+J%)X\4F*<M9>6DU!5+&&WO5/3[4S2W!)N$9;1WYL
M8?CD>PKX5E$=MJ>;%J(D>7 N:M#RIM9-BR&U(6AU"?H<4\4FE1]UJ+62:DZE
M=WI'L5OL<W;:D3[B,\W#RUO&\BQ^:LG#9L*E6-5-4:V'%D7*["L*M^,M)?K5
M,]3J<#/I+675IIP1.7H%N_V^9KI)A]I(U3P3$K2IQ6E@Y-CF6Y/28S:T5E65
ML2'8M*B6\BL.56HEH,F)3"#CO(-/)Y*N*$]DU0MY0DI:F1O](]KW3Z^X!5QM
M):2VRO3'37.X?E9JZS&>BXF>76M/:0JS&*,Y;3$FV2W&<=<DS$)[';6J.E*E
M$^TM?$G75J*MJ.R_C?*? 9*Z*C6K2O$M(,[P#+<[QG$\G1J58Y>S"R>YKJ!N
M=1VN+8A3L2:Z5:R8L><ZQ/H'TOMMJ4ME*FU*+@LC"+T'6]%N2:6BA++J%5GF
M6F6<4E2ZB8>58)DM76O0W67FY1WF/S8D-V*\2C8=0_V4DT*Y7(41D?'@.Q16
MAJO&57MH6K53M^W'8/G6:1I<:AIY=W19210I+MA40[JIL:*5-[ ;(I:GJ>5*
M2Z\R3:W5-M+0E!N&DA33HR\G':@TM98\1O3VK.,PGFM<<'?\(*0B)&CS94BP
M6XXZVRVT[6,Q%V,9U;CA$E#K2%'U3(N!'PJ51:]'/B9GG*LUQ#!JN7=9CDU'
MC-7 B2)TJ;=6<2O:;BQ6UNO.I*0ZA;O)0V?!*"4I1EP(C/J =4F]"*H>VG.L
M7Q+=5IMG>26C5/BL/49=C/MYB'$L0(-B[.8:ES.0E:F([2IB%.K,N2TCBI7
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M]]HTR"=>3)-DVUI3RT+XBW6C.]VW%1VHDZ [EN
M
M
M
M
M
M
M
M
M                                    '5[?.@8D6/TOFLKT>-'8=GZ:
MZ%RYSK++;3DR4C3*B@HDRUH2E4B0F%#99):S-1--(1QY*4D7/ ='K,:_-N/[
M:39E_P!XG_PHZZ %K.U3'!W.JS^<9[<<0VW]*OKE7X'!K:?%=7J?#==XE!5Q
MTQ8M)<Z@UCC>;,DRVTS';.WSVDM+1*6BYMMN>E!=5)D7)T>LT7Z,O5_--"ND
M&V<:DX#9R*R^K-Q&EE))-AY;"+7&,TRRLPS-,;F+;]L=;E&(7\ZODD75YF2H
MR]L1&0X.XT'!4.KV^= Q(L?I?-97H\:.P[/TUT+ESG666VG)DI&F5%!1)EK0
ME*I$A,*&RR2UF:B::0CCR4I(N> Z/68U^;<?VTFS+_O$_P#A1UT +6=JF.#N
M1(=,)T6>EW2;;9LDQB314U;N.P"AN+S;OJBIEJ';TN61XSLUC![NW;:5)D:=
MYU):3#LHKA/-1ENHGM-')C-&".&JG4_Q)N;:6YLS.K9V3:?:BZ?9,3L2PK)E
MGC&889F&,6?M)$*?"=A6]#D-#;PN*'&EM2(TAKB1I4GJ<G0[+'YO;TQUGTB^
MDM]H?N M:@]V^A=- FVMHP<2O>UJTP)<*HBZH-TS1,(CY/2W$EJ!DK<1HH29
M,J'+;)DI_8L;AG=,L? <G7L_/#HD5&\C:M.1&CIFR-LTZ)(F)9;3*?BP]4\P
M>AQGI!))UV/$=GOJ;0HS2VIYPTD1K5QYX#I+65[NC$_M*>CT_KQ[3/Y^\  +
M6=QN.#N?+MGJ0XY5EZ[5'%O.<J2K[9<0X]P4U!QW:PHDP^;L.RVW30IGDKYQ
M*N29&1\ !3EQ?H7L]V9_.$=N&O6V_2+().R;*K'/]2I5OC=4;N(: W^0Z4ZG
MXU?:<VKS;RCJJ'RHG1I-'Q::8:@VS,%OEG#<6?)UI1ERX<'8   (K]__ $R.
MR#HV,LPK3_<7F&52=0,YI963P,(TVQIK,LDIL89E*@1,BRB(JUJF:*KN[!B0
MQ -UWG)BXDCFT&EEQ1*'#=#%.RKIZ]AV_C7RAVWZ#*UF/4?(Z3)L@KBS33N)
MCM#V!B=2]<VO/VC.36BVG^PF%<TGF3Y:^IQ+Z(YH*U)IAP<@
M                              !6>Z4^0\]NMGMNK-:(F X;'CI,B(FF
M5-3Y:D%P(C,CD27%=7B?%7^#@*<M9=V?D>$CB'4J@
M
M
M                         $D716S'HNZN,PT:>18Z>YC#D\2,S-E!U5@D
MD\#(B5V1 ;^CQ+AQ_5ZI=HZRE>^1X2RX*A:
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M5+XVC45YR:M4E\ID[ [EN
M
M
M
M
M
M
M
M
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MRL;C[",+_>4@4Y:R[L_(\)'0.I5
M
M
M            )%^BU_*QI_L(S3]Y1QVCK*5[Y'A+,XJ%H
M                                 $*'2F:P;@-.,\TT@8'E>:X'IY)Q
M=5DB[Q&SL\>;NLW3<VS-I4VEM52(STY%91QX#S<-Y1LF4E:^2L^)HZ2;+BS&
M+3KI9Q+3_=AN"W=Z14VVK#*2P/4^\6]0:KZR\UV+0TNFBEL->')9UYH.+>WD
M);T.8G@T3Y-**,E;LKA&5;5 X1A+;>K@1,SI/IEC.CFG>*::XA'YBBQ2K:KX
MZUH;1)GR5*7(L;><;*4-KL;>Q>=DR%$1$IUU7 B+@0[+04&W)U>LR&.3@
M                                             -/]UFFVXS5QG%M/
MM(<[H=.]/<C\(Q-5\E-J7Y7QJLB9)J'3K8?2N5"M([CK;D=@X;KBT$AV4B.X
MXD^'5G>#C'2]+X#+FA6A6!;>< @:?:?PGVJ]AU<VTM;!;;]SD5R^AM$JXN)+
M33+;LIY+24)0VAMEEI"4-I2E)$"5#B4G)U9F0<G4
M
M
M
M
M
M
M
M
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M$1$1%P(#B6LPW\UX_M>-)/N6ZY?S>6@< 6L[0$<'<
M                        *S'2E?E8W'V$87^\I IRUEW9^1X2.@=2J
M
M
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MEYJ.QKOI@\^^ZVRRTWEM4IQUUU1(;;0DG^*EK6HB(B^B9A5'&Q/B9L2.3J
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M,F+Y".4KDIX%Q/@.ZU%M)4DTM53)8Y.
M
M
M
M
M
M
M
M
M
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MHU-.\A1IYQI2DI-3:^'%)F1&9'] 4R]/&
M                        )%^BU_*QI_L(S3]Y1QVCK*5[Y'A+,XJ%H
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M[V=7QB9E"$MI2A"4H0A)(0A!$E*$I(B2E*2(B2E)%P(BZA$.Y0/Z
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ML_(\)/3MD_)MV^?</TG^T*@'=:BVG\M]]F;QR=0
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M4X:<4RV@R)1-H4M"UFFHL)ADA"VU$9_0(TF7Z@'#36M,YP.3@
M
M
M
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M+J/J/F.<1HEK(U+QYJ19QF,FN;1IBP?:=4E;R2)Q25&1F9&8/4<1UE\,<'<
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MW9P(CG*ZG)XD9#BAVJF;/@
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M&_IG ;3(7^D!Z0'7'I)-<:W<!N K=/JK.*K3ZATUBQ=-:&XQW'CQ[';C)+N
MZ[ N\DRF:NS7-RF23CA220I!((D)-)FH<-U.-;'-ZVK_ $?FX7'MR^AL#";+
M4+&J/*,?@0]0J:SO\8=@9=32*.T.774][C<]Q]N))-3*D2T$APB-1*+BDP+O
M_0)=.1O'Z3'>!J1H1N&QW0JHPO$]MF8:MUDG3'"LLQN^7E%#JAH[AT)B7.O=
M0,KB.U"JG/9JG&DQT.*>2THG"2E25\,[)U+;X'8
M                    "LQTI7Y6-Q]A&%_O*0*<M9=V?D>$CH'4J@
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M9UC"$/DJAJ(.#L78>B[_ "#=O7^H\M_G&S$58_)+&_\ E7X/@12>%(O@
M#>";TC.[^?HP>@\G5B4>#KQ]&)/2&Z6C:RV1BB(W87D\_ES=>F\7"<@D3#CG
M.E*=CD;2WE-J6E7-72G =.CAM;=/C&CXX.Y,[T+.ENF6JFL>L%7J?IU@FH];
M6:9P)];79YB./Y?!KYR\IKHZYL&)D-?8QXDM<=:D&XVE*S09IX\#X#M'Y7@*
M-]M6ZIT=><P+TKN"X3IUO(RW%]/L.Q7!,:C8A@4F/CN&X]4XQ11Y,S'H[TN0
MS4TD2# :?E/*-;BTMDI:CXJ,S'#^4SM:;=M-Z_MLC<'!4
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M;9=1A&.HP@.#L
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M=@UY.J-2V:FJ;-NKIXO%1\&HK+39?J)'2M2Y45'48Y'!R
M                                             >:/(D1'V941]Z+)
MCN(>CR8[JV7V'FU$IMUEYM27&G$*(C)23(R/Z  DJVR])5JSI395F/:L6%CJ
MGIP;C462]:/%*SK'XQJ)!S*F^DJ*1>(C(,U*B6"W3<2DD-/L%U3[*36LI3M1
MEICH98@P/.\3U-Q"BSO![F+?XMDD),ZJLXAJ)#K?+6R^P\TXE#T6;"E-+9D,
M.)2ZP^VMM:4K29%W+5IIT>LY<.3@
M
M
M
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M77K^;F_'".7J*=OS._\ *^W7_P!6ZH_G/QH<\!UCK.P>'!W
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M:8;6^I#+:22@B21$#.8ZB=(<'(
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M09#/HW6[S(+:(463<XO7R%&EM+G+C)(E$DU$?%3M1(WH Y
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MUC33SR$R(D5%6EJ7)9)*%',D+2YRR:;-/$51'>[+:E3@1(,.Q2
M       PYN U@JM!](<VU1M6VI1XW5*54UCKQ,E<Y#.=;KZ&I)1'SI-S+22T
M3RD$I;4<G'.!D@QPW1':,=J5"H9FN9Y)J'EF09OE]F_<9+D]G)MK>QD'Q6_*
MDJX\AM'ZR/%C-DEIAE!$VRRA+:")*2(J1>I)*BU'%P.0
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MF2Y+JGY,J5)?4MZ1)D/+4M:UJ-2U&9F9F8I%Z>L
M                                             )1^C"W(3M.M5F=&
M,@L%JP75264>H:D.GS%'GQ,\FJD1249DVC)D-)KW4)+B[(.*KJ$A7'M%Z:%&
M]&L=I:T6-Q4+4
M
M
M
M        QCK9_(SJY]S'/?M5M@6LX>HZFCH8_P"U5V%?UD=/OX04.3HM9V\H
MX*A5 ^=WZMXKC.PC131Z1,IG<YU3W*T61TM+,4VNV1A^FN"9PK+<FJ&>=2\V
M=7>Y;10'G>0I!-6JD&9*6D<HZR(@OFAVW_+<JWGZX[CSKY+6GFD>A=AI\Y<+
M8E(C3=0-4<HQF745$22;:84I<+%<.M7Y:"<4XQSL4U(X/)43@.(ZRYATM?\
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M\LG"<(^2;9IZO'CPX#@J%6'6+YP7GNXS>'2='YT1FFNE.K6KF17>58XUN$W
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MD^)&74,AP=C]
M                                HY?.,^BEZ0'>MOWQ;5[:_MSN]5M.
M:_;?I[A$S)J_,],<?89RFFS;4^ULZDX.8YMCMJMR+ OXCAN)8-E1/$25FI*B
M3R=6G4Q=T!G1#](QM Z2+3C6[<=MGO=,M+:7 -6*:SRV=G&E=[&B660X785E
M-%77XIG=]<K.=.=2V2D1E(29\5&DNJ' $G4OO#@[
M                       !68Z4K\K&X^PC"_WE(%.6LN[/R/"1T#J50
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M.M6[)L>0JOJH#<]Y:8J2<-;RDK6XKFT$7+;>LZ0M1MMM5J1K#@J
M                       2+]%K^5C3_81FG[RCCM'64KWR/"69Q4+0
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MMMEEEM#3++2$MM---I)#;;;:")"&T((B(B(B(BX$.Q2/V
M   A[Z8/+Y5?IMI#@S+QMQ\IS*^R.6VDUI5(3AM/$@LMK-)<E<=#N9$LT*/@
M;B4*X&:2,NDBO86EL@%'0N0
M                                "V;L7RV9FNTO1&[GK<<DL8M)QI3C
MQ\7'&L)OKC"XJUJY:S6:XM @^49\I1'Q/@9F0JK465Q4FS;$<G0@#Z8/+94O
M5#27!#6HH5#@5CEJ&RXDE4K+<AF4[BU_\U:FV<*22>/$T\I7#ARCX])%S86A
MOND/HZ%<
M              #ZU#=V.-7E+D=0^<:VH+:NNZN27*XQ[&JF,SH3Y<E25<6I
M+"5=0R/J?1 /3H+JE';1[ZEI[R)Q*+<U=?;1B/E<2CV,1F8SQY:&U\>;>+Z*
M4G_A(OH"L8]Z-!]0
M
M
M
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M&U$7CT^NG2X^=5U]J!6J@Y64!]YR%DT/$(=0VIB22)"(*8QFDD*;,^3H]9V
M'1TY'>9CT?6Q3+LFL7[C),JV;[8LCR"VDDV4FTO+S1/"+.VL9!,H:9)^;/E.
M.KY"4IY2CX$1=0<'9:C<@#D
M
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M$_K&9;_-GI$*D-19XCY:[W.5[M\?Y8VYS[M^HWVSV Z/6^^74/D1^]7P&,M
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M2YICC[A'^Q)DY35T-G$0LN;/BXXUA[YI/EIX$E745]%/217L/2T0-CH7(
M
M      !:WZ/VDF8_L^T4@3DJ0\_3Y#=H)2#09P\ES;)LCKU$DS/BE<"U:41_
M\XCX_JBI'46=W3-FXX[%,KV=+]0S(^MVF>3K)78%QI6W0QE&V9).9CF6Y)83
MB)WE<%J2SE4?BG@7)XD?$^5U*<M9=6/DM=TB4'4K
M                                               >>+&D39,>'$9<
MD2I;[4:,PTDU.OR'W$M,LMI+JJ<<<622+]4S %UG%JA6/XQCE"I?.*I*&GJ%
M.<25RU5M?'A&OE$E!*Y1L\>/)+C_ ("%4L'I=3[PY.
M
M
M
M                                    QCK9_(SJY]S'/?M5M@6LX>HZ
MFCH8_P"U5V%?UD=/OX04.3HM9V\HX*@   1Y]+7_ &8'2 ?U1=>OYN;\$</4
M4[?F=_Y7VZ_^K=4?SGXT.> ZQUG8/#@[G7'_ #OG^TIT0_J.::_S][EP1UEK
M+LG1*?V8'1__ -4707^;F@!G*U$A@'(      $>?2U_V8'2 ?U1=>OYN;\$<
M/44<OFDW]I_FW]4757^<;1@<G6.L[)D<'<     ZEWIZ_P"UZWQ?=.H_YM\(
M')3>L[1'9M^2#M4_JW:&_P V&+CAZSNM1LB!R8BU_P!7\=V_:&:PZYY;*BP\
M;T@TRS?4BX>F+-#"H>&XY8WRXW!"DNO/S5029::;XNO.N)0V1K4DC Z?39YM
M^S+?!O(T1T KU6-MD>N^KE369-:,*1V?$H)M@[D&I68.K-M:"+',/AV=L^HD
M*X-Q5F23_6GR4SN0[N[Q33K#[7(LCMZG$L(P?')MQ>7MW/9K:/&\7QNM<F6-
MI:V<YU$>#5U%7#6Z\^\LDMM-FI2N!&8X*A43U=^<EZZ[K-Q=-M Z'3;97:IY
MME-U/I*?6/6J-8MU=G"K>S57&7T6 0[7'&\5PRIK8Q6!762V2%)C\4OU+3G)
M0OFAUKQ&^F-="AK-NAK*G(.EVW[:[[KK26W"L+O;AI!D:]"]J57.Y*9#E1(Q
MW"*S&;3.CJ)IF46Y;C8U-<0A/.-=3JJ\1S3C*/.B&%8GIMT]6D.G6 T4?%\%
MP'I=\ PK"\9B3+6PBX[B>+;RZFCQRBC3[VPMKR='J*> S'0],E29;J6R4\ZX
MX:EF.O"=M&.#N4Q/GD/\BFQ[[J6L/VIX:.5J.LC>3YJ-_95(_K(ZP_P?A ,1
MU%E<<'8K']*=\Y)TDV5ZE9'MAVQ:;_*:W-8_8MXSDCSUA*B:3:?9E)-<=.*3
MGJ$I&3ZB9K5V"F69M-5G!:8>=5&79-S67HJ%#JW0^II'L3Z7+I \5B9UTFV^
M'/\ :CIWE[#%C%V<[)F*C2G(X-'-A1W$UFI6JJ&KR]ANS.==1-Q^5(R=*6E(
MYR7'?)<9GG5WQ1O65'?G#&S#;KL0WNX%H9MEP>5@^"*VS:?YE<MV669=F5SD
MV:7N?:KP[C*[JWS"\NY";*? IX;"F8?8D!#<5!MQT+4ZMP<-4.Q;Z,3^S6Z/
M3^HYM,_F$P <'=:C>,                             'B??8BL/29+S4
M>-':<?D2'W$,L,,,H-QUYYUPTMM---I-2E*,B21<3 ''/+G"OXX8M\(*GOL*
M,#RYPK^.&+?""I[["C \N<*_CABWP@J>^PHP<BCR8\QAF5$?9E19#:7F),=U
M#[#[2R)2'67FE*;<;6D^)*29D9 #S        (9>D_Z4W7+H]+R*Q@71QZ_[
MM,%7IQ69W<ZPZ?65Q2Z78?8OY-DU3=8GFN04FF&I3^,S**AH&;1<J1'*.XBQ
MCM'R.*G"4.&Z%>ZU^>89.\M9TG1ZT->V;!I;3:[GK"X6F3[?@\MR)H)1)6QQ
M-/[&24JZA^WZI<.:'&T34]"+TTF9]+-=[C:?+M!\8T:\QU7I=9U\C',WM<M\
M/^<"7GL66Q,9L\?I^PO!WD@TIM2%+Y?/*(R+@1@SE.I8"'!R   &*]<=:M.-
MN6C^H^NVKN0-XOIII3B-QFN97BX[\QR'34L5<EY$*!$0[,L[2:X28\.(PA;\
MN4ZVRTE3BTD8%+O+?GDD]C4.Q3@FQB'9Z3Q[@VJEW+=:WJ+4.WQ]IWD%.L6*
M? <BQK';B<P7.=BM.6C$59\WV1((N<5S0Z[1;DV0[S]&-_FW#!=S.A4^Q>P[
M,6YD&QH[Z,W!RC"<NIG2BY+A64P67I,>/=T4TR(ULNO19<=QJ3'<=COM.+X.
M4ZE>#=Y\YMUEV=9Y(P[5#HC]=<+@>$[6LI,FU@U9M-)ZS,#K)C[2;##)+VWO
M*Z7)JJ5 2V_ST6>LVS<-M22-!F?-#C:-#;#YY1J4XV@JK85@\)TE\75V&O\
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M2J,W+YH<)EI(<'8
M      "LQTI7Y6-Q]A&%_O*0*<M9=V?D>$CH'4J@
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M;5-*^D-VJ2L@CX_H#2Y7BV5/0I5WCESJ/II#6F=7MOLQ["HM8>=J772ULO\
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M@S&7(TN%-B/+CRHDJ.\E#K$F,^VI"T*(E)4DR,B,A2+T]4
M                                                     !ES0K2'
M(-==5</TQQUMXG\BM&6[.P;:-UNCQ^.HG[V]D_\ P:6:RM0XXDE&7.N\AI/%
M:TD?*56=9248U9<*QV@JL5Q^BQ>CC)A4F-T]904\-)FI,2JIX3%=7QDF?5-+
M$2.A!&?^ 52Q;JZGV !'QTD6@4[6G0=R\QN N?FFE,V1EU5%80;DNRQ]V*4?
M+JB(CC[=YR"PS.2A)*<=<KTM((U.$1]9*J*MJ6S+3J96(%,NP
M                                                       -^NCJ
MT!G:S:^T61SX+B\&TGEU^:9%,6T2HDFYA2#D8CCYJ6E33CUA;Q2D.-J2I*X<
M-])\#4GCVBJLIW9;,:<++0@J%F
M
M
M
M                     8IUXF1*_0[6:?/E1X,&#I1J),FS9C[4:)#B1L0N
M'I,J5)>4AF/'CLH4M:UJ)*$D9F9$0+6</4=3+T.-A K.E.V$RK*;$KXRMS6F
M,),B=)9B,*F6=ZS6UT1+SZVVSDV%C+:CL-\>4Z\ZA"2-2B(^3HM9V^ X*@
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MW6WFTR86AN#0YD=2VU*23\26PMIU'ZYMQ"DJ(E$9#@[+4;U <@
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MF(U-3'8G&A-$DS:B--H4I:DFM7)3+-/S-+_;7I ?L6VW?PMK6' =HE[8<'8
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MO)[R!THSK4__ &2\PF%>%O"WD5V#_P!IQN8[)Y[]DYOFE@G4M4@<@
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MU.*<(C4I7'JZ<"*T8SC\J55WOLF@ X*@
M     2+]%K^5C3_81FG[RCCM'64KWR/"69Q4+0
M
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MI6H^&
M         #*6DNB^IFN.3L8EIEBECDEFM3:ILAALVJBDBN+Y!V%];O<B!404
M=7V[RTFXK@ALEN&E!\I5.LI**JRR_LZV>8QM8Q24IV5%R74S)H\<LNRQN-S<
M=EEOFWBQO&^>;1+8Q^+*3RU+<)#TYY*774()+3+/=*A:SFYON&YH[%,   (-
MM[W1PVSUK;:M[=:0I\>Q<>L<LTMKD\)T:>ZM3LNVP>+P)$N'*4I2W:M!DZTY
MQ[$2XA:6&>CCPHN+=W[F9"I.@SJR9*KK*'*KK"$^Y%FP9T=Z),B265&AZ/*B
MR$-OQWVED9*0M)*29<#(="X/5
M                            ;0;<MH^KNY2Z88Q*E?J<.:DI;O-0[J*^
MQC-6RASD240GE<T>06[1%P3"B*6X2C3SJF6S-Q/*39TG.,->LL]:$:&8-MZT
M\J]/,$AK1#BF<RWMY9-JMLDO'VVT3KNW>;2E+DJ1S:4H0DB;890AILB0@B%1
M*A:2DY.K,R#DZ@
M
M
M
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M*")?%2S-G*3X3.W2,[ -(NDHVR9%MMU=F66/1Y5S49A@^?4,.NG9'IWGF/\
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M4C&IV#9M84,9PVY-WCK$MR7293#B<.5)16SI4J$VI+DEIE"T*4H$TR4L#D
M                          *S'2E?E8W'V$87^\I IRUEW9^1X2.@=2J
M
M     !-%T%GY6VHG]7/+?YS-(AWAK*&(^0N_SGW>G;_*1TE^XA#^WS-@GK\
MP_Y/^E]A$( Z%<
M                                               )%^BU_*QI_L(S
M3]Y1QVCK*5[Y'A+,XJ%H
M
M                          !K=NJVYT^Y_2E_3JSNI..3H5U"RG&;QAGL
MQFNR*MA65='<L*_GH_A"ND5]Q)9<;)QM2>=)Q)\I!$?#54=X3V)5(T-+^B;S
M>FR"6SGFM$.-@-HTS"R>ET^\.Q;7,J6/81[)%'9O6#<&O@PW)T".^9K;GDAQ
MHC2@EI2X751*LKR:T+230XKBV/X1C=+B.*542CQS':Z-54]5!;)J-#A14$AM
MM)=53CBNJIQQ1J<=<4I:S4I1F?8H-MNKUGWQR<
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MPX4*.U%B18[220TQ&C,(;989;27!*4I))%] AV*9[(
M
M
M
M
M
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MN[/R/"1T#J50
M                  /;ASYU>ZIZ!,EP7E-FTIV'(>C.J:4I*U-J<96A9MFM
M"3,N/#B1'^H $RPGV+B7;";+G.H1S:')DEZ2XAOB:N0E;ZUJ2CE*,^!=3B8
M]0
M                                    $B_1:_E8T_V$9I^\HX[1UE*]
M\CPEF<5"T                                           #P2I46$P
MN5,DL1(S7)YR1*>;88;Y:TMHY;KJD-HY;BR27$^J9D7T0!\>)EF+3[ JB#DN
M/S;4TJ659$N:Z38&E+7/J44)F2N2:4L^W,^3P)/5^@.#FC/OCDX
M                                                 #T9MK65G->$
MK&!7\_R^9[-F1XG/<WR.<YKGW&^<YOG$\KAQX<HN/T0!Z-3D^-7SK[%'D-'=
M/14I7)9J;:!8NQT*4:$J?;AR'ELI4LC(C41$9EP'!S1K6?<')P
M
M
M
M
M
M
M
M
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MKI1I0F05>B,[,0T@I*WN0G@J<))$E('(
M5G.E-:=;W7V:W&W$(?P3#'6%+0I*7FBCS&#<:4HB)QLGF5HXEQ+E),OHD8IR
MUEW9^1X2.0=2J
M
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M.:D,K;=<C3:^?'Y2SBV59.8<CR&N)\V\VHB,RX&?;646G%T>LYT.3@
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MQ""9/JXK7PE:%V2I%_)(M^C)_*_P3_4.=_:A;#K'65KWR&6@14+,
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M3YCN6P
M
M
M
M
M
M
M
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M1=)+A+BQ+0XD+XZ%P
M
M
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M*)K+]A>/?PY('$2K?U+OD^8[EL
M
M
M
M
M
M
M
M
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M*FU0O(R4E5&(AP=@
M
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M7]A*F/')ER9UQB518RWY4A1$I^0\_(4I:SZJE&9_JCLM1;R5)-=TRD.3@
M
M
M
M
M
M
M
M
M                                                #TK.LK;JOFU%
MS7P;:JLHST*QK+.)'GU\^'(0;<B)-A2FW8TJ,^VHTK;6E25)/@9&0 ]IIIIA
MIMAAMMEEEM#3++2$MM---I)#;;;:")"&T((B(B(B(BX$ /V
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MA$<SC1D%R"<622+AQ,#ANK;XSG@Y.
M
M
M
M
M
M
M
M
M
M
M
M
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M)4-@QR=0
M
M
M
M
M
M
M
M
M
M
M
M
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MK3GHX"00=BD
M
M
M
M
M
M
M
M
M
M
M
M
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M>2/Y!FVH^M-7%?@UT)>(XKF%+!PLCK>)LS44%MBEXV5@\O@IQPUGRE(29$7
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MVA))0A"$D24(0DB(B(N!$.Q2/T
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                         #;3R(Q/Q%!^E7[L<G2K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K'
MD1B?B*#]*OW8"K'D1B?B*#]*OW8"K'D1B?B*#]*OW8"K.5 <
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M:T^V0@E%P40I7K-N%MRBM)WMW)RFDWH,L"S+@U4&8+
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                       #F."?[21/\3+_ 'LX*&(_
M)/OHJ6OEHST,<79JH,P6
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                 ',<$_VDB?XF7^]G!0Q'Y)]]%2U\M&>ACB[-5!F"P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                      YC@G^T
MD3_$R_WLX*&(_)/OHJ6OEHST,<79JH,P6
M
M
M
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MIV
M
M
M
M
M
M
M
M
M
M                             YC@G^TD3_$R_P![."AB/R3[Z*EKY:,]
M#'%V:J#,%@
M
M
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M4W.)EU. UOBNBZS<Z#\AMRV>]5T\1.</TG5X=-^5V%7OTTG-!;E8
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MM<#[J^RN VK&&,H
M
M
M
M
M
M
M
M
M
M                       ',<$_VDB?XF7^]G!0Q'Y)]]%2U\M&>ACB[-5!
MF"P
M
M
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MWKEO\E27CEH_EW"6@0LE(
M
M
M
M
M
M
M
M
M
M                             <QP3_:2)_B9?[V<%#$?DGWT5+7RT9Z&
M.+LU4&8+
M
M
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M(;YQ<9Q1H-7)3Q-/'@7T!&)I1DXQ=8IZ^/NF>BVXIM4;6KB/<'4[
M
M
M
M
M
M
M
M
M
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M46E[#8C#NE^$X=]-?"7%J_8O:;4XR[S3.6B@5@
M           B&Z2C_;/3+[&+K^%6!-]U/U>[]^O@(IO#^6M_>OX3Y6UFJW7S
M-,GGM%LEP>IP_P I[5#D7(6(;E@=PF+6G-=)3]!9+['6R;))_9.'$CZA?J]L
MXGDT<73'PN2O["TQU4TT^Z7=.F61S1X:N#E!6MIZZ5KH[C,JY/M:W7:SN,,:
MPZRXPS1MR">155"9LJ-&43ADE[R?K*3%Z:6^PW_T3CLA;O ^!K(S,SL[.<9-
M@$W@;$^DIK=/QFY/Q%U<RW-,9HQ=Z.QQ+F22\9MAH?MCTVT*97+H(LBZRN3'
M./.RZ[YEVT4RO@;L2M9:0B+3P'%EU4-%SKA$1.N.\E)EALPS;%YBZ7'LV5JB
MM7??&^_X$C*8++</@M,%6Z]<GK\'$OY-G*=?\/M,]T8U&Q.D0MVXM<;E'5QF
MEDVY-G0'&;.+7H6HC02K!Z$3!<K@D^<X&I)<5%1RV_##8^U>N?(C/3W$]%?!
M6I5Q]J5_!W+4/EN.COK33PZB&K;/N6M-NMQ?5MI0/7F+WTB-X;J4N]@7%59U
MO/QRFP#D(-HY!-NJ;?CO$CG.0CV[9H/C.LVRF&:0C.$MF]%:'K33X']AKQD1
MR[,99?.491VK<M:U--<7V42T:=[K]"]2EQXE1FD6FN)' D466-GCUCSAEQ)A
MIZ6HZF<^? ^"(TE\^H(7BLFS'"5<[;E!<,?C+Q:5X4B4X?-,%B-$9I3XI:'S
M<C,@8EI+B6%9MGV>T16+-SJ._7RLCCNRFUU9R:XI'-R(,1$9M;#TAV6ZXZ:G
M'.4MQ1EPX\!;7\;>Q&'MX:Y3H[2:CQZ>/DT%>UA;5F]._"NW<I7BT<1]O43"
MJW4;!LIP>V(NP<FIIE8ITT\LXDAULU0+!M/$B-^MGH:D-\>IRVRX\2%/"XB>
M%Q$,1#Y4))]_C7A6@[XBS'$6969_)DJ<S\#TD&6W#,[#07<171,D4JLC%<V.
MGF;,KYTFX[,J;X/<>>+@A1LU=W%8DJ4:3,VV3X%Q,;#S6Q',LK<K6E[*G#DK
MXU5>$A>7WI8''I7-"JXRY:>)T9/^-:DZ-&-&F?/)N3U1UP?(Y.,:>$>E6G+Z
MDFIAR1&;<*_LH:UI/J\B4\M)I-/%FUX&7$A(<>^HY59R]:+UW^LG_LI^+S3"
M81=;S&[C7^3M_$A]E_R\HRQNTSJ;I]H)G5O5O.Q[:QB1,:K9#/M5QW<BF,UL
MN0AWDJ-AV/5O2'&UD7*)U*>!I/@HK/)</'$YE;A/3!-R?]%57CH76:7W8P,Y
M1^4U1>'1\%2/KHY,:C6.I^99/(;YQS&L01$A&?#DL2\@LFFU24]4E<\4&M?:
M+Z)<AU7'J\#*2[TW7'"6[*U3G5]Z*YVC!;OVU+$SN/7&&CPOF3)E!!27$4MO
MT>646.J,FW\L\<>T]L<F=N)I25W"<M*KEV+DZ56IB%7/5LB7S*S9*0J:CE&?
M.&@OUAS*&\]F.#4.CEUI0HM6S6E$ZUK3AI3N$8GD-V6)V]N/0.57KVJ5U:J>
M&I*T(:2<K_X;'8E;QZYB2PS(87K[,Y;+[:'FE\G-)2T\IMQ*D*Y*TD9<2ZAE
MQ&RK[:R)M:'U9?B$$LI/-DGJZ?\ VBP -:D[(_.D=CLJT8Q&4II!R&=3ZJ.T
M\9?LC;,G%,P<?:2KZ)(=7$;-1?JF@O\  )-NLWU^<>#H7^-'G,#O EU.#X>D
M7XLCT.C>4H]*\Y3RCY):@+42>)\DE*QRC)2B+Z!&HD%Q/]7@0YWJ_7+?YK_:
M9UW>_5I_?_81(D(P2 KY[=/RI<#^SZ=_[5D-F9I^Q[GYI?8('E_[2M_G.<L&
M#69/#1_4;8MI]J+J98ZA2\EOZJ->SV;/(,;@,0C9FS")DIJX5DY^SUZ+/FE+
M=(VWE$ZXI2%)+@DI!A=XL3A<(L-&$9.*I&3KH7!5<-/ 87$9+8Q&)=]RDE)U
M:7CH^"IM5DF:X#IG3QW,IR7'\2JH<1MB$W:V4:&I<>(TEIJ/ BO.]ESEMMH)
M*4,H<</AU",QA[5C$XN;5F$IS;TT5=?'Q>$R=R]8PT/ZV4812T5?P<9!KN_U
M1Q'5O5Y6381+EV%%$QNKHV["5!D5Z)TB!+M'GI,./+2W,[#44Q*4J=;:6:DJ
MXH(B(SV%D>#OX+!=%B$E<<VZ5K2J6NFBN@AF:XFUBL7TEEMP44JTI6E2:S0K
M^1#1O[E6GOVHU @.8_M"_P#GI_C,F&"_4[/YJ'XJ. [OOR;]4O\ 5%7]L=,+
MG(_VK9^^?XK*&;?L^[WE\*- >C=_E1SO[ 3^V*F$EWJ_4[?YW_99@MWOUF?Y
MO[*)D!!27&MN[[\F_5+_ %15_;'3#*Y'^U;/WS_%9CLV_9]WO+X4:*]&PVV>
M;ZENFA!NHQ6I;0X:4FXAMVW6IQ"5\.4E#BFD&HB/@9I+C] A(MZF^KVEP;;^
M PN[WY>X^'87PDG^>Z7:?ZGPXD#/L5J\FCU[KCT YS;J)$)QY*4OG$FQ78\V
M,E]*$\XE#A)7R4\HCY)<(CAL9B<))RPTW!O73A[ZU$DOX:QB4E?BI):JG***
MBIL8IZ^@QZLAT]+4QD0ZZL@,HCQ(D=OCP;::01%Q4HS4I1\5+69J49J,S.C<
MN7+TW=NMRN2=6WK94A"%N"MVTE!+0D07[Z_RD,M_U1B7VN5PV'N[^RH??2_&
M9"\Z_:$^]'X$3?81_L9B/V,4'\%1!K_$?K$_OY?"R96/R,/O5\!"+OESJ;EV
MO=_4+>=.IP6)7XU51U>U0ATX<>RN)!-$DB)U^TFN-FLS4I;3+?5X$24[ W>P
M\;&6QG]W<;D^6B\2\;(;G5]W<=*/W,$DOA?C)G])<:C8=IAI_C$1OFFZ;$*"
M(X1\"4Y+*MCN3Y+G S3STN<XXZOAU.6L^' NH('C;KOXN[>>N4V_!71XB7X6
MVK6&MVUJ4%\&GQF'=U>WZSU_P^EJZ&\A4M]C=L_9U_A;LOP//1+B*BR(LU<)
MJ3(BK(TH4V\EE\T$2D\CVYF5]DV9PRV_*=R+E;G&CI2JIQ5^"J+3,\!+'6HQ
MA)*<755U,^;M+VY6NW['\I1DEO4VV2Y;85KLU5$N:[51*ZD9FHK([+]A#KY4
MB0;MI)6XHV&R(EI21'R>4?;.LTAF=V#M1E&U!.E:5JZ5U-\2X3KE>7RP%N72
M-.Y-K56E%JUTXWP&VPPIE0 ,+:[ZW8WH3A+V4W:#GV,MQ<#&J!EU+4F[MC:4
MXEKG#)78T"*DN7)?-*B:1P(B4XMM"K_+LONYCB.AMZ(K3)\2Y^)?8+/'8VW@
MK/23TR>A+C?-QFD>E&D&0;PJ:]U>UUR*T5!M"NZ'3?'Z5;E?38[S*UQGL@@0
MDNJ;=:K[)*F&FW5+<DN1EG*6Z7($@QN.M9'<C@LN@MI4<Y/2Y?S6^ZM/<KHH
M8;"X2YFT)8O&R='502T)=U+N/EII-*ZV?J5M"UL<)QLFKG'WSBV$7E.%3Y?B
MLUQ"SY"^"3>K;9AI+K*S+EQY#:3-).M&DL]..$SO+]'Y.2T<<9+[*X>-=QF'
MC+$95C/Y\=?%)<S\3[J)WM--1L9U6PVGS?$Y9R:NU9(ULN<E,RLGMDDIU38M
M)4HF9\!X^0LB,T*+@M"E-J2I6N\7A;V#ORP]Y4G'D:X&NX_Y:2;8;$6\595Z
MT_BOQ/A3[J-$M\\%S4K/]"M%<?;9>R>\L;2SDN\VTX_55-@Y$@-37.'[.4%M
MBNGR7RXI+D0N)$HR]K(MWI+"8;$8^[^1BDN^U5T[^E)=\PF=1ZQ?L8.W^5;;
M[R>CDT-OO$@&%8;CVG^+TV'XM7LUM)1PFH<1AI*26X:$_LTN4X1$J3.FO&IU
M]U7%;KJU*49F8C6(OW<3>E?O.MR3J^;O+@1G;-FW8M*U:5(17\O"<H%$J@
M
M
M
M
M
M
M
M
M
M
M  ',<$_VDB?XF7^]G!0Q'Y)]]%2U\M&>ACB[-5!F"P       _BE)0E2E*)*
M4D:E*49$E*2+B:E&? B(B+JF (G=S6^2S<L+'!-$K%N'713<A6^H,7DNS)\@
MC4W(C8HXLE-1(#753V>1*>=7[:.;:4I==F>4[O045B<P59/2H<"^^[O<U+AK
MJ46S'.I.3L8-TBM<N%_>]SN\A&58V-A;S9-G;3YMI8S73>F6%C*?FS9;RB(E
M.R9<E;K[[ID754I1F);&,814()*"U):$O 1V4I2>U)MR?"STAV.H
M
M
M                              >]6V=E33HUG3V$ZJLH;J7H=A6RY$&=
M%>0?%#L:7%<:D,.I/Z"DJ(R'6<(7(N$TI0>M-53\!VC*4'M1;4EPHDVVS[YK
M)-A7X+K=8-RX,QQ$2IU"D$U'DU[ZC)N/%RHFFVV)$!P^"2G\$N,J]M(YQ"E/
M-1+-MWH;+Q&7JDEI<./NQ[O\WAX*:G(\NSJ2DK&,=8O5+B^^[G=Y>,EA(R,B
M,C(R,B,C(^)&1]4C(R^B1B&$H                                B&Z
M2C_;/3+[&+K^%6!-]U/U>[]^O@(IO#^6M_>OX39+H]?Y!)7V?9%_!]",3O-^
MTE^:C\+,CD/ZB_SC^!&\XCQF@ /@9+E6-X;6*NLKO*S'JA,AB*JRMY;,*&F3
M*7S<=E4A]2&TN/+ZB2,^J8JVK-V_/H[,7*=*T2JRG<NV[,=N[)1AQLUUUDV?
MZ2ZPS95])BS,2RV6:G).0XT<=GPC(/\ ^'NJM]ER#8NF?56ZDF9+G_.=,B(9
M/ YYC<#%6TU.RON9<'>>M>-=PQ^+RG"XN3N.L+KX5P]]</P]TCGU6V&ZJX#"
MG7>+S(&HM'!;<?>14QWZ[)6H[9IY;RL?>7*1))*%<>3%E2'>"5'R"(NK*<'O
M'@\3)6[R=JX^/3'SN=(P&*R3%6(N=MJY!<6A\G,V9:V%;@,HD9.WHME%B_<4
MTZKGR\.D3WW)$ZGEU$8YDBE8?=-3CE0_5L/.-MJ491E,$39$E9D5EO'EME6>
MOV4HW$TI4U-/17OUIWZZ2ZR/'7'=ZG<=8-/9KK5--.]3D)9Q"R4D*W2":8>2
MNJ%=J!7QR;J=0X'*G&V@R;:R:C:CPYW*(C-#9SZU45XNHDW'2>5U3Y1B>[M8
MOIL(\-)_'M/1]Z]*Y'5=ZA#\]PW18E7X_)N+QK7RJGC-HHFYMUW9LSFS$Q<G
M4)R.C2F.VDSD6$C.W&"@,S4(0LW7K!RB45L2>!FI?4Y)_0/$2RE+/>KM4PM>
MD[FQKIWJ_%,DLR;RCIDZXCY'=VM5>_3XQM/H+IJUI+I/AV$\VVFQ@UJ)E^XW
MP/G\BM#.?<+-PE*YY#$Q]3+:N/\ T+2"+@1$18?,L6\;C9XC[ENB^]6A>+3W
MS)X'#K"X6%G[I+3WWI9AO?= DS-N>2O1T&M%;=XM/E<"49HC'<QX)K(DI/J)
M?FHX\>!$7$^(OMW9*.:03X8R2Y*_8+/.XMY?)K@E%^.GV34/HVKB/'SO4>A6
MM*95IBE7:1TGU%+:I;8XT@D>V+B:3O$&9<#/AU>IP,9O>JVWA[5S@C-KE7VC
M%;O32OW(<+@GR/[9, (02P   (!,&_+-J_N^SOMRF#9.(_8+_P LOQ$06Q^U
MU^?_ -HG[&MB=&@72-_R(8M]U6C^U'.!)=UOVA/\R_QH&"W@_4X_G5^+(^1T
M;W\EN=_9^K[7:4=]ZOURW^:_VF=-WOU:?W_V$2*"+D@*^>W3\J7 _L^G?^U9
M#9F:?L>Y^:7V"!Y?^TK?YSG+!@UF3PB$UHW?:FZDZ@'I7H3*<HZJ;?-8M6W5
M8:$9#D]@],[ [,C6BN5X"IW)!\IIQCFWR93SKCJ4J-M$WP&283"X;KF8K:FH
M[33^3%4K2G"^_HKH2X2*8S-<3B;_ %;!/9BY436MO5KX%_\ &IMWI;LXT[Q1
M+-_J,2]6]0))-R;6]S!Q^WK&Y9H3SC-?4V"WF94=IPO:O3DR'UF7*+FR/FTX
M3&9[BKW]7A?ZC#+4HZ'3NM? J+OF5PV48>U\?$?UM_A<M*\"?V:D?O2!,,1-
M<*J#$9:BPH.G6.QH4..VAF+#CE:9$Z3$6.V26H[)..J5R4$2>4HSX<3,27=I
MN67RE+3)W95?'HB8+/4EC5%:(JVJ<K);M"OY$-&_N5:>_:C4"%9C^T+_ .>G
M^,R4X+]3L_FH?BHX#N^_)OU2_P!45?VQTPN<C_:MG[Y_BLH9M^S[O>7PHT!Z
M-W^5'._L!/[8J827>K]3M_G?]EF"W>_69_F_LHF0$%)<:V[OOR;]4O\ 5%7]
ML=,,KD?[5L_?/\5F.S;]GW>\OA1HQT:_^V>IOV,4O\*OB1;U_J]K[]_ 87=[
M\M<^]7PDO(A!*P (&M]?Y2&6_P"J,2^URN&QMW?V5#[Z7XS(1G7[0GWH_ B;
M["/]C,1^QB@_@J(-?XC]8G]_+X63*Q^1A]ZO@(#]W$"37[C-4F92#0MZ[B3V
MNHK@N-8TU9.C+2:DIXDIB0GCPZG'B7'J#8^2R4LKLM>33D;1!\UBXYA=3\JO
M*DR>K +B/D."87?1%I7%N<4QZT84C]:;4^IB24$7ME<#23O RXF9&7 :YQ-M
MVL1<MO7&<ER-DWL34[$)K4X)\J.6B@5@    "%'I#\CL++6>HQYUQ95F,X=7
M'!C<HS:*9=2YDRQFD@^HAZ2TU':5P^BF.@3[=BU&& E=7RYW'7O*B2^'E(=G
MUR4L8K;^3&"IX=+^QR$ENU5416WC2@X1H-GR7:2LVR;2GLM,R8FP(R;,T\M,
M\G"4?ZXU<35[;B(IG.U[3O;6O;\5%3Q$BRRG4+5-6S]G3XSX>Z';Q6Z[X8I,
M%$6'GV/,R).*6[B4ME(,TFX]C]B^7 _!MDM)$E2N/8SW!PBX<XE=3*,SGEU_
MXU7AI?*7^TNZO&M'$=,RP$<;9^+17X_)?V'W'XB)S;_K?E>V;46PK;^%9ECK
MU@NGS_$'4<F9%DP7EQUV$*,^ZRTS>U+A*27%24/M&IM1]5"T3/,\OLYMA5.T
MUTM*PEP.O ^X_%K(O@<;=R[$.,T^CK24>]P]]$A.UFBN=5-0,XW4Y?$=BHR=
MV7CFFE7(4:SK<9A/=@R)2."N;(T-PDQ"6DB)QXI:^'!PC.,YQ<MX/#6\GL.N
MQ\:X^.3T_9KYO$9[++<\3?GF=U4VM$%Q+5]KE-]Q&S.
M
M
M
M
M
M
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M Y.
M
M                 YC@G^TD3_$R_P![."AB/R3[Z*EKY:,]#'%V:J#,%@
M    !HEOSUBEX!IO"PBAEJBW^I"YL&6^RI1/P\3@MM%=\VM!ES+MLY+9B$:B
MX+CK?Y/!22-,BW<P,<3BGB+BK;M4:[LGJY*-]^AA,[Q;L8=68.D[E?-6OEU=
MZI".-@$-
M
M                                                     )OMA^L$
MO4'3.7AMY+7*R#3=V%7,OON&N1,Q:<V\=$XM3A\MURN7$>B'PXDAEIGB?%0U
M]O'@8X;%J_;5+5VK[TEKY:I]^I,LDQ;OX=V9NMRWH_HO5R:N0WG$>,V
M                       'HV-K64\<I=M90*N*;A-%)L9D>%'-U25K2V3T
MEQIOG#0VHR+CQX),_P!0=HPG-[,$V^XJG64HP59M)=W00R=(#GV'9IG^'0\2
MR&KR,\=QR9'MI=-,8L:^/+GV'/M0TSXCCL5^4VRSRG4H4KF^425<%<4E/-VL
M-?L8:Y*]%PVIJB:HZ):Z,B&>W[5Z_!6I*6S'332M+XS8;8#J=@-9I;:87;Y7
M24N31LQM+)-5<V4.K?FU]C7U"(\NM[,>91/;)Z*XAQ+9J<:4GVZ22I"E8O>7
M"8F>,5^$)2M."54FZ--Z'349#(L38CAG9G*,;BFW1NE4TM7&2.1I4:;':E0Y
M#$N*^@G&),9YM^.\V?T%M/-*6VX@_P#"1F0BS3B]F2::) FI*L75'G'!R::[
M\V%N[=;YQ'#DQLBQ5]SB? ^0JU;C%R>IU3YR0G_['$9W=QI9I%<<9? 8C/%7
M /N2C\)\+:-NCQS4/$J;!,QN8E5J+C\*/5-%92&XK>7P(;:(\*PKI#ZTMR+@
MHZ$IE1^5SJUI-Y"30I1-U,[R>[A;TL18BY863KH^Y;UI]SB>K@[]/*LRMW[2
ML7FEB(JFG[I<#7=XUX3<S(\EH,1IIV0Y/;P*.EK65R)MC8R$1X[+;:%+-)&L
M^4Z\LDF2&T$IQQ7!*4FHR(8*U:N7[BM68N5QZDC,7+ENU!W+C48+A9$ULNP*
M3F^X'+=98%>["PC';3,95+)<:-AMZSRE<^' JX[?!*5'#H;5YQ[D]1D^;29>
MW(3//L3'#Y9# 2=<1)1KWHT;?A:5./21;)[#O8^6+BJ68N5._*J2Y&3 "$$L
M-:]VFF1:H:(976QF>>O,<9\L<>(DDIQ5A0LONR8K9&7*4Y8T[LF.@B-/[*ZD
MS/@7 \MDN+ZGF$)/\G/XLN\^9T9CLTPW6<%**^7'XR[ZYU5$7&RC!+#4;5FG
MB3G7GL+P&5YP[.N<4:H#U]$2U7T'%DR4VN6N<IMSVQ<%,1G$_J]67Y_B(X7!
M2E'\O<6PGPT>E^+QM$:R>Q+$8I*7Y&#VVN"NI>/Q(G;&NB;'$\\P^LU PS)L
M*N.45=DU-.J)#J"Y3L8Y3*DL36$FI)'(@R.0\V1GPY:"X]05L-?GAK\,1#Y4
M))_:\.HI7[,;]F5F?R9*GV_ 0&5K^H&TK7&-)L*]2;C$[!UN1&6IYBLRS&IJ
M5QWUQ))),G:^WKUFIEWDK['?))J1SC2D%LB:PV=9>U%_$FO#&2X^ZGKXUW&0
M:+OY7C:R7QX/P27,UR> FHP;<QHCGU+'N*W4+&JAQR.3\NERBXK,=O*Q1$GG
MVID"RELFLHRU<E3S"GHRCZJ'%$9&<"Q&4YAAKCA.U.2KH<4Y)]YI>)T?<)A8
MS'!WX;<;D4^*32:\#^QH,+:P[F6\E46D>W"8C.]3<J)ZM.^QUY3]'AU<X1-3
M;SP\R1P'I$=ISBV^RZIB*?[*MSE)0VY?X'*7:_\ .YHNCPD--):Y/@5-?@>E
MZNZK/%YCTG_E<O>WB9:*K5%<==7AU+6;1TDM.!8501-1,XKYEK5TL5F[RF]F
M5M.W9S8T=)SIO%:8#!,DLCY)FGG#01&X:EFI1XBY'K.(E+"VVH.6B*3=%P+A
M_EJ,G"7068K$33FHZ6Z*O'Q$"F)YMC]=N8J]0)DOFL73K$O(WK#FW%)8I965
M.S#GK:)'/&VQ#>YU222:^2DR))GU!L>]A[LLI>&BOZ[H-FG=4:4Y2#VKT(YB
MK[?]7TM:]S:UEA&ER&@R2(B?CUW47L%:&W$3*>QAV492'2-32B?AO/-\'$D9
MEU>KP&LKEJY:ELW8RC+B::^$GD+ENXMJW)2CW'4CVZ1/+L7F:6XIC,+(*B;?
MJU"KKDZF'8194YNKAXUE$1^:_'8=<<8CIDVC""4LB)1K]KQX'PD^Z]B]'&3O
M2C)6NB:JUHJY1=/$S Y_=M2PT;<9)SZ1.E>!)\Z./='7G>(5>)YOB%ID%55Y
M#(REBZAUUE.BP7K"!)J84 G*\I+K1S5L282DNI;)2F^6@S_7$*F]&&OSOV[\
M(R=I0HVDW1IMZ>+64\@OVHVIVI22N;5:-TJJ4T$DM]DV.8O"?L<DO:BB@QF'
M)+\JVL(L!E##*5+<<Y4EUOE$E*3^AQ,^'4ZHBMNU=O2V;492D^)-DAG=MVEM
M7)*,>ZZ%>O1'+:'&MP&$Y==SDP<>BYLJ7+L74+)J)#FO2F$3)!<.6W'9[*2M
MP^'%"",^'4&S<PLW+N6W+%M5NNW1+C:X"!X.["WCH79NEM3UEA)JRK,IHY,C
M'+FLM8EA"D,P[.JL(\^"I;["T-.MS(+C[:DI-9'Q29GP^@-9.$[-Q*[%QDGI
M35'R,GFU&[!NW)--:TZ_ 5X-*KSS,ZY8K;YC!E12PC,.QLEA\SRY<%##K]9:
M.(84A9O/04.K<2E)$;AH(DF1F2BV?C+?7\OG"PT^DA\5\#X5RD"PL^J8V,[J
M:V)Z?@9.O(W$Z%QJ$LD=U7P8ZI3//IYF_@R;)9<VEPV$4<=QV\7-0A9<J.48
MWT\>!H(QKM97F+N=$K-S;[SIRZJ=VM":O,,$H=([L-GOZ>37X*$-F[W,+'4;
M4BLU /%;G&L6R#%X3.$2;MM+$K),?JY]BR5_V*1J5!1-EO+4TRL^7V,;3OZU
MU)G.LDL0PN%>&VXSO1F]NFJ,FE\6O#1</'5<!$<UNRQ&(5_9<;<H_%KPI-Z?
M#\%"6/;=JMIUD.D6E-+6YECRKVNPO%<6ET$BV@1;UN[HJ.#5SH95#\A$]PU2
M(BE-*2V9.M&E:>)&(9FN#Q5K&WKDK<NC=R4DZ.E&VTZZN'3Q$IR_%8>YA;4(
MSCMJ$8TJJU22U:S[VY^DF9#H!JG60&7I,L\7?GM,1T<Z^Z5-)C7+C;;9<5.*
M4U 5[5)&H_H$1GP(4\HN1M9E9G)I1VZ<NC[)WS*#N8&[&.O9KR:?L$1FS'6'
M%]']4YD[,Y)U^.Y-CDG'Y%N4>1)353#GU]C!DR6XJ'G^PG%0E,N&EM9H4XE9
M\E"5F)KGV!O8[!J-A5NPGM4XU1IZ^'34BN48NWA,4Y7M%N4:5XM*:)A*S<3H
MA=6U114^I>,6MQ?2XD&JKZZ6Y-DRYDYSFHT?D1F728=6YU#)PT<C_G<!!YY7
MF%N$KD[4XPBFVVJ42)9',,%.:A"Y%SDZ)+NF+]Y^8XO5:!9]2SKVK9N;IBIK
M*NH[-CJLYLP[VLDK;9A)<.0:6(L5QUQ1I)*$(,S/CP([S(;%Z>96[D8OHXMM
MNFA*CX?"6V;WK4<#<@Y+;=$EPZUP&B71\YQB6(Z@9E!RC(*O'W<BQV!&IG+>
M6S7Q)LN'9&Z[#1,E*;BIEK;>(VVU+)3O R21F7 2+>;#WK^&MRLQ<E&3K15:
M36NG$83(KUJU?FKLE':CHKHX29N'.A6#"9,"9%G1E\.1(AR&I+"N*4K+DNLK
M6VKBE1'U#^@9"!RC*+I)-/NDO4HR58M-']E3(D%E4F;*CPXZ/U[\I]J.RCJ&
M?MG7E(0GJ%^J8*,I.D4VPVHJLFDB C>;D5'D^X3,K''K6#<U[4;'JXY]=(;E
MPES*^B@1IK+,IE2V7SBR4*:6:%&1.(4GCQ(QLG(;5RSEEN-U.,JR='H=&W0@
MV;W(7<?.5MIQT*J[B52:C1O/\.SK <2E8KD55;FSC5*S,AQ9L9RQK9+%='9D
M0[. EU4J!*CO(-*D.)3]#B7%)D9P+'X:_A\3.-Z+C\=T=-#TZT^$F&#OV;UB
M#M23^*N'2M'"N T4Z0#0BTME0M:L7A/3?!U<Q3YQ"BM+=?9@Q7'%5F1DVGE+
M<8C(?./+,B_8FDM+,N0EU29#NUF,(5P%YTJZP?=X8_97A7$83/<%*5,9;5:*
MDOL/[#\'=/B;--VF,XUC<;2?5&V121ZIQTL.RF<;AUA0)+SC[E#<RC-?@Y4.
M0ZI45]?"/S"N:6IHVF^=J9[DMZ[=>-P<=IR^5%:Z\:7#7A6NNG35TZ91FENW
M;ZKB71+Y,GJIQ/B[CU<!OODFX?0_%:E=Q::HX4]&)DGV6*>_KK^RFMJ2:FS@
MU=*_/GRTN<"(EH;-!<2XJ(CXB.6LLS"]/HX6;E>[%Q2[[=$C.7,?@K4=N5V%
M.XTWX$JLQ%H-EVK.LF>WNKMDJUPW1EVI\!8'A<Q#!NY,3<E;J<JFM/,NJ95P
M6HS?CJ;)U2D,H6ZTRM3E[F-C!8'#1P4=FYC]JLY+[G^:N9]_0V6F!NXK%WY8
MN588.E(QX^[]M=[2D;AC!F7  BGZ0_2"V?L*'6.EA/2ZUFJ9QG+NQVW'#K%Q
MI;[]+;R"22^1$EE.7%<</DH;6TR1\3<$RW8QT%&6!N.DZ[4>[HTKQ5Y>(C&?
MX23E'%P58TI+N<3\=.0QSM!W;T^DU4]ISJ.<XL/7.?L*&^AQW9Z\;>FJYVP@
MRZ^,A<M^IE235(2IA+CS3[B_:+2YQ;NL[R6>-GUK"TZ>E&GHVJ:FGJKP:=%*
M<6FWRK-886/5\17H:U3UTX]'%PZ.$D(M=X&W2IK3LE:E5D]/-\MJ%50;>?9/
M*,B-+10F:_G6'%<>'[-S24_\XRZHC,,CS2<]CHFNZVDN6OP&>EFV7QCM=(GW
M$FW\!'MJG@&=;MK#+M==/=._)K&*6FBPJINP2XUE.IKE4\XF3818<9+L27/A
MURN:(T*4E28[<9MU]Q)I;DV#Q.'R6,,NQ-W;O2E5T^3;KP5UT;^%MI+7@,38
MO9I*>-L6]FVEHKKG3A[]/@I5F/-KVZBZT+M#QO(TSKG3:QE*5.JD'SEAC<UQ
M?!ZUHVWEH3P6KJR8AJ0A[]>DTN$?+NLWR>WF,.EM4CBDM#X)+B?V'P=XH9;F
M<\%+H[E7AV]*X5W5]E$P^):\Z-YQ%9DXWJ3B,M3S27B@R;F)5V[2#02S[(IK
M5R%:1S01^VY;)$1D9?J"#7LNQV'=+MJ:[M&URJJ\9++6.PEY5MW(/PT?(])E
ML61=@
M
M
M
M
M
M
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M8P[)IA3SJXQ2>9<4;C:QCXQ<+RB]:DOA+IM2MMKB.V\&3+,
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M)W-F3T> KW(1C&J6DO4"]+<
M
M                          .8X)_M)$_Q,O\ >S@H8C\D^^BI:^6C/0QQ
M=FJ@S!8       0C](7</V&ND&L6I?8]#@U'%9;/J-\[-G6]F^\DN4?%;B9:
M$*/@1F39%PZG$]@;LVU'+G/AE<;Y$E]@AN?3<L:H\$8+[+-$A(C"
M
M
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M]\]0?C6*GM_-_6_@P]$Z>Q\M]7^%+TC:D8<R8
M
M
M
M
M
M
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M+YM";* M78ZY##4UJ(^\VRJK;NQN:OE<1TG!PUZB5053H
M
M                                        <QP3_:2)_B9?[V<%#$?D
MGWT5+7RT9Z&.+LU4&8+       ""[?U^4+8_8KC'[V?&P]V_V8OOY?"0K//U
M]_>HTK&?,.
M
M                                                       ;J;!?
MRA:[[%<G_>S P&\G[,?W\?A,QD?Z^OO63HC7A-0
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M)2DB2E*2)*4I27 DI(N!$1$74(18D)_0
M
M
M
M
M
M
M
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M-,V,:',<2;C"3+&)]'=T<#+QK;AWT=L*,F68
M
M                              !S'!/]I(G^)E_O9P4,1^2??14M?+1G
MH8XNS509@L       (+M_7Y0MC]BN,?O9\;#W;_9B^_E\)"L\_7W]ZC2L9\P
MX
M
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MQ0LC(^J0C-VU.S=E9N?+C)I]].AGK=R-VW&[#Y$DFO"?;%,[@
M1J:PZ[[TM)JMR]R33S2^%C*)K3!Y%C\:VO8L=4E:VHL>PYS+ERHC;SBTH)YV
M&PVMTTI2HE*)!RO Y=D.-GT=J[>=VGR71=^GQ?%5Z".XO'9QA8[=RW;5NNM5
M?+\;["/=V@;H-4=;-3K_ !?-G*!51"PBTR**U4U'8#K4^+D&-5[*>?.5(<7'
M3&MG2Y*N)F?)/E=3J]<[RC!Y?A(WL/M;;N*.EUT;,G]@YRG,L3C,3*W>V=A0
M;T*FFJ7V21X18D(
M
M
M
M
M
M
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M$6S!=E
M
M  YC@G^TD3_$R_WLX*&(_)/OHJ6OEHST,<79JH,P6       $%V_K\H6Q^Q7
M&/WL^-A[M_LQ??R^$A6>?K[^]1I6,^8<
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MY"[;C=MNL))-/C3548RY"5J<K<]$XMI]]:&?)'<Z
M     $[6QW99H1F6@F/:CZBXPSGN09^5S(/PC.LXL+'JZONK.B:K:IFKL(9%
M)6=8;STE?%]+B^0@T)1[;7>\.?9C8S*6%PL^CM6J:DJR;2=75/CHEJ)KD^4X
M*Y@HW[\5.Y<KKX%5JB^R]=2*G=3I50Z*:^:A:;XO.=GX_13ZV14G(>Y^7"AW
MM'67[55,>X%STBJ*S['Y9\5.);):N"E*(ICD^,N8_+;6*O*ER2=>)M-QJN_2
MI&<SPUO!XZ>'M.MM-4[E4G3P5->QDRP
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MFVWR5&DDDGVH@^*S/'8Q.-^XW;?W*T+D7V268? 83"M2LP2FN'6^5F9A8%X
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MC]')_+?E/W*KS[;L'$MWI_9\/SR_%F1S=_\ 7)?FG^-$FG$")@
M
M
M
M
M
M
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M[F!D.,Y%4R#43-C37-8_)@6$1Q2%$2VUJ+E),OHD9"HFI*JU'5IIT>LYB.0
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M>SXV'NW^S%]_+X2%9Y^OO[U&E8SYAP
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ME^<IW-N6F3;>OC=66N?6K5G,'"S&,(;$="22Y$:/B0F%
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MLQ_4;OWC(PNCD_EORG[E5Y]MV#B7;T_L^'YY?BS(YN_^N2_-/\:)-.($3
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MG-K42!$L?EF*RZ5+RK;>J2U/F?<?@J23!X_#XV-;3I-:XO6N==U&<QCB]
M
M
M
M
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M"HS7%RNK_*?!GKR)(<4EMR9+CUS/+4:&FU5,-/9GLO4SK>C6->%'9(#(%J
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MC.%<$:ZJTTMOB5-'"9[*\DGC8=8OR<,-P<;XZ5T)=UU[QY[>ZZ."@REW$8V
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ML5R?][,# ;R?LQ_?Q^$S&1_KZ^]9.B->$U
M      CQUW_+8VV_ZH:_A3)1)\N_8&+^^^Q$P&._;&'[WV6;?ZP:4XYK-@EM
MA&1MDAN6GLJILT-I<E45Y';<*OMXA&I!FY'4XI+B.4DGF%N-&9)68P>!QEW
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M<?=?=?B-5QF#&
M                  $B&Q_<E-Q#(H&D.8V*G<.R.5V-BLN8Z:BQG(93AFQ
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M9'&X=7=5Q:)+B?,^ SL,<7P
M
M
M
M
M
M            !2%^<.?VW?0T?99H%_XN*X6.(_+1[R^%EQ:_)OP_ 0[_ #I/
M9W\FSI*[O5W'J@J_3S=]B<+6&O>C-P6*YK4NK4WBNKE4PQ'Y$HY\JWAP<BF/
M.H,GI&2&:7%F2TM],1#9N5X'I.]IUAWC6#YOKO$/9MTHF@606U@F!I[K?->V
MV:F*<YTFDT6K$^KA8M8.N)<2U%C4&J-;C]A)><0XE$&,^7!)J)Q'6S/8N)\&
MHYN1VH-<)VT(R99E.+YRWJ#EF[O<ST?W0WZ.6YM9-K5J9CNJ^K+\),R2>.5-
MI.M\'P6RN&&78<&;48MCJ,MR2R@K>6_S-?"?)#?%A;MIB&Y2C:6LKVE2+FR%
M;YV'IWB.D.^S:CI3I_41L?P733HY-#<"PVCAMM,Q:C%\1UEW'T%#6L-L-LLI
M;AUD!ILN2E)>U^@0I8E*,TEJ4><[V76+;XR/OH!_[838M]U&]_FVS@4[/Y6/
M?.T_D/O';E#*%F   &@G24](1I#T:>UK--Q>J3K-K:QFW,>THTW9L&8-WJKJ
M?81)#F.X?6.+2\Y$KR4PN7;3DM/>#:F/(D$V\XAMAVG<N*W':>L[0BYNB.L9
MSSIUNECSS-<JS1S>UK/B)Y3?VEZ6*X'D;V,85C3=E,=E-4.*X_&YUNJH*EIP
MF(K*G'74LMIYQQQPU.*Q[NW&Z[3Y2[4(+11%^/YM=N,UTW1=&VWJAN&U3S'6
M#4)6O>J>/'E^<VKMS>'1U$/$EUE7V8\1+[#A+F.FVCZ"3</_  B\PTI2MMR=
M77F+>\DI:.(G^%P4@    "'KIV=\'R#^C<UQU%HK8JS5;4V G0?153;K;4UG
M/]3(-C!D9# -UF2@IF"83#M[]GEM+:<D5C3*^!.\2HWY[%M\;T'>W':GW$4'
M]_G0[Y+L]Z,#H^-Z<BGM(F9ZT1KAC<C5R_#?/8M8ZI)EZB[>2?IIQ*3CCT;3
M:%(K+Q#C4/L>Z0RRI+CSQF5E.TXVXSX_Y(N8SVI./$0K:4:FY?HKJCIQK%I_
M8^",[TJSK$]1L-M.#BDP,HPJ]@9'12UH:=8<<:9LZYI2TDM)K21EQ+B*:;3J
MM9WUZ&=TAM6W#8;NRVWZ);E, -2<4UJTWQ;/ZZ$ZXVY+I)%Y6,OV^-6*VE+9
M\+8M=%(K9A(4I"945PDJ41$9Y6$E.*DN$L9+9=&9^'8X/5G3H59"F65E,BU]
M=7Q9$ZPL)TAJ)"@PHC2Y$J9,E2%ML1HL9AM2W'%J2A"$F9F1$9@"M?N]^=0]
M&WMNR*QPC2QS4#=OEE8[/BS+/1B)21-*8<^&TV;<96I^56E;%OX\U]]*6IF/
M0+R :&W5&]Q2VAVWEB81T1TLJQLR>O08@N/G&&\G%=*8NY',N@UW-8YM<F-3
M+EG621JW:*5'PI+9R*K-K?%I&W*#X"QVVBNQW6Y\N>S4N-O<N/-DH)*G.O6)
M4VMA[/\ +N'/11K3:5?Y=T^13_/%.CG?KV'+_;]O6K+11'V3#I\*T+O*]H_U
M"8LINX''I$@C_P *HC7 <K%0X4QT,N!H^G_?#NC.]!N^K[V>@/\ \\V'6K?%
M+Q<YQT,NX6KJFR8N*JLMXJ'6XUK7P[*.A]*$OH8G1FY32'DMK=;2ZEMTB425
M*(C^@9EU1<)U52D0O[]NG^Z.?8!?W>G6<:BW6L6M>/N'%N='=!JN!FF18[8%
M(**Y79ADEA;4.GV)6<%SBN772[=-O':2:CAJ-3:7*4[]N&C6^X5(VI2TZD1Y
MZ>?..MVNXFAM]1=HW0?;I=?]&JY<UJ+J1$U+MJ:-<28$JS8F0*>+CNWG4&FO
M;."5=R9,6KM;"1'DJYA:"4IHW::Q$I:8P;7\NX=G:BM<E7^7=&C'SMK9A=9H
MO3O=3H!N%VDY/73)5-EDJYJ&-3,>P?(:QQV/;TV40Z.'C^J,21!FLJ8-#6*O
M24ND9.LL\#X%BHUI)-!V7P.I9PT@UFTFW :?4&J^B.HV&ZK:;90RX_0YK@E_
M79)CUCV.ZJ/,CMV%8^^TU/KY3:V)49SD2(KZ%-/(0XE22N5)258NJ*333H]9
MA?>SO1T7V!;?\BW*Z^KRI&FV,7.,4-EY&4*,DOU6&6W4:BJ4QJIR?6MNM=FR
MDFZHWD\ALC/JGP(^LYJW':EJ.8Q<G1$!^3_.^.C#HY2XE-IGO(S-/89/M65'
MI?I37U2I*^=),%Y64ZYX_;M.-J0DW%IA.-DE9&DUF2DE1ZU;XGXN<J=#+N&Q
MW1]?.,MKG2-;H\3VLZ0Z(:^X=DV4XUF>2IR;4AC3N#10H^&4;][)C*8QC-\H
ML'WIK$<T-F2$)2LRX]3JES#$*<E%)Z3B5IQCM-GXW^?.5NC^V.YQ=Z14KN8[
MG=7\;>EU^38]HL= YA>'7D/G6W:#+-2;NSBTZ+AB4@FI,>G8NG8+A+;DI:>0
M;03Q$(.BTL1M2EI>A$8FFGSS?16VR1Z'J_L8U.P+$^RX[<6^T\UHQ?52]7#6
M^\B3*F8QD6!Z0PHKL>.3:TM-VLCG%*6GEIY"5+Z+%KACH[YVZ#B9;0VN[IM"
MMY>BV)[@-NF>UNH>F68,N=@VT)#\2=5VD3FTVN-Y)336V+/'LFI'W";EPI3;
M;S2C)1$IM:%JN8RC-;4=11E%Q='K-6^D3Z5G:GT7]?I/8[GGM24-ZT3,SA84
MWIY@[F7J6O F<8?R%=O(795,"J)M.7PB80MXWI/*<-M"DLNJ1UN78VJ;5=)V
MA!SU$.&0_/!.C1JY%A$I-'-Z&3KBN<W"L(VG.C=72V9<4<7F7K77R-=QF.29
M\.>KT.&I/ T$1\12ZU#@3_EX3OT,N-&\'1C]/EMKZ4W<%F&WO1?1[7' ;[#M
M'+K669?ZGQL"BU$NHH,VP;")]1&9Q3-,GF%9+F:@PGF5*232VFWR4:%(;)WM
M;OJY+92IH.L[;@JMDZPKE,A%Z0WI_M@'1UY39:6YMD^4:S:YU!MM7>D&B$"H
MR*XP^0^R3[#.?Y)=75#B.)2C:6A:X"IDBX:;<0X<+FUI6=&Y?A!TUR*D;4I:
M=2(X,$^<P[GM9F(V;:!]!OO-UIT-F35LQ=5\$M=0<G8DQ8;RX]L[&BX9MDR[
M$'YM<^RZA3"<B-/+;-*W&S(^%-8B3TQ@VOY=P[.U%:Y*O\NZ<O3\[0V25V$:
MM,9]H5N-T@W"Z;XWDKM-H9JEC+-3#S/46GKI2ZS39W.,9:RZVP298WK"(4J;
M=XY$;KTN<ZIITTJ:+GK4:.J>T.AE70U0E#KNEOTJI.B@Q?I8M6-*]0<:TTL\
M-PS*<ETJT\G8YJ)G5+)S35RGT8B5E'9Y).TKH,D8AY1>,ON2)"ZI1P$K6EGG
MB2PJHKJZ+I6M'VZ'1P>WL+64E_G ?35[6.E9TYVWXAMYP'<!AMEH_FV>Y)DS
M^L^*Z=8]!G0<IHJ"LKVJ)W!]5=1)$F6S(JG#>3(:BH2A232I9F9%:7[L;M-F
MNBI7MP<*UX2!/9IK%C.W?=_M3W 9K!O;3#=#-R6AFL66UF+1:^;DUCC.F6I^
M+YK?0<=AVUG254N]EU5(ZW$:DS8D=R0I"7'FD&;B:,'LR4GJ3*DE6+7<+_W]
M\.Z,[T&[ZOO9Z __ #S8O>M6^*7BYRVZ&7<+5U39,7%566\5#K<:UKX=E'0^
ME"7T,3HS<II#R6UNMI=2VZ1*)*E$1_0,RZHN$ZJI2/?'(             #F
M."?[21/\3+_>S@H8C\D^^BI:^6C/0QQ=FJ@S!8       07;^ORA;'[%<8_>
MSXV'NW^S%]_+X2%9Y^OO[U&E8SYAP
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MG_>S P&\G[,?W\?A,QD?Z^OO63HC7A-0
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MC;3GX5H7C:?@,3G5]V<#)1^5-J/+I?B5/"0+C8Y"
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MW:DN26AKEH_ 9O(K[MXSH?N;D7RK2O%7E)M1 "9
M
M
M
M
M
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M+LU4&8+       ""[?U^4+8_8KC'[V?&P]V_V8OOY?"0K//U]_>HTK&?,.
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M!?RA:[[%<G_>S P&\G[,?W\?A,QD?Z^OO63HC7A-0
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M<G\M^4_<JO/MNP<2[>G]GP_/+\69'-W_ -<E^:?XT2:<0(F
M                               1Q=)(W)/3G3UU!GV&C-I+;Z>/4.2Y
M1351#,N'5-+33W5_4XB4[JM=:NK[KH_LJOV"/;PUZO;XMO[!#N)R1,
M
M  )_ME"%HVR:9$M*D&:<P61*2:3-#F?94XVHB,B/DK0HC(_H&1D8UKG_ .UK
MW]'\2).LG_9MO^E^-(VG&',F0N=(XATM:<3<-*R97I=4(;69'R%.MY9F:G4I
M/Z'+2EU!J_Y#(3S=9KJ$UP],_P 6)#]X*]<B^#HE^-(C]$F,$
M                      &R^SU"U[DM+B0E2S*SN%F24FHR0WB]XXXHR(C/
MDH0DS,_H$1&8Q.>?LJ]WE^,C(Y5^T+7??P,L'#69/
M
M
M
M
M                          #B&?:A8#I3A][J'JCG&'Z;8!BT1$_)LYS[
M):7#L/QV"Y(9AHFWN39%-KJ6HB+ER6VB<D/MH-QQ*>/%1$?#:2J]""3>A:S2
M:XZ6GHO:(UE-Z0K9H_S<54Q7@?<9I3D1&TGG>*$'C^469.2CYD^#">+Y\4\$
M'RD\>CNVE]TCML3XF;*;?=S>WW==A=CJ+MNU?P36K!JC)IN&VF4Z?7L7(*>O
MRNMK*>ZG8_,E15&F/:Q:G(8,E;*N"B9EM+^@LC/M&49JL75'#BXNCUF=!V.
M                  ^'Y3XWX?\ )7RAH_*CL/PCY-^%H'A_P?QX=G^!^R/"
M/8?'_P"%YOD?\HXJJTX11Z^ ^X.0
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M^$A6>?K[^]1I6,^8<
M   #]H0MQ:&VT*<<<4E"$(2:EK6HR2E"$I(U*4I1\"(NJ9CC5I>HY2;=%K)N
M]X6BV3PMA>@S*JJ8[>Z1P,)EY=#[!6<RF@6>)/P<B)]*4+D,-4][(C-/F?)0
M2$&XYR>1U(!D>/LRWCQ+JNCON6RZZ&U*L>55:Y$3'-<'<62V51[=I1VNY\6C
MY'XB$$; (:6DMEVLT34W;%AV5W5@RW/PJKEXAF<V0M+;467A<5I!SYCQ\E"5
M2\:.'.>5P)*3?5_@&H,^P$L)F]RS;3V;C4HKCVN!=Z54N\;)RG%K$Y?"[)_&
MBMF7?CP^%4?A*Z.X'527K5K'GVI,A;QQLAOI*J1A]1FN%C< DUV.P>2:6R0N
M/3162<X)3RG>4HRXJ,;0RS!QP&!MX5:XQT]V3TR?*WX"!8_$O&8N>(^YE+1W
MEH7B.4[1($VRW.:&L0(KTMYK4?&I[K;#:G%MPJN<BRL92R3^M9AP(KCKBOH)
M0@S_ %!2SJ4893B')T7127A:HN5NA5RE.6964M+VUXB=7I(XDJ5M-SA4:.](
M*)=87+E&RVMSL>*WD]:VY(=Y!'R&4+=22E'U"XEQ&O-U9)9S;JZ5C)?@LF6?
MIO+)T5:./XR*SHVN:\)]-H>AV05FSEK)="IN/XYK-K+'GE<Y_E;D[E4-/"O+
MBF;C4'@RMGO,.08T'G(Z301=ER%ON+5S3+2=<9WF%J>>]#F*E+ 6*4A&FEM)
MU=6M==/<5%K;)SE>#E#*E/!N,<5=6F3X-+6CO<'=TFLKW1.:Y27G9$C4O3%^
M0^ZX\^^]+R]UYYYU1K====7C2EN.N+49J49F9F?$QEEOGER5%:O)+N1](QSW
M8Q3=7=@V^_S'.])^C#U?P#5/37.[//=-IE;A6?X;EMA$@O9.<Z5!QS(JZXEQ
MH92,=88.4^Q#4EOEK0CEF7%1%Q,6V-WMP.)P=W#PMW5.Y:E%-[-*RBTJ_&U:
M2MAMW,18Q-N]*Y!QA.,N'@:?$2%[R= <EW(:2Q-/\4N**CLX^8T^1JF9"J>B
M J+75]U#=82=;"GR.R%KLT&G]CY/!)\3+J<8SD696LJQKQ-Z,I0=MQI&E=+3
MX6N(SF:8*>/PO06VHRVDZON5XB!/<QM!SG:]#Q";F&2XG?MYE)N8L!&-.7"U
MQ5TC5:[(5+\*5=<DDNILT$CD&L^*3X\.IQV-E.=X?-W.-B$XNVE7:IPUU4;X
MB%9CE-W+HQE<E&2DVM%>#OFI8S1B@ ))NC1T(G:A:SL:H6U8ZK"M*R78LS'V
MW$0[#-Y#*FJ"OC.>T)]^G2ZJR<Y"CYA;$<G"Y+R25%=Z\QCA<!U2#_K[VBG"
MH?=/P_)[M7342'=[!2O8OK,E_56_'+@7@U]S1QFJNZ3-+#/]P^L.2V)2D..Y
MW>U,1B8VXS*B5.-RUXY30Y$=U*'([\:JJF4+;,B-*R,CZO$9C*+$<-EEBU"E
M.C3T<+E\9OE;,;F=Z5_'W;DO+:\$="\2,!C)%@<]TNSVSTMU%PK4.HXJGX?D
M=7>(8XDE,UB')0N;7.*,CX,V4$W([AEP/D.'P,CZHML9AH8S"W,+/Y,XM=ZN
MI^!Z2XPM^6&Q$,1'7"2?@X5X5H+2.N6!5&X_;SE.-5)M3FLXPV-?X5-<2VT7
MA@HL?(L/FDY)Y'8C;\UMA+JN*#YAUQ)F1*,:AR_$SRO,X79Z';N;,UW/DR7=
MT5\-#8^,L1QV"E:6E3A6/?UQ?+0JAV]1:8_:V-'=U\NIN*B;)KK2LGL.19L"
M?#=4Q*B2H[J4N,OL/(-*DF1&1D-R0G"Y!7+;4H254UJ:?":SG"=N;MS34TZ-
M/@9/'L2TRQO+-E&9UV!W#&/ZD:BMZ@8UE&6QTD=I07BNRJW'H3DF*I%@S71:
M!V%+)I"T*2J8XXWP4HE#76\6+NV,_MSQ,7+"6MB48\#6N3XJ[55X$F37)</;
MN91*-E[-^YM)RX4]*7=T*C\)H?;=&5NIKWY+4.BQ"]:9=Y#4JKS*L89F(/A^
MS,(NBJ)"$%QZI.H;5U/H'U.,CAO9D\DG*4X]^+T<E3"RW=S)/0H/O2YTCA]G
MT>6[NL;=>\U)3V&6N=6Y69G@4MP^J9&VU#+)T6$ATN'ZUME1GQZG'JBM#>?)
M)NG34?=C->/9H499#FD?_EU7<E'GJ:E91BF383>3L:R^@M\9R"M<)N=3W<"3
M6V$8U%RFU+C2FVW#:>09*;61&AQ!DI)FDR,9JS>M8BVKMB49VGJ:=48N[:NV
M)NW>BXS7 U0G-Z+77:MOM/;+0JYGLL9)A$R?=XG&?>)+MMB5U+=GV3$)"D\7
M7Z&^DO./%RN5S,UKDIY+:S+7N^&72MXE9C;3=JXDI=R25%7OJE.ZGQDSW<QL
M;F'>#D_ZR#;7=B]/B?PHC(WN:066D&XC/8;T-QG'\QN)^=8G+)#G8DFJR28]
M82(D=U:2)2Z6S>>B+3Q4I)-)49F2TF<MR#'0QV66Y)_UL(J$EPUBJ5\*H_"1
MW.<++"X^>C^KFW)>'2^1Z#5&)$E3Y4:#"CO2YLV0S$B1(S2WI$J5(<2S'CQV
M6R4XZ\\ZLDH2DC-2C(BZHS+:BG*3I%+28M)R:C%5DV6<\1F5&RG9ICKN9N16
M;/"L07)DUG+:)VVU R>5-NSQN'_G"%SWO#]JM@UH5Q*,PM[@AM!\G4M^,\_S
MV2L5V+D]?%"*2VGQ:%7ONFMFQ;3AE&51Z6E80T]V3TT7'I965M[2;>6UG=V;
MQR+*XL9MI82%<>4_-L)+LN6\KB9GQ=?>4H^K^J-L0A&W!6X:(Q22[RT&O)SE
M<FYR^5)MOOLGAZ)-"RT?U-<-"B;5J4VA*S2?(4MO%Z52T)5PY)J0EQ)F7T2)
M1?X2&N]]'_YVRN'HO]IDTW8_5+GYS_91%+O);6WNCUP2XA;:CSRT<)*TFDS0
MZAAUI9$HB,T.-+)23^@:3(RZAB8Y$ZY/AZ>K1&LW_:5[[[[",)X'_MSAGV5X
M[_"\,7^)_5[GWDO@9:8;]8M_?Q^%%E'I#DJ5L\U@)*349%@*N"2,SY*-3\*6
MM7 OU$I29F?ZA$-5;L?MRQ_3_NYD^SW]E7?Z/X\2L$-N&NB?'HDR/S0:G*X'
MR3U):(E<#X&:<8IS41'] S(E%Q_]D:XWT_7;/YK_ &F3?=C]4N?G/]E$4^\I
MIUG=)K@AUMQI1YW9.DEQ"D*-I]N.\RX1*(C-MYEQ*TG]!25$9=0R$QR)IY/A
MZ>K1&LX_:5[[[["-RM&]M4'7K8%;NXK0TSNJN.:B9#?4%DU A-7ET5/&BI?Q
M*1;(:3-6Q85=BZ<9AQSF>S"849)+VY8+'9M++MY(J]*74Y6HIJKHJ_=4U:&M
M+6FE3+X7+XXW(Z6TNLQFVGPNG!7NK5W:$4<J+)@R9$*;'?AS(;[T67$E,N1Y
M,63'<4T_'D,.I0ZP^PZ@TK0HB4E1&1D1D)DFI)2BZQ9%VG%N,E22)&NC R_,
M:S<7&Q"IL+ \2R7&\ED953I6X[5_^2ZTY=9<.1C-3$><Q9LL1TR"(G.0^;7'
MDK,CBV]UBQ/*W?FETT)QV7PZ71KO4JZ=RI(-W+MV..Z&+?12BVUP:-3[_ ?*
MZ3G*:3(]S\N%3G'<>Q#!\9Q:\?C+0XEZ[1(N+]XG7&S-)R(<&_CQG"XFIM;)
MH5P4DR+ONE9N6LH4KE:3N2DN]H7C:;\)TWBN0GF-(ZXP2??TOX&C.'1%S&$9
MUK) 4H^R9.)XS,:3PZAL0;B>S(49\>H:7+!KA_AXC'[ZQ?5K$N!3DN5+F+S=
M=KI;RX=F/PLQ_P!*MB]U7:^X[E,F$Z5#D>GU1$J[)+;IQ79])9W#5G7*>4VE
MHIL1N4PZI"5*X-2&U<>)F176YUZW/+964_ZR%UU7<:5'WGI7?3*&\MJ<<;&Z
MU_5R@DGW4W5$88EI'
M  #=38+^4+7?8KD_[V8& WD_9C^_C\)F,C_7U]ZR=$:\)J
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M<MS&[EU_I;>F#T2CQKG7 _L%QCL%;QUGHYZ)K2GQ/F?"1A8YI!O VQY9-L,
MH)=_ F**/+5CR6LEQK)HD9U?8IV=&AUFVC.,\Z9MN+9C2&2<63;A)4YRI==Q
MN1YO94<3)1DM6U\647W'J^%/A6HC=O"9MEUURL1<D^+2GWUK^!FR5?J+OPU-
M;30UFFN+Z5H?)#%CF-Q63ZQRO-2.#LB%%R"WN'EMJ)?4)FOF.)/AP67 S&*E
MA=W,(^DG=G>XHIIU[[BEXVC(QQ&=XGXD;<;7')IJG*WXDS:'0K06@T5J)ZTS
MI.3YQDKW9V99O:$I=E=SEK6^XTT;KC[L6N1(=6LD&XMQQQ1K=6M7#DX?,<QN
M8^:5%##PT1@M27/_ "1DL%@;>#@].U>E\J3UO[7\F1\;I-G.H*<\OM0]+:9S
M)Z')K&3>V%-5.LIO**XF.'*L38@.+9<GP9DYQ3K/8O..MFLT*;2E*5JD^3YY
MANK1PN,EL7(*B;U-+5IX&EH=3 YEE-_IY7\,MJ$G5I:TWKT<*KQ&3<"U1W[3
MZR+BOFIJGI[++,0LTSJGF44AIDB-M4ZR6]?5<"QE,HX'RF8JUJ-/%3;JC/C9
MXG![N1F[W3/9U[$&GX%H;2[[\*+FQB<\E%6NB6UY4E3PO2D^3E/0UXV:ZA95
MAL3,T9+*U+UK*>],RYZ1*:K*^RIGHJ29HL1KGU1JV!%QV0UQCM\F.<HGWE<$
MJYIA/;+L]PUF^[#@K67TI'A:?')ZVY<.NE%W6=<=E&(NV5>VG<QE?C<":XHK
M5HX-5:ON(]/;3-WB:>5U;ILQI*P_AT.\=,K#,FSIW,>@3; Y=WX/D^&:Y-E$
M4_*=D-)0U(4IY:N0I2>HGMFT<CQ4WBW??3N.J.G::5%70Z/@X-!QETLVP\5A
MU:_JD]<M%%7332J\?"9NW(/;H\UKLTTTT^TAJWL.N6FJM.:KS3%F[&UJ'V(S
MU@W&J+*]JW*Q;[QN1EF\APS:)1I(C4E2<?E2RBQ*WB\5??3QT[&Q*B?!I2=>
M/07F8/,[T9X>Q:70O1M;4:M<.AM4XC3W1;0G>'H=FB,TQ;2ROF2'*V52V5=:
M9=@;D*RJ)C\22_$<6QF#,F.XF5!9=;<;61I<:3Q)2#4A6<Q^8Y'F&'ZO>O-*
MM4U&=4UP_)XFT8G!X+-L%>Z:U:3=*-.4=*\[N$N^#V656^*4UCF^.,XEE4J.
MXJYQV/9Q+EBLD(DOM-MMV4%U^+*2]&0AWBA:N3R^29\2,0G$0LPO2CAY[=E/
M1*C5? R5V979VE*]'8NO6JUIX4<K%$J@
M             :N[Q=.Y.HV@^4PZZ,J7<8P[$S.ICH3RG'7:,GTV2&DD1K6^
MO'YDQ+:4\5+<-*2^B,QD6*6%S&$I.D)UB_#J_"2,9FV'>(P,E'3./QEX-?BJ
M5_!LH@H
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M57]['3\-.1F>R"PYXEWW\F"\;T?!4F;$$)>
M
M
M
M
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M"CL%+-E4OF6NRE1DK3'.1R$\\;"75+<2R;G'DDHS42>'$S,98L3S
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M/#Q;&-%=.-06XL:-@UME\EY$3$[3-*2W;G9!8/&94^*.'R4*>L$.Q+3$7?\
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M0:DZ.O,6]V,G*J7 6V])]7=+=>-/Z#5;1;4+#]5-,\J\*^36>X%?UN48G?>
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M64VN&#6,]]3DAUEA"68L9:C-:T(+AQ-1%U1:P=)I]U%>2K%KN'<^C+%B
M            !S'!/]I(G^)E_O9P4,1^2??14M?+1GH8XNS509@L       (
M+M_7Y0MC]BN,?O9\;#W;_9B^_E\)"L\_7W]ZC2L9\PX
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M----:L);;:;;224-MH3ID24(0DB(B(B(B(1U[DMNKQ6G\W_O#,>]/_<?A_\
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M]%6X6X6[4771KXM+T+Q&IHS1B@
M         W4V"_E"UWV*Y/\ O9@8#>3]F/[^/PF8R/\ 7U]ZR=$:\)J
M
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M,+;M2^5&*KW^$R8+0N0
M                      &1&1D9$9&1D9&7$C(^H9&1_1(P!"!N]VMV.EE]
M/SW#*Y<G32\FKD.L0VE+5A=C*6:W*Z6TA)\U1OOJ/L-_]8V1DPYP43:GM@Y)
MG$,9;6&ONF+BN'[M+A7=XUX5PTAF:Y;+#7'?M+_R\GYKXN]Q<G?T9$A,*
M
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MZE\:/"GS/@?V:D$QV!NX*[L2J[;^3+C7/QHP.,B6(
M          !S[373/+]6,K@8AAE8Y864Q9*D2%$M%=4024E,BTMYB4+1"KXQ
M*]LHR-2U&2&TK<4A"K;%XNQ@K+OWW2"Y6^)+A?\ \7H*^'P]W%75:LJLGR+N
MON%A31K2>@T7P&HP>A_9RB$J7;VJVDM2+N[E$@Y]I(01KY'.J0E#2.4KFF&V
MV^)\GB>LL?C;F/Q,L1<T5T)<2X%S\;JR>8/"PP=A68<&M\;X7_+@,IBS+H
M
M
M
M
M                             "C7\\PUPSB!5[*MN=;9O0M.\E?U2UAR
MRK95R6\@RK%?)C$,*>F&7!1M8U6Y/=&VCCR%KL>4HC4TV:;/%2=5'@UEQ86M
M\).?\W">T^>Z'#:&>GL>)&:1!U29S%MCE]F+U!:UCSYO*Y%LIYU^2J7*EI2Z
MSRU<DH*XY-)0P32$U</3HE3NE.[\MDXHKE,H'?.]-@V,X'FFC'2!:=T,*E3J
MU:KT4UW:K(#,.-;:@U=+/R/3?-YAQ(:2DW^0XC2VE;82'W24MFD@$A*E<ZH6
M.*A1J:X2XLRJME\!>AT/_D6T@^Y=@'VIU(O(?)7>*$OE/OF4!V.     "HQ\
M\:_(%VV?UP*3^9?6$6F+^2N^5K'RGWCE7S/'^S.UR_KU:F?S [9!VPOY-_??
M81Q>^5X"UZ+DI             !U9W1M_P#UR9A7]>K<K^^=8AC+?Y9??%Y/
M\F^\=IB,F68 'Q$XQC:+]S*D8]1HRAV$5<[DB:F F_=KR-!E <N"CE8KA$;2
M3YHW#1[4NIU"'%%6O"*O5P'VQR
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M_+X2%9Y^OO[U&E8SYAP
M                      S5ML_**T"^[5I9]O-$,?FO[+Q/^7N?B,O,O_7[
M'YZ'XR)O^E1_)HJ_NIXM_ F5B ;G?M67YF7XT29;Q_L[_P 2/V2NL-GD!
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ML,A0
M                  !NIL%_*%KOL5R?][,# ;R?LQ_?Q^$S&1_KZ^]9.B->
M$U
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M-HQAS)@
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M>D/8.._F<OVAZO37KMS3_P"$-E\7P]Y\NXKOFKTA[!QW\SE^T/5Z:]=N:?\
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MU>D/8.._F<OVAZO37KMS3_X0V7Q?#WGR[BN^:O2'L''?S.7[0]7IKUVYI_\
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M3E+@XEWEJ7\JD@P^&L86&Q8BHKQOOOA,@"V+@
M
M
M
M
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MM(9::MHDTF6FXW,)%Y8N.Y#3\I%"Y#9EHU$U0K%,
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MLR;:01$9F9]3JF,MJT%B>R
M             .8X)_M)$_Q,O][."AB/R3[Z*EKY:,]#'%V:J#,%@      !
M!=OZ_*%L?L5QC][/C8>[?[,7W\OA(5GGZ^_O4:5C/F'
M                                              #]MN.,N(=:6MIU
MI:7&W&U*0XVXA1*0M"TF2D+0HB,C(^)&.->AZCE-IU6L]V3:VDUOF9EE/EM$
MHEDU)F2'VR6DC(E\AUQ:>41*/@?#CU1PH1CIBDF=I7+DE24FUW6SYX['0
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M\ZHUN///.J4XZZXLS-2E&9F9\3&<2452.A(Q#;D]J3JV> <G
M
M   !NIL%_*%KOL5R?][,# ;R?LQ_?Q^$S&1_KZ^]9.B->$U
M                                       \3\AB*TI^2\S'81R>6\^X
MAEI'*42$\IQQ24)Y2U$1<3ZIGP'*3;HM+.&TE5Z$?*;R7''IC=>U?TCL]TR2
MU!;M8*YCJE)-9);C)?-Y9FDN)$23Z@[NU=4=MQEL\='0Z*[;;V5*.UQ51]H4
MRH
M
M
M
M
M
M
M
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ME<9?;75P;<A%8SP:-\VD&D^2DN)BK"$;:I'4=)2<G5ZS:@=S@
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MN%M4BBE*<I:S=L=SJ
M        !S'!/]I(G^)E_O9P4,1^2??14M?+1GH8XNS509@L       (+M_7
MY0MC]BN,?O9\;#W;_9B^_E\)"L\_7W]ZC2L9\PX
M
M
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M)IAYSGAX3N*EQP3??:TG-!;E8
M
M
M
M
M
M
M
M "LKDO2C:L:._./"V+:F:G2ODLZN:-87A^G>"2Z;#HU+BFNV787C^98QD#F2
M>"HF9/2,KLZ.701HISI4=R??,EV.7!+K-MTC6(V&_B_:*VPG:VE\HLU"Y*(
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ME]?%3[IV" OBV   #J2.C-_MT-M/]>I?V^W8Q5O\I'[Y?"7L_DOO';;C*ED
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MA0
M
M#F."?[21/\3+_>S@H8C\D^^BI:^6C/0QQ=FJ@S!8       0M=(IC;];K#CN
M1DT90<EPF&TE[@HB<LJ.RL(TUHC,S29LP94-74X?])U2_5.>[KW5/ RM?=0N
M/D:5/'4A^?VW'%QN<$H>--_:(_Q)3!
M
M
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MR<;+X$W3N]ZO#0MYX3#7+BO3MQ=Q<+1D46I<
M
M
M
M
M
M
M
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MJ(S(R/B0OBW/V
M
M           YC@G^TD3_ !,O][."AB/R3[Z*EKY:,]#'%V:J#,%@      !J
MKN]T1?UHTO=;HXY/YIA[[U_C#24HYZR(V.;MJ!MQ75;.VBMI4V7$B7*CLDHR
M3Q,LSDF8+ 8RMQ_U$]$NYQ2\'P-F+S7!O&8;XGY:&E=WC7A^%(@(=:=CNNL/
MM.,OLN+:>9=0IMUIUM1H<:=;625MN-K29*29$9&7 QLA--56H@[33H]9XQR<
M
M
M                                          >1IIV0ZTPPTX\^\XAI
MEEI"G'777%$AMIIM!*6XXXM1$E)$9F9\"'#:2J]1RDVZ+63^[1]$GM%M+F(U
MTREO,LL?;R#*$_17 6IA+=70J61\%'41#/G.'$BE//<DU)Y)C6V=9@L?C&[?
MY""V8]WC?A?B2)SE6#>#PU)_EI:7W.)>#X:FT@PYDP
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M:6KC)+Q$R1@
M
M
M
M
M
M
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M[/M),VRF]A5L)IOGI#SS[G)Y3BU+,U'5225%J13;JZO6<E'(
M
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M8O2U/R.3@
M
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M<GW79Y@V/:-:B8]?Y-1P;V_Q*UKZ2AD3&'+BQG2XRT0>Q:ILW9RF^R"2?/\
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M^!&<!CR]
M
M
M
M
M
M
M
M
M
M                    YC@G^TD3_$R_WLX*&(_)/OHJ6OEHST,<79JH,P6
M
M
M
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MW=/"7N49G=Z6.%OMRA+0F]:? NZGJ[G>)=A"25@
M
M
M
M
M
M
M
M
M
M                                                  <QP3_:2)_B
M9?[V<%#$?DGWT5+7RT9Z&.+LU4&8+
M
M
M
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M="U&_G;Z#\G&YM-K5HTOE>CPDU @1,0
M
M
M
M
M
M
M
M
M
M                                          .8X)_M)$_Q,O\ >S@H
M8C\D^^BI:^6C/0QQ=FJ@S!8
M
M
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MFI+0EWE]G69#"X.Q@X;%E4KK;UOOO^2,JBS+H
M
M
M
M
M
M
M
M
M
M                                                #F."?[21/\3+
M_>S@H8C\D^^BI:^6C/0QQ=FJ@S!8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                         <QP3_:2)_B9?[V<%#$?DGWT5+7RT9Z&.+LU
M4&8+
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M #F."?[21/\ $R_WLX*&(_)/OHJ6OEHST,<79JH,P6
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                       ',<$_VDB?XF7^]G!0Q'Y)
M]]%2U\M&>ACB[-5!F"P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                YC@G^TD3_$R_WLX*&(_)/OHJ6OEHST,<79JH,P6
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                    ',<$_P!I
M(G^)E_O9P4,1^2??14M?+1GH8XNS509@L
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                              .8X)_M)$_Q,O\ >S@H8C\D^^BI:^6C
'/0QQ=G__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img188018671_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img188018671_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )'!<D# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(!Z4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF8+$?)GH93T_(9/UQ71.7+%LQBN9V/4_">@1^&_#]O8* 9L;YW'\4AZ_X#V
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MVR?[IX/^/X5SX:K[*JGT.W'X?V]"4>NZ]3U:BBBOH3XH**** "BBB@ HHHH
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MAD$D3LCKR&4X(_&NNT3XE^(=(94EN/M]N.L=SRV/9^OYYK.6&?V64JRZGO\
M17+>&?'VC^)-L*.;6]/_ "[S$98_[)Z-_/VKJ:YY1<79FR:>J"BBBD,****
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M?^&S&E\:/5Z***\\ZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3_$^Y_2JWB+Q#>^)=6DOKQL9XBB!^6->P'^/>LFN^E14-7N<E2HY:+8**U]
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M82Q*7PHUC1?4^>8_AWXKE7<NCR ?[4J*?U:H+GP-XGM%+2Z+=$#_ )Y 2?\
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M7\C4%;GBZ#R?$,Q P)%5Q^6/Y@UAU\U5CR3<>Q]WAZGM*49]TC;\)W'V?Q#
M,X64-&?Q''Z@5Z77D6GS?9]1MIO^><JM^1KUVO4RZ5X./9GS^>0M5C/NOR"B
MBBO1/$"BBB@ HHHH *\+^)WB<ZQKATVW?-E8L5X/#R]&/X=!^/K7J_C#6O[
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MCW-8O@'PVOAWPY$)$Q>W($MP2.03T7\!^N:ZJN*M4YG9;'33ARJ_4****Q-
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MP5_YCG_;#_VI737_ (;,:7QH]7HHHKSSK"BBB@ HHHH **** "BBB@ HHHH
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M+\7?]!?_ ,EHO_B:P^K3-?;1/H.BOGS_ (67XN_Z"_\ Y+1?_$T?\++\7?\
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M\)_] UO_  (D_P#BJ/\ A6/A/_H&M_X$2?\ Q5'UF >QD?/U%?0/_"L?"?\
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MM%\(:)X>NI+G3+0PS2)Y;,97;*Y!QR3W J)UXRBTBHTI)W-RBBBN0Z HHHH
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MHH **** "BBB@ HHHH *\\^,,'F>%K68#F*[4'Z%6_KBO0ZY7XCVGVOP+J(
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MK1TN<;7TEX.UE==\*V-YNW2A!'-ZAUX/Y]?QKYMKNOAIXK70M7:PNY-MC>$
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MYO>1N6_+I^%;5%%>8W=W9VI65@HHHI#"BBB@ HHHH \M^+'A8S1KXAM(\M&
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M_,<_[8?^U*\GKUCX*_\ ,<_[8?\ M2NFO_#9C2^-'J]%%%>>=84444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7,>,/!=GXJL\G;#?QKB&X
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M/-49F:#X=GU>02R9BM ?F?NWLO\ C7HUM;0V=ND%O&$C08"BGHB1HJ(H5%&
MJC  IU>YA\-&BM-^Y\GC,=4Q4M=%T04445T'$%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
7 **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>cere-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-05-03T16:04:20.7553+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.cerevel.com/20230331" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2022" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:cere="http://www.cerevel.com/20230331" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cere-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cere-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cere-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cere-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" id="Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited">
        <link:definition>100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails2" id="Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails2">
        <link:definition>100020 - Disclosure - 2027 Convertible Senior Notes - Schedule of Future Minimum Payments under 2027 Notes (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails2" id="DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails2">
        <link:definition>100030 - Disclosure - Financial Statement Components - Summary of Interest Income (Expense), Net (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" id="Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical">
        <link:definition>100040 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited2" id="StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited2">
        <link:definition>100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited" id="Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited">
        <link:definition>100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" id="Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited">
        <link:definition>100070 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" id="Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
        <link:definition>100080 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNatureOfOperations" id="Role_DisclosureNatureOfOperations">
        <link:definition>100090 - Disclosure - Nature of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRisksAndLiquidity" id="Role_DisclosureRisksAndLiquidity">
        <link:definition>100100 - Disclosure - Risks and Liquidity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100110 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreement" id="Role_DisclosurePfizerLicenseAgreement">
        <link:definition>100120 - Disclosure - Pfizer License Agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilities1" id="DisclosureFinancingLiabilities1">
        <link:definition>100130 - Disclosure - Financing Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotes3" id="Disclosure2027ConvertibleSeniorNotes3">
        <link:definition>100140 - Disclosure - 2027 Convertible Senior Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100150 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponents" id="Role_DisclosureFinancialStatementComponents">
        <link:definition>100160 - Disclosure - Financial Statement Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureStockholdersEquity" id="Role_DisclosureStockholdersEquity">
        <link:definition>100170 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensation" id="Role_DisclosureEquityBasedCompensation">
        <link:definition>100180 - Disclosure - Equity-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>100190 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100200 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureLegalProceedings" id="Role_DisclosureLegalProceedings">
        <link:definition>100210 - Disclosure - Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100220 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedParties" id="Role_DisclosureRelatedParties">
        <link:definition>100230 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>100240 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100250 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesTables" id="DisclosureFinancingLiabilitiesTables">
        <link:definition>100260 - Disclosure - Financing Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesTables" id="Disclosure2027ConvertibleSeniorNotesTables">
        <link:definition>100270 - Disclosure - 2027 Convertible Senior Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100280 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsTables" id="Role_DisclosureFinancialStatementComponentsTables">
        <link:definition>100290 - Disclosure - Financial Statement Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationTables" id="Role_DisclosureEquityBasedCompensationTables">
        <link:definition>100300 - Disclosure - Equity-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>100310 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRisksAndLiquidityAdditionalInformationDetails" id="Role_DisclosureRisksAndLiquidityAdditionalInformationDetails">
        <link:definition>100320 - Disclosure - Risks and Liquidity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100330 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails" id="Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails">
        <link:definition>100340 - Disclosure - Pfizer License Agreement - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails" id="DisclosureFinancingLiabilitiesAdditionalInformationDetails">
        <link:definition>100350 - Disclosure - Financing Liabilities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails" id="DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails">
        <link:definition>100360 - Disclosure - Financing Liabilities - Summary of Changes in Estimated Fair Value of Financing Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails" id="Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails">
        <link:definition>100370 - Disclosure - 2027 Convertible Senior Notes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails" id="Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails">
        <link:definition>100380 - Disclosure - 2027 Convertible Senior Notes - Summary of Net Carrying Amount of 2027 Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails" id="Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails">
        <link:definition>100390 - Disclosure - 2027 Convertible Senior Notes - Schedule of Interest Expense Related to 2027 Notes Recognized in Interest Income (Expense), Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails" id="Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails">
        <link:definition>100400 - Disclosure - 2027 Convertible Senior Notes - Schedule of Future Minimum Payments under 2027 Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" id="Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
        <link:definition>100410 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" id="Role_DisclosureFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>100420 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails" id="DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails">
        <link:definition>100430 - Disclosure - Fair Value Measurements - Summary of Estimated Fair Value and Amortized Cost of Available-for-Sale Marketable Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails" id="DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails">
        <link:definition>100440 - Disclosure - Fair Value Measurements - Summary of Rollforward of the Estimated Fair Value Associated with Financing Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails" id="Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails">
        <link:definition>100450 - Disclosure - Fair Value Measurements - Summary of Rollforward of the Liability Associated with Private Placement Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" id="Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails">
        <link:definition>100460 - Disclosure - Financial Statement Components - Summary of Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails" id="Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails">
        <link:definition>100470 - Disclosure - Financial Statement Components - Summary of Property and Equipment Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails" id="Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails">
        <link:definition>100480 - Disclosure - Financial Statement Components - Summary of Other Long-Term Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" id="Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
        <link:definition>100490 - Disclosure - Financial Statement Components - Summary of Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails" id="DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails">
        <link:definition>100500 - Disclosure - Financial Statement Components - Summary of Interest Income (Expense), Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails" id="Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails">
        <link:definition>100510 - Disclosure - Financial Statement Components - Summary of Other Income (Expense), Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails" id="DisclosureStockholdersEquityPreferredStockAndCommonStockDetails">
        <link:definition>100520 - Disclosure - Stockholders' Equity, Preferred Stock and Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails" id="DisclosureStockholdersEquityWarrantsDetails">
        <link:definition>100530 - Disclosure - Stockholders' Equity, Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" id="Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails">
        <link:definition>100540 - Disclosure - Equity-Based Compensation - Summary of Equity-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails" id="Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails">
        <link:definition>100550 - Disclosure - Equity-Based Compensation - Summary of Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" id="Role_DisclosureEquityBasedCompensationAdditionalInformationDetails">
        <link:definition>100560 - Disclosure - Equity-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails" id="Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails">
        <link:definition>100570 - Disclosure - Equity-Based Compensation - Summary of Weighted Average Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails" id="DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails">
        <link:definition>100580 - Disclosure - Equity-Based Compensation - Summary of Restricted Stock Activity (Details) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails" id="Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails">
        <link:definition>100590 - Disclosure - Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails" id="Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails">
        <link:definition>100600 - Disclosure - Net Loss Per Share - Potential Dilutive Securities Excluded From Calculation of Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" id="Role_DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100610 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>100620 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails" id="Role_DisclosureRelatedPartiesDetails">
        <link:definition>100630 - Disclosure - Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" id="DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>100640 - Disclosure - Subsequent Events - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="cere_EarningsPerShareOtherDisclosuresAbstract" name="EarningsPerShareOtherDisclosuresAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_LicenseAgreementAbstract" name="LicenseAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_AccruedExternalResearchAndDevelopmentServicesCurrent" name="AccruedExternalResearchAndDevelopmentServicesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_AccruedPropertyAndEquipmentCurrent" name="AccruedPropertyAndEquipmentCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_AdjustmentsToOperatingLeaseExpense" name="AdjustmentsToOperatingLeaseExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_ChangeInFairValueOfFinancingLiability" name="ChangeInFairValueOfFinancingLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_ChangeInFairValueOfPrivatePlacementWarrants" name="ChangeInFairValueOfPrivatePlacementWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_ClaimsOutstanding" name="ClaimsOutstanding" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_ClosingPriceOfCommonStock" name="ClosingPriceOfCommonStock" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="cere_CommercialApprovalMilestonePayments" name="CommercialApprovalMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_ContractualObligationDescriptionRepaymentTiming" name="ContractualObligationDescriptionRepaymentTiming" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="cere_DebtInstrumentInterest" name="DebtInstrumentInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_DebtInstrumentMinimumPrincipalAmountForRedemption" name="DebtInstrumentMinimumPrincipalAmountForRedemption" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase" name="DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_ExpectedFundingReceived" name="ExpectedFundingReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_FairValueAssetBetweenLevelTransferAmount" name="FairValueAssetBetweenLevelTransferAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_FairValueLiabilitiesBetweenLevelTransferAmount" name="FairValueLiabilitiesBetweenLevelTransferAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants" name="FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities" name="FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput" name="FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="cere_FixedAssetAdditionsObtainedInExchangeTransaction" name="FixedAssetAdditionsObtainedInExchangeTransaction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_FundingCommitmentFeesIncurred" name="FundingCommitmentFeesIncurred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_GainLossOnFairValueRemeasurementOfFinancingLiability" name="GainLossOnFairValueRemeasurementOfFinancingLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty" name="GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" name="GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits" name="IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_IncreaseDecreaseInOperatingLeaseLiabilities" name="IncreaseDecreaseInOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_InterestIncomeNonoperatingNet" name="InterestIncomeNonoperatingNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" name="LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_LossOrMaterialCostsRelatedToIndemnificationObligation" name="LossOrMaterialCostsRelatedToIndemnificationObligation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_MarketableSecuritiesWeightedAverageMaturityTerm" name="MarketableSecuritiesWeightedAverageMaturityTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="cere_NoncurrentFinancingLiability" name="NoncurrentFinancingLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_NoncurrentFinancingLiabilityRelatedParty" name="NoncurrentFinancingLiabilityRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_NumberOfMembersNominatedToBoardOfDirectors" name="NumberOfMembersNominatedToBoardOfDirectors" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="cere_OfferingExpenseOfSharesIssued" name="OfferingExpenseOfSharesIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_OtherNonoperatingIncomeExpenseOther" name="OtherNonoperatingIncomeExpenseOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_PayableOnFundingAgreement" name="PayableOnFundingAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_PercentageOfExpectedFundingReceived" name="PercentageOfExpectedFundingReceived" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="cere_PercentageOfFundingCommitment" name="PercentageOfFundingCommitment" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="cere_PercentageOfFundingReceived" name="PercentageOfFundingReceived" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="cere_PeriodOverWhichFundingSupportReceived" name="PeriodOverWhichFundingSupportReceived" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="cere_PerPrincipalAmountForConversion" name="PerPrincipalAmountForConversion" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="cere_PerPrincipalAmountForTradingPrice" name="PerPrincipalAmountForTradingPrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="cere_PrepaidClinicalTrialServicesCurrent" name="PrepaidClinicalTrialServicesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_PrepaidResearchAndDevelopmentExpensesCurrent" name="PrepaidResearchAndDevelopmentExpensesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt" name="ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_ReceivedFunding" name="ReceivedFunding" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_ReclassificationOfPrivatePlacementWarrantFromEquity" name="ReclassificationOfPrivatePlacementWarrantFromEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_RegulatoryApprovalMilestonePayments" name="RegulatoryApprovalMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales" name="ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_SaleAndIssuanceOfStockNotYetIssued" name="SaleAndIssuanceOfStockNotYetIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="cere_UnderwritingDiscountsAndCommissionsOfSharesIssued" name="UnderwritingDiscountsAndCommissionsOfSharesIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="cere_LicenseAgreementLineItems" name="LicenseAgreementLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_AtmProgramMember" name="AtmProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_AugustTwoThousandTwentyTwoPublicOfferingMember" name="AugustTwoThousandTwentyTwoPublicOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_BainFundingAgreementMember" name="BainFundingAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_BainInvestorMember" name="BainInvestorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember" name="CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_ESPPSharesIssuableMember" name="ESPPSharesIssuableMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_FinancingLiabilitiesMember" name="FinancingLiabilitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_FinancingLiabilityMember" name="FinancingLiabilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_FinancingLiabilityRelatedPartyMember" name="FinancingLiabilityRelatedPartyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_FirstAnniversariesMember" name="FirstAnniversariesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_JulyTwoThousandTwentyOnePublicOfferingMember" name="JulyTwoThousandTwentyOnePublicOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_LongTermMarketableSecuritiesMember" name="LongTermMarketableSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_ManagementAgreementMember" name="ManagementAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_MeasurementPeriodMember" name="MeasurementPeriodMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_NovaQuestAndBainFundingAgreementsMember" name="NovaQuestAndBainFundingAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_NovaQuestFundingAgreementMember" name="NovaQuestFundingAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_OtherOfferingExpensesMember" name="OtherOfferingExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_PfizerIncMember" name="PfizerIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_PfizerLicenseAgreementMember" name="PfizerLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_PrivatePlacementWarrantsMember" name="PrivatePlacementWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_PurchaserDiscountsMember" name="PurchaserDiscountsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_ResearchCollaborationAndLicenseAgreementMember" name="ResearchCollaborationAndLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_RestrictedCashMember" name="RestrictedCashMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_SecondAnniversariesMember" name="SecondAnniversariesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_ShortTermMarketableSecuritiesMember" name="ShortTermMarketableSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_ThirdAnniversariesMember" name="ThirdAnniversariesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember" name="TwoThousandAndTwentySevenConvertibleSeniorNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_LicenseAgreementTable" name="LicenseAgreementTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" name="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="cere_LicenseAgreementTextBlock" name="LicenseAgreementTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="cere_RisksAndLiquidityTextBlock" name="RisksAndLiquidityTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="cere_ScheduleOfInterestExpenseTableTextBlock" name="ScheduleOfInterestExpenseTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock" name="SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cere-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-05-03T16:04:20.0807+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="cere-20230331.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:href="cere-20230331.xsd#Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:href="cere-20230331.xsd#Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited" xlink:href="cere-20230331.xsd#Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:href="cere-20230331.xsd#Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:href="cere-20230331.xsd#Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNatureOfOperations" xlink:href="cere-20230331.xsd#Role_DisclosureNatureOfOperations" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRisksAndLiquidity" xlink:href="cere-20230331.xsd#Role_DisclosureRisksAndLiquidity" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="cere-20230331.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreement" xlink:href="cere-20230331.xsd#Role_DisclosurePfizerLicenseAgreement" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilities1" xlink:href="cere-20230331.xsd#DisclosureFinancingLiabilities1" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotes3" xlink:href="cere-20230331.xsd#Disclosure2027ConvertibleSeniorNotes3" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:href="cere-20230331.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponents" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponents" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureStockholdersEquity" xlink:href="cere-20230331.xsd#Role_DisclosureStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensation" xlink:href="cere-20230331.xsd#Role_DisclosureEquityBasedCompensation" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:href="cere-20230331.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:href="cere-20230331.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureLegalProceedings" xlink:href="cere-20230331.xsd#Role_DisclosureLegalProceedings" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="cere-20230331.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedParties" xlink:href="cere-20230331.xsd#Role_DisclosureRelatedParties" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:href="cere-20230331.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cere-20230331.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesTables" xlink:href="cere-20230331.xsd#DisclosureFinancingLiabilitiesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesTables" xlink:href="cere-20230331.xsd#Disclosure2027ConvertibleSeniorNotesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:href="cere-20230331.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsTables" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationTables" xlink:href="cere-20230331.xsd#Role_DisclosureEquityBasedCompensationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:href="cere-20230331.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRisksAndLiquidityAdditionalInformationDetails" xlink:href="cere-20230331.xsd#Role_DisclosureRisksAndLiquidityAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="cere-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails" xlink:href="cere-20230331.xsd#Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails" xlink:href="cere-20230331.xsd#DisclosureFinancingLiabilitiesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails" xlink:href="cere-20230331.xsd#DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails" xlink:href="cere-20230331.xsd#Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails" xlink:href="cere-20230331.xsd#Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails" xlink:href="cere-20230331.xsd#Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails" xlink:href="cere-20230331.xsd#Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails" xlink:href="cere-20230331.xsd#DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails" xlink:href="cere-20230331.xsd#DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails" xlink:href="cere-20230331.xsd#DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails" xlink:href="cere-20230331.xsd#DisclosureStockholdersEquityPreferredStockAndCommonStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails" xlink:href="cere-20230331.xsd#DisclosureStockholdersEquityWarrantsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" xlink:href="cere-20230331.xsd#Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails" xlink:href="cere-20230331.xsd#Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" xlink:href="cere-20230331.xsd#Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails" xlink:href="cere-20230331.xsd#Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails" xlink:href="cere-20230331.xsd#DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails" xlink:href="cere-20230331.xsd#Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails" xlink:href="cere-20230331.xsd#Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="cere-20230331.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="cere-20230331.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails" xlink:href="cere-20230331.xsd#Role_DisclosureRelatedPartiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="cere-20230331.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentQuarterlyReport" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentInformationTable" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NoncurrentFinancingLiabilityRelatedParty" xlink:label="cere_NoncurrentFinancingLiabilityRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NoncurrentFinancingLiability" xlink:label="cere_NoncurrentFinancingLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="cere_NoncurrentFinancingLiabilityRelatedParty" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="cere_NoncurrentFinancingLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ConvertibleDebtNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_6"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NetIncomeLoss_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_8"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_9"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_8" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_9" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AdjustmentsToOperatingLeaseExpense" xlink:label="cere_AdjustmentsToOperatingLeaseExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FixedAssetAdditionsObtainedInExchangeTransaction" xlink:label="cere_FixedAssetAdditionsObtainedInExchangeTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ChangeInFairValueOfFinancingLiability" xlink:label="cere_ChangeInFairValueOfFinancingLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt" xlink:label="cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="cere_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cere_AdjustmentsToOperatingLeaseExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="cere_FixedAssetAdditionsObtainedInExchangeTransaction" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="cere_ChangeInFairValueOfFinancingLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="cere_IncreaseDecreaseInOperatingLeaseLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNatureOfOperations" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRisksAndLiquidity" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_RisksAndLiquidityTextBlock" xlink:label="cere_RisksAndLiquidityTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="cere_RisksAndLiquidityTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreement" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LicenseAgreementAbstract" xlink:label="cere_LicenseAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LicenseAgreementTextBlock" xlink:label="cere_LicenseAgreementTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cere_LicenseAgreementAbstract" xlink:to="cere_LicenseAgreementTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilities1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionTextBlock" xlink:label="us-gaap_FairValueOptionTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueOptionTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotes3" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponents" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:label="us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_AdditionalFinancialInformationDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureLegalProceedings" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LegalMattersAndContingenciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedParties" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DebtPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock" xlink:label="cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ScheduleOfInterestExpenseTableTextBlock" xlink:label="cere_ScheduleOfInterestExpenseTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="cere_ScheduleOfInterestExpenseTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:label="cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRisksAndLiquidityAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended"/>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202006Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LicenseAgreementTable" xlink:label="cere_LicenseAgreementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LicenseAgreementAbstract" xlink:label="cere_LicenseAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LicenseAgreementLineItems" xlink:label="cere_LicenseAgreementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PfizerLicenseAgreementMember" xlink:label="cere_PfizerLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_RegulatoryApprovalMilestonePayments" xlink:label="cere_RegulatoryApprovalMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_CommercialApprovalMilestonePayments" xlink:label="cere_CommercialApprovalMilestonePayments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cere_LicenseAgreementTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cere_LicenseAgreementAbstract" xlink:to="cere_LicenseAgreementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cere_LicenseAgreementLineItems" xlink:to="us-gaap_RoyaltyExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="cere_PfizerLicenseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cere_LicenseAgreementTable" xlink:to="cere_LicenseAgreementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cere_LicenseAgreementLineItems" xlink:to="cere_RegulatoryApprovalMilestonePayments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cere_LicenseAgreementLineItems" xlink:to="cere_CommercialApprovalMilestonePayments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FirstAnniversariesMember" xlink:label="cere_FirstAnniversariesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReceivedFunding" xlink:label="cere_ReceivedFunding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NovaQuestFundingAgreementMember" xlink:label="cere_NovaQuestFundingAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_SecondAnniversariesMember" xlink:label="cere_SecondAnniversariesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfFundingReceived" xlink:label="cere_PercentageOfFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_BainFundingAgreementMember" xlink:label="cere_BainFundingAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ThirdAnniversariesMember" xlink:label="cere_ThirdAnniversariesMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ExpectedFundingReceived" xlink:label="cere_ExpectedFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NovaQuestAndBainFundingAgreementsMember" xlink:label="cere_NovaQuestAndBainFundingAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FundingCommitmentFeesIncurred" xlink:label="cere_FundingCommitmentFeesIncurred"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfExpectedFundingReceived" xlink:label="cere_PercentageOfExpectedFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PayableOnFundingAgreement" xlink:label="cere_PayableOnFundingAgreement"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfFundingCommitment" xlink:label="cere_PercentageOfFundingCommitment"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ContractualObligationDescriptionRepaymentTiming" xlink:label="cere_ContractualObligationDescriptionRepaymentTiming"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NoncurrentFinancingLiabilityRelatedParty" xlink:label="cere_NoncurrentFinancingLiabilityRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NoncurrentFinancingLiability" xlink:label="cere_NoncurrentFinancingLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueOptionQuantitativeDisclosuresTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="cere_FirstAnniversariesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_ReceivedFunding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_NovaQuestFundingAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="cere_SecondAnniversariesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_PercentageOfFundingReceived" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_BainFundingAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="cere_ThirdAnniversariesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_ExpectedFundingReceived" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_NovaQuestAndBainFundingAgreementsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_FundingCommitmentFeesIncurred" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="srt_StatementScenarioAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_PercentageOfExpectedFundingReceived" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_PayableOnFundingAgreement" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_PercentageOfFundingCommitment" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_ContractualObligationDescriptionRepaymentTiming" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_NoncurrentFinancingLiabilityRelatedParty" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_NoncurrentFinancingLiability" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityRelatedPartyMember" xlink:label="cere_FinancingLiabilityRelatedPartyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityMember" xlink:label="cere_FinancingLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueOptionQuantitativeDisclosuresTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="cere_FinancingLiabilityRelatedPartyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="cere_FinancingLiabilityMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_MeasurementPeriodMember" xlink:label="cere_MeasurementPeriodMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfExpenseAxis" xlink:label="us-gaap_NatureOfExpenseAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PurchaserDiscountsMember" xlink:label="cere_PurchaserDiscountsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember" xlink:label="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_OtherOfferingExpensesMember" xlink:label="cere_OtherOfferingExpensesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase" xlink:label="cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PerPrincipalAmountForConversion" xlink:label="cere_PerPrincipalAmountForConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PerPrincipalAmountForTradingPrice" xlink:label="cere_PerPrincipalAmountForTradingPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_DebtInstrumentMinimumPrincipalAmountForRedemption" xlink:label="cere_DebtInstrumentMinimumPrincipalAmountForRedemption"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDefaultLongtermDebtAmount" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault" xlink:label="us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="cere_MeasurementPeriodMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_InterimPeriodCostsNotAllocableDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="cere_PurchaserDiscountsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="cere_OtherOfferingExpensesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_NatureOfExpenseAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestPayableCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cere_PerPrincipalAmountForConversion" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cere_PerPrincipalAmountForTradingPrice" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cere_DebtInstrumentMinimumPrincipalAmountForRedemption" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtDefaultLongtermDebtAmount" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsGross" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:label="cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_DebtInstrumentInterest" xlink:label="cere_DebtInstrumentInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebt" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="cere_DebtInstrumentInterest" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrivatePlacementWarrantsMember" xlink:label="cere_PrivatePlacementWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityRelatedPartyMember" xlink:label="cere_FinancingLiabilityRelatedPartyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityMember" xlink:label="cere_FinancingLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="us-gaap_USTreasuryAndGovernmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_RestrictedCashMember" xlink:label="cere_RestrictedCashMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="cere_PrivatePlacementWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="cere_FinancingLiabilityRelatedPartyMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="cere_FinancingLiabilityMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasuryAndGovernmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CashEquivalentsMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="cere_RestrictedCashMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityRelatedPartyMember" xlink:label="cere_FinancingLiabilityRelatedPartyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputInceptionDiscountRateMember" xlink:label="us-gaap_MeasurementInputInceptionDiscountRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember" xlink:label="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_MarketableSecuritiesWeightedAverageMaturityTerm" xlink:label="cere_MarketableSecuritiesWeightedAverageMaturityTerm"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityMember" xlink:label="cere_FinancingLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput" xlink:label="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueLiabilitiesBetweenLevelTransferAmount" xlink:label="cere_FairValueLiabilitiesBetweenLevelTransferAmount"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueAssetBetweenLevelTransferAmount" xlink:label="cere_FairValueAssetBetweenLevelTransferAmount"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_MarketableSecuritiesRealizedGainLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="cere_FinancingLiabilityRelatedPartyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputInceptionDiscountRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_MarketableSecuritiesWeightedAverageMaturityTerm" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="cere_FinancingLiabilityMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_DebtInstrumentAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_FairValueLiabilitiesBetweenLevelTransferAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_FairValueAssetBetweenLevelTransferAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="us-gaap_USTreasuryAndGovernmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ShortTermMarketableSecuritiesMember" xlink:label="cere_ShortTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LongTermMarketableSecuritiesMember" xlink:label="cere_LongTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasuryAndGovernmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="cere_ShortTermMarketableSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="cere_LongTermMarketableSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_InvestmentTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilitiesMember" xlink:label="cere_FinancingLiabilitiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cere_FinancingLiabilitiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrivatePlacementWarrantsMember" xlink:label="cere_PrivatePlacementWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReclassificationOfPrivatePlacementWarrantFromEquity" xlink:label="cere_ReclassificationOfPrivatePlacementWarrantFromEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cere_PrivatePlacementWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_ReclassificationOfPrivatePlacementWarrantFromEquity" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrepaidClinicalTrialServicesCurrent" xlink:label="cere_PrepaidClinicalTrialServicesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrepaidResearchAndDevelopmentExpensesCurrent" xlink:label="cere_PrepaidResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivableCurrent" xlink:label="us-gaap_InterestReceivableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="cere_PrepaidClinicalTrialServicesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="cere_PrepaidResearchAndDevelopmentExpensesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidInsurance" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_InterestReceivableCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LaboratoryEquipmentMember" xlink:label="cere_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="cere_LaboratoryEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PrepaidExpenseOtherNoncurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsMiscellaneousNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AccruedExternalResearchAndDevelopmentServicesCurrent" xlink:label="cere_AccruedExternalResearchAndDevelopmentServicesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AccruedPropertyAndEquipmentCurrent" xlink:label="cere_AccruedPropertyAndEquipmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="cere_AccruedExternalResearchAndDevelopmentServicesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="cere_AccruedPropertyAndEquipmentCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_InterestPayableCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNetAbstract" xlink:label="us-gaap_InterestIncomeExpenseNetAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_InterestIncomeNonoperatingNet" xlink:label="cere_InterestIncomeNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestIncomeExpenseNetAbstract" xlink:to="cere_InterestIncomeNonoperatingNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestIncomeExpenseNetAbstract" xlink:to="us-gaap_InterestExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestIncomeExpenseNetAbstract" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_GainLossOnFairValueRemeasurementOfFinancingLiability" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiability"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" xlink:label="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_OtherNonoperatingIncomeExpenseOther" xlink:label="cere_OtherNonoperatingIncomeExpenseOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="cere_GainLossOnFairValueRemeasurementOfFinancingLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="cere_OtherNonoperatingIncomeExpenseOther" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AugustTwoThousandTwentyTwoPublicOfferingMember" xlink:label="cere_AugustTwoThousandTwentyTwoPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_JulyTwoThousandTwentyOnePublicOfferingMember" xlink:label="cere_JulyTwoThousandTwentyOnePublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AtmProgramMember" xlink:label="cere_AtmProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_UnderwritingDiscountsAndCommissionsOfSharesIssued" xlink:label="cere_UnderwritingDiscountsAndCommissionsOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_OfferingExpenseOfSharesIssued" xlink:label="cere_OfferingExpenseOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_SaleAndIssuanceOfStockNotYetIssued" xlink:label="cere_SaleAndIssuanceOfStockNotYetIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="cere_AugustTwoThousandTwentyTwoPublicOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityNoteAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="cere_JulyTwoThousandTwentyOnePublicOfferingMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="cere_AtmProgramMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cere_UnderwritingDiscountsAndCommissionsOfSharesIssued" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cere_OfferingExpenseOfSharesIssued" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockVotingRights" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cere_SaleAndIssuanceOfStockNotYetIssued" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrivatePlacementWarrantsMember" xlink:label="cere_PrivatePlacementWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember" xlink:label="us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities" xlink:label="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ChangeInFairValueOfPrivatePlacementWarrants" xlink:label="cere_ChangeInFairValueOfPrivatePlacementWarrants"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" xlink:label="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cere_PrivatePlacementWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OtherOperatingIncomeExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cere_ChangeInFairValueOfPrivatePlacementWarrants" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_EmployeeStockPurchasePlanMember" xlink:label="cere_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="cere_EmployeeStockPurchasePlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NASDAQIndexFutureMember" xlink:label="us-gaap_NASDAQIndexFutureMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ClosingPriceOfCommonStock" xlink:label="cere_ClosingPriceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_NASDAQIndexFutureMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="cere_ClosingPriceOfCommonStock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_EarningsPerShareOtherDisclosuresAbstract" xlink:label="cere_EarningsPerShareOtherDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cere_EarningsPerShareOtherDisclosuresAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="cere_EarningsPerShareOtherDisclosuresAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cere_EarningsPerShareOtherDisclosuresAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cere_EarningsPerShareOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cere_EarningsPerShareOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ESPPSharesIssuableMember" xlink:label="cere_ESPPSharesIssuableMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember" xlink:label="cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="cere_ESPPSharesIssuableMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits" xlink:label="cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LossOrMaterialCostsRelatedToIndemnificationObligation" xlink:label="cere_LossOrMaterialCostsRelatedToIndemnificationObligation"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ClaimsOutstanding" xlink:label="cere_ClaimsOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation" xlink:label="us-gaap_ContractualObligation"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="cere_LossOrMaterialCostsRelatedToIndemnificationObligation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="cere_ClaimsOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ContractualObligation" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PfizerIncMember" xlink:label="cere_PfizerIncMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_BainFundingAgreementMember" xlink:label="cere_BainFundingAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfFundingReceived" xlink:label="cere_PercentageOfFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_BainInvestorMember" xlink:label="cere_BainInvestorMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ResearchCollaborationAndLicenseAgreementMember" xlink:label="cere_ResearchCollaborationAndLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PeriodOverWhichFundingSupportReceived" xlink:label="cere_PeriodOverWhichFundingSupportReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ManagementAgreementMember" xlink:label="cere_ManagementAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FundingCommitmentFeesIncurred" xlink:label="cere_FundingCommitmentFeesIncurred"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ExpectedFundingReceived" xlink:label="cere_ExpectedFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales" xlink:label="cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReceivedFunding" xlink:label="cere_ReceivedFunding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagementFeeExpense" xlink:label="us-gaap_ManagementFeeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NumberOfMembersNominatedToBoardOfDirectors" xlink:label="cere_NumberOfMembersNominatedToBoardOfDirectors"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="cere_PfizerIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_BainFundingAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_PercentageOfFundingReceived" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="cere_BainInvestorMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_ResearchCollaborationAndLicenseAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_PeriodOverWhichFundingSupportReceived" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_ManagementAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_FundingCommitmentFeesIncurred" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_ExpectedFundingReceived" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_ReceivedFunding" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ManagementFeeExpense" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_NumberOfMembersNominatedToBoardOfDirectors" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_SecondAnniversariesMember" xlink:label="cere_SecondAnniversariesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReceivedFunding" xlink:label="cere_ReceivedFunding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfFundingReceived" xlink:label="cere_PercentageOfFundingReceived"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="cere_SecondAnniversariesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="cere_ReceivedFunding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="cere_PercentageOfFundingReceived" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>cere-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-05-03T16:04:20.0419+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:href="cere-20230331.xsd#Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails2" xlink:href="cere-20230331.xsd#Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails2" xlink:href="cere-20230331.xsd#DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited2" xlink:href="cere-20230331.xsd#StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited2" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited" xlink:href="cere-20230331.xsd#Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:href="cere-20230331.xsd#Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails" xlink:href="cere-20230331.xsd#Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails" xlink:href="cere-20230331.xsd#Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails" xlink:href="cere-20230331.xsd#Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails" xlink:href="cere-20230331.xsd#DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="cere_NoncurrentFinancingLiabilityRelatedParty" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="cere_NoncurrentFinancingLiability" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_ConvertibleDebtNoncurrent" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="6" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NoncurrentFinancingLiabilityRelatedParty" xlink:label="cere_NoncurrentFinancingLiabilityRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NoncurrentFinancingLiability" xlink:label="cere_NoncurrentFinancingLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="cere_DebtInstrumentInterest" order="1" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_DebtInstrumentInterest" xlink:label="cere_DebtInstrumentInterest"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="cere_InterestIncomeNonoperatingNet" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="us-gaap_InterestExpense" order="2" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_InterestIncomeNonoperatingNet" xlink:label="cere_InterestIncomeNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="3" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cere_AdjustmentsToOperatingLeaseExpense" order="2" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="5" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="6" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="8" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="10" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="11" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cere_ChangeInFairValueOfFinancingLiability" order="13" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="16" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="16" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="18" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="20" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="21" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cere_IncreaseDecreaseInOperatingLeaseLiabilities" order="23" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AdjustmentsToOperatingLeaseExpense" xlink:label="cere_AdjustmentsToOperatingLeaseExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt" xlink:label="cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ChangeInFairValueOfFinancingLiability" xlink:label="cere_ChangeInFairValueOfFinancingLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="cere_IncreaseDecreaseInOperatingLeaseLiabilities"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:label="cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="cere_PrepaidClinicalTrialServicesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="cere_PrepaidResearchAndDevelopmentExpensesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidInsurance" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_InterestReceivableCurrent" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrepaidClinicalTrialServicesCurrent" xlink:label="cere_PrepaidClinicalTrialServicesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrepaidResearchAndDevelopmentExpensesCurrent" xlink:label="cere_PrepaidResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivableCurrent" xlink:label="us-gaap_InterestReceivableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_PrepaidExpenseOtherNoncurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentNet" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsMiscellaneousNoncurrent" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="cere_AccruedExternalResearchAndDevelopmentServicesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_InterestPayableCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="cere_AccruedPropertyAndEquipmentCurrent" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="6" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AccruedExternalResearchAndDevelopmentServicesCurrent" xlink:label="cere_AccruedExternalResearchAndDevelopmentServicesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AccruedPropertyAndEquipmentCurrent" xlink:label="cere_AccruedPropertyAndEquipmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="cere_GainLossOnFairValueRemeasurementOfFinancingLiability" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="cere_OtherNonoperatingIncomeExpenseOther" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_GainLossOnFairValueRemeasurementOfFinancingLiability" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiability"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" xlink:label="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_OtherNonoperatingIncomeExpenseOther" xlink:label="cere_OtherNonoperatingIncomeExpenseOther"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>cere-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-05-03T16:04:22.4016+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="cere-20230331.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:href="cere-20230331.xsd#Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="cere-20230331.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails" xlink:href="cere-20230331.xsd#Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails" xlink:href="cere-20230331.xsd#DisclosureFinancingLiabilitiesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails" xlink:href="cere-20230331.xsd#DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails" xlink:href="cere-20230331.xsd#Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails" xlink:href="cere-20230331.xsd#DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails" xlink:href="cere-20230331.xsd#DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails" xlink:href="cere-20230331.xsd#Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails" xlink:href="cere-20230331.xsd#DisclosureStockholdersEquityPreferredStockAndCommonStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails" xlink:href="cere-20230331.xsd#DisclosureStockholdersEquityWarrantsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" xlink:href="cere-20230331.xsd#Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails" xlink:href="cere-20230331.xsd#Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" xlink:href="cere-20230331.xsd#Role_DisclosureEquityBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails" xlink:href="cere-20230331.xsd#Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails" xlink:href="cere-20230331.xsd#DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails" xlink:href="cere-20230331.xsd#Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails" xlink:href="cere-20230331.xsd#Role_DisclosureRelatedPartiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="cere-20230331.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10210.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10230.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10250.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10270.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10290.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10310.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10330.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10350.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10370.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10390.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10410.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10430.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10450.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10489.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10509.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10529.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10549.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10569.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10589.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10609.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10629.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10649.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10669.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10689.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10709.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10749.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10789.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10829.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10849.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentQuarterlyReport" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10869.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10141.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202006Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LicenseAgreementLineItems" xlink:label="cere_LicenseAgreementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LicenseAgreementTable" xlink:label="cere_LicenseAgreementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PfizerLicenseAgreementMember" xlink:label="cere_PfizerLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_RegulatoryApprovalMilestonePayments" xlink:label="cere_RegulatoryApprovalMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_CommercialApprovalMilestonePayments" xlink:label="cere_CommercialApprovalMilestonePayments"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cere_LicenseAgreementLineItems" xlink:to="cere_LicenseAgreementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cere_LicenseAgreementTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="cere_PfizerLicenseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10150.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cere_LicenseAgreementLineItems" xlink:to="us-gaap_RoyaltyExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10170.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cere_LicenseAgreementLineItems" xlink:to="cere_RegulatoryApprovalMilestonePayments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10190.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cere_LicenseAgreementLineItems" xlink:to="cere_CommercialApprovalMilestonePayments" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FirstAnniversariesMember" xlink:label="cere_FirstAnniversariesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReceivedFunding" xlink:label="cere_ReceivedFunding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NovaQuestFundingAgreementMember" xlink:label="cere_NovaQuestFundingAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_SecondAnniversariesMember" xlink:label="cere_SecondAnniversariesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfFundingReceived" xlink:label="cere_PercentageOfFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_BainFundingAgreementMember" xlink:label="cere_BainFundingAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ThirdAnniversariesMember" xlink:label="cere_ThirdAnniversariesMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ExpectedFundingReceived" xlink:label="cere_ExpectedFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NovaQuestAndBainFundingAgreementsMember" xlink:label="cere_NovaQuestAndBainFundingAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FundingCommitmentFeesIncurred" xlink:label="cere_FundingCommitmentFeesIncurred"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfExpectedFundingReceived" xlink:label="cere_PercentageOfExpectedFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PayableOnFundingAgreement" xlink:label="cere_PayableOnFundingAgreement"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfFundingCommitment" xlink:label="cere_PercentageOfFundingCommitment"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ContractualObligationDescriptionRepaymentTiming" xlink:label="cere_ContractualObligationDescriptionRepaymentTiming"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NoncurrentFinancingLiabilityRelatedParty" xlink:label="cere_NoncurrentFinancingLiabilityRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NoncurrentFinancingLiability" xlink:label="cere_NoncurrentFinancingLiability"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="us-gaap_FairValueOptionQuantitativeDisclosuresTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="cere_FirstAnniversariesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_ReceivedFunding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_NovaQuestFundingAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="cere_SecondAnniversariesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_PercentageOfFundingReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_BainFundingAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="cere_ThirdAnniversariesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_ExpectedFundingReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_NovaQuestAndBainFundingAgreementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_FundingCommitmentFeesIncurred" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_PercentageOfExpectedFundingReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_PayableOnFundingAgreement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_PercentageOfFundingCommitment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_ContractualObligationDescriptionRepaymentTiming" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_NoncurrentFinancingLiabilityRelatedParty" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="cere_NoncurrentFinancingLiability" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityRelatedPartyMember" xlink:label="cere_FinancingLiabilityRelatedPartyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityMember" xlink:label="cere_FinancingLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="us-gaap_FairValueOptionQuantitativeDisclosuresTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="cere_FinancingLiabilityRelatedPartyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="cere_FinancingLiabilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_MeasurementPeriodMember" xlink:label="cere_MeasurementPeriodMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfExpenseAxis" xlink:label="us-gaap_NatureOfExpenseAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PurchaserDiscountsMember" xlink:label="cere_PurchaserDiscountsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember" xlink:label="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_OtherOfferingExpensesMember" xlink:label="cere_OtherOfferingExpensesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase" xlink:label="cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PerPrincipalAmountForConversion" xlink:label="cere_PerPrincipalAmountForConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PerPrincipalAmountForTradingPrice" xlink:label="cere_PerPrincipalAmountForTradingPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_DebtInstrumentMinimumPrincipalAmountForRedemption" xlink:label="cere_DebtInstrumentMinimumPrincipalAmountForRedemption"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDefaultLongtermDebtAmount" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault" xlink:label="us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="cere_MeasurementPeriodMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_InterimPeriodCostsNotAllocableDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_InterimPeriodCostsNotAllocableDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="cere_PurchaserDiscountsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="cere_OtherOfferingExpensesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_NatureOfExpenseAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestPayableCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cere_PerPrincipalAmountForConversion" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cere_PerPrincipalAmountForTradingPrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="cere_DebtInstrumentMinimumPrincipalAmountForRedemption" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtDefaultLongtermDebtAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsGross" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrivatePlacementWarrantsMember" xlink:label="cere_PrivatePlacementWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityRelatedPartyMember" xlink:label="cere_FinancingLiabilityRelatedPartyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityMember" xlink:label="cere_FinancingLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="us-gaap_USTreasuryAndGovernmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_RestrictedCashMember" xlink:label="cere_RestrictedCashMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="cere_PrivatePlacementWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="cere_FinancingLiabilityRelatedPartyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="cere_FinancingLiabilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USTreasuryAndGovernmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByAssetClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CashEquivalentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="cere_RestrictedCashMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10180.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10180.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10200.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10220.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10240.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10280.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10280.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10770.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10973.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11270.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11470.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityRelatedPartyMember" xlink:label="cere_FinancingLiabilityRelatedPartyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember" xlink:label="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_MarketableSecuritiesWeightedAverageMaturityTerm" xlink:label="cere_MarketableSecuritiesWeightedAverageMaturityTerm"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityMember" xlink:label="cere_FinancingLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput" xlink:label="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueLiabilitiesBetweenLevelTransferAmount" xlink:label="cere_FairValueLiabilitiesBetweenLevelTransferAmount"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueAssetBetweenLevelTransferAmount" xlink:label="cere_FairValueAssetBetweenLevelTransferAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputInceptionDiscountRateMember" xlink:label="us-gaap_MeasurementInputInceptionDiscountRateMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_MarketableSecuritiesRealizedGainLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="cere_FinancingLiabilityRelatedPartyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_MarketableSecuritiesWeightedAverageMaturityTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="cere_FinancingLiabilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_MeasurementInputTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_FairValueLiabilitiesBetweenLevelTransferAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_FairValueAssetBetweenLevelTransferAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10100.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10180.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10200.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10300.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10300.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10320.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputInceptionDiscountRateMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="us-gaap_USTreasuryAndGovernmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ShortTermMarketableSecuritiesMember" xlink:label="cere_ShortTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LongTermMarketableSecuritiesMember" xlink:label="cere_LongTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasuryAndGovernmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="cere_ShortTermMarketableSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="cere_LongTermMarketableSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilitiesMember" xlink:label="cere_FinancingLiabilitiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cere_FinancingLiabilitiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrivatePlacementWarrantsMember" xlink:label="cere_PrivatePlacementWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReclassificationOfPrivatePlacementWarrantFromEquity" xlink:label="cere_ReclassificationOfPrivatePlacementWarrantFromEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.02" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10120.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10140.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cere_PrivatePlacementWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10311.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="cere_ReclassificationOfPrivatePlacementWarrantFromEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10351.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LaboratoryEquipmentMember" xlink:label="cere_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="cere_LaboratoryEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10110.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10110.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10191.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10220.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10380.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10420.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AugustTwoThousandTwentyTwoPublicOfferingMember" xlink:label="cere_AugustTwoThousandTwentyTwoPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_JulyTwoThousandTwentyOnePublicOfferingMember" xlink:label="cere_JulyTwoThousandTwentyOnePublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AtmProgramMember" xlink:label="cere_AtmProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_UnderwritingDiscountsAndCommissionsOfSharesIssued" xlink:label="cere_UnderwritingDiscountsAndCommissionsOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_OfferingExpenseOfSharesIssued" xlink:label="cere_OfferingExpenseOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_SaleAndIssuanceOfStockNotYetIssued" xlink:label="cere_SaleAndIssuanceOfStockNotYetIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="cere_AugustTwoThousandTwentyTwoPublicOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityNoteAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="cere_JulyTwoThousandTwentyOnePublicOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="cere_AtmProgramMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cere_UnderwritingDiscountsAndCommissionsOfSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cere_OfferingExpenseOfSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DeferredOfferingCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockVotingRights" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cere_SaleAndIssuanceOfStockNotYetIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrivatePlacementWarrantsMember" xlink:label="cere_PrivatePlacementWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember" xlink:label="us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities" xlink:label="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ChangeInFairValueOfPrivatePlacementWarrants" xlink:label="cere_ChangeInFairValueOfPrivatePlacementWarrants"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" xlink:label="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cere_PrivatePlacementWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OtherOperatingIncomeExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cere_ChangeInFairValueOfPrivatePlacementWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_EmployeeStockPurchasePlanMember" xlink:label="cere_EmployeeStockPurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.02" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10100.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10120.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="cere_EmployeeStockPurchasePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10160.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10180.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10200.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10410.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10290.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11120.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11950.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12351.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12480.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12881.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NASDAQIndexFutureMember" xlink:label="us-gaap_NASDAQIndexFutureMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ClosingPriceOfCommonStock" xlink:label="cere_ClosingPriceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.02" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10081.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10120.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10140.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_NASDAQIndexFutureMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10233.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="cere_ClosingPriceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10283.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10130.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10170.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10210.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10250.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ESPPSharesIssuableMember" xlink:label="cere_ESPPSharesIssuableMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember" xlink:label="cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="cere_ESPPSharesIssuableMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10030.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10210.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_BainFundingAgreementMember" xlink:label="cere_BainFundingAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ResearchCollaborationAndLicenseAgreementMember" xlink:label="cere_ResearchCollaborationAndLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfFundingReceived" xlink:label="cere_PercentageOfFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ManagementAgreementMember" xlink:label="cere_ManagementAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PeriodOverWhichFundingSupportReceived" xlink:label="cere_PeriodOverWhichFundingSupportReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FundingCommitmentFeesIncurred" xlink:label="cere_FundingCommitmentFeesIncurred"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ExpectedFundingReceived" xlink:label="cere_ExpectedFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales" xlink:label="cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReceivedFunding" xlink:label="cere_ReceivedFunding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagementFeeExpense" xlink:label="us-gaap_ManagementFeeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PfizerIncMember" xlink:label="cere_PfizerIncMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_BainInvestorMember" xlink:label="cere_BainInvestorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NumberOfMembersNominatedToBoardOfDirectors" xlink:label="cere_NumberOfMembersNominatedToBoardOfDirectors"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_BainFundingAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_ResearchCollaborationAndLicenseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_PercentageOfFundingReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="cere_ManagementAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_PeriodOverWhichFundingSupportReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_FundingCommitmentFeesIncurred" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_ExpectedFundingReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_ReceivedFunding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ManagementFeeExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10032.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10060.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10080.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="cere_PfizerIncMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10160.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="cere_BainInvestorMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10217.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10257.00" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="cere_NumberOfMembersNominatedToBoardOfDirectors" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_SecondAnniversariesMember" xlink:label="cere_SecondAnniversariesMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReceivedFunding" xlink:label="cere_ReceivedFunding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfFundingReceived" xlink:label="cere_PercentageOfFundingReceived"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="cere_SecondAnniversariesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="cere_ReceivedFunding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="cere_PercentageOfFundingReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>cere-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-05-03T16:04:22.2011+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueAssetBetweenLevelTransferAmount" xlink:label="cere_FairValueAssetBetweenLevelTransferAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PerPrincipalAmountForConversion" xlink:label="cere_PerPrincipalAmountForConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AccruedExternalResearchAndDevelopmentServicesCurrent" xlink:label="cere_AccruedExternalResearchAndDevelopmentServicesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:label="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ChangeInFairValueOfFinancingLiability" xlink:label="cere_ChangeInFairValueOfFinancingLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AdjustmentsToOperatingLeaseExpense" xlink:label="cere_AdjustmentsToOperatingLeaseExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:label="cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember" xlink:label="cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_BainInvestorMember" xlink:label="cere_BainInvestorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LicenseAgreementTextBlock" xlink:label="cere_LicenseAgreementTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_MarketableSecuritiesWeightedAverageMaturityTerm" xlink:label="cere_MarketableSecuritiesWeightedAverageMaturityTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ClaimsOutstanding" xlink:label="cere_ClaimsOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ChangeInFairValueOfPrivatePlacementWarrants" xlink:label="cere_ChangeInFairValueOfPrivatePlacementWarrants"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ShortTermMarketableSecuritiesMember" xlink:label="cere_ShortTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AtmProgramMember" xlink:label="cere_AtmProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember" xlink:label="us-gaap_USTreasuryAndGovernmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ResearchCollaborationAndLicenseAgreementMember" xlink:label="cere_ResearchCollaborationAndLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PurchaserDiscountsMember" xlink:label="cere_PurchaserDiscountsMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_SecondAnniversariesMember" xlink:label="cere_SecondAnniversariesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ScheduleOfInterestExpenseTableTextBlock" xlink:label="cere_ScheduleOfInterestExpenseTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member" xlink:label="us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_UnderwritingDiscountsAndCommissionsOfSharesIssued" xlink:label="cere_UnderwritingDiscountsAndCommissionsOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LaboratoryEquipmentMember" xlink:label="cere_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PfizerIncMember" xlink:label="cere_PfizerIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="cere_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LicenseAgreementTable" xlink:label="cere_LicenseAgreementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfFundingReceived" xlink:label="cere_PercentageOfFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LicenseAgreementAbstract" xlink:label="cere_LicenseAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_OtherNonoperatingIncomeExpenseOther" xlink:label="cere_OtherNonoperatingIncomeExpenseOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrivatePlacementWarrantsMember" xlink:label="cere_PrivatePlacementWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LicenseAgreementLineItems" xlink:label="cere_LicenseAgreementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NovaQuestAndBainFundingAgreementsMember" xlink:label="cere_NovaQuestAndBainFundingAgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt" xlink:label="cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ManagementAgreementMember" xlink:label="cere_ManagementAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PfizerLicenseAgreementMember" xlink:label="cere_PfizerLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities" xlink:label="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNetAbstract" xlink:label="us-gaap_InterestIncomeExpenseNetAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PerPrincipalAmountForTradingPrice" xlink:label="cere_PerPrincipalAmountForTradingPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ESPPSharesIssuableMember" xlink:label="cere_ESPPSharesIssuableMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NASDAQIndexFutureMember" xlink:label="us-gaap_NASDAQIndexFutureMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase" xlink:label="cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_SaleAndIssuanceOfStockNotYetIssued" xlink:label="cere_SaleAndIssuanceOfStockNotYetIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrepaidResearchAndDevelopmentExpensesCurrent" xlink:label="cere_PrepaidResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ThirdAnniversariesMember" xlink:label="cere_ThirdAnniversariesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDefaultLongtermDebtAmount" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PayableOnFundingAgreement" xlink:label="cere_PayableOnFundingAgreement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivableCurrent" xlink:label="us-gaap_InterestReceivableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember" xlink:label="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfExpenseAxis" xlink:label="us-gaap_NatureOfExpenseAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReceivedFunding" xlink:label="cere_ReceivedFunding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ExpectedFundingReceived" xlink:label="cere_ExpectedFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" xlink:label="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NoncurrentFinancingLiability" xlink:label="cere_NoncurrentFinancingLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_JulyTwoThousandTwentyOnePublicOfferingMember" xlink:label="cere_JulyTwoThousandTwentyOnePublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:label="cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityRelatedPartyMember" xlink:label="cere_FinancingLiabilityRelatedPartyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsGross"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FixedAssetAdditionsObtainedInExchangeTransaction" xlink:label="cere_FixedAssetAdditionsObtainedInExchangeTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits" xlink:label="cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:label="us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputInceptionDiscountRateMember" xlink:label="us-gaap_MeasurementInputInceptionDiscountRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_BainFundingAgreementMember" xlink:label="cere_BainFundingAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ClosingPriceOfCommonStock" xlink:label="cere_ClosingPriceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfFundingCommitment" xlink:label="cere_PercentageOfFundingCommitment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock" xlink:label="cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionTextBlock" xlink:label="us-gaap_FairValueOptionTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_DebtInstrumentInterest" xlink:label="cere_DebtInstrumentInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualObligation" xlink:label="us-gaap_ContractualObligation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NoncurrentFinancingLiabilityRelatedParty" xlink:label="cere_NoncurrentFinancingLiabilityRelatedParty"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_InterestIncomeNonoperatingNet" xlink:label="cere_InterestIncomeNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_OtherOfferingExpensesMember" xlink:label="cere_OtherOfferingExpensesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput" xlink:label="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NovaQuestFundingAgreementMember" xlink:label="cere_NovaQuestFundingAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault" xlink:label="us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_GainLossOnFairValueRemeasurementOfFinancingLiability" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiability"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales" xlink:label="cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FundingCommitmentFeesIncurred" xlink:label="cere_FundingCommitmentFeesIncurred"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AugustTwoThousandTwentyTwoPublicOfferingMember" xlink:label="cere_AugustTwoThousandTwentyTwoPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FirstAnniversariesMember" xlink:label="cere_FirstAnniversariesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_AccruedPropertyAndEquipmentCurrent" xlink:label="cere_AccruedPropertyAndEquipmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PeriodOverWhichFundingSupportReceived" xlink:label="cere_PeriodOverWhichFundingSupportReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LossOrMaterialCostsRelatedToIndemnificationObligation" xlink:label="cere_LossOrMaterialCostsRelatedToIndemnificationObligation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PrepaidClinicalTrialServicesCurrent" xlink:label="cere_PrepaidClinicalTrialServicesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_RisksAndLiquidityTextBlock" xlink:label="cere_RisksAndLiquidityTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ReclassificationOfPrivatePlacementWarrantFromEquity" xlink:label="cere_ReclassificationOfPrivatePlacementWarrantFromEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_RegulatoryApprovalMilestonePayments" xlink:label="cere_RegulatoryApprovalMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_NumberOfMembersNominatedToBoardOfDirectors" xlink:label="cere_NumberOfMembersNominatedToBoardOfDirectors"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseMember" xlink:label="us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilitiesMember" xlink:label="cere_FinancingLiabilitiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FairValueLiabilitiesBetweenLevelTransferAmount" xlink:label="cere_FairValueLiabilitiesBetweenLevelTransferAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ManagementFeeExpense" xlink:label="us-gaap_ManagementFeeExpense"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_LongTermMarketableSecuritiesMember" xlink:label="cere_LongTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_EarningsPerShareOtherDisclosuresAbstract" xlink:label="cere_EarningsPerShareOtherDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_RestrictedCashMember" xlink:label="cere_RestrictedCashMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_MeasurementPeriodMember" xlink:label="cere_MeasurementPeriodMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_CommercialApprovalMilestonePayments" xlink:label="cere_CommercialApprovalMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_EmployeeStockPurchasePlanMember" xlink:label="cere_EmployeeStockPurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_PercentageOfExpectedFundingReceived" xlink:label="cere_PercentageOfExpectedFundingReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_FinancingLiabilityMember" xlink:label="cere_FinancingLiabilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_OfferingExpenseOfSharesIssued" xlink:label="cere_OfferingExpenseOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_ContractualObligationDescriptionRepaymentTiming" xlink:label="cere_ContractualObligationDescriptionRepaymentTiming"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:loc xlink:type="locator" xlink:href="cere-20230331.xsd#cere_DebtInstrumentMinimumPrincipalAmountForRedemption" xlink:label="cere_DebtInstrumentMinimumPrincipalAmountForRedemption"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueAssetBetweenLevelTransferAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value asset between level transfer amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueAssetBetweenLevelTransferAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Asset Between Level Transfer Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueAssetBetweenLevelTransferAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value asset between level transfer amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from financing liability, related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Related Party Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PerPrincipalAmountForConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Per principal amount for conversion.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PerPrincipalAmountForConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Per Principal Amount for Conversion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PerPrincipalAmountForConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, conversion price per principal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Quoted Prices in Active Markets (Level 1) [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AccruedExternalResearchAndDevelopmentServicesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued external research and development services current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AccruedExternalResearchAndDevelopmentServicesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued External Research And Development Services Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AccruedExternalResearchAndDevelopmentServicesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued external research and development services</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of Series A-1 preferred stock and Series A common stock and common stock in exchange for cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance and sale of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of common stock related to follow-on offering, net of offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Number of Equity Instruments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, convertible, number of equity instruments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fiscal year ended December 31, 2027</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed asset additions included in accounts payable and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ChangeInFairValueOfFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of financing liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ChangeInFairValueOfFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Fair Value of Financing Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ChangeInFairValueOfFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of financing liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ChangeInFairValueOfFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Change in fair value of financing liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Quarterly Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Quarterly Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, immaterial effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AdjustmentsToOperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to operating lease expense.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AdjustmentsToOperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Operating Lease Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AdjustmentsToOperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Adjustments to operating lease expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Option, Disclosures [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, conversion price percentage applicable for trading days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Non-vested, Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Non-vested, Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long term debt maturities repayments of principal after year four.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments of Principal After Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature of Operations [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nature of Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited, canceled or expired</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation and personnel costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock Options Outstanding [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under equity incentive plans related to vesting of RSUs, (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock Issuable Upon Conversion of Two Thousand Twenty Seven Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Issuable Upon Conversion of Two Thousand Twenty Seven Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Issuable Upon Conversion of the 2027 Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in fair value of private placement warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_BainInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Bain investor.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_BainInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Bain Investor [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_BainInvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Bain Investor [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adopted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LicenseAgreementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pfizer License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LicenseAgreementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The entire disclosure of license agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LicenseAgreementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_MarketableSecuritiesWeightedAverageMaturityTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Marketable securities weighted average maturity term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_MarketableSecuritiesWeightedAverageMaturityTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities Weighted Average Maturity Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_MarketableSecuritiesWeightedAverageMaturityTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities weighted average maturity term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ClaimsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims outstanding.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ClaimsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ClaimsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ChangeInFairValueOfPrivatePlacementWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of private placement warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ChangeInFairValueOfPrivatePlacementWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Fair Value Of Private Placement Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ChangeInFairValueOfPrivatePlacementWarrants_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of private placement warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value measurement with unobservable inputs reconciliations exercise of warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement With Unobservable Inputs Reconciliations Exercise of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recurring [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ShortTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due in One Year or Less [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ShortTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Marketable Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ShortTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Short term marketable securities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AtmProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ATM program.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AtmProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ATM Program [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasuryAndGovernmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury and Government [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Purchase Commitment, Category of Item Purchased</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ResearchCollaborationAndLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research Collaboration and License Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ResearchCollaborationAndLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Collaboration and License Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ResearchCollaborationAndLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research collaboration and license agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash, end of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash, beginning of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash, cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PurchaserDiscountsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchaser discounts.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PurchaserDiscountsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchaser Discounts [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_SecondAnniversariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Second Anniversaries [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_SecondAnniversariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Second anniversaries.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_SecondAnniversariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Second Anniversaries [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ScheduleOfInterestExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of interest expense.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ScheduleOfInterestExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Interest Expense [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ScheduleOfInterestExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Interest Expense Related to 2027 Notes Recognized in Interest Income (Expense), Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202006Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202006Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2020-06</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares used in calculating net loss per share, basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_UnderwritingDiscountsAndCommissionsOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Discounts and Commissions of Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_UnderwritingDiscountsAndCommissionsOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriting discounts and commissions of shares issued.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_UnderwritingDiscountsAndCommissionsOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting discounts and commissions of shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Debt [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Net Carrying Amount of 2027 Notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Other Income (Expense), Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PfizerIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pfizer Inc.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PfizerIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pfizer Inc [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PfizerIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pfizer Inc [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in operating lease liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LicenseAgreementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LicenseAgreementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LicenseAgreementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License Agreement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Construction in Progress [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction in-progress [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New accounting pronouncements or change in accounting principle</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock options granted, weighted average grant-date fair values</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Available-for-sale marketable debt securities, Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, number of shares converted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Risks and Uncertainties [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PercentageOfFundingReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of funding received.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PercentageOfFundingReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Funding Received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PercentageOfFundingReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of funding received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LicenseAgreementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LicenseAgreementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other prepaid expenses, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense Other, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Convertible Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of 2027 convertible senior notes, net of offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_OtherNonoperatingIncomeExpenseOther_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other nonoperating income expense other.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_OtherNonoperatingIncomeExpenseOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_OtherNonoperatingIncomeExpenseOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PrivatePlacementWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Private placement warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PrivatePlacementWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PrivatePlacementWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeContractTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Contract [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LicenseAgreementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LicenseAgreementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LicenseAgreementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License Agreement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NovaQuestAndBainFundingAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">NovaQuest and Bain funding agreements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NovaQuestAndBainFundingAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nova Quest And Bain Funding Agreements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NovaQuestAndBainFundingAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NovaQuest and Bain Funding Agreements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential Dilutive Securities Excluded From Calculation of Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from financing liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of long-term debt excluding related party debt.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Long-Term Debt Excluding Related Party Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ManagementAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Management Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ManagementAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Management Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ManagementAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Management agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.0001 par value: 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2023 and December 31, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PfizerLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pfizer license agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PfizerLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pfizer License Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PfizerLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pfizer License Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair Value of Private Placement Warrants Reclassified from Equity to Other Long Term Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value of Private Placement Warrants Reclassified from Equity to Other Long Term Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of private placement warrants reclassified from equity to other long term liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fair value of private placement warrants reclassified from equity to other long term liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash flows provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeExpenseNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income (Expense), Net [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value recognized in other (income) expense, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gain (loss) for change in estimated fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Life (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive loss:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income (loss):</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock related to follow-on offering, net of offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from issuance of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PerPrincipalAmountForTradingPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Per principal amount for trading price.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PerPrincipalAmountForTradingPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Per Principal Amount for Trading Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PerPrincipalAmountForTradingPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, trading price per principal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Property and Equipment Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ESPPSharesIssuableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ESPP shares issuable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ESPPSharesIssuableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">E S P P Shares Issuable [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ESPPSharesIssuableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ESPP Shares Issuable [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, conversion rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NASDAQIndexFutureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">NASDAQ Index Future [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NASDAQIndexFutureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nasdaq [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale marketable debt securities, Unrealized Gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument principal amount issued for additional purchase.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Principal Amount Issued for Additional Purchase</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, principal amount issued for additional purchase</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares used in calculating net loss per share, diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash Equivalents [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_SaleAndIssuanceOfStockNotYetIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sale and issuance of stock, not yet issued.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_SaleAndIssuanceOfStockNotYetIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale and Issuance of Stock, Not yet Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_SaleAndIssuanceOfStockNotYetIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance and sale of common stock yet to issue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PrepaidResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid research and development expenses current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PrepaidResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Research And Development Expenses Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PrepaidResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid research and development expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total unrecognized equity-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Marketable Securities, Realized Gain (Loss), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Realized Gain (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gains or losses recognized on the sale or maturity of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ThirdAnniversariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Third anniversaries.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ThirdAnniversariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Third Anniversaries [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ThirdAnniversariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Third Anniversaries [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Debt Default, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDefaultLongtermDebtAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, default amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other long-term assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Option, Changes in Fair Value, Gain (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value recognized in other expense (income), net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gains (losses) on change in fair value of financing liability, related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain (loss) on fair value remeasurement of financing liability, related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain (loss) on fair value remeasurement of financing liability related party.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss On Fair Value Remeasurement Of Financing Liability Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PayableOnFundingAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payable on funding agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PayableOnFundingAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payable On Funding Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PayableOnFundingAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payable on funding agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Receivable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2027 Convertible Senior Notes.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand and Twenty Seven Convertible Senior Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027 Convertible Senior Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfExpenseAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature of Expense [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Income tax benefit (provision), net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Income tax benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Tax Expense (Benefit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Option, Quantitative Disclosures [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Shares Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adoption Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adoption date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ReceivedFunding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Received funding.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ReceivedFunding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Received Funding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ReceivedFunding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total funding received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ExpectedFundingReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Expected funding received.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ExpectedFundingReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Expected Funding Received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ExpectedFundingReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Funding expected to be received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ExpectedFundingReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Percentage Of Funding Received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net losses related to changes in fair value of private placement warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain (loss) on fair value remeasurement of private placement warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss On Fair Value Remeasurement Of Private Placement Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on fair value remeasurement of private placement warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, stated rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NoncurrentFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncurrent financing liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NoncurrentFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncurrent Financing Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NoncurrentFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Financing liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NoncurrentFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing liability (Notes 5 and 7)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional fees and consulting services</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accrued expenses and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt instrument, accrued interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Voting Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, voting rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027 convertible senior notes, net (Note 6)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Marketable Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale and Maturity of Marketable Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturities and redemptions of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value by Liability Class [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Accrued Expenses and Other Current Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Marketable securities (current)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_JulyTwoThousandTwentyOnePublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">July two thousand twenty one public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_JulyTwoThousandTwentyOnePublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">July Two Thousand Twenty One Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_JulyTwoThousandTwentyOnePublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">July 2021 Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of prepaid expenses and other current assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Prepaid Expenses And Other Current Assets Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Prepaid Expenses and Other Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fiscal year ended December 31, 2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value: 500,000,000 shares authorized;156,760,109 and 156,502,285 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilityRelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Financing liability related party.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilityRelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing Liability, Related Party [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilityRelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Liability Related Party [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Warrant Exercises</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the exercise of public warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Issuance Costs, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt issuance cost incurred</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FixedAssetAdditionsObtainedInExchangeTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed asset additions obtained in exchange transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FixedAssetAdditionsObtainedInExchangeTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fixed asset additions obtained in exchange transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FixedAssetAdditionsObtainedInExchangeTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fixed Asset Additions Obtained in Exchange Transaction.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax expense (benefit) related to net operating losses and tax credits.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense Benefit Related To Net Operating Losses And Tax Credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Income tax benefits related to net operating losses incurred or research and development tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Financing Transaction [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stock by Class [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalFinancialInformationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalFinancialInformationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Statement Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Assets, Fair Value Disclosure, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fiscal year ended December 31, 2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LegalMattersAndContingenciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Matters and Contingencies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LegalMattersAndContingenciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Proceedings</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputInceptionDiscountRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Inception Discount Rate [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputInceptionDiscountRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discount Rate [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive income (loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_BainFundingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Bain funding agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_BainFundingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Bain Funding Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_BainFundingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Bain Funding Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ClosingPriceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Closing price of common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ClosingPriceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Closing Price Of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ClosingPriceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Closing stock price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PercentageOfFundingCommitment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of funding commitment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PercentageOfFundingCommitment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Funding Commitment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PercentageOfFundingCommitment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of funding commitment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income (loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other comprehensive income (loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Debt Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non-cash interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, trading days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Restricted Stock Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Payments under 2027 Notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Liabilities fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Liabilities, Fair Value Disclosure, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of Changes in Estimated Fair Value of Financing Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Changes in Estimated Fair Value of Financing Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Changes in Estimated Fair Value of Financing Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Weighted Average Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Agencies Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government Agencies [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, maturity date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOptionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Option [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOptionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_DebtInstrumentInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument interest.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_DebtInstrumentInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_DebtInstrumentInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: amounts representing interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractualObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contractual Obligation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractualObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities related to obligation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractualObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Contractual Obligation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, Unrealized Gain (Loss) Arising During Period, after Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Changes in fair value attributable to instrument-specific credit risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants to purchase shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants outstanding (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SecuritiesFinancingTransactionTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Financing Transaction [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total equity-based compensation expense included in total operating expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments of Financing Costs, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Financing Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deferred costs related to financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NoncurrentFinancingLiabilityRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncurrent financing liability related party.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NoncurrentFinancingLiabilityRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncurrent Financing Liability Related Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NoncurrentFinancingLiabilityRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Financing liability, related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NoncurrentFinancingLiabilityRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing liability, related party (Notes 5 and 7)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_InterestIncomeNonoperatingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_InterestIncomeNonoperatingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income Nonoperating Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_InterestIncomeNonoperatingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest income nonoperating, net.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_OtherOfferingExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other offering expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_OtherOfferingExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Offering Expenses [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash flows used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity-based compensation expense expected to be recognized over weighted average period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated fair value measuring input</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Financing liability, related party and financing liability measurement input.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Liability, Related Party and Financing Liability Measurement Input</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Financing liability, related party and financing liability measurement input</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NovaQuestFundingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">NovaQuest funding agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NovaQuestFundingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nova Quest Funding Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NovaQuestFundingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NovaQuest Funding Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Debt Default, Description of Notice of Default</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, notice for default, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt instrument, accrued interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted Stock Units Outstanding [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants Outstanding [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Options Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Guidance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization of premiums and accretion of discounts on marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of premiums and accretion of discounts on marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Other Observable Inputs (Level 2) [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale marketable debt securities, Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Available for-sale securities held</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Notes 13 and 14)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsMiscellaneousNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Frequency of Periodic Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, frequency of payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gains (losses) on change in fair value of financing liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain (loss) on fair value remeasurement of financing liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain (loss) on fair value remeasurement of financing liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_GainLossOnFairValueRemeasurementOfFinancingLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss on Fair Value Remeasurement of Financing Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reimbursements for research services, contingent development milestone payment and single-digit royalty payments on net sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reimbursements for Research Services, Contingent Development Milestone Payment and Single-Digit Royalty Payments on Net Sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reimbursements for research services and contingent development milestone payment and single-digit royalty payments on net sales.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FundingCommitmentFeesIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Funding commitment fees incurred.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FundingCommitmentFeesIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Funding Commitment Fees Incurred</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FundingCommitmentFeesIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fees incurred</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, aggregate net proceeds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AugustTwoThousandTwentyTwoPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">August two thousand twenty two public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AugustTwoThousandTwentyTwoPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">August Two Thousand Twenty Two Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AugustTwoThousandTwentyTwoPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">August 2022 Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Restricted Cash and Cash Equivalents, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Other non-cash items</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other non-cash items</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncash Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Noncash Income (Expense), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FirstAnniversariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">First anniversaries.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FirstAnniversariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">First Anniversaries [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FirstAnniversariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First Anniversaries [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Instrument, Fair Value Disclosure, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AccruedPropertyAndEquipmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued property and equipment current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AccruedPropertyAndEquipmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Property and Equipment Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_AccruedPropertyAndEquipmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense), net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other income (expense), net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PeriodOverWhichFundingSupportReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Period over which funding support received.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PeriodOverWhichFundingSupportReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Period over which Funding Support Received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PeriodOverWhichFundingSupportReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period over which funding support received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LossOrMaterialCostsRelatedToIndemnificationObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loss or material costs related to indemnification obligation.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LossOrMaterialCostsRelatedToIndemnificationObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Or Material Costs Related To Indemnification Obligation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LossOrMaterialCostsRelatedToIndemnificationObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss or material costs related to indemnification obligation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerator:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentRedemptionPeriodAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Accumulated depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividends declared</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value measurement with unobservable inputs reconciliation recurring basis funding commitment received.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Funding Commitment Received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Funding commitment received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contractual interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Insurance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid insurance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Direct costs and fees incurred related to funding agreements included in general and administrative expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Issuance Costs, Net, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Issuance Costs, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, purchaser discounts and other offering expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Forecast [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, conversion price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash flows used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Instrument, Unamortized Discount (Premium), Net, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unamortized debt discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unamortized debt discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Additional Paid in Capital, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, consecutive trading days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Issuance Costs, Noncurrent, Net, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsNoncurrentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred expenses associated with financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options vested and expected to vest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Parties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PrepaidClinicalTrialServicesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid clinical trial services current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PrepaidClinicalTrialServicesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Clinical Trial Services Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PrepaidClinicalTrialServicesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid clinical trial services</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_RisksAndLiquidityTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The entire disclosure related to risks and liquidity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_RisksAndLiquidityTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Risks And Liquidity [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_RisksAndLiquidityTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risks and Liquidity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computation of Basic and Diluted Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Category of Item Purchased [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Category of Item Purchased</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Rollforward of the Estimated Fair Value Associated with Financing Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Payment Terms</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, payment term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fiscal year ended December 31, 2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ReclassificationOfPrivatePlacementWarrantFromEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification of private placement warrant from equity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ReclassificationOfPrivatePlacementWarrantFromEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Private Placement Warrant From Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ReclassificationOfPrivatePlacementWarrantFromEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification from equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_RegulatoryApprovalMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory approval milestone payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_RegulatoryApprovalMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Approval Milestone Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_RegulatoryApprovalMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Regulatory approval milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Non-vested, Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Non-vested, Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NumberOfMembersNominatedToBoardOfDirectors_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of members nominated to board of directors.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NumberOfMembersNominatedToBoardOfDirectors_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Members Nominated To Board Of Directors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_NumberOfMembersNominatedToBoardOfDirectors_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of members nominated to board of directors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherOperatingIncomeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other operating income expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherOperatingIncomeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Income (Expense) [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total future payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Prepaid Expense and Other Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Prepaid Expense, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other prepaid expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASSETS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accrued Liabilities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of cash, cash equivalents and restricted cash:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Financing liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Liabilities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued, price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Face Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, aggregate principal amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Principal amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest income (expense), net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income (expense), net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueLiabilitiesBetweenLevelTransferAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value liabilities between level transfer amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueLiabilitiesBetweenLevelTransferAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Liabilities Between Level Transfer Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FairValueLiabilitiesBetweenLevelTransferAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value liabilities between level transfer amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManagementFeeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Management Fee Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManagementFeeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Management fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LongTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due after One Year through Two Years [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LongTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Marketable Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_LongTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long Term Marketable Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Marketable securities (non-current)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities, net:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_EarningsPerShareOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Earnings per share other disclosures.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_EarningsPerShareOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Other Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_EarningsPerShareOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Denominator:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gains (losses) on securities available-for-sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Equity-based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_RestrictedCashMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_RestrictedCashMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_RestrictedCashMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash flows provided by (used in) investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Fixtures [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock under equity incentive plans related to exercise of options (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_MeasurementPeriodMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Measurement period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_MeasurementPeriodMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Period [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Unobservable Inputs (Level 3) [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_CommercialApprovalMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commercial approval milestone payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_CommercialApprovalMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Approval Milestone Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_CommercialApprovalMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial approval milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fiscal year ended December 31, 2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under equity incentive plans related to exercise of options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Purchase Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PercentageOfExpectedFundingReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of expected funding received.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PercentageOfExpectedFundingReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Expected Funding Received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_PercentageOfExpectedFundingReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of funding expected to be received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net carrying amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, carrying value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Financing liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Liability [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_FinancingLiabilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing Liability [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_OfferingExpenseOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Offering Expense of Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_OfferingExpenseOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Offering expense of shares issued.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_OfferingExpenseOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering expense of shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Estimated Fair Value and Amortized Cost of Available-for-Sale Marketable Debt Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Other Long-Term Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk free interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale marketable debt securities, Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Available-for-sale marketable debt securities, Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Operating Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Other Operating Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ContractualObligationDescriptionRepaymentTiming_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of timing for satisfying repayment of contractual obligation.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ContractualObligationDescriptionRepaymentTiming_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contractual Obligation Description Repayment Timing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_ContractualObligationDescriptionRepaymentTiming_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contractual obligation description repayment timing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_DebtInstrumentMinimumPrincipalAmountForRedemption_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument minimum principal amount for redemption.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_DebtInstrumentMinimumPrincipalAmountForRedemption_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Minimum Principal Amount for Redemption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cere_DebtInstrumentMinimumPrincipalAmountForRedemption_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum principal amount of notes outstanding for redemption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027 Convertible Senior Notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential dilutive securities excluded from calculation of net loss per share, total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Interest Income (Expense), Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents, fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental cash flow disclosures from non-cash investing and financing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FairValueAssetBetweenLevelTransferAmount" xlink:to="cere_FairValueAssetBetweenLevelTransferAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PerPrincipalAmountForConversion" xlink:to="cere_PerPrincipalAmountForConversion_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_AccruedExternalResearchAndDevelopmentServicesCurrent" xlink:to="cere_AccruedExternalResearchAndDevelopmentServicesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:to="us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ChangeInFairValueOfFinancingLiability" xlink:to="cere_ChangeInFairValueOfFinancingLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_AdjustmentsToOperatingLeaseExpense" xlink:to="cere_AdjustmentsToOperatingLeaseExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="us-gaap_FairValueOptionQuantitativeDisclosuresTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:to="cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember" xlink:to="cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_BainInvestorMember" xlink:to="cere_BainInvestorMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_LicenseAgreementTextBlock" xlink:to="cere_LicenseAgreementTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_MarketableSecuritiesWeightedAverageMaturityTerm" xlink:to="cere_MarketableSecuritiesWeightedAverageMaturityTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ClaimsOutstanding" xlink:to="cere_ClaimsOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ChangeInFairValueOfPrivatePlacementWarrants" xlink:to="cere_ChangeInFairValueOfPrivatePlacementWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants" xlink:to="cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ShortTermMarketableSecuritiesMember" xlink:to="cere_ShortTermMarketableSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_AtmProgramMember" xlink:to="cere_AtmProgramMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasuryAndGovernmentMember" xlink:to="us-gaap_USTreasuryAndGovernmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ResearchCollaborationAndLicenseAgreementMember" xlink:to="cere_ResearchCollaborationAndLicenseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PurchaserDiscountsMember" xlink:to="cere_PurchaserDiscountsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_SecondAnniversariesMember" xlink:to="cere_SecondAnniversariesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ScheduleOfInterestExpenseTableTextBlock" xlink:to="cere_ScheduleOfInterestExpenseTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate202006Member" xlink:to="us-gaap_AccountingStandardsUpdate202006Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_UnderwritingDiscountsAndCommissionsOfSharesIssued" xlink:to="cere_UnderwritingDiscountsAndCommissionsOfSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_LaboratoryEquipmentMember" xlink:to="cere_LaboratoryEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PfizerIncMember" xlink:to="cere_PfizerIncMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="cere_IncreaseDecreaseInOperatingLeaseLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_LicenseAgreementTable" xlink:to="cere_LicenseAgreementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PercentageOfFundingReceived" xlink:to="cere_PercentageOfFundingReceived_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_LicenseAgreementAbstract" xlink:to="cere_LicenseAgreementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseOtherNoncurrent" xlink:to="us-gaap_PrepaidExpenseOtherNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_OtherNonoperatingIncomeExpenseOther" xlink:to="cere_OtherNonoperatingIncomeExpenseOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PrivatePlacementWarrantsMember" xlink:to="cere_PrivatePlacementWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_DerivativeContractTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_LicenseAgreementLineItems" xlink:to="cere_LicenseAgreementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_NovaQuestAndBainFundingAgreementsMember" xlink:to="cere_NovaQuestAndBainFundingAgreementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt" xlink:to="cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ManagementAgreementMember" xlink:to="cere_ManagementAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PfizerLicenseAgreementMember" xlink:to="cere_PfizerLicenseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities" xlink:to="cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNetAbstract" xlink:to="us-gaap_InterestIncomeExpenseNetAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PerPrincipalAmountForTradingPrice" xlink:to="cere_PerPrincipalAmountForTradingPrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ESPPSharesIssuableMember" xlink:to="cere_ESPPSharesIssuableMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NASDAQIndexFutureMember" xlink:to="us-gaap_NASDAQIndexFutureMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase" xlink:to="cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsMember" xlink:to="us-gaap_CashEquivalentsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_SaleAndIssuanceOfStockNotYetIssued" xlink:to="cere_SaleAndIssuanceOfStockNotYetIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PrepaidResearchAndDevelopmentExpensesCurrent" xlink:to="cere_PrepaidResearchAndDevelopmentExpensesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesRealizedGainLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ThirdAnniversariesMember" xlink:to="cere_ThirdAnniversariesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDefaultLongtermDebtAmount" xlink:to="us-gaap_DebtDefaultLongtermDebtAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty" xlink:to="cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PayableOnFundingAgreement" xlink:to="cere_PayableOnFundingAgreement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivableCurrent" xlink:to="us-gaap_InterestReceivableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember" xlink:to="cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_NatureOfExpenseAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ReceivedFunding" xlink:to="cere_ReceivedFunding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ExpectedFundingReceived" xlink:to="cere_ExpectedFundingReceived_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants" xlink:to="cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_NoncurrentFinancingLiability" xlink:to="cere_NoncurrentFinancingLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_JulyTwoThousandTwentyOnePublicOfferingMember" xlink:to="cere_JulyTwoThousandTwentyOnePublicOfferingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:to="cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FinancingLiabilityRelatedPartyMember" xlink:to="cere_FinancingLiabilityRelatedPartyMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="us-gaap_InterimPeriodCostsNotAllocableDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsGross" xlink:to="us-gaap_DeferredFinanceCostsGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FixedAssetAdditionsObtainedInExchangeTransaction" xlink:to="cere_FixedAssetAdditionsObtainedInExchangeTransaction_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits" xlink:to="cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="us-gaap_AdditionalFinancialInformationDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="us-gaap_LegalMattersAndContingenciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputInceptionDiscountRateMember" xlink:to="us-gaap_MeasurementInputInceptionDiscountRateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_BainFundingAgreementMember" xlink:to="cere_BainFundingAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ClosingPriceOfCommonStock" xlink:to="cere_ClosingPriceOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PercentageOfFundingCommitment" xlink:to="cere_PercentageOfFundingCommitment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock" xlink:to="cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionTextBlock" xlink:to="us-gaap_FairValueOptionTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_DebtInstrumentInterest" xlink:to="cere_DebtInstrumentInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractualObligation" xlink:to="us-gaap_ContractualObligation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="us-gaap_SecuritiesFinancingTransactionTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_NoncurrentFinancingLiabilityRelatedParty" xlink:to="cere_NoncurrentFinancingLiabilityRelatedParty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_InterestIncomeNonoperatingNet" xlink:to="cere_InterestIncomeNonoperatingNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_OtherOfferingExpensesMember" xlink:to="cere_OtherOfferingExpensesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput" xlink:to="cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_NovaQuestFundingAgreementMember" xlink:to="cere_NovaQuestFundingAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault" xlink:to="us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="us-gaap_OtherAssetsMiscellaneousNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_GainLossOnFairValueRemeasurementOfFinancingLiability" xlink:to="cere_GainLossOnFairValueRemeasurementOfFinancingLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales" xlink:to="cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FundingCommitmentFeesIncurred" xlink:to="cere_FundingCommitmentFeesIncurred_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_AugustTwoThousandTwentyTwoPublicOfferingMember" xlink:to="cere_AugustTwoThousandTwentyTwoPublicOfferingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FirstAnniversariesMember" xlink:to="cere_FirstAnniversariesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="us-gaap_DebtInstrumentFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_AccruedPropertyAndEquipmentCurrent" xlink:to="cere_AccruedPropertyAndEquipmentCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PeriodOverWhichFundingSupportReceived" xlink:to="cere_PeriodOverWhichFundingSupportReceived_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_LossOrMaterialCostsRelatedToIndemnificationObligation" xlink:to="cere_LossOrMaterialCostsRelatedToIndemnificationObligation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="us-gaap_DebtInstrumentRedemptionPeriodAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived" xlink:to="cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="us-gaap_DeferredFinanceCostsNoncurrentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PrepaidClinicalTrialServicesCurrent" xlink:to="cere_PrepaidClinicalTrialServicesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_RisksAndLiquidityTextBlock" xlink:to="cere_RisksAndLiquidityTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPaymentTerms" xlink:to="us-gaap_DebtInstrumentPaymentTerms_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ReclassificationOfPrivatePlacementWarrantFromEquity" xlink:to="cere_ReclassificationOfPrivatePlacementWarrantFromEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_RegulatoryApprovalMilestonePayments" xlink:to="cere_RegulatoryApprovalMilestonePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_NumberOfMembersNominatedToBoardOfDirectors" xlink:to="cere_NumberOfMembersNominatedToBoardOfDirectors_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="us-gaap_OtherOperatingIncomeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FinancingLiabilitiesMember" xlink:to="cere_FinancingLiabilitiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FairValueLiabilitiesBetweenLevelTransferAmount" xlink:to="cere_FairValueLiabilitiesBetweenLevelTransferAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagementFeeExpense" xlink:to="us-gaap_ManagementFeeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_LongTermMarketableSecuritiesMember" xlink:to="cere_LongTermMarketableSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:to="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_EarningsPerShareOtherDisclosuresAbstract" xlink:to="cere_EarningsPerShareOtherDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_RestrictedCashMember" xlink:to="cere_RestrictedCashMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_MeasurementPeriodMember" xlink:to="cere_MeasurementPeriodMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_CommercialApprovalMilestonePayments" xlink:to="cere_CommercialApprovalMilestonePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_EmployeeStockPurchasePlanMember" xlink:to="cere_EmployeeStockPurchasePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_PercentageOfExpectedFundingReceived" xlink:to="cere_PercentageOfExpectedFundingReceived_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_FinancingLiabilityMember" xlink:to="cere_FinancingLiabilityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_OfferingExpenseOfSharesIssued" xlink:to="cere_OfferingExpenseOfSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_ContractualObligationDescriptionRepaymentTiming" xlink:to="cere_ContractualObligationDescriptionRepaymentTiming_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cere_DebtInstrumentMinimumPrincipalAmountForRedemption" xlink:to="cere_DebtInstrumentMinimumPrincipalAmountForRedemption_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652628379168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CEREVEL THERAPEUTICS HOLDINGS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001805387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,832,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-3911080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">222 Jacobs Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">304-2048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CERE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652628515328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 153,816<span></span>
</td>
<td class="nump">$ 136,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">673,171<span></span>
</td>
<td class="nump">755,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">13,795<span></span>
</td>
<td class="nump">13,621<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">840,782<span></span>
</td>
<td class="nump">905,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Marketable securities</a></td>
<td class="nump">36,048<span></span>
</td>
<td class="nump">58,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">27,006<span></span>
</td>
<td class="nump">27,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">21,434<span></span>
</td>
<td class="nump">21,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,867<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">3,208<span></span>
</td>
<td class="nump">2,891<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">930,345<span></span>
</td>
<td class="nump">1,017,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,315<span></span>
</td>
<td class="nump">10,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">52,614<span></span>
</td>
<td class="nump">59,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">3,028<span></span>
</td>
<td class="nump">2,899<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">62,957<span></span>
</td>
<td class="nump">72,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">30,381<span></span>
</td>
<td class="nump">31,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_NoncurrentFinancingLiabilityRelatedParty', window );">Financing liability, related party (Notes 5 and 7)</a></td>
<td class="nump">34,668<span></span>
</td>
<td class="nump">28,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_NoncurrentFinancingLiability', window );">Financing liability (Notes 5 and 7)</a></td>
<td class="nump">34,668<span></span>
</td>
<td class="nump">28,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">2027 convertible senior notes, net (Note 6)</a></td>
<td class="nump">335,962<span></span>
</td>
<td class="nump">335,482<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">498,636<span></span>
</td>
<td class="nump">496,584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Notes 13 and 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value: 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2023 and December 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value: 500,000,000 shares authorized;156,760,109 and 156,502,285 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,500,046<span></span>
</td>
<td class="nump">1,485,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">3,688<span></span>
</td>
<td class="nump">3,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,072,041)<span></span>
</td>
<td class="num">(967,755)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">431,709<span></span>
</td>
<td class="nump">521,238<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 930,345<span></span>
</td>
<td class="nump">$ 1,017,822<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_NoncurrentFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncurrent financing liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_NoncurrentFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_NoncurrentFinancingLiabilityRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncurrent financing liability related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_NoncurrentFinancingLiabilityRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652628437616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">156,760,109<span></span>
</td>
<td class="nump">156,502,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">156,760,109<span></span>
</td>
<td class="nump">156,502,285<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652628146192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 78,181<span></span>
</td>
<td class="nump">$ 55,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">21,370<span></span>
</td>
<td class="nump">17,507<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">99,551<span></span>
</td>
<td class="nump">72,530<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(99,551)<span></span>
</td>
<td class="num">(72,530)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">6,440<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(11,090)<span></span>
</td>
<td class="nump">3,941<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(104,201)<span></span>
</td>
<td class="num">(68,294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (provision), net</a></td>
<td class="num">(85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (104,286)<span></span>
</td>
<td class="num">$ (68,294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="num">$ (0.46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="num">$ (0.46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in calculating net loss per share, basic</a></td>
<td class="nump">156,648,365<span></span>
</td>
<td class="nump">147,984,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted</a></td>
<td class="nump">156,648,365<span></span>
</td>
<td class="nump">147,984,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (104,286)<span></span>
</td>
<td class="num">$ (68,294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax', window );">Changes in fair value attributable to instrument-specific credit risk</a></td>
<td class="num">(906)<span></span>
</td>
<td class="nump">1,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gains (losses) on securities available-for-sale</a></td>
<td class="nump">1,497<span></span>
</td>
<td class="num">(1,624)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">591<span></span>
</td>
<td class="num">(348)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (103,695)<span></span>
</td>
<td class="num">$ (68,642)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of unrealized gain (loss) from increase (decrease) in instrument-specific credit risk of financial liability measured under fair value option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14172-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL75136633-108610<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652628193392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss) [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 578,729<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 1,195,944<span></span>
</td>
<td class="num">$ (986)<span></span>
</td>
<td class="num">$ (616,244)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,719,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under equity incentive plans related to vesting of RSUs, (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock under equity incentive plans related to exercise of options</a></td>
<td class="nump">2,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock under equity incentive plans related to exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">449,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity-based compensation expense</a></td>
<td class="nump">8,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(68,294)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68,294)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">521,499<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">1,207,356<span></span>
</td>
<td class="num">(1,334)<span></span>
</td>
<td class="num">(684,538)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148,182,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">521,238<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">1,485,880<span></span>
</td>
<td class="nump">3,097<span></span>
</td>
<td class="num">(967,755)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,502,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock under equity incentive plans related to exercise of options</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock under equity incentive plans related to exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity-based compensation expense</a></td>
<td class="nump">12,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(104,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104,286)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 431,709<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 1,500,046<span></span>
</td>
<td class="nump">$ 3,688<span></span>
</td>
<td class="num">$ (1,072,041)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,760,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652629273712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (104,286)<span></span>
</td>
<td class="num">$ (68,294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash flows used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,321<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_AdjustmentsToOperatingLeaseExpense', window );">Adjustments to operating lease expense</a></td>
<td class="num">(280)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity-based compensation</a></td>
<td class="nump">12,592<span></span>
</td>
<td class="nump">8,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ChangeInFairValueOfFinancingLiability', window );">Change in fair value of financing liabilities</a></td>
<td class="nump">11,082<span></span>
</td>
<td class="num">(3,940)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Non-cash interest expense</a></td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premiums and accretion of discounts on marketable securities</a></td>
<td class="num">(5,206)<span></span>
</td>
<td class="nump">553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(147)<span></span>
</td>
<td class="nump">1,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(440)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(2,768)<span></span>
</td>
<td class="num">(2,499)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(7,263)<span></span>
</td>
<td class="num">(4,613)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash flows used in operating activities</a></td>
<td class="num">(94,923)<span></span>
</td>
<td class="num">(67,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(187,631)<span></span>
</td>
<td class="num">(60,242)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Maturities and redemptions of marketable securities</a></td>
<td class="nump">298,750<span></span>
</td>
<td class="nump">23,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(336)<span></span>
</td>
<td class="num">(2,197)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash flows provided by (used in) investing activities</a></td>
<td class="nump">110,783<span></span>
</td>
<td class="num">(38,542)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">1,574<span></span>
</td>
<td class="nump">2,854<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred costs related to financing activities</a></td>
<td class="num">(139)<span></span>
</td>
<td class="num">(251)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash flows provided by financing activities</a></td>
<td class="nump">1,435<span></span>
</td>
<td class="nump">2,603<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">17,295<span></span>
</td>
<td class="num">(103,587)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of the period</a></td>
<td class="nump">138,388<span></span>
</td>
<td class="nump">197,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of the period</a></td>
<td class="nump">155,683<span></span>
</td>
<td class="nump">93,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">153,816<span></span>
</td>
<td class="nump">91,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,867<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">155,683<span></span>
</td>
<td class="nump">93,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">4,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental cash flow disclosures from non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Fixed asset additions included in accounts payable and other current liabilities</a></td>
<td class="nump">$ 779<span></span>
</td>
<td class="nump">$ 731<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_AdjustmentsToOperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_AdjustmentsToOperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ChangeInFairValueOfFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of financing liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ChangeInFairValueOfFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652628221952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. Nature of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unless the context otherwise requires, references in these notes to &#8220;Cerevel,&#8221; &#8220;the company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; and any related terms are intended to mean Cerevel Therapeutics Holdings, Inc. and its consolidated subsidiaries.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biopharmaceutical company pursuing a targeted approach to neuroscience that combines a deep understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. We seek to transform the lives of patients through the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer's disease psychosis, epilepsy, panic disorder and Parkinson&#8217;s disease. We are advancing our extensive and diverse pipeline with numerous clinical trials underway or planned, including three ongoing Phase 3 trials and an open-label extension trial for tavapadon in Parkinson's, two ongoing Phase 2 trials and an open-label extension trial for emraclidine in schizophrenia, an ongoing Phase 2 proof-of-concept trial and an open-label extension trial for darigabat in focal epilepsy and a planned Phase 2 proof-of-concept trial for darigabat in panic disorder.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information on our formation, please read Note 1, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Nature of Operations</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 (our Annual Report).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632718512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risks and Liquidity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_RisksAndLiquidityTextBlock', window );">Risks and Liquidity</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2. Risks and Liquidity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to risks and uncertainties common to clinical-stage companies in the biopharmaceutical industry. These risks include, but are not limited to, the introduction of new products, therapies, standards of care or new technological innovations, our ability to obtain and maintain adequate protection for our in-licensed technology, data or other intellectual property and proprietary rights and compliance with extensive government regulation and oversight. In addition, we are dependent upon the services of our employees, including key personnel, consultants, third-party contract research organizations (CROs), third-party contract manufacturing organizations (CMOs) and other third-party organizations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our product candidates, currently under development or that we may develop, will require significant additional research and development efforts, including extensive clinical testing and regulatory approval prior to commercialization. These efforts require significant amounts of additional capital, adequate personnel infrastructure and extensive compliance and reporting capabilities. There can be no assurance that our research and development activities will be successfully completed, that adequate protection for our licensed or developed technology will be obtained and maintained, that products developed will obtain necessary government regulatory approval or that any approved products will be commercially viable.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our unaudited condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets and the satisfaction of liabilities in the ordinary course of business. We have incurred significant operating losses since our inception and, as of March 31, 2023, had not yet generated revenues. In addition, we anticipate that our expenses will increase significantly in connection with our ongoing activities to support our research, discovery and clinical development efforts and we expect to continue to incur significant expenses and operating losses for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have funded our operations primarily with the net proceeds received from the issuance of preferred stock, common stock and convertible senior notes, net proceeds from the consummation of our Business Combination (as defined in Note 15, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Related Parties</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements), and our Funding Agreements (as defined in Note 5, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements). We believe that our available cash, cash equivalent and marketable securities as of March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, will enable us to fund our operating expense and capital expenditure requirements through at least 12 months from the issuance date of these financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_RisksAndLiquidityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to risks and liquidity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_RisksAndLiquidityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652634019680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3. Summary of Significant Accounting Policies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying unaudited condensed consolidated financial statements include those of the company and its subsidiaries, Cerevel Therapeutics, Inc., Cerevel Therapeutics, LLC and Cerevel MA Securities Corp., after elimination of all intercompany accounts and transactions. The accompanying unaudited condensed consolidated financial statements and notes hereto have been prepared in conformity with the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting and, therefore, omit or condense certain footnotes and other information normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) as set forth in the Financial Accounting Standards Board&#8217;s (FASB) accounting standards codification. Any reference in these notes to applicable guidance is</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Update (ASU) of the FASB.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the opinion of management, all adjustments necessary for a fair statement of the financial information, which are of a normal and recurring nature, have been made for the interim periods reported. Results of operations for the three months ended March 31, 2023 and 2022, are not necessarily indicative of the results for the entire fiscal year or any other period. Our unaudited condensed consolidated financial statements for the three months ended March 31, 2023 and 2022, have been prepared on the same basis as and should be read in conjunction with our audited consolidated financial statements and notes included in our Annual Report.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, the fair value of our financing liabilities, the fair value of stock options, the accrual for research and development expense and the recoverability of our net deferred tax assets and the related valuation allowance. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors and adjust those estimates and assumptions when facts and circumstances change. Actual results could differ materially from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with our entering into the lease agreement for our headquarters in Cambridge, MA, in July 2019, we were required to provide a security deposit in the form of a letter of credit. We have classified this amount as restricted cash in our condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to our other significant accounting policies, please read Note 4, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Summary of Significant Accounting Policies</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our audited consolidated financial statements included in our Annual Report.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Guidance</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the company as of the specified effective date. Unless otherwise discussed, the company believes that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652716509792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pfizer License Agreement<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_LicenseAgreementAbstract', window );"><strong>License Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_LicenseAgreementTextBlock', window );">Pfizer License Agreement</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4. Pfizer License Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2018, we entered into a license agreement with Pfizer (the Pfizer License Agreement) pursuant to which we were granted an exclusive, sublicensable, worldwide license under certain Pfizer patent rights, and a non-exclusive, sublicensable, worldwide license under certain Pfizer know-how to develop, manufacture and commercialize certain compounds and products, which currently constitute substantially all of our asset portfolio, in the field of treatment, prevention, diagnosis, control and maintenance of all diseases and disorders in humans, subject to the terms and conditions of the Pfizer License Agreement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the Pfizer License Agreement, we are solely responsible for the development, manufacture, regulatory approval and commercialization of compounds and products in the field and we will pay Pfizer tiered royalties on the aggregate net sales during each calendar year, determined on a product-by-product basis, with respect to products under the Pfizer License Agreement, and we may pay potential milestone payments to Pfizer, based on the successful achievement of certain regulatory and commercial milestones. To date, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> regulatory or commercial approval milestone payments or royalty payments have been made or become due under this agreement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to our Pfizer License Agreement, please read Note 6, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pfizer License Agreement, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to our audited consolidated financial statements included in our Annual Report.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_LicenseAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_LicenseAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_LicenseAgreementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of license agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_LicenseAgreementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652716562192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionTextBlock', window );">Financing Liabilities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5. Financing Liabilities</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Funding Agreements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2021, we entered into a funding agreement with NovaQuest Co-Investment Fund XVI, L.P. (NovaQuest and the NovaQuest Funding Agreement) and a funding agreement with BC Pinnacle Holdings, LP (Bain, the Bain Funding Agreement and, together with the NovaQuest Funding Agreement, the Funding Agreements), pursuant to which NovaQuest and Bain will provide funding to support our development of tavapadon for the treatment of Parkinson&#8217;s disease.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the Funding Agreements, we will receive up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in funding from each of NovaQuest and Bain, for a combined total of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in funding (the Total Funding Commitment), of which approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Total Funding Commitment, net of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of fees incurred by Bain and NovaQuest) was received in April 2021, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Total Funding Commitment) was received in April 2022, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Total Funding Commitment) was received in April 2023 and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Total Funding Commitment) is expected to be received in April 2024, subject to certain customary funding conditions.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In return</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we agreed to pay NovaQuest and Bain significant regulatory milestone, sales milestone and royalty payments upon approval of tavapadon by the FDA that collectively will not exceed $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">531.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. In addition, we have the option to satisfy our payment obligations to NovaQuest and Bain upon the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">earlier of FDA approval or May 1, 2025</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, by paying an amount equal to the Total Funding Commitment multiplied by an initial factor of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">x. This factor will increase ratably over time up to a maximum of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">x, less amounts previously paid to NovaQuest and Bain.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We determined that each funding agreement represents a financial instrument that is considered to be a debt host containing embedded redemption features due to certain contingencies related to repayment. We elected to account for the Funding Agreements in accordance with the fair value option as permitted under ASC 825, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 and December 31, 2022, the estimated fair value of the financing liability related to potential amounts payable to Bain under the Bain Funding Agreement, which is reflected in our condensed consolidated balance sheets as financing liability, related party, totaled approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022, the estimated fair value of the financing liability related to potential amounts payable to NovaQuest under the NovaQuest Funding Agreement, which is reflected in our condensed consolidated balance sheets as financing liability, totaled approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in estimated fair value of the financing liabilities in our unaudited condensed consolidated statements of operations and comprehensive loss are summarized as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.716%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.719999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.719999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability, related party</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value recognized in other (income) expense, net</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,541</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,970</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">453</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">638</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value recognized in other (income) expense, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,541</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,970</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">453</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">638</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in fair value attributable to instrument-specific credit risk were derived by benchmarking against the prior period credit spread to isolate the impact directly associated with the change in the credit spread utilized between periods.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to our Funding Agreements, please read Note 8, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our audited consolidated financial statements included in our Annual Report.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a company's election to apply the fair value option for measurement and reporting of eligible financial assets and liabilities (as defined), as well as certain other eligible items (as defined) included in the statement of financial position, whether such option is elected for a single eligible item or a group of similar eligible items and is in addition to other disclosures concerning fair value which the company may be required to provide. Such disclosure might be expected to include: (1) for items included in the statement of financial position: (a) the reasons for electing a fair value option for each eligible item or group of similar eligible items; (b) if the fair value option is elected for some but not all eligible items within a group of similar eligible items: (i) a description of those similar items and the reasons for partial election and (ii) information of how the group of similar items relates to individual balance sheet line items; (c) for each line item in the statement of financial position that includes an item or items for which the fair value option has been elected: (i) information of how each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with other fair value disclosures and (ii) the aggregate carrying amount of ineligible items included in each line item in the balance sheet, if any; (d) the difference between the aggregate fair value and the aggregate unpaid principal balance (assuming contractual principal amounts and fair value option elected) of: (i) loans and long-term receivables (other than securities otherwise reported at fair value) and (ii) long-term debt instruments; (e) for loans held as assets for which the fair value option has been elected: (i) the aggregate fair value of loans that are 90 days or more past due, (ii) if the policy is to recognize interest income separately from other changes in fair value, the aggregate fair value of loans in nonaccrual status, and (iii) the difference between the aggregate fair value and the aggregate unpaid principal balance for loans that are 90 days or more past due, in nonaccrual status, or both; (f) for investments that would have been accounted for under the equity method if the entity had not chosen to apply the fair value option, the information required for such investments, if material either individually or in the aggregate; (2) for items included in the income statement: (a) the amounts of gains and losses from fair value changes included in earnings and in which line in the income statement those gains and losses are reported whether or not combined with gains and losses from items required to be accounted for at fair value; (b) a description of how interest and dividends are measured and where they are reported in the income statement; (c) for loans and other receivables held as assets: (i) the estimated amount of gains or losses included in earnings attributable to changes in instrument-specific credit risk and (ii) how the gains or losses attributable to changes in instrument-specific credit risk were determined; (d) for liabilities with fair values that have been significantly affected during the reporting period by changes in the instrument-specific credit risk: (i) the estimated amount of gains and losses from fair value changes included in earnings that are attributable to changes in the instrument-specific credit risk, (ii) qualitative information about the reasons for those changes, and (iii) how the gains and losses attributable to changes in instrument-specific credit risk were determined; and (3) certain other disclosures as required or determined to be provided.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14217-108612<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -URI https://asc.fasb.org/topic&amp;trid=2134543<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652716573072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2027 Convertible Senior Notes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">2027 Convertible Senior Notes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6. 2027 Convertible Senior Notes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2022, we completed the offering of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">345.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million aggregate principal amount of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% Convertible Senior Notes due 2027 (the 2027 Notes). The aggregate net proceeds from the 2027 Notes offering totaled approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">334.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, after deducting the initial purchasers' discounts of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and other offering expenses of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. We accounted for the debt issuance costs as a debt discount for accounting purposes, which was recorded as a reduction in the carrying value of the debt in our unaudited condensed consolidated balance sheet and is being amortized to interest expense using the effective interest method over the expected life of the 2027 Notes, or approximately their five-year term.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2027 Notes accrue interest at a rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% per annum, payable </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">semi-annually</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in arrears on February 15 and August 15 of each year, beginning on February 15, 2023.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> As of March 31, 2023 and December 31, 2022, accrued interest on the 2027 Notes of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was included in accrued expenses and other current liabilities in our condensed consolidated balance sheets.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2027 Notes mature on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">August 15, 2027</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unless earlier converted, redeemed or repurchased. We will settle conversions by paying or delivering, as applicable, cash, shares of our common stock or a combination of cash and shares of our common stock, at</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">election, subject to terms and conditions provided in the indenture between us and U.S. Bank Trust Company, National Association, as trustee (the Indenture).</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Holders of 2027 Notes may convert all or any portion of their Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2027, only in the following circumstances: (i) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on December 31, 2022, if the last reported sale price per share of our common stock exceeds </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">130</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the conversion price for each of at least </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> trading days, whether or not consecutive, during the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (ii) during the five consecutive business days immediately after any 10 consecutive trading day period (the Measurement Period) in which the trading price per $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> principal amount of notes for each trading day of the Measurement Period was less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (iii) upon the occurrence of certain corporate events or distributions on our common stock, as defined in the Indenture; and (iv) if we call the 2027 Notes for redemption.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From and after May 15, 2027, noteholders may convert their notes at any time at their election until the close of business on the second scheduled trading day immediately before the maturity date. The initial conversion rate is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.5633</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock per $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> principal amount of the 2027 Notes, which represents an initial conversion price of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46.38</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share of common stock, or a total of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,439,338</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events outlined within the Indenture. In addition, if certain corporate events that constitute a &#8220;Make-Whole Fundamental Change&#8221; (as defined in the Indenture) occur, then the conversion rate will, in certain circumstances, be increased for a specified period of time.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may not redeem the 2027 Notes at any time before August 20, 2025, and no sinking fund is required to be provided for the 2027 Notes. The 2027 Notes will be redeemable, in whole or in part (subject to certain limitations), at our option at any time, on or after August 20, 2025, and on or before the 50th scheduled trading day immediately before the maturity date, under certain circumstances defined within the Indenture.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The net carrying amount of the 2027 Notes included in our condensed consolidated balance sheets consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.156%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, <br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal amount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">345,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">345,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unamortized debt discount</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,038</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,518</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net carrying amount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">335,962</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">335,482</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table sets forth the total interest expense related to the 2027 Notes recognized in interest income (expense), net in our </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unaudited condensed consolidated statements of operations and comprehensive loss for the periods presented:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.225%;"/>
        <td style="width:1.433%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.062000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.433%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.849%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,156</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of debt issuance costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">480</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total interest expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,636</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective interest rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future minimum payments under the 2027 Notes as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023, are as follows (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.128%;"/>
        <td style="width:1.937%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.934999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,312</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,625</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,625</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,625</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">353,625</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total future payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">383,812</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: amounts representing interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38,812</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total principal amount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">345,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1) For the nine months ended December 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to our 2027 Convertible Senior Notes, please read Note 9, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2027 Convertible Senior Notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our audited consolidated financial statements included in our Annual Report.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632834352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7. Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The tables below present information about our assets and liabilities that are measured and carried at fair value on a recurring basis and indicate the level within the fair value hierarchy we utilized to determine such fair values:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.511%;"/>
        <td style="width:1.223%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.223%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.223%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.223%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.15%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted<br/>Prices in<br/>Active<br/>Markets<br/>(Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133,866</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133,866</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,950</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,950</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (current)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,909</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,909</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">230,658</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">230,658</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,477</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,477</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">415,127</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">415,127</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (non-current)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,048</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,048</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,867</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,867</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">153,642</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">711,260</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">864,902</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability, related party</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,668</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,668</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69,336</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69,336</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.903%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.152000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.152000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.152000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.152000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted<br/>Prices in<br/>Active<br/>Markets<br/>(Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">136,521</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">136,521</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (current)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103,238</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103,238</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">165,555</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">165,555</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,416</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,416</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">477,300</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">477,300</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (non-current)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,126</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,126</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,867</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,867</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">241,626</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">710,397</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">952,023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability, related party</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,674</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,674</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,674</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,674</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57,348</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57,348</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There have been </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> changes in valuation techniques, inputs utilized or transfers between fair measurement levels in the periods presented. The fair value of our Level 2 instruments were determined using third-party pricing sources. The pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly. We validate the prices provided by our third-party pricing services by understanding the models used, obtaining market values from other pricing sources and analyzing pricing data in certain instances. After completing our validation procedures, we did not adjust or override any fair value measurements provided by our pricing services as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The carrying amounts reflected in our condensed consolidated balance sheets for our cash and cash equivalents, prepaid expenses and other current assets, accounts payable, accrued expenses and other current liabilities approximate fair value due to the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">short-term nature of these assets and liabilities. As of March 31, 2023, our financing liabilities represented our only Level 3 assets or liabilities carried at fair market value. Changes in the fair value remeasurement of our financing liabilities can result from changes in one or multiple inputs, including adjustments to discount rates, changes in the expected achievement or timing of any sales-based, development or regulatory milestones, changes in the amount or timing of expected net cash flows, changes in the probability or timing of certain clinical events and changes in the assumed probability or timing associated with regulatory approval. These fair value measurements represent Level 3 measurements as they are based on significant inputs not observable in the market.</span></p><p style="text-indent:2.267%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Marketable Securities</span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The estimated fair value and amortized cost of our available-for-sale marketable debt securities, by contractual maturity and security type, are summarized as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.512%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.248999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.248999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.248999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.248999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due in one year or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,970</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,909</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">231,391</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">770</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">230,658</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,485</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,477</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">415,820</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">719</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">415,127</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due after one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35,986</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,048</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total marketable securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">710,652</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,558</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">709,219</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.822%;"/>
        <td style="width:1.043%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.253%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.043%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.253%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.043%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.253%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.043%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.253%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due in one year or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103,800</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">562</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103,238</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">166,327</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">787</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">165,555</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,454</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,416</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">478,657</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,428</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">477,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due after one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,327</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">208</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,126</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total marketable securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">816,565</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">813,635</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> realized gains or losses recognized on the sale or maturity of marketable securities during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three months ended March 31, 2023 and 2022. To date, we have not recognized any allowances for credit losses or impairments in relation to our available-for-sale marketable securities as these marketable securities are comprised of high credit quality, investment grade securities that we do not intend or expect to be required to sell prior to their anticipated recovery, and the decline in fair value of these securities is attributable to factors other than credit losses. All marketable securities with unrealized losses presented in the previous tables have been in a continuous unrealized loss position for less than 12 months or the loss is not material. Based on our evaluation, we determined credit losses related to marketable securities were immaterial for the three months ended March 31, 2023.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted average maturity of our marketable securities as of both March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five months</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:2.267%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon execution of the Funding Agreements, we determined that the agreements qualified for election under the fair value option and initially measured the financial instruments at their issue-date estimated fair value. We revalue the related financial liabilities on a recurring basis at each reporting period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023, the financing liability, related party and financing liability each totaled approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. We determined their respective estimated fair values using a Monte Carlo simulation model under the income approach determined by using probability assessments of the expected future cash receipts and expected future cash payments and a discount rate of approximately </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022. The probability assessments of the expected future cash receipts and expected future payments and the timing of expected future repayments are based on significant inputs that are not observable in the market and are subject to remeasurement at each reporting date.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table provides a rollforward of the estimated fair value associated with our combined total financing liabilities:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.288%;"/>
        <td style="width:1.941%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.771%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended <br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beginning balance, total financing liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57,348</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Funding commitment received</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value recognized in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_1f0cf8c7-35f8-4a8d-a01c-7fb92edd3948;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other (income) expense, net</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,082</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value attributable to instrument-specific credit risk recognized in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_293c1bd4-3ed9-476f-92d6-7047da56d7a9;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other comprehensive (income) loss</span></span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">906</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ending balance, total financing liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69,336</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to the fair value of our financing liability and financing liability, related party, please read Note 5, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</span></p><p style="text-indent:2.267%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2027 Convertible Senior Notes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of the 2027 Notes, which were issued in August 2022, may differ from the carrying value. The fair value is determined utilizing prices for the 2027 Notes observed in market trading. As the market for the trading of the 2027 Notes is not considered to be an active market, the estimate of fair value is considered a Level 2 measurement. As of March 31, 2023, the estimated fair value of the 2027 Notes, which have an aggregate carrying value of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">336.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">289.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to the 2027 Notes, please read Note 6, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2027 Convertible Senior Notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632864032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Statement Components<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Financial Statement Components</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Financial Statement Components</span><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Prepaid Expenses and Other Current Assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.156%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid clinical trial services</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,551</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,872</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid research and development expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,592</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,228</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid insurance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,171</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,460</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other prepaid expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,912</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,556</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest receivable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,202</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,046</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,367</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,459</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,795</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,621</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment, Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.411%;"/>
        <td style="width:1.541%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.754000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.541%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.754000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment and software</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,009</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">996</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">459</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">459</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,886</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,489</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,461</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,461</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction in progress</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">705</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">321</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: Accumulated depreciation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,514</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,259</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,006</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,467</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Long-Term Assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other long-term assets consisted of the following:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.156%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other prepaid expenses, net of current portion</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,932</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,792</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred expenses associated with financing activities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">287</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">286</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">989</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">813</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other long-term assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,208</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,891</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 and December 31, 2022, other prepaid expenses, net of current portion, primarily consisted of deposits paid under certain contract research organization agreements that will be held until the completion of the related clinical trials that are anticipated to end more than 12 months from the balance sheet date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accrued Expenses and Other Current Liabilities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.436%;"/>
        <td style="width:1.542%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.739999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.542%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.739999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued external research and development services</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41,397</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,967</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued compensation and personnel costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,377</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,057</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued property and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">439</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued professional fees and consulting services</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,365</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,187</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,078</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,210</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">958</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,143</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52,614</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,604</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Income (Expense), net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income (expense), net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.716%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.719999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.719999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,076</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">295</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,636</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income (expense), net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,440</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">295</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income (Expense), net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.436%;"/>
        <td style="width:1.542%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.739999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.542%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.739999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain (loss) on fair value remeasurement of financing liability, related party</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,541</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,970</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain (loss) on fair value remeasurement of financing liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,541</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,970</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,090</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,941</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652716580512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Stockholders&#8217; Equity</span><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preferred Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the terms of our certificate of incorporation, we have </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> authorized shares of preferred stock, par value $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, all of which shares of preferred stock are undesignated. Our board of directors or any authorized committee thereof is expressly authorized, without further action by our stockholders, to issue such shares of preferred stock from time to time on terms it may determine, to divide shares of preferred stock into one or more series and to fix the designations, preferences, privileges and restrictions of preferred stock. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> issued and outstanding shares of preferred stock as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022.</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Common Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the terms of our certificate of incorporation, we have </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">500,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> authorized shares of common stock, par value $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. There were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">156,760,109</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">156,502,285</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock issued and outstanding as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022, respectively.</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Voting</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The holders of our common stock are entitled to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one vote</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for each share of common stock held of record by such holder on all matters voted upon by our stockholders, provided, however, that, except as otherwise required in our certificate of incorporation or by applicable law, the holders of our common stock are not entitled to vote on any amendment to our certificate of incorporation (or on any amendment to a certificate of designations of any series of preferred stock) that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon, and there is no cumulative voting.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Dividends</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Subject to any other provisions of our certificate of incorporation, holders of our common stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> are entitled to receive ratably, in proportion to the number of shares of common stock held by them, such dividends and other distributions in cash, stock or property when, as and if declared thereon by our board of directors from time to time out of our assets or funds legally available therefor. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> dividends have been declared to date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">ATM Program</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In November 2021, we entered into an open market sales agreement with Jefferies LLC, as sales agent, to provide for the issuance and sale of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">250.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of our common stock from time-to-time in &#8220;at-the-market&#8221; offerings (the ATM Program). As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> sales had been made pursuant to the ATM Program.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632724000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity-Based Compensation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10. Equity-Based Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.253%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equity-based Compensation Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes equity-based compensation expense included in our unaudited condensed consolidated statements of operations and comprehensive loss:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.401%;"/>
        <td style="width:1.502%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.797%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.502%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.797%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,339</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,006</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,253</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,552</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation expense included in total operating expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,592</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,558</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes equity-based compensation expense by award type included in our unaudited condensed consolidated statements of operations and comprehensive loss:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.401%;"/>
        <td style="width:1.502%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.797%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.502%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.797%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,663</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,359</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">703</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">226</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">190</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation expense included in total operating expense</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,592</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,558</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock Options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options granted during the three months ended March 31, 2023 and 2022 had a weighted average grant-date fair value of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26.21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.62</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average assumptions that we used to determine the fair value of stock options granted to employees are summarized as follows: </span></span><span style=""/></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.35%;"/>
        <td style="width:1.166%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.656%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.166%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.661000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.76</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.85</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.08</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.08</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96.2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, total unrecognized equity-based compensation expense relating to stock options was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. This amount is expected to be recognized over a weighted average period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.0</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our stock option activity for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three months ended March 31, 2023:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.65%;"/>
        <td style="width:1.001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.614999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.914000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.116%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.094999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br/>Shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life<br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(in millions)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,178,861</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.59</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.55</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">309.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,015,264</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.29</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">257,824</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.10</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited, canceled or expired</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">517,077</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.38</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at March 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,419,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.74</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.49</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">199.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options vested and expected to vest as of March 31, 2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,419,224</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.74</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.49</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">199.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options exercisable as of March 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,619,438</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.70</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.62</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">161.3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate intrinsic value represents the difference between the closing stock price of our common stock and the exercise price of in-the-money options. Our closing stock price as reported on the Nasdaq Stock Market on March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24.39</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options granted during the three months ended March 31, 2023 include our annual long-term incentive awards, which were granted in February 2023.</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Stock Units</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our restricted stock activity as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.636%;"/>
        <td style="width:1.381%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.831999999999997%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.861%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.291999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted Stock Units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number<br/>of Units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-vested at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,932</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26.41</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">570,922</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.38</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,737</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.41</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-vested at March 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">559,117</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.11</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, total unrecognized equity-based compensation expense relating to restricted stock unit awards was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which is expected to be recognized over a weighted average period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.8</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632932432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11. Net Loss Per Share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table sets forth the computation of the basic and diluted net loss per share:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"/>
        <td style="width:1.622%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.837%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.622%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.837%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands, except share amounts and per share data)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104,286</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68,294</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Denominator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-average shares used in calculating net loss per share, basic and diluted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">156,648,365</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">147,984,926</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.67</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.46</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since we were in a loss position for all periods presented, diluted net loss per share is the same as basic net loss per share as the inclusion of all potential dilutive securities would have been anti-dilutive. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The shares in the table below were excluded from the calculation of diluted net loss per share due to their anti-dilutive effect: </span></span><span style=""/></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.96%;"/>
        <td style="width:1.16%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.36%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.16%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.36%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,419,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,901,741</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">559,117</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,270</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ESPP shares issuable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32,410</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,889</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock issuable upon conversion of the 2027 Notes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,439,338</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26,450,089</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,930,900</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632632256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12. Income Taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended March 31, 2023 and 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t record income tax benefits for net operating losses incurred or for the research and development tax credits generated in each period due to the uncertainty of realizing a benefit from those items. Our tax provision and the resulting effective tax rate for interim periods is determined based upon our estimated annual effective tax rate, adjusted for the effect of discrete items arising during the interim quarterly period. The impact of such inclusions could result in a higher or lower effective tax rate during a particular quarterly period, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarterly period, we update our estimate of the annual effective tax rate, and if the estimated annual tax rate changes, a cumulative adjustment is made in that quarter.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have evaluated the positive and negative evidence bearing upon our ability to realize our deferred tax assets, which primarily consist of net operating loss carryforwards and research and development tax credits. We have considered our history of cumulative net losses, estimated future taxable income and prudent and feasible tax planning strategies, and have concluded that it is more likely than not that we will not realize the benefits of our deferred tax assets. As a result, as of March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we have recorded a full valuation allowance against our net deferred tax assets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632834352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Legal Proceedings</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13. Legal Proceedings</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We, from time to time, may be subject to various legal proceedings and claims that may arise in the ordinary course of business. We were not subject to any material legal proceedings as of March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and, to the best of our knowledge, no material legal proceedings are currently pending or threatened.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632782752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14. Commitments and Contingencies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023, we have several ongoing clinical studies in various clinical trial stages. Our most significant contracts relate to agreements with CROs for clinical trials and preclinical studies and CMOs for the manufacturing of drug substance, which we enter into in the normal course of business. The contracts with CROs and CMOs are generally cancellable, with notice, at our option.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Guarantees and Indemnification Obligations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">enter into standard indemnification obligations in the ordinary course of business. Pursuant to these obligations, we indemnify and agree to reimburse the indemnified party for certain losses and costs incurred by the indemnified party. The term of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">these </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">indemnification obligations is generally perpetual after execution of the agreement. In addition, we have entered into indemnification obligations with members of our board of directors and our executive officers that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or executive officers. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited. To date, we have </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t incurred any losses or any material costs related to these indemnification obligations and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> claims with respect thereto were outstanding. We do not believe that the outcome of any claims under indemnification arrangements will have a material effect on our financial position, results of operations and cash flows, and we have </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t accrued any liabilities related to such obligations in our condensed consolidated financial statements as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632868816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15. Related Parties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Pfizer held </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,349,211</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock and had nominated </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> members to our board of directors. For information related to our license agreement with Pfizer, please read Note 4, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pfizer License Agreement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 and December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, Bain Investor held </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,632,356</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock and had nominated </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> members to our board of directors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research Collaboration and License Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2022, we entered into a research collaboration and license agreement with Pfizer, pursuant to which we will collaborate to identify, screen and evaluate compounds directed at certain targets for neuroscience diseases using Pfizer&#8217;s chemical library. Under the terms of the agreement, we will be required to reimburse Pfizer for certain research services and make a contingent development milestone payment and single-digit royalty payments on net sales of products containing one or more compounds derived from the collaboration. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> amounts have been incurred under the agreement to date.</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Funding Agreement</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2021, we entered into a funding agreement with Bain, pursuant to which Bain will provide up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in funding (the Bain Funding Commitment) to support our development of tavapadon for the treatment of Parkinson&#8217;s disease over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, of which approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Bain Funding Commitment, net of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of fees incurred by Bain) was received in April 2021, approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Bain Funding Commitment) was received in April 2022 and approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Bain Funding Commitment) was received in April 2023. For additional information related to our funding agreement with Bain, please read Note 5, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Management Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following the closing of the business combination in October 2020 pursuant to which ARYA Sciences Acquisition Corp II (ARYA) acquired Cerevel Therapeutics, Inc., with Cerevel Therapeutics, Inc. becoming a wholly-owned subsidiary of ARYA and ARYA being renamed Cerevel Therapeutics Holdings, Inc. (the Business Combination), we entered into a management agreement with Bain Capital Private Equity, LP and Bain Capital Life Sciences, LP, providing for the expense reimbursement and indemnification of such entities. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> amounts have been incurred under the management agreement to date.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to the Business Combination, please read Note 3, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business Combination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our audited consolidated financial statements included in our Annual Report.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632769232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16. Subsequent Events</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have completed an evaluation of all subsequent events after the unaudited balance sheet date of March 31, 2023, through May 3, 2023, the issuance date of these financial statements, to ensure that these unaudited condensed consolidated financial statements include appropriate disclosure of material events both recognized in these unaudited condensed consolidated financial statements as of March 31, 2023, and material events which occurred subsequently but were not recognized in these unaudited condensed consolidated financial statements. We have concluded that no such subsequent events other than the following have occurred that require disclosure:</span></p><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Funding Agreement Receipts</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the Funding Agreements, we received </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the Total Funding Commitment) in April 2023. For additional information related to our Funding Agreements, please read Note 5, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Liabilities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to these unaudited condensed consolidated financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652633680256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying unaudited condensed consolidated financial statements include those of the company and its subsidiaries, Cerevel Therapeutics, Inc., Cerevel Therapeutics, LLC and Cerevel MA Securities Corp., after elimination of all intercompany accounts and transactions. The accompanying unaudited condensed consolidated financial statements and notes hereto have been prepared in conformity with the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting and, therefore, omit or condense certain footnotes and other information normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) as set forth in the Financial Accounting Standards Board&#8217;s (FASB) accounting standards codification. Any reference in these notes to applicable guidance is</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Update (ASU) of the FASB.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the opinion of management, all adjustments necessary for a fair statement of the financial information, which are of a normal and recurring nature, have been made for the interim periods reported. Results of operations for the three months ended March 31, 2023 and 2022, are not necessarily indicative of the results for the entire fiscal year or any other period. Our unaudited condensed consolidated financial statements for the three months ended March 31, 2023 and 2022, have been prepared on the same basis as and should be read in conjunction with our audited consolidated financial statements and notes included in our Annual Report.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, the fair value of our financing liabilities, the fair value of stock options, the accrual for research and development expense and the recoverability of our net deferred tax assets and the related valuation allowance. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors and adjust those estimates and assumptions when facts and circumstances change. Actual results could differ materially from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with our entering into the lease agreement for our headquarters in Cambridge, MA, in July 2019, we were required to provide a security deposit in the form of a letter of credit. We have classified this amount as restricted cash in our condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For additional information related to our other significant accounting policies, please read Note 4, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Summary of Significant Accounting Policies</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, to our audited consolidated financial statements included in our Annual Report.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Guidance</a></td>
<td class="text"><p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Guidance</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the company as of the specified effective date. Unless otherwise discussed, the company believes that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632868816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock', window );">Summary of Changes in Estimated Fair Value of Financing Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in estimated fair value of the financing liabilities in our unaudited condensed consolidated statements of operations and comprehensive loss are summarized as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.716%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.719999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.719999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability, related party</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value recognized in other (income) expense, net</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,541</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,970</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">453</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">638</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value recognized in other (income) expense, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,541</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,970</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">453</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">638</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of Changes in Estimated Fair Value of Financing Liabilities [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652628376032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2027 Convertible Senior Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Summary of Net Carrying Amount of 2027 Notes</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The net carrying amount of the 2027 Notes included in our condensed consolidated balance sheets consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.156%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, <br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal amount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">345,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">345,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unamortized debt discount</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,038</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,518</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net carrying amount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">335,962</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">335,482</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ScheduleOfInterestExpenseTableTextBlock', window );">Schedule of Interest Expense Related to 2027 Notes Recognized in Interest Income (Expense), Net</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table sets forth the total interest expense related to the 2027 Notes recognized in interest income (expense), net in our </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unaudited condensed consolidated statements of operations and comprehensive loss for the periods presented:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.225%;"/>
        <td style="width:1.433%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.062000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.433%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.849%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contractual interest expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,156</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of debt issuance costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">480</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total interest expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,636</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective interest rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Minimum Payments under 2027 Notes</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future minimum payments under the 2027 Notes as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31, 2023, are as follows (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.128%;"/>
        <td style="width:1.937%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.934999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,312</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,625</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,625</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,625</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fiscal year ended December 31, 2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">353,625</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total future payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">383,812</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: amounts representing interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38,812</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total principal amount</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">345,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1) For the nine months ended December 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ScheduleOfInterestExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ScheduleOfInterestExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652629249840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The tables below present information about our assets and liabilities that are measured and carried at fair value on a recurring basis and indicate the level within the fair value hierarchy we utilized to determine such fair values:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.511%;"/>
        <td style="width:1.223%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.223%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.223%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.15%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.223%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.15%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted<br/>Prices in<br/>Active<br/>Markets<br/>(Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133,866</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133,866</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,950</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,950</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (current)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,909</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,909</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">230,658</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">230,658</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,477</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,477</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">415,127</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">415,127</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (non-current)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,048</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,048</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,867</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,867</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">153,642</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">711,260</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">864,902</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability, related party</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,668</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,668</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69,336</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69,336</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.903%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.152000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.152000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.152000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.152000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted<br/>Prices in<br/>Active<br/>Markets<br/>(Level 1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">136,521</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">136,521</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (current)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103,238</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103,238</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">165,555</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">165,555</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,416</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,416</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">477,300</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">477,300</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities (non-current)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,126</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,126</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,867</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,867</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">241,626</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">710,397</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">952,023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability, related party</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,674</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,674</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,674</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,674</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57,348</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57,348</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Estimated Fair Value and Amortized Cost of Available-for-Sale Marketable Debt Securities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The estimated fair value and amortized cost of our available-for-sale marketable debt securities, by contractual maturity and security type, are summarized as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.512%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.248999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.248999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.248999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.123%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.248999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 31, 2023 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due in one year or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,970</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,909</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">231,391</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">770</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">230,658</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,485</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,477</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">415,820</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">719</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">415,127</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due after one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35,986</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,048</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total marketable securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">710,652</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,558</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">709,219</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.822%;"/>
        <td style="width:1.043%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.253%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.043%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.253%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.043%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.253%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.043%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.253%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due in one year or less</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government treasuries</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103,800</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">562</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103,238</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">166,327</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">787</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">165,555</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,454</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,416</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">478,657</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,428</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">477,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due after one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government agencies</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,327</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">208</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,126</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total marketable securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">816,565</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">813,635</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of Rollforward of the Estimated Fair Value Associated with Financing Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table provides a rollforward of the estimated fair value associated with our combined total financing liabilities:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.288%;"/>
        <td style="width:1.941%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.771%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended <br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beginning balance, total financing liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57,348</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Funding commitment received</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value recognized in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_1f0cf8c7-35f8-4a8d-a01c-7fb92edd3948;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other (income) expense, net</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,082</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value attributable to instrument-specific credit risk recognized in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_293c1bd4-3ed9-476f-92d6-7047da56d7a9;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other comprehensive (income) loss</span></span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">906</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ending balance, total financing liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69,336</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652629176016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Statement Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock', window );">Summary of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.156%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid clinical trial services</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,551</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,872</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid research and development expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,592</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,228</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid insurance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,171</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,460</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other prepaid expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,912</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,556</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest receivable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,202</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,046</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,367</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,459</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,795</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,621</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property and Equipment Net</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.411%;"/>
        <td style="width:1.541%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.754000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.541%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.754000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Computer equipment and software</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,009</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">996</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">459</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">459</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,886</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,489</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,461</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,461</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Construction in progress</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">705</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">321</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: Accumulated depreciation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,514</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,259</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,006</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,467</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Summary of Other Long-Term Assets</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other long-term assets consisted of the following:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.156%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.662%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.759999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other prepaid expenses, net of current portion</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,932</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,792</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred expenses associated with financing activities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">287</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">286</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">989</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">813</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other long-term assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,208</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,891</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Summary of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.436%;"/>
        <td style="width:1.542%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.739999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.542%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.739999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued external research and development services</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41,397</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,967</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued compensation and personnel costs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,377</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,057</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued property and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">439</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued professional fees and consulting services</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,365</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,187</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,078</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,210</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">958</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,143</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52,614</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,604</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Summary of Interest Income (Expense), Net</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income (expense), net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.716%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.719999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.719999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,076</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">295</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,636</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income (expense), net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,440</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">295</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Summary of Other Income (Expense), Net</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:63.436%;"/>
        <td style="width:1.542%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.739999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.542%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.739999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain (loss) on fair value remeasurement of financing liability, related party</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,541</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,970</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain (loss) on fair value remeasurement of financing liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,541</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,970</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income (expense), net</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,090</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,941</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652634141664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Equity-based Compensation Expense</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes equity-based compensation expense included in our unaudited condensed consolidated statements of operations and comprehensive loss:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.401%;"/>
        <td style="width:1.502%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.797%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.502%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.797%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,339</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,006</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,253</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,552</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation expense included in total operating expense</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,592</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,558</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes equity-based compensation expense by award type included in our unaudited condensed consolidated statements of operations and comprehensive loss:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.401%;"/>
        <td style="width:1.502%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.797%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.502%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.797%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,663</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,359</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">703</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">226</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">190</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total equity-based compensation expense included in total operating expense</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,592</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,558</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted Average Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average assumptions that we used to determine the fair value of stock options granted to employees are summarized as follows: </span>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.35%;"/>
        <td style="width:1.166%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.656%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.166%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.661000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.76</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.85</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.08</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.08</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96.2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Options Activity</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our stock option activity for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three months ended March 31, 2023:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.65%;"/>
        <td style="width:1.001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.614999999999998%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.914000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.116%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.094999999999999%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br/>Shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life<br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(in years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(in millions)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,178,861</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.59</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.55</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">309.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,015,264</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.29</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">257,824</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.10</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited, canceled or expired</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">517,077</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.38</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding at March 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,419,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.74</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.49</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">199.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options vested and expected to vest as of March 31, 2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,419,224</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.74</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.49</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">199.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options exercisable as of March 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,619,438</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.70</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.62</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">161.3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Activity</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our restricted stock activity as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.636%;"/>
        <td style="width:1.381%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.831999999999997%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.861%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.291999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted Stock Units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number<br/>of Units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-vested at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,932</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26.41</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">570,922</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.38</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,737</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.41</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-vested at March 31, 2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">559,117</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.11</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632960320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table sets forth the computation of the basic and diluted net loss per share:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"/>
        <td style="width:1.622%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.837%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.622%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.837%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Three Months Ended<br/>March 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands, except share amounts and per share data)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104,286</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68,294</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Denominator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-average shares used in calculating net loss per share, basic and diluted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">156,648,365</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">147,984,926</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.67</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.46</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Potential Dilutive Securities Excluded From Calculation of Net Loss Per Share</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The shares in the table below were excluded from the calculation of diluted net loss per share due to their anti-dilutive effect: </span>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.96%;"/>
        <td style="width:1.16%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.36%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.16%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.36%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 31,<br/>2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,419,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,901,741</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted stock units outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">559,117</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,270</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ESPP shares issuable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32,410</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,889</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock issuable upon conversion of the 2027 Notes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,439,338</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26,450,089</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,930,900</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652633673984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pfizer License Agreement - Additional Information (Details) - Pfizer License Agreement [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_LicenseAgreementLineItems', window );"><strong>License Agreement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty payments</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_RegulatoryApprovalMilestonePayments', window );">Regulatory approval milestone payments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_CommercialApprovalMilestonePayments', window );">Commercial approval milestone payments</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_CommercialApprovalMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial approval milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_CommercialApprovalMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_LicenseAgreementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_LicenseAgreementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_RegulatoryApprovalMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regulatory approval milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_RegulatoryApprovalMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cere_PfizerLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cere_PfizerLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652627371520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Liabilities - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ReceivedFunding', window );">Total funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingReceived', window );">Percentage of funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ExpectedFundingReceived', window );">Funding expected to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_NoncurrentFinancingLiabilityRelatedParty', window );">Financing liability, related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,668,000<span></span>
</td>
<td class="nump">$ 28,674,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_NoncurrentFinancingLiability', window );">Financing liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,668,000<span></span>
</td>
<td class="nump">28,674,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cere_FirstAnniversariesMember', window );">First Anniversaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingReceived', window );">Percentage of funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ExpectedFundingReceived', window );">Funding expected to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cere_SecondAnniversariesMember', window );">Second Anniversaries [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ReceivedFunding', window );">Total funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingReceived', window );">Percentage of funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ExpectedFundingReceived', window );">Funding expected to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cere_ThirdAnniversariesMember', window );">Third Anniversaries [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ExpectedFundingReceived', window );">Funding expected to be received</a></td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfExpectedFundingReceived', window );">Percentage of funding expected to be received</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cere_NovaQuestFundingAgreementMember', window );">NovaQuest Funding Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ExpectedFundingReceived', window );">Funding expected to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_NoncurrentFinancingLiability', window );">Financing liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,700,000<span></span>
</td>
<td class="nump">28,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cere_BainFundingAgreementMember', window );">Bain Funding Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ReceivedFunding', window );">Total funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,800,000<span></span>
</td>
<td class="nump">$ 15,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingReceived', window );">Percentage of funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ExpectedFundingReceived', window );">Funding expected to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_FundingCommitmentFeesIncurred', window );">Fees incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_NoncurrentFinancingLiabilityRelatedParty', window );">Financing liability, related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,700,000<span></span>
</td>
<td class="nump">$ 28,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cere_BainFundingAgreementMember', window );">Bain Funding Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ReceivedFunding', window );">Total funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingReceived', window );">Percentage of funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cere_NovaQuestAndBainFundingAgreementsMember', window );">NovaQuest and Bain Funding Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_FundingCommitmentFeesIncurred', window );">Fees incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PayableOnFundingAgreement', window );">Payable on funding agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 531,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ContractualObligationDescriptionRepaymentTiming', window );">Contractual obligation description repayment timing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">earlier of FDA approval or May 1, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cere_NovaQuestAndBainFundingAgreementsMember', window );">NovaQuest and Bain Funding Agreements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingCommitment', window );">Percentage of funding commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cere_NovaQuestAndBainFundingAgreementsMember', window );">NovaQuest and Bain Funding Agreements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingCommitment', window );">Percentage of funding commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ContractualObligationDescriptionRepaymentTiming">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of timing for satisfying repayment of contractual obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ContractualObligationDescriptionRepaymentTiming</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ExpectedFundingReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected funding received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ExpectedFundingReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_FundingCommitmentFeesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Funding commitment fees incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_FundingCommitmentFeesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_NoncurrentFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncurrent financing liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_NoncurrentFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_NoncurrentFinancingLiabilityRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncurrent financing liability related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_NoncurrentFinancingLiabilityRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_PayableOnFundingAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payable on funding agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_PayableOnFundingAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_PercentageOfExpectedFundingReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of expected funding received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_PercentageOfExpectedFundingReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_PercentageOfFundingCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of funding commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_PercentageOfFundingCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_PercentageOfFundingReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of funding received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_PercentageOfFundingReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ReceivedFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Received funding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ReceivedFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionQuantitativeDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cere_FirstAnniversariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cere_FirstAnniversariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cere_SecondAnniversariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cere_SecondAnniversariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cere_ThirdAnniversariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cere_ThirdAnniversariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=cere_NovaQuestFundingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=cere_NovaQuestFundingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=cere_BainFundingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=cere_BainFundingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=cere_NovaQuestAndBainFundingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=cere_NovaQuestAndBainFundingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652629136048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financing Liabilities - Summary of Changes in Estimated Fair Value of Financing Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax', window );">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</a></td>
<td class="num">$ (906)<span></span>
</td>
<td class="nump">$ 1,276<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cere_FinancingLiabilityRelatedPartyMember', window );">Financing Liability, Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</a></td>
<td class="nump">5,541<span></span>
</td>
<td class="num">(1,970)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax', window );">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</a></td>
<td class="nump">453<span></span>
</td>
<td class="num">(638)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cere_FinancingLiabilityMember', window );">Financing Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</a></td>
<td class="nump">5,541<span></span>
</td>
<td class="num">(1,970)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax', window );">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</a></td>
<td class="nump">$ 453<span></span>
</td>
<td class="num">$ (638)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionQuantitativeDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of unrealized gain (loss) from increase (decrease) in instrument-specific credit risk of financial liability measured under fair value option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14172-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL75136633-108610<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cere_FinancingLiabilityRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cere_FinancingLiabilityRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cere_FinancingLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cere_FinancingLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652624155296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2027 Convertible Senior Notes - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($) </div>
<div>Days </div>
<div>Instrument </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,000,000<span></span>
</td>
<td class="nump">$ 345,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Debt instrument, accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,078,000<span></span>
</td>
<td class="nump">3,210,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember', window );">2027 Convertible Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, aggregate principal amount</a></td>
<td class="nump">$ 345,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Debt instrument, aggregate net proceeds</a></td>
<td class="nump">$ 334,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt instrument, frequency of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">semi-annually<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Debt instrument, payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The 2027 Notes accrue interest at a rate of 2.50% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2023.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Debt instrument, accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">Aug. 15,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt instrument, consecutive trading days | Days</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember', window );">2027 Convertible Senior Notes [Member] | Purchaser Discounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance cost incurred</a></td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember', window );">2027 Convertible Senior Notes [Member] | Other Offering Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance cost incurred</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember', window );">2027 Convertible Senior Notes [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PerPrincipalAmountForConversion', window );">Debt instrument, conversion price per principal | $ / shares</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Debt instrument, conversion rate</a></td>
<td class="nump">21.5633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt instrument, conversion price | $ / shares</a></td>
<td class="nump">$ 46.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Debt instrument, convertible, number of equity instruments | Instrument</a></td>
<td class="nump">7,439,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember', window );">2027 Convertible Senior Notes [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Debt instrument, conversion price percentage applicable for trading days</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Debt instrument, trading days | Days</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember', window );">2027 Convertible Senior Notes [Member] | Measurement Period [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PerPrincipalAmountForTradingPrice', window );">Debt instrument, trading price per principal | $ / shares</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember', window );">2027 Convertible Senior Notes [Member] | Measurement Period [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Debt instrument, conversion price percentage applicable for trading days</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_PerPrincipalAmountForConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per principal amount for conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_PerPrincipalAmountForConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_PerPrincipalAmountForTradingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per principal amount for trading price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_PerPrincipalAmountForTradingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=cere_PurchaserDiscountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=cere_PurchaserDiscountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=cere_OtherOfferingExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=cere_OtherOfferingExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=cere_MeasurementPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=cere_MeasurementPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652630610448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>2027 Convertible Senior Notes - Summary of Net Carrying Amount of 2027 Notes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 345,000<span></span>
</td>
<td class="nump">$ 345,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized debt discount</a></td>
<td class="num">(9,038)<span></span>
</td>
<td class="num">(9,518)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Net carrying amount</a></td>
<td class="nump">$ 335,962<span></span>
</td>
<td class="nump">$ 335,482<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652629155552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2027 Convertible Senior Notes - Schedule of Interest Expense Related to 2027 Notes Recognized in Interest Income (Expense), Net (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="nump">$ 2,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense</a></td>
<td class="nump">$ 2,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">3.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652629322352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>2027 Convertible Senior Notes - Schedule of Future Minimum Payments under 2027 Notes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Fiscal year ended December 31, 2023</a></td>
<td class="nump">$ 4,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Fiscal year ended December 31, 2024</a></td>
<td class="nump">8,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Fiscal year ended December 31, 2025</a></td>
<td class="nump">8,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Fiscal year ended December 31, 2026</a></td>
<td class="nump">8,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Fiscal year ended December 31, 2027</a></td>
<td class="nump">353,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total future payments</a></td>
<td class="nump">383,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_DebtInstrumentInterest', window );">Less: amounts representing interest</a></td>
<td class="num">(38,812)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 345,000<span></span>
</td>
<td class="nump">$ 345,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_DebtInstrumentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_DebtInstrumentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652624364432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities (current)</a></td>
<td class="nump">$ 673,171<span></span>
</td>
<td class="nump">$ 755,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Marketable securities (non-current)</a></td>
<td class="nump">36,048<span></span>
</td>
<td class="nump">58,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="nump">864,902<span></span>
</td>
<td class="nump">952,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">69,336<span></span>
</td>
<td class="nump">57,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, fair value</a></td>
<td class="nump">133,866<span></span>
</td>
<td class="nump">136,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, fair value</a></td>
<td class="nump">19,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities (current)</a></td>
<td class="nump">415,127<span></span>
</td>
<td class="nump">477,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | US Treasury and Government [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities (current)</a></td>
<td class="nump">17,909<span></span>
</td>
<td class="nump">103,238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | U.S. Government Agencies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities (current)</a></td>
<td class="nump">230,658<span></span>
</td>
<td class="nump">165,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Marketable securities (non-current)</a></td>
<td class="nump">36,048<span></span>
</td>
<td class="nump">58,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Corporate Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities (current)</a></td>
<td class="nump">9,477<span></span>
</td>
<td class="nump">9,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Restricted Cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="nump">1,867<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Financing Liability, Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">34,668<span></span>
</td>
<td class="nump">28,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Financing Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">34,668<span></span>
</td>
<td class="nump">28,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Quoted Prices in Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="nump">153,642<span></span>
</td>
<td class="nump">241,626<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Quoted Prices in Active Markets (Level 1) [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, fair value</a></td>
<td class="nump">133,866<span></span>
</td>
<td class="nump">136,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Quoted Prices in Active Markets (Level 1) [Member] | US Treasury and Government [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities (current)</a></td>
<td class="nump">17,909<span></span>
</td>
<td class="nump">103,238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Quoted Prices in Active Markets (Level 1) [Member] | Restricted Cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="nump">1,867<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="nump">711,260<span></span>
</td>
<td class="nump">710,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member] | Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, fair value</a></td>
<td class="nump">19,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities (current)</a></td>
<td class="nump">415,127<span></span>
</td>
<td class="nump">477,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member] | U.S. Government Agencies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities (current)</a></td>
<td class="nump">230,658<span></span>
</td>
<td class="nump">165,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Marketable securities (non-current)</a></td>
<td class="nump">36,048<span></span>
</td>
<td class="nump">58,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member] | Corporate Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities (current)</a></td>
<td class="nump">9,477<span></span>
</td>
<td class="nump">9,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Significant Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">69,336<span></span>
</td>
<td class="nump">57,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Significant Unobservable Inputs (Level 3) [Member] | Financing Liability, Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">34,668<span></span>
</td>
<td class="nump">28,674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Significant Unobservable Inputs (Level 3) [Member] | Financing Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">$ 34,668<span></span>
</td>
<td class="nump">$ 28,674<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=cere_RestrictedCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=cere_RestrictedCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=cere_FinancingLiabilityRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=cere_FinancingLiabilityRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=cere_FinancingLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=cere_FinancingLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652624271440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesRealizedGainLoss', window );">Gains or losses recognized on the sale or maturity of marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_MarketableSecuritiesWeightedAverageMaturityTerm', window );">Marketable securities weighted average maturity term</a></td>
<td class="text">5 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt instrument, carrying value</a></td>
<td class="nump">$ 335,962,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 335,482,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember', window );">2027 Convertible Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt instrument, carrying value</a></td>
<td class="nump">336,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt instrument, fair value</a></td>
<td class="nump">$ 289,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputInceptionDiscountRateMember', window );">Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput', window );">Financing liability, related party and financing liability measurement input</a></td>
<td class="nump">0.100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">$ 69,336,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,348,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_FairValueLiabilitiesBetweenLevelTransferAmount', window );">Fair value liabilities between level transfer amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_FairValueAssetBetweenLevelTransferAmount', window );">Fair value asset between level transfer amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring [Member] | Financing Liability, Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">$ 34,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_FairValueAssetBetweenLevelTransferAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value asset between level transfer amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_FairValueAssetBetweenLevelTransferAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_FairValueLiabilitiesBetweenLevelTransferAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value liabilities between level transfer amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_FairValueLiabilitiesBetweenLevelTransferAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing liability, related party and financing liability measurement input.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_MarketableSecuritiesWeightedAverageMaturityTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable securities weighted average maturity term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_MarketableSecuritiesWeightedAverageMaturityTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputInceptionDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputInceptionDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=cere_FinancingLiabilityRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=cere_FinancingLiabilityRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652629367424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Estimated Fair Value and Amortized Cost of Available-for-Sale Marketable Debt Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale marketable debt securities, Amortized Cost</a></td>
<td class="nump">$ 710,652<span></span>
</td>
<td class="nump">$ 816,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale marketable debt securities, Unrealized Gains</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale marketable debt securities, Unrealized Losses</a></td>
<td class="num">(1,558)<span></span>
</td>
<td class="num">(3,023)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale marketable debt securities, Fair Value</a></td>
<td class="nump">709,219<span></span>
</td>
<td class="nump">813,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">US Treasury and Government [Member] | Due in One Year or Less [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale marketable debt securities, Amortized Cost</a></td>
<td class="nump">17,970<span></span>
</td>
<td class="nump">103,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale marketable debt securities, Unrealized Losses</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(562)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale marketable debt securities, Fair Value</a></td>
<td class="nump">17,909<span></span>
</td>
<td class="nump">103,238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. Government Agencies [Member] | Due in One Year or Less [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale marketable debt securities, Amortized Cost</a></td>
<td class="nump">231,391<span></span>
</td>
<td class="nump">166,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale marketable debt securities, Unrealized Gains</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale marketable debt securities, Unrealized Losses</a></td>
<td class="num">(770)<span></span>
</td>
<td class="num">(787)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale marketable debt securities, Fair Value</a></td>
<td class="nump">230,658<span></span>
</td>
<td class="nump">165,555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. Government Agencies [Member] | Due after One Year through Two Years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale marketable debt securities, Amortized Cost</a></td>
<td class="nump">35,986<span></span>
</td>
<td class="nump">58,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale marketable debt securities, Unrealized Gains</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale marketable debt securities, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale marketable debt securities, Fair Value</a></td>
<td class="nump">36,048<span></span>
</td>
<td class="nump">58,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities [Member] | Due in One Year or Less [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale marketable debt securities, Amortized Cost</a></td>
<td class="nump">9,485<span></span>
</td>
<td class="nump">9,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale marketable debt securities, Unrealized Losses</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale marketable debt securities, Fair Value</a></td>
<td class="nump">9,477<span></span>
</td>
<td class="nump">9,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member] | Due in One Year or Less [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale marketable debt securities, Amortized Cost</a></td>
<td class="nump">415,820<span></span>
</td>
<td class="nump">478,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale marketable debt securities, Unrealized Gains</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale marketable debt securities, Unrealized Losses</a></td>
<td class="num">(719)<span></span>
</td>
<td class="num">(1,428)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale marketable debt securities, Fair Value</a></td>
<td class="nump">$ 415,127<span></span>
</td>
<td class="nump">$ 477,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=cere_ShortTermMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=cere_ShortTermMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=cere_LongTermMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=cere_LongTermMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652624143696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Rollforward of the Estimated Fair Value Associated with Financing Liabilities (Details) - Fair Value, Inputs, Level 3 [Member] - Financing Liabilities [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 57,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value recognized in other (income) expense, net</a></td>
<td class="nump">$ 11,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Other income (expense), net<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss</a></td>
<td class="num">$ (906)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 69,336<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which other comprehensive income (OCI) is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cere_FinancingLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cere_FinancingLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652632082560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Statement Components - Summary of Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PrepaidClinicalTrialServicesCurrent', window );">Prepaid clinical trial services</a></td>
<td class="nump">$ 2,551<span></span>
</td>
<td class="nump">$ 2,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PrepaidResearchAndDevelopmentExpensesCurrent', window );">Prepaid research and development expenses</a></td>
<td class="nump">1,592<span></span>
</td>
<td class="nump">1,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">2,171<span></span>
</td>
<td class="nump">2,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other prepaid expenses</a></td>
<td class="nump">2,912<span></span>
</td>
<td class="nump">3,556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Interest receivable</a></td>
<td class="nump">3,202<span></span>
</td>
<td class="nump">2,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">1,367<span></span>
</td>
<td class="nump">1,459<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 13,795<span></span>
</td>
<td class="nump">$ 13,621<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_PrepaidClinicalTrialServicesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid clinical trial services current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_PrepaidClinicalTrialServicesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_PrepaidResearchAndDevelopmentExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid research and development expenses current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_PrepaidResearchAndDevelopmentExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652627139616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Statement Components - Summary of Property and Equipment Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">$ (8,514)<span></span>
</td>
<td class="num">$ (7,259)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">27,006<span></span>
</td>
<td class="nump">27,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">1,009<span></span>
</td>
<td class="nump">996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">459<span></span>
</td>
<td class="nump">459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cere_LaboratoryEquipmentMember', window );">Laboratory Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">9,886<span></span>
</td>
<td class="nump">9,489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">23,461<span></span>
</td>
<td class="nump">23,461<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in-progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 705<span></span>
</td>
<td class="nump">$ 321<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cere_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cere_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652634291216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Statement Components - Summary of Other Long-Term Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Other prepaid expenses, net of current portion</a></td>
<td class="nump">$ 1,932<span></span>
</td>
<td class="nump">$ 1,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Deferred expenses associated with financing activities</a></td>
<td class="nump">287<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">989<span></span>
</td>
<td class="nump">813<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">$ 3,208<span></span>
</td>
<td class="nump">$ 2,891<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652627329712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Statement Components - Summary of Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract', window );"><strong>Accrued Liabilities and Other Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_AccruedExternalResearchAndDevelopmentServicesCurrent', window );">Accrued external research and development services</a></td>
<td class="nump">$ 41,397<span></span>
</td>
<td class="nump">$ 33,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and personnel costs</a></td>
<td class="nump">6,377<span></span>
</td>
<td class="nump">19,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_AccruedPropertyAndEquipmentCurrent', window );">Accrued property and equipment</a></td>
<td class="nump">439<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees and consulting services</a></td>
<td class="nump">2,365<span></span>
</td>
<td class="nump">2,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">1,078<span></span>
</td>
<td class="nump">3,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">958<span></span>
</td>
<td class="nump">1,143<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">$ 52,614<span></span>
</td>
<td class="nump">$ 59,604<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_AccruedExternalResearchAndDevelopmentServicesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued external research and development services current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_AccruedExternalResearchAndDevelopmentServicesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_AccruedPropertyAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued property and equipment current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_AccruedPropertyAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652628362784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Statement Components - Summary of Interest Income (Expense), Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNetAbstract', window );"><strong>Interest Income (Expense), Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_InterestIncomeNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">$ 9,076<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2,636)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">$ 6,440<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_InterestIncomeNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest income nonoperating, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_InterestIncomeNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652633772848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Statement Components - Summary of Other Income (Expense), Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty', window );">Gain (loss) on fair value remeasurement of financing liability, related party</a></td>
<td class="num">$ (5,541)<span></span>
</td>
<td class="nump">$ 1,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_GainLossOnFairValueRemeasurementOfFinancingLiability', window );">Gain (loss) on fair value remeasurement of financing liability</a></td>
<td class="num">(5,541)<span></span>
</td>
<td class="nump">1,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_OtherNonoperatingIncomeExpenseOther', window );">Other, net</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">$ (11,090)<span></span>
</td>
<td class="nump">$ 3,941<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_GainLossOnFairValueRemeasurementOfFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on fair value remeasurement of financing liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_GainLossOnFairValueRemeasurementOfFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on fair value remeasurement of financing liability related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_OtherNonoperatingIncomeExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other nonoperating income expense other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_OtherNonoperatingIncomeExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652627243152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity, Preferred Stock and Common Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 10, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,760,109<span></span>
</td>
<td class="nump">156,502,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,760,109<span></span>
</td>
<td class="nump">156,502,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock, voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one vote<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance and sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cere_AtmProgramMember', window );">ATM Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance and sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cere_AtmProgramMember', window );">ATM Program [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_SaleAndIssuanceOfStockNotYetIssued', window );">Issuance and sale of common stock yet to issue</a></td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_SaleAndIssuanceOfStockNotYetIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale and issuance of stock, not yet issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_SaleAndIssuanceOfStockNotYetIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cere_AtmProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cere_AtmProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652624094576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Equity-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation expense included in total operating expense</a></td>
<td class="nump">$ 12,592<span></span>
</td>
<td class="nump">$ 8,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation expense included in total operating expense</a></td>
<td class="nump">6,339<span></span>
</td>
<td class="nump">4,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation expense included in total operating expense</a></td>
<td class="nump">6,253<span></span>
</td>
<td class="nump">4,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation expense included in total operating expense</a></td>
<td class="nump">11,663<span></span>
</td>
<td class="nump">8,359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation expense included in total operating expense</a></td>
<td class="nump">703<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cere_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total equity-based compensation expense included in total operating expense</a></td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">$ 190<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cere_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cere_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652629387328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Stock Options Activity (Details) - Stock Option [Member] - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Beginning balance</a></td>
<td class="nump">17,178,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">2,015,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(257,824)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited, canceled or expired</a></td>
<td class="num">(517,077)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Ending balance</a></td>
<td class="nump">18,419,224<span></span>
</td>
<td class="nump">17,178,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest</a></td>
<td class="nump">18,419,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable</a></td>
<td class="nump">10,619,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Beginning balance</a></td>
<td class="nump">$ 13.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">34.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">6.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">21.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Ending balance</a></td>
<td class="nump">15.74<span></span>
</td>
<td class="nump">$ 13.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest</a></td>
<td class="nump">15.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options Exercisable</a></td>
<td class="nump">$ 9.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Life (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">7 years 5 months 26 days<span></span>
</td>
<td class="text">7 years 6 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options vested and expected to vest</a></td>
<td class="text">7 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options Exercisable</a></td>
<td class="text">6 years 7 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 199.0<span></span>
</td>
<td class="nump">$ 309.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options vested and expected to vest</a></td>
<td class="nump">199.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options Exercisable</a></td>
<td class="nump">$ 161.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652624167536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Equity-based compensation expense expected to be recognized over weighted average period</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized equity-based compensation expense</a></td>
<td class="nump">$ 18.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Stock options granted, weighted average grant-date fair values</a></td>
<td class="nump">$ 26.21<span></span>
</td>
<td class="nump">$ 23.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Equity-based compensation expense expected to be recognized over weighted average period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized equity-based compensation expense</a></td>
<td class="nump">$ 132.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member] | Nasdaq [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ClosingPriceOfCommonStock', window );">Closing stock price</a></td>
<td class="nump">$ 24.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ClosingPriceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Closing price of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ClosingPriceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_NASDAQIndexFutureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_NASDAQIndexFutureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652628261504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Weighted Average Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors (Details) - Stock Options [Member]<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">3.76%<span></span>
</td>
<td class="nump">1.85%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 29 days<span></span>
</td>
<td class="text">6 years 29 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">90.50%<span></span>
</td>
<td class="nump">96.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652634244128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-Based Compensation - Summary of Restricted Stock Activity (Details) (Details) - Restricted Stock Units [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested, Beginning balance | shares</a></td>
<td class="nump">18,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">570,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited | shares</a></td>
<td class="num">(30,737)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested, Ending balance | shares</a></td>
<td class="nump">559,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested, Beginning balance | $ / shares</a></td>
<td class="nump">$ 26.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted | $ / shares</a></td>
<td class="nump">34.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited | $ / shares</a></td>
<td class="nump">34.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested, Ending balance | $ / shares</a></td>
<td class="nump">$ 34.11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652628121808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (104,286)<span></span>
</td>
<td class="num">$ (68,294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_EarningsPerShareOtherDisclosuresAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in calculating net loss per share, basic</a></td>
<td class="nump">156,648,365<span></span>
</td>
<td class="nump">147,984,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in calculating net loss per share, diluted</a></td>
<td class="nump">156,648,365<span></span>
</td>
<td class="nump">147,984,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="num">$ (0.46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (0.67)<span></span>
</td>
<td class="num">$ (0.46)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_EarningsPerShareOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings per share other disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_EarningsPerShareOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652629284768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Potential Dilutive Securities Excluded From Calculation of Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential dilutive securities excluded from calculation of net loss per share, total</a></td>
<td class="nump">26,450,089<span></span>
</td>
<td class="nump">17,930,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options Outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential dilutive securities excluded from calculation of net loss per share, total</a></td>
<td class="nump">18,419,224<span></span>
</td>
<td class="nump">17,901,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units Outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential dilutive securities excluded from calculation of net loss per share, total</a></td>
<td class="nump">559,117<span></span>
</td>
<td class="nump">14,270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cere_ESPPSharesIssuableMember', window );">ESPP Shares Issuable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential dilutive securities excluded from calculation of net loss per share, total</a></td>
<td class="nump">32,410<span></span>
</td>
<td class="nump">14,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember', window );">Common Stock Issuable Upon Conversion of the 2027 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential dilutive securities excluded from calculation of net loss per share, total</a></td>
<td class="nump">7,439,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cere_ESPPSharesIssuableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cere_ESPPSharesIssuableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652628376496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits', window );">Income tax benefits related to net operating losses incurred or research and development tax credits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax expense (benefit) related to net operating losses and tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652633622784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_LossOrMaterialCostsRelatedToIndemnificationObligation', window );">Loss or material costs related to indemnification obligation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ClaimsOutstanding', window );">Claims outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Liabilities related to obligation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ClaimsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ClaimsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_LossOrMaterialCostsRelatedToIndemnificationObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss or material costs related to indemnification obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_LossOrMaterialCostsRelatedToIndemnificationObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652629213408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>Director </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Director </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingReceived', window );">Percentage of funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ExpectedFundingReceived', window );">Funding expected to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ReceivedFunding', window );">Total funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,760,109<span></span>
</td>
<td class="nump">156,502,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cere_PfizerIncMember', window );">Pfizer Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,349,211<span></span>
</td>
<td class="nump">27,349,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_NumberOfMembersNominatedToBoardOfDirectors', window );">Number of members nominated to board of directors | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cere_BainInvestorMember', window );">Bain Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,632,356<span></span>
</td>
<td class="nump">60,632,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_NumberOfMembersNominatedToBoardOfDirectors', window );">Number of members nominated to board of directors | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cere_BainFundingAgreementMember', window );">Bain Funding Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingReceived', window );">Percentage of funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PeriodOverWhichFundingSupportReceived', window );">Period over which funding support received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_FundingCommitmentFeesIncurred', window );">Fees incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ExpectedFundingReceived', window );">Funding expected to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ReceivedFunding', window );">Total funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,800,000<span></span>
</td>
<td class="nump">$ 15,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cere_BainFundingAgreementMember', window );">Bain Funding Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingReceived', window );">Percentage of funding received</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ReceivedFunding', window );">Total funding received</a></td>
<td class="nump">$ 15,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cere_ResearchCollaborationAndLicenseAgreementMember', window );">Research Collaboration and License Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales', window );">Reimbursements for research services, contingent development milestone payment and single-digit royalty payments on net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cere_ManagementAgreementMember', window );">Management Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeeExpense', window );">Management fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ExpectedFundingReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected funding received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ExpectedFundingReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_FundingCommitmentFeesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Funding commitment fees incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_FundingCommitmentFeesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_NumberOfMembersNominatedToBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of members nominated to board of directors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_NumberOfMembersNominatedToBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_PercentageOfFundingReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of funding received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_PercentageOfFundingReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_PeriodOverWhichFundingSupportReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which funding support received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_PeriodOverWhichFundingSupportReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ReceivedFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Received funding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ReceivedFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reimbursements for research services and contingent development milestone payment and single-digit royalty payments on net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cere_PfizerIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cere_PfizerIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cere_BainInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cere_BainInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=cere_BainFundingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=cere_BainFundingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=cere_ResearchCollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=cere_ResearchCollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=cere_ManagementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=cere_ManagementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140652630294944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ReceivedFunding', window );">Total funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingReceived', window );">Percentage of funding received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Second Anniversaries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_ReceivedFunding', window );">Total funding received</a></td>
<td class="nump">$ 31.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cere_PercentageOfFundingReceived', window );">Percentage of funding received</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_PercentageOfFundingReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of funding received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_PercentageOfFundingReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cere_ReceivedFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Received funding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cere_ReceivedFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cere_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cere_SecondAnniversariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cere_SecondAnniversariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>cere-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cere="http://www.cerevel.com/20230331"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cere-20230331.xsd" xlink:type="simple"/>
    <context id="C_9eb38bce-595b-4efe-9ff4-a8a9196c17ff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_5b04eb63-d32d-4cf7-8974-ef0d2c24455d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_c8cfcc32-37ee-4a6c-b545-88aa98593ba7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="C_1dcf3112-c3d6-445f-a9b1-a8a6aff84cd0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_d2d20274-f65b-4fa5-8e5b-96f09f3d8fb8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_e73b579d-5fcf-44e9-b4bd-a01478ea5126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_4196d9fb-4e85-48d1-88b7-aefa2a19ebc8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_e18c341f-7f07-4b88-b7c8-d5a4564e49f7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="C_3cc8784c-e0c6-4b6a-85e8-a6747b0ab075">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_8a957d0a-6024-4753-9804-3a0360e90e6b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_623d5c61-4653-419b-bf3c-247bbbbcf873">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_ba176f35-ab1c-4a1b-9969-20f064b37357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_284250e0-ecad-485e-b02c-3498eba26ca3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cere:CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_55492269-e353-457a-9ac6-63c9a890f5a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_e2cf588c-4935-44e7-a87b-fcb9e12be2cd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b7ca6fdd-c4aa-4736-9d2f-d4a2eadbaeb1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_ab2f0a63-9c4c-4701-a647-f506a160b8d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestFundingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0729e16b-d27b-4daf-a728-90d90397b869">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:FirstAnniversariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_1cc94817-d461-46f2-8d51-8d0b51788032">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_4555fd95-af90-4446-9ef6-c7bf5c673ad1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d181ad3b-847c-47c7-bf08-243985685e37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="C_dffe9ddc-8c99-41f9-a548-0172f9e0b2c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestFundingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="C_4872d125-2e56-4840-bde3-171e61b545d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2ff3f43c-87c0-4d83-99a4-d515d051d791">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d24b1d9c-01d0-4045-a903-8d6fc008d906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_d05795e8-7fcc-4338-a3c6-f89d386c6435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestAndBainFundingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_db439bc0-f8f4-4c4e-9791-8b83a63b6885">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d68c6b2b-198c-4278-b56f-a68363510239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_40a019d3-e92f-4c7b-9557-6132ab2cd1c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_ca7f0c1c-48d7-455e-8ddc-e9b062b461a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_135ea648-306c-40d9-860b-a47360a9895c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_1972858f-eae0-4299-8170-ba14d09bef4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">cere:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_effc1829-ed70-4ee5-8e04-afb0f9066e16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5b90efb7-656c-4625-b566-b99e3e6f4649">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_c79a6dff-9b2a-4bbe-893e-f8d5995f53c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="C_75cbd078-eab8-4a1a-b86f-1ede351b764b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_99242e6a-e59a-4179-94bd-0b1937c5d461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestAndBainFundingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="C_dd4efdc2-f871-4164-b259-04d75db7dd0a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_9e127b71-4539-48d9-9d6b-1b9b6c4de7ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NASDAQIndexFutureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_2029d649-08bb-4a87-a177-143045bff540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:FirstAnniversariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="C_ecd82ae5-371b-498f-b1a6-1a95342b510d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_bc22ae5e-bffd-445a-9a22-d08330898d6b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_60585c7b-083d-43f2-85ea-156ce6ac7bb8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="C_70d32b8b-7e10-4e7b-864c-8890ec4855c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_2d54aabe-0480-4ce2-84e7-c3be541b8858">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">cere:PurchaserDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="C_2713ad4a-1c03-4894-a1bc-032d17c08682">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_549c1b5b-f5c0-43b3-aeb2-af8128f7fddd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">cere:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_f130d7e4-71de-45ed-8562-45858d825a2a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:SecondAnniversariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="C_529612ad-d864-4e48-8033-b7bbacbe0414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="C_834332ad-3dba-4592-8eb7-930c35444385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_54aef7f2-adfa-458b-a966-d50f782d3ddd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_abd57310-685b-4fc9-a762-295bbda69277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d374cc27-3d6a-4e93-87c5-2393b48f37f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:LongTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_d366786f-fe3c-4859-907c-c7fecd5cc013">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_bbe2ff29-60a6-4d1c-adfd-2653531ce2b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5bf423a6-8367-4279-bf95-e9c42308340c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_47e15855-977e-48e9-91e6-f3cd78249b53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_4d6806dd-95ea-4244-b45f-b725e95152fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_75c3c100-0b73-4ef8-af8d-e6ea2c2b07ee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_6d74330b-6d7c-493a-b8a3-9eb0e26049d9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputInceptionDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_1c59bb28-7d9d-41f1-a3e6-9fdb1e61a326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_3632aac0-7ea4-476f-ae3c-22fcfd7d2a0b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d4d1c9e3-62ea-42c4-ba8d-fcc51bb68150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestAndBainFundingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="C_12bb81cc-4118-4eec-9061-466a6e2d707f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_cee0bc25-bebb-4a35-9362-2d58a9e6a342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:LongTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_15c8f494-814b-44c7-b085-58997b57d0ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_5b514de5-a814-4d92-a947-476c997998cd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_62dad9f2-d603-4b31-9fef-bda26f8a826b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_a2a1794f-7768-4f98-8c78-709345fc1417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_77182ead-68f3-4560-a065-2b0a465b0858">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_7d230bc1-cefa-46e4-a861-24a211270b6e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">cere:MeasurementPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="C_7c3a2ba3-5a06-4c1a-8098-9614f0f55d00">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cere:ESPPSharesIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_d7e7b52c-2a39-4e61-89ff-8d10c8cb2f4b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_46d1eb9f-1608-412b-a122-ad9ff076c478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_33aaf712-2416-4ca9-a789-bdc80db6c833">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cere:AtmProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-10</startDate>
            <endDate>2021-11-10</endDate>
        </period>
    </context>
    <context id="C_45210d29-9cd0-45f9-a714-edc3c13d8747">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestAndBainFundingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="C_21573dc6-6769-41aa-991d-b0f72b895688">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_fec256c3-1d62-4da5-88de-9f274918ad60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_35f07075-ec20-4015-be83-0dc61fc1e438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_5d000a15-9017-476b-9666-76dc3f8dd464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_a4c793ea-57ae-4e0f-8312-eeac8baf5953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_2e9e51f7-25c0-4608-9ac4-8d13311a476a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cere:BainInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_4bf2f962-7b29-42b6-974d-afe70add4992">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="C_cad0267b-ea1e-4815-90e2-2028b29f8fc4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d0b1fde3-c686-4afd-a78c-adda507ab1d7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_f1ad0af9-f8fb-47b4-9d88-2f035f335eb7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_2ea39b76-7e86-4e9f-a3aa-1c43d8682c03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cere:FinancingLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_bdc36db1-2f84-4df3-9e62-252cc883a96c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_c19150ee-ddf1-4d6e-b02f-c9d1f4985998">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">cere:OtherOfferingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="C_0a7718ed-8940-4540-a71e-a8480e029877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_03207e80-ade5-41d3-ab71-391279e55fcc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">cere:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_533da935-ec87-4ed2-a0b1-6924af3f7975">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="C_6ce49664-9b3e-4193-9202-c337a0a78589">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_84a4ec65-be81-43b0-a2a8-aeab6b151380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cere:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_5f8f5a42-ba06-4506-a0cc-bf786204f23c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_4b64ecbc-3995-4a70-91be-00b3cba9da84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputInceptionDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_8e7da2d2-92f1-43a3-bb9a-1d0277243751">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_954014cb-1c62-40cc-b12d-3f0d6d59529e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_23d05b6e-4f80-4669-8884-9503ff410b15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_3479d27f-e186-4ab3-8410-a1a5d7ecfb11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_616d2b60-239d-4254-9414-de1400659e3e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestAndBainFundingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="C_174d7111-d0da-45ff-818a-2c32e6395735">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_67e3ff37-67dc-425c-9e5c-f367e23d4a36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_7e166e56-61db-491e-be50-d60c4a5deb31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">cere:MeasurementPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="C_ff391d2b-6167-4ca8-b599-0176b18ff847">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_27a1eff3-cd98-489c-bf8d-10b9567d6a6f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_9d7b2424-bafc-4343-b726-7e736ab93480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:ManagementAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_7913329b-0f1d-4200-bcd9-ef012e06c589">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cere:FinancingLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_b465d2c0-b208-43d9-8601-c79cda11d054">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_286de79d-0111-4ffc-942c-17519af10505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cere:AtmProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_e5a1da7f-71cc-44ee-bf79-5b4c0a66ac10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">cere:PfizerLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_89bb3f05-5b57-4cd0-a75d-a5ee2689d120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_f46ced43-7a95-48b1-a3d2-c0ef57876a31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">cere:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_4651d696-b2be-4638-8c92-24388e05ccf4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_a5c731ba-b89c-4f18-9704-24f50e1a5925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="C_5bed7e0c-dacd-4d4c-b250-020234b8f6be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_a1b4107b-3ed7-40e8-9ad5-1379b770ce94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_0cfe1f22-841b-4d40-be3c-5ab39c7eeed7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">cere:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_7926166c-1158-47a0-bad4-4df4c981c1ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cere:PfizerIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_e9e3b32d-3528-4ff7-ad8b-b7449522bd16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_14d54740-4fd0-463e-8f77-ee503f66ded0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_ddc57f0c-b90e-42fa-a10e-071a42e87507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cere:PfizerIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_ca5c0abd-f008-4c84-a189-a21791b234a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_8ac1ae72-06b1-4095-a857-71c8c60c5b47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:ThirdAnniversariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="C_ccf68073-2afb-4b1e-ab7c-853f69243b41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_5a48c315-c949-4b47-9d4e-d9576b76a0dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_a4ba2f01-2e93-4b42-9142-63c99321d789">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:SecondAnniversariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="C_ee2b045d-5198-451f-83dc-eabf28665da6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_c290d454-3c40-474b-a8cb-1192e1d1df68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_3b482e46-cc89-4ce5-85f5-a366efdf2856">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_47e87e92-f44a-4427-9ca3-b597abbae8dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cere:BainInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_be2d5f10-585c-4657-aa28-2c74500e83d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:NovaQuestFundingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_59a5c3ef-611c-4d06-809f-b96bb1ad592d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0b7810a3-d9b7-44b1-85d6-d1e3794eb8db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_476db5f8-cbfa-499e-9fce-a46c6af239cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_57afd6d7-6dec-4c48-81b7-57d06bc6ff76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:ResearchCollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_7297b579-f439-4a6b-92e5-a571272517af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cere:FinancingLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_92b2e51b-74ba-476d-a0bb-1a6c588851a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_516c25bf-7ea1-4aa4-a5d3-a5bed62d8860">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_4cf7a89b-841c-4850-9973-eddacfecc0f0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cere:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_fcc62a3a-53fa-4dc4-ae07-5eb1877c37d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_377cdbcd-01a6-4d76-a487-4dc2f01fee00">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cere:BainFundingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="C_899c628a-be1d-4d05-b35c-2e06c2ed5337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_8bc95105-86e8-4b58-bd13-577576fe83fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cere:ESPPSharesIssuableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_8c284975-2e05-4ee0-a774-8114aaf9d295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2e7c8a68-2e85-4e0d-844b-1b1c499fef1f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_68912430-91ed-4690-8c20-dc2d611fbea4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_bfd4f2a5-80b4-4cd6-9aa0-3d4d61332a45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_0cd9a4b8-d9bd-4d67-875a-67846552b346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cere:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_4929b4e3-f0dd-4495-b868-bcea2881f576">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_e16b464e-4443-4323-83d1-f03a4129c2e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_f76fd2db-e57c-466d-8c84-9a10342d867c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_a7ea4b46-178f-4956-8746-80498e54c789">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cere:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_c4a52621-de21-4dff-a35d-fe8c89899498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_47e0732b-5a0a-4840-a434-85dd5768ae62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_8de10066-7b96-4965-9078-908525b6b838">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_3e5cfe38-545f-4b20-972d-38ee76239160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_c61bf99f-af2e-40be-861d-98e1836d9630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_911f321f-1399-42d6-924b-a7af11513555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_f1a2b453-d388-477c-8259-cf29dcec39b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e39da301-bc58-44e7-8b68-aa3c32c22b3d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">cere:FinancingLiabilityRelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_a7fd9625-1e0b-4179-bd94-31438f3f9f0b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_03e49eb8-2103-485e-b8d0-fe702ee84736">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="C_d67b9c2b-3a7f-4577-b857-ad3a7dad44da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cere:ThirdAnniversariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="C_efca2e92-f443-4333-9998-77bef5b93ff9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_77c90c0f-d4ef-4cc7-bf3d-e8aba928ea56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cere:TwoThousandAndTwentySevenConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_72953f01-6eb8-48e3-9861-55ca4de20b51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="C_a2e21f3d-b1a6-4ed0-b2c3-cd5451e8a75c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001805387</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <unit id="U_USDollarShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_Director">
        <measure>cere:Director</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Instrument">
        <measure>cere:Instrument</measure>
    </unit>
    <unit id="U_Days">
        <measure>cere:Days</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_90652cbd-aba8-4da1-8f12-b942c9f78721">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_8b2f3ca7-5df0-4c8a-96a7-fab3196d2c54">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_5336dde7-7794-4979-8692-87d01f808589">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="C_7913329b-0f1d-4200-bcd9-ef012e06c589"
      id="F_1f0cf8c7-35f8-4a8d-a01c-7fb92edd3948">http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <dei:EntityCentralIndexKey
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_02e0c39f-59cf-48e1-9099-37cdf410d6fd">0001805387</dei:EntityCentralIndexKey>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      id="F_9feb81ed-2327-49d3-b434-e491e2b47f86"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      id="F_cb1cf151-7d70-41f6-97dd-2800ab13dd5b"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      id="F_6b4c346b-dbd4-43a8-9bdb-1f8c976acb19"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList
      contextRef="C_7913329b-0f1d-4200-bcd9-ef012e06c589"
      id="F_293c1bd4-3ed9-476f-92d6-7047da56d7a9">http://fasb.org/us-gaap/2022#OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList>
    <us-gaap:PreferredStockValue
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      id="F_8d1f5bfe-2f8b-4ace-a39c-60af1cf31d5c"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_75103e70-76a9-4576-8efc-1701f3c6a07a">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_75e94afe-87ac-4604-a944-756025ff41c2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_068733f9-afe1-4425-90ef-983bd4e168c7">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_abed7561-cf6f-4166-b930-2deb2d31eb0f">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_ac2375b2-66b6-4491-8f39-d62d696530e4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_4f715c8f-e906-4114-8007-34521c405442">001-39311</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_530c99dc-49bf-49b5-bdff-022bdf79555d">CEREVEL THERAPEUTICS HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_ac2f062c-e28e-48aa-86c6-9653e917e9db">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_0d1c50b4-bd1f-404d-8bf5-9f7308d125f6">85-3911080</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_1ee7fd72-9828-4f4d-9755-f51637b437d5">222 Jacobs Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_b6c74ff6-1e58-4745-87f9-978352323fdd">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_9bba832f-6732-41ea-9f33-267db529f89b">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_eea85f43-a2fc-42fa-b717-be4295e2f0de">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_8ef9b18a-9b24-4a10-b4a5-8b71a2b5db7d">02141</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_2219b12c-f8c5-4274-9b91-bbd0d1827727">844</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_9bfc661f-ee34-4872-bb77-729e90567a84">304-2048</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_ccf68073-2afb-4b1e-ab7c-853f69243b41"
      id="F_25a9cf9b-606d-4eb9-9434-cd990bf04756">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_ccf68073-2afb-4b1e-ab7c-853f69243b41"
      id="F_fa098cce-4251-4313-aa1f-1c10f192ec5f">CERE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_ccf68073-2afb-4b1e-ab7c-853f69243b41"
      id="F_28a75c17-c977-404e-a05c-3730150f28e8">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_19eae25a-c9b2-403f-89ec-7dc62afce01e">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_60583fd2-8d63-4843-8d80-3cf72edeb6a1">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_6781c756-bcaf-4473-9b24-df8b91e03f17">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_f76de658-f1d3-433c-ab78-5369c1c1471b">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_81226095-60fa-4880-bc27-4cb0f5e1eb55">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_56fea903-43e5-4933-a59c-9af7854ffece">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_03e49eb8-2103-485e-b8d0-fe702ee84736"
      decimals="INF"
      id="F_c9d6d9c3-8888-4b70-927e-cda75442daaf"
      unitRef="U_shares">156832992</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_cfbca051-bb0d-42d1-b430-38ee27267083"
      unitRef="U_USD">153816000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_b4b363ab-9bf0-4b82-ba49-faeee02ec7b2"
      unitRef="U_USD">136521000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_71f0dae9-3610-4f86-a16a-02762621695e"
      unitRef="U_USD">673171000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_37255516-423f-48cd-991d-5cfb433b6163"
      unitRef="U_USD">755509000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_1bbfc296-4d42-404d-84d0-e8b478f96967"
      unitRef="U_USD">13795000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_1ba2c285-529e-4e86-a6a9-c25c905955d4"
      unitRef="U_USD">13621000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_df75cff0-92d0-4ae1-8880-beea39a04721"
      unitRef="U_USD">840782000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_a0288849-d172-4e55-bc8c-0e84f3edd0c0"
      unitRef="U_USD">905651000</us-gaap:AssetsCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_b7f3abfa-807c-42bb-82de-4af107230275"
      unitRef="U_USD">36048000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_c6895d91-03e5-4868-a540-3ecab21f2196"
      unitRef="U_USD">58126000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_23e9a090-d40f-49ef-9b30-9d83f57770dd"
      unitRef="U_USD">27006000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_7fb3187c-6d18-4fe8-931f-af4a8c6c4d3d"
      unitRef="U_USD">27467000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_f2df0191-abcc-4c9d-8363-f5707f072526"
      unitRef="U_USD">21434000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_5827fd02-1a65-43e7-8924-64556effd591"
      unitRef="U_USD">21820000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_c38cc3d5-9301-4c76-9259-589b76254c7f"
      unitRef="U_USD">1867000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_b0927f6b-8f0a-400c-975e-e4f287d2ca38"
      unitRef="U_USD">1867000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_1c71a8a5-8dec-4468-a3f2-9a36a2ed5550"
      unitRef="U_USD">3208000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_6be01824-6f50-48d8-bf3d-a15b8e5b8a17"
      unitRef="U_USD">2891000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_4f7b79a2-3216-4473-a00b-b153c9972250"
      unitRef="U_USD">930345000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_0ad325df-d2b3-49e9-b73d-e2659212f2f8"
      unitRef="U_USD">1017822000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_26802546-d14b-4901-9658-128374b6ad2c"
      unitRef="U_USD">7315000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_9afbd405-404a-480b-8ef9-d5e22593c331"
      unitRef="U_USD">10061000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_8671cfbc-4e6b-47fa-b978-701b479936df"
      unitRef="U_USD">52614000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_6567461d-fce8-40c9-9530-dd0dccef0dd6"
      unitRef="U_USD">59604000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_19a1efa0-0dee-4979-8050-9e6b8bda602c"
      unitRef="U_USD">3028000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_96a3d632-d0ef-41fe-a68d-bfd91c4bd283"
      unitRef="U_USD">2899000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_f56bfeb8-bdc9-4772-b29b-0c486167c4f7"
      unitRef="U_USD">62957000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_73553e36-0182-443b-b549-b79fa9727754"
      unitRef="U_USD">72564000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_93d9b518-bf29-417b-81b1-f5de532759af"
      unitRef="U_USD">30381000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_8ae2d2cc-06bc-455a-9630-c109e31c1c2b"
      unitRef="U_USD">31190000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <cere:NoncurrentFinancingLiabilityRelatedParty
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_832d5ba0-eb11-4167-a1ed-bf3d7d5f6d2c"
      unitRef="U_USD">34668000</cere:NoncurrentFinancingLiabilityRelatedParty>
    <cere:NoncurrentFinancingLiabilityRelatedParty
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_684599c6-b7a2-44cf-ad9a-6caf0d9a774e"
      unitRef="U_USD">28674000</cere:NoncurrentFinancingLiabilityRelatedParty>
    <cere:NoncurrentFinancingLiability
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_6d716446-a3ea-4f2c-9720-278fac3bd6cd"
      unitRef="U_USD">34668000</cere:NoncurrentFinancingLiability>
    <cere:NoncurrentFinancingLiability
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_7dea0715-1449-43d0-ad7f-6c5acbdc4879"
      unitRef="U_USD">28674000</cere:NoncurrentFinancingLiability>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_5ea6818f-c02b-4c72-9ee3-dd00421bc5ae"
      unitRef="U_USD">335962000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_6276d808-3c32-4743-83a2-c635b131c150"
      unitRef="U_USD">335482000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_623beedc-b673-4e44-8238-7c70f0c5c4c5"
      unitRef="U_USD">498636000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_f5cb2647-2de4-4a6b-8c5d-436f1f6bbffa"
      unitRef="U_USD">496584000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_ad02f887-8569-4803-8fa1-215145cf0deb"
      unitRef="U_USDollarShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_e601acf8-8cb6-4cca-8e45-e76692c76712"
      unitRef="U_USDollarShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_3281a38c-f5eb-4a6d-b115-675fea11b893"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_33e34c55-556b-427f-990c-7e4f614ca8e7"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_ee0576ee-4c80-4baf-9791-51938f73dd7b"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_2e550b59-90c1-480c-9233-cd6232b0e330"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_84775c1b-4376-459b-bcfa-362711261f60"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_6b202d58-975b-41a2-968d-c9b7ce7e070a"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_aec28300-8f6b-44c9-aa0a-806b2cfa9574"
      unitRef="U_USDollarShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_0e582e10-5497-48cb-8884-bf27a7e5fb96"
      unitRef="U_USDollarShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_9d1103d1-f1e0-454f-9c08-975ee953700a"
      unitRef="U_shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_18b71a3e-9a27-49ba-a60e-246089016ac9"
      unitRef="U_shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_73d342e3-91d7-4e77-9d9e-9f9ee5b4a887"
      unitRef="U_shares">156760109</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_fbc700ae-f0c3-453b-a8c6-9f5660e23fd9"
      unitRef="U_shares">156760109</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_a95f4944-33e1-4763-915e-37f483aa621d"
      unitRef="U_shares">156502285</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_cb3bf84f-791c-4ef5-8211-0edcf464edc3"
      unitRef="U_shares">156502285</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_f37d2159-0cc2-4a27-964b-fefa105efddd"
      unitRef="U_USD">16000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_82e58756-259d-4dcd-8ccd-cf80dc70d18f"
      unitRef="U_USD">16000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_ead3025b-1f8a-4b7d-b302-6fb06b4ed818"
      unitRef="U_USD">1500046000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_58695340-5705-4d2c-ac6a-5239ee6d6a1e"
      unitRef="U_USD">1485880000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_dc9e5b43-123b-425c-987f-d800d055264d"
      unitRef="U_USD">3688000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_56ada548-aac1-4853-92fd-28f6cfaa82f9"
      unitRef="U_USD">3097000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_c035bfa1-cdf6-4459-80cc-da3b844b0ddc"
      unitRef="U_USD">-1072041000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_b0f4fe91-00f5-4349-9e62-ca5702cdf4cd"
      unitRef="U_USD">-967755000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_0804a877-b0cb-4407-aff6-573d46e0851a"
      unitRef="U_USD">431709000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_f4e94a6c-39d7-4e0a-bcf9-fd4e87a09569"
      unitRef="U_USD">521238000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_4c7543e9-2643-4080-ada2-1cb1492378d7"
      unitRef="U_USD">930345000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_8d55e0a5-f927-4d89-82ed-161dc474a606"
      unitRef="U_USD">1017822000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_cdb66670-ce73-4215-a838-e169bdb14f29"
      unitRef="U_USD">78181000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_63195a2a-83f9-4d5a-bcdd-2336c47a1412"
      unitRef="U_USD">55023000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_f2faa554-64e0-46cc-a274-b98abfa11756"
      unitRef="U_USD">21370000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_b3e10127-2795-463c-883c-3a54790b5f7b"
      unitRef="U_USD">17507000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_48f2efb3-f7a3-4d1c-bede-dbc6f27a9968"
      unitRef="U_USD">99551000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_77b51da4-085e-416c-8537-61e01ba1740f"
      unitRef="U_USD">72530000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_54a01dd8-5e04-41e6-a642-a436f2c87c97"
      unitRef="U_USD">-99551000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_c24d952e-c52c-4e21-b4c1-0ea706da0635"
      unitRef="U_USD">-72530000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_de8cb691-f0e1-40aa-86f6-894df1611d44"
      unitRef="U_USD">6440000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_acd75dae-f7f0-435d-a00a-604e4a1f5b85"
      unitRef="U_USD">295000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_3f34e9fa-2050-456a-8e5a-555fe2952ad9"
      unitRef="U_USD">-11090000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_b88e1435-0670-4bac-811f-1d337fc805fd"
      unitRef="U_USD">3941000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_dfe149b2-a97d-440a-a2b4-6a1af6e84057"
      unitRef="U_USD">-104201000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_2261be07-35b4-4e4e-869e-1d4c3550fbdb"
      unitRef="U_USD">-68294000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_9e3097a7-e153-49a4-b55c-6dbfb03abf0c"
      unitRef="U_USD">85000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_32f3a1a3-d6dd-4104-9260-c6099fad0a50"
      unitRef="U_USD">-104286000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_46e60938-ecf0-45cc-b0df-273b70b93999"
      unitRef="U_USD">-68294000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="2"
      id="F_31573b50-bca5-4408-8009-acd7056d7fb4"
      unitRef="U_USDollarShare">-0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="2"
      id="F_a2654d77-6eba-4b67-bee8-9485636e9cb3"
      unitRef="U_USDollarShare">-0.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="2"
      id="F_fd4f78ac-e889-4954-8d13-e2d9f294dcb3"
      unitRef="U_USDollarShare">-0.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="2"
      id="F_b9c04907-8244-4548-a95a-932095b589f3"
      unitRef="U_USDollarShare">-0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="0"
      id="F_f522bc3a-5f11-40d5-9020-6e35bfe1c4f6"
      unitRef="U_shares">156648365</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="0"
      id="F_1ea41f45-dcf9-466a-b366-9ee856350c71"
      unitRef="U_shares">156648365</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="0"
      id="F_bce14634-9cd3-4639-8d68-17eee2bc0a81"
      unitRef="U_shares">147984926</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="0"
      id="F_7d46053c-76b1-42ec-bf52-b43ea7ad317e"
      unitRef="U_shares">147984926</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_38af907c-6782-453b-a16b-314e4c48a303"
      unitRef="U_USD">-104286000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_b1dc4b61-4e35-4327-bc25-462d23fc8a3c"
      unitRef="U_USD">-68294000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_37c69656-0861-4d9a-99a2-635bbfffab02"
      unitRef="U_USD">-906000</us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_23e4d695-2798-4711-b065-7743e1efa7f4"
      unitRef="U_USD">1276000</us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_bcbef964-e4ae-4418-afc1-3de952194070"
      unitRef="U_USD">1497000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_17dfb59c-a325-4952-b2a7-d66ee5e162d7"
      unitRef="U_USD">-1624000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_1baecce5-4411-4216-9d16-88c7dccd1167"
      unitRef="U_USD">591000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_5e9a690e-bc6d-4c5e-aec0-4f9464ba3f75"
      unitRef="U_USD">-348000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_55c8e0e7-fb95-45ee-b133-5a98b7b68127"
      unitRef="U_USD">-103695000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_c0f47288-5280-4184-8103-bbe2012bbbe1"
      unitRef="U_USD">-68642000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="C_62dad9f2-d603-4b31-9fef-bda26f8a826b"
      decimals="0"
      id="F_73571c5e-30fd-4fd3-b831-121db6f409a6"
      unitRef="U_shares">156502285</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_62dad9f2-d603-4b31-9fef-bda26f8a826b"
      decimals="-3"
      id="F_5b73b79b-793a-4104-ada1-af32e3b3475e"
      unitRef="U_USD">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_cad0267b-ea1e-4815-90e2-2028b29f8fc4"
      decimals="-3"
      id="F_b7a15b3e-1e5a-4e8c-9e8f-2afea543132f"
      unitRef="U_USD">1485880000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3632aac0-7ea4-476f-ae3c-22fcfd7d2a0b"
      decimals="-3"
      id="F_217cdc74-f31d-4af5-b7f7-d98219256d97"
      unitRef="U_USD">3097000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_bbe2ff29-60a6-4d1c-adfd-2653531ce2b5"
      decimals="-3"
      id="F_46652bd5-78e9-41f9-aa80-1c5d69a6f642"
      unitRef="U_USD">-967755000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_ff555382-bef5-4a3c-bae9-269fb0e8d515"
      unitRef="U_USD">521238000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_ccf68073-2afb-4b1e-ab7c-853f69243b41"
      decimals="0"
      id="F_7ed34278-bd6d-4c4d-acab-d928fe9c7760"
      unitRef="U_shares">257824</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_47e15855-977e-48e9-91e6-f3cd78249b53"
      decimals="-3"
      id="F_59f4ef4e-0b2e-4c9d-97ba-0a4b5d1da8ec"
      unitRef="U_USD">1574000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_d69c4310-282d-4a60-b448-abf82d0dca5d"
      unitRef="U_USD">1574000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_47e15855-977e-48e9-91e6-f3cd78249b53"
      decimals="-3"
      id="F_91e3bbae-00d6-4f22-ad89-b2954f1ddc7c"
      unitRef="U_USD">12592000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_dae2af9e-7bfe-4325-84c4-9d8b9d382224"
      unitRef="U_USD">12592000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_75c3c100-0b73-4ef8-af8d-e6ea2c2b07ee"
      decimals="-3"
      id="F_6a4418cb-b862-46b8-8a75-bbcf96ac0140"
      unitRef="U_USD">591000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_39e9ff96-41a7-4d74-a697-bcb5df3382ae"
      unitRef="U_USD">591000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_5a48c315-c949-4b47-9d4e-d9576b76a0dc"
      decimals="-3"
      id="F_ffde6315-dc76-4729-ba97-99d4cfdb5152"
      unitRef="U_USD">-104286000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_d292d3a9-a14d-4834-b14d-790c08f7f37d"
      unitRef="U_USD">-104286000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_135ea648-306c-40d9-860b-a47360a9895c"
      decimals="0"
      id="F_ebc8f0c3-3502-40e6-b5b6-3df7aa693110"
      unitRef="U_shares">156760109</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_135ea648-306c-40d9-860b-a47360a9895c"
      decimals="-3"
      id="F_cc4ccac5-07ef-4068-9c81-d982c3a14158"
      unitRef="U_USD">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_2e7c8a68-2e85-4e0d-844b-1b1c499fef1f"
      decimals="-3"
      id="F_97042799-5ec5-4aa9-a66b-462abe1fca19"
      unitRef="U_USD">1500046000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_70d32b8b-7e10-4e7b-864c-8890ec4855c4"
      decimals="-3"
      id="F_c77c6c65-3163-49b9-8f1f-868534ae5b09"
      unitRef="U_USD">3688000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3cc8784c-e0c6-4b6a-85e8-a6747b0ab075"
      decimals="-3"
      id="F_2280f85f-6edb-4408-986c-e5480b91c1ac"
      unitRef="U_USD">-1072041000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_8ac9def5-f321-4dce-9db7-3695de28bd9e"
      unitRef="U_USD">431709000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_516c25bf-7ea1-4aa4-a5d3-a5bed62d8860"
      decimals="0"
      id="F_b498f660-1dc4-4ad4-83a7-eb815e7d65ea"
      unitRef="U_shares">147719523</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_516c25bf-7ea1-4aa4-a5d3-a5bed62d8860"
      decimals="-3"
      id="F_a1909352-9bc8-4c08-859b-484dcfec0f42"
      unitRef="U_USD">15000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_bdc36db1-2f84-4df3-9e62-252cc883a96c"
      decimals="-3"
      id="F_37b9e594-5f18-48fd-bf7d-33b3b42f94f9"
      unitRef="U_USD">1195944000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_ff391d2b-6167-4ca8-b599-0176b18ff847"
      decimals="-3"
      id="F_45d17ed5-15c5-4503-9a48-7d0da4477330"
      unitRef="U_USD">-986000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0b7810a3-d9b7-44b1-85d6-d1e3794eb8db"
      decimals="-3"
      id="F_61a68d85-41e6-45e3-9b68-ffbefe5977e0"
      unitRef="U_USD">-616244000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f1a2b453-d388-477c-8259-cf29dcec39b2"
      decimals="-3"
      id="F_e9fdb32a-a8cb-49c2-8e4f-5c2aa6673413"
      unitRef="U_USD">578729000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_d24b1d9c-01d0-4045-a903-8d6fc008d906"
      decimals="0"
      id="F_8eca41a4-3bf9-4afc-bf0b-13f8c39eff64"
      unitRef="U_shares">14270</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_d24b1d9c-01d0-4045-a903-8d6fc008d906"
      decimals="0"
      id="F_d7538594-68fd-47fd-b36b-066289330c0b"
      unitRef="U_shares">449005</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_35f07075-ec20-4015-be83-0dc61fc1e438"
      decimals="-3"
      id="F_6904727e-64c8-49af-b7d0-2e19f3c96dd6"
      unitRef="U_USD">2854000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_2e901979-5dce-4f68-8c01-6bd2b73d1116"
      unitRef="U_USD">2854000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_35f07075-ec20-4015-be83-0dc61fc1e438"
      decimals="-3"
      id="F_91f1889e-d09e-4f4e-be04-9d2870c27693"
      unitRef="U_USD">8558000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_982f7cbe-f71f-4b5c-8e1e-c617a6e28459"
      unitRef="U_USD">8558000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_d366786f-fe3c-4859-907c-c7fecd5cc013"
      decimals="-3"
      id="F_8d0189b2-d1a2-4274-a4cb-7ee777205ed5"
      unitRef="U_USD">-348000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_d1f01081-b651-4875-b052-26bdf90dd7d6"
      unitRef="U_USD">-348000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_77182ead-68f3-4560-a065-2b0a465b0858"
      decimals="-3"
      id="F_ebd73770-45e9-41c9-8010-c4bef2f58370"
      unitRef="U_USD">-68294000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_bf28d674-d162-49fe-819c-7226a9e79b0d"
      unitRef="U_USD">-68294000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_9eb38bce-595b-4efe-9ff4-a8a9196c17ff"
      decimals="0"
      id="F_ffd3349e-ae2b-44dc-a7d8-fd08bd8ecb68"
      unitRef="U_shares">148182798</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_9eb38bce-595b-4efe-9ff4-a8a9196c17ff"
      decimals="-3"
      id="F_e802b9b7-8f6a-4530-bab2-5b8dba63f5bc"
      unitRef="U_USD">15000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3479d27f-e186-4ab3-8410-a1a5d7ecfb11"
      decimals="-3"
      id="F_4a6d828f-6b0e-4f02-bb42-b83721a4231f"
      unitRef="U_USD">1207356000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_5d000a15-9017-476b-9666-76dc3f8dd464"
      decimals="-3"
      id="F_b8009b62-cc43-4aaf-96fd-fa92f03c5fcc"
      unitRef="U_USD">-1334000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1dcf3112-c3d6-445f-a9b1-a8a6aff84cd0"
      decimals="-3"
      id="F_0151f93a-5d29-43a4-91e3-0216ff491f7d"
      unitRef="U_USD">-684538000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b"
      decimals="-3"
      id="F_a068ac64-88a4-4828-ac7b-a9c048aae697"
      unitRef="U_USD">521499000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_a25a1e5a-1002-4df4-80ef-029f9fc63750"
      unitRef="U_USD">-104286000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_3f253b70-df7f-4bfb-b010-364f09c6b4bd"
      unitRef="U_USD">-68294000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_95c8728c-9762-4b12-a2d3-a27025033394"
      unitRef="U_USD">1321000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_00cc287d-742d-403e-babb-acd37a1d490b"
      unitRef="U_USD">1118000</us-gaap:DepreciationDepletionAndAmortization>
    <cere:AdjustmentsToOperatingLeaseExpense
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_7b402b05-eb37-44ca-b63d-9d4b2c1e70d5"
      unitRef="U_USD">280000</cere:AdjustmentsToOperatingLeaseExpense>
    <cere:AdjustmentsToOperatingLeaseExpense
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_24b3de8c-0da9-4681-84df-e0bd570678eb"
      unitRef="U_USD">236000</cere:AdjustmentsToOperatingLeaseExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_ba2af994-1372-45a8-b4d3-a9ae153d4bbb"
      unitRef="U_USD">12592000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_a093754c-6e68-452b-89cc-bbb40e00b58b"
      unitRef="U_USD">8558000</us-gaap:ShareBasedCompensation>
    <cere:ChangeInFairValueOfFinancingLiability
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_ca66c1f3-f2e1-4d3c-9410-5ba0a0d9d281"
      unitRef="U_USD">11082000</cere:ChangeInFairValueOfFinancingLiability>
    <cere:ChangeInFairValueOfFinancingLiability
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_8d1adbed-f4c1-4b2a-afee-65b6e513889f"
      unitRef="U_USD">-3940000</cere:ChangeInFairValueOfFinancingLiability>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_2bdf05d7-61b3-44a6-a0d9-406afed977cf"
      unitRef="U_USD">480000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_5f90bce1-724c-4a85-8564-5013d6205354"
      unitRef="U_USD">5206000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_b24e40be-d060-4ed5-94a9-d5797f4a3158"
      unitRef="U_USD">-553000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_65462eff-0535-48a6-b353-b34b2ec92819"
      unitRef="U_USD">8000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_9774ce2e-1191-44bb-baa0-7c5cce5981c7"
      unitRef="U_USD">147000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_bdb3d168-d06e-4137-868e-972f1d22f0d7"
      unitRef="U_USD">-1811000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_b595a4a2-efd5-44e9-aa2d-204cbcedf9e5"
      unitRef="U_USD">440000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_853eb2db-d891-4d26-b26e-2eb9ba054842"
      unitRef="U_USD">106000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_803ce0ca-60a9-4eeb-a5bd-497d4e9ea79d"
      unitRef="U_USD">-2768000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_8d8047e0-4f89-41b5-bcff-279eb000cd39"
      unitRef="U_USD">-2499000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_cb939449-553f-4987-9e61-808c6c3ad94a"
      unitRef="U_USD">-7263000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_b57ec675-6c33-4b3d-abfd-3539f7c65e56"
      unitRef="U_USD">-4613000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_e52546c5-64ac-4222-b4e2-d536a87f5bca"
      unitRef="U_USD">-94923000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_6ace786d-ff35-46ec-a30a-a057b4fb3e2d"
      unitRef="U_USD">-67648000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_3f938335-22e4-44d6-9164-e61bea65fae7"
      unitRef="U_USD">187631000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_68d81b09-1c6f-459d-8e35-55c6c9945bfe"
      unitRef="U_USD">60242000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_c369883f-8a0d-4fd8-b39a-5ed435fba68f"
      unitRef="U_USD">298750000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_b20533fd-db4e-4329-9b96-afcef6003e07"
      unitRef="U_USD">23897000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_afc77d06-0f65-410f-bcff-56b368e3f8c4"
      unitRef="U_USD">336000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_d2e1deec-0007-46e1-ac0d-ea6d808629a2"
      unitRef="U_USD">2197000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_7ed8d02d-5869-48ed-9f7b-86d8e62d29a7"
      unitRef="U_USD">110783000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_af6dcbbc-ab10-4855-844a-91b161d1c46f"
      unitRef="U_USD">-38542000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_6a0f2f1d-59fd-491f-b6b6-0fd5196b59bd"
      unitRef="U_USD">1574000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_749ab798-ba34-4c53-b711-21b78423f62d"
      unitRef="U_USD">2854000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_75b8cb32-387c-476c-b0e8-47c1ea44ed26"
      unitRef="U_USD">139000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_e501587f-8416-45bc-80d3-3c0a074d330e"
      unitRef="U_USD">251000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_99869ea2-4f26-4f03-b7fb-d4b7c798e0ea"
      unitRef="U_USD">1435000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_3d463699-42c2-4978-a165-07930aa80936"
      unitRef="U_USD">2603000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_75c1e45b-399a-4106-8739-960a01e35b56"
      unitRef="U_USD">17295000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_fdabbd89-ccc9-40eb-b18e-36f5e832326e"
      unitRef="U_USD">-103587000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_17291517-6e93-4818-bcca-b9cb2a111bdc"
      unitRef="U_USD">138388000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_f1a2b453-d388-477c-8259-cf29dcec39b2"
      decimals="-3"
      id="F_4b3c1f81-f42a-4ac0-bd6e-ddc428bef886"
      unitRef="U_USD">197218000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_8a0c8036-788c-42ea-8f47-21ae6a33a724"
      unitRef="U_USD">155683000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b"
      decimals="-3"
      id="F_f31044be-aed5-4d7c-aa92-29f1e4fbb32f"
      unitRef="U_USD">93631000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_21c6824b-2bb7-4891-9eb9-8338e210c10f"
      unitRef="U_USD">153816000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b"
      decimals="-3"
      id="F_ac7687a6-7fc9-4774-b0e2-a0e04812f5db"
      unitRef="U_USD">91764000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_4355bc90-1f66-47fa-a490-925d54b9c2ec"
      unitRef="U_USD">1867000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b"
      decimals="-3"
      id="F_d0910b8e-c44e-454e-8400-109801e2ead1"
      unitRef="U_USD">1867000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_bdec2803-b9f0-41bf-b9b1-f2a4e7e7ba5c"
      unitRef="U_USD">155683000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_4bde0c95-124a-46b7-8a34-cddcb1fe955b"
      decimals="-3"
      id="F_fa8c2a3c-56b8-4851-a891-70a953711d9a"
      unitRef="U_USD">93631000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_adc921a0-cbc2-4e82-b32b-50f49843287c"
      unitRef="U_USD">4289000</us-gaap:InterestPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_fc4daf4e-bff0-4f34-b3a6-7dd0dc6993ab"
      unitRef="U_USD">779000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_4076a59f-6895-4838-a4e6-06af2cdda739"
      unitRef="U_USD">731000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:NatureOfOperations
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_3e7f970b-316c-4fe2-8d91-0aac798a7047">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1. Nature of Operations&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unless the context otherwise requires, references in these notes to &#x201c;Cerevel,&#x201d; &#x201c;the company,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d; and any related terms are intended to mean Cerevel Therapeutics Holdings, Inc. and its consolidated subsidiaries.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We are a clinical-stage biopharmaceutical company pursuing a targeted approach to neuroscience that combines a deep understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. We seek to transform the lives of patients through the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer's disease psychosis, epilepsy, panic disorder and Parkinson&#x2019;s disease. We are advancing our extensive and diverse pipeline with numerous clinical trials underway or planned, including three ongoing Phase 3 trials and an open-label extension trial for tavapadon in Parkinson's, two ongoing Phase 2 trials and an open-label extension trial for emraclidine in schizophrenia, an ongoing Phase 2 proof-of-concept trial and an open-label extension trial for darigabat in focal epilepsy and a planned Phase 2 proof-of-concept trial for darigabat in panic disorder.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For additional information on our formation, please read Note 1, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Nature of Operations&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 (our Annual Report).&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <cere:RisksAndLiquidityTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_0e90a12a-0a8f-4724-aa97-2df5e2e8b891">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2. Risks and Liquidity&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We are subject to risks and uncertainties common to clinical-stage companies in the biopharmaceutical industry. These risks include, but are not limited to, the introduction of new products, therapies, standards of care or new technological innovations, our ability to obtain and maintain adequate protection for our in-licensed technology, data or other intellectual property and proprietary rights and compliance with extensive government regulation and oversight. In addition, we are dependent upon the services of our employees, including key personnel, consultants, third-party contract research organizations (CROs), third-party contract manufacturing organizations (CMOs) and other third-party organizations.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Our product candidates, currently under development or that we may develop, will require significant additional research and development efforts, including extensive clinical testing and regulatory approval prior to commercialization. These efforts require significant amounts of additional capital, adequate personnel infrastructure and extensive compliance and reporting capabilities. There can be no assurance that our research and development activities will be successfully completed, that adequate protection for our licensed or developed technology will be obtained and maintained, that products developed will obtain necessary government regulatory approval or that any approved products will be commercially viable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Our unaudited condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets and the satisfaction of liabilities in the ordinary course of business. We have incurred significant operating losses since our inception and, as of March 31, 2023, had not yet generated revenues. In addition, we anticipate that our expenses will increase significantly in connection with our ongoing activities to support our research, discovery and clinical development efforts and we expect to continue to incur significant expenses and operating losses for the foreseeable future.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We have funded our operations primarily with the net proceeds received from the issuance of preferred stock, common stock and convertible senior notes, net proceeds from the consummation of our Business Combination (as defined in Note 15, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Related Parties&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to these unaudited condensed consolidated financial statements), and our Funding Agreements (as defined in Note 5, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financing Liabilities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to these unaudited condensed consolidated financial statements). We believe that our available cash, cash equivalent and marketable securities as of March 31, 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, will enable us to fund our operating expense and capital expenditure requirements through at least 12 months from the issuance date of these financial statements.&lt;/span&gt;&lt;/p&gt;</cere:RisksAndLiquidityTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_b61e36fa-214e-4c6b-8950-2afcccf6b97e">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3. Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying unaudited condensed consolidated financial statements include those of the company and its subsidiaries, Cerevel Therapeutics, Inc., Cerevel Therapeutics, LLC and Cerevel MA Securities Corp., after elimination of all intercompany accounts and transactions. The accompanying unaudited condensed consolidated financial statements and notes hereto have been prepared in conformity with the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting and, therefore, omit or condense certain footnotes and other information normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) as set forth in the Financial Accounting Standards Board&#x2019;s (FASB) accounting standards codification. Any reference in these notes to applicable guidance is&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Update (ASU) of the FASB.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In the opinion of management, all adjustments necessary for a fair statement of the financial information, which are of a normal and recurring nature, have been made for the interim periods reported. Results of operations for the three months ended March 31, 2023 and 2022, are not necessarily indicative of the results for the entire fiscal year or any other period. Our unaudited condensed consolidated financial statements for the three months ended March 31, 2023 and 2022, have been prepared on the same basis as and should be read in conjunction with our audited consolidated financial statements and notes included in our Annual Report.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, the fair value of our financing liabilities, the fair value of stock options, the accrual for research and development expense and the recoverability of our net deferred tax assets and the related valuation allowance. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors and adjust those estimates and assumptions when facts and circumstances change. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In connection with our entering into the lease agreement for our headquarters in Cambridge, MA, in July 2019, we were required to provide a security deposit in the form of a letter of credit. We have classified this amount as restricted cash in our condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For additional information related to our other significant accounting policies, please read Note 4, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to our audited consolidated financial statements included in our Annual Report.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the company as of the specified effective date. Unless otherwise discussed, the company believes that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_d416ff58-b6d1-4734-b3e2-07b7c039c226">&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying unaudited condensed consolidated financial statements include those of the company and its subsidiaries, Cerevel Therapeutics, Inc., Cerevel Therapeutics, LLC and Cerevel MA Securities Corp., after elimination of all intercompany accounts and transactions. The accompanying unaudited condensed consolidated financial statements and notes hereto have been prepared in conformity with the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial reporting and, therefore, omit or condense certain footnotes and other information normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) as set forth in the Financial Accounting Standards Board&#x2019;s (FASB) accounting standards codification. Any reference in these notes to applicable guidance is&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Update (ASU) of the FASB.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In the opinion of management, all adjustments necessary for a fair statement of the financial information, which are of a normal and recurring nature, have been made for the interim periods reported. Results of operations for the three months ended March 31, 2023 and 2022, are not necessarily indicative of the results for the entire fiscal year or any other period. Our unaudited condensed consolidated financial statements for the three months ended March 31, 2023 and 2022, have been prepared on the same basis as and should be read in conjunction with our audited consolidated financial statements and notes included in our Annual Report.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_5d455974-387b-4030-a004-4f02adb493f6">&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, the fair value of our financing liabilities, the fair value of stock options, the accrual for research and development expense and the recoverability of our net deferred tax assets and the related valuation allowance. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors and adjust those estimates and assumptions when facts and circumstances change. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_615c9ecc-f922-4fbb-863e-8a02f970dbf4">&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In connection with our entering into the lease agreement for our headquarters in Cambridge, MA, in July 2019, we were required to provide a security deposit in the form of a letter of credit. We have classified this amount as restricted cash in our condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For additional information related to our other significant accounting policies, please read Note 4, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to our audited consolidated financial statements included in our Annual Report.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_2299a034-b28d-4f5e-bc13-e04e80b59387">&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the company as of the specified effective date. Unless otherwise discussed, the company believes that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <cere:LicenseAgreementTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_a7f87ee9-a447-4205-a2ca-43640f69027f">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4. Pfizer License Agreement&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In August 2018, we entered into a license agreement with Pfizer (the Pfizer License Agreement) pursuant to which we were granted an exclusive, sublicensable, worldwide license under certain Pfizer patent rights, and a non-exclusive, sublicensable, worldwide license under certain Pfizer know-how to develop, manufacture and commercialize certain compounds and products, which currently constitute substantially all of our asset portfolio, in the field of treatment, prevention, diagnosis, control and maintenance of all diseases and disorders in humans, subject to the terms and conditions of the Pfizer License Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under the Pfizer License Agreement, we are solely responsible for the development, manufacture, regulatory approval and commercialization of compounds and products in the field and we will pay Pfizer tiered royalties on the aggregate net sales during each calendar year, determined on a product-by-product basis, with respect to products under the Pfizer License Agreement, and we may pay potential milestone payments to Pfizer, based on the successful achievement of certain regulatory and commercial milestones. To date, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; regulatory or commercial approval milestone payments or royalty payments have been made or become due under this agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For additional information related to our Pfizer License Agreement, please read Note 6, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Pfizer License Agreement, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;to our audited consolidated financial statements included in our Annual Report.&lt;/span&gt;&lt;/p&gt;</cere:LicenseAgreementTextBlock>
    <us-gaap:RoyaltyExpense
      contextRef="C_e5a1da7f-71cc-44ee-bf79-5b4c0a66ac10"
      decimals="INF"
      id="F_73b2284c-e17f-49cf-bf42-ceeb461340d7"
      unitRef="U_USD">0</us-gaap:RoyaltyExpense>
    <cere:RegulatoryApprovalMilestonePayments
      contextRef="C_e5a1da7f-71cc-44ee-bf79-5b4c0a66ac10"
      decimals="INF"
      id="F_546edad6-c042-4623-ad9e-940698449865"
      unitRef="U_USD">0</cere:RegulatoryApprovalMilestonePayments>
    <cere:CommercialApprovalMilestonePayments
      contextRef="C_e5a1da7f-71cc-44ee-bf79-5b4c0a66ac10"
      decimals="INF"
      id="F_d544fc76-d8e3-4a61-a6af-64d4941d82c2"
      unitRef="U_USD">0</cere:CommercialApprovalMilestonePayments>
    <us-gaap:FairValueOptionTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_6dbe210c-11f7-4d7c-b826-4d8ec3690cc9">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5. Financing Liabilities&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Funding Agreements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In April 2021, we entered into a funding agreement with NovaQuest Co-Investment Fund XVI, L.P. (NovaQuest and the NovaQuest Funding Agreement) and a funding agreement with BC Pinnacle Holdings, LP (Bain, the Bain Funding Agreement and, together with the NovaQuest Funding Agreement, the Funding Agreements), pursuant to which NovaQuest and Bain will provide funding to support our development of tavapadon for the treatment of Parkinson&#x2019;s disease.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under the terms of the Funding Agreements, we will receive up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in funding from each of NovaQuest and Bain, for a combined total of up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;125.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in funding (the Total Funding Commitment), of which approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;31.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the Total Funding Commitment, net of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of fees incurred by Bain and NovaQuest) was received in April 2021, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the Total Funding Commitment) was received in April 2022, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;31.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the Total Funding Commitment) was received in April 2023 and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the Total Funding Commitment) is expected to be received in April 2024, subject to certain customary funding conditions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In return&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, we agreed to pay NovaQuest and Bain significant regulatory milestone, sales milestone and royalty payments upon approval of tavapadon by the FDA that collectively will not exceed $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;531.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. In addition, we have the option to satisfy our payment obligations to NovaQuest and Bain upon the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;earlier of FDA approval or May 1, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, by paying an amount equal to the Total Funding Commitment multiplied by an initial factor of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;x. This factor will increase ratably over time up to a maximum of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;x, less amounts previously paid to NovaQuest and Bain.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We determined that each funding agreement represents a financial instrument that is considered to be a debt host containing embedded redemption features due to certain contingencies related to repayment. We elected to account for the Funding Agreements in accordance with the fair value option as permitted under ASC 825, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023 and December 31, 2022, the estimated fair value of the financing liability related to potential amounts payable to Bain under the Bain Funding Agreement, which is reflected in our condensed consolidated balance sheets as financing liability, related party, totaled approximately &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, 2023 and December 31, 2022, the estimated fair value of the financing liability related to potential amounts payable to NovaQuest under the NovaQuest Funding Agreement, which is reflected in our condensed consolidated balance sheets as financing liability, totaled approximately &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Changes in estimated fair value of the financing liabilities in our unaudited condensed consolidated statements of operations and comprehensive loss are summarized as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.716%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.719999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.719999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability, related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value recognized in other (income) expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;638&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value recognized in other (income) expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;638&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Changes in fair value attributable to instrument-specific credit risk were derived by benchmarking against the prior period credit spread to isolate the impact directly associated with the change in the credit spread utilized between periods.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For additional information related to our Funding Agreements, please read Note 8, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financing Liabilities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to our audited consolidated financial statements included in our Annual Report.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOptionTextBlock>
    <cere:ExpectedFundingReceived
      contextRef="C_dffe9ddc-8c99-41f9-a548-0172f9e0b2c2"
      decimals="-5"
      id="F_2310b23a-7900-4a95-a67d-9d4dfeb73a35"
      unitRef="U_USD">62500000</cere:ExpectedFundingReceived>
    <cere:ExpectedFundingReceived
      contextRef="C_529612ad-d864-4e48-8033-b7bbacbe0414"
      decimals="-5"
      id="F_c7368b03-61c7-441c-8596-62f46ebd11d3"
      unitRef="U_USD">62500000</cere:ExpectedFundingReceived>
    <cere:ExpectedFundingReceived
      contextRef="C_72953f01-6eb8-48e3-9861-55ca4de20b51"
      decimals="-5"
      id="F_a4d85026-927c-4e28-989e-8bf621ff6869"
      unitRef="U_USD">125000000.0</cere:ExpectedFundingReceived>
    <cere:ReceivedFunding
      contextRef="C_72953f01-6eb8-48e3-9861-55ca4de20b51"
      decimals="-5"
      id="F_75f103c1-9e75-4d41-bd3a-57680bd48f10"
      unitRef="U_USD">31100000</cere:ReceivedFunding>
    <cere:PercentageOfFundingReceived
      contextRef="C_a2e21f3d-b1a6-4ed0-b2c3-cd5451e8a75c"
      decimals="2"
      id="F_89e1ef91-29a5-4a69-993d-adf164d0a68c"
      unitRef="U_pure">0.25</cere:PercentageOfFundingReceived>
    <cere:FundingCommitmentFeesIncurred
      contextRef="C_45210d29-9cd0-45f9-a714-edc3c13d8747"
      decimals="-5"
      id="F_d5cb4d65-e7ac-4043-b3fb-0e2082cbd4ff"
      unitRef="U_USD">200000</cere:FundingCommitmentFeesIncurred>
    <cere:ExpectedFundingReceived
      contextRef="C_2029d649-08bb-4a87-a177-143045bff540"
      decimals="-5"
      id="F_53889d56-85e2-4a4b-8cb2-9fa688274169"
      unitRef="U_USD">37500000</cere:ExpectedFundingReceived>
    <cere:PercentageOfFundingReceived
      contextRef="C_0729e16b-d27b-4daf-a728-90d90397b869"
      decimals="2"
      id="F_a098cdbc-732e-4357-806c-c2fd3d4ed954"
      unitRef="U_pure">0.30</cere:PercentageOfFundingReceived>
    <cere:ExpectedFundingReceived
      contextRef="C_f130d7e4-71de-45ed-8562-45858d825a2a"
      decimals="-5"
      id="F_cbc8eefe-eac2-4226-9a6a-cbd325487ffc"
      unitRef="U_USD">31300000</cere:ExpectedFundingReceived>
    <cere:PercentageOfFundingReceived
      contextRef="C_a4ba2f01-2e93-4b42-9142-63c99321d789"
      decimals="2"
      id="F_060c8778-62af-493d-bce1-df5f8e0f2907"
      unitRef="U_pure">0.25</cere:PercentageOfFundingReceived>
    <cere:ExpectedFundingReceived
      contextRef="C_d67b9c2b-3a7f-4577-b857-ad3a7dad44da"
      decimals="-5"
      id="F_29798776-b442-4b86-98f3-b456d2c03793"
      unitRef="U_USD">25000000.0</cere:ExpectedFundingReceived>
    <cere:PercentageOfExpectedFundingReceived
      contextRef="C_8ac1ae72-06b1-4095-a857-71c8c60c5b47"
      decimals="2"
      id="F_26859e16-c3fc-4720-8f68-201bf36343b1"
      unitRef="U_pure">0.20</cere:PercentageOfExpectedFundingReceived>
    <cere:PayableOnFundingAgreement
      contextRef="C_616d2b60-239d-4254-9414-de1400659e3e"
      decimals="INF"
      id="F_a08d195c-ad34-42dc-8e3f-f01206f25a79"
      unitRef="U_USD">531300000</cere:PayableOnFundingAgreement>
    <cere:ContractualObligationDescriptionRepaymentTiming
      contextRef="C_d05795e8-7fcc-4338-a3c6-f89d386c6435"
      id="F_0e48a67e-0973-4b5f-86c6-ce0d10e0c630">earlier of FDA approval or May 1, 2025</cere:ContractualObligationDescriptionRepaymentTiming>
    <cere:PercentageOfFundingCommitment
      contextRef="C_99242e6a-e59a-4179-94bd-0b1937c5d461"
      decimals="INF"
      id="F_f812ce2d-1810-451c-8a58-f5da777874fc"
      unitRef="U_pure">3.00</cere:PercentageOfFundingCommitment>
    <cere:PercentageOfFundingCommitment
      contextRef="C_d4d1c9e3-62ea-42c4-ba8d-fcc51bb68150"
      decimals="INF"
      id="F_6547ebb2-cc31-497d-9304-38e21e533770"
      unitRef="U_pure">4.25</cere:PercentageOfFundingCommitment>
    <cere:NoncurrentFinancingLiabilityRelatedParty
      contextRef="C_12bb81cc-4118-4eec-9061-466a6e2d707f"
      decimals="-5"
      id="F_52d0346a-ec67-403c-b377-532574e25c72"
      unitRef="U_USD">34700000</cere:NoncurrentFinancingLiabilityRelatedParty>
    <cere:NoncurrentFinancingLiabilityRelatedParty
      contextRef="C_effc1829-ed70-4ee5-8e04-afb0f9066e16"
      decimals="-5"
      id="F_cfe3d67a-4304-458f-830a-aaa64c73ea71"
      unitRef="U_USD">28700000</cere:NoncurrentFinancingLiabilityRelatedParty>
    <cere:NoncurrentFinancingLiability
      contextRef="C_be2d5f10-585c-4657-aa28-2c74500e83d3"
      decimals="-5"
      id="F_3148368a-65e1-4d3d-9747-e3e39be610ad"
      unitRef="U_USD">34700000</cere:NoncurrentFinancingLiability>
    <cere:NoncurrentFinancingLiability
      contextRef="C_ab2f0a63-9c4c-4701-a647-f506a160b8d3"
      decimals="-5"
      id="F_2cb4e268-dbab-4135-b268-fb61ffc15152"
      unitRef="U_USD">28700000</cere:NoncurrentFinancingLiability>
    <cere:SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_c6f08398-2f5c-4e31-b22f-ddc4627b195a">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Changes in estimated fair value of the financing liabilities in our unaudited condensed consolidated statements of operations and comprehensive loss are summarized as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.716%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.719999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.719999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability, related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value recognized in other (income) expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;638&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value recognized in other (income) expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;638&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</cere:SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="C_0a7718ed-8940-4540-a71e-a8480e029877"
      decimals="-3"
      id="F_0288eece-e888-465c-83ff-8bef77ca6475"
      unitRef="U_USD">5541000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="C_5b514de5-a814-4d92-a947-476c997998cd"
      decimals="-3"
      id="F_fc4f13ec-6428-45a1-ae36-d054bf10b5ff"
      unitRef="U_USD">-1970000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
      contextRef="C_0a7718ed-8940-4540-a71e-a8480e029877"
      decimals="-3"
      id="F_e8e3ff6c-1bb2-4b8a-a7dd-aeabf3c216a4"
      unitRef="U_USD">453000</us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
      contextRef="C_5b514de5-a814-4d92-a947-476c997998cd"
      decimals="-3"
      id="F_bf27e90f-c843-410b-9343-86a4a0f110ab"
      unitRef="U_USD">-638000</us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="C_2713ad4a-1c03-4894-a1bc-032d17c08682"
      decimals="-3"
      id="F_5f9fbbc9-ef0f-470f-a191-93c7731d79c6"
      unitRef="U_USD">5541000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="C_d0b1fde3-c686-4afd-a78c-adda507ab1d7"
      decimals="-3"
      id="F_f62cd4bf-d54c-4945-9cab-a8ced3065dad"
      unitRef="U_USD">-1970000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
      contextRef="C_2713ad4a-1c03-4894-a1bc-032d17c08682"
      decimals="-3"
      id="F_f38dcfb4-8cd5-4607-811c-95ceaecc4dcd"
      unitRef="U_USD">453000</us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
      contextRef="C_d0b1fde3-c686-4afd-a78c-adda507ab1d7"
      decimals="-3"
      id="F_8b5e49e2-2bab-4cb2-ac5f-2e75470b16e7"
      unitRef="U_USD">-638000</us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax>
    <us-gaap:LongTermDebtTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_bf27d0d3-f8b9-4173-9d0f-e1e973d501ca">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6. 2027 Convertible Senior Notes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In August 2022, we completed the offering of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;345.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million aggregate principal amount of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% Convertible Senior Notes due 2027 (the 2027 Notes). The aggregate net proceeds from the 2027 Notes offering totaled approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;334.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, after deducting the initial purchasers' discounts of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and other offering expenses of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. We accounted for the debt issuance costs as a debt discount for accounting purposes, which was recorded as a reduction in the carrying value of the debt in our unaudited condensed consolidated balance sheet and is being amortized to interest expense using the effective interest method over the expected life of the 2027 Notes, or approximately their five-year term.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The 2027 Notes accrue interest at a rate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% per annum, payable &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;semi-annually&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in arrears on February 15 and August 15 of each year, beginning on February 15, 2023.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; As of March 31, 2023 and December 31, 2022, accrued interest on the 2027 Notes of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million was included in accrued expenses and other current liabilities in our condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The 2027 Notes mature on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;August 15, 2027&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;unless earlier converted, redeemed or repurchased. We will settle conversions by paying or delivering, as applicable, cash, shares of our common stock or a combination of cash and shares of our common stock, at&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;our &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;election, subject to terms and conditions provided in the indenture between us and U.S. Bank Trust Company, National Association, as trustee (the Indenture).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Holders of 2027 Notes may convert all or any portion of their Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2027, only in the following circumstances: (i) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on December 31, 2022, if the last reported sale price per share of our common stock exceeds &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;130&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the conversion price for each of at least &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; trading days, whether or not consecutive, during the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (ii) during the five consecutive business days immediately after any 10 consecutive trading day period (the Measurement Period) in which the trading price per $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; principal amount of notes for each trading day of the Measurement Period was less than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;98&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day; (iii) upon the occurrence of certain corporate events or distributions on our common stock, as defined in the Indenture; and (iv) if we call the 2027 Notes for redemption.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;From and after May 15, 2027, noteholders may convert their notes at any time at their election until the close of business on the second scheduled trading day immediately before the maturity date. The initial conversion rate is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.5633&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock per $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; principal amount of the 2027 Notes, which represents an initial conversion price of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;46.38&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share of common stock, or a total of approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,439,338&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares. The conversion rate and conversion price are subject to customary adjustments upon the occurrence of certain events outlined within the Indenture. In addition, if certain corporate events that constitute a &#x201c;Make-Whole Fundamental Change&#x201d; (as defined in the Indenture) occur, then the conversion rate will, in certain circumstances, be increased for a specified period of time.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We may not redeem the 2027 Notes at any time before August 20, 2025, and no sinking fund is required to be provided for the 2027 Notes. The 2027 Notes will be redeemable, in whole or in part (subject to certain limitations), at our option at any time, on or after August 20, 2025, and on or before the 50th scheduled trading day immediately before the maturity date, under certain circumstances defined within the Indenture.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The net carrying amount of the 2027 Notes included in our condensed consolidated balance sheets consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.156%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Principal amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;345,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;345,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unamortized debt discount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,038&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,518&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net carrying amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;335,962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;335,482&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table sets forth the total interest expense related to the 2027 Notes recognized in interest income (expense), net in our &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;unaudited condensed consolidated statements of operations and comprehensive loss for the periods presented:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.225%;"/&gt;
        &lt;td style="width:1.433%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.062000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.433%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.849%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Contractual interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;480&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Effective interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Future minimum payments under the 2027 Notes as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, 2023, are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.128%;"/&gt;
        &lt;td style="width:1.937%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.934999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal year ended December 31, 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,312&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal year ended December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal year ended December 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal year ended December 31, 2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal year ended December 31, 2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;353,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total future payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;383,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: amounts representing interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total principal amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;345,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(1) For the nine months ended December 31, 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For additional information related to our 2027 Convertible Senior Notes, please read Note 9, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2027 Convertible Senior Notes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to our audited consolidated financial statements included in our Annual Report.&lt;/span&gt;&lt;/p&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_c79a6dff-9b2a-4bbe-893e-f8d5995f53c4"
      decimals="INF"
      id="F_e77cf387-bffe-40f6-9e84-d67c7dc41825"
      unitRef="U_USD">345000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_c79a6dff-9b2a-4bbe-893e-f8d5995f53c4"
      decimals="INF"
      id="F_ca7f715d-4787-477c-b4e4-688dc2857476"
      unitRef="U_pure">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="C_c8cfcc32-37ee-4a6c-b545-88aa98593ba7"
      decimals="-5"
      id="F_12ad9853-3cfb-4afd-911a-593d33c4f98a"
      unitRef="U_USD">334800000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="C_2d54aabe-0480-4ce2-84e7-c3be541b8858"
      decimals="-5"
      id="F_aa70b1f9-93d1-42bd-ac0b-13e336a18ff5"
      unitRef="U_USD">9500000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="C_c19150ee-ddf1-4d6e-b02f-c9d1f4985998"
      decimals="-5"
      id="F_5adf6ced-709e-4920-a52a-2c2485ee0a89"
      unitRef="U_USD">700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentPaymentTerms
      contextRef="C_77c90c0f-d4ef-4cc7-bf3d-e8aba928ea56"
      id="F_10ac3d8b-9814-46bb-abdb-c43632358ac7">The 2027 Notes accrue interest at a rate of 2.50% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2023.</us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_c79a6dff-9b2a-4bbe-893e-f8d5995f53c4"
      decimals="INF"
      id="F_46be4dcc-359e-48e0-9a30-a7e34dd42e57"
      unitRef="U_pure">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="C_77c90c0f-d4ef-4cc7-bf3d-e8aba928ea56"
      id="F_5ca72953-0502-42e5-96f1-490e5b24ce5e">semi-annually</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:InterestPayableCurrent
      contextRef="C_d2d20274-f65b-4fa5-8e5b-96f09f3d8fb8"
      decimals="-5"
      id="F_00c0821e-1985-4ccd-b98e-1639d6bf0482"
      unitRef="U_USD">1100000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_c4a52621-de21-4dff-a35d-fe8c89899498"
      decimals="-5"
      id="F_85f2e6a6-1bc0-4fe5-9f9d-2668105aea8e"
      unitRef="U_USD">3200000</us-gaap:InterestPayableCurrent>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_c8cfcc32-37ee-4a6c-b545-88aa98593ba7"
      id="F_1146a6c0-d90f-4926-9993-2c27d3321610">2027-08-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="C_60585c7b-083d-43f2-85ea-156ce6ac7bb8"
      decimals="INF"
      id="F_9dd9e85b-a8dd-4663-9c84-949d5c4dadcf"
      unitRef="U_pure">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="C_60585c7b-083d-43f2-85ea-156ce6ac7bb8"
      decimals="INF"
      id="F_04bb8521-73de-4e28-bbfe-74b6f4a9732a"
      unitRef="U_Days">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="C_c8cfcc32-37ee-4a6c-b545-88aa98593ba7"
      decimals="INF"
      id="F_3a9f736b-afb0-4b10-96d3-0d9983f31fe7"
      unitRef="U_Days">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <cere:PerPrincipalAmountForTradingPrice
      contextRef="C_7e166e56-61db-491e-be50-d60c4a5deb31"
      decimals="0"
      id="F_d43f8e34-6405-4e2e-9b36-4aacd3e02d35"
      unitRef="U_USDollarShare">1000</cere:PerPrincipalAmountForTradingPrice>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="C_7d230bc1-cefa-46e4-a861-24a211270b6e"
      decimals="INF"
      id="F_940d3bd9-0000-4ece-99e2-e8465e1c231b"
      unitRef="U_pure">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="C_533da935-ec87-4ed2-a0b1-6924af3f7975"
      decimals="4"
      id="F_d353a879-531c-4dc5-8d5a-f46bb3a0f899"
      unitRef="U_pure">21.5633</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <cere:PerPrincipalAmountForConversion
      contextRef="C_a5c731ba-b89c-4f18-9704-24f50e1a5925"
      decimals="0"
      id="F_73f597cd-7230-43aa-ae9f-123bd9846c2a"
      unitRef="U_USDollarShare">1000</cere:PerPrincipalAmountForConversion>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_a5c731ba-b89c-4f18-9704-24f50e1a5925"
      decimals="2"
      id="F_f8f38e21-aea1-4463-97ee-5814491fde3e"
      unitRef="U_USDollarShare">46.38</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="C_533da935-ec87-4ed2-a0b1-6924af3f7975"
      decimals="INF"
      id="F_575b3890-df88-41e7-8fcc-e7abb6fc27c7"
      unitRef="U_Instrument">7439338</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_cefae69a-d73b-4d39-b00f-0004671e20f9">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The net carrying amount of the 2027 Notes included in our condensed consolidated balance sheets consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.156%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Principal amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;345,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;345,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unamortized debt discount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,038&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,518&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net carrying amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;335,962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;335,482&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_ad9c640a-bb1f-42d8-90b5-a293d39b67d7"
      unitRef="U_USD">345000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_dfa01a11-d955-43c4-9054-8b5c1f94ae98"
      unitRef="U_USD">345000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_c7ff9891-092d-4aac-bdc7-5002e96bb2b2"
      unitRef="U_USD">9038000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_ba393147-5f75-48da-b74f-e14861125365"
      unitRef="U_USD">9518000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_6653c2c7-bda4-4c33-8c63-c88bdbdd00e3"
      unitRef="U_USD">335962000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_8129843b-3668-40db-983c-c32ea7ba50f7"
      unitRef="U_USD">335482000</us-gaap:DebtInstrumentCarryingAmount>
    <cere:ScheduleOfInterestExpenseTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_ff0a5ba2-c35d-4233-85af-a7ec1a6f1c5b">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table sets forth the total interest expense related to the 2027 Notes recognized in interest income (expense), net in our &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;unaudited condensed consolidated statements of operations and comprehensive loss for the periods presented:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.225%;"/&gt;
        &lt;td style="width:1.433%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.062000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.433%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.849%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Contractual interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;480&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Effective interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</cere:ScheduleOfInterestExpenseTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_de1e5426-a913-400e-9d70-581fbfdf7e29"
      unitRef="U_USD">2156000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_120986e7-57b7-4401-b029-1c1abecea4d0"
      unitRef="U_USD">480000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_489eb575-4734-4074-b1f2-8c8d39cdc1c6"
      unitRef="U_USD">2636000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="3"
      id="F_838582c3-2d63-4ced-9dfa-71408b956acb"
      unitRef="U_pure">0.031</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_7e9dc5bb-2dfb-4150-ae60-580d31a8472f">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Future minimum payments under the 2027 Notes as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, 2023, are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.128%;"/&gt;
        &lt;td style="width:1.937%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.934999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal year ended December 31, 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,312&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal year ended December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal year ended December 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal year ended December 31, 2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fiscal year ended December 31, 2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;353,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total future payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;383,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: amounts representing interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total principal amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;345,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(1) For the nine months ended December 31, 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_f5ff925c-2549-4d6e-998d-f4a677aceaed"
      unitRef="U_USD">4312000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_6398a423-dfd7-4dcd-9499-6ce8466cc309"
      unitRef="U_USD">8625000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_2387220a-ea61-4b2d-a1a2-a5d42c84f0b0"
      unitRef="U_USD">8625000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_c144b06a-68b6-4629-bc8d-eaf3f6b0be61"
      unitRef="U_USD">8625000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_fba98e6a-cb02-4dd0-bb58-938378023143"
      unitRef="U_USD">353625000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebt
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_4301c71a-0a5f-4569-9237-91cfd88fa4e3"
      unitRef="U_USD">383812000</us-gaap:LongTermDebt>
    <cere:DebtInstrumentInterest
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_140aadf0-7cd4-4761-9a4d-22cdec99a249"
      unitRef="U_USD">38812000</cere:DebtInstrumentInterest>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_59e513a8-7927-47f6-a013-9cc799f9c595"
      unitRef="U_USD">345000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_c94df195-1b4c-4c89-88c0-33273cd3025b">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7. Fair Value Measurements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The tables below present information about our assets and liabilities that are measured and carried at fair value on a recurring basis and indicate the level within the fair value hierarchy we utilized to determine such fair values:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.511%;"/&gt;
        &lt;td style="width:1.223%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.223%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.223%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.223%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted&lt;br/&gt;Prices in&lt;br/&gt;Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;133,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;133,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities (current)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,909&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,909&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;230,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;230,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;415,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;415,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities (non-current)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,048&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,048&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;153,642&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;711,260&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;864,902&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability, related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;69,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;69,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.903%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.152000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.152000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.152000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.152000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted&lt;br/&gt;Prices in&lt;br/&gt;Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;136,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;136,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities (current)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;103,238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;103,238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;165,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;165,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,416&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,416&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;477,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;477,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities (non-current)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;241,626&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;710,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;952,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability, related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;57,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;57,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;There have been &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; changes in valuation techniques, inputs utilized or transfers between fair measurement levels in the periods presented. The fair value of our Level 2 instruments were determined using third-party pricing sources. The pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly. We validate the prices provided by our third-party pricing services by understanding the models used, obtaining market values from other pricing sources and analyzing pricing data in certain instances. After completing our validation procedures, we did not adjust or override any fair value measurements provided by our pricing services as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, 2023 and December 31, 2022.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The carrying amounts reflected in our condensed consolidated balance sheets for our cash and cash equivalents, prepaid expenses and other current assets, accounts payable, accrued expenses and other current liabilities approximate fair value due to the&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;short-term nature of these assets and liabilities. As of March 31, 2023, our financing liabilities represented our only Level 3 assets or liabilities carried at fair market value. Changes in the fair value remeasurement of our financing liabilities can result from changes in one or multiple inputs, including adjustments to discount rates, changes in the expected achievement or timing of any sales-based, development or regulatory milestones, changes in the amount or timing of expected net cash flows, changes in the probability or timing of certain clinical events and changes in the assumed probability or timing associated with regulatory approval. These fair value measurements represent Level 3 measurements as they are based on significant inputs not observable in the market.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:2.267%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The estimated fair value and amortized cost of our available-for-sale marketable debt securities, by contractual maturity and security type, are summarized as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:46.512%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.248999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.248999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.248999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.248999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023 &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Due in one year or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,909&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;231,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;770&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;230,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;415,820&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;415,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Due after one year through two years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35,986&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,048&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;710,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;125&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;709,219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:46.822%;"/&gt;
        &lt;td style="width:1.043%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.043%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.043%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.043%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022 &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Due in one year or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;103,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;562&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;103,238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;166,327&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;787&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;165,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,416&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;478,657&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,428&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;477,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Due after one year through two years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,327&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;816,565&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;813,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; realized gains or losses recognized on the sale or maturity of marketable securities during the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three months ended March 31, 2023 and 2022. To date, we have not recognized any allowances for credit losses or impairments in relation to our available-for-sale marketable securities as these marketable securities are comprised of high credit quality, investment grade securities that we do not intend or expect to be required to sell prior to their anticipated recovery, and the decline in fair value of these securities is attributable to factors other than credit losses. All marketable securities with unrealized losses presented in the previous tables have been in a continuous unrealized loss position for less than 12 months or the loss is not material. Based on our evaluation, we determined credit losses related to marketable securities were immaterial for the three months ended March 31, 2023.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The weighted average maturity of our marketable securities as of both March 31, 2023 and December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; was approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;five months&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:2.267%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financing Liabilities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Upon execution of the Funding Agreements, we determined that the agreements qualified for election under the fair value option and initially measured the financial instruments at their issue-date estimated fair value. We revalue the related financial liabilities on a recurring basis at each reporting period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023, the financing liability, related party and financing liability each totaled approximately &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. We determined their respective estimated fair values using a Monte Carlo simulation model under the income approach determined by using probability assessments of the expected future cash receipts and expected future cash payments and a discount rate of approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, 2023 and December 31, 2022. The probability assessments of the expected future cash receipts and expected future payments and the timing of expected future repayments are based on significant inputs that are not observable in the market and are subject to remeasurement at each reporting date.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table provides a rollforward of the estimated fair value associated with our combined total financing liabilities:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.288%;"/&gt;
        &lt;td style="width:1.941%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.771%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Beginning balance, total financing liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;57,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Funding commitment received&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value recognized in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_1f0cf8c7-35f8-4a8d-a01c-7fb92edd3948;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;other (income) expense, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value attributable to instrument-specific credit risk recognized in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_293c1bd4-3ed9-476f-92d6-7047da56d7a9;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;other comprehensive (income) loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;906&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Ending balance, total financing liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;69,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For additional information related to the fair value of our financing liability and financing liability, related party, please read Note 5, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financing Liabilities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to these unaudited condensed consolidated financial statements&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:2.267%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2027 Convertible Senior Notes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of the 2027 Notes, which were issued in August 2022, may differ from the carrying value. The fair value is determined utilizing prices for the 2027 Notes observed in market trading. As the market for the trading of the 2027 Notes is not considered to be an active market, the estimate of fair value is considered a Level 2 measurement. As of March 31, 2023, the estimated fair value of the 2027 Notes, which have an aggregate carrying value of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;336.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;289.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For additional information related to the 2027 Notes, please read Note 6, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2027 Convertible Senior Notes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to these unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_32a8ce07-5bff-477d-9c17-6f1f99e87a6a">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The tables below present information about our assets and liabilities that are measured and carried at fair value on a recurring basis and indicate the level within the fair value hierarchy we utilized to determine such fair values:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.511%;"/&gt;
        &lt;td style="width:1.223%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.223%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.223%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.223%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.15%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted&lt;br/&gt;Prices in&lt;br/&gt;Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;133,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;133,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities (current)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,909&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,909&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;230,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;230,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;415,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;415,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities (non-current)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,048&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,048&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;153,642&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;711,260&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;864,902&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability, related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;69,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;69,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.903%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.152000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.152000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.152000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.152000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;&#160;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted&lt;br/&gt;Prices in&lt;br/&gt;Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;136,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;136,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities (current)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;103,238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;103,238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;165,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;165,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,416&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,416&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;477,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;477,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities (non-current)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;241,626&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;710,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;952,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability, related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financing liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;57,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;57,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_5bed7e0c-dacd-4d4c-b250-020234b8f6be"
      decimals="-3"
      id="F_6e639460-72eb-49fd-8bd1-a594e1b3986b"
      unitRef="U_USD">133866000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_ca5c0abd-f008-4c84-a189-a21791b234a2"
      decimals="-3"
      id="F_dfd6d625-8c19-419c-8ea8-18d8bc93e517"
      unitRef="U_USD">133866000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_bc22ae5e-bffd-445a-9a22-d08330898d6b"
      decimals="-3"
      id="F_8ca5c725-2c51-45a3-8932-cb34abc62d72"
      unitRef="U_USD">19950000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_54aef7f2-adfa-458b-a966-d50f782d3ddd"
      decimals="-3"
      id="F_337f365c-4269-4966-bd22-5f0aa0c85ce1"
      unitRef="U_USD">19950000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_fcc62a3a-53fa-4dc4-ae07-5eb1877c37d1"
      decimals="-3"
      id="F_8ed68ce9-d17b-4002-beaa-1ac28058bf8c"
      unitRef="U_USD">17909000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_68912430-91ed-4690-8c20-dc2d611fbea4"
      decimals="-3"
      id="F_f134315f-2a0b-42b7-9356-4d8fbee0cddb"
      unitRef="U_USD">17909000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_5b90efb7-656c-4625-b566-b99e3e6f4649"
      decimals="-3"
      id="F_83efe4aa-19c1-405e-84e6-ed92b7e532bc"
      unitRef="U_USD">230658000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_89bb3f05-5b57-4cd0-a75d-a5ee2689d120"
      decimals="-3"
      id="F_538e2038-9baa-4b85-96cd-115004a67084"
      unitRef="U_USD">230658000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_5f8f5a42-ba06-4506-a0cc-bf786204f23c"
      decimals="-3"
      id="F_272cb3af-23ed-4ca6-826a-5aadd5cab94e"
      unitRef="U_USD">9477000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_4196d9fb-4e85-48d1-88b7-aefa2a19ebc8"
      decimals="-3"
      id="F_d3e460f4-b863-4e2c-9089-711669dfd70a"
      unitRef="U_USD">9477000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_bc22ae5e-bffd-445a-9a22-d08330898d6b"
      decimals="-3"
      id="F_a4674b12-80ac-4a0c-92fe-19c70a798148"
      unitRef="U_USD">415127000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_54aef7f2-adfa-458b-a966-d50f782d3ddd"
      decimals="-3"
      id="F_e357d63c-e88d-41e5-9d32-3422cf5867c5"
      unitRef="U_USD">415127000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_5b90efb7-656c-4625-b566-b99e3e6f4649"
      decimals="-3"
      id="F_7454896a-4ed4-4d6c-a25b-5f0ca0fba1a6"
      unitRef="U_USD">36048000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_89bb3f05-5b57-4cd0-a75d-a5ee2689d120"
      decimals="-3"
      id="F_b82b409f-3cf3-4099-a3ad-836de3f0c20f"
      unitRef="U_USD">36048000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_f46ced43-7a95-48b1-a3d2-c0ef57876a31"
      decimals="-3"
      id="F_412728df-aba9-47fc-b4f6-ffea6f794606"
      unitRef="U_USD">1867000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_549c1b5b-f5c0-43b3-aeb2-af8128f7fddd"
      decimals="-3"
      id="F_0204a520-d3d6-42a9-955b-c2ca138231b8"
      unitRef="U_USD">1867000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_55492269-e353-457a-9ac6-63c9a890f5a7"
      decimals="-3"
      id="F_29f54d65-a954-4e51-ae39-c3ea0a6f4f83"
      unitRef="U_USD">153642000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_d68c6b2b-198c-4278-b56f-a68363510239"
      decimals="-3"
      id="F_a201edb9-1426-40d0-bb95-9152235fd153"
      unitRef="U_USD">711260000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_174d7111-d0da-45ff-818a-2c32e6395735"
      decimals="-3"
      id="F_b982e72f-f4ca-492c-97ed-09d9eac520f7"
      unitRef="U_USD">864902000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_bfd4f2a5-80b4-4cd6-9aa0-3d4d61332a45"
      decimals="-3"
      id="F_261b18dd-476e-4d3c-a800-490eea3ba936"
      unitRef="U_USD">34668000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_5b04eb63-d32d-4cf7-8974-ef0d2c24455d"
      decimals="-3"
      id="F_570fed6b-0553-419f-bce6-95dbf6f9aef7"
      unitRef="U_USD">34668000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_a4c793ea-57ae-4e0f-8312-eeac8baf5953"
      decimals="-3"
      id="F_83541a1f-8185-4736-bd5e-e2fdebac067d"
      unitRef="U_USD">34668000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_27a1eff3-cd98-489c-bf8d-10b9567d6a6f"
      decimals="-3"
      id="F_fdf5944a-a303-484b-9d2a-4c617878b03e"
      unitRef="U_USD">34668000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_a2a1794f-7768-4f98-8c78-709345fc1417"
      decimals="-3"
      id="F_fa5cfc0e-b45f-4d61-a5a9-8ebdc2c9532c"
      unitRef="U_USD">69336000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_174d7111-d0da-45ff-818a-2c32e6395735"
      decimals="-3"
      id="F_9e549a11-d085-4dbd-a6fb-26daf3a4b69c"
      unitRef="U_USD">69336000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_ca7f0c1c-48d7-455e-8ddc-e9b062b461a2"
      decimals="-3"
      id="F_f62a994b-24da-438e-b5fd-9a9bbbb74e08"
      unitRef="U_USD">136521000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_e16b464e-4443-4323-83d1-f03a4129c2e8"
      decimals="-3"
      id="F_bbff286a-b170-49e1-b2d0-6e0d2a9ecd61"
      unitRef="U_USD">136521000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_75cbd078-eab8-4a1a-b86f-1ede351b764b"
      decimals="-3"
      id="F_6e61c66a-325d-4533-841a-e592c75b60b1"
      unitRef="U_USD">103238000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_4872d125-2e56-4840-bde3-171e61b545d5"
      decimals="-3"
      id="F_14dcfb3e-433b-4393-ae55-a9d387ffbaad"
      unitRef="U_USD">103238000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_4555fd95-af90-4446-9ef6-c7bf5c673ad1"
      decimals="-3"
      id="F_34503bea-c758-4390-9b82-6bfdb2a374ce"
      unitRef="U_USD">165555000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_e2cf588c-4935-44e7-a87b-fcb9e12be2cd"
      decimals="-3"
      id="F_2caca35c-1504-4bf2-94fa-90411de90c9d"
      unitRef="U_USD">165555000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_3e5cfe38-545f-4b20-972d-38ee76239160"
      decimals="-3"
      id="F_734b4186-8a1a-4e15-a3c5-ef2075d47e41"
      unitRef="U_USD">9416000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_a7fd9625-1e0b-4179-bd94-31438f3f9f0b"
      decimals="-3"
      id="F_11e15c3a-14c3-49a6-841e-42260bde7e75"
      unitRef="U_USD">9416000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_6ce49664-9b3e-4193-9202-c337a0a78589"
      decimals="-3"
      id="F_747b8491-5845-451a-8e77-50e35a2e8554"
      unitRef="U_USD">477300000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_db439bc0-f8f4-4c4e-9791-8b83a63b6885"
      decimals="-3"
      id="F_9007773e-043c-4a37-a8fe-466be7408539"
      unitRef="U_USD">477300000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_4555fd95-af90-4446-9ef6-c7bf5c673ad1"
      decimals="-3"
      id="F_70a6ab2e-ebc7-4c97-9862-7f8700bbd85a"
      unitRef="U_USD">58126000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_e2cf588c-4935-44e7-a87b-fcb9e12be2cd"
      decimals="-3"
      id="F_cd5701b7-7c40-4a77-953e-b0cedee410b1"
      unitRef="U_USD">58126000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_03207e80-ade5-41d3-ab71-391279e55fcc"
      decimals="-3"
      id="F_ecfd4dbd-3ef7-429d-a75c-46de4e6f4102"
      unitRef="U_USD">1867000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_1972858f-eae0-4299-8170-ba14d09bef4d"
      decimals="-3"
      id="F_5501e78f-4eda-4ee5-ae7f-a84f3459b641"
      unitRef="U_USD">1867000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_67e3ff37-67dc-425c-9e5c-f367e23d4a36"
      decimals="-3"
      id="F_7bb78a1b-6ad0-4ca3-85b5-19faf102ea58"
      unitRef="U_USD">241626000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4929b4e3-f0dd-4495-b868-bcea2881f576"
      decimals="-3"
      id="F_ba477823-c7d1-4d0c-84db-3c02706a5c90"
      unitRef="U_USD">710397000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4d6806dd-95ea-4244-b45f-b725e95152fe"
      decimals="-3"
      id="F_1e89a9fb-f166-49cf-ad63-1ddedd497da5"
      unitRef="U_USD">952023000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_e39da301-bc58-44e7-8b68-aa3c32c22b3d"
      decimals="-3"
      id="F_f0daeb44-2a28-4040-b760-ba88d67c0669"
      unitRef="U_USD">28674000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_c61bf99f-af2e-40be-861d-98e1836d9630"
      decimals="-3"
      id="F_4cf9e1ba-2de9-4190-bb84-830c1675a155"
      unitRef="U_USD">28674000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_dd4efdc2-f871-4164-b259-04d75db7dd0a"
      decimals="-3"
      id="F_ad526da9-5446-4aae-b824-422e9025f301"
      unitRef="U_USD">28674000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_ecd82ae5-371b-498f-b1a6-1a95342b510d"
      decimals="-3"
      id="F_45a730e1-2906-46bc-ada9-1e9c423f18b3"
      unitRef="U_USD">28674000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_5bf423a6-8367-4279-bf95-e9c42308340c"
      decimals="-3"
      id="F_ceca2348-18a1-4a89-a486-6e3311f4974b"
      unitRef="U_USD">57348000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_4d6806dd-95ea-4244-b45f-b725e95152fe"
      decimals="-3"
      id="F_6ea75d48-a828-4613-909e-5df47077ac65"
      unitRef="U_USD">57348000</us-gaap:LiabilitiesFairValueDisclosure>
    <cere:FairValueLiabilitiesBetweenLevelTransferAmount
      contextRef="C_174d7111-d0da-45ff-818a-2c32e6395735"
      decimals="INF"
      id="F_525c9399-70d3-4d43-b45c-9141e500bb62"
      unitRef="U_USD">0</cere:FairValueLiabilitiesBetweenLevelTransferAmount>
    <cere:FairValueLiabilitiesBetweenLevelTransferAmount
      contextRef="C_4d6806dd-95ea-4244-b45f-b725e95152fe"
      decimals="INF"
      id="F_ea6fe403-611c-49e9-86bd-a7f43642fa20"
      unitRef="U_USD">0</cere:FairValueLiabilitiesBetweenLevelTransferAmount>
    <cere:FairValueAssetBetweenLevelTransferAmount
      contextRef="C_174d7111-d0da-45ff-818a-2c32e6395735"
      decimals="INF"
      id="F_8e3ff23d-7e0e-4bce-8c3f-94e508918587"
      unitRef="U_USD">0</cere:FairValueAssetBetweenLevelTransferAmount>
    <cere:FairValueAssetBetweenLevelTransferAmount
      contextRef="C_4d6806dd-95ea-4244-b45f-b725e95152fe"
      decimals="INF"
      id="F_a2f9b2f8-11c7-468d-928f-0d905ecf968d"
      unitRef="U_USD">0</cere:FairValueAssetBetweenLevelTransferAmount>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_02a9cd65-cf7b-4fdc-9666-4203e522af70">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The estimated fair value and amortized cost of our available-for-sale marketable debt securities, by contractual maturity and security type, are summarized as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:46.512%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.248999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.248999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.248999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.248999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023 &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Due in one year or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,909&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;231,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;770&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;230,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;415,820&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;415,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Due after one year through two years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35,986&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,048&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;710,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;125&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;709,219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:46.822%;"/&gt;
        &lt;td style="width:1.043%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.043%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.043%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.043%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022 &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Due in one year or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;103,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;562&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;103,238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;166,327&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;787&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;165,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,416&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;478,657&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,428&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;477,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Due after one year through two years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government agencies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,327&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;816,565&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;813,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_8a957d0a-6024-4753-9804-3a0360e90e6b"
      decimals="-3"
      id="F_caed5def-e2e1-4e2b-8520-607c71f4f1fa"
      unitRef="U_USD">17970000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_8a957d0a-6024-4753-9804-3a0360e90e6b"
      decimals="-3"
      id="F_9768dd00-15cc-45fe-87d4-0016755e270d"
      unitRef="U_USD">61000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_8a957d0a-6024-4753-9804-3a0360e90e6b"
      decimals="-3"
      id="F_c9fcd0a8-8267-4614-a740-11d2af1d6965"
      unitRef="U_USD">17909000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_8e7da2d2-92f1-43a3-bb9a-1d0277243751"
      decimals="-3"
      id="F_bdd52223-7979-4684-b2dd-76780b56f7eb"
      unitRef="U_USD">231391000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_8e7da2d2-92f1-43a3-bb9a-1d0277243751"
      decimals="-3"
      id="F_8f3d3a3e-6eb1-43e8-a9d0-8fa58a03d388"
      unitRef="U_USD">37000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_8e7da2d2-92f1-43a3-bb9a-1d0277243751"
      decimals="-3"
      id="F_47d1d58a-b414-46ff-a6d1-b3b0d430ed62"
      unitRef="U_USD">770000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_8e7da2d2-92f1-43a3-bb9a-1d0277243751"
      decimals="-3"
      id="F_2fe06802-bf49-4621-a2c6-3a1b56dc15b7"
      unitRef="U_USD">230658000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_e73b579d-5fcf-44e9-b4bd-a01478ea5126"
      decimals="-3"
      id="F_ce686df1-0395-4d79-8533-e89339a34c67"
      unitRef="U_USD">9485000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_e73b579d-5fcf-44e9-b4bd-a01478ea5126"
      decimals="-3"
      id="F_39027448-1967-48f8-a09d-eed158032050"
      unitRef="U_USD">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_e73b579d-5fcf-44e9-b4bd-a01478ea5126"
      decimals="-3"
      id="F_1b31d23a-712c-488c-9cf3-93f687758075"
      unitRef="U_USD">9477000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0cfe1f22-841b-4d40-be3c-5ab39c7eeed7"
      decimals="-3"
      id="F_f5a562e4-117d-41cc-94aa-e88d10b3dfcb"
      unitRef="U_USD">415820000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0cfe1f22-841b-4d40-be3c-5ab39c7eeed7"
      decimals="-3"
      id="F_61671e0b-f061-47f5-879c-505cad09e486"
      unitRef="U_USD">26000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0cfe1f22-841b-4d40-be3c-5ab39c7eeed7"
      decimals="-3"
      id="F_d2eb614a-a55e-4344-8190-b37d9b7b2f1d"
      unitRef="U_USD">719000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0cfe1f22-841b-4d40-be3c-5ab39c7eeed7"
      decimals="-3"
      id="F_487bd321-4f6d-4cdb-b630-47b4ee0f39cd"
      unitRef="U_USD">415127000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_d374cc27-3d6a-4e93-87c5-2393b48f37f2"
      decimals="-3"
      id="F_4294f88b-8f43-4819-a1ab-63d8d04159d3"
      unitRef="U_USD">35986000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_d374cc27-3d6a-4e93-87c5-2393b48f37f2"
      decimals="-3"
      id="F_7c7e93cc-f4a1-4142-8bfa-4440dd8d4f31"
      unitRef="U_USD">62000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_d374cc27-3d6a-4e93-87c5-2393b48f37f2"
      decimals="-3"
      id="F_a63e090a-7091-430b-9bff-ec5335b86ee8"
      unitRef="U_USD">36048000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_6fef9623-24d1-4260-aa1b-96080319f244"
      unitRef="U_USD">710652000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_352d8cbf-35c3-4fdf-be2d-e5bef9188d56"
      unitRef="U_USD">125000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_31e0b511-64a3-420d-acb3-be713bdff749"
      unitRef="U_USD">1558000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_503f2a7f-123d-4379-9f95-cee84e213f29"
      unitRef="U_USD">709219000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_abd57310-685b-4fc9-a762-295bbda69277"
      decimals="-3"
      id="F_26f227f6-8d6c-403c-894c-1c97746b7695"
      unitRef="U_USD">103800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_abd57310-685b-4fc9-a762-295bbda69277"
      decimals="-3"
      id="F_f913c86e-1bcf-4fd6-a739-99825bdefebb"
      unitRef="U_USD">562000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_abd57310-685b-4fc9-a762-295bbda69277"
      decimals="-3"
      id="F_2351433f-1e06-4e54-8231-5c4718b2a95d"
      unitRef="U_USD">103238000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_b7ca6fdd-c4aa-4736-9d2f-d4a2eadbaeb1"
      decimals="-3"
      id="F_8266632c-ed67-4a94-b7dd-c0e3420b0511"
      unitRef="U_USD">166327000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_b7ca6fdd-c4aa-4736-9d2f-d4a2eadbaeb1"
      decimals="-3"
      id="F_78ffb01d-ddc4-48be-89ba-038a3b1f727f"
      unitRef="U_USD">15000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_b7ca6fdd-c4aa-4736-9d2f-d4a2eadbaeb1"
      decimals="-3"
      id="F_ec4731f1-34a4-48e5-9b66-c8cc0b6dc2b7"
      unitRef="U_USD">787000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_b7ca6fdd-c4aa-4736-9d2f-d4a2eadbaeb1"
      decimals="-3"
      id="F_049dc627-4950-4375-a19c-d6f1540b5d44"
      unitRef="U_USD">165555000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_4651d696-b2be-4638-8c92-24388e05ccf4"
      decimals="-3"
      id="F_b22868a1-ea68-466c-b04d-2dadaa777c5f"
      unitRef="U_USD">9454000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_4651d696-b2be-4638-8c92-24388e05ccf4"
      decimals="-3"
      id="F_83dc8e73-f475-4f73-a563-345e625fcd47"
      unitRef="U_USD">38000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_4651d696-b2be-4638-8c92-24388e05ccf4"
      decimals="-3"
      id="F_eb531197-ae3a-4473-875f-870e831e3d73"
      unitRef="U_USD">9416000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_ba176f35-ab1c-4a1b-9969-20f064b37357"
      decimals="-3"
      id="F_9fd54315-d6e4-44ac-9595-5726eb99e466"
      unitRef="U_USD">478657000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_ba176f35-ab1c-4a1b-9969-20f064b37357"
      decimals="-3"
      id="F_95638f69-a9ca-4f08-a991-2b2f38a56d26"
      unitRef="U_USD">71000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_ba176f35-ab1c-4a1b-9969-20f064b37357"
      decimals="-3"
      id="F_c2e3862f-74a2-433f-86b4-5211a6f21990"
      unitRef="U_USD">1428000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_ba176f35-ab1c-4a1b-9969-20f064b37357"
      decimals="-3"
      id="F_15b2ebe7-2e04-4c34-99f0-d2142cc289ce"
      unitRef="U_USD">477300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_cee0bc25-bebb-4a35-9362-2d58a9e6a342"
      decimals="-3"
      id="F_0d3ef5d9-c45f-42dd-8559-1194a4133b78"
      unitRef="U_USD">58327000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_cee0bc25-bebb-4a35-9362-2d58a9e6a342"
      decimals="-3"
      id="F_3afebdf9-bea3-4edf-aa69-0cc3e4c41144"
      unitRef="U_USD">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_cee0bc25-bebb-4a35-9362-2d58a9e6a342"
      decimals="-3"
      id="F_2e44a38e-fe0d-42d2-9e1c-547e6967dbdb"
      unitRef="U_USD">208000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_cee0bc25-bebb-4a35-9362-2d58a9e6a342"
      decimals="-3"
      id="F_8ae86c6f-de5b-4149-9041-ce3f84bc75e4"
      unitRef="U_USD">58126000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_6e384935-d42c-4031-95f9-afd4a2ae0ad6"
      unitRef="U_USD">816565000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_6a13f919-40d7-40d5-bf7b-7194a326d8a8"
      unitRef="U_USD">93000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_30764b5b-9eec-4480-ae53-8aa56589d320"
      unitRef="U_USD">3023000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_6b3a5cd8-f923-4a5f-a4a2-73e92fd51a10"
      unitRef="U_USD">813635000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:MarketableSecuritiesRealizedGainLoss
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_ad7c7237-b76a-4c02-abec-c0d374296f1a"
      unitRef="U_USD">0</us-gaap:MarketableSecuritiesRealizedGainLoss>
    <us-gaap:MarketableSecuritiesRealizedGainLoss
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_8e05aefc-8f7a-47b3-9a2d-3326dee52b76"
      unitRef="U_USD">0</us-gaap:MarketableSecuritiesRealizedGainLoss>
    <cere:MarketableSecuritiesWeightedAverageMaturityTerm
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_758e49c7-c864-45c2-b6e5-e976ec488e00">P5M</cere:MarketableSecuritiesWeightedAverageMaturityTerm>
    <cere:MarketableSecuritiesWeightedAverageMaturityTerm
      contextRef="C_59a5c3ef-611c-4d06-809f-b96bb1ad592d"
      id="F_def91091-ec7c-470b-a221-956881fc6481">P5M</cere:MarketableSecuritiesWeightedAverageMaturityTerm>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_23d05b6e-4f80-4669-8884-9503ff410b15"
      decimals="-5"
      id="F_e6bfeb25-5d72-433c-8bc2-ef899ce8acfb"
      unitRef="U_USD">34700000</us-gaap:LiabilitiesFairValueDisclosure>
    <cere:FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput
      contextRef="C_4b64ecbc-3995-4a70-91be-00b3cba9da84"
      decimals="3"
      id="F_a0b394cf-765d-4b0a-8af6-7057bb8506af"
      unitRef="U_pure">0.100</cere:FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput>
    <cere:FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput
      contextRef="C_6d74330b-6d7c-493a-b8a3-9eb0e26049d9"
      decimals="3"
      id="F_5e32fd6c-63b9-4a6a-a88b-0cf9fa83f85f"
      unitRef="U_pure">0.100</cere:FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_5171b7f4-c3cb-420f-af32-f6966ce24dfb">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table provides a rollforward of the estimated fair value associated with our combined total financing liabilities:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.288%;"/&gt;
        &lt;td style="width:1.941%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.771%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Beginning balance, total financing liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;57,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Funding commitment received&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value recognized in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_1f0cf8c7-35f8-4a8d-a01c-7fb92edd3948;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;other (income) expense, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,082&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in fair value attributable to instrument-specific credit risk recognized in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_293c1bd4-3ed9-476f-92d6-7047da56d7a9;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;other comprehensive (income) loss&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;906&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Ending balance, total financing liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;69,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_2ea39b76-7e86-4e9f-a3aa-1c43d8682c03"
      decimals="-3"
      id="F_378803a3-c177-4463-88bf-5b152ef5cc51"
      unitRef="U_USD">57348000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="C_7913329b-0f1d-4200-bcd9-ef012e06c589"
      decimals="-3"
      id="F_acf10696-68a2-4225-acbd-98f98914403a"
      unitRef="U_USD">11082000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="C_7913329b-0f1d-4200-bcd9-ef012e06c589"
      decimals="-3"
      id="F_880b4ee8-8636-4af8-bdf2-3ebc5ba94709"
      unitRef="U_USD">-906000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_7297b579-f439-4a6b-92e5-a571272517af"
      decimals="-3"
      id="F_6ea5df3b-27de-4bba-8cd2-db6ea0d63215"
      unitRef="U_USD">69336000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_d2d20274-f65b-4fa5-8e5b-96f09f3d8fb8"
      decimals="-5"
      id="F_0f7ee7dc-d0a3-43a9-86f8-2ab5a6c29a93"
      unitRef="U_USD">336000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="C_d2d20274-f65b-4fa5-8e5b-96f09f3d8fb8"
      decimals="-5"
      id="F_7b501f50-4a83-4a86-a6e3-fcf8fbc27b8e"
      unitRef="U_USD">289400000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_c07c8962-c25a-492f-acc6-221c3fff1c12">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Financial Statement Components&lt;/span&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid expenses and other current assets consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.156%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid clinical trial services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,872&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,228&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,171&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,202&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,046&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,367&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,795&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,621&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.411%;"/&gt;
        &lt;td style="width:1.541%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.754000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.541%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.754000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer equipment and software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,009&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;996&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,886&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,489&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,461&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,461&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;321&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,259&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Other Long-Term Assets&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other long-term assets consisted of the following:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.156%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other prepaid expenses, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,932&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,792&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred expenses associated with financing activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other long-term assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,891&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023 and December 31, 2022, other prepaid expenses, net of current portion, primarily consisted of deposits paid under certain contract research organization agreements that will be held until the completion of the related clinical trials that are anticipated to end more than 12 months from the balance sheet date.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses and other current liabilities consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.436%;"/&gt;
        &lt;td style="width:1.542%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.739999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.542%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.739999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued external research and development services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;41,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,967&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued compensation and personnel costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,377&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,057&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;439&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued professional fees and consulting services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,365&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,143&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;52,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,604&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Interest Income (Expense), net&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest income (expense), net consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.716%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.719999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.719999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;295&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest income (expense), net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,440&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;295&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Other Income (Expense), net&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other income (expense), net consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.436%;"/&gt;
        &lt;td style="width:1.542%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.739999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.542%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.739999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gain (loss) on fair value remeasurement of financing liability, related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gain (loss) on fair value remeasurement of financing liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other income (expense), net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,090&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,941&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <cere:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_5b605563-1656-49eb-b88e-03c5893b29fd">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid expenses and other current assets consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.156%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid clinical trial services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,551&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,872&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,228&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,171&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,460&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,202&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,046&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,367&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,795&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,621&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</cere:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock>
    <cere:PrepaidClinicalTrialServicesCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_82e7c9bc-006f-486c-927a-8a57c2ac4c40"
      unitRef="U_USD">2551000</cere:PrepaidClinicalTrialServicesCurrent>
    <cere:PrepaidClinicalTrialServicesCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_f239e8d9-5669-4123-b5e3-11dbd09570f2"
      unitRef="U_USD">2872000</cere:PrepaidClinicalTrialServicesCurrent>
    <cere:PrepaidResearchAndDevelopmentExpensesCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_f8f0366e-d019-42e6-b934-bb5f30abe2c7"
      unitRef="U_USD">1592000</cere:PrepaidResearchAndDevelopmentExpensesCurrent>
    <cere:PrepaidResearchAndDevelopmentExpensesCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_a50408e4-1d1f-4abe-865e-1282bd5b6451"
      unitRef="U_USD">1228000</cere:PrepaidResearchAndDevelopmentExpensesCurrent>
    <us-gaap:PrepaidInsurance
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_ba31aea9-3024-4773-af5c-5eaf108f1197"
      unitRef="U_USD">2171000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_e9bb4cee-c0c4-45a6-ba13-dabff6a6b512"
      unitRef="U_USD">2460000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_3d0add28-deb5-4050-af22-98b882d9ef46"
      unitRef="U_USD">2912000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_96631a5f-8fbb-463d-9b50-8291ed5534b8"
      unitRef="U_USD">3556000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_c7afd3be-80b0-4475-8c39-c331a3922ebb"
      unitRef="U_USD">3202000</us-gaap:InterestReceivableCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_f5d09915-ab58-4174-9bcb-1c5a7ecb2bd8"
      unitRef="U_USD">2046000</us-gaap:InterestReceivableCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_3c68d4ea-d664-4fde-a269-414a806ad9a7"
      unitRef="U_USD">1367000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_d9b9456b-1633-4924-bf59-3067467740ef"
      unitRef="U_USD">1459000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_01213566-e2f4-45be-b4f6-e7d5a0cf06f8"
      unitRef="U_USD">13795000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_e853a563-fe7f-45f7-88a1-40873ca957f4"
      unitRef="U_USD">13621000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_b4f38f28-984f-4319-8706-b238470f2200">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.411%;"/&gt;
        &lt;td style="width:1.541%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.754000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.541%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.754000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Computer equipment and software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,009&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;996&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,886&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,489&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,461&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,461&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;321&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,259&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,467&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_3b482e46-cc89-4ce5-85f5-a366efdf2856"
      decimals="-3"
      id="F_7e27eca4-50b7-4a52-943c-581783cb0287"
      unitRef="U_USD">1009000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_14d54740-4fd0-463e-8f77-ee503f66ded0"
      decimals="-3"
      id="F_a19fe518-324d-4130-acd8-d96609a7cc14"
      unitRef="U_USD">996000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_efca2e92-f443-4333-9998-77bef5b93ff9"
      decimals="-3"
      id="F_17479ad1-31d8-423c-9916-cbfa422647f2"
      unitRef="U_USD">459000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_47e0732b-5a0a-4840-a434-85dd5768ae62"
      decimals="-3"
      id="F_8e7f0840-04ca-4814-ba22-9e6cbc493099"
      unitRef="U_USD">459000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_84a4ec65-be81-43b0-a2a8-aeab6b151380"
      decimals="-3"
      id="F_8b7a5668-312e-48a7-834b-0e9ee7078ba1"
      unitRef="U_USD">9886000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_4cf7a89b-841c-4850-9973-eddacfecc0f0"
      decimals="-3"
      id="F_5d2f8daa-11cb-4ef3-b938-bbbed21b570c"
      unitRef="U_USD">9489000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_f1ad0af9-f8fb-47b4-9d88-2f035f335eb7"
      decimals="-3"
      id="F_3cba9482-6e02-4915-859f-e33b10ac9fc5"
      unitRef="U_USD">23461000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_2ff3f43c-87c0-4d83-99a4-d515d051d791"
      decimals="-3"
      id="F_e3bb5f1a-14ef-44c5-a9d5-c2608f3ac6ce"
      unitRef="U_USD">23461000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_e9e3b32d-3528-4ff7-ad8b-b7449522bd16"
      decimals="-3"
      id="F_cca0c703-f3c2-404c-bc0a-f8ec67ddd3b1"
      unitRef="U_USD">705000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_8c284975-2e05-4ee0-a774-8114aaf9d295"
      decimals="-3"
      id="F_39dc652e-226b-49b6-b395-1f815c8815ff"
      unitRef="U_USD">321000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_2d8040ce-d58a-423e-9838-9ff1a3b31273"
      unitRef="U_USD">8514000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_3adbaa26-4938-4091-8c41-5e2ad68562be"
      unitRef="U_USD">7259000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_656b786b-439b-4419-a5f0-b536ffe6652d"
      unitRef="U_USD">27006000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_df1fff2c-2f7f-4cfa-bff7-efddf0ae20b0"
      unitRef="U_USD">27467000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_b64ab8e7-d978-4f7c-8fa9-d0274299ac16">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other long-term assets consisted of the following:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.156%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.662%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.759999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other prepaid expenses, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,932&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,792&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred expenses associated with financing activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other long-term assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,891&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:PrepaidExpenseOtherNoncurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_10853d43-f507-412d-a6e9-ab6cb78a29bf"
      unitRef="U_USD">1932000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_08758faa-a0be-4512-8b8f-63682d6f5c45"
      unitRef="U_USD">1792000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_8d2bb594-c556-4f63-b66a-20e37bdbe5ea"
      unitRef="U_USD">287000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_fa5ce578-47bb-4b57-9a90-63121c0fadca"
      unitRef="U_USD">286000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_6656cd2a-da25-4e71-b87e-0466e28643c4"
      unitRef="U_USD">989000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_80897923-a11f-4d22-9b65-a36a8a7c24a3"
      unitRef="U_USD">813000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_6226f4a7-de2b-4b65-a558-2f0801b15835"
      unitRef="U_USD">3208000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_0c848573-8476-4dfd-b222-7e09b8edb673"
      unitRef="U_USD">2891000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_5ed1c743-e8f6-4c90-ac1f-d8a4441884d3">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses and other current liabilities consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.436%;"/&gt;
        &lt;td style="width:1.542%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.739999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.542%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.739999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued external research and development services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;41,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,967&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued compensation and personnel costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,377&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,057&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;439&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued professional fees and consulting services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,365&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,143&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;52,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,604&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <cere:AccruedExternalResearchAndDevelopmentServicesCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_b0562290-ca96-4beb-a214-9e3863e6c792"
      unitRef="U_USD">41397000</cere:AccruedExternalResearchAndDevelopmentServicesCurrent>
    <cere:AccruedExternalResearchAndDevelopmentServicesCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_6de4174c-7757-4256-9b86-d2021df450e3"
      unitRef="U_USD">33967000</cere:AccruedExternalResearchAndDevelopmentServicesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_62476063-447d-4607-a411-39f814f5e4d3"
      unitRef="U_USD">6377000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_391b1c20-42f9-4bb3-834f-35b52f2093af"
      unitRef="U_USD">19057000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <cere:AccruedPropertyAndEquipmentCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_1cfb9261-09cd-48e6-a12b-8164e93850bc"
      unitRef="U_USD">439000</cere:AccruedPropertyAndEquipmentCurrent>
    <cere:AccruedPropertyAndEquipmentCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_2f1a5087-a18b-4051-a9c6-cdd21837f6c9"
      unitRef="U_USD">40000</cere:AccruedPropertyAndEquipmentCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_e9e8ffb5-589b-4204-b72c-295ef4d4d66a"
      unitRef="U_USD">2365000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_20f469e8-5858-4283-a9e5-f5ded1970d6a"
      unitRef="U_USD">2187000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_1601c998-1a03-4deb-8799-4a258b2a6ca0"
      unitRef="U_USD">1078000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_bbe714b9-cd6b-4925-a18f-d5895830360e"
      unitRef="U_USD">3210000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_23d05d38-7772-4719-98e0-5a73c1e4c4e8"
      unitRef="U_USD">958000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_0c7a304d-8aa8-4c4c-9ba6-286a20d142ea"
      unitRef="U_USD">1143000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_c0b5ccfb-34ee-4b17-9095-f7475a62939e"
      unitRef="U_USD">52614000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="-3"
      id="F_5eebf274-b3ae-4220-9706-288ce2f85edb"
      unitRef="U_USD">59604000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_4f1f28bf-7fbb-4502-9c63-d09c77e18d17">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest income (expense), net consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.716%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.719999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.719999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;295&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest income (expense), net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,440&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;295&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <cere:InterestIncomeNonoperatingNet
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_38ce7081-00f7-448f-a489-80fe3b35a7e7"
      unitRef="U_USD">9076000</cere:InterestIncomeNonoperatingNet>
    <cere:InterestIncomeNonoperatingNet
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_42bf976f-763d-4834-bf34-ee6edba064f7"
      unitRef="U_USD">295000</cere:InterestIncomeNonoperatingNet>
    <us-gaap:InterestExpense
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_57e83b9a-8a98-448f-89f9-7eb94bb7121a"
      unitRef="U_USD">2636000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_03426aa1-e1b6-4da2-a48e-bcf98d1f1a6c"
      unitRef="U_USD">6440000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_a8ce7797-6b7d-4b54-bcc9-7726cbf0f6b9"
      unitRef="U_USD">295000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_2d6e4eea-0afd-488b-a6dc-ff25640abcac">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other income (expense), net consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:63.436%;"/&gt;
        &lt;td style="width:1.542%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.739999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.542%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.739999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gain (loss) on fair value remeasurement of financing liability, related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gain (loss) on fair value remeasurement of financing liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other income (expense), net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,090&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,941&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <cere:GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_c262a97e-8d9e-4ea0-b3e6-ea5588ca8895"
      unitRef="U_USD">-5541000</cere:GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty>
    <cere:GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_4554611f-43ce-4b23-ad9a-3682c1a09297"
      unitRef="U_USD">1970000</cere:GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty>
    <cere:GainLossOnFairValueRemeasurementOfFinancingLiability
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_ea02561c-6cd1-47d9-a311-b7b256df2293"
      unitRef="U_USD">-5541000</cere:GainLossOnFairValueRemeasurementOfFinancingLiability>
    <cere:GainLossOnFairValueRemeasurementOfFinancingLiability
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_43aa388f-089a-43ab-85ed-7971c11167f1"
      unitRef="U_USD">1970000</cere:GainLossOnFairValueRemeasurementOfFinancingLiability>
    <cere:OtherNonoperatingIncomeExpenseOther
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_ab6b4f06-c96f-4d0d-a563-b6f9063b0bfe"
      unitRef="U_USD">-8000</cere:OtherNonoperatingIncomeExpenseOther>
    <cere:OtherNonoperatingIncomeExpenseOther
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_904f7739-b5ed-4421-91fa-36154046839b"
      unitRef="U_USD">1000</cere:OtherNonoperatingIncomeExpenseOther>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_07345cc2-7278-466c-b228-77ced576cf53"
      unitRef="U_USD">-11090000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_a91f2985-5252-4c56-b84d-75a5f79a837b"
      unitRef="U_USD">3941000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_8b456a4d-2e11-4536-a772-70292f425d5c">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Stockholders&#x2019; Equity&lt;/span&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Pursuant to the terms of our certificate of incorporation, we have &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; authorized shares of preferred stock, par value $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share, all of which shares of preferred stock are undesignated. Our board of directors or any authorized committee thereof is expressly authorized, without further action by our stockholders, to issue such shares of preferred stock from time to time on terms it may determine, to divide shares of preferred stock into one or more series and to fix the designations, preferences, privileges and restrictions of preferred stock. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; issued and outstanding shares of preferred stock as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, 2023 and December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Common Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Pursuant to the terms of our certificate of incorporation, we have &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;500,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; authorized shares of common stock, par value $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share. There were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;156,760,109&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;156,502,285&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock issued and outstanding as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, 2023 and December 31, 2022, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Voting&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The holders of our common stock are entitled to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one vote&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for each share of common stock held of record by such holder on all matters voted upon by our stockholders, provided, however, that, except as otherwise required in our certificate of incorporation or by applicable law, the holders of our common stock are not entitled to vote on any amendment to our certificate of incorporation (or on any amendment to a certificate of designations of any series of preferred stock) that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon, and there is no cumulative voting.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Dividends&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Subject to any other provisions of our certificate of incorporation, holders of our common stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; are entitled to receive ratably, in proportion to the number of shares of common stock held by them, such dividends and other distributions in cash, stock or property when, as and if declared thereon by our board of directors from time to time out of our assets or funds legally available therefor. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; dividends have been declared to date.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;ATM Program&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In November 2021, we entered into an open market sales agreement with Jefferies LLC, as sales agent, to provide for the issuance and sale of up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;250.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of our common stock from time-to-time in &#x201c;at-the-market&#x201d; offerings (the ATM Program). As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, 2023 and December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; sales had been made pursuant to the ATM Program.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_21dd3293-bb3a-4087-8162-d25ffcd4d57e"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_ede175d2-3b78-4f35-aca6-9fa4d3a82b0b"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_7e78614b-a571-4972-98e2-d6db3f16fcc9"
      unitRef="U_USDollarShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_9f73a934-51b4-4308-9651-c59d2f580f6e"
      unitRef="U_USDollarShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_78a5ce2b-e3a5-4721-a940-3d8a110ed332"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_181602f6-36ab-4e9b-901a-0575714c0759"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_6fb368e5-aeb6-463d-84c1-6c18f93a0e85"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_252c0733-a120-4ce8-bac7-44598577ae14"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_5e479185-c6ca-4bf3-87f8-19cc2c2ddf09"
      unitRef="U_shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_6a14ca00-d95a-4d55-ac6e-81c84d1f5b98"
      unitRef="U_shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_83441a03-5c5d-4f16-bb93-d1980007bfd4"
      unitRef="U_USDollarShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_f74ce50b-f173-40d2-af8c-a7daf2d4faa4"
      unitRef="U_USDollarShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="0"
      id="F_1eb38ba3-bdf4-43dc-a2a5-2538a6e7030b"
      unitRef="U_shares">156760109</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_a17c6135-492a-4ff7-bf96-745bcd328da1"
      unitRef="U_shares">156502285</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockVotingRights
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_06034287-e34c-4760-9880-70935dcd49df">one vote</us-gaap:CommonStockVotingRights>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="-3"
      id="F_7aded220-e0ab-48f1-bb18-b1d27d48ba0d"
      unitRef="U_USD">0</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <cere:SaleAndIssuanceOfStockNotYetIssued
      contextRef="C_33aaf712-2416-4ca9-a789-bdc80db6c833"
      decimals="INF"
      id="F_6a3050a0-5cd9-44df-9b1e-7f5e57617a58"
      unitRef="U_USD">250000000.0</cere:SaleAndIssuanceOfStockNotYetIssued>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_286de79d-0111-4ffc-942c-17519af10505"
      decimals="INF"
      id="F_76b284fd-1bc1-499f-a545-93d6ab50c1be"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_59a5c3ef-611c-4d06-809f-b96bb1ad592d"
      decimals="INF"
      id="F_dbcb2ae9-2569-4764-9e23-73f23e0e4cbc"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_5403db72-eaaa-4289-b121-2b519f0d0c23">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10. Equity-Based Compensation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.253%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Equity-based Compensation Expense&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes equity-based compensation expense included in our unaudited condensed consolidated statements of operations and comprehensive loss:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.401%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.797%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.797%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total equity-based compensation expense included in total operating expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes equity-based compensation expense by award type included in our unaudited condensed consolidated statements of operations and comprehensive loss:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.401%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.797%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.797%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;226&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total equity-based compensation expense included in total operating expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options granted during the three months ended March 31, 2023 and 2022 had a weighted average grant-date fair value of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26.21&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23.62&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The weighted-average assumptions that we used to determine the fair value of stock options granted to employees are summarized as follows: &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.35%;"/&gt;
        &lt;td style="width:1.166%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.656%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.166%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.661000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;96.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, total unrecognized equity-based compensation expense relating to stock options was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;132.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. This amount is expected to be recognized over a weighted average period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes our stock option activity for the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three months ended March 31, 2023:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.65%;"/&gt;
        &lt;td style="width:1.001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.614999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.914000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.116%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.094999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(in millions)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,178,861&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13.59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.55&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;309.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,015,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;257,824&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeited, canceled or expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;517,077&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at March 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,419,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.49&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;199.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options vested and expected to vest as of March 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,419,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.49&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;199.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options exercisable as of March 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,619,438&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.62&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;161.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The aggregate intrinsic value represents the difference between the closing stock price of our common stock and the exercise price of in-the-money options. Our closing stock price as reported on the Nasdaq Stock Market on March 31, 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24.39&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options granted during the three months ended March 31, 2023 include our annual long-term incentive awards, which were granted in February 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes our restricted stock activity as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.636%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.831999999999997%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.861%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.291999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number&lt;br/&gt;of Units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-vested at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,932&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26.41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;570,922&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,737&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-vested at March 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;559,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, total unrecognized equity-based compensation expense relating to restricted stock unit awards was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, which is expected to be recognized over a weighted average period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.8&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_e39c512b-c734-45a6-bc53-6911f114a373">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes equity-based compensation expense included in our unaudited condensed consolidated statements of operations and comprehensive loss:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.401%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.797%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.797%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total equity-based compensation expense included in total operating expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes equity-based compensation expense by award type included in our unaudited condensed consolidated statements of operations and comprehensive loss:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.401%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.797%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.502%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.797%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;226&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total equity-based compensation expense included in total operating expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_1c59bb28-7d9d-41f1-a3e6-9fdb1e61a326"
      decimals="-3"
      id="F_83d53336-3914-4325-a647-f90fed347b54"
      unitRef="U_USD">6339000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_40a019d3-e92f-4c7b-9557-6132ab2cd1c4"
      decimals="-3"
      id="F_9bd43404-03d9-46e0-8c65-a94bf383f7b4"
      unitRef="U_USD">4006000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_a1b4107b-3ed7-40e8-9ad5-1379b770ce94"
      decimals="-3"
      id="F_3dd61df6-506c-4f87-b4de-2f7b661ec5fa"
      unitRef="U_USD">6253000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c290d454-3c40-474b-a8cb-1192e1d1df68"
      decimals="-3"
      id="F_34b8a3fe-6faa-4aec-ae04-84f819a0b89b"
      unitRef="U_USD">4552000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_88f1db47-1162-4a31-89e4-e90005553ba8"
      unitRef="U_USD">12592000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_5bca1ef3-c17c-4f5d-af8b-167c7c8dc463"
      unitRef="U_USD">8558000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d"
      decimals="-3"
      id="F_c72ea9ea-659c-41c4-be7a-1413ef433138"
      unitRef="U_USD">11663000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757"
      decimals="-3"
      id="F_4050a7ea-78fb-4571-9fc6-3b3493af107a"
      unitRef="U_USD">8359000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c"
      decimals="-3"
      id="F_91696951-7a3e-4c8a-a706-97a742d863a2"
      unitRef="U_USD">703000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_d7e7b52c-2a39-4e61-89ff-8d10c8cb2f4b"
      decimals="-3"
      id="F_bb2ca80d-2dd3-44f2-bece-d30b5823fb62"
      unitRef="U_USD">9000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0cd9a4b8-d9bd-4d67-875a-67846552b346"
      decimals="-3"
      id="F_fc8474f4-81ee-4fba-95e3-bc68765310df"
      unitRef="U_USD">226000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_a7ea4b46-178f-4956-8746-80498e54c789"
      decimals="-3"
      id="F_a2d55fbf-1bf7-479f-8e1a-f298c9b5c920"
      unitRef="U_USD">190000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_a7cedc5a-a54e-4c55-b21b-9f258669a8aa"
      unitRef="U_USD">12592000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_7f949623-a153-402d-89ed-585208010759"
      unitRef="U_USD">8558000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d"
      decimals="2"
      id="F_2da3c822-30ca-4c2c-a241-16b24d8038af"
      unitRef="U_USDollarShare">26.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757"
      decimals="2"
      id="F_f1843f31-08c2-4376-b318-4b67625f628b"
      unitRef="U_USDollarShare">23.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_01f0eb4d-628d-4caa-bcf7-e68006d2ae66">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The weighted-average assumptions that we used to determine the fair value of stock options granted to employees are summarized as follows: &lt;/span&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.35%;"/&gt;
        &lt;td style="width:1.166%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.656%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.166%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.661000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;96.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d"
      decimals="4"
      id="F_c59afe00-1ac3-499d-8088-2c9740cd4ebb"
      unitRef="U_pure">0.0376</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757"
      decimals="4"
      id="F_0ca7e27c-c323-4910-ad5e-1e1dba77fb75"
      unitRef="U_pure">0.0185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d"
      id="F_442f2f91-3176-430f-931c-ebd91985df17">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757"
      id="F_4ad236f1-74a7-49e1-ae74-e28503bc52b1">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d"
      decimals="3"
      id="F_3bbf4346-05ed-45c6-8557-24d1004072ed"
      unitRef="U_pure">0.905</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757"
      decimals="3"
      id="F_1501a98a-eb8a-42ef-b7f6-a04169e895e2"
      unitRef="U_pure">0.962</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d"
      decimals="3"
      id="F_696e930b-13e7-42f9-888e-b0edf18cacfc"
      unitRef="U_pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_5fc6cb6c-cce7-4510-ac73-4558e8cc0757"
      decimals="3"
      id="F_fb87335a-c223-4cc0-9d13-a40573af33ec"
      unitRef="U_pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_46d1eb9f-1608-412b-a122-ad9ff076c478"
      decimals="-5"
      id="F_02dafbd7-312b-4344-bb3a-0bea1c7630cf"
      unitRef="U_USD">132200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_50c7f288-e026-4d07-9cdc-7e93e4fac70d"
      id="F_0412a789-3145-432d-8448-322ba44f805e">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_30317269-dd0a-4bca-95ad-18fda709dae8">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes our stock option activity for the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three months ended March 31, 2023:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.65%;"/&gt;
        &lt;td style="width:1.001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.614999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.914000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.116%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.094999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(in millions)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,178,861&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13.59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.55&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;309.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,015,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;257,824&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeited, canceled or expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;517,077&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding at March 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,419,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.49&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;199.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options vested and expected to vest as of March 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,419,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.49&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;199.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options exercisable as of March 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,619,438&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.62&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;161.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_21573dc6-6769-41aa-991d-b0f72b895688"
      decimals="INF"
      id="F_95f414e3-cc6b-4f45-8c1d-9cfcc6fd18e1"
      unitRef="U_shares">17178861</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_21573dc6-6769-41aa-991d-b0f72b895688"
      decimals="2"
      id="F_faa11440-9773-4411-9fb2-f6455969198c"
      unitRef="U_USDollarShare">13.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_92b2e51b-74ba-476d-a0bb-1a6c588851a7"
      id="F_a1edc90e-9016-4be4-a5bd-3b6c723315f8">P7Y6M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_21573dc6-6769-41aa-991d-b0f72b895688"
      decimals="-5"
      id="F_8eba0f61-e222-419f-b6dc-725fb932e0fc"
      unitRef="U_USD">309900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="C_8de10066-7b96-4965-9078-908525b6b838"
      decimals="INF"
      id="F_785ba6e0-05cb-47f0-af1b-ef67ea573db0"
      unitRef="U_shares">2015264</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_8de10066-7b96-4965-9078-908525b6b838"
      decimals="2"
      id="F_39dff4ef-33fe-4f88-9edf-8793427f5883"
      unitRef="U_USDollarShare">34.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_8de10066-7b96-4965-9078-908525b6b838"
      decimals="INF"
      id="F_c89e9c08-1eed-4936-aa11-fc18553f21bc"
      unitRef="U_shares">257824</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_8de10066-7b96-4965-9078-908525b6b838"
      decimals="2"
      id="F_2788bd52-5d51-4a7d-a8d6-ac269091ffb2"
      unitRef="U_USDollarShare">6.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_8de10066-7b96-4965-9078-908525b6b838"
      decimals="INF"
      id="F_50270fbb-ddbb-4d20-a2bf-c8649094faf1"
      unitRef="U_shares">517077</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_8de10066-7b96-4965-9078-908525b6b838"
      decimals="2"
      id="F_e363d076-8c0e-49ad-b618-b836e3077324"
      unitRef="U_USDollarShare">21.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad"
      decimals="INF"
      id="F_d09e24c9-3159-4bdc-9529-d1c29afd54fa"
      unitRef="U_shares">18419224</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad"
      decimals="2"
      id="F_93066ced-c7f2-4ca9-b31e-1954166acfdc"
      unitRef="U_USDollarShare">15.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_8de10066-7b96-4965-9078-908525b6b838"
      id="F_e34769aa-ad55-4f0a-9b33-af0d6a128464">P7Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad"
      decimals="-5"
      id="F_456e588d-60e4-4d61-966e-7fe7c4360230"
      unitRef="U_USD">199000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad"
      decimals="INF"
      id="F_a9d7cb26-a03e-4306-86de-754b1f8a6b29"
      unitRef="U_shares">18419224</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad"
      decimals="2"
      id="F_54962822-1ab1-4fa5-b6b8-b9e119f399c4"
      unitRef="U_USDollarShare">15.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_8de10066-7b96-4965-9078-908525b6b838"
      id="F_71bd3312-f488-4176-8958-2fae7798fd9b">P7Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad"
      decimals="-5"
      id="F_8051b344-a40d-463d-b3f3-dd941d488b1a"
      unitRef="U_USD">199000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad"
      decimals="INF"
      id="F_362ebfa8-343e-495e-862a-c3565dd95453"
      unitRef="U_shares">10619438</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad"
      decimals="2"
      id="F_5c6a2ae3-dfa7-4fd5-a72b-97857f5ad4ce"
      unitRef="U_USDollarShare">9.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_8de10066-7b96-4965-9078-908525b6b838"
      id="F_babf07c3-f244-45c9-b92d-edbc210decf8">P6Y7M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_15c8f494-814b-44c7-b085-58997b57d0ad"
      decimals="-5"
      id="F_ea2cec11-fcc3-49ec-81e7-057a987231de"
      unitRef="U_USD">161300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <cere:ClosingPriceOfCommonStock
      contextRef="C_9e127b71-4539-48d9-9d6b-1b9b6c4de7ad"
      decimals="2"
      id="F_d5964bc6-bca1-4116-a8e5-5dad2f5c99fa"
      unitRef="U_USDollarShare">24.39</cere:ClosingPriceOfCommonStock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_9d3ba08d-012e-44fb-af57-239e282acca6">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes our restricted stock activity as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.636%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.831999999999997%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.861%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.291999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number&lt;br/&gt;of Units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-vested at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,932&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26.41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;570,922&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,737&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-vested at March 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;559,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_899c628a-be1d-4d05-b35c-2e06c2ed5337"
      decimals="INF"
      id="F_0b98a734-01cf-4b10-ad85-f3d4a15b6f57"
      unitRef="U_shares">18932</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_899c628a-be1d-4d05-b35c-2e06c2ed5337"
      decimals="2"
      id="F_c9902dbf-07cb-4fdf-9b0b-6b35b9243856"
      unitRef="U_USDollarShare">26.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c"
      decimals="INF"
      id="F_f6e27b47-4586-4446-b1f5-979b233a697b"
      unitRef="U_shares">570922</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c"
      decimals="2"
      id="F_d13962a5-9a0c-43fe-8965-a5ae6a4a857e"
      unitRef="U_USDollarShare">34.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c"
      decimals="INF"
      id="F_88695575-5d3e-4bf6-8435-21cf0c284338"
      unitRef="U_shares">30737</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c"
      decimals="2"
      id="F_6c00f496-2784-48b2-93b5-684a36e2b4fe"
      unitRef="U_USDollarShare">34.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_1cc94817-d461-46f2-8d51-8d0b51788032"
      decimals="INF"
      id="F_305484e9-8015-4f13-8056-1403706ab928"
      unitRef="U_shares">559117</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_1cc94817-d461-46f2-8d51-8d0b51788032"
      decimals="2"
      id="F_23c2f2b8-5746-447e-8b44-a3a2f89dac77"
      unitRef="U_USDollarShare">34.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_1cc94817-d461-46f2-8d51-8d0b51788032"
      decimals="-5"
      id="F_06507c8b-58d0-4de1-9eca-e51f47d0db0a"
      unitRef="U_USD">18300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_f76fd2db-e57c-466d-8c84-9a10342d867c"
      id="F_7052be1d-697a-4f93-b986-daf69b5f8d65">P3Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_711117f6-dfd7-46c4-b40c-1c5b9a9a14b5">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11. Net Loss Per Share&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table sets forth the computation of the basic and diluted net loss per share:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.08%;"/&gt;
        &lt;td style="width:1.622%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.837%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.622%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.837%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands, except share amounts and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;104,286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;68,294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-average shares used in calculating net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;156,648,365&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;147,984,926&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Since we were in a loss position for all periods presented, diluted net loss per share is the same as basic net loss per share as the inclusion of all potential dilutive securities would have been anti-dilutive. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The shares in the table below were excluded from the calculation of diluted net loss per share due to their anti-dilutive effect: &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.96%;"/&gt;
        &lt;td style="width:1.16%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.36%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.16%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.36%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,419,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,901,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;559,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,270&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ESPP shares issuable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,889&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock issuable upon conversion of the 2027 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,439,338&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26,450,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,930,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_4f9dd041-4d16-434f-8f10-f3108fe94a57">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table sets forth the computation of the basic and diluted net loss per share:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.08%;"/&gt;
        &lt;td style="width:1.622%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.837%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.622%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.837%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;(In thousands, except share amounts and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;104,286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;68,294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted-average shares used in calculating net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;156,648,365&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;147,984,926&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="-3"
      id="F_953a2fd7-7741-460c-ad4d-c0031ff28ccf"
      unitRef="U_USD">-104286000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="-3"
      id="F_14b8027c-6688-4b74-8816-14c99bf25181"
      unitRef="U_USD">-68294000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="0"
      id="F_ae2a75b0-51d4-4f81-aefa-22e07e00e0fc"
      unitRef="U_shares">156648365</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="0"
      id="F_c1ef667b-8c0d-4268-8c82-2697ceff5214"
      unitRef="U_shares">156648365</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="0"
      id="F_b459541a-edc9-4434-b9d6-4afa9fff8fe8"
      unitRef="U_shares">147984926</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="0"
      id="F_d02e88e3-196c-48ec-8dbf-0ecabe4799a4"
      unitRef="U_shares">147984926</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="2"
      id="F_d4db4fc7-0341-4259-be91-b70d1871e651"
      unitRef="U_USDollarShare">-0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="2"
      id="F_64cbc886-1899-404a-af14-87fe8cc5ad66"
      unitRef="U_USDollarShare">-0.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="2"
      id="F_1d5b20fe-d849-4811-8b2a-da41874ff262"
      unitRef="U_USDollarShare">-0.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="2"
      id="F_1e0be976-c661-4909-9e34-e25b8023447f"
      unitRef="U_USDollarShare">-0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_9c7fd929-1d59-4064-8ee6-b2c337535496">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The shares in the table below were excluded from the calculation of diluted net loss per share due to their anti-dilutive effect: &lt;/span&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.96%;"/&gt;
        &lt;td style="width:1.16%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.36%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.16%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.36%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,419,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,901,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;559,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,270&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ESPP shares issuable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,889&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock issuable upon conversion of the 2027 Notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,439,338&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26,450,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,930,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_623d5c61-4653-419b-bf3c-247bbbbcf873"
      decimals="INF"
      id="F_c885868f-d249-49b7-b2a4-7cba7bd9d98c"
      unitRef="U_shares">18419224</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_911f321f-1399-42d6-924b-a7af11513555"
      decimals="INF"
      id="F_c4464aa9-f15a-455f-97f5-80b0c875a7e3"
      unitRef="U_shares">17901741</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_fec256c3-1d62-4da5-88de-9f274918ad60"
      decimals="INF"
      id="F_c5ffe7f5-8db5-498c-93bc-b541f62166d0"
      unitRef="U_shares">559117</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b465d2c0-b208-43d9-8601-c79cda11d054"
      decimals="INF"
      id="F_ad73d19c-eafc-4eb8-8eeb-48c3f6354567"
      unitRef="U_shares">14270</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_8bc95105-86e8-4b58-bd13-577576fe83fb"
      decimals="INF"
      id="F_2b16451d-b81c-452c-879f-29b1f71000cc"
      unitRef="U_shares">32410</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_7c3a2ba3-5a06-4c1a-8098-9614f0f55d00"
      decimals="INF"
      id="F_06b38142-7d8a-41f1-8f3b-9b820b0cdee0"
      unitRef="U_shares">14889</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_284250e0-ecad-485e-b02c-3498eba26ca3"
      decimals="INF"
      id="F_0707758b-cbee-4b5b-a329-424242f7b798"
      unitRef="U_shares">7439338</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="INF"
      id="F_5bd0dc13-73d3-4df0-8071-9821b8acac5d"
      unitRef="U_shares">26450089</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="INF"
      id="F_c9f302db-99cf-4724-ab70-7a94ebfee9ea"
      unitRef="U_shares">17930900</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_42ffd9b8-dcad-4ac4-bcfd-e50c5b6b92ac">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12. Income Taxes&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the three months ended March 31, 2023 and 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, we did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t record income tax benefits for net operating losses incurred or for the research and development tax credits generated in each period due to the uncertainty of realizing a benefit from those items. Our tax provision and the resulting effective tax rate for interim periods is determined based upon our estimated annual effective tax rate, adjusted for the effect of discrete items arising during the interim quarterly period. The impact of such inclusions could result in a higher or lower effective tax rate during a particular quarterly period, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarterly period, we update our estimate of the annual effective tax rate, and if the estimated annual tax rate changes, a cumulative adjustment is made in that quarter.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We have evaluated the positive and negative evidence bearing upon our ability to realize our deferred tax assets, which primarily consist of net operating loss carryforwards and research and development tax credits. We have considered our history of cumulative net losses, estimated future taxable income and prudent and feasible tax planning strategies, and have concluded that it is more likely than not that we will not realize the benefits of our deferred tax assets. As a result, as of March 31, 2023 and December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, we have recorded a full valuation allowance against our net deferred tax assets.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <cere:IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      decimals="INF"
      id="F_02e92101-d3a5-4dfc-9c34-7d9745ea23d5"
      unitRef="U_USD">0</cere:IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits>
    <cere:IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits
      contextRef="C_ee2b045d-5198-451f-83dc-eabf28665da6"
      decimals="INF"
      id="F_0e15b131-d331-4263-bd00-387514799197"
      unitRef="U_USD">0</cere:IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_c96930bd-135a-437d-86fc-29e0e80181b3">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13. Legal Proceedings&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We, from time to time, may be subject to various legal proceedings and claims that may arise in the ordinary course of business. We were not subject to any material legal proceedings as of March 31, 2023&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, and, to the best of our knowledge, no material legal proceedings are currently pending or threatened.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_378cc67b-3316-432e-a6d4-b7c236fcae5e">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14. Commitments and Contingencies&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023, we have several ongoing clinical studies in various clinical trial stages. Our most significant contracts relate to agreements with CROs for clinical trials and preclinical studies and CMOs for the manufacturing of drug substance, which we enter into in the normal course of business. The contracts with CROs and CMOs are generally cancellable, with notice, at our option.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Guarantees and Indemnification Obligations&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;enter into standard indemnification obligations in the ordinary course of business. Pursuant to these obligations, we indemnify and agree to reimburse the indemnified party for certain losses and costs incurred by the indemnified party. The term of&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;these &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;indemnification obligations is generally perpetual after execution of the agreement. In addition, we have entered into indemnification obligations with members of our board of directors and our executive officers that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or executive officers. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited. To date, we have &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t incurred any losses or any material costs related to these indemnification obligations and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; claims with respect thereto were outstanding. We do not believe that the outcome of any claims under indemnification arrangements will have a material effect on our financial position, results of operations and cash flows, and we have &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t accrued any liabilities related to such obligations in our condensed consolidated financial statements as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;March 31, 2023 and December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <cere:LossOrMaterialCostsRelatedToIndemnificationObligation
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_ef4303bc-539f-4b1e-b62c-97450b9edfd0"
      unitRef="U_USD">0</cere:LossOrMaterialCostsRelatedToIndemnificationObligation>
    <cere:ClaimsOutstanding
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_60259fd0-09fc-41bb-aa68-6e8329b0935b"
      unitRef="U_USD">0</cere:ClaimsOutstanding>
    <us-gaap:ContractualObligation
      contextRef="C_b26045f3-5a6c-47d0-9ed5-64df9586b32d"
      decimals="INF"
      id="F_4dc2a493-f619-4a50-85e4-5eda46a0c136"
      unitRef="U_USD">0</us-gaap:ContractualObligation>
    <us-gaap:ContractualObligation
      contextRef="C_954014cb-1c62-40cc-b12d-3f0d6d59529e"
      decimals="INF"
      id="F_0072bbf2-f25b-410b-8ba4-9615857a7e1d"
      unitRef="U_USD">0</us-gaap:ContractualObligation>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_c4bad249-5a5a-4c8a-a729-b8a7e90cadb6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15. Related Parties&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023 and December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, Pfizer held &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,349,211&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock and had nominated &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;two&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; members to our board of directors. For information related to our license agreement with Pfizer, please read Note 4, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Pfizer License Agreement&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to these unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of March 31, 2023 and December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, Bain Investor held &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60,632,356&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock and had nominated &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;four&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; members to our board of directors.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research Collaboration and License Agreement&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In June 2022, we entered into a research collaboration and license agreement with Pfizer, pursuant to which we will collaborate to identify, screen and evaluate compounds directed at certain targets for neuroscience diseases using Pfizer&#x2019;s chemical library. Under the terms of the agreement, we will be required to reimburse Pfizer for certain research services and make a contingent development milestone payment and single-digit royalty payments on net sales of products containing one or more compounds derived from the collaboration. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; amounts have been incurred under the agreement to date.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Funding Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In April 2021, we entered into a funding agreement with Bain, pursuant to which Bain will provide up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in funding (the Bain Funding Commitment) to support our development of tavapadon for the treatment of Parkinson&#x2019;s disease over &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;four years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, of which approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the Bain Funding Commitment, net of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of fees incurred by Bain) was received in April 2021, approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the Bain Funding Commitment) was received in April 2022 and approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the Bain Funding Commitment) was received in April 2023. For additional information related to our funding agreement with Bain, please read Note 5, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financing Liabilities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to these unaudited condensed consolidated financial statements&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Management Agreement&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Following the closing of the business combination in October 2020 pursuant to which ARYA Sciences Acquisition Corp II (ARYA) acquired Cerevel Therapeutics, Inc., with Cerevel Therapeutics, Inc. becoming a wholly-owned subsidiary of ARYA and ARYA being renamed Cerevel Therapeutics Holdings, Inc. (the Business Combination), we entered into a management agreement with Bain Capital Private Equity, LP and Bain Capital Life Sciences, LP, providing for the expense reimbursement and indemnification of such entities. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; amounts have been incurred under the management agreement to date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For additional information related to the Business Combination, please read Note 3, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Business Combination&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to our audited consolidated financial statements included in our Annual Report.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_ddc57f0c-b90e-42fa-a10e-071a42e87507"
      decimals="INF"
      id="F_c5481185-fe08-4b11-a0c3-71c4e5ef518e"
      unitRef="U_shares">27349211</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_7926166c-1158-47a0-bad4-4df4c981c1ea"
      decimals="INF"
      id="F_1e0c798b-3685-46c0-9210-7e59a0820383"
      unitRef="U_shares">27349211</us-gaap:CommonStockSharesOutstanding>
    <cere:NumberOfMembersNominatedToBoardOfDirectors
      contextRef="C_ddc57f0c-b90e-42fa-a10e-071a42e87507"
      decimals="INF"
      id="F_0b30d029-cc66-4747-aa51-6f2a2ace7977"
      unitRef="U_Director">2</cere:NumberOfMembersNominatedToBoardOfDirectors>
    <cere:NumberOfMembersNominatedToBoardOfDirectors
      contextRef="C_7926166c-1158-47a0-bad4-4df4c981c1ea"
      decimals="INF"
      id="F_0be43598-2ddb-4be8-94bc-2cdc3e20f3cc"
      unitRef="U_Director">2</cere:NumberOfMembersNominatedToBoardOfDirectors>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_47e87e92-f44a-4427-9ca3-b597abbae8dd"
      decimals="INF"
      id="F_49d2fd82-b859-4ea5-8e22-e2fefafc14d4"
      unitRef="U_shares">60632356</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_2e9e51f7-25c0-4608-9ac4-8d13311a476a"
      decimals="INF"
      id="F_049bf8b8-2d50-4f01-8c89-972b21deb881"
      unitRef="U_shares">60632356</us-gaap:CommonStockSharesOutstanding>
    <cere:NumberOfMembersNominatedToBoardOfDirectors
      contextRef="C_47e87e92-f44a-4427-9ca3-b597abbae8dd"
      decimals="INF"
      id="F_a629b3f9-c30d-43b0-9d09-578fef662a2a"
      unitRef="U_Director">4</cere:NumberOfMembersNominatedToBoardOfDirectors>
    <cere:NumberOfMembersNominatedToBoardOfDirectors
      contextRef="C_2e9e51f7-25c0-4608-9ac4-8d13311a476a"
      decimals="INF"
      id="F_f76f04d2-573e-4d30-b1cc-0f111c843aec"
      unitRef="U_Director">4</cere:NumberOfMembersNominatedToBoardOfDirectors>
    <cere:ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales
      contextRef="C_57afd6d7-6dec-4c48-81b7-57d06bc6ff76"
      decimals="INF"
      id="F_2c6587a2-01ef-4576-a866-692d9669502e"
      unitRef="U_USD">0</cere:ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales>
    <cere:ExpectedFundingReceived
      contextRef="C_529612ad-d864-4e48-8033-b7bbacbe0414"
      decimals="-5"
      id="F_17747c5d-6d39-40a2-b07c-109166cf4e6f"
      unitRef="U_USD">62500000</cere:ExpectedFundingReceived>
    <cere:PeriodOverWhichFundingSupportReceived
      contextRef="C_d181ad3b-847c-47c7-bf08-243985685e37"
      id="F_afaeb87c-3ba8-436f-b031-4016ece533d0">P4Y</cere:PeriodOverWhichFundingSupportReceived>
    <cere:ReceivedFunding
      contextRef="C_529612ad-d864-4e48-8033-b7bbacbe0414"
      decimals="-5"
      id="F_14fe3c92-6adf-4a5d-a5de-b00019275d06"
      unitRef="U_USD">15500000</cere:ReceivedFunding>
    <cere:PercentageOfFundingReceived
      contextRef="C_d181ad3b-847c-47c7-bf08-243985685e37"
      decimals="2"
      id="F_6e1da8a6-274f-4f0a-a6a4-d140c845924b"
      unitRef="U_pure">0.25</cere:PercentageOfFundingReceived>
    <cere:FundingCommitmentFeesIncurred
      contextRef="C_d181ad3b-847c-47c7-bf08-243985685e37"
      decimals="-5"
      id="F_8c14d192-3a30-46f3-879a-f6522f660664"
      unitRef="U_USD">100000</cere:FundingCommitmentFeesIncurred>
    <cere:ReceivedFunding
      contextRef="C_e18c341f-7f07-4b88-b7c8-d5a4564e49f7"
      decimals="-5"
      id="F_622cdb3a-8db8-419d-ad86-353e94c153fe"
      unitRef="U_USD">18800000</cere:ReceivedFunding>
    <cere:PercentageOfFundingReceived
      contextRef="C_834332ad-3dba-4592-8eb7-930c35444385"
      decimals="2"
      id="F_9246a32f-4d6e-4097-abd5-24aa33761918"
      unitRef="U_pure">0.30</cere:PercentageOfFundingReceived>
    <cere:ReceivedFunding
      contextRef="C_377cdbcd-01a6-4d76-a487-4dc2f01fee00"
      decimals="-5"
      id="F_ce594d2e-af3c-4ecc-b430-34a397c7b901"
      unitRef="U_USD">15600000</cere:ReceivedFunding>
    <cere:PercentageOfFundingReceived
      contextRef="C_4bf2f962-7b29-42b6-974d-afe70add4992"
      decimals="2"
      id="F_d358cd26-8c17-4f69-b52e-24e2fe507029"
      unitRef="U_pure">0.25</cere:PercentageOfFundingReceived>
    <us-gaap:ManagementFeeExpense
      contextRef="C_9d7b2424-bafc-4343-b726-7e736ab93480"
      decimals="INF"
      id="F_5baefca9-9509-44b8-a750-551f6df878ab"
      unitRef="U_USD">0</us-gaap:ManagementFeeExpense>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_476db5f8-cbfa-499e-9fce-a46c6af239cc"
      id="F_b8013df0-14c9-49c3-86fe-ca4981db9446">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16. Subsequent Events&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We have completed an evaluation of all subsequent events after the unaudited balance sheet date of March 31, 2023, through May 3, 2023, the issuance date of these financial statements, to ensure that these unaudited condensed consolidated financial statements include appropriate disclosure of material events both recognized in these unaudited condensed consolidated financial statements as of March 31, 2023, and material events which occurred subsequently but were not recognized in these unaudited condensed consolidated financial statements. We have concluded that no such subsequent events other than the following have occurred that require disclosure:&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:2.267%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Funding Agreement Receipts&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Pursuant to the Funding Agreements, we received &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;31.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the Total Funding Commitment) in April 2023. For additional information related to our Funding Agreements, please read Note 5, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financing Liabilities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, to these unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <cere:ReceivedFunding
      contextRef="C_f130d7e4-71de-45ed-8562-45858d825a2a"
      decimals="-5"
      id="F_cd518aa2-a4a6-43a3-be10-b557c3a08506"
      unitRef="U_USD">31300000</cere:ReceivedFunding>
    <cere:PercentageOfFundingReceived
      contextRef="C_a4ba2f01-2e93-4b42-9142-63c99321d789"
      decimals="2"
      id="F_a368a650-f6d0-43b4-b234-345690c8a186"
      unitRef="U_pure">0.25</cere:PercentageOfFundingReceived>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?JQOM%PUWP^NI=:R:"Z7G %Z8P"_WTB0#NV-^231?8*:_0=02P,$%     @
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MWXF $?Y#-TI0H^V1W9U:C94#1T=>-=CJ/S3K_W/!,,K(/[)TK)"$KZ<3\U-
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M]Z?#&?E0-, (I[ O+AQV&=2Z?"256^\'_.+BV_Z^@!V2(8W[^]U]5KOXK%S
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MFI'O)J]N$5V3IIV5BYB=TF<%9[(7 9RO';S:+^2"8?Q=_@M02P,$%     @
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MN;/-'#D%A9"YR?DHRN^0%I\Y_4&6RY26P7<+G!/X*(3RDCJ:JR;?+;[F%1>
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ME;6+T35\2=B@/6W .KWK]#=D8/C.=O4?4$L#!!0    ( &F!HU9:SI#Y:@0
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M7&>3;]YD_8#=OP3;I3O%Q@;<4-)C R'(L0&^5Q:*#"\<8+QDKOX!4$L#!!0
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M%%:M+@?+R>OK.<WG"1^UVKJ#9T&2Q,9\HI>[]'(P)D(J5XDG!(F_C;I1>4Y
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MYS)G+V,!H5!H+^:*C"+]R/6_"3P6]A!G!6Q5H1&EK\.M$#66YG90H<+*(JI
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M:$&(X\H <$:Y>>X)&QD/*LH6U7%P,L*UDK\" KVB;Z3H9U!\?$.82%XZ/K"
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MLE7^,"+76GE'M@_Q3X_]*Z& PPE+4G&DKI8'%N?ZFA[7EZ8_)/.)9?ZLBDI
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M?FB9JRH3(Q%G[(DS"XINN:"A[$LB1X/G)JI9XUE6Y@?&R/1.\ D]G!-&T(2
MK$*S,_*9=Y6*&&J".?_"8HN[B6CK.PP47J*L8C0W"Y/3#H/&0LI9XE0K!US
M2P-1;7/6GYE;*>T**R2 :%LC9#.2!7R4-.^4X"=Z(ZEN<CA4GQDW$ #_;)=U
M+IK *D0\&#O?53O917L#IU5_B_H;RJB: N=N=S)45R@6\/G?V'J8/D+7K'7X
M!*[>PV%\>)2\.DJ3<?J#I,+KPW223(X/MQC?AMO3T4FX4C7)F5;>#=47%]D
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MH]%T[(/J!F2W,;)Q0VDK#8XXMZSP/P555@#O=Q*=ZC?6P/ O9?4_4$L#!!0
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M?4P'X_Z^*&DD66&T 7XJ7)/;AMT9BDY'V>N9N(:ZJIR/J;ANGXKD@UJJ2A4
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MSZ@?JOK=5D^,+-U;:2D-O;S<,*.G+BHK0/NI))XU$WM ^WB>_P]02P,$%
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MB3QGTIR,&9TQV4QQA_8P<+:ZUJ-9 [U&%&YDY803W%) <FI].7\^)U,Q9[+
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MYE(U#?3_[\JR?GG2)-C<C6;Z#U!+ P04    " !I@:-6\?U$((<#  "D#@
M&0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6S55VUOVS80_BN$5@P)$$=O
M?DMF"VB<!BO08%FR=A^*?:"ELT6$(C62LIO]^ATI1;%CQ6T HT"^V")Y]_"Y
MA\<#;[*6ZE[G (9\*[C04R\WICSW?9WF4%!]*DL0N+*0JJ &AVKIZU(!S9Q3
MP?TH"(9^09GPDHF;NU')1%:&,P$WBNBJ**AZN  NUU,O]!XG;MDR-W;"3R8E
M7<(=F,_EC<*1WZ)DK "AF11$P6+JO0_/9V%D'9S%%P9KO?%-;"AS*>_MX&,V
M]0++"#BDQD)0_%O!##BW2,CCWP;4:_>TCIO?C^A7+G@,9DXUS"3_FV4FGWIC
MCV2PH!4WMW+].S0!#2Q>*KEVOV3=V 8>22MM9-$X(X."B?J??FN$V'! G&Z'
MJ'&(GCOT7W"(&X?8!5HS<V%=4D.3B9)KHJPUHMD/IXWSQFB8L,=X9Q2N,O0S
MR1435*1,+,DG1N>,,\- DQZYJX^5R 69Y50L<9()\D$;AM)!1JXH4^0+Y158
MDVZ4HTLPE'%]C'B?[R[)T;MC\L["_)7+2E.1Z8EO, ;+Q$\;OA<UW^@%OC&Y
MEL+DFGP0&63;_C[&W@H0/0IP$>T%O*;JE,3A"8F"*.[@,_MQ]V@/G;@]C]CA
MQ2^=1ZOK"?FCM)E^0OZLJ##,4)OPY)+IE$M=*13XZR?T)A\-%/J?+BGKK?K=
M6]D"<:Y+FL+4PPJ@0:W 2W[])1P&OW7I<""P+57ZK2K]?>A)G8(V=196GY7+
M.VJ,8O/*T#D'8B2N:J,J+#&FITM(V8*E)%60,4,4T_=8=%*Y%.P_S%X$DB8'
M15)9(-W<EB74]H@)G(!C@@)WYF;-<NA8V@*Y2GIGP7#BKS:%VC4*H]&3T98
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MK)FL^K%JH$5>MC1SH;%!*F]7V,."- OP^4)@'U(/3)?4=,71'U!+ P04
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M,)LY6G*FY.AO<_3!(?V6Y-N3J"Y1OZ&C ?.&#MZ16]-L2#=G/IW>!MO@!N
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M3+AOWWT Q]EYY(_RS%CMH3&8I/;*W.ZS8\? *29QBAU2DMHG\R88Z99V-6;
MTBZ3^,3>6)EZB\QA75LM6MGRIG:CY#D&%ZWVZMHJ:]GRICX4*5G+/Z1RM4?7
ME0^V1]<:,YVN^[5'YHO?*Q 8]!3&&8KXHVCGG/IB8J2;GP#8O,F39?D4_23)
M\V11OISS8,;3PD!\_Y@D^>N;XL'\[0\QC/X'4$L#!!0    ( &F!HU9W.XG$
M# 4  ,L<   9    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;,U9VV[C-A#]
M%4(MBBV01A=?DSH&$JO9!HC;($&V#XL^T-+8%E8B79*V-T4_OD-)D:Q8H>.
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M'!M@IJU%HIX(G^.U^(8)IV,A=: P)4&VD5XX[^?.=;'?C+V1N]EE\F"+T#B
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MKA3/\LLET!B$;H#OYYRKYQOMH#J_'/\/4$L#!!0    ( &F!HU8$] !5N@4
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MU/4E8_+[@7ZYH7R99?P_4$L#!!0    ( &F!HU8*IOV:I ,  %8*   9
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MT'11S@I?Q,N)BUXI:K &!*Y(M7LZI":ERRFF7%BU\9/#4EF:0_QG1H,?:B=
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MIFJB6''F3&C"88:0WFD?(Z>JQE1-C,S+VCZ5!CM%.4RQEX.R!K@_D]*L)_:
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M*O)#POQ!\75VSO; E>))=AL!#4'H /R^Y%R]/.@!RJ/:Z;]02P,$%     @
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MZ/[].^$1%<T$_!J!:^0%(=HF8%SB2 )!22 P$E#E8DRHRL 5B/2+%*N3DG%
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M(EQ/4,_'C,G5C5Z@_#-%_W]02P,$%     @ :8&C5KVQLLCE P  B1   !D
M  !X;"]W;W)K<VAE971S+W-H965T-3 N>&ULS5AM;^)&$/XK(_=4Y:0$8YL0
MD@)2('=JI*:-0M-^./7#8@^PBNTENPN$JC^^LVO'&,[QW2&KUR]XW^;9>1[O
MC'?H;X1\4@M$#2])G*J!L]!Z>>6Z*EQ@PE1++#&EF9F0"=/4E7-7+26RR!HE
ML>NWVUTW83QUAGT[=B^'?;'2,4_Q7H):)0F3VQ'&8C-P/.=UX('/%]H,N,/^
MDLUQ@OIQ>2^IYQ8H$4\P55RD('$V<*Z]J['7,09VQ1\<-ZK4!D-E*L23Z=Q&
M Z=M/,(80VT@&#W6.,8X-DCDQW,.ZA1[&L-R^Q7]HR5/9*9,X5C$?_)(+P9.
MSX$(9VP5ZP>Q^1ES0N<&+Q2QLK^PR=>V'0A72HLD-R8/$IYF3_:2"U$R\,_?
M,/!S __ @)2I-@AR@\ 2S3RSM&Z89L.^%!N09C6AF8;5QEH3&YZ:USC1DF8Y
MV>GAA^<5U]NS$2D1P5@D=#P4LP*?P744<=-D,=RFV8DQ$R<WJ!F/U7M:\CBY
M@9-W[^$=N* 63*("GL)CRK4ZI4%JW_$X)BO5=S6Y:S9UP]RU4>::_X9K =R)
M5"\4?$@CC/;M7:)9</5?N8[\6L [)EL0>*?@M_V@PI_QUYO[->X$A?2!Q>N\
M@?> 2DL>:A)^HD7XE,D&)P^31]+VTQTF4Y1_5>E6BVL"_THM68@#AR);H5RC
M,_SQ!Z_;_JF*=$-@>Q)T"@DZ%CUX0X*).3)0<?BNI63I'"E?:!AMH;SNGFWM
M\/6&R0@^_4*0<*LQ4952=9J4JB&P/:G."ZG.:T]+'JA3JT%8U@I?3!OMTYXF
M+6"*E&-#,4_YWS0@UBAA8S,:]1CU*$/#$B47495H]9X$L$4F%5Q"DL6GUX.(
M;:LB?%R+=*1BW4*Q;JV?OPM-F6N5EH3 +XE8I4:VBY=M8SZ+ZZ'7:U$"69>9
MUOIR)-.+@NE%+=,L??RV-$Q4;>:HQ?G6<&@(;(]RKZ#<^\Z9H]>D5 V![4EU
M64AU^16G0^2G8T[R4!8X_3P?V)FSB&F$&>,2UBQ>8>5W.]NO5PH(O]ORO8.(
MJ%@5M+I^L6J/C-?>75C:_YM$^ 57\DQ8]<+K+8]\XU[I5N?])[DOWV8_^05^
MRS]XU_7N'$O7W]'UCTB \ _\RE3$GFM38CWTMP9Z4VC[0NRNE%[PG=.BU^CE
MLRFT?;EVUT^O]LHV',="\70.RIZ?)=W&JZ.@\WDJZ[2"R\,@:/1^Z):*N@3E
MW-:ZBB)WE>JLYBE&BWKZVE:1!^,C4V?;8G$'DQ7I5-',.05,C#.";+<NZ+HF
ML[HWZVBQM*7C5&@J1&US@2Q":1;0_$P(_=HQ&Q3_/@S_!5!+ P04    " !I
M@:-6O64%O!L#  !\"   &0   'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6RM
M5F%OVC 0_2NG3)I::6U"4D+;022@W59IU:JBMA^J?3#D *M.G-H&RK_?V0D9
M5"E"VKY [-Q[?N\NN4MW)=6+GB,:>,M$KGO>W)CBTO?U9(X9TZ>RP)SN3*7*
MF*&EFOFZ4,A2!\J$'P9![&>,YU[2=7MW*NG*A1$\QSL%>I%E3*T'*.2JY[6\
MS<8]G\V-W?"3;L%F.$+S4-PI6ODU2\HSS#67.2B<]KQ^ZW+8L?$NX)'C2F]=
M@W4REO+%+F[2GA=802AP8BP#H[\E#E$(2T0R7BM.KS[2 K>O-^S?G'?R,F8:
MAU(\\=3,>]ZY!RE.V4*8>[GZ@96?MN6;2*'=+ZRJV,"#R4(;F55@4I#QO/QG
M;U4>M@"M^ - 6 '"0P%1!8B<T5*9LW7%#$NZ2JY V6ABLQ<N-PY-;GANJS@R
MBNYRPIGD^G7!S?ID0)E(82@S>CHT<PD^@5%969!3>'+IH)#^$A55%_J:ZE[8
M0 T/%FLD7*%!11H1OC&NX)&)!5KPR,C)"_RJHK\KEIL2<)T50JX1-; \A2NN
MJ+92:3@B)L:%/K8B=L#/MYB-4?WN^H;,6PO^I#(Z*(V&'QB-X%;F9J[A.D\Q
MW<7[E+0Z<^$F<X-P+^$M4Z<0M;Y &(11@Y[AX?!PCYRH+F3D^*(/^$9SIA :
MZMA7E/ 9TIMG8+"&[;@[MG;;_153*3S_M*6[,9CIQOR6YY\UGV^[S:4NV 1[
M'K43C6J)7O+Y4RL.OC8EYS^1[:3JK$[5V3[VY)[K%Y@J1.#T)!*_ <4,-GDN
MB5J!8[(=<9D$IT'4B;O^<MM.<USKO%W'[2AMUTK;>Y5>OQ7T2MB7A5XL..(Y
MK)$I?=PD=3]37"(AO("4K7532?Z!8,=<7)N+#S.WE((>54%]J,E7W)3:BZ#]
MK@+-87'87(!.K;%SF,:4+WF*U*76'$7:I+,DNM@^_YW$?1&E.G^KD6>H9FZ^
M:9C(16[*SE3OUB.T[R;'N_T!C=9R$OZE*><R]9T9ITXJ<$J4P6F'RJ[*65<N
MC"S<N!A+0\/'7<[I\P"5#:#[4RG-9F$/J#\XDC]02P,$%     @ :8&C5IO6
M0=Y7 P  Z D  !D   !X;"]W;W)K<VAE971S+W-H965T-3(N>&ULM5;;;MM&
M$/V5 5L$*6")-UT=B8#D)&T>G!@6DCP$>5B1(Y$PN:OL+J48Z,=W=DG1:D71
M1HN^D'N;,V?.S%YF!R$?5(JHX6>1<S5W4JUWUZZKXA0+IOIBAYQF-D(63%-7
M;EVUD\@2:U3D;N!Y([=@&7>BF1V[D]%,E#K/.-Y)4&51,/FXQ%P<YH[O' ?N
MLVVJS8 ;S79LBRO4GW=WDGIN@Y)D!7*5"0X2-W-GX5\O_< 8V!5?,CRHDS:8
M4-9"/)C.AV3N>(81YAAK \'HM\<;S'.#1#Q^U*!.X],8GK:/Z.]M\!3,FBF\
M$?G7+-'IW)DXD."&E;F^%X<_L YH:/!BD2O[A4.]UG,@+I4616U,#(J,5W_V
MLQ;BQ" ,+A@$M8$5PJT<699OF6;13(H#2+.:T$S#AFJMB5S&35966M)L1G8Z
M>O>CS/1C;TF!)7 C"LJV8E:O'JRJ3('8P#TJ+;-8TZ*5%O$#+(R:9 FOWZ)F
M6:Y^.VGUSM=_YIE6\.T6BS7*[S-7$W?#P(UKGLN*9W"!9PBW@NM4P3N>8/)W
M>Y=B;@(/CH$O@T[ 6R;[$/I7$'A!"+^""RIE$E7]Z_ 0-M*&UD-XP</* +4I
MNY"2\2U2;6M8/\+INCOV:(<7!R:3*ZBR Q\XJ5F:"06?=(H2=,HX?-H9.'4%
M'P7?D^!(%A]+([!)V:H*Y]N]R'.@"C:(K<)740S:HS"GPK7:L1CG#FU[A7*/
M3O3J%W_DO>G0:-!H-.A"CXAY[TA]B=N,\XQO:9OEC,<(?[8FHV)=X0XMKCEZ
M]I$_F8;!S-VWT!DV=(:=='ZGQ)B:[7(\/',\''O3X(+G4>-YU.F9$K3![#G?
MHS/?O= ;A^-VW^/&]_C%2:#M]=(,C,^%&$Y]_P*924-FTKEKOMIS%)/>8H^2
M[@6P.0$ZW!#>LTS"%Y:7V,9G\C_4\;1A/?U/=?QTOK0QK[ G)TH&H_[ ;Q?2
M]YZ.=N^%U=SMOH;QPQ,"X: ?3BX0.+E;_!<7]3,4_%8*%S4(GB@$_[ZVG^$4
MG*6%*/G_I.2>7+X%RJU]8BB(1<EU=0\WH\TS9E%=WD_+JS<0W4E4.@IRW)"I
MUQ_3YI+5LZ+J:+&S5_E::'H8V&9*3S&49@'-;X30QXYQT#SNHK\ 4$L#!!0
M   ( &F!HU89E4(P$0,  ,<)   9    >&PO=V]R:W-H965T<R]S:&5E=#4S
M+GAM;+56:V_:,!3]*U963:W4DI"$\!@@%=BT2>N$VG7]["878C6Q,]N![M_O
MV@D9[0)B4O<%_+CGY!Q?7]OCK9!/*@70Y#G/N)HXJ=;%R'55G$).54<4P'%F
M)61.-7;EVE6%!)I84)ZYON=%;DX9=Z9C.[:4T[$H=<8X+"5199Y3^6L&F=A.
MG*ZS&[AEZU2; 7<Z+N@:[D#?%TN)/;=A25@.7#'!B835Q+GNCN9#$V\#?C#8
MJKTV,4X>A7@RG2_)Q/&,(,@@UH:!XM\&YI!EA@AE_*PYG>:3!KC?WK%_LM[1
MRR-5,!?9 TMT.G$&#DE@1<M,WXKM9ZC]] Q?+#)E?\FVCO4<$I=*B[P&HX*<
M\>J?/M?KL = GG: 7P/\UX#P ""H 8$U6BFSMA94T^E8BBV1)AK93,.NC46C
M&\9-%N^TQ%F&.#W]AAOEJU"*+$&2NY1*(%=D+O*BU-2NLUB1&54L)I0G9,&R
M4D-"6E#G"]"49>H"\?=W"W)^=D'.B$N4F56$<7+/F5:7.(CM[ZDH%3*JL:O1
MA='BQK7B6:78/Z X(#>"ZU21CSR!Y"7>1??-$OB[)9CY1PEOJ.R0H'M)?,\/
M6O3,3X?[1^0$348"RQ<<RDB9@Z1:R%';VE38L!UK2GZD"AK#Q,&:5B WX$S?
MO^M&WH<V8V]$]L)FV-@,C[';C9?A%FHS62$CBS3'T&9ZU?5"?Q"-W<V^_I:X
M:. /PR;LA;)>HZQW- $+X (K[6 *>F^9@C<B>V$T:HQ&1U/P8,\X2*[H!G?<
M&G:U6BHL<2S2F&9QF>$QP->$U^DB!5:\C;LTQR>+VU:H^FQO+R_=7A2%@R#J
MO<I@2V38'P["H1^U)['?>.O_5V])==*UN>N?[*XE\KB[0>-N<%+QG)2-BFJP
M7R5>)^J_TMH:%1[0.6QT#O]9YY&5'9ZDM#7J+Z7NWIV(!^K:/A44B47)=74W
M-*/-:^3:7L*OQF?X2JD>%7]HJB<.GOQKQA7)8(647J>/F9;5LZ'J:%'8F_=1
M:+S';3/%EQ9($X#S*R'TKF,^T+S=IK\!4$L#!!0    ( &F!HU9+VR8B[@,
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M#GBXWK-_\MI)RYI;F&OY31183H+W 2M@PQN)-[K]#+V>MXXOU]+Z7];VL5'
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MUQIIY/VR)%,&XP+H?J,U[C<NP6#SV6]02P,$%     @ :8&C5@3.>!1[ @
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M22Y\N[1M0VTG:)K0DQ8&J<.%X9K>(+#>@/:7QN!^XMM<_ZH5?P!02P,$%
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M^:RK#;YHU)U6J(L-BCZ#\LB5R/5"D3"?\5E#?.2.]QWQ77-:VW.CC^=V09W
M=TMY1/S>6T)[U">?;@/RYL>F\[IT8WY?Y5L,=6""PX_&A0D/QW@.3.3&7+$"
MX]G7A@2)-$.$,$/5@DFN&K"Q&QOPZ19+W3@KI?Y6KG[)]P^0ZP/Y*%FNV&9,
M^_S!-"7O-<_4WTW:W7#[S=QBP#]52S;EYQTSHBLNU[PS_ND';]C[M4DP2%B
MA(5(6(2$Q2"8)9O^5C9]%WU\S>64Y]K,K43,R7R5SY+\SLRD4V[FP::AZL+)
M:RL7)"Q PL(-[*2$%57+>MP[HH.S[GI7!L@>8Q#,DL%@*X.!4P91E7C^;6G&
M)3.,:$$FW*D#)["M#I"P  D+-[#AC@X\.NB5__;$@.PV!L$L,0RW8A@ZQ?!1
M:)8>-!8X.6TU@(0%2%@X?*(!W_.:)(#L-0;!+ D<;R5P[)3 I<@R4SJ8(GOZ
MY6U5I!!SOZ8TVZCB^_.%T(43W5852%B A(5(6+2!#7:'F<'P>-CS>B>VQN+&
ME@-35([JV<G*^6B;\Y&[%)@G_W!)WN=3\OF*9Q,N&\M%)Z1M=I&P  D+D; (
M"8M!,$LC)UN-G+S27<8)4C9(6("$A4A8A(3%()@E&Z]7FRF]UYM0W.RVXH'2
M B@MA-*BBK8[5]!COW]"/6]O4CFDI9WY'1O-<V;^CU4QE11WEUDYJ2B2BRS)
MV>-=AF!R5GP[JRP19:3P:(\TBL'976LQ(&D!E!9":5%%LU*\KP)7$SO]M$X_
M=:;_@B6YJ2G67!5VEZNP<(-:)Q9)"Z"T$$J+H+081;/E4KN8WFO9F![4QX32
M B@MA-(B*"U&T6SYU&ZFY[8S_U^9 ;4VH;0 2@NAM*BB[4X;P][0I_Y@N#_!
M'-#2SGQM8'IN!Q->9D#]32@M@-)"*"VJ:+LI[N^KP-7$3G]M67INS[(L,QY=
M['=WDO.,Y]I=;T#=2R@M@-)"*"V"TF(4S=9-[7-ZQZ]5;T!M3B@M@-)"*"V"
MTF(4S99/;9EZ+WBFK1^?NH&M90,U4"N:_=#3MT?OL+'1DR>CT .+430[R[7I
MZ3G-L2++B3#5P]H4&/>+9+K89EJMEDLAM3OC4.L32@N@M/"%R]@G#YS)IM([
M@AY'C*+9[U;57B=U>YT1-S<=23Y=2=FL"'=\6T5 :0&4%E8TZ_%YTX-3:*\Q
MBF;GOW8\J=OQ_ \O4[B)K14!-36AM) ^]1B'U0L5^YI ]ANC:+8F:AN4NFW0
MP]^I<(-:2P%J@U8TZ]=Y-&I(7MC4<M"<9JA]B:+9::[M2^KTMUZZ#27?R>UJ
MHOC75;$W7+]TB^KNK;46H)XFE!9":1&4%J-HMJ9J3Y/V7^D6E4(-32@M@-)"
M*"V"TF(4S99/;8Q2MS':_A:U KKO\"[=W;:6 ]32A-(B*"U&T6PYU$8I1;W<
M29^^]N@-A@U3^*6[R]92@'J?4%H$I<4HFBV%VOND[I<\;PR3R>F"7(HT91,A
MV>9OX/(9^9"8,4/Q YUT=S^MYQFH%0JEA5!:!*7%*)JMIMH*I:/7*E.@EBB4
M%D!I(90606DQBF;+I_98J=L<O.%)-EE)58XVBLR%)/)Q?"IZ,P.2>DNF(M=F
MWBH&I!E?\U0LR\$I2]+B_2*CLB5[*/<4@Y@R+5/^RRRY2S21XH&E1IA5 T6,
M,'.NB6)I\]L [N-MK<J3)Y/IWBP:0#L,H;0(2HM1-/L/)6M_UG?[LU<L-]5P
M*9/#YC<WKZT4H+0 2@NAM A*BU$T6S6UJ^M[KS2_^5!S%TH+H+002HN@M!A%
ML^53&\"^VP#>&73FG#?*!&K\0FD!E!9":9'_U&K>FUIC5(>;W'=W%I7(N+PK
MUPM1IC99Y7JS!L-V[W9-DG?E2AQ[^R^\TW"SLDB-V2QT<L7D79(KDO*Y0?:.
MC@<=(C=KAVPVM%B62U=,A-8B*S\N.)MQ630PW\^%T(\;10?;%5S&_P)02P,$
M%     @ :H&C5J0MOD3B @  90H  !D   !X;"]W;W)K<VAE971S+W-H965T
M-3@N>&ULK99M;]HP$,>_BI554RMM)"0\=A ):*=5&A(JZ_9BZ@N3'& UL5/;
M@4[:A]\YAHQV:50FWB2Q??<__RZ^Y 9;(1_4&D"3IS3A:NBLM<XN75=%:TBI
M:H@,.*XLA4RIQJ%<N2J30./"*4U<W_,Z;DH9=\)!,3>3X4#D.F$<9I*H/$VI
M_#6&1&R'3M/93]RRU5J;"3<<9'0%<]!WV4SBR"U58I8"5TQP(F$Y=$;-RTG?
MV!<&WQELU<$S,20+(1[,X"8>.I[9$"00::- \;:!"22)$<)M/.XTG3*D<3Q\
MWJM_+MB194$53$3R@\5Z/71Z#HEA2?-$WXKM%]CQM(U>)!)57,G6VG:[#HER
MI46Z<\8=I(S;.WW:Y>'  76J'?R=@__2H?6*0[!S" I0N[,"ZXIJ&@ZDV!)I
MK%'-/!2Y*;R1AG'S%N=:XBI#/QW.\X6"QQRX)M<;O"KRD8SBF)D<TX3<<'M0
M3,;/KT!3EJ@+-+F;7Y'SLPMR1A@G4Y8D:* &KL8=&5TWVD4?V^C^*]&;9"JX
M7BMRS6.(G_N[2%+B^'N<L5\K.,ID@P3>!^)[?E"QG\G;W9LUVPG*[ :%7O#&
M[)*?7]&"W&A(U7U5NJQ<JUK.5/2ERF@$0P=+5H'<@!.^?]?L>)^J6$\D]HR\
M59*WZM3#;T+C\5GF/&9\A>4> 59K7(5<JW,LLA5K6C7S!=N$0;.!KW)3P=(N
M6=JU+#.0$;X\_*@1L7P34ZW>L4Q6K'^ Y#7\=C52IT3JU"+]>S"GD"Y WI/?
M9 Z1X#$9<8YX4E')0)7K5;2UH8ZE/9'8LZQTRZQT3UNNW5.2GTCL&7FO).^=
MJ%Q[E146E,?1LM1&^T^6?LG2/W&Y]NLKS"+5!CT6R3WX8Z<@5T4CHT@D<J[M
MWZZ<+7NE4=$BO)@?8P]E6YZ_,K8!FU*Y8ER1!)8HZ36Z^!V1MJFQ RVRHB]8
M"(U=1O&XQCX0I#' ]:40>C\P <K.,OP#4$L#!!0    ( &J!HU9^Q&B/4P,
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ML>U*SXTL=Z]?[5X=^_P?4$L#!!0    ( &J!HU83)^RZ[P$  *4B   :
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M*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$>AOJ;01Z&^IM!'H;ZFT$>MMDLX1
M;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]#O8U ;T>]G4!O1[V=0&]'O9U
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M/AM^(+EZ!5!+ 0(4 Q0    ( &F!HU8'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ :8&C5M#W5Y7N
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ :8&C5IE<G",0!@  G"<  !,              ( !S $  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !I@:-6;:21H2H&  #J(0
M&               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ :8&C5KTCD*EK!@  CAH  !@              ("!;0X  'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( &F!HU;<R>5R_P(
M /\)   8              " @0X5  !X;"]W;W)K<VAE971S+W-H965T,RYX
M;6Q02P$"% ,4    " !I@:-6P'XM]SL%  #V$P  &               @(%#
M&   >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ :8&C5LGO
MX#;C!0  #"0  !@              ("!M!T  'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+ 0(4 Q0    ( &F!HU;[K4![90<  )XA   8
M  " @<TC  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !I
M@:-6[PM_OMP$   *"P  &               @(%H*P  >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&UL4$L! A0#%     @ :8&C5I<N=95^!@  F \  !@
M         ("!>C   'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0
M   ( &F!HU:./[0_H@<  ',3   8              " @2XW  !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " !I@:-66LZ0^6H$  !P"@
M&0              @($&/P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+
M 0(4 Q0    ( &F!HU:+M_/W50<  /L3   9              " @:=#  !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ :8&C5IL&8M36
M"0  0AH  !D              ("!,TL  'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6Q02P$"% ,4    " !I@:-6(;W@\JT,  "X)0  &0
M@(% 50  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( &F!
MHU9E<%DNQP4  #L/   9              " @21B  !X;"]W;W)K<VAE971S
M+W-H965T,30N>&UL4$L! A0#%     @ :8&C5HO4,SVS!0  HPX  !D
M         ("!(F@  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
M    " !I@:-6R"HM"4T&  "2$   &0              @($,;@  >&PO=V]R
M:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( &F!HU9^:)U?]@,  +$(
M   9              " @9!T  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
M4$L! A0#%     @ :8&C5G4IH49\!   >PH  !D              ("!O7@
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " !I@:-6=V!+
M)Z<"   "!@  &0              @(%P?0  >&PO=V]R:W-H965T<R]S:&5E
M=#$Y+GAM;%!+ 0(4 Q0    ( &F!HU;F[CJ?VP0  *D+   9
M  " @4Z   !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @
M:8&C5IW,7/ %!@  :0\  !D              ("!8(4  'AL+W=O<FMS:&5E
M=',O<VAE970R,2YX;6Q02P$"% ,4    " !I@:-6CY13FG$#  !P"   &0
M            @(&<BP  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4
M Q0    ( &F!HU8OP<I W0<  /P4   9              " @42/  !X;"]W
M;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ :8&C5B,G__ - P
MD@<  !D              ("!6)<  'AL+W=O<FMS:&5E=',O<VAE970R-"YX
M;6Q02P$"% ,4    " !I@:-65V!- F@$  !("P  &0              @(&<
MF@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( &F!HU:B
MW\09U08  *P4   9              " @3N?  !X;"]W;W)K<VAE971S+W-H
M965T,C8N>&UL4$L! A0#%     @ :8&C5@:@LM2=!0  IA   !D
M     ("!1Z8  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &F!HU;Q_40@AP,  *0.   9              "
M@9S!  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ :8&C
M5J3%!"GH!@  J#$  !D              ("!6L4  'AL+W=O<FMS:&5E=',O
M<VAE970S,RYX;6Q02P$"% ,4    " !I@:-6WJ\'S8X"  " !@  &0
M        @(%YS   >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0
M   ( &F!HU8+$6-2S0(  * &   9              " @3[/  !X;"]W;W)K
M<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ :8&C5D=60FL2 P  (0L
M !D              ("!0M(  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q0
M2P$"% ,4    " !I@:-6LAAGDR\(  "400  &0              @(&+U0
M>&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( &F!HU9W.XG$
M# 4  ,L<   9              " @?'=  !X;"]W;W)K<VAE971S+W-H965T
M,S@N>&UL4$L! A0#%     @ :8&C5@3T %6Z!0  V"(  !D
M ("!-.,  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " !I
M@:-6"J;]FJ0#  !6"@  &0              @($EZ0  >&PO=V]R:W-H965T
M<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( &F!HU8M$3TF&@,  $,)   9
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M970T-2YX;6Q02P$"% ,4    " !I@:-6]W;86_D"   I"   &0
M    @(&F_0  >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    (
M &F!HU9".4+?6@0  .X8   9              " @=8  0!X;"]W;W)K<VAE
M971S+W-H965T-#<N>&UL4$L! A0#%     @ :8&C5K 3SGT@!   MA4  !D
M             ("!9P4! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"
M% ,4    " !I@:-6MNJ>G/T$  "R&   &0              @(&^"0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( &F!HU:]L;+(Y0,
M (D0   9              " @?(. 0!X;"]W;W)K<VAE971S+W-H965T-3 N
M>&UL4$L! A0#%     @ :8&C5KUE!;P; P  ? @  !D              ("!
M#A,! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " !I@:-6
MF]9!WE<#  #H"0  &0              @(%@%@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4R+GAM;%!+ 0(4 Q0    ( &F!HU89E4(P$0,  ,<)   9
M      " @>X9 0!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%
M  @ :8&C5DO;)B+N P  &Q,  !D              ("!-AT! 'AL+W=O<FMS
M:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    " !I@:-6\[W9DWX"  #R!0
M&0              @(%;(0$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+
M 0(4 Q0    ( &F!HU8$SG@4>P(  .$&   9              " @1 D 0!X
M;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ :8&C5M:3CBU;
M!P  S44  !D              ("!PB8! 'AL+W=O<FMS:&5E=',O<VAE970U
M-RYX;6Q02P$"% ,4    " !J@:-6I"V^1.("  !E"@  &0
M@(%4+@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( &J!
MHU9^Q&B/4P,  +05   -              "  6TQ 0!X;"]S='EL97,N>&UL
M4$L! A0#%     @ :H&C5I>*NQS     $P(   L              ( !ZS0!
M %]R96QS+RYR96QS4$L! A0#%     @ :H&C5A7;<,2T!   OB8   \
M         ( !U#4! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( &J!HU83
M)^RZ[P$  *4B   :              "  ;4Z 0!X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( &J!HU9B(^<8V $  $@B   3
M      "  =P\ 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !" $( !1(
' .4^ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>172</ContextCount>
  <ElementCount>274</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>63</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100040 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100070 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100080 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Nature of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNatureOfOperations</Role>
      <ShortName>Nature of Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Risks and Liquidity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRisksAndLiquidity</Role>
      <ShortName>Risks and Liquidity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Pfizer License Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreement</Role>
      <ShortName>Pfizer License Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Financing Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilities1</Role>
      <ShortName>Financing Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100140 - Disclosure - 2027 Convertible Senior Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotes3</Role>
      <ShortName>2027 Convertible Senior Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Financial Statement Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponents</Role>
      <ShortName>Financial Statement Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Equity-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensation</Role>
      <ShortName>Equity-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureLegalProceedings</Role>
      <ShortName>Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Financing Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesTables</Role>
      <ShortName>Financing Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilities1</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100270 - Disclosure - 2027 Convertible Senior Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesTables</Role>
      <ShortName>2027 Convertible Senior Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotes3</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Financial Statement Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsTables</Role>
      <ShortName>Financial Statement Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponents</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Equity-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationTables</Role>
      <ShortName>Equity-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShare</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Pfizer License Agreement - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails</Role>
      <ShortName>Pfizer License Agreement - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Financing Liabilities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails</Role>
      <ShortName>Financing Liabilities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Financing Liabilities - Summary of Changes in Estimated Fair Value of Financing Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails</Role>
      <ShortName>Financing Liabilities - Summary of Changes in Estimated Fair Value of Financing Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100370 - Disclosure - 2027 Convertible Senior Notes - Additional Information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails</Role>
      <ShortName>2027 Convertible Senior Notes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100380 - Disclosure - 2027 Convertible Senior Notes - Summary of Net Carrying Amount of 2027 Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails</Role>
      <ShortName>2027 Convertible Senior Notes - Summary of Net Carrying Amount of 2027 Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100390 - Disclosure - 2027 Convertible Senior Notes - Schedule of Interest Expense Related to 2027 Notes Recognized in Interest Income (Expense), Net (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails</Role>
      <ShortName>2027 Convertible Senior Notes - Schedule of Interest Expense Related to 2027 Notes Recognized in Interest Income (Expense), Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100400 - Disclosure - 2027 Convertible Senior Notes - Schedule of Future Minimum Payments under 2027 Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails</Role>
      <ShortName>2027 Convertible Senior Notes - Schedule of Future Minimum Payments under 2027 Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Fair Value Measurements - Summary of Estimated Fair Value and Amortized Cost of Available-for-Sale Marketable Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Estimated Fair Value and Amortized Cost of Available-for-Sale Marketable Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Fair Value Measurements - Summary of Rollforward of the Estimated Fair Value Associated with Financing Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Rollforward of the Estimated Fair Value Associated with Financing Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Financial Statement Components - Summary of Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails</Role>
      <ShortName>Financial Statement Components - Summary of Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Financial Statement Components - Summary of Property and Equipment Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails</Role>
      <ShortName>Financial Statement Components - Summary of Property and Equipment Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Financial Statement Components - Summary of Other Long-Term Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails</Role>
      <ShortName>Financial Statement Components - Summary of Other Long-Term Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Financial Statement Components - Summary of Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Financial Statement Components - Summary of Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Financial Statement Components - Summary of Interest Income (Expense), Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails</Role>
      <ShortName>Financial Statement Components - Summary of Interest Income (Expense), Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Financial Statement Components - Summary of Other Income (Expense), Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails</Role>
      <ShortName>Financial Statement Components - Summary of Other Income (Expense), Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Stockholders' Equity, Preferred Stock and Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails</Role>
      <ShortName>Stockholders' Equity, Preferred Stock and Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Equity-Based Compensation - Summary of Equity-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Equity-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Equity-Based Compensation - Summary of Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Equity-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Equity-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Equity-Based Compensation - Summary of Weighted Average Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Weighted Average Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Equity-Based Compensation - Summary of Restricted Stock Activity (Details) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails</Role>
      <ShortName>Equity-Based Compensation - Summary of Restricted Stock Activity (Details) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Net Loss Per Share - Potential Dilutive Securities Excluded From Calculation of Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Potential Dilutive Securities Excluded From Calculation of Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails</Role>
      <ShortName>Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedParties</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="cere-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100640 - Disclosure - Subsequent Events - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="cere-20230331.htm">cere-20230331.htm</File>
    <File>cere-20230331.xsd</File>
    <File>cere-20230331_cal.xml</File>
    <File>cere-20230331_def.xml</File>
    <File>cere-20230331_lab.xml</File>
    <File>cere-20230331_pre.xml</File>
    <File>cere-ex10_1.htm</File>
    <File>cere-ex31_1.htm</File>
    <File>cere-ex31_2.htm</File>
    <File>cere-ex32_1.htm</File>
    <File>cere-ex32_2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img33027544_0.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="522">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>78
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cere-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 25,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 522,
    "http://xbrl.sec.gov/dei/2022": 30
   },
   "contextCount": 172,
   "dts": {
    "calculationLink": {
     "local": [
      "cere-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cere-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cere-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cere-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cere-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cere-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 508,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 6,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 10
   },
   "keyCustom": 42,
   "keyStandard": 232,
   "memberCustom": 26,
   "memberStandard": 28,
   "nsprefix": "cere",
   "nsuri": "http://www.cerevel.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cere:LicenseAgreementTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Pfizer License Agreement",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreement",
     "shortName": "Pfizer License Agreement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cere:LicenseAgreementTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueOptionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Financing Liabilities",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilities1",
     "shortName": "Financing Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueOptionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - 2027 Convertible Senior Notes",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotes3",
     "shortName": "2027 Convertible Senior Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Financial Statement Components",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponents",
     "shortName": "Financial Statement Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureStockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Equity-Based Compensation",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensation",
     "shortName": "Equity-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Net Loss Per Share",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Legal Proceedings",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureLegalProceedings",
     "shortName": "Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Related Parties",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedParties",
     "shortName": "Related Parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "23",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueOptionTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cere:SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Financing Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesTables",
     "shortName": "Financing Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueOptionTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cere:SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - 2027 Convertible Senior Notes (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesTables",
     "shortName": "2027 Convertible Senior Notes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cere:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Financial Statement Components (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsTables",
     "shortName": "Financial Statement Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cere:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Equity-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationTables",
     "shortName": "Equity-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Net Loss Per Share (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "U_USDollarShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "cere:LicenseAgreementTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_e5a1da7f-71cc-44ee-bf79-5b4c0a66ac10",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:RoyaltyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Pfizer License Agreement - Additional Information (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails",
     "shortName": "Pfizer License Agreement - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "cere:LicenseAgreementTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_e5a1da7f-71cc-44ee-bf79-5b4c0a66ac10",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:RoyaltyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueOptionTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_72953f01-6eb8-48e3-9861-55ca4de20b51",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "cere:ReceivedFunding",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Financing Liabilities - Additional Information (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
     "shortName": "Financing Liabilities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueOptionTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_0729e16b-d27b-4daf-a728-90d90397b869",
      "decimals": "2",
      "lang": null,
      "name": "cere:PercentageOfFundingReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Financing Liabilities - Summary of Changes in Estimated Fair Value of Financing Liabilities (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails",
     "shortName": "Financing Liabilities - Summary of Changes in Estimated Fair Value of Financing Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "cere:SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock",
       "div",
       "us-gaap:FairValueOptionTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_0a7718ed-8940-4540-a71e-a8480e029877",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FairValueOptionChangesInFairValueGainLoss1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - 2027 Convertible Senior Notes - Additional Information (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
     "shortName": "2027 Convertible Senior Notes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_c79a6dff-9b2a-4bbe-893e-f8d5995f53c4",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - 2027 Convertible Senior Notes - Summary of Net Carrying Amount of 2027 Notes (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails",
     "shortName": "2027 Convertible Senior Notes - Summary of Net Carrying Amount of 2027 Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "cere:ScheduleOfInterestExpenseTableTextBlock",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - 2027 Convertible Senior Notes - Schedule of Interest Expense Related to 2027 Notes Recognized in Interest Income (Expense), Net (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails",
     "shortName": "2027 Convertible Senior Notes - Schedule of Interest Expense Related to 2027 Notes Recognized in Interest Income (Expense), Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "cere:ScheduleOfInterestExpenseTableTextBlock",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - 2027 Convertible Senior Notes - Schedule of Future Minimum Payments under 2027 Notes (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails",
     "shortName": "2027 Convertible Senior Notes - Schedule of Future Minimum Payments under 2027 Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_174d7111-d0da-45ff-818a-2c32e6395735",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:MarketableSecuritiesRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:MarketableSecuritiesRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Fair Value Measurements - Summary of Estimated Fair Value and Amortized Cost of Available-for-Sale Marketable Debt Securities (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails",
     "shortName": "Fair Value Measurements - Summary of Estimated Fair Value and Amortized Cost of Available-for-Sale Marketable Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_2ea39b76-7e86-4e9f-a3aa-1c43d8682c03",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Fair Value Measurements - Summary of Rollforward of the Estimated Fair Value Associated with Financing Liabilities (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails",
     "shortName": "Fair Value Measurements - Summary of Rollforward of the Estimated Fair Value Associated with Financing Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_2ea39b76-7e86-4e9f-a3aa-1c43d8682c03",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "cere:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cere:PrepaidClinicalTrialServicesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Financial Statement Components - Summary of Prepaid Expenses and Other Current Assets (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails",
     "shortName": "Financial Statement Components - Summary of Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "cere:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cere:PrepaidClinicalTrialServicesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Financial Statement Components - Summary of Property and Equipment Net (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails",
     "shortName": "Financial Statement Components - Summary of Property and Equipment Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PrepaidExpenseOtherNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Financial Statement Components - Summary of Other Long-Term Assets (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails",
     "shortName": "Financial Statement Components - Summary of Other Long-Term Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PrepaidExpenseOtherNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cere:AccruedExternalResearchAndDevelopmentServicesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - Financial Statement Components - Summary of Accrued Expenses and Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
     "shortName": "Financial Statement Components - Summary of Accrued Expenses and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cere:AccruedExternalResearchAndDevelopmentServicesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cere:InterestIncomeNonoperatingNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - Financial Statement Components - Summary of Interest Income (Expense), Net (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails",
     "shortName": "Financial Statement Components - Summary of Interest Income (Expense), Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cere:InterestIncomeNonoperatingNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cere:GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Financial Statement Components - Summary of Other Income (Expense), Net (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails",
     "shortName": "Financial Statement Components - Summary of Other Income (Expense), Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cere:GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Stockholders' Equity, Preferred Stock and Common Stock (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
     "shortName": "Stockholders' Equity, Preferred Stock and Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:CommonStockVotingRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - Equity-Based Compensation - Summary of Equity-based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails",
     "shortName": "Equity-Based Compensation - Summary of Equity-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_21573dc6-6769-41aa-991d-b0f72b895688",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - Equity-Based Compensation - Summary of Stock Options Activity (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails",
     "shortName": "Equity-Based Compensation - Summary of Stock Options Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_8de10066-7b96-4965-9078-908525b6b838",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_f1a2b453-d388-477c-8259-cf29dcec39b2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_f1a2b453-d388-477c-8259-cf29dcec39b2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_f76fd2db-e57c-466d-8c84-9a10342d867c",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - Equity-Based Compensation - Additional Information (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
     "shortName": "Equity-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_f76fd2db-e57c-466d-8c84-9a10342d867c",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_50c7f288-e026-4d07-9cdc-7e93e4fac70d",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - Equity-Based Compensation - Summary of Weighted Average Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails",
     "shortName": "Equity-Based Compensation - Summary of Weighted Average Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_50c7f288-e026-4d07-9cdc-7e93e4fac70d",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_899c628a-be1d-4d05-b35c-2e06c2ed5337",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - Equity-Based Compensation - Summary of Restricted Stock Activity (Details) (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails",
     "shortName": "Equity-Based Compensation - Summary of Restricted Stock Activity (Details) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_899c628a-be1d-4d05-b35c-2e06c2ed5337",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails",
     "shortName": "Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - Net Loss Per Share - Potential Dilutive Securities Excluded From Calculation of Net Loss Per Share (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails",
     "shortName": "Net Loss Per Share - Potential Dilutive Securities Excluded From Calculation of Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cere:IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - Income Taxes - Additional Information (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cere:IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cere:LossOrMaterialCostsRelatedToIndemnificationObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_b26045f3-5a6c-47d0-9ed5-64df9586b32d",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cere:LossOrMaterialCostsRelatedToIndemnificationObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueOptionTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_a2e21f3d-b1a6-4ed0-b2c3-cd5451e8a75c",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "cere:PercentageOfFundingReceived",
      "reportCount": 1,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - Related Parties (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails",
     "shortName": "Related Parties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_ddc57f0c-b90e-42fa-a10e-071a42e87507",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueOptionTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_72953f01-6eb8-48e3-9861-55ca4de20b51",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "cere:ReceivedFunding",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - Subsequent Events - Additional Information (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
     "shortName": "Subsequent Events - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100080 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Nature of Operations",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNatureOfOperations",
     "shortName": "Nature of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cere:RisksAndLiquidityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Risks and Liquidity",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRisksAndLiquidity",
     "shortName": "Risks and Liquidity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cere:RisksAndLiquidityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "cere-20230331.htm",
      "contextRef": "C_476db5f8-cbfa-499e-9fce-a46c6af239cc",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 63,
   "tag": {
    "cere_AccruedExternalResearchAndDevelopmentServicesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued external research and development services current.",
        "label": "Accrued External Research And Development Services Current",
        "terseLabel": "Accrued external research and development services"
       }
      }
     },
     "localname": "AccruedExternalResearchAndDevelopmentServicesCurrent",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_AccruedPropertyAndEquipmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued property and equipment current.",
        "label": "Accrued Property and Equipment Current",
        "terseLabel": "Accrued property and equipment"
       }
      }
     },
     "localname": "AccruedPropertyAndEquipmentCurrent",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_AdjustmentsToOperatingLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to operating lease expense.",
        "label": "Adjustments to Operating Lease Expense",
        "negatedLabel": "Adjustments to operating lease expense"
       }
      }
     },
     "localname": "AdjustmentsToOperatingLeaseExpense",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_AtmProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ATM program.",
        "label": "ATM Program [Member]"
       }
      }
     },
     "localname": "AtmProgramMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_AugustTwoThousandTwentyTwoPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "August two thousand twenty two public offering.",
        "label": "August Two Thousand Twenty Two Public Offering [Member]",
        "terseLabel": "August 2022 Public Offering [Member]"
       }
      }
     },
     "localname": "AugustTwoThousandTwentyTwoPublicOfferingMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_BainFundingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bain funding agreement.",
        "label": "Bain Funding Agreement [Member]",
        "terseLabel": "Bain Funding Agreement [Member]"
       }
      }
     },
     "localname": "BainFundingAgreementMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_BainInvestorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bain investor.",
        "label": "Bain Investor [Member]",
        "terseLabel": "Bain Investor [Member]"
       }
      }
     },
     "localname": "BainInvestorMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_ChangeInFairValueOfFinancingLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value of financing liability.",
        "label": "Change in Fair Value of Financing Liability",
        "terseLabel": "Change in fair value of financing liability",
        "verboseLabel": "Change in fair value of financing liabilities"
       }
      }
     },
     "localname": "ChangeInFairValueOfFinancingLiability",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_ChangeInFairValueOfPrivatePlacementWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value of private placement warrants.",
        "label": "Change In Fair Value Of Private Placement Warrants",
        "negatedLabel": "Change in fair value of private placement warrants"
       }
      }
     },
     "localname": "ChangeInFairValueOfPrivatePlacementWarrants",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_ClaimsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Claims outstanding.",
        "label": "Claims Outstanding",
        "terseLabel": "Claims outstanding"
       }
      }
     },
     "localname": "ClaimsOutstanding",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_ClosingPriceOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing price of common stock.",
        "label": "Closing Price Of Common Stock",
        "terseLabel": "Closing stock price"
       }
      }
     },
     "localname": "ClosingPriceOfCommonStock",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cere_CommercialApprovalMilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial approval milestone payments.",
        "label": "Commercial Approval Milestone Payments",
        "terseLabel": "Commercial approval milestone payments"
       }
      }
     },
     "localname": "CommercialApprovalMilestonePayments",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Issuable Upon Conversion of Two Thousand Twenty Seven Notes [Member]",
        "label": "Common Stock Issuable Upon Conversion of Two Thousand Twenty Seven Notes [Member]",
        "terseLabel": "Common Stock Issuable Upon Conversion of the 2027 Notes [Member]"
       }
      }
     },
     "localname": "CommonStockIssuableUponConversionOfTwoThousandTwentySevenNotesMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_ContractualObligationDescriptionRepaymentTiming": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of timing for satisfying repayment of contractual obligation.",
        "label": "Contractual Obligation Description Repayment Timing",
        "terseLabel": "Contractual obligation description repayment timing"
       }
      }
     },
     "localname": "ContractualObligationDescriptionRepaymentTiming",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cere_DebtInstrumentInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails2": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument interest.",
        "label": "Debt Instrument Interest",
        "negatedLabel": "Less: amounts representing interest"
       }
      }
     },
     "localname": "DebtInstrumentInterest",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_DebtInstrumentMinimumPrincipalAmountForRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument minimum principal amount for redemption.",
        "label": "Debt Instrument Minimum Principal Amount for Redemption",
        "terseLabel": "Minimum principal amount of notes outstanding for redemption"
       }
      }
     },
     "localname": "DebtInstrumentMinimumPrincipalAmountForRedemption",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument principal amount issued for additional purchase.",
        "label": "Debt Instrument Principal Amount Issued for Additional Purchase",
        "terseLabel": "Debt instrument, principal amount issued for additional purchase"
       }
      }
     },
     "localname": "DebtInstrumentPrincipalAmountIssuedForAdditionalPurchase",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_ESPPSharesIssuableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP shares issuable.",
        "label": "E S P P Shares Issuable [Member]",
        "terseLabel": "ESPP Shares Issuable [Member]"
       }
      }
     },
     "localname": "ESPPSharesIssuableMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_EarningsPerShareOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings per share other disclosures.",
        "label": "Earnings Per Share Other Disclosures [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareOtherDisclosuresAbstract",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cere_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_ExpectedFundingReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected funding received.",
        "label": "Expected Funding Received",
        "terseLabel": "Funding expected to be received",
        "verboseLabel": "Percentage Of Funding Received"
       }
      }
     },
     "localname": "ExpectedFundingReceived",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_FairValueAssetBetweenLevelTransferAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value asset between level transfer amount.",
        "label": "Fair Value Asset Between Level Transfer Amount",
        "terseLabel": "Fair value asset between level transfer amount"
       }
      }
     },
     "localname": "FairValueAssetBetweenLevelTransferAmount",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_FairValueLiabilitiesBetweenLevelTransferAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value liabilities between level transfer amount.",
        "label": "Fair Value Liabilities Between Level Transfer Amount",
        "terseLabel": "Fair value liabilities between level transfer amount"
       }
      }
     },
     "localname": "FairValueLiabilitiesBetweenLevelTransferAmount",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis funding commitment received.",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Funding Commitment Received",
        "terseLabel": "Funding commitment received"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisFundingCommitmentReceived",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement with unobservable inputs reconciliations exercise of warrants.",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliations Exercise of Warrants",
        "terseLabel": "Exercise of warrants"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsExerciseOfWarrants",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value of Private Placement Warrants Reclassified from Equity to Other Long Term Liabilities",
        "label": "Fair Value of Private Placement Warrants Reclassified from Equity to Other Long Term Liabilities",
        "terseLabel": "Fair value of private placement warrants reclassified from equity to other long term liabilities",
        "verboseLabel": "Fair value of private placement warrants reclassified from equity to other long term liabilities"
       }
      }
     },
     "localname": "FairValueOfPrivatePlacementWarrantsReclassifiedFromEquityToOtherLongTermLiabilities",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cere_FinancingLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing liabilities.",
        "label": "Financing Liabilities [Member]"
       }
      }
     },
     "localname": "FinancingLiabilitiesMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_FinancingLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing liability.",
        "label": "Financing Liability [Member]",
        "terseLabel": "Financing Liability [Member]"
       }
      }
     },
     "localname": "FinancingLiabilityMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing liability, related party and financing liability measurement input.",
        "label": "Financing Liability, Related Party and Financing Liability Measurement Input",
        "terseLabel": "Estimated fair value measuring input",
        "verboseLabel": "Financing liability, related party and financing liability measurement input"
       }
      }
     },
     "localname": "FinancingLiabilityRelatedPartyAndFinancingLiabilityMeasurementInput",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "cere_FinancingLiabilityRelatedPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing liability related party.",
        "label": "Financing Liability Related Party [Member]",
        "terseLabel": "Financing Liability, Related Party [Member]"
       }
      }
     },
     "localname": "FinancingLiabilityRelatedPartyMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_FirstAnniversariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First anniversaries.",
        "label": "First Anniversaries [Member]",
        "terseLabel": "First Anniversaries [Member]"
       }
      }
     },
     "localname": "FirstAnniversariesMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_FixedAssetAdditionsObtainedInExchangeTransaction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Asset Additions Obtained in Exchange Transaction.",
        "label": "Fixed asset additions obtained in exchange transaction",
        "terseLabel": "Fixed asset additions obtained in exchange transaction"
       }
      }
     },
     "localname": "FixedAssetAdditionsObtainedInExchangeTransaction",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_FundingCommitmentFeesIncurred": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funding commitment fees incurred.",
        "label": "Funding Commitment Fees Incurred",
        "terseLabel": "Fees incurred"
       }
      }
     },
     "localname": "FundingCommitmentFeesIncurred",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_GainLossOnFairValueRemeasurementOfFinancingLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) on fair value remeasurement of financing liability.",
        "label": "Gain Loss on Fair Value Remeasurement of Financing Liability",
        "terseLabel": "Gain (loss) on fair value remeasurement of financing liability",
        "verboseLabel": "Gains (losses) on change in fair value of financing liability"
       }
      }
     },
     "localname": "GainLossOnFairValueRemeasurementOfFinancingLiability",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) on fair value remeasurement of financing liability related party.",
        "label": "Gain Loss On Fair Value Remeasurement Of Financing Liability Related Party",
        "terseLabel": "Gain (loss) on fair value remeasurement of financing liability, related party",
        "verboseLabel": "Gains (losses) on change in fair value of financing liability, related party"
       }
      }
     },
     "localname": "GainLossOnFairValueRemeasurementOfFinancingLiabilityRelatedParty",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) on fair value remeasurement of private placement warrants.",
        "label": "Gain Loss On Fair Value Remeasurement Of Private Placement Warrants",
        "negatedLabel": "Net losses related to changes in fair value of private placement warrants",
        "terseLabel": "Loss on fair value remeasurement of private placement warrants"
       }
      }
     },
     "localname": "GainLossOnFairValueRemeasurementOfPrivatePlacementWarrants",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax expense (benefit) related to net operating losses and tax credits.",
        "label": "Income Tax Expense Benefit Related To Net Operating Losses And Tax Credits",
        "negatedLabel": "Income tax benefits related to net operating losses incurred or research and development tax credits"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitRelatedToNetOperatingLossesAndTaxCredits",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 23.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in operating lease liabilities.",
        "label": "Increase Decrease In Operating Lease Liabilities",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_InterestIncomeNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails2": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest income nonoperating, net.",
        "label": "Interest Income Nonoperating Net",
        "terseLabel": "Interest income, net"
       }
      }
     },
     "localname": "InterestIncomeNonoperatingNet",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_JulyTwoThousandTwentyOnePublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "July two thousand twenty one public offering.",
        "label": "July Two Thousand Twenty One Public Offering [Member]",
        "terseLabel": "July 2021 Public Offering [Member]"
       }
      }
     },
     "localname": "JulyTwoThousandTwentyOnePublicOfferingMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment.",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory Equipment [Member]"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_LicenseAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement.",
        "label": "License Agreement [Abstract]"
       }
      }
     },
     "localname": "LicenseAgreementAbstract",
     "nsuri": "http://www.cerevel.com/20230331",
     "xbrltype": "stringItemType"
    },
    "cere_LicenseAgreementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement.",
        "label": "License Agreement [Line Items]",
        "terseLabel": "License Agreement [Line Items]"
       }
      }
     },
     "localname": "LicenseAgreementLineItems",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cere_LicenseAgreementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement.",
        "label": "License Agreement [Table]",
        "terseLabel": "License Agreement [Table]"
       }
      }
     },
     "localname": "LicenseAgreementTable",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cere_LicenseAgreementTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of license agreement.",
        "label": "License Agreement [Text Block]",
        "terseLabel": "Pfizer License Agreement"
       }
      }
     },
     "localname": "LicenseAgreementTextBlock",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cere_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt maturities repayments of principal after year four.",
        "label": "Long Term Debt Maturities Repayments of Principal After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_LongTermMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Marketable Securities [Member]",
        "label": "Long Term Marketable Securities [Member]",
        "terseLabel": "Due after One Year through Two Years [Member]"
       }
      }
     },
     "localname": "LongTermMarketableSecuritiesMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_LossOrMaterialCostsRelatedToIndemnificationObligation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss or material costs related to indemnification obligation.",
        "label": "Loss Or Material Costs Related To Indemnification Obligation",
        "terseLabel": "Loss or material costs related to indemnification obligation"
       }
      }
     },
     "localname": "LossOrMaterialCostsRelatedToIndemnificationObligation",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_ManagementAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management agreement.",
        "label": "Management Agreement [Member]",
        "terseLabel": "Management Agreement [Member]"
       }
      }
     },
     "localname": "ManagementAgreementMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_MarketableSecuritiesWeightedAverageMaturityTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable securities weighted average maturity term.",
        "label": "Marketable Securities Weighted Average Maturity Term",
        "terseLabel": "Marketable securities weighted average maturity term"
       }
      }
     },
     "localname": "MarketableSecuritiesWeightedAverageMaturityTerm",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cere_MeasurementPeriodMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement period.",
        "label": "Measurement Period [Member]"
       }
      }
     },
     "localname": "MeasurementPeriodMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_NoncurrentFinancingLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent financing liability.",
        "label": "Noncurrent Financing Liability",
        "terseLabel": "Financing liability (Notes 5 and 7)",
        "verboseLabel": "Financing liability"
       }
      }
     },
     "localname": "NoncurrentFinancingLiability",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_NoncurrentFinancingLiabilityRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent financing liability related party.",
        "label": "Noncurrent Financing Liability Related Party",
        "terseLabel": "Financing liability, related party (Notes 5 and 7)",
        "verboseLabel": "Financing liability, related party"
       }
      }
     },
     "localname": "NoncurrentFinancingLiabilityRelatedParty",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_NovaQuestAndBainFundingAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NovaQuest and Bain funding agreements.",
        "label": "Nova Quest And Bain Funding Agreements [Member]",
        "terseLabel": "NovaQuest and Bain Funding Agreements [Member]"
       }
      }
     },
     "localname": "NovaQuestAndBainFundingAgreementsMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_NovaQuestFundingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NovaQuest funding agreement.",
        "label": "Nova Quest Funding Agreement [Member]",
        "terseLabel": "NovaQuest Funding Agreement [Member]"
       }
      }
     },
     "localname": "NovaQuestFundingAgreementMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_NumberOfMembersNominatedToBoardOfDirectors": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of members nominated to board of directors.",
        "label": "Number Of Members Nominated To Board Of Directors",
        "terseLabel": "Number of members nominated to board of directors"
       }
      }
     },
     "localname": "NumberOfMembersNominatedToBoardOfDirectors",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cere_OfferingExpenseOfSharesIssued": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering expense of shares issued.",
        "label": "Offering Expense of Shares Issued",
        "terseLabel": "Offering expense of shares issued"
       }
      }
     },
     "localname": "OfferingExpenseOfSharesIssued",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_OtherNonoperatingIncomeExpenseOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other nonoperating income expense other.",
        "label": "Other Nonoperating Income Expense Other",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseOther",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_OtherOfferingExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other offering expenses.",
        "label": "Other Offering Expenses [Member]"
       }
      }
     },
     "localname": "OtherOfferingExpensesMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_PayableOnFundingAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payable on funding agreement.",
        "label": "Payable On Funding Agreement",
        "terseLabel": "Payable on funding agreement"
       }
      }
     },
     "localname": "PayableOnFundingAgreement",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_PerPrincipalAmountForConversion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per principal amount for conversion.",
        "label": "Per Principal Amount for Conversion",
        "terseLabel": "Debt instrument, conversion price per principal"
       }
      }
     },
     "localname": "PerPrincipalAmountForConversion",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cere_PerPrincipalAmountForTradingPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per principal amount for trading price.",
        "label": "Per Principal Amount for Trading Price",
        "terseLabel": "Debt instrument, trading price per principal"
       }
      }
     },
     "localname": "PerPrincipalAmountForTradingPrice",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cere_PercentageOfExpectedFundingReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of expected funding received.",
        "label": "Percentage Of Expected Funding Received",
        "terseLabel": "Percentage of funding expected to be received"
       }
      }
     },
     "localname": "PercentageOfExpectedFundingReceived",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cere_PercentageOfFundingCommitment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of funding commitment.",
        "label": "Percentage Of Funding Commitment",
        "terseLabel": "Percentage of funding commitment"
       }
      }
     },
     "localname": "PercentageOfFundingCommitment",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cere_PercentageOfFundingReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of funding received.",
        "label": "Percentage Of Funding Received",
        "terseLabel": "Percentage of funding received"
       }
      }
     },
     "localname": "PercentageOfFundingReceived",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cere_PeriodOverWhichFundingSupportReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which funding support received.",
        "label": "Period over which Funding Support Received",
        "terseLabel": "Period over which funding support received"
       }
      }
     },
     "localname": "PeriodOverWhichFundingSupportReceived",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cere_PfizerIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfizer Inc.",
        "label": "Pfizer Inc [Member]",
        "terseLabel": "Pfizer Inc [Member]"
       }
      }
     },
     "localname": "PfizerIncMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_PfizerLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfizer license agreement.",
        "label": "Pfizer License Agreement [Member]",
        "terseLabel": "Pfizer License Agreement [Member]"
       }
      }
     },
     "localname": "PfizerLicenseAgreementMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_PrepaidClinicalTrialServicesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid clinical trial services current.",
        "label": "Prepaid Clinical Trial Services Current",
        "terseLabel": "Prepaid clinical trial services"
       }
      }
     },
     "localname": "PrepaidClinicalTrialServicesCurrent",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_PrepaidResearchAndDevelopmentExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid research and development expenses current.",
        "label": "Prepaid Research And Development Expenses Current",
        "terseLabel": "Prepaid research and development expenses"
       }
      }
     },
     "localname": "PrepaidResearchAndDevelopmentExpensesCurrent",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_PrivatePlacementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private placement warrants.",
        "label": "Private Placement Warrants [Member]",
        "terseLabel": "Private Placement Warrants"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of long-term debt excluding related party debt.",
        "label": "Proceeds from Issuance of Long-Term Debt Excluding Related Party Debt",
        "terseLabel": "Proceeds from financing liability"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebtExcludingRelatedPartyDebt",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_PurchaserDiscountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchaser discounts.",
        "label": "Purchaser Discounts [Member]"
       }
      }
     },
     "localname": "PurchaserDiscountsMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_ReceivedFunding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Received funding.",
        "label": "Received Funding",
        "terseLabel": "Total funding received"
       }
      }
     },
     "localname": "ReceivedFunding",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_ReclassificationOfPrivatePlacementWarrantFromEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of private placement warrant from equity.",
        "label": "Reclassification Of Private Placement Warrant From Equity",
        "terseLabel": "Reclassification from equity"
       }
      }
     },
     "localname": "ReclassificationOfPrivatePlacementWarrantFromEquity",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_RegulatoryApprovalMilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory approval milestone payments.",
        "label": "Regulatory Approval Milestone Payments",
        "terseLabel": "Regulatory approval milestone payments"
       }
      }
     },
     "localname": "RegulatoryApprovalMilestonePayments",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reimbursements for research services and contingent development milestone payment and single-digit royalty payments on net sales.",
        "label": "Reimbursements for Research Services, Contingent Development Milestone Payment and Single-Digit Royalty Payments on Net Sales",
        "terseLabel": "Reimbursements for research services, contingent development milestone payment and single-digit royalty payments on net sales"
       }
      }
     },
     "localname": "ReimbursementsForResearchServicesContingentDevelopmentMilestonePaymentAndSingleDigitRoyaltyPaymentsOnNetSales",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_ResearchCollaborationAndLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research collaboration and license agreement.",
        "label": "Research Collaboration and License Agreement [Member]",
        "terseLabel": "Research Collaboration and License Agreement [Member]"
       }
      }
     },
     "localname": "ResearchCollaborationAndLicenseAgreementMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_RestrictedCashMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash.",
        "label": "Restricted Cash [Member]",
        "terseLabel": "Restricted Cash [Member]"
       }
      }
     },
     "localname": "RestrictedCashMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_RisksAndLiquidityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to risks and liquidity.",
        "label": "Risks And Liquidity [Text Block]",
        "terseLabel": "Risks and Liquidity"
       }
      }
     },
     "localname": "RisksAndLiquidityTextBlock",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRisksAndLiquidity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cere_SaleAndIssuanceOfStockNotYetIssued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale and issuance of stock, not yet issued.",
        "label": "Sale and Issuance of Stock, Not yet Issued",
        "terseLabel": "Issuance and sale of common stock yet to issue"
       }
      }
     },
     "localname": "SaleAndIssuanceOfStockNotYetIssued",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cere_ScheduleOfInterestExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of interest expense.",
        "label": "Schedule of Interest Expense [Table Text Block]",
        "terseLabel": "Schedule of Interest Expense Related to 2027 Notes Recognized in Interest Income (Expense), Net"
       }
      }
     },
     "localname": "ScheduleOfInterestExpenseTableTextBlock",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cere_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prepaid expenses and other current assets.",
        "label": "Schedule Of Prepaid Expenses And Other Current Assets Table [Text Block]",
        "terseLabel": "Summary of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cere_SecondAnniversariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second anniversaries.",
        "label": "Second Anniversaries [Member]",
        "terseLabel": "Second Anniversaries [Member]"
       }
      }
     },
     "localname": "SecondAnniversariesMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_ShortTermMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short term marketable securities.",
        "label": "Short Term Marketable Securities [Member]",
        "terseLabel": "Due in One Year or Less [Member]"
       }
      }
     },
     "localname": "ShortTermMarketableSecuritiesMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Changes in Estimated Fair Value of Financing Liabilities [Table Text Block]",
        "label": "Summary of Changes in Estimated Fair Value of Financing Liabilities [Table Text Block]",
        "terseLabel": "Summary of Changes in Estimated Fair Value of Financing Liabilities"
       }
      }
     },
     "localname": "SummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesTableTextBlock",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cere_ThirdAnniversariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third anniversaries.",
        "label": "Third Anniversaries [Member]",
        "terseLabel": "Third Anniversaries [Member]"
       }
      }
     },
     "localname": "ThirdAnniversariesMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_TwoThousandAndTwentySevenConvertibleSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2027 Convertible Senior Notes.",
        "label": "Two Thousand and Twenty Seven Convertible Senior Notes [Member]",
        "terseLabel": "2027 Convertible Senior Notes [Member]"
       }
      }
     },
     "localname": "TwoThousandAndTwentySevenConvertibleSeniorNotesMember",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cere_UnderwritingDiscountsAndCommissionsOfSharesIssued": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriting discounts and commissions of shares issued.",
        "label": "Underwriting Discounts and Commissions of Shares Issued",
        "terseLabel": "Underwriting discounts and commissions of shares issued"
       }
      }
     },
     "localname": "UnderwritingDiscountsAndCommissionsOfSharesIssued",
     "nsuri": "http://www.cerevel.com/20230331",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r337",
      "r510",
      "r539",
      "r569",
      "r570",
      "r585",
      "r589",
      "r594",
      "r634",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r337",
      "r510",
      "r539",
      "r569",
      "r570",
      "r585",
      "r589",
      "r594",
      "r634",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r329",
      "r337",
      "r365",
      "r366",
      "r367",
      "r486",
      "r510",
      "r539",
      "r569",
      "r570",
      "r585",
      "r589",
      "r594",
      "r630",
      "r634",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r278",
      "r279",
      "r280",
      "r281",
      "r329",
      "r337",
      "r365",
      "r366",
      "r367",
      "r486",
      "r510",
      "r539",
      "r569",
      "r570",
      "r585",
      "r589",
      "r594",
      "r630",
      "r634",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r338",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r217",
      "r338",
      "r602",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r217",
      "r338",
      "r602",
      "r603",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "ASU 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r11",
      "r593"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premiums and accretion of discounts on marketable securities",
        "terseLabel": "Amortization of premiums and accretion of discounts on marketable securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.",
        "label": "Accrued Liabilities and Other Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Accrued expenses and other current liabilities",
        "verboseLabel": "Debt instrument, accrued interest"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities and Other Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees and consulting services"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r66",
      "r161"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation",
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r167",
      "r534",
      "r547",
      "r551"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r21",
      "r24",
      "r105",
      "r470",
      "r542",
      "r543",
      "r608",
      "r609",
      "r610",
      "r617",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Financial Statement Components"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r6",
      "r593"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "periodEndLabel": "Additional Paid in Capital, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Beginning Balance",
        "terseLabel": "Additional paid-in capital",
        "totalLabel": "Additional Paid in Capital, Total"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r617",
      "r618",
      "r619",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r204",
      "r205",
      "r206",
      "r207",
      "r217",
      "r247",
      "r248",
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r374",
      "r375",
      "r376",
      "r382",
      "r383",
      "r384",
      "r385",
      "r394",
      "r395",
      "r396",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r453",
      "r454",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r512",
      "r513",
      "r514",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r100",
      "r101",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Equity-based compensation expense",
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash flows used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total equity-based compensation expense included in total operating expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r30",
      "r306",
      "r456",
      "r612"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      },
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs",
        "verboseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potential dilutive securities excluded from calculation of net loss per share, total"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r127",
      "r140",
      "r163",
      "r195",
      "r241",
      "r243",
      "r245",
      "r254",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r398",
      "r402",
      "r430",
      "r593",
      "r632",
      "r633",
      "r646"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r156",
      "r169",
      "r195",
      "r254",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r398",
      "r402",
      "r430",
      "r593",
      "r632",
      "r633",
      "r646"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total Assets",
        "totalLabel": "Assets, Fair Value Disclosure, Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Available-for-sale marketable debt securities, Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Available-for-sale marketable debt securities, Unrealized Losses",
        "terseLabel": "Available-for-sale marketable debt securities, Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r251",
      "r270"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Amortized Cost",
        "totalLabel": "Available-for-sale marketable debt securities, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r62",
      "r250",
      "r270",
      "r527"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Available-for-sale marketable debt securities, Fair Value",
        "totalLabel": "Debt Securities, Available-for-sale, Total",
        "verboseLabel": "Available for-sale securities held"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r61",
      "r270"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Marketable securities",
        "totalLabel": "Debt Securities, Available-for-sale, Current, Total",
        "verboseLabel": "Marketable securities (current)"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r61",
      "r159",
      "r270"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "terseLabel": "Marketable securities",
        "verboseLabel": "Marketable securities (non-current)"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r47",
      "r48",
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Fixed asset additions included in accounts payable and other current liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r45",
      "r158",
      "r571"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cerevel.com/20230331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited2": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents, fair value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r46",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r40",
      "r45",
      "r50"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r40",
      "r116"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsMember": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Equivalents [Member]",
        "terseLabel": "Cash Equivalents [Member]"
       }
      }
     },
     "localname": "CashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "auth_ref": [
      "r150",
      "r151",
      "r203",
      "r247",
      "r248",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r382",
      "r394",
      "r395",
      "r404",
      "r407",
      "r408",
      "r418",
      "r436",
      "r438",
      "r439",
      "r440",
      "r443",
      "r444",
      "r453",
      "r458",
      "r459",
      "r460",
      "r461",
      "r465",
      "r466",
      "r512",
      "r513",
      "r540",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether accounting standards update was adopted.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, adopted"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "auth_ref": [
      "r150",
      "r151",
      "r247",
      "r248",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r382",
      "r394",
      "r395",
      "r396",
      "r404",
      "r407",
      "r408",
      "r409",
      "r412",
      "r418",
      "r436",
      "r438",
      "r439",
      "r440",
      "r443",
      "r444",
      "r453",
      "r458",
      "r459",
      "r460",
      "r461",
      "r465",
      "r466",
      "r512",
      "r513",
      "r540",
      "r541",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date",
        "terseLabel": "Change in accounting principle, accounting standards update, adoption date"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": {
     "auth_ref": [
      "r204",
      "r216",
      "r249",
      "r262",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, immaterial effect"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r87",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class Of Warrant Or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants to purchase shares outstanding",
        "verboseLabel": "Warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r87",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class Of Warrant Or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r19",
      "r132",
      "r146"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Notes 13 and 14)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r68",
      "r276",
      "r277",
      "r568",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r617",
      "r618",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "totalLabel": "Common Stock, Shares, Issued, Total"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r5",
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r5",
      "r593"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Common stock, $0.0001 par value: 500,000,000 shares authorized;156,760,109 and 156,502,285 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively",
        "totalLabel": "Common Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockVotingRights": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Common Stock, Voting Rights",
        "terseLabel": "Common stock, voting rights"
       }
      }
     },
     "localname": "CommonStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r25",
      "r176",
      "r178",
      "r184",
      "r529",
      "r536"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive loss:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer Equipment [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in-progress [Member]"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractualObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contractual Obligation",
        "terseLabel": "Liabilities related to obligation",
        "totalLabel": "Contractual Obligation, Total"
       }
      }
     },
     "localname": "ContractualObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "2027 convertible senior notes, net (Note 6)"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r586",
      "r588",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r47",
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Debt instrument, number of shares converted"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDefaultLongtermDebtAmount": {
     "auth_ref": [
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured.",
        "label": "Debt Instrument, Debt Default, Amount",
        "terseLabel": "Debt instrument, default amount"
       }
      }
     },
     "localname": "DebtDefaultLongtermDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the facts pertaining to a notice received from a lender that an event of default has occurred with respect to the long-term debt instrument or borrowing, and a description of the expected financial consequences of receiving such notice, including the effects of a demand for immediate repayment of all amounts due, and the classification of the debt on the balance sheet.",
        "label": "Debt Instrument, Debt Default, Description of Notice of Default",
        "terseLabel": "Debt instrument, notice for default, description"
       }
      }
     },
     "localname": "DebtDefaultLongtermDebtDescriptionOfNoticeOfDefault",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r128",
      "r130",
      "r139",
      "r198",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r457",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r2",
      "r130",
      "r139",
      "r308"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Debt instrument, carrying value",
        "totalLabel": "Net carrying amount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r72",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Debt instrument, conversion price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r17",
      "r79",
      "r82",
      "r84",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Debt instrument, conversion rate"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments": {
     "auth_ref": [
      "r17",
      "r79",
      "r82",
      "r84",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.",
        "label": "Debt Instrument, Convertible, Number of Equity Instruments",
        "terseLabel": "Debt instrument, convertible, number of equity instruments"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleNumberOfEquityInstruments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Debt instrument, consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Debt instrument, conversion price percentage applicable for trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Debt instrument, trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r118",
      "r121",
      "r291",
      "r457",
      "r581",
      "r582"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails2": {
       "order": 0.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, aggregate principal amount",
        "verboseLabel": "Principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r299",
      "r429",
      "r581",
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt instrument, fair value",
        "totalLabel": "Debt Instrument, Fair Value Disclosure, Total"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": {
     "auth_ref": [
      "r18",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).",
        "label": "Debt Instrument, Frequency of Periodic Payment",
        "terseLabel": "Debt instrument, frequency of payment"
       }
      }
     },
     "localname": "DebtInstrumentFrequencyOfPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r15",
      "r118",
      "r310",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r15",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, stated rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r170",
      "r580",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt instrument, maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r18",
      "r198",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r457",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPaymentTerms": {
     "auth_ref": [
      "r16",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.",
        "label": "Debt Instrument, Payment Terms",
        "terseLabel": "Debt instrument, payment term"
       }
      }
     },
     "localname": "DebtInstrumentPaymentTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r18",
      "r79",
      "r83",
      "r84",
      "r85",
      "r117",
      "r118",
      "r121",
      "r138",
      "r198",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r457",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r635"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedLabel": "Unamortized debt discount",
        "terseLabel": "Unamortized debt discount",
        "totalLabel": "Debt Instrument, Unamortized Discount (Premium), Net, Total"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesSummaryOfNetCarryingAmountOf2027NotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Summary of Estimated Fair Value and Amortized Cost of Available-for-Sale Marketable Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance cost incurred"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r119",
      "r635"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt instrument, purchaser discounts and other offering expenses",
        "totalLabel": "Debt Issuance Costs, Net, Total"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Deferred expenses associated with financing activities",
        "totalLabel": "Debt Issuance Costs, Noncurrent, Net, Total"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r629"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r43",
      "r239"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation, Depletion and Amortization, Total"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r109",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r342",
      "r370",
      "r371",
      "r373",
      "r377",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Equity-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r1",
      "r3",
      "r129",
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r185",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r218",
      "r220",
      "r222",
      "r223",
      "r224",
      "r228",
      "r416",
      "r417",
      "r530",
      "r537",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic",
        "totalLabel": "Earnings Per Share, Basic, Total"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r185",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r220",
      "r222",
      "r223",
      "r224",
      "r228",
      "r416",
      "r417",
      "r530",
      "r537",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted",
        "totalLabel": "Earnings Per Share, Diluted, Total"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r225",
      "r226",
      "r227",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and personnel costs",
        "totalLabel": "Employee-related Liabilities, Current, Total"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Equity-based compensation expense expected to be recognized over weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r639"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r639"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized equity-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Stock Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options [Member]",
        "verboseLabel": "Stock Options Outstanding [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r78",
      "r152",
      "r179",
      "r180",
      "r181",
      "r199",
      "r200",
      "r201",
      "r205",
      "r213",
      "r215",
      "r230",
      "r261",
      "r328",
      "r374",
      "r375",
      "r376",
      "r384",
      "r385",
      "r415",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r470",
      "r542",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r43",
      "r74"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Change in fair value of private placement warrants"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r111",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r110",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r299",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r420",
      "r483",
      "r484",
      "r485",
      "r581",
      "r582",
      "r586",
      "r587",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r419",
      "r420",
      "r422",
      "r423",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r299",
      "r330",
      "r335",
      "r420",
      "r483",
      "r586",
      "r587",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets (Level 1) [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r299",
      "r330",
      "r335",
      "r420",
      "r484",
      "r581",
      "r582",
      "r586",
      "r587",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs (Level 2) [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r299",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r420",
      "r485",
      "r581",
      "r582",
      "r586",
      "r587",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs (Level 3) [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r111",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Summary of Rollforward of the Estimated Fair Value Associated with Financing Liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value recognized in other (income) expense, net",
        "verboseLabel": "Gain (loss) for change in estimated fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r299",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r483",
      "r484",
      "r485",
      "r581",
      "r582",
      "r586",
      "r587",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfRollforwardOfLiabilityAssociatedWithPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOptionChangesInFairValueGainLoss1": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.",
        "label": "Fair Value, Option, Changes in Fair Value, Gain (Loss)",
        "negatedLabel": "Change in fair value recognized in other expense (income), net",
        "terseLabel": "Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss"
       }
      }
     },
     "localname": "FairValueOptionChangesInFairValueGainLoss1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOptionQuantitativeDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Option, Quantitative Disclosures [Line Items]"
       }
      }
     },
     "localname": "FairValueOptionQuantitativeDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOptionQuantitativeDisclosuresTable": {
     "auth_ref": [
      "r432",
      "r433",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value under fair value option.",
        "label": "Fair Value Option, Disclosures [Table]"
       }
      }
     },
     "localname": "FairValueOptionQuantitativeDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOptionTextBlock": {
     "auth_ref": [
      "r115",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a company's election to apply the fair value option for measurement and reporting of eligible financial assets and liabilities (as defined), as well as certain other eligible items (as defined) included in the statement of financial position, whether such option is elected for a single eligible item or a group of similar eligible items and is in addition to other disclosures concerning fair value which the company may be required to provide. Such disclosure might be expected to include: (1) for items included in the statement of financial position: (a) the reasons for electing a fair value option for each eligible item or group of similar eligible items; (b) if the fair value option is elected for some but not all eligible items within a group of similar eligible items: (i) a description of those similar items and the reasons for partial election and (ii) information of how the group of similar items relates to individual balance sheet line items; (c) for each line item in the statement of financial position that includes an item or items for which the fair value option has been elected: (i) information of how each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with other fair value disclosures and (ii) the aggregate carrying amount of ineligible items included in each line item in the balance sheet, if any; (d) the difference between the aggregate fair value and the aggregate unpaid principal balance (assuming contractual principal amounts and fair value option elected) of: (i) loans and long-term receivables (other than securities otherwise reported at fair value) and (ii) long-term debt instruments; (e) for loans held as assets for which the fair value option has been elected: (i) the aggregate fair value of loans that are 90 days or more past due, (ii) if the policy is to recognize interest income separately from other changes in fair value, the aggregate fair value of loans in nonaccrual status, and (iii) the difference between the aggregate fair value and the aggregate unpaid principal balance for loans that are 90 days or more past due, in nonaccrual status, or both; (f) for investments that would have been accounted for under the equity method if the entity had not chosen to apply the fair value option, the information required for such investments, if material either individually or in the aggregate; (2) for items included in the income statement: (a) the amounts of gains and losses from fair value changes included in earnings and in which line in the income statement those gains and losses are reported whether or not combined with gains and losses from items required to be accounted for at fair value; (b) a description of how interest and dividends are measured and where they are reported in the income statement; (c) for loans and other receivables held as assets: (i) the estimated amount of gains or losses included in earnings attributable to changes in instrument-specific credit risk and (ii) how the gains or losses attributable to changes in instrument-specific credit risk were determined; (d) for liabilities with fair values that have been significantly affected during the reporting period by changes in the instrument-specific credit risk: (i) the estimated amount of gains and losses from fair value changes included in earnings that are attributable to changes in the instrument-specific credit risk, (ii) qualitative information about the reasons for those changes, and (iii) how the gains and losses attributable to changes in instrument-specific credit risk were determined; and (3) certain other disclosures as required or determined to be provided.",
        "label": "Fair Value, Option [Text Block]",
        "terseLabel": "Financing Liabilities"
       }
      }
     },
     "localname": "FairValueOptionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilities1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).",
        "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement in which other comprehensive income (OCI) is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).",
        "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfRollforwardOfTheEstimatedFairValueAssociatedWithFinancingLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r252",
      "r253",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r273",
      "r307",
      "r325",
      "r405",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r578",
      "r624",
      "r625",
      "r626",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total",
        "verboseLabel": "Direct costs and fees incurred related to funding agreements included in general and administrative expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r27",
      "r125",
      "r133",
      "r148",
      "r241",
      "r242",
      "r244",
      "r246",
      "r531",
      "r577"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r274",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r196",
      "r379",
      "r380",
      "r381",
      "r387",
      "r389",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r197",
      "r214",
      "r215",
      "r240",
      "r378",
      "r388",
      "r390",
      "r538"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (provision), net",
        "negatedTerseLabel": "Income tax benefits",
        "totalLabel": "Income Tax Expense (Benefit), Total"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities",
        "totalLabel": "Increase (Decrease) in Accrued Liabilities, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets",
        "totalLabel": "Increase (Decrease) in Other Operating Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r119",
      "r135",
      "r182",
      "r238",
      "r455"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails2": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense",
        "totalLabel": "Interest Expense, Total"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r33",
      "r304",
      "r311",
      "r583",
      "r584"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Total interest expense",
        "totalLabel": "Total interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r35",
      "r305",
      "r583",
      "r584"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfInterestExpenseRelatedTo2027NotesRecognizedInInterestIncomeExpenseNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Summary of Interest Income (Expense), Net"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestIncomeExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income (Expense), Net [Abstract]"
       }
      }
     },
     "localname": "InterestIncomeExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "terseLabel": "Interest income (expense), net",
        "totalLabel": "Interest income (expense), net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancialStatementComponentsSummaryOfInterestIncomeExpenseNetDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r187",
      "r190",
      "r191"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest",
        "verboseLabel": "Debt instrument, accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivableCurrent": {
     "auth_ref": [
      "r605"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Interest Receivable, Current",
        "terseLabel": "Interest receivable"
       }
      }
     },
     "localname": "InterestReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterimPeriodCostsNotAllocableDomain": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.",
        "label": "Interim Period, Costs Not Allocable [Domain]"
       }
      }
     },
     "localname": "InterimPeriodCostsNotAllocableDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Legal Proceedings"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureLegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r12",
      "r195",
      "r254",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r399",
      "r402",
      "r403",
      "r430",
      "r576",
      "r632",
      "r646",
      "r647"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r10",
      "r131",
      "r144",
      "r593",
      "r615",
      "r627",
      "r644"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r157",
      "r195",
      "r254",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r399",
      "r402",
      "r403",
      "r430",
      "r593",
      "r632",
      "r646",
      "r647"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "terseLabel": "Total Liabilities",
        "totalLabel": "Liabilities, Fair Value Disclosure, Total",
        "verboseLabel": "Liabilities fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r2",
      "r130",
      "r142",
      "r298",
      "r309",
      "r581",
      "r582"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total future payments"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r71",
      "r198",
      "r302"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Fiscal year ended December 31, 2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r71",
      "r198",
      "r302"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "Fiscal year ended December 31, 2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r71",
      "r198",
      "r302"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Fiscal year ended December 31, 2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r71",
      "r198",
      "r302"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Fiscal year ended December 31, 2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r616"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "Fiscal year ended December 31, 2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesScheduleOfFutureMinimumPaymentsUnder2027NotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "2027 Convertible Senior Notes"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotes3"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of items purchased under a long-term purchase commitment.",
        "label": "Category of Item Purchased [Axis]",
        "terseLabel": "Category of Item Purchased"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment.",
        "label": "Long-Term Purchase Commitment, Category of Item Purchased [Domain]",
        "terseLabel": "Long-term Purchase Commitment, Category of Item Purchased"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ManagementFeeExpense": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).",
        "label": "Management Fee Expense",
        "terseLabel": "Management fee"
       }
      }
     },
     "localname": "ManagementFeeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesRealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).",
        "label": "Marketable Securities, Realized Gain (Loss)",
        "terseLabel": "Gains or losses recognized on the sale or maturity of marketable securities",
        "totalLabel": "Marketable Securities, Realized Gain (Loss), Total"
       }
      }
     },
     "localname": "MarketableSecuritiesRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputInceptionDiscountRateMember": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate at inception of contract to determine present value of future cash flows.",
        "label": "Measurement Input, Inception Discount Rate [Member]",
        "terseLabel": "Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputInceptionDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NASDAQIndexFutureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A standardized contract, traded on a futures exchange, to buy or sell National Association of Securities Dealers Automated (NASDAQ) index at a certain date in the future, at a certain price.",
        "label": "NASDAQ Index Future [Member]",
        "terseLabel": "Nasdaq [Member]"
       }
      }
     },
     "localname": "NASDAQIndexFutureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfExpenseAxis": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cost or expense.",
        "label": "Nature of Expense [Axis]"
       }
      }
     },
     "localname": "NatureOfExpenseAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r232",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of Operations"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNatureOfOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r189"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash flows provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r189"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash flows provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r40",
      "r41",
      "r44"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash flows used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r28",
      "r44",
      "r134",
      "r147",
      "r155",
      "r174",
      "r177",
      "r181",
      "r195",
      "r204",
      "r208",
      "r209",
      "r210",
      "r211",
      "r214",
      "r215",
      "r221",
      "r241",
      "r242",
      "r244",
      "r246",
      "r254",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r417",
      "r430",
      "r577",
      "r632"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New accounting pronouncements or change in accounting principle"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r53",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r202",
      "r204",
      "r205",
      "r206",
      "r207",
      "r210",
      "r217",
      "r228",
      "r247",
      "r248",
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r374",
      "r375",
      "r376",
      "r382",
      "r383",
      "r384",
      "r385",
      "r394",
      "r395",
      "r396",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r453",
      "r454",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r512",
      "r513",
      "r514",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Guidance"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental cash flow disclosures from non-cash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r241",
      "r242",
      "r244",
      "r246",
      "r577"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Loss from operations",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r464"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r464"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r463"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r168",
      "r593"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets",
        "totalLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax": {
     "auth_ref": [
      "r172",
      "r173",
      "r428",
      "r431"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, before reclassification adjustment, of unrealized gain (loss) from increase (decrease) in instrument-specific credit risk of financial liability measured under fair value option.",
        "label": "Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, Unrealized Gain (Loss) Arising During Period, after Tax",
        "negatedLabel": "Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss",
        "terseLabel": "Change in fair value attributable to instrument-specific credit risk recognized in other comprehensive (income) loss",
        "verboseLabel": "Changes in fair value attributable to instrument-specific credit risk"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r26",
      "r78",
      "r175",
      "r178",
      "r183",
      "r445",
      "r450",
      "r451",
      "r528",
      "r535",
      "r608",
      "r609"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r171",
      "r173"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized gains (losses) on securities available-for-sale"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash items",
        "terseLabel": "Other non-cash items",
        "totalLabel": "Other Noncash Income (Expense), Total"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net",
        "totalLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherIncomeExpenseNetDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Income (Expense) [Member]",
        "terseLabel": "Other operating income expense"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r606",
      "r628"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other prepaid expenses"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Deferred costs related to financing activities",
        "totalLabel": "Payments of Financing Costs, Total"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities",
        "totalLabel": "Payments to Acquire Marketable Securities, Total"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r4",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "totalLabel": "Preferred Stock, Shares Issued, Total"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r4",
      "r593"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Preferred stock, $0.0001 par value: 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2023 and December 31, 2022",
        "totalLabel": "Preferred Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r607"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseOtherNoncurrent": {
     "auth_ref": [
      "r604"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.",
        "label": "Prepaid Expense Other, Noncurrent",
        "terseLabel": "Other prepaid expenses, net of current portion"
       }
      }
     },
     "localname": "PrepaidExpenseOtherNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfOtherLongTermAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidInsurance": {
     "auth_ref": [
      "r572",
      "r579",
      "r628"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Insurance",
        "terseLabel": "Prepaid insurance"
       }
      }
     },
     "localname": "PrepaidInsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of 2027 convertible senior notes, net of offering costs"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Debt instrument, aggregate net proceeds"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock related to follow-on offering, net of offering costs",
        "verboseLabel": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r37",
      "r98"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from the exercise of stock options",
        "totalLabel": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised, Total"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from Related Party Debt",
        "terseLabel": "Proceeds from financing liability, related party"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Maturities and redemptions of marketable securities",
        "totalLabel": "Proceeds from Sale and Maturity of Marketable Securities, Total"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r611"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from the exercise of public warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r155",
      "r174",
      "r177",
      "r188",
      "r195",
      "r204",
      "r214",
      "r215",
      "r241",
      "r242",
      "r244",
      "r246",
      "r254",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r397",
      "r400",
      "r401",
      "r417",
      "r430",
      "r531",
      "r577",
      "r591",
      "r592",
      "r610",
      "r632"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r65",
      "r160"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "terseLabel": "Property and equipment",
        "totalLabel": "Property, Plant and Equipment, Gross, Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r67",
      "r145",
      "r533",
      "r593"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Property and Equipment Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r336",
      "r473",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r336",
      "r473",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r471",
      "r472",
      "r474",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r102",
      "r149",
      "r654"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r45",
      "r50",
      "r567"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cerevel.com/20230331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited2": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash",
        "totalLabel": "Restricted Cash and Cash Equivalents, Noncurrent, Total"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units [Member]",
        "verboseLabel": "Restricted Stock Units Outstanding [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r7",
      "r86",
      "r143",
      "r546",
      "r551",
      "r593"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Accumulated deficit",
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r152",
      "r199",
      "r200",
      "r201",
      "r205",
      "r213",
      "r215",
      "r261",
      "r374",
      "r375",
      "r376",
      "r384",
      "r385",
      "r415",
      "r542",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty payments"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosurePfizerLicenseAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Summary of Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Potential Dilutive Securities Excluded From Calculation of Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Summary of Net Carrying Amount of 2027 Notes"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r96",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Equity-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Payments under 2027 Notes"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Summary of Other Long-Term Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Summary of Other Income (Expense), Net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFinancialStatementComponentsSummaryOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r122",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r339",
      "r341",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r90",
      "r92",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Weighted Average Assumptions Used to Determine Fair Value of Stock Options Granted to Employees and Directors"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r79",
      "r80",
      "r81",
      "r83",
      "r84",
      "r85",
      "r86",
      "r164",
      "r165",
      "r166",
      "r231",
      "r312",
      "r313",
      "r314",
      "r316",
      "r320",
      "r325",
      "r327",
      "r585",
      "r601",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionAxis": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.",
        "label": "Securities Financing Transaction [Axis]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionTypeDomain": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement of financing transaction securities held.",
        "label": "Securities Financing Transaction [Domain]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Disclosure [Abstract]"
       }
      }
     },
     "localname": "ShareBasedArrangementsToObtainGoodsAndServicesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Equity-based compensation",
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Life (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Non-vested, Ending balance",
        "periodStartLabel": "Non-vested, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Non-vested, Ending balance",
        "periodStartLabel": "Non-vested, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "terseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Forfeited, canceled or expired",
        "totalLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Granted",
        "totalLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value",
        "verboseLabel": "Stock options granted, weighted average grant-date fair values"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "verboseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, Ending balance",
        "periodStartLabel": "Outstanding, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, Ending balance",
        "periodStartLabel": "Outstanding, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "verboseLabel": "Options vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "verboseLabel": "Options vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "verboseLabel": "Options vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureEquitybasedCompensationSummaryOfRestrictedStockActivityDetailsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfEquityBasedCompensationExpenseDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfWeightedAverageAssumptionsUsedToDetermineFairValueOfStockOptionsGrantedToEmployeesAndDirectorsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Options Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Options vested and expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares issued, price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r52",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r20",
      "r78",
      "r152",
      "r179",
      "r180",
      "r181",
      "r199",
      "r200",
      "r201",
      "r205",
      "r213",
      "r215",
      "r230",
      "r261",
      "r328",
      "r374",
      "r375",
      "r376",
      "r384",
      "r385",
      "r415",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r470",
      "r542",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Disclosure2027ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r230",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r4",
      "r5",
      "r78",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under equity incentive plans related to vesting of RSUs, (in shares)",
        "totalLabel": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture, Total"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r4",
      "r5",
      "r78",
      "r86",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised",
        "verboseLabel": "Issuance of common stock under equity incentive plans related to exercise of options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r4",
      "r5",
      "r78",
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Issuance of common stock related to follow-on offering, net of offering costs",
        "terseLabel": "Issuance and sale of common stock",
        "verboseLabel": "Issuance of Series A-1 preferred stock and Series A common stock and common stock in exchange for cash"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r20",
      "r78",
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock under equity incentive plans related to exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r5",
      "r8",
      "r9",
      "r59",
      "r593",
      "r615",
      "r627",
      "r644"
     ],
     "calculation": {
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r88",
      "r194",
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r328",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r452",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r452",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r452",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r452",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r477",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityPreferredStockAndCommonStockDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationSummaryOfStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r252",
      "r253",
      "r307",
      "r325",
      "r405",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r624",
      "r625",
      "r626",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesSummaryOfChangesInEstimatedFairValueOfFinancingLiabilitiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureEquityBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r204",
      "r205",
      "r206",
      "r207",
      "r217",
      "r247",
      "r248",
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r264",
      "r374",
      "r375",
      "r376",
      "r382",
      "r383",
      "r384",
      "r385",
      "r394",
      "r395",
      "r396",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r453",
      "r454",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r512",
      "r513",
      "r514",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFinancingLiabilitiesAdditionalInformationDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r574",
      "r586",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. Government Agencies [Member]"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r532",
      "r586",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfEstimatedFairValueAndAmortizedCostOfAvailableforsaleMarketableDebtSecuritiesDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r233",
      "r234",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrant [Member]",
        "verboseLabel": "Warrants Outstanding [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromCalculationOfNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants [Abstract]"
       }
      }
     },
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Fair value of warrants"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/DisclosureStockholdersEquityWarrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r219",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average shares used in calculating net loss per share, diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r218",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average shares used in calculating net loss per share, basic",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.cerevel.com/20230331/taxonomy/role/Role_DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.cerevel.com/20230331/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "825",
   "URI": "https://asc.fasb.org/topic&trid=2134543",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31010-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL75136633-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14210-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14217-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14217-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL120154346-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e639-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r595": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r596": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r597": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r598": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r599": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>79
<FILENAME>0000950170-23-017180-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-017180-xbrl.zip
M4$L#!!0    ( &J!HU90+0_*C&4# ->I+P 1    8V5R92TR,#(S,#,S,2YH
M=&WLO6M7W$B6*/I]?H6.>V9.U;H$5H0BI A<56?1&'=SQV6[P9X^?;]XQ1,T
ME:1H26F;_O5W[U"^@,3&=D(JL6JF#:244D3L]_N7__/I?)1\\'535N-?G]#=
M]$GBQ[9RY?CTUR?[)P='1T_^SV^__"]"DN<OCEXEK_S'9-^VY0?_O&SLJ&HF
MM4]^.OG]Y^1H/"K'/OF_?SY^F3RO[.3<C]N$)&=M>['W].G'CQ]W72C'336:
MM/"J9M=6YT\30KIG']1>X\?)<]WZ9(^E+".I(&GVEN9[*=]C=+?(4_K_I.E>
MFBZ^55U<UN7I69O\9'].\$OPYO'8CT:7R8MRK,>VU*/D9/;*'5BCW4WV1Z/D
M&+_5),>^\?4'[W;QD?_VRUD+9P'G,6Y^?;*T[H_9;E6?/J5*J:>?\)XGW4U[
MGTP]<N7\7OPSWLG2-'_:7;QR:[OR5M'=VB[?6EY9P/+=V5,XQ!:VYF?WP['_
M\9G;\;+1S?SV3S?NO[(_O#J[M?QTVW,I+@/AC>">W3ZNQJ\ ['5I5W_-M?73
M]O+"/X4;R;B[<[ZJIERU)M@!??I_?W]Y8L_\N2;7M^[\M=-OO-T]K3X\A0OP
M7<9F-TX:<JKUQ?SFH!L37S"]<.7FLJDXH\7G0-#=,?N"A\VP5;!EZ5/_J?7C
MIC0C3WS<<\3SAC"DM.DNVIK@N31?.#9\'DDI873V3>MK?^5+^,$'/XK$A?20
M9AE=0+,E<#Y7[I^=UP*83]M:CYM0U>=QH0AKH$-)KCQG]4*_]!!&6#Y[2%.W
M-X$!'UZ%6EO?"@3U%*X^^>W?DE_.O';P,_FE+=N1_XVFY&^_/.U^QT_/?:LC
M%R+^GY/RPZ]/#JHQ@*0E;^%,GR2V^^O7)RU ZFE'W4_QL4^GS_W%5.XR:=K+
M$1SUN:Y/R_%>HB=M];_*\XNJ!GQLGUUHAPQS+Y$7GYX]B:]UY8?9EUS97(ST
M)=*'AZN_E)_V\-F^[GXMG?/C^.N"@)+2_?KDQ7N5YH)9XX@V6A+N-"4R4$:,
MXLRJ4,@"<6&LS_$MOMS;!Z;KD/&^&.G3Z=X^M<<^P*[?\R)W1@1)K F:<*4\
M4<%ZHGEN<QU8IJQ]\EO0H\;_\O3*:E8O3AH6,JL+(EQ(";=2$Y7#GT&;C*K<
M,2OX\N)F0N$%" X]>@-/JMP+^*SYMH7^C=YIE2++<CC@@A2%XO"P0A&9*T9D
MX5(:9"J%5,NK/)C4]7R1__"Z/AP[%$K?MDA" %K9W59*0VJ#M 7)\+%<2P![
M2BTI@E',.Y<I+F<KG;*MO1>ZK/];CR;^V%M8..#@GW53-N_&E4')IH'M'(TO
M)K!H6+TM1V6DQY>E-O![>_D778Y?5DUSTL(.$3:O XC(ZMP?SKG6R[)IK^^]
M4#3+F#(D#=01#M1(C'6*^)!2YM/<XIG^]CE6^Z?7[9FO7U7CZB)RQ/'I[+T7
M\-Z[X5\*K[*9"D0H&PB7GA*5*D6RPKK :>KRX)8A>S@&IG!Y +NL]>AH[/RG
M__*7WP;6%,223$4FBUM6^J+6-NHS4SH.WDCJ'6$9*^"I+B.&9YQXKJAGAA=!
MYM=!>U"=GY<M J79'SMD6G!*H)J5_@;!*,%3RJTAU.:,\-1:8BAS) MP"$XH
MP13@[V1<=E]X]_[=R7/@L4VY-RY'P/GJB0>V]/3JTF_9BC74!BHH*5P!5$]#
M3E3A8&<R3;6AF7/"7-_*F]H'#V3E3MK*_A'Q]?H6#,M3+D)&A,XMX4"<1'DG
M2,Y=4$+F)F-N75O(#;<9SPUQQ@%+R("U*N/@](#Z5)%KV*+Z#FC<ZU:ND@!3
MF:6XB<P#^0'N!J*8RTF1PFNUR%VA;^QD_2PCTC(<T$7MSY!K?/ /R416O!C7
M-]?_YRN?;_SU!>[HW1ALCE'Y+^]F6]JORP:.X_D$#Z633_NA]?5;_>EN9"X=
M#<($3UB0!C@X\@U@&"1/=0"JR:@3]AMHXY[(^^E5Y2.N S#:-[_]@D; 7A-U
M;GAD$HV"/=1!?WW2@-8S0@4\?G96XQM1ZR0S=7/W4^/P=5>?T;UN^1WQSZ::
MU/&O:/3L3?<=CQ/V[4TF#1PB;!&.$[X+O#APHJ56H&!86H3P9/95'[G[[*_2
MX=^A]'42E^!7:KT'1_]UE9=?__+L<8T_153O_G3PLD\7H]*6[>_^W, K7'F.
MZ(<&] RL<_(X!*43I X@*6A_R#T^E<V3WY;92C6.H.^>]<O3E:_X;;:V^4J>
MKMKV143:^2%$:ZG]#6D%3.FHAUR],OM[]KVG5\"P&BK"I-R;/",.^!BH?:$@
M4A4<Z194/L:Y$*ZO4'D.^_R@V\@H&J +_/IQV?S1 071>&_*-\:G<[YQ[$<
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ML((_-51EA168H=4W[&WJ=N\859<.(/CG[^6X/)^<KPL1^AR5V%!:AN,^.,M
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M<]FQ%(R6#XK;=S W:CA-"T,R0%_"4X\=;)P@-"N4*8K4>M5;,7BG285_\6-
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M"Y!GAJ5$%=A@1'I?Y"Q3M+^9*'TU>H:1M0_%?FQ.35 *I'A@8'NEQA.94T=
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M6J'7CQR2@5H?C%IKC>KT5X=#A_.\15.\/(?'_[1YQ^3 \P:>-]#H2GB_FI;
M1@7%?[)G>GP*'XP36!5\LK#POC+V)!\Z]H2=?[8HXOI-0+S-(2RTLD$9DJ>Y
M(]P;113/.+%.J=2$E!?B1I&2M2&7:9$1IH,AW%!/M,%9P2(+N6(\,YPN.^6F
M5O\E928JM5N.]MB2I<+55_:/G02,T.0#C@%-_AT F:846^8D<;113W,+[HK9
MJ@\":JW.F7X(J!^4TP2=*FFM)YP)2GA&,Z(U#IVW- U4,6_%C?:C7\MIIEIX
MISQN.YLY/#X<.,C 008.,M=5XLA+6A"KB@(+JH$;I,*2K,A2*M+ I)?KTE4.
MI^IL[&]THX$ *KN;ZAVP7K?%F4]>[9\\W_];<H+Z3(*3/GR;O'QY\ UY9%],
M)QDB97>N&1P[K!?TB;E,[)D'R)SC#):/9SZ6/&-4K%YT'OJ)_IR<Z28)Y<B[
M1(]&<!%;R6*8[9^3$H-L;948/[T!GCF/LV58U]NUXIQ&VY:"=#,JP @<7L96
MG(F;X(#[>"L<C/4QGX6R)+9H;Y*?X'E +TDS 1NP.:NP_=&LC61[IMOK:_^H
MKZX2E]A]>;J'GW<2/7;)3ZS;HP&J@^OF?V '>'^\%;Z$JY@^![OJ-G$1<9&Z
M:1.5)DY?-KM)9-6?37KX)CC>5A*EO/9@8P'+,@Q85A:(5-Z2PMD<.)+U*5U3
M@O;!I*YAVUT+8=2!6MT^2./U^Z6#?_AFPPDX]QPO7HF,#]/4>:V9*M>FR6P[
M5)+D5?6X8,.'7)8-2FB47""TSLNV!3'G1R"\ZFJ,JOWH,O&@YE\F1ZA):QO3
MLI_K5G<-?Z\)\,4SEK-FCB=P)T_%M"'A9-1U&C@A;Y.?T&0IGK&,[4YO:,_*
M!E:L+[ OX7U+\VZ]<R'MFY]W'U8"YZF067",2)=GA$N>P6\R)9D-!?/.FUS3
M=34AF\,/P3<5R%N/YX,$WB8N/TC@_L)FD,";E, @]'0R@G/QB;86)# F#[HH
ME&JT,%=^F@"[(RLN-+ M^&5JHJ+(M-4Y'.;E#IK3\#"P01$"IPD<Z<?V;'9Y
M%ZQK'U?F?"C'<<9"K,WJJD;LL]L6V%UWS^8WWN&6VQ<YOQ4-Z]GMMRQY?F\Y
M[O0,R@QA,V?!LH=@=\A]?6PM>!G=3?EWI[8*MENP[\^RA5OR[W_*+I5?T3%8
M?DLFPJRV8HK.M!Q_9W+"[($=6*>/[-F0U'M2WPM);2%R8JP.A/,BZTK#79!&
M49]F@7YWP=KA?/A(?0 T=%K5ERM<_O&FR&GM]*8'\?[?KPA]N5K<W$_<L5]D
M,00GMP!(6SS@^6&MO4<![8$D!R!MK2C=OU6(#E"_*]1["-;D48%QD*=W]]#=
MQ4+,=O/M-Q!9'\3NFB<,?U;L DCPRJ]/V),!8 / !H - /N! 78/+=3[!<S!
M8KFE?F]5;.M1J;N#0V$+@#38)-]@DVPMM >2'("TM1+SY+:,B@'Z@Z^O;V!\
M\+C_6KN%AB)W/A>2!.HRPK/,8N&>)"++E:66\H*N:<Y&).H_3YIR[)OF9N#?
M5-7(P!U5:ZI/CT^G^+HN\=M-$3^253\ :0#2#PJDO\.V<&O- )X^@F>@H0%(
M Y &(/T@0%J;-!KB-(-K< #2 *1M!]*@GO<:/ ,-#3&0SX'Z<'69Z #[@4"'
M^,973+JEC.6I$B1/,58A94J,907AUJ1!>.J-$.N);\P(]B^17@\Z<AWB'-_>
MQ3#],4O8O[5;Q2 WNVX5X3-](7 TZ,IF%F58U4DJ]H_R+AE7L?W3I.EZ2L"1
M>0"+2_#.)C:7F/5JPAY.^*[1);[\8PFOAM<F8]A#A?D,'\HF9@".]=B6>H0E
MP7"X,<6A:?78Z=HUR06.?7>W36S+?M(_KVP+,31Q&9JXK+.)2W/F1Z,9Y20_
M 3W$9BJ EU]L4=)U'_L'+/.1(N5V(\/GNC[=DQXF\N"U2C'%Q O0J;*,:*$L
M43H44O 0O%U3A]831-M5ZE=4O;P>!SUJ'F(XQ@-7IM]M9.W /;^IZ#@VC]J_
MJ,M1PN1.PE*6[=S4&-PC80_WT#9R^TYARL9>Q%Z3H'AU?,PJESME,R+A/\)-
MD1+%"D^LTX7@G#FM;XS72#//E3>2,(H,4 I/C'0I";Y(F?>2%UF^HM-TG'\3
MV\6?X)B;YO6DC3HB*(M/DLFX[![_[GT<@M,\ >EL2SB/YM<G1Z]>7.5\X\FY
MJ]KI#4]^HR+?D1G;48K-^,9LFX^EVR0>RN/8BH^\Q]YU&M).4BWPY.ZMXNY]
M3GEW_]6I<6R7X=@X5TW,R'^G8<XW8YCWTDEQO^,&M^LLUJUT#8?1R\-8/2!G
M\\=Q-L\AN="GOG/A$QU@K7MZ]%%?-L^>)$_[=W /,&!GO8?_-C;^!$%YT'W4
M] ,M^TFC6]HE%4Z&?J'MJ&2[\DLM4(O=],ZM2;]N1NKRE&*Z,HZWC'WYK@3M
MYSM">^>E<Z W?3&ZMPSAZ4LW/S%Y/9KV6C6=;ZQ+^S+4[Q_$ SP?$I[W0<77
MYVFS:Q/0YX>Z$A<^-ZIPX^3_.,9POP'][7[SA?O.2+8XYGRONN>;_>.WR='N
MXY0>]PATG9S5Z,+\$ZB+[?MR'A5_7XX[YV59?5_K[^F9WE4,Q24Z;ZLZOGH/
MWN+K43GV]X8Y+XY>[;\Z.-I_F1R]>O'Z^/?]MT>O7\WQ2/<)EZ8S<;\D?1:\
M?E/8%5?V"+K2B$'8;*FPN6?$.&K]>4('<?/-X@9V<OZ>OE_(FZ;5;3?-]I&+
MFWG>V<E\Q\E/[\9ZXF#)[N=!\@R2IP^29QN\9 \DG_J('X_43_80H@<.$=[=
M>/<>?HO>'6P)^M[H$3!F_[XY\_ZQ"Z&#V1%@J&9^!,F?NR-(3N(1#))HD$2#
M)!HDT2")'E@2+4RA]]4%-JS^(871DGE4A>1U/(@X0A8'N6)N>>W/X&LX0OYE
MU0S2:I!6N/Y\D%:#M!JDU7U(JYCW?%:-0!XT[_T_)V5[.0BFY&3I5/YW<AB/
M99!%@RR"]1>#+!IDT2"+-F,Y6=V<O0^#@$H.X""2%Z/JXV B#6()UZ\&L32(
MI4$LW8=8&E>M;]ZWU?M;Y-,LW>%QBZ57> K8+^<6^;0J!6*038-L@O73=-/"
MZ=$RJ2W'C)AQQX:,N^_+N&/OX:OZ=&HCN;*QDZ8!J? >/AU=-F7SV$VFW^?;
M_\\_?6(I5<^:Y/G\&&)L:7]Z%&@\+405RK*NS1S><^R;R>AZ9&J088,,@_4S
M-LBP08;=*L.R089]GPS+WO\3&W*68#N4'SS^,9K]C@)M5#63QRW#_K:T_2B-
M_K8X@BC,\ AJ>.Z^J29M\KNN__!M<EPV?PP2:I!0L/YLXUD2CY95;3EF1 G%
M>RBA^MQ"_ZIXXNCR:^MJU+R_J"OK';+BQRV0#J8;CL+HS7S3@[09I,T@;;99
MVCQ RX:A9\/W]FPHWU?8/SYV;'C<<N;UV[\>'@]M&@8)<UW"R$'";*F$&?HT
M]!+LU_LTC/RI'G7VC(\#+1^WH'F)V^TLF6Z[@Z 9!,T@: 9!\P5!LS](FN^4
M-/I]739_O _:ME7]R*4,1F22%]U.!P$S")A!P P"9LA_N^?\M\FX&Q?F:ZP7
MTB,_JV5]WW@[J<M'WFSAW=+VDQ/</N:P=66K.-\43Z#T723G71.G.4S-H$%$
M#2(*UR\W7M;Z:'G5EF/&D-ZVGO0VYX/&[.+WDXMJ#&)I7%;U3#J5CSV7X/ET
M\\D[V#Q()-S\DF :A- @A 8A- BA[<M@ZSG8KR>QP?EZL(^"!\O(+7**'[?P
M^1T>#E81;GHYD7H0.H/0&83.('0^+W3$('2^3^B(]U7]X\P=>HU)>\G18KN#
ME!FDS"!E!BGS>2F3#U+F^Z1,_MY_.BM-^=AG/!Q.=SF(E4&LK$>LP+;P";\^
M84\&7O,E7M/ I[I]_"Z3D_D^!T8S,!ID-)_M+PD_M1GY^.MM)_T?#Z\-WGYH
M]W!"__DGFJ?/EDYI.(RU' 9EWWL:#S<E_9Z)L+QVH&=SZ7ZA3WW'28D.L-D]
M/?JH+YMG3Y*G#XB'4U"M./JD=+\^:2Y\' J*_33?U_Y4U\B\WX>J_@B_CJKJ
M#_RS^;Y<K1Z4P![LO\,RQOWC?\S@M=7;25Z]?GN8'!_^9?_X^=&KOR0O7A__
M'7XE+U^__B_\^^3M_MO#WP]?O3VY"[WS79%E&V!_6TCN!Z#SZ!)W,._\#7^U
M9V6#O8%J(*S197+L+ZJZ3:IQ\@)6D]"4_&TGJ>K5M^TDY_HRP>:U;=E.6I]T
M[?+LLRD-DBD1+KVRN\,]2^"6Y&)27U1-EUW8GODD>%!$]2A9I+$D(_VQV4U>
M3^KD]F?"-NQHXOQ.8B9MHFN? $M(1N5YB8UDVVIG^=XYHT@J>"@L G\L^ATF
MK=?GBZY__A,PF;;KW+>3G%47'GX8/RI]@%_*>+1QWE2%O!/T:7^*JUZ\)&YK
M@JKO;G(T3E#!Q"_L)'I\N;RL]DRW\+7@:^R)>U%7_P/O[=X*&_=6-VU\2:SB
M3NR9KK4%4)3_FLZ[@A/L7I/X#UU3=[BKK.WD'%XRMCZN%D\)%X7O[I3^R_AG
MTTS.+Z9OP^.[_:AWD[>P(=2KFSFPL<^4+2_@EITY=&?7XE%]6'$AHN7YQ6CE
MM_!B.9ZLO#(9N9L?>T# \Y6/Z@!X\_,(.M?<O  8O>)#I,^;'\/RQRL^K9JF
M!/5UU96(+WJTXE+M7;EJH5-4N'FA.5M]%A_+T8KG?UQ]LUVU@1;8H5_QQ@[!
MYA]'K@"T!K@>FXIU1-QX(*'ZO*,((,&1KI&*P/1K(J(BQRB1=9?A\C.(UM$R
M/E^;QN.\T?GC.^QS%= 9TOFYU^..?/3B^TG97;SV@EWD:K=SD5N885SRC,4@
MW_*?-*"NO\)7-+91V[LFLESY828PKK:6S_/B/ZZWEO^/9ZYL *4N]\+(?UJ6
M8%D4 _\S:?#09AP]WD5@!77[+,HI@I[+9L_HQD=C?I546\B&;#=#P?G8Q-R5
M,YT?:#G&$R'Q7#_[WNN:P6?.?/DH14%3R:EDG&<B5?\1318@$\;F1LL2*EQ=
MU=8?^9/?HI"+$4K0%4R47!]0XHS*/P 5SZK*(?4V$PMR"#ZV5=/&V@%@VE$0
MARB$+9P&^F22M@86V547=.(.>*";V#9Q($I&U44D<(TOB3K"LF3#E3B/;C5\
MZJHGPOG,/VY:^!8^ +^V6 Q<!28];^-K*R3V^.<MSZS]*/:LAV=?@&!NJ_H2
MN=0?.W%?VI0C+)P N0[ &\'IQ"^A!*KA&^VU1R9.M[H[GL6JXEE,6EA*9(2@
M7TQ&W7OB8_1,5UB<Q,<S'\]NNLQS[SMV:D&Q F!J7 Y %9M#1GVEC.H+/ 7P
M9,[% &FG_P[<;.!F/P@WNT:SP"_J2=G1K!_70,' R<KHH$Q Z2UGNL,*%C80
M4E^@.A#2AM2"N<F3Z!:( I3Z:=V@\6,/MS<SZ3^3\6"1N#@"9J">WH!RH)[-
MBZ'*1.<=DLXY_!+_6%(#]040T <@LS!U:=VDIYWX9?3]S/15,,J!)F>Z8W28
MZ;D["\SD,78U0E\@4O)(&S]":H53[=X6-=YK;QF(MB\8-!!M;X@VP!;0)IO1
M9C6?!K-LL<WN&GLTDW4]M1BC\8E.Y#K:<TLV\,Z"ZH'\X%%A3IAH9)^?^QH#
M9%,?\2!H^X]  \UN2DV%.]!+]0$H#-9CSY*/.#5C%MCH_#@?=#F*9E^8#WP"
M"0J7@%X3=+N#?1BO3^)@0Z3G97('TL9HQ+CIYG%8?0'B=M1]YLH8NZFQRTC=
M>90'JNP+B@Q4N7'C<28YS:2![37-%5>P#W"YC31WKC^!%OLOGUS].HC(B9\+
M0+@Y5*.R&BBL+^ >*&SSNNHL*(LJ*1F5-@HJ(#MMHTR:IRX .0TJ9'_A.I#2
MYDEI[J#!SV>DI$]KW^4F?"S;L^1-@&74 ]WT!8@#W6R>;M#9@;Z.2"#33#?X
M2(\QI\Y.ZAJ^-;H$\L)9A3%87X/)=:I/O>NR=_P5O1 SAFJOVRY!)TSSE0#&
MI9VZ.6/:$%IZ(-\N)G4S6?;2#%*NOZ@S4.OFJ7551 *S46**RZ13$R]\#3?#
M+VV7SOH9XIJGO+A)/7=8-A-[MO3U@0#[@@T# 6Z> .,(26VG"N4T$>VRB]>5
MM4MP\A=*3KA5-TW9M"@DX4M(>+,$^%7I;+">"?;6G]2SNP91V%^T&"AQ0]Y)
M?&RD%UC[1R# A;MQ6L[2Z:G-%T/RU\BZR\ILSZIF_HB=Q)=1'=:C:AR],D#)
M2-YC7S=GY<62QCQ09F_09*#,#5$FUF%%RG(>G2Y(CQTA)=I:?Q$+HFX/AU\)
MI _4U!?0#M2TJ2A<7=I9#4+MRW,SJ1L_<[ ,)+1%\!Q(: ,DM)2DN>2<;&8.
MRW?C6*5\TLY](%COBP5,%K8)5ME@:_4'F@,!;4@&E><7Z.@ @8,- 79FF<_3
MDG4;265:SCMVNG:+6Y#NEM.J=I+_F;@R)F\Y;\NN*#E:<1.07:@8EDTS 8HT
MEXF>@!56QZ1HL,A,Y09B[!%F#,2X>1<D%O7H:4%K[6,(X ]_F32VC,DDI=U)
MSK&Q@1XM9R2C V.IY<:%KYMJ//9#X6EO #W0UH9H:];)9+F'S#1K&%O!3*9I
MPA\\MD>9YQ O"[A(BV.<Q1<=CTMI6].TY?'I0&=] ?I 9QNBLRDE+3+Y00C%
M%A:@ 0[DT1=8#>2Q>16O]K8Z'<]RZA<U,5=+N&.O$OU!7VB'61XS29. >CAN
MNO8DR4^+6K>;[_!H8DVI\D)?SKJB^=K'3F4_+[6#63P]%I*O*@E8>FWS+!GH
MN2?(-=#SYNFYT6W9A,O.<]\16E(9P+&9.P7TR"Z5JRL^+:-3) :8;05ZIT;"
MC#09B1Z.L4A>5:BQ_J21"($Z(V\851]_WIG%LTOKI\F7.%2ZB0TFJ[HC_8Z<
M_?6G=9?/]1\>U-SF;,$4NB26\32A;)K[$MM0?@!#<IHX=O5A<1WX$> ?[G>J
M+[MGR$$&[M 35!VXPX:\JSX$WWE7M4,:FN6=='X:6U>@ HRK\]+&[+%RRB>F
M]WRHT!$;N0M0]F04_;"AKLZ3TU%EL,!U]N4KX8]9MB=\IW0Q6[1J6G+P^K^/
MGB=^_*&LJS'>V-6VSP0_2/2JCATID.)G76,K,)6K:3IX=Z/&WM"+WC)S%6%U
MX3UVFKS:,?8[^]&=>3UJSRQFE3>7#5+V?+M7SN02>Z_IY.-9-?*[M["AH<OY
M]W8Y7W.;\SMTG,Z'CM/QZ-^>?:Z7<,Q?U5%;N+7U*I(0"D6'-#^M +G2E'G:
M2RHV9,8'6A^[ULPLB54LIZR74O4ZUA=9RJ3K;ERCOC&&9P)/B*V1ZZEVHMO5
M3XU/P'=.IET S"Q[;U9><J8_7+&<XGN:SYY-.0:^BM]*QI-S SP'NSZ6S1_
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MYLT/EP^Q7$RTZF(YLP5,']V]IINR,:L\GOD#KE0H(Y)&V85V191?2_N#UW]
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MEF'X=S=K_OX?/]N9/VD8&=5AN'^ZJ+WV]5*'[0. #EI] *#5:.$3@%( T*T
M4(HIJ\,F 1O!N8)S!>>Z6<Z5UF&3X%QK;[GM:]C ]?[:"HI&!UBC=+BL3RCU
M;_'#62EEZ%[4,42B,M76U.9R?WC=NF.@:E(3J 94 YX,/!F8"ZBF<DX.1ZX-
MC[F_C5U<)OU*H6&([^-X>E9JCNO8AP/HU="'69D6H/=\(_#O6Q4P0&?[A0/*
M@I-2*HQ\5 QQ2@2RFFD4B30N.,(3O3$5D2L9G$@:>9<LXL9$9)*/R'+II4V4
M&>]OGL2Q<O4[D_#JTM'OK0(VO;23*STBNL[SR"KS81L!&@#>=>AA2 L?P!O
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M7QUGEY(29_.FFX[;T'R^=BO3UD8HYBL&<E_5U$_U!N@K:VIU_<I"N$J2L@S
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M6>FBJ,,LP;]NB'\%O8#'!8][^WH83SN('VR\60.=K4$+X%RWS+F&F%K?0K@
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M#,!8 <T S0#-*C,00#- ,T"S@1AK92('- ,TJ\M  ,T S0#-!F*L]1LA !P
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MG:1%7#",G'44":>#LY(EX7POI&$^];^?Y%UIG'5[_UJT\X^]'/M&!) &( U
M&NK6 Y &( U &C:'-' K@Z8Z(>EP1#QABISC^1_-%"664T;2==+ N#*!JH0B
MT1)QZQC2G&!DB15!19\<(8]%&D9EE3,A@3L =X ^FL&I!N@$T(D-H!,#I -0
MOW-G_8[&V#A)D?><98IC$S(RA?Q]AB;,O$C^1BQ%!(RQ)0(93!3B2KK\'BF1
MDL&SI$/@DO=)B^Y3Q$-&C/56PP/<:$!>'@Z"@, ,,"E@4L"D@$D])9/"1)!D
MF$4B4(,XLQP9$AG"E,B4N"%)W:B$)L$G1DAF7RQ(Q+E(R!I'2E9*VI0T]P$_
M-I.2FH\$@\*6;?3SP*6 2P&7 BXU,"X%'.2<@U@LM?62(ZTS_>"::F2]<IE4
M>,RUM5$:=9V#<!<B]D8@0KE%7):Z&LLX\B%X1U(T0KA'2G()2D;<&* >&Y+B
MNNBERC]MEM/RX9<D\M=MP_4G%,:E&Q_XCO3X)#;6^^EIOHV/[>1=,YG.\Z?8
M67XZ^\3\LG<S.V[.[&S>3%,S/XE=S([*+D*^[E <899XMWJT[*NTY>G43NS$
MM_F-W3P_<9J_JWO>B^8(!=6=JTY?$^C)IV[+,_LNKAPULBG?[ L[_L-^[%X^
M:_X.'F3K/,A:NT)W]][N_;KWNCG^:>_MSIN]7X[W=X^:GPY?O]H_^.?1J-D_
MV'U^6\RKOAMIZEH62SKZR;O^=M6[_G;I4W_SMCOY+0U^$1T>O-H[.-I[U>1'
M1X>O]U_M'.=?CFY;.8.[N>-\+S_O'1P?-8<_-KL[1S\U/[X^_.];[ZV^BZ_,
M*AY]*>B'"'/U]G*-+]IYO@'_Y7S _B13JNFBLY/0?;^N);'FFX ULMXU\LL%
MVX8%\NCT\^9NHV_ZN=S77US.U8,^[6(^O8B9E O,F[,7^.7RY6AL/TX7\_SQ
M'V)XN?HJ@I<2/']#7A5C>];%%UW,6[=,%RZ$LXS^K3[[V?4A+>_;KG7MN)U_
M?''Q_EM&M:R^3JKG6/^UB/.V<-+Y)3V7E'[U-?AKKZ#/-5/?_C%/=S%W#,19
M6=X#SYSMLYSYPCCN%6[3C^2\OV*=#W);0YA6]W1Z>("/?$PM9)F7O_SCF7Q6
M_?S *BVJ5CKTI?7PXW168H[-\<DLQN;G_/Q)U^QE&8;FW]VL^?M_?!I%58?E
M_NEQ<[4OF#J,'Q!TT.H#!*U&"Y\0E *";@6"4DQ9'38)V C.%9PK.-?-<JX/
M'7\+SG4(SA5F6:^I7/BIBV=V;7?2I/'TCZY)L^EI,SV+,SLO!5"E8O)].V]C
M]Z*..N/*E%U3+?_] 1<&@6Q,RP6H9JBJ 4\&G@S,!513,4O_?%MV5<;GG]0?
M<;]:[$&NR!NX_)]<& =QWHRG75?'3AQ KH9SORK3PF8VU*XOF5HIW@W0.<+(
MD3O;?:FP) J+",84\9 XTC@FA*E))GG)E+AQ]C17,CB1-/(N6<2-*8/P?426
M2R]MHLR4@6^?M_N^F4WSY?1_\B+!?$1U;R-MP04/;6X(D!<@+]MM.4!>@+QL
M)WEAB0KF%$8AJ82X2PXY3#!BDB=LO'3<]7)R]+K(2\7'1H,'_E;NLK;,.<3D
MAN"Q=L+_+KKYLDF]F4^;6<Q_\NTX-I/S8%UYMCSVEXGX19DCTDX@%S](?@P9
MK-K3))#! M6 )P-/!N8"JAEV+IZND_=3X/T/7QBO8OY6W]IEF,).0F-/IUGR
M_[=\HHY('2 ?1%@J&.T*(6H80_W%T*X17BNJ/3)*4L0=H<C2P/(_"E.!&6.&
M]Y&7ONJN\^-Q+ ]V)F'GBM?NZ?151@F$>L$152AR0. :M+ 1 @<$WA0$QMA[
MJE5 BM. .&81.>L<LCXP94G@!KL^DJN/B,"$]'8F%3BB2F,F7\Z50LRD5@=T
M+5=ZF?X<1]O%)GXX*T/ ZXB#5F:KPZ%NO1ZE4YD6-D+@@Z=N _1\4-]W%P55
MCN-,* 6*CBG$N;?(21:0"=Q13Z+"07Q+$,C'67QQ!7R.IX<7T/.Z(,_>"GAZ
M89]4XRH/):O,DPZPT \X"'"0"K2P$0('#@(<I"X.0KEC(6J/<+ &<:D)TCPD
M%+$+0F&I=/RF,-BC<A#66Z/D)GO2 7(0*#K:Z@#:Z@!EY.SJ(-+3XC*@X&CX
M?!6R#)4+?/!\%7C>.<]SEMID#$>$*9HYF]7(\5)P9&PD@@7NW V>]Y""HZ,3
M.XL_%$>]>\5/]Y/@I"-A*&0XP?=4*'( W1JTL!$"!]#=%-"UV# EN$<RRA(H
MH0[IC)DH8RW'$6,G="\U1FL$73T2 JJ*JG0]4%6TU4&1W1,[>1?+/(5DVUGS
MWHX7L9FF)K43._'+\J+6+H_[;>-#1Z="8J\."K')X>B-$#APMN$YT-LYF[=2
M>I(82C02Q /SR'""D7 66QQ,H)I\<U'.RG?O3W[,GOO7XK@/TX\7;OOUN=?^
MV$_0A(RP[BUH GYHV'ZH,I$# ->@A8T0^. !>(  "I4U=Q$)'8@-+@:4N,]$
MPE&+;(H12>%D%(1I;=(W5];T3"3N,]63C0R'6E^HLX$ZFXT+*1U,)V@YK[,M
M$!F[^3?VID'*KPXR!7'WR@4^>/8*K.^BGMJ%A$502!+'$.=6HA(U0AS+S/Z"
M4<K?8'T/J;.Y.C[@"N?;G7;S/S'%_0Z:Q_MKZ +W,VSW4YG( 7=KT,)&"'SP
MN#M W/S;OWV@F'"PJ1IL"FI(MGK#?Y5%EMJ1? VG[>*T6TWV]7X6+_X2VL[G
M6YMW3?X]"^?W.+=N'//G^\4,2DR&SU4V.1*[$0('K@(9KKIB'2(9['PD2%'N
M$;=:("TD1P(3%B3%@HE>AACO7 #1YT&/5Q>0M#,);\Z!:W_R/IYWFO<2!<E$
M$T-3^68FN\!'5WO(R)8;TT8(?/"V #A_T3M,>>38112PQ(C'()#AUJ @E%&)
M6T:$[J.-:=TX?Y_J%B$8P'V-'@I*4[8Z4G4X/XFS9O*I0&4>3Q\:<8+L6!V$
M B+YE0M\\ QN@'X.(DYW,5$IN*0Q)51B2XAK*Y%C@N5_N*/1&ZJ)Z2/BM$2;
M@^FD8,W^Q$]/>YU3"/WT6QM0VCH7#'2D!F/:"($/WA8&",-0K%.134&QSE:'
M0%:]?EV9^')YA)3MNCA?U>M<&?<R:B9Q_J*.0']E9EL3(<E2+W_YQS/Z#)(O
M]:H)5 .J 4\&G@S,!513.:__<FJ3K9/7,^#U#U\8;V;QS+;AHM=^1>:GRWRG
M7\QF^47G++^.. N@( 1#*@B&0(!Q(P*,D.^\*]]IE.(^TH@(,01Q[AQRUF*D
MO/ ^"J.)5WWD._<G?E9.8WL55S_W)^>@]"JFF"$HG*<_=R9AF1K=6>)1/P,J
MN8)T**1#@9H,"2F'9#D;(?#!4Q. ](MB^N!8(%*78OJ(.&$*::DS1BN:2* T
MX7 #TA]23+]N2+]/,3T9:4( W6OT48^22X:84ZV^:55._TUA)4BNU$$EH,VH
M<H$/GKL-T+]!6.E.#BJ,L-Q2%%,0B/-HD+4T((JY=SZ&9*)83UAIB3N'%]5+
M/8:1.,PDW]XP$E"182+CD"QG(P0.5 2H2%U41 L6'0T.!5TR7(%*Y*B,B$9G
MG,6":T[7$PY;&Q4A,#%J0ZD(%&IM==!LQY^/0#VS'\OPTSIR/Y69]7#8*B04
M*A<XL%5@JY6Q5<Q\Q-XBB:U!/$:'K' !<:,"CR9:9<)Z F<7V/-F!3W]YFGI
M2$D82K&9G!4("1"2"K2P$0('0@*$I#)"$C3F*F+$D\Z$A#B!G$\)466BPQC[
MP&X,Q.HG?+9F0I)Y$A"2C20D4'FV[4&TV2+>VNUX98!)'?FPRHQ].$RVU[R%
MRZ^.LTM)B;-YTTW';6@^7]F5:6LC%/,5 [FO:H 9 S-^9&;LG6&&<X.$8 EQ
MHQ4R41*DL?;2,QL,MVL+U16$>WV)9OV2XVS"LLY#"K[B#JXR\;P"ZG/9 V33
M0(J % $I E($I A(T7T*_U7T4@F4&1!#W+& K$L!,<%,4EZ**.3:PH5K)45\
M) F0(B!%CU>GQ]<98N008GSXFCB(\V9Y2E0:3__HFD47P[6AR=D[O/^6."-D
MS.M@;KVF=H!25YM9!TH-E/K)Y7 [I8Z""BY]IM3<>L0II<CQ2%$03%JMDG"^
MESAC!K7=C&EO9M/W;8CAAX^_9%C;GUPVL'S"M'Z)M>$C0WMCUH_IL(%90S4A
M<"/@1D-7#'"C>CD!<*.[N)',EZ.T#"BE<ERGC!Y9ABVR6"C'DV.1WFB7>$BX
M\:FXD50CR>MLG !N-.2H8U\9J>LAQF$J]JF=V^YE+#'-IJ=-.WD?NVN!1#AL
MK7:V#$<4U7X.#@R\ =6 )P-/!N8"JAG"X.LOUP:0==8&$*@->/C">+.8^1-;
M^HZFJ<FW_'N<E_;%_"Z_F$%)P!#@;WN[/3="X(,'L@%Z/0A3WQ6F9LDPS9A
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M"]^'X!U)T0CAZB,9AHTD&\) *^ 83WHJ(82\ON*GW'0<UN:EWL;\V+?C=GF
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M!M)'8 >( !"!IX\&?1ZFNRK-\T]:SV'/Y(ID(6;T)Q?&\71NQW!2S[9P2>@
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MW:R[C8D+2=_38[T-NX,NPNI\D? @D<S^D'22R[>;3>/V.7=D<=+DH;B&$.F
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MY,EY85#,ZTV8P5'I@]5F2;N\T4R@X/*Z_^ I,M@2)'6R?9'%5K?B@RW?RZW
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MQ.2<1YIKC:0+BDOI',,'O4,?F<G],/\YW>OW=V'V-O0[:AV%QJF)I*+:<@A
M*HA" HW#64-KB4=4)NYQT3CP<4<PZ$#CQ@>AM],XRE1+*38H&$D0M]0C0PQ%
M1GA.G>(1VX,6:X].XW($[O=WBSK9&P#4"-@;!.%J@I[WLS=93PRB,G&/B[V!
M:SN"00?V-CX(O9V].<*YQ=(@J:Q$7%*-K%,^D;G(HK38!DD^#WO+V]K7R=\
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ME?PX$@32GE'$.*4N"B5;)P[*@[D)L8T4&9\WMA/*(J.E1%[@V"KJF?<>?#]
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M!<09L^E?FB$3A$!&>Z;:&*TQ_F9@D:N6>D(%HD%(Q!7'R/K $&E)D,0*+KR
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M)T*0:L^65X9FHZ$0H/-Z;#$D!P Z!SH?&YV7S,.H@T%"2H,XH0PY$1DB)+B
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MHB[/Z(0#]K27*L,?J_;\G+Y=7)3B?=TS_MKM X1O%^VJ[9)+_FK;&/)*N"C
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M2]Q]$$JC&IT5OW]TV,$+=$2=(!?_[9&=DR_^3)R6!FZ:E$X?26::E!H L $
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M*;2MZB=BJ%O62/AE06YJNFCCU V%]RA9:4_*TE@[  [M/U!!,R[<#H0V"HS
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M@ Y%3\&'U[_>[@;@):A S/V3]Z< S7V$3K6=T?77UW]Y_<2XRBM$$R*&75$
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M8.8E7[;R58<\Z(Y/0W.D9W^'[X<!] P?]0KEUWS5W:\O@JM$SVOI=4$T]\(
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M'H?GHU%X<7RV_#%*8=";1.RN9I:M88D7XY;^JP*3-*MFJ-G#X#5[7CJ#.FT
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MLH]UE/IWH8L;+G5E M]<#"7#<[(>^ZOY-QI?UB_C4$2 CBQ.F'"R'V#D<;7
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MY#-Y]TA->41$?=].ND=19=].>IO^W/#XJ(=-#7>OH?1SH-2>;;D795Z4]8M
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M)C A@,PE(^RC\?H)#('((,'^JDJR,7K&G3PO>JK4CD0YGJ=&E5!445<!SN0
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MX)@'B3-)KK$32!11:[HKK./2S7Z %-GMN#1*2/UF3$LFTXA)YQ*:SC8,'N[
M?6.9&/R\T9$C9)A/I9V;&DLE(6@?JD+#-'J942!#ZE[F7(K C:-6I,Y0DB?O
MS9J5#=R5A8OEL#4?; D[;C7^BZ(E$W<"R5V5;A\8"]A1T$EP^CYB36 &Z9CR
M-@6V0:)K0V6!"UT27#?@@<<8. 0S3P7A9LIBN;R"2P7M/R;-% 6]!\99[&;8
M$XA$-RX\9;/B=.T^PQGI--7,)BF&C>,).1U"8_@TCY$Y*)<I$L(G_U6#R>.A
M,=*IZ:-5=X.A.E:XC^LEH'IHAGM ,UQX:(9'@V;P\GWM3:T[3J&@:21!<Z6O
M#6$[#28X+][@^UAX)=MR&62"!BVN%;B..FL=80.62I@^[4KOI"[EYG(O[/RT
MW."*)T.5X\E$EWP++6TU$\0J#!/&LU7[<_A**5O0Q@TUD^ F3#L[3#6SC09;
M,]65!*VN'[=B">Q7;94O>OZ!HF<NG,)Z_^7*EJZR*0-VQZ^,I5.(Y.N(=^6:
M/3+54EN]NFY5VRALP*!KVBU>8\PZ9:K%;BEW#:B;!U@II8D#=4:17"9*NJQN
MEET7:-F!F_5]NH<GX["@89(:LPNT8+#XM)RA66-EW\K26ZZE8HC+9L9P#4D:
M-IJ?=A8IT]<<'9Z ,:U6CR7/MHAVJ7B6#54#+:=;"1C10.V;L+>)=:PT8G2U
M64O8<C4(C#5MN[H?U'B&*W9$%RITQ0<;4K"=XZ)DFG+H,*]?9_%HB[1Q7U:?
M!UQ76(N:+'C(11O'I@%@0B:+LY9;$: T?TRN\38E"%[#:0?%,B[B(/B+I/83
MIM-ML[$F$0>WJ50JCQ)BPP[(2IT69*M J\Q<16-.:G@^S'A("!Y%&ZQ<%IG,
MS):*&64"8D=E6TE.';B^EX[V,*D*HC)=>L@:#NTZV(&XZ81*8]I4&)(F\K4V
M)$L)(@.W=:^3Y 3S"0F'1JMR<1Z:$VU*)3M7[:DIFO0K,PHLXQ$QDN**B?WJ
M?JK[H7H"VF#7VZPJ15>,M#*MES9>Y,KZ?]FFI>0"RC#$-A8J\764CR!F''"A
M6\4,<TYL7:O6ZZK,'A.R0>I.M8YT*D1"95?D7@S=?-H:B(AP,A5"-KEJ>(ZM
M9;$MC89/J,MWW;KO]Y-&=:^M)3:UVHJ]0]>RJZP[U#XZ=+"8BVS@P[@L'GAM
MIJ%A$[<9M-7O4K9W\+?H#:6@E>T8[;7R1];*:[ TUZGMI-E,.*S!:D9M!-<R
MH7$_F6?C> A42/=*0Q "OXP8J8"LU=# V**\EL4,NZC+QNW%!D$HVQ9+Z>(6
MUK>1T&H4$IW<XVV$7;GT3\"\'=P?XF08.ZAF[4M/R@HA,Q F!;,[!\%B)?B"
M(C3LKK$:#TZ=&CZC/G4A=*SVI@0-BK7$YY9!:3IT,?%)Y%A'$E5-R+@3*=\)
M3K9^/0@^DH[6A.^CT JW6B\2)>N("VJR9AT=F7=&ZKAF#D6I5@#RKRJ4O+%V
M2XU,:6P15V=S-L@Y9<W:./F/PKA8S@SJ\G0IC"$Y2-,Q#XM40L#H8\<]B+T>
M,6YC6MY:(X@U!YWI8:/):R9W=(>:Z6; K%C^8F=:V-8%N@.3&6,_2--_WFQ
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M'SU'U-*)IB&9D_"ZBSF5(&&'E(9_G9CRY(U$P%A>0ZQKVC'%BG<_J=6&9SG
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MSE7D :/:J)Q-<VT6=%Z-*<8Y7**,I+LNFZ&K+KHS)46_DO*OWMXMUN,? @T
MJK;<(5AB]Z#%S04'8962_/^$.%(J/W.R+5C,W^_]X[;,-\5FVU\8'ECA5WG3
MO!,F^) T8)VCX.?1P7K,P2FK!/KD8RJ*6<CH-\@O"]&M2W'&<WQO<O(N(]@"
M/3V'IXIQB>,S\DEN9A]2#L+1G6U& LSPY&P()SNS\0Y, 8"H=ZMN5&C.F@M\
MU5_\ZZNB.>=9Q%]'QOO ZCJY:(3I2$5,D3QY\9-WE"DL!++F3GK7OREIKZ%*
M3>PE%=[GK&8T5MS<N;0:"*.ZVS5M04W<@2M%V(E0< UEWVQ3>=>A&G/[28U=
M8@CRQP@" C@LLBEUD;=%]^6,/0^6>M21CLUP7U,=7W1,.TM3N("E#*/4@J"?
MC+MV%"5X"'DVHX]!0VX?B)^#YJISW#W+^8F<DEBHP?B-87SJF4?2]!Q)&.T8
MLM#8S:$+G\,VOU44E1231'Q>P5VF.CA"FBP,-F]L>EF!@,QLXFPV9\10Z*FP
MT<(^#X(*HRR5*U8EHB<]P;^9ST)&CD.F&Z,<0RDL8[SC:&&CI%^Z^W:BFFVW
M!4""\Z/&#@7H1M*]'L6R_+H(^H%W)"Q'"W I6;FZ7A_*QO@7)-K"8;(%EDC[
M1!?6ML4"/KR55/7A_%.;A!?VER02S,&&0[]=N--(ZB>!C,UO63G@'OQ.!E$5
MK$*AK@KQV/]S8 ?T/J9@C'%F;1Q_YI>'? N1O<A8@<.U+U^YL__&F:CT^?2Z
M!"RZMQ%^0>4_NS/X_7/:^$W-B1^(9VQA<%S]<U.4^%)9.ZJ"_?G_?I5QMXTJ
M#)R/WFGA&W47?E)@-P$6)H'%@,#C) Y!#\6%B(]>2K)1ZC&1'7Z$1XNVE2IF
MNN:2R3(7FA4"^ QKK-E#)8$2FF?S[7V#X=:W25;&':/]OFRJ"T::<Y&B54"Z
M"*2MF+=;4IAHWI<%G(QC7IDD*\2JNJ[Q=C<,3@"WDL/_OG3]Y??>7/@[^"LK
MX#N &#FK>O>8=7%EEW9N<$>^>E%VWD=U[0B[<G>;]QQQBJZVL/PHZ2E5JVN)
MO<#A2?@DSMG=XK6IG&O +.GU]2KC+8)1:H:#!&[>'!_Y4?!LIZ'SLX(=1K3$
MY[[A(G%B.Q189X'W=ZY+VGL,J<>*$!J8N%P9S#5SUONI?I_7#6<:5U3>$Z+R
MQ#)H!G=>!SCLJ %ESY\G70:JT89$=\)X*2N6EBBO%+0\N*Z_9?+'2W<4T$Z\
MS437S']YKB5%0MF!GBW?=!7$:#9]*:IIFY/SVP.!%]1G_0;4X'WA 4,O1I15
M%KV@I2L3=7U)4$47<H.'W%L'M N0^$G"F)38!GZ!4)D@P"*'>"JYHJCGGH,A
M_4XOJFS@2%-S3,%F/U+I'M#E(B!P_V=_V14,^P1.XFUZ.2:7-2N9!YC]B9,8
MVT0#N&E#@Y."/'Y1ODSE9' $4TF, CE8 SK!2,8&"H9,*>"DC-K2J3+9(=_B
M5M3/7 O^G/)ZK&ODACZD]K9ET[O=L?83=D!JJQB @G5!7YV$H(I$':IS/::_
MTR-JP>=DB4/6 ",FA+%'.Q(02](2XGF9?AG9LQ-MH[U_GW#\ZJ-I;B8\:I2)
M9 S)1U:26H&I 9CZAQ68N@)3GWL5;B\).@.)M/K /:_!C()U!I]Z5\&[$ASU
M34XF1YV /DJ"=$\3&!V1#D!?9KZ[B+<O)7JZUOW+HA:/8NJB0QWR^*FCM/HL
MC[M.OO4A;T-J?\LE.6KRI;9E_R-_8G<((4N)!Z_S]L+@1\M&*.P2U#@I$W]*
M'08Z9L6[UH+27(DO]+L:.>&2=+KO7<ZIFQK*V150+_!XN((G&>*'T[/8%LPT
MD)D/=9.T-A=:!;B6=N[/O/V6U35O)C7?D^28I%N.,ECT5>1YJJ$SH+>TEJ1-
MR+3IL+M"JFA&)31UO^;"KMRV%>J51K'C^))W:;JB_G73I,_5,;VE9*3T9<8C
MK:JFRC ]HPG;<0^TX\Y\<FV3*$_J<@$5,M.-K+XX*7,SWC<H?-_NG4O3_TQI
MF,!/>(@]O'/*=5$)/PB>$HCSV.SBGJ*V*ND47LM@3XTK(@ G5KH_FF*7J9\4
MSHQ'M%[L=8TZY)1/3L.[:7-]-D$AI 1L=Y9)UV+5A[)\GSH/$0XW+A7]<RBI
M"V6F&-I-VS9N32%PGM!'\"/2<$X2$$ZY0P3^(%#<P^0X4!,8_%AT!#H:Z>K.
M[;X'<.L(4*/TUK>7=AUS'=N6<:_+6>=VU!$;YJ*C$RL7&;] 5D)%%?UP,FJ-
MIFC8-0?]ZS?_\Q69&;H:S:Z]G(B#V8Z=R_B<)I("2^(4?G"#QBCVFF1P7. >
MT9^'V2"<BIF2>O"+RWOU_E'AH71(D; O#WS^TOS0PF#H,(\'CS 54B9-XZRT
MF,B@S>),G&#/I@ 3%Y$#8<K^:V265F[+E=OR(^"VC)8IH]"F[ <Q>JP@N-DV
MP-Z1L?GFAS_S?W"2@;^ ';AM"JM=J PF3F ]C-*TU YZ#,%BC$U+)OS4H8V!
M :5E/4R_2QUQV.($V2/$A#=H_K\).1C)%5:^ZA>SY-9=_GPZ,-B<+7$8DKC$
M24# K#'*$0JUFC)JPNPJ](C/>'3<+,ZAC#2I[B,S&=>UB!B+>YS47:S=H2&?
M2YKA\&A(+(TH<#FA6914,O)/&A["W'O=V"]FE:T;^_DVMG' (]M=2H7H_>9V
M*'O.O,\3+N'LI(X$YH  DHZ:,5<ATQ>\!M9M]TR,\#,\FHA:%7D8Q SW,T6"
MVS'!( 'S2YGJ>  P,?".T3R9)=4KM8%G#I\+/C/+"H_=+6BFF:MJ\WE\J_$U
MMR[M"A*,B]#>^E'4NQ+61!C0!(^T=[AO?IV7%3<$Z2AI<H*O,A,(A&^2*E;;
MG)EM9K_PXA0/4/]WNU&%N]&[KK;KQ6RDU78]@^T:$S I1U0SII)JNK'XS(+-
MX@@=G\ZE+[79WWG'9)\Q.99T%%FFV(5V0**"B 4^?=@!Z;YM!<]%^3 &@:83
MH<%%F ZR2)NS[OL7LPC7??]\H0+3S3<^NG;3>#[R,Y..7-]S&6!!M2;N^X0+
M6XHK]+L]$\(+VW;:HC?>YH>A+$(#D+#H;(TJ-%V0GXM[8I&0'+<2CY6@_4"[
M][F2#*\VX,4LR-4&/&NV_XXT_KQ$7381J&MLNU\EO]OG</L#$<"C"]@1=A@0
MM";F,;M[J=EERL*H_) M&.@K2_PT=F_B0"F;41<:-A.ZI0?'>#8Z@^>5%WX8
MY8Y41@GA$H5:-DT+* J]RS3_D^I/E;6\*NGXK<;OA>S$U?@]4](F\KI9D;Q[
MB/JIX3"L)G.@T8-82S 5O  ]OQ5&=>_5\4-R-*+4K;-ORN)D4*7 -<X\M6Z2
M(B-9QZ$#WTZVJ4HXKEA&"N.=+WW3_)^:N@3TF2YW(D]<#H[6<>6\"*U+<H>[
M+BV:!KE)\>VG8;_VB)F#+2%["1WE8\J?6QS[9'D;+B _L&>7:&6/L<0I378H
M^ZE2P-=6!'LA"(B*-H*0*T_<.292VO&>QZ;RTR0=#]PS:=NZ.W1@2M=E9L?)
M8N/RT!1-2&)M4$6C76;#H$1[(;$XN*&?PY(NB&II'E6[*[^M6'E(/(7]P'28
M0@=*&(GI.%[YO2!$URS#(JCQ,1O$ Y!SC-4Z@9F)H(9G9C](J3\G6P3;0!27
MA.04/7G'!IFF6SPI@.99/:]6V3(PEH_XP(VD4U+XNK]?1LX2.-+'-R.T6]&0
M5_:N;F[ /<IMO1-<W82%0VESS1K1V0LM-<1XQ>M.@EQ^I3D^&X@7L9;&PENH
M()]Y_D2 ZSRTW> 7#5% W48G(B_,MX#8TW7#W1*R:";$HW>Q\-R7[DG)]!\)
MY[XV*X9FQ?]<FQ6?K%EQ];7N/:B00#(':,+I%2''',*S%.',43(^>NE4F;&H
M2;!^BXFZT["R]&#JUJ,!?J1N^]W<KY-.#VXD(;M'\.D@D< DTK, =^:4.)@
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M C'OAWY2S:?-O01%I%[G8'XC^E%?S!QF/'FL7&<2='SBA1W;NI^BO0-Z)UZ
MQ6?51[VWJZD4FF$NX2/O6D<W&3^!KEX-]EJW'[C*QC BYIN-SZ2&KW [9IJ5
M;%:@ UM$)$@.A"5'$I&2<%0:>>%@%R78'>5)EOC%9)G1TX2U/F'D3P-GR9@:
M6@DIPF?6HL[9V_V<K\ZGSLS7K?2*R<Z(?QHT].C6G/DSD0SE\,I8XB7FIW!I
MKOUS,I1NPY@1,]5FB8IPBQP+_@FN2ZRJWY9<WGJ(W9\7?+F:,$WU$#* ?J 0
M3ZT;V%VQZ':QZ1!.E31A%!K)-9O4S+*BA>ZQ'/Q_?,B,<K=*T[:AK3N8VK'1
MI^2T[ZH5]-1:03#0Y0D^[QGX0)HO_V"P<J2('06O%@E_J"VO;I"9)-,W<%S#
M''QH*$30I(V% J#+.U:&5?%UNLT6F"BX6Q$Q"\<KS1GE_KSAS!>D7O=Z[M%!
M60RM2UB((@8C:)@:SX'R$<3P?F\ZOM5NW=MN?3V>_R!7H"ND'"\^/L_OM_;@
M<=#/K;KGPO*DA:>)^]%Z8BW&[IWX2OP4M#;'8#8?*?/Z)-6 :*KBDM;5;'I[
M%<\E+MS"FH]+_FKSO1D!HM#AL6$/CD/[4\Y9FP?NB51<(%W] GHTKQ49.Y1-
M<SHY-XDNJLPK8H4WD3@MTWF>MRW=43TK^.Y!'CRGC+&/T7L<8^FC8@;-@+T1
M9)\^\(XX6/L;<):=T\$L[9)176*YZNXV7$#KSD,?J4Y"X3 <BK\M]VQ%8ST
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M-?))6R._H>8/[?(B]AGBJI"VU8GBA:%JG^%7TH:>V%+DA^<FG5G:^R/A(%E
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MO.,*=PE992"<+UJ@][]Z?[7Y3@M-S.!OL^7$M,OEV5AF($5&EA )588Q5IH
MU+;@0!5E2HS(!8>(_UQX7GYGC-G*R?BQ<C)^MG(RKIR,S[T*;3E6:>05BA)K
MOE8/B<[P]VXW"'EO8M;:>$"0W-D^/;X%G) %U)ZP'H:CH90/4)<^M,(/?&*I
M*0NP*NM]FW=].Q",X6H3Q;#DT))R=O(*AI,J/G,W?>@$@Q1P%(%<_XS$=4&1
M@-Q,R[E^QQ*4D8:E%HT]I.D,7S&A- 1T$V7OQ%\2<*,>JXQO0;J./KVMF$[4
MR*X]Q?RA/[\*$[Z8R&4%53PAJ$((+Y(5ABEV:%RL0*KI6N@.-6<7V/A'?--
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M*Q8V>K?+.Q7D:Z&W@FT0.C@Q0F7-2I_Q&UF85NF>H$.!%H&>8''?G'",ELV
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MB0/4DD!"P>D:I?"H7@4S%L1<Q=WEF"0"F%HG^KI+3F<.I] ;Y.HBWV5?S%Q
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M/,AEE2#%#CXF;_+Z:V'A24]<$FM1X5$M\A*1 RV (#UJZ&9/+J\%/B1$XLJ
M'JJLE)+D?!_WD+GW[G1F.\8"\V*@XV;G:FIN"'X$@:$2:'3DA$P;+4TR<EKP
MXHQAN$T.^M^".)2FK[4Z2!_*=GAB!^G/8LR7W(DH,I,%+R#F E!2_:EIA029
M^H*A0YV<_W,^4< 9/,'6N]K\G;ABY._M0(BR6$D(I6&K81M\NN3)RXY/EBW
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MC?I[LXRJ:_WAL3GV[[%>&%J(NG&ZVG+S_7U9#+L2V'BU9)&(-+G8T*4&)^+
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MA93?1RX&4--VE13VIRT\-Y P$3/(M&S2SQ5H[!9=JE7K]<EZ_1+(BE]"%4D
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M^V:,AV%72# G0 D7U2WMM43P0)>ZT3PG6!M6*6* '0 ;?ALX2+3D^:-0T@!
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MQ<#R\J)36WX6X]QZT9B^IH+WICPB-6*@)%SA0S=-+R'O+]JSN+>)&JW"!HM
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M=HEOBC_,^Z6HPW%/C2?28ZF4Q'5*>C3=Y#JY \/J;1F&;8!,;/)4&>Q ;98
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M,RF,)TX\=3/JP8?PS8*SR>0 [0)+I<S<C<6@9=&Z;*./IDI_>HG !F<30-D
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MB >C-4.IS2Q!T4LLGTET2G18<)D\ABSFG,):%DK2*7)V>3"X,097XQQA^@U
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M+4[/\U]7G+Q8U0>/YYN2RBK?P4U[\<F+3R2EI]P,\-R: TF(;0@K?BRT5:F
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M9O9T(YT-MGJFY.D*\_-E6M'T(5]G$&?."/Y:6>F2VL^TX.^%-6GG\R"[;=P
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M+.I23OQ%N\@2-/%"1Q:UEO,N+"@Z(Z[VC0E('DEDF@Y)9+K"V]Q0.IK4;5"
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M?^=B41[5HGQ5=L?^)&@=5.;REG#/R@+22_VK;V6O40DYLN%-^T2>T'2<WW-
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MG6B81-WD?BN?G9M/=8U:/C$KYI]K@@OI4U16>/V"5;M+(CSN"J]-$L>UK5O
MP@]OE0XTW7!=]%>5E%FPH>^!#?W/!1NZ8$.?>A7F79I9858E,E;B0$P=5TZ#
M\D)SLO4\<P5!RP<(9BU(G\#U^^=97.;'+T5N"^(J -,W9]^F^F>FL X.P%=V
ML<9H*66N3QX*DN%BM& (CJJS83#=?30->*%"%1<12ZQ*C'B#!NUV];8HCJ->
MN'Q+[DZPG@ECP,(/_=0+;Z'Y>@KN/G9/%?4KF*=#_K90VJXHE,?L&93QB;ET
M&&H/HIV'7!I1A$;!@]QLM/>#4P0)T/1T('0N?W[AWGPNBVG9OT]$T_?R];<1
M/S"OZ0F\-N6/>\2_(H^:I"4-]4^7$USS:MOV$6?,.8&ZF8 2##L'%*Y! @YB
M*LK6M\@B*@>.GC9]L#7+7GXN"VO9RT_!)C^F,9FN['F<W:$0T(]G#9.#&96D
M&SIE:R8TK-UVI)JI+QS=)_6[(P@1#NOA99F?+$/G@#2 >ZVXM*S#$KEE:_)$
MY>F\[/OGL@B7??^L]SVP[P:'!_=< H>8A>'L&J5"B"7D9=<]ER6P[+HGV'7E
M!!7?/>VEG*FD_3>';E_VU'.9X&5//9,]=6*,0JO8!,;6,@*C(9(PR^OWW,\B
MS1#LU [.1:/'C!WC$^=DPYSQEDLRGW/9I<]LR2R[]-GMTKZ.2/D43S)=\9F&
M^QNVB8 9@D]/6K]^!F9[V;;/90TMV_:)4KV@#:>BK#2]6+>C9Y:PZNC<Z3E]
M:J9Y&DGB, B)*?GD2_H,HYZ<97\^E\6R[,\GVI]I#9,Q^@. _KA5:[*'B-JR
M +,I:NN2TSU^J6-ZV83/944LF_")M @?LNWFB)BH*C()%HK4:-JY#W>7>O\1
M<"K&?!92GD=R*+(/C(.*9+R,@G"]8<M&?BZK:MG(3W2:<JT"%#F[Z5U]3PL$
M[UC@'(0H14@D7 -"-@;B<Y>&R'0+T#4!(#F DFQ^W&/?A)EE!%6OE<Y[NS2T
ML]3H/.J<NLSR+K[^8@J>R[I<3,$SR5?-GO/W;3<""8<)+,.IW^?5OW?_P=?K
M]MJ.597=*=U_]"'<A>D8Y[\MO6:35_#$0(R$3JGZF];AIKO>ZZEV,^1,S?U.
MAQ%Y4+M2>/?.^#WQ-IUQ9> R?,4M-3##2FX+TN(D-ZCDN5CLT#/9%(L=>AJ<
M!C"4]4V(!]C[-TH8QR%EPN<@ FA71-B1NO8,HN060ON>]D(:B?KVIYSZV-!W
MS.Z*YWN5G'A$5#?]B9HB4WD)YZA\&2ZT[-]GLIB6_?MT^Y=.Z;C)(F_QG!H0
M8:<BUUI>SS.:OH\^^?U=L(NTVB6BE52I)TK[H3M\QTRVN;()D!GT:E!=EM!,
MJV#%2"XM-NDS]\?2:?C!2.<PBV/J\#L0%)R#?YK?AINM^F/XZ-NZN;O:-W>7
M5+X2L2Q23XB $Z_6GD-H3,F1\HZB?(":$T7W$^O-%H=CU9R+ LS -67R<KW&
MX'P?2?'%):G$Q&9LRMKX_;,5R"VY&>,.)?DQ2\<$\W/'#/KAD@#.*$DTDX<R
M_3,\@2;LJS.SLS*ESOQ;9>903'HY2)QT83*ZAEJXE!::>LFB*G&^O2W!?@0R
M>^;.'NY.-\Z86VDH.Q#;F&I,\Q,>S!G"0Y(WI)P3W;X\=LK<"3Z&+IEES?*R
MLU15Z82X": _;(JV5F""60APW"GG?+[;Y67;Z2G"0>B!EB&MS%IKIS%09(Z3
M$ZC!F+R37Y-$>",9?WLZ1](0_VK&25IJU/<VQ&7C5863C9=YL1T341?O*)R#
MXTJ+#!/J";=-]@1E81OW0F3O+@ZH8Z;"$()Y3#S7JG#\;W%0,M='+D0DN1..
MUDXF"HPK8D??)K,Q2T2N4R$#S18L&/*69.M6>U86:I3UHP@QL=(,ZZ33WK!K
MS>[47+>/]#$43M%Z8-= 52[$D(<B!^@-INW4GB^=7JM:229'>H5^S?*3'_?G
M#LRQB<02?@.1!EI\>O/KU1L*/O1'=8N85M DU,MT-821BE;&Q&P2\TLD-K4M
M&\Z 1CY +K!$<<$<O&&9+283,KU'J]&].U-UC=Z/"8F2E^%B3R%T@<DS1JLG
M"H?)B\JB2-P'M>'AL64S'Y@!,.:5,U%WETU.DTU-M:K(B.#O0"2AD.4>U:/R
M.@Y'6*3%=E(G-KSJB3ISPG'QZR+N73ABWH,CYK<+1\P'XXA9G/D'#^K7R#LS
MAR63Z[%W(-:_K%#R)N(K<U'HK/;&E@Z%]$01QC?3J\X>H.-"AY8R3X*#)(P&
M$4.+.^R)KCUC[%2<&%6V)YB[A'^3&13 :LDJ+A[/KD<.E_OM. C?ZYD9W\E4
M)4?_)==#9=TFPEKF;.8\_H5A5BW:7$F0O3]QA\K%[ NGI]R<TOB0-G,P\&"Z
MZY*DY8#?NV7Z\1.68J7BT-)?:AY3,EEAW&ON3N7+4R3@R% 'PC[$01,NQSH0
M_F1-+KJ$_!^")G>S;QK6RKEIV$,6XD-(4*<TTO#)V,=UFV6T[B_QW6I(2-#5
MOI1MS5:#G7CCO!V0W5[@NOW(_*TE&SE'EN6DU0W].4UYIC1IB"W!1ZE2*B(#
MDF Z54+@/ IQA=7R\9;@OWC,%NV.Q]WB(JH@/"YJI%9\@G=,GMJ:\)C3KC&!
MFW"K?D<9BA;T$E"208V2$JAS,I[A[X0M&(;G2?&$8OYPR'OJ5%&-M<\K,<0N
M35<INS&8T[U%SP_4]  ,97 FF/+"$:A['HL'\ ]&?2W7>(3P/I7;"JNR[T18
M*G)*!V=4<FVBJZ&R0WCQ3,GSW(,.89[4RN_:C1]&FDB@41G+?%;R1]1G9Z?&
M2!NY-_+2#:]7_Q5.RI;$;5D;(8R/MJ ,@+48NDL*O3'A9Q3V@^0YZ'--_(-D
MSIP @QS$LG+GM:V@QOJ>,TO3";4^J-&TTU(U+$+8O25?HV6=WTNS0 N%^*KI
M.W!X_"'ACH-$DM7M"0XO$K'$DRJS<S0?KEAPDYR\R9F'<E,>.9$?:91[&_]$
M<,24BT_G8]&)*%=LR,/R<(+'V/2MMQF>_!QLY&M!/,C!:""G 2>YY'BIKE,S
M)WJB#M>83FR7>>(HPF+'QW'/$1FEA/*"MB.&UR67:9C'KS!/7'>]^J.@J":U
M9\+)@<P>Q(A8PUMU73)IJQ1C$=_V(L> P<2X=7)62.^^5:?+:Q3R#J7NDGJV
M640Q72B-QFB^[VRD)HU)K.)$;)O%N5-+ @'KD)T]3,U/?2OR:K<% VGC9'EE
MU]EIXVK6J=5E?&B"<>LK>L*.P?NL*TU@6U>4F;Q+IG(_5 .J[&8ADBBJ768B
MA4U";V:BA6PS2,&N8"ASGDH/C>@7(W_YG,Z<'J+I.X==Q(%R(7.*?(IJ4+ $
MG!.\B7JU_(*LBY4\F.A[LQ5@>#*& #D!T:11W. <"%&*#?%!?"QN9''OH9"Q
MFD( R"+.G3"O4V3-)];>O;?,XCVSR[-Q81?2P!R..80GU,V/3/5*>K *ZRUX
MH*2AN LS R-!IU12A(R*EC;!<51Q+FB'2E-?65E*C- :QY">EXD$%WN+ON$S
MV=JIM,S FI0_1]LQ45/ >3LII/5X0HXV1HK[:=K!#+IJ8R0\'AX$OZJ0?XFO
MWB=GE::DO'SM71$]Z1+'Y[P?;7FJ<,(49*OZPYHZ.7=\MGM?C<4RR$PJ,_:I
M63BJGWHM++C-I^C_\''2?6&]:L?@?,V$[[(23S$8_/*4N>!]MI+$IP:B]L*(
MZ$4TS9Q?@UM$&37BH0].1%U4_[N# IE3W>.#-QPM>J O_13/99$M^_H)]K5/
MZFWS S59(VKW^SV+"0,39052](SRY2!>W!:;X&-V1FDT$2*E#$.D( 9JHAB_
M,B_U;=E4\.&A"!>/?@?0DQ,]7-G<8'Z:$"%MW3,DYHMJJU3'W/55%K6[U_1<
MVT+$Z>CE@A--<8@.BY:U-7*YJPLG,!;L3-/6Q3G2H^V*I8'\^2SUQ;H\A6B1
M[,9@ O;ENCQQ_I-/XI@]SM*$CQ8_$">W*'_,IYB1'W#5Z4N%D$QS,P-[HJ%I
MA]A![Q$YF&+&-J9]$R'+9MGFSV7-+=O\*8*#G<LL4JW0,HK8F4G<GDVY$=X+
M:9MS7G$1JC^&[Q,BN"B2E@84'_G8I^H:N.]7F[;INBO;RBC%7"C?.5 SJBQ?
MTM66;?Q,UM2RC9]@&X?C# PK\Z=MRLK2-5R1& @0>I8%*3$8;X1HP&KKD]_W
M!Y(NIB.;)<_+$YH(-"OP7GV=2UKUO;K_!E7!")30VBD'2%I4%O+HO*Z;7AK$
MC(N2"Z7X<5_DM!RH3MP8>6W,&K4D_$U+J:!,:\=U&8-7N9A.&DM*+(:\.G<G
MX<ZX+3K43H)91Z^3%#SU$;@@5A?T*K>%JUS@X!G 6;:W!4&"6>EW)2UPP8G<
M%!$8? @KE+"1F[=4:B^Y4C^ P.C^P$O)_=R-JK,A%I@]!=+-]%$2:I'E'K9A
MO^&_1PRD.U+3D7+:R :*,76*KB?(-K4.NLXYFX9X=:K.17%'[8=!%7+NY<+=
M_J;"DI@<'G?/F1+>-7PY-QU)6G5EW5OCD@32Z1TN(F\$0.#7C:Q-GL#*=-S'
MI<)CP1K97&"F "-8[TVQ%)0^4LOWAEH3)O39!SB +K@.N7;A-1W;-NZH?#>Q
M@@%98C,2K$YU9CR\D!8H$Q!.3=F@WC;<H,[J-N:@T$N6NO\G-QU=PSTOML^O
M:@LL;6OOT;;VNZ5M;9$V?^I5* Z9X@PGO+'!:=[F)5M1".)U#FXDC=[!X"4.
MEGB?["O P[BC*SSLQEHIS+QW&R^<.=>*/*?23&]P4ZC)_S&;!)Z#@5U\C >/
MYY](OI6.]DR=:H0%5<EEZQ-@M2ZS->W7J]>:-N>5G4*[PN\BKO!-OBM6?\[;
M-1KOB\-12%7"DYXH=CA1G^'JLR\ (G]UO2)[]MLO7_SV4T&("MVYZ_*:@K6W
M!;.=W$92B6^^>CD%;#W1U;JB> L"$D8D"IP9,';%H*T)V%EQYZJX54G13MK&
MK'F?4'!_WQ/3ZYV">YF:A1M>:]\)E, I76-HM 1J BB &(82'J1F;M1<-8)2
MH3(PW @[A%O71)E#,.O,-+@9LDD?=HC-++X7Q8Q-V]*S8"6$F<?+,NIUNK$2
MCX!Z!>,3U>$3?I&R$U1&MO*,EXS)':^U-0&A[\+C_=000/A(AE!65G@_/#],
M,X:6NX7;8MV?Z!)-70GM1$'@PWHC4Q0>@4NEFR\9/"_>ZFUX6ZH"\1^W7X;[
M[;%9T=)!WO*6U%,9V=CLEM[0QS59W_0M[0J*8S+IO.05D:\[3%Z2\(A]O86P
MQC DUM+P$I9XJX!DPVU>QQP'D\@0T+>JPO9XCPUG*0^5XE5(+ILOS@C9PZ 3
MWB&,*9Y#SJ&>P!W33E:L<\U+%HV">&7C)(O@YQT/7*2U8SZS>Q'**0QY!#A.
M <D/6NU+(^D_U4B:'%]YUQ'<S/H\YHBZ4@Y1$;^KJ=< 3N9=VVB7>R]L )$:
M8)8(:X*:8>F+_X"V[R6\*LGTOG]3(BP#+Q!'L47=1 VWV%"K,?5XA54@ZVA+
M-J:O"=/8L:]G*=!PX\&=:%6EOS'LO6\P&R:TZ&O-J=!6?/O#]>IE18VA-_O@
M/*BW%-VK07.8M$NQ4Y/K%R-_5K"P?5M,;!0]UXVJ3\I%D@B;9=0*CVT<@]:#
M)[,2G$<B$T,NW)%+K".12&SR4X"XU'MG^ -143"Z#6,+:W0#AQ"/_,(3#X9.
M$GS'\8:>S%[[*4HI,VS*9\E&P/*%/BE[@39^;="R^U>7C91>%!\?;XM=05,H
M$\U')(^5=O7@, TCS1]5T@?F2A9H;SEDC3S3QZR&)Y@YFQD:%_(3>YR6%POS
MM%P5ORN%%F[U[%2+D%SSV#T%U[(%9Z.?]E&/K[XP0H-1IXGIL]T7JW_V1?;9
MI]EG+YZ#O5IH)3ZH-_#WL2;\O)E1%2'M833A$.*.;%@H07[P7<;W]\B;_;J#
M3528#<61,%JN470AH_BEK.0/;!C>:^5B@:6'2S'ET4X<-I)!K=WJ5DI$79E^
MF5]>X%%!A'M=^;=HCN:E[SZ0+GM)!)4/)=FUPI@>\>2A6:Y%-(KD%@FMZ1RI
MC./6];S&G:)IA-YKYJNI!]/7D>"('H(O;%<A4DJ]A:15<F2WP.ZY)]0;=;89
MO?I<,YR.+Z>!E,E,1EK(S92(N?,9)FJWOK*'&C!\ALLPS<D%PN X0IGB@=;<
MO;K9$T?9]Z-EBTX]%2)NJ&*ZJ23V'RUS _.[A1Y7)V&V>LY@EMWX\:6#M=Z%
MZS'^>%V)+]4-R'@'SJ.XIS0!(*IPJ^@!-!GOY[*YY*8_=69/'.]YXGG:\C;7
MAF #4FCB[\WK'[]71W TN@_P#"?@G4.WT)JY'NX61L*]R/7KCU0L)7R4=Q2H
M<R>]<)]MB;E>Z@\7V,@]]1XF7AF7?);4S(=VQKP12DPD)_VD7T"UT$$\;;LH
MHOEC?NX\WV9.*4'JR3^>8DIP\:Y^*4OS WM72D4CUORFS0_*]@*K/U T&2XM
MG+P>!6MD.+LI3B[E91FJ&X0OA7&[8Y*')&/,"D:4RKA .Y9O</-LX'8Y4;31
MHRQE[(]TP7_C?20YWT>"G?1QM<*2@6R SF H1'$%2C%FR1\E,?%)=OUF.%R
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MY02FBB@5CZZT^8:0 5,;0S<=MZ WVRD?!0VITC9JJXGT<F#18:W47[L050(
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M\"H(W($G#_>W,=$@8G08,]S&_O0-2]P9$]$O>AOF@P*PIN[N(0;J"@2L2O?
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M1:SV(LY=4Z,7"M+)I3[#&D [LIHB1#[A'+T8I<[6-IL&9YO0W\3,^)\@"B^
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M+:-@;<TN1\&Z!\%:@S0H380(MKMW\#PQ3YIJ(6=8A<,K. R0L*^M/ HN:(
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M<#>%;,<MH+G:P5^C6HTV\(%NEMA KKP?[']X!/;KG-*74&4_O:@TPH2.P%)
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MW[ZIS5\4()?77Y^M>L-(?&__\?/IK[^]?WU^F]=\/#XY.KIKB7\@ELX?V"(
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MWH0"O/T!@0P=DIZ]IYI@#@561%)0?<]N*\O+@)L?]^[#T)M,A5V?5HF05 R
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MB\3@K'RV(RR/0@:=>QJEC.>"?//!!(.'TIE6CLC@HGQN(^&  A:=DPZ>US]
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M2&QZ5CL+R%"0*/\33&ZT+"@4)IKU=)![1LCI[P1LU(7WWWRZ5F3;&<AGX&L
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M%J=ZP>:>K .U9M1-([AIL1<?LAB=KH[?#@$\W%?/HTVGD8)E;]O23HUQ.*M
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MO%K9G DY1P<;:EGY7*%H!^K JX@\Q."Q.I!3*JYNDYF)JIY.#IATLYC'==)
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MKT.WE-1BX^:U</IE! &'M,*?&R>&WO7P1PMB!G.ESEZ3EJ9R$$00@?0"#HC
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M?CH**@&\("*2_H]JDD_ I\*4022'*?G^ULJ)JU72_=H'6/S40F.?TP#=]S"
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M=R5(V(N!3W.@+D30MDR)3:MV(Z.W"ZF%52OU30M!S*V5 5D2'E'=G22KIB$
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MKXWF'6]TBQN\*VIR^QKL\>8W1E%_D"5V8;$/"&^*5D2-QE>L77IU)UG+PQ-
MU#OW@VU]\GO=T\8F\B9Z<7[8T@3"*5!!(-04-5<-V[7KJZ-Z%N=,+?5@TMB&
MS(P+#OQ%/7XUK#?;5"3C%.>[N]?1V$ 328/ME,6;SXE1R!U-]K&=L0;*E!)
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MY*WFX5' <LOU*'?W#XUAW.9WQO.8-S*=?V8B^=WZ9:JG7A]8970PX6GE^O#
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M-J7C]+\ -*+D)TGV_[,GS0U]U4#%XRAD?^7PILDB/GL&SP5BEJ@G<'Y%E/E
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MHM<$<'Z4X%D(RAE W(/A4/C7DJ$))/C9+)^=4 "EW$38;XRV8Z3<14%P&<5
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M]6!]P0'WP]8!UPLF&VL8\]<]^QM5N6KUH?)0^M=#M#Q2"YD-W;<$65O(C.A
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MK:37$7# D.H )H-!:7(K4R>23<2"2S^@\1FS*)ZB^%#=5< 4("DB:4V6Z0J
M!=N<9Y^S*DZ#<[$WGI!>[ 8$A\$4,B9%J7C/U>1)>/%>"!HWUN1P[9O\P:+:
M7<K;K,(X-)VR60/F:+M!M U1@SVE/!;QVC.,!X:=U-M[B\9#GP4(YF)E?-/F
M>L2K1DN?-=3-D?:P[5D(^DW $4NN'\V"LK0X8^K1-8]?C;#S5;!#(NOW#C%=
M6(?-[\VS_C7RA-5(L6\?]5^%VS6C\#./@'N+\ X6/6:<G#J)GSR$T2,X6F _
M7(6;+8+2ARY["QVV1>CJ?L"W67;"XTZ#J1%0UM;,@$P/%>ZK.[J)8I'RGFX/
MW9%"%Y6HZ(HHX52G+T>%8CV<,*7-RC.&#]ZG^'K_/8IDK._(J0E?RMSF,V Q
M$\-]IMXVH(N5J#])!,80=*<J.;F6\)O>C9;%D' 'RD&)1#;"EE45'MN?<&@R
M3$?F ><DC_.Q9CK!3LP+3L&%[N?D'FMY,@SBN<8DG,>&1!V1I_-8DZ<CLG#X
M]Y*R[RCQ7?S.#L6H[)(6U34K2F,.DQLX>_QB_"U,::[T6.BE&G6+WO,7QP]@
MB,LH!B4\T[;S_3H/#7)I2E^A5^>,J+%/5E%\ HT05!#/NMEE6>Z@D\CWSB!P
M:[;7.&=F#6I(698L'P6JE(V\$WY#BQX]#)T\1X'')II7OH 3T1S6B4[_7XFH
MK4$_Y>#0)]9$S5WN%?(.*9+)99H7T,)O';MG27]I-I@B?!%*%^0%KUAY= +H
M#3Y]SIGQ%Z>"]U/ZY(?AD;!?=L D&LU_^=V_?_KXQS^+WGB6\IS^]S;8:9"*
M'$]Q$=+;[6/@NXO5BH)]9P0P$X8BZ6M$4@DJF7) R2BD9(/C,>V>#V@KQ<ZF
MN.)00#%SV)D"-Y,-0_@X1 YD&RS3IKCZ^8TR?_KPZ>.  FK9)MOU%O-CT08\
MTSLM\-SU_@)J@TA+,]?0(5=0<,Q"2P?3XNRJYB:SO6<S!X-H32O-?)E$)%1'
M[HSJYV HG%"Z\V4C^N(V)%/Q'B^VCJHAYZ'H?,)"/"Z_<K+,2TX6/C+ASB>[
MVNC@,U+C>BK-2MGU-!^J\X_N4.V1K)_S)0\'&M&/]\%=P=!V;"G:CF61RSNV
M&WA& ):) E@0M"&$GK/LVNV7)X[=:W?0O9:&'H4>Y"Z>N^3;CS.X:W]_W,**
MW0=#G<!8(M-(QIMGO'$O(VPS0K5TWJX\)A&T<.)ML;<]+DT1G0)0L3Q5PLD>
M@205P;8!Q<GCO:F*I.N(C]NKJS+J9XHDD32M'WD&9:E CBT+-&)=<EU9,C>.
MM3:J>&$NGYTP7[!,/5FNW"^%:H"BY"G.Q3CEV1.>"7-1,>':TSLA<Z4O9>R6
MD 1XQSO.\S!)_*!2F<O>_Y\?OO[PX<-'Z%3%L2F^([__\&'V@?]?PB,[V_0Y
MBJ&_WY\__OX/LS_^X</LXX<_H4(,__[]AT^S3__^^SR8,C>BMBE"*&*#GD2D
MN;G/4J_Y%A\J:CN?H,48=%L$0// :C)UOVD-<C,JZSHX.+MM?.S>6T+S1S8(
M8#T4V%>.LENX49K,9WQJVV=L1K+,5=\HE_#C6Q>JD!_$K/'^*7T]X>CTE@C"
M30&GBIXT(QD#&![%&D'>9D3GCB![),_?(,A\=S1U_)!Z%TX,VS/1O'[GE&GC
M![==D82)I$S>Z1Y.0=QB -6\9'7>6H^3.PI1*K798Q6FXD[IN.VLWR_FI2S?
M.)UE'?#VL25W=A]UEGJHNTD9R%R%!_T_"D&![^%,$-9 1LM^'S634N1\/$51
M++GNF[O.&@DO5R%K#-)SUX9LU9 A:H 9*> 9V0W)V9 PJ!5N,-GDU[5D#RU6
MLI- O[AI?1N% 1+U]?HM4>TMD?[,%*G)$G)%]3ADR7=[T@5*GRFA$M<1HKX\
M?<$^T";"M/EK[B0ZBY(TN8G2>1!$+I@<O8I#!&D%9(G4(7N0*/H#[,5ST8:*
M?^ 4F?@^/AR\D0/N,<L6J'&99@0)'H$,92 ]*8C+:!*?E[K;PH:^]-^HAU;P
MW/-\]%4N'KF>=A5>O'&PYB7;\ DS9]EO^UU6;^#FPY"L(T<CD1@._*)4#$C2
M;,0C%3SX#<I<TKI =AZ"5P.2A2:[')-H@UI0Q;)0Z,6:QLRD>F)?ZFOZ#*JM
M$_;$()$D":=)!-')2U$1SAU,E-HRY9ZNO7*)]2"^.&-BY N+BO76%GO12&18
M(0#<0WTT#,"Z%:1FF+PQ:<[+S9DD4IB<^FFS7\H4M\\^7B<U'9F%B;:,;FBJ
M-O$U]H&8AQY[_(RI,W[O)@I:\VDJFS<_BN;->K\)P/')L M$/PK,,&=ONIP5
M6^;_P#.D/L%26VLQL#*?EQ&![AS9&<-'QT1.>$\P<.33TK$7>]*Z7:02#OAH
M3#"*,6G80QXTLXJPTZ6^GRQ>-9!:<!.%41Z!74QDW^L3\Q9TZBIY70SP?I#[
M-"L%5"X@34'L SZ=50)FSB6-M'UGK4I3QK#L*<<DP71D Z  2!/2543&+M*U
M*<VA%=EZ5'B[EN79O-\2)'R.6.2N0;QHS,V(ZJ,%_/T6IC1G'ZC.6Y"-^XY9
M;I!\;+,]AK07G4!\J)!.O(KB-<Z'N6K:;!RB!B+:2,,7U5J7O")^P&3.LD5M
M!GQZ9P:*?+ILDK()Z6L\FD3(T+:5QN PE^>4IC:7>?'T%*,F9A\R!%PEY\)<
MP.L=)>*04(?ZF 4YDM$3&%/39C_G7AY0AM8>O7U*DNJZ#A^!&&5G@^VB,'.L
MZWCR3<M@/4EG_R*DYYCV:V;66G/UAV,75WQ@;5570'J"MU=KR<#W&+6M:7J'
MOSQG=Y/Z3/IL%J1VG(45EF?)G*K5L>R"R]/8NQ$?(2"6=II9_)B9#A2PCPHV
MS#QD"X@I(91]OC3I:\T@;2*(HX,J1WX@"\:*A+EFARBFR-: 3$*;8?Y-3%V>
MU\W^'E#\T$)OO@9TT5^='J%AG31$201QCN2HD3\NX?+I#!E]%,LY7K%RT'C=
M%LZZ&O0Y:PJ,=0A7H4LWTDL N6;0Z+%7SIHV B]U +Q',0B1HV!;RP%R\2R*
MF]NU XL%=3I^BE=8\;0TY^?2!JFX%P9W<MF5N5B^6"OXB!I:6Z-FE=!X+*VR
M%<-?1J-LJ_.?]ZUS0D=I+MQ ^YR$S<I=% 2740PO3=XF4$S/!%H%QLYX+?)/
M( @1DHP+T@61;XB$KY;.FZF*-P%2E<,G\T6(-[#;\-RVQ/EFA]T1V6:8"<%V
M !O4/I"QW4D(>LIO*=_CU/'#RRU6=<V?8HJ?LI&Z'B!,5EN!%R!)V\KF,2>&
M6"=D7U DBJ3MBAUS8NBGS#BRG+%#BPV(E_!BI570]]Q8@B[9 &'X.%P-!</6
M_C(FC-3YA1!($'#[=$2 J<N0;U/)!<'9YVMBM3=-QC77"A89*DG/3CLY2 :A
M<FC4CT6JJKX[@XN&^XWIYBY\MD]LMXG3)[/X>AX"&6TX >0UXRKRMLX!HS*)
M#:C)P@X">4YG9(]!E%RI7LO:6,[ M*BN+\93T6WKY:*1W)<E8* OVVAZMC(P
M-/\S^^1DDBN6)QYJ36@D@?^*:LOCD"=G%!>$\DJ5ET<B5+[KR4T4GKA.\CQ@
M!0O;U=E'=. 6@R\C#Y,^=*>,7E+H&PM$":Q6'O=C53N.[;,*1T7FC=.Z>$,6
M20*]+):Q S?WN;/K5_RM!H&:=C7,C*B!B!B)P%!'*G&Y5%P3.Q7R>5;ER^IR
MJ)/0K+5JK\9;6AD24)WI8";6^VV9E:BZ@C, T@I[!GN+R48!V*74*C2O*CDY
M"(O/"E1^EG;>!L#GI'J*(039BX!\7^C,R:B(5M[3#[APT$Z@61+YK>-[5^&9
ML_'9Q=,//R?+J0>B)WY(!-DAFJJ8%"BGB-9*95$8+0S*]C)3&IWL)UHY7-)K
MO<ZB@/TM@B.0V4)Z% \39;1_:T&Z_$OVH6@L3T4^$Z'O? P&TWH@,&N?.L:*
MPZTO"JOM\L<1)RV7FIZK6,Q-W*)\"TQ@WK)[-4L?8/^-?2@Q1 ?R0^BSSQ'P
MO+%]A04-)!M05,W*T;X0L2O4!S5J67@<6$W!()J"7N.DU3=>^R&]2NGZ8&M0
MECCI-9P_ 56"9(] DLJ*K>'$*6_7K.1DL=)+48SOT&P@^%>^$&6D1O9V9,\=
M2KJ&OTTA!_.S'_KK[5JF-R5D&WI,(?CTX=,?L=.O!9LGBQ/>T2<?BCW#],99
M'WJ;BZ!@1HL L>FR71'0M,Z[*I?([#=S99+7NJ]AX%I)LP*5"R8U^L<B1-Y+
MKUOL*UB;%\LE1V871',AMV\S^PU!G.09<LC9'Y#_R:82;;GTC!ER.Z;W]NK4
M J$4S!J'OVCD9^"8DB/8KABS(F'.,I5B8NB(9F,<FTQZCYH]ENXX]VA%)YN]
M9!ZRM8T]^;5^-WM);[O) .]*RPW.Q>H,84Z3J_ B2?TU).:J@U@+ &NGJ=G>
MQ9G=*QA!\%7)2L[#OB)EV'5>.FI?_1YUSJ0]\L^Y.MBI<NB$V3MX9*N16QIC
M2F+?W:%:ES""/,EQH((Y8X(4<Q4@B2"39A#DN\I2(W1$B1(=V"V\1"G#,C/N
M;&BH(^).,54OI-C1$>%&\D>,,7DU7WNIMD^?G8>$PVF>4X", W]5_AS(33$1
M@!GPPL5Z$T0[*C!:S_V8NFD46SPB'NZ_CY@ (4ZFK$&ECVF&%=DK"O9P3S+Z
M9*XJ;L&EI<%1VH]@VI)3WQT/7]]_72FN??'RB3<2M 90/4SE%4F:"!5R#((T
MI@NMI32>56FJ2T\-E(BJ(SN+FV)E)YJP%[:3'LV(5>ZV=8*XGI@<+8E.7@C-
MZ.8+]-AY@:P;W@K5<K'B.9.(-E#*_^Z+'*FP,Z-5=0KX$,"/MS' -J>[6T8@
M97+"CD)D:J;F'=[A"4G."!+%*UF1Q83VXQ"GT.0)Z:(P-!,F/!IAM _NZ(4I
M.[':]]R@KBOSPF8>JRZB#M8,\U#@:6EV8&H!3) $G8[@1UH%8 % XXY":A>6
M/81X-&Z=8&3L[\SBXWD2N!X*^CK"'\_THL8*@!,E%M'DFBIH^.AKEX^+27/P
M)9M^JDT__'B*B#'X'V@4R680/F0(%_?JTH<$"5 <( -R"G+G$F*5\ .HA=<]
MTXTRS6^@I)S>C.><.0-SWQR'[JF$MX>B!]'"[<B80[_,1K#8$:POC/S>=\I0
M@&8#Z "3 3F;U!I-Z*Z_H:]9-V:FA8?LKZXJ E#!-/T9Q-<.>C>9:&H"C;%K
MW@_39ULV>U*-;O4$@UPZX0S>??STN/33@Y/Y\5UPAGS\].[QO?1S6^J)V9?G
M7(+94(R7:@CX]] WP*5747"* \4G3<G1W-S>2JP8(^EYK[OLRM@S[Z+@=%=%
M^;: 8\P(41W_()+<-'FO;/5W39/D.P"=WH;8Y&_#2%)^I/K6I,DZ>[HQE/V>
M4_ZGNDX2=A/W*)22=,D[2?F]=ETD1% _(L$*8)5<C,WQB:'Y93LNDOW$PPST
MJV<M9X;N-1 D=B^VBPC00_)>F>N8E5Q5__XV"GSWT$[D#9F/6JE7PU-\=/*3
M^',8"/ !YTG?#H49L8K3 @,P\^+%]ZAWNH.<F*M0H4*(<CN_MTT!:5RXIG(H
M,''?80:.'[[7FOQF(P[B"K$_ :4D]E40O29D%4=KK8FOH\:QZ"_A\7O5.[&7
M_U?@6"MB WB!C;!?SF?(9!C ]-BK[%H!O7S/!(4DR%*JP,5;"D%\]OJUO[\6
M75VAG8.VV;^F?4: 6P4HE\L[$)D&40T(W4^9..0B9$IVC!2', DGM2X5AO)O
M9TDRW+!+=D3R5AA;)JTXDJ,P.:6K**:J03M-&(^Q$\4>L\7C'08(((<'PGY1
M$&#_\5Y69A[U#0_NC"V2\44>D3$Y=<@:3R?*6+%HHDYP G-E>)#$+6;(5_WM
M[=8)SSV//<,_ST6,EWQXL.->U-P*FN(S@@]'TIV^)!4EQ$.*DYE.*B*_> S\
MIS[YEGH&0T9LXKS7A,I(3'E#A#0BT='(HA<T5BZ&=0_"CXB'A'&1.X@%&0!#
MER31&.5$[2*%VY"EI-^]R-*&5S'*.##&"EI/:34%U_Q#&%,G\'^EGM2PYK$/
M\/KG6U!\>+.C^8K)UQ/(.@ME937NQ"G@NF;>\9-D0UU_Y;O$C:GGIX1Q]3/[
M:MWH*01N@5 5=/0[?N&]MPQE.MTY%U]5!P#J#'914WFU5 G.+"B]DEU=N26"
M9\*95CV^'.#;+JKU="<_']36"B /W_._J6FLC-M\&2>'C@L%Z6Q]$:WLI,3U
MY;(2K<IN]IZTF  OLV<Q #H--XP.8;;3($'!7JPKHUF NP,9Z+SH!EO>SX,C
MA^*FEP_-*AW -NVI^V<:!'#,..&A$0UA0"$E(DA-E>4*P\\RW\K&")PD6:R$
M6KN(4:GMKY\C6:SPY83!<$72LV'4=--BZ0ND; ]V@VP8#\\0I$UXMZ+H&(7+
M*R!*/$T6N.>$B!9;JV1EQ"IM1X//A0NA5TA$*Y7.TH*T 8: "@Z"R 4MI3KM
M4I0TVBIMM5[2:D>\,GH;K2MTE:U*P(/)[C.NMZ6\99"ZP:RW,Y&8B[V;S>A5
M>A+',0> @F2M^V],R1.TBC)A&2JMC'.ZHG&,FS!)<_[!E1+,L:@P8=H;Q )X
M)X@22L_NCG-TZ\3IWDI)(1,Q&T833O:CV"G9-S"4K>Q$6Z**G:F)6$X<!3A/
M+B(.<602YN_XR_("SO(K>&3B5>?\U@E'WB$$+OD]NH__:$&E06&E^<0])$QT
M=0?U-#F5\<:]#Y9JM<W+4+0]A6]1IVH'$,"\*(7#L; B)-2HX_+8.A'1'[=8
ML6N(C204K -1> HB<6=P)$A+K2DY D%RWFQ)4FJ_-H&$]%*2BS<779 ]$+ E
M*2)I643 -L%VKBYT(-Y+F4*B<05LY!_]]+F4*I3D<V_RB46ES*$K84=<A76.
M[W^&MXYN"0(MY"KRMS26R2OCN2)I*REE;94RO;20F![TNM*,T=80FW6W$2:Q
M7_<L6E?^/9$2?SU$[?<\3'W/#[;0QRASYG#7-?5X-M6:K91HBEK$N^PKLSZ\
MCKLG&9"I9XH%F)\JM,\O>K)RE3AM,W99G+'%B#-V[[-CE)VN -*35>U"L0"
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M-X[O787LZP7_X<$N&21#%)WI<IQ+6A)L^_;9+N39]_%_E=/L;3N!OJ<AC9T
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M@1*:$8<@^A@:Y/] )8(6I<T[ES*1K9PJ'$R9EPV=L5_XKA,L 0I2^$H3,XT
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M;P?C'_&2F3:2RV^[B4*5;]<3OE;2EVE[[\3Q]GX&#?^.2ZZ@(%(QAP^3A]4
MEGNF65FX7-7C. LGE#,H\9-?58]XB**F'7G60R&&1,C799;E&*%RJW?S(TP@
MO?9?(".;,0?@X%Q%M;XH%F3*H_W5"'84;E1PE5Y.T6%-?@+6B.#M.'S2/2:S
M.K^?:YX6LZTS*YA]&/=IY/X,.*&,%UXST]./I!O9LE83P!:'0+:Q)%GNR[^:
MGUY=7RVO+N[)_.:<W"\79__]7XOK\XN[^W_YW;]_^OC'/Y.+'QZNEG^SZ'H/
M4]\#^#]V -T#(@F*W#L-1R=+,KK6TW%LB97S[#;)9O4:6OGI]>'=M4I-R&?P
MSV"+I^4MM("%0S=-8_]QFR)*3AIAOPAHDL=.)GA,ZG93%+,J8#])/C4CQ^2:
M6(L(<5]J!9C1*4U?*0VOH;TBXG:O:-S?.D?XH1>$'])\Q.21#T8"& WZL^!P
MULS< 80.-'DYW))^X8EQ" Y$Y$C6_"T#R%L,!1RPSA8B!?D@M)E4P3$2 HWP
MGTNAR_F.+42:5!MJ)W2XJGQ)I3_BP(G/2!%&2T8UILUZKGMVQO^*V@(0DC62
MO&<ZW"J9%M._ZO:<?<_.*J4(@<13?]/G.-H^/9/E:X0_^/_;N[;FV&WD_)Y?
M,8^;JN/:M5V5O*12-9*.CI7H:&1=[-KD88N:P4A<<T@MR='1^->G&P!!D 1
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MUY'H[<188R,7X0)24ROB>;VG@O4\S 1->C@9,.F1*ZA,0!U8TL/<[\Y4*S!
M59UH&0K_E\N6_.D6AMWEOGS)<HRF&*%Z@[3*N_PD,7@6=:\?8BEM=;N2OC])
MJ_LBFG$]&%[_D$?X9-T?=D]9<N1&R#X6HI, YZE_Y;DGRZ_M:KMEJ+C)D!U9
M^T\"GAX;WB?[5!C""GA*JJ\?82VMMT"MB=5K*G08U[E>ADD7U2B8TK>B>:4/
M+2"RE1','<)C0_T\HDM/&LPWYY)M\7G2% \:3)TZBU$?(.;E)8\4Q;A '@O1
M_3A:WG3K6YXBTD'#PZX3P4>'?VK1'TU(\WH,H@C/:==K.1!BS;6Z-'?=X?O]
M4\$3@,O/;[B<<7B?=6\+WMT"^YN_%ETWRGMD\'NCQS;6%RJ!L%/0^Z<.RM=M
M-"_LQ(1+U?7:YGKGQ6 [.J%/>:WA3NQWPC9\%Q>_7>:,57!J=\!+Z4*#-!ZN
MS?'3 F>)B?9,P;XM<*+_1-^X$5>,7V.+7R.NOD8^Z]=8KM=H,RE@H7A/Q]7>
MJ#I;R-Y.4&MCFOFWZAR)1;R*+H.?N\:KK!LP>W&MMD38DA?7H(SLN2.+6S?K
M9!]\-\YX$M3(_*%E)R]HL:M%P V*@(4F3FOI1M<\S^@/]FG\U8A/"VT*POC<
M_CHJ3VW6K+33?B=CO&*XA\B G(+2L()/$;+PQ!@Q7-ZND6+FEK<G7J-QA\6:
MYJX>-,]N>=15-&_9[-R_5@0MX"C%V:'QRT0Y$%:X%&19A];/)TQTF/$KV/(9
M[)]B<7;R+V&M,($Z[RC4,4?5C-F1QV98%5'=#!G3F')\A7V4K)Z2^)GK01>L
M6.<Q5VY4%-Q#O ->,M( K76,-[?D?2[@F5V@ E9L#R+V0@XI8J34_!:9FN!\
M@:NS?@UE/*G75 ^ST#^.&F@A1OJ8ZVVZVTP;">)4O>AZX\N9%FUP*0(S7.7W
M)3)&KM>/+/'7]))"YPLXW*)[:?@X0;V_&99G]YR^1OE<<1'S0UQ]@2[*8@J8
M+][3Q\3Y&O<1IK,.>N)\B>F>(J?P OI_BTIN2:[FA,:Y$0Z NLM35&#C3+X9
M)O4U3A&O1T6TBW IT+;OV(8)@^;H1[X1/K78B1$[12CYNY^K4>=ZTV=?OFYE
MT?94CK2H:U<NZV77HWW453<PH&P[# )<FI6L6&1:";/FMA,RS**GAEF3+_[*
MXN<7X/#+-]"KGUF5#<#KZ<[(,PO?;.LV6_RTJ&:\D%-6R12B\O _Y9<_Z9.M
M)Q:-]?LW X1!>S^%;W^2!>B?_(>__/#O<-13V,DR%E48TACXP4TV2[:E.5+X
M>B3V<)O3GP9Q>"1NQJCH](E@1C[-7E>;Y",U,A3@(,,<X E4WTO#K6.-[[6.
MDC4Z,^3W2F5UMQKQ]=.BG-=DJ[S9=SA'#*0#CAP7>FXZ3TU'*#9XV9,X$B#7
M,HZY0@;D^B5>!1D#9 C"^/Q>XO^%#J_C8GPA-9DKJ&:".9-R!0N^A$^&!/M%
M<QF-Y@U 1K6>.N#(&/"26?[^O_5J%Y]38!(Y'_ 4@ 6!;V3R_WOH\!?I%<R7
MZ:;Z@XR:K;&))PDN;9=MQZ!*];<JZ%DO%G#"F,)3?0I+C*&KHOV<%:P1@ X6
MB_]!6\A;E#3JT-2K/M8XB0!W A44_J$-T8C,JH?Y@"MMV"EQE4Q?Y5859YP1
MJA#8$PQ<0Q,B\IU, >(RXA20UO?[U]>$LS>0-!16HXX-+T0,7B$*?];@&F'_
MMRHGJ09OG!&@?+9/(L^U[%]#:12X@-4B^1B^ .;+?-U86Y2OJRG!/WMF)2G^
MC&\4>RV_$Q.4S7%'1'K-9Q 1R\-RLX$/5YS#/U?Y0_8M51\U<Y+QK_3GDT^\
M64N5.R7M553UI0QJ2+0XS;V[9FQ3H*J@N^E1Y]/7Y$-/N4^@T72M?4+Q+M!*
MV]Z>'GKB73$\#(IGF';%14^\E!OV309H(M)(GJ7PS[4PBJUR4;3J*M4I^*;(
M[!K36D=U2/PQ.OJW8T]MM*$<30TJ[GN1WNL\F5UR2G8!YR/?LPWJ/'F*,$<%
MP]J$\%!?X PS'N%252B3X<0='G),)\2[Y\+^@8O%?RE,^^C5D)S5&$&SE5Q4
M0UF[[MWP7HB7C;-M*19-Y'<XD,T_:)1B&]NAF\* R!-8UYRC8HK'Y^V6F3_9
M:6= ?86F3*6I,&,N8CQL\)5@E<;K-_>@1!\5I?XE3';#"YHFT7-;)6C\2+SS
M+?R5VJMSL\?W;+7M1)Z8MG)X+\3+'@ 7>)4B;-\EZ,:FE1_5$3ESY?5DN$%L
MPS'XBRN1ZKLYVY<W6?E75MY&\<;,%OW:4@I"E<"L^ 0"/;9!83J2CU<K:C[=
M3606X<I&_FHC)EZ$2FJXQD?Q#N,"5EL02+A1P;009P-")G\A8Z9^WD<YB,O)
M :Y]EI=M=F\A"XKQ6S53 QGU':B<0M8Y-RF".NV*D=3@"OTGWM"(^@6QFR3J
M/]UCL!B(:\7CZP8VY&J'&"!Y#(^'7>B>H%]2%5R5_\/2X(U-E.ZGKL+=VX3<
MFLJV#-]W#;UK58<"F@VJSB:A6'M$H!JP9331\WA>S=1HY2X#F@?%XC6I_.$%
M9OB2)1L=ZE.D&F \WD,>/S^;35\CNZ1^.F8+O[_)N-N*M>,<>7CB!? G=6HF
MU80GG-<?=FN:%= #VY^!DZ-\VP9HNDNL?&O2FD=U1&V)Q:DB0M:K#",R6D*Z
M5!_U8LD3>IGE6R84?<R4?7^-Y;JJ0SOIA?$=E-KGI4.VVQU%!K( 1 )1UD?%
M6]F>^199(%]<^N>[1>9=W]_:*)!%:14J/ ^33DS-8)REZ(R,8( SSM4-M0VY
M/D[ I/C\40!F>2&>?:.YN*<-J=FTSCCF%4Y JG]\S=(Z@&2U??B6/;QD^P+T
MN(=O<'\.]^R-I3SQHWMP)^LT%'VQ5M57VU^CG.<W.35$4P/*'3Z+8EEN.<LM
M^]4E^8"FIN4F>P5^/Y6%279'*GR##IT6;/F<,V'9-+W>;DI"0[F(@<1 [/PU
M$Y(<M]&>X_?.#^?9IJ%V>3:AW(\:E+C.4&II;U4I,%1U.KLTL#WU$Q\EE37G
M)MK!/S54(H?_J;<5Z6N71/'.9L@T4X0C;SADWF"$7)M3]9:#)V"!*Q'A:'I)
MA[8-(II:J]K[:UR^=/*VBF;:DZI%9Q8FINX[%"%*6TFA<L4\8BT=[8B7ULIK
M,JVB14)Y7.]?LKS$-\7T!%F$0H\VI%ZW<G>;9\]YM+/,OTU ?& >[Q]R?IH/
MH -^R>"Y3SG A_42.!M0OTK2FEO5%D2%+RY%,:^2/6?Y8;7%W)WJ]XU=8#BR
MJP#]HW5U(U_W:*L>$M%-JL*]S[,$2*3<#6>NK518[MFPYM1"K0+Y5)8U$=9N
M,5XGH$1)R %\;)]3W"QAI,+J)7:'\2P#D6MS][LH2<[V19RRHB&X6$A"D3\$
MD*Z4)C:K=&"RO40=<9M])AF"VNXR)O[=:'D9TR%I&IY\;G(,[^"H_!;V9R,D
M%??P<&V6:1JCO37*'4*>C9+X(&+<ZFJK^0X19\]TP(R$I-]>,?Z6_-\$/.CN
MA%\[<K4'K<05:K*4T.+?([<7J[\5\;*L5N ?_@)=_9M]95X- W#_:C"8"L!/
M2!=VR=RG'?6^\4?781AK$)#K#!8 <J> T=^*>%DM"W:5_-,) $4Y:&U:X: .
M*%G[8[IA^3<T@*3/ZK5',!1460OT:Q;- ID=)C^X!T*)'V$KECF+3(X:_3=J
MC6YDU)%VP.#A!8$=#MGT,8%]@U%_1"5\<,!(JZ3B0T_]VJEP[-56WR09#L25
M:;Y'3]H>.?.HQ_48S,[R*-2;+,VJ=(,*%JY'.AW7$ZG_7)BCLOR@'DV+&F2E
M)%5!M_'O+(=O:],\F[]3FX1K%V2/AY+RFQI*.QFSKEJK&-HV@/Q$(:5_3C<7
MK4Q\*U%0H2YMNZJ=BMIDEG$5B0<X7*7<X\0*@[G%AYXZV/U(0"*G_C*Z4^H'
M=*3(YT1$GSD3Y;@I4.OT[D*25?5X%+NX:=VH]@_L@UIFA>G5P;$RP0XSA"KC
MBZX2?F^SU?CW0+Q<K,2"6N\C4.9E%*=]2$;.!D2+*?+R;W=X =N6Z<8/Q$B"
M*BGS<L^5SCNV9EBBKBM+VFE#$@M,A\1)2&[R8Z]1O)&:4:4W.3  G VH00UP
M-KT6URX5]0/>1$1Q"BLV6O)C5&.5:NG7/M"F+7)JSN]56=7FZ_-O3<FSW-81
M_FN'?7FTH9;*^(VVNUA('SI+@+#-;N(D)Q<%JS)SY[+NIAOOR44?TLMM9+MN
M2NH\S19L[066A3'']EE(*;__3?86_;QG!;H,,;U+"G7J*]LNAV<[ZC==V:)'
MU@WRM'A/-4HH\7!#,PN:P6P*FLIJL9AE(/+H1XGG?YL5993\3_QJ3V$S4=*^
MD+5$R#-R@7RUU3$Y%$RM"SM_;%\!F,4OXV(=)<(2=@E_ZT2Q6@EI,P_32(:W
M]41C6RFIS>1)5!0J,6F5<T!':_2TG9I</!-!_*LM_!=..'?^FN4R R&Y&JFG
M(%B9MX&,6OG0X?* M\;X5L#EC.+-52K!:6L/?--'_X]]7,1E%7TO[K.,L$<"
MZU>8>TQZS[)G?H>+.(@43'N&*'QS9"3Q-A9"FH#;>,BX0EV]6"Z7[PQCD/OX
M?(L"F)UYOJVI%80 P/7NLB2YS'+L=5*OWCQ3) \LUPL'2L,7'#>76ZBO#?49
MK&MRR@L"ST=6\"? M2R?=A]4D;2H=U454]A(KE!?I94&/:5R.7AP<H7S,JZ*
M*9C5S/IW0B?H/0@&$4@XCVGQRM;\'>R:*YV$X=Q3?-PND^R;TQOMHJ=>RK%O
M2BW@?F$I/!:)9[VV60<,464UVK']6E '*G3E^]9/U(>WOE==C#S/"VEO2+VX
M_5,1;^(H/V@(239'IY68^D9TJXJ#N+7:/D3OKOWQ:$:].YUC@TB$[C/G:D&]
MG&88@YN#6VA#D3!U>'V7L\;9@'H_)@W@G/0=-HX00J"1@6F@E%XQCEL,X805
MEF4>/^TY.M%#=AOEEB"QB;L.X3QU[([=W7ZR[+8$"L.5M4P$=PP%<FZO%M$$
M^RA! Y8QZ)1@&N06=)/O2X.[[0O',C8B#A+MEH]^R*.-B,5?=Y,P>EO0[Y$Y
M8=KY?/2WHMRES_>WMW4$-UX8B['>1DCMP!D7/W%V,'=@DY]G'([^<!MXB=AQ
MGEP.SQD<6I@V(HT;A0(\X=+8Q6$K%+"\#7Y@O@')G;F6ND9U)L4=KL":<>'5
MF-KAL[R_6/Y\!5OU?KG'XAKVU#0+*?F1U]W1((>M<J[PBY+=U9WM=V3;6E*S
M1G>JTGJ]W^UY%,V7'&34QS1G48*Y2VBV/F/;+&<@LAJ9X!0=4SYZS1O6DCE$
M)A,L37/-2R2NSJ-X;$?44GY+,W?'*MJ(PT2'D1&R7H4%!W9!;2-K8M@Y$H%-
MA*3(93 1>,2U5YZCN//JSA8\F_XFU$'</N";RE_.E=/B(2NC1/\=8[?$FFIH
MSKHGT:CM@S?M.-EDJ*^$+.?0>H)<.?*.!M0I3-DA2LJ# _>[24'^[5'18;D#
M :6'E'@!TCT(7&:YV<5IC 8X5#?DY[4OQZLA]6&2V,DPR0OVQI*,?W?-@J:2
M>C(05T$FVX&@PF]WX4X+FJ1CVHAUG@AK7H?<0E,:ZN#&?]@'JD>Q/\G ],QO
MAR9F#-M]98;J5TY"2NP]<39%#@*60K7@^-CHR(/Y=+Q7FY6N2Q6*S_'LH*+#
M>$B';07.!L2+,57MN--4?/1XF=;DTXX:'!ISO[?P5*')D;,O4/NT8$DM-!9/
M5F'^R?YX3MD_Y1OZ\!+G7BC@-L( [+,7;!OMDQ(#Z4N97B;L-C:;K+5!"$YM
MD2OOA@ Q$H;"&<6[+F"["JU*5\49C*9R_];D$;<R<5/^YSI.V??M-]=*2'G5
MJR^XJC_J'<CY*CY:L:CT6;U4>G9FAR6,[9!4=X@.^'ZM.LGK747!1DDN0(G,
M!H'!A%-T(.Y8B4G?GKJ^[[)1XE?SE-VS-,YR5R'AHWJA=KAA"4^L^R/T3)OL
M:" C]S>\OB;\](.2)P/;KU*T#42]*2M^3<EO%89Z/43O\IN?L91M8\N=,I*&
M]0S_O(_P+>)6+2WJ\=JK7I%?%Z'L6#TWIQ?,11^4&]M6):"?.@@Q=KW.82I^
MM6G=+:AW1:*U/V3+]3_V<<ZL<6#&7?)N'=X]<B=66LFI+7K'5G+'\M,M ]I4
M?=+6;A0@G5)^[0A0K=^I8UVX5FN(U'<=QMY&H3S*9P?USY]BEJ/GX7"-?@</
M\Z&C)?6>=3@W\#4!;J#]R;5_0SJ@]L;TYIH%D50F0GU!,L6BB7W0OA:ZL*T5
MWO7BC^^*6MOJR]@I>E)V+K-\RV)4(FW0[E4]^$X</]4<J&77)KJJS0-B( O
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MQ5U@?)(<F,H<T6 AIKWZ[VS#GYP*2:I8/0G&>Y5^?E_S*%.M;+&!#0SK@%P
M_[QC^3.P+?CTW\H79,)1:G$G&DE#\]\X@8-MQ"&P!%94J!:VDN &,LJ[8DFO
MD<_>0X90S-4'Q_@K;E  \G.X]+$A"G!D?]0'T5G]NQ?.NK<EM72GC,Q*T-&X
MF%7$ZVU%O2QE^^*:UIGP1UI+6CK(J1=RK/M$5[3VN\J7(J*-IP<-[QV-VG2L
M\",U- B5 NGIPQC<20AG9T3=@7J]<Q<<\AF04**JR@YS'A>+<F48'] 6IVQT
MU(??EJ1C/.0VX@]G37_)F7&%Q_7T4>]RKQ&U65VDMRKE:2V\ R='?4;9<Y3
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M=GJ4&T;#3DUMK\R?HU0^$^=PFT%5WT12\X#37V Z5*/.7)0H]#*G^C])QP'
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MT:^O,_*/8% >E.=FB,:A-_K@:G>_,?5F;PU0/-'8Y(]5#5RDU^JN70).S\&
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M=0Y\??623U0Y(;\QV\):K),0&2./1$87>W2;.'0M;[[= G*14QE#CP02+*[
MD:VQ<BM,H1TOQ7:IOK@E9 ?TX29Y6GA(TFR%2HV8D_=<P_U2VDY<85.^[<]P
MM"3NEYSE=WB4BKDZH9.35$:VG;W-!4SZ]B1!*QM^7J?-OM6T0R?D![08D+EK
M^!6_U=;]"X2WKHV2'F>[$&"P-0A)$FZWU2EM"R!2&BJI41\!* "H;N$U6IP
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ME?4,0JI4M+?51#5]%%9-'V4_P=UD9A'&UY_9[Z%9)X7?2P,IF.[G]2;$:OT
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M#<(]_NY4" 03;UPAD#3+RGHLARX>@.6A1T%^A7)RBQ\V:YT]5U>UMV"+&);
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M(\UCFQ+]ID2_T1^O38E^4Z*? 8E^I+V5G.S'Z*$+M%/"GY*$OVC^BNX41:#
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M1.8:,67PC+@KYR$VL7S]%02Y,_H6/I0?*#ND^'2CF0)2,4M6&;4=>(X.2EX
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M1]=;TBPHG*?)5V54YK=4G Y^LT)G S] .8>MME%2$"AG:)S(7L":/<J $<3
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M=-[ZBC?-:JK,_L@75QW&Z+NE09J)Y!AU<[NZG' ;6'\<\, R8<0GX4;X!2$
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M[:"#-D&!MBNW6_7]I!19F[J9<&:QEZMY(LBQ5V>D77Z)*=D=CNYPK.GA0+B
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M817%V<%_T_ IF\*8U 1TAZ-3L:ROM:^^'6AS,!.J.R?)M--]R.MG=<O4R_U
M;-@;\?T[B)3!>B#I:IXO1"EE/A1)I>@E N5TP4X^_>^*)[$J<%SB1UG67AF
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MG-.47EM@PP5^;=9X2#&CHXS!^_L.\_(J([O6[(=8_G%69*;@23NHN817:*A
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M$F(S=!>P.$H@L>M/];7 ]<C?62("KQ85]MU("/$#["C6O&BYLV3MKLR6P3F
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M>/9DF$:+G_[T[,DDG\8__1]02P,$%     @ :H&C5M! EO+O"   U4D   \
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MJ;%/]UIU^Z?6V[C6KO5N-^"4X1*>+T7X8!8=WL3<YX9TV\WV3[%K^]V/&C:
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MAL,\/ U$'L*<0-PE!M6!]!SS,&Q28\C 4"+$(B84=-1K2X.F(<>)ZRB1"Q"
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MJ FM,K/'=7B2E^9S76I.DYCJ>=&"<=)R@(4V@=C=%\%]1@2_9J(XNUN3K_^
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MT:4RF/"H4+;9,M\[?B24D;#OU+;P.E9.,:FAHM@N&G(+GX2,9_:4A32!4[J
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M&ZH=Q,!5#^*TTGF' >YQ5]:.Z(#P7MJ#?/\$A[.I,ZO2;OVNC"O%%EN8B%%
MJE#BD*H39>;<WZ.D=6$<+GD^#I\C?V/CP:>#+IQ@>8,F:CH$J(*/[ .6IL+'
MT':595HZI#?K[J9T4$<:1#W>MK&L@.^WPB874RSPHH20L[#M@3S'>16B^MU(
M.;WA^@:]'-\:/G=%0HP^(S<L"V;8:!6>5,XTBM,C[L!#9XG=1H+VE%F&$"?#
M%:;Z#4T3 +%OJDNTBJZX5W31,VO7Z5?WXWP9+@P45.,.E%H5;#MUI4KXHDNU
MT<8H$+=C; .-*A#/YN4YNBP\L#KSKA0<G:?M2?T+\<LB47![?T+!AYHYK1U'
M&X+BL',LY1G@5561CI/9R?($LTEV,<N)TVWH%7:=USK9WRM:6K<KRX(Z:_63
MXGHXAMDC5TR?:+,QEN&*MGN8G- A[T[@Y+3EAK,ZG0YLXK5+P&9VP=KEP8M&
M@52Y$;$+N\2:93 ;@&J:W8OWA$I-77VR'NRI!],]:C9>P$0+U0M&6VDG2G7@
MAYYI &6<C1Q9Y<#$P(OGG;RRO\\=&'EO=.)7D5 7D7G+VL9SQ0>*L#T;;(NT
M!HUU,A3A49(<V%M1*<_GQ+F$[D*\@A6,<I'QAWD*Q'3NXP,?6.G0P"&O02GE
M5>/2TMP@]+/GL!N*4TE<AN<$<K.G [PQD1'ODZI4_4'D 2K6]B[3"&)\WYYI
MM:?W-3%V%Z^\%>A4H-/KF_:ZF_;9:3\>5Y[9<V_;Q0'-]P&\(B!_L0#UB%>A
MA,%C<8\.7)<[B//#%1LKX J/U6[WH(8>MTQ*?)O/0-]O^>4#B:^8J4T' (>O
M*]8)?BH^VYN+]2/$_T;6QMCQ=Y@3B546JSW[>V7F)]'G#F#RPFT HK5!W6"&
M+S:]S"?3[*(C5@378@#BH4" , ;7R,=34L$F[1H3+#+T2OHE=,7L#6QPB<@_
MCFU (7&:ZC+=&G8@Q^:0\<-ZY5*:/=UUCTJC"UHFX)Y!:W@<=*!*N__*#%]D
M6YA"ZZ+\/@G]QP_3I5UIQ3:-JY0I8(&DV')4#MX9YT/2B[U:QDK7@8?K!-"\
M%G&L9MCCE?$(>S&Y2&ZUD+<<I8C'HOG<Q-A1?X03X@PZ+0F#UAF$BK<J$19J
MTKL;U$R5JIW--Y+(X(C&4W#72;\&OP[]?>"=@J@)F]U&&D_$-#_Q<$ZEV1?#
MC()-+]FCN^L/$\T_<\[>^<4TK*=@C0(E^PPJ;O'K_JB5(:;Q @8VV(@)6 PZ
MF!%\D9J9Z7-Q0A3NRY36XSTIF)BJXIF>YR=UD7#'EU8=Q)-;@M>P%&:W&>9U
MCN7$IT1%AOV@7E":\!5T02A[*R=6R-D/>;SQ%^7TA9@&U],K *8";ST> 2EY
MBL1TAS%0%FU?Y-Q;2RD0E1LM&()96-! 0AY@L^;3#'A^?Z7'^'-J-@IO/;&:
MMGQJ1ZL+R=WV"Z=GX@3:BO8%VBX0FNT+ 6760H>CA>4Q4V;A\KPZ-?$5E4 U
M)Q/PZ$_+)']PO2N3:;SXM55_53E1%?#)NUI<[A:KUJRY[B0(CZT/'K/$G.]3
M&.0+<*&L$D4O"7&$P]">OF,4;IA^#FC6N"E=K]YAE!JPA\F)^8&QJ"&T;\6;
M'873%)MDC-?M 4C&Q9W)TX+>U? U0O"N?9W"KE2.IVUWV.#C,\NM&W=;;[_-
M^L_E!>DO*TFLUTI@BN]MF>_'*!S<0/3XNBLB@T.U[Y>%K[Z!$0T!( 0Q[L=-
M#%K+?]MBH[\D_?T6(+1C&'DCZ O6^,D$7H:A3*H#V@O-K>$GVICI_39EQ1V_
M%OC?;;&QO[;XM?*%-/ZV\F?;^>M"\-]K\72_SIS_H@4E?NG[#RJ[8O6Y.(%.
MF[AD/ZQ&4,27U8@T_YJ @X5=JQJSFAQ2VU4J/@@<C0]M2(I$#Y+&B5FP <-^
MJ?TYK9B P'@R2#F#HX<[/"Y[22,)^$GS:3TY*PDMJ)O0NWV9TT45H (;<&BK
MVP4W( !NRUI+=J!SZUD6?M!;.6JT%[!1RFRQO68KU_0P.6[Z<S*5)JJ2)OZE
M^O;+*/Y[V;"6\9E 0J..G\U,,_4K,_UH4$A$>5+4E15T>IR=CQ\Z/7U+WN ;
M,&*1<W)<_KHZ^%C&@GA#(LA>;J$'#Q2_A:EH@G4BHMV=.\Q6/8O-AJ!%N:RI
M319W,B_^0\!#"(U?9-6L%5[@,W#/]N+(VZ72*O1>Y**5/PI#@XYM&"A6PZKQ
M<)3^49>O1_M$Q8(5S5:>7D%006_[D^B/(GU=0'# Z]GS[Y=Y7W[I^YUC6XY^
M2SK)@7/'--2$?:.T&6MWP!% /%#'#E1U&MQ 4 \LT'3N3^3'D;I^D4ZR+(*U
M;;$&"D2/CG13(:K=9%D/4D9'N.FS1XG;*5>C\V#\X';+GZ4VO'9/68Y2)([&
M],2;L1P?@7Y/7U:P,1$X9=$K( >N[#"<*@)IB&.V@;Q#3<58I;'Q9>H!,J[5
M]N&V"SW8-S(49H::%FTDUVW,?"XT-@FTZ Y,#;BYB6Z-5LC]47EH1G,S\ZA#
M*1EC( ZP=%"97.I7(^A-CMW\DA]3$>\.5;NQ16PIF>T0GTU=OLE<WL]=B:1\
M9+1R!(DD UYH11=>2_,B$""T'#8?O.2"@:"G#:#^ *Y8C9OG%4?A">31YKP
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MA!89Z:XZ6E'9<5Z%E>NCL>)K\J<+/CS=VX>:I?UMXB\N,Z5!&4,KY<3UI+
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MQB8.QJG;557V!Z63WA.T\OGK<@[^E:BTCKQ@!MVA(F[LH/[!-BL.%2T'08L
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MZG^%<*]=_HO4_Y@PQRZGJ.T6CV*V\]6]KZIL<!U=!NJY-);JIGO4:"@11O9
M2H1*& GU\:@T22"D""5\+D("QMG0)KN!!P/Q!"0:G(BRF?%8A%BD 2'43#3H
MD].N,A/,2AP ["(H242U346W"#T>(XQLD4#P/!Z>HPXC4I@J/I_'PT;U[ ,
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M+5':>WO,;VS4KS]$1Y@G< <;W0*0W<!B<4U4"A_&M6O%.CO;22?8B-%N=JA
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MVYJ_6#[\[#5BX-#I7]_JVV>$UQ<C^O0=T>=#51\_KSY>/73Z]/'ZM7PU:,#
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MX:*DARO7<5.G0"@77OY$7AQ[;6_MDC<%]V8Q4_S4E,3M;"XN:Y<_(65ZW>H
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MH9D/-3>[6N,[&6F^T\^UJ2] #T!U/DV19?</J2Z67X35*Y\CP_;7;[?U]S;
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MO _>S5F^_0>;S\G?\O]5R^N*#UYI#37/EYP/*XF<[_.RZ,RSFTOK*Q\KJ4[
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M=Y]SR[DQNISU,55<KE((0C)Q.>\7ZD#KL!YB=8^G8/,A4!2\!XM#GYG+6_N
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M114.>K#0[Q2F5O#NE*)Y0UH\YLZ_.1^H'^)X?MB?#3\5"-<0('S?=2RUR#K
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MY1B(<,[U\E8O[YR8B>VPK\^6B[>?+R^3'$1?GS^<9M6"(36_:LZH)ZFYQ7T
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M*Q]>4%? K3OITR98'[R6[,)I7R/'ZLT4LS2"GHH&H2@I2</;\N,,OFS!/>0
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MH6,&XW3LY^/\Y&%73NB9CXMD1YD':*20,ST]/>W@M3&,S7^&AH&ES,<G@18
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MJ,.C5:DDB/.A@K0*UZ)\33HD>IZUA@N.M;1;-OG45UZ*\4QZ#M>[\ZC $/#
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MA)JTV=@2="P(12D!K!J'X=[U'$AT3I/?UZ[  ;%CXD#FHI0Z+CGS>.V=Y['
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M)*DIM -1R=R*)87$0C%_%LA>K;-46ES<CX9-.0-B#Y\^/]V/DXA\(E,Z</
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M1QW$>(KVJ"&[+MSQ(IQ1NDV#ZUUZ-K>KQKF1)9T*W4-1Y%UZ[))C6*>VTTX
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MES*PH,E;\4KBP2F)]9*GX"=#K KOO\ES*/YJX[MO/-5B8\:]3W[1.+/D7>?
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MRY34E(YP5F;<X8PAZV\:_D#'ZK[*^?Y=]37NV1+=9;ZYL'S';?UFVL(LG2D
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M5@<E'EWY]$L[C-\?S33VX5_:6#G?&H_>,L[3K]D^EMZCO/0]:)H5^%)VR &
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MEP)W?UK/+SV?'HZ0_.NWY]DY^[L/>U57%6VN6*4#&6L2COO55+P6M0KF'\]
MKJBJM]3_SJ9_^3^6OM]/)QM_U9RT(&'W^3@-XDN(T8YC5W(-N'C07/#-PC&<
M#2&,FLA"/<?\QU=)L9$QD8<53XK7:]S5S>I#_0<NW<',@,I\F]\FWAK4#E!6
M9 V%BD^G*GW':U(*ETR_C-#]*TGH1'9ZSOL;Q>Q'<H]C^.ARM"HMHK9$1Q+$
MABU$.BMH%BMA)<S\O[HB5Q0&>#G+I#(Q]A&MIE>]7BR)&PX;A$%90H!/8];H
MLXJO1X_JDO'([$59XLL^ZQO:KK1BC@ISK@I1SA;Z+B=WK#Z,RG$9MH5?X?KX
M9V5'!O/FL_;:UTZ7DQSIJ%7$S+6D\]W@5$T(WE3?'V8\7&F+;-F?(SN*^BK&
M/%Q^T468,M!%;)6-:9:8@K/852A1(X@/2(6M$#SBC"<!L_D/6A/@'8W[5YF1
MNZ&S0I:%IRUE>"DI2ADA86E3G>,SM5N\- 6V<$D@VTE!^%[(W?"18+-+<4_3
M;&>5WVE[8,ES4B]&JZNN:VG2#,1%SO7_&!06 7X%Z8SX9*84CA<7M26-3 _#
MC#Y$_9>2JP_=@6J4U/G#"37FQ-VY:T+XU?JD8]L/)X*[YC''\]HBTQ,!L)W+
M>*XMK#RJX<8[AW^00G9SB;L]L?@PW_#)9_VL"K5P"F"S7WW]I>?./TA:S(T:
MD"50-RGZQCZA^5W;K*_'A.C(\?+AJ2RV\_V"I[?^=ZWF]1JY!-:P+XM/8CHL
M3,7:EGR73A##PZW-4->&9.GA4JR3E8C*$_,*LY^V<MX_<D$24YJ ]&#9J28U
MQO"4 ?Y^$PF]@$@F<"=<D"]-M;W/NRZC%*4#2:X71?KNFE67:].ZZ*2O$ LN
M&\$5S5M^@JXQC4-9U/H1[SU%'TT^K">&LECI7<^J=7^K7/%?LB:#YF5C3!-L
MQKK!)$V90$77O)IGJ0/O]8V$+==+V.%U$F:]WZ^([(6="-I8")=_NCJ;M&S<
MX^8T93]WE0T/"+IZF8-XO!F-&#:UF,)8<3= &KPSI'CZK=U3M*Y7&F!U^D"H
MU> 6G-)@R.OUP^+N<[G'E8I*YD\\M[R[34\8;Q6F[(MD)^O&.?H2C$=L=+(_
M%KQ(-&?#U26AVG5&'5P,L8S'8H:Q*;;)BP>4827B$[EYC-$;Q?0$J791;MN@
MNX\3[Z)UFZVXA1GO'@5X1X!D>'W-UPR+GVZY5U\+47RKF\6[Q<R<+'TK^%>>
MEN!K7G^;!TA>IP!8=$6[(.B6[L !R8>@@,+,YP*U34BYNTDS->&><3$3OD@0
MBF\ZSA^':U%)=T$PA/2V+^XM5\PU:@=2&=^%C%/0EJ[JE;>&>W^BKIO@'+4C
M+I$*L64\;W-]1!K:#(-X?) 2'FOP=!7V*>\(P"2&>,$L74@[^"=B8EG+L9,>
M!X(4G]K<J@ZB)->617IG":X0[:%6",W*&VXEK9*_: ;-HS-"QS;#O(7E0$;_
M&'1KIH3W1\%^0L6I3CL_P4+UGZM&!NP[/6=N'P1 4DZLU=(6,4:2Q6R.RG[&
M!1-Z&5"HV!\=53UZ':I]V8!2D5NSX)'J)IFKC.D,(;L=L(AK6)>!8^?!<.V8
MCR'%0A%IHG@E,?)%=H[; R$F!)2QA.J/IQ^C.(_6'V^8 -]MCT=LAZO]WE(Q
M9.FQTY+TU.6N$YEXP8+1[82Y\E<]DTZAYBAQ#W[Z*D?KA"/!XB$0^*J"^]0;
MVR!ZK-U35@N/]D$QF86X3O'HQJBO#:%*22U7BPB+3K/.9P#/'0?<[.14?LBT
M3O*2;N0W[HBLQL4@S#PRU4XQQJQSCS%B8D4Q-RB^WT7IY.+.Y[HX-6U#5Q8(
M=X)BNI:!Y)W"+@O7YW61J&3LDT[!@J#]M"7)YKG&H#NG[@-=T]A[O@1"QZE1
M_H)W\"T!'P\35'V3?8C);%T]Y6WM"'0/6C2+D^&(.PKW$3<OV)O+ %7BW5VE
M;1Y3E-5_T8"K3%B%;XF@>,9,_NSQQ-H2SVPM+:4":+<. ^#+;)$O$+3:S'BJ
M@%.JY9U>7"SI45-P12\8MH(N[/<?R<?+NUJ?&H54/6IIOB>%26',UP<:(BOP
M!P3-2M.;(H7B1*MF_.LIU?+E'V\+IX#559[$=^6_:/1GJQ)74D+C&0MFLQQQ
M.E1C)A@G<_VD5&]+S_N_1I:8X*M//*EG?WU9GU2PK7J9H%]]*F 01^LA?3+2
M,%X8>6J8:5>=^1P)2_(/O'KM ?+86, R+D_D%7_\F5.^_7 ,,;3!4O+*E)GD
MGXVH55$@X+%WC.56/A4Y_R@))K/T/P_4?C4E9Q3"F$*)7J?O1H>H/V';67X0
M=!NSY.$?63='BDOW,>@AUIK"RLTSYK4Y4B_E(Z5WA^Z7+&!ROO)YB(5=OWVY
MKV:]5XTW+O6DJ!^K ZWF3%_FRRXY782T']Y]V,8O'Y&6N."7:"4<DB!#7NT.
M3R6O,-7BY3A.FOPD11MD/3P+;2,1FM_;1%9!?MXX[NU**L;/E)^49H>+["A=
M%*5HC FI@ YP^(K#0 ZI!V#5"RG+?>MJND^;S2O]VO\Z!J;'@M>9NS"EBK%D
MZ1C3^]!<B_9WD6'"[^\KT(W]JQ(&YA!7]U5_&$S$9(@-G84^B"#G9RWE%:4N
MB0"$X*@X*R$K"+;/W8K=TG'NS)EU/2; *DK>%E]0D!)7./9ZLT)(T0CJ:KP1
MV3TYMRMSVYDCXHN/Z?T>M[)B^E #\Y+4;88X9H7";-V:2',9NB:YE\=RHZ5+
M%E6/+5P\F;JF0_)UOFD!@KXFV=;T5Z\Q7!DU5L_6>W3!@TVRFP/9%Z%Z7QSJ
MLW9J'M_]G&3"B4Y?0+GK!Y7 #=XW0R@A:C.*'2=2"'=DWKMT417HMQ+CV!66
M;U/PD@!KK(/<RV(!*.S(,&Y;Z!%NK-;B3[#BEM']Q\X%45H'##ZLSFRK._PN
MU3%H]]N1X*BMN(X,?12";^E\;HC^LURK*"F:/*=(_XNF?XH"Q;>ULJE*MT"6
M\@N)D(_N[XUI;FF.7%N-<3'V7M6.</V+[#TA]MV[(4'H:=G,O<#MKUZC;6M?
M1-@GEGL%T5BV&A1GA4[]S>Z-NV[6=VD3:L8.B(N^ T93:'VHB[=C%RM;U%?+
MS<])'HTZ4)3J P8!N=SV@*"JL>M?-)O\-TN#8L?UU=OPQ81GE\JFXJ/WXG^$
M!XVENV*F3)6$J[N"#JP]F3^8S+T>39*6?V?H\\)U]KRGVNW^GG7'PG<BT 9"
M FG1RIAWJ@AYX/\8\CD*)K.EE\F74;+P48HJT!=4M<SAG[UNESLQL%\T[[U[
M;(.$KEKD]H'!4I(<)S]P"8-JG<+&<D+X_P2 2N;:"4/J?]/\-KX\HGD1O/>+
MYL=7%^<9Z<4MX,0_]\*K5K+%E?'KG:/3+H$CRKDY[H:RW9=_3]W1V_CX<U"E
M)&1H_;INI;V_<?5G4=<;OVL,\BKF5);C2.+\S@OD [>9CZW4<%(6R[Q/PT8%
MH1$2G[GEG:]<)6)7-236]'AAL#TWJ.92+5M;:L#S8L[<T__@2:LD=4*$E+SX
M0P_,K23O;T+ZJ^2%\'BEIKP^-'6U/O:(XS L9E#L>&.4;]M<T4@K/<G\V\$P
M;7GJ6LV21>$L/YL<^+7W[%$K146F]R-*2OF]+.)!E0':P3C*1ZK*)5/GV:F;
M+S^C%-\0(HP#P"6\_LIBMZ6.HXYME>WYV S6&XRZ$%:6B!D3 .KC:4WU?73\
MG'VKY(/UO.ZU*7'<7=((K]2T86;!531X&X%U-MLV-2EE*@I-4X5SU5O]X_LB
MR2RRI+7)T;IQ_W&UA'&R4_O KB;5/A!0H>GNR)Q$\!2)=OK#!$OG:K&O2G6U
M^C(K:HPR')(25/)=*'.1'!8"E2((>$WQ)"MW<$%&W5S3S_ZGA^2G:$BK"J.K
M3JR_O8W0ENM;DP:=%+H^5XVJ6_!-]4"!*I+/L,*-AF>/'1I\1%[FV\7('IJ?
M4_4!W7P#Y7G>Z#R7$4JZX Y>:_HAZ<7X,H@7I>H<87G6IBL^M5WY6"6N$EVP
MIQ-WQD+ZKJ)U4#\V#IX3:S8MNPHT:51BA^LK1@>ZM.KR[TE2RCJ/O623"0,L
M[7DRND7L:KD/LKF,HI:K&,)S-3+0IC(<@KWE+#//ZR4!H+6YCR1.#:!7-&B/
MRKVV0G3UXT+8'5!\LLBM;'T&%H:A+")1@+*P;^-F^(W^BEZ-VX"(MD[(TW<P
MAK'"Y)6\/<:I;]HC0G@.#&$TJVY[STC)T-.2]P$8]ZI^=23#3RCT4<)'Z'*]
MS"U=N_ ,W_,%V,K8D#KVKPF@8,!:)JIKI TV896+[+HM'%9.$7M'<%DY%;AY
MZ%N\RLK\%<H&!;(S&E/,D9OKJ9G=!6WVCH1 ^NG8.DM7;1A*MO;,.Q%(.<@S
MFT/O$W9R6&*X[^E[4BS]H.)/-&TE4ITE/;<![=4*?\+%ZI+KO?WS622Y^$A#
M>NF'<?P5D FIG?7'?AR-LW1KU,]G5K6_:#)>]"EGZ(LM/?<*_OZQ?2WZBD'G
MI'9^GI]R8-0.43D5*E+T*<OHF$E)WQH--Z?TDZ&H:+<4Y0@L6TSJON[Z$_L'
M+^!=UO&#%J\IS-$6KAJ10DYPB/%S1\ <IXG(3;1=E9G:N*T36%EZ&7L,=5QX
M6@^(>90YWAFKK\AFH!.LR*'[0Q\PB[]K<;4P3V/'<??+@:7O22PMW;86*_39
M^V7?F_&F*_[-R,=I'3EQ<K'0>A:F*V3<@W8,PNLV-V_5\O<5]H_)FW,##;HS
MG9Z[/<<YHZ ^3PNPI&<,9#K0.#L9-C:6P1K,'J[_8N#K<2)(0!^GE0EO*RG,
M:BOF$*,6YB&,4 V.I3\"O&QO]K!! 6],-;DAT^4#'F2.1P>2RN##)V553NTU
MY0%M<#!.)THP'=V;>VJ!4HI1[?L^U6(:1!L5[?,>%2R!AL8F+>1/=)5FA[LV
M8;E"?TN=KG<DL,J7B-%J-DA/W(_(C]H$SA[]72O",@J,G=YF*F;>78/=2%W$
M>D^4NE%>E_LI]6U*;__591X"E'=]:V^;9#J((J0S#IKD/L^3E!;7/75/M6YW
M_\-#J.4](RU_G6PNJXS8#T.7UL&5R9G%,$*00 H/R)OHR)+SH L=8[5N9=79
M 7$VD& ]NOI%<^LKKZJAP]I4O%1D-QJN$ZUT 1@5=LJ1QK]0C\+RH^O8(Q,B
MC'O<,Z&KX>V6'3)0)$.RZHG<*9UI6'75HS)_WXTB3XE*%HKN3LKJ9N/;Y%U6
MV\:0;W$$&?<B&,<JS/M2(3G&*YDB8&IB;S#YTLB!Y!/R@92<.2VCVC75^0F+
M4)3 K^8(=2@5RMTR\<(O=:RQ50Q0WW1196N'ZPWKBFS0Q?DK1?GO,L0#LZB-
M_"1[\6E2A)%AD*(0NR+_26EMZ;EU^''#:)+^B=K+XR#QXJ%:DG3/=]'!:'6^
ML16SYH+2,D&R>N3H=%;LTAT][9YZ\:>;P(@,*8U(B%[/F:P(;7BW60H'*U).
M% 2/33;]1<.]-5)'!P_OM'OJ!]T17;U;%J86\;9BN514>X2KR2QC:2-HYK3(
MHC<WIDQ^;QT5&PI];:=RA^_#BOQ>VE:G?MRUIKJ-)1$N*6TU/L0'X!OU(<O^
M.=:?F%TSFXFV:&V9S.1CRKYO!E)RUQT6FH'+E5858'V3%P44UM2F+ZN<67.M
M3/.)C:52,7F47&+ZGJ3P#XE3V-J%G'XL/.SK4%2AV:@0VUX%S%0T-660&<0C
MPGWK/1_U]?*4(];(;IRX[%1D+P?H!:GW*:(!EU/9EZT8 U9D JM<%4)-Z#NA
MDRFSL5;W0SSR%%+C]A56;XV_25 ]^\/U:CT_/MG54-Q*(:B^YMN0W"QW!MS_
M&*N'TE<JK!UUV6'-ZJ:(-<Q"8)VUB_42"E%QP]I%48L<?+F=_,-DEJ0GNK)S
M.KE6.2N?^Q6M5@="*SH'MU]ZG4^;]F5Q1X^-J.IS"7U*VD?"O?[ KSYB';:8
M!%LHJHHE/Q)V@0EOX@U-DC5]I-4L9920Z5G16WN)CB;R\8C(28)B2]O=0CV]
M5PE)LME+#/6&B W\4@EJM>-CQ*./[=$Z: =[9R>V-XS2;08WX]YE195*G\NG
M!].YZL/UWK^JJHMMI><$LX/E>*[H/ KKC'["=&N/T;N7MS9O;*R^K_3QWWD=
MF!2WD2R[*IT]6PTG^Q.,/A<K[&F_;59Y.";65\G7F160LDQ?.[T+"[](8]32
M^=:(3[.3<P^8LU%0+1/9Z^S\"A6XJ>@AWQ?? AY9E.WR>UN3N7(MS8PL"P$0
M"5=9I:;1NIHR)@EOF52XPZ47:!Q5Z"K:*F1JM$ME^%U]&GQ<2P-#K'+,&D!&
M+Y^63"&>NY6ZEEB4 _0[\WS.F+1JZ=&AEC;/84X,K?=N7BQ"4<+]5%9.C'7?
M:J[?WW$ER^5=UXJLOG>@8S6U9=:K=[>/FXU?#1V[(%5+3ZT S*)Z2JRAS(!"
MY==AH<]2ETXG?50X1+W@&J<LS+$=ML2[;Z47$['2.D_6$>3L)^XF++ZC.!0U
M9>)N?BPF8Y]_IK(-2;<85N*0&CF;]XX$G3=&'> T*HT#7XZ$85H0)D9H[8GK
MCD51/>Q*7$N"L:.LQY_CQ;?1]FDX?7VF3M8;B!)X>9_;R^Q;.K![YP=\K (F
MOD5.%/)GTK259--2SGUR#,*OC,F Q+#RPTVSM"7!22R3N<Q:A@Q>'/KIQ7TW
M]FL?,:W$T-PVMI4_=RQ3>'6)1XC%_R>;THV&[J3=EY:&^FKR50!VC%-(.IJ'
MAW?9?<J$9P=O_[2BHL,1J5NW4I@C'+TB[#Y;%GKA^H-Y@L2]K>M8^8?%&Y3)
M(G$@\-^P[_^/PL\OE-?[Y"G5&RPB#T#) JYFM?[#^412SL?+:?V;1#/;E)$B
MKH ))I .1 LGV!-9ER"\Q!X?)'L,B,&>Q<X3CQ<AL!\RW[G\F2[U9E4U'!G2
M$Q#I9PA7!1<D()CNKU%:R1PC!'Y=GTXFH<0RW P!EL]?2)G1P>3S):8%.JUY
M86#OZ[V8(V)9B'L:F2,2?34*O5KR02>A_5@).'<X.,9RV=44:U$_^YQ]Y[%$
M3!1L?'./T=7Q'FY!VO<S>LTH:ZTF-<6G=KSR)6Y27P,UQBGHWF>9AZ @1+>
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M)IH&%V)6=ZRT09L6'60%KV<^KR4]F:Y,V(LS/@I>^(!26DG^>V.Y[N0%0Z#
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MC_YE0GGM\PAA5&$ZCKV0<R8D<Z3:(YBQ3"1"KR@U'<_WV]K$*#K+9VO3S$M
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M?;C/%MGX,$Z8$Y//Q>D[5_1"2BN;,S_KPY0>0&7KU"\=>>N?JJL"@T&V\64
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M#^ZZ_+ TY(?:006?3/>@_-2/2ALK&F!\>30\"FY"0!K(WX?26=6,!86W*:)
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M3$9<:X>\PZE#<YA.DYXD-S;!>%'EB8ZP%KB!ZXSQ*[($$9=&(U67KGY]U(9
M2*V?%AEMO6[$?YI2-N-]MVF_93PHZU41T(JD,_2/=>T^(O6[LDVS:3@RE#\K
MLNH+_QB=]AAJ6R_B^!=YMYV47U2\^T&)'&E5]-H'.7<PNC$_X.6NA)9.'365
MB/;<7#TM5T:*@O#'T"*+B:+176?:X<%F84=SI'@EK (!\(0VI;I#E\=V9.:[
M*CYR!&^%.5<J9'LM*G^&G]&TAG,U0I^<1$2S?EEXM-SS\J1AK\JV=?*=:R9I
M-=U99N*/Z7K.7[\NUS''B2Q24[%7JL_Q]P2D=J,FEGZ%H"JU>4<?/E32YMR=
M^UP1-!2Z#0[=%.P)07K[$Z5P,0-2#9IGK"_F>R=K1Y%DJ=004& '[Z=P4-:-
MPILK%: .+V,3.-L6QCA99T"8G:SB3"7H<6C! 'MM$8/>0:X2S=;B304QHR+V
M<8MI6+T:6Y%RL7B:TK4BP?+-F?.ZJZ93<E%XY^@[_Q866$/>[J%AE8@>J3RN
MS0/?A,O?#!YK:T5T&:.7* GG>RXC&A,0A8&S7SND:J?LSWF\OUBC)0#6QG.=
M%7F]&^YSZCC:/L3;C=>N93I-[7H#O/.'6.T?Z\PY<&N1;BLQ8S%,=2^=()&_
M<,M@ 759H9UTRK<D(1^V9R7VCK5Y2"Y&2W0A&)68[3!1Q4X_?6KO"(S]\5A!
M[\S;]&1#)K%Y.,SBG\6.6#,;!<,RC$CBE0?:6DM688=FR,X-N)ML!TK=Z*[_
MXI 5U^-30O#/LIEK6=H;_P:[='9:<S7:*RLE-+6#YL>*&"\4[+.,8@4*2W?4
M/&6#&:+;=@D>61OU!.Y;HUA7?U^IXM--S^HHK8O_<X.M1^;_1X,M_O\TV"JI
M40M<=6[:JX+60[V+O><'JEHJ"N.VUB/A55R"6D[A\MZ">1T&K?FS1*L,836V
M_.)4:Q@/4G8@FA&XUJCA+(OS)@MATI>%SS+KZOYN\$/N+A&Z8'VD:F8@^EFU
M;%?9CO)<GPYE%';,U-O5&["[$+62K#]Q^0*%:.?Y5IDV8K!9L:5(+/21+R9=
M+*G'K*8(=PC>BU\!V)84S=:],>F/U^CV967[D!W:S=TX-#'8/JJ?-0$9T!NA
M<GT;PW&QGZ,U%=,@DK0'\.9KF #CBH!;$Q/S423=2> 1:UNNK5!1+_D)4OEM
MW'3GOCW\H_V2YY?XS_N6_ME/_A5!>$*#V""/*$4_YZM)=M[60:0$1&J2QLA9
MUI[PPT@XV\"^OZVD;K<%]W&X+Y/9.; ?17XA4=(<4^%]T<7_+E/L\]8+@@A_
MZ2@]E'^K>XJ':=YC_&M_458@ H<-;G#3\WM(?ME$YJE1_X@O1Q68E7;P_I;Y
MUL&(.M1!1H![G31WRQ-G.SO9PV!3YL%LJ*0X#Q?D-0_(E]TI:6I8K8)OGSV!
M37%X=,]B0[O-.A<-VI!N,:D,T?#+\68G8NBU6(<S!-L#],XH/WK\\_]#J1:6
M=W.?O*C4,XOEHV$OW3-SM$A59S2G&I@!&P!EJR-7&F[6;&:EO:C CV7?E%3$
M8@AF9H#\YPI*C8K\6Y[?/!7-O#_A$'T6H[V>O+8,U&\\3H3#2])XGMB,66-Y
MO%Z/O'XP=\I&N!"QC!D2?__*!VV<L>AYJR<'P:2*-6 _1IL$ C]W]DHV%N]K
MB[C[PIZR-.5$\6[/X_->2*)61)QY,M-:OS,$-!/F9J/GHL:RX1K-\#P U%2<
M#ZC=)QU=(%A 2R@>\Q9M?J;@<6[\E'5P6T3ZP<C0KBI77<QJE"+/<"$R)Y>W
MJ_[7*B^VTI/E]-HC,7Q4"J$ _!17U?J,?2=[N$*Q<R5'R&H0\%)/%SK%;@9C
M*<[P-83..4+:?9)(]<_ZV%,L6RL1NB5\[S!EF_FN'@405X#TN$SV8[^3CB4+
MHG"U)W/Y.3H15,_D0E1+-'Y<?LDL*>F(A\6LC^]PR408BEBJOP[C[K4+%LC\
MY8)%35@!_^:3<_'^ G%W1(W:HL!7\6UU*HL"B'%Z*Z_X=+QP&V]3X742N7[)
M)W2Z8[36(&A?'56F_[G%H1D_61JSUO:S<9_5-6U=@-79#SLB4^<7V9"L*B^'
M!I\XHN\AZJR'\J(3YHTM)LSUU/+,E9(X9WOXRFQ(24-9\V]; U]FK*6;S[4.
M43HS(_VDYCU<P XX@>),3^C6L5$R--6GZ3YK7(@1-8.P$MD<_+H"9%B<4<11
MOC.I9['CY;<X 1EL"'5<W,+\>1/[?$;.\$<DZ!SM $,+T=?ZCX@=:PH)@GXV
M,_R)96&+ZY6Q+L(^SA)YY4/GHGQ"D_EG[YJYBGEP9U$0'>&Y.D(UGJ6W.ED'
M5&41OBAMUL V0QNW69<6?8;V(P.PTD>PXJA&<@F+<' N? F8"SSE@37O%ZK6
M0DH6.S=.#QYZ03K/<'KV/%(3R[",8 ;Z5%V9^I(7[R?)GO&F7?"TG9=LP#*I
M$3_CE3K3LA:W3>2\28K[TZ.U@OS@E1BV1$C?X!RB_=E-LFR;G<KW&3!UMHZ(
M(ZE/!\CS=0VDJP(H*OBTXV+7!OGG(#Q_2:03S2+2L7;QKEW?9=7)^)W4"6!X
MT]Q1X#.^2:CWY$&Z%YU(R[P_T]*7(>I ?\4_(ORQ/9EN+!I?^]U;@_TJS3I;
MI;A\'U].;SSKB#I%J!<5\;TF,D27L-CH2 VY(Y9PK-NGV5AEAF@4OAIE.';Y
M4=]P/W]"F9YUN76);L9TX.P7U]1*%GA"1\F/9$'N=X=<-GJ9P?0+ST>XC#NM
M(J3[^P5Y$YWKQWD:9]50Q0N(9*G/DYD;7TS[)9'1M!9%7HHNU=G94JX5$YO3
MX=U3IIY\U]A,'9FA'^"ERH6485RKH,%R^5')-S4K3"*F#4'0H 7&V7MMG0 J
M5J69W"IM5YL]Z?<7!PJJ4AA84@9TZ\TL.ML9=.H=-ZS[9>5JRI,+4A;2AN,E
MOL+2(LV'Q5QZH:C\F&P9OPK2@"S!,=MB_:.PD<P@)J0;_%!JYUWY3/-I<2M-
MH?:AIU^A*9)EKTPQ:!JRB&3YET:/:RMMK1M_D,MI2<SLK[<'AP@.M_EHV5K.
M)T(*Z;J%;G0*;+8Z +H$E87@0)LTP.R(Q+5)RGW*,*/U;"&'Q4DH BBKL9WA
M:)%<H29M!(L</93#I2D9\5YG0:?</!PBBY,_&G)4!4S<LLA*F,=]V3(,#2F3
M+!G%^W/8S#4\]]+"HE;)C,[ 9$'PH.D$=[^/ W0:S9)2("DI*;XA[&'-AMCL
MX6'T@O.4 8J1;))N7:;.8)?XKQ&:6U%; I-[OPRZL.?M_;M/E?<4_^2)A/ *
M_/-N)4>F ,;PGH!F_"6DI#Q_C5EK.L=U"P6^H^#Y!D;*Y+CI._?F[&OL6$FR
MRDI6$F5339QM60(5HRJSRDIL!9/ :PHE>5(DW$@.2<R;,V5M/VTHJ;+1WX!(
M;SANW'LF\M/X17<+C8O?KIOR*%D6AJ/5F5YX@P#VG[0H&R@,SCY%TJ^].4;$
M9(0+X!)9>)+"GX3O\BB4W7N](?&M#!+EC7O9;=JRM_91B3WKUR F.J(IM%UF
M*&JBF7Z\O,9D<7$+FB53-YNE/FP*M2E1MUC3][U<S.%^=0 <#7-VM@+BAU]M
MN$/KJEF-6D9?K"DX*@H.BMK(:V9\&-;RK)3EM[J6KW=8D];]<%TW3@\V;$*P
M?L\+6[+JEE0@*G7]N2B2<B.6XG+5C6@>T1#2@NG$LC]HT=.N<%!@A#K4.5U3
M9:RQ,I4$KA':1NL0;?26;J>;8XLEFD43%>J]&*KBJ_;JS7.[$JAKQ1Q=\'JZ
M$"/-Q':OP+N1MEMN%XD'F?"=FIK SB)105+U;V?[S$!8[UP*.N]U8R&<!L,8
M_LT:0:HSXHJH>S!-R'Y2P91LSE$\B5;6&.F=Q45V@7JBZQN\# HG*J#Z8^7H
M*I9+D,9IV*HR-PXP?7%JIX]!-[,-5I.?Q**LKFRE*UI28\;7WYDW+D +O/HX
MPE%Y$4R[[XQ L0H,U6"9*P$)SVDVN..2']K1LX'046,E]LQ>6W(N"88D9-F@
M?+G)1;K%.7''\(P*A1R?9-*/JAOS+?7>.@<WD*XGU-!#H3@#OU1$%3EFCEQ*
MN9+!Y$$E&\QRD&G6<MHI*Q^+5RZRRU$BR5_,M[E!SWB^O)_7PAXY'3ON.'"1
MHA6;QA(-BA@06A$A33?]&M9_$XE+(T?/=H\?G"VD%@G)F7KD!SO;>@N\*;Q=
M9X.2 8(23ARBLB.U3"Y8LVR<"X;1[6;'6! >(]TT0]-\:83A,-W8+%T\GVR\
M77(7NU!+<IP*%#[Q4@CV,0\H?:(0&Z.>+4P6$N2>74T]%MGZT)]BGLM9UI_,
M*,HZ"-,=YSPO7.AH9[[G&AEG*,PM-I$3P?O/BJ!H8KY@+/Y5$;L =%Q)!(&;
M:S*'D:=?&"=Y#)3P\! GB,:L548M>I4CV:SFLBVY+R.6-@.72\\8W!122M&U
M38L_&2R>3B+4AZL0UO@NO'#O#]-H7Y,WB3:$)F=8T97X2F]*JK8^,6*P4K;$
MQ2555%-L".9('5KAO9/_*,K0^T5*E8&+ :09#T-([' MMKX&@*EB]3L"H_.+
MTT$0O*U.EWE)<>1T=<3\R-O-I2W0XC#<9YHL&Q]O[XYYO3NOW HO;V"EH:8)
MEA"4SV MLKXX-4Q$Y*>[BPZX$D*[> # -))A_S-_WE-DW*OIYT)?AQX5Y"WF
M#&9EK!A"BCI3NZ\G;5R9.0YMRXA]'PH<6JKZX+W*?1K)?AVL[2\S6W =*A%[
M$]I?A<\XKKS>%<Y'@[-4+,">B5L<%59-@@*NZW7&7BC8X'6_S0GM=P<I4]#%
MP&2>4_M\OQ/E9R+Q=)")5Z:@06HB93!VR TJ8-B9S2Y(YH' $T0:,O<7W^\.
M.CL 9%DP5#T7SW\CYSLV#RUMIE20?^P4_+"N;"XWFE8M?R8BF66D[CG9]J(M
M*ZX8@-HNE@N12=8N\WU5H/I-8/D$)$+9]??)J.I]=]%>XM?%FZ),5/#^;HNA
M-P>:(+/_]#&-!<NBX%(_EI*'4%ZEQ!*3#Z#^^_]Z7_3_8M'5L>.-1DH(ZV1!
MX:RDO5@CW/:9TX6=U Z#>>;]MV[/ZK/2AD.;KR52KD&R]&@!N$DZ<_H11^T@
M#_.:G$EOINA#1+E#08@GRU.QZ#B5&]AQ\E9-IYT-T[QSWIJBVQA-3O. X15'
MY);A*2-/MU*R&N:;O1,7B[GSN>R;V2\Y#W1T+5^W! _-56%-1L1E8,<%@:2
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MM',0K!JN(P\FL/)*E5Q,F5^TRXS,$1S;:W2KF,1C5EY")E-+N4+:87)B.4+
M2@EE;!QY)(D>.3'3]HQ+L8IY^RZR,&<P_[),W1YQ*"+19/FI(67%.J1K3U$7
MF>SI:^K\R:4^Z:<"RYISQ7]]W54R'-";BK;WU) MEFN]GP7E0O,\&:LW:_GV
MZ))!:R S:7'@/5%$;RF63CX#*_#J<=NURM#*9R+.&&4N\T(/R[?B&E7C)J#@
M(C-BVM:,_>">OH ?GP,)H:J.VU]'/X)W0"PU-#*W%BE+/%GJDJ3U/UE];'IJ
M-!GPYZ2M-=H\6O=;0<@"+1<+G%8B8DP/".3A3DIX_#C@ERIQT\BVCY608:W=
M+N3:P'_].*=U0W2T[">"6?%?9ANH'V,!:>KJ_D '4):& E%4*UY3I!%18GF*
M:C!PB\2P)!1 $\/>]@6!/']5=.BOIWFUB.-PK^<9DZ97(!/;NR)=IWB:)C_K
MQ43$F*VQQK=>TLS0QF:G\4,[J%1W.(\-$E/*7 T*TIQ5@%%?+;HT5K-*''0M
MZ:$$J!F;#;?'+VM>:1=OPL0AOVRPAF=O(4O(3Q%YG:^>UP3K/)>V$OEGP5+A
M#:;;FC\B]IZ&V<=#+E )L6 NE#B7M79<M8CA67*V7DY\D9GM]G:T@+'<:SW7
M-].21M=Q\8M%_(C<%B5>R_+^B)L?@?Z:LG_5)@WI&-\9#.?%+CPX,R(8OIN<
M%4AQ*D.D@^D4%IQ[_',C.E%'/$)J&=Y>%XF,N(]8DO K60 A;CA_P;"@'%X%
M@2\[Q&Z29M-'(=;R=:S&-BMRH#H4'K0)+ZE2O9?4F+/8WZ1;T,;.PA<4:BWO
MM//F'%/?@'@UZ;]N#E.U&WG]YFS<B&QO*BWWDU'9QD &;TNZ!&C+80Q*%++=
M;Z[96R\OEW"_9\1U<SYH$9QI7W!>-AAS3X:]<TJD$C):G7=VT$M^ZMZ*LKQY
M$[]5N_5P7J8082F_8)2R/:51[A#X$K5\8A2KA"!D/BX(C8&AGR86+FSH_E&G
MB5VW J3,?Q)T7_MS(M44P3?$H-Q%S-JASEP8<?6"V5$]@_@'1?.N,27_>2M+
MZU%85E8OVV8R;1HDFG/_H:M9-TCW2N%#*1X/,(O=$K<<B;VC.";<4>#L[BCX
MQGWF.^XHWM]1]-U1;*9<A]]1_)MI'W;\""GRF-N,@U>S_C)I_XPQ('3J-GM5
MKKI"_J7QH-E.!ION54*][5Q4RG19GVZ\&;!AG1[N.OIM>0DPJ@:.V&=2Z;5L
M]2J*=)#9[S7:/N,3=+JHX"ZPV,]F,0CVK4UU]9&:2B*L\"B(/$$?\R[]71VD
M'J3%N>O(6#M.:_(-<#+"V##( Y.6F4U*@ZS/LL=VN:2U.K";5XQMNT$%^J@D
M&)CUEI6ZDQ4:6U841PKLG -7K[_Y6!]Z<SESY-5/5M1)58#0QDP5H/'BLCR]
M0C[OB\PYF44&AOM*0LGZEH* G;%3Z2Y0E?0$= G)SG4M3M0?<SB--Q./E/<X
M1@#@MT9N+C%[;F9ZK')O77?S,F8.EA!]],F"5?KII/SE!I8@*:+_!9_V1X+2
M5.B%Z^7A 5:C\3:9N?90?MTX#<TF/7M:LV_9D\I5Y,\HP3O;%%^8J5$Y.6C^
M7$.3/M/@3.'"\$"P>H_KW5]E_?5_'.:#0V,UHTW-,@;YCQSG$"E/O\N%R*!D
M&;^&5B.RK=W+YK&Q<^X-<%.(H"RCL0G<T]?<(N[(\I>4E?I90A@K7&.M3R9S
M+),T5MK(Z'S5Y[OFC-I7!$D]$"Y#D%HLBW?7FQ[%]J#I;1&E,E["6$[7B=>$
M#DK2Y"-]]C666+06*@3UL9*P$)"Z=HA.7AR&FDOOX*@.2U^*@ 9:JDF'?\DN
M/14@5RU/^2JZS <%\-[^GJRXNQ00[8$Y]=KKL%?T'S?]J=5?7N__'+)5L,XX
M)E6CG$K/X>CFO.I3Z%7\M2_Y09!LLID6SQLX6&V;M *PJ=;M\PYVE\V4&JV3
MN_8J$#(6:4O9?VDD1.I32S;N 6O>*Q!-.N  ?AIR6K%S ZT"JHKJ1)-.AX)C
M&^ E'ING=B:OTLU5#27*7)Q>](?*",VKESVPU0)" )'B1)W$]CE,NBM0-[#L
M6;=FP]Y.2%*![0/@5) );:#K%[^%+P-R.!3\CD+"K$?;5[3>NS8PX6?UNP\-
MA3@6[?J>;JYAU1/-8C*V@BE-:ZT?#A%-F$LRKF99D$JXMM9YDDO)1%Y<$'K<
M<MF\""KO2I8K>@!QDW)L_4QNR+%:0VQN>?G35P;>\Q**EV"MI*!X<$=Q>D>!
MI*F+I<*SEXW;&'Z\!6,KC\NR4!.+(XR&3WP=(\P,!M)E_ZR#RC-*,S10H1V\
MU*)!=&S,(3:%])=.@:,2BZEBN"RS?[4'#Z8>5>&.\M U ZB#-5DCZ9;8G#5#
M,*F=(,D.:2,B?0QT^I)I2NJ(%]D;[:Q6$/3J-![2Z$Y''/U;-F8KYVF\5?(#
MHWQR59N@,JW31Z&Z%/.<K7+/@CT1K5"6I*+V[4E;6UOKW^+[,05BO<0^RV\?
M?$TQ/'Q'/)T[$&A*$4&BV0S/U6E5M8+XX'3JM9S?+K%L4-W.;O/;Z>4ZJ\[,
MO\<Y?_%/RTGA?&RIE')VD<^B?-C:::IW@S@SQZ-!<=;;SI"C@5TVMZ5.U\)F
M_PU&:-\+;M03NSJ<0D,6K$W%/&WE -H%2N444"\LRI<P])<P!03L<"ZL>(OT
M>KP;9M]Q;VWG3K+)G)L@70],J?R0R5U?VC<Q3N.HW0/==J4JWJ]S-&H\5QR5
M07*(HI0Y,F6KHI;04,Z)U?Y@T=L@@854K>&(B/C'\V&&XR1A.Z:9GN86^9^G
M'M\N" ZX<0TUUZ-K+^0:WO?].7G1E[N5+OZ'>HY&"5^A@T=GD.WHMDJW:] &
M%S5]U< =A<'R[:UE)!=EZU+MT7/?#A;N1S?S[XZFJA73DHJ9#8H]2NCCAI.E
M@K],^LC[50.M2F*5R$[];EP@Z)L!(?TWDEQ2J;2A\P6!WSLU6A3@@:(+-IJN
M>CO>2P\UGX<TVK8C')W]\HM+\V;V^'L\93J>)[] 4"WVH:9BN2-C&R?QI2T5
MR9:>9H15L3F5!8E'"S<3M'#=/#9I7O/,=1/U ;,A9^W)PM*M,KRA?KG'<OEX
M82Y9XH;)BI$&UDR(\32&'DAK8"%\6_(C93*P\;P*1@5Q(+7."CIJ?',TV^"#
MKJ[.?9;X',+KWCWNO\Q>NRV#PF-&ZU,B>7HN^%!&)50SM!/?D3D<ZSYM1G9Q
MB5@ Q@L)-6MB0%5Y3H,$,\J^0>X)J>!H:EY@V03?F@H^!JO+9+,KT;8<)9=O
M0HB+T^?PTHR=TLRHP4I7/Z=XZN[#5MKY8=D7@X7@ZF0?:Y_T)HSK#QSE=/UD
MAJ"U5$OQP!DS"]!L/$.F^'85V^X3UK52WR_0*<LC,*T;RTX?/^C0LK9X^ 4Q
M-5Q_4WVV<SDG-ZBK&_MB,0H# .(-P(]_7/R0"1"!+?E"WERV2*=.K9_^B/!?
M57X!/_#2W(&M@],J.[2F-YN.<,2A]S\PF)BX/JX2:XW2P^%Z]3A1GV@Y$T8.
MRXQWM1O62R^#1:"$PO:8N>:03)L4/90*=QX:PRHP?&Q6ODXM&17SPYM_ F3)
MV"OTJ?W)U1O>4]MGPD//:;0?:.MN)IGK0PT*+_UBF78VRP;W)%7B?I:8$93(
M)UQP)RTK.H45A8::;_N PW*/C*NF'[&3UKO<$?TCW*\U'"36.%*7J,7J6F?[
MU59Q"Q;,1;+D1!F- [-D0BJM@./FUG*TJP4WW/#^7X'SI1>@Q17_%3MW<7YH
MG&^N8<&#3SH<*8PD$>( YX1BDA@,)O2HNED&6YH=1TA^;9/N!0XKDO/9R<Y?
MQTC$VWH836TX%G@[;$_)F,Y--4YCH(93/*4]:NZ'8L,*^X0?TLKH!X)&Z"+/
MW9)O(+PZ\.V,^0*BQ&EJU,2Q"?U>P<W^?6$#Q-5C,JOI6["(TIH*@UXF6^=A
MLZ=.[7*[S2O.U-6Y:D= 3'O/4(MGT9%Q(#+!@BF23E3BZWLN=#3N#V_6B>MQ
MP\1#KIJ.0B'3PX"^ U'SLP9(,G*=-L<&K>^*.7#4SA\U>#"L\SQ/OL:H:H,8
M,3S'"/8):;;9JFUD&0O-^)+[9G_:,F+P6$GE-\:&:<"W,MTIPT'MY'UC'0^\
MR;3(M*)46U2=19B;07G!&&IJ69%7,V5D]?]![C(67 U9]@?.W6[/><\'JSEX
M&?^X%3T1O_E W6%9_NZ&?*.7T^7%\E^E+;_Y*8@'-3+8+WD1U"XFNKW]@O#O
MEH;?C")G]H95ESIZ8,TMOG<4#=&Z@=\;"_9&*?#FV4'E@$"'#5+#AP/G72'B
M9: 2Z%F\6L9'"I&1L9>-9;@/"R+NS43+B%'&A)WHMQ(R\0*K>C7TX_X2[$GS
MIM%E,G&:#BC>UVLQ0W9)&U)+P;I4&XR3RXMA>]0*<8B,A2$QG4)T>&6@2'9%
M/5RJK,8V2LBR=QZ,:Y(%"Z=8_IW"]ZC)>;' <[R!TCSCR-%M>6S"-^KZM/V@
MFND<(T9.$UX;'*=EC[0*@;NO$M+V5BM\/SP?DOZ=##)I'H>EB#._U@;4-I0'
MTQ#AF)$)5BXWC*\)G>$=19I!WY*#MVIF :GKAT#+SN7(^$2(I*_DQ_6T*6JZ
M9K"T;J!^D*#YQNM45^.0<=KZ6SW%@&O,EN;"&D6";4?]D>K:?B"7V)7=GK#J
MQMZMA(C528AJP]YW'#+C]FSP7LSNPD]0A[C[+BO8[X["BG!]&2@A@$-G,\4W
MCW1OGH<.]5OT<#GDN.N$*Z,TJ]2[3DO1GA#V8$_D<#72-TV"/,*Z1]\>SM\>
ML<C<J[SF8W[3*:[OA< Z32>74-IO]3O25-QGZQ)#!V=E6;NB#:OLG7<YUK=.
M?Q.<MR5+:[ZJ9Y9D;\1KM1NP.'W292_U^[//J'A/;+==^$/ R6>3>\J"W)-Y
M#Q6T /B7<@6:_)>#DD+RH\:.8DTI/;.&O>A"-$@T+JX"URTIS$BH>:XDA*Q-
M[4DIKW)%[>.C]<N791H0["(+:PNOM].F,KYYEET"_&I-$TLRVGANMO-^-"-E
M.^O+CXE]];OF2=V@#+CTR:Q5O2YS8_TKO7?^,VX70=(Q694:HYPSY(7+N%:$
M:#1 P:.\79+K[\68!4KN(E=B/;K7U\/XLZ6 *P @P@NM\90?33\8REO2]VP)
M$))Z<L7QR8;EF_J]J\=\D&Y/5BU]ZP]1@S@NQ/TYT-!1^I-A+;BPO 0;^G$>
M58!3[,O$E2/3MO;IVL<I4_T?#)NF0_FUHZI<G0: 55*.6/T/MD^=;/VPWO0S
M9^Y=V,)+%E-P9T8>XQV%3*J1PS]KIIGC5-\;IWHUP9^WD7*#V3 ,=T\/C&AM
M GTT'RG:WA3/7VY"#WD=@AKN;X\<NC;XIFU4FQZB/QM3@C0?*0>I1K]0;&Y.
MF[BEQ3N4.\;^',:JB I\NG5%AII;79=_DR9&B%8\FH;(5Q7ZXN>K4AK:%'U^
MX$ ]**,B31Z2.WS1+N4-7_)W-WFSB4L;1?%AP.*@"&SDCL+RPX['K<UIR88
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M"5--I(GN3F(E,T1W)H7FM'''E4Y+O!D&!!H3]RSPV@5&U"6M"X5IT_G#$_0
MN:/0HB8%&M$)40,YZ6/\4$.M&?8%O0L1U!2GDV!:5KTYYO>><S(#6J23>$7W
MZM-?_Y)RY[R)JNB:=[3I/]>WJ]68IP:$/6B_E<>&0$SV!C-!88B>B@(S^N@=
MQR<UWH8ZQ8[)J3-O-+L_>UT2E[JX@T4%J-*M3LRTR% ]1R1MUF=CN 3RR0$&
MB&HJJ!Z*&LZB^=+'OS8)?VZ246C>MEN=8*KM6!2K%/O(T^@3EK_[S']XJ'&
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MD<;1*V<,Q' L@;"9GX[^22,Y5^-2848:7TJV;&!&F+!B8FB?[TOO'/:\1SB
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M%A;\D)/A*^KU>^^9FT685*X?&RA"KTHY4$+)4*NZ[0)R@'&ST1Y);^53B$F
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M&MOTZT@@26(,.4I\J9<SNAF.(D_<E?JK&V2]K3[T\7J5!';CVO8X]^0,XG/
M/&>)ICF@)&-92AXF_Z^M;P;W^SSUP918-/KLE(]=()Y6DTOX=7_,-0#.Y"U:
M4 F&APOE?EM.#9(-9=!@L#TS?X-VT"%%Y @++_./Z6KH0#M*GV$2;&DD>\18
M-\<FL\AD'\3_18"02SMU=,S;+"BI^2C6([37L&=/NMH[(/&HB+]&)Y:<TA9+
M"J&V 3X1*UT]XZO?D!@L4]:8G%\<72/;AH4QSZS_?'><%OD@+*I"JO%4=:")
MOY$.9&3KP[D&$LU#*"6ZG+$(AH'; <9]*/0@F+O6V^EB,+)%@ZZ+*?B*?/,\
M=%]H9"J[HB;?&*+JU[S@C?M)"$Z/XX*S3FD'/\EFG;#1X>:H/HJKHNKIWA</
M2$I+MJQDO+<_?^C*F[BWWBY#3;G][2S+NQBZ%6U$AP\ .8J\D.ZIE&R08D/[
MD&G(5*U,E)N">=1W.W:4U?85WIO&S94IIT=:>EFR#B;2G%OD?_5==_PVZY.A
M0:<+GQ5/2::>4QQO<U"*%:/.[68ES81W'.GT'S?&\_24>OIZ)>.+QOC<DX*T
M*@.W1]Q858XN,58I?4XT\%ZQ$08=\\U21BJCS@$HC1[]OXS5O<1JEDNWD?)Z
M3,8-=BQ2L^TGT1U!2M9RY<KC7W/E@VI'<3A&V03788+MCL$[ GQ4WVXY\RU5
MLIQ7V(W%PKS:HEJ6RZVA9< M6<33KC__'8)47QV_:E4HRA.['FEE-&RY\@O>
M8#H/O0G;+CYQ6I0>42L"/20@>/Q_%PWM@9.\J_RXZ)6)5[R!UXH.M%C8QH'<
M3)C_L9(K3=W$KKU4<1TYTGTCNQ$8==IOB*4T4=S0K<9R.]J\0IQZ3Z8K0'T'
M.1Y\J$JRLED\>JX%<_ GR>\H/TFO/J<0$[>1X.&O"?K9[[6:NZ>CVD@\@=42
M+=2ZDL<.DLTUY\V[W&<<X]J'5<QQ?(?S6K+V;+WJ"^)UOA+NA3#L^M.UVO)2
M),K+:9VJ6JFXS=D6AKQ>6:YR3MF:*0-]PB(;U^%1%4D<G!TMM5&>.G#Q;?SP
MEDJQ9>!I?P6#G12L3G)IG!P-H@--6=("'">,\C7TPQEC@OO&[%LF!0"WLXZ?
MAOP4QI(7CJ<4*.(&YF]J0J\WIFUSY=VI5F70P9/8Q[<.-?V._P-M1E;Z;[29
M$>@O&#O_V3G+FZ^D)^&T[R-WG02;7#EB%>?5:X=6R&/Q(C1>6N QLE*0J2P.
MJ9V+9UDCX0E[@#?MR0"^ZEU+[L35KTB6INY>YX,\_1K:J9A[E])6ZM$]M6I6
MO85&!I)7ZU5KQO->.;BXN&4)%5B8(V/JF@_U7*553Y()3 T!00KS<"281-%#
MG27;:_M6I3\""F7)S95HG"3<+JYY797LUBEWR1,=QJ(2#0P3(&5M)']U:(RY
MAS+/IA;!1"<C\K.W%@,X$P(+/6<.]%S./;]419WUN?E!&$W9O#X[)K0\6QTT
M<B=.>:Q2*)P:EZSX3<DL45B/53LT$6,&.=3M7Y;J7+(QR:@#OH!95< <$IM(
MRKV9V,J.M>O5W>?V^@\]HN#"6X<X;O1QX2P2<_NK)I^P\GN3A%<JK*R)FL1K
MZ9,:;-N4F&8"Q/VM^B-%U-_3X#3[V.&>7.BHZ9#R82A7<I%-=ZDT)MV]IH8'
MZ2R>NQ/X(Y-'8'[(OGY48Z\A7(Z)1,)BCXV6XWI_A]U_BD@R*M3H5(+JB<KA
M-93M$!!W>>)8$Y-3)3Z+_&BB;A494!]&/#YK\%P2SX.,$C? R"!5') (_3K9
M02/C8SJ-.@ T+*E'%#&>PN'XGF:PDTKH@\O+A-*^NAJ 6M.Q32-GZSX_M\+4
M8N[D9'B9Q+GPZD5C7EW TAQQXP]LK%*I7"3;+-"L>O_S"H[.Y8S')#2CTYZL
M"04,ZW5(CXVI ?'6TH+,D>5.>\1J";M#@MC//6Q_%6U].[>(71]:X=B "=R#
M-$\#D2=_6&_=&/1!C2Y'7(KCBMZ___R8CCHDQ5+54\(02YQ*F;%9]L2G(*6H
MX,!=N*O -*:PF;!S)Z,*F^R8Q,SKOHZJ5K>MLI3AUBM5M>)7]T4FV<?T"YK8
MQM3$UM$9!Z(9\HLJ/8$J0:/%GH#*G<<?.B 'GM3J4G,S+A&1BI.GU<WS(;D=
MQQ! "+NR5-Q".#_+?F<B)5!+Z!_>@YYVUY>V0J62YKX"T=*GS+KZJJIF*CA'
M@ :?9$TV<C0*Q4'#GIM!ZS>V;/^7NQL!/?9>WP;TS"O$?B(N!U3YXWC60Z \
M3#934G@#8O1R/T<U56?.^DU[D#(K>E!QN/E-%IMRP#.=]ID8CA<>+]C'711U
M8$X:@%)ZM+/<1EB[:;N* 3[=5DL.F2&K\K%(WCUF@R:S+0GWX.N903@<%?\\
M>^]-;N:)\HF&[S/C_E[W/XYFW:7XN'1SZM7!")1&.'N(D\F92:+DZ#S'2_3<
M6Z<XE0!6G,QYN/:*U>*4.R@P[)"N+T<&MMF^%3U*OZ#S+9 R"2OGDH?9!?WI
M^@ K2?7>#A1,ZMGK9&"H#*2FM ^W>=[IU6GIGODL/_&I$M>N"IN&?C!3JJO=
M*@2VY+I@G/X0=20^H9]3:&!TM,+6BDDUT 8DMRT),VRT <F(S!E?2VMD4>K$
M+WE>5&J#80H/BG@8FABR'55[Q!9>CS"HB3L;D<KZ[RKP_4VK[!BU\:0J2$_T
M4@RB^[[T(WQ:6Q79Q3?8GD5S)M7UI!)N"F$>/*R[M:0/HE(Q9Z,J(P4O7^II
MAXB>.HJ=N28N] JY$OMK0HW[/NBL[,L3UC*Y1TW<2Q;Z5V;R_S=Z&=O!N,&H
MZ:8VP]4!5*'KWM-?K7.NE@II=9N(+(^J<O:%S+""XESL<*;,^?QH<,R]GR'U
M\\W!$AXCC!OV%J 6.1(!+Q TQ@P/F7+++*W/J<H"N9JS(+2_5Q<G[-(<9K%R
M.6SD]%DY&#T07F.]H$[!UQ%A5KSQI76L8RO:&@&?[-;J<'4\1A3\*M539%K1
M[EF"WM($#__::T,]]L57C-G]=%(Z[2UG_\'86--E@OTVY&9F.U7*Y4]?8NK8
MP-S-XTS91X1(.&E<$$>3?HX:X&B52'5U48NWKD?*[Z(^ZVA%D"+#BC5 -+.$
M^W:^,336WT;"%/$:E4 ]U,B"R-3_G-@#AG_/3$!N<+ Q+<B/)=:BFD?W;*R8
MQB)\YQ&KLX>.6_D]7Q40Z7+>+UD%SJ/Z  PJ#8-*D2^SM-&Q5/&\S$\:*+0+
M<0/K(Q)L9V*HQ'ZT,7V(1U*N>9N"C.RT!)10DRE_=2X>K%T46@F1&V5KC$Q
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MQR">5%^2?L\IADW]&8H2LRO1R1)\<'UIM*:+MU2X-=A'@G',V$@L3Y=G-\_
MO#\VPERPL)M9!]C-;XVN7*.GT@>(F2Z7'<P'/PZM",,FO5LOY-* #L;^ML.V
MJ B2X$&50<;Y;9M1HWV+]XWZ#J,:%45+@ !+::U4VE$GNSN">JOSQTT%F%0?
M;09:H:_"\\Z98^E^'1[[580Y\N$D#..:U2MOXCQ[;<2UV>MYA'C>YJA)SR:9
MN/S9N[^^:EM'9%R<-;4.W%\M0'55,(A>;9C 13.>V7DT4?</R,HECKR;K\[J
M1-QZ+-\ZCG3.O%QV4'WBMCF'(XS<EM=#-_P]&;T+2U(4,GMA4,Q?<CHF.=YO
M23^QD_#.L,;WH4U';L_>YM?)49M*L+)WB?Y.)TYJ AVF/_/:;6!S\.C"U*AR
MEO !U><F]SZ-55BOX23.R4P/UF4NZ@95SF?N$Y3@<!+L@/""W];5?%NC$(C8
M+C;AYM#B4\GRV4'ND@6DP7M$&:>"KBQ^Y U@4;U"Z97\#5N/VO1G^&5>=[V6
MLM4H.6YHG7!?U@B2&6!7(@+(:KTVRR5AS)O#TW5]L?O2;Y5DO:_"0:.675M,
MXX2:]O1+'>Z9= KF&! 4^:%-$Q8Z0>NXRD#K!1:O+A-#J3WE]L^FMGM=718O
MUS0\.%5*/F[&\G!R@+,&,[G[6+R@<E2D"X;6-P8/^0@FLJ4Z<.:4?8.G4=2>
MBST%\N?."KLB_<.$6H*EYS1!W4L5E!54O&8:X\L3 VA]Y"#6L)B!UD#TY3/B
M-!J+0^-8;<>USST2<(#S2'[I!%J+@77O?U'VGF%-9FV[,(ZCC@4<0$! 8)3>
MI84.HS0I 2FA) $&(6 (H83>1Q&0+KV#E! "A$Y"1Z43BB00:J+TCO0B;<^S
MG^?=^]W'MX]]'-_ZN>Y[K?O/O:YUGNM:YWFYH=MCAU,J:J_HF+N/-3 !JLWB
M/)GR]%UR@H+5F!@,&*?%+CXI9<$FJH5).AWFVRI>F:E,O_D)5Z ^Q?"$[SU1
MCV=BIOVXRLNEYW"3?^94:ZE!2$NUQ0T$A3?<-DDU5!8WU0LP(\@1$MWN46/\
M8MQ[9[QBR[#\>J/PX@6:=TR5MP(ZYFMH)<M$%>M'5UO'2>[\B7[WK4,FUWH!
MLYLBT_Y"9I,@D]?K#LJ/EPUFX9GQ$_B@>SG^=7,]]N*7G_3&W4^@WH/ZXPS1
M\:W \9-R&N_H[*QSTX7WN8J+.&K:38>+PP;0LHQ:H_LV_ [>/E(]''N1NK1W
M*'J]5[BLM,$(#+6K!SEX_&'C#['7C=;CDS:E]>TS*Z;)\/)60V)A3,JUOV\,
M:"O[''L^[7;RI%4<W:$\,4$1$!'BN)3%1H#]/SBFJ@=NS.9/\P[K7*KIV\,>
M?# V3CG$I>($Z@$GX%%M$KGL@<]"(Y?&]'+]7UDKZ/W1N^*?D635#!)POZRM
M/+BALZ6GRC)^@V&@J$\DWT<LA?^UU>-AB+-&U'.RZI#T+,#M[Z;T^7&7V3AE
M[(ZNKRFIZ7V\;7Q;VOQ<3,W>_$'ES4;3;?6(A+^;@0Q[2O(_P8!#99W#4-'>
M:M' Y8+!.C)0<P!;77%%]]O@QD+IW.)/^]29%'#%VV#E6II0W1_H[;[W!*O\
MWXHZGH@<  <3 N3EI2UG'_"C&,LL'K,)Z4E"G5C0@EIF:SHZ[" !),0J0K_5
M3SZB28@"GA.LDZ5D]<;G.)>_V2D4\(Q_0_WUB]B2@_\MW7](-P>0+?4)" ^)
MG_>0+&!4.,.6;J;+H=JCO^A79TH8%.^+FD94&O SO4B7Z3R*S/CVML%-M$T%
M\34%BK?UW4/B5#A"3N)M9@?YL<JU/4)VYND-+&;M9W!)>I6;.%=E?XC+3-J;
MQ3/^U>] :IY,?H$Q@:4YJ(3]\]!A<+O&Z.(KRWYE:U/ 30[C/)14Q8*F4XVU
M?\9F52W?2'K:P)[*A.R@7;Z;]D"+&S!'Q=K>+=(9#$;-4:BO9[X65DB=ME^7
M_*R">5P>6P]M/B2^*5XMMU'B2^^? /%DRU)[T"X8ZQJ<*]DI4+CO-U3VTZ[%
M?I2<MO\[RQ?1AS1!5_R,W[2SR5S=$YGSF>A()64FIE1.:'+22I,$FQIQZ>_N
MUY49Q AF<'$3&!$.:#1@,,VR'?"(87$R\-9384JXLZWVX(0'55JSO<92RYVM
M*OEYGUYP(O;^<X+GWV,RUM?O4V+>O7(S*&M(0E54<RXI#>3V.R.0N2A@</=U
M'QB+&TY21Y<H*U->F^"VS2JQ%.O(O<PKT"32!(: S<,53L5Q##)35=='2P(3
MXD%M?J^)=P, NSO@!_5R8'-IJ$C]R2B.NVP<P]7H].?1]U547Q+!J.PG,R&8
MNRHKO59L>\%D#6U44Q)[IIMG^4XX[A-N<QRPSF0([OM[+,1;U 0J+6 AV#$M
M $$1K;1RM 4Y)KK?AA4&<0)!Y!^F;DT5GR=G!QU<,0DMSC1VA#/(:PYMHM]^
MZ*&JO>:&02<_ YP1P%L)!UY3-;X<& :;K)GU)? C7\XN*2V-D/:Y'($U2N&I
M;?[B0/ QVO;IU*?X)M%$]I6E1OVH-]2+H4%/L:&5LT$\)&\:?VF&!N/0QT_C
MHY^M>17I(@8<S_K#/GVG0)+EA$LWM\2EWL$_7:Y;CYOE94T\ [TA#+G3L3:O
M,GS+RX(?13DO?VN8,:D15RLC0RR\Y0VW/*'17*+,'JV9]_V=8LE^>O; P63]
MT&NL]SZ_GU[J1\T=/F9 W4_&M&A3-\UY>9RDB5N&B]N5\<["S7KJ H8QS^&D
MJN=3VOVSLQ329Z,;[U/L1U5+Q]&6 SA<P.OU<R'<\/(A?@'%^99"[]4J.).)
M;=JZ-.)X$)G^>"!:5X9U6.[/]#2TL,?NK,?[:O#Z(4=\DD0!?5'*]\>I2WCI
MLP <Q+B*$],3P@XZ><$-B_4[#YZU'U?$MTP7MC+J/A1SN/ODA9)L\_/:X80+
MA]1D/S6B)$EE758/:?;I\:0 )X71KG&]3#I+HI__DR$H1E%X24=0][=4KI4%
MX1[=>?_2]D/7\=S%3^6@ESTSW@1 N=Y&S-Q46O2N;"Z7T/[I37^5[-]GR6E,
MH2*BW?Q4&[GO8G6-7"JKG6NQ75(5$]RS#/SO$"RJ^J"Q)@W6>LOADK$_C5.+
M<TS5R+'-6EIIQD9F:%V V32)?!\[\7C(5,0K=]S?5310_LEY]?%3<M/;E+(%
M'5'D^O2[!1#K@46<J;,<6G"R%:#52@'US288I$5IH64;T6PEN3V-JWV?&E>?
MSP 27H2*S@KJAJ2^A =[_@-W+W5Z:YH-.@7#'O5[?A^3@V']F>RL.?5TI6=?
MR \+ZTM.@L;X]>TZIBKE1!5=00&6^$9HSJL3ZF..RK/(H 35D<]VH;A>^U?5
M&XV%W\('=%$RP..9]C:!@?HBEBF&/H] <=6IRSPK.:2'I^/,AWWZD,%7V?=Y
MI09G@B/$R&!JMG,:47HP+^VG?>L^HQZ?0J),8$O+Y(Q"_\KI^?CL]GJAOH%+
M;W_"#7B1]KNR9.]DO\$-I2_43AVA =Z:M$[(V/+ASAK:"W] P&C)7C8# .&%
M 5%I<,<Y.4) (.SKIOZU<?!&BZKDL)S&PQXYG\UJ427BB>ZK; %\410D8;&.
MPUG)A7[%/")JZ3%:_#:_/$9Y\"F^"M9X[Z8D8\!26FK?3 H.5T\F/YCQ ,-[
M@;R/_P.+%OXW+#HPQQD#&AM0:5[?ABVJ@_>WB']\C1&_1(9=RQ;8CA'MV2O-
MVBA*]]B0?N0_,?P88M*4:U%)*H'J)M1N( =BUQ_,0_5&LA<ES5RW<N>IYR3V
M6-2L=5]IXX JR[@ET9J[LVB,$MEE6 >94H._R;MC.:@"*"5;_+%*+AMM0'O@
MN/8R6^JFC]3QHIOF18]F\;1CP;LB;^ JE5ZWE,*SNGM5.,Z%UL)34]AXG/.^
M?#9):1S:K_2,DT5[2-S4:JUUF=Y&NGJVO.N:@]U,E7S6/=! YB!AW;,Z98D5
M2WMOZZ+JWIM49L@>P8%>KJF5\;M87NE7GWY9"7[8]GA<(5235N T'<4_10B4
MK")\YI7[*U/;2H5=JFA@5 D PRU/>M8N4WM[IN$$3JC/'W@T^K;)(YM8VM!T
M[M8>(:)3!-(KI\J#VKA ["I. "$[G!:/AQ]S4?^56K](56C?'H#<AL\!=<)T
M#:$MHGTRK54"0WLMPFR*VG:A'BD./GNI \GPP%"[)Y3ISX?!UP,<3@T5*KD,
M13C;N[/] I]V3D$ =BP/*_E2F1;EO,\FI-@P(1NX_O[^XYERA9U24SJZ7W9M
MY0/W;C9=5H.CCNHPG7\>_5=B;*BJR;;FVPIZ1S.WIDK7P\@MI^&\<2M_VSCM
M@E O[P0+K=O]5XXMBQS2 :DY;0KB?]TS]L?'_TX#71-T1"BT"Y^@$DJQT#$C
M^H7<8^UD6>5T<\#\/9*#8SJG%5KK@%[ (5CC(=<JN>7?DL',W/^2#!:U_Y^2
M09O_JV10[UH[O250[>W!NNN//_''QA]3#K+<TLKO]QH](&]I#B+V[CZJ8BEP
M5.Q"1YP[5A61'&Y$:R[669K8[R.EB4"U*'KY/C-FJ<UC_D%/84>9U$EAHK-[
MC)YTP Q.E NSAZ4ZQR7-<I_8[V3PA[N_6WE(DO$NTP=94$W;6QKF(L[?7FZ(
MM+<,2.LKIENQZKK!0H,]_]HKMH180PT">DC#7N&[D'W!X0\+E14_R\"#(ZM1
MW2T^FS-QV;K:8T^2]$UTC?EIFN9+_=0F40*7JQZ0T#-3'H3IXQK^GPS[YE?D
M?5^.AEH<K(*2RY,*]C7><%PXGCP\,X79LT=(.BXZ81:F'BB=CM=^>X=U+^J'
M =MG8O5CR5@UH>]^.1O\GYTFV?[NP=28C:4"BOC+]+"[]0=P8!%OZG)&#H:%
MXGX0("S49@(UVE2[U>>T=7:0BYAX<7MN7"D*$FWWD/7.>8R2P?U;SN-RJ%K=
MQ'$&;:-@P')/#[*AY:DU2M;F)I&15V$>XI:VOZT<1QTB$X_=7/W@ALL"\T4Y
M6.M4#(PO2:_9!D^57=6U=8)\CAXV0\[&(B?#RJ+)%F6X]B5X 2*@;XXI[+_]
M+Q#;92+.*7+[H@X<5^_0+%&/=Y9Y;KYD@^;O1JOX"YN02"\&FTMT)=3_C,C<
M@AS&,L]--NU\F@J,^8F^HAN6['YRJV3CS.CXWPX)JFL*V:[W?QK=OJ*+N3C\
M(MH62MCE^7JY_:OI[3?<_^N3FXV3D8O*=4;K:$+H<LQ];@L:S\S)C_WTCM;$
M-NF$*07;O:,K.B8!2JQB(MT=OH,KNM#7$;K'PJ0KNN]-15]S<T)+[$XW\N_(
M"9Q<3J<OS^U(/_AU)_H_QR/7A+-55B^^#GV94Z 4.Q^_8)@";!C;>2 8-HSJ
M5";NAY4_+30%-]VC:MTTRIC?+:@)9*STX<.8U:,EF$[33:"IFIYMBX.H0<V=
M1C$"6W16M+-';"Y^NK*Q!YQ7WV3,1Y2&WI3NDGI8@<R6<ZUV%8$+&K*+@$1*
M)AA*H.O)/L$\9N! XQ)&0F0#]F$<@//Z+PE,-HOU!29YO:)8CMZL! &OH!Z5
M\!>HFB0]ZC-\G7'6>U*0PNO^Q9E^%?WN5@9Q&T_/T5<K Z[->+^AG#J#@F>0
M#<O@%.RII?/XTH-C:J3VY>R!+_,8TF!4(K&M;$-",5;;&J]<DBC'>2N]@LUX
MT4HKAH>GHJ);>N/$G[_XX=ZI81^L\=V^BS@I?I3GL7*5("V'S!E 8>-)71"#
M9A=7N@ A8#535+2'411!CU1!.8W02+,D>#*^ZYW,>94="RC\9Y?.RDI+_[[#
M^(M EQF=H'WA-SC'-8M2SB J!>]&@/_TL(IR"'&W7^T>QMF-955Q'S,W5\<\
M@Z11EMB\8A?$7M3CG#\-)@OW?A2N??8'39!SHH6:LVS:^0H%O6D=VR+<:X\V
M7]PBZ0+FY_,H$1,W\W9EJ.<MUQP/<T:8XSJ[>Q>\7(U-#./X-O@-5377#E((
MU;0/XK?+R7QN5W3.X,#TN:EW+AMW!G@F@/S-%3O)#XX.ZH2J$%DCC]7* M^G
MS9J?B2@RYMMAF-*9TME];;?K:.(S@]R24XU$O!-]E$YA8ZY(%GQ351AGI '$
M<8R5*_L#/,,LX?9/=W(<T6RD9VNZ.%$X2/;;?49CK:WG&02'MDI"TT6=1$9*
MH1L*,981M]7_0EQ!];E>>JFNW62I2?X579^V9BJC;6C6KLQ1I^?9JY6:MLJ=
MC,KD,1>U[*7-H+C0D;,A <(1,M\Y4+UB:C48::&S!VB@9%U*=*1^)!AI&VRE
MN]QW]>%0]B?=K0?^V;>'U.D8FXV@%4$/RLK2Z',IZE$+OV%*-6>I:W6/-7&=
M116+*FFL"R.21WQ\R;T&;E!/ZL(@18D&B2,XLZ8V8IP7D(+"(-(#G,.!Q!U.
M'EY_;:.WZVV^]Q45F^1)ST3JT\+K3YAV/MB3"/47A/[!PQD_I;OMP37K7BZ=
M0I'9,Z]A$F5V_JS8ID3'4R#(4)/"S,G:]R,(6Q%IAUIJ*5[X/?UFP_W$_?!'
M.;Y_N?IX9&GW\/ -HLZM,;\IE%?.%KDY2KDJ0XPAXN@Z',5L892%9G#3%K6T
M2;X=4Z.H6[*%U>K'C]D,\6TL.7\M<[GUYX\7E8FK_&KP!IS?P-K!49C$$$O>
M&MX_46W<59+G"1Y;5M17$YMW>JG)P2H@]8S!0-CSD?-CQ1'\0JG)E%Y-6\%V
MC[Q4T[UO$F%-*-8CP=_64IE=I:,I:^998&\EA*2\AE*G'4Y?HGOH>5T%Y]?Z
MC9@@#A#()HO\?J;]@T04%><::%:K.C3'V4?:NIN>G8JD?91*!':B5-7QN9/5
M=AWI8S-U.?-E'T.&FQ5UDR)9Y#+)#S"Z/8KCI7:^;D&>09A;]\H9W[2]#V\N
M=<%JP^&!XB[ZS@G/QTBC)1$6BM0<;MA[OPW?\>RDDG&X4+.(Q9*($H*L P1/
M%<SXS,KKI&L#Y@]6N$?/CN6!R="E>_/3IRV!/RU$JZF 3^(S ?@O$F_L']1N
M%>MF#$Y,9GK"AZ>3#VNX(F^OW9#2XM#(7,HFMF7"9AHG#_6-(\9SI+U3ENLQ
M 4").Z6]\^>.:#XLAO%-SZ+536E6=]+:MJ$NM'6M[F%#V8/ON$=8:PX16K@D
M52 [<)J@RYVX9F@/:MUB(UL<-(?H*O\^XK0\:4V[[F2:-V&/VE-"C)6+%:/H
MWQ;.5_/K^!5[)B:12SW"F4OP!1!LYO(9+J[-T8_S&+3$(B34#U10=&G8M0XQ
M!9H"S7,Y'#*7(6]'GE*V17?"PJ%.9@NZ)@VDM"R!7*_?=[]N8+,8Z\3G7>>Y
M/1I5I:K)!A!ME,AFJ$EN1V'WFIQAB%36J[H%&0S.EBHSMZ'O1S]H]E JW__4
M(5Z8]\DZD/#M;L8_//Z.99#<4G3NP2P FML@U!\4G%H@J(<O?4_;LOX,LXH0
M&1_4PM@]E\VU9U&"GS0$>#<4U.6[FCI"Q-:>]+D0.*NI(Z\O<YSCW=T<E!()
M%W9-AOE]Z<EZT2UW [/6>R&IOL]\1<#FYC<XN%(?]$=#(QQK\\!YA(&ZV3/O
MK8HJO^KT[3GQ<TL;//Y2HCA[G*]19$&V7J']3N-FD>C(\NZ4UIE[5[_YR[3H
M=D"[F2UW1%[#%]JM4=K[\T!M3VB@F2^QA;X&'A%OE_X2=1=\S\AL?LEJ&465
MC1 LC$AJ8_'X/8/B5B#6VMB6:S>TUU]:4J0?GMC[(W?0.^JOO7O<$D=*BV!#
M\UF[.ZOEWM\G2F) MM<0853OMQV/;)#O:^[)-0EJB4LC]$!P_I*L,EH*MN)+
MKH0U[Z[\6EGCN'9N5TWYUSA>T=))*4B7P=V*YKU=]ZSV(9Q=TJS/ ZO$]:(Z
M"./"2I&V'F4>$J"!>W)%YREOO;W-Y"L%5.DY!*RAM41(PCL;KD:FP5V9=JU-
MFYZ!HPT199__P70% T;:XPHL<A:&Z3;+'S>3_93":KF">AJJ?GV^]:I'(R5S
MF'4KK&&\:9OYKPT&B+WG(F"PN,=O-GXLP\2,2(U24I;T1/!QL&2-[!D 0M/U
MK[T?%7=/%9GC+]/_[ER&K;>7#J(<&<=:9@<@VYCB0LS\*?67G;#Z_:T7JQUK
M&:-E]T)%QI54U<8&S&FI,;W]E:757# R-'ZJ,$H ?YW]"1F4LT!>DN,R*?K3
MQXO=(<(H)T%8R%0)<3^<1NWIU5O*EFX*3R[&F^:61[FWY3Y-:Y;7KM\ 'P&)
MF:S[<Z F0]4GI/K2V; ?ZMR-;5Q?)%&N;X;N?W8RZ//,2QKB[C[ WV?[UMK<
M(Q60G9(N1!-I\ FID=?+%(V>)D7=]N]NK-\UT%CH$_:N_+I_3Q-4H08*\>O]
MA!9H^2D^\?E$,R0P,[Q.T.=(6JI37*)&E]R^8D2O<K-AFQ# Z?)UJ,W&1:8H
MKKR?PS==EW^;&>7_BS*;#*47(I^9'&NAU%R6V1W5./HX,E__=UY5YMPH#JF>
M1!&#S1*C1,?,"">N>5IP:M3;RY(OIX#&XH.&AMER[R)7K-#DLC_^^HTW_@"=
MDK%Z:.-_CMC8"DPU05QF?%%K]^GN'>*'6- 3%V8X,N("1J+>K*HI;ZHQ+]S@
MUF!F^_R'JNEM4X[*?$^ IB/O8(,LIW'R@(S' E^BMU^:LESO+-'=C<6Y>]-@
M+&FR/J=DXTN2T?,YR;U-K@H?WH]M =3W+H0&0-(HD -,.EO*4%+PB:S>2D*H
M!(<,*P$!N=C3!FWU4*V8EU^=VY/L+0^9FQX]+Z]I2G:RP_H<6<BP&!Z\'ZI/
M>_RX,%C/)$?M5W!5@ QN;F1';;ASR9)HZ<NW2&U)2IXB)>G=Y@>KNEE<4^[;
M.\\6ZE*![IX$IN/!MMR,NDH6V]EN.ASR\L6VW*M+:_?(L3J,?0%_^HR63+GF
MT:RLYZS:7!M?+QMTW6?02+AS5/F-/;$T!3E#F2K\U>)^=B;C46YTF$9QF,?=
MSZ[=0RO4"K,?TT0/"Y?9:).8!A^YHC)G"$,<:$<.8YP\;*Z3,Y<:DT'\/<?:
MGA_%$)]"PM=7+ED$85UW?=+#D<Z&O\6*>I\%4A^H4/WME"[#EUD457(46YWZ
M\[K-G9A*:$MEH,7(#XJ3M^73C'Q^C;\9%#;7)*VRPIA=GFM_*^J+<J!Z:DP\
MA3+17P::FB)WFR%R)L0[E\ZX;)D13)@&ZXAV<>'*I+3FU1\R>A%^7?]UL7-Z
M0"4DX $='0.!.TF2N.)[14>Y:ZHVA;EO[-KQT_/&)?C;?)&.4SY>2CTO_\N0
M$/L"Z[\',MVH"TY=*UD5EI3FTJ"5S ((3&&"KN$_XUX1A42D9]Y+F'=5[X6Q
M%[0.>)A7BF:CGF<8YY3\;@2 +^W.:W&.R&S:F*( U9/WS,4'6'"EA <;>KJE
M PF1IJ.?G*1;,7<SP+X>#XD*/F@]8%F#YGIRBA<<\W<S8/KP1]&^RS0C>IH^
M^D>@BZ]9EGUT9R\O=,:54^<?X,_/H H8GM87<[PY"+("$X,7J\-,'C[OKS6)
MXG,JK#-H\9>!?CFR#[P6$T>L0Q76^<1$!>7= *H(?/UB7^O"S4ICI8ETAC<*
ME6P_KXR!D,R/ X*YE'7[92Z<)L3OK(E/_QH-3>I5&7]"&DPPWV&?TE369Q.7
MCK(,$41JY$!54R60,=$)X/3YWB3-!:0"9E:W=7FT[SA?J2&BYN]!Z0HWW1MW
M@_F00UKH%UNZ"N)9XM)%"(@9^(&D3-]>CO:3;4GZ##M2=@H>^O&@&9]L.FX-
M%OTFN@=X=HN.GCI%^;K3-JJ>TI'C2G:%_(7I<I&:K$W'G78;2@4G:;6*"O(1
M/Z_A-N&%BS?TQNU2"LWZUI#]]_C&-%<>?)=I_<&8XB*F=I<E)H<<.OZL7SME
M5" 9C2C2&!L<!J7.[?\VX!<+RE%Y12J>!AZ;(-E,B7*^1562TVTEY KY.KSC
M3B 7D_9[>7?:O*Q;YTOL_-S6*SE"12*L]'U+P**V,YBI>/].<"T_WU?'Y%'
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M8$:>UP6C[LBX#J9_5YY^6/Z!+ RI? Y9G&;]\5BPFD!\TI*_^.-^! 9"D%,
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M./Y5?.67ETI2A*'*;,3L<L++L15_$#YYY6?X^^]9;TK2S,G(W>P[8LT_FR-
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M+ARJU;[VJZ+CM;;VJ*$O]FE'-WR+F]\\C._EZ%O=9/;X>]U0G675U<HBI7%
M"4KD]'"3IH:[U'O&BK]>R80/P[6J-^=1]'M$V&^;M$Y5IABS'$X<EUP/^,BA
M8:W(N?CY4LZ$KT=-2KGK43VYPJ'1XD$Z1\B#F+6MZ^[N!! ^F'/V5Z4C$3:L
MPKM _0"_A"8!+C4C:VG836OC._K%1B_"+5+&#.Q2*Z*ZZZ>!FGHRCU=<?HBG
M&65](SK,-@N/RN.ZB^>_>7>7#'6D+9C;_=T0JY?+YSS!#.;8D1T%7='EY)^:
MOE:?O:8^+.$(.(9UU$KQ+(=.1E415H["\_^). U/>G)9U:>6ZJN:N-1_$*]5
MR+=<Z,>=GYW]^LWWBN[57(=L[$7+_7XG5(<[O<.E:ZU4?'\'8DY]</K<+STS
M8?/LW\7#,K_)[Y]IO+Y<#,@]&ZYPXR:IDTW.+SIJ$?1#%_4=<I+5-I_\=V9@
MZFJH;WMDO'J3#_QHZC?7]H$K.N/NRP#UZ"%$ARWNGQ H+QG.7//U^");V>*,
M<4 ])_8K8NN?8&ZVH':I'L4$:5&OWKFB"[BBX]!,?8_-_7]X'/P_6KQALNI;
M^^R3KTX> C95A>/G],1[R3J>[*6RO6&!3YYPU'17\<D2][*[ZECGJ\<ZX2)0
MW\DXH0]KO<LY*:XENU3J8&^)=]J=)5X?T7!WW5 E)7A/-E@4]&ZDUL_IH5J<
M\2L[B]N^?J;;^I$Q&M\+@,BVC?A5)5Z"]5_;^F^FORZRX*H>C7/Q$Q]<P+0_
MSE4.N$\%W*AW7-;\T.O0J^B5_C500EXAWH1!TXD'1IW+A)T:_G18 S>BX><(
M7U[T%^OQ@F/!6SHTN%R%NV5KI\\^&^E9#T+S^X&P3L=";*I%,$@Y96L$[6L/
M^= KZK)V2*0GQ^9I\JDC,,T=@:88?Z FR2DWW69@3[AZ=<\T.@6K?6C0A./4
ME6/')-5C=)8#<UO9K2=NSVU;U^=%S1AZ(!+F2Q9H2093DUSS QY?3>)6ORS)
M]B"U*JWO?YKZ(!=:'&@_S1NOWU>G.@B7I;WBW)M?.-&V Y8J>M?4ZPD44>P?
M.K246[")[RUG>U.FHU-WY;F>,S4(S-QH/ON<T(RS_&(#\JJ8GV/YEI($5O1+
MA##GP11>*%([D*OC[,+R-./RLU_5X"[BEFMEL\N<E4J)[Z!KQSJ.-)0N&P?R
M[6)%$A_"%6&S#G'6(O]**'?312TP0AI''"PF_GR^SMNX&24#NUTI;:G:-> *
M.X$DMK1.9I \_XF)(O=CPE^?RA477RKK"A7*15KFKO7VLH4PL/-GFDN%GO=+
MJ-VB?M>?+\-/ ;(ITT>JK<CZ==<WM+XXB*A8J4&%QN,D8@(OV_ :MU8);TC]
M4QB_\1-(CX8GYVL2X;O2&5_0(ZGK?9Z!3=P(A!0^^V5Z3T+JK4+]#B#4,.'O
M5,>F(!D5^L%'!XKB]Z/U]8*:3\:-C?-BD0']S6*$[NS7^'7G32\RX]B+T?HS
MXV^$.'Z6R4.J7 [AX-AX)DDS0OQI78A#SYW^)!_Y,!R;L(BL;*'J2%NF-VZ;
M>N9WGEM.P*DVFD*3]5VY^E\;P=:FXT=NX_8>P8:^#6'"!YD)KJ&LH+&L4%;K
MR0UR63SZ^Q\S(*OQ[A9<754U.OMVN9#YCJ-VNH5$TY&>ALS\B%WODQ?O#KR9
M2.NL2.RM =ZY<8X[+W,$MOKE/)1D*2DGV,H2BDEL(88U!XSS$S(-+,GV ?[(
M=P=KU5V4H[<@;_YV8#6>#;WS'#F_TMSQ(1FD8YLP^'J<Z4OZ;^B(/997Y*AW
MK@89#8VENU]W:)Q1R:K?B&XK_AV'TDTL>_4ND/BL?H0ALBJF2M,+])4"(6><
MV7(BQ(A7=!4ODT^5?$H.7F]KN:^33ECT.0Z<7<;C$I"VC"0$VV.#,>5,$YDV
MR_J_2_(C!54[8FYD-HSO_][)8(#M*?]#"Q>_3HQ98C%BY,U=%+1T,_?;/Z?Y
M]8W;%>+%,55VYG&5MP1F\UG@GX![8CB88I [J:B5-C:]E__+-E^2]?I.!EM)
MMN5!"\OJ%=WL36;_O%<[^P84!L'85Y.1$>74_LI*4.X"P$T[\L7L_^#L/9R:
MT+YP47[G'/6@8@$!J1[IO7<$CR(@)2 = @'I))#0.\A1*=(A@0 )12"A!!*D
MI$#HO4MOH4COO0OJ/;^Y[[YY,V_FS;UO_0-KS=JS]O>MM>;;.\JR] &NC*\W
MO,T##48^@J@_@S]+6GKK'4A&,'PBPV =9&%=TU!A#QUP2 T)ONQ1/9]MP#T/
M"!E;9PX \[/CR#6Y^!"$Q_L\]# !!<"$QDYP^II4UP?^EE4:XJ]M$=7?N_O4
MR,1F;L2I-.W''0L6P\Y_QL>Z1WN\>?%@4P+8S3,^,DW4(2 C8UFZUCF>HN=3
MRV%A#8^#8I8)\0!FN<9[7']H^!P&>2@H[-:_6K[E0Z]%B*TY-3O8'*+H%?1V
M"[T=NPB!SKU2D7!F?"8OTLL9DML5&*/PBR[2-OC!9892!K]-H\[AUN-AW;D>
MP\($ISUOHTF$58W-MT+2S)ME0I+Q/^%RP,0/6S&O8=5.(8'IQBZ9.[H#S[J8
M(Y(LM4C8=\M/FC=$88NM-9'+0\5<(+2!5C! W.U5=+8VM_'=^&%:?%2[O:)+
M1[D^/VS;-YVO9%.XIVAT!%=#6"Q6+/B1K>4?$,!7?%O33 57@CDYYTZZ#!#/
M<I]/=<^=/PE8U_>]MA Q";'_V$DIPC649T4D IL[<4O $:>TRI5:1P#43)E8
M=6Q(^L@O&.O]$EXX-+T&2NP[%CT[#%B_O^VJ-:JKTU.S="HWD:X!<0[J5Y"\
M 0D09(NP8,>,FQ3@W(%N$P89 VXC_1SVU-2.(X_]QQ6]1SO"]<_9V\?];>H+
MUG[^G"!^>O/MC8#.C#HR:[4G'.PVTJYEX^_R^D5F'\S\=[9/\V+BV^9K.ZUK
M8UCM*K@!O@'4T3FC&7WD\.7,)_YLST!D);\JW<P:"@%>5=1B"(8#9Q,Y8B/B
M,Q ^<<-!Z?X;[!\+3;S+#;Z*U<1HZX'AFOV5JI%O@FP[-@YX9@SQT5>I;[:&
MC!^UHEZ@>\%DA0BPTEU;10&B&'^M3<!^J8ZFPEB 4YEF42S15F32#!@)@XG>
MC^YWJ61*4-@U4MA SQBDAX@";,*/]@[$_@*V.;02//2$&%,'M7)^TY-]VNV1
M!EZM%%"9=5[Q@3MWB,@L:;S4E8G,=D'!OX6P$=/2D&- M^WE3?>:$ 3FRL?"
MB :=W)*_]6>-?7&M35_%W\U>8"AI_^EK.P5BS2O"3>WF[]%J_+4I%HJ&=V[A
MS-=J767U]SFS9:^.@&-+O^AN\B\HO*]7XYR/3AW:2DI;D3_B[ZZ(M,J]MW-!
M< X)3:6TWFOC[A'E\*URQ#W+M=).[Q8ZSN2K[TV+\I?C#H0[5HEY?,GL;DB;
M[]\\=.6FU[P6!?X;9-7LUSLH>R3O?7Y@F-NDOAV3W>]CIX4F(1;?_Y;BRMM=
M5^[8/.K-XH@9RW;XRCP:)O/'V4*W6WW^IU6/!@U*#/,H0MLDL3EM)=-0AT\
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MR7.AJMV.!H:)PQ!4<5+?X^$-A3<9+"W,QT@:P-;5I$#71XYZ<\3;009;R6#
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M-W;:96TWIK$QG%_9/G:\*'VFQL\F4 /E&S4T2#ME YQ0;5@X'CKH8$-P.I,
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MU\;_S\< _G?L=_5=FCOJG,HY89Z[>VP@+L\A4E&2&N[,R!7%S.5O]LHY'SM
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M($H.!UL!->LF4SU?\FZ(\ I<SON_YL5^^JHX>2,F:-; VGYQB80I#*A.,,\
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MOLX2-P>S&LK?DFTI=)$3B#):33T42^I]GXW, O1DSN JK"N$C08D51#.8P?
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MC4&^^>OLGTQXUY=E95$2O;V]-D',XT.\#3)^EZ/<KX)2\E\EQ?#I9HAHQ&I
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MH0),BX% X&NF5M\IJ-H?=/(_Z&Q]BC1/X3GMXS8TWK\=-U03AKN0UDVE0P#
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M?8GTLMJ]B!3EA9HO+.!.FPT"OKIA=S%5?[]_YJ2U-+4P>:>KH9(SE/GY5X'
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M=)77:[@0-HOO(%?FE:N@[0BGU!F0CF#P]=SH>:U2EY[WFSI&)85//5+;M&#
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M9;TFY)N#4U> 'U[/+YDC/CV[_X+A3VP2(>L2+*EW_,<0 M/[&6HVHF#:'.B
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MYFT8?S@]9\V0QVFDUN1D\*$3-!*RHR^!9*/S\>IKVY(%YG0W^FO<$,BY0,_
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MWX)5MB.UUS67(21(:P0M7KS],[*&BX[U/1L7U.(D:THF?1SJJFQGLWHK5F#
M](XNG1]N(INR_TRNF*A>A_UT8W>Z07LA6"*$K3/\=@+_1.*@)A,QR@-JC(^9
MCC4PR>CQ(!?G%=!,ZFKGUZ1GYO40CGKLQ._V#99:UG!-Z)6:^Z(*II4,;DZ)
M#^#3H#\:\[8D01[K)MUG'\#57B_*P]4^36M7'0E8S7F=FCQI"13,& *CPD6<
M2DZ_6S/TSJLD.LG@2E&-KM:N^M?$IQX+&D2T+))%&J):3;1>!TO$FT_6#6@]
MERA!CL;8.@IT"2T]\L-AN<>;QS_X:6M$HBF?2,3E!RL35]W=+LW2Y"\K?#6/
MYG5E_[,7,7+J A-ROOS#)N^Y*]V"+!(QBKUU:8_I==#H:7+^F2ZX%+8%J%$G
M%W'.YZT(JEG0+XV4AN:R7W3(4M7K&V2]RXGE:#G/\,M"_&D)XE-D2YUY>>GQ
M\LD>]WP)<W<F\N*[J%"-+$O36X4BH_-A!1J&@F<7@5> Y8*3WLG&C].;3.-9
MQ,.D<5N-9\;+ETGM@=! ,;7,C<#)EN/%DU@N\^5G"(XT/?(7!Y7Q)0GQY?]L
M&6OYJV7L]4!=I*498NGX"F!'0GA.@B[6PZ.?'\5=(A')V"/UICKF?R:8!,II
MQ&);?=.Z,2YZV>L98XE7TYLWB"[BY19G.>$*X&C9U&MR[D./SY$DJW@6' 78
M'*7$A5/^ZZ\7Q]%_9U=F&E$9W_0W$;Z^-TJ3]KIO\B@E9SR!BL/B""]:W'Q+
M'G-Q5ON@V9%8L$[@PK3CYDD'&Y!^AXV8UI_8(]%9(<7H@$7>:7/II@3Q-8_(
ML7,];>\0(I3."<I T+WX0=V2LE]ADE."TD,\&#["S$:E[T'=_03(.Z170EW;
M^S%M%CQ]2H*B3#CO1A)SCDOHB7K@V*-:5W^)9*[)+,'KGO2@Q#WESQ/^<U/
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M"WZI;^Y_2?WI3L<??^,C8[="$9O<XQU$,Z-SXE(S7^,58-7);DJ%W$D_2;S
MAY*73RIE*3M2U;\[))*O "R3BU< /8%6A)C1G[WPX\WS^Z<]"E.*';8_W<#%
M_&>%P1Y5[;+V0>G/GZJ=\@G"8*=Y+T:KUE6&92<T9AN84VT;2CMAJY,^T)GV
M'"@2RL3M46[D^FH-I NU03)?FQ'V65RQV',R7<]BE?++^KB"WUPQ'6*+(V5,
MC%'^QMN3_V&'AW/Z'6>7T6FKKYM%N#."L6^$4C5_A)*N=5FY7/.Y4V==ZZ9S
MA9\W)QRE'E](4\%G H&P?TF+)Z:X#E=)(6R]DTT[N4(USWH,%E*W@#Q<LQX+
MUN$!&WWT&7@"PD"6AVLRW&-7O%NQ<5A\:=[).&I@TCM/-\Y/0]2W)%PUYHE'
M**K"A\+4S.JEAL@Z[X+Y7-S22RWZO8=)O?$@32KI1+>D5Q+=VXMC/.":<=,N
MQ_ =(-<,FX^9^.)I<"EDY/8J>2S'_/VD;($%YR:6\9V][= ^:L@M7OJA'-\-
M-\E!/\GYEO)PBQ3;A\Y6$ _>!"*O37M<C&HOX\?Y@>&DJ!JGH"0>"@C-4GT:
M7ZLM?5M][KRR@:#3!$2/C0XC,]1%1&<P AESF2,P[[_V,\E(-3."Z\;SH-/P
M3&I4SM)</PL6TU27>I% 6(Q?#W>DY^7HRK*SXR%6+74:/:#*2N YQ%7-F.CF
M/LG#_@8)@I%TL0]C38#VJ@,&@AJ;7::X=5?UFA.2AU/Y&*$*.C094OM<'>>$
MQ89%2NVR* \R^6F_I:D<GV!=X.AXW4Q@MVM3#*8/N,;0C^%LB DUD;>["*/.
M:--$63+?4F$.ZC*7#N85T!Q/)?"R\UT;;D7ZWX]%LK&T14(Y JYI Z&B0L-S
MYK.TDPF!11'FQY_/C6C^,:C>[+#_Z$YK)-IQKZ])PN]4:]+\Q[W4BPKK>5W/
MDK/,^_M5YX9Q%RWG^5P-SK,I>0'R3>/2A0BW"QZR1I!H0_H5(%_@TG-Y_M'D
MP45EDRASB**B)?,F7.A("7C.\4C=A?ESUI3"NYA2YG7/)FGF=J6S?W\VB):!
MWS^K^H^^6D(+W-E\XZ[*@4+]N[&=EFVE@!3A#&,JMCK2AMQXY#V1?3XN!@\,
MG1X?#,K&)O3%6O[I8*R+KX[8@@TW$"08JU%TK-$ZP<71?*8I(VVNYN<[[V96
MK=WR>[<)%,9?'@F!QV<;2TJP/S>.F6S=7^E,[@'#.,]U158E"?7O%42F,0CW
MXRPU\TOCWY',R\8H/;[%5RHN(_J%DT=;1GU[G]K.P4>I[N3$$8;MMO-;YOJ%
MT"B/7(8/B:MPY'S-HWRW(%-P3F?A1HJ.9FO: __;H[K6ZCUEJ5W9)Y40<6%>
MT8\>2!X,4F65GU/H?E3+*[K@V,PG"SKA)B;K.I"A[P2!3RUFW^8X0EJY&,O=
M'3?0\Z-9=Z34[ =MNZ+O/?9:[$DD:^6T10Q%=\5Q'%,-/9@O']1?[Z]?Z^)^
MJ3J,I'] ]\ 4\W"1,UY[L%LX LGQ*']AD@I"FE/>WCJV)*)[RS<;C-:B[**X
MM#WP-\O[A*I-A;D4^ZJ+&?5-(W6G-)1=OS2VY:E0?7 !?=SW=%EJ 0OF,RP(
M_1+K3!EQ=,GY".RZAO/[Q+NIW]:A+BN3&7V'Z.)AK"LJC59WXZFR]%I^4N$I
M@--1DY/1F9L9RN:,L]TY0+K[S(_3Y*1I3RR%S!0HY1OU1:YN/B\3-A99&I5_
M7D32:NMDM3D"8=-L6*^;;*;9L<:(5;^T5'?]717F:LS%1LZNQ[K=]13E[16$
M66Y.IV$AO"2-*-YX=!M?ATJ+.CUJN4M@ULFH8^9+KL4W9:B#^JKVSFCD&,3$
MFKD]CO-A\CY+9R [+AK#R5_8AVM-'C1T$:Q@E=WDN5=)%OP2'YS7!=1Z$+-+
M?10?%Q'KX@ABB8G/Y>"NR<OX:8MY):(,P,N@E!STO<'H&^8#9V6?IJ*KG$C9
MW9ZRJ<! U2WI!)V)(JE)5,NZSIB 59F5"6[[.1P$UI'&X/*_=VMEXU6Z=J1M
MK>P>O'^/'67AXD8]& \WIQ>D1*%X[ >R'27:5Y8>E7K^ZM(&[-//S\D[Q( &
M&FEQA[OQEQ/(?!8?7$- W= 2R>Y7W"A*M[J9WC$6)O[1T,Z@<C=_7"PECZ0D
MVAOKS7SONJ29'L7H7KUXO<KZ@Q:2-GGQ!F:^J'2?YZ51%*O^%8!SFX ^&BKX
MV-BOLN'EFAF.:M+[3L5O!X&55ISP9X^F@(]O@!U!A<H'"94M?$JY#C8@2&Q0
M801!4:G59]J''>7LR>DEIBQ5W'BH4\:"JT1$QLX.CHW,GQ28L>-BWX#B;CIY
MY:B%LJS$SG7"U!48U+P>]NQ.0ZW!L"73%TB@"!O'@YAHL#)(2SN\%%)L&Q-O
M<UM*71LX@.:,_+IR,>$.*]B^]>JP?7A*SHJ^V\ @+5_6]//N&V* ]8:*0'RK
MF;$-KZDI!VF(#=NM*:CHV1,6\"!H2@VU+,W)]LL=]\%@B^-=!ZU%AVA<;XU2
ME)$GU)%:$JQ'3)KJ>15(&?CK#R;Y,\ZMN@W+:(.W@AU=T4J59Z9J.Y'\R8DN
M_&)-W 5Q*@B8'B=OAN+);Z8)>C&-+>&.Y9:X[1M/PZ!##1E6H^;U5-_FG@MI
MWH)'%97$0/-.,L.4HX/SG-2WFL%T<?B::KRVSD +@]@I]?C.0R_&D^&@\8-;
M]O)]1=M8YN&RFSSG"G\(FZ2)-U3X",8_-%_033348-+5R,8@]<L(#8%M(<-Y
M#S"Z>R=93S_CZ.QK(Y[Y-? +0!'44M\$F>*'\\C#(*'M&(&)B<=E2PTV!0/$
M#QZ7[HG=)I%-O]0Q2Y'=,/0W-?,8U=HW[YA$4!X?6NGD"+.T"5]CK2_8T<_2
M!UNE@H&8X'#B#X("',DI4,7UC;UJ\0U>J-L./G*^M):#JY,-&,ZP'7.#*GG-
M]:+/K;(%PP4_E Z1DMQ>:9D])"W,\PW5F'>K.#=Y7G"3_;\P"OUGU_:='@6H
MQ15 P7DWQNU^.LM%%CR Y#YVC'XM9F<[O:9W&I[U9MQXFGQO>;IE-T;YEQ6V
MU[1[IU57@"[;M<85!N>CVEA*OO&"=9PF07,WI@K+>$@QG7D%L/F=,.1Q44!.
MNP(,-UT^.4C7P-ZZX JZ K1=GLU233613J)7$%Z_0AIA4XM%C'FCD?G3XVVA
MGO@C3)J&!<@G)!-O"5/W%"\4_RX](K&^QT/*+DI.WMS_I"/4[1T;7ST713\>
MI>>65Y%.4B<15_)/"B>^3 =6ZFUQ-(<]GY_/Y:-S/6U:9Q/ '>L Q? $O8O=
M[ 8YDDK7@94G%G)JH"+@JXF#?VVRW!.]AS=0+WI=G#MF<T*(B'V1SY'0O Y:
M?>^BJ*TE/F>7\*.?HY;.SH>0[JG^N,[5U(U23X/NYCJ]H%A)Y4EA"<K@?J,T
MK/>YQ=A<6LL4J.P=D%=\HAB(EI=3I*-\_XJP0:II<9OT)AW->4DZ)@RL"D;;
M"[*Q#DK8I1L0O2E>NX58-W,>;#,G420\+<T,9T_C^F'IDI".^_TT3K?%Y>.1
M7;VA$UZDQ>994)E5!75^+T,I2\%\W4J!"V97%VG*X.9]-_9(\H;?LUIQ1PH'
M@2*@1-YH=5%!K6YF8JSZ:"HG.^?O_P\:E?ZW_&WY!:*0CCD/W<S:0B4%%(I)
M%-@@RN9^'CIS^U/\X1DRND^AC6=#T@+UMY37&Q"FSM^A$:6T.0&EJSO?Y?,1
MA?.7$.9(4<<M@PVOTU7_!UQ.CH,F.J1E 82@K!TYWJ8)MDE)))IOG)LOYY[D
M5T^7C6X$PLUO0X0QOW'_4RNS(V/G]L[Y^SC^-CB_RT8:0TU90\=VT6+#KZ.I
M2\4Z.B5.Z_D=QLZM:3>-?W,I^-TZ3X#=6L84 [\H,FJ@X=,)5Y?G*<C.QZ7*
MCN-=VSJG*B?@;2/B*#$(WBE+"@S>(SPW2W7&@C;X"P@%B"=-O3OIMN&\S:+C
M1:\_/3Q8.O-P%+RM7SPNDZY68R'Y_'K<VR[AW&K_<?=+&!$MV,>%@A\NY"#U
MZ('M;SV*B:DHZ-=)AGFG'Z>!I[-"D!4W0ZF^>%>P Y7N+&3$NW#@O5NDUFGM
M=_Y%NQ$&CA+Z@#3_@IB"1[$>@>]#NELG L%NLK=8A^]:IC:*F"Y(%!+4'1Y(
M %D_5B[&5DKY<T$'W[=H/K#]?6]QH)9C^G5<P)GDI("0I203<(X-UNU[9(EF
MG_;!=7S+]OJM?PJKVFY<)^?'. "3_"H\B=O4!'CP-5?3:9Z&\"ZJ62Q/.;(0
M"O[XH-W^PKU@06!!+'E3R6+YX2IR%>1J7%D:ZLF_2&<7W6:2R"=5NX?NAVR]
MD%C!\4$PN2^_OQ'UO]RR@KW9V=$767$(\H:6.,1#Q M1MU<'5WHO!JX M?!P
M^=(&9&I+"8,.GG_=S1L(T4R3R!1,,89R**LN1N8^'$N.5+Q0;A5D!Y=UF$=W
MZ<7!D2E+\ZC<^! 3#4GO/=0V862#]M[1O2D=US"N&K34@!ZP$ CU.)5CD.J9
MR!*9G,#GMIIB/B9:W$"BDACJBO.6<,QW.*A= \3EZ60Q@^N43\?D 9-F!B&]
MY:$>-'?GZDSU8$J?1S$\J1.?WD\UF=$G&3O?2.FO2<@;)I7*K0MFMYNZ8!0K
M&UJG)M)H*VH#N6Y1K(KOH<6&1E,][8=R=O)&&-3ZK"3+GG;\\'8R35?<:+RC
M!(6D.LQ!CQM_Q9]L)K92U\FNWRUAGJA*DX%L)$4.##04+):I/QA2V7FEOZV.
M5WX$2_Q#X^@%1AB\P:;Y]'0ZNW*KQ;LAYA$QDX[D*Y%&6L&L(FE'B[5+S-^&
M&M?&\K>[X>'D[M5=RR(L1 #!$(\*7/]8T?[.?<'=#I8$W)6G&9BDF(1+OK.H
M0(H;W9[0!/,7="=9R:@C&QHPZ9M>GJ;!J(:\#FNYN8C/"4*?!QEM*&LBK9*/
M$ U&:!'O<T^V6W**4TD8%X$[8>RE ^P)=%%E0-'F;4^E]RT=E"%5'R.3!2AL
MF8[1B\;.8&L!]V#':.7,IN)I;<^B7'+P(,JU1S1^>DE]Z4%Y:@,7%EVM5-^;
MTR?.))&S3$MCI$@NR,&17L=083\7])) !#D[8TS2MKYQ57"?T&R9S0Y6=6,3
M'U;L5(Q[(84T]?#]V.<1U2D\D'!.F3:Z.YA@[*[E[P%R'3Q< 6LDVDY%,Y'<
MC9T.+^1&^=>!DN8I6XC'.=APJ,_->RFF4-2-Q3J[$1#F:_'2FBV;51\^$B0U
ML1E^#X54]2:!--,@3I))'%,;FZ;?++9G-A=%8G/@<VF@2!X,'&R6RO6UV'3A
M%+VU^.E1F%$KF/G10,]<=9HNG(?@50+Z_CE@\*#M0->932,NWW<?2QA=J'Z[
MX2_^PN8:W6"W21Q-@YK!;,[\$_P[=&<,E8I5I[:)S:#OX_@=+J)[;"SWE%8M
MXVS,7-V4:=BWYGE=:/=\1-+#.$S!K DEO;_G ?S(QJIDGM^2"XZ!/$WUAY8D
MF(P_>=_PR&DS1KS6_[VMGSKNE%%)=R)BU[?48N(7F;V/MQZ>QZG/)]+V6G#Q
MB*K6L_0"Q?:5_<=HWC)RGGN]6]2*>F*HEZ$%DX8=*/3]="24GND>L\,2J(J^
M[T"HOC*+EC?-8Z!L7B<Z]&-%/JG.2>;945;>@:]PSC@]7N8N;Y1Z\#M6N !2
M?_1HC+;_2!TY,EG:X"ZY3"2\C55&WX;5I+U29Z&4".(RLDT+;4AI%S'<"&2[
MP;<'M$]HC87$@D:#&DF#:N5^Q,\SSW:;9YWFV&S%<_+,L ;(B2*J2192V$K'
M1'\20QF6P#+1F+X%ENB<,S?1Z+::2:@S^*Q1CI.NC;Q85(<C;8]B1&3M^W!Y
MZ3=SVSVU]J-R$[&/=7L\70GKW75R3VP0%%Y\V)NQ421<K.XG==)[HNGHI!BK
M?(8M_4T+^NEFHZ:[S>HR==P-O"BD--2A+K'!]L7*X62T4N+WK*%(R_[J:$]Z
M]/+N)T?]4O1,RQ X0_1+IX".A>Y%(X6.J([+[2V94KA%>9+ HP"U.G()E =B
MY$*+[XES#G1'SY0?[WCNI71I28I+TBC'CV,YRC3;?.U+FL,CLL0F)ZIR6T%]
MK(8G[5'F-'GCN2X:CN:^U>R2[J;"DS2R[4-YT*CZS7V/6OGKLF)F ^K!$=
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M!GK&V&'I8&6W=,>Z3[U.3(F4]0 -P7M#ZQI GKM!J_J3HU-Z\!DI2+C1J1K
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M;T@UI59!IXBYL":.UC+(\98 ]_:$RD^<HJ^T!'AI9ZDKJI'\Z9EU<((7"9(
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M[>.JVVVN WH<;Q',4LSO&3/&N2-JNL4CGI9QN#AP87!!Z/@RPD]_@0>N7+5
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M&/G]7:O/:@7KN&9(^/OX^Q(_J,\&&F ]E:?Y!L6%KZ.5U(Z$^%M3N#N,"?%
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M2'OF=Z=L]@;DO<B#R/['Q)MW9UXPPE^.+$@8L2L5YW2YAG])MBHK>AMYG?>
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M&@@B+^[7FZO-XD3=L6^)%&[C!*&WOCNA^D..UKF- Q4,4Z.)0ODFU> 0QYA
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M#'\)* ?-N9>&[C"F>$29D'&3%X-$N&0BDN=,)>*E^I?S0<IQX!.V'4TZ9I+
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M<!49/&=]4Z7RM 1#5F$\+*BEOAC.MK%/"="B:50"$>>!8JSD2NTNFCT\68>
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MSR+Y<Z'73$MF%#Z$"9D/\O%3_B/;PO(_X__WS,\&X9SU\\HR;&[#,#9E^8*
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M(\E47>NN\6IL5<CU<"[4+,;&G=_&.BTR]EO((?RBTHGSZ@YEQ]50((QQ+.
M)2C89%8YYM10^;#YUI"[^3+U2CYV>%6FA8/SL#!>S[]V1>L>I\+/[AXGA.HU
M:?: [YF-Y9&>Q[X1<=[O.)3U;>+;@!3[&G?#:.[O.JKOFZVG["MWC:#)66%K
M!"G69)ISX31'@ +5W9 M9@,^2<]QY2<1$]^VS+P!S'\]L.]^*R@PJC(;-L-#
MRXYB DVVN>_<] (MJQB'ZOJ$-+_&4CIPNBH[B>N>2E$DVUCMR-4-5&ZSK[1R
MRZ!K7]=1&*+S"YBMJ6HS$ H<1G$7JEWSKS 3"NYO4XE#QG*9F.2L\E.)8F.3
M'S(P;%-0X &_,."<'8\RC4;'SN]_ULW>X['Q9%9.M^W>MAY(R<I"Q>D6FU_[
MN/\.7K##_Z:3#OO#0=?R<%9H3,$8%:K,@-S\U6 S!N+U']";Y=A;;*D30-X@
M;VO4#IJ\JWP=,^T"3XSM#YQIZ%,S# @FDMPCE^K2>.O2J*QB8ZN2=@ %$]^<
MLN1<V'A>IY+"+(?LQY+6&9)4U%BB0-["'LJ.L?[<LDT=NR4+<6&']SC<H$!O
ME]3B20FQV1?F9<*WW$RESDU&M1U@N$7#1(98BSL%&F+4D^<OU+O);;=7\=5H
M;-QJ()&2LY!%#2R+7] E>:2MSO'"MM56S(PCWPS/7]2%(*V.[IO;/AY;D.CA
MG2?/VJ?:BNT9YYM-JR]XJ7XFOLL7!O'?[X"WY]/RB*N'[57W.!;M3NEF&\_X
M*9X3;E?]NN&L[?8S-27\1'S%/> L?;IBD4G=R%PLUI+9"SUW0-A*$L_+GPXW
M;OOJ2H"Z/2VX)NME8]:3R9W>K^AJK/!"EOF)79O,G*@]AFHQ(1 \H-%<5?#L
ME@.3J=!-L6X@!KWY<UXL&U68O-T[_/MT]U\_!F!=([G^E?3I$*NF[#A^"J3@
MK(0/[)-0;RXDR<SQ*YBWQQ2&%R]:8M)N$=>''OW%QZ[5:Z !GK>17+XS9<]<
M"6R8L%'J;=+DV,"U'=YU;?85WL_=O[9/Q"@-(>JN/Y,]S"O;YI: G_\22).T
M@:NM3!FTR4<..E%10!&R2Q9N5)4E5KRDQ>L-$*:"C4/A1N/,O=+8F7C#YLS%
MU?!KH@#H[O<)EK+=A,WFN\']J,5MKMKH=5R-'F_"RR=_C211>/.E@>_QA=H6
MJ;+-/_"Q)P'#<5)K Z37"9JW]1NR+F[.U\0'EW!_]P]35$O7ZG0IT2N#T3E2
M]'_^S47_>Z RJ29$!:OZ7VS=+%A_YFA;W(K0N*,[KQO<W_.;K;F5VE_59_W
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MJ[U'6^?$\[KB^9')2/0;-H3,_;]/_PX"3^O_X>R'QXK=/?<]0Q-D5S%-Y^F
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MWR(J0VOVK;ES8&[?5C&'/)@#FL.LDT0K(WVV\,(4I2[3P2*24/3TX+)4J3B
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M0[^3-A$&;^+O,>_S8"[NGP]<:<&6>[VE_RBHQG)Q.&IY3QNU&RDN<@]RYQN
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M#"Z;<C2F^=(4UO$L>])TN^Y1K]N^5!_+^E_1OZIH"4)>(_G9#X1RB&#Y+4*
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M\2)=R%3I$2/:)<7>O1IUVY3M=^D24*/^Y4*?]NK989FAPC0[CYK%$ >XC@Y
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MO2BD--=3Z;%H6&_O*,Q%@+M6D$@<M<,7^KE-UT:\/= TI\@:Q_!HUJ0! 2(
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M_4RP N2Y?X?0UYF0N/W56?,C[5]5!OM <4--BJN++:XDCNZ'42$62Z@30_M
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MNY*HU;P:8H"+H$8\I\JYM,6Q%U$5%*CK=^2S0<@[&=Q=5FNG_[J>G4,7G$N
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M)31G7)(+ND=T41NA7$:K\<RAF9QO>8=P=TN_'&72E 3;B\T.C^/18JJ)1X9
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M%[H;)]@P^JDBN;?&G6*JA"TE8N9@@N* 3T;LYNXK9D2_JP.\/UJS0 /M%3D
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M'_ D@;OB9^1M*7SY1]LPM8&C\AQVOKC+,SWFN9MD%U\U,%&S.%1W4, W_6T
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MD%"^2+^F?L"3B"A\P$/>F,JA8LZ#:*]P7PM,]ET0/A7%Y[#4;&80_UFF;?)
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M?NGW@K:3X?)XN:GP['NNS(Y"#H[4!?GE?..CX\:F8F22Y%=V&,N/BK9,-8Z
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M2FDGCV.8ZE.A:L9;_'S/59*B<\UTQ.O/6EUSDAQFNIU-!#Y(]@BAFEB+@0)
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M94@._/V?><3_!ZXSW>*#*OQF5]PX9,OIFF7_#7:O*T8P<^"T60=Z7++ZSD[
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M;X?NV$*T6*S] I?6/U<3V7] Z=[Y0>@3UN".WN\W.337N<O0J"2OB!I6D.J
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M"*XOJFI%E5"T'] L[1=H 5!'@F@59-.$,SQI^:\H+:?G@M[*@P=+^Z\$ VV
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MELAR?\'N5WB"'$N6)'W\.#**JZBA/H93)I[OO$:['4Z"FSG]"[L@Y&9]"W>
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M5/S7R0K8&2/Q<YW.Y6J^3.)TF5BTN,DSP+Y$,<SZ9%N\V[>KX/F0A^9?)RO
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M:LNDBR]RV0X'BT)!D]%C*!FOX,89]_<ETJJQV%W.]6ML#JJ"N=/8TVU>-%9
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MD[P=KC9GMC^^?Y#OWKMEA9@>;MH\E@^+-8IH4ZF3]-/#1DY"K51L3(DF=)=
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MM&<'D5#=X8T?U;/3%?7ZG$:GP0& GVBW(#!C-$7FZ;@_D?GZ/#'/Y!'?+7W
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MIW[$@.?496[-@L-Z=TUQ.\:+VW2W[*IVF6%:<M&Q1S -:Z"I%3*A1Q(#IE/
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MD*:G)"3:#4\M=C"V7%QW3N"5YLJ<[CY_W/BJ@\E^6M5TL6E?W%Q7E,SF>V9
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ML,TGYZVBVA=G%"&P3K\U-60Z HNRN8T$)ZJ/U7%5@P)R<%E8%NJW0QU*5$W
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MA%*GZH*-0C3,\4>G8GV&;+6X?!'&OJ($%<=)581_^JH 9X7H\]$9_M/7'>9
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MMITH0/%5!OWS6(H=FWI1Z/''[S^=_?FU(*K6][J]#GB5"?+)'<2*V,%($VT
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MF .Q/5#;)"W""KF2"0 R_B'KX1?W%R(EV- )G<:[97$1H<"XB A4':ZHOGT
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M6-*4?6T4+HE)M45_KRFLZ_DJZ:JK.>$Q%U402R\6)( 7,H9A"YA='VH(*/C
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M5B@:5C,GI>SI8@ Z3SWJ;]1-1W=UNR2#R,N'1"[=--'5@+J3@%=:)K0FHI<
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M9G@/!M=A*MMQSH"#HI[*+++O*GQQYL$D?_ V.C>F1;G5K,A%$.+ZDI([QP7
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M*B65JP]D8 0%@<2(ZNH:XZ(;EA9LM>Y, >WL?57"]R00HM([;+XU;G%+2RG
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M1;%=,-88J1_6B)MTS$I0V'C5<YP_153Y$@] $60.$!("[@6FO?ZX$WD!24@
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M_B%$Z6Z=1X9,KB:B,Y7O+?,+-$3MA65]BJ[I[ \2RH GJ]M?>OM, @5< -
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M;M!O$0WY$*?CW_YB.DESK74[IRV [7GSIEX],8$WWF%W?OWR2HQ#(YP!U13
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ME1>31XM1C( UD,V2\P)3FS33\]G_C*9+NH]*..)(FCOSO[D*%GT)Q3^SOX*
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MP^D[/JJ:*>O['CNM2%N8HA!FU^KMP6R"]P2KOX^!.Y07C T'?O'>_G#<F;K
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M%/QN8.\GR7N4C*[#MPJ;$$GV;HZY]>OR[*'G?U^Q,EJ=4^!^DI0?4R[ZKE3
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M+/AWD>>-OG1!P K&T,"QY,+S -,7;D5OCVMO-7R)@W[$%GN'EY4L)=+YTV#
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M&"Y'$$JM 5=Y\,)%Y\B+B%?4B[5])(P%5!.7=*3'.C&ZJ@(MZ_T!TG*#?8V
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ME>&4A;NQL4CB)6=#WKEE_;SL'VK:ER0D3)#&\LS5IGEL];R-MK:Q_NMV9H_
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MFC'H' 4$-BI=NWAJ7'W_:=X.F8I]MKV\MEFWY8>&UF7EXK:M<A4&]6Y".*5
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MQ#GNKJ437'4GU+,^3@+RQY*!GINIZ[TO364U:?M3X52!2C$C!.K#RFN?@GM
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M@*6=(S;_C!IN4OR3@G983Z39BD<EO'%"(GW.A-/ZN-ZXGKSGVU<7)3:!)Z"
M_]I/NM^VALLK:J*=^9<[*B-R.7A%STLAT?D4]"#E@2")F13**-SAY7WI=B)>
M>ZZ>B\ZY8.R(R>JANOT@UXOMXD.9#U_;PI,+O\Y&G]!<GDE/P4^(0]K;.$<#
M<J K^<M#QU5KGD./W.:."HL6]R4Y8T+)2HNQS,3 OVGVM"7Z^Y3?A6LT-N2[
MTXG!JV/R^S><YED/D-(#4O]7AU+E#!,=@\8=O3(,YRD1?DQ%!Z]VI@_@GL-)
M$O^@^@?5/ZC^OZ BO?NUMQ=/UO6P]SPV4?JMLK+IWWJOR(LLF7P9=LHOCC>8
M8&3;*^OE%G$U8_9U(2DH,M%9$%G-*.4<*IOC*\\;2L7XO,A-"MK?[.<<*B!\
M>9B<\7^M_WQ#1Q$;&TOW3W!F8]NFHV,>82-Q#GWE)[#Q;&<Z!+!3SCU)*'^K
MBR-$:AUI)]8J GF4 Q4'SB/ST=U*6B:-F!NWAGY!LE"'\GF^']CD:^\''P*I
MA#0_U#*M,_DR_?/@_L]:RG]0_8/J'U3_FU3,YG6)J2FD#ID%5<7UFO&K?'\J
MO0^E-GT-4=-/!0^TM9LGX*<JI!;3"Z88'%=XWRPT^0AT"\$[D[[X"_WK>ZH7
MXD9(!3NKLS3O)%(,02,;(%9S2[*O'QR;KW1+PO*1*$YKV/AJ%!FCU4U^]^O
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MG=PDXF9@IO0##SXRZ'CCU!TGIG7LZ(@4BH"I1=SXTKC5?+:<F34$ :G^6%%
M:*KZ^P65=1TSO#X$@R!&AV#5<4L5_:Y(7-I(QW1DPE8?=WY9?39;_ES=[ES"
M7)GRO![,[Q%S/\.V?4YFT\N>TI7Y49BR@Q4JPW<SEM+84^+8&#%.ET1=A.8%
M'6H_4TZ@X(X*#^C:%=@R.Z)P:GF@\JQH3*+68^$*N9?" \.4V.F\%+E[75/2
M5GKWH![TP<\B< 3S2TE/_;"=F';\SA@XV-9C]3[DO5@Q,YP]L->![X=![M7;
MH:!;DNJL.<_ ?OP57E''3]Y:X>3H&I3%EFMPP3<LM_G@K ',>Q9SI=]S$7BV
MYC9_,.YPX_DSWL7AXRZG!RAGXH+#%2"W3AJO6%VI@  6-T)41WDY5=GST,IJ
MF@&L\7X2'.70F'?L S /?W0(@V0B/2&G#='E?PK%F%#GK^3P.5K3&U01?>CA
MQ057PPI'8U_,':*N"X2QM0J/G5?5N@M&B*^F1>1TCO*$6 OZUFBY\4$&%HK@
MX7>!8UPE@<4)>URD@#A2-&15HI_L2'0\IQF8Q,8O+G;M(;B2=CX1E>2KLY9#
MY)!!'CNH5*CN:P^:?+0P;(2#;:R,\FSZXK0?:>@1)D[8AYQYY!TL!X,V%:V5
MOC3XZVS'OOBR>T#*U] RH"?'@14PN!A#"%+&4B]>;=/Y\?N/[WOE9/BA&"UR
M31_%P4(V+DX+$D..(U,;Z7--?^=BM> ?#+!/5(V)2 MPGQ*U#CPAT-$^K6#(
M'#FJ;(CJ6&8]G0W*!US/@KRH[5:X'3SHWW8L=$%TUW*:1LK\'#+O($Y_F*Y8
M^PR7I(J+E<LJ%?R.VQ\#J9U\;,8T<(;L6?**Q$[OBN]D)C',LF@<?]O"1G@_
MZ!9,MA3Y:CEMO$KI6AM6/IHOQCQ?,C%9X^.&W$]IYK1CU+ (%(S7M;'3J>@W
MEMW6<]X1?N:91V]67%I<>O"@ITJ<K!4A0ORJ(/Y$O".N-]+["<&X0Y-\'''J
M__LMR6]/ AZ(#QS/&-P)(-9V9G7YGS=VG6MY1N /#2?4](K4CVH+OW(H-S\)
ME5U%(9/>&&?W.S715:S2\5_0J.@@MT 9(-L!DP%$@0WE'\7?.%^-]6M*8-SC
M'#'YDOUL FV-#".^,@:O<+U=YGM=$*04=2X484PFA?RV\\5N;[E/@!@M?KC7
M++/ _;UKM/%<9VP!/JKCD14[1X1YC>ZD33'[].FZ[, #M"?7PH4V'<JX[8@R
M.R$.,KNIE]WIP*)!"- E:F X;.)J(K0Z>/&)7MHC/E_$"%)#*RH5OCZ;+=Y;
M8=P6/]W@4>XK@+BQ<]:,995J!+<EJ)'O!V3526=_OI+XF11XW7-%P0HC7'ZO
M& RLZ6/\=\FG!_^:?$JY^R_)IQ.NIBL*\\ZV'!G&7E;25,CCF)>2ZPZ&Q@*Y
MR25*7XS=Q$9X&V5"_UB1RN=!44HRZG4V\8>X+BPY0N-\Q3VL'B.CRTJFT/E@
MI\E"@]1NR;:J#6JL(U*XO+X\_L @]*_^B^B,Y=1@\L\B?BK,_6P<CQ7DGI=&
M"BMJ&[S@_2#4?25\)T/G;!<WBP__[I-+\V% :,;O4HUF+C'_>D8TRQ\90(V_
M5J8BC8P>XISG;"J6\LRL76;]X.4KW^E6_4R_$%%]PE?,-M/^SCMB./[[AU>Q
M")9N5HW"S_&%-JX"_3"ULG!2;V-:/)=42-QL6G;+=/,8S>Y %X^)LX,(&+U;
M4LM>@\26%-)(J (.+9_[D44W?4!!?VEWAYKR@K2Q\HCHEA.4E+R+M.]>&_#9
M1,^BX_,!0>=^3TL!!QX]LLXBG%6-0 >0@<+*N!EOU?/^CYF7.$K5")ZV:5\Q
MD1]\("Z/ 1M>;[UX;VB$8W2MR!S6ASB/M7;/ X#Y6A2OU6L<#H,I__9WT'+_
MP'\(<OI;$N/A\U\:GGV3>*=7XG^X>\:>.[<D"+-;DHB4JXD1FYB?4/CWPR0)
M4SS@1&0S)N4MR43#TM:8_(ZV/)X?G'U,Z_U<\KIP259K>OM7X]\>M["/F"A7
MFXW%*PVHCM%/EV&QG8NA"5;#<BKC:X?L&HZ;=%D&V([B'E</9]%CWV]7^>&.
MB<^V#D6,#X),:U#X=S,0C,X&6Z<])>?_\+S^&[A_[.;3X:&Q_.W$:H_O<WJB
MQ4\EYON)1+@W,W4L)M F/;H$1[OM3\4JH6)+I=4K9M)@^MXTZ.9NG]A65_,D
M]OUXUI?6/JD/*FFO_A,>B1#?>+4.(8;2S+;GS0,%NE4= P2)<0/K16C:&)L2
M3._(T.J'B7OBDKBNXH<S=-%E\ 1?\_UGSP>,7TT!V@<X%VS$57L4?&"%-#(<
MK;S7G\^]38(X7+1,.7FK?!#97KU1"R^LRJ]"'1F+W]7M&7157B-U9_8*].D2
M9XUF-!-'V?)_)$Y*4H2IJ43%@8U4I*SS4]$V>]H9U4W/96(\%_#U(HP"\TJ=
MB9&)!.K$5,'H.=3AYL$?,@<4*>O]SP@?VDC?HK:"TE"W)$HZ+86M?C\K+"\O
MZA$-?)1BQ)(4#?F$<Z&^D=3VJNTF;BK>)B %L1U3Z@(39G!/V8&4XN*/T=S:
MQBKW*+<=Y1A8%I_#XET9!4J5RDKD,/-QVODZ,$09E'Y_0I9Z"[,X*!RN+L-T
M,=L O@85I)8G')F^2" 0DLB$AOB!Y-06[-7M+AGRB:=]E331UJ^8RYJL*!@Y
M1WAZJYY'KZC$J_2CC#%L+,4G,C3-;=2'DQ6SG:_9S_9J"(7OBUOX@C+_K!3I
MFC8H=/#(UZ^S+CIU&FNT9(D!# !Q/HB9IZ'(#"#<[<I7\MP*KS>1$&NI_CE#
M4FAP.C:[(VRNRDIN+604A'JDG>C_AHT.O=3R1,XSN,5#*QBWB+;BQ( ;88YO
M=%>LY<7J^6:LKIPT=#P6*/50AUH"E@A;B[G4V19C/JPL?Y]P"V" 3JEE$OB8
M?V+10@0$B2@>-O#@W3W"NW6;U<J%"S510CAGJ5<903QEL9DJ'O4YNZ6S7;#:
M5"-?H30[:SLX51D7?3U8-F][<Q+G8'B2'OUX;5=C_?%Z$G7FN$G):$(DH217
M=PP.,]R_=N)YBTEW57=_?\7Z<13\5&:1CRFA10"QJK68\J+_JRJ*[ZP$QM]K
ML(VA9L4[.Q]EW5A0!=6':JJ=S>40<B'=4WY#+1OM_?+C,YT:)Q-,F2]^FH;+
M';5[G-1?7W%-DJ('[*RDO28&@X/F9$Q)#7A$6/!QU#L6&M51*SB<<TG)<&H$
MOG\W00KCWIG[,1J^?VAS_D1,BVRVSWK?*$H[8^A^'%;+#Z ]QMDJ(,JYO86*
M)QIB9X*JT_NE:1D<7JUHQ&.-J:&4/G;Y8R$J]YLX>@9QQ15M134Y=='A"9YZ
M8R7V.9*W)"J\K=TBG]=53&^.S@]XN&Y)6"(2'>8K/<3WI.!!\7&KB GY.U+&
M]:1U1.1J*7NJ'1JHK, Y<78BQ)#7NP.8=? 'A,Q/0Y($PP&B5U[':XH=:%Z4
M#.7)4&X[SYN&^YF=HJ5AYWD.LIN+#V6GZUWP,RW1[T%.1349PP_F R$J=!7"
M,@40Z70 HCXD#G74./HBZ:_4D0*R**],JY0G32\4U%L[]LJ2IKT?_5-9"<Y0
MJ'L^YI_*2BB#0;&QL8="_0X"8(%BKNQTT=3<T93':4$ST=F(;@,N\9'&.;MK
MU=T15SURQMVDXV9A"X<S"S4A2IZ,^-Z$8QA1,>%YXHXJ&#3*P95NLK'P\PA_
MPLCZU88RN-ED:"!],]L9B75\@_++V\Q,M76#;H@MS)L\O>HD]NM4UNKF'G_Z
MO@V%:NI #<@9^J;%;DF PIE5P&>?-A<*]&*54!0R MIKNRY6\7G'#):EW%,Q
MAE7S,S)>.-PVHMKH2IE2Y4ME\EX[WA'N>?B\=[:C'IZBC0"LU8WE+)>9,D;.
MBWVW$/@*[5HA2N.5],SG]GNLMOS[/2DP?NE3>XO@,AL=H1DICNQ83J"%"(U:
MN"K^!/AYE2GFL?. -75[V$Q>?%)F*%E0:GCWC']GMKJ%3[="HU8<WH'?P8.@
M) 6(7G"O!9?\H,X[9X@H\<QX:I?5QV_Y@H%?HUS*8V/>/;?0/0^G[:C?CPS)
M'_IV&67#_+5&1VZ<N_6A!Y,:XV.,_:S/\_%!I?#?[^7AWNYF_I64YLP^M:O!
MHXJRF1#>[A$>J*-;V,%%>8AUOX"YQS6QYW/QUJVF@<9"P9-1W>)T_'7S F:?
MIQQZK,-?B^4D4*KG;<U_4R!3IL$U^JL'ESB?:NH8^)*+*CM.#R&&K)U,LE8^
M-/BPA?.6^WY>D\H7*W_,@:'VHP8O6S@O=N]_WZTR,J[$69G-;.Z,P4I@TL +
MZ&0K;^KQ(H-X/=J0&-(RBDUSV]P 3]9,%*7)TDP,?-!CF:]@&S6^ A>.LN:F
MQZ3JJ;][.H,7G3[)5P#X/>XII8"6'&\,3+_^E&47[FN6?Y)>2)XP1$H>V;%:
M-FRGWL!)J-:,CTO@@]/#;<_1,4D6^X1<0&K7'!5:#HJ0FEJK2T"H2TEH,</*
MQM4-I^:AD4^ZSV;*W!+<O1GH1+%\S0QLNEN4JWJS>CUA ]PTE,^MWCNL$ 60
M_F"M?'80H(+N;)MXH:\0D2E"E?)GH8?^/"5Z6HN+NZ]N/JZB"\K3K20R8"(/
MK&2437_!^2KJ+,TI 1FGFP.?:O=#%6_0C]5/2SZ3]*TG,^]UWKGB_L$=@+W?
M1X#J3XO3X;2]A  ?<X=C>/D$#D'-?75UER'E1L=VCAH/.(?W89W3 TX>1\]6
M"2#XATB]DM%\W3''=Y,M[9DJX0,N14.#\R]8/0IY-X-*,@O+$"6%CX\P5\Y:
M1A]U9[3@;\S[<U;O-N*E+E2)/6F_NY*B 7R]J\JHUHX(T*&PW(-Q>LS@3K)O
M99NUAG@V!W=MF>AVZH&PO\L\8"X!&R[MHBYZKC,9%MPV-UF#DM=-F5!G+$XK
MDC 6Y^#I?9OB8H5UHTK7TN@^IB]JWHM*A$7%%XL01 FV,%M_! JTAJZW\!)&
M;?<O&J1K2/A9%"3E2-OIKG!E2_W$([:<U0NU[WGR#+CP.YK@5_=7DGX?/3/!
M]0D('F#V&QE>,^>1J_C> U7V %^T<2$80X_N]+"UV.I0+@G8O_H1-!M1A]_,
M=RA.2)6MK(L[RQ$2^#HDMN.P3F]H4[(^IU7(<%Z[5IY))5J/%9PY/VRN\&:0
MLL-K0#W19I6C"ZZ+!86= ZZ,#GC(:7<M]P=#3W[Y9[HR_H)I^R(J]WV%B/!%
M:"I:8W"=(2B.E<W@_AQ"V\Z[0*4AQ>+K\KX*30I>K0Z*&(HO32V)LOA*W^ I
M6F=F\W[@1PQ]Y?,PZ><<V08*6C=('^,LTGQ)2HXD\LZBSS(F,>3=9C3^SV1-
M!E'VVEJXFJH^NN*I!8/Z -VD^$(39Y.9'OU\9MT!9*DUX$::1L::8\^T@7-N
M?16B;4SZ6JICNC:XFE$V ?)6%W+AU.*(CA4HALKC%!;N%VY[Q)I/55J:3T[,
M< !+<1B^%4M$G)$1?3?9DR8QB_$URPUI%F'S; +Q,\0>5SKZ87;&P?&C;V4(
M7L3NLW,3[2,ET7D>'M&U7".%]YB"1EFH*J>(X&!+K2_#7T%QOZX79(0>N$1@
M,XE,SUV/0?!UJT_C9EC91!G7^"Z?<,B<;77%NZ@6X8:-R/A0=@7U]%2\1&EC
MW2 (,3G5R[865WX(9'2DP/UPT,SKK_2RFQ8[%1?-\AX!"[:F5E".6Z,<15F8
MHOPC)X](H5HE!R4CY2=$:];Q RF&I98NH0$#DEZW'ZI'.[0HZW7) 1H#T.>/
M._"HM:(1RGJC^%TO#0'<2$ZY"BT<*+-C^],:QG]FO3;=%-YE6A\V6*YB!:O9
MQDPIG_.>UK/7\+(O-CUQA"_"ZG:G:Z4-'THU#&JU/L[OR'T#;C1)3"PFW47N
M,8Z>O21(+)PIP-X1G,WT",FG2E!+C]TIT7&WVJ=\E@D:-?%^QD:Q%+AJ[39=
MNY_8E&[KC? &AX6Y'PSQZV=FSTZW_"B@2939?#,AIN^UJA]I//N$B=*SW.K$
MP5@(;J23+5]MW&?XF9JW]Z5U0'_K(G,S\@(8 /SB"^SG'JP/P$3#HMOG?1Q9
M!%Y.@B"6UM5 NF>+"PF8M>=T9N76SR%)-LY]M1Z/!!ZQ8WE;],K1/NC #%\(
ML(MOI-V<Q4%H!M2NWB(PL;F_+<Z D,*6N)WB]-$VC63%-<X[#'%Z\$SYB"7]
M$96_1JTU(XP>"_":59O89\NTFRCL<"7:LKW1M;;Y8W&@@J_%Y\SYKQZS0AX@
M%T(#H+ZI:6&MT>R6DU..4?A(J)S<F\-7&L)&M$IT9C!HT=I:W>(NZ-;(I\XK
M[ C*;-A3\/X/2.5.)ZB\G<=AF6@YT#^K[^B\L;LF<I\3?/*H,,:KW.J]54+S
M$DTQ9RY8;=P(/CE4%75_K[\;X<(@W,:-LW5Q3HU M3=I2,&AFLHE51TR^.HG
M^B[ERV8"^2B@  ]*N9&ZE@>94YQ8*;NU:.Z4TN-Y+R\U'&W]RDC,I":W6_<G
M_.BS[>MA)&,#S0:-(R9L8AJ?0(-<S>-YI W3X*)M2'36\8KZ0!O:\"%NA$X#
M@_;BC2N3;A)>1K1P_$03FLQYA^S,3X4>V6F- /:8>)9+5@MRW]O=S]GF/"A9
M05A';T4;:84,UG\0X1AV+3G)+>/<6=@@5,W.N5CJKU2RR%SV/947(J >*?!L
M8RJJHIH$%QBJ!D6BU(L);/>SD6.SB1EDAU*UV;9:>BA\Q-2KKM63<_ZGIM9K
M3ON@?E<8GPIO(3FIW\,E6<;12S3C6*DG2:&[=FIA-"&NE!'$,@?Q'@; \]^/
M38AR7#@4I;U..5'+?[CJE\E*FF[M61W5O2YWG)OVK3FYC,+D7@5ZXA 3U7;/
M4;!=@=01'#%Z/C>Z!"CG^-1'>&[RU]_#</X#_Q&\IB[7 [N9+[A4N%^\_O(_
MW/FZ!/,5A/Q:=WBQ/%(F<'OTH"*HH?W&R#,E2]&O_Z_[94.W)!HIMR30V!LC
M<SWRCTV]7X>)<A?;T3UO?S5^N+C%.(8PF'[!4TQ3F7B2+!M?@E^T8LQGC627
M"#-WW;Z4Z?+OY$P%,/]M/27K;13>_,PS1;E;:A_N/&(:$1]P25,"GWJV=*H:
M\N-/HB?I$TL:>,%XZYGNV#)"\!'9'6?ZP__AR?XW\,AQ<VX,]&K'%6[X.;H@
MU@EE-DV(%JT1.']KZM#S,KY_XJN@@L]7"B-P7&?#9GG><(1:I,X9.D79TYZH
MOV L7YKE7*L*N(1IMG!T:XK+WR>0)F]5)!RQ+4(MKR9R#@K JI-WI__KHWDB
MF>'P0$5TC.U=N W= OS^:\L.;<._KNU [)V>DZC//]-[_^#X4H @@%+UA"8?
M@0!:OB9% W^Z/"$(=^!IWU?R)7LUBJ7K02=STC1,1S3#>E9=C=L>>!MV+D0!
M:K$0(D*T68 9[33)"W\QQF>_-V6AF;CKIM#YDF7(O?G#RRHK9&%$>S*0H9+F
MR]+_8N^MX]K<]C]?:E2AA1:WC3L4=]C%(4AQ"5*<  &".RVEN+M37(.')&B+
M.\4A6'%W]]G[S)Q[[]QYS9WS>YW^YNP[)^]_%\_G\_FN9['RR$J6NZ5HKOEX
M;G(F361:+'UCZJK]M]RE-UN0BU?*2R+"PL_KACK,DH"]^ZKM@@*J40;J&7ES
M"]ZM(3NN@%*G:<5H+@;YM%'6WZL2T]>&Y^6%6/;8-1VB#2YR0E2+NP9HL2GI
MP'%YPKDG^&RNF5SPI%4@H>'4N5N)9LQ8-1F>H=>)_?9V06%6S(>"S]]W#&]L
MMQQ3%U )*6X$$?E=3S:2_O-& YI_#F'K&T>QI9?7L3EQ+W_[^8O%'4E?WN0%
MWC)9[&E)98B=@%PG6O06?%GJ^P:S1<U^?Z"YYEN@<(<!E;W#8*ED"NS27_ZP
M=ICI=2)C4OC'P8][Z_.*NS:VU]E_ZZS.1WYFJAUN4E6$K+Y+ZIF,)1NFED>R
M<5>ST9AF7]*8FDHS336ZOO3@VY;K.*9)TQU/&4X>7D$8P)FU5..1="E>C%'/
MD>"R%8_7WFPM-*!$76LCCM:OW=,V<X*G<_81(FRR^>]E/UM^9TF5**;AXH[M
MM?9#=J3,"\$;SO4.6^"\6<G28L3$)9T,D/8M:SUGD3=VFA9$M-=56VEJ"5C-
MH6QLRXA,5[5QA.J8"N/;#[^X%_]1,#O!:V!D1J,I"]\SX9 TJH>UH;2]F99#
M^%Q/=?&HFK*4*!4GY^JZ;SN&Y60M^Q(V\H0%5&9_S@F32P7:@I5): ]8H>!]
M 8A,^/ZFAKDA8_<!4=YH=II]]S5HWS61M#Z-E-8/(JP;^:1C@X/%ZKESC?:-
MET?/)/C$'7$PU)JP.3@MQB014$#NK*>Y5:(Z:IY'E.'7;ER^!.%J7S1=\5E.
M2]UM_L0J9P40_P&VQF<U*NUH_V^W/P=-^ XXMAK_>*7W65U!U6"YT7"EZM%&
M(8^J@X8$'G%6RVT6DU'%TE1EM?OAL'<>%GR8ZD_?;J4ZZQ6\WR3G2:25XTZ:
MNBIJ(G+13Y!A[7OS=0=ITTU/2\LH ,J/&P%;6<51"NSNF7 D39F\C>!4DZ^T
M#>>.<]*24->8T!U=0SV%B;PSUGSIBQ .KU]'&>%Q.$TK:R>E"M;A9:W(&[?,
MJ2G"<-6+S_IIR6I(_6@X>]3/>'MMX@.\&P6\LGPZWH&G$QC'3\9KS5C?6#'K
M*G^ILTX(@5-M,7<=6&F6K8Y,AW\!N&QID&]YI.H1G[!RR^$2\ERP_.>-%33_
M)'_E=UP8&![57UNJ ^F:>DB!3U[K. AW<>54LY$B=G.'MW!-1 .)O!-QO=[$
MTPR;'<NZ^*_96JW4+D$$\].)O4!0ABV&#HA]BA(62%G>^QBDY%O!BM5GUFPF
M'3ISWWH3&&I"E$B&XA%LHK/>%RD%%87XB7T=U3+ACMG$E55\2W*5\>$G='[]
MX)4>E[+U0*C&7C??+#4".M[+@>L(AUDI=WL($#OMT44'*.<PA0;OCTT;L]%_
MBWP98"YUZ6^N<P\B=OO]1>>XQAU&ML0:1;:)=Q_\.-@]=%@LH[18###>_"#K
MVNAE:<D=AF3@@-COGLEV&[A'!+DB.NH^B5"?QQ+G+10Z6K?!+]-\/IYQS@_3
MKK++>E05WK#K7F,''OB+5I7?X%+PW]S;-6O.!?091)V8J5P:P,[)7BX]\38S
MO*01A5P^F.GUE4U,:J3<[,DY;K3>%Z3H>'79TWPLZ[5T_!B9<!O-SN$A,18O
ML^$Q\=-)+(SR)-YW/>JB<_VE(^L-E8'Q<6 )4^3P2?FW=5]"B2VF.XPARJ/(
M'^2KP$O)AO:-EYH:%'E;AI]^W+X-_'N-7T7^6XGDZ K1%:(K1%>(KA!=(;I"
M=(7H"O^W51@&\W/RLHQ@94Q]$7X=*1K3,US36I?2[TS 2J8Y6HPR-P;X^ET6
M2PRGFYE*RK]+9(@/Z;2[=0X)A0=J;DOMMVOJ58'9'ZKIF=T2.'-.XTXWK+D
M/M7)1*L<UM8'[(Z.:KR?D"S(A7Y25C/HYL"L*J-Q>T59(6U%E]T:,JTR:1>7
M(_I4CN UUZL2N.T\8L\PKL!%J4P57'L%W3"-F47H^L%!#-.Z,>J ANCC1UR(
M7WRG@>9?QN-PWS*+ZS]N\F*<'#XMD_YB=6R33W<8-15W&.T*-YOKU9VW4+;+
M<T :^TJB>_*Q3%\AAM7,WO%&YDD1Q4H"[?N+YPUAI+=J>QF%V\Z_. B:?V<.
MRD_Z[C#"Q Z5(MX+?_[X:\7O]=F+G290G!=E-NKCN]UAC.7-&SYU_')=M<<E
M&G01CX$%3+]-Y[J%45]7M1534+I&?\[L\3X:(XOX^FMSH/EWYB_[=5@T:'X)
M?^5MFM&@^27\=5?SH$'S2_AKO[5$@^87<&_)<.N/J930=SF=].O?-W7X93Q(
M^NF[PR)VH";F4<=R<(=1 FAJPEU[?F$V9^Z-<\2$0=PK^&(D]6T/:0YU_&]=
M/4+YTM*;YT04U,72-/MIO/CQ1?9).M) 98EQC\;/0C4KKD)S/UVG XE7!+<!
MP1'?TU$.]>E[]B3V2WHYQGH*+B]V1^)G]CP__OD7)+B+)A46+FEE:YXSF#/\
M$PR3B:_)_J[!N]"!E&Y#)&T3S18P(^?.[L&Q>7IX:=LZ/PSL".@/G"&P$) R
ME4HV.B%,5U#/KFOC-W!KN$-X,(1CDJM>2<NQ<?>!+:EUG TZ!#H$.@0Z!#H$
M.@0Z!#H$.@0Z!#H$.@0Z!#H$.@0Z!#H$.@0Z!#H$.@0Z!#H$.@0Z!#H$.@0Z
M!#K$_[$AN#H0KY&*OLF 37[?VX&S':4[C+T'N8%Q2*4_CAZD_W\>KI;^%\F,
M#H$.@0[QEPKAL$W.DE_%'^K"'?!#$; ()X(\9>-(HUK,HPE")%5W*K&_&+:"
M&3Z%? F+7T8YY7!5?$O^_1>OW4&#!@V:?S^P7M36PA2A*6H6'^+R6ZQ4X_IC
M)&,8V7!P< 2^!07)9CVQ87VN^I,#-ZXV(['T8HZP]B OTJ5[*Z>VC3^1LF,4
M,;G?#@]G\:Q5UL<*@K"]@['Q"G. EP#D.[$3$L:D@"@P(#SR!=!MN+/>].3'
M9"#N,HGJDDDK_AQWY>Z4B!,O91L2$RV"%D&+H$70(F@1M A:!"V"%D&+H$70
M(F@1M A:!"V"%D&+H$70(F@1M A:!"V"%D&+H$70(F@1M,@_(V+Q93K41\_N
MNL1DS%W/=S#WQ+=_7FS:MT4B_@GH!Q*;-$\C+\/N[P<-=?SYRG_@_^\UHT70
M(FB1O[:([&_AR7ZBNV([ULHG8?/S;,$THN)[U"_9XZ[6!L@&_M5+IM#\'X0P
MVQW&L/0=!FGYW.%C9O^%+?VC/GZ!7V[S% _G,Z?,;.<-%'1;F7JU,D3SYZZF
M1BN'F5X7K<AOO]P/S;\MC[_,7\K.+\5?S?V^8I\F8MWD'OCXMU]M<H\J^ZVY
M[!7B#@,&%1OG\O6JHXGZ<Z<0X2:UO4Q^UU_]^[%H_IW9K[_#D".Y=FCV["(M
M>QT(=1U\^W/YE[O0J$N_Z*9PI3B%%5QVV.TE2L;\N2](8&*/]]$:]MHOMT/S
M[PLY@>\&M6^$UI[[@_@6^Y.RBU52TH^_VN1A2-#W9.K=I=OQFCL,[?Z;P_68
MOVT#<GBAW.2U,//S5_NA^??E0<O>#8W=0<_-WF\.""5RV+QPZ^>H7^X2K4+(
M1>,]XXL:S]PB:F[2QY7]<\L/<D/&L\$TH;1?;H?FWQ<W_3N,W/!; </&96RM
MIZWC]6M)]@Z_W 67B1K3-+(^\DIWY,:$[ZPW6^[/#3Y:>U=$+XX"'3_^<C\T
M_[:\?-Y\'-W<R7S6\*EG@=]CPNL(&_OW7VUR7TKR0U_T&>0.PUK7M]3\]L))
MCO+/S3S<O0KF1>UW_^L.:&YS[DG;]502T(I6+.C:O#L(E* #HH.3.;>GO)\&
M9]%9J23CX$#>RL&E2A=JX@VR!4YB\PS-4P2,V.+[+EM5][Y"P7W%PU9Q9F#.
M1:PVQJINVH&\EF7!1!+N(BP=1 WSR7(,)P?]MUT?]X@0!+1$<ZX LGW[3$FO
M\FT2=+%GO\I^VI4.\5O)TA %44G)QL1T$:OI7+2U:BHM0U1>Y6=**YG7RT66
M2@:+[W.4AZA4@R)/E-?#FL=V+5H].A<NZ<3FME^6U)^+1E^<;(.7AK"K;Y0?
MGT]2:"$SRRO/?8+.ZA]LEMV^S!7Q)'$[EBB]PU#[?LO[^(^CM[9]*+)%=K]=
MEC1_WGAIT#$G\FI+;'3?-_S3B6?RY15%X'JD9X5H\=[/2XF)2GBDI.#@B3#%
MT@=O@U6?IC]\J?^P+?[#-@KMBG9%NZ)=T:YH5[0KVA7MBG;]A:XDU+GIK*GL
M8]9/8+A<P%D66-H9!RY;J0I?I#@PH.S1%!&K2(1,T#AO]F;,RJ2,\B9DQ1F3
MG02)W,5FLYJQ>V>]/C=RI!N6Z<?2U&I'IQ64T)L&[;ZPRN!&&> 'TWWAQ8OC
MK\4;7IS\/9VLZ'V!>-1HH2-5DW]=6U*5-C"L*^+(BI;24B5/CI-3]#XK0P\G
M),9*;J@ 2C0Z&A.G"[&H^D]X,8OF5_%2U>N<Y[TY2E<Q&*@#Q%6X(B$ZU G$
M?$AH4R:)K#;K D(6VT+)8*R=^+E93^2*I"6E3<)U#;+*Q<<M9R/E9:2AAEQ3
M0K=3)0UW& )=^R[+QW[SL?T. GIG?@X;C9&=:6S* MTK)^["[O0ML6W:NFOD
MNM>/I,RWQO#-TYMV>\% :%DWZ^D\-,43RN/FA;J<R?;)7,:Q6U)1AAE+%J\G
M*+5S*;BNR@0M3LN=J,<11?RHM]WQX-,E59I9.!QCLGE;Z/2/E_I7>=SI-9V:
M4NJ2/7Q[V4$F14OKU6OM"7P\'7J_MJI)*&9-*9EVC+;PP%@:!(!8<=+DT9D+
MB;^NY[%%.2#I8@! .W% DW-:SA-D?][#XNF?LH4&=QB7<ES]0\L$NKX%M2[\
M ?/,!<WX3?FX*YK35D(<"7$\[JF%"=.[$[+..3ZT\C$!U'FRZOY"E#70QK'Z
M5&A@#VOGZV!Y]UA=X'#63*#KIU[@SVP/YS+'C+D^NNTI6WZ:8U8E_2E7_L3'
M6#KXV;HRWWYYC_UC/"6=S)3UR=VA9RCM++= K>J^M!#(=U @5MM5]"4V5O G
M+8V\MYV,!=>R>Q-70!H D&2^ST/;(I$_$Y!#TEK/K[?:6P]F,&?TTME$+8:=
M3[CJN7%K",^II!OVVC(H(C],CY"S;;ME.JKM;6CAMG'..(JT5VY/O*H-]@Q=
M4=]G+V3[K70"OZ-X@,MAH=NR+Z;&,0RAE\L04\,<HBZ9S<E*Z]$_([*AW4Q
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M<)5I.MLU6?3TGG%A="[$C6?$<1ID"W0M( XT1JC$\NJ\7[R8!3^<J<3)8LZ
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MQ_GF>KM__D,*#*'X$%7[P"=TJMXJ9^"05=NCV%H5]&'M,K_A77&:J!T7)<A
M.<!$V\ZT6YG:WW3^-5V3.WOM. 4%1&G1[RKS2_(+%M(/R^=R^A?%J?1]W 16
M=9EUK!*%J5*0>D#8NQVQHDJ)4ODCD0(64[E.AVK_:\N]-CO!YEX;4QD>DJ!$
M+=P7^9&IWG3%%]YP0J'(79AKB'91_B@!9K6#CT/BJ:BM\G;B.]_,<$$\CCN,
MDG.5D><7AO=TYE-[Z].MAKWI9_&G>5US1=W/4LN(RC+G0<LOTI$:=7QY"&P!
M18A<DK52E1EK\U..2@7YCLO76)H=;@53 TFM+-$IP<Q5+7II;[) FLM%2K3E
M +9R<4XK-2>_(CJA3^NX&]8S>;1SN=84 .&T:9W5L7,EWL3VT"+^LI#V+I-W
M7*'O(I4Z')B(2952J^+R>]19*"/H8**(CL69)5TW8<GQT34="(BQ$\=<D"I%
MDL$)?%QJIY7#[LDS[3$KG6.%-1[Z;8P0Q8Y09!AGJ>UD"L\3"7499Q02_&[+
MOD.?@^?[2.5-^^G#F(*Z(I"<KE9/(!L/+/2,16\JUI,G1_G"FFD&3E)9G#_&
MS55U;J'PX<^1<*]@^G966#'69L2^/B?Z?A/*/ 9T7:]GFSVU9C*FM\;GN'4@
M(II7[1Q(').RY;5XV\1U/1QS4+,97+V2(L5\)LBLBH#EG4:<9L$A4IMF+^L>
MD[9X2'KH.BI,Y&(VIO>O)>-';6+F&8>,R5#/FRAM@K&U/C<_KZHH4BP@K\C)
M:J4'YI>E)@EZ=*!D>)X$)^!1O/ZB4A]T"U_BS6CBO+VRAQUPJ_T4(J)HAP3S
M'R6%I3D$2#-LORYQ)?3):)QQ1XT1T&REY3D(EF@]'!GE5<RQ"]Q\,= 'JI:J
M;C.IS=,O;LPI8UXCMY%1/'W0 /YM#%H^+C-TS:Y_L,5R&OKZ.VEL>,<(6&=$
M.*2TZKF(F)3N$CU.?E3H)NCDX&M1KN8@(UE8@@X=B=WS,!@)GP]=$,S@(+H2
M,A/8,9YLU_2I_\3<\V+]LI7GM7JIEFO)I5:2*3%>L0!U:9RKP]:U8#E94VZO
M*6^FY4K\[O/$4:3QX5-6,1O5!/_:6+JAF!9]5YMQ0T9!_*0@!KWSNHP8\T=#
MOV-@8!<VI>_MV,W-SS(%7L!;)'U?7[B?]<'*NSL;(@:@F;=R0+W;LCK::Y0)
M-9_%X=NKL7W"WLRXQ'DQ_\DL]75C$=^A:T=[7:)208)$:2L#KI)+BU10XX@R
MX^IPDD""D)'X=IP8X0@32Y!WFC+W$5UBLO-3H#E 7J%.+V"&E.*9D#CPM>JB
MA;)FH%6"-2R\ ^13KL9GI)%F*5VZ1!3X>2JI;B,0Y&=Z8#ZU-+S,-8!K,H7G
M^<.L-AM2H.W<,1Y?FT>S5!D;%I=0TU<M5RPBX\ 3  E5_SD"HQN88V%A@K^)
M3=,V%"X_8DBJ$72>!\"=P4>9JY6;0+4>[L/&+&?^8/+AR>FK%/6V[49H!/&/
M;"6QX06D3PI;]"S[5 ='N6Y.9?A7*Q?EM!%5ZG=F4EGC:1&)KUJK^E#1UQ.J
M)%$N8\GX]MKU]FG!>IM%O[F .+>!N.!N=F-!SZ34GKF1\-KSY[LAO!^6$T:C
MWUY]ND 2N_(I''J"2W:/W"]=$9<])0"]UVP#9X_=8Y9TZ'3?9P#MN7+*\XL:
MRP)CNGFXJ'J@IP;^14Q1D)4LLJ"5OGV<*=N9//BL[_4SE7;Y9C+6&'K!AY>F
M<*-(VRVR]=.Y"$CBI@]?^KSII6.0J6Z!"=V5.G>B5N7XCF%DR(PY;V1/EX."
M[65'\J5!:X6']0\6_>#)@4J\ES5UA J*[1!=Q'3H4,&G>/:IT- T#9K0_%TM
M91B]1LUKC>,E&1BG0;A5@%F [M"'NI)[7*3)'Y<=@?+,AV[]OT?C G?'^?6J
MP-BUMO;+*4%A?::[':JU2X_E1'$'IL/,T^*-G2^<CK;O,'Q)-$?(FAKK,Z*$
M<]P),R#IJUB+B/Y9GW=:K[&Z('T^,&6#VG[82IN[*OWXG !I7 P83!,GU9;@
M]?:\1 M:>%R-4FKP-6VN%G(LER[Z*=U^S+8MD5OO"&3Z5$ABOB'<QPO-/4%E
M9AK'>\AI:,2BO@6"](I# ?4=I&5=Q5D=^S-7>?SY44-73BG]TM:<;.?6?+M
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M<'W0%&FPL2J"%PH_P.FC?Y-FT&>\.AY/4''NHVBFE=-@7,WBXOMY@VT:9K9
M-4M3C IWXJU-Q*R3#AJ["3E.WW6% &N&;VA&">PQ]TN[JHUKOT0N J )4TLH
M<,+R#[QGWZ] P\D\ND.<!0+F"XR8-8GW.9=7X(%.AVG5=(WAK4[I(HTA?$S7
M11ULQ:&?JBGB+,ZO7<SLL#Q-LA/&+(N*6;?*B5GT>*+Y_N.SP;\>84[3SH#6
M&+,N8Q9SM5X/R42@44"4M%0O9$(]85KY]26=J41<6CI5\0")G,8F_^,,+-KC
MG )#K,KR,N.E(A,1Q7E>O79R6,!)PO7*@/ ^B#V/3/ <'.[MB)T7=L+G->6(
MC6Y#MZ';_NW:')]9;PJ'$&F;G/'P5;S)$;=0TVZM#K!6WHI2-1*^HLN]+7)
M1.4(N;("S)?US-I&E#LTPA9X8)AIGA$%8V38W_XV.=U;UT&-#;=Z="SV/%+T
M<DI95JY.)G_(^RJNR$IM.(]_!(N642XY)4Y24EI(_#62-8F>4?1A\4!5W(?:
MW.%(IP51-^[$X8AT+]Z.)F3(#8!HT_:B:I71N92O%+[&!EG[+.?-L#'1:F.]
ME>3,8E%4O]J;A&[[W][F.%\ZVBA0E]3O+.KK/ZTMJT(E_*RO.,2K<SP/%S?
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M#"+GG T&@_';MVZ]?N]4==<[MU]U_^BO:OV:J^:L;WRCYAQCC;E&J,5FL2:
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M-PG7I V<4M MNAII6V?ZL68RT7)"A=I6CVN;M@6W4RR#2 Z?:\K]Y7OZ$)I
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M<+IM&%CBQ<6?6@&7JY'.A%Z@^<$LE!BGJ8,6&.9-"@SJBXJ\SQRK8;;WLD&
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MEBI%AGA&WZTN1TS"I239^<@&V _]3N'6&QIEW<9QK_/X64G"@_^<59:NW@B
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M?U8U1]"3A'"V5BOQH!SEVL3A;-UA7;[XJ\E,_D=MIHYI.@SY#"1%F[K2 _J
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MMY<A7@T+3Q>%K?C3.!\^5)CK=),?1-3G2+W@J;BY>%3B"0NEX[4?>=2@X=@
MZL=QV?IH%)5^6#<+\,%F;!C;VT;*^ 5O22C7LWTA%>07FMB!FKQWU&;0:^"V
MC7^$9_+ACM0/W$1F^ZH&<"[@GW]VOJ(GAB&]:SP$F7(UV)>YZT^++([J[$E
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ML3G5UIFBZM6O[=<*I 6)$^W'ANIUUFY!.:E_,-,1XTO@FJ_6*<:!XT<UMH+
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MF.]#!GIB-20=P1V&B@R:@$[-IY!HCKGP_187/<N+S%KQB9$P^*UR>@4@YPP
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MW4J.V8RWS_WA&07P<E'Y^*0MAX@_3]Q.?IC81="+>KD4F;%EP((!,83O4E"
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MH4L@4L6+A82!.OB<B=?1K3KO5Z'LXL;*07FL]UI!%SFPU?:<@%2?'MM4-?(
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MNB>2+J/4UQ>:*R>J&>JL GIK$6/@+#6TX_*_^F(?M.S?L-H=]MSLOW.L5F7
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MQ&_VX:MFJ.[#S,;@H,K+@5=SWL8$R ^PKG]-1VBCDK"! ,[+W%)8D?TJU,Q
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MNT79A8RM33BQ">K%AU=<=<+>C7TCXXC)N%+HMX]/X6VS5YDM-U7E7389KVG
MK= @HT.@R 2A#.N]B =D?S3WFV'""1@-=3].!:PJ]$NM=5V"\\:[KSG2;[IR
M+Z' B:UE7$]EAF#^B'B?:H^%8IQ_E);NQD"JV6@A%VL1Z]C4CR,NXA])&B^Z
MR5E$OBY:@!BM)HL,YPPEJ\&B!+?7F$FJO0&P%%=[SKR%H%?A7%6*48T('HU\
MR?<YZVG[:/VH8O2?!5=09[4=-]VF!.^_'/XGX8S*?U0\V2-_,E@SI"&IPJVE
MJLRT!7A+4<1U8\A=6?A#-XN^K-SQQS\>:J]I?%Q@0(>4#3Y^CTE:]"94OGA_
M_@Z7V>S%U_=CRM:5Y9XG1+B4[*N_B[ =NG0?+U9\O,1*V/W<%-1BT#ZCJEZV
M5A%['S?8L<]!+WFY <8NT=5//!H2>^5Z,M 'BBI(+)N%1CFW)^N%:\84ZQA1
M:I<Y^- TOYM12J]+LCLJ9.86+.VR[(%3V%*,L@C?L^; ';]7"%W8Z?]9TY^4
MRE,T[U]];22N"Q_76/3B9#,8EBS2@H_/&39->]@>5@]N_71:D2RB^Q#B7$)5
M>=6O5=BI9+S+MJ_IXAE>U-\98Q(,]F3GS*XX]@#':.>XUQKZ1[ZNU#KYUEY6
M:[!0D=#S%H9233GZ"/\"#B^JTQ?H<O32>SQ:7\");Q5%..\!R-3\67]SFNV=
MJ0D[Y!^V]-;SV1I;\*F\BLFYYV%4K2L[=ALVQ]QQDMY1@U]+%.HX*#3PINYY
M+7:=HA E&%)$JB1+FO\Z/RSM)9!38686*:OJB,DBB[JX$L+^J!OUW..7#H[
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MP4G_?'/J.N7$;Z\GM2(L4USR)L?OF'&WS>X_*O-"XAF^55X)BE_T]IZ@W5U
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M=H#]]'.I_#.PK5*5AS%LF?;.+S*94,$*"G^#O=I[$:]B*O 9UBJFE'M*FF&
M*ES5O' ^RTL,,DQ!H?B'7C#MWG9Q5],>;<=YQK>N!Z<-*S72)P-I$0JU!ZC=
M0-0B_;GD["5%_5@7W6\=&!VBE5<&':1*YR;*2R'"<.'OIT+NE8KZZ?E>LJIX
MRP^;.M-U'>-*+Z*;=/4!@;W,25-]OK.W%-D<@30[C^T7L@B& CQ2UW<  *]B
M C8-NERBA>WI-(S,T1TKWW[L[\$D&[;3UWGEKIP+RY./VH3$4X^W'D2Z, 4M
MUQ2/&W"!1[O-#1^+E*97ZHF.AX5TK=E.QO9@9-J=MH5KMD8U?#;5*TNV7X[S
MJ@:U2MWUC5V%& Z.GX7H9RSLE4=&")8-UZOULM:W@I,?+$C8*G>*U4:ZB;N8
MJ#CK/:?F!!1T#VJM1'X6Q[N>E-07^TTLSHDF 7I76Q)S[7LFMDY=+A<&U3WD
MW8BV)9LZ4QW\;K,W&CO=2EZ^%-D_2$RI;B<T[3AL^SR;.D4A^!>AMJNT3[M1
MCKM>PR+JUG[%AB4 S<F)Z,K2+O1A-D2ERC+WN4NJX-JN+CP!9E&_,$)*O)#_
M/-W>:;W>DU[?$Z^IL=;]Y,,\@\EP)"R\<66@EC>O([_T?75OG3Z76+RU*!WG
M_<Z1(OP917!QM/')J@KD27;?5SW$- L] [9*N^.@QV):,?!V/30O1ZLR->;-
M<(81D-;BA<['.<E>'*O'ST^XJC!IP%B/IZ9AQY:S 8,]N\W=^\(Z^!W R\$=
M]BE=?@,E,1_5>>?_44S\WW<4 ?>I"ZMXRBE>X2[%]Z.AOZ2"@N=]NBF :2NC
MFI42&VS*=^K1$F&^QCHOBHSN(FS8!94\&Z&Y0GW'']E-,Q:6J[$\*[RT8:V_
MR$REA8/=Y,F_\0 FL_<J]#_.= ?=:WYV@K ZL:)]/ 4U1N4EYE7MKTGQ7K9#
M%HY .)&_+VI_RD;:CWB]V"S/"/PV0&]Q93=3^G"E[RB4H3W(U6N[ JMY0'EW
M/+TY+Z>6B6O37& 8XNOZ:)=FD<IKHD,6?_[@B1#*T= N^Z1#;.$E#MM3 9<3
MMA8=B/) NY$K_13F+"&,2B36FMA=GP0E8VORAW0&GQ31 A:W-R%@Z,M-'=&Y
M;?86Y!6UF=<7EQ3'1V*?7)=6<)]>RGW\0D+PKGG*4+EV6$G3>+G&K9N'>JVR
M=LB64L"RKT2A>9S^[L7[XY&+SL^[PW^72W645('>OMYQ$-V&]AUAM_M=ZB,"
MO1L[C>887&0"%;<!KTF?[SEJUL! !8Z$Z<<&4@$(SM,%@E[9.0B8!E>2K_"?
MT5/5;EO3717Q6$4$?G*7D'MN4][?Z^\Q%52*,#1:EPQ5%0L5#>A,$%$%)[$6
M'DO'#PZ/C]N,4VJ_ER%5)6HX<FUJ+F'N:9H[(NHFG3F?)"_[""V2"]$I,7MQ
MSSGN:8J\*ZW:J*(G4C31)B[0\9(+F V?&9KI('W.DN5_D<UHDTS/.C?$A+$.
MQR,E1:?6INT'20)PQK3#W-R"T8A>ZPGU#Z0X#B-O(7-)^B?C<O4Z_L>0=U'3
MM2:U^^&>EG3R6A>:*?Y5Y@MO"#L[/=PA$0D25]ZZ.DE[L<]K>U&4 RYR&^&Z
M:&@Y,DV9*I-ZZ/X0I;2UE_#?BU()2[FCT^I88%1P%/J*;MC1VNG<(#,\ 4,5
M%4+*96GBG@[(X21P!W](/\]#NWG$+V7@P%QQ\QI<9S!U=^&Y;G?9EJG$E@*Y
MUF=%&OE&,REX(O/(]UAN'[U>B:EMJ4Q<N/V$9,Y%*JK2I =2G1 VVT_P&7<;
M3Q7D:]E8PN8U B,EJ5FU)4%JRP?Q.F[ GG@(U7@(4$&K/N1;T$C1*%1_:-?V
MJ$@16+R3O"E_&!&%OG_"+E]UKD',GS4*XNU6PR6]8OMJOM.HNWT@S#CI91A7
MJUD7I)1D.P$5&U*U&LTNV'A*)#&8*CCVFAI+_SBQK7Z3?\_4O6@A\ 5?]+95
M5EQ)RO25D3 "X1%+3"!M@O;QCNI%\2-?&[5\D ;=];G;)MY24D9FD' @%E,T
M6FOYQ],])63&T<;7QN+B@>U<8Q*I.>9&3<V=3%BSS+.G35"JA9?!U$I$:3:A
M5^63FLP(<LU''U$&*BHJG*BM)O:TM-6W3$O3$'?\I$OP+S(C6]+E2J$^I,EP
MU_Y"V4*:<>@)YC+GA]L5KY'79J4CM=N5FZZ8[W%0['(?3$V23EFW:FI+2Z =
M]_RI6\K@/4M+F]H>N<0HV%S<@@UWHK.29?P"^Z=&:^3P1SR>M7U+JYJO=:(H
M0$[+S.YXL1S/:_VS1*I[8<0(6E54:#0US33'(:3SYP]A_S?K8:,Z.>LKTOD7
M>E_]597'?@K&BWG>6-02O[5A87J[BUZH^U"HE&EX"P'JS3IFYU\6^TCC)&&6
MP<?YJ'O236QKE49!5YPFZFQP8@S$64ZO&6#2.578U=BA=-]O?^P^5=,8+G0\
MTJ X$I\N,Y%2O,=,BS@,/TT.A$BEG*I)!7OJ05G;$R6-)SR+\))X*E: 5GG>
MCV1,GVH":_/QX]!'N<F!U QC7M#8251Z[=E8#PSF-62^@J'7"SPT+MBV2KD<
MO_X\F)Z#L)%95YFY8ZBO__#>H !SQ^A$:>'!,[\;A8U'LU1)OHS5DG)O/[VJ
M"(3VFD+*;^01EV6TL\P6(Z1,/%73>RL#E-:6/L=/=XUR)-3Z.U>D%6+=\JF=
M=5,\A849K@@B]76^N4LG"(@+S%\@#,"7-Y/T Y2C-:0I"YO:*=]>S1(!8 >$
MD]XD*T&)$4Y@@&J!7UC116'!B0E4$;$E2WM4ACTJI6DOIWS>[5:HSV3^0<"O
M1I[6P<S^SR6,HXJ)G>&[[M.3KK95 CM%A?CX1^')]W&.(X-+\?D,&/!D8CIX
M*NE)Y/>=5!/MBBET1)I7:OS* I$&J:-*4"\4<.-435X_6&>$:>F5R@Z%"4M=
MN@!H)D"1/.+;68W@[!KBMNBS+Y[<[?I92_(=SV$5H-OD][=6O9CR6B:ND5]<
M L6C!97@1V%WQZ3UU.I@V(6J6N53QH_K]5C)XF2TU!_Z27,>IPR].M'+C!ZM
MCDA/G6!Q#GQ.34[<9XTHUB7V+R@3YY>SO!8K0ZSZ]8M;NX ?RTF5%!7+(UX]
M!&E&'%^GZ)" 8OS0>#%I",V'2XY,]=^7J7-Z]F4-,E;-3<LW(C%3E#<-6R/R
M3ROQ]KX>4!!+XIUL:!CZ*\(\>56TDE6Q)R-ZV(LV5KF9X6M5,X([Z]-V-6 0
M*]D]YMSAV\9B]C*DP]59[D_O+<*3(*]R6:=)+^&MWN<];D6H73E>U::J,]W:
MPX_X''MF)D$,46D##>+),'@FQ3\X7:T8,:"8?[9D!C<\"C[?-17/3^XPP9ML
MK<>XGQB4=8<4:=&L@1QV\;ZAJ>FWI@S2M3WJ<,1"Y[T=.U =O5S/J*#,<"'A
M7H MCE]US6,.%O.^JE_](&JE=5GJXIX@T>+/>DKOE!$+GDRWD*T-RUZQ*8">
M>9N>QWTUB4MA%?ZRI_;T#\QAMZ?OBP]^;#A1ZF[N_ROBZ7E5<IZ6.Z=,;I),
M9SN1X@%])0M^^-NA3.JI$%#Z]BM>73G@@?Z^N/#;(*1AL) )X7Z:LZ[1GL%S
M<D;(V_6GTU*SI^RQSN_ON*YDPWB\*3NC-'31:27O*Q6^NIF1.^17*%-_U2JR
MPW@B.W' G98]N YW"+EHE!, F.S<H)\,179"7;*;()XA+30?<H#@37!]T2@<
M,I3[?8[P0?3'(CK:;1V@8P #YQ:#'=#\IQ+]Q,*OGRD#UJ]&%1%#FP&4Z?5K
M2@K%6[ NUO38*95V=W]83OW?QY[3&1P1Y,>?UWA>12_X!LN%%47G4D?I\J$<
MHJ'3:= S"LUF!5T.33$]J 'YP B_OAQ6$2CNDW[2/%.U/5GN+ 9+0'1]4WUU
MQ>5QY.=<S#P>M+8W_7V9 8KWA80/08_#LG*KHO2M799EMJZ\*TWC1/.S1<HY
MQX@YB.8]2[9;CDKW^*4.;4_=I[)]$:FQ!-E.  88  ([#'U_4\'2V0N,V?1>
MY%>V*E)+*,Y+%^9T>M:0EGYH#4XJD$W(T(B$23TL2*8=:0F)@ '%DWG^4 4Z
M&^141BS$B )*>;)RBS"!0I*LA=/AYU6Z&M!CS)#[P[>5/V?K@W'65.DEJ@6Y
MV!];/3B]*&$DHEX2#71(Z;?%N(3 7:CD*\;2PSIKJ<$<Q.P1-@P3O$W'7C!W
M77."F[)\M;^&6VJB%X/6U8J*K?Q"!+^]-^[,[E#Q(;?B: +!<I<S15:'Q5='
MH6N*!3',5U/E[!SBZ<8*-NT5+(2-CY]M(^73.5P:JS 4Q:PK75;N>=$0*TL,
M+!>W/Y1#@H4<R^E(JS=X@PM'A%#?6(<T+[G 0XX <JH+)P#7"9C'9FR2)<P0
M6Y%J3-4I-5.>P$Z5N!C*2%Q':BBT*M<DJ^UBZKC,]A'Z4QG)AF$P?4N_!!^(
MJ"]^;_'096,'1R$)+V<U[ZQW"_S)PL^A="O^!RJU7#=QNV/+(FS[>1O'(C@S
M5Z3/KR-=H5>SI:+-7ML_LR(AQ%;2P"3S9:UZ8&6WPM0:ST+\A@UZ&=.BXAWJ
M+E8_5TURKC9M1>L0#1>Y"S5%E/-O&@70YKU7CW>1DN8G].N;-^ZIKL'K2$7[
M$I?QTO8&U\C$>3>_'3G_KV#1_'$8N\Z[FS)$M\W7@#73C'CNT_(3.Y[WMTSO
M]N3VB$&2&5NXJEN-5;^_<:W_LHQ'_R)+;IZMMBXD"KR00PZ6HF+"DN&7A^%I
M_-8M1+-%-[?\][%GKSHG?Y%IW%G'_R*KIHCP>"0>*DFC+TYT-H)I>@HMV](F
M+]]$S6FI*J(8$FZ8&TK"BZ.!1:5>(A_ CD+/-"+A5FXE79X'D5V"T8:"@71,
MDR52?&FL3$6CX)%MXUKP3#K/W=MUC-$/687<DS3<8'$&(]S@(55^O>J\X!:=
M6W_#5_56JC>=,R%S3MN[+_:7+6V,3;:VHA=XE%,G@:Q;=XNQ6_N/3?1*0E^(
MJ7C3=/,/ZQAY/HV'(57B5-P!6XLBWZV-V1>0U/HH?X'/NM&%FF$CR(W"U.9=
M/,]QOO-T!#+.J-C9_$) ??ZIC),!M9[NQ+4KW>J1O"ZR7KQ7XI*,5%,GEW+G
M>?02R!!0;M8C<?QL<72DL0Y7# PVG_\>RBB<]W*.(+K#DC_C:0=7]$[Q<HE?
M82BT+CMU-HE?FLI&Q<.F(1H#1?O&:1HTVG07BZXGP#15XC32R* X(GNQ?RAP
M^F[KU%V]ZX/C"$9"DVN*CO@ D_P8G:=4Y3[8U%?)'% T$FJE^3ZUKA.(,;IA
M=C<^.HC;R=<!'-4Z@U")5@\@5 ;$W/22WJ>N_51-EV+@+UHTF,ZI=K0G*]D:
M_:7GJ!OYR&NO/SB>E'2 GL/&_+"ECWJO_/>_HRV[8>S'^(M,N.AY->EKT-XG
M]LO#RSN6Z:&-'0\VKTDQ,UISPCL2Y17_SAZ/[$_9]7'/BLGK:#'GIQGN)O&;
M"*9!76&\:TGL V)(][FFLF;@K1R.N3BPST]JFNL^PY.$TQ_];W'4W/6SA1-F
MBB*70AWFY,[XE5[$Z\E/X"^DM/%\5#!:$]KTM7&&9YI#7(KD5!>\I_2/F2;]
M8G2U%RE]G.>? L0 TH8G-E=;#7^BSMA5XO\UOP=^7N9.OSTZ)S+U$V\:B5MN
M4JTJ+@*1)LBEC&6O5#+X/)CY@J^=R$7*>*[R\1=9Y?!/=.">QY-ME3 7[PVO
MI(=:UUUBH)<03'5EJI'4 EV>9+Z4XU*6HT&RZ]HS0ACA560/+E6$/>#ANP,C
M]2.*8.QU7F7[M?43BHBHX9]?_F7.;L.?^MS__?]<3NEI!$U(=?R6M/=KRYXM
MM_>A$&F.I$^+_0#'LCS$N!W43<S>=L88[*6=TD'9Q0-?T//(D0MF>D6*3XL3
MFC8;E?Q1Y\6<8PP;-LH=2I!03*>$#YA*YC8NNF_=N4E=1L!/=PH, -5JBM&*
M8 _>KQ>7C3-2LMF7?IA>CT[2 \?,3149"68?;/:*LUGG[@&QFU9)]4;]G?R2
M(O[DC.$$*G:5H^"V<*SF$I='AY@6<:MG?M]QLLD$,>.BUAE-)'R?YI\"!MP-
MZ!,/H;]5:C61OEF4.#AD?"SGBB[]IMKH'H7:'O=WZ*>P^;/:4XHIV.^J>Q>X
MJ[.8S+&K[Y8!,U^,&1/F]_HA*<R><I*I3YT!XS#3=R-AI<Y/[+?-.GT^.32I
M?<;C#*CZJUQ!VH4_P+1N)?2O?[0.5\V\97*)UK,,2JF[,Q$IBOIW.N._X/D#
MJ<D>8E=/%BG]Y:1G_J,$_")< XT@!E.A'<#:[?_ #ZETX\HH/[9L)9Q[]BKT
MHEY)M7E:2(W<5QCFII.7-/ZJ<=(7-M\)+E\KC/W$/5(:GK@ #QLIZ1[.$1?E
M_N'B[/\^_*.+1^+H[1;<F:7@7J04K_=!G=:$UPG/V9N3 $O>9KC[SSNUKWQ7
MS5T4IH2,9'#"5&-=5=O:%7%*7).:<6@Q+J9'YB^7B;BW'[NA] Z,@T9>>WT7
MXC_9K4^UA%V69P]SUMA$]*,'?[+O",X[I[Q5L3I^EW91(I+Z?)#%'YUX[GUN
ML_;PW_[^T*-B%O"+3"CPCPW1"<M<Q98 X2&]M4BE,O%,8/"A_<6+G43(\NQR
MS%=%-7FMHU!B:7"-XT^J4-(=]XVR!J=?9*\4![L":J_*C^X6M#D&?3ZEW2/H
M/,]^=O&]-]"8OB=S_6Z-J4O2VT2EOX\9MD4&V18:Z-;SC]2>F##V%36>5_Y\
M^IO P>Y!6S];#BOZ0GD*U#@M<?VI:?.F[+&)I=3;7+9U:(/YM<G%S6&;JF^O
M_,//('F9 PR!;^R5BN^O]!U]F!8B='WK>O*77Z17TOI#I.5]CZ$+SH<E%*LC
M5@&_&Z-_DO\G^7^2_W^,_$/G)R]Z!ZP;=+^E[-QHJ=",&QL2IR"G8"Q>$QJQ
MS'O$=1![D<8R?TTMVDSX128'"Y]A5%JR/W$63Z@QA7FZU_TB0S_Y:PI!L?9S
MPFNFQ'IVCLG0E%<X)+>:7K2;6[O;C<\EYQA5E%GO9\1$[@C(E[=DX^B.;.\^
M^_)CA;DCS0[IM2^=4G&](A'Y._"#+U>Z\VAXNLH,#"L1\A$[Z/W,]S7T[SC=
MU2@Z_Q'E [1CF-K<[VFQP(6S\CKV)WTV(N"JGXU?$O,K(AONY/$:CXESL.1I
MM\>@JOB(250S(Y-X@" >RF<>T3_DB#T$ZP\NUWJ_V9X.CV>K&C'<$Y-ROP[=
MCENEHQ;Z:LWHE?Z-?T3A4N:.C1BW;TT545/FV%<H(+OFIAD:%5;0(]:I<TM#
M@S=>G;_)!1L8&OXQ_WZA+U+GH WZC=+T?7VM+' =H2;VX=JIRDT.JTSUKXQ*
M_^W_]!EVQ#]]\I_D_TG^G^3_UR-_X6G^)_-?I9^3EI?E=OT&^-$L\F9=E'9R
M801R^,L$C7RC@W,1KFJ!N74^5-#P(+9@4_&Z=ZF0P6KA;!AZ8C<P(9^?J#K2
M>;C;^=R:;V;[_GC>A-1<17)NBGY,OT4JW+&[PK>WP^TXBS0XE3C14:%AC#_>
M1U/[5+,)EJCI_R+;L^6L#O%-68FP9_8S("P5J2DY&>BF.9?60/>2+6[>S*=T
M%@APT:XV!^\Y2'E81_[].QW<W6N/5TN@XA?@Y.9JCXR,)#(R/GG=WOY'CMR/
M@=K**%@F8)-[8*.((AH>[J>KG'_(.S=D&=C$_9S'[-[=A462V!(?D7A4H*>
M9LP4#$M.^W"[GG'EAL!T\4$"^E1<$_Y]ME6+F*+&21,+]<E;=AN,G*4($@ES
M"'H,RYWY@,G6]$FW$1_=&*:FCFX+_O+&60S&J9\:4LPJ6A;;I?_DYL^XN&'
M+7,+V4^[UYZTZBX4E_N98\1(]VD%7#U-W3?TD\J;0__*GK+_E[T?_*_A#_^_
M%L,_R?^3_/^&Y.]N-WQ0S,UJ)97\(G/=Y;[_<K@KV2N-QADMP"DU)>61GJ]Q
MGV,N((';[&&!;>#KP*_VPD%ZE/\X1*'TWQ>XXS$4'1:(<IP:.W%Q;,G+,E%Q
M38_>R5DB@?I1V4@MCMB8[W).=BT-&BA?ZBRE#YI:8<@%^Y@6E\3 L(CW-1C5
M<RJ-@YH.'R; EO,*T&I;1K;#5^<;=7;0XU=H86Z -/!.!&M!<59NR9L<XZ'!
M[V$@H"4C#YI'@>E,6)2:\Q::$<7\TK"YKX"3'F!6*^VVE8951-009ETT4C^R
M.PL\TG@!T] 7^>.HS;#L'_D!(_58D,^M>,M:M>R=G'RYW8]4UL+7*ZJ!]QS/
M!G.40AEC65>&'<%T<9HH.S6SNZ+Q.=Q\^-QT0_! DZ9&JX9,A9*G7G8;5*Y0
M"E@2)2!$O6 ]A;RD%*O.#"V#N2?F2)6WT@L^C'9$VF&%1Y]V7X38H>:XONCL
M])4A7X-J7@'NAVGM-8#F&<S4=J$FH57;6QI[/[;.&O0^C?JRWIE4#SQEA<M-
M<4F1L 8VZEU'Q]IB9O<GI K]0 (:^;_("$C[7V1\'=A^\=R"[?G4R_&?$<%Q
MTT*X;TF^;S65WLW],W7\?S6 L$2'9HG;/]X5VPY.K%Q^A1A"(G<K_?BVVE^@
M7GWQ-6EECGZEI2&VH#;1W\ 38!2H^QCKLN(K^:KXT>Z+7V0X?EKVFF1;RU9O
MZ"SJDNH?;Q5C22>7!)]>\9P48(25F^6;',W:*,9+[3PG-W&036^7B"W8MM+&
M;=A.1U98)S93GXOSR]6L6/<T<C0?B82%[ZH:"'[NMG*[HB,WO._\+,!O5K!X
M/_G()N(_>J7C?XRB9@JO))'S0;G]L*6$ <S^5,X;P3:7#;NG:6&.6M[!CB,(
MC$=>7\&28YDM<7#HHE#_<^N UA.^>MWG6TF%N& =N-[/[ S?!(LL#V6/@O&6
M0OZ=V>V;;OJ(M=='7]:24M8CZ)"E#HR9[/BPO)R-Z!B+9V$JKUY^;LD>^G$/
MD*>X;5)_M=9>;53]8%'=B2=C]0N^\(V)6M[<27FI:[U*,[)[E:KVXR$U^Y2-
M+%1!?D-0IH)3[LH[I[<X8ZC $ Y^G$ 5F^RI\E[,(!PU/!".0CJ+@&5]MER!
MG- M\4'QH=O?&F(9ZR*BZ,83[R.K=$K[D 4'7\=L7^5V%%:D%;-5*A\\6I+:
M7%Y*Y)_[R+2P*FJDR8EP- 8\&9VI]M^Q3C'+O#(-^$561+C_UF.B=%S@=O_D
MS\)4ZNMR$][=MMM1,5U-NTF-9F97:0W'5W<17V,94#*X6?10SENG<1(D#SQ=
M\_-YH^?]6PAXEVO?W153-M57&]9>OG\E@,)LZ >3G(\XE3$O$8*)!ZP._1-A
MI'/C@Q:3CVE0D<C:F"]%)>:H(O 3G_-4X_5W:\<SO:7GD9-TM9K#VZH'FK.2
M0"M'W?+YSW&JRCP4$)#NZ.LR"MT_VL-K>1ZF<J<D)BGF\PUF:S*D2O.6WP7I
M I""].RLA0(<VK=_O%I([O7]Z!C-'9@)4[.*?,,@)6QQC-7ZLN(]XM,J$D-2
MG^\S,9LUUPPVA5 V<*DM]F8I:$?$T+"3#"*-A].I.B/B<H&F?R;;]RJO?<OO
MSIT; R!*F-9=R"]?'60.(*A[Q,"#0.4".\@>VD*]E=X;G$^I-MQYI!5RZ+#Z
M:!V/3US.+2?19!?O<M0T3L/?,84-R@XQ#XS48R,P:V_ ],2BN\> /NUY]<(A
MH9.B2QWWB-'Q'M$PK'I+T:'FQJ?Q^-R_0K:"*W6O3I.MT)CFKRCLX]T%I^FF
M3M&WS&HQ]P3 Y6[3P[,=ERIN5WV6RZ'^L^[FS)<.O:I"_^WL;UR#R '\VPFC
M?WFBT#]<7VZAP?VMNHV_^72DXO Z[@_0&GZ;>]S,HMR2,016SAI8ZI2[*AEF
M_9AOZWM$P6OC&56&&>3H\GBUJ^-25:-!&H]4G[H[[#F'Y4-R5-/49/"33E64
M$H+PRC^U>?R#''L!O5;9J'!.><SZ<=.A&;+CW *E%<&C% _%-ISB4^4:;JND
M\&]PR^S*&G4GC72E94@3F2>]+J0/<O9<W>G&4OW%)BVYK[@&=H;<:QPKS6LV
M\,N>SLCFQJI2^CA_'DZ19SW1ZJZ;42 ;F< GMOQ"U6^3EMPY2(V:D;'CU 9P
MB:_QV36U;E)?5X5?Y3@_6(K7)V>]Q0SL.TQFJAX\KV5@3:YA/1[3:7?]L_(1
M3G4(4=?K=:-<YLNP8U2U5 W '&CX1\TAY, H4K,"38FY<U7A-7074;, "*B&
M[;X5H;*DDD!5/D1%/(TX&&Z3*RV^ &7)")/RX6K95C6F^<0#)O->:(:MY)=>
MQ3\,6'BLU=TZ)[0=-E/E7H85[/?#@I0[M1#L<'VNBU[D^XE435[1R-QU6N.7
MYGV]AFO=,2)/#\3Z7&M*8ZRWY'E.I88P9-WH!6#Y^-8H2Y!'74X'1.!L/>RV
MF^PX%2/\R\E4*:Q"-:=M3$]M:(_^_GVWM#LG3K-HB-7D45ER#*+28JTB<J5&
MHK#28Y*SN.$[CE)R+X$%#08M5"<@A*["L\6@%<[=Q5MC)<R%RECV7H-[N!*=
M5.SGM\QA\:MVR_7"#EPR('Z&4,CQ+S*5DY%W)K"0AHU$JER?VW!,:VR\/6C/
M 9Z>=L%B!BO:Z?*D!@#RT&CW1]GLYRXIVJF(W]6+QE0P#B>%DE>C3OVM&PK"
M+S)9^1PP7C&8)+.SY$GS)X97YZ=ZD]1N*N?=A::\X8_I&6],XM?:6,WB+)_3
M9NL)<P5-AM$6MXV!\2F[@17?@-53UQ8WW4Y<!H\'+K]1)%\]= $?0AP+A=2\
M8!*C$EGM58=2E1^;])YSZ$J:)I& ZMTT#R0\:[EI'_9Z,?.O<G'G,O)M3#2/
MUYQ87TO3]!NF1R2.@(MVJ,& >RIOX/0Z=U6OWRW[XN\70;X/32CTZ8I@]ITF
MZ0OS^]PA4V^YOQ)C7_C'=);\0+(D&A(D1JE88P3$^9%KFPBSJER4W3_"UP=D
M?!5V<46@F![\.WIY,M+8I_-.<L[6K^387!J1I'$ NP2C 0L[%\VA'IWO6: 1
M6]TQ44O19*:84&OSQ/=QQI?.J#])XSGQT'8Q_4,7*M@F[$&53'KJ9XT.N*2(
MV;5KOJKQ^PV*>HGZ*<'QZ9_:1Z0E.B;5X*6:V+#7'0L'MMQ7G2'4^\49/PQ5
MDH8,>5I:TT!/A[JTPE1E;9Q4!S&GT?M-YBAL\"QWDKIGJ([T'WD,QI4.*Y;
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MJP>WN4'6#&P[#"WE!6).JS57FXQ4_$7)")<&7-T!"@Z.4K,3@M+>WQ$T2%>
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MT[05I1<5L>*FGW&OK]3&'V0MCL2GIOL-V[_-6WE_?^)-A&/NBVY.Z!0@P5[
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MVG$_?^G('E^O44OJS&[VY9<-#O;NL-<H5TTSM!9B,W9^)RFF;0_[?LSQA/B
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MP:S.M\Q$4$01]F6]K/%UE++_2P$07J^A]358Y]E2\>353I,J \%'3'"]U#
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M>[5B]Z\-PB+7>]:"UN_%BJEXA"<O&00W0S1'??VM_%<0P]-RD$Z6'"]+:HT
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MO%-NI8[J"[#E&Z)?>@L3G1J+I@]NB%Y,M#$8/$MKQOZI&NNW:P5/*A6Q!B+
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M4(7 ^O;N.$TVWDG0*UN^4&\#5=%*^P<VMJDL.0]GZ!9^/YB@:ZA\?8]C)0?
M6:%2][Z/_./?ET*XJAN7_Z;\OZBZ__T0D97@3^@<$0P/,T8&JDRRF.D^04^G
MQ4I>U.+%I[#A]_Z)LC*+T,6:OW4JL@NM&W(G@)"FOYLHQ$)#XGPMZFLN..L[
M#)4$9JI0E:..I4'+R)=>/@VL+=(D"_:V5:VT,4+2#8;U+KF2+AI^C8]<T_^0
M&8D6G4Q8;8#BVSK8\K-KB6I:2=_<^^J:8I7B):$8H6*V&=PSLM+,*0>SF5)8
MX5OUZC;YFE!\,[>>*(JX.#1">QKS>OULT-TYA=#L=5[QSMFXH=*'NV/EHMU%
M JJDA%T]I8V4V-FEC R$W<TM7["Q/^9#%C6)8:X-LW?=W<LZH.\'(7NZ*SJ9
MX]1(HPOV\9)QD7 +K'.'U9G;"M9 !QZQH:=]X.+2^-R>H&B55WP-@-"T/1OE
MZQ" <1L&--HGVJJWG%&0Q\<%*+M]1G1#NHU_A)OE54:Z_7AR40EI.&X3G90*
M>&NG^T6HT#^OV=#4_I[]["^\K^)7@%5,R@>EJ V)J':C9<\V!@>VMDY[H40=
M6>R^2%EBKX/J$UO[-YD/S< FB/Q7"2?CS=YZ*JJI\,ZW5<$I):\44GLM@5I'
M+LE*XY,[X6D>P4T53E\IH5^1XC:C*S"[O:!1M57S4D#&Q<L;VIJV(M9,Q?$?
MS_B&P^EE^QI+ZIS6DM2D]+GMTPV$)R"#ENWDS=+HK'\Q<_ ?:5: "R[_)3GZ
MJW 'T-PZMWOWT58^"Z[P&'VYM/9?OA<6+46"?@8/AHOZHFN4PV&R?!P#HT=L
M</* [^DFT>9_^>YP^9\;>@J_;6:_*-U#SWN)G8[GE5<;M+0?_R,;_L8@[@%L
M5VK+L37G;7J'_=)1,VQ7/;1W=OTP^^V4);GH^,D.3-,$JRW )B.,+"(QV+<+
ME&;)=V>VJVE078"Q5;\QM0/J/S&FKINX"JOLF4"DC2VQ4.IR_M_O#]O81/XI
MZE!+8Z 6[G)]$V3]$^5B; 4/TS&'+P!3G2#J;#Q25$/5"AIV"*9J+E,:UA;5
M^/!U4@F#P!.80;L-NJ!7\69=&=HDHE>:]TXX6_OL%YY!W>K3R6&NONG!LTWI
M8IM?>,0#3)VU5:&^P)O*>NKQY[8I(A@Z?Z%4D:\K,T CZ_$50M4*+IFC!"LR
MCNUP22 ?OR5T*$B*]M\]++AZ&I?_IOSGZVE"HFV)>3,IKNF@=;'G$PA3\Q3W
M++4R],+[?)[LB;U9>3MVM1B5[F7>#;/UJ_L TL>U@%QNOL8"1 !G]_=N@ZWR
M 9"AL,<,>$CT@/6;IOI&%ES *Z<Y4W<>HZ&WU^)G+R[5.$)A)L@] !_6G]RP
MTFHW>]C3&UI"NN6Z0(<FG5D3K_OA+A6F:=6W*="([ZWKOE!<1<,OH#G34-LY
MTC&6^O_<.T-G8<C7=*<]'HF&6>7,FG#JO"P]%\*?L4\9#"6%AY,=5]-F&<IX
MQK^F<E"4+PT;EFONVYN+&4^-*$6 #\6MF7WU>.0S;T$:J[F"[KD5L]HK95)L
M9^UJ M+T:$.9<0.B^N<_%%-,Q!'9)N>\V9PBC2@ZI4?TN0$@F=(1$0MO91$&
M;44#]5(SL3^*%=[8 (-$P<[Q\9B9D6"SC__>P?W?]S;'!9?_DCP*7+Q67EQ-
MO%GX<]TQ0]JVS3/XT8N_5VUE/%M5,V 6-^*%1?9HNUF7A#Y/C;Q5R$8+S)+Q
MPVV .!IDDF;GSU55[;:&O":%@2QSP>,&XJE/[,_SM]:?WVP=CLV=&#,+(;A3
M3"&3PG;1CP<$YGKI4^]"?</F,>;"XZVYM+_P1.N*X_GP?^%5(Q.]M;/K-1B^
M"])-Y+'JU8U-%E$ V%+[@MGQ?NNHY]:LVU4\\@D&GYN)][BNJE>+*YG%67H6
MK+M+1(YW;3[MLA]%U,52TW#%LDX(#Q :-&0Y$2* T+CX74Y%?!LX1P:*3RU6
MV_RWC=<2W/ K-C./CWM5=C3(Q< [&8U$$UBNE[8CBKT_V?267+5@(-"B^#%H
M*V@WHO%"=,B3?HP7F2=&6,9IE@/5C\@W*.<I@=1%"@VTN=F;Y*7ZZU6N7W.[
M=;TQ2"3ICS%9AY; ("D@BZ;JU?1]4ZJ[C[":Y*=Y)9.<$RH0UC7&RH<@,9*Q
M#4))(.'[#V/84EVM%F.[&,(BGW692-[AA:GE&3[C5'BX0(U/3D=T(S3-P ._
M.GDH?6?/$(0Z(<@F* []%OG8_4*!L?'8^6DBI^K)#K87DIY?1C$_.:"91+WF
MBHI\=DFMXAD[G4QR82&?, @V T3L,$2S26V!RMNZACE56P:'BQ,268:Y +&Q
M1Q1I9Q4*;14$IT1_XH$]-CWL6U(KL*+]QS>BJOWC=I<T)=\A;FL#-L(LT"5J
M=;)3&,S$<5,Y/D'9,Q@ W&22=PU]16H5-L0'BRQ8]#/;2VY4MG;QD7Q<>]5V
MHZ(X(2EP)I$.3="QNO[1G8FRV@4;<ZJUESA]:?W4DQ!J7-OE506T+4[YP'^?
M,;0DQN<S= Y<^=7]@H>]B_?5 E,4F[<NY[>Z9T9\ _<Y#K!%@^^PT%%BQ>*J
MT\BQW>K9^C<;Z7:4<[Y*=:$?SHIRV*)Z6=W'\XBD4):]^OR8-YDR"T+Y '=J
M5< JS(7*DMA"!WQ \;3+("DYAV2YXK6$E).7E,X=S.E[0[.!&8C2>J)5#I-^
MNZNX@W7I),UAY&_GAJ<:B7<!07"2\GV5 =FD*9:K&OT$(QF-\7VDQ]W8O(GF
M]Z*BUHO1]IQL*2%3JI^WU+S6XQ5.W_] >W:Z"'@AL[4<9_-DLX3I&F)K]$>:
M&E*!$NQ/@FQ")].TXF0]NS8D A%WKZ#'H28LR3VP-ME!28TRI&'E--'K4JA0
M,652T39&DZY?_,XJP.C//J<;827?OKA9T\ZFS1F5@:ORQNZ47>%V<CE;V 1C
M-R>K[V.4K0VA>%)-1.XVJZ*YQO02GG!9OK%KM:AAC73? < Y1Q&)KA!N,GHR
M_XFS+_Y<C'FC6E6PPC=H*.N#\-S!02MQ >USC6&;E3A <?%BTQ@DX0<LKTVK
MGK Y[-4#-AF;J,E%3.;ACM&NRQ]J<QK[Z0_CD/JV8JQMI[/#Y0ODO:7EJIL3
M<&C[H_N!\1(OYL0,3+4:HQW9">N3A'YSL+G 3I*M^O4G-Z;N86>6K4R6AE)6
M!*X!UWJB\V.VZOE)6']4O0N/3AW$4F0Z4"=&8^ERBC )GX(V/D8/VC/L1JR>
M;H.06'?49V=N8I7?W68MN)^?5FS<+=LCBG9;.7@/3-H'[KO#OH3Q'SJY.EP_
M7]A<6)1]?;76TU['<PR*=4GT*A@1_W$5?-F(%/OYQ,'ET"&'X?;$9!__%7C-
M8+748#4Z.L7/.SS/[WOAI<S%-<DOO%$V^N^U/7P*(Y+_W#)<VDSLZ*3%@7Z
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M+B]%$2NRFA[A3<+N$SL7^P*/Q]<W!#>\(USY*S-L7\""IT-M&Q31R^0ZVI$
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MZTQMT 733C8?/\+VN6G.#UJMC^]-&T;\Z!%X&X/F+1&(FU6@5=CT6G6SIWT
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MKA_,,6IS:^GD,R-O[&^>FKVV]41(/T?4>(F84TZZ5<]GOOXCEA/%O<LH1!5
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MEOLS+L:OD<<NTPZ%-C$06'"L[<A:C!FOO\?((C-#=39B8Y\6D:@]O*0BX;J
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M@_EIG*ABVH_Y#G._Q 3Q'4<?!@WR>%>UX9^0(LWHCH+?2XWOR(8% &:7\(]
M"3,RQ$>YML&9/K(UX@$_):\91'M3]GVB!W.34CR=VM\5.!\G'%9]W/8BKN,Q
MN<?;\/DV+UX*WNZ?>'KX2V>G$&_H-:DFZP=T;<MD^9/J+.TC=C,Q3TV =8X4
MUE>JDK;^1]]Z_W[_D1:J&U6=1@@<?U;S5CY-_>#T3@Y.ESE3JI<::H20B/^M
M7E)Q>GZX3CC[I\[OLU_][G[-=E#%MR4*ZT*W6:=BL:Y7TUCS7[TCP98'IU[F
MR:=\ZTO<%BL85U< *X7HXAA- I2Y0.GM=6]0_@BO507_?OJ"OE-!TV9-%J&F
M&O+-MU_]<MSTLCVW,CT)KP;K 0T?NP>H;%3 E1FI;.OAL"'>]J:9<RF%4QBG
M2;)8>Q)C'5"8'3"&5)\8-OU2(46>#?%RCMJA8+"V7DUZS-;I_#M.R"U;3J-V
M+5;0QFP.^5O]\;BB"3#B<U:TCO&8=N$4?4%#KY/$;00LUYE:L*&%4%4#4)'I
M';.9\FW1%<.J*^UM/'C>L!Z5J3-WA!9TG2,_[L?7(>42_*AH+6_'A!%VPV:N
M*+*YSF;%DPI6EWKBX9ONVMWCF2Y^#K;4,[]0G>2/;+Q^[3WS)?HBJ/Q[, &W
M^812O7-"L/+!ZFDMHA A=(_'T3]JZ $O!G_L]H4<E)7M9=*9RAN:)$;JA^'X
MYJSV\KI$-O%#9/!?YW5C+0&GH*+G^%N'Y/NC,'P3EH2;:<(%^@CGD7L\&&9B
M@H%@L>W9V6\BV9LD$\9513\.!&E)=.-ILCMYAGK,^W8C'\6!3]@55'@:I5)F
MOBS,MM:> 97"WQ5%ADTU'2&E-JTBAE^N9DNS!?AI7WF>1X_-&117"<E"^+&3
MK1T]0!TVW79>)P< <-+/<9I.5SBIP,C"4VP$0(5C4_E2U\<JTE8E,\#O?8]W
M\K)ASIQ-XHYRR-SX#M'9<-:.B[JX66-A;,LP717!ZH1]@[?D/7FCPO&&%&7Z
M7%4GN3 B,3G!A8DW[P6J)ZB.[_&7J(;@OBJBCN'D2\0]'O;3X1ET:G0EX)GW
ME[OJYJ$UXDO*[Q<:_>^S^#__*[_]3^7&+GR?:\9:ZH\LV/@2TO-KC=+[33"B
MWP--1G\KLQL9J4V@%@QXD22XFK]#G%X&FYH?GZVCT@A0$;DD'O<&8..F^CEZ
M8^O38CJJ8+L.Q(M>4K$C^^OALZY.+8/8B>)]B4$DQ[<U#71+"C>T9SJ)E:4O
M)J;A99L1K\N4 2FIYK#F&,#,)HU=*:+&O#U>?.W2?)_O)'^^:KE.74;P>6!D
M]BTI^8GNJ89T2>HM4^^(4G9 U7G:Y1ATYG"N.)<J9#9C=(S?7%A6WE\3<*40
MGQTO]K_<X'&-8&Z^99M#4,1Y#O@TFD&<WO6X'6N^J8 Q;[?-#+ ELK23E>\.
MF+PEWI?";%/(N$FMK0?7MX]$P]J#AH4NANB[1H(BHR[+KIBQOL[C/ $XW]Z!
M>SQ(,)QB,>@V$_(C7?K_::!2_?%RH>%EWTE\RMWX/9X$H.GV6FAB[94_J?@5
M&_=&R58\9+U=N>8D89.!^[;HS@/L>7T.*>EY>\[F?JH&^E,%^HG!H 2K3>81
M&= U\&8+O?MS;T(SYNN>VN96>E5F;O[? OPMP-\"_"W WP+\+<#? OPMP-\"
M_"W ?Z\ H^.B_O4S%&'SBX\6IU<GDQF?3+<*ZTRCJ%@YWN@F9B87<5P04^H-
M24=G(_F>1O[S2N]Q'M\?FX(:XJF6<[%^T!K:U!!.A%$"TRAM8V5+E7892S[+
M<$42ET#,> #P0]N[ZF;;LT@GLX]Y,IQLN<R\^PL8+TF#(BJE6*&9B.O5C(7_
MN@3'W_S7\(RP0K)T_OF2G8[^[MU:/8V<T[%AXN9:"K:S_,J_V+WJ^Q??TI/B
M<?EA 6H5BAI&Y< GGCTDJS3&XRE45 G/$QMAU.PLN9Z%7EK9]=TBS3V-[$7A
M!:_GJ3,C_+?G"8N*<-/<#I]U'#98?=FL+_EJ*'CDA36MQ-7;N>23&0NK$F$<
M%^SQ#U: _]@I]][BO93]Y?>.[X7_HKF/5V; %AAZWRZ!00YP9=/.^#Q4!*ON
MZ-I=T<_QAD31UM9:7OZ!T0FG<VFM(2%V#:,O>@9#3F?6%M6$._[22V6$/H$.
M?3CY,8U.-4DAYAAFG^3O@"!*]-PFH@OT[*9I_]J[#'#F^''XW)=_9<>94Y*H
M@U[31X<H7/)!/'M="^GH>;#%<5/VH6C?VE5!;)%I)K( GJ'K$&]]S9ST[G^V
M\L&:+L[G7&YN":^MN.7(NI=[KX4(\FCTZP3V'J\H1+(Z-[B&3?0>3[Q$G)MO
MBK$CT2_3CE<@KG[L7(G]'Y?34P9O,P?'@0Y]'Z1TN)Q57F[0TK[[=^7X!X^:
M#A\<JRXRG'E.+V],L)%5!2D&^]T]:&T?4#I,Z_"8>+*=RD=U O'[PPM<W_K!
MD8*JD;!_&Q:_?N)M54HU] STJEU-+:Z7-*U @E"3Y!B=*"G@M&<QB.JU4W),
MAW0WG()>)&>4O.O_7H5%0<KZV5'GQ'81*#=W#2Y$]F;?=L9E'S4IHNE!:;/F
M;$!%ED2PH6O9A4'![G[1PQ'2Z(FWH#ZW9N[N(^-GB+8J_N;6@3)]IC;K_D_<
M^6]".%5CRC3%@-$][#14W?,H8VFGC1&Z'K#[3)=^M&T@/4W+<IL=#?&\61S.
M%^IGAR)@G/1_F6A?7_#T#3PN@\1M_S6<MO2S)(548G#U2Y,LB%J>'05+*,LX
M#Q3;Z#F.7S14\I*K?XPN!TX)I\OT'<M%-1$^[.*YJ1BLV#,=]@S6-HW0RAE!
M48^3<7@)6LB?CQBLD7W[7/=K,5-R$>JYA,%.&NO,HKMX>'6%G TD:=H*MNAM
M8]YH'$E)/J @T*1G.[2MMMV,M5.$/DA$G@HZC;^URXJ,)V[L-L'U?W/TI-0S
MKDOM_+'FKCSQ4JAAT6.$2X^@>9LGC=-15RFJ2S2B6W'@DMN\8W 7F%]](.U\
MR31$QTBCG+=4.>#YTW$\;P;%+3W1/W9Z^_-3Q _^1>4>W^QXX/XWJ/C+M3>E
MPYR?:;;D8EEG37;Q9:#="<O+]95&7M--]M</D65[)CI!I*4D!ZG+-(V87C?\
M_DG,)(7[-FR[8DT:?Z!X":%;[53.8]$GY]P%_]61 +*1F@B&_3YNK:C(W*/7
MAAD&+&FF21!49+$,5+[8OPLSY]8_K?TMS2H?V 0NG08JVAF!Z C8%ZNZ//GM
M)(#E2F3MJ2(Y1FFL' /K/[DI(4<0<^O:[D[5W'>8;_T4;W\!MCK=X^TVUQ/M
MJ4;?XSTU#N,7E;7GO;H@#B::"B!:L9.XG)]7-C#-ER!HN8'5PS%C-SD:<0YZ
MZ?M*[#,E5Q&K^RZ#CD^?NS'H!_'!9Z0?IGXKRI5-RFRDS3&>T'V%T:<I#Y&[
M?JS&<M;9H9VE<B;*,V:J,Q%K^:58U#1KV\ [TH&741PGL4;L9L)[]4A)^30L
MPT^R2E$AQ3U@E625T'XU1]MUE1_2@&)%"OSX1TX5\[YU9_L-F@-^R_F3M+"=
MG7G!<HT4>:%<-A&2\[;%B*46RMWOSQ.'Y'%A172>,_%J'Y$\S_"@$WTT'#06
MO;4,'/L9G!;Q+CB+(>_2-L_@8+>(P7!-D%D/$UZ>$2HC:.G$DCC-2<2;E>9@
M&LN,\-Q^IF-]E2LM?!N#HA3$%5@K].,RL&]_7YJZ='3>KUTC9RF#.AC[1O4%
MK)GOIRV)WBZU'R'S.D:IKH9:&'[E7KG'8VJ1)1 !;I3?XSG(M4]A0+*A1_SS
M#ZXZ#@5CE'#F(2N2;(^<>O[CB0/OG]\23)0YD-UWU#R+65[FC621>7/(3,27
M?+TY0C?RUU^>B&X_W+:P4SR "8&@([KF.P!(JWGZCE"AH'/\]VG.]=I;NM](
MUU^W#[[E:1\Q#<Y^_\OD";>#W,*)Z^8UIG&4[LG:B7KIBEEZIUYQP_QT_@5G
MT2Y"#\8*=V;03^KX;G^()$E%478U8%>^&]<WC:/]PA'&\>7>AS;4\.QU\?7K
M'9>14<ZF7)?K)Q[C=O3$:K[3Y7F_?TK."R.9!^1QJI(D%T:@4VF>AGX%;[FD
MKL"6R71,ZJ>OJU0>MD:T1^:J1&27R(C,W^-]=^%WT?E/+HG_M3Q(^WX5 H<4
MW9B4: H^2WO2M\*10KU+T51=4/.:^(=("EOK.:V?8.@D&"@LLJHV7IBIUJ?=
M95%]T0P;87O1"#E286NQ 8*J##,;;74^SN!#98DMI3^<-O4/5VX+N7NZ<_V^
MB 5D#ND:8AT  ,^BZ"B@*U?=!0]C%*(LR13$F"76'_]BVEYN#[-?R&UT2+]>
M3K$>US\)1Q4;H.H;3.C1:<],S4G](M&:+95[TY3\$/4MW<FLU;1?#Q&\PAV:
M1S._]?VWJ/8W_Q[Q@5?-XZ[4%%FJ6ZNQ];N/9WDF1O9A&U.Y3$XCVI9V)>LE
M<1;CC""6L?YF;O,G?8YGWRYS9.M<,.W30AYD*\@ !; I14[:%SUNMV Q3'&T
M?69G\I;(BH>@([5WV<6'/*[I,*\LVVGMY1 [XK(S$!G& [MNH1*H GF*:^AJ
M<*.W41IX79HM%Z$AX=.BWRBF$05L,%/LC@24;IL>@T0ZF^*S/9NA#R>@/=L:
MI&.(I1P')$_6GI&X6B"HI/THP-&?VH9KH%;$W7I(%,2%[&9EN1K-$LHX$A1*
M\7?O-?F0[>5E[E/"L6(!R#!H(S46U9P@G)@9ZPU6]VZ!9T&#EI6AR#@$K_L[
MO4T2E^OMAPS9,$+;/*NF]F3^4!.@9W!U;Q\D,XGSF823HHX.K*3PAU@ST=5D
MV4V#]I#3R@%?Q/+Q8>+,F/-$/^H@,<M+*&_ '_#K0N/T8&U\(95GER,V&\MJ
MHC_<D%0TM^ C3%Q;LF,A4D;B6/0&B9*WEKC6QBG&,\F!1/@_M9R;=^=V+G$L
M=@Y@L<:6RK MD8=UT"U:=HPT9N@QB&>GM'!-:([\5+RZ=H!+W#V Z2SPN:F<
M1 EKD?UF)IPYFK.(U=$H(0T0@/C)8]Q<O%K.V;&WCU#8DN@4M4$U!:9ZE&Z
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M&/62;WW>&NWDL0)K.0$=U6<[_*32W9!"COA]V9%L[#QKJC%&Y/J(EXD=,X/
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M'*+O472!\S)*L[&=TX1"?37&\T]KD@!1M-5K/DJ/!IJI5%6D[I@SOU350:2
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M *X+6?&>/)DZVW-3ZV."JR"=#4<W5&6,MA"W3<<3$FMX.;!(BC5-&.FQ<*2
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MS#*E)2@?+6,<Q%Q)OX/&IO7;ZF]I;2TU;HW.K4!D\H#=O)X8J=%CJ/Q4\X)
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MR7"ML]=#J&5WE7Z='6Z4ZV$ISXT.\1+W!E4)[UOV"CVP$<8YAXI.7M\'Q3J
MI;TU%E#SKZ*<V^13GS1\E#^<J&:=.E7!$:?S6.GLODX_WE[C_I$ZLCLG 2;^
M&_OZ])-]:1 AM\]>VMN>=ZM>V_%^"^_S>^V]U=#B._9A*XES)>*&P/*Z^H;
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M3#EI]F6GK>"1H0QZR8E./#!#K:^&FN\;U+V\,H)A<C0SU4IER76L(7N6Q,*
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MUW91I=3VQUN[;?=2Z91)=Z?'?5) AT?V=_+JH1RDY8;D18JTM'+!YC6U7?:
MAYY!C^]&T!5K8(L'---6*(&S&D[9DX6QFB4"[CI-=\W@9SK/>"<V.;3#80I@
M/X8"B9<I,H%5]O9![\S.2./5/UI0I-)T/JML4'X^*__Q*API/NF= Q$@8:K]
M;J558$&?/Y2,2,#/O=?0D<,(.8K&>_[ND1*EUOP T\V!18$%].OX?V@/Y=HV
MK'+I&0'T E)+0&**C5Z367G>AL2PG4C5KBS[61?]P5F^NYDSQOCQLH'F=]2$
MS%=Q9H?64QD?>'__WP;6?\D_A$8).+@'E@I($3\4:"M/'A%@/QJWF*"5%'J@
M_$W6 >S)NV,I\W;R([Y LW#9R9Z#$?(++ZT%6^<R?_TJ!V]"-QAI02<\!O?B
MKG6(;DCA^H[\K1,A]:2-/UV%?\7-*FB\K:'-[L"+L0F-L:7N*DJ+@GP>&XO_
M;1C1&[(8-<)<HQ:8']4C_@((1Q[/;: HQ8CAJ%@4[^PT ?7WR1G#H0)T/W-P
MJ:B]>N&Y7.B2;L076+QJDIG'#D)6\(5C3'^H9;'#P%#H@_'I$:U1YM:*B 13
M##X7.QK,U662^O')=M,[:51V45F3OBF@?\I9$=5["[7IB,;W88*2/.\C\O3U
M#>Q'IQ0!3P11E#G6^LIA86%=7>W[]OE7OTM*K,A&+CXEAT7/:"Z.A"-H*QJJ
M C5O5<W9S-6ZS$;2OAAA\=7V_85&1%Z*/=LY)CY[8L0".UV6#$L_:M]A-3S:
M9"@;/%JH@KI.&G %/4^B&JABM%6J $AT.)/#\?S"R9NZC@:F&OA0]CQM,I B
M4'!A4D,'?G&@T<RN "J(0R>C8\9D4<_D:NYD4H>VLB/NR0I [HPH*[PL-IVI
MFR7LY@1BU>F8X'(!;Z+)13-]%%)7S-OC<;RF;YAY#ZT1'-)6&<[DI&]Q/,X!
M7]:9A@AG1?CT^#.#,OV=O6".^:=:M++#8H;/<UJ<W _T Y:3!.+%,/; 7L>L
M8;-EKFV+4VK:]KR>V&R4M0FF9SF)[A<Q _LN5Y)P'5QNY$-.DWE@%"C2:OOI
MG4.E$^+,9(42?#G.4&TX54GUH-&DU35:)T6NSY$3WN7I&BY5/<QLCD(=ZQR8
MM"1%\9!SA](GWM?/>1,V%025B:+%@=-^@0=V9&,+@3P\L5_0VM:]30[I!K@:
MB5+;Z\4O6%8^ ,400&&D[OS^07?B!,=>F"">[8-1$<M/UFXZIB=B%%#/_,!I
MT@0$9]?+CO:$)@@"Q$+!I$ILLC8V1/(Q934V-P3"F]D=\@?\"S<$6M6B59JN
M96H_%,@[JAX_",]+U%;AH2/MJ7Q3_60,MI5<J%OK"UC^58Q/M&:F.G8IZ1%*
MYV%RC!XGT2.+'Q*Y&T7Y7:#V/-K8@FDQ9GFGCI_4?"P*IXXK*Q+=+)O,JPKC
MN(O(A;[!]BOV'*7HLI?38.MOC4I\XWS0Q;IPAE*L^[0CD#;V=AR<$VB[]:W4
MH;2[UNF&P*+*05IJG-@)DZI5JOA-6U\UMENOBH*CD4]R!]?D+#B&EL[K@Z$G
M1.GW[?FR!"?W1HH?3Y2V\O:Q"+4KP%(L1^O-DF(M7/IM^*3[8C?AG\V'77E[
MGDYZ0SN@J )"U[WUTR=5%6(1E>FAVRF:5_LW!-=Y4I>&-P27KQZF8:^M(K>?
MG^<=-AC;^?OXWQ 4#-X0D/]\?71KFWO%X_K[1OK OF_E#B.;WN_W"B1;[FBQ
MZ^C$F.J,29MT:]JQ=EO2L,&3%$O627+>0.T43+*)D^.K233DVOJ<)D%E:HHU
M<L7%Z0,&,Y+C^+7%X?Z&T4V'E*4Z7*'(QZBJ\'4T:\+0,J7M4YY&Z8[#3>C%
MACY[U<HBYM U<;' P7Q)P>3L"0H'TA]5)*/81$^7!.#B=#)W'S\HV.;'9AC<
M$*3P-$S?G@0>_0"R+/!-N8 J:*V&1#"(NYF6.GU#\S\HX\B@$>9['+RV!24U
MFI%C,QHMY2M;+#WAE+7PI B?G![IS,$[SF2E-4*O1R1_:6(@266GA2'#3UGR
M8.C\D=Q#Y6K">\/Z<A5D&L!7RI5!P"(MO<Z7&8K@CU*2+0R)B7#:E7BEI=I^
M[FBK;DG*_!Y>'%GR#L7J'W?_A@SX;&R[8(5]Z<9'P\^^MEMLQ,/*Q@$E+QX8
M>^I)L3K'/,WM65YR/UA?!#F[<HC&]0?33@#I ;$%Q0+GJX2!'R6=W&(U5:#&
M)@FZNHI@=+*6 -U*G(.QS*LKMBFWF2I:]=:*Q\;="*\4J;;ROL*#9KJ*OHJ:
M/:]S12+3%Z11I W1OLI3OHLI)/3U+)R$]B-?4O38"I9/Z$G9NK/Q8@L9[.KM
M@G%*2 /SQ!T)@FW'W0+KC>YJ<3<(V6?;E\_>."*A>;RV6PHKV#&T@#.&Q*OY
M-_.I3!0ZFBO6_(AI R%XU&>C<J>HD8VZ:_@Q3R\[7^J+7:WD<*5X,Q?JRB]U
MHH]4J3NVF30G*CH .=[NI"14-IH/G?ECOR M.JGTR8KOG+$;Q6;E"%K8YY:T
M2[@JV'P,VQP-<Z![D#5L^'1XBU'KU51(=0JHMX&;L; I(G^'DKXCEZ%)<Q>B
M&L@82F+V1LF9H4LF&7$?SJ'X-^\F1S3PZ^@VX]<Z@#LT:+DN- B[0O4NU RC
M\^P3J+E813MV:91R@(>YKE#<(QO9&+IO^Z4KB6G20C'\(=\@!F9?G5]2$1,D
MS39B+VJ]%U>^EP#*4:@Z#FGW&?;M67/XY "!G[XHL]%AS:W1[\T3II$0CDHQ
MA)AI)0G,,,="2ULI@]SA'+3NL3B*;DKGYXQZ$@( <3!)["S35OFS *  2YRZ
M2W!8CN-"X1 RD&>)!_ QN]TWB2?='EC!(/;),RA9C^3SH@HZ1W#15G&?D9&7
MES( IZT?Y@*V]AHH4DD1=^3XKI)8@IUIUF0.#AE5MM6',\]^BYZV.'H4GT4Y
M4&0II_E$=B_G@;[X$7,M[0*O,U]Q\O<+!Q(GBMA%/\/S@R0H6$P]C]@/_'R]
M:^WKJ 1'1S5@>VJ=+*D/G5><Y)TWF1?[^EO5%FA#TUHN7LPL8M:-IE=H?4ND
M P+$Y$*: IYM-2T2RH;TRI*;JH.[6=MT>XD0HLQ:;RP),8^?#Y=P=@HT$PYO
M22Z^.5@C*>%IE#%L\RJVG$$_FD <Y+55U(HNT<CG?$.(+P2S\RJPA6'-K?0,
MT NYR1,6K XV4'[O-QL3TSM-Z^ \Y9G"';$7/1G+7F)Z31ZB(0-6H4F&HS/S
MF(_Y6KJZLXLJK1KXIM*DNTFK7QIIE6QL6?#A[&_@'.*DW:R^_3[(W$M+C0=%
ML)]&!9N)M96,VD33ZZ6O->6^G2P(G)*W,70#OS,_.I.3W19/8PKLS4]@)\Y&
M^ZAM @]>6+05/&'F!$7KK0T\T_X IJB543]3S"K<]?DQT33H92J  PPWZ)@=
M8^Z>.IS<)LM8)>FV%$;D5G#K5K!_9QT(!8I%.4\9N5KDC* .H- >V4\"]-84
MA,'X!MQHML7;X2_)PT,3C_.F.:^HSV-RU!#1"5Y0E_S691WI"B2=P$@8]_W>
MBLYB2L3X49(*4:S!J$6L",D([3 #X3[)92#:I\50,4<A13>%)&(4FQ?YN:->
M2 MM??T--)CZKMYTUJX199L6MJ[B Q7[:O?#'X3J=:D%*#>X4XWYOJYP(:SN
MG_RV7_3I>Z6UAQ]O!V^?M6#,8@>X;Z5XTJ1RSW:1/ Q3IJC"?N05L\AM)XV/
MZ#W3OVA_?^T /$!7;7S[_OA!Y1@2V%'] >0,T.O@>RS66V7@_:R7LF( @5.O
MVE+<2#9XW]+D>V6Q?=?B?E9/0-"X08L7#V>Z21O+R3TO;/F7I=@XQ-H\H()L
M94>$:=+\AL VEYI5':6DBSHF%YM(FHG;(*-^EB@8O-/=P\/I)2\2X],=[8Y,
M-4C3B_:X>O&E'H,NZ1&'7=ZY+PH6*LS?:%G[?3J-?6@;*Y8MVEV*&'LN_$)
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M<"GEL42N1[Q5#E5D'FGM1T,+DLAG[V)G3N].Q@M*?QYOIJK\2)MD-M!AHYQ
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M%<!_TSO$*"EQ?V9" !_YJK?T];"]5!1II[YL:#B]9JZ<YOYP=G*2I[HY9J)
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MK\("SB)(U(Q(DH2'8 &YLIM+7Y8+S5FBY?-64#+T*3N"?/?N^0-CFBU@$SE
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MYL(M&R 7E7XM1]2JO+J\5[I;?)[>& 4J)F>[1[D@DU]N)H;<VS>P,CRC!0$
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ML#Z,>N["]T]]7<%W^]-3(BLJ;.00&0EZBZ@A$3TCMR4 /'$J)HF2[AP.$/Z
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MAAX_>))$FSL?_(*O[:=M8,V8T/?EN);.6W]VT 8/.YH2O/B7SN!E%?7&6X9
MX["(^(2$'))?HE<US_=JVJI26/-[^Y<92W78(N\WN6T5]HA$H 9W5BH07 )^
M(BAH<?"Y]I1Q^)D*32HH&=">S$_ZH!=/_7V^@CE&\*FBL%<Y9(UBBFJZG934
M32U$9W?/TCAR)XG2?,8S$W";:=Z_>L[[#1EK+=LQB7/PFLOUR1GW.Q5#>,#3
M/SVQ;A1JH9J>!8?(JV[E+%,!4&.CG'2 [$2Z\C1:=.TW5V;@+KJ#5L8=*FPH
M[Y<+XSVSCS>(6$PTIYWG-'07GE-LTYR]6?+4>#-1\#(QP#E<O^X,DM1+T&AV
M4N!PYR2]_-ROUN]>G!+Y>4"\D'XF/&9)SQCUV$L*R9C*;F5B?!66*B45_GGI
M6ZX+9G/[>1+>LG3ULCYH52VZ%P!O[;XJ5(YF?]/>M,T2 $H^E<B@C #WQB<&
M#F!YU2^-N!L$3OO<*W\EFL9RC@2C>GVDOHGU@]''5_(U\I8L_-F:?9P#?K5]
M5O)Y/%Z/'K6EW_92H%TX=,D(($U.V(7+EY2>>@!@/R[UN>-K0R8F77!F_4+X
M>[AB)'*](*U1C:K<QT[A6D-2DVFS,K]DT2$O^=9\\="TZO!*Q4&M#QK.=.N+
MOE%&=X=S[D*2]]!LLAHBL1$JT. 5.&*\YGHN+;9#WXN!OS; 5R;2T*3&_<D3
M9F/^L4U 43YM$@R/#I) D$NTUP7JRA3T#&%&!+->O_B"B%.A4IS9O@R<E%M=
M6A?)/(*"_UCXT<,Y ;.L5;_U#W*[0"%._9\K6R<+J8:26] \T)&=A/++UBA@
M-7W2"-CS@6;'<+=$X,\!IYX=QOY.?JE\Y@$'W3+LOIVFO+S\GLL3TT'QV6>$
MC9J@)=I$F&L4+,!O$<%A%SP(MUR_,7.W>$T=4 "#_G4R[VWAC4SJ[SJ83F)#
MO'R8=R8'KV4,W93)A)&5#:^C,&#L'X(9KZ?!U@ZK41,Q)PK F0;LO10=IJAD
MPVY*3NY3PJJ;!^EK)D(:>L4":_AN)WNE3@T4VRSH@R?"<Z*X$-0&.>6TEZ#.
M)/]FMLLUZ@4W3=,ILV>];DK*/6,FB58N/95>:9-O(@XX\#FV^74/[$O57F>9
MJM6S2R&IBN[URYH&\X.^73;6UR:9/$P2NV0L>UT17YQ6AH75S) F _A_F U(
M1K$#_Z[W=W!)9!FJ/!OEKY^D!91S*&4[:N=LH%4D1,2C?=E8@<1T)*!:)1OK
MEEI?&ZN=@D0UV39Q)CB:<W_JYK4V+Y3J;37=U+F/DIN9&@<YHJL-$&2G$#^V
M>SHR5<YVR+'W>DV<M]VS,(U]Z%/C\:E?K?96"Z-D"9YLENC/?T4+\22"3/,2
ML^"67I]+UUV>@0C)OV_(<_>J'4SP)DUCX^B=3%]N+)N(W)N$M_/)\1S0G>']
M<@J',QH$Y3<-BE7*[8A7O0PC!YY53*<Z"$;")I1AWMF(^J,3?)Q\X2B0Z*U/
MTOC2,_*:IP]B,\![U7!S/4*W>7[8 0UVT+6@QX"\7AG*8^RC[SS!E($L9O?0
M5SL>[CW;I<#B(CV/Q2$&;"V^?"<JMM+=IQ4MNWYT!0DP.ZGIU;EYD_5J\%0R
M8?-1$$?=QH;LQ9=\GPUQ;M._1V5,'@I]3;0"7E1QH_[NK_-G%-;N;G50E=V;
M7.E*AS]JFLH#BNQ85);(,KWC<_,!DR9S/5T]0)W:B9H.J/W1@D]>[OX<[K0X
M6P'/2-=\O7RHPQ<ZG&=>_2C@U=#Z.3VJ?L?1Y'+E[0B\]]*?X7QLC\O"NKFR
M- C%?&A\_/'F3Y1<MZ>^WHX^Z!/E9X_J&&FB*QT(WN%4"E33XBX2T:G!IVT\
MC>EFILTP84D(IDW*\+IW)[S/]>^6!2N\G[,&[2)JC[N:8&99 73QXOG4M(X6
M^GWC V+L^^N.),>@*WG-RJBLH#C;O9/,FF>6HQ=A;A$1!>42EW*.-M3BAJ.Y
M)>$VGIC.]P*BW?RTR)*%["4W\F9;=YEWU'?TR<9$L"MA5E(JK:S7(\+4@Y3@
MF T%-5%PG.,!9LY9T_&M$(MOXA[%T/@=([C'F 9]_9$<-<5#)H_+P9BMH ;)
M?GAX[8#[877F+--Z."E_[L:UZ-G?XT?>N0V_%"ZN)-]^ZBC=%Q.LBIGZ4[^?
MB"<$YR29I*#)KI^,J=!W9\*G/8*_3IX-ZJ'XJZ=&CHK7['=C?MB9>"9'MEIB
MO<2&^;L!8#AI,G T>R]=9FB"Q&32 (,'*$N4XMJEJZAPT3;.1L8;/<GB7Z6K
M'JA#HSLPF\,OO!Y%]N-?LI#7U0V2Z*?*>(;!LIDK,T5+R5Q!K>[?33T@FY%C
M52+WH$5[0VL&P^\P=KI]\]L(35EB<34>Y%I.C6\Q< ]<:YT[DA85F03""_;W
MM?RIM>I+&3<BI).^6IL\DZO!.&5TLA-SJG(^]U;W?/BTS\3)5?9RN('>-N^%
M@80 >JFY:"#;<S9AK2#SQ=/J(KQZ5MWHT%JVD;1)SZ\:0&)3C/@P8PGO$3D1
MXI#/H'N'U6_=8/JHT7,8F798MEN?EWAR0GOX27@^S=NPK9A>?S#P+$)=)I0\
MWH_9[ -^*@*'GBKFQ3OP\/>=4-O4,6OV[G2*M/Z^L6IJV#J5/@Q=!N7/S!=4
M<GV8?>;? ??IG3NWGAUKCQC27M+?984T! Y[A$TBA=+?YX:21PF_;X@<E'UY
MT+D$#F&%50%%ZP6D91B7B$#W#09.5NWN+:_I8K#3\R1,8C?JF"*AF.ME$7V"
MZAR3Y&%<6KO@'X;!]/P\C!:1%%)4C%V*G5ZKY[A(^0<4?WE]HJ<,KNSE8^HJ
M10_E7283[]LP;,%D9]R; 9OYXQ%F7IED$TXN[_#W2 F49S2@:M]*0\% YD6!
M6<QE W:HQ_,A;+@_WF?[N&M/SEDEXGL[/+ICD;^85,2;1EF .(S.B)S:2;9;
M^8&?%J&(W,-^1VO(_=/[]4\X_Q\VFSX=-,'#F7[." T<.TOX3':Z*/JAML@_
MJV4X6T[TDAP%WA8-\\;T7(R>O%#C8>;1XWX>U17[J>[[_*[MTUX?(8[$6NYD
M]^@F"M29&!E@R#M+]U@1,A?WYUAS6_WV&H*LF^PB?UJH$#\J' O%<PYUU\BX
M&49<C,@?%+OZ,69Y>AHW*3./\F</CTJM8VC-9E8-:C*E&S8CC;ZZ3=<_2K3@
M^OBC^+40>"%^(7[1N;W(_LT(L<]FRXOSW^JG*N#9?1>>:7/4NEAA$^"O_UQO
M^G] QMF2]7LW, 3'(,=G:PP>IDHSD$<9M!M[CG&-_Y1=K\[X\(R=MS>55]"Y
MV$":AJ=33[MC.;OVH?C[V6<8LN?[Q&*>R _H:>(7NB MO/*M?#V)6G4[=T"[
M4*+S8P"=J6-L$[Y,FW9;FOP$53(_20;'OB0,/'-\<#Z$  _9MJ3U<+<E,R\Q
M9X\?6!$3LU5M-4%QGW]61F7SW2\HR&2A.)K@<WGXB]3( "C[_/P2B?WSHS&9
MZL!FTY51O@?J.4NDH;#U? ^22E\6Z&WKH+*_"&=X8!PBDBRVU9X/ F8%"FO
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M-6%, "#)5CDZ=1CW>E0R0QC)K)FL-VI4',248XK"X@C:WN92B3W+8S,PZ,<
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M=4/"JMB\RL!6+U?'H<X=U2V6U+&S4#6;OY;[ \Q\*5$S2W\Z:7GF';#:@G>
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MT741GU>;<'^<46*ZS^XIKEM,9ET\4D'+8J.W6'!#SFL45:L]S3=1:=HN_6A
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M91F"ZEU2H\[TF/+UMAEP]NI72_*JQ5Z5^4[S-O2\-O##\,5"49R4HX:T,K2
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M3JS.E!81+9CI@3YNM5[&#3MM71N184[M]K]BSZ@<G-!&*3:DB8Z)6N>ZL?;
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M2_8=P2NQ$RAZ "3Z>!PV1TLRZ\U_"!6;R3NR7)HT^KPD/2RQU?M&@+#\GJS
M_BS\W"8ARJ&&O@NW .WCH^\3U+*AM6L4Q2""=\7>P*SKGR6N-I):Y@:\RY[6
MZSKTUP\<S::I"<AQ3RZXY8##=/ZPG9^E@I12@[R8.#HR:]!"(;6 +[0E@6U_
M!_CQ#_,.KJGOU)A_]60<9YS#?]%S$0P8Z*?EI8Q[QJ^T)QX5Y/PE<(QO:,.K
M=/&*4RO<XZ6%)1VB@!,XT.LW%7(QX'A;2>.,GO:2>$*305)>]5 C"V.R1C92
MPN?9F%1+9\F\B+9X^KD G^&1/41)E(BZFWJDX_Q_<?>646UVS=\H]]V6*J5
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MLV?MTJ0AZ7=$[G=$]I4C0SNO!#>)PM@]ACS9AY5UKXHFAK]8CL72Z= TDAB
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MX9(/8RO#C?>KW"7_//Y4Q0I4[2^6\$&3B9I8H0B,')%!,H' _$)UI1_'0@!
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M$F]^3YRXZL?A:R6Z1&.QP"J$*:[;A XB;$L9M_DSA6S$;"P5-!C;6.VVSI3
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M2K_&%;;@X.J3;8!>?K$&ZQ4:!W2F?2X8LD&D6 DBV17U&+'1&:T->85GGG0
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M<*6.1XMSH#Y=3J%PE,7/U:&3;W3/9B:-X$,Y5#W[96][=A\&\@3_-3>Z\T$
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MKLU,70U\D<O'3#/>4I>TJK'N=P14B[)(C-K7>4%IE 4ED?EJI?:QL&[WMM@
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M3<LA%\,ZW14)Z_XVB5)&DCE))<.;7W_SX9)\"]3UT<DKIUE>D3+YT@S7QT.
M #WH1'%>DV(/[FWLG(MJF%6"_=F&X\Y+Q-M"@MT%25D/DWSYF\$LE&8;A'^2
M#_R74'U[6GG1SEQU<+17$GM*Y!)=]M9//MEB0C?0=%;ICJC*K[>)I"Z[J[QE
M-&]/,B7-B!XR74LB!IO.@BG6S<.Z(4Q<3]^&1_^;PCSGB)VFZ,L <F>!^5+E
M$T/)2)>;@-]RG__5_!%/+(C9\67J/83],U5VRZ $)9^:E:I%XE9UMG#/GWP0
M?Y*VM1/(:$_I\W^P]YY!;:Q=OB_>W@X8 P9,3B9'"9,S;!,MB6"R 0$FFR!
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M[GYTT5PPUY)ZY^YWWT=4W$Z"LPS6T.IHF&=96$L30$.#HG9[L/K\Z)1S_&W
MIOXSKCDKJJGY!.@.[>B+_*IYJ:,-$'@U[FE/GVS $)R&?V1]@L7.S$G3UKH
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MM0W*Y1*OQO5>YW?EY&OZM8C$<_RI&$KS'WMBY7\.]Y2=TYN;PB^O@K.DJ;H
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MP5ZQ34P"0T_#^_/6T< &GUO4B2CNG9%="%YW<K+>8T<T Q/J$1BLO?AF6+9
MXD[8QP!A&(:/*X'-1#]\GBJ]^[F3(L6GLI@XY?<)T15GL_J1Y1.@W :SV[*
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M]92+?O+U&&6$W2!X>I"[EKGH2G\#YB<'Z?OFV1/CS;[*,Z][E<"@N+ALMG\
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M$A!$E6ZXZ^SZY]X7ZG";QVV9U/K'+]7U3P4)2[5JG5(_<7KP--Q07$ )*B/
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M';RM[E[Q;;^N-Q'Z19#RXT9AS_@*3I(?>N3K@$*$RWSD&I!O3, )7*)^$70
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M7XHT 5EHW"#E7.Y5J*+_EBFIP;ZY"=$X):.3<C$H(%HS8<M%:_ISIZ/=K7P
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M"\6YV5H7F^6JI(G+Z@97DYM7\;?C9G#S]W$S?9I5%?Z@1 6I8@IF9V!@X'G
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M,^V0/U3H,YY_.+O2$X[/*!<W#7[P&ER%U)*3D^TP3+.-&.0[%^#J6JD+:^!
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MW!QE;-TP!UH"R,QDR\<C]-<IE$=5VP'WRRZY0T4HQ8JB7O0<OIT.6&>5SN3
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M+RHC.\-<1!ZAFOB7%--\@_;0<)K!UK6K]GJWU\OPZ4$]WB[^%&3MQ'S!M?M
M27:I_)89*2>(R=B!& VXESL[,2%QPS0:(M->FIK55^$5E?^9^7._R*)=;H5
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M&6OX$&_?RHUH+W.CG&Q Z4 W1@*_RS4D-#EJ*E*JORQ$I9;S_2FN1ON*H]M
M:0%B?#Y>L9P-'1F\4Z..XQF./I:LL9T1];SP1AF<Q&W@Y7339!<VY'_'K'X6
M/9TP";&T U.0JD=JE& P:)[2(KNQ31>/$A;G.+RVL[P3T9M[UB']1SM/E6F"
MRJV;0$YAG LS;]%KEZ2NR7E<18]#.A7$OW/J\VBWE%-HM[FS5X39,C 7T?7D
MEVG-J-J+VWM<\<O@>$T7V#Z178U!WI01;\&V\!WK NY3%WUHL3DRE5N1WIBK
M=N[G?[?"#K9)4%&CJ)$?F4FMK]??P]0*GD?6\^*^!;BIJ3@W)Q1Z(Y'5 V.*
M(AKJ)=F)R!1EEE*8:E3\?7Z>^UEU#Z7#42-"1OJJHIO%^24FB/DU"F?V871$
M\*&^KF=@?UU/^34L8'55I&J,+U4SHX!,V+%P"F;=RR@+'?0.F,@4BB=B7!GG
M/0@A+T8\O?_0Z<<HDNR@G;+RX)K_;6/?4?&H<.W.FL$[!98C71@*ZDII#'DE
MC)*6'=!U4?4DSQT!Z1FW"S"PNVACIKH$!)%!P1<1C9/$P,/O+W]'M&,.:ON\
M>8C6&JIKEYF9^TB'U:GB5XYFY\WXRCT)@HZ@,AKQ9+U(]0YO/D?#/_YM@G-O
M*99%DFV$1<D%5SZHO<*J>?D DK CG&?J8OL]"%)%D7[M)VY<]U1O#;&B-*<-
M:7X0"SI@*$D6@9%E!%:2<8XBP[0FUECEXEUJ9)X*GCKLN;H^X]Y/AJM*E:KS
M,D3C'!O-A =C=AJ$"V,Q9W,)^_+O*:E2TH#L#FPW!45!1[1*&S./P1H=*\1Q
MI.L,^L:F.38C</^:.3N^C^/Z+"<ZWY6;^&JF-LQ='2DL-?JYWJQ8"(03Q[$^
M&^.9-VKFC]DS";>7?U"5(X,(+!M*^O->+M79=1K$I_?0=[&(LJSZY8GJT#%I
M"_D)V4'?'4"(RS>ZPX=!Z'[6QTO-P>8OZKL!"?8\;7> ,=&A(]\; ZJ5BZH[
M@()URU7>'4!FDZ]]C/6]FAB,F**?<__@2EYO3B[YWE;?=\M/[7N9-*%/P:I]
M$3-CU]HN.109"D!-"B*DU^LP TS)&P$)LHI^147$V-(RG$1UIU<+:32NEY<5
M3O'NX?4B?:>YTPY14V +=*O.8J\/.#BK5AZM$TLY$JM__^N ^\S$![-O-*;N
MRD[VZA#\<W;5V <AW>L-K%\.LPJ9M&NANA!/S>*4M\B\9[V-(SHV<I4\OQ!/
MKZ^ON(H0A+59E!K5V9TQVLU^C/;$T83DD>=P:!5**-4GHB3>[HIP[4I0Q=F(
M>8>>\2Y_-J'Y-J>AN6G-7>"L)L*R!A'/K\L'%NJQS425XW%XS2J'A(@6IKK8
M@]0?/FYUXF95* OYN&3;JL5<W\<N_<!VG$^6,*3=G/MDJB%NU\C,18RM5&^$
MY\  %V'M;5ZQ+>* ,<T'^>6Q+H1I^S!B)FQKN>=BVG,'^"3<[;4T@E")-)*7
MG$871T1Q#/TNX^Q>T4MRQNI_5+5OB"GP>).2D00TP YD=I@NGR?SBPY,+:C4
MC[8D6%]LDQ)!T&NAG\-)F_@_&(FJ&? KX (D>7LL.)5]E'>ZS:G30$.U 4:*
M[')^1W,PH(R[LB8A3+H@_=Z$DW_M[IS="V/N87A%3H,^KRJHDD)M90P)::;!
M 8]GWXAOJPBN#(D&&%H_=9DT,0*!<Y.!)=W4,!N@S#.D@(   \-O,5F_U@WD
M/"^<_8HTYMK^56UUO &,7DT",NO]>$=9&;*EV%_8P^;@R?@EWH5,*JC93O]#
M<<840J!1QW@NHL-]S]I+R[K5F"#?(H".ZF,7Q$6YNG2G7BI80<=+W;K>37D.
MJI^XUB ]W+[8OEO8G5TC"N$1W676G5<H=L@[<NSSG9A*GZ5QG/0N\\V O4RI
MO-E1';X6O@,,%!.L\[V<,Q:JR7IY!^@VNRU]>2WU3*WUY2WW'6"IY?8K9 CS
MUV[FVN(=@. .<,:@\SB3@/0_;S'UO[((@T>!-S$2-[?%,Y'7I!9W *X;CT7O
M:]SVC3M ^?[-UK65AOYZA>\[4J0WVF7RLK&"2'+R]&GZ\+75*U>GLX'TS5NF
MB!%-/.&HR:'CSNJFH#<S^ZB2"4S"CD??KFNGP*[$N+WXQ8""S3;]" $#36L9
M3\R,AA,_)ZXZGT]5-F\,INB;994-T+R"*"SB),]"S[H03[N)X]N:ZH6J=U.M
M@5'G;$<K\TCG9/V*JO3SD0/XCFW_UTGCD<% #T]H=56\Q/V.=;!IV;)N)+>:
M8O?^T3XG3.5@A2J2HF+B%15%MIF@'Q%.#Y1K*&;YJ,"V.JL<>CZOV]U: @>O
M<>[Y7Y[4?&ZYKB'A.5:+C!4R/6*1V)#TM>19]T%7WUS?@GO*>UM,S#SZJT]]
M?HRR'9'3#&7KEG< ^JOUJZ*W^S,!5KP"^[?Z)RW3? W_]SMTOTB<)X[4?:;Y
M\-HNW:DAK,-Q;D;%X-A\TQ_7/N4.H$,7S$<4;R:NA_-1;Y7L1$A8RF_+X'.5
M'9Y3Z6]?U8_J/QP3_-%IH3>>?ZTFDN'=\E#%5$2L[P"O[69H6W^N6_GPK2EI
M4$WD\6=QYH4*Z--X3_]@$O@5C3Z_H,F:7M60Z-N=<\I09&^M: IR[4!%_F7O
MR^_2^BBRYO;.T370FD]PZ'D-=XDPKWOY2>^GF<>O:0==-T/[T=599>2(8CZ-
M/MY5@Q-F@Z^V"9E,DJLV^K'@/=U?(H6Z5UXCT;,6<@G<G3%O!<PG-5L5(SO,
M^<CU;YR-U+4GTOU]#P5$N88>)O!>%X]EQQJ-,R]YQ>J:C,(?EOO\2,B],>O1
MPYO/R9M7^<-W .&IWU.6?+51YZ%+0K0.5]J$E]->K.#!_A;&W?P[@%[3TUO[
M0W/\+I\:UV/DM<V[Z\HS*-TQZ1V A(HE&QDTDLG,+ ?6TI&SRN1?LK+REF6D
MAYI6)66-:41O2#IS+AGI1H*<HW9!A/8D68DQDW+STHF6CID=G7:Y:]'))7D3
M.W:E+RUKY$*]<HT]=D*8K-@#-PRZT@*2-*<:=Y+9^YD][P#<[A,8,Y+#G"]7
M14N312J/W?G?FK<<7\@K<U^[E6@Z:!L#F_ <Q;5-2&TNRU(%$M-RYO1.WD$_
M<D<A3?0MCJPALAH.V<233G9\E)<"^R?J]-6Q7&MS3:KA\CK7X,[J/,.RLD2<
M[G \_8JTQ.9?)'C)K#5O1E;VSB\N3@\G2G<VB+0-H<P3!$>0 ^T]SZ$]M[0(
M$N6&7Y?%_FO;8L,['O2-*PFYZ4.E[U8^)@H+/76_N0-,*30OW $F2WSL;PI(
MF[^!;M$T[WWU(**W3^D#^N\ IG6+9K\PBSW>\:3SN -0(!%<N%_^O;7^:V[&
M@38I;D'E#G4FK+-01\F2V<COE3]&_!K0[=4S[U]OB5O6)D3N !Y-=X"<UJ1'
M@KV;2S^[KO^\1-3?H#6A1(W!"G*-VJQ*06$],<A(&N-80F^B-:;(P(O7 >,[
M8%3SYSQ\ROTOD5)W .("Z3Z>ZJIB!&V:<Y18UJ3BP->_KO.+9)%OE=(=8,]M
M: ;UVXC>RPWO_2/.JV3;0ECZ;:&;V<WX'6#+@;*R95Y44EN?8?W3U/H6BK1$
MP%A+ PP1>\@(*X(D\U!K*)S(RWW*VJ),<;=M/U4W10Q$>8JX6R;-Z+2OE.Q*
M\R!G-),.2H)=C1/K?0/P=L\6,$.N9>C:N=SC#T4C.Z;P.O#AMWCEAYWDG:XX
M3Z:;<]R[O\XY53*EA/8+C@<8'T<0K?*VXO$['Z5@O+;0JE3#O6J<D:)'U%N)
M4>'3TPCOW?GA\I$^>PK_VTP7#Q\&$-[!9O5*SC8R+BG7W:QF]^NY<I67V2N\
ME)H7/Q[W,YG9^DJ+RB1?JAW81SA76]ME5"E"]9TNZDURZR)<69.URK^#";Z8
MCS.SQ<,8HY_$$84K*5;%VS/'C;>'!',(, CP_*+>.#W>M- #,^Q$ZPWD8M+G
M5:]!L(.!3NGE7^94)YN:/>?_F"\24B8)"K.9J)V)[&X0*E.!=&GI#NL43E0:
MGT7GC<#P[E6@>8 ;_*D:%BO"M;&<\=-J;<E$KS3I.XO>UP8N40PP\J_T)347
MQ-][O#/+G&98%R^ JVMJGL"^F.PQ9Y6N:'KM6[P_Y]W^#K'6)%RY,+IK->V#
M[H6#C=J,PGR44IAI$W.^C-T!"O-($K9<&)R@='T34=[IENEMN)&B4)'OW5QW
M #'[PZC=VPG?M;0?PP]J\78W3IAV55HUX5A7B./CZP-0_SZCUOB3#+\8-Y4"
M]EB(+;/5@(N.M":%TS%3/M)NR6K4*H]D5R.+7!4S]!F$BC$=Y!M'E' 3&FVP
M9KZ(1*@'OM=3E[$J@M<H"BZFKK9#)[20'8OQ7<F7PKN=>J[,UU/R(JKPV-^:
M!:-(9AQ !9YK8R#W[Q^1AF.;$3S5S$-9V>ZP0@QU-]E2OT^<0.,*OB%03K[V
M>N/K53ZDF?7+Q(CRX"5)V!6J_VAW9^NFS_ 138'2?,UK[KQ#[E;Q/%:%-;B2
M*O-\B%1!4VW3UUNJ<ZTN,I?/<0[[$4*B;:>K.7 0CG/\7J^6TIQQC+D-/B$\
M+F1G(+E/Q&H6%J_DO/MF:+)>Y8BRP3]J59K2>N\)8YQZ7T4\X7G8A&V/>R Y
M(__2-)&6? W/F7KMY(M4/5%%'&WYGOFZ$=9N0V!G\TIHY+$SAWL+P;7<&<KR
MQ?9Q?Q:"2A>19]$M-QE=205#&A$5VU+< :1+:O[<'!)2MC*J/</A6? QRWLB
M.@$#OZ,VL@!9DN*75.^R/SN.8$'N<:R(]Z4,Q[@RO<@TTHL QB4;=AV<J3:6
ML=8AW%)"Y<;K[%(+Q-EG2SPD0B)XTDG0W(+C%)O=#1+QU_)[7*YQG:$&>+N@
M'ZM/' BHXQ7+[@*8)ZD_)DMTE[NV#=S9I:MF41Z&3.?K!L.+?315<WHX+8PF
M>AD$J:)L^..36:E>ONO;/:KC$2Y] @$+IM]GI$WO.[PP'KUOS]>J[(#C,9-B
M1HDL+%RRUS8:+;1]?YR21??)IC8L7C!0,<'<06F^9SO[SV_?3@5/NY3EHE7?
M6LGM$[S[=)).630(2VG@;LQ-]>@4&M<#O0L%:^;V!?*K4)$[:?4+N']DXX1T
MB ;2*$W$$EU*9JHG2:C//075_5&3O,0GFCQEN*"1PJL.*1#M[=*,9=0]- +G
MCH+SE$;G4S^<=08M>BV<[6Z0X^)3T3G@<5:7FD,D-&,81140:X\V% _',C$K
MI-%J$CH.Z^]NH66+%I>E26 &1LN(>>/62K2+=$\*7)I>?4H>+S]FV A8:*IL
MEYNZ_FM_716]$N.KV_X!_'[HOK  ;^>J1%66A3ZTR[4<7J1G7ED10S2)</:4
M!(IDK77MUZ0(8ZP3!TV:KHXV0@/H""3<WM7//R_71YREE/9>ITC5=SN@(2PY
MEQ*)MW> K%SD8/6[KE-]]O*![*HZ?&.S]F">ZJ[^$3OM: .EN6IP@1HA48H8
MG/I=9&QK.P^P_[ I<)F/E!4A%L'@7A5KO"<OBO8=-+*)]I* VYMUC=E=EUV4
M]3NZ];FYKR9P@AIPV(KTF-GF:AQ"\$-&848Z'FP*1D5/QL$V'^S4K&O"[2,C
MC7KC\;,KAIA<[E/KY)2BO%A3!?N>5Z@]MV4=E;B2=!UMCXN[I"Z%=,+&0:GI
M-LE13;!6"V:VY?HAV6"46>A1-3.'7H2&+R7_LE+L]+L37G!#5L--X9F[Y.3#
M7XV[76A1[YNSE$,QSN4U1A V$S,B1X^4ZFH$IN"E['1@/[&<2&"]H8<L3=CC
M^RZ1O'MOGD]/%,G""4-T>D0H(XY51)7-9^NV9&+0QLST<=&#[(_[WH%O1Z]D
M&QI>& JK359#V^VTOWXG%\\>\:#I!4__%^K>,ZK)[6OW9F^W!1'9@H" P);>
M M*K\-]*,:$9.H0BW0 )A%YEJP@" 830FU)"[Q"2$(H*!.G2 J3006FA-VFO
M^WG/..=\?#\\8YSWS,]KC'M^6/-:U[S'7+]E5"$.4UAG&Z6]#I1Q?DGO#SE*
MESMR9@ERXAA#!.?4%Z7 P)4/*TP1T"%C)SF(O(K2/[";12H]ZP>6/JPR?K8?
M9%QS<&8DK$4U]G:#X_WL([JK7NI@+H6Q6BWC!!5RJ^$MRA,&6DYV/))OU%#R
M?AV]XUU<Z[1WR\12D''(TXUUC%,I.Q<M=-@<F.J4WQ\?()17%KB52!L8I2\'
MVMU7LD,]%]H8VB0H4?*^GED3QUTYX7^^,>+QN.T''9+3=VT'5ZL+?/[0([+4
M KC6>7/XA7/-4 6O':9RNV8F:C1W@V-,R2O+/#VIX(_,8=V 8K]6QB[)=$\C
MO=!3D3[15_E: 8X:(GYNZCY(466>1 F"I(?A%V\S5XZT@%*;*F7WCB[[7<A@
M]3)O@2TFDSXD :+U4C$>\@TEJ\V'#^Y1L1SKOLJ"HHV[+LUF#C>GAS9EY B9
MV?H5\I.N?@ LZMVR[W#4R181VD,K;/,_OIL5GSB:Q@W"J2R\A^$\$4_ENPX=
MR$8RLMUZ@4?1\!4)X+[RASX4$ M?G$]CFT:-DJ?37,:$'K4?\J8O93)N#:W8
M6/@>*Y+J1D[^1&:##M*.'I*AMLWM4J:FKY&"0LUA=H'3=C46XTJ-?EZHN^;L
M_MG[LH_35?%0E%!Q3L/=M5&WY@&<T+N6*#>E:T=TX01ZUW07K7NV4_TA MT2
M[M$R,1G_SUA>]B$^?F/V2NQGQ]T-$265G/J<H$JKC1ZWY,+Q@X8[BBPLWFP3
M Q^N>8P&O#'+2LT-(<2Z?;CQ%*X8^T2[)T$$*GXM13B )>;.TL"65"*D%8<L
M5!95(7>K>W@O*Z ;FTY+1V 3P^A\N!)+B*@;K7S!]W@VL&A78)D9>_5LYG=P
MA(.99B:&92IF\OK'"W1=9)OL[)NAX.&+<GDMJJKE_![/Y#OGP06K?)DX13F=
M>*LA=?TD94=YU+1?#KHZP28V!2\"W8@%(O4=;I>*ZRI=6+].A*3/[_[H,TWD
MZR9XF$P*WRC;U%Q'._COV8=E]VL,RV91-[^,[V02)JF"N\_IU+2>&[^:'W4S
MNZ[_\*ARU_,.#_3F5.0$;XHT4JUD]6UL*YF@MUS';C_R%UBJ&C+H20 4O38+
M1P?<&"Y[*9>HNISW49^O>FB_VJTQ)>JE&;E-0O?1]".F)Y/E'YZ)IE8=U1-"
M-&HIG4_8"*2/=.H)1^%V'1G_R('C9D.HQ=MJ3Z'$68^?\35#)X:UY RHR5+&
M;4.+7,>WO/XJ\4S+.7?4I9V*O^0YC1FQ\D7(DA8&D@Z#V'J7MKR,W4-6CO5K
MM_(UE[&B5HY>ID4-32,6YLAB5#&Z@;)+1FLDO]JL#%!7C*D_?=B[,8OD&!QX
M*0.U[U8$];NIR[]MGG"^KLCNT-M-:N'' W#4S>8CWI:/7TNG%S-8[YNS[]Y8
MEUZM\8PMG;AM6I<+,A5Z7QBJ$1W2;BWLV@O$=MN$O3SB8<=E]M]K93^A?J*A
M?M##<][GOCB$Q$\>@5.A-H\8JS73-Y(PN1V8 2QGAENFOH6?YQT[Q8QSUYSF
M&@MUL*F#2*7;DC &U+.H*"'^C*Q;;;U^+9%$<^B8#E&\FCI@^5<V%,3I+(?/
M]!.PPI$AL#_V6RKOK:P6)TB$Y\K-_QS_R=]HM]3EK;E.Z7:V)VD.]EKC923
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M*9)$7QZ-Q(NUQW%V$:VX@;N/XS5%Q6]//GA;[>U7RQ,']CT1TI925Z.V3<X
MJ-%!N=;Y,HIMO@MX=:ST(]G<%+0P+V(:UM=0[?]M('"2G'C)0+<XI='LIKMM
M^K&1S&[]]?#N'-GC1@S7H^HR?1!N)25Z0,DD3+'RX6VZ@@#?C)R&'M@_/:!=
M'HQ0TK;(C(6J-^SDQK&YBJ>9DZL/K [9<P6MT=C["%AUS"-\ ?3Q@S8T/**Z
MM\>Q<9"21]7DWB"#Y-,G*NO-(6PUI(%%&Q&*D=SH&-#KXLNI?E=@9>KBD>E+
MV!31N0J"S$7#>53BV<( MLU%(YN4/$DQH@0(<5P!]DU-@+E;E'I*OS=UF01!
M!U*:70;<A4)2E2B^, \4[[CA2LY<M%U=90[7T3/@8];U"B&AY%Z>GL;!I;8V
M]7I/_CCH8G6?10U&.W=>#Z-3WL>*S/Y606,7"U%O3B!VPJ]=.,F%MP%=E:L[
M[\08-B]ZK(SZ5(Z.2S]>$J# B))0O!D1@B*W\CYU?CC.;=OYL'+P)MJOR*QB
MLD%6_.6UXB1V]H3Q0CG73^K7/$UT%XW%8H\L,$K?68'/E;<:":H;LM8D-O8X
M;/9^&(@GH.$0@*XK /5 =: FD5S-BP#MS@9-<KTZVN^WENG$*[^%!;5$Q-I9
M'")D5[U!1HLM2XN/8A!GUG^'/R5*(-"VMILOC4+XK7;VH<42^!#D%.?!!)S6
M AL?+PE0^+HGX\X*!$5D6\7;)KZ(!048IC!*RB])#N=]L!UZT,9A\83)=U"4
M*?D-;O4&[#'(4IA8P-V7[3$AMJZW,3,-@P_2/G7KA]'ML>\A!+?E;E>+S4FF
MNE2ISM?2&RG18U =8"\.W51<TN\X->,&M_> 5ZZYV>4,0/7D=O!-R94F/Y/[
M1 HFK$PH3Y/L^!ZG#=91T[^E'PL+)5X)F]T(^RW;DO/#BLJ9$4QXIP8& =?>
M=10S+"NUT3&4> 'DT_X2R7K2OH7.@+\$HN:"?*GMPAE,HWCM56OJ6PHXK5<'
M4-Y'S4G/4N66K,B&5$!4AM9\;^E+90=P)*KY<^F$><91OR2&X^^J DPF!)A&
M>6 N1=#P=58>3<3]--;W,P4S@)D9OOZ]^& JEDVS&M&>N&%^M[R&-@6-A_JH
M$?47)13&(T3QD._XB';ZQ%FMQB?*.LED=7O/PXC'1C",!>$UJ(,Q1#>JZ"_T
ME1--TY@9)];L>E>UITVF)"BNQ)RX[W>W7=1&"_2S&+WP$O4'_"Z8FZ.W$D/5
MCLL-9=)G 1Y0D)8V_.6>8]!6D*COVH\=:;G&EW=@7GW@(I_0<7=.#.>G=6XL
MQS!'8!HN*\8E;!/>'>L_Q:[BY!/D?O=PD:NDR%=+>(BZV(AX80*1GT:ZI22<
MDV%#/4\@Y?T^&Y6B]5_@I7GZ.["J)2UG'7BS0Q97FD$BF)QFIZ00Q(@&,"(P
M35!PU;BN@B54/2'2W]E;KF]')3[+<'I#414KZ5>4 @'%$H%J2BA#,-9LV.:0
METSD;(IU^+IWQG&;M..XZ5^?5HE(()!02)=#UZ9%7];4P!2XG$F5V8N1C$"V
MTN- !S[[PBF'Y<;& <$'O@_&'P5]B992O]F=!HN=1*.!J7Z00%.'1HT7HO?D
M03>^IOK">^1L:^6C&ON/ZN6''F:LUM$C+8K$SJR]1FNAJK7(5:L6 /M?'5TS
M^^XG[%/P?$ZF5UB":B*[/MHBLB9U'N&??DB93NRT6-X1M,NJZ"7%Z>\.V%<J
M$.FRD(;4 ,OWN6^4Z]#JUZSEYM&V9;M3"@3>)< ?4!/C,A=EDFO&_)XM,Y7
MB9FH?>(& 72/X4BIIZ7OY32^\Q"FF_G5^IO5Z-P+N4H+I=RU$G(C0F-%!C'Q
MM"8K?6K?OM[UX5U5!=GR^:7IJ]VII6BKA0 6.6KL'9%#P63GH=RFWKC,M:6'
M:16>V@T"PE)GG4BJY&30"3W=-*%#ZCY,=[.W%ROYT*,:E""N;Z!D)_ !R#UB
MGG_4K^[0:;41$1C?&F+/RI6[P]8YA8%+/.RB&1+EHD=3"ZXV(JCF.:"!0PA,
M.[U:?BR.5Z*KP/%X(Q[Z7N"1 *C$WM@\+1?OFZJ?+&"0#TL_K@9*WX#=@ G9
MLJ;PI7R5D^*C+]?U;<OA)65AF[;IXTLSS336L:X4_5=\/+/,FP-'DQKX#RLC
M];?,OQ(E.!Q'*$CG0EFDQTRBJK+HE^EAXHOX3!D_RR'GT*L5)*\6KY96W0A]
M>/$Q +,DX?%* F9;S'U?L/&P0G!9V/962_'C!QU3O<^#E&6[=$:-F<5$3_H@
MR\<_51)04X>06Y2F,]1U!.QOY_F FFM5%A=Y 0X3JS;9W_;O=(ST/(M5J\RB
M 81J_YB#=WK&9C2%SAP6N,R+QHB-&UC@\C6"[T@=G[/.%YXR=TKF=,=U=US8
M,W<'???E#A&8C#JHW7%-2LOK[=_]T>)_DIU#K[2 5_A2X[>E!5ROEPTS_',M
MTYNR&X(Y%>V^9'A9Y=$^=<DPHJPU8'/F_,VA4^9LO/["^,[QN]&7255)?$2,
MJ&):LH/I,YW(ZRH;P):F-V:=P\>A!4..I:6:G?!'@P6@I>1LO)![YRMF\%2S
M^M5_ANN#9">KK;%2PFQXE<_*HW^/J"KDE/[V(VD!)3[H%S'27^6JXJ4KL>\'
M*.51^NX+>L0\8?&Q>+025*MCQZC5K\Q2F.EJ1M"'@3J7[ENMOX]K@?RL)/2V
MLLXWC7/'3?N*:.)O*[SXM6U>9/P\*,9EA5Z7FXT8[]O>[7)"'%M[$0E_XIDR
MA&OB'L;[!J#9"LU)(XM>20TUWX[>\'A??=4GNTW)CL<'=O<K.5;4!,%U'X+$
M)RKPBKM.,V\,#]6S^L8-;:B:"$"1(S5?A[U!D!L?$<.AD__WU$-\Y%[?7:'F
M2?Z))00WH<& M!+4FC4#"_#JOR/I5YJ22_?J^2E;N,US>IQ(.U4OQYV6$]*%
M,;?NR]CX3F#$*/58-1_8L(?97+G(E8C\_SR47E8,-(I;U1ERAK"7!]4"8W22
ME(5O^O($'N9N*4H[L;IX)EV3"K)?0@@$P-"-<L((,?B%-V!PG-:/1[\K=[Y?
M!"='"AL%%*.I<49F\U  >WECF  58E>PU<[_5_=@)P I''H:7YQ7Z5_EV"W>
M!W[[<AG8E^26J!%8D/",'J0\SM06A K[, /N*LTSY.Y;\P\-+)K^VN@V*/[6
M=E\PCFIIA31XV)<3EUIN"UD3@FH./;SWZ))AL![7MIVV 9<><!03-P(Q @>-
M%[J)L8K,F=UET$A.\%H^I3%\N'Z0UK=+'WP0W;=+-:!_V:@F1]7@(0E8[T6J
M*=G7!(]5+;>%R22ALR !D/^,90,4L>/,#TOL 8B8!EI>GA?T4%ZR1AP2P#PE
MDUV? ? I)35]=WE 3$\%-*>_?0 RX8CE?-&6Y1*L$4T/(!SF\[._A?C%I:*Y
M*-7"A29A<G''O24H8$D.M,S2*:_5V\VU[5#9(;R>B>>?GEX*UO<9EBF]5H'*
M#B-*^.!(G4B4APDR-<4$V9[^&3,L/%CD8N.8:=-+R$&2=%N)7J7MY4KVOQND
M>WIY"@-#W,XR#U+0.BIKEH 73]:\QI_J W_UT$<$_AQ(!^$DK]>.$--<8Y.:
MYSHRH0N&K7H .EU;FHHG7A3&:RWX-7H5!7D[*O<\:+RER<\5:H'@F&N&[5.D
MEPG)<6;(&EUEI=%"^$T@# 2CIU>MVDG7.6TN8">Y'@F)>)$QVJTF$^Q*-]]W
MB6]#7(_R8A6S_DS@D+#)@KBEJ41Q733![)9H5)&]Y75IHEV735.-^*9U?E=%
MD=A(<W'N2WDX -STX;?O;3VSMCT^>QEYRYGA?()W)*4IB2(4PE5.%4,<6DQE
MJ X(!%5(ZT?]TQ8XED4&5X3H,JM-GV[]T<;X59DUQ"Y9K8;8#D@(71(V4GOQ
M?@"J/5:LU_N=QU*4O,VG.'LK\9#N?5M0K TQ\R/7UNV@CS4NU1.]"AS9-E=[
M4;"_WFBWT>G=OCR'13$[J<#SY4TQ_"BF].^2?N!OE9QB>+T8-U"+Q]-3LG7%
MZ;NQ8A?\Q,$%>VG:5)CQG T8N><:A,):@M(L*$M;7Q4[58.\]4"+#YOS5RC^
M>*&1'5/"$(30&K:57/42$7K()A3-KJ%Y>T)-OX+C0HJ.W?%$%"]RH+4GE +Z
M>RV.QGS5Q6>P*#J)ARESRYP:9D7MOV,?<YMNA^ZW"B:F3#<43_26/_$ !U#,
MGHTFY/3W?H2+7DMX[$?9P"L]:Q ;>!!.20569RZG2&6#66]JN"JD)=?&/-C_
M:VSS1-#LT,Z/WSUB.W [S-/#)&$<XQ\F1R;;@F)7)X3*2V(*U5_6HQ8(X@.U
M;G9L4V_Q4RB/BB/@51@E]+ XQT;Q<U\'1W'^_SYR-'O^/T>.C.]',G?L>5XY
M01H?<3+#?@Q?,NQ,7C)4)ETRL&BS_4MKCH\\EKED:.+Q.^ZX9#@)NF3HO&0X
M?[>24T/N<3%9R6[[9RE+PRM:H$JN*HDW&2J@8XZ\Z]<(F"E] H0;^N.J?//U
M=4NY;7@4A,7 R?F63?"APVU<]4IO[8)@0N+$>G,N):JHQ-2G)+,7(&[>C=9&
MC>J=WMDL+1R0.^^:"1>Y'6)V^) D0Z0Z^U)I@E [&(Z*S!-8?MJK"E,6-H,&
MCFUO.%MB%(,#/RY-(P-IQ3FN.AR%)\],88ZVS?9I=K)'.2C1Y+G.D'W4??+Q
MPR+%9,XK$Q&YKB$O]]RW)(?J[Y5UDU.KRVRG*:DOJ"XTAZ_DC.ZBXUK@#TW*
MWMEWA/(C]]/J-Y^,].\P!:$#AR@8IMBR7\(H6PMLO/:]J5WMN-8F/WA F4/]
M3O:R'S@+&GWBH5B;X\H(NX_F-P<ME59$5CA/I<]5?X8D]<8!@Q7XY>'4M/6&
M-C78D&'+"W-XU;NVV1?L+YF"HJV@0\ TF;\F;K48:H1+F!-VOYU']7!9]Q>'
MIPZ\VP%KADE59Q@N" /_1K\ ^NIEAQE2^U4U99C"!#O>!5,[6>>J5/$6)IZ&
MV (T1JR[>Q.:4J3_-SW_\ZEQM[>T7:9C4"/C:VM[PW\2IIT6H3IE?RLVAD"1
MQ?.,?7*)@^9X"SEXR0%L#SZ1S6]SEM' DULDC7_%H?FWNYIG?P7,4.:#F0WH
MB"F-3]";_S9B O ]1*-HZ<X>E'*:AK\7,5I'-SJGZKH',MKF%A^R*XQ2[<M*
MOZR+UNJB5V;&3RV(@4G(A,I@6TT6@4Y::A4DBA6W5HX)]5P&UN+CGB6\:,XF
MA_TEJEO\?VYTX?_.0!IE&V\4S&X=N(U'SC5RGKBODTZWYMSXM<Z3(K<L%P5>
M=RBB3I\WH>BF-1V#R^^35SK*;"^2%@68"!^:O2X9C'>$ E/>09L2";5Y6ZU5
M5ZR4>;&T$BC],6V?5@=V/^&KZ3!5+3=[K\ABP1F-,8TV6A&J9NI[F.O,*"Z7
M\D*Z6^J?3,6]WO=C)KD9+)(6PJ&A:KKE,^9%VQ/'8H-!;5:48*3+0Q+9HR\@
M<BA-HI51>J\B--;O! WA'CC\I2:#YC2WHK&A CSM8(A[)<_,^L&/W;.!U4HN
M 02U:?YI/.]Q@OOT;0=G ;G44IX,\]NWFHVSWZ/L\H/>(>EZ+)R["NVGXZU,
M\W($].LT@K(LEET-)':4CIV!YWM+KX5_3]IPI0Y/6\QV?!A4Y3A17J_<L@YJ
M<VCXI6V"AR#"&16VL)[^'LJWKM33L,F]1VNK#AY26/]K+/0,76Z>#4!SAR68
MT, KH;/5JB9"?VM[Z;/4?WW>X]$LWZTY&DZZYX(<?VKO*5?OMHX-8@/D:BA5
M$BEHUJ6 ^6,SB !QH6ZG+>;3YV&N,&?W.'&8A7%;4[G=_="R918$OW)_"9-?
MDV5+3K6=C(E\&RS/+#"YJ4(APJA;05=:CYNQ0OI1HC%13BJ2OTO\MDWJ-.C-
M&SUI2=-U)%SE.X^^:LVU_F<8.!C;H].W/[$[WNL4Y*?2+1IVYR6GC*FI[];(
MB\*EIV]>(O/3!W?\;;W3L?"PNO$\W9:1F^<6"840Y"BO>_^&[]<6_:F,!"<+
M+OIUQ'ORL#<KZI]R845W!V&%R0!F<4G]J#(_08>%[4#9YL"YC*>+5KT^VQ7M
M=R^F8_KE#2S,XRSHJOXWS7)Y_:%%A7,II7[F?&^:I)XP_[^PQ">BQIQ/X=8C
MA+I;M19-G[WT2-4& V5-ZGH ])-X5T[V_MTU9-)?=8,N)$,W ]6*;A_JXU$#
MA:?0J3C,AO;3)PD PUK!=$?GN*X-ZEFNN4/0*QE^ 3>68'G&N8>W+>QDAB#B
MV]6PCM_-Z$I9$*UL9W18)/6PREO?3IGM%7&2F00]N$AWG2*5>?R<*).;>S*.
M560?0 F7N@M*<B27R2P%-UC*[1JK.QGT0G$U36D&WQNF!RDDV&.E7Q[2;+4H
M+CXQ^R#X*6G=<3NS2F?:J;#TI;C*)M0&0O8/Y:E67!W[V%I3]R+Q/?PZ0\OH
M('S,5L9L?^M!])*DEYYRSWKM:K'" C-C0.9>IO_<4,*X*:MSCHFS2BIN]%L3
M6N<^)G0S"T9&(0D?W).^&"'N&2A)S.J\BW+WCJVVH[//FJGE8 $L)C_OA4("
MHBL]3[H3F&>F,6C3?5)XZ0K0:<QP-YB=BZ3\ZCM2UHF292X<S9C27=[JVI,C
M>1<]L>WJ 516:IY'?A%%B')U@HY#^$KG%0V7_:0&7'E8/99SDER/\N..2)CR
M59O$R4&\I^'M):73@M/7W8MM3'RD<^&Q0:O25\)0VXHI[E>QX\M2Y@,*7,6E
M%B)C];,R)S7-A>=_W^R 3K=)&M-=)D55,3[!;^._4+HJPH-%9V!0^^L?!Q:2
M?1D8KH,SC'L.OWB7THOTSBB.O_N].C>:G)'Y9SRD8]- [[OK=EZINMQ94G/1
MN<V^S$EM=Y0ZUT_:[)#^3E;C[O T+G( <F;F]1$K8Z",2^ B8CD_9@]_S$):
M""]R]Z-/AK)H"C_S83?>9CL'*MP&/=DQE%OX&E7>M6<L!PW)@.@G9 '$Y2J=
MUAM#.2VIO9H!\SK-\K?KK?0SW8V3KJ4%D[^=W4:N(K\E6 XI%> ?29) VE;C
M[ME7*J>:W<PW#.V\9IF>JQI8DS(W\%)[Q9DD5_M]QH2R7%<2'P++VCQ>7!&B
M0O3QR>B%ELZXY6-] VMT-WA%N40^!*@5M>3W/.I:>\A%_@#UX[C-;!W3.^SE
M>SV->%?#B%UBERM(NKK&#VFUORE^P!UB_ZTE5YNI,(?P#7WN1AJ.;CHV["4!
MI)1MX.F!2NMG9,LY,=XD_TYX3,E6,19T:!U/9S(/9&^T,^MK[ .)')Z+ *YA
M75*# [DRW._*N*NECZ-PU;WRP\(\KY= W\WU'*:[^NNE@%BA-M$U"[DSJ5HQ
MR8R%2LM#E93)'IKBZ:!LR(SF/:!=&E)H:12\]<(HU=?[\>B/2ALV+5QMCE[)
MF#]! DN&[V QOS2WL@R#_>1[_A^J^8IQ_-)TR-\A,$OW4CN@<22$1335PTDG
MSS;:_G6YQ'M$R0/>=\L)5?3U[(3C)X7SA0%V-,#:@MQQWEA=-2A8/2.T;[0Y
MUR9B\*9"+:\_X@[S7H2:!S8@88N3Z\?WF960+(\:F0]+7$;9\WB^RNF^KP&F
M>@=)]^'3/W!Y0U"8@#TP99'ST*QVY) Y?LR^ICZ0WXG )R&D0&@=EFE49^VR
M!BD+5*R6U_ M!WMV;COMWEIG]^2\Q2%BDL_G[6JIC\Q_J[L_VF16S8&AX>TO
MF@01/$F4MQ?IFWX(4H[9Q+I4_-W&<I)-(,#5"%U1TNP!V[01,#.N3A/F//AA
M9BXT V(U\AU CFH'2_&N<\C %AY@;RJ"1$N3@+*##Z=:[;EL/MO^J(6)8BR:
MH"-6JPMJM);(P-[6\TK/EV_F<GIG2IZTJ5,&)?#]/LC\GX E%H$*U^71U<TR
MIR<M&*S<=E2?;K'*NB=0];.X240!5U\=9]W1INK\7 %SA4DLM'"LJ-VS:I$)
M^<7)V9,G@(:;RPXS26.#F2Y"25G*C[AYN<YE0H_J>3$>I+C];G<;%C17X.^E
M/@#^&.,L:^U/LGUAIU4OF6]9)\MEWK'D31W/_I8^_9A;/^KU G AT*K5[?<A
M 8LM:Q-<N64CITWQL7^6%U9R2-9*S*'3*8]PNRF1.B$NDO^VR,;[;VA[0EL3
MO=&3FR<->KBM#/-K;=/'380-]"69;OT%L>PO^%PE>XLCI?%W6$Z\/A249!F9
M9#W%FK( 4;01BQ5R*=+@4SJ(/S+;WIYZG2"NW32Q.C(G/&W$R?6FLX^DM$X(
M&&Q:%P>#)2QL DJ.F]+<5_=..G^>%A'>#2O)-H2_:A-+0(]ZRM(\J,P1=JX7
M'P?[T9_CG2-BH*EA;P(_\%1W%UH)"*U?;<ZQYAC4&+?\B+E?K#^PC'<M]5!!
M/B:GIIF$ILQ5S->TJ:FG"4S3(V/7V3X_+YZ'WTY).3&LAFKA@3]&T&-V"JR-
M;"L+,"S81\7B9T:[?7+"\_&-)+X$:5T\E6X!)4\#ZQ.S1@"58O#Z]>.1"E5?
M9I+C8&A8+ZQ;N)?)>N^MQU[.8<D\3^#B'ZN&:N*?S49W.+=I7KRGH(VMF;QI
M78*-V#I:36'V=JG$$=@JEK"Y*GK2\4APVH*&<?!12\.?7R,V:/B2*+?&JSX\
MZ$><6WQK+4UV_]53K(=@JEO;I,?EB]^O&_.Z-'6Z__7/AK5^??1G\8'*^K<#
MVWWT/N12D^9=4N*R23B+?=L?@2JM/7_U]+,T+]_0-X <-Q@EEJN-8 PE0>/K
M:%Z45;JI3NY"YA LWA@^R36 6+,MY6UR24WW*FO@GB)-L)%!O9(B*Y;]L*[D
M9/ZK =JZ/FEX@N\)&*;Y4\FNLJ[-0[GZ++8;&)1=H7ICS>S_I\]W_@'81UXR
M *:PU!K4)E:%SV*SY]PZYI*!4GW)$/%.,RJ2<79WG>>2H<W^DF%T;O *M\O^
M]G][MO^?@P==%]G'2MBP%#W?^$IN2[ADJ':\L/\?8](?=ANV3JA:BW)^,35)
M.1__7?]'B,4EPXNT2P;JS@>,Q]_%59%#I[-+ED=*PV:+6N=FVQVGE9<,XS-R
M-0?[B_WGM]IRV-_\VI8AK7VMW\CI:X663>O*58B_N4^*2M[O$6UO)7@))GU;
M,-&<V-7RHB>L-T\@K)1J>Q*3#6WM-J.79^,>.'02#\/JR;H\+"\A*K?Z9!C5
M6H3%FS;ZC>+VZY&2GTHE/(N^720- C4<S*5\@*,A+=6/*Q6TGR1R*2%38EF&
M:DV >H,?ETDU$+W.U[E^V=*BG]Y!Z=U[6^Y;=W?#1DOX>>#Q\6BLM1Z^1-VS
MY1"\ZKV0Y!_1B _$9C#?7/2MG$#IZW?.>+#1VW+BQG%%O-@OT\V0!I2@Z0&+
M7O/DL]/BW.S5JAY5VP ?E<Q!=U?A&I^13X-V,1R?=V'Z?_M5U>\;0N6F>8MM
M\[?=0^SGYW-*!-8ZWI52R6^A#C\J4XH\%W7O0ZOYIR(J(3DM^$L&3]QQR79P
MT-O/Y1$D@95!J,-W4!</\,S:;B[>.!#FK/<6.?WD73^B4+LPBULJ\)EA0U>@
M)!6:;O,X6)BYB<PH+K!VYT_R<;P/YA^\!QF,Y9$# H!B32ETH9#9JZ%T097&
M=QVBZGM=1!-4@&]J20YLNYD&D1S$LBRO/VT?KA^>OZ87^[]8!#_1Y.&SQN'(
M0\(E ZV!V$F-Z6V05 ,VE&NO9#D"-*!1Q7;+IE/"R>@3H,H!.XMX@Z6X*#MZ
M4*BL_]4>43OB"5_@YJPL'I.Q+!LY8;*\*JU<^*<_71HUY(Z)C/)*'QI"M)HF
M(!BG.Q^;37!B M=J][(;R'-3YB3D5AVWRD3HM<$<P[^*7;+@3US%Z06X[XXU
MBCS,Y;:JVA3#"01(9?<I"<UIKBO"BYP'S!\I.@FDT\X,>Y6_'$)AP1S$MS3O
MM]ECQQ\':IW5C=)OP_:M#)CC$;9,,-!>Q"$=&DH&>CRE?6XV5DOV&P7_IZ\
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MXM=U07T^9'&C;VG+F@-W3C4K51'6GF[8V$KT2%1Z6<320\/&6O20^;+45O\
M;C^X4=_^9GU.%VDS<$#O64OX4OIPH'O3]K"N,455HBZ.,?!7RKTE5G=DF+2C
M&$7N#2\+.(!?6 3AQ2^1T1>7G;TZ <<+%^WN+-/'RA=_].\)+D54P[\=I'>R
M<9MCK:]ITH-VKB8CSM%64R&?SQ2T,0 %39ZV#R_A)4W%<3+9!]Q^^\OL',D@
M!?EX_]R-_=_+<E"^HS\K!<>O:5HV@C"8T,=+"?B#QYU5:57IY$7OE!3CCM+U
M/CU<2-RI[K"$L=B(C*4  82S[LBXG]"O/Y.]X.N_6, \MJ1@^7IBR(JZ?U,P
M%>$?+39022F);P'XG3VP*TZW+9:138)]D"STTS0],@J:FA!D.1%E+MZO7H1]
M/2%;:M 6 R,8FSDR[8FUBX+YO4*WHENX]N,:UB_%C.-GM5!)ZO1Q8T!OSL?!
MUEH]HAFB9/YFN91V+/#'\^I(A(TF4*K%)12A602MBOZNP7X#$VK&S"CY->)
M +YU/B@=&0JS41TZEMJ-^Q,KCE<9EJOZO3X:-0//W39^?@7!E.UD>/5S<I[.
MQ+9SM'>F?- "LU6?O"Y _Z#ZJ8>%0>PEA0:6%N0,]%YUKOB]O'KGBJ7_^]NC
MUI-ZA-DF:XO2B?/=7OF#X\D/*5(7YBL3];\(.PHOH7(DWGHO#)_AIIIZAH&>
M^GEU5HS17[SO.=?HZ_RP\[$/ZK"V=DV3BSG%W-=<<+MR_47 'IV7RXAWOM!K
MFB_9R<<@ZXN'R=%;0L<:JA=#FK\C(G[%APW;LHN$;SL /@[BOI8]'?'J%:GF
MV&AU1]@9EU<44=/(?<"]A?M9-55V436@.5#7E^6X1VU<!MJJ9D:7L5\JJ"/<
M.-L4+>A68T8LA;Y4RC2D$"C(\M12AZA!6_T$^^E[?$OCBVK2L>A]B8-<J9JT
MCT.5FY2N(],=I1+"@E'91&C'S[DY/'6V2[UBA8V320W;#$UODJ S;$89TLD_
MZW-Q<=']U;1=7$)?]/\L<0$?ONAK.5JW24)(R*T=%7Q7$D/5XGU49EP+>XN?
MN?2W$H.FCFQ>%9L(&$ &6"_ /.Z _611@YON,GP;8A6XP.B09?'Y<&GT;APD
MP'L,\W#39&U2S%YVXYMK?13UV#C-?BCG8[6&Z?T3T:9>27*G:*U2KUD854Y<
MPO(?E96#&^@'Q.&W=[W89)=PI&C.9FK6?BK*6T[!07OHFF99FAJOGKGP9;>[
MFP**=,*. J3^/'-(P'WCB,?&MYP93((5YU-S"UCN+^J$''7O9Q"E6I$9NS_V
M+(ZO:>J\.\_C.]LT2H]]KFF$X767Z?,G M%]Z&]I?_R#YE1Q.<WR)"3G>%D\
MD"!\39-M<4USDA41P;>^O7=-TW]__BK^^34-@"'\3L.W3-UW_SI*QJN$F35!
M4 V4V-TPW(?YW-<TWIC+D3\.3_X54:5__4QBY]+BP9GZ_XON?O(?=/?A,7D#
M2==TQ\F7_)/L&0H&C#$BBU!>4O[7!R^ >S_2$;SL(,W="F+B98LC;'9V1E*2
M'4KJ&;,;;M9/:K<B=(P:GQH-B5O-VX;;>8\=\TG"."<A6QQ)$:Y&=FN-2[XP
M%^_YKT>,#*LI)AO[S=9L>K):$L ="-\$QW &?YZ-R8H2P'I/[J]A]6?R(1[V
M7?7?\X&)>(]+<-M+&*$%?H_)5H7JOCA:V0KG[NDP]9_;6[9>P:])O79S]C!4
MJ)Y-&]2X571I$3G+U?HF!=B>Q/<KB?G?N,>::"1S^TE<P@8L0[)G/X9=KTRA
MSGG$\MFG8[O/?SLHPEHLDCERV+,;K.EK4:5BE*;-N@;W,".E%_HY_%*Y!_.0
MV4+7H'!'"5+_MBH#YN:.;6+,A+?)J\B.9>&FF>*]'%]#X.1T9_>DTQFS'T(O
M'-,PY/T*"S>X[P1!HZ$#798P/?/>53;=IRE>P#B$"3QQQ)*L0/#Z^02& ,J+
MHJH)K_:M@'4S1CI=$ZWOF*$8!3G?9QG?]/)\H](_OD@]4VE2[Q'/?I$ >W%R
MIS&T\<Z[QGRWB0DQ59R6;9A47T)[*T BPUPLM3AUV0)9)*??$'G\E1P5EK4R
ME4"<O3^&/[&\ [>PU+JTPV^3O5)SEP#/".[EH*A!K^(6"Z)C[T^]WZ,.&W^#
M-B'IBM6>_1[)GQ+)H[3<99**Y-=.+8E[1^]W]V,2S%TOP,L[MLCJVU7J4.=N
MEHAQF(\R ".4KD">F#?V,-#HTU/<YTN]')>\(G[Q]ID*^&E,?TW3/'.U^M#Y
MFB:.^RSN_37-]-M?#%8?=>!P33-EZ;"1PSWG28>-OS3:65D^K3X(MSXW>'1V
M'A'_278*L\P=$U$)_X;"TU-@_1&35I[#<U<;>F/<BP97)DN=FE%75]-JSZ?T
MAF_88J#NS&6PUF)>DQ@1!("])F6)FB$Z-]>*EGFEK0N1"08*G[( ^5U#[\8/
MTI$L>.<XO ]H9X(%P%H!JTH]@?,\:%6ZK_9]_G4(FR^5"S%I?3,)59:2^AUW
M1P-L;&;O_EC;[UNQVC1$;;Z1>9?HZ.\FLG/6GN:I<),5F%3NA@\JZ5@(^^W'
MP%'$JT,'IT QS$GEBHS8SQQ6Z_$3-^%>L2YTP:'UIL-BF5SW@JIZ??JO-&S%
M.^AC>UIW(X0Q=WG.V$EJ9U3^PWC9-][[ 9C2'?<.S,! )0C.:11J;SD!>-V2
MVM<)/13B<<]X]>*:1D6GC!<2WUJQA3L*3.(YKD\VYIV;=MX=Z*:+OVJE>X/$
M7=-4 VHY6XU;T$DEG=VU)Z"YN9%"Q))-2R)><Q_#)Z%J\<3AGR2_T]I9J.CF
M6@DTO&13KMU[U(Z)L&7CQ#%TM#U(=_L5,$&P$G(! 8FOC)7( 0SJBVI[(EM3
M"_CGWF<$J97L+=4WSJYCV[$5:2XMONO9JXI\,*K&HD*V)=EFC&1NH#O>7FG.
MKN<;HED_W?<FI+M=>1Q]$N$O/G+,[7%-DZ.F#>K2E3(KJ<$P'V[9>]7BQWF:
M'J=-#7-JJ!I]U:DLJGIG#.+D3Q%\/:D#X;>XK'R%D&L8\);A70P#8KT"#5@?
M"%0_9'J[4$V.YVTN?ER4P:M6D[6BU#8O@W-M/H,N>2N6^5.:5^%&)N',TT<?
M!YQHV)>PV6FS4+S9PE_QP]E6"GU_#VN,1?TL/>I>3!4_9?3K(R[\??4NB\7L
MKUGD0KZ8=R.'@0V*[6*VWS;\%WWO3D#SN_9&\>?6 YYXLWI&U$*[*S6MJQD6
M5E;^O2,!STPB<FJ7*SXV&NEVM"HLLF9@GK6;"1QI+CVS-2L=]WK/]R,T!9C!
ML#1.R/OH$.]3[<_>R1YH-9C7;PO8A];:KZ\7+,[3*F^CS1,!;T%#0M!6=Z/E
M+(#H2;"0>;=.3]'KZ+)'M_\'BQ\0'R8^6M93.?^')IK=L1I[_YKFU9+F+WL[
M>NV9M$BX9$N_IMDNN+Q?TO?H5?XM)9V'N8Z!(^9I*T3?BG<(MWN1;44#LM5S
M8CJ3/% <\"M"?F,- I44B^D#%WL-#8<6;\0;/>(=_,*6**3093/5MW@<; TU
MI&Y=%,12EM@MMYVJ:L93U+Z%*'Y0&O!2Q68Y<<X42)I:A<"8)W5KY2CHI5MP
MOZ+2&61#&I_VZQK'&?X+;JNFD!=[5D0+A2#4I;XL$UE>_HC@;)$^ZC&M,JY5
M'Y4NB7P: U/\AB3^D?.62$I9N!MUL%.S51PLTT["%[L&QMNM^9Y#C)V(*T5H
M?S"[K0>TIF2L!!1GHF"TX&\=-:?>]0VSJ9(O./%(LFLVT-S]JUASG#]2<0Q*
M3H/J8+W3N^-"3/4!N$-,6#,''5U7Y50OXY,#VT'M-=\4%W3, ].N6HA*C:21
M;(RIB4N?V02'(^8N69%SN3P]??A>,0GVTV'V2>6,S&4!9!$I3(::/Y,V@/D2
M2:38V&#1C8TB0O,67\.6E#M'=_"*-VK[V.&NT:'3C-WT#-R""I60CD<+B0QJ
M<KBJBO0, "#VXX<\(1_"\39^O7-+LI'#V+0F/P6T2;Y.6S\__D!@JMD(\:DD
M<G, _.EMCJ%24W5ZOCM_M'RG6TC^R42 8E5([6R/C:4MM ON"0,6(]*S#[VA
MND\3&-U+T>8";2'N5$GU='+C](X;\].S<%X+)OPDE!SK7ZS2*XVNT MV5S;:
M0B,?+RX>DU,5N^W6W?<N6S=J#.G,_21L[33[1]E;2Q]#3J4)/U:#XW&?R"\5
M]+JKO@K@8'2[78Y>H*1?:RA_*JF[[Y9_<J294X<8,07 Y;Y%>-JWDE?EDKDU
M<KFEJQ"$C!;+<!,9<9B0@".@I]8<G$_F\?ZF)V+8<^C7WIC_J+2J^UQ87=/@
MJUFNCMRN:0SB!3\'EYQM_W/[9X3P!>;2-.:RUO(1UW'[52ON"O;M!*B1<4U#
MU[F?<>/LPOCDA!;;%3$UI+?E].%4](^C=--S,;HK^_E%OE7=O8ARZ?E5J8@@
M/D3\NVCY._]1!VWX=QW4\W]9!_U+_?? +PD/D^V>[B:JQVT,^SJ;Y091%J<Y
M$M"Z=3>L-3#K8(T&X\>-ORWTL4D*C=M2DNGNDZ-V#D_%-?:MDH[2N77\ZGB-
MT.1M76A?IS=7Q]7C 'RE:_-L7\](NC=P4X$QXH+LKKMELI2'9#NI;HRC8N![
MN[-?($] RM JWC'TQ(@(YQ'#;.Z([?GPTLO"LM\;4V;]=3=Q9_SI+W'\\$\I
M.GW<S3GG#^H:+Z!MVAGV^#3QLEK] \A8\42Q'][#CD=_E"U_4O4/;,'Q0)K]
M5[*'Z @I,$OBWJ-[")P" 23I_UA!S+ *:P;-H2WB,".X'O:QY%5D&EH8YSMT
M6Q@@K.<4MK+6OW1Z6^C\8_P ![#S#;H+'GD","Z$+(86RL]*CC0(4UA#IJ\8
MYOB4VKG2M[;-\9 ETG1P^+(\2Q__/&V5J@ZU+J2L0VE(875%<3>D\6/+^.[Q
M%HKUK;4=%\EL' Z$)U9J]<I]!R>E;,^K,R[:]9Z$TG*/;R^'4[N#ZG(CPWS\
MD><'G*MUVA2KVH_N#Q\%</#AOCP(?[_/SB_//M*A6@, M[Q59M=G* X"4-JZ
M*P')R4</',#D0JRRD:32%N:6ZXBD"%*I--M0[C30]$V/FUW)SJ\E*F'09XC
M%(N'*;6 <A%QWBFI]K6T_*/IVI\__/F_:7_K/T?[!VN>7,'T\\[YC>'R:YJO
MKE+[WR9K3N;_'M*(..>ZIIFKZ]6Y%>XA=/S576BFS"XB!\_#-QSQJN62NU>;
M)4#S[?15P>(+JL#O!/=?GZ+15%XZ9PN0/3;'[*P>&.E:"E[ZA6WRA8R?2UW3
M,&BZQ'9F)5U$[^1LUQ1W0M@^MWWK/',8NZ9QZ=T.N*9Q_[<R$V];/R<Q.E<R
MKHI=TT"C#CNWEZ]I(H?O,HI7'=V/&+MPA<PN73:&_.2.843I_?)XIZ<[];8A
MI[RLG^8NFJ[.+@0'OEY5>!QX7YC!"U^V_!M >=.0LX>KTNJ5'AHZC2]-ZI1F
MJ!;*]XP^.UE"B>KF(<E!SU\2RTW)'=C>#:8G:S/IQ:ME.KR4/8&49OJ9!3XG
MJT]]#.MNAH%*G/(!;ZQ<?7K(?X\$/IX3,06;=/I6%9Z(FA "?E8<U*$,C,4K
M_"(\@XL_K+65NXZ4.N6HU8ZI4'6'O&\@V.*CBNH$O\*."BQ$W&S,!^'*@=+1
M6:8>-G/1(NFS;RD*$I3C%:1[=\F/JMJ"^V73/*S8\^%@0A2O8EJV._"C:#-D
ML4I?761M2==Y360>H\4UU1CI;GX[:0--P!BG- =RCOR*91;*6230]"]BE 6_
MX[,L7_Q.6+=U1E<+KNB$L./$D/W:OOW>9W>?L9=E.3;>'ZUV08+#ADR-4VK;
MVBF6_8T/,FCERFC)N'8.. 00: +2\ PWD^)/8_B4BA 0T-;73W%Q*9)9U-6U
M>\['PR:T7EJ)XO[7Y0U^;+X7$6\%?X9OR$4,HW\74N(F4L,63^GT<JZ(N'!_
M!UJ23Z-4_SE$<[SNV:^L^\+J>7U!S>P%I9,M1U/\,B?ZHJ>S1W?P/OR0\#"9
M<_3[5K<+-FTF;SE.?F<=G489J^=7EB@WLME0)\H[M[IK,9T\UHU1S)I%A;I4
MW$2AC=@'[E%V5:N9,C[U/)L515>>XPWV H?"/6(3'TEAPUH-',L)]H11]D#?
M-2(B](Y%]'.N7AG.:YK#]V]<DV5?5*G+X?;UAT&3(7<R$X_,+9)?,X]/9'Q_
MB^#!(7M<C^\P<L9'\BRGYK@HE0Y'Y9L(L@X]ZUI8]KNH?+/=\6@9Y_&D\99X
MN +KF[K86?!,[,39+P/Q[]J.]F[U;(*V;ZPL^_G[?E()*LX$YSM_/F9PKAW!
MU],VCRL=\<E0M!.$> :E!'1K:L%]-L\)R*8/-@!;?2:GH3V68E=NT7_58-F5
M$!SO=:KY\:6QQ^[L=_,R#F+&QZ98CK7>GZWF5]X6!V#HI.$1GG?:8L+=H_J@
M1J?N^T#&X[@NWZ);5>;QLFEN?B9O]F>-ONV701<GZNT/?_X$&#.F$&RZZ4MV
M$8.]]\7J"4K4&1O&8/*VE]2=.VPTF+AAQ6C6+Y5+&/ XBKV\5^PCLM26UGS3
MPV3<LSWC4,$W>,N^(]T>\>:A=!KD(X0M/+S=XZ8P>T[UB6)N%]N7_N1TE]_S
MDCY]PW@E##QPKG?_BWVB^*7OGH;2$UWG.)RBM5)WK J+ZB[B ;-.^H^B"J@1
M5</L2G97J#"0*:3,3I+U?+_#.U]$T&!D "%4VA%SQL#M[:EQON-9*I;8=E#+
MGNLW:0NLT =FE7^+.=(NVC"03+%I93DM[>@"X%4P(@J4/2"T@WN3GOQ/'L%I
ME3V-(,WE#TUU&Y,^%VLN[\V3KRJD1C1[8FI/L,>IFD\[V<%UP3<BZD^<.N$Y
M#JN/Y%C?3AZ=%XQ>F.D'^!S+%ZQ?J<6$LRXIO.(H\5F]Z6D0"&JW^/NGN$1:
MZ6F^3F6]'!_;>#Q0.G]<W1D/GL7&6KG(*2,2IK3'+I_NYD3S"B1X0&TP(,8N
M8RM=\"2OM$@7.#!4O3:'.;4TS<Y/3X^%3LG#?J%.EO-'[Y(WIZ44C-D6[=Q8
M9.)7Y#=1>21@M/Z:+C5TGJYHS5IK'#I;VEWRR!\C\?S+B'R2CZPX2O9)$ASH
MQ#@^%4Z;A6\N1P!!HHJBXN>'(#N.J#)&7E6/EQ;>F;FDR[[ZZ*O:;[?D]W<#
ME:T+_H;-,7192A=,+OJU3H(U3F8#ENMB(*+@ \Q?7\O7Y0@J*IG>D'7A8W )
MJJGI:'3ZHZ6Q[5SIYH>UNJJZ7^1EV?5\_XFUW-COTQ(0C2=FH3[*S^%?J08O
M<_,<[N\DVRW'.V:K>@% \;PI-@QF-0S$-%"P$@A\\G]7UEC_+V7MR7]29>W%
MO!YS_'IZXVIVC&G%5.[+AM8<^KKZZ@1)NQ(Y7#85[YT;=K\J[]9XQ4MAPE=]
MDPC*HJ*GXWG-9T_[H/@NS]M<2KGJU;RYIJE+ -_D! ]:G0THL/5?UU&?:\US
M?0MP%NW;]E<)?&+/QZT:(,!*SB<RE0DPUSYS#P7;E!3XDH;QX[[AU-HN+ ?J
M>_]9HKMZ5!DV_KN+-:-8>57@Q,MA;($8O\*/6H<_AJ-H'ZHMAK4@Z;(M:J([
MI^Q[3ACI'W1L R<.W 6$(+/G>*='IBU"?ELM'O%O*!,9+YKF$%L1G!? X_9(
M;,Z/DQ3K\!T;Q'N<??=4F$2/?M<07[011+YD%<7:<V&V+"!<[8-1M<N$<9LM
MK.?Y$]AZ+14:-D:KLEH_)$\A)<STE/G):5N >!=*Y*YD<>\+S<OO7V'J5_B
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MBX[2O]PF/$%WG3#F=1P&\#*UXY7#^)'T2C/-Z J(N\'K&4 A3M8E(\OD9;-
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MQZE.)V_*G&Q4WQ&D4Y8%')*6S%&^]D"P?YR_-H8U\5.ULDHHLL+3,!L=?R9
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M3+@9@Y)7^LD8F%&-/D-&8P,=SAV6^6-:@[' /E]>01<D)%Q7(,H4V7HV6D8
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MGJR![5T=PP;94]^BE//O.(,MC;*-D\=%#0%%3&F#LB$YJ\HLYLM,'R[9H\S
MP&9D8?WDP.;7.$SL356022S_"L[*HYHNRK+'X#GF31FL,+FH2T?V\A7M*LJC
M;;?>-HD!!&S%9A<<BPKC-@Z&\H0'UF:3T3 GG.I3HK"];&"<_&@L%\KD %B_
MIRNJ[B>(MH&P272^4I>5(&&_2F^\%+(13(4;HBYG^#'6?J T=$J.V^/4F:P=
MKEV*649A_%?#!4TQ@0ZKMK7DBB]!"HE)]LQ. DTP[K(IC1)H<F&[?D2&FP)M
M\4-6!K5C@T]'EZ'B$<4, UHL;LY#4X8N1@+IMS.\DGKLKRRX?GSJ"MFMZ-,V
MVB]L87PYT[%8T6!93]M@L=2KSG/-NU*/0,.<=3:2\788'9K7;E:#?(5SB"P%
MYQ8'/M*-7+B'%*U/\TV<*L0M6PWJ/#S<P-C7)%CH:\4U(5U41A'3 5U@X][)
MZ2=?K>0SRIA'E'JMC0+!PT4-FJ?YS!')=N5M7DF3B)?ZBGG$4G!4S%E.8\F0
MOJPK*O!J26!6)'0M?XM>!Z=<FSD.J6?6ED/_:,G.42CN=:\$LHPL54.#XB5Z
M$GK"POUTW^,2\0^ZIC&%GMZ-K/"N67QGKXY;S2@!.[P D?65]O=0)T_L#S[$
MC@$L-$_\RG ;A*3\L.;=>&#\Z'C>T<QY,B&I"W.!8E%XYV"&3^JVZ6B*I94B
MWM,7Y0?Y8'478 7CYR.R]W"T?=;2^N28=.!LA548<^^@*&6, M3@OF..%S;A
M':0?^ZXV(9DJL>(Z8Y'N%/@VS+!VN$]EI^XNZ6UH_-3THBIJ1)P7D&"+L#Q.
M9>S+$.L6?NP+4ZIA/$S6=/VH=T3Q)KX)DQ0J+,L]M0Z](@\)>C7!+]_LUX_%
MUS&ECVVR%>FTE69G,]8X03E3AV!#&Q'I;CQOMPJ92RSG)JZCI^\M*S/K9^%D
MDBSHHGVMY.64/:V<4&-?HXV$'Z=29!S(,(^&,%+B \9.RT;(<<.SFLPL;CEU
MM3MA4],0*;JH-FMS5W:@=9RQ6VFTL!D>>M]^_>%Q!=PZO\A X;"08I%UZ^H8
M=R=YK(PSQ#X-:/C>TH':DGIVNS]&3R.?[ZU[0M8/7445SYP,2;'UWP6<A#C7
M5_(T;>*-WE1'(>L#8"+#@G/+H4YM#J@4^8X%[,,I\T7EPED2M$2 RM-P@&<*
M[-?YZAQH4^?::JT>.D0WM0+;(LXG.OIWY2ZJD)K\(GEZZ+,G-F?A%+K^.VR$
M0AS)EX&5P\RY.BJZ#P1A2LGA<TTOR5@HMPSSG+:63^)8&)NS8,F+WUDC-=E.
M+TH;>QM%C"1.%(] 6S@F2AM\6);8&!S_&P7X]@?O9U5"][">=_X\I0TW;<MM
MF!U,6_78TA2=>I^GW3@@%_.%%V_@*2U>&]X8$("&) VY*(7H,!J/]-=WJN#Z
MCJQ'ZL.]$@D=Q8TSFPNC"T/N<5OMUI6I9<GC*L]@CUK*]*D^%HT6;5:L:VU[
MDPISBMK7%$V*3UG8Z>UK\?J])P<9%ZX,W[,&V1.<J/&N17M][\(*"OC>,@^R
MY4'AH9D2I3[X4? 8O#YFT*-K0@HN&H.HB, _^G I$.M;:=R:HFKBFU2R4]$,
ME5\NM>VPC'($BM X]9]:^.2 <EN=2CERBM(][3EN[@H,?O:V\;P3R5-91Y<B
M;I_T;GKRX1C+'!!G"-"<%B&Q'S(_@'R;4U@$2"YY+HC8=CJ4J]C7P^F3J".Z
M.CS)OG=].K<AZ7MB!5_\S[OSI\7UR/K(7<L MD(KVTZS  %Q3Y[<CA5;$XT0
M8$VR I.AZDU02$%Q#&SEPNQ=QN(#,7]WO_4\-UJ-IR8018=0WL!O1=;(>J$<
M#D+DHBKS.>#<SN]>Q84B)8DQ(W%X3FJ\_)9VS:GAMSO/B(9&TC"-_HVCINOT
M1=TRK- RY(6*:U6_N6;Z:.+-P::"AZ0$!4-O!MJ-76WIJ=NF"-E,!\ 38YA2
MZ;;OPCCH(/$R7XF\_@^BV^J4=2-\UG$L/:'7M!0>/9$T7!8V,Q>TZ;_QF0)Y
MY!I2\BN*SWK*P[P-[WV29WAK2KSI9O[&U/RO%QP(61$RC^DW$<QH3%34>L=8
M$4,8'IKK+M5EF]Q7)SB'F;93\2^ULQ\\:E)3P 4R3.9)P5K6._&J27E[V/-Y
M0M/QV\LU?7"7CY33#'L&M.63W*D _+#YZ7B4>_N'QLM:1N3F_)BM]<!]OI/<
M7O\+$YQ644?E.GPG[2E&L&$LDKFM5=5Q@A- '+''H%::I.J9"5GSX+N7<&'>
MIM1PU^NTX@(\,1O ,Y/ 1-S+FF$ST88)2@A3%K,*^[#57Y&%,SX%:V!\AE A
MQ5:^MJOYKB=13 @/,7[1$7DG)]E_[VIL%CJYQ.WNUQ)TY%S .F\:GUZDE_^.
MSV&*Z#$8G#+]2ZNQ+@K(1CE[SGM225(?2)C#[6!=NN E.H'/W_+S;J&4"!FF
MNJT]T"VY?2.(\9_"-AF/F$>YS=MD9P=Z*J=!XQ(S:&O>E$=I"VY>>>SWXP:!
MW'J%B @551M Q2VPLB^38O(XN5YOKI6$=;[HW5S!!_44G@YX;?Y.R>Y3U,=/
M^:U6!ZH#.DX9BT@X(=E29>=:=Z^9VY__Z/$0_IA'EIR/*9[J- ":8?JMP'J)
M+ VJ!YSP)Z26F9G!M2EW4J:*N9D+NWFF6X*%3Q1\[=&=UUU]EBG5<*_IBM]]
M]2WJ\^VOT\>)'G*B-Q,V+BDG4@RV\$6Y"Z_ G"1_F4:0SW6/:8@J0:6WS,H<
MA!6^W55I8V%87I%RXVC3LV9,^40W$ER-4.,QQH9)JKM*=MHF";+>D("#HB75
MY2K>=N@C O9L(^J(G.\;?2]3/Y4H4)G-C ^HHL?<4 _7-,G7Q^/+X,^-'AS=
M?^X=_\K=4F@GYU"?!%JL/)JE\=K+ %^4Y&N6D"M(SGX^X^= 1 ]RX4'7KA.N
M+A^#.5(B"S.CKBU""W&P NHV![^-%>F@'BNYQ+>T^\48LVB*@:$&IVT%9^V^
M?-M[8##TW7-$WSYV(96US"YM2T@PHU1=/>?.]6E=5Z[:RD NH)L&B&7KN7:5
MW \2.DQTC>=[EJ*#2.DH"(K, '?)TL9\M]L1V@0#A$;V\.YM,4J77R7D6N/*
MK44F!,S!C;&SFX6XS?S3&U'$D<>M7<CTS#Q!Y^C=ORBQ[NZVR2W;X@T%)2<.
M#871FN2N-!8MN8.O=:<@WU7=U##/D'IQ6%E-$/VXFJA^:Y=FV.47>#IWU+(M
MSXQJK7[;]H_,W:^6)Y>#1I$&A'$QV4^5Y77,:2G. 1J"V&5VEZ_=Z,\(G]J-
M< W1(GGY1C9X_12^ZQ6@'I:V2LU(37G5[Y<K0#1Y"I2P^_WB_N"!4O ?7JDE
MQZC[<Z)9'+ ^(O!P!%VY%@G?]\@8Z?(%-)=MMUPMCW.43OVKEW @YHHO/2Q#
MEQ9VS@CA9G3B4[?>?37B0F':9JV=O]0*I!4DL*JI[P@LBFN"]2??Z@/L&)YZ
M<H;W[\S5O2'A!#G4Z8QZ5=QUH[>65'!^]TJZAW-'<O+86U8.,] AG*Z3%'$3
M,)21%KE[^+($?F'@K?IR?"-<_B)2VG+RSO3#,<C ] 8:VPTVW88S=5VJ='$\
MKYWL?IN_,%+C3V?_MN&#_P7*4U@7Q8A9'#JF&LUPPD:&AY. N,T)Y8O]F<4%
M@S_]O!D6W.EY/=^33>Y:5;TWO/Y;2556SF!?_M-WX:IZ ^#=#./HFVA=C6=1
MXJT<Z\/'WC/[+U?'EQ6\!ZMP[H6;NSNH'XH91TTZM@F#_).S9%10QVC(1';8
MED;\AF3)2WDZEJDJ&"AL3G^0M FG2UMK6L,KQB-,=[3I=0(P3;N^/GMZZR(I
MMHXUN#*69R#DA>Z=R T%;!'+2<G'^71_.E26HYTLQZ$;0WA)I\>D=0R5>%!#
M7CU6]'2"SK0.'U:J7?ECEAYKM:7!69MU:]@F16_5E6W5KF!\RR!ETT\^PB65
M,L6=A/; &=:Y)[3L:!4"ZE1HZP!O$9%WJ^.6/Z1&.<+UVPPHB4G&,*.&;2IP
MS3#M!7S!PRJN1ZSO7@09JNL&D*!M:#@PL0]]+-W.!?E(0W-8\:W_)PWZT9%!
M? 5X_WN$7WP)JJ5/[6WEV'_QMJ+_W!0*/&2!')\>?5=Q_0[7.7.)NKK?1][/
M:8-[*&Y-_#AZ]+NZT:\TFX;FMULA_(_(?A*G8@47L,'K28V(GS3F#C]I3K9#
MOSC>R>5M0UTV=/VDV;=H/2;)_MF5IJ[VGP[]VX,LWL#IUQNV)Y6K 9UC*O/F
MF2*'Y].W?!ED=-,W8ZL@\4TS#C\8UKW_F*'3! J*DU)GY^(\(4;U9Q&N:6MU
M_'=^TK#V@F/Q\%DT=ADN9Q!O+:>_83;R63R4*2O+4Q%J9??X_=X:#PJ:0<A>
M@59'$I5\X,=;RX<.Q)J1D1$?[017Y<+'Q?416IFK)IF5/3*Q5N8GR&37CU\P
M+2(.8>QIL@R< LF6'LUE>K58@6@ 'T>1?/]A_81+J'P_9,\)P<JU+MQ&65@"
MOHP!,P E;AS#=_=.+!K2Z!G]CG3=)LS>5'*:+Y'RB'7M )4^9*"+T,IQ+;Q"
MVW/5Y/$)?]I/FJMQ15,ZEUWMKQQ_TIP:JWV]?!':JV9_MB-\6GCJ4_.3AO_<
M]11H/],\-,O;D7*.DOQ)HRJU5Q"03^7\26/GRGOQY"?-&/B^IO_!.1PXH=-P
M4P*X\3VI4-G/B#VP#.W,-JC^.\$Q2]4CEN6O^L(T"Z\494G%^XMFJE,$O+LN
M090CTTADS,V<VNWW.NRS*L<I2J8E^V"QD@7?)MEH(4[!V@B#C78Z=U2(PI46
MYEN7OM@3^31XPJ$6W5'/!V_KI+BV):G!%>CP5,<7HA^KA,E3:Q0KD"D1;3;.
M-&)J%".GO&.2:@Q="TW44IZ:ITMUOAMMDY@&1,^!.P411D@#S1O&[(((X#>E
M'[GH>%:1@<JA32]+&ZUM]PB6=7DR6\T+;^ZM.73VJ?E M?@UUGN@G?D.<)V4
M@G?L(2_?-G>/=#UM]'LCFR&RA7)OK*^5 N%)/0[)O5*M',&E 7/]9&N0^^VV
MM:-7:A/7N;AM63(!82 II=W, $PY>^6>M#;1$%S&&-DQ94J=(#Q9\=D$OY@9
M(2)RV*Q3%OX[+E<=(@N:QOS[&Q^<)B=/.T1,; ^2JE=R:],]L'4L^1I_:&I#
MG%*[3#!H$V0@9F(P1=*Z^KK?#A:F958[ I2 U>5*;G[F&K$U@RA"&@L#WXQI
M/.'>J7O8'W>OODY9C9)Y7@8D/#G3^D@]T!#\Z.+RSO5#W:CNU5CS$MLBR*K(
M-Y6=$73<TU>*HJM[%9Y*?:M19=9BK Y]9>!I"S$S?='(WWR+V!%==C"8VLC$
M*%XE7&'90"$?1$'<Y#-F";_W_OU[=O;;)@8272",9CIC>(]8\@Q6(%%?I3"[
M,.=F\.U+>OKNW1O694]AN09*2Y@(RA-]=_"$,S:7%LB!Q8E0[[&:]B,3X;&Z
MK@Q8!U;EFK^2K ,9=*T]OFNT#V=9,UCYJ>Z*89:E:FNS8/8ZF-I9 ?S-A= _
M>P39M79ZY04_#M;N63=>18YA\<WZ<J/[\KF9]=^5QI2(X;YB5_J730!<2["<
MSGWV<@4JP&;1$'G3,5U9Q.AP]6!!Y\=O[[(-,RB5$P0'A'1;:Z-?8?ZZQVC7
MBUU/R+9=5Y#*H&O*YX<&64P(%MN^0P_ K@5H85'I13?[ <V/]QQH#$965H:/
M3U(($O*$CV\K+>T?,$&+XO5^J'8),"KCQHQ[3L\_:K'G0I41*P8=UK3\\FII
M$I. )#D,\-!([+47^TMGY5VRK7H3BZ0YF#!2C>C*])W&J18XKEW 73+V;P4I
M]BW'&$][^9?=!!YZ-"95().4]'I,Q%::;P8#'T)T+/@T@6A5#MU;"Z 5M?;>
MIW@QC',PDV;P;2=)ZZR21I3C,L)=WXAP'@AD1FNAS5*7'HZ&DQG,T'EC>9,<
MT)K+V]\BGQ33A,R(VPOU\9K:N'(W]^#NDPCRS%KAC1N2H)1.O<GN=TNZ[\)Y
M35M>L__XJZ%M 4':/+844_2T60H35.QEFH[KK\[,%ZJI6*,V*3"0Q\4F'=S4
M;MFL,N-QBSJ8BWM]ARZY33EL/8AN;@O! GOC:5.)3B3#NB#MASBN"0),DW#U
M/$+G^+I2^;5'5R0R?6,GG*G"M(]_,.C8U*GURA;7KU#[)25O65?[S8W5C.J&
MX?155%?3%"W.6-P49[MR?M(TXG@.=SE_&#L]ZK&Z=-?IWNMH_>YPE/-]Z?23
M?]G0 ?N)*8W&=Q8 UH6^!.W*V=J3\_C 6L[T1&'OK[.;WF\R*A(>0#5@-RU,
M6\':H7^&3[!>B>LVS/]DU1@8_#RLD/I-2^,*>YJKE8(^S';@T-]#L*ADOO&6
M+AB\+H*'25X\.ZGX$#S) J-?H;XRB9?;?"^W>_((]IP2D6\D\*[QQON1:J."
M'A*OQ>N8U*9JF8\"AU-!)R;C(]:98NL"1F3%!%1UB9(S]9)%$C%1_H7H2S@/
MPSV-O<4H0\/CYP1,'#Q10ZWXJ=(#0].@W0&I U[KSJH]H/I:SE56@.LGP>Y2
MIQH'@(6+HI:%P=6NBW#5%!AX>M.%;1>H98:S4C<RF_CR.]CJ>RR+Z>;M]G#V
M,\P**=FI,X:,$=#8^OR&PR4"4V>+<!T3*$#W/Z"=3:^#*>LW""19!P,E'+]M
M*P49MT9EPJ;>E..$\IF2:REY0$1UDC5TXJ^AQZJZLXPRN'(!G(X3#&T[\4F@
M++'7B)QV-?4R"4E^?=30I'O)]Y/F7N+:E*ZMAM2M:*)37U9]EQH!P*9'_VVO
MQ35Z*P#N\H\.)[$C"4?QV9P,VGHO#?HK$6A$SO]*XD W,O5HE=;V1"SQQXDS
MS.Z7]D]\^$DCA5K0R?Y)$_WYS IUN<=[F*;</JDS\,_KJNGI0G'GT*0IT2^
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MF "LI;1/P^IPM;.BE,!I:>*,\$L6">V!S%/E\%0M;>EX189\-IPFQN(E!LP
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M)EC7C-P=U3<QA-520,\IL+Q;)4_NAKT7O/'D6514[.N[F*6E_#>-; 5Y>*
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MRT'/FUDR75A&]=V@> #A6HP26H.7U='?QO0!B@XI*1.VA&/7*E7JDY ;!7-
M"Z-?S=#OK;F.Y$%?%0VX!+C*#BQ-JS8E6R0FW@!/FKD!GUCJ;^OQQQJR"A0*
M"B6Q:F@6?9>?3H&BO#/>SWU?2 ](>E3:<.Q3<Q%]X!,=G/:2 DI8WLP)4T7M
MB';M6&6?P6'UX@EN)+3*R(=O4+'DK=D&5F'@4T/-&>@Q6**G9UXX\3_AQ=_O
M>K; >9_RZ =X8^P\*-7PJEONG.2 5A'8>-=.HRXTP?!#TM2A?)_:L^_O)9],
M]D!K%.+5&#!\?.()Q%]\?.#4[Z ^V]MLN/AY1,/PU$V%\2>-S!=JW%S.\1[/
M>/?YYT\)#T^]A;X]BGST; Z6>FRS8Y(_OZ_24_LZM^4EP5>2D)RBD+8N:^F]
M3V?N-+)N4!0W=9Y3K%P.GF]/<CZJ1]QMCT=2)4!\0.9;U%D#(5'652+3=HG4
M:[[]ZTDO'C*B'B:?"(USSB0.5X2W\(>&E[RCN6$]]BB#/'1:6O\#4<I^,M2D
MGN6F[9#H.HU;S]D=&J>ZBO=+%JXH<]>]!1 )#=F-;8HL4NK]FO$=D(#@B(PG
MM #Q-P/2AR#1M;"FU*]L5O 30X R:#!Y^VA]D^O1!9&;]B=-FN>E]M[G<Q37
MA07O]J-K:MT\>\[S10?KFYSCA!".(.'9[.F:(-? \;QY,(S\9].7 -QHA=),
M=?R9\%HU3=W(SIV?-"T[AFIY@Q7!5]_,D]_^I,'N"OE9J'Y^MEX@2%\X,R]U
MSVVG@I(DV4?T ;MM'<OKNWR[;+P:W?Z4-I#3,LAGV@Q3V#<--M$?5H%"8G[2
M^.7G/OHJ\9,F:F[Z)XW!TOH,Z2>-%55Z33SD/U9&H=TUY!XWC^H?8^0!QQGS
M^<O1+0W@F^E-W(36NI.-;,M &USFMA.@"G>@C=NR<]'BK/+TFIF\$"S&DW6<
MD Q;UH@QR?!+N!CC5?AQ[5]9OH)%'U/8?</ZD)=7NX-H/1V7X_ZY!*:;."*>
M7\(3]:+19I-^I#C]40-,39S"4=3H+MB)%\.75Y;7T?=PNB LW-'.-?O=.7;U
M[S)-&"R-&AE,M#6_ZLK='^WB9 VB56^4LJOY)EO[2*)MS3RI"13*/"ZW,<FM
M>@DH; )PF3AD<:@^VJ"T'>FINLUXK(F>(/A*[4+25Q3-V>U",GOR(-9RN'<K
MR?$ %_OG&>RBL;]S&HGE-P)..1TDU;92*,QQK6CHG%NL,9CAA^UHH7W2BZ,>
M8H0A'+PJ;'Z1CBD*X _1RL70W)2XW%<G[[T%?G-R;? M#"PK";0M. T,R5RG
M+S*L*H^\Z0X8<\LLO6I:)[%32>$XW>/I>)E=86-N(ZLG:"71D0+8$Q3LV:7X
MN2(*]F FG[1.W+\<W.7>;0YQW)TV=ONL0S2@PY<(71SK-B\*YZ_MNE^K<Z_0
MG)\CLMI]M<DP0DXG-Y0E&*_5HW_2W%I)\;>[5U*OS9I -=X=M4VBC&O0!/X&
MRJR#J*3B!I5:_LCO6ALBWG8RQX 9?99#W="?]\;)ITA2WP4<XR9Q)HH=;4LL
MW3-.?Z_XELUUD+2?M5M_R6NNF)-[X=]>[F0SO?M6#WG5C6G*F+\GP233G2[I
MZM+A];A$XU%7_6C')%D!09U/UR')5,8HK[!JP6HQ?POEEY0DBR"+1_^8N!B-
MK@N5-L=O;OR5]^.L=N9 *'%OW(OEY5EUQE/R2=IP4-BS,1!P:LVW_O:IT*QO
MUM5JH-M$(C<9<(@V-'3L=\YX6GGSR^]M8GLF[.TFPX/3SWPR?#*A3=J(0$5$
MD'3@_9+%D2_M.G.:&7X/,>TNS8*=P+GD210D6KOY7%ER69Q!6C.*AK\]P)8I
MX^KF[_W2XA<H\*UU3XE/B*+*V^:4P?B:%W:WNIW!P(; Q@]R9".OONG91D"\
MZF>@RSHYJ5<0<P-C82Y-*I?C;I29?NL[EIUS,UA;E16[2KV(.9&<G^OD$"8*
MYN%'G^I:0[)"_R]AUOH?_ >^J$\,S&G/*7C4:#24<Y;\DZ8#OO.3ILCKA/!H
MXM7M@,C&-,622^5S[4ZHU!-[S1_1ZM<,Z"HEKB9*?E@F_+&KV5WD+DZMZ/#.
MCI.HG^F$9I%W3G@6:GKD,U8*"LZ"C;.YA=.<"DO$XK/ZI#B 21(KREHE,.T.
MZ[UZ(!)(7!(X:6AHR?X#U)!ZMW1;;)G(<-77Q_S!G^',6 Q['(. LSR/G-\[
M3> 3!FQ![.N[55B<,%%H-H<]*>P!7)1E!,U2D,1PP+.QL.,_!RV:04128&O_
M_-.47*P;IS(:+:=$B2N/NP5[*<O_3UMXD6%09M4. G:!*IVO;*\/9&QD3#8_
M)HVE^(3*CHAEQG@TJIZ',(S14NW8'5SE7R(V*Q_V#E5QH=@, =?;Y.4"IS3=
MC>L3C8XBS">\T77<*=6B7KTJU/2*2"!W:\.9[7;\2J"N[T*LZ0HB296LPZ!X
MQ5F=/HMGCI<5#@E"# 6>?S<(O$*,WQKT#@@H#HSJ!]PN5>L"2"*CJW,7!Z:Z
MP1G)Z4KC)<G31SS"#)I:3QE3ERIU'5=*/*-?VNRWD6?I@2FK1YOBG7U'%R4J
MQ/FQE! !JMC3L/V,OT[SJPOX-5 6\LM B3+B*Y<07]N68FB$M?L;%RLNT8@7
M;64&QOT&_5U54.*X_.XG1^>M,T;P&^S#E.C:5%W;#]/)8K?HX^E4@VGQMEM&
MU#[_R[=2_9+'IZ;Y =L('P(>6DA2:KR\YC'5K=75>ZXTU9\ /=?GOT8:4Q#C
M6V?7&G1/7YNF!](G;2(!"[TIR?;66A5O;7;632->5#,3 1 <)CDXUY YOL-Q
MQ (\;?@$%--Z!UV1LLHF3JQ?Q#8 114H\/3-SJ62K%/#&EC]OCUP1T[7^]PJ
M8:LK<S!]H%J>%91S,T3PV++ZP=->:8^89!>(5LR*U^+4,Y?Z\:-\H)"];[Y5
M[7*4&2=;[!3T.-E6\.!T&('^N(@X:> R]<O'>\E11^TO>6\ZBQD'CV='@<M.
M"<*;754KQ,'FP7RFQDFN3S$W>M:']IVJA;G40@$F:C/Z!$DKI?4'VL$$^ZO)
MP'7_KF(LXW+^>FY8_.9JC!FR:9(14Q0#H/;64B+&_.9JQ)G!L%I;YM%=IG9[
MS-B%:!,K;ZP%__T:1['GX/J^/716,[G"A!8K.SV!=.E7>(?EC,"^9U$XX3OA
ML[8H6/E!?S3V?Y#RGD%M9LVZ*#..&-N,B2:/R4GDG#RVR5A@<A#!)($ "42.
M9FR"338@H@@#B(S(0@@1;*(1R610 )--#B:#X<S4OG7OK;/WN?O;W^T?[Z]>
M]58_JWOUTUV]5NMM'YIWG=\*1A=>%S!79\^'M6 7P F[^04"17B4"$"_V'TJ
M41<]691 =Y]B/D9.Z3-H ,U(Q*0O]1$2&_/[I.]DQG \RLYPMY'R=2W3$U4;
MA_"F#;-)]=@[UMTN]HRU@LQ-7#(6V"=^\;X,&TY?=J89 47HM)]#2BX::WP[
MV:!GS6'T%ZY#;K),1<^V,7;B?1ZLC7TN[B50GS+?B1^91N:<NEY1@0)43?XB
MY0(LIFDFDU+K] G99HBR"LK0?H9C?<[KCNRR,Q T4/!5%VS8_'V^#I]R@ILQ
MI%H])6S-E"S_(\2&@_1B_>%G^.4=OQ8=NS+94]]U?PN-0SV]>)!T)]@"P0 *
M$D]?\JF$N?]%P5BRT!<@XR)DBNH]I3"U!&1CEZ/X N^*\^94'F(P^JG(YU6)
M5]U]+]_HZ2>X37X&LF:[=T)Z1Y1^"98^UJI0R,.N<Z:L8*VZWG7(F7&5L<:5
MSR8:V">]S.O^;B3PQU\Q]L#(G-W;,V)2G-[H/C;WBE0!!DSUZI5[7/<S4OK@
MZZEL@'N7T0 U/@OV<,M30S_ 82.GN+R:54/#>Y+^#\D27RHJ6M9K*NN1TZYK
M*M[O&T?5UU0S+JX;&2%;15^4.?[X'Q=M_XW<<-/LDDFN^IN:CI>$3RV'IUO\
M:7M9U7YVR;_:]0;MN<NSQS/)0/CVM^9OV#'I2ZS#O'>+01/Y6Q (RW4$YKJF
M@F%_'O]^_NA2('R@RO/J*.2:2B]"YCXD=?R_JBG^=_GE=PZ6CC3@G9E$ETLF
M>2Y[KA]L#\[BKJDHV@?75/MO_T9@/WRM-G\.21D;OTQ:SZ?PA;N=O/ *I[-;
M)^,OMSI:DE>3OGG^#,H)WZ:YIC)T??MHJ6N]F>KEB1;_Z.&)1%?KV0901;3I
M)7+VZ-16U97(_VJZ3GO78;"E >V3QCG6J9&L0 )HZ\[:WZ?/20-T(]\4;2DW
M6*?*#=@>KTT5Q:2V"5I@9'*;RUS3^OM,EE=,'_=[]&BY)?0K7%Y<B5[XSE5%
M/#UOHK!K##XHLR_P87Y#@K?)!T&?#^'CED"1T"V"=X0Q,J_'\7&_P0V8?%!(
M?N<1WE BF^.9"]U?GP](.3X<J-XZLK^J(X-L*@66K%_86=WY,N;A)%^J;XX?
MM%@3\MPH\>83_#8Q^IIJ!3F=2*@-W$&_^[Q8;86!3>+A[[ PZ(L7\<@0(3-T
M]:VB9PTA E=<%VQSG,/UZ,7!@W+'AI<#-]Q^7LS$G:QXFU<_4Y[PPMWM%5XE
MQL6;9!>E>H]IKT[)ZD>$LCX*3W0WD]1(MG5,%_QKX+$U4W:,4U8R,W^<2!6D
M7O<[(-<USV.:$5I>+IF^R4]D2A]MQ:O,W6=V1Q:$B\T-JE:>DE4FQ"Y-$(A4
M_]WG,;X!K$; 3@3"ND@#D+;<3@P0D;YB#]'K7/V9YRBI\!++#)GKDI5;\730
ME:^=9KML0QWSZ<64@W"/#6"&/H@'[E.9RD6L766L3DN[!!>&CF" 1[D@KTZ&
MEFPT '[F;:0-O<5MPWZZH]@O]@RMU;^8=ULEO.WLY@DHJ YWDY3290>/<TLT
MH_#!@' "N4@ R.KKJI9Y[-+^:ON.5WW;?J0C]5)MA3D/LT7O(1OVS2,_3[!\
M@4+%>J'IN)%EDVIK(+$FP]QUN&+!XD5 JCNG/AO"^.OG&F#JX=>\#.[" _K5
MBWO91Q[.S5U;/DX8*5=C,":EK_""9UML> _L?V(>N!>HUJ ,M6BC>94X'FF=
M(R9@0HH-D4H07JI?)%>TJEYJ^=\*\982H?RUH^^8I=)"6=X/=,>NJ27*@XO8
MFL#E@"AO'7UZ8F'>6':\]4ODV)/RV>KW#@H9R,NG5)ZLPTG<O?5ZF_=M<$V3
M#<,W]-[>;NM69+TO3CV%!T#@VGX[UL8R;*%YPB/'"[FKH-(,^X)4>PG)@?V*
M[4HL1YI0+T@X.6[T\?;G_E(MX<^-2T"):ZH% Q]L2&/H"?M)$5>VRI+H=\G'
M(1+=S5:X!TVEBB7%BH<!C*C%''N]&!W=EM_O91.='_28;GMG:T0!$&RNPF'1
MQ1)9:6/968P&FF$/)9\4AB$./C9F,]F\X.'A5.B:QT5U@WHL2X$P.,(MU30.
M:*I44H&1U>H,^V-00B%TY)=P0$^YBACWX#:0?_%83*/7!&$%]X4ER(R/Y>IL
MDS@WV08/[YAA?"SW[LO) 'BM75>"DAQ'7\MGZ*71YH +?K.#J6MC8W.YV=A+
MR"_NF1S'DUP_#-EVD!]^W5X%(;-V.8]>>^4R6=:G#?@[<N89Z7^<+8K%-6[W
MUJ'"J^+@L:;A4B&.6[HA'<0W&LUM^>"LR'V6#40+V\F*?%2\LU8 5(%@YL_C
M[YOBHSLXAB#IJ#?5N.M#6X;4>[B'4=UU16]FJ]Q_*^QSMZIZ:[?"E_,X@;_W
M4[^/:)[QNGM.V#AOQBTV:%/J,JW"KM@A./<O%S/&307W!T-6#; )!A[.%!T^
MH=!RI;'ZU*7"V*\A27!E5<I<]XDQ6\B#F#Y'!@\53>&CB\3EM:^@'&2DC"91
MSQW\:.Q02!<*I7^6[CK\M!Y=Z\(2'6/RJL847B$<(XVAY2MU6-SIG]ZNJ*RG
M]A#6S0$Z^9KK?5RV .Y_B.*[N<$A;36Y$3KN)V&#\ ^+&PHPHV2TI@- WCTV
M3:7>^L:18@K;IL\\"/H2IHF1J))-@1]KW-MW9*^>7#@/>#\<]5Q,7UZ2E'>\
M_Y!S"VW95.2V/? H?4A)1_EC),PF3:QQ>4&0[W$9=GPX696PF!5F,V6<C<]S
MA&3WSR].'2E<@CW<30[T'4U_N+O9ZY;7\C^P2=QT6_VX)I #[?WR]4U8O[+'
M_"!6&AO7Y[ 2_UFH.F7H"TD77M-KB'B=PV>0*OA=/\THP>%G?IM=9X:3XNJ+
M$+%^[^\K60U-Y^S RHSE;7)IMT_40'W"C!D2GD*$5P\N\*-0XV'!#_[<U(RP
MVLP3-WZ4,\W:8^^"P?$^=DV2YND"1??DQM.L2$583_$X#E=;^S7K>BO'TQFA
M&K':)_/NI-R47;,U@]#Z 4-+=(X*_!'N\9BYAT>YCG5)&Q(X#)CL Z<9>NRO
M[4T283^.0XC0Q*&&RA_INP[[#9^MNX9AK^KB?-+P/@WFVHIVNN0)"$LO3%\,
M'O6['=#O5Y*>C]O+@\26=\2I*+-[,3<$*S0H;(2ZBERCQ9(IA4W!CR4L>:4L
M:H8^G@4T8A5:2=XJ2X\^KJ8W> #P\N*S1!3LLW73<8%@J*OJPUC3)(:4T#OC
MP!U**-/9SHZ ?P-;<^5C4:-WB+UI&^2 P[(8.BY&GJ/T%HOKZ5?O)&K'A(\P
MU=R>]:MGSO)T?W4=#)JMRH*UZ)F39AK-M/,?&%5L_]4;M$Z_D-H]L"V4D1OZ
MU>,@92-&$Q&25*]ZAFV?5>/>)@/BQ9RC\8\I9HX-,#=(L[X0EJ_"$)Z:)N>&
MVM2^S+SB">'%S:H=VGMEAKX1X4I>\CK .5AD06V;%OC8TDMYBZB-:E-R>.Z5
MCW[VF+(2QZEZC@%P,'I#[_L"OY1- H*:L=6-V'Z_7WE&'*P@_055L/94EO+X
M0TLS9C=(-*H_Y_T2NA$_)+?[D_M1*78S&.OI+4_B2"!X^3=P[.""I7/)+T$-
M4:?)LU@W(H2P&B5D0XQ+\'>X,K)%;,4UY)YON]2WEHK,B0Y?Z<WF<=%Z4ZK4
M;NLX^-!N5BO.==ND(.S!U6;;LU[9J8GD@@,^<1^M%K/=U14)MZ,&ZIX"1S,C
MY(<=K;<8OUOGOP8!Y6)^;(CM> Y/T=#(LET.;"E%)R$BFU$^,!O8]#Y+$BZS
ML_=H06)T8(TW=U )QP)"J\D4>*\,-=>TZ/2,ZU:"I)KFY[\EB70M8^&YN:L*
MI*R>,D61Q]-@>(<Z*5)L%N-8A!RMPU#W#*CG,#0599[@Z\GR1EYQ4+?1C18B
M>:ZB/$@5P1Y4MCWNQO@K-U;*I,FQ1Z8'>"'[Q21SMS9/^I3-72]1@?0AY;AA
MUM8T=X59'N\')6&S0)AQ?;DR]"+44(<@%&H*?[%4RD58!^H:O?SSFNIA>+?8
M'BQQ?V9K-[S&M@V/W:U2Q<U[!WC)DW-XF(7,;&B:)W&=L'09?3&)R"7!VYR*
M:OE,4J,V58MX+]+/WD+#KTMG#UOK2N3.(BS-]&[)/W([\(?WFZ=-,L0+=:<Y
MF[#$0*/:V$G)(BDP@'6JGO;QW,9Q4/J.VK+-W'U9I/Q)KZ+O_KWMF<I8RB2$
M' GH;8QW6&<6'#/R2_5%,??O?+V #%]8;>O1M@0E"C!&;1$LAZIXNNS71G5W
M..83D!F>NOE3UCGNLM2E,(J)(VNYOJ&&^1A]R_EE#/+D2!"=I3[<GYQDL90Y
MG7HP(WN08;ML82I1K!6+8N9%= VII6P4=YK3<_IW'8\09>.]>P<D NC2;' @
MS&B_5T_/,T-5.\9>O;>EJ.-5Z5.+K1>,:7HBF-1#>O]CQS>42RT#9B"]4>YL
MKU%UMCY=Q,3BU#M[60.@S$4(R:5RXG'@LFL6NOW^JL8[4M, ;&YT&>[8NG1:
MU/2R]OT69 [_88N9)(-TYUE#0L6*;]MFSXF^Y]MV]P*L37GM1\-][NY89)OB
M:.KTF]A3]+T">$2@LD!E>&P:[2V8V<FNP=X*Z=;V9+?#FD^ !UBW5VH<:MGF
MH"^LD ;%L@689FD>\F:G7.:@OBWG0MY'CM2HQV[I@9.QMR#**A-R:Y+%%H/+
MGU\^'E:]IPD-)H+"-M)=9%S? &1#Q'Y?;26D'$PL6D%<S1660 WUG ,%[3-9
MJ[/#Y  ?6M5L_L5=\M=S6;X2B5@(.>64:.(P#GMUD+0O<OF'S1;VEJ=_@"DI
M_<(1@-ON%^JC=IX2WHRH2)MMG,P$*A0S*_8:SL;_.-[ EJQ&4_J_/J@R=51@
MA-$=5!Z$QI9RE7ME=T#;P6$ /M^RFLD?M?=38L914H>E)4]T=$J1\IQ9_N^)
M**P>,V!@:X<2S\1,#4!B[6&,ZT:S.4]8!+CB"JQQ@OB4YEQ60V)>S9;Q:7 2
MA,57V7"[XDI:IA<L2>J:P;_90$<?%_@?+@F248=X.7L%4E0Y_SC)$/NN,03U
MU,C1NK-7_K8)L:,X0"H[(EG]BV3L';3;-YV0B*G?"(!0[0"A]\/(N 3%TK.I
M\:&FIK9RQ M_O-L(>M'^SWG].!G*0(HAGJT)38#'!3NS:@@U3^'E&5+UG!5<
MW9T]=_?*6^3K+[+ZG',=G\Q;J[!OZ?=RGV.]X59/5,L)_DUEA=66"#FGXQ66
M=7V[@+29?-[<UWOATC.<+^IF;)+ZM]YT;YVW]ZXJJDUGK0:IY''H&_RR_F8R
MF*M2=*!RO/+(PF/<;$3'$YQ+,,KM^GQ-U75B<+3^\0A=C=EF@6Z'HJL3=Z8F
M?:<P-;Z5OY\=A*%XB^Q#)*.JQY8WP*@&GJ%H59=OIPQHI2US'_>9<LB986[*
M6#)??##F88$4T]C'Y?<90T\@R\I=P?ZJL\[H@S;1$Q6CD^">H;2;Q( =87E6
MM##9& 0U[&_+;)S("8V[!(;_9I$X)/K"YT33\&2 V0468&5DH2=5$8^P<10Y
M88414^"19N3"XP+K!!SE: XR90 IQ-O$):Q/L;S[DIPX8S>Z=)B(=X;?)# 6
MR4@Z=28;VEG^,F7Z&,47U?]Q";S!H1MT.PC]<SN .<5Q!U;C4E?W9_]>BG^Q
M-P4/)>>\$3T68;[;(UM?DIJ333(N4C>HFU^H <RU9H^XAC48,",]'SK?G8^*
MF][E@TU<J6*##7-@P\OCQO[DR69-73(:V^A%:?>-V5"QKL _(G,D@ O7$_7X
M6D)P6%]$U8SCZ!:7WALZOR^,^P[D"0UXEW79 3$(W,<)@2SSW>O9\83BMJM"
MI88.<UO?[,RG1 VG4-HJW0Q6IB1UEQTHSBSE9DK<DW2\'.7A]T#%(7SXO&-+
MMV/C=@L%Y29'\-$:S<&[&DW$FI 5GK<<YE]\"WNP!"CE2Y;?KR/[W"E 5K-*
M6U'T5:F_; Q[E5GKMU2K]&7']^HD8'ITXVR-\IX[=^L@/5(C-]6C/RX:YVPG
MU5L_!$:F'^\T,K:V WR/F?O?I>K88'KN\",6BC4K#%'TAK'A]^VZWT!;LW+;
MAY7_:-U=G>81*XW+7Q'3I>Y?V*?=J?8HV;;Q11Q;\Z]X&WI_36B#/>4AM:$'
MST6U;@X4+>N5 ANMAY,'A![TENT5\%7H,?'UOLF=U6[RR;7DFP  &]V?Q["G
MCN.SVF<H ]V4CLC.;W6OVNJ::D@DR M/==YL+T_H9$7)A%NVB:H\,=\)9^ V
MPZ[&+-6W&DC3K!%0F$YW@&46:>-$3I&=V2K$)OR-X1#=$"E]4S-[%+YB\B=U
M3$C2D]A[;1KCC(1JL#V]Y/?D%,=$WJ)!N6S(S4F]^H2'@$8Z!F!V<@__B[E
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MR[!GJ=$\+%11&M.\7-6FAM9<Z>EBZ24]D0GZX_SW_RGP?PL+\@\_3=A'MQ)
MIO23WHI1Q8K!W$B6;/XE.0.9G@8]CP3>C2793CU>ET\HB=FKOQ [X#T*)7>Q
M:Q6>:N$G2U-)P/ C)A5<VV7"<Q\WV!WGXS+#+LE5L!?>0DLV6!]:@>K'<1 \
M4.V6P$]KXD5,OU>ZHFY*8[&.H9 PMY%)*H]NBG,W(E6,U\DI[ 7G"E#6M.Q,
M9CRNZ.OH3_:<1^YC@ HC"TTAE*QW0A-8PO*-"4EWHWV,%T_+_N?^7^<)_.J6
M4M80.PV=Q':.Y](_IF%L7=XT#_ *049T-K++S:;64(T3X6+^_'L1W[0:KJFB
M'@PT>%M0+GJ?8P$#%0M(.[[F<KOLFH>#:%)\Q@T\)Y.&]H_R;:]_ T3R@]0-
M%%IE*CA6?KE<8;5(F8L!D^BFYHIV4JCO62OF>*YXGZ1BB-,,I1O$&E2$WA[:
M*@JL=D).NM]1#%^&#UEF?R-YGI<'3,R->$MG>'V]INK67+&<JQZI637[*P^*
M*'> #KPOBK5Q>' F-K8NA!Z>8*I(_:0:&3I*===J_JJ<0)!5DLMYGM)!M7YH
ML9G9R:39W5JXR"/MK&OW^X<<I?/^^UK/!"<\<"/)7BME[]-"7.9$LJ+#V6,G
M\HT_:T#%[OA#=-IW!MD=*@]LY]G4(J^I:"XR7/C)Z[LP;AIB$&JYB+^QC]9-
M_U%L-1J?G$,1PG FM&R5N/X^KE7ZQ_\<K%^U@E4P^D!-B!_JQ[S51OV,MZ>K
ME5$\04P+R):;1Q*4YM85_9X%A^6;G+U"<HM5Q'NJ=6-C5]ED\?@ 9*#'2YL!
M]]@M1J>,>1*P8Z@O(0]X)1P@-JP<4'NQ&Q5KL?7@RVSKV)F9&.$C=)_4.A:[
MV";<1DU_6U4A4)2*ZJ[(_,,*W1&_E &6!(![[^$W<N^W7MV13)O%H'O]I4+U
M1BE&K;_G=4G_K&8-C@0[?K%![S(.K@6+O0;TMSZ\W538K&1PY5'>A]E7_FHS
MOBZ_MX0S"W#T$EUC_BL=BC1^I&BLVU!:^?FI@/UAY=FT,_K5N&2EP?\!HE^V
M/^7+582***V+/Z]%9["&4B=/0;_$R+%]26;2>RA DOM!VY16K#')]^AQ.?B(
MK/K=052G\Y*WF 7P0%>LO+0WNT+0H78F%,:Z2LM\E]PYAQ74IS.-+^!=$L1T
MHI! KQ)+&O6C1VWF8X/2*KP%.',_(1$SD)B>A\VTVI$-"<@34WZ?$24 +%0K
M;X0\G>1<IZ@<*/?AFZV7GN/\Y_OTWBV#HKKQ2+COSJLS$2+_AIYWP+@$)9W4
M$-WQ$Q1,0<98UY,6,K04MHUW4JUO&]-Q,_P/W>!VA&^<KS=T"37RC,\5W&XV
MHV[C]W99R:?\<7]W4LYZM'5Z"%M7)AF7O-R=3-?[),>=]0R HPMUY#8R^@&?
M!^]2Q^,C<%C/E[:83U?$;^$.)?+2 Z+@="41H@"'9,HT<]>\0508(LMNFXIH
M-\S__6/OB/IQG;0'A1MOVKO:;N7Y=LT<[CN@TB.\#39HQ"@Y#/QXH*;/-3)G
MJ<Q'[%FQM/&!EL;+-&X.H^JQGBL*NYOBVZ"VSL/I[NRPXPHMKU/@,L'\1>1,
M6[0I1*ZL]4&O7F+,6"O882*A*_0[H&^B[9WK5>?QC[KOYA_!?]1.J:R!9$:,
MZCW"CIX &.*#I5FF_C"M$<+=1BGML,'44? 7"64?DE  IR9GC'(*TIK5:E^\
M85Y#+S-WO8<T@P'+&8_:W+.+$BXNM4H(S/H4K-CNOLJ"RJ[.'?--<JMZ,+?9
M&!\Q4/AI*>\9I/CE!@.>KKU^T.\&_P">672*5"HVX<F'?VR*2:PBF\PTG'6G
MBMIZKW#&W<UQU#5__ZE9^?RB"T!QABUV@XW,!:RVA#&VBJH/3DR%>HE?0:9"
MO,E\O#JZVBD(U(<87HU/'SZT1*J_N/F23L?0[>E?_U\;_/_WR=(;7&[ME9"Y
MZ/5VETHB-GWR=;9[*4+:.W1$' _Z4EE05/-,S&3=)GXP1BPE,.45"=B\62TD
M^-P$0V?05NG3)@LC5LVA#+L=1!<\"#_//(B)V.(3!>&C['%,7G("8A=\327<
M<XRN:>YMM%E@V-NMG\ELT[?N,F$TD]9O;]&(OVCUK\"5"@P\'^M266]=EUG\
M&*&GS^H^_]G!:]2X@R,3"X2L[\E9??MA?5MM"1.)P\I47(FFQXY'\77"FC%2
M_V(0L!G)L: 27N=?Y4I?87DNZ[M_/5EQ/AE9D)=C.W(/#^)ZRUE68OZ/8E1[
M<OX*GNDB;2RL:>T&@=)\354I<4UUX=>Q6W?G:]*"\I6-8_A)Y?RY-<M?CB_S
M\OZ5GU-3?1^ZK'!5Z_9Y^JVN^>+N-57FC.>@W=6&5L;?^T9[)A!W3:4:>74X
MMY.>OQS^\FI=Y,*\A2WB-.6:2G]E?LWYYT223/B-\,W!I6LJ5[OS./6[29Q<
MP$\W((?&0:Q+?UF@$UG^)(^G/U4+.:[J:D4EP?S,C(B)@^6FL.:F]!$G;N$'
M0,7AOI7D*B1?N9O9)XKM.!;OXWV19:L33/8RYU]K4(;G#1)U"("-BM@*OZ2'
M0R!/O>/W,[0N'*5K9@$1P1(G<Q"W"2C.LDW$AJ\9I]"[:&K@W#]F.)LKQ"SP
MN$=,,<8U<3& Y:/%\ND5;0;8YP"D8Y8^&Q7I-&7TLJ[V(TZ:3[L?,&FC,2S4
MQU $I87S'M$ELM^U6$%6MB.WX_.4?XGL7MR=;UY1'O+X/ S$*=KD#362H./N
MK?%-041Q9]74%?_ZT'&I3\ZGUAR9)$Q49(O>5^S=LD[)+N*ZN"%O^G@"V]@*
M.M5E]*3 2(8[W]BU1OJ21F@0ZB$)R6*2CJ1@ H]_^[!E)VG#^O,0*2ZM-*H7
MGA(E07*"FW\!H30A1YX.(46JHUVKCSULY6]]&-PA#.#<:>'6@6%I?AHV;@C$
M)H"AM-L7T:SF'\[05FRU+<Z5NFH),\]^74_#5"=9]Z%GUM],DF#&T6^1B%B
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MP#:6QF1SX[=^X5V3G.@MS:T=6-2,SB4H\"+99B=QL)U%>BUIW_(]QJ4Q1W7
M+;4-89F#KS??EZA!WJWYI?T%G-/EWP#WOY$;O1W3TE<2UU3]2DIM[AW'+$2E
MXKD+P8.'?:_^2_U%I;>&J?/?@C /Z5/26;(HBXI\FCR9PC?DRKL/0H0AM=^E
M3$W[KZGDZX5%S+,1</)QDH]UE-_]OA"8)(X%:'9/MS+!7'</4?<;SKM[ 0R2
M=[Y=>(K43_ITB$A>ETGZD1XL[QN[!O<YUZ@;"OAJ#1Y@JQR0JF+6DXGC&I3H
MZM^R+*QN)M3&1VBF,>9 M])]E99U:YKJ?5'Z3A3[]"%W]20:T4IFM42F"1A<
MMJ9-\PN_HWM@_6:8ZL!!;@(C/'74QA3(W_B]&BT"M+3SW*7W'7H3,FL^U_#'
M-57AV^3C-S23W9T7+C)')XIZ_!YWJ,]Z*+^'Z(VA*:]S1;,]WRZR-K9^+Y?T
MP&IY40?Q^01RHIS/75Y7:@D=\@,=S.7F[W^\$'*>UJO+]9AP:C"BC^^V(=1.
MYR+303F0<F&(SIE>_,CK6GQ/4I<6LPM#&FXJAF#ZE3BNC4'#\_*6EBZW*!_,
MK-P(LB?ZV(+BYK$2XO(KF8Z7AY5RM7%)S^2'*N^_OX$L;'&N%()*#.2ESTER
M?Y:\BRBU-08B"]QGFDO^*JI3N[G)Q>J["RD??N*I#V*&DP,  *@1Q!@GN,W7
M^SV#;>+USX+0_?@YCEQ;U79H@R.VT4!;CQ[S%#JV]LK.M/MGS-TT<3WIS8&*
MUD0#>JLY:X_8@IMVA_#!G^7''<G$%$]: 1:XJDB&U7ZN!)+T(<*PEQ2_T+E4
M:'/N%K8;-R^6A$&3H2/!V<;F:&7'20]',YFK_L[HGU'WWULU]L'H66(\EX(2
M91T&5>(>]B]J(L83IV<UXH0 2B14!*1WJNSGI>J6S+DR(:G[8B0RZ]O^C'58
M-9*&3W"OFN$T^]LIURW#NLX8___+#V_IJ068[:2B+GC'@66&%G)S!BU#ZK 1
M_@]INO*IQ4I"4DFB#2LY/B\DIQW+QO?K7?+-^8X+^_F_-D#=W1639XAXD5T3
M4^:P'^*1'SQAXHZTGG>82Y:(&<%*J3MRF_,QR6J0G9'0+M]06Q@/=ZDU^V[
MV6%.A4S,JYPH126-DH&ZKL95F@]!TTR'D(SA97/)?-[&K-^V9Z1T/R(4VG&4
MGZW/Z]M?,N5=7)CLI\D;4(^^7HM+.3UQUCBI&UU*<Y_3$EU_2)P>9JH9E,VW
M;)(?HWUON]XUK6AF$[&=KI\-&7Z:XWB:$YAH4/[9JQ7),WZ_%ROW9:(I4?J6
MNZ/1>S/4?GC,@5X3\Z,TA<[)3=]<.N_@RLZCO9/8H.@[@8[>JSP/P@CCB.Q(
MIPF$&U''*#%.@[Z&4?>UXH\/YRY65L2 D"!'F!Q&;@D&,7OW!(J^#;%BBH(\
M$Q+1C7N;?*3=ZSE[*FY.)[2=,SY-7N&G+_3TSGU* 52[ST+D==H5B]'0GZRV
M071']-J']<89,+?R#:ZWJ;ISLH5F0KSF L"5G#2UDL&$8YV;[2(RE@Y+Z:^;
M@D&F1+1@QBT%XI)4EE,#>=JS<M$Z6,G<S<A.N+&8^S2+5ZD/8Y<;5S0I)<W!
MOTX]:M,G5G''63'2R+Y%,G'5+,6H7#7M7E.&2=,/@W?Z3H5/&J!]GD4ZH$HC
M$$3X.1/>PJX?UA8#\K*&&O<QS7[$O9NK$EZ'SJU;54<!:A@64W>,:N)T6(CP
M']5*FO[]%?)6P'8*>GW*$Q)E61BAV-/Z"V)[TZJ.I!GR>$6XKSZ'(/D"_BIG
M*[J(4Y51*F@"0/<;8<QA8]4@ L]1^:"W\H4!)/#H(%TNH$BFR]I_'QY/](6@
M8X3=K013=WO2M[^OK@?/!NBTRVR>W\E5U:F0.:JH'VRD-7QT@W.RRE9$K('3
MM$%F<"3?+L,!K9W2'VB5_?)[_/$+ $%AS'K+]UM=(,VIEF4%Z5O*Y,)B>+^<
M7CUY\TX6 &D _BG3:77)3F>SK0*A>R<:7_O?'.Q0[1EPBNR[\'/?D7-RTL'
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M&H,;O"75>K*--6(U(]!ED)[FY"C'Q?!FPL_-/\\7,3=:SY3"JK/#?&[LOGA
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M!'G'C^*F+E-FEUWXEQ,2@*Z7'=WO5VL8-&#@5!Q$ T[/OD,7&D!8^$H^MI&
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M1TUEY<1C%X=3V4%%ED5^%J), ^I">QD-_P(VH\1@RO"PVTVG4>FQISK]N!<
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M4G[DJ="('^N@V3UEG"'L[D'F@])/M$&8FR/!(S1VU@K<_<_F6D7,R$B.J8:
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M/.AX8I5A)5LN6_,S\,C1_1O45!GZ_-X)]P/1UBG&@G^I?/N[TL</_(XR)Z:
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M],%OFLBCHL3++.,9>E\19/E0^;)@=VY%YU(;CS8$)9S[Y\'90P<YV!O"WZ'
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M=KHGS6$U"1#.R.FLIU7<7!WH+Z/>BF]YFYQ2"IG,_&5&MAA -0,\KG>P$O?
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MK]_[Q=NCM=R9UF__X^WA'MW?:P=A%QNE!FA"D>6HY1X(4[FX':#"^0^8MA+
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MM03*U,ZM$'45N:Y8=%1JX2D/D #P!-91.8H: RH-)>A1<KP/(N%:B[#F0ZM
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M=;]6F8&#E9^P6%CEHN('9;NI/<=6E;*,PEO(;Z1[/DI;Y2:'.3$T')[7/$U
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M9F;GQ^XY^_R][_UQS_O<]S[//5>.:^9W>^ @2Z<D@>6Q$1>LY\<IYDX3+?-
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M#VI=[?=5__V?*G/WN)>-@27&P<#O%S%_Q1N+'_4^L"SN7M*NM;6YC?>V_)Y
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M2U*,"ROXN0LD>C%"G#)6.?!/9VD!#F*BG&H9T[ 3=@IDE:%5EWFB59@MW5%
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M>@"$&GD1 $@Y7LIM+[ZXJG+I//V]H6&JLWY'A;\0?L9SI26%O*64*L^,>#2
M+,4N+9H<)IAH&P6*6X+7\KXFOEPL7("\E!!,$HY3RIP>;^OL&5.8MPCA9 0,
MMQ[63MAG=Q-X'@2+EG=,[O&$OQ=W>TP7@:+Z[!TZ;$X.&SY&@:8>L=5UYS,A
MH/!#RS_;O#,*Y#$IAATBM]IOM?+*FQD+)&SC $@-;*DPH-8IJ2F)GRPM[]4
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MIJ7I>3F)]D7W798/WVC+@X?V+%$#M/SZ5]#0J6ZFS/9*Y+ITS*#\M]RGOG=
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MIU(]56!K+Q;*0RIUFU[9/5P9S<,GX;0-2+JUZS]KQZE8$@FQ9E? K9*TV7J
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M^JD92\^.H2@ZB@,W+06.[7*,CE3IX3MJ\*O9L#ONNNNZU;C5^*%9]'E.4IB
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M==<(X:T.TA,0KUJLRF^"D;@J=&L\.B;#]*]$2ZSIS? M+@)O6^"+Z"XG):>
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MB/@:4$QR7+>>4R-&YI5'*!-B?)3.'.L%"M&3TI.<GF$(3LO)1^L53H%^;$B
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M+'A4@]E $$[%KA0GR%3#MB!&^(;]D\X:C0\VM'G$<!HG=>G?#KQ"T4:)%,L
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M2CNOB__+XO\O_L8#(Z\!TB'>!/H!]_2MQ].RCE(S8R"B$8,7/+S3.\);?YS
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M\+XCU4=/Z>C/C;2FG&Q M6RQ%YRI<_3N]@NAZB$/)(TE7WF]=$%-E"KJ'8M
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MEGC9\M6WYRJ"@P 6+FGB6)!W!'"#=3)2H&DG8:MQW)5R4<@ZPX+,>F-EN=R
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M<S% O-5',@4A)/8HMX&P+G64I++5!1FFMX5V'$HKRPL?Y'O9]<K%=Z?&. ,
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M=ABELTK93%NG7"X0+5M,81-INY&PI8\^XX[=:MLT-2/WBB^(U%K=Y\?O8AO
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M^XB'C.#K!S;=&2N_"%WAZM"&A!-C?B@&?EPM6!YI?UNP".UR)3=BZC;.^97
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MILM=^+_L,"GM)R)\+GM#EH80*CF_(2L+V(*9Y8BIU&(Q#LTQEB/C-,DBC^:
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M&Y)(^;\]+(#KNJS]T&NU8<(FY(:L;&B8P/]C4B46+O7^[YK?,6N&[PC%$(_
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M"]RV-]1Z:VIR"HDCM=>]0NTKDT<N-5OS>UBBP4(N?[13D7+86-5(U;BA2T2
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M<?!I[%1I5V*5CA?=PX7\:+$XU]WTTJNPBY$;L@;$->_1;RH'I>/;-V0:^\:
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M\XO'*DJE7*2Q(H;:2U=LM6C*\Q/ZO$W6@9["59X+[XAL>?J14W<JNL&/.]+
M;5'8GJ/'-1-:H8=Y33,N]FGU0_P'6'YF-%O-#@3G /A4TJO,IP:JYZY:+V@H
M\O)@SLQA@OWZ]Q.2_]FE<3]1R;*G*B+< B3:1O;SV1\P\F:?KIMX2W-.M8*$
MS#PK#'DBX44L&O;"SZ^2K)4#S%@<MHF"Z96/*/2SCETJ>;"N=?T68@WATT5S
M=G4MGR*1H\+^1&\;AKF&,%QH9!%:+'ND]\7EJB^%QEEYZ4_TN:]9OOR[S<'^
MA[FE("59X4-SCD(LY%<G/HHA!X6G<3SF,##:SA,.J?YM-%Y.DS',IN/SJ&E@
MZ&T1OLD)N(6T='M8/_J<\12"#I(:7:P\%<GRZO(Q/RWKW;;$"?R4H>.9SFDQ
M/)9UV7"R6H/Y<8)U%2"G3GVU(?+EM_\\3U+^3>,]?KX2U,5Z]D+%$.MUW2ZM
MHM\P9\/R:F+C[QJ_E1V&;3+,P-]O.,T<,C6\V=.T KTTZ2YQFWG94MIY3)',
M9I!T4L!&UUR%ZMG<M*U?=C,QF0E^QFW169#0J6@#I@PT<N@[HG*+\MP8*9I>
MY'.MU?#>$BW#F2;5C92(:BMH!P-:"Y1S:BNN[>:4.\YT[;3&F\Z &6(*(RN:
M"+3)0T[].EU3O1'VWMB3R>3# U8?VVJLK;UNY,# 0)<V,:6%<XZ]B>VGG6CP
M\MQRS)^^-V33>VN#1\O-I<VV[X,.RT-Q0H' 9C5?A1DF7']+/^OO%T]8155R
M<4]PH;&6%]'KM[IV,8D;FSMK@" %Z/9WOA7F\(/Y24,86J8'#1?9A"D'YXT&
M%[T8%?GM9$6@%]<KH.J7FWSF=6:U1IO_U%*7C.R.X8^90YT3UWJ8XO_#SGL'
MM95]Z:)TNQTP!FRB 8/;@,C!Y QMDRR13 :)T 01!!*('$W;)D># !$$V.0D
M,$%( @,V.6-R$"+G#,8$DYYG[OW->S-O:F:ZWKRZ?]S[E?Y0U=FGM,]::W_K
MVWOIK&YOES^\5?FGCFW2S466N#J0VR)Y!EY0GQ$ACBQ/N'J1WMR?Z(>U99Y)
MU49FS'VC&I+OE[XX13E[2D4,[('#V]=W<*U@%9H( _Y8LJ+P><4JZU)M-F%[
M1_16VI"OY,F]F_CF]$[<-N^3.$\B^_AF7=/8LVH'%]GL&Z^'G0" <FG_,'8-
M+;'M&E,/\Y<%PC3T R9ZQ:C^\B@\&.S?;D3,GD$6-,#$EQ!- IQQ68,U+..7
M9Z!'( '1%&+0;PN[$Q\B;$BX:01US3E<("P_P#]O*UU&5:360\E!(GF#NAU]
MTTJOLU"WLBX*T6%["/2_P12G+8CO%L_G6\-QV$DS23S2R=P]#]2UYE=F]<49
MOLD@Q':(<GZV=:]JZ5!Z9&/*S.[<Z(WU*5,';WB-1^_JG*']5-,A*,'ZY^+%
M!+D>.-RNQF=,7T50C=.&TD<A'<5*AKS<+N@&"(LRWKV?S/+[M'YB^:'5[#5%
M_87H.0_5S-Z!RM0U!8D797MY^]QJDFD6K_*!5:KXQU69\.R?FG]MSE;U]CN5
M28D7/G*%*+<7"Q_A-K5U:>1>S]KLP"S+>XB@U\JJGACG;AJ@EG =QH=7K"&J
M@:I"S)*M%.PW,M)91G#89^%X?".\(2)VC3= 03R ^3=TNY'7$&]%O?^=X^Y7
M3LV:J8Z!T&0'-M3&K9Y#2$2/3I-ZTA93I-7L=+>63G4ZD\EXIDN*LN=R+_"9
M\ 1#!>@%89^367FF_4SZ['&^>6 !6DEDY<?E4?"-A6L*S]8\F9'4'TUG&;]<
M4PQT</SS*,#&HW\$&YW^T,37!'Q\;+]F9K$\,T%X:?4=CPWZU,;9IVJSB39Q
M@X'G4+#49<J?^QXO[7 L9=J4J[_7:CB/9\<+F'V2 0/B$.46U;>WN'-DRO5;
MV>>L(#B:<.\M)=J6B;-ME\@]QKVD(R_%5QF:;A,O$1%U_#"Y=2B_>C1M&(R,
M>C 'IWUZ3OL[R1N=X9Y,PLI/QPF (KO5@FB+*6LW<1B0 + #*(O3R*$TNB1=
M#,/CMBH\W\%NO8;YY,&5K;0$@I/[F#D*"D;A@+):C"<WX4HX:J:_TT,(0301
M-VB^+>;G/32I:==BRV;QQDW&4;'QSO;LFTP+J;S]=9=Y3C_L<*LE82V<**@?
M1 T'S(XPH8-KJ-9/^F:F"V5LC&4L?%TJY"LYJ#YRZQ5_KKHGH>F",&598T?3
M&*9ZX&QG <9)E'6ID<,9J:2@-1F ()AI#+@VXO*CP5FK?FL1& 00#,QQ!N$K
M>UXNZNL'51B<4I8/!C =)P37**K:9@!1NVRP $#D9D(6KI?D4PGJE*(2[K9?
M8E$6];XATX>[A3;(7S8;!S[FE9/X$YLO7?+RR3>-$;'N%#--\;9RU;9>!U-I
M'R\LI4D]WU!:MNKK5,H_GPP_[\DF(0,L2FH*:L=3/B>-1E9?K45HN!4)?P_^
M)GGCFB(KUN+<DWF9M(S.-_N']VEW_;P<?GC,F<Y)_*%R-MGZ/VGOR3]8SZS9
MZ=RIT\<?'R=/"@<4@_&E::L9-4F=I0.X0:&W&%A<7Q!*K,L3()9D_SU9MHWM
MEM-L5XJU1>K\Q[0QI)W8%XTAK%F?^IFMF\(($&0T5O:\R#=R</YCZKZLTP)<
M3L$=^ZAX-G4V@YO@Y31JVA \)_78D:UP5!MM4GO;2#PKQX$E)6E77-&1HV53
MBE?#%"[^96-">A3L=7E,B8P!X>4$ >JO@_K5[$ TBDR1J6CQM*#=[\6N5O&D
M?_:R-]=D_TC+7/VN384"<"M^8'C?.8[94\_],R3P#!-HU>+Q<$(AD8PH<]DQ
M8N-QJ(F:EV7G>6, ;G5,TQ^UK^'HE?(%I-PU^+J@N&+_(TIQNBO3NZ (8ZR5
MOM/)"JG+$Y'>6LSEFYHY%\MRFTO^T):;>P9!?];EV EXZ,/>8%DX3U*I&RX&
M:Q9E*!-17N);FESC=G*Z[V;,W8V7+P+L-\^=4K<=1+G1[\2<1EL:@E "S^,#
M]5<E;.S$VJ::]O"U*X>HA:) 8UG^LL@^VT.A6[Q4CX3LACH8D<CQS GP!*S6
MN *MXU2Q/)?N&RJ70A1OR.<2B'F+*1P?5Y"!&],?UC[GN8^V(Z:+8<=P-#T6
M20;#!R\_4#Y+HBY@81T$[.R=5[9<4U3_V3CP3X6KG,MJB*3AZKSK^;/C_M),
M]Q&R_ZST[\<$Z ]HVF9\U9\!E=$V 5E>JZ@O@_.VDUC5K[6;"%'-4.$L'?QV
M5S;-*XO98,I7D$CGVL)A__8S*U,CFP-#H'PC7%FJZ/FBN#3>[K8;M9!BA66@
M06S^"*A! ,A=?&2@6Z:;X3PO93R8OC&4NSF^5;_5U/D("4-V/AK=^14\ ^X;
MQ6%AI"<E6@8)4>G?M3M#$+87F4%)1]&OUE>:+*_,?MQ>.L]F9VG"X,=.^K[2
M7OD\_7]E4O:INM$#I63XVBV2#W4QN+'T845.Z7?)J7#B2@JQ+@\4Y1ML%T"&
M9C_3CU],&31YR=/ZT<4<1L4?8\V>JI72M<(A0Q^9+;"GA50'5E!;4TFDW:,N
M;Z =*^_Q"(.<]LL4?4I-^*66\W7 OZN&V RD6?+C_LRYRI*XPG-=5+?]>K("
M/1E<D)%F^^X2XO_X-4=QH>D_#0QK2LQ9:6 Z3QD.KEN[T4,F7%.4/;VF./=N
MWJNZ_35A0>'*TB[DI&SNAP7+>SOM[.S_'Q7<?X(;7G6T9\]-@Z.7KRD:T]E,
MJYJ_EZOTDD\?K#4O>EZ96%Y3*$1<..BZ?Q_ZYO6_;I;_!_^MH&6]IK 8/&V]
MIN!>W_Q><4TQZ>BTB0[<SNM28/_CO_O'_NOMP^[CAR4N\+9S'O5Z=3/S_A#\
MX^\.CZ\I$/C+X]]_/+C@#>DM=[OZ'GA-H?56\IXS:N3S?_=4_^M I'ZYIN #
M[559Y)S4<,&.9:YP$6>!S;\JGESHAO3T-J^Y7U/$=@]PU"LC_OH?=_QR!OXZ
MS; 4#6)[;O23!;D_W &R)A?P:Z@EY\?\),,[$=3%1?SRW#ZQ4#F^=AF>]:3Q
M.3HQR<:@KZ?\*R_&+J4VY?I9'_8CIQ %00P.6@Z MWN_H[K$)203'WR_=YI^
MA]Q_2!8$U?3MLV[D7I8HJ_-T-\;W!6JVU8.[/(.-RUJLHXN0/91* :A*RAW;
M^HG\L_8Y5%IX8/RR:5!;%,#:5*+:RL@O'_7ND"'44U=Z2(B0800=8Q3?V2+W
MS3&/>O1!8T[K96HHC8=<@G1$SC05MK\%GWB*'-<%IMKNI_N,VN$]V 1AU@#Y
M^L*-DCR^*,I[2E14H)Y40\[QCIOVW@2=)^>4B0OB1=IQ:M.624M.AN')Z?M<
M2Y_#V"9CE5D5_&+>X6]MF /53:.QN6M4;SKL*A3,!$W=+$'8Y^*91>R<F45>
M)TGY6'X#(Q H,CF%NVLX/QT)X.Z-8F%Y_++=:,08'..#L>0(3UA?GO_W_+4/
M3&%E\(5JOVM[4?[[S"MM-,1601@]!*F4SY>>IKK@L5<MZ$W=>3;3 &!S-JX;
MUFJ:#36N<3CFW'9=6."?1>7&&B9G+@*-\;,/"C0RV4M>+HN)"*[S/D2QC,_%
M?W,\8AKIYX<3WEY34+*\@Q 1VXR]!@9U8X8ZDN?]3K;?,R<#JVLB0S\$B,2+
MZXKK115IY 1]BU_Y_5]/\<:B#,H.019D<_D]WY-3S1=:&M9@1E6O;<(PS9%4
M6MLEUQW?0P;R.\P!>'*YE$NHU!,^]S*.<@7T=O+AAW8Z$3&0R8HQ1F-+OE)[
M*&KU:^^XFZ(( *H+$OB&EW)Q'BL^RE1@T^$9QEJR2SUVM4S[=\WT'T#9&]>H
M0QV4Z=(+VH05VT\73)%TXBRM&47J2=0"VE/Q-2QOD"<&H1G)%B:YG)OI=Q]B
M=-ENVYIA++O K9HKNA[ZT66YY?G#QG!A4<@'W]>?[6H4C9[*P3,)L?">;1*.
MT@)3C,GNX\1DT<&'G("-+[X]^_C:F;%D#&5KUA(4IZW]%I".M *RY(^.1FXA
MB^XD6\@FYACYU 0,<$XW1F <G3>3P4G!JZ7I>O1A;?-[6M2Q>(]Q3ODE64*W
M[Q)WQGX>B1'T-Y_X_^#OX&^V[/O_@K_3)_F)6[[C&:*]:<4K!T[\?(A'J&SV
MJ5R1W<ZWGQUQG>I>4Z#-YBXW3Z[0MYP>CO 6_3?-]<8@AV1Z J?BB[V>=VN"
MF;8*NLJ'9W<,)KJ<\TM@RQ]X'#_7AVK8U=KP]SI0$I5O%B3ODG&VI(97^F$%
MV.[\%$M&R%"E9M YS6*ZUOVLFD#69@=<:$;V1Y_L=H)V@0 WOVZOA:U-;=+@
MZ_3B^L9GEO-5B75[H+$QJ$MJ7_$GR0]V][9XB)%F6GZ?)*L\QF[ZT+A%J!F5
M'B&YYJGLN/^NL3=<'Q^&5IPS=E]3!(I+5]J%;)F%H!OVN09#VM8NRANN?&E/
M^S +6WFKZQ2:X]_Q@+0-QG#FJ(WV$<FS>ZOVRZ:'IA!]6&XAK^FO%;]TUH4I
MI2;:"*<+@K\F*ZJS*Z8D\EMXX6&DDPS$V(4()-'2I*I&=Z>SAO("M-TBB;%/
M'3& Y^>T&P68;^HM+%4KOGWUD1CNWTCPMQ4O,XB+>6 J0KJJB_;EQ<'<X2TB
MTT \<]T6:SXB-6O5^T?4F\7T1IO\7/O1=W"Y_.*QR20K^^B@F\5=L>0*#/JA
M^24-Q+$UREMCM.L;1&Y6/[S_XS4%J@T<N]$V?3JTUV$<LYLW&#C1<(H=G=5&
M[-H)CLP?2."M!?@O@!4K7;+]OMSQ#N+Y03_5%!M6^INN^"'=DNX'N/QT5W($
M&Y(G[ -0^4,!4()+=)^F.M:1F46@O51JQM%)UV2UXAE.MG8$/ (VU$AR&1CR
MLFK5]13L<Z%[&[%\>B7G'6ALIW%$T&>ZU)9CR@J3KQ)5 !\!L^+A_&J=\L/&
M[3AF&N!F\,'VB+?;LE^YPPWJ>R(V#FV[STUF\EA;1 +%PRS *?R6&?E'2@Q*
MC%,YB,8/-KXUHKV>0=Y]K_2BVZ=K/,@K+-T:VTMN"&964X8/N-K4V;Z,T^[Q
MPJAM^L.W8<< 5$ABM-1M.^N??D[]Z>?AG+:3"RSQ*I!VOPM3M85:/:.R?.*8
MEETQYF=6Q/2[61]=6VQ_:YGA3)'NT33G-86,H&Z_.&_,%3J=Q^]<]X_#2GCV
MR$G&G#GIV-$T0;72MCX Y [?":I@SXI>_W#$>VIZ?)N _Y&@N;-+5*XIRR]@
M5K6N7S]6UIS9.4H^)6D<;T<K0QZ[G6YZM'P$RD%ANT_).0I3U(OQ_&_+>)+.
MZ+O^PI]][^ Z;HS/9U6QDZ3^,B4IP8>P#$N'#\UDXG#@(WEI?DL%J6GD_!0L
MARDBHSFR@<@X.XITXUK/-,&6J^)UT%' HY3"""GV,,\(.%!K:8?-75H_]_._
M7=*+<\MIN_P6#4&Y/]!L)?#Q-,N"RWS6@&7%'T2A:F*=:&<LVDK?':1C813R
M!]A.;/)1?6O;*C/6K)4GE=S=\:!LM"Y_N&S>>-A>O"]/:N# Y1>4#?+A)\\8
M&#G3LP%9@"U^!C*R$$FVX"V+6S5[Y="6;O;*-&X%:?,I[1OWDB_.MUPMV&GM
M?ANZ= 4$CTB=J^,N[M;(KJ3Y-?N&9*_$"]"J>515%/XV4,'T"9*W(NY+;98L
MB[4,^>+<=[=E(/A-^WRE1?RH762-1U\!P_J,<5=[;79T:>FZW._-8K\Y>+T3
M%==5*8IZ4[+QQ51YOG*$!<0GV P2''MN$OIV,8^O0&C)H[%($/US-Y@D^1B1
M(&DF=+=V;3M"[BCY3(FW??WX@BU0:@B\__68=C_ET>M58EE;F=6AH$D]>V5J
MN4FPC*;UFI<E0'+$\4U1PU#+K#U&1=FCMT;KML=L7K=7SUH@BRD?K*O:5"#*
ML9M'KJE5:S5)DJU-3;-'ZTVE36(_DWE<RF6SO<*[]3(P?-A2I--S&6ZH,>']
M G\ES-NPI]RS$+I^N60B\CTN ^ZE0]K<7%'>;!0,\RIN5&'\G&33.,CU_W3D
M+XO!QW;B1^FB4AR*/IA7:A$SJMH?>U_(L/NO64A^*,QXK@,RB(WBMM#VQBP@
M:%8Z\NX4DA!1 "S^,YI*@83W^-XU5<,"VLY/MD7!Z]:3M+3@ZT!GUQC%$RMO
M"<^ )"S+5RI^V=5'J'<Q?>UA*C26<?::<F6")=(/>FL$#D:D"@C;XO!F*2V0
MA3[]IV'%;YB]^)#FJ9-Z4KJ'B7BC$N"[6<]+,$ &</#!Y8U8'$"^@/>@SK16
MQK%&:7 [T,O4B;W8/%Q4)5!D@,DHV<8#5+>C07>*%UWW(,KQ/Q_6^2)#343<
MBH+[ZGJI'S84[1?L.EW<?C\%1=-;KRWCA#NL,_I@A-W<ZD>.RT]3'O#3*JLE
M 12;2K+[R<J#U4K#.9"6(W2-Z6T6*TP6&*4+?*8463@\GTQ8/O52<<JJ<7-T
MJKO,2EAW)S6RE?KLC[^OLUW,>)O2S>MAH ^7E_TRAD/(TRU.KX4T*-K.#L\!
MJRX>\[9PM44>^5'%\2"LADF1<Z')RXR3XYS./F 3N S#K+=.>J"A*9W0JQ.[
MP!>]!S)B"G@[RL@>.X91IQ5_ T%8U73X>,:0JO-PAH!#@TS/.<V N[0[VT%T
MW\? =KEN$$P_G+&(=V@81NZDC=$IL9B,3O$:COUZT^NMRR)#O@C'K13N?@%0
M52]#B0!P7[(X_B@V-K8^7[)UIRP(E1=/TYR!WJ!]*;K@4L,"X)OIF[&^O&S^
MFKF7=Z+0WH4H%OHNGJ K5L[_S2+&[]%,:G5[J\>C,#6^Q ]3D(X8@$%<@3#Q
M+MSI67$RT-Q#RP/1(5A[@1 9X%*I>5V5HJ6]5& UA?2:TD\>]BXPRG V*5&Z
MG7;R[9=)'E/TXL? G*C^JLQ65HW1+>9P X/X\=$BQ&@!>U9^P4UN,BM"7J>%
M3?;K/QC(G:4>6S"&IK$;ET?]-3%7PT^@&>KO0TZBJ76]OJ9^()I=QGCJ\X_)
M)FDYO ''J7^NSW\ZX9O@6VZ;??=*Y>8]6%(,7O X>32[F" '-Q[3-\C/H24J
MK,5^%IJ@3'9 >Q"?]5N%,UU@907&8<MP@FRI?$^M48#7HU.'%__"@;?["?BR
MSLUR-Y$BC?+BD@C.EIX6NQ('(5DDQ'"86WFQ/@I>-^P04AKR1WUNN"!]Q!>;
MM9CV >G]\<45?N"0!K]QW7EDP^<_Q=(+I<<MT>"L;>_SQ##",Q-#3!87 X%D
M[R5'['>;N.CHI"9)L4-O,NH?%JX1%4V6Y4<]O>&:5>]F)FO*8%RZDH+IT>YK
M.M[\*^YZM^_'L0M?4\R2O_6+0 /?.I Q[,TID?4H9Y-H'2#HJ<%YFJM%9H&7
M?L'6'1^%J4'HV<VL^9VW](&,Z59G#X44,88I]"D$ HA9I(<18BH/D<Z=[8>:
M]5A4=VK+#*JS-("$?3H\T@]>HK,_9.J;4A.C.?7D:"1&#E):0S"+S@!Y H:J
M%/2<X-YM3;Z:<$\=Y[J-L3E@SBW=Z;D?C7YDF()%SR$>>6M_69#I/47T52HR
M01O,^IB8$-%'(C.9$0S+'R(-C;YN,/KJ1K!PT9CO+1F*"0C%W.^O7126QAJ)
M*/+5<,"TP>&S:R0C]"X?]R>#)%BE,D0@#J#]PF"X]I!MH4,T<@>ETNON>]A'
MNL$&Z78N+I$<%30V58!/+&_$Q&*@1F-<H,&/(:T<:VOIJ?3*Y)EIO[B.I@(Y
M==F>+8BH@W1ENVMS0BYL!:?@+-M8,I[$E3L55_A^PX0JPQ+/6!84\SC*SC92
M&)L&Y7>HE4=.(3M31[0,@X \.%:__44[7T2%<^0 WO=VQN*H"<]E"K]KJ<8G
M29UZD17S%=VO'O>8MMPJH U3GIB/LMI&V"_]1<(I&G490.DRT)!IY(H_#S1B
M(58C)0WJ-\O/9->30*,+##15:\-_C4>Z:@0,&YG,^5.?VX&T1X&;^_/BLA<C
M0CT+;.G9/!VL,V3.W9FPVMEZ7FF4U[P&/=_/#.<G,C"@^J9]R0T2/YH74>-Q
ME,>TCDDA=.?/1M<+K"N5WD.Q]VPENL7,&2RGB,AOW:E]7_L6:8%/,P6LZDL3
MSQXD;PDHWP4*1NNM1Z<I^MP6^U@E%[QENM^/PR.0&!@.6UQ72C#V8I!0S)/J
M%G/[!;. ?*CM$8T@;WGBD+PE!!T-HR":Y*#;T\P.BO]&-"P1$;P)CF8K%8 4
M4Q[2XX;XM#KOS421)T HK=032OZGW.II+>_.^?7Y\?=S)=$WF.12(6_Z]V7$
M9SK8>>YN.\N.E98650@#G8%CDGUUFMD.F?A,LT%QK8H.YXC4,6)Q!T2XB/G
MD>79F'1&,MAYD\O.V$OAI72Y@92CFYSQ@NU+"X0&),S\4YG9D&W&.Q(J7\U
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M*H<RY^K#)4>4*AO9:I+VXE6CR=B%JD<:AC&U"[*-L/JBVQ4ROV\H>%JSTH.
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MMJFR^M*W]A<.YDZ*]@0A0$8AC%B0Y+#CN?L<=2M9V\=Z[Y6ZBTR;K;#E^@H
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M?BM(%0C<WO#LU-5VPG,*UKT=^2>N<_N/BMT+4_?-:ZP+NPH4G^Q9JCUX+-_
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MM2U,_#B:-_M36;QA%""/05NA7^%[9CJ%:MWETI$=L;3"24M0\4LUMK;!CCJ
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M&(=PYJYB@8CSA4YV-+QG%Z?MFR"(?NI.B%PY;S9*E?YJ8U:X3O@XV:SY#,5
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M$4X,4#B,IAJ&O^5(R>8Z5!VVJ'C#;;WJGM1R[S"TMU(:=>\9TQE#>U607'7
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MA>WP-$&&8B!Z63MALWP021&&0:]0 <8.P3TO=YM0IKGQ/W\#5G!>+(T]R1'
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M&H\?-!S;).9F>7D=Y2=(HDTE)E\)\VT,EJ'+$'1]56-HHT-W-_=W;7,E1HO
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MBD<]SU"C$!&2O8'R<OJ^[F0S:2;*UO9')4J:#EQ@F-HGLP69#=*C9D#LFYE
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MK+:H@;%V';2WN5F(3&M#[V?X9RM/1_QX2(AX2]^0"".NV'X0^U?VN]1>M;X
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M2=<%7ESON];4^3;R$+#X<W#W..A.1F0?YGR1<,G2X-39WO/N8?7BT-6JB,F
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MA?/B8'_>MMO^_K8-\7,9LLHTB_>->:YD3TO)TDDXOR]$F_T<'(1H"]^*&FI
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M3M=^EU$J6EMJ/J8QD=9$^;U,<%D_.B>'?7G_=,$DL\]\V-\F7/)&+=(_D>P
M)3<1Q+"O6'.8Q8%$C&[+S5#9*WP)F?U/2$%E:NV:*BC3>; V1[J7PE0CF<^N
MJJJ\/B#1)^6^?=C=I)J(:=?J%HQ#PC:I(0<2=VH_E>AIT).:*C8<8LV32 P
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MSG!(-P8?@GB[)[X^VL[34<PKB<[4I#]Z_M?U!L?09-F4I:TXRSHE;5 L>!A
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MFTFB;L(,: 33V3'!626ZK;0*Z%8\RNK6*KJ>IZDE,5K@:Q6$>[AK31)[J*A
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M<6AM&1.HA120.-PQCO9+G&PO'9H!H=_.P6D\!!CI2WML3%[#]#=.HLOR\_K
MK?8X-)!@14LYC5TVE_V@E[!BHJ8*0U0C%9H5FE @X(.(VL+T X8;,F]<C8]4
M]4FSVI&ML*WP;!22$YY/HMD:^U9K!&#.X*Q!I<PIF*K-)6S_&%I_F&2^#;!N
MU@G5Q+,O:[6Z,2TZ?M>J8?MY1SS,54H7ESBC7^(=H2@!"A%D E5\.G$]" F#
MG09%><[JM+<[?=LZ%/7UGAKR")+3_@UK)MF[:MOD/M[#A8IG&Y,H_^NUKI9\
M"BX9(4G=D\FA!O;%KIF3OC])GE@V?^1B.5AI]$(N]GT(D:J!GG!@WL"KGB0D
MW $&+=1HR%0XTY<-*3"7B.%LVD9J'&CVW,QU8S^"XAU[OHC/ELS%U>Q23&S/
MTDM@F:,%5\X2V<80PO:+.=@ ?RTW[E<(^;E5H"=$0OK8I6Z[>*L,*%)1,S_D
MI:'4H\$242-GW- X8HBIJCM?I<$PM," O#A,'<QB='>]UF)DT#I^$2Y910\M
MW,&'LBT 1KLA2"[,PW1>)Z0]KQJ_BJYZ33Y>?91<&.OP,YTISMV/H@-QNUQ/
M?,^R',Z5J_'-AE&G> ;U451<7F=XA>'U6+6B/,1.(6TO:7^91NRAC1$\SA.Y
MKP'M/NS6>:G(Z[(K="?2C(@O<,*O?D@R2;$AA0TZ%,D9.WD G4- !HG]J@>=
MKM:34\(O!]S+ZIU:,2NM1FOG>EX-O_5$/%J7"XCOA.I\1D6*\;\W\WJ,!;LD
M^7M7.Y0KXL/['"ZB&AM.E>9\ZB@L>W8*=^62;8J8-1RDV)E9_ J"._86G"T^
M[X7J[ @2ABP9^?$)I]1H^?F)S=J)/9.,;M-W&NJWGV2';M#$;)[4:A#D?L_/
M;?@0H=5=&^-NB1YW-W&3SWN6BEJ1S9/M' "@D'WA/]&R'^J,&IJJ4,NVR($#
M1.GRYS0],Y &6/Q[/PXC&65^0U:[>S6/?G1$N"$3Z[)QNX@1,ERM_$Q@2+ <
MLGV6!E9X-EZZ/&LXX?%0LJ^LNCGK]X.,JY7<=+#2 'J,UAX@SEKC7N5\)/TI
M]30Z[AVTEKOH^QTED9UU=S$7SZ'>%^W?4P;'YM"-9H<EDZ9J6Y&37U!B,MS0
MEH*]/0-;COX:Q3"!3F4;@FP=I9](B<=<1H36IJMFWH+'+X_[KTV[^F<AX<GG
M(->(*Y'$&[+"P)D@_Z SKH<W9"W($N><1D>O NR<@6,T G1;_TW\[V&=,K?D
MVXT:<=G)(>QS6+=]T>6AJ^80M_H+& >'=_1$GX@/AY07A:TS%ZZFQA6VG#]8
M&BB;EIY+BJ^X?[\=$=)*CSBQ6#!_+F;K4]&P.[]1JE!6FW!#5I*( QL(/82@
MGXD8_:O0LF<9,+[__F3W4"F?:^%?=7;HA47U1FB:79SH#O?] R'EVZDNJI5'
M\4)5:VD9]'VHN)FDZ>/%BHR8K?AN+?J"6,I%_T=V1]'M1($P9J:OO!T>QC-<
M"8UF8SDHN"^WF\Y8NJF1]Y=]81>%7-= '7>V>8'>4GLC>UH>3W_!QGH 4!@R
MF:*E"U"@-)C80AYP<=5(5.C4)68WIMJR;:U3&VBMX,C[D^F:I\$<FG# 8H%]
MEU-&41PKY'3 $QZ]6EA?I-YU_N5X9!BGKM0F8,A//FJSLLT[%U^W<CYG\-$?
MVE,1DN[E<>&VR^Y^4#5X= EI2\+K1Y>J4&]TO^/I']NQP?*41/)"(K^]([C;
M^/GW[IA5QFD%H-+YE*-?]>U;Q)DG,XKI"/9AX[;B!;G\9;1:8;4Y0G?BA>3A
MWL_[I/AO!UAEE,Q$0J+QT3TET2]?M6P:*+*]3 ^BS"AR2#$*P89W+$[$@Q "
MA<,%7S!N1I)^J-"AY%L3T,F @ !-'FSB&^LIHY?V%-E&TST.3#SP.2$-%]4(
M>O(JYJ3Q"> ;%(#V&VOUSDQ-*)9)\3D%SN9!'%(7:9.4A\H!P-E5;:J,2Q%L
MWD/0P>0J+XY5F1&0>T)F U 7INL:4H=72C+ GE$?%T.M>ZI*JR,O&>]1T:N$
MQ[,.@#7[HCG#[FLU#@X+C.6ETM/3654Y4MMXNVBRRROTU0^(&NA&Z8-_#="U
M(L'=RY5T)=X[U/US/29HQ_OM]0-44:7V-+7Y:5H2'>#=S([3']9V37><12%)
MYAY$ P,'M1^&R;QJ&,D/&<_]U](4Y65X_1LX)[1_*X4SQ\ ,+O:^0Y<%NQMW
M7FW/7G+R<LXG>R\8*RT[8^6%R*UAENT+];F@I-60,:_YKNP[%^6/FR7$8.E.
M-"@PWP#H2>BTD6DZG[77V,15V1'^7;U\L)E)$Y^YH1WM%;LF;W[BE_J"PE=&
MG_8<=F'X35&T &LX1E;=A) [?;B"!QP4CBJR6^Q[@?'';2(;N-@735ZWL08.
M<I([^5@IR!S2CG0FFI:0E!6-05-V.N!AM5F2(PBT^W&I?7^&R T9_W%/PZ;N
MO'G$XV.75?+J!>GC4/\$3EXA^7OAC1\I_*IWN[LL,]E.[^ <N7D5TY\6KVP1
MJ2<2S1;U.>HM%YK,VJW+%@]FZT88)NL['A8O9K _RZ4V"H..<A3C74,R"_ZU
M*GG_:\ZK^&6,KBJOSV_(]C1I;\C\&%690W,JNQPH^FSD!"L'9(!&K/EODO#J
MO Z8$E1P'%Q,3&F2\<'3Z'K^=Z/W\I)]G-12F]R\RH$GO6;Q\=##NJWY:(;S
MV!<[>B(PB5Q9K_#U!C7,M]%G ITO5$+W!?R$S,I:4U&Y(#1\J7%KN5-_LXK1
MDP3EE:+)Y&*?(9_J%R6L4V2]W=EQ\,Z;[#>H/4U+**+99"[B6%4I/HF77Z@E
MW_KJY7B[D3Z3.Z_OW6.AX9:4_#IV'F4(@%?#AC+!MG9^P$--EY*2CHS)G:]+
MQ'\Y4TTI^=ODBOY8/2/VM(HAH5\:I:B\<QPAT9,P_9S'LT:Y+,N CWTKBJE7
M8/#87Z#2)"/=ZZ!ZFCYO.@ N\6628='!C/.K>P:AMU.\KTJJ,C58 D1 6TC;
M;.;H!'G2<],+DHM#+)*^G%XIFJ%L50<WY]X-#9##7CN'3U/S6E5EE#+*H.\E
M?@DGZKQCN[+D\IV[(;.52_8E-=Q;+E.]&H)M6.S6CUB*>2_>D$7L3;R;HDX?
M_V+#U;JW]AP5<!V#6"*.4I<.FEK763", ;1,;>IS7:UJ/RK[,'\/@Y4S+)LG
MRI#WJ\]XQ@K* S3"!Q_HZH/%Q+-^XR1>M1.A<_55] AZ>8A58CUAK?6D+>HN
M,=AF;K3PHVNRB]P-69NDY1.YGOI5-T^$0+=I[05*YWR:<BIQ=I@KWM1 \R>7
M6A49V:UGVY9)!MM<Z!4Z0=2GSO%4S6(SZKS)Q?1S\P+(CD(1PX\\>0=\5Y9+
M_9[TAZMW,:Z6>TMGN>PM"59Y]A)F;D="ZIJ<\^41\.[^=_&PKU+CC/6,LR'S
MFFQN.(B95%G%-31UH^$Q'_;P\WR(=(_Y'[!=*CT!R5\2-@L*WNH7IH]PA\PM
MMMCE0LA!Q@D2%#C0JP8!;V[><@UY0BO7:+H /3UKMT"MD4/JU>[05Q'&[.;$
MSKDFN$N#$U+8"3!MV+VQ,^;;*O \?^ZD#=:4%;*K['%@@8$IB"0?G#*DU97(
MI4 :)&HJ,)WF^#GL$2JC6ZNPL,'[>8H\QUO_;9=&UB(?CN8FR0Y_B4\C#NR4
MI?)Y@R4-4Y][8!SZ"$ZMRWL\:[FU"8<:*I"EKO,LJJ<["^^\-!1[-<2&*S.$
M),'<0DG?(3D)AN'F2 ^.I) %28==1.><Y(8]S9$@<<BWU0"B"P\SZB#DHM%Y
MI^6S:*(=?IQ;"QB^]+]J>\]_%>K7_\60=:[HU&FK!>TG??9W?E(<_>7GW=/S
MK/$G/\-VP\YZ;\C<WK9=S/A'2O9O?+TZFG@2;?V?=M?ZO]7[\RO#KY*K +"9
MIU&!192CCB(SQB.+OZ:@Z;FG?^AJ5U!J7'P3\SQ$&6#$Z:1+W?DA?##BP0QL
M2(KQ?C@NLG,1 :<IH._^/A,&4"V@5?<L4(O/U8+G3#/C%YSI8QZ<6D4/UQUX
M[8*(?2?F#'/!RR1.XZ6)1)NY8G 9.-]Q*)FN]Y@/<+ZFIW/G-&8XW@$*_<@;
M*-=/ZN9G4WQH?VJHDD]\B>E)4LG[Y>Y$4VV/+FG P9EW1; /9S0B4<A$O35G
M4TBT F^^LT"N]+#HHYXI*&JA(72H=*"RX2Z N[MKW)23!FV7KJLE&:T<]%8N
MT-<=A8]-Z8[!-71-B:"./M?&%/QH@@'?<_7-;@50O];+NE@J79\961TX;J".
M1#*6=S0=&KF5"^GO][=NMD"#J*X*\9W\5$F_>^F#QS2>'.*/TI D6,LV1*'3
MOG8?Z'$!A#!COE2E/'NZ4O08!,_UU;_@?IK(^=C$9 2A%4QR22I_90Y_[9)@
M]P% _RES);T!M;=&OR3J(B\PESP *=<-&D&G)S0E>AAXO)Z0FVS%C[?.;*S)
M#2.;(KM>2ORQ26>F;8J#/7@1XE1,>K:J6HM7^Z-M9GY!N'R^23YP/JO:$J&2
MEL;?\!2<X;DL9"1%#NUSHP*X1XX1'.FA7/[W.3+O\\#$?CG)'IMYX>PF9W#=
M$HR$9/37R9TUYU7M%N)SDH297*J?8I+L1P<;)Y%J7?JVB).4D2V-&'"WUKAR
M8M^(MIEGB:34'U_@@N*];,O>6J]XG:SK+X8Z-%-KGKGV6\FPGMD;OT[D7<^R
M,E##9%VB'Q9RRRAJ):U(TZTV:&&<[]+,1=L+"IO!M.H6/-.R?+RRY.<OYWS6
M#JV\D2/+@*\.3\^K])'ZUG3='+4<<>T2MJZF1F4/HKFE>B=.FGFN(AY?5]N>
M) NH<-8OVQ1KW(%J(,.8=3\10N=?/<,PO(Y6[WW2G![?U#1!<I>L,==D?TT(
M1G,E)0/+* V@&(XQZ%BB7;*;G/Z"Y=>$G;TU7O5;;F9Z-6XB#1#='#,ST7%Z
M<91;<,X<0'*C*+)J.&IWZX.9'H?MF0S?K$D]WH3YLH%"QG(Z?J2K3$O?AT?]
MR91LXN?S+)[8H@ZY]SMA;N^,J&=GFP(*LBWJYPYZY.Z?I3G'Y$U+7G,TZ0\+
MR-%4&?LSV142HT20S90-8T#!P^[\HNPRKIE)_<E1(^6"O++WVGJ6 [9_E9:&
M=]U[FIL;@4FI7*Z;\-[E&+HJUE7MZNGMM*X\EZ/H6!+LF&)X$!=,B;2I3S"@
MM""]MH7/$ 9IW5E2YIN"F!%F>@UNNNAU[DY>0 /@S,Q!:2*#;ES!+)S@<O:L
MHA$A!X%19[M7PCZSJD'$E>L_K/C=296XL'5&2^KGL.L^LG8G3O9))8WAT$O9
M"!U]Y/>>E<!3>!YJS\C^(!\HI5[+?$!PWCO=(94O+4F9X$?EQ/S=L!(\4EH/
MS.0 $)1$V^2/S[]<D\+ B$RK'WK'BH?DSA1CQ5_UP_+>3KEC_*[W\:^E77L]
M+_QPI0&#S4]?NSI@"X!%\S^H"^XTGD&@;3]S=^5R-C:3=G?&G3\G38*U*@9V
MIL-6=J8_I)&GC9=QC)=QER-POW67%#+$]<E4IW%CYF88'LYYOYIWKW;!9-_M
M^A;2"*V#*+[2Z^JZ(6,GEL9Z"<C12SZGL15.F#1?/1N/=TN&2ZGF1S#X^9ZM
M^YXMT%2E?XUNBD3S5]&^QH=X[IA^B*['%6&9BW2@4LKLCY:H?LD@TZJL1D%J
MG4[4FH^A>/>(>JAT<E7#F,,<:_&Z#B<5X[MMVQ&'<@@^8<[\99_U/'!,S5SZ
M:?N:' [E,!O*(C[DPE^_PU]6) .*\YPK'T %%XXY0X1B=03ZO=9]<5Y</7O7
M&E%)++Q#U")/D8(XN'2]Q!CP\0I5%-R/*EH/O"VMEKT;IN(IJSQ^I,EVBU:X
M""3G\Q?I_"IWI,P<TR(XT$L7;7=T_;Y<3[OD_8DTRRTZY'[-U?C7M7W;RD_&
M!1A"';$!U\O]@%=Q9R+B^=9I[YS0NFD,+<\0;% X,J?&A_]TS#3!H)O73".2
M\+E^B.FK>DR(A,!*.5XGK]JQM_)Y6Y[F*R%>18"0XHNN/29*^TG_K^^SC&)O
M\23(41+O$3:9ASQR5YJ2-I=K,>=JO0V7!HA$.>9'+O8O&E9+:.L:.,,3E&Y]
M;+-('8=2C5UQ6/=4R@-;,S5VJ41WDUQG+(9<$V",;D("S/$*FD6=J^X 4Q/V
MI?8_5%3T=L(\SH(0GTGQ2]D0DK[[.#_*'.0&TZ_X'2+_>AQ/G./ZX3H\J;#6
M:]%EBBQA!'ZJN0LTE/R<^V!<;1RD'0HJ'<A1>16CE&!3O^>L:HU<]7RZSP,U
MU1#;=OQSJG-3.=P'0Y']VC,YQ:>V#/<TKWYN# B,^+\H=\^P)K2F;52W;MRH
MV.C5+;TCO>.C2$E"0#J$)B7!!!((59IN%>E!20B]2 D]=!)"4ZE2%4)+ >F]
M2P?UV^\YU[F^'^>[SGG?^;W6^K'6/3/W/;/FL:%LW?7F2YE/EU.7U K"KJ M
MS%.*B\J;,N J5+"J%54I72TP8^O0TTNC5X'9 0L2LW-\4V -U@T$J]"3(6@L
M4H7Z;!2_P>X3EU4*?YM"%@1:Q!%YE8O_O.P1?BM5(*99&?C2$O_WUW-Q=P>]
M;K+4=# '6EK("'@8 J&?BX08'>=L ESQT?Y_;!%.C*(=?-J2\6V@9Y-3.B-L
MJB-IE5V?T'P5SQ=(446FT!M]Y"PJ#*CO7^G9+#WB(.E" GD]9P 3!J7DA?VQ
MJ"']YI2IEDPV5 >VL+!L6;113%-=K?'9%/LHQJS5X:B5L1FJ3LZ]^Y+C R.!
MW[R!Y:#QOW!/JE?+SX3P>PJ-8=K@L'IA[?2V!T/T#H_Y]B^(0HIM&.\;9?/[
M_CQSS,D5\_2\4KDV*L(\P\(0YNG>DHG_-^XFUWEQ=G99J/_-E!?KJJ\'H*5*
MQ0B%9=!@D0:Y_8U3BZBM.9*OK5B#-K=PI3UN?C+452*_EBP)!(@R #PX@<FB
M[XIG+!6B%M,+17TC\T_VM)<+;0F==SDR:V1XRAX7HN7+??PQDDUQ@-0GAM6Z
M[U$V5_=:M6UKV+1*IAJ97E-/GE2%6IN]9<]B'"=O@E3:6^0J#/E9"DL6W?H2
M5HX):";ZY=!_*6.324<&Z+Z@?B?N#=2.R=K8_^?=SP?#WP)[2X+XKV%83SW_
M%@B6$8P6[+K7YC&"11J^$7F4C,N$,9IQGB$^M<K\MW(N6L)DYC8TR@P^=V?>
MD!KVIAK8% V7JP='J.<&^O>TI,O+;[;,.3@$BQZ>6JL15 /-X(Z66(N4,><1
M"S! O-I0IE;W8I>\N[.R03!:Z?*"W43^^KVL?3L+^T!R?B9Z)CM45%@&D_0A
M=[DQ=YWB9'KKO+D6.=!?8][5/<@@N^J6[*>*CD+@99(;XYAG=/K6*,W^^RXG
M_45PZE<Y2FS'9,<4:7.05O.G5%<1P=X,V=6K*\__8+ (9Z]NUJ1K;%.LF=\$
MUMR /ZGPDI2MG",4,IG?Z8?WR#>N=^5-2)?/4A1)&&_L7?2(_=Y)&T#@2KW>
MM[J)W-;1*4KS#6X1E"VGVK)?V ,NI9%9'HJ8W0AXPG20G:D;'Z3<!/)/?1:V
MB]+H\AOK/]SHJQPKYR*5:WY6J30%*N%%F2+<G'4--J1B3KI:VN-8(51! [R<
M4EY-@WV7_2I?*9\;,2*"'O>: V05W9L@W^O*E#+7.+6H\EY+&.CN[&]6F3H+
M*@C6M576&>N2FNXT]4>N(Z3ZDN*0&^.U\SB5RD!&T?'WCSIZJWU#!LW#C5,5
M:E?'RH$R%O[)K@V:C83Z\0%^%RY6@3AG*FE3Y;T9W$8G\:$L;C*1/I&^=Z)3
M:?^I)@'%ZP>*EGDG4=X1S<Y-#M-@QM?3^RND0^31Y_;2QX&^/.6"Y$-B-)(Q
MM&M:?P)D'J"1#+QV_41'Z>W 5L$+G?5&8IW%3U=3;PH.WIN2XJA=>N Z4\YW
M91T(<0.GS-=E_7/NE78>V49V GZK4^< BA9_S2Y#P1R:GI^K,@L0&@*.* L&
M+J63V+AI88$RE3-5L4 6Y78' L*4C\,W]74VN25[7,F8]B6O5&:=PW""Z\BC
M/4I=PU^$/S7Z1M=F"KBR7DC#R?):UR*\<"O=Z2[.&O.'XQI(D;I%G?#BHC:F
MVJ3FMLSK$#,ST..]=]&7++[^LU^Y[*ZH&;6V>#S@X,.N(T<6/^C=H,*/H.#B
M[SH*=)C]Z][FAT-* PV2,T@8=[)PPR-YY(;\@DQU<\Q"R'3FTZ9,RQG';9[R
MWK__'FU<U,29-,I74*1#2=U:Z=7$", :WV1@@Y2NOK+\A[8A)8'<!QV!)O,W
M43]SV A%"HE*5LDN07+*[,T.4RW-N8F'B9ON"JZ*9H])=[LR(/A^/U-N[JN6
M"=A0&YR-Z/Z+E6O;C3^<'=J1,,.TFEHUK@ZQ3_%8>I$U".L!<XQHCM.3V'\>
MR-)"F6Q;,D69K_O&S]A:<X<AV/9(J,P'7=SP0Z*,_V%@KT(3/E9*[U?79 ]6
M\NNI^P>Z92$K^KF\Q(VFKD-*NBV6^6+D4-_S]#!QY'/O'1&C@&,^VE,ZU/ Q
M+%'TD>=[5- 6JL]'LL.0>Z%D"T!A>L6CP/6YU]V-VT1LM]_!,S<_8HQ"%"?D
M9T6DNP>LD+3XF0@!#G<I>58S!((H95YWGU7STGV]V< VG/X./S]-2;@5-^2Z
M8H?AF_:I]49F/\PKE7FWF:75U,6K*S8DD ,$M(F2;QG=^([<;$>E@'6@O09+
M[*9JR#$;R]!LU0W]1<!:/@$Q7*<ML[&LN,D?L@DEN6LL'"X4Q[7@:&2X5F,I
M8E4^/!/14.Y7-  %WYNL?,N 3/=-G"]I]XE1='9J<UXO$XFR5F?!O&XCM2)+
M]J!*95Y#1\' "0%Y 3H'$4QC67%#\_3ZY/AP&RY^0WIE+5IK3RW:\K1Q+8J!
MD[_G_[X0JS?BJR%+$DS=8LYE/%D/NVE0'G3H5*%4?*W0$VT[UWT_OI*)Q;NN
M%'3]/ZU@0[W5H_('_ WU5.1=G"!7X);F)=$A5ME^2>7;_2@G4XW^6#_%@9B/
MD]_39A4R?%.BWH, 6I K]:9C54_1W$IRD\DVPFS=FS]OPB"$:R @/;$4/)Y8
M)ET.#V.O\9E=9LN<J=@.^O7([$J@U.Q.J#OYBA$_F5Y($FU3D3/,-*<E+]8R
M!:P=G1P]U.[(51&]*S?%9/#B??2 3-X]#J='ZH3^P.4I)86\+J-/(0S.^"YW
MGW[V!(K?EC!D45,3<,3,]#XD75+X!+6SF_'KY_(]EI0VG"HQ9(I,)UC$[8@L
M7?/[;_V@_]^FZ7PW:XGO)6ILBSN)X1Y$S'C>5YXR?_GT5GB^F_<+:8R>5/J!
M?<0-E:HQ0$*B?>92B+R8NU+YD:P;]W5^ZZU_.?<60.4X03RB.>3&_E-GAQ8-
M$$\+^UEFD@7-)^K.R9-4C@_S8I]Z\?2BS?QU:?/(I=Y8Z]);<Z637^\G]U0.
M"!MZ3PB;<&GLQ*)Y"_FQPL5TJ<NHNL^72;2#NYY.A8SIY-HL!FPZC&=,-5\=
M"W&T90[**;W^-@859.W6N[A95\U@O))H<6A:?AE0:8JU.)ZX7XLK=%<_LBF<
M'FQ^!PQX^S5A7B;SDQIM^>\+!Q)?WUJS0+.3B_Z>F.AZX;U:FPU2S'\<-Y*3
M)*[?KZ1O4CO"!C3/_4.8H\JY(;I.UN!$TB[2D2"^DFQ1CMP1K:]MXV:+Z9Y#
MSNR\QP]8T[IO15KZ)1>N\G3)R9%& %X>2EL*8?8PM+MK_*IU\H;EE<3U)-.]
M.]FOL!XK 'X48"-_ 40H#W$,*8*H+<BUL>S%)WL7]#OLTKNAF=]S7)K)$E%]
M[%Z%&/>@[4N!$ZB;KZ6Q7B8YV?C]*[7O9ADB4P-B%<L1WHP>'P%LJKZ6V<WH
MT-&@@.Z#KB.+E%&.>@?3N(5ZP1Z!D!ZAD*ZF'^4.B4USH_.)&G,8$+JK9! $
M&87]7Z;")$@!^L 4=9MITC%M]<LCKADB W@_#B!:@H7< 2! K^Z^^CSY/X/0
MA>OQQ:$U)5J6B"G2-1S-0C9'O_:#VEY.<9WHGC&]ON3YQ!]^7)%WGA-9ZE.M
MKP)C$NK2A?8\'2@Q=ED%M_VH1$?+"@EFUMVN5"Z\]2?JB(%Z%?K((:+:[%)+
MFK9&S$8#;P.(=$;:*C-E4X=(&!T!RO)1A\,4B&YX7D0TS0VGF^]*5I*-:"@U
M_YY P,E-6\B-24V4?0\$@&+,2[^\DWQ?9V%%33SM]R7_8&VS4V<E>&G6XIJ1
M""\+"JK)D?_;>*,:K@R=W!80])%V TI+].1/(<@:;LQYC,5ORA%$RS:F08\:
M\8Z00E27IH$$;SO_?]18BSY=PBR>(%E8,8Z+M,>'Y<]*\C35PLG7&['LG^7N
M=X0#S/I33D>H<A(,K;61R%WE>Z[I2W8ZN1>#E0?$B3,;G_O Q]AY7( YA &7
MD^U?T!3R;*%TWQ7N)6K34L3G(H4;IU,89VE=$E*]*PF6N&\Q>A,1,VMJE:;I
M]@9:+VZ_\DL>15RE(-ZYPS[SICY(@ABH/)#S2=K5(!(5;SG^-3*'&RKO=9BE
M!X6TD G1[:;/33(MR%< 8/14!E7ZA'5#[BK6"_Z3;X-:[41E.JJVP*"H<?>6
MT8HJQ\2Q9I_>&I1U@M5S>8!V%:B"?1(2HYK7^I__(2(N*-M@MRY9[L.Z8C42
M'XH%L@:GJG,T!)Y,#L8CS*5&*1"RQ9/O_EB7Y=M6G:]/!=H &:;6S6&K+?S$
M",=^A=[9\MV*00H$.UOAM>NP]V%>?E,ZI_5[3O^1=OUU4:)GHYWLB\%[L:1D
MQ5OA'(VI/7%[\E(=T;!ZA'^ @J-B1%"'0V^)1>#A?2:*"Y!H''%S,*_.@LUC
MA GDVR@[@0-3N0#W6$-8E53R.C7HNH%-_(S4[2B;FN,'L2\48)M%ZS)^<Y5Q
MW9!9:3F"TU6@N8MZ&&!C67-CXD&('NS44:QS.?HC3V/[0=-(J=JAI^#5Q28R
MRYA GB30OA X&'J!9\(FT)9S>$"I0Z5?5$K1+</==L)(1?#M5'FO?6<I$8X
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M: TC=,:B?G$K-I<F-,=LU(7]R'IS+33,LG:FQB8GSM+5J:/;5(O#$^V8$5>
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M6(\B)AUKJD.#RN<^Y.7^XSJX5'?H"</V@Y4G_T;U?;WQ[4JD5V=P/XFWS?V
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M&(RS1&T8FL48MQ;6#;PY2_"J5-1?\<-^!-CSH5!%1^.)P\O=$70*A3)/EM6
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MI9_Q+[!/;38J<R34RYZTFF_M8A+R6O7[#=L7=JUVVRE"(C*?+H]:TU;HQN<
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MS3U)(OR=!)A>3&ZS$4_N?M5.;+<$=.O)WZ!X$E8.;1H C4\+%V.V/$JB!Z7
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MS<Q <_)1W^S>PH^:9KEM]_MM#]P:<FL*$FDBX;+-SQGP,;9^AS.[2^+/!W'
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M,CIFJ"4U,9UX@#>>( 9C4^E,X<2D?.I?9J"S;,*6-Z4)O$;)D3ST"Q_S**^
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M"+=$5TLTI.&,CK'(RAFK,A\JB9*-F9TY'VIQ9FK<)5 [IN"F%9%IRH:8-T+
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MN.EK]S$N O?1^I*::#YQ?A6C)LF8C>TM03_#[XNA'9W+-37"$PXKO0N1KO8
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M']>*=T5)FSAJ.;G43AU4Z>T2Q-9BA;\6&'%; O7D-@+]:$%U/Y8%1/4:J5#
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MQ>:FDSI,2XX*^O%=5U/#6Y6<#6'Y6:V/:H,667_+%TG\WIBS[(Q" [;MP*0
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MV7AN"7R5)F:/(0Z/*-:/<OM^N([IQ78,[/V3Y44BQ;2[>58F!>T=18IX4-,
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M*=,QM?U2?PV%?P%L^QB.]HKQ0KU_;;!609,:EI+!W@8#2C=JCE:$$'#/+T\
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MQ[DT=._6*\_7J[Y="5/@SS]<DR%"6]HMMRVT[B>A;?KC6::XGCN<[3$DGUC
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M@=!!4CG_+PT2%?]3@\0JT_]#@T3:P[B2GHW0ZVAQQ$R*GXZ:B_:DFH%IEQI
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MSKG^? '7BR/UF)T>;LW #9S XQ5 *%1S\'/U<SMZ,D9 X)E4(:+6NM5^Y \
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M__,'2OZFGQ"A\"_E-7XY(Z#RG&W:"A]WP3#P"T]' Z?K5OSW/X -^W@+U"4
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M$ >I]UT*V9;0U<.Q#\HWM'<?.#,!.R^V%>O)1_KQ_G/KZ]>.I(M8T<PX$+>
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MF"J'#P7L/)Z(?W%0, $Z"P%!7H?72V9F+$[P89CA:MH[;<X(C\]GALXB]RZ
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MQ>GU2F\8[L=>\>3D*K\&VF1,F;^PA@\<E1V63CMZZ%F%3T-.=Z[W*!B@1SV
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M_G8)V%M-V\>Q+\8]9&@0%*T/N(DKGLX'GW:<W=A7%J_^VX>E\-^6_Y(?XJ1
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M+L@MF,D"<CR]I[>+W5A*8"ZRI[$3TQ]3YI[]D<9AN[]!ZBW.)7Z?LWTRI%:
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MQ4WO2+SFK[D<ZJ$MA9#;F"567':=XU^>?\#AT?095OO'O>+L-4FHT&%YJMG
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M+EP'A'?JZ]6A[S.IO@+=W!"BDRF]TF(=8^J4,RQVWF=0_$QO37,T?*4Y;H*
MP'E:FNCK P#*Q5K"H *4@8!PDB6%RR__4W]B><;5LU'U)&"-IP?*UAP7TJ"/
MRNA$.7!9O89I-=C#JG4K9'.T.<G^C$+R]P+8=6(?:P3(/$YZ5[Y*A^>QY&\=
M<EG4T?>A23J/&YT+SNNUN=!2D!]\>2%NB)@=<#:T1A+UJ6VYE0V..=N69W1
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M)0/0 @^-8; S@XJ?7B@.]/[QT&!J*/UV&FAZE;!N>.1MPF5LN$ES1X(Z'YC
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M6D12Q?DDU_HTMC&/#RB/!3J%&2&35ZR=_+)"_A"\$C]2F/1'=3 C\\H VBQ
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MK*-DDI-'J"O'!EY4FB^^+_I5S#RDCN#)-S=(=;\:W^;<O,>(O$MC!L=#G,4
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M\XU&6?](<BG[\"1[0ITN/J".XO<RB:^+I8:R\^K$0/2N6=/+H">P>6_2+WI
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M<SV'J/B5GTQ-F8(.52U?RN_WS9VQK[<L!5[8._]DTH[Y[F4>\&7D*.A_]/J
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M%J'Q-196-%H8V\%SQQ^3#E ]E=^\$B?\>8K?Q8DO+R&JMSX/T[IH[18H&R6
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M*0MGVX+R8T.-*\S$>TIZWLM2!YX2A1:0*DS\?3R(K[M@MR-";?U"GYGF0.&
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MEOJW+XDFOBA=4T'LF D(>X#2G5EJ/EM T/6?FG'$=LQT#E=,8A6-?.,<&#'
MNGRV8D-=[M+O2&N4YX!:U3>'-?.%Y*RCK0+9WROIQRY0O::.[11I!RNOHP;?
MH" \?WR I#\TI 53L+UZSM%SDM@H#\[_^RLX59(Q"2F\\GS,[=]\)A:K+Y,:
MO&/+O$&J=M?YWPYRO#(M(BW00,)\YZ9L\%W,E%&6B]6D7UGR/R@OG8;7\XN>
M[B7,&X5W_;)<L^(DBLC"[Y&@>M*PTF!\6T3S&R(0_>(S=,.$UK2>HG A=L1X
M2AT?)"CU/6?BA\>I7.?;PZ"6WRW"F>Q7:YF'0.04.[Q CUK4_*B<UB<^087@
MI;/PA=VQA2QV%_3>)O3I&L>8>6!FZFX_X[,M/ZNXDN;B^7^+</SSJ<7X)Q#N
M=;@3!XHW_19P.'#^M;_[F)Q__=O?MX!?Q#^QJ(2^4KL%##]=NP6TJ1Z;.^QX
MGAYY3XK]U+6=8WM!V)6\IDP+]^18_%I-YKJ!.+;F$JZ[QO^ZD%-->;I#_N-F
MQC4RG2QVK?9+ZO/= B;?;^VOCE\SI_Z2M;G7E 4]U&]R[CY7+1"\\(NOGQIK
MJOA3?%X4TZ"3> AL=A5M#YT%<8ER_^@LS%2YW_&Y'6Z6P,'O/XTDPD-$5IS.
M69^8\U>0YS%\2\%,P?P7SZ^$-M(\^%P":BG=;P'2L8.BA):-AO8_$X)"7459
MA@[>S&#YIR"=#AE.?QLZ6-EG![RTC?Y7VLA_\77:=V)$X\R^)"SU83.XSXIG
MN'?]4$5?OB/FFD9^86AK*?3QRP_M;V7# [R].ZS>-%2,%\3WN_G.CN*M2P-T
M]5NN<T],,KWB7=,V+]>\J-,7>I8"/)I4QFNE84!2Q6).;";#EXJA=\B/1^\7
M.#9S'0Z*6^J1TRW9>?!S@NHOWURC<5-&9/YE.A:GKV0O.X"^JEX9&\@=SYP-
M1DN7SV_&IC=3QCVX&Z(1<5:FZ[7J7RQC7TUY2-),<D\ 5X';/^\5+8CT+Y);
M0UY8?+JZ>RGWVCY?0!:D2;6U,O&%-%E\K/]NH<3?*\L_(&-]1F>-,F90=./T
M^8,B'B$TO3M+J''I.@KC]UU2%:BBIEASW$K_:H@!P_&LUU%&:]=Q6/;95(?E
M^+%<^]M<[MQ?F!6Z>2FPN\0:4C!P-+'EX+S1W;!AWJWB1BI:DK2%/Y@U9?UG
MV(<@N'I"-D<<V0'GDVSA(K'7JY*Y6I/<P0L4P:-U3([K%MGDK<>9X)22/],K
MB^/[Y#N'IBS)=TM4_TK",_YR%9+H$Y&(3W$C@1&MY:VQ!-ZM]>(VP0-,S5)8
M[2\Q2)\>-V_K"FW[)4:-(@;([8(XD\SL605OV7K4BIOX'D]3OB>[U_.> OBY
M05OX5^W=R/6@$+S^S\?45[^&;^K2TAK1>NSL= MHA!^+T/+AEOI^ &\Z\VX!
MJ9]EX2ZMW\OQ5W7AC$':]5[GF!QX3FX;G7),8OG?_WLO33H5+E.#:+Y<H),P
M[6[JPJ IJ?OT%4#.J87<.\;E(\4N?;55[J3$Q++O-(FY-,Q+P@.SBF4)/47
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MY-8VG7J*;B!UN"\41VUIR8&3[LP"8BD4)EA#$ZT)G4SE>5'2*9"4Y;%Z(.O
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MV8[\+@0=5_VI6";PG-K=J:7=:0');E*9*8,]011K7S/\GLHQO<%'.<^F-(W
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MTMWJ%!)K\5=] I_.=19/]$CEK(ZQ<.C[%Z&%[)M\LXP=,O:-[<CU;",/T6D
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MIM;JLOF*WTXGR%90"8TQG3NZRY6$FG+-<KYJ'=ID'$=<W+"G@('F)D@_ZES
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MPSB=M=<1\:?W'O)/0S12058O]YL2@M$4A;TS:,<1;$G*W+3%R!=N'-J5!6J
M@),-NA7,XG: S9#N+Q:J<+L4.[CM-Z<33JK6)"/LFSNLOX@"ZM>0RXISXF<N
M()XI1U<1S;'TY9\V;SO<Y,KR@9:OPW7J/Z.W5!?K9SUUR]ZKS;Q2FBA32SJ7
M[P4(B]LRYCU0W0U6\/<7A]3GV.?;;R^D,)<(3+J:Y;,J]C3+8U].JBFSHN;
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MO((LS3I+A-]0PS+KQJ\P'0A7KU>[.^&ID/LM;K/P6NXT^B+E\1A05-^0YC)
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MKZ!MQL=9!#!^N9GBC', :T/@S#N>XN[_&KG<H%_CR>I!5:N;&//PX;;J..>
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MGNHYVP56$ 6;(Z:=*V%*.I,M"71QB[ 7BOQ,6ACY!ZY!.81'/T:)^*F/KGA
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M5=AW&<BV2L?5'+#'BBVU]Z&]5G^XDV]B&:Q8Q^!G=9+S!KD7<9?I=^"O"N.
M2F1$]#;VE,K5W!4@=QUFMO$(TWV-EJ_B,+VLC@'Z.8>\1Z&>W'1TTBR/-F3
MFQNQB$[Z[**FW<#>A">1J=_>GHJ,-U5YZ\T]]+EEF:[P<6OQ:9Q!$,& V-Z3
M*\-V+D<_XHQI8*-_V*#P$4=F$$_FXYE;9$):+SQ$596#:A3]INN&W7$V<D)H
M%\84G[E-R^R"S4L8C9?>:@4)%Y%?>EN;4]N#O\_E3+^RMB9G1^BZD)L?VS]U
MJAU"S6_W10O\4;^NR@IOA*1E,M2^*K+MZCNFXH=(+3Z]R?^<X X<>-X)<HL\
MNY".8\2):*U;_T5R8DB#8V*[3\9"<[HTLI[V*0\V1.VBYK:?&6Q/>9IMQL@\
MT\^*UFAW%+LT=6#[UQC5:%[)+*@PHB!Z_6>K1FFH^;:'7-"AK]_:&8P&&&P%
MKET.J+>'JC6>GAU(PSCCJRL#-9=C[(_B1]"><))TJ/XV3#*$$W,_A_KD6:6;
MNAK0,J-<;7RU_(P1C+X72(VC-W&"_QIU&1B5;T[;+A3*>C?%=F$"()ZU*J.-
MNJ<7M7W.O\+(6HEN9MYX\JOTTJ<Y)JO[X>EUJ^G.L7$=AI!I!/WTQU);6Y"=
M"=LM)%9$N9V?%YX2DAN^\,8?$4'!GOO"G77%!L:$U)K,1#:.DM 9)4FO#+UK
MY)[5?])WCN[<]?UXQ_M_W*Q\5B.+7N:4WS"9&M'3RF:M1MJL*QPERI\Y./-2
M(]C[PKYU;%''ULJ,LE_'1DSE?%-:VT[)'>WXIIF8"SL"N\.W0+S#*?;6#,DS
MQK]BOHZL3J6X#4 2HL*]F\&1#9367CC-Z<F5IV.=ZFDKS]2$#P$66]C,V]@[
MP-,A:=U*K$:%3$O[.NMY4W*WM,77I1V?$>^W'PM=5XRVVAE*[)GE+^;@$NVO
M_YR@> NV%J6#A3I!0[]\P9RBVNU!!#<MAUVN\J.RS#E]DA>@A_(!ZVQ?F:GG
M"OKQ!>D-M"#?E%7A#-3LB"M3T;M*NK-J7#?GHP)SK'.DJP4GE%!LQ0X6D'^^
MB03,+C#GAJ0U]'EWFN89H(%MAXIYLBKU](9*EXDZ2"_QQ-:S^,^ 7UO[(D2[
M57G+BT^2)<5]03E98]TI* +G+E.<*@00HLMLVTXFH+NS12PH5<_YQ<)%ZOH/
M:?Y%I\W/M<Z</#8\^P[O-H[E: CLH]E:B';>9V,;?.6DIG)[LSD]@/ZIV3-#
M7I=#5IS@9BA+@[^)1D+*$R+JR*)$RNBWGD^U749FO:O-#XE0>AR 5=5C2EP7
M#@6C;D'QEW%+'@;>:CQUVT98UZ#^D,&0=M>#MP]DAU0F- /-4?\1HKYM?1VB
M;-#?+L&P)3T -O9^.;R<?[**8V-[+7GJ-GI [X5A2)[(SEBS@6&]<6O#_:G*
MLTO+M,H4ND)A,#8DH3Y37ZVB]+9MI:H1F3)GAYX?W%F;ZWY+#[Z\]S"'+DO7
MIB D]G+_X@6'7T32;WMEY"0I*D>;4ASO/BULO<"F(Y-\YRZH5D@KRH/JVPW%
M0A]43MS*#):8:,CZA:P35]5T2KU^Y44.P#U)].ZR"%XQ(?8SSJMQC D<:>TD
MB3"-CHVRZ,*MF724&@*Q/>P$#BB$XCEQ,O/ &:H-C*[9%Y-BN9" _14H52C#
M:O1=PAR$.[H+D',MPN%!K_#!TE8<1*-62#L;C_J?+WWG2350^QHII!\4,[XK
M6S &"[^J6(V\(:KLWDK]>7IX?@+FI'&$.W^4?_7";_\^"6XQIOP&E$=*>?^]
M%L637XR;,L5Y#3BW]S,/(RE%[_MV&G\&/ORE/7S_TUR[:6:HN\ 3'A+!%LVI
MOM H*J*GY1%^N%2+TU)<^5P9D:0K.]*2RHHKPY297M=+JF <[12:JHA=,U@V
M'GR9*DJR &I,W;/EBZP-[F@^VLO5&/$1=6^"$GS5#$K.Q>MDE!74K4#5738N
MAIBF$@ZIC#U6F%_IQ<UK+_K\_B#,(55&5#_@N'0C1^=X'6@(0%/5^/8D>'WV
MXZ ',,-/!ES,LOG6O,SSUB@S=LL<2DQ0])R__6=^#>J*W9%*YH .*A_G@ N"
M)PJ_.JSU?Z@KZ_7(B[BB4&U4RWNW%&*.R<F:OLYDZD^7OMO+^E>#%]O)0\/:
MTH.)Q8&O"/61A'KU$'@_4"L=Q0MNYE4<Z(N;%\5!HD;B_S]'$RG_;]&$\-;+
MMD*G(-+$E7%0C [<QJW3K682X;[I.2[4UN$0OF)'=C.^U5;!2=L&3 -@\]W^
MP5F"H\R7.8=LF/>X?B K7=X_>TRCZI\3$NT.X:_C;MEKWFJ?8,I;G7VU?NK:
MN?#QXZY.4]8\-B3RM_REZJE&AQ4.,4FI+8H8;"^Q45;7@BLCX@L3J[M)^>W\
MG@")R+ 4N5 .\8_I!ML.T%W(Y#L_I+NN,V>2HBC]>L9Y0E5U9['!R8X S^4,
M1HNSW"I>I>'J2C5U7+/*XO5:]0W0F8L(!P799/NA@I5MN[GON_Q@?Y110F2_
M9?L<O6FW PKI4 ?]<\+PSWWZ3U7LGRV.O+U\T&MECYB*KL^A3?Y_.2$*'G!>
MGEX46GY]LPC$(Y:O<(8;8H_G@@J7FB[_-)STJHL5C#<+AK+E=Y;R+Y6;_' S
M8<N[9-&&1PR@5C);CYR9L\HCD=O';S7"[0Z\8N$OSQTVMWNYMQ*3&\%Z)#<@
M;0J[<;F\Q4/SF-4)*Y^7W_"CGXE .X\:4FYF#5K>3#+P/0?2H80,0D! 0W&I
MD43Y*8'J0=M=KIP?^Z.WW^0F3_3#M^=>.KF;89 L&%72^3R_@1)B!D&L73UL
M_".#,>-.&WV#]P\(M]CUC2E1[,I9/E!/:\D]KRRG_2\*AB8#&L7L=R2^K<DF
M=1DA!:QNO8:1W&M0=5IEF8#^E77G7E%^#0M^.V0 \.5QP/>*X]RYE<;9.;VZ
MX]OJT0<K^9G6*%+VVB3<@#VW]2;M9W:*R+DX8S*R@_TP]-:W<$#_KF&@;*\@
MHYF?3\X?;"KK.3<-$@.1'/YEUG(/:5NW\@^G8_[D62[?B+QQGB(IM4PV9T8"
MHXY@9,A=9@@5D)J0/UBG6Q$HU)7W9O%!T1_?+2TTHOH&H^6]#ZJX-@F/%.5<
M\T4UX.^?W\HZ]DC.'0Z_>I*L(E UOV>OSA$9"J61Y[I0:C-7Y30"B.EH^FE>
M":^J,62R#S3YM..BSN(O"?I7D3A,O[].^L, 64R/^NP-*2X4OEI4=!DZ&>5D
M-VVA768ZT#SUXZ5*W[[<G=*D%,:KE7UAR=YY- 2IS<.*D%+DI"\/Z,V:1YM_
M2X_NQSF/*>-RD%3,JZ);G,3M]T-!4O!)2\IYC:;Y7%M?D_'IFK')2H)XL+(2
M9\+69LH;<M!T/]9[? 03]NA6AQ0I[V@)?7=3BD9#+O:8AH;,97H#;MVRTVP*
MF:YUU,OA9))1V1GQOPVTL30G?]Z*ZTU==9[U\3_Z^KS.^YE!/.M/[-I!GM8T
M\Y(.L!QR=S\4V1TQE;-L[7L8S[E\T\OBZA^CS9ZS<:P/*QA^5XW1B%,PJE%3
MQ+V@HL -B=!K0LIEP,<,2;+=QA(A!'OAU/0NS-CQ3[EIHUNJ!ZX9TP. H@I2
M.H0X G;&(0PW5M[]_\CY_Y_JXU#K:"9^8SKU>D/.T6JVPW.76I[X?]YQ=L^3
M2WH=<W$H<+57M2@OX+6T3*%![M_M"J/ELL.='I_/<F(3>N1>%O')4O&8XL'Q
MMZP0\R)R4WKOAZ/4G94=1\D$E)^$KO$()MTS,=.(N]>V@]S^T%8QLS X-/0^
M:PIQ4*9*5P]N.GXV7*=Q\9:^B_P0N@92^FZR28A5/>Q O&"/'1\,PY5E38P4
MUF14O^(( 6@C8@-!=I3]XE]^AF\3T8=-Q[+:+4]:SLA&?- "SH"-1YS*0:WS
M:66N(-60.!]:_+77AS[S**?'Y^@EB@-![:SLHLUZR:3G(:<44;P;D\"M/@2*
M3%=U=,QV37L3?V]*)/"=B6PG:!U90'W%ABUH74,EWI/&6].2C#]^T&^]T=Y?
M)SY4<FFFWDOOT4AOOH?&/R<"!-DWC.</H[M,2<^8Q.76*R._1+=WLD$2FH/H
MG R_24>^HD2Y3$@6J['C0]HAJ^-GR6%1_M(^KR>^U4S3W_]\@Q%\8&D=$>&A
MC-&!9 I4@*8Y3LMCP+ ?1269&M-B193:^M9')SNJM]1+'>,:7ZO:?)\-'$18
MOU(J/0>YI"G#,^!=U[T.=7KR\K9OD\.E9/JC" )C_%+.\VY7&+"=]6V"?#5:
M7GYHJ?39T+U>&!/UD^D1? HCXXNV<U2+"'?(8',R8V4L7C1"3YPTWU4._1:-
M0J+KOC]VL/@J-UQ1M_C',P>Y#6+>E^-D@N=;5Y4W<'H]0 &-#Z<YK-V#5:Q?
MNS)?DL=TWCK6:2%Y+Y@1IW;OHT6Y#"EE56[[+U>:>ZY0S\NV>HHRH$[-8Z'H
MST-6MM]7[.#JKMWU&5G]UWUE+::M=^F/>G\4&JQ.N;'0O\A6KMRGR>-3--RZ
MC&]W)JBU+BFEI^SP^[.B6R\E&&(/&L*N,P+VD:7/1SL;/XG4-P?4XQS?1!4I
M$2M5OFE4)/O$'-][V[2T1'128V:.+8G+U6-PF*BJZ3<'D>@$G>AR]L9E>T/6
M$9)_7LE@+3$\-BPPGH[!D)(V(W T$F:.$EG55GV5\1R+Q0'=5RQ^,3X$=6]J
M%G@%?>NL>JM7&Z>?I5J>5S_L#= W!CR@*2_H6S2DZ#VZSJY0U:Q5M0X-:806
M.3SH7-A^MVB^\2:8%,2^-TV;:GC?T)-Z-I%_KQAW#'4ABSIJU^/2!@[#.?9!
MID^Z#F-B8N[_7.B1MA8K6';Q:.2786EN-][YWE"8=%2EJXS'JXGBJ<_"C*OH
M'ZILLV?\371Q@DT6J2'3'ZR)^UYW)\35<4[I2M/96/V9]Q39WK>5OQZ>7*3=
M@.0,R_SK&'[,QL>XR#T:_$V])S66(*YB&O/')$W0>DB#IL$P$(XKNVY:9)@K
MOXN-Y,B[/1\,.G[][&_[$SL@_MP"!:.3*1!IWXI*'6.5/4ONX[S[4 FQHU[\
M;=H[GOL+G+FF-]5^&AUBH5\I87E:X/ZJX"7DA]"7+_DBY69;,96.B;ELJ@Y\
M4LW [>^Q<RN=E,Z26#H+LR=UGCW=(('$(+#;@_%HT 6=#$VPFZ%2I8?<I:.F
M)\6.?.\U7N,H\^[KM6^G;UPJ0 E($'K<C^VH2$Q'M1"O!<D&W4Q_!GHL$P)W
M X&RF64S'4EMB9[>W>7O'R8],M7I\)8 O9A>^Q'\OK,"E!GH<1]DXN#RQ$#4
MW6X*=R.L"*CQ,E5$O*.]<)?BO;)IO'-1_/SYO[;Y%8C">P05A\^1\_C0LC@:
M(;J8MBU\JJ.K V7U]PXQ^$]F 9<I.Q>CRG8N: A$K5H"PE%B"!S],TTVW37H
MGQ-."S/BT?!C&:=DA$2%(#RGY6-=*-IK^_6=G5 \E]CZKOIJD%A01>UX(!V^
M^E,4>%6#;KXSH]/@EB+"[5U!?TNO>WXC"&;J.D$[H(KWM9)V <JYGQ;[:)\$
M1^V\Q8P^M1&=VVP/35[_Z[=^;0A>E+)AI3W".3-V<2#!)13F-]Q22)N$1Z?D
MN_]U[PVUM;X<Q'TE4."ESE_D\:&=[,+@/I=+@$%2(+56FQ,]#L4OIVJLQ)OQ
MSC_Z38?1Q7SKA+R'%PC'R=+5R0P>R<U;@5;@#*ZI^L@KND':+J>9E1B]V3I$
MM\,<HC]-T%&"CT;U[YK+R%!:T57;,U(C+CC'U7(Y?*G$3AA*\&GTV5T]P[LM
M9E[4-SVMY#]_)MA-/6<:NQD28IQF]5!&;.--*>K.S2RUZ_I&-H_?BQ7]'-EC
MS/R[_7@,8W]-6'H:5-""$4-#W?-5VLDF\[7'?RR<;XH^OCU"&=VH$1##P8Z.
M;2D.08)*](2A Z: 5$:^;BV?LO:]DKYMC=FA_+>SF:39&"@^#@@%QXA\>W<E
M,3\4]'L>@G AS)A0"_5>(SY0 )PN!N'-*!U>M$\[][![L0ER&WP" U:4W[L*
M+W?]43#HC'=QS,(C\&'?SW L=G9\$*9UK5M!P<G4Y*0/]ZBI=.SHBE!->UU7
M5[[5W?;)+'8]&A=]FTB6F4;&3I':,3I=XJ'@3X_Z\0=,&-/XGFSNC3R?^]K>
M3OH%C&V#S8]6Q,T6_**!G4V"J]T]'!^YLGC^6%)ZS1CR=Z LX-_V;\A6#S@_
MQRO4?>"B*_5-VF+#'W]5IH G6(W08<-DK^Z][0$[/@G]P5^&S( SSV!$*EW+
M9=-@8#=GD^V;<T&Y)RXNE?Q7U\+<2O?CI?POEG_;V 4]/OY/C2 D2B]&E8^M
M-KP0;Q0T_:7..[5TIGYMU2C+]MQOJ )CP)WL<Z<4AB%>UL5S\\I>$#;<^('N
M1X394%O8+X/J*TTQD5X^Y<X$EJ'_Y2.%%5D,TF,G5&+VW/L#E,,<<=WQ9^WN
MZ>\[VYV*+H4:?@V.2(\[_L8+S_TX$W2*7G%1OF*5FJ9>BD_X]G8X,BK'K9+C
M[>5(:\5WF;&$,,%SP]B X7/7JZ\KFE\3J!Q%&^7M-ZIC8UC2J8R,?@$CHT4R
M6'7X2R@G4$F@_-D(%G8X_MNCXYNLFP8Z/(EXG/6I%(JP^W++',).8KGT;--F
M['6<XLIMNF3M?#3Y-* (^=9%6VARY@6NM>2$]T#_2FW5Y<W)=;6UXK:-Y5J
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M.FNC/[7,RR-9%-5T5"C5)&EHTVN8+1!2EI8V0#;1-N5*"5:#();\TH"6SWO
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M%AQ/=KBSB^%IU9Q'$ESDG*.J^O5KWFB.<IKX+"73Q.'IM\"^)\! (V35\8O
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MVJ;#ESG'X%U/H\RT[LI->?Y(9[[>A6J)6P%S1P9>E_NI.'8PTIU;JG)GUFQ
MGQ+J-ZR1-@MPI13#UN0 IJ5N5/<N0Z\:W]NL;_,"DS,5)Z7I]ITH!S<WLR7!
M!38DK-&UE8XS]4:IMC :H\=>LW0"1R_$ZKJ>?[]ZX_N,$4MXL&,F.>DK.-/^
MBRLD+E4B>*;.4@BJEM,H;80!R S"F=CSF!/L%V/BQ]#F6MLG.P.K\*\> ^YQ
M]0LS1F+@D*XOF(4(:^Y$<U:[0"B'HK4_%Z_JOPD,?PQ3;SM7?1T86,%M$#TX
MD$)RJE!5 &>,VI\L#;@K"32S/16.>:[-MH.ST(V:)TLY"71IMU]#]"#:7DIU
M[DO&)2ZY&*;+%W[E"MA1_2=:M<@+&BPFN5L'=5#LU>WYFC%^KB/+O!<AFM0*
MWU_5_CA)(O@@(JH3?E7*J>^[[2B3V./JZ\#Y'5Z1M'U/5LL4?H@^R:-.6ZFC
M?3H!]2^7G;3<,>-[!0W#9"S7QF;.>]#&NM0K241>WA^YEB6^3_(ORA.MSBYH
M'F](LC9- I;/"USU,A:_MY<5R3)>>B(O5CY0)93_<Y$J.68^N2;/#C\0T2OI
M>Z^6ND.-.EEC#+!H7U,HXY58KQWJ]C*O8B'5E ("B2U-OR4+8&[IDXSUJK2?
M8OLCD.)U94B=N6!;02W1^=Q9PUY#N]*T<V)V5+L.??CS5TSX "T)B-V^@5]M
M"^.#U'BX(^YRU:]HC\-BM_3Q7&LA=K31"#:_]S$3EE_8)5 ;UW>^XTR\)<.<
M[6>;\9-9EMMGG6+V)!X]6L(Y*@8"'?.DJ +TG@I4,[Z" <]-2\P$?ZU*0[3P
MZ(F^VLQL(HZW3D_)IEB*W&7M>L:R>G,EQS)Q-G?)]51"?$JTY)<(-4MV'E2?
MRU>3+$WGV-&L8<.3P3R@6RO9/8.%Z6-0]B7M-IVG6YL[RLAGSXS#D\+AMQTE
M ?WOJH4UBY!6*H</Z8%K[CIG65MJE4W];HK" Z>RY&[/(MLM0?W+ J<E>0Y_
MXV6TEY82.OWAVB6AUA)#.1GG5J.^=7\I$ [8'MUP*HY/"5_7*,X9 [OVI/\A
M3\X.U\NW9.M%5-IR!YZP?YDU2:I]OB7#<+E-E6A>3D=7>S+>DD':KAKG_F3Q
MO.%17$;,'=;Z=EJL/H.S2O[^+T_Z_W=(I+A R&Z:3>/B:-Q0:P=,Z $BQ*J(
MT;4W*32:1LNBI5S70A; SZS)INI=)6.7+.5LS852?UC%W)]^OJR_-^597AE1
MCAI\JEH+*H@4S8&4!&;'YBBHE42T3 U9T^+?S%),;=DS&*:6TB&@]7^/X"F3
M[)31)\GAR2.IG LYD.W.9%?6MT=N:%ET38_>>W^S)#OC]R\X1.<_#GQN^\/Y
MLUP>V[2R)*=R3$*RV?L!WOC>KQ;SKMY8U 0^ \^<;:_,?=DR_V8J5?ZL0PJ_
M'X[.O!&,@[BJ]LAT@3T#C[:%??'/MZ'W_(S2S2-_+#HF<"Y*S?-(;X&Y!)RR
M$0R2KU0E)%7HLM1$N>%_XQ-)@K71U2GB[8YRM(+9:AK,_MR(E!*YR4WC;T'A
M67T8,.](4+;&MT"##G!9C!B7Y:'0X-SV,9[1<S2L[?-!<(_"7YUC*38!D^]=
M?N8(Q&BYHOZ:#[6 YYXH3B/"$O"*??O3Z0>#3^5MZ,OM.,_8)SO#;7)::3^O
MY.>X#DO4>2!RSM#1"\,H)GY<F8TA)".6[9CK4M9H\(7J)B/2GZ@"L,F. <AA
MOC\"??+_3@Y20UHP-L?M3,"9*OEPY:8R-4>#3A[+TEIVJF<O=%4Y8^1NR9H8
MES-V)USE3MT=7!+KA!([ON"L*?3PGPJG_QHYKB$ZQ6)2'-B>3-/^O^U__Y=X
M=+%.-J'P#<S:X2CM239]PXQ/K;CHX@A(U5N!M/DC.9D>OS2DV5DT0#J+]Z%^
ML]@VTD2_UV@/>YT&@G Q$#DX9/NY&IA.ZDG+OV%!_)-P=U;'3DN#2C40RT U
M1?&D#3('K#O).U'_]3'W+CY38/692["]HB!II6FKC]%&HN>S]O#;O]LD5JV/
MSM!L8>;1LB\2Z#L_&]GS;XS73^7B3"#+ PE<Z]K,*'OZTC\_VIH?]$OD6,YT
ME=6.%<Z?90O0QZZ>;7TH-]@JB8%I_P4*#1&.P@H_8[1-2(_(V!4^\OS"(E(C
M#6>H-R^M5_F#?ZMJM[=Q:+OOY1#JH^2D/OV3!O<#0K%O34E=IRF1\-&)^H7U
M($QY!DC%4PZ-;*,UQ%J<%:8)EO1*LM3S(7,C7S4]Y>!):/M:L4E!:=_.@Y!4
MXGM74 ]G2!XV@$L P%&@VK2W*I)L1?8Q-W!YB\)>RQPQZ8*4D.>)Z,'RNO*)
M16K&/R5LOJ2]PP21,V4G14>'/QG3)?@5\:^=3=X1K=H!C<''U4KX"T-&07MB
M6T_SG"0NWKD.9<=^9#-]+B./5@RR)XSR%/33)%HDE>"1LQA=I%VCVY^0=FJ>
M5P.B#8 NN8AO_%Y=,'7&5XV1R3?O2&^;"+&>_KB_DAWHG#ZY_HRQ;V(0HTZ<
M'2CN41&JI(A&C9!BLG:E/WQ7$/GI>^BW3SDP9G\2B]SNF@39V5@YBCB93UYG
M,JFX\C6,]DT6<8U)E@RT1!LHOM8>5.?0-&]F[JC(3K$6#V&J%*SYA%Y6#![G
MJQ2"U ;+B3*=S(S[T&+1HMJ:]K-5&QF]B\+-P]/%:1P7C5&KY1Y*:&B G3!?
M^\)G\+R!(4OU9YDLI<)8.T+O:+IJ6(1I7:2GHL;B@J;N.#;7U@Y18&9W+B15
M&;H1*1D6^)325;47.5$-UM&3HG-)6\8YJY7']&^_(\4!81!/R&:!=HZX4USZ
MNOOP7"KS2$O.A7<F\)KV#!BX;D^>_^W8R/58%D<$>,?-KHR[UX"#QA0%N%.*
M#(N]9 Q?GJ=EG!?JI2Y&-@7P'7*'\,2WD'K+G)P#ID%V.NJ(P@$.HUQ6]\./
MRN,D.0YK0)5.8 ((632;/2.[>G\MG)@WR+>67#P&>T:S-M]:7:HB(?G:+VGF
M\U?EM9..$)+VRK?"S!%YW] 5&IDY:](S2JUW40Q>7^/B'SF7+0K%?OZY_W$W
MO#G._,NJ*U9%1RLA:@%ST,^]C]" 4P;W4N?HYCQ]2J-:0 >890DA[>@@+^.(
M$[*Q/$^:)RDIQL&\N;UI'Q+,/TVO3NE-B#SN='XS8Z8;.L%IQ+DL3AC!<1R,
MJ+1W/J1$ U'/\5R&G:K_I/<R=;$G<ON& K6>#I;.?JK7022/#%2:'5[IO$&>
MO\1!34TD?/'W4G&_9Z/>QJT'ZI.P8M%PQ"LP4"1D>=^.Q\)0:%M^K.=KP%@B
M9A.N:[T2?]Z#EN[= F)P*?$S_66.%3M\G1!QKN)3OF)WL)TY^P# 3"_(VG$T
M%ZPM@*_&GC&6WB'\SF8Y3D9VKZC9&W['6YSH/QNX*5%1:4LG$Q1E;?RKVH:_
M38QQNWN[6)].QE<16"<O9R2"L0F'7O2NN;\36'SGQY>X8]"*R"?U<0Z+A[@6
M#0D'Y+?98T)UIQ/HW"?<#IYL;)_/H%-3LV=@\P8&,]$%&3/YZV57?;X+DLB,
MT5KL-NQAT16]\TMOTJ"WYGS;".O_:=C3X,ZFX@-8VTS_ZM@-DSS;-2$RY5D_
M[H8#G70M&U3MR%*YA^B7_Y^FLB*XR2I;#F^\VL0VUNJ 5)@UWJ_6\JGB 4<N
MK$A',+?BSUA3>MLO!:CT7F?Z?K[/ T#I+WQ"%;FZF6JA5#  V[Q#Y\&H2@XJ
M[_LM&4#,S-*0=^65]#R<.N;G6?)(QI1W;YJ7!_7PT.CRSVD\DA!7 ZZ;L?8.
MHSE]Y9(:JVG]:^,F=%,AK:>LL-RCDB.WJ":_'VF=9Z3_(694ARIJ5CF:$=/[
M,T8[@3>= ]!E-(V7VFIZ< +Q8:$A%>QFF4!:K)(T!+++K5<_5NF+.(<GT/J/
MLU)GP3O#>-:=%:4DL].I&7SKF3S5ZH6 7:B[3^RT>JK^DATYU<*.:9O'2BNP
MYJG5C44HQV8'=S^W^5*,$--"J@>]J(FSZD$%B3B?&-_?GK8_/BXHP2K(9">T
M7A)Z*)O=G;\<&08P :G68E6Q$NVQ]A#?3"S<(\W3X_<;A\%K(+0Q<](XHOAE
MGP3=>Q1<J<TUS &8>'\9[9:.?  .(RQ.TQA+QBR<VYY6] 7M72VPU<&%U$DJ
M2;JC +5O>;TZ7WI,G9F W)V=[%H1O=JJ:YH)RNF >_>CNO?/F*#I3^EX$* R
MC(^8;I9>+F9T/C=9SW%D69Z.L#M267Q<%SX80YF#M)Q^K:.U6%ZF.F4/9D&K
M9BP%'N56>%*H@X"95IOMR*RR/A"B[JGX9F1]B0I?54S4_<C*/ZH2=%,PFSDV
MJFYK3;1J!^$:J& ' C#+?B0R"*3:IURU="9^A2G,CR^/%/OC#C0]VN[+>0M]
M*XX"MYUZA$:&PX6Z2?U5I^2DANO.->?IN)WTF5;T]Z(VAA;1"//6U-8#+,U!
M&E!C1'"PP[%'A3$^1B2IM8L?5_X_V'OKJ+;7+G^4<^K%"A0O<' -%)<@IZ5(
M"%+< A0G0*#!G5,!BI?@7B2X% ()4J#%G>(0@>(2W(IS^\Z],_>=6>^L-7/7
MNK\UOWO?G3^_*\EW?Y[/MO7L9S\!VWU>9;%E<KP_XC(4-^@'A=U9CGW);;KJ
M(Q*3#- %=8L$FG$%\JH50S]&;;S2*M&+N'%B'NW8H#I6L>\Z<K]W0^Q2C0>)
M;YWX [_4J"CI2+?Z]J3(1>X@U7IVPJS=69FBL$^K"6M@H<>8FK&RK3M<>D,B
M!>DT==OQID,R2R"N@Q0X)IO 35;9MM&VAC)315[VV_$&PNR2O_]^_'M(@Y,;
MO;M=.$Y9#':0@0=[>91PZ02/S&;+9?2OWF](A/OML7_(KD#H88UY:3L3B^/(
M3_NX*U1/<&_?5YAE0L3@Y;M;>'!G<+ &]N>P^GR+V9[6:SQZO$E>PGE?;-&^
MOADB])-S,O/AM)*-,_5V(@QJRP'</P,E15UN1J:#X.K>2'05E"4OD*]=H5PW
M&1>M[Y(3Z3OA[-T<-N?:!?2+Q'7,!$Q8MMX[\,FL?NA1(%U0H//)TY; A.!8
M\PM74C+#W,=";DA^'I?#!5P]GGCFQI74<D+C9*G%G"06Q0?E-NEYQ*R:_(L)
M]L1[MJ5"1>/TZ8NB8.L@L#PXHO4T$$O_NL^^N>WM +;IAJ2RL[H)\;WU1 XZ
M#VOEB:Q@&)?[<UHG_D5PCX8/X6G=ADJ.DEHCX+>&7@^ 0" O8L7[KI5:<GNE
MK?1XIKF#2>(/7X\[2Y.UY:MRV!D;K\=2F^DVRKN8I '1T78(O-DRRJL:7L7Z
MD^T!ZQQ9_JJ]@WC'> 6NDF:T+O>.WV:=L6J+H2#E*,KJ,%Z.%VF/Y2YLOM=_
M+*(I%C/4?$&0G C2S2K_O7H J5Q>4=^W%ZSS5?S<&1N)>7P,YU1'&*$?%^E^
M7US*+-4;$8^*,XW5\!5^!@*0@WBU!91J/[1:_<J#!9,J9VK@.'=-"->2A6%9
ML8!7@* 91ZA DV(3J,GH<WF]5Z^C7]R\A)G6G4.3N]TG*-GS=? (TF@X,GRS
MNWF3U@>:/M"/A$XFA</*:E*J74N7<2]B>?3A>@-[]DL!<Z2_CWTMEIW6S*7U
M0N:Y+(&$;TCN^LXVHN'WA+#.DQD*F?"#C%%^:$#]*/JX.KK#+#O/R^OHZ.B9
M^ZMC7G=F505(TYZJ?E&*3[*8D[@"Y21!O#85%&A+$7P95$[;W/E*IZ:'Z/I*
M5@$+Y*GXHRZLMA:\#^DGM*7:NKKB&VGIB\$:H)^YE&^J?V/I>'4X6,XX9H*2
MACM]SRK@KOKEI )D]'4B"SZ+V#=6;=53NI^B+5J"V;X=L5E5%A&:/T)]<I?W
M#YGDW;+I**3CV"].?<_D'_A2$ZE3D=R1U1(#T<M4^Z /W0(,3A:S[7W]DY*M
MBJQW]IAO"3?&-8?C!MF9?7$3#77Z.\ABRZC3A_9!/UK?D"]NGNP?;J^Y$K6Y
M78IH*C_"RRM5OI5X/+Q_=D*:^WWIX[X+E-:/L)QA?" $9J_JR=.T^Z%D_8H0
MDZY5!=3]WIZ<,^#)S'+;U1(1V[L^GB?YK=C8$T0VXB'O",D1)'T 0<&G55,R
MITJK+9/& M;M*].(H</#[]Y:,S&;HROD8*S2=S&/JR:O<(L-<R*(I9EC&M?N
MMU_B\,?,-$T#"=0-&3&ET06-#1GOF:/-#V2G8S]@$F6!J"1G@N5@9GEPE]5G
MSW=M+0)4';/O)ZCS<6\-P,T27[P75=(DS1WDDEM88R'1CA?K@WN!5\Z36J("
M0^ )!;ZB9/I[!9,:%R>'9-)\WS8K\EZ.).N_6Z[WCH:)U)#CZ!;XLL%!Y[V?
MOW=B.Y8,+R7,:G.*JY(*%H*GOMPNVKE%%=MO2<G&]\7<BA_P$#0E3ZJ7[V5F
MZ-<OL*ZCIJ23JNRP7>QL-"OU*_$Z$3+&6X]Y:"F4ORL_%ZPX]^5IK^K:'(S+
MJ,46B"++LNU-J<%:FJI*_DPOW/0%GX,T(%%^,<TLC@Y;2[6GS+/04S]CC_+6
M#PH5=/Y)BTU@NBJO:!5;>ID^N).6[KZ<)-ZI-B15_/!= &A!M/@BKZ>N.7_<
MU??1']V33S+5.5M$O)FR57ADQ1,7SKV:L]4GH'+J,6_NHJ.F]"7IDGKA@E"C
MH%0&3WHE^Q^6A)1=*[.RS<2E,E"02$O%1]S/"*EXE0^Z'=:LD1(9B1"0U$KQ
MN4#R=.DTII!R]7)WW+X9"_!>QXYJHG2]I&DG(-(FZ$/H7Y;&COZK'^UF6JH4
M$@R7_(5%4D8"A1I"*8<YF)/')H8Z_9.UQ)8;'P8AI6)2Z$4[;%Q=;;@9\$BN
MG/=G7M#%'T]-+N/9WG0U_ECP\#$H?Z"V)*DA:0;54F2"(HW)A?5'@ZNN!.7F
MS=,&-_[ &J7 $'<D68',M[/#ET?7[-*OU=TU7'@_UW46./.$?%'- )+5%9E_
M7-)N()8M>V2"^/9,B#*D(&]0HW:345UJ2/2"71M?YQI#^%6!L]0VW[I785:=
MB[;..YT^C:9(%X8EF7]8U_Y7&Z$&TH+F%#-@D5[N6^Y&=9Z>_B&!^B6S%&N'
ME2;Y/7M7,KUBR[.+QDQJ^29(9QSF?3B48Z;_R[<MIE4[D./')'87O9=U:>T.
MIMZ7ENR0NL7\3RDII[C%(#L4Q_">OP.%D>C#I<R&E7V]@"<V#6;C>6D]1:1K
MHI#=-M !2X'KN(9X\-,Q%ATW;KH"QX"_5N N=_,-E5[UQ^O4;(')T+U0N%#
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MB9BGXZ(/H^;]' L2ZE S_# 8FH49CZ8UR#"HXY_\;E:E$D;3SZ%H]G*L7].
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M %)GK2;A.Q:WU4XC?ME88EWY#%DF:43[*R/J#J,M7%@YM 'J_$@WUHH4:?4
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M*T3H,J@[9[B[D= @US'.@Y77='&L!;OR%V,F>'B)4MR!*S=<(9'*^%T&Q/7
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M:W8?E5G=/*.88-S_2[;5)W&M^N=W,_XO!I8SYK[W,;\P4J6UMK=D.8;J);4
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M G'"=XZWU<4EX&@:2UC6]!'?@E!C.E,#[Q.=3H_W3$<.-T4CPJ#94Q\/?J*
M33FPESJVL7QC\LM8RO<[4=-!_=E_W[#X& \?GL:ZL41'I5()U@EILQ=Y:8K5
MX@XSFTW/H+X/!=E?JB3]B^C^.QY@?P_$-QV4;Q<H4G8T6X /'&HKM48<5?UH
MN%Z#+:VTRE5F#9.N53GUA[8; WYTF2;%;@ UA5WTHTM=FC-*5.G".U?<I\1\
M&P730!@2>?>F?FA23-YEK$R.>VU;JF/LEDCFDAG.?I8AT:XA57_6Y29*.2EA
M-/IUQ:%^? )-/]9<I(K#69F$FRGW&(PG1ZE'+M0P234(&*R@YQ-=O@9^6M">
MS]YR<[3!)9;%T3(@YD!3@A!M0M(>GA#3PJ?"E"BFWOYZ.!=8WNU.E/G[UZQ0
MH6?YAPOALJ3AR;>5BE[N"Z(7.\"&1+>#:PU.[IZ(W5[%ID\#U4T4Z5(UM#XB
M!N'TFS4,<QX!EI?.)U,'.<T8>/J\3>MT6N&!\8KMD*^(E;X/;R.:!3Y]22B/
M@*]Y$/_^U_6];_)C]V4"NKDLS#%6!6-K3%1WW!0PRY40O[SG34&@I.;@M/<:
M9=4G?P76*G[9" >2LV\Z>1!WESL<:Z @K)=@%@%QCJ6]B8::&  /_H@;.3.>
MO-C3L<.-1:5<3OLI&AG-M%/%.U327=O;9DDU-FD8."1JX*@2__FSZL+KRMQV
M<.;RK O=B:\L?;'@I;H^FH=RP9IYA$DT/YZGVV1,XV6&":6 0"7#5KRX]U+6
M=VK4TA&+VZ\8Y<I$ESC2D-'E-/?836"\?\@CQ3*W![@TXEXKW>0A]M=CZ+:Q
MZP@^WIR XRUH].>OE>N)5;;_]^R#9N-/**YH+0_3M()>%P_'^CKD*Z$1K,&#
MHZ4,P%J5%VW$8ST"#Q-<2U=.[=<*"U=M^9Z?RKG-KNP;&<E?D96RS_N;X651
M@!;R@9B16[(ND2W"O-60>%I$MU(PZ(TEMB/?[0C??&J)E)?NY/_6^NHTWBY'
MXB\RLO?7^Q#63(*E&T#_:$+[[]H> =-O<OG.Z-K0@;9D:'!-DPCA->BQ'ERZ
M@:F-;_=U=&]KA9./)'2_-5S[Q(+&^%U97MF*A>>*!TPT]J62QNC^TG<OU[U]
MQVE7CRC3JU%=6OB8SD" C)TE##!N.+J8TC]F:943:^_V/V,/^>Z,56[?.,7#
M+VH?>ZXK&22,::5))9KP-8!9)&]Z-^*\_.*I,76&-%Q/&,I_?KB<>/K<07[N
MN.)[;97"LEBB-_>Y^0<=JC42G15]CE]@_PVGC_'D]BDRRM=T9['N,;S[FS"0
MB(B=R%='_6@"..<EFA?/S\1^=OY??;#T_T, ^%KFXT0S6UL"0PP\48(+\WAG
MF>MB*M#8P%B@2*_26&^E6*1Q8E;LBV3[:<S(=[DLFN%TZ*N&OWWBIG3?I78.
M-8]5)J5ORPT6=F%V9S,RECQ#GF0IW56D2W'CE2 T1'29>>?\#A,X.X665EZ_
M-K]9_P1$%@E'71]+WY+=DF7%6 5XD*_.K<87V"F/#+;@6&M_4@S,4@U=;-Y,
M:T^J^M5GG4$?:U@/))#+:UL&?X%,ZD:NZABSM%$@?4*=0!IX,8(B\VJ?UQ--
M_]]7)0B5G(^YY>I+8W?&1+HT'$^:^GU2XXYG2P\8Y"SGOXL9;(IA=U_J6O(
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M>)'W,\:L67ZTEES-P;("7=YFUW:M:,P(G2WF%7H7EWE.$UG3#9,*>"X?]11
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MC6W6$[A/LO,6QJC?0"=C8ZDR*2%ZA8;LCSNM#[B;FH+>[!30NJA.XZ!?D -
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M[)4;S2U9:>;4+=DP:^_!+=D;%]U?8<3]6S))"2LMZ^LM%_J-T_S/FSU_3!8
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M.BPZ1R0<R=8K+X>?NK6!6^BSW,\S+8C87HBH[41 *ZN=U6;RJ]!P:H]1U8]
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MGM@LHHWQ*=*RE-V!#+.,&(4?YFW3<DZF-S4T9!?8X^(V5AO_,##=S%ULRC
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MK!S GN^;^F96EX&4WZ2Y,C 0AG$\&P3[O]Q^/H&/QYIXL/L<K[(?C4MBS'L
M@A(%):Z^X,P:_5^T7Q4/P7:RE_I\L\@FE! 1UC3KNF]KR(L7A<=E#^0$(049
M"$0S"+A6,:QH%G:I19NZX!ES"YRX4%E6.HMN M9E0A6K8QLH%!PJMGBX"2\L
M_$?0@8-E>,D(=\^0WV-XTE,K_>1 K\.C7YEI'3*<^1;58C,E[DDN>[U8*:%!
MH5\ 6=/X&IX?Q/74MGS+1#@_O>Q7SX5DE<M&3%KWFW)KF$;56;HT)-;*.9]&
MST(&ZST'*3O!,1R(47@[QW%1+22KI.\VH$>S(K('8SJ!>Z*;"!-(4Q76O-V8
MD>EHU%B;WD]]+8YQ7*IWU4RR5=/[XHZ>),B &P37!@IUQT0,10M2,A2[!0'+
M9Y=DQ2Q9M,?/:\S&X_4L$4BXAVQIW5[LRA7/B5&0F-K$ 2*$ZP%VTG:(?6\!
M I.*H]$##)L ^-8SQF++QB^5QW2NE*7=:,U%Z[(:7.HU1LHD&DY0CXWDOLR^
M@::LM*B7)H\?\Y*3)6N-LE!!NDKOEJK]<O@&#SY:XI-6_22G.O7=[48:=N!N
ME VO]V&=_(7BE:[OPI+(RANSNI.$B);F:9K,?3].O&M!AW:_&\4[XS63)8&]
M='5,N+#D8;R&;Y8T_"K6G]Y!65*O49G'*CP3=5%T>(3H#GE>)@=).-AQ[O7I
MRO31Q(AIPF2X&%1X#8:J(LD9!"\YST8!DCN-*6F$%&R'Q6-JAX]_7HLN,X5K
M=F:18D35A"6BNOB9&(OS4%\,^.KXZO@_S;8PC8J>Z'PB33JE?W$OW7/ OQQG
M"1.Z8.'E0K0P#,OPRY#ZIG&.#FG4R#4K<=?JIDQ_V ).SNC1H">5G)M38Q:9
M2$8SM1 "[\T-3DP2_<2U TWB\/G.8>4'>)? !0+[0F1U]"PEC @,N+?5,FR]
MP1L\\*5]4436UCU_.J<GGK@A/>K(V@S2]71!7!1O29*-=+ZO)Z9*O:S150L'
M?^BR?;'FGV:0RGS6HYZ_F([V57_N[V!3W: KU)\ 8O/#B0IP2?95L4(:&IW]
M]JIC/]0/EUJYGZ7;UIT^[ L0#K _=>ZO3GOHE^D\N8K=J6 03NZWRH*:]VCW
MQE]N31.J<GKC9H ]'631&]1EH_TB#]J@T3^O"2X9[PG/>/2A&O5JYEF]LO0!
M5EQ5'_%<7F^_KS0$*;QW7FXTY>+KK3K38]F7%=.\LU>_7W!>D^QP7OZ5,-S\
M8&!SCL-ISXD+:_^X=\F*3O?"7'SY4?YO)SRE7M>3GCSZ)_4^TJWO;J?/;:Z,
MZ%7CA,KUHD2O[TZYFB]\^/)@QF8S1IY_#-BG.)$H6'R&U&+R_2ZG-#U(UA]%
MJ:LIN8&WE9&I7#=T#8B@=P;0BEM.-32+@WBP-#YSYTI@E46ROM0C8)+:D<5\
M\%X.&X-A3(,1+Y51DP+B8ZI .["F@6%KHKYI3C%5;,I4XJ5SI\0BI"V6AS_^
MALJ=M>G('F"@8_F/HK6+G]>J+JS$M8^W%VT5:<8M6\Q[_'@] 43( (:&C>1<
M?:)X6MFW8Q[&$O)$#FZ' LZW810]0XS+!PV26W<Z*DPV8TS?FZ]2)CU?VAC=
M'04:RK, 'JMU2P#=Y+,-4=J@F+FR!.>>I1X+?@<KZNZ&A#>S%'P(9<CV&[\X
M!6'AFFRUIZ"RT%!U^?E8*P)7(3IW?T>/*""F<E!;U%K:D+89E"#'O=XT.>_F
MNO45<^3XV8:PXW_\^879CU-*TLEX3GI'R(=_WR38PGURYSP[N'*$MC*N1S78
MXJQ<:UVKYX;GPVAL\#&QM>7V>,IER&[CVLSEH[\1?R/^1OR-^/\'<>Y-$" '
M=WRHV[D[P'NK0GL-XO"*\FJ;JWZSY&.*EYN5_J_(11*5>&[J\"95LZ C^U%4
M=G\5;$RI+!7.UWS7,Y7/(JY?-2*NQX,Y<R$-1.>9S@WK/ .>.B*8)_T'5*\W
MS:@.[\4LH?)F-P=&GV:>]H&P2]+KB0PLH!)Q_H4[GO<[,:/JK7?YZ+EQ0?+R
MJ?1.B?5X^VJK6[>6D8$]/G:5&N.6H2:E/Z\IZ"6E[QA2O=,&/5O+NKP">,7,
M].]O=[7W/6[7-5@4I_0Q:"UKBIM2FERPB![7Z/= E BSJ(M$?GLH:X3'8@WY
M537/7X?A_)IW\!3>JI&7HZ)U'U"&Z$1^/JO?PK[C$;-ER'J8L&P>"LB' JD!
MQ>Z(WXP7FFL)9 @PCU%?\;Q87@$ &[4-$=B>)MQ?BLC'[2!NY:_X*]%:M"%+
M5?Y@?Z]Y-8T@5"+'49DYC X,L-![A/*"B=(G*]+]O ;+-GP%* +RI;ZL.S=X
M-T=#ZI7+N?G]:0O&<RZ558SA_6N?.Z[12Q-9 +Z)=^!&TEYS1GAZ.<EW[][
MFH:\:BR,8G3&8EL* N4/"XTW:$N.:!SG'?JNC4LZ:(]:Q>6+ELJD=6$)WL4U
MS"\K!,)BE^"]0.(TRZ\*B(X5UL0DC?&%-?)!-?4:C:>9)/MQM7S >FS7,!G2
M.TQ*#:DZ'YT&EUR8(H@*_6Z[(?17M]GU8SU[-\KEVC9, IB^Q0W,> Q\_W8;
MY]<HP $&C9S_"KBE[C2P"N"N750/&5X_&:Q9\% ]*U6I?/F<?SKLLDWO\>,L
M,Z8^,<^R6':U>?>L1/*[3*\,XR!?I$0(DPB@\JZ2#1]-=X!X_0F)[<>APN7_
M\EG.JU9%OLLCY]5JKERN?]>$RQ1\=-ZZEN-Z^'YKJ49_WC3$E>X'W?[OY/"\
M+9O@ZLK*9_\6C%7^1OR-^!OQ-^)_ X(A;8F=@2QVOEW8^R[C?E0M,+,_FJ?<
M._)6R%2O@,H19=\2= 6;T6*X-!0O[EVY3'#'R4)M:EUIX)?CI*H0$<1R,PV/
M:N;/:_19R2N^Y*J/Y9HJ^^?1S.)BJL'!%J&*I?H4>KK<0*'1;<$T!O[NY;/@
M-'6P>UN:"AO/UY$>MX$7(:5I>CUK3G7YXCIIX@H%)7? +QP=.Q#8KY1\_MF^
MZJXES*37BR:B8:P8*<@C%.+0P"^P/H(T<$X)!%YQGQ2%/#GHE?P8^-AO-3V3
M6TYD,N^(N#*CF1 DNTT$%"X]M8IL>@[+#OR7+/%)2LWVSVMZ/L1J.L\?G;5(
M&HR< 7H<T( _<G"""23QZS:,K=^J9RV5_J PQ,2&>N'UKE>P13$U<=>7$]R_
M71\55?#XN4:WGX@FAFNU1P93KU4PU9)SG-N2E6G/28G:3_EEN<R/QK.FUJMI
MR7A!P3#UT9+8'3FA"7$)J=9X."07=?Y1(_F6O[E5?DQ<GRM[LP%=<0]M&^Y5
MZ?V@[)O:.D?T\?'T0)KKF;Z YJFGC8YRHDM/+KA8+1L78N:Z0JV^\TX1ZB^,
M$ +.3A)S(O+EM:PG^HZ+HB=CV^+))UG)&B6U]QX[DQ+5QMZ/;$E) X!2&D3Q
M1>H1)TVHY6/&T*)('^J8[K[U!]&M_7X;"DJM*V8'VZI7N2KQ[A"4MC#H::UF
M ]R.8=D71A@"GIT]0CP?]JELG9J<S.WZ7]J*F_1_FNO^C?@;\3?B;\2_(B15
MN*L@?MU\4BO45J]OO\/0M5ZVC"E:1#I<1>5_Z;*JAT\V^ #O-7\)R2T1D&IT
MM@<OQ*9O55=_J&U;\Y1*5DRL6\W8>:K5-$P_]#ER;D"28'ALO&>1(I#.5&:(
MO_M7HN8WCDOU?9*#E 0>/H:QN>=QS-:9SO;66JM]705[MK_PY;'BU2;EE:O-
MQ>J,#(\9]K@##0#J[FRT">!Y;T7Y;KSVQPSHHI=EB"74Q$^L7?O=SH1A@%&R
M]$/-;4'<]O8V6P/[P!_X@))RF<*99!G%23;#IM&Q$G989!D,!*6<3MW*^)<H
M)I,!D<46L2TG3P]!^YVEGP-@*C8Z[5K\A[AWST7G)K&Z6LUQ([]%"M3+\-\!
M\M-R<QAZ<.Y2=GGFEO=8DMI72PRLWYEXCU5HJ36D_FJ) O+SU;&_KT7,X/&U
M856O+$2==I^:FH.Q%&(%=CJ]O+RG":\A L<#P.BZXLE^V5\KZN@?[L/+_9Z^
M ZET^5:LBBD=R71$) O?TUQQ\.7D670*6VZUHBK.5_DTS)ICKSC_+F-3F"@Y
M[BVOJV:\0]QITV_ B)]ME8>?YE!(4O5<KDK6X,@BHIF8-H7ARHTB@D+M])(5
M2\0$I/Y]#'KSHV:^<O9$Z=RF0(#+AA,5\J/VP#S^:SSJUK(RB^7Y=FQP &V9
MV(_+>:^A^A_/CO:F!7?+5&4B+G_[=Y!/_\;X&_%_,"*;0I.VHQVX8:L Y^'F
MNF$5>79+A"YLM",:C7GJWV=S0W4B5\2&=HS)[1C\V:^HJHH^WM=,M* 1$<04
MW$9BN/C]6"NL;D=I3BJ(+C1&I^!,=-B/!&J"BZ=Z>P\:?SRV)"1K./&Z@J*(
M'D=-%VE"/(NZ>MT"7;;%CGWB5.JO=MD2NU#[3'_VV>Z<V)YD+KWVKZ8S3:K4
M<,*V+E< ^1]NQCB:E (WI(EG/Z\QG3K"7NEV?-$SF\GKL$,91"^%1FCK!:B
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M0ZBGANJW(VGY'<7G1IF@>D(+H3YES"615YH2*<GY')X+,J [>65E;(3&D@U
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M>]C^MG^UZXO!QSQ5AVF/9=BDG3)#U,/)ST6?M O)<?JO64GC1G5EDPS1^3Q
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M_I2Y_MQ;_K#975/&#$NO>4H &<64&#6YA YAE&MF0M:#TX11ZR^?I2R*VWV
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M'_L=/C#->$&7YOC8,3BP6.3"H"+0+=>PR3E%W=NHLBS'VF^X3':DP=P<ZZ3
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MXE#F4,:?.7P))AK2U@=BUI)7T/NSAMQE\AXQ=E[[-(<Z/?DIKK_5F%F.:;_
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M<_ Z/U9Y&K0*PX8>WQ"$*6YRZ^RN;DEVW&P/E$>YS[O.*CG29RXUV;Z9QTA
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M:X$F4ZW\\Q):^K/B7V=DV%[?,@Q64ME?JV(RG= S;2 F'"Y&R&P3T]\.4$9
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MP0K:D/1T-BT,MP1FO"BOP71,6^+5G33<VWB[Y!#_P/54F#"N&0SWZZ#K_<Q
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MSBSU9S;Y;WWZXA&@^9HDR0&@WB?WS<WO=P#W0:+'BNM;^0Q6!9<FP;I6=/(
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M#Z/N$57;Z. /V7H;@^GYX<IC@ZCK!&<4!/J<8<#D$PIB[NW/3,"]6&5V2:/
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M^TC+0Q1$O3Y488SHP@\H,H40B00'VL:*Q^AF:)9_^\7QO%JH[N$JX/L?0_2
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MY<BR)XP"*3.8=Y3PUV;XAF$4#C/\:5OC$O"<52+>$[L364]:A&Q8]*I:OJG
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MU<@DAW^O?!-I0L;N(ZR$^N[\&TL)LH'8T%/W9MA8>.G A:3/+ LZLS_1XIY
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M?(-F0-F]51RD=_U*H.ZRVF[KQ3X)DO89IU1?F@]E07)UV>U'$GW%<4"R1G=
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M=CT>, T)4(>=>L7RY2M:F45)6A'GPD(G6;HJME2^.OSR3_>+&"RL!W,;L"!
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M[1+<87,K'7:V:)6IIWAUO^3I5#\B $C&Q!U1Q%J3@2"*/V?]I]DA,BW, A1
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MPB&\S@+?<B=& >&AYOJG _JSF_#."=-CN-F@//034HE=.ESTC:G#_KUB[.%
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MNUS(&YL5?N6\,]%TB4R^[V^\" UJ#/52G4J_SF6[T2LGU%L]>^:\>IA)7O^
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MF[&M&FWWVBY>N(XT(3P,3EP> VS6"_@=SA]C>D)SH,>4XST%^9ZFJ *]%!L
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M F'X)17O55,.YC1$R8IIUUB[W>9EYT_17;G(+;ET0WE<MDUN4#3?1VZ*N+$
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MQ$81P68J.#@T8,[5FL8CC=7/V+YVAQ5+6TANG!PE%U?N6Z-(\J!/3$'$VN"
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M4F[U[\?>3C:2E8"!%OK60EJ)+$5"BIP^JSU5;O81^94T(&T&5SV2'J#V (?
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M4W\'Z"VHLM6&$6EF3U%M&,6/Y\(GQ >+UL*>Y7$")6EKRZP'@<4R*HYA\M]
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MG9G+=4(QA4@LS3&?]/TC.L&FD+JR^9!Z3:H,]TL=93&:Q)F>12^GA>82C2=
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M+%@OO2;3Q0 XV38J?3+NZ'W%,=QZ94P/?9+]>]D[;<AWK38))S &) $N5U&
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M/LYE*YU>GGNT/2Z_GZ]^D 6B/EATID(ME*XT(PX-*:!>"(R?&_EF_O*2<M"
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MG2VTQ*K'1W"9(_WMG/._"]4;/:H;RF:3-JPUM-3!Z.([CD$:U>YI]5@08:*
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M'?[G[/O.^_^L?MY3Y3BS.H//C:39VHY]K[KEYN9TY9B9&9T+#%+/D'7O1;-
M9ZLWWO*I)O'IAE'4TT.0O_4IAB8E):;IV1HT+#!A.XE/WS>SI#QJ^2?:M/O=
MM?;9O1M9HD\(OM?CT!/,0&_Q?J[8+P+,=)793]T @I^Q01;TH#AWM'21:XVK
MP%,Y,OR!,6-[)8\Q?<?+=.7,-L;NEW?R"36TW5413Y*'.TMR>ZMN["J+8;!]
M\]K0W)ZH0?7J.> +(-NG,#B$=*QNT;0FR('QO9WL6M7>@8H+A"//=S]"9P$;
M/V%)VYM_Y51@.>E#^,Q67RC !)2F8S+5WF!3-Z[N/@#+:T6Q2<YR)ZSU7<%D
M?#5U,4P)<R*=DQYC:;\(QO=G*GX1<,F^?Z?2&?W;$H5ZH-L FEL&QT C0^>A
MDVTTY>[O&%@W4 ?U.9]Z*9KU^=\>O-E0#1>EP%T1NK(,1C+7EM4_RRLC!'*R
M*RN:5Q$#^B1!F;H-1DWK55_/\]M#K(GU J)4ZRA/DSUY9H0LL5ST?16?YP.%
M"T>S>ZQ>GMH+__X4 Y1] "703]6O9A?I_!R6H^6B8P79-@:,-QJ'"V9E'I8G
MM"3M.(;9#FRFAR>LVVTI!4W.-I\L@*? ZWWRZ4)&>=.'82I.).]+JZ@M.W7?
M0K32A+YV@VRIAOW V 9QI[K;-T[G^RZN^_0^!<_VU9*(,K0BPLL =A=#S0[F
M$RF8+EYV*_$=\R[7[V)FU,Q<QIZS*'Q=O#%?A>.MYS@#F7U_:"Y4"W] &Q'Y
M=YN%)!*WTR^(8F$$)7A*(OUG1]%_C]V$*C1&61918%S=KC5J;!YRO"$8?_SC
M-X.>-?FSLV>_&1P8&("&7X@*761]QG-H90AL]J%%'1N>$R8 0$G,W;R]5!A>
M!^TB91L;R_(N<33S<E[#)B@IL^!_[5%5>XT[P[\(=CT.#'X1)#&]DLM=F0DC
MVV  C')!2Q>DN1]UG,V3]Q[S2G8A_!\^Z-IG!:_-F%*^UHNT\)X4%G9EGEB_
M.J10I3B;C->>@'\:JALG+$3^7CC)2XK.ETQ99MC-*R^(,5-])%X3_460 SE_
M2!%OSD\55D:K\]$>"772JT$8U2:^9A+/;K')5$I\::@8TLL^<6+TFF<H+I->
M.+,V90"9>V*L_.>YB;O-+X*SQ@ON7P0#L9^9QH[7_S'A\-\"9L3\O7O@@9":
M$"VOPOAB IQ:P^,>-;)A9L3M/;Q>N7*AER'UP'950C"2O==E8+\X7%,!N:_F
M*G58.H< "FT4]EUK1XPG%'4VB!9N["Z+[KAZ_$?!#U.6'DKME_HA:OO#7N5:
M+_*\R"M*NE7G6V;AQLKO\3^I&Y5^$: 6C(^,@!?S:>$V2C=Y;>*_"*C8R'WE
MS,*V#-;5OVJGLK[]%[7Z_7!)/K;*GW/LPN.TH#BL$&?TBWDP13V3B:F( +=_
M0@*8X<7X/) ,E_5W@K\W#>GK^G"19/8K>$5(FH*[5::.4IE)@G_XW=.8P,3B
M_F=BK_ET=@7M]^]U.:ZF9 ,!*G:E,&1>D8D*8?6>"1]@8DW93#'*UBL0N'D&
M)4^X8IIEN5VDII^K."I3NN,^(-T2"H;^P\".[IQ6+K:TJ3AA@UO-[Y%G4@WM
MBF97EAF@P66CSN;WZIZ,1BWR)YC!^OD('QF>JO!VZ)N3*U9\(2AO#:\57O:B
M[@&W<]21I?,Y2L<(-O1.W_U'7STI[6N>DHUY@Q8CO\<Q[S)8T$I.Z#FXOUZ_
MST>PKO]C!6-H]- #D6[_)IVQ%0]HR:J82,KLL.NFV#7W5&TY5['(LF9):T2)
M#2ZC]2%ZXTKOE+U[A#/ (796K!\,=MW+;R&:-MHDI5UO=3R9,T*HS8-UE:VL
M+"UGF^BF<GV96+0UO#4D/E5)BURO'OGC@-U7#!),?[ 81\DE3GT],W/21B($
M?V@8V8\45JHAR(QAFP(LK>5^7"!_(M%'T70[3/6Y<KF]X2N53-<'(T<2/]66
MN\)F_9/>C0,D?N?$B!,I&O!8X.4Y6I96CHCZ[%$/&=G?!%1".UUWR:P_,C>7
M;_4^/FYFJC5;4IPS+KAE"'0U>TSBMWY7@LTZ"&T[=(I3<XV=K6L]O^,)=J8^
M+/E%X-]&Q5[X-#Z8@*ANC 'EP+[R<KJF]+%W!.QY4\:K55-38'G:[/GWE8%W
MP9[%6VPS6Z5T&R7H25D9^16!Y.9YPH]-7Y?FYC'N7#N!C*OI@R=//6W#]L6]
MX,9S#NNB&7I2L5%#LB6+PX'S!4Q/MGZ84[4>;_XBN$S/<FR]5!!9K]F64UR3
M^*:"6A%>)^RO&0H?>K;S7=('[8DQ2P E":^^=EQ\5V59GA+<?,G64JP!8Y6;
MI'3<3N:^M+196EK(H(JM>]-UU&H=4B6MU.N0&PS-8-M7*E#I?JF_>/Z-8QZ5
M*U!HV/6<:H0O/^!^MTC"LCV@A3<RWJJ%U)651HYFJL"@-VX^'$ &M9;.*Y(&
M>R4?4#8'Q'S\;[R]=52;S;<OSEMO*;1X\2()FE""0Z%OBP8M#L&*$SRXUW M
M@20XQ=U)0M 6=XH7+^[NVOM^O^?:.?><WWW/7>O\/G\]ZYDU:Y[9L_>>S\Q^
M9L^BG2*\]%[36;6Y2WWWCG;XI@X2TX: [^7)EWU65/OF>CVXLRHX\[@>3N/F
M+EKZ*ASHBG+3UF#O$^'EO62DX+7G!0!RNGT30J<< "#AX+CN7W)VZN&T'OIV
M8 UG1TTT[@QS2W8,D3K7-TVYD&%+E:E::T+\_EZT@.8]Y69JU%2\5RU5=8.X
MKP8'?V1KVPO-SDI]:COA1ZEUB:X0P)OX(!:PUYM70;',"8I:&TM[\#O81++-
M>E^OWOZ%<EQ*GJPJG<TEE0BI'MHD#K:I9OIFQM+XT96MU$8)5\?7$JF"E? 1
M!Z6!PV4((@+2Z_(2E5_(CLR4K\%AQ'EE741C4Q0&6*JD@+9+^P)_(=UTV^V9
ME_[!<PRKD)0(V5B%)T(<U8/$>(MHU3^8<8Q\!#!PM"]^@(2W"Y[RU*D7< F
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M\=V%X9X#B?2]N(IZG'MU_L3G/W(0OPQU-H.#DP&B"^0>/^NUBQE# G:[#!E
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ML&:V9A(35=5:M%D^ ?FGI#\PUV2$0(3-A:P(]B YN3@/ ^B"G&5W3IT7BG:
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M2_,7'$WZRIM\J() SA&6^CH]E=6-"!1Y_']C[ZV#XMRC+5'.24A""! @N"5
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M.GYE%%@>[FTPZU(;5J+H,B'%H9(7_*L?'$':)MP'WZBW3ET!IQ1 W27%?%.
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MNJQ$U&TG2I=W(3FM<"LSX][$QL3K[LS8S]JKKC*-N7U'8/<25)*!*4ZI7K3
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M5XNPK.$1&814QF[24/M2?0 OB=&P<6'2)NU#QYEE#1?%)+N*-(JZ$O76Z%!
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M>*"X)# -9R8O4UU3!/+(B +JN.7&\.08%RNG&-5&GR 9@:SPRP51.O%!O(I
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MZJ6H/1N7I"3E%.N&"!E5[".5>PIJ"4:>[I4=8]S8$F(/F)XBNBI4_;P #0*
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MI.[HPQ*]#7S+=VF::9:],]<58,.I>*5S=)(0L,+::=PY2!5<"2 T8'*HHC<
M!\B8XO<]7:W%)MWX03U%$C?)+\0-[Y(UI="H8G9K<GAF?0Q#DBU$3 4\6*[@
MPYER4A%&19=K\HO< +YHS@,J62V2HVS;-\VJ7*J_5[3.N$]V.F;3\JX+&>ZZ
M^$W G;7/"W&Q'O:"ZKR<"%CH3R!)TX<CK]Q)9@1>R7?+^((4XFV5!@0DU?/W
MFC]%FO-0:1[X1',$6>I[</??1D6 W*%7DQQ!*J<^N)04ATL(U82OV%P,PVAI
M]-!"SM0C*Z->HXSD[KX&/JF)II+#^$ =<G4]C!.EM.LG3623C.(/0E_S[_,M
M]8=OW"<UV<J!$AB!<+*EB_FSF/XMK3T*C^E'" $ZD\%'(8T7(<Y/],Y8V9 !
M).OM[F]-GETEI#Y8#53(L'F_\_ZY^[CNQLWP[&I>E4=S''G&8K3(>&G5+Y#H
MH+9K_38-'QM!Q]=[*+_/R']B[[V"VMC:=5WF],09;+ !DTV. I.SF28+$)@,
M$C(F(T" R)EIFYP1($ BF"2BR%$DFYQS%CGG' W&Q_]:^V)5G:J]+_8Y^Z]3
M9SVW?=$]:G1_[_OVZ*\'0%'I-+#$0(:]ID+82/.8+Q-S0JO](_4)P>UA1#XS
MU8'KU*9';[QO<<:R_;FO2 .# OF:+C,FQ^?Z_7?_;Q'[P6M 0<:)S<M?1*;/
MY[=^.B]NM,Q:A.Y[G/B-QI2+9ZSG/&4P_W&^V,QZK;Q'D/6,/..-C"/YR>QI
MCQ]0[ZBT$%Z>M!3'<T]>$G,]K.NR;-:F$7%[OR@!,7\YG)Z9/UK))_TLL(@9
MGQN2F(&/+%H*@ N2-%ZP/3468$2(Z[11]4]%+@ 2-]XX#[2L"!@BZ#/"N-LH
M:Z(3,U5-KW3H$XEM@4[:.NQ9%FYQ*50U(F341RMOKJOS[&C9[]3SITX.QV,M
MQ%9] )]_SV'$D0P#>U3)JS'!=Z37OX@X]RI_ZH3]+#%XA-+\$>AS<F54<OGE
M(N=FY%87U$QVUVDF:_Z2\;O67TJ7ZY:70\L<T_^Y=; <Y>6;:\.2)>>P$N&J
M;_W,$Y8BT45AN>TJ@1-NX4!?]2C0G('*19.\*HF,QGTEY]NLG?K/X3?Y$[)!
MGNC7U#]#K 53FS=@_WD'J2E4>DJ&Y;YB-R)>DW07WW?1?_@N^W9VHREP:EY>
M6^O'6)0U]7@2.1\GL\&?+$P4'3/N D)55ZS;"]X&H:E+ F0='_<78Y[J^>S*
M&U<+QM;PDS+"\E]9LAN]^TRPT!L6G,OBK4\01E)6]9;'/.SAYZJ.MZ;/Q1EG
MP4@!3V+A=2#RZ^H3V\Z.F=G$K8X&+6\3JI-CIP2.L'*',Z=3I $6HQ8T=FVS
M.@92/ZLVN.8?CRGC;=OW;G<)_FFVN-BUK/S?ZPC_'Z'HP6#Q_,8[;(/\&" >
MIH82.H_P]0YZ0.D>');BN* YVB\ZBH).*)"V+JVZ2S0'P&-T!5MC?C\@[YR_
M?U;M3ET;:>)6MK2SG*2DB,>,AW5L7<U<"%6D1<,O89'OBM+3I,8>OOSQ3T7D
MV'F*_M>UK;A8VXZVD0SC=ED3I#55C:9H7X07H-WMZ4E"X/."5WL="MG./AYT
M20Q?"LUS/:R<:UZT#'3"OX?/Q+Y)]1%-3(#15FAQ@31&;O<?]9Z=EEOWNLOA
M)H"*5N$I2&#'27%13J9QTO,J]D'$3+R2ZMS%4H[J@P'[A=J>D!SW4L432([^
M=OJ)#>THK6AN WWXAALX929I%F"[6X++2S(77=]]:OM"122^0M"9Y5T*F\VA
MK6Z:.+4F&4F1VS)88YC,W5PS#0'2BIT8RFXIQ#7F5H>?T:KZA K8[^QEJ@ S
MKUQV-ZIN@7$F[U( M<]S./'!2G^(INE7YG_)XW' &U3S)<(7;-S#5A%O]M]T
MGL#?]@A$:M1SV^;1 +1&FB0F[,(E5;#56<V??_L@T83^A[@C6U9AX3Z8FHVJ
M:N^*%D9-*[&20\I6TR@-_Y>H<A'T-21B8AYOCMY';6DL.I.PF+6YCQYQ'1>=
MR@!'Q26PTLG>.G_?'&$S\RKF$C>DV&8>05W>&_II&R4;SW'Q()P3*8/D(\;T
M5ZLFH*X>?>L0W_F#4!_Z5V4CGA#E3AMS]0+_IU#5XNZ*:YH>/9O=QVI&O  5
M?&--H_<H;QO7PRC6Q0*1).$ZVYB.3RXC<@F9%N54[D50.F5]AM4J=__Y2Y)2
MJ8#J"H>=,7F1#%U7]]YEK YU$>R'9>H'4QU>='3(.K.4RYHVU_C7-*=8M255
M U(.FPGZI^$^0*"M3?.S_ODY4B@&WN!!BVC$O/47^8I.Q-8OD+NPYEZ=';FM
ME,K8'C(4VHP,R?\S<!<O:X&]MAKIK?9JS^5!C$$[0C*S^B@3S?FHM*=2@F?<
MY_.-**)-,^"G"D*1-8OETH $*QJM3VOU%'D?WT49W&L5\]!]8;]Q06'!;EXY
MB"^!![^?]63B8BY>I<K-U9[1@&F))OENTU+>-]X3N\[%^ _#];?6)U,C=%W5
M5*HY7@<U12GEAOADP&IHD^<4\F(R(8YI#%B1=$4U<Y'P3O;I;J^G;!:C4+\.
M)%!-*VT@N:-+%=Q'I[Y)&Z985="U"$C+PW-D2RKM%_W0R?$VQ_(OU)(5U59=
M_MGA5.M 4ZH;],UVHM\!6^U.TFI<"TIHM&,?F$![.L=$62#'D0#C7/X$@F39
M6T2\Y$ET$LFP3$F4Q2/8KKIG%8R@JP&BQ=-,_/7GMX@GQI\Y-;1%59$Z/L\'
MLIJE2%UN-S,H/7AJ=BSVQK(@T@I;M_V>X'J&0]_XZ*QMFA<PS>PH^KEQ36O&
M +U"CHW;#G_QVN4TBUW]<BF#*<3T4.[6 #U"10YY9LF,"Y\X?HEPG3%V$_Q%
M-"0X6@S6C]IK@/0^57(!@]3' =S0>*U'0L7E]GF4(4DB]^W7I+]XL['5,-0R
M5ZTZN*B5Q6+'%\6WI0;.,X5*R%JB&/[,@K[T/DV%M^386=.D?"(,%J+!OXBP
MGE8J[6+&<HY']/)]W&61E]3)O2;1XW53GK@]+#))?9BP0<C=)P 3'XKFH%?Y
M\B@XQ9MTI9!!QV&2$3_</.(+&MJWN>8:]T9W)CPU0G;2?;Z"98)E>:= P<O>
M1O%#;18]Q9\#,Y,GC2;F7URB-'A2_;2M3MEWDF/H26:,XQ-2$JN)'[)6_T2V
M!0A1J7"R@A8UF@P-)GI[BEZ-0#DZ>"?HG]3EYM7J!Z V$>#8-7-C3^J7^&(_
M)50:'\*MI8)CML8,%Y3;3+Y(.<_"\$!;XZV[?Z3IS*7BC621(TG"AO>S$DDW
MKQ!CIOR?J:$29[5G-]Q=&O*Y0UE9RYCD>!-8J?U:87*A0;5]ET^/N$'0RR-<
M4923L%LWG  ^J-DLD30I>?634BC1$%9B8H#D?S' 67"BKL97:-JAW-Q>(6FW
M0["=<9U1?!GVAI4F&5)<^WK>8OB$%@S7R2[PG] CW1AX-=+48!XKL*\U*O-H
M%"14U8>@F2D_<!H0;'6Z#<UW5G&[Y-#A&Z/#?A'02A,TU10:Q*@B<E+BT-J6
MWMD4N:R1NKF2=3TU19UN6;[+S8G%A_Z$N@%7R+-N'(][1DWJ[,U?8WMRK-E6
M&6^'!"0F#3>,<&+'TP;LL_#VM9Z(=T/H>!,Y%5%T##L\1,;.W4$[[T]!2CB/
MT]A)>J6OO\W]$0$2O=]UO-8$8][A?#'C="M&-;K)N\2T@]Z7F^1P[MP[0==F
MA&/G>A#V8H\32:0)C6:5L2[AR@![ 'TQ=T\S"Y;;X8V6,8<IGW7PBG=$Z-HT
MJ4?TV/JT/DS>+F(]N>;=GS)I#/(Q'^2\\0OH6;PV78QH<^?3H*I=.V"NBE8L
MWA;/D/7]7U4<*Q: <7&TN9F<IR28,9V-;M^OWDQ.9Z_7:#XK>,5BX&RU],*R
M@;5^DVVH%?O-:TRK-"*:D;BXCG>/M<9B!!59DY7;&3'G.UF2.'?ICC9/M2]U
MFC'N[S)T/XV<LD1#,0O3=',9XL.K:4_HDK3B^I*8"$\:FOA;RKZ\*M:W=099
M%BNEK>SI-3&O].\>?Z@R6H%S_B(RHM<TXI,1IS4>D>EQM3Y\[%#T<=R+Y"X"
M/F4DTJ564;N[>JT5:(U7RTMA\)&7I6]2U;(V[(C$OVTMLZP%II2Q-O;E@RDM
MN(V!WZ="L\V<H]I1V,',3 O+)U>N3*X<'S%=LQ_F/""C8DD6A,A6[J.;8A\;
M@F4B"CJVK12['2B]<NZ\7R$NWH@&&J2(0A.^^YNV*B #G4 ),R\O034\!P""
M-D1[M.Z)U&4JZS()^;+UX2:C*Y=]J=*%6+RCF)VW?+3-?9?,%-%TI8'M-^3Q
MT*#-.H:O5N-@J]!3 66KDL):MIS>BA\SZIJ?"1I2KW*JV9Z=I+AS[]?E[RN_
MZV0X6P>$X<<S1<7B%DUG*.Y#PPE#72>^X)U2EB[^PIQZTE'DCV@72M>+\TIJ
MX09*/WB@_H)E>PH7Z>L$J#;E^O:\=17T0]D<P]A%6ZG[B,_]*<C%:1:^R?K)
MQ;-3*1+5,7L[H12JVQFL>0"F!Z\M:RY'-GY1P+PD=\=7KEEGQIY@-3J.>9VQ
MJ0Q7_KMR(1( GVNZ2%GI*IDE<\E&U9'F?R^(@*9T1:'M/F"V'11C9A??*?@\
MF;-U%TOI-O@(,@[%]9F&# ?B1RG1'EDU/*T&;1JJ*T'^/)*M09FQ4FAOOI9*
ML>S2'^'[C-?_C"W_QQ^)V^=N<YJO;]DTF[U(-T7(*]S'W4,4W<PUL3/L,@EV
MT5\G6MVT5C:28OG![66<-3NP%6<+.K4RN"6SX$@_M^YDNA9@>@\C[-@SH?P/
MOE51:RBXZG7;QJ:#H[W/^^TW;2(<;F*O-IB""-LE7I],\7&H;Y%W4ECOQ 2I
MO]'2A;,+\AKI+(_AK#R2UH!NY#@KA+H'D6P;>^JZ+T(]L<.S$)D+S]^5TA'8
M2_ISPE@2<,<5$&JKE+%^KB9N8'B.$S4-L7SICABH)05$V5T(U[KIDS$(9S Y
M5.S:+4\ (P:>-9K3(+QM4X!I1ZZB/3-4ZK5*"WNB:MBIX9K+8L+@R'TWGGO?
MG*X]/ <73_Z<L)=HW%&W&?ZH&1:R+0H/-!Z*I^"&YWN>#F]DAIAU[MTWK$UL
M2LFCU^,W]7#H3VC6UESB0V3 ;]Y5@U=$%0LEV7+ \;%RQ58H^@,_[+2#.8(\
M7;H@/GN\L[*[P-ZJW+"=0/V,*; 8K59:5P'DLA4J6:7",0]H('0C8!Z#Z:1(
M/-C7,<<N8/I 2L=(/F;XT-Q-MTI7MXQY8FQT;&*WQ.M^!19;\41=KJ2X)+"5
MVC3X?7 *[)$<.9"9R9(_X69#F^ P!YE2 +-L>&YUQM@>%FL.=B; 2O*N94Z4
MCQZD2E-1#?@^6'9,V SR?;;.!LWX(LVQU#T?UW\B<=#EF-2%T7Q<H^U6J%[;
MH:HU,P.WNR%>.P(U;I&BYB60VZC@K8LT"XUO_CC"[0OUHT:E[=X>C2Y_D NJ
M[B>;[_JWV#,EU"K[<DVU\!=!(:!3G5;X*))W;I,-*#KEVW\O/O^_A (X9U=*
MO!%' +;_%Q%.Y1<1=[E_-=]Q2%*OW^G$?_;=R%VJM)P0(OSZN-X27!"\W2VZ
M29N,*^V?'95WCVY[;V'HQT(*]O^F2$/TO_$E?/8-;A;LEF8S<%3P?%?D\4O1
M%;4($>,.![W'W)Y*5@HYF<J/%WC\1T+&5>'MY& 7)%(MM-^R/D/W#GL.#;[E
MV2>[764S_$5TVQ&,8N.CUS8Q/9:]MPHVQ?[HJ@/EQD]C+?-J7QQU6DB><#FN
MJ@61TP[6Y5DT15D>91L:O"!/7:?ID4FA3>K5UDY$#Q@9*U'=2_E=YVUAT%6P
MEWGF[=/OIHB9=+6?H!MM=YZ"";;+"CV3QZ(4T7'HOONS,9K9*?1I!&R6HCGU
M4P]:HSC&U^@XRFCC6A+EMIB'31JR16U%9B=<RNHE'?+1&8Y[*6Q-SY$YO,"Y
ME=D;T%6,XBT+@M!8B9,!_7,18W/VR%Z3US79']"!)_!/,?]UHI@PL_LN18S=
MSEX^.O%DQK+C!-G<>W&/)V+G,+=#1/6(__&(QLKHE5%;VT;*W!0$>I]8<N^H
MY=[HHML( ":H?#SGG_$RJZ"S_(IW<G3D6Y21$?'GMP[2*KA<+-)6"SV/4$C7
MGLP6J:L4X1Q0LO*DC4^<:8AWP[A99$WD&]72ZB<".K3X5D0:O*8[%B!?ZXGU
M)101<7.)G2+<]% *UUT[*B],:$_LZGN>F3BV-2&*C@(K%4%5M01?<035-:@;
MW-EIP)K]6 8P8KMJQ2]3Z7P!Y01'YKK8"@-%STN(YT0T@2X@_]D@8U\[;>$A
MUKXJO!H)Y.^R+AKG7GWV]0@5#)\@ ^L++0C'/-CDDVPY"3G0#C8(+$KM,8-_
MK.1R1?$IB4>!9&AU[\ T)5%6M,0!@CU?<6;[&IZBA:FN=5-JAQXZV#2NXTT(
M=%]KIM69- 7F4&!%'5@S.:^GFVJD]9I9=:S'DD#U<: ,C2"X*=BJ@1AYD19V
MCOF9UG19"!_#"-0JS,[M2H3ZT>;%)GTJ&V:L^1R0QD C>FL<DE<U4+=6!^BX
M*]WY3&WW7G!M2!=LE0I?UU+"H_7U*ZPQ2FNND.GFA#C1V4FMZ74FU74<3%DB
M_>W\5M>3D-M 3\_M3)VZ1FMJ40./9Q+FB(SB0;QXX<[NO-^ 6DNVP_F#O[K.
M^9\UMCI[=K!G7=!DXW.0$E?.Y!9[4J_LP+H@T">NAVZY3CL MJXPZKB5O0_I
M##M-CNL<MTF! RM.%\?N;"'XHD=\&NP-16"FWCZE6MJJV\/>/0:28'D#NH7(
M3L68R>[:_+H"+PN[DEY.,]QV&:U+;!" ] C^C%RW;0?\R)([FO^/%*.M4A%J
MA)A2!HVO;&_^E[Y[:(OIZ S2U*_-.]P%)5P NPP=4=&D@&N+Z?Y6#\=+=Z\7
MC:AD,]1.=[:F;W__=;)M^^9@S'?9=Q6Z08S/IJ@8<@-/U(!3>:J+;@#&H'Z+
M_4/ -AM5<'S#G*/F%\N6P W#FL2=@Y5*;GK%.47(J^A'$=U<5ZBX3%)D7A\;
MYX@02^C-P=M>+QME:>W0=&0"QJ+M*>^U:XF94QVM=ODG'X/<D[R.A1MP'8&/
M=^FX/NUJI5(X,^1+,?RX6<(/O>V=CZHG>B6G0O1J4]>ECUZJ,RY6;ZG>*K,'
MFOH[[!"95A_.0'(+ $"$RP2#%+DQ)V)0@LUV[8A-/+U4UZ!M)NH&0Y[ZL0#<
M,^(18?R!W1 "904,[N*X* P6#\G(ZKF\]^N>5A3NU?PL%)\'D6@7%A8E!EG6
M"%%J HT+7-C[-63)*A&7)*RHX<]JL'=4%-3H:*U_#*4I\DC3YW(Y]"^RFGL>
M#U@F;Q@D#N*\GT?:H/HQ!S476CTUV^D.:G]G&IG_(N+8!_8A>*3NU>CI_%90
M'<GF@<Y7$<QZ;D@$X2^V EXEQU3+3LIX'0L;T?Y)V[SHRG\ZJ]^FSSGDJNXK
M3GCH:1GPM&_4VT-+<.[N$)RH!=J[2B:I1P/$3O#-<QM<SE7J=(_/MS>L\R5H
MK@L6<]E-&\71&'M4'J/'NQVWXNX&>ZCN#L_O"\U<B6_7AP</.4==8:Z>3E57
M/D$#/I84!$A4-2),'@OD-L]=TM<1T 2H7V_!D2^X675-KK6\6L"4O8DT[K0G
M@H%EM#!>8++%G N)'?3+TDIZ/6K\I2Y:]H]_OD0_YO-@G)>AN'G[%Q+ D;B1
MDMLAW8NHM91Y'HUVUC/ $_S:O*O&U-Y$L731=KZQM=I9<AZ]G7D"SC&"@-A'
M9S=GAUPNC)Q1">>R8 +L I?YD!EH6OX*,UV4QK9IL )M#R-]\2#D.WC+Z3C'
MTY.PZACTBXC5Q>>1ZI<_[<>5XD3>KP 3DIT(8I9]NN[ZVTKA(V[&L=?9L8%W
MA9&A6N'%2!QW7YA,<KT6'J!F])RVL.?<PXEO)=;FXKA8^.55!2XG=]>8D=V_
MMQ5:\,[F6ETAW]@F;E6(J(Y,? >5]RR&%6E<H 1Q?/)YUJ7%5B=1!*BETS;/
M)-$QYV"Q3.L).0[D*2$OPHFCHI3D9QTR=PX2QM^-/2UU_%' '.ZO-O1W3[;I
M#!WCGY[PJWY5J6#KL6J*WNZA8S]GB8OQ/M\2+B,RI\R4Z=85BV/*0P)!:[0&
MA49H[1Y0&8ERT'[YW/JA[</6W)F:E6KB:N%$&WA+0O2R*D9Z@O=2)7/I:A\7
M,?2NN03C/LY#\7Z4<V.R.WA_OM$0R3Q64\*'UE_.F6@KZ/HG+\&L>+EXWB,'
M6>@Z8E"JO<Q]>/\)662[830#  \44U;,U2[]$GA9!AJU?9OP+2SH0%:M<MQP
M(O/-ZXWQ1*Y*A^WD?318HF\OV(XW-Q-PI%OGG+;9'$Y@0TXV\UM.^ZJGS1%W
MVS=) 4;3#B@6;/9#!HX-.8NH<1B,FAQ:KS3@4_..0Z,Q1VFASZ?>ZDN*JM'Y
M)Z.-)]_[<0GCBY82;))<A=RV:SAB >SB7OWS&6/4$ 8RFFX)^#K5+3<.TW()
M_D;X;FR8:MD-2./BT%\\69%<%9*:24P*["N><_"FR\E'+B]CTT5'*C&.PU=X
MLKPH<[6$@6A%F("!!"C5WZ@SSF87H*Q@>'\7+K.T<]6?6U,/!.)^*SR7& E;
M=-<J@^ O(F#AK*Y:_?Q!)7_B^BY?FZL>;G*78_[ @XJP+"T52?C)UVQ&HB?#
MA([$QG7EKM0_GM'I"3S=ML<:#, K.>@+*]4X.8!O9ZIK0LA5A9TI!N_12E/,
MYV()D\U#?G16*?#&WLXV'[%LK.#*JF;==4H.7JR IJ!*>/HCS4!>BOJ M(2S
MO:TSG3^M^S%L[6V%1(E<A=J 'B@_V9<1$=3<G]RG51IKZS0L>-7XEE8X]Y:M
MN^@L6U/19Q?J4Y7]YA6=OA"K)DE,M5@03C<[ET]21M=[6W>*,IY_ [-0V@W+
M&=UBH,)8S53'JT7\J;4JF 11WRU@Y8;$,9<8WSPJ![9J4V_$=G'VJ+D@C8-F
M9WO9''P\9UHI]9LD3:85SV_OQ#[NK]<<&+?+F%#)'8Q![,(3#E)=;&_D&CM/
MV$5<#$>ZN&UU4,D7PGO8394OEIQSB/XO++&CZ:8$,PAV]2F;W8;Q6T0;1VCL
MO'J?<%"WFS'_VKG8W IT4.SBL=%;H//$0D/T;;7=J]WLD]SY%6.:A33M>TDF
M#1'F!A)/7AIX"4V\F0+@GSK3%/,#7@:QR408/6*85<]UKD.J;<6]:@5_KD>\
MZU$4PVVI-0/YC=WAJCN1V)4BE<+:!05!!U/P6&G*.!V*X9^=#F*0R$MO[F[G
M,GNL[B9&H3Y^31V]*MQC60N-$QY%#=NJOI_U*T])3ES_J4-L2?#85P5-W%HN
MK+ZNKS7I+W^\YS25_; S3%P53R@:F1=U^=NM3Z_L*0O56&,+'-S&UNA7I=O:
MDMM6P<K4_21V)QD:^(0F=,NT.W";K>L%$Q"L,M$#3"(V+Z^3%KD9;;$CLZT8
M4V8KK1N[N0\!] LDVTN_F3I*6A@,'+<LPJ-O6&,C'W$)4-;"B"EKEO3%+7M[
MZ8( HB_%N"PRO)$'DG3J1@,UMO;SEBIN\+<S7-*KI%RL%KXO#0RE=8^2$J=A
M8/2JL2)*EMB1,=B=S\9[;,4WP/3R85*7X9Q&7Z641$AX=V67]2D"EVK+NBO-
MPQ9$W<'-B@4L5RD;??PNG6TQSYXC,LB9"@,* 7M*I$GA,$ AR'8)>>142N4:
M##9*E_?K,VW0_%#[B(^$1V=E>55I?A4R/ [5@(MX0VH;BGBVP]00>\6.T+AP
M/7PV*Q^T^HMN8B0=YP%G:(]V%LW5^<M$)^#*@:7HFU]$M"_\./G^:A8ZY&[Y
ME%)D=,!#=?S&$R85$]02WG 0H1Q$ Z^3>3PU@TX^(]CR]NDX'NP4%/.=&-L]
MPR=&EL.XXF&N;H++!H4O]*KLJP@/16B5>S0!,&7.[HHZ.JM'IMO4<G,O8!QL
M8$23Y$+E@Y3UF81R!YVHOBG6>.?(#P.>B12<U;3[M?LZ4^U3RX8,7[=$@>2\
M]S/-1X4N-[AQ-3Q+B@HV8S@;JZD2M9C,8&V-1L):2.I;U@0W)2KZX.]PC?.(
M$?CVS%3NL>3/S\JH52%ZC*>O!HTM=QP!)\R&PQ8ME\2S'Q@X)GI?APH1UY,5
M"CVF:.*G:O+[@LCA6LO)'3>D-:F\XNM#*W,!U[F2GH<\XEE#4SDFK>9^;H"Z
MY^+\$N<5%^Q0\H+EE7JTQV-4%XR(J^K+AY/?!:&]>S]6>K/:[E>5=;#WBFU.
MJ(6)=E&EO49J8:JRNVWCV7D?E69CV%*H"VQ8V3:\@)HLLMX+]X0_)U@EME?)
M@#QHO*=.U,--#S;JZ>8XX V ;8T2?GQ.M>S:2*666%L!=82E3A[&N9M7T&.D
M1UG6VMK1Z,/.T!?-?EM2$?W5X>[N:UMG!=:<B,**G13S!:V0ZN/2Q?#:!6 +
M[14U*OK(K/16G8]2X]"OJN$L?&19R6+8[V$?=T4?"#Y)$+^<K0^@1RS+F8):
MC+[H2R=6K;O91=:MR:/RP]F?3O\,"P:U,SF<EM0U&#L(CN-XV<GLE\W[.#KO
MZ-]R4\VX0[VITF49QLLKP%1_49$O360KX22AD("!'ML%!% /M3U(D86/1T\O
MKHS:&?46'!=!>+69G1]JML;F]!1_$>EQV4UVLQ7U9)+>9$THN6_Z3^M,:K;_
M^:Y3I"44->HM=?O4JFY.L4[SB5D' 9G 594UIS^*K4H#K[!HRFV?;RI4DU=*
M17R=3?&>,ZPLRIN0^6+U/)&;.$)Z;)W&EG/-G1<[GH![HJ.1-WLDG,)(/K3*
M\;ECVAVZBRA![RN#C^*,\=31]UZ6/R%Q![*CIY'#-U7L_$ WI3$=4TA/]1CO
M+R*028$W+30B34>E0"_#$JLZ,)O88R6Y(?0R.TZR1,[K,8+M1Z,"Y$5(-'TN
M;6Q=!G)7XUK\N]EF1&3J/K1J51-5 #Y&7*K_-CC#_R??&?PW_S=(:P'].PN7
M> UOQW-YEY^,- ^ >/3^)TOQ=(&<Y L8!WT B)M;>'#AI))ND)>V<=R8E*3(
MBZ^LTB5A)$'MO@4 T(GH3$@^B)L5XYHKUK.QR'XU6Y4MIKK+MKD>?UKWB^@'
M5,KV1S35+Z*A?[CA'U:X[$T];RT#O.W/*K'F'Y;,:?NW*6?T,[;2^.+-S\$@
M?AW7>L]X]5YL=T6*D !WZB"]5?5.5.7QDL44DE :BV(1[)NT@W?DS]N$_[9C
MG4@>L'M2>TWOT8J7AOP72_%)>.AL;V;OT>X/^[Q7C9]MU&?M0QC+H^!J=B0:
M3)UCW/A>%DU16]50U.<5);D4PP.O::5=Q/SAWJ8C)*_K!;F4=U.>\&4*L2XU
M9Q(MW1#/P%Z 5KG2&L>GQE2(='YY*5L!)WB,+B'G]40/SU:?+5<R)G8:$U9K
M7CZ\\^FZ3Y9@WB1[4Q^P+/2N(VVQ5W;]F\71+Z*X#XQ!R$^G(BV\ $* /MYQ
M4YZ&OMBWY8\QJFN1RT73M)#6K:XTP7G.EEG+4:Z?WK6(VU]$.P_+,_K\+BQQ
M=QJRWLU_3C,*UOXBRM+[1>02<V<;!^YZ]D]UQ\^AD#VJ BKBE!%#@0V+O83K
MM,493(G)5)&.;#))>401(TNK^7% @HG/A9'=L6$-<T9.2\Z#;!9K\75[OW,"
MS!^6</%G:1F.-.VS.;JC\%(+2]=I6)GYS=YTD->[<%11:H106^U>F-E#-I"-
MTN! 2FJ\-^'$V5)97DOF=N673"@/&LQM[%339,#\2/SH?L]SR$8'JO&=-X:Y
M::.@/-ER$&I!Z>WV"?P1C\!2B&CV.=[>=?&FZ(?Q_7:=M8SPQ-%MB_G7X3\_
M"$ \<F;H&<5YX% N<=%%UQ<??@!K,6&[Q)..Q6*O!H5J!E@Z]=1R:)39-;B\
M/".2*<N6EJNO[[\C1Y?C3]T56>NCL/+;/$8/U^LY<!W"1:*ZE3R@.H*N2LE%
MCZ&WQFE-%(T07W<<B\OL_;:G;V;GO2[3)HRU:E(LL3UJ;E/Z6:K:2"&MC#]?
M9I\D^9;R(V^ZW/);WFQ"+@=YMX!SI+$'$+#'2.V\;.WX?+6=_CN[(DGD))6)
MX";["$BA.^,H.KNOSR:;KH'KE:@FLCO>@V%'R)K\CP%OUBI%!<_#_NH&>%Y5
M-34ME3EGOFQ"H_6#:QR4%<U2 6K?K8EQD)7Z.CKP9FZ2)U E;[RX=^J[N#M_
M 5A'C%./_H,BC*LBO]/6><Y'NHH#SBY+PZ-=E"6XTV(IAUGI'X<R8 4HY[OS
M&!/"I*Y'TG@Q.A-I^:8-(@32VFULBZ5D7/[5@D]!/67<[XR?O73E_\<G,=%.
M;/H'ZTA05=<$RN(Z-?29$ U=WF+$XQ(M-35B9C&9A;,Q"&=><#5GSZ J^O'&
MV=^N(@X/<J; 3M<QR]<:+ZK":;?TP?4E-=5".^4$:>_" ?C\1[PY H!B7L=_
M<7>"_J-(K W.UDF+EXI-J.H/?_\%<T!Q,!]5-W%;\I=[X4Y[T!+-LP+G\H>"
MS/R/1J5[E00@2LE1O>&-CB05SB@220Y9RB?.U.(@,;ITMYHPA70P,IW=($;N
MZ-7T-KKTB>2[CD])4D^;K=)T[[MC&FXZI]=F#0]8J I3>-(\K[=>SMH9"59'
MFVK0N=_0*)Y5.P\'XGP/B6G".%GGIL<77<L[=F,"ZQ^6@.E59<6#@LW/^@X_
MU5## GG>C"F/!T/D571&77G4+'H\1S\#:2M8)6LI2[.J\\=]U?L[$H=0_;B,
M'N5&RQ;,(]3B:IH0Q#HOSY50,E0.^K9B!)8@+4K_&O(5'9&F9#-.")6W,-*@
M C=K]ZA<I(H[1W'SP?VUZ!&,<?[/ O=@VXIW_0MQFCL\#3$;]]XKCM_)'PHQ
M.I[$W:P?I0FVMO?1XYO^")B^+M>L!]6>AJ"?])G$F_0%=IK)\MXR_BF@.6AT
MU[Z__8MHON\7$:4W*54 ^R^BI(=M=T:>_O?=_GXBQ.XA? 8-L')4-CFGF)4]
M_2.O]0<CDT=<6/TUT._T"D3QNSY-I_U'?5H9>M<%:8D/Z L\#+FM.+I]NO,/
MI97Z 6P+__L"HUMV>*H"-NYI!IV]E3MD>>%R@KS9/(KM.$W!L[LI!X !6/S/
MFGYO=U@I 6[-6H+!)D8K@FJPVZ(::SP\H9[C7@_54/4U5"ZZ88D3^XVC>\SJ
MZ7TJ<<++97B/KVN%U5G--#M?G%"!@U68'=I^\ Z!IF<;7MX?'MP*55PG/G?M
MC2B$@"^G*/TLJ_6^"&P:&,HA9S%>21CY*!Q[(FMD9%"!OU737_/^&Q?5'NOW
MYZIO#%Q5>WI&>*V]JH<JC+7Q&^HLFN9Y++F%93&@> 76O-BZ"[*U+K=*8<#C
M=VC-A-EQIU5J&R2(\L=6U/6X9+:0=AFTR36^M]-975:@$M=A4ZL)-=(+_F":
M1,F?1:(;99J;%V,2"C9[UN.&S87*Q1C^U!;O087!,2658*HTF(PB;DX8C&MZ
M%MK\K9Y7(\4AP61?</OE71.D[B[@_"_#H?7F&\')7T0<C$TF?]@_2X'\(AKA
M_D54W_6+2$0%9Q[R#;QRM]EV\60\XG/_?]7D_V4WA^<V0YY7E/JWP_&@!!]I
M"M=]WJ$+$1GE6##([R'?.Q]7%B;[B?V8_*P=JA$)#7G6H].0QVE>VANO;\;N
ME[L?.$FYKL%_$54I&P[&_?-O,1W_@5AM]F3:S(]E:RO0L5G,7_C86I JD.FZ
M1GBB7U0!*0B)KF8:8S;X<RU3N2N,C(%6&AE-HAPTX$N"!,Q\07W<_$[KV#FZ
MR5ZG$+;U/SD)8Z#PF-5R#0&.&70I03]/P)2</%\47\X)G=QDJLH+.W[[B/GG
MWP4=9#?W8O^/#?R_^7^0AX';_8M"M(^VUJ8 P-Q&JVS]<\JT^1?#X\P*^K@G
M6B(T=+W9/=R&"2&$. Y-A%EYMPIJK+B@MUUXV<FU[JP>D'RI.LE4BT  V*-O
M)_RPRH1?1$I^#A4$?:RH6T/JR8VN/6MC&VA:*&^ZN,#S/EI'<M?*ZJ=S<EY%
M4UBOD!8'D\GPZC?\3!3+!Z%F;KWZRF]QEB.Z-2)='@3[MMJ@&A)7 H-W($H$
M)^D8M\PW))KLM_/$ZVC\@A_U32'Y9#6QF3Y!*<3ND1JL/<M8=-S&@/1!.VK4
M9O^1/4@M+(W/.RV/.CAZ1RD@!Q_R?O^^#U8"JYEWG4O;)U^B:VGH-S[G?U>O
M*6P+.PF#?=AYU$Z=:9&NK=[=W?%E)#/%=:>PFBKP.MUG2<(-_7/D.@6*<]3C
M@H2//(RG1QX^[G&8,,-W1'WS6A$O-V^M< ^?Y:5,4$7T3"*!#WK\+!%FX!6C
ME<Q,8^C&!T-C2F7=9[_UAT#_/_3G$9J4]^#N7XW[]SA";L./;GD3GJ7@KDT=
M"#^JQP(D7PWOFZ]?D2:W])0VWSS=>TNE)+V-^BU_8WQQFKL3#3&;OXC>*T;>
M00XK 8XGB)N)(\IOUXDM/\E+;U(#3G7#)\5]B4OX#WQE/S:IU/$.1G@=<>AI
M8(RL'T/AB?;USWGM\KJ\Z;9>9#;6G2R#PIA(NB/X>(/'0VC!VE4 ]D0R:NJG
M7BE2M'?6;]\9<62W.%U5:N8:"!.&^RH>'=?;HU.*>UREWNT6FHB.;C<G=">&
M#0!I8A-XT(*J"185H(D8Y,UZ,,#7]8H30G,R(%Q5<\ECL<:.+6D=4&>SF,U0
M?QC=J\/E-%KQK@[DK'+%2"KM^;BC0@^&2&-KB)MCR'.HA+JI(6BZ_'B8QZ'@
M?C[!V\\682ZY2I^+N-2@_E)*&&H="X.5Z6I3(8C>PU2=]W99E?3-#^&L^B0U
M.^<IK@EZE#D?#C?L8'?$5':T-1,J$WI=!9?HWW$[[]+#JF:^5HDX?'M2+&[E
M7 6NE/?10")V0_20<UA%O5;;N-FH4YEYI8-S\9%UA$.Y\8.^ZXT4 25">F_9
MBNY;,>^I_&M!9*VG(9G9%0 .IJ"/=JIW&NHC=NE;8V2S&$'P&1#S-SUZRGRM
MV:A=E#UU\F/Z\OP;0?ET).B)YVWN(C_;B8GG03S5!EU>Z:#$]MC<ATX1><J9
MFF$&W-A/1?Q8H9_JN)]CU=>\GA).VPH?"+Z73EZSH,(0Y;EFQY'U7H:Y<]""
M*QQ6H%[[+,6/5#J<RD&\*3G)TT<@P7TS)Y(T:-]_2VB<A'-\US_QQ5@JQD<R
MHGCF+2QYLP']_:""+H"U:U\U)9RJS!X50Q?_925Q9$W=<[,U>8VK%^7X%FE\
M/V7/ 36/]PU(U,:M^Q=E70OS/OEDT2*"H>@VA:PXGAFT-06?"MGM\>^ZHEWT
M3E^75K"  N]@I'INOE=#K*B^?&'I)/+X=R?(=(J @H.7-!TR-,"PX?UC>P,(
M]OMWT6/\?)FM8B/GGASNVUF;8=7HR07OJ[5QP^)O;?F.:356317"54-B+U-V
MG+7.Q*G<.)L>947BYL 6*=6H";?+1'==U#%-AA["1+!D\,F:57_OS<,#!0S9
M"C!7:3QTB.OQDH7O4W=)#F6]XFVOQ9(1EZAPAU5C]Z:TUG(K_12K22>$C]V?
M<C'\8PT/-(8TA6PJC*+(>>NN-9CX6*MI037JS:N1.!+\6%16JYH5B-H3J,&M
MIL-W[U3 S?O/K<N!K\@UC'X<W-7#()^IQ ,@]%4S+'DYQ3?Y'-NK(3"A4I*M
M-A0?[3*/'@4!3A4<#,K.LZ8HJY2@)R>?ERHD_?$.(F ,6-)0;")U]02">;^
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MB6#!]VP865 ?H-O0A49/.YF#(SP/N]5Z6?WN:7OW]/"'%PY>3-3R[])J92I
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M^TWNTFS54HV-/=I2"H%G]_]MK!Q*_>0B+%?^].3$Z"?E0?**65_,[UR6'J?
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M:/&L&DX/27X)-<K&&P_F)T?(?X0:(^W0 ?%/'&;!51CBL:"0"!)P=\;X]0Z
MU@C,$#.R3MWS\7T$-#-0&R<3*LFEC:,"KBXI'4KPLS\[3H.F^:Q:ZA="]%/^
M>D;/ H#!W4+"Z85%3]64))]BY%/]^UJCC62>]2$G,FCRL1CD>O'6P]M%O\<
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M&Q-9+\?8IRXTR+[)M%_(RLT!:6I28Q4*U859+M)FV74_=R$FSI<=QO4]ZX@
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M<B7"+&Q9P40X,896EH:8$Z,2WYIX0Y 7ERHVTFU"?R_O0'R/VHU9"P33S3:
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MH(:!B5YJA#EUGL6#IK%GX+T<DGEQ"8MD1S%O %NHO=GAJOV,^:;= TZO>[-
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M"$O3WDBL;%Y7^8^8D.[.,MC7'(E<3I+$N ?A'D+W?IJR\0'C'.*FA2.$"[0
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M"),P9= A6,JH.8AT7S9?E@HSL.&S]^44S*?IEYJ'^+2]1]3.$<%[M4P^FH;
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MFC,?)AM6%PHHT[J8C]NCLP2Y)04A("X(5*VM]^RM2N+KVV?6H$:I(Z5HVX,
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M\MXU,C\O\<&4!HE?LTXA^SHB(W-\XB8 _'!I3W?OPF:,_:KM!X"TS9*99'6
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M8P8058Q#X!ECQ:::$"<C$?E0VRRI1MK)I=9(2F[%C"Z.'C3MZ0BX@T7;!]H
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M9HJ<][6>YS5,@#A4DB545'$ SLJ6^D,YCN/=I$,$86/^!>CF:^D]K]+&W*'
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MZLY)(9\C8_?:H*NNU[=UHG:/?7J+RI0;]<I*YDLQ XLP0B;NM$*NEV,&;S@
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MZXYKGD!S5I50.2#)/[&H^!#,=$6(CX\$\S20O*;ZJ-7"29UXDS ?\E:P*$%
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MO#; '5\]4*?9C(GGTR=(%-4A$^D&>[(=,A0/8T:XU"_#9$"X%LR]/R8E/5P
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M+?Q-E;)QTX$^]4%!1?9&DL+,/EFQ<>H)K?,Z&%Z/U"&O\U5.44,\^CN*.Y6
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MQ4Q3^\WE.V* ,$=))K<-X2*HH@'9)J=D5@:1W#M,SKHE\<U4&B=]7>""QK%
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M:W4&%299?;[ASL,)>$,*NU+&ZC&E.41;J\F^R"??@G%Q7;O/!9^1_M1P1CO
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MOJSU2"D^Q21U8V4JZ:>AH->HP<K3LQZGE2]FTW,GLPH)8UB$U>*3HJNUF4\
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M_*O A4KX3D@$0**2_%B\1P1HT%8EPM.!VJD6V^?1R\)68PEKTWK([J^?)MT
M/INUBO)S, ^3&X<M18.6!YYO0<T6AA[EYYH7+7$B]I3L']7T>%*_E-*=6WN:
M:1_Z:V$;&A4)M]O=V2QC4*7CR5@6;+N@<?<7]H( Z><P^83$N<VK[VSOA<7N
M$*SB=EK;N,*2 9*):]P)CT5[W#P]Z657+"E9K%Z=J>QBD-!U"8F&:0-F#+7
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MUS-PS3VL2@)_@7A"-%">:^9>+#"_5JN<S0S.-UV<FPQ[7IJYZ&<38BS\32+
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MYT K-!!%YFT,'MDS;I#<Z*J.$0PY-UY1BV#?\8,/!C6.<VO&S^>E")I&_4N
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M>IP4WQK&+Y:%4L-4\7W:JY:0PE1GB'T/CTS+1I3FP'](E.;8N2\=C3P<Y-C
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M4?)R3M0E.'+TI6Z2#V3V1)M&+S(LVB^S.Y78@R7!PC],U#F(CO^_BJ5_ 87
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MN*OOD^FW 02%K/,['Q8DV*[A<9X<J*.X4F-;J&H$]ZV+HB9?6C3%1Y?Z4XR
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MH#KB& "_=<Z 9GI<%C9YNI_+7X<'+<]WAB(+0D<3[H:QY9*S7<@H\?CQ>0Q
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M& 7Y-CNUBK@C0&H%E7:?P@2$J@M.G?6YI&$^HMIQG+0Z>JYPMS:=$^JR"MJ
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M&<W(I:] X(=/PK7..*91\MEN8A@1U$X*S]>*OL=\LU^BVP>>N.L4M0EA=:G
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M^_4HUB-D0S?R I?NME=W495V<GO:>=EG4T9,&JLI_ _VWC.JJ>W?^V7;E:*
M@%2EA!Z0T*N;3A)"":&%ID" $ (D$#JX+?0>('20$GJ1DM $&[U*[RB]JR @
MB.C=^YS[C'O.?7'N>,:]Y_F/>R^?5WGQS6?,K#7GROS-M<9<CA^?2^R2@=NT
MZ**X/. ZRT#QS#WB4X%4QQ+C?Y;RD[K^TU(^C4RU7V9?AQPE3C>21\:M %$K
M'*<:;2^AMFQLW[':=+=7/V6"+C=>EP?J"L7RZH5XE9C 1.K)D^E;\S<2GF5^
M9JPIFQ68K$0/1P,_.*=KS67:>.3_V==G8&^N&\_ FNUSH["C<YM?9D1 -FG2
MO"T2V*YKE!#:*=,*#%K\.NKZ"F"*ER*].Q%BV%A;@'@'G%7>'BOG<X"!RFW-
M5+T>[B=T7DTV],Q$WL4-BD3&?.R1.0*7C/0KZDY?[=8DF@5ICZH/S 9"T1AQ
MA./L0 9"CU!LY.CHF$)=QAA>Y.=?2LE#/SA[QFM$N2<O.;M VQA"Y&JXT%6S
M0>! /^\J;AI;ZEQ*4;D^(EI:EMWX/.Z=)DPS.Y!H0;$!P)@EQ1)Y#]@K!1</
MR([6I0K(\HF>Z2Y<1>"MXF?Q]O4$BU46#'W7$V/H!5FLMPY2PTK332MB5I^J
M]9P1Q[<4I%10XSX;8%NW&V= <Z'D[!Z]TN!70LU-N66H<ME5L 2OGG']+[98
MM??/4QC9J=\D "X/7A26Q#2':2134DEM&D*C#QGDUH8.8+!*!H%2R4Q97JU:
M(8[^6IUL]0S];M)LB4Q)6Z1P3'R9YBL"Z_<0*_E;/B)_76&8VQJ)I;K3312^
MB-<BF%YR!8$YLMYZ&#U/3$_$DRB,C,',TI\4 N(^G&#:HFJQD3=L5XZ.]2 D
M5.4,HDX@L:0'N(Z (F,B8DZ$-?3[?],814<445*33FZ^0FY;OTZ$/3HE;=V<
MR6XL.63%G4#;S#4+A/9?OWTPIOAQ)O3E)C=J_$M"WY]1H>E?:W./'/C__O[L
M;YJKW5Q<E:B'S8I26_I)OAQ8CA^UP(J "5#@L;Z^1S8J.D,?W_LN_TV&](J$
MMMN1T:E@/@B[ G"T+BSL*R2D^GJKDS)8:$&TS8ZB#Z4]&DXGEO/D2*;-*28@
M8T:O^#_)*<_Z*^,*%MN'.;1_4H1^F>M[)^(<0CDIPQFG0V[?#3D)'4!&=^D)
M_L)?S_3+Y5J3BX9_7<J*%+/[U1OCQ:VM_!J8\6UDM5P:=Z;\QCNJ##FEJD[)
M37 <J!LSJ5<@;@]2+R5)2WX+I-W<"!8@2LM.$O2C2ZH$CAF.^,TI[2$!BH>!
M'ASJ#<+W]^<1HZ],I'OQ%:F\W1@)T(TI-K<DZ: _C,:.[((*Y8;'1^5.KX$@
M8"9ZM(2$"$2[,'2JU^1#-OW^B1W6=W2!]%.R='N98FQH'Z1?B:6:F#_]PM0E
M/=KBY[4A(OO+5CO*TK@MDN4;;M59[.73=G,DCHIZFP3?T[5DBFRP@B?]&+\1
M!!@7NZ'J#6P3)6D;4K;:6'*."0Q504Z%D]/N# B182[)J<+VS+3Z?BJW0#I[
MWE&VL5AY^W%:X6%JS<^,+ZSI/?<KK"3:@9[B3XET/S6VTN="@F_*3GTP-]K!
M1QE-:9F@C#Z\%[#NJ74Q$4S.H!<D@DHLBT;+)C!'3]TF-8^6'_LG;\[#WM72
M=NN:E>M'S9LSB8FRGL)SRTM^T\C'1 R3N^-&YN$]79,# K&#8'9V@;B1)A%1
M59VQ.(.__GAW*'2B/-3V;C_WD^+[9RF5OKUYV*O[^1\,FTF\/\7?_-T%Z_[N
M@E;MIN)_7C1N6"DIG9%HR*I76K;5?PMA&HD4$X'TB#!?=W)RM!XU@5'$VR)?
MQ$1X'G+O_JPW+W# -G[>E9$%YKD+UPDTHC40%&:LJ:725C]1QS$L0[U4]X")
M**V6=P-C2?!: <U<*'4T%7/Y34,:3#T;JWA]5'494-&:N_+1CU)29LEB.KIK
MW.WS^)5*JF!OR>I<3V<=W2QWOR@)]KZFOJ0I7:IXIYS+;^R=73"#]"-&ZRHG
M:!!Q_7J#_SMR:6JLR+N(E^Y$C[ON 1_&Y/;H(861_N)$8OM^\6S'OK>>\=<=
M,TPEZ;U/M=!&^AL?JZ";)05;7TLR4/65O4K#.VNS;@5]#3?)RM&Q 6<,L"**
M+V+TGG:YO0:H=Q:R[;HQO&ZHJ*],MYW>2M+*QR[C&(C!I0)/,UQO;[(Q7 DZ
MVW!M#8O9K3.15@)#PA.KJM3D8R%8K71&"7SZ7DEZ343!$5DB0V;2J:$]ILDX
M.I*=0#=_JX&[E/Q&,U=KX8^K0I,[J?)U:)"AP==T?)E_.WZL4SU9WS4]?6YI
MI)"86?@U.D@I2E8%PG]4I#NBU/L]F]] SN(- JAWMBG]AM<I$-$G8<Y>C*W_
M_)&[;^NNW&\:9Y0H-39^3BX\Z2WZ42^F(0MY,XJUR,C)NI ,_F?)WR#I2X;L
M,&V9F907M]YP*9[4;!5P88S#99!@%4DPE*N*6J[Y\0H\BYQ5Z/6,C^1XR)AZ
M<;EW2?*OTA"EVY')DR" 2TX-0$M'EYSQ5$?'6J][3PP/ JGE)2;L'-[FWT\-
MJOJBPZ)J0]W!4:;?1*N:WJFRPEE.N^4=O*N/O5S$;_A(@I$,*I 7&<0&*>1!
M5H6>1L3\<_<R<(65;E+U]6;.$D[O.*P(H9=[Y?)3H*OSQ ">NI3S%BBAM&(^
MB!432-J;AW-AVQ7Z0M^,/8,;H3^/0UUZ.L:Y!.,OC>RF;%PA"%TJ"5!EX-9.
M<O8QL.Q'; >1/G/#LQUWBO?O0&N+?6[[80'U,J-H 2(\IS130Q?80C056ZW;
ML7=?](U\#A[,#N2S"3/Q*F5/+NVQ)M8$1,GLY#Y?P:V4 6)W_/8F0D.Z!EJ[
M/Z&/BH?1J(&N.@]UU[=&=3+;A7\4Y<Q<H2154C?Y2*%CS!&0'@9*VG(TNIT8
MT2,A5\L/3D7$-";\??RA=D#&@O^X((ICJCR#MD&J]BGV3M&[KTVD7=,AX0DI
M4(4CT&F0,F_T7+Z;JW"2 SXF<6A,5K&'W+OE&1.L??=2KM-&U/VX,>(GWOC\
M[_='N%7&@/J#AX;R[?<WAZ5<,^AL?E;-<'N-I#QV%D0MC^O*CGG%ZSB%ABW@
M+F$T!(CZ/1+L8H7H=^:O"D>,M29^5E-;-K] 0]C&#O<62O)JU 35V< DFR+_
M7Z\<3DAI:W<F'.S0Q;<_?'%V,#.NF';]4?:%-[Z']-,4>"T841Y&!.<*)TS?
M_0#B!E0TUF?$WF57"I3K75_+M!GF/-7-3E3UDPW63Y=,+ST1Z\Q)BA6$;LLV
M%MLF1#U%3A2L*I YXI^D)_HBHP.CDEPB#%*7)%4S'*LNMQ_4"#B_+W.T=-=R
MU'FLU1VK^_XWC:,WJ;8UGGBZ4K4#SZG*1<^(1S4R/A3L8H&U_^I T8MBR<F;
M'H.Y(F )D_W"QI!I5VDU, #P5@3,1BC)\UJM6VF?,IC-PUQ$CG.RU'@(.-RS
M-1L0"ITWXUF X)456Y[#10J0W/&H7_A9@1,MS3D%V1X^,$X;F760-#W]B3^W
MB).]3>=105,BA;??7D?>/R;OH-XU\L8/[GRL#?K[2(%@H>7DH'I]*-&_O=WS
M@^N*9%)[%)6CP%JP#^M0^%@;I,]_ZQW%;%4)DV4T/&X$R<6_CWS_):LLG.>B
MC^<7?MZI@]Z,497MBD'A 5"=3-[DM8BA% 'O[%(A4S+GZ[)&'OJF2O:>KS[[
M')G6SK(54--I&.WA-)<>*Z.CE%K5%F6C-HZK ;.NBWTGH)*#U!OMY3..LTTV
MB?9,\3- D1L?9*K*O979J5QH\[C2OE$C)R&@HR54W/&B*MZ2Y3N?W,%S7>E8
M]LO=0JQ@OL7V-XO-U.-!/T6%_^=6Y,[Y_SVE135.U=MJ>]55^ 9EP=I9R[QE
M^O8,C+5?6K"!R5W.B@HK6.ZEVG$NK:3V:3:%K2P[!GC_8-)(WU1EFC&.M9=/
M(!$@ (;H18K\^V*LEO88'Q\+E.]",]C'UB+HE/[M)DJ*GYF2,N2JHXKL^>8W
MW]YE&&=^0TQOI4[; ^!HPI1SF</J>:T$>G2M&>R9OS;>^].\XNSOL4E&^A>P
M.S&6&^BW]7QU0WV7(8Z/0=)^Z2_=BB#<0?T,^[ TK=0DD8<=P&GI6H?FV=6"
M/JK APL-QE$66P$#OS9^#EN=*8[T!>N.W59J14QBN@BT$HFRR?).[>R?P>G@
M*X]W8(US#7&=VL]VRY_4'QS*H0'WNJ2TQ8BP85>=4X:.^S0T8G4C?>3:O5:/
M+HJ&BO8Q&QSGE[ Z +6K(9E$\++@"]JVKHU O7AL\!FKZ2*.L\]S!*:_%@-1
MXZD6HQ$?VZ+Z/PM"J7)[?$%Q[PVDN>+2CXN[2/,AZD!+M^NH Y/^WE0O8/W7
MK?TI.Z8?5X(+2LC^<,*R0(6/",V5E(/GZ[C[L&+7IPN$^H&^?/-/*71 M'I?
M*G$(%;DKWWY<VGW\3=K1DT\:Y/CK"0[TS[\8I$Y+R-MM,VA <YX5X(G+PL?#
M^ T'W1V]+BW3]T2R=]_9\?)_7$,!S)[TJSS=JM2+6RR,)KH:6E0".J;AW!,6
M0_^QY/E\R%KS/U?R./T /1;[R7RFF7U68L60.&&S<$)7?ZW$,N')J-AOFI7E
MWS25OVE^:;\OC([F4KOHV0QZ+$#'?!:<?=8PR^!0LAFX6J<58&\/UB'D>R7W
MCC(9"*6TVZM_79M/NK%4N:E?>+RW^G+L"%%]PL7;'D62E5;9N>G>XC6>7;/8
M).% OA,&(W4T](O4TI;?^=*="]*WSAFT\8? K5'"UJZ*>QP:T)13)J8@O]P+
MVH)Q#4+"@Y$;\LHK,,I==0LA3[TO>3,1Q2.&L3EF/I84ER%9WEB&M^G!X5;^
MJ5:A  F9;0B NG0;?DQV0>IU]VVP7[ZU*=3I=KRR82IF]4"2;O)'U^-C[!UX
M0-_4+YAO-#**G/#WL+I*.Y:[\D7ME+;W\5_K# QFE(^BH?5W>Z/5U;8LPK_6
M7<B8L!U:4=OS8$34T%P;WS0:4V@LFIY_#X$;8TJG;5C$&)GLZEJ,XV$.8E12
MBN=1C$ZJZ?54NIAD9Q&13VA9SW^FC:)UU8P\K;=_/'@@,:DX4R[*]#-KI-=R
ME<.KHF19KP_O!T*_4$=A/HU6:Q4FR6EFY<#3C$%.8/E;#A5F&2D>D,1B6G$7
M458RG!I_XK;Y>![2]YO&]1,<V3?]"_8]&@E$8T618\F\UV4K,2"(47)B1C*9
M/1$@PK?D%*S!BZB5J?;B%!H^&Y/IA E:-5)]QF0TGY3<Z>4;W#E.'(!U13]&
MNE-N\D;?.B93F"L@;A$)J3VU*PR5@HC0'DW=/QB4*,-/FNB5W6WBQ%A3S827
M]SRSV@6JY'0B5JK $CI =^/"5R<E?4?"-RTDG^S]N%3%;6UI*__B<$,MK+^A
MH;19J.0V$E7J,^E_)=W*IJ/3S17O6]CJ43PJ"-.Z-#W67:LV^.1*K=7S4LJV
MFG.&T.U9E\"R?&\V8*EHI6/V 7ER,+W^%,W(NF51.NC90BM#39)1O-R#+YO5
M[(2  ?FUM7'YTOP22+BU0CJ[#RD_-I>$#M>LF-H8D&UK@O*EB+&]7ZO]>'L/
MX<<Z*0ZV9"Q/=IPEP=B,8J)3QD%;N"4 ]$>BRG*3FVO<B5/GD_I6?(C)\U&#
M1UW714'2_$DHC)4-?5OQ5BL(?LMNO^3?*S?-N]J7M39/<W(?<67K0X"@7J<I
MA>1<F:+5:8=QX^7&-C@<BM=?:4P^=3"7<=)^*UAX$%>[]+W[:])>E5UWT<NS
M/L+578,YWX!HEY_DCV+SPZ@3<[.SITZ/6Q?_'HK6"__LY&^?YX(1_+8$SJ38
M^#J)B06/H>?G*+Q<"D4RE^25'+K:^V9T(]G=_QZK 4E<JKJ!CX&^W;(;=4GL
ML9/C,K]IA+(SGZ[A\G!(8C QHD90,H'(+\0RA>,^*G[3B'N0KZ6D:XG[NV)
ML=!J&OJ>G-S#>/P(2]U]S<V-*BG%K.9+_\>=,!CX3%^7^@YL;*I'"AJ,@,+3
M4.Z4B^+O /U(/\]X=M]8=>@@#O0I%)HQ^OBLMML+J*W\0#Q.(KI5;/C,JFU"
M_#'"T^VQ;/J% OJFKAM[#;9XJK0T7MB\F+YH;!H/:%&ZJ51@;C2CSGB7&;1]
M.]WL@,PAT_/\A!FK^\'L^AR3\H9OOK!WTK+#_S'\7^1S"QQ/O[P3=C?FD\*J
M+6_8J&9739E9CE-91JN8E@)0+_GG9.8C!F '@#8%@%EL/^:(#S=BJ*1N'28
M1G[3_*1LQL_5M\V"&$>0?9EW =][L-/R*P5Y=@\3'@1!N"?R0X=(IVLC# 9A
M"F,#2J.MJ(XJF4DCUVV\4J @1Z(H>?K2? P;I_E)]JNK!8V1AU[YC:^G"N5<
MC/&Q@DXI(J*+FXK1.(*6I.MW+0,;VX-9(-/8C8JHEN3EX;V855KR*U254'<D
MQZ^F2 )K]=?%MQXUR#@NOURFI6!KO^B(CW;>L?3Q8MZ< D-+I9W[\Q*OUQG
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M+U'951 W1DFZ6+M;9;[[#)IH+&M<O,6#+/%5>H+CG)6:WKU?^RQN4LDI:-=
M(5*".IMU;45E><@3K$ :GA?E"^W9[6MTXZDP[7DU,@ M#$N10'7FKIGB;CT7
M&2^#A2FC&)^3"W%642;5C$S0,N>Q>P%Q-<. CZ(G-3#]COI<KQDODE/25$DG
MJ7R+4RS=@_E6Z1#OB]K2T$>*XP*SKA?-0$CH9_$/84AX-CQ26$UF(LS6VL (
MC0%RM>J-4I=T<EY]I]5BCUS5S'A5%"L%$"*%G1@79BVA#O;G('YDW7%CMJVH
MT.R[C#OK/O=+O\9T3O1"[V]OX]R>>F_BN33U=2)9RZSV[Q*ZZ(4UL?7/I*5!
M?'PTE)24C866TH+YM4QE#S59+SDIT)9??#^![OYN=IR(^X"WA/][*#HD* <J
M7C@470VD+XY*)JK]72[,_UTNE/Q=+GB-"HF"5K$+3'=1)OQ=XVC##FBD_'2L
MU("B$_]G&=T^39#-TWVC HD;)E"^,W0<44+<\YB^::.-4IE;_\J>3K%F9:"P
M5UK/; ^)$PUI0V2>^"1.)4\'.I'.@HYL#7GR$Q;90ZK_O>+(U2TT]S#+V,V;
MSX[24)SN3)_2ZQ.Y1TVI,FW56)10@VE?OP89Z"$NU?>3C+1["1MZ+HV<3P (
MG*L5:+0T,768TA+CH?D9SRTZM@TJ?"MM)>CN"F)WA6-P04V- Y/]7U_?/8#T
M'3,Z4%=RN-*^:'MD\6'=%3Y:-+N@,"_Q5L83%E%M(]29BZP4L_MNVP 9CXZ:
MZE0>Q^OBB26Q:X(ZN.XO,CI)$G $JCT& 21@^&<]3QM>YV8OG@;,8%,$[2J:
M&-3_\&=09V]49  \<Q@?@6CWR8/@\$^BFC&@_"R]U98K?-8"^X#&+J'R(%I+
ML_O#E =$O63O-M(=_6+V +@E%F0;]V[Y_O;*\Z1!*?8>IKFXOCB<3)Y!<Z%
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M%O_S@ &C!_% T?SO><+BCVTY>M<%#>.+@+<6]=G<S];INUBPYL31KK3]X%+
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MTP=,5E:Y+"QO\[\?J\!Y(,U!WVY/HP1R+ZTBNH.Z)R)(8/010!>0*ES0[X2
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M)W]&1ORF0?:AWC_Q5.,R_+<#HS.[^^61$DM#GQFHN=LGO<V?,VH)-9TY[/3
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M $Y&S (@CB<@FCDI^@W]1&A_!?U+00.(!1 P>$G%!XOIG&V9W@;D.LCJTFY
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M?71";8Y))3-$0]8G0_UBL$K1TOWCOKPZ]N$V1*<T86R1;%ELW=.GG')]1/!
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M\SY@50S>6ZE%7GIGS7; ZY?#E5_*A62:]7?'A1O4QM=H/!^!2\1,-4%)OM6
M061:I1*1/QX_J74.,U3.$<@P]%_57L:<)-Z ZQKL%$A'^5L4:*U6AHUC>OQ-
M?C"&A@TT[_KIUL#DRDN:@RSU=B<(\X:.'ZOW)%,J4R72N[W(D=SE$?#66.8
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MYJ;XK/_,M?;+/F!\MBTPZNL]2L3^M6F,1QK37K/[]5HAO_:"26JH']>0BTE
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M>AYG X,B([U+@[S.%'BR.G&_!:Y/.L<]9HA(Y8364WVHM&45+5,R(6>E(C9
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M(<_OG^'^9\;COS*7?,AR%C3WWJ3TBQTEYD*"F$B! C64OR@N[-J8>LB*5^B
MLT%>Y"S)FT]3$>>13]%6P12 SLL)G5=DQA^#-T>=.O./Y GWJF0#0UO_9UKR
M_P6'1(6HON]"K2/%Z8*=C=^ >H@ 0 %0\9.9B@G]R%HRF:%%+@.S1FTBP)8W
MV]R";L';5M\K\SF<E\8N:6!- -%9>Z1$TC[*UO_'TR__);\C3'H4RJ5M31YI
M5=W$D",7Z"W[[2@*:_QTF-8W__!"1?!Z.V0 QV'1LRGZN'<G-IF*,!+(2QJ
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MZ=0LL]J@_G>B3JJN/6_BO;Q4$+ VQ^)%D.RB#7+86U#T2ZJ3-WK.P'".8-C
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M/\1=V2 D1K5<LP+J$>WYX76H_"K1^Z-)\!#$ZG"K;[3#.3#W,6"XHW T1YB
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MYL9X)DOK;, TY,;B&Z9U@0"O/,=5U("EZ;ZH!"<$?2ST\#XJC8R<BUK6Q\S
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MHC^XR2I/1I):S&FK5MQQR*1:AVU8",0X1XCTT.UMT');?_?,?MB]O=:RD>I
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M^5?%XRW5^,P*N=-PF1]CP?D;T_I)(B$UC7B*+-?T*&IB4)9'1%H\CMFKR:_
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MW/<4>\#PQ#(37]W?HV>'5 X+D^SSN;QZ@TT(33E=U<2)!X*?GB"F&='5GL*
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MNAK <UUE=[BO!<%ZG QTON[YS-^^#.&W$;LI_F9?,"L:!<0TL:)[6.N@WOF
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MHZ\[9E43 5DS]499#BU<&1^1TXX/!!?\:-XO"^T';T=WAY"[0+^F*%GG59F
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MMV'B;-) Z#O$Y)K&'G,:W8"C$G4K?>M3FDO+$78Y=I4?C]Z+3M0SLI<O3#H
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M6[WB;';HW##0:WZ2?Z$#!1JUD0H'Y =J(KFGQ"<(G9/#U*:$0[1[G8E900E
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MYA$IC$S05AW+W5+W."3R63ZQZW1Z"D&F>][(/'-P[CA3]V0*K3.7L2.30AV
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M>_=8@(V2\2Z^4G3L;$XV_8$ FN W?:>]L2$[HZ!SP%5DB&=O8)J<ARIGS4B
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M/&>5B]X-7(77,(%?51R&F^70#A.H)Z$2:JE;AI:D7$^FFVAU.)7GV(TF\*Q
M#TS;_;/B&(@#41/_2U]\ L).77Q5D%B7;\(-+7V99#SD& DZ(EM5,WO/I7MO
MM9(*W[G 5RLS^VIVJSI>&<-Q4N=>(7 S_E7%@G,<\U)O&/3=(GZ-]&M!79JH
M+WWJ B<+6"H"H.E"J CS]%K;&GPWAEW/?66]HG<2\$G5DR%MD9;LAZ6PWBZO
M:;T)QS)8OZ7\2:2]<:Q:;Z>JQ;W)3?7Z;Z7KD\'^@>3S!C9O:I7B==>IAE6>
M\I2\J>]?.]$(SEYC$_&,.EH[:?UPO#RY.B'3F]SB@3CL_A&=M:B1RJ\7<X>X
MX:+J\6SQF[/T9:XA9)3HOTM-!(<N#$D9;[QY6VAA-Q\+0VF7F1H59"D]7>96
MQ4?I424I8Z=,#Q@$1JH.W G(9Q-7XR%<2]IHUSL9WK9:G@K)%D 0TT942?-H
M309 L&#4*_2QHWQMW^[6_O86U\*?/?W>R"?$I-431Q/Y+H><O_#H0;MI36#D
MA 7P,8.?\^ON00IXCMH?XAD:@YH' O+"UC*7]N&@H\_;'.SI '3NY55DX51<
M@^LFZ'2P^89UHD^(3\#PR?V'38)?$QX^D[YR^3.,.CM0T'N3 C>.'S2==*BG
MT/R&$-;0KC(IT/C0J48!.87%>>%&RNM!E^RVU,@-7--)F\<$, @8_R#L4OD#
M= +O^9A0UBF6 ]@I<2HZ7NO\D*'2#R.D"&>5:ZMCCEQV((+0*3:#R.9\@Y2Q
M#@6;BWXQWJB>6G5[8=>[7W>3^S4K&(0UC,KKYLQEZ;W3YEM-8H&U,=AD7*]R
M26D^$"PQ8 <('!MRLW3'V(($F*!EOR,5Z/K2[ 4UT#6B5+3=^4 9SD9/,.=:
M%41#$J$9.;'" (1ZS/<<6+Q'UQ<\4L[O:9BY=W._1^:^&Y-C?G94.?>QO&.'
M*HT4BN$KD=E$O)/D"_+]KS;1LAC;?F>.GAJGA"PKFZPL>B:'.9'8TP(H#FNK
M;I=I(K[,H>.!GH$U,+O9JSWEH.,WLZ+1"^XM7=8-@[ST.4K#6G@/=)DGKDSD
M!#M?T=48?H]IHP! 1<72G6.V35G8A6Q3YXUTRSR:)^&4?6&T+^IQ_M BY"2G
M\X9DXG*[_=<A&W38PM#+;2X?7UQ>NO<A#KWJU-?[)&LEA!W:,\.8#LDLOTH4
MCU"LHPE5@7"5BZ#6KGLT+QT=3%IRN7U GBF8UE4 0X7\GNF:NK<S.T,,K/>9
ML[<SB%*'16C(U78C^=GKH_'G_!J>/TG8[:J,&?PDY61 Z!/4>1OF-HV% 448
M^5(HVSHIQU_@R97;7V:W.*MO*#W@]JJ"4]*C#!!)R8_D:D^3ZI8>M3F%8YU%
MN>O0W*:H:WG_\)WQCE6.:H^'42T ?E,_>E,F;4K[I*7M]??DV%PNHY2ZQ19&
MGF95P%>,6@A^EVVE%0+)SA[DZ^+#2Q>FJ; 6J,=A=&K,9J;<^>R%X;\/./!,
MY^M2B^_$7A%6W ,;Z)H61 @SU0]R/CA!!6Z.\C9ZN&23#"NBH/Y @Z,6;GD=
M_;&9N/0=&L/PKJ%QQ,!DBS/WH?9@=@)WR< -CV,>*BVORSG' #+[!$:@@,&7
M.*4&N!9!OY6F6\O5[%U2.-Q4?2NW/T/YF09Y!!"1E(UZOB8S3$DV @00-FO(
M/D3B5^=H7B,XA6'IP4L\47MA!;SN[9HAA"I3B%!J]AKH%';9GN_] JB2\@UY
ME+B<OD90UC_)^CSQ=C*,>[WT,YJK*)M0YR%KL,B_%"P#+]J> ^N!E/*_?1N#
M(;7$.[NMIRIW$F?XGQGB 3S-09RN\Z'$_&'G6H H?I^U-)"R 5Q2MU$Z+.2P
M!X6PV(A,4_04U;24>E2[-;NJFC1'D,]QT*O':0!AU\ !/LU%0>K@LV-\=34/
M5SN:RU+N_L:[4YGQ;.9N]%@+@YE>J;DT@\&*Z*5*'9=? %/Z2]'NNII6NPA>
M>R !9&H_R_"YK(13@4KKF-&,+E38%I?VUL2[GL&$WAPLJZ$NQFHR%&*;L/$\
MI#+@5!,#4/4&N-]F<XY'M7^K=:$^2)]"+;S")WE5RN"T6A_9)YNM)$U+M4J.
M<"1KPE<J8+,7, 'CLL]1@G5$*.&-]U4-XLR.=?&5:8-LJT8.E1!IE^*0H*:D
M_SY!5[EH*H@\F9!,F .V,,54FI:#E]5XGVG^)[<)_X9?2INZ\0W2<5^NM:6W
M!I"P6)FG(L7P3R>9WG/"P>+J8'953&MSB%T7-ND8."^*:HT<LC-&APU9<TLK
M>L<<[=RRQSI (_QBR9.\1A3H_,2N2D!'+GD/__N7(/]/!+J_&*K-HL2VBM1R
MS0[&/R!7?>RJP&-7G\ LZO#6PK#Q9H2#F^T[IVT9^KG*B$Z"9OGEDSDA#X@0
MGG/+Q%/K-?9L5^=U&6LMU+FG>FZ X(KY2:+"UH_;MBC#_BC131#H[[40X.@E
MQNG%=LD:\6RP_IC/L#BX_\U G)-F%-39,9KXK%E67B2'S*:!/OAE@"_/*&VG
MF$"K5&.FI5USX LSIW7N$N+,2RD]_G5OJ2=YIKUF+*7=A#Y6W@478-ANJH9"
M2E+^DNE,&/CHR<*WS@:S<$X%CZV;45#\,MMS0-]_2L$OK!;,]/YLA_JNYY1*
MOW]K9DN^>HWBYE1NCGBIN,Q*7H;OM[(=+["25@Y">0X?[_"6/E\, M9_@E,K
MQ'L8O@]D4J"0HLONXY-:L;@\>=?LIM8.=.AZC/SKG_?^_[2PYN\Y$%03S\@C
M''S#G(J5?Q6M!&Q/P1!KXK*KI3\2-G*G]2=!O5J)%2>\-QI\'14?Z"@U,H0N
M"."'IGT1)AIOH%IZ SHZ,2;Z/_BVI;91VZ4CM7U9SR4+4O9"(<;\IWX_4I;/
MX05-(L.<_<"QT[,18S-;J3M!WM=9<$T'V,3;U5$FGBQ%]J4G"C2*Y8:#,UG\
M6U$F'0N8X[-:!4C!G+SGW3Q;=M'6DCIGE)NE@,@#^[CIJ/4YL<+G]Q??S?N-
M-GPKD>3Z"U3][CB=U&E#>(ZN0CI)/!3&JP_96XT*3]IQST+FECQ!EK;)#,)F
M[R*S<[KFF.509BM=WK]DV@+Q1:]/S)@XRHN^A ESOB-LK\>-<!3/A@>457_J
M.N+XU "8?AWQ;&]FD<VNN-G@ JRIOE?6@ZGL%G0L3'M6UD;27M-?5LOLH!>Q
M*O4,=WQMWDE5L6UM(C_(6"MVRB_#/I'-U8M0Z;+LGN:^?$BA-[9Q+_$O$A*A
M@JJMZ617,AUAP(OI?85NC);6Z6]&$DGOTLJUS88@QZ+UA@U,4K-&VHJSP=Z^
M9\<.O7I([C0A(HQ32U$;!P,:I.0GS7F;CK159A+'SC%R,=9SK(T4Z)7X;0&9
MHN\Q8#1]%%JHHK*&'.#/N!=R*M'KR0CPE^MNJ7B-5NK=LQZIL)^:2G_(EE=+
M3@Q"&Z_PJSY+\A9>F9PO09>E*:2M_DB;6_\1@!&Y_D!\41YVFW%S6!7MVPKZ
M"[/5P/WO04-?&W>88T?(1E7G2X8<7=0F[_Z6090U%4]:#0R=,%O02$@$9G;-
MVY:]P_A[E>42YY)!ZMQ"3Y^MO7:1&E3T?[@\XTHQ+F9Y/3*$&1^;LY[]=L8?
MQ/JM2? W3WGJ/=)L\CTX8^\G&::1CLVK<ZGLOVO>MLMF-<JZ\3(FR=GOTHH'
MTAJE<Q_O*A0F%"]6^I,U$+LC$'UZ(LTY8-2G?^MVW=/ <-NZ,R7O)TD?WYAX
M+>AA5PXYJ)>X3*R,;;UJ4AC.G0]CJ'DH<Y^/8-!J7S%@8%<N-*+&*GM<A32H
MI^IOZ$5HBNAQ13P5H;/I.OUOG)R'#X/66KR[W>$9(W&[9-MO;5;3?XG=[]3W
M#(S@:)QSMFEJ9*SDJ(]Z]S'ZT*;>)-9&;^.T:!, &/[A^,S=$,Y:D>Q+=:65
MH?4=:X4F4RI2BBL7$%\!8N<5HYQ,:911Y0\UT@V2V:\2D&_[K&AZ+1^-W!!&
M,UK&MK!GL.B4V5Z))V&E.F+T!CP;=%#I2M3XJHB&FZ=-?VZ__LFP2,Z#9P:-
M89(I,-_W=J)4;Q?">433D72>#H;PT2=/@G_)$)+;\\ITHF&!63;,N>5?J.'*
MC=C4I)B&=#7V>/:*P1NY+K*#4P2?O*'\PI2Y. PC]R$]C9:FBLQK(@[YH+:E
MWZ6[]2EVS&Y0I+QM,^(]&![^DT3/0N3N?;TXGY!5DE7@A8FGX]J5>ML690*S
MH#9EMSGB1HAH5#JGIA7?&/ZVF.KL4B3JR:?R;@[.LV+=W +\]W5<'2IRJ"^,
M]Q_3T@[_95K:7P,T]G_*PWZ2:*&:.0W?J\!GO%FH.\^19DRYW?6"I;[7LK)F
MS\<M)"=I5GKB0LWL3RR5M77PHJAZ5Y\W[X[3]%?@+!P/ ]HIN^JZ+'Z2K/>:
M38,PCYH<ML\L(+V*/TE4!::.+7[!+WX.SEC:$/&/+30]5QF&X9VF&_.+3UFK
MAKLG/I>>RUG$3*)K0E7,!O3^++=G7,E.V6L RI@F9\#R$)6DTY"U!:<MMP+[
MB87Q8,%' RO=V[_,L4<)PYIFCU>K*TV]=D=;S\T+"/8I"4%HW&[%*T12 EU:
MSJ],ZP'$&(UR-4/2&7WI@'#19AFR$)>#GR3B*O7,<>)GJU:^UO4_Z$<3*[^7
M!I3) #&ZCSMK=.^9*G8]-8,8TJ9\WL@*6E?Q2O=+Z#/!YKU<25SVCVCXXTVQ
MM/0IS:4M%P_ZJYF;QKFOEO>J[I:8F0J&[-$40&2@F7=M.O"#U?3Z\ZS+OP[*
MJIMR?EN<5$^VD&GW/3O)51C&54"T?1E ]UF501!-S>K)M^!"M;*^_,\DS_JO
MB4T]U;)D;ED,IOI"1G.AE73!G 4[(7+ 6ZZRI:YMUZ#?4<;FLQ6),5"I1;3T
M>J+:@/6D3)S0?EQADF9=MZXAIM+$<BAD.P5),)H[_I$-%7$+M.U)I'OK9:LE
MI"T>M!6;)P-J4#:]6'=HT)Q[P_%'<LH&<)/0]C4R;MM988KV,;SKF5^"JBX$
MD"$ODTD]<STBP\D_Z^5B_STQ#E@R:' 1YM3BTV,1G8J6U\GIB30,F%(M7!->
M#0/&LEJ^E1WD@<ZLK<* R;P1XNNMG Q&.YB\\F*@P3='H[%>I)J+[_#NXO6A
M9[Z2VMZ)#(:X,_(7ZF*WE%++1VO:8^_L HN1U-&05I[@-D)XE(ODZ J8KTH\
M99O<*$PII/=*1%3+-05XE]]'S^X-XH;KMS67E$/@%@F[E#OXJ)<R?:^G8=\9
M69Y\/AV'''C&$E]4=%>W/=*"8]?4>ITY37Q<[L!.P;/5*7@>K1%Q^[F][Y)0
M]RQKIF+]OW8[QN#)?%9!<JST8L59DOY=+6_G%I]M!(L7DA;B<>")YE_O=E(4
MA1S<JIBD>EF&A9L?5'@\3JZQI,'X*!J;)P_8;7#L4L-TP(MXJNU>!]'Z,BP%
MQ\RP'#:&?NZ>'$.<L&LQ0,Q721_ BV1:?7,!$-"P>  Q!1)WG@YY,*D9-*@+
MB^!^D@Q<RMJS[#:A$K:8KP.>>D'R.._54XR<>3EU4^?'\6=: <1HWXB6%'CU
M ES%B]UY'%>KEC"?S\)8]M8\+(*[82LK\7'J(P/CM,^\8+CS@GX J@757_)N
MR=:7VN0^4_Y]GIH=1 ='.2#6GAZ1]MCEG>RME NWAC '%L,^%%_"RYF=7+2M
MZ61/'N+G,.3A%X"L_W%M*WK*N0R:M67PG=*HID*RV:992L$2UK_#W!SFC/?"
M@ZH+^LJ^^2AF&GB5(&14 8VG03]2>)Y!@LAQM?P,LAQVWWF\ QY\\D*X1!A4
ML&?2\P5Z!(#(V+/UFQFC]ZQX^I>MK^423P!(1!%FDO;$RC^?O4 )4)QO9E<+
M$S\*%-']B#;AZ:Y8GL\41B=HC69;E$Q.$8,)V1$^6LY]'C]L1\Z-<[_TZ_06
MX&,YFM\ [5 9P%17NWU]]AJ(*2G>>E%#,$,O#T]SIN*>O,?O@J(<QPX6F?7/
M%\3M([5R^Q)3G1^XZ4?WI@P)9T_+:.]&"'(/E=ED%K'OBU/'JJ0YOV[8B%WI
M-.%0SF=U?-Z@H>)L[S-A& #?;N:E*OCZ>E[KM]Z72=J!#WN<8#S//ZEKJ!;T
M[.3I3_6R8Y/$$0[DHEP?U2-QWG]$VB/R_M%<;6?'>^#VZ'!?:&QIA[?@_>C%
M1C><]R3F,&10P.4VA[3\O1CRYIU7XH%^1=OP_N?MB-N:HUOR?=\3EWUV.K:Q
M_^&?83_3KE=/D9TF_R3!=@9877K\).EP^$3N^O)DM/V([6!F;;S%2J3W1MM[
M\'OTCN/I#^R;);)KM<LV>R:WH!Q2:$XF:1-@> ^9/SWC;@8<3L?_4.DYC]?<
M<17F.@ZB?6TM::DF/5$RW; #^#.OKR0;,D*X(B_N.Q[P5*[0=Q5'P.P]0SP^
M\5)0HGGU@,D<75!+O/=/$N<L_ALN_()ESH?MZ>+M$310B%;/*UY/:,_S+<]1
MG%H)?-Y\]-?^X]OP^Y\XC&VQ%8+5V0$R$*3EGG\YK0@'FL5)4R+7*%&Z7U+S
MD]W!X ;VS,:5_L$;1_3S HNZ!94ZS770FK3:>VNW4"$7;<G!A[43L2/05IEO
M CR*BZ&J=[+HXCQ1^?%BO$=FU?1B.?E!I8;SA/?(H2_8Y*+;U[#L1G>22)^1
MV:;F89Q,Y>:$YVC,C$ZY^)CSNDM876B#E6JY-L'Z^AEI"WR3&S9\ZC)9J_9J
MSY&65++%J0&@80@1.#T5S;/;FCLXX=)RM;9&B)T^C/KS9'+IG2!76&%DH("K
ML(;YMC:D))BUU4$Y47'NFX-=!:V?YH2YZ4/:*W*F4_P+'8]'JN<9[N@*+&/+
MPI](F\A#'G*3:>W]%!4O;JJ)4'A7P_$.FC]E,L^L*'8'H0HH&XRUFK\*^5K=
M^8U';KSMO4FT5\2>('=CL!"XNGP+ZG$WIYF"!\>; "J>B\5>3JY%F%B3.O#9
M%PT[*Y)%/-6C-3!MGP!?ZEEJ5COC?.5CJVW^8\7UNU"[PIQZSHK]W87[VZX0
MC<MQX,R@:L#SE;VI-ZE\_[+D#X&EF74RVPO>V)"+(!<YXH_4UCLKTH>C"E;O
M ^)XZ4XI_PN2R.T@S/4GB9H7,)3."9L<N>Z_3FY78)2O._12Q%.^G<K"OTG=
MQ1C\8Z?(GA6#_@V6L^ZNQ@PRZ%,]94QDBF^0F'$D%\WITQM#/D5-@8+IYIFA
M81V*W-;6O.-6@F##5@7$]@!4\[O5VQ4:8H:/)M'4("PWH$I3<2Q/M)A,LZYO
M E7,];7O>[@2Q8&*:!GHXOTA>7R+PB5+Q$^2=V-9/;MW*;MVFC.O6QILYD0^
M]V(-;@)O/;[S+5$J&6B09Y**&<Z&\-\OI.9>:RYF7I@J9J3NC:="V/N[BI#,
M==D4AN#CJ!"0K+D&C<M7UI[D(2QTU./6JY!UR!QXIB&/MTT_=!N[?+K/C[<
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MYAKWWLE<;@MHX!=0>/N3Y.8W?^>[:K!.64G4#VGB@5SNZ0O-N@2? SF$GZ7
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M0'I\]*MYWT1T77KAR;),NUEA;X#FGZXOOPQNDKFV&=<"@N8I"7OG+$9BO[J
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M[#W1MY>]QP/0@%1 _#\#(&UC)](\S>G*G?8Z/;:W86:4ADRTM3_:".=4#'&
MWE=YC[H$*0I4H3(C#FOSD%9!%_4JCOJO^&KSP%_I :O.L98;M(#'X"&(-XG9
M'28*SUW+"L'7LM4&(9!VG86?K]GM<+-WSPSIXKMB24-"Z_F3Z/#Y[(8D7W*U
M9L?)*UQ;I:[B)-#DP"OF/>3D"R3GXP'E.UTHCA$:+YK4SA;S/.^5PI:=5XW(
MMXH=,0$@^6@D[/@/#"!=1I%QFEF)S_5\,IO33<(O/BDEIFS*R4I6Q3IZ;5*F
M%V2I8R*K8ZIBEKXHG:<3J$ GN(+;BHU<]"C4T.-75QM2*MG#T%*RI1O4_I);
ME,OD&1;SLTQRRNI@<^]05-.5I@PL->H9?O.M598X&Q=.ZNYCY=<7L[0;D9>3
MB"YKKI"GY)(5W0#9*G/UV\S[3S<H<2F9@Q?;J^, &FO*2BXPF_*9,.>2DSR7
M?M_+M6:A+O'T9BG9OY&C5=RX%@>ED_R1S!C;D:K:*8LM_M'0/L,OE,49B>\0
MDFY,T'2]L(@YXY;Y1&_'[3]*5-)N<K?9+AJQT42+99?6YBF*OKV/IL;"/")X
M_Y1!84F>+$ :K:7E,_8)BP.F)&NUA-F!2@(,);GTPHAZ4R.^V"(>-2U49) '
MC$B>1?5\9\66@XB6&C;^HQ-6B12E<)X=CYIFVDEPDN;VHNUQCN%9AA1: W"I
MO?:@-A#]ILQN9DKKO@KY, \3HH]=7#0U18QYS=<9L6Z4I*R/QC!:)N1*7MS9
MK[O\:A L=MD%. SF]AY*4S+\SE*^Z?/[%LRK.=BJ4OOFC=> O$TPS\W5'F?,
MLN GL,N+X9K ESU' <?2'\MZ74=$GC4/'2WDGME)3C8=2":8:C:TM37FL6O:
MTD*-[36L TF9W U8@]CS)TTH;M.2(HPE76T*+Y'^HTLV5;M"-X+Y+FFO&]KZ
M9")Z X(()ZR]+IY$; +#&A&C'I!Y[7>UQD%J&MYYNM ^1S1B5RY4ULH@F^ '
M,O=-<SK;"O)_X?$67<>L/Y>626V8?3V[3VN29RZBT=A/O!OBS*3 #"%WA[@!
M.H$#K2)BV/NC9)F9=J<,-Q(G0XP3%3+#SK50:/3L*RHM<</BG]YA<0+8.;F3
MSV$"5-SC^A.^;3H%W^,.8I526::\2@QZ28/S02$5LK&M6J-_35AJ(<:S#?_T
M&Y;!WHO)T20&+&V7K"_B)C1L6&-@%0M9K[&0.SFM$Z%GPHA*RHE&1@V$W/#F
MX]6%HF#-8-W-G<:W;66ZL4$1\F9&Z8S":&F0\T^V>=>%IF&Q:,),N70Z7NK8
M!M+3?9)WM[@D1]C+D(TK!EBS\E+@PUS\I#?>?*&=?[B0,&2AOF#;4*QY0'6,
M/(D>)GLKB+[:WWXXI1.$-6<=P9HA&VD=$GC8-$9PT^LK$M,G%ZD#GHF5=&N'
M*2Y2B\=H&*[Z73/9P8=Q/_OYI.EBY#I.N1U"LXU;$-'0 RJYU^Z_7C I</YN
M?]J:.]2PDXT'']A;.\A8JED5CDRTH$QZW%J1S#%FM!Z[L0NEIP\ 0YF$;5]T
MH6KR&E+MH26F>6_J0ZG!:\,X.) N=9OLV]&V^$+?"NOD:(E'_D:K*A%C8S9Z
M&PX F!@[D)ES@_8PZ%1W0B:K$0]KLS/DH:&CX^?KA52$N'Z2A46CET$%5&V%
M7]T5%&><X];ZZE\^6NC+:=<WZG@L6U5Y]*-]B]?W7\SM=_=Z$=5(/.[^B99&
MUEME1G#12MA G9MVHY6>0L0S_D>@20L<0TV<1;*>%G2X(*:JC#[B5,9C_?>M
MDPO//[_V>1[.6)Y(MS4.#;%R?^3]REU=A(7.CRV&>7&*. :RS]X,.KON[#J/
M]=?$*E2+CFK5)^I659I+J5BFO+9O(CZO5)VSC":%<,U-X3F45LVDD!:-LMNQ
M6?Q=^@E#QG(_1 $K'CCX3^#][/W/:/FYQ?U<O;<N=G],!&IW5TCS5S0P& U'
MQSF4]XOQ")98#W%\&>I!S1DNANLH(YYF#3[<Q/*P@-3"2:.5F=+YA^GR+W &
MX/B9FE2A >;M3]N572T"]40L59= R2FSMUR-CERWMNMC[V43^; UG7:>&G!Y
MJ>CNNGJM.S-B23ZI')GE)_@SA5,3U3B+$$K'YOO]5"_I@ A &AMQU\E\+2_]
MQ*1'B23<^<UIB_[/C99K?[W3N"9?6!)J0DV<2-S!ZLC[^5KH0^E/OB"?=1YJ
MNPBO2_UR$A@RJ$W1GYF@M9^/%TLK59[\#FB-&\=PRW3N=0ID"OH'/H DSZ:E
M0^?SOF4M.Y\<5JH0LV8S?QW\O07N1F'U$;0\\B8+,0,9,:_+=U8M[.]9@TOY
M< /([P4+'9;Q<VLWG[YL>K$2"/#V!U1-1=L2L;-?^">NES4#"N:FMN?Z#A67
M#(EC33UN8+Y1_57LV_YMSE:Q_;DA#OV^?H(@:YG]IIF)FGY/'AE^2P4A+Z09
M]XP0<Q5,%RRX(M/LXK"FH0\(Y)1770S:<[T6_HB0/YM4C%^?0?H&Q&A\:%.B
MTS(N/19.H'5GC4@SX_C)-BAZ[C/X9025CEQV3S4YJ-Q\Q@.!&SLK&UK3&<DI
MZ\<3#"M;)H(MN;%NRU"OG(.)@/F/B9#@12BK2:/=5E,@LK%[FEGG5$K(8O%2
M6Z<MFA9:)0[5L^8? /17PS-)1U2CA-$VH()_3J\ L/W/V.;9&&,@7*V78 J4
M@[9 OXJ(]4A6]1<@[3(I@F%P)<K0)9U%KP]V$TPA''FRI!D?Q4V _*/"(?;*
M?J9\H62R/ILQA!'S'\SN"RV(T_V7//>>[L^/5ZG9^8&D!(D)7Z*RX6-U)!=I
M8W%+Q3&Q@NKNTS5=R<<&-;X46Z0DZP&%A,D1I65V0AQ=W\X?YK6%:G[0453;
M0^)@[S,.58_YL86]EFGK1P)]Z*82RX3W+D7EG-MB,]<4:I,GO;IMVSS6\IJ$
M7(N'+W9V:UN'=LK*KX-?(P5VYQ$4]@&-S*UVM87UX6#$'!<16KSF3D:?)BR?
M.'&4I+PN!2W4EU2NT?YOJ"I*P9S@&L:$F2J5:ZH7GNF#@5\).<PAU-8Y_VZY
MM_^=W3L7)-^#9JN3RBT&X2(SJT+0!QU1HH;4H0J/X79_S*-!5Q!$^S-O:;EV
M?[X/:-Y4B_VML(O82/JXP?#C#4G:$(8]E4!!/7UO!/:^_\5[]WHYGM^W/).5
MO)H 2./PI8K5;\K[QD\+Y;K$RF3!>+I0G%"J;WG3B8^SQIY'=MX= O+38&X
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M9Z00J\C4U=CIM VV*TI0;GI8*=Z!#:IRK,3\BC%LF5K *I@N9Z*&Q3JMEY[
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M@/6L9FW&*X"'+*SLX*@2ACCA>Z]BP.#7:Q>"C57+YI/R/$\SD\L??7AO).M
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M9O.E6OL3N/<G<KU=32>-*(I2=!W&SD>7,;S85I1<@Z%7_TTQK2+#(H4QDX.
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MJ_6@KZ2&W I?NZ7WPTH^SK@75U2U=P44=RH^HW7BP6X5*1P?N/GJ K3$]4E
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M)8K?ZH^OJ)4\.W-Q8+FR@QB.^=<8@=TCH9)[=@.60>EC6V=2%A4^33%!"Y@
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M5K'J%KKH&>BEVVV=H-+CQ/,[-=VXF\6"G4M'\6WYEB,%#GZU:2)"/Z*S@O:
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MA/R<_E]02P$"% ,4    " !J@:-64"T/RHQE P#7J2\ $0
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M+3(P,C,P,S,Q7VQA8BYX;6Q02P$"% ,4    " !J@:-6#RG!J==*  #F[04
M%0              @ &D8@0 8V5R92TR,#(S,#,S,5]P<F4N>&UL4$L! A0#
M%     @ :H&C5@_\ WE1(P  /5@!  \              ( !KJT$ &-E<F4M
M97@Q,%\Q+FAT;5!+ 0(4 Q0    ( &J!HU;00);R[P@  -5)   /
M      "  2S1! !C97)E+65X,S%?,2YH=&U02P$"% ,4    " !J@:-6W@3I
MZNH(  #'20  #P              @ %(V@0 8V5R92UE>#,Q7S(N:'1M4$L!
M A0#%     @ :H&C5@L]F2G.!   T"D   \              ( !7^,$ &-E
M<F4M97@S,E\Q+FAT;5!+ 0(4 Q0    ( &J!HU;VNTJ>S 0  -8I   /
M          "  5KH! !C97)E+65X,S)?,BYH=&U02P$"% ,4    " !J@:-6
MEI&HP(FE%@!DH1\ $0              @ %3[00 :6UG,S,P,C<U-#1?,"YJ
8<&=02P4&      P # #Z @  "Y,;

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
